v1	geneId	geneSymbol	DSI	DPI	diseaseId	diseaseName	diseaseType	diseaseClass	diseaseSemanticType	score	EI	YearInitial	YearFinal	NofPmids	NofSnps	source
7	2	A2M	0.529	0.769	C2239176	Livercarcinoma	disease	C06;C04	NeoplasticProcess	0.51	1	2004	2004	1	0	CTD_human
76	16	AARS1	0.647	0.462	C2750090	Charcot-Marie-ToothDisease,Axonal,Type2n	disease	C16;C10	DiseaseorSyndrome	0.71	1	2010	2019	5	3	CTD_human;GENOMICS_ENGLAND;UNIPROT
77	16	AARS1	0.647	0.462	C4225361	EPILEPTICENCEPHALOPATHY,EARLYINFANTILE,29	disease		DiseaseorSyndrome	0.7	1	2015	2017	2	4	CTD_human;GENOMICS_ENGLAND;UNIPROT
100	18	ABAT	0.628	0.538	C0277839	HoffmansReflex	phenotype	C23;C10	Finding	0.30	1	1999	1999	1	0	CTD_human
val	18	ABAT	0.628	0.538	C0277850	Reflex,Pendular	phenotype	C23;C10	Finding	0.30	1	1999	1999	1	0	CTD_human
val	18	ABAT	0.628	0.538	C0278211	Reflex,Corneal,Absent	phenotype	C23;C10	Finding	0.30	1	1999	1999	1	0	CTD_human
val	18	ABAT	0.628	0.538	C0342708	Gammaaminobutyricacidtransaminasedeficiency	disease	C16;C18	DiseaseorSyndrome	0.70	1	1998	2019	5	8	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
val	18	ABAT	0.628	0.538	C0422850	Seizures,Somatosensory	phenotype	C23;C10	PathologicFunction	0.30	1	1999	1999	1	0	CTD_human
val	18	ABAT	0.628	0.538	C0422852	Seizures,Auditory	phenotype	C23;C10	PathologicFunction	0.30	1	1999	1999	1	0	CTD_human
val	18	ABAT	0.628	0.538	C0422853	Olfactoryseizure	phenotype	C23;C10	DiseaseorSyndrome	0.30	1	1999	1999	1	0	CTD_human
val	18	ABAT	0.628	0.538	C0422854	Gustatoryseizure	phenotype	C23;C10	SignorSymptom	0.30	1	1999	1999	1	0	CTD_human
val	18	ABAT	0.628	0.538	C0422855	Vertiginousseizure	phenotype	C23;C10	DiseaseorSyndrome	0.30	1	1999	1999	1	0	CTD_human
val	18	ABAT	0.628	0.538	C0424230	Motorretardation	phenotype	C23;C10;F01	Finding	0.40	1	1999	1999	1	0	CTD_human
val	18	ABAT	0.628	0.538	C0424605	Developmentaldelay(disorder)	phenotype	F03	MentalorBehavioralDysfunction	0.30	1	2016	2016	1	0	GENOMICS_ENGLAND
val	18	ABAT	0.628	0.538	C0427201	FloppyMuscles	phenotype	C23;C10	SignorSymptom	0.30	1	1999	1999	1	0	CTD_human
val	18	ABAT	0.628	0.538	C0427202	MuscleToneAtonic	phenotype	C23;C10	SignorSymptom	0.30	1	1999	1999	1	0	CTD_human
val	18	ABAT	0.628	0.538	C0494475	Tonic-clonicseizures	disease	C23;C10	DiseaseorSyndrome	0.30	1	1999	1999	1	0	CTD_human
val	18	ABAT	0.628	0.538	C0522345	Reflex,Acoustic,Abnormal	phenotype	C23;C10	Finding	0.30	1	1999	1999	1	0	CTD_human
val	18	ABAT	0.628	0.538	C0557874	Globaldevelopmentaldelay	disease		MentalorBehavioralDysfunction	0.40	1	2016	2016	1	0	GENOMICS_ENGLAND
val	18	ABAT	0.628	0.538	C0558845	Reflex,Ankle,Absent	phenotype	C23;C10	Finding	0.30	1	1999	1999	1	0	CTD_human
val	18	ABAT	0.628	0.538	C0558846	Reflex,Triceps,Absent	phenotype	C23;C10	Finding	0.30	1	1999	1999	1	0	CTD_human
val	18	ABAT	0.628	0.538	C0558847	Reflex,Biceps,Absent	phenotype	C23;C10	Finding	0.30	1	1999	1999	1	0	CTD_human
val	18	ABAT	0.628	0.538	C0576612	Reflex,Anal,Absent	phenotype	C23;C10	Finding	0.30	1	1999	1999	1	0	CTD_human
val	18	ABAT	0.628	0.538	C0743002	AbnormalDeepTendonReflex	phenotype	C23;C10	Finding	0.30	1	1999	1999	1	0	CTD_human
val	18	ABAT	0.628	0.538	C0751056	Non-epilepticconvulsion	phenotype	C23;C10	SignorSymptom	0.30	1	1999	1999	1	0	CTD_human
val	18	ABAT	0.628	0.538	C0751110	SingleSeizure	disease	C23;C10	DiseaseorSyndrome	0.30	1	1999	1999	1	0	CTD_human
val	18	ABAT	0.628	0.538	C0751123	AtonicAbsenceSeizures	phenotype	C23;C10	DiseaseorSyndrome	0.30	1	1999	1999	1	0	CTD_human
val	18	ABAT	0.628	0.538	C0751330	UnilateralHypotonia	phenotype	C23;C10	SignorSymptom	0.30	1	1999	1999	1	0	CTD_human
val	18	ABAT	0.628	0.538	C0751456	DevelopmentalPsychomotorDisorders	group	C23;C10;F01	MentalorBehavioralDysfunction	0.30	1	1999	1999	1	0	CTD_human
val	18	ABAT	0.628	0.538	C0751468	BulbocavernosusReflex,Decreased	phenotype	C23;C10	Finding	0.30	1	1999	1999	1	0	CTD_human
val	18	ABAT	0.628	0.538	C0751469	BulbocavernoususReflexAbsent	phenotype	C23;C10	Finding	0.30	1	1999	1999	1	0	CTD_human
val	18	ABAT	0.628	0.538	C0751470	Palmo-MentalReflex	phenotype	C23;C10	Finding	0.30	1	1999	1999	1	0	CTD_human
val	18	ABAT	0.628	0.538	C0751471	Reflex,Anal,Decreased	phenotype	C23;C10	Finding	0.30	1	1999	1999	1	0	CTD_human
val	18	ABAT	0.628	0.538	C0751472	Reflex,Ankle,Abnormal	phenotype	C23;C10	Finding	0.30	1	1999	1999	1	0	CTD_human
val	18	ABAT	0.628	0.538	C0751473	Reflex,Ankle,Decreased	phenotype	C23;C10	Finding	0.30	1	1999	1999	1	0	CTD_human
val	18	ABAT	0.628	0.538	C0751474	Reflex,Biceps,Abnormal	phenotype	C23;C10	Finding	0.30	1	1999	1999	1	0	CTD_human
val	18	ABAT	0.628	0.538	C0751475	Reflex,Biceps,Decreased	phenotype	C23;C10	Finding	0.30	1	1999	1999	1	0	CTD_human
val	18	ABAT	0.628	0.538	C0751476	Reflex,Gag,Decreased	phenotype	C23;C10	Finding	0.30	1	1999	1999	1	0	CTD_human
val	18	ABAT	0.628	0.538	C0751477	Reflex,Knee,Abnormal	phenotype	C23;C10	Finding	0.30	1	1999	1999	1	0	CTD_human
val	18	ABAT	0.628	0.538	C0751478	Reflex,Knee,Decreased	phenotype	C23;C10	Finding	0.30	1	1999	1999	1	0	CTD_human
val	18	ABAT	0.628	0.538	C0751479	Reflex,Moro,Asymmetric	phenotype	C23;C10	Finding	0.30	1	1999	1999	1	0	CTD_human
val	18	ABAT	0.628	0.538	C0751480	Reflex,Triceps,Abnormal	phenotype	C23;C10	Finding	0.30	1	1999	1999	1	0	CTD_human
val	18	ABAT	0.628	0.538	C0751481	Reflex,Triceps,Decreased	phenotype	C23;C10	Finding	0.30	1	1999	1999	1	0	CTD_human
val	18	ABAT	0.628	0.538	C0751494	ConvulsiveSeizures	phenotype	C23;C10	SignorSymptom	0.30	1	1999	1999	1	0	CTD_human
val	18	ABAT	0.628	0.538	C0751495	Seizures,Focal	phenotype	C23;C10	DiseaseorSyndrome	0.30	1	1999	1999	1	0	CTD_human
val	18	ABAT	0.628	0.538	C0751496	Seizures,Sensory	phenotype	C23;C10	SignorSymptom	0.30	1	1999	1999	1	0	CTD_human
val	18	ABAT	0.628	0.538	C2267233	NeonatalHypotonia	disease	C23;C10	DiseaseorSyndrome	0.30	1	1999	1999	1	0	CTD_human
val	18	ABAT	0.628	0.538	C3495874	NonepilepticSeizures	phenotype	C23;C10	DiseaseorSyndrome	0.30	1	1999	1999	1	0	CTD_human
val	18	ABAT	0.628	0.538	C4048158	Convulsions	phenotype	C23;C10	SignorSymptom	0.30	1	1999	1999	1	0	CTD_human
val	18	ABAT	0.628	0.538	C4316903	AbsenceSeizures	phenotype	C23;C10	DiseaseorSyndrome	0.30	1	1999	1999	1	0	CTD_human
val	18	ABAT	0.628	0.538	C4317109	EpilepticSeizures	phenotype	C23;C10	DiseaseorSyndrome	0.30	1	1999	1999	1	0	CTD_human
val	18	ABAT	0.628	0.538	C4317123	MyoclonicSeizures	phenotype	C23;C10	SignorSymptom	0.30	1	1999	1999	1	0	CTD_human
val	18	ABAT	0.628	0.538	C4505436	GeneralizedAbsenceSeizures	phenotype	C23;C10	DiseaseorSyndrome	0.30	1	1999	1999	1	0	CTD_human
val	19	ABCA1	0.467	0.846	C0004153	Atherosclerosis	disease	C14	DiseaseorSyndrome	0.40	0.992	2000	2020	1	0	CTD_human
val	19	ABCA1	0.467	0.846	C0009402	ColorectalCarcinoma	disease	C06;C04	NeoplasticProcess	0.52	1	2012	2018	1	1	CTD_human;UNIPROT
val	19	ABCA1	0.467	0.846	C0009404	ColorectalNeoplasms	group	C06;C04	NeoplasticProcess	0.30	1	2012	2012	1	0	CTD_human
val	19	ABCA1	0.467	0.846	C0020443	Hypercholesterolemia	disease	C18	DiseaseorSyndrome	0.55	1	2002	2017	1	0	CTD_human;GENOMICS_ENGLAND
val	19	ABCA1	0.467	0.846	C0020445	Hypercholesterolemia,Familial	disease	C16;C18	DiseaseorSyndrome	0.33	1	2003	2019	1	0	CTD_human
val	19	ABCA1	0.467	0.846	C0022661	KidneyFailure,Chronic	disease	C13;C12	DiseaseorSyndrome	0.30	1	2010	2010	1	0	CTD_human
val	19	ABCA1	0.467	0.846	C0036341	Schizophrenia	disease	F03	MentalorBehavioralDysfunction	0.31	1	2011	2011	1	0	PSYGENET
val	19	ABCA1	0.467	0.846	C0039292	TangierDisease	disease	C16;C18;C10	DiseaseorSyndrome	1.00	0.991	1999	2019	23	24	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
val	19	ABCA1	0.467	0.846	C0342898	ApolipoproteinA-Ideficiency	phenotype	C16;C18	PathologicFunction	0.30	1	2004	2012	2	0	ORPHANET
val	19	ABCA1	0.467	0.846	C0473527	Hypoalphalipoproteinemias	disease	C16;C18	DiseaseorSyndrome	0.40	1	2002	2020	0	0	CTD_human
val	19	ABCA1	0.467	0.846	C0745103	HyperlipoproteinemiaTypeIIa	disease	C16;C18	DiseaseorSyndrome	0.52	1	2005	2019	1	0	CTD_human;GENOMICS_ENGLAND
val	19	ABCA1	0.467	0.846	C0751544	TangierDiseaseNeuropathy	disease	C16;C18;C10	DiseaseorSyndrome	0.30	1	1999	2007	3	0	CTD_human
val	19	ABCA1	0.467	0.846	C1563937	Atherogenesis	phenotype	C14	PathologicFunction	0.30	1	2011	2011	1	0	CTD_human
val	19	ABCA1	0.467	0.846	C1704417	HyperlipoproteinemiaTypeIIb	disease	C16;C18	DiseaseorSyndrome	0.30	1	2005	2005	1	0	CTD_human
val	19	ABCA1	0.467	0.846	C1704429	Hypoalphalipoproteinemia,Familial	disease	C16;C18	DiseaseorSyndrome	0.80	0.972	1999	2017	9	6	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
val	19	ABCA1	0.467	0.846	C2931838	FamilialHDLdeficiency	disease	C16;C18	DiseaseorSyndrome	0.40	1	1999	2017	2	0	CTD_human
val	19	ABCA1	0.467	0.846	C3711531	HdlDeficiency,Type2	disease	C16;C18	DiseaseorSyndrome	0.30	1	1999	2001	2	0	CTD_human
val	19	ABCA1	0.467	0.846	C4721453	PeripheralNervousSystemDiseases	group	C10	DiseaseorSyndrome	0.30	1	2011	2011	1	0	CTD_human
val	21	ABCA3	0.592	0.615	C0006142	Malignantneoplasmofbreast	disease	C04;C17	NeoplasticProcess	0.30				0	0	UNIPROT
val	21	ABCA3	0.592	0.615	C0009402	ColorectalCarcinoma	disease	C06;C04	NeoplasticProcess	0.30	1	2012	2012	1	0	CTD_human
val	21	ABCA3	0.592	0.615	C0009404	ColorectalNeoplasms	group	C06;C04	NeoplasticProcess	0.30	1	2012	2012	1	0	CTD_human
val	21	ABCA3	0.592	0.615	C0013990	Pathologicalaccumulationofairintissues	phenotype	C23	PathologicFunction	0.30	1	2016	2016	1	0	CTD_human
val	21	ABCA3	0.592	0.615	C0020192	HyalineMembraneDisease	disease	C16;C08	DiseaseorSyndrome	0.30	1	2017	2017	1	0	ORPHANET
val	21	ABCA3	0.592	0.615	C0020542	PulmonaryHypertension	phenotype	C08	PathologicFunction	0.30	1	2016	2016	1	0	CTD_human
val	21	ABCA3	0.592	0.615	C0034069	PulmonaryFibrosis	disease	C08	DiseaseorSyndrome	0.42	1	2014	2016	1	0	CTD_human
val	21	ABCA3	0.592	0.615	C0035220	RespiratoryDistressSyndrome,Newborn	disease	C16;C08	DiseaseorSyndrome	0.40	1	2006	2018	1	0	ORPHANET
val	21	ABCA3	0.592	0.615	C0085786	Hamman-Richsyndrome	disease	C23;C01;C08	DiseaseorSyndrome	0.40	1	2005	2014	1	2	ORPHANET
val	21	ABCA3	0.592	0.615	C0852283	RespiratoryDistressSyndrome	disease		DiseaseorSyndrome	0.40	1	2006	2018	1	0	ORPHANET
val	21	ABCA3	0.592	0.615	C1800706	IdiopathicPulmonaryFibrosis	disease	C08	DiseaseorSyndrome	0.32	1	2008	2017	1	0	ORPHANET
val	21	ABCA3	0.592	0.615	C1861829	Cataractmicrocorneasyndrome	disease	C11	DiseaseorSyndrome	0.31	1	2014	2014	1	0	GENOMICS_ENGLAND
val	21	ABCA3	0.592	0.615	C1970456	SurfactantMetabolismDysfunction,Pulmonary,3	disease	C08	DiseaseorSyndrome	0.70	1	2004	2018	4	8	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
val	21	ABCA3	0.592	0.615	C4721507	Alveolitis,Fibrosing	disease	C08	DiseaseorSyndrome	0.30	1	2016	2016	1	0	CTD_human
val	22	ABCB7	0.678	0.385	C0002896	Sideroblasticanemia	disease	C15	DiseaseorSyndrome	0.43	1	2001	2016	2	0	CTD_human
val	22	ABCB7	0.678	0.385	C0004134	Ataxia	phenotype	C23;C10	SignorSymptom	0.43	1	2000	2016	1	0	CTD_human
val	22	ABCB7	0.678	0.385	C0240991	Ataxia,Sensory	phenotype	C23;C10	SignorSymptom	0.30	1	2006	2006	1	0	CTD_human
val	22	ABCB7	0.678	0.385	C0278161	Ataxia,Motor	phenotype	C23;C10	Finding	0.30	1	2006	2006	1	0	CTD_human
val	22	ABCB7	0.678	0.385	C0427190	Ataxia,Truncal	phenotype	C23;C10	SignorSymptom	0.30	1	2006	2006	1	0	CTD_human
val	22	ABCB7	0.678	0.385	C0520966	Abnormalcoordination	phenotype	C23;C10	Finding	0.30	1	2006	2006	1	0	CTD_human
val	22	ABCB7	0.678	0.385	C0750937	Ataxia,Appendicular	phenotype	C23;C10	Finding	0.30	1	2006	2006	1	0	CTD_human
val	22	ABCB7	0.678	0.385	C0750940	Tremor,Rubral	disease	C23;C10	DiseaseorSyndrome	0.30	1	2006	2006	1	0	CTD_human
val	22	ABCB7	0.678	0.385	C1845028	ANEMIA,SIDEROBLASTIC,ANDSPINOCEREBELLARATAXIA	disease	C16;C10;C15	DiseaseorSyndrome	0.74	1	1999	2018	6	5	CTD_human;GENOMICS_ENGLAND;UNIPROT
val	23	ABCF1	0.674	0.538	C0020517	Hypersensitivity	group	C20	PathologicFunction	0.30	1	2011	2011	1	0	CTD_human
val	23	ABCF1	0.674	0.538	C0032285	Pneumonia	disease	C01;C08	DiseaseorSyndrome	0.30	1	2011	2011	1	0	CTD_human
val	23	ABCF1	0.674	0.538	C0032300	LobarPneumonia	disease	C01;C08	DiseaseorSyndrome	0.30	1	2011	2011	1	0	CTD_human
val	23	ABCF1	0.674	0.538	C0235874	DiseaseExacerbation	phenotype	C23	Finding	0.30	1	2012	2012	1	0	CTD_human
val	23	ABCF1	0.674	0.538	C0887898	ExperimentalLungInflammation	disease	C01;C08	ExperimentalModelofDisease	0.30	1	2011	2011	1	0	CTD_human
val	23	ABCF1	0.674	0.538	C1527304	AllergicReaction	phenotype	C20	PathologicFunction	0.30	1	2011	2011	1	0	CTD_human
val	23	ABCF1	0.674	0.538	C3714636	Pneumonitis	disease	C01;C08	DiseaseorSyndrome	0.30	1	2011	2011	1	0	CTD_human
val	24	ABCA4	0.493	0.769	C0006142	Malignantneoplasmofbreast	disease	C04;C17	NeoplasticProcess	0.33	1	2001	2019	0	1	UNIPROT
val	24	ABCA4	0.493	0.769	C0008924	Cleftupperlip	disease	C16;C07	CongenitalAbnormality	0.41	0.75	2010	2017	1	11	CTD_human
val	24	ABCA4	0.493	0.769	C0009402	ColorectalCarcinoma	disease	C06;C04	NeoplasticProcess	0.32	1	2012	2018	1	0	CTD_human
val	24	ABCA4	0.493	0.769	C0009404	ColorectalNeoplasms	group	C06;C04	NeoplasticProcess	0.30	1	2012	2012	1	0	CTD_human
val	24	ABCA4	0.493	0.769	C0015397	Disorderofeye	group	C11	DiseaseorSyndrome	0.34	1	2000	2015	0	0	GENOMICS_ENGLAND
val	24	ABCA4	0.493	0.769	C0035334	RetinitisPigmentosa	disease	C16;C11	DiseaseorSyndrome	0.70	0.974	1998	2019	1	19	CTD_human;GENOMICS_ENGLAND
val	24	ABCA4	0.493	0.769	C0242383	Agerelatedmaculardegeneration	disease	C11	DiseaseorSyndrome	0.70	0.957	1997	2019	1	0	CTD_human;GENOMICS_ENGLAND
val	24	ABCA4	0.493	0.769	C0271093	Stargardtsdisease	phenotype		DiseaseorSyndrome	1	0.995	1997	2020	1	12	CTD_human;GENOMICS_ENGLAND;ORPHANET
102	24	ABCA4	0.493	0.769	C1855465	STARGARDTDISEASE1(disorder)	disease		DiseaseorSyndrome	1	0.978	1997	2020	21	306	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
103	24	ABCA4	0.493	0.769	C1858080	RetinalDystrophy,EarlyOnsetSevere	disease	C16;C11	DiseaseorSyndrome	0.6	1	1999	2018	0	2	GENOMICS_ENGLAND
104	24	ABCA4	0.493	0.769	C1858806	CONE-RODDYSTROPHY3(disorder)	disease	C16;C11	DiseaseorSyndrome	0.9	1	1998	2018	3	53	CTD_human;GENOMICS_ENGLAND;UNIPROT
105	24	ABCA4	0.493	0.769	C1866422	RETINITISPIGMENTOSA19	disease	C16;C11	DiseaseorSyndrome	0.8	1	1999	2017	0	22	CTD_human;GENOMICS_ENGLAND
107	24	ABCA4	0.493	0.769	C3495438	MacularDegeneration,Age-Related,2	disease	C11	DiseaseorSyndrome	0.7	1	1997	2009	2	26	CTD_human;GENOMICS_ENGLAND;UNIPROT
119	25	ABL1	0.432	0.923	C0023473	MyeloidLeukemia,Chronic	disease	C04;C15	NeoplasticProcess	0.8	0.983	1982	2020	3	21	CGI;CTD_human;ORPHANET
141	25	ABL1	0.432	0.923	C1961099	PrecursorT-CellLymphoblasticLeukemia-Lymphoma	disease	C04;C20;C15	NeoplasticProcess	0.6	0.96	1998	2019	1	0	CGI;ORPHANET
142	25	ABL1	0.432	0.923	C1961102	PrecursorCellLymphoblasticLeukemiaLymphoma	disease	C04;C20;C15	NeoplasticProcess	0.6	0.991	1987	2020	2	0	CGI;CTD_human
143	25	ABL1	0.432	0.923	C4539857	CONGENITALHEARTDEFECTSANDSKELETALMALFORMATIONSSYNDROME	disease		DiseaseorSyndrome	0.6	1	2017	2017	1	2	GENOMICS_ENGLAND;UNIPROT
187	34	ACADM	0.638	0.462	C0220710	Medium-chainacyl-coenzymeAdehydrogenasedeficiency	disease	C16;C18	DiseaseorSyndrome	1	0.991	1983	2019	24	107	CLINGEN;CTD_human;GENOMICS_ENGLAND;UNIPROT
194	35	ACADS	0.663	0.538	C0342783	Deficiencyofbutyryl-CoAdehydrogenase	disease	C16;C18	DiseaseorSyndrome	1	1	1989	2018	11	41	CLINGEN;CTD_human;GENOMICS_ENGLAND;UNIPROT
198	36	ACADSB	0.691	0.5	C1864912	2-Methylbutyryl-CoADehydrogenaseDeficiency	disease	C16;C18	DiseaseorSyndrome	0.7	1	2000	2016	8	4	CLINGEN;CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
206	37	ACADVL	0.653	0.654	C3887523	Verylongchainacyl-CoAdehydrogenasedeficiency	disease	C16;C18;C05;C10;C15	DiseaseorSyndrome	1	0.989	1985	2020	15	116	CLINGEN;CTD_human;GENOMICS_ENGLAND;UNIPROT
229	38	ACAT1	0.538	0.692	C1536500	Deficiencyofacetyl-CoAacetyltransferase	disease	C16;C18	DiseaseorSyndrome	0.8	1	1979	2019	12	29	CLINGEN;CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
290	50	ACO2	0.619	0.654	C3281192	INFANTILECEREBELLAR-RETINALDEGENERATION	disease		DiseaseorSyndrome	0.74	1	2012	2019	2	2	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
291	50	ACO2	0.619	0.654	C4225384	OPTICATROPHY9	disease		DiseaseorSyndrome	0.7	1	2012	2014	2	1	CTD_human;GENOMICS_ENGLAND;UNIPROT
295	51	ACOX1	0.61	0.731	C1849678	PeroxisomalACYL-COAoxidasedeficiency	disease	C16;C18;C10;C19	DiseaseorSyndrome	0.92	1	1994	2016	7	10	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
304	54	ACP5	0.561	0.731	C0432222	Spondyloenchondrodysplasia	disease	C16;C05;C20	DiseaseorSyndrome	0.57	1	2011	2018	2	0	CTD_human;ORPHANET
306	54	ACP5	0.561	0.731	C1842763	SPONDYLOENCHONDRODYSPLASIAWITHIMMUNEDYSREGULATION	disease	C16;C05;C20	DiseaseorSyndrome	0.72	1	1958	2018	4	0	CTD_human;GENOMICS_ENGLAND;UNIPROT
314	58	ACTA1	0.54	0.769	C0007194	HypertrophicCardiomyopathy	disease	C14	DiseaseorSyndrome	0.53	1	2001	2013	4	0	CLINGEN;GENOMICS_ENGLAND
323	58	ACTA1	0.54	0.769	C0546264	CongenitalFiberTypeDisproportion	disease	C05;C10	CongenitalAbnormality	0.74	1	1999	2010	5	7	CTD_human;GENOMICS_ENGLAND;UNIPROT
325	58	ACTA1	0.54	0.769	C1834339	Myopathy,Actin,Congenital,withExcessofThinMyofilaments	disease	C05;C10	DiseaseorSyndrome	0.6	1	2009	2011	1	1	GENOMICS_ENGLAND
327	58	ACTA1	0.54	0.769	C2750537	Myopathy,Actin,Congenital,WithCores	disease	C05;C10	DiseaseorSyndrome	0.6	1	2009	2011	1	2	GENOMICS_ENGLAND
330	58	ACTA1	0.54	0.769	C3711389	Actin-AccumulationMyopathy	disease	C05;C10	DiseaseorSyndrome	0.93	1	1988	2018	16	48	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
331	58	ACTA1	0.54	0.769	C4225181	MYOPATHY,SCAPULOHUMEROPERONEAL	disease		DiseaseorSyndrome	0.7	1	2015	2015	1	2	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
346	59	ACTA2	0.508	0.846	C0026654	MoyamoyaDisease	disease	C10;C14	DiseaseorSyndrome	0.6	1	2009	2018	2	0	GENOMICS_ENGLAND;ORPHANET
366	59	ACTA2	0.508	0.846	C2673186	AorticAneurysm,FamilialThoracic6	disease	C23;C17;C14	DiseaseorSyndrome	0.7	1	2007	2017	5	0	CTD_human;GENOMICS_ENGLAND;UNIPROT
368	59	ACTA2	0.508	0.846	C3151201	MULTISYSTEMICSMOOTHMUSCLEDYSFUNCTIONSYNDROME	disease		DiseaseorSyndrome	0.78	1	2007	2019	3	0	GENOMICS_ENGLAND;ORPHANET;UNIPROT
369	59	ACTA2	0.508	0.846	C3279690	MOYAMOYADISEASE5	disease		DiseaseorSyndrome	0.7	1	2007	2016	4	0	CTD_human;GENOMICS_ENGLAND;UNIPROT
371	59	ACTA2	0.508	0.846	C4707243	Familialthoracicaorticaneurysmandaorticdissection	disease		DiseaseorSyndrome	0.6	1	2000	2016	7	0	CLINGEN;GENOMICS_ENGLAND
412	60	ACTB	0.325	0.923	C1846331	Juvenile-onsetdystonia	disease	C10	DiseaseorSyndrome	0.7	1	2002	2018	2	2	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
414	60	ACTB	0.325	0.923	C1855722	IrisColobomawithPtosis,Hypertelorism,andMentalRetardation	disease	C23;C16;C11;C10;F03;F01	DiseaseorSyndrome	0.72	1	1989	2018	6	29	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
421	70	ACTC1	0.61	0.538	C0007193	Cardiomyopathy,Dilated	group	C14	DiseaseorSyndrome	0.65	1	2006	2019	0	3	CTD_human
422	70	ACTC1	0.61	0.538	C0007194	HypertrophicCardiomyopathy	disease	C14	DiseaseorSyndrome	0.7	0.962	1999	2019	12	3	CLINGEN;GENOMICS_ENGLAND
435	70	ACTC1	0.61	0.538	C2677506	Cardiomyopathy,FamilialHypertrophic,11	disease	C16;C14	DiseaseorSyndrome	0.7	1	1998	2019	7	9	CTD_human;GENOMICS_ENGLAND;UNIPROT
436	70	ACTC1	0.61	0.538	C2748552	AtrialSeptalDefect5	disease	C16;C14	DiseaseorSyndrome;CongenitalAbnormality	0.7	1	1998	2019	5	4	CTD_human;GENOMICS_ENGLAND;UNIPROT
437	70	ACTC1	0.61	0.538	C3150681	CARDIOMYOPATHY,DILATED,1R	disease		DiseaseorSyndrome	0.8	1	1998	2019	4	4	GENOMICS_ENGLAND;UNIPROT
438	70	ACTC1	0.61	0.538	C3150682	LEFTVENTRICULARNONCOMPACTION4	disease		DiseaseorSyndrome	0.6	NA	NA	NA	0	1	GENOMICS_ENGLAND
471	71	ACTG1	0.477	0.846	C1858172	Deafness,AutosomalDominant20	disease	C23;C10;C09	DiseaseorSyndrome	0.7	1	1996	2014	8	10	CTD_human;GENOMICS_ENGLAND;UNIPROT
479	71	ACTG1	0.477	0.846	C3281235	BARAITSER-WINTERSYNDROME2	disease		DiseaseorSyndrome	0.7	1	1996	2016	4	9	CLINGEN;CTD_human;GENOMICS_ENGLAND;UNIPROT
499	72	ACTG2	0.505	0.808	C0042781	VisceralMyopathy	disease	C06	DiseaseorSyndrome	0.75	0.917	2012	2020	5	15	CTD_human;GENOMICS_ENGLAND;UNIPROT
500	72	ACTG2	0.505	0.808	C0266833	VisceralMyopathy,Familial	disease	C06	DiseaseorSyndrome	0.52	1	2012	2015	1	0	CTD_human;ORPHANET
501	72	ACTG2	0.505	0.808	C1608393	Megacystismicrocolonintestinalhypoperistalsissyndrome	disease	C16;C06	DiseaseorSyndrome	0.66	1	2014	2017	3	0	CTD_human;GENOMICS_ENGLAND;ORPHANET
520	81	ACTN4	0.508	0.808	C4551527	Focalsegmentalglomerulosclerosis1	disease	C13;C12	DiseaseorSyndrome	0.8	1	2000	2015	9	8	GENOMICS_ENGLAND;UNIPROT
526	87	ACTN1	0.695	0.577	C3554663	BLEEDINGDISORDER,PLATELET-TYPE,15	disease		DiseaseorSyndrome	0.7	1	2013	2015	3	7	CTD_human;GENOMICS_ENGLAND;UNIPROT
530	88	ACTN2	0.686	0.462	C2677338	Cardiomyopathy,Dilated,1AA	disease	C14	DiseaseorSyndrome	0.7	1	2004	2016	6	5	CTD_human;GENOMICS_ENGLAND;UNIPROT
534	90	ACVR1	0.535	0.731	C0016037	FibrodysplasiaOssificansProgressiva	disease	C05	DiseaseorSyndrome	1	1	2006	2020	5	9	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
565	93	ACVR2B	0.601	0.615	C0266642	Situsambiguus	disease	C16;C15;C14	CongenitalAbnormality	0.61	1	1999	2019	1	0	CTD_human;GENOMICS_ENGLAND;ORPHANET
567	93	ACVR2B	0.601	0.615	C3151057	HETEROTAXY,VISCERAL,4,AUTOSOMAL	disease		DiseaseorSyndrome	0.9	1	1997	1999	1	2	CTD_human;GENOMICS_ENGLAND;UNIPROT
568	93	ACVR2B	0.601	0.615	C3178805	HeterotaxySyndrome	disease	C16;C15;C14	DiseaseorSyndrome	0.7	1	1997	1999	1	0	CTD_human;GENOMICS_ENGLAND
574	94	ACVRL1	0.493	0.769	C0020542	PulmonaryHypertension	phenotype	C08	PathologicFunction	0.51	1	2003	2016	1	0	CTD_human
575	94	ACVRL1	0.493	0.769	C0039445	Hereditaryhemorrhagictelangiectasia	disease	C16;C15;C14	DiseaseorSyndrome	0.6	1	1996	2019	1	0	CTD_human
579	94	ACVRL1	0.493	0.769	C0340543	Familialprimarypulmonaryhypertension	disease	C08	DiseaseorSyndrome	0.56	1	2010	2017	6	0	GENOMICS_ENGLAND;ORPHANET
585	94	ACVRL1	0.493	0.769	C1838163	OSLER-RENDU-WEBERSYNDROME2	disease	C16;C15;C14	DiseaseorSyndrome	0.76	1	1996	2018	23	91	CLINGEN;CTD_human;GENOMICS_ENGLAND;UNIPROT
602	95	ACY1	0.653	0.577	C1835922	Aminoacylase1deficiency	disease	C16;C18	DiseaseorSyndrome	0.7	1	2005	2011	4	0	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
615	100	ADA	0.44	0.885	C0268124	Adenosinedeaminasedeficiency	disease	C16;C18;C20	DiseaseorSyndrome	0.6	1	1976	2018	0	0	ORPHANET
617	100	ADA	0.44	0.885	C0392607	Severecombinedimmunodeficiencyduetoadenosinedeaminasedeficiency	disease	C16;C18;C20;C15	DiseaseorSyndrome	0.8	0.977	1980	2019	0	7	CTD_human;GENOMICS_ENGLAND;ORPHANET
620	100	ADA	0.44	0.885	C1863236	SCIDDuetoADADeficiency,Early-Onset	disease		DiseaseorSyndrome	0.6	1	1984	2019	12	32	GENOMICS_ENGLAND;UNIPROT
622	100	ADA	0.44	0.885	C2700553	OmennSyndrome	disease	C16;C18;C20	DiseaseorSyndrome	0.51	1	2011	2011	0	0	GENOMICS_ENGLAND;ORPHANET
635	102	ADAM10	0.489	0.846	C3810041	ALZHEIMERDISEASE18	disease		DiseaseorSyndrome	0.6	1	2009	2013	2	2	CTD_human;UNIPROT
638	103	ADAR	0.501	0.808	C0006142	Malignantneoplasmofbreast	disease	C04;C17	NeoplasticProcess	0.54	1	2015	2019	1	1	CTD_human;UNIPROT
640	103	ADAR	0.501	0.808	C0393591	AICARDI-GOUTIERESSYNDROME	disease	C16;C20;C10	DiseaseorSyndrome	0.8	1	2012	2020	1	1	CTD_human;GENOMICS_ENGLAND;ORPHANET
641	103	ADAR	0.501	0.808	C0406775	Symmetricaldyschromatosisofextremities	disease	C23;C17	CongenitalAbnormality	0.8	1	2003	2020	5	11	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
649	103	ADAR	0.501	0.808	C3539013	AICARDI-GOUTIERESSYNDROME6	disease		DiseaseorSyndrome	0.6	1	2004	2016	6	13	GENOMICS_ENGLAND;UNIPROT
675	107	ADCY1	0.659	0.462	C1857809	DEAFNESS,AUTOSOMALRECESSIVE44	disease	C23;C10;C09	DiseaseorSyndrome	0.6	1	2014	2014	0	1	CTD_human;GENOMICS_ENGLAND
678	108	ADCY2	0.695	0.308	C0005586	BipolarDisorder	disease	F03	MentalorBehavioralDysfunction	0.62	1	2014	2019	2	11	CTD_human;PSYGENET
694	111	ADCY5	0.617	0.577	C0011860	DiabetesMellitus,Non-Insulin-Dependent	disease	C18;C19	DiseaseorSyndrome	0.7	0.947	2002	2019	2	3	CTD_human
717	111	ADCY5	0.617	0.577	C1847627	Dyskinesia,Familial,withFacialMyokymia	disease	C23;C10	DiseaseorSyndrome	0.72	1	2001	2017	4	5	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
719	112	ADCY6	0.729	0.5	C4225385	LETHALCONGENITALCONTRACTURESYNDROME8	disease		DiseaseorSyndrome	0.71	1	2014	2020	1	2	CTD_human;GENOMICS_ENGLAND;UNIPROT
745	114	ADCY8	0.705	0.577	C0525045	MoodDisorders	group	F03	MentalorBehavioralDysfunction	0.51	1	2009	2013	4	0	CTD_human;PSYGENET
796	118	ADD1	0.612	0.615	C0020538	Hypertensivedisease	group	C14	DiseaseorSyndrome	0.6	0.861	1995	2019	2	0	CTD_human
810	120	ADD3	0.641	0.5	C4310767	CEREBRALPALSY,SPASTICQUADRIPLEGIC,3	disease		DiseaseorSyndrome	0.6	1	2013	2013	1	1	CTD_human;GENOMICS_ENGLAND;UNIPROT
822	125	ADH1B	0.502	0.846	C0001973	AlcoholicIntoxication,Chronic	disease	C25;F03	MentalorBehavioralDysfunction	0.7	1	1994	2019	8	8	CTD_human;PSYGENET
833	125	ADH1B	0.502	0.846	C0085762	Alcoholabuse	disease	C25;F03	MentalorBehavioralDysfunction	0.6	1	1994	2019	8	0	CTD_human;PSYGENET
849	126	ADH1C	0.547	0.731	C0001973	AlcoholicIntoxication,Chronic	disease	C25;F03	MentalorBehavioralDysfunction	0.7	1	1991	2019	6	0	CTD_human;PSYGENET
851	126	ADH1C	0.547	0.731	C0085762	Alcoholabuse	disease	C25;F03	MentalorBehavioralDysfunction	0.53	1	1994	2012	5	0	CTD_human;PSYGENET
880	132	ADK	0.584	0.769	C3280381	HYPERMETHIONINEMIADUETOADENOSINEKINASEDEFICIENCY	disease		DiseaseorSyndrome	0.7	1	2011	2016	2	3	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
884	133	ADM	0.436	0.808	C0017658	Glomerulonephritis	disease	C13;C12	DiseaseorSyndrome	0.51	1	2004	2010	2	0	CTD_human
885	133	ADM	0.436	0.808	C0020429	Hyperalgesia	phenotype	C23;C10	SignorSymptom	0.51	1	2006	2017	1	0	CTD_human
895	133	ADM	0.436	0.808	C0243026	Sepsis	disease	C23;C01	DiseaseorSyndrome	0.6	1	2000	2020	1	0	CTD_human
1062	142	PARP1	0.389	0.923	C0006142	Malignantneoplasmofbreast	disease	C04;C17	NeoplasticProcess	0.6	0.968	1997	2020	1	0	CTD_human;UNIPROT
1177	150	ADRA2A	0.578	0.615	C0011570	MentalDepression	disease	F01	MentalorBehavioralDysfunction	0.53	0.75	2001	2011	4	0	PSYGENET
1183	150	ADRA2A	0.578	0.615	C0020538	Hypertensivedisease	group	C14	DiseaseorSyndrome	0.52	0.75	1999	2012	1	0	CTD_human
1217	153	ADRB1	0.555	0.769	C0007193	Cardiomyopathy,Dilated	group	C14	DiseaseorSyndrome	0.58	1	1998	2019	1	0	CTD_human
1222	153	ADRB1	0.555	0.769	C0018801	Heartfailure	disease	C14	DiseaseorSyndrome	0.6	0.933	1991	2019	5	0	CTD_human
1223	153	ADRB1	0.555	0.769	C0018802	Congestiveheartfailure	disease	C14	DiseaseorSyndrome	0.6	0.94	1991	2019	5	0	CTD_human
1225	153	ADRB1	0.555	0.769	C0020538	Hypertensivedisease	group	C14	DiseaseorSyndrome	0.6	1	1993	2018	2	0	CTD_human
1247	154	ADRB2	0.442	0.923	C0007193	Cardiomyopathy,Dilated	group	C14	DiseaseorSyndrome	0.51	1	2002	2008	1	0	CTD_human
1298	155	ADRB3	0.533	0.731	C0018801	Heartfailure	disease	C14	DiseaseorSyndrome	0.52	1	2004	2017	2	0	CTD_human
1299	155	ADRB3	0.533	0.731	C0018802	Congestiveheartfailure	disease	C14	DiseaseorSyndrome	0.52	1	2004	2017	2	0	CTD_human
1315	156	GRK2	0.532	0.654	C0018801	Heartfailure	disease	C14	DiseaseorSyndrome	0.6	0.98	1994	2020	1	0	CTD_human
1316	156	GRK2	0.532	0.654	C0018802	Congestiveheartfailure	disease	C14	DiseaseorSyndrome	0.6	0.98	1994	2020	1	0	CTD_human
1317	156	GRK2	0.532	0.654	C0020538	Hypertensivedisease	group	C14	DiseaseorSyndrome	0.55	1	2000	2019	1	0	CTD_human
1331	157	GRK3	0.621	0.731	C0005586	BipolarDisorder	disease	F03	MentalorBehavioralDysfunction	0.56	1	2003	2010	6	0	CTD_human;PSYGENET
1336	158	ADSL	0.631	0.654	C0268126	Adenylosuccinatelyasedeficiency(disorder)	disease	C16;C18;F03	DiseaseorSyndrome	0.79	1	1992	2017	11	25	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
1375	174	AFP	0.429	0.885	C1863081	alpha-FetoproteinDeficiency	disease	C16;C18	DiseaseorSyndrome	0.6	1	2004	2004	1	2	CTD_human;ORPHANET
1379	175	AGA	0.57	0.808	C0268225	Aspartylglucosaminuria	phenotype	C16;C18	DiseaseorSyndrome	1	0.96	1990	2019	7	52	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
1386	176	ACAN	0.528	0.846	C1842149	SpondyloepiphysealDysplasia,KimberleyType	disease	C16;C05	CongenitalAbnormality	0.61	1	2005	2017	3	0	CTD_human;GENOMICS_ENGLAND;ORPHANET
1387	176	ACAN	0.528	0.846	C2748544	SpondyloepimetaphysealDysplasia,AggrecanType	disease	C16;C05	DiseaseorSyndrome	0.7	1	2009	2017	2	3	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
1388	176	ACAN	0.528	0.846	C3665488	FamilialOsteochondritisDissecans	disease	C05	DiseaseorSyndrome	0.61	1	2010	2017	3	1	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
1390	177	AGER	0.42	0.885	C0004153	Atherosclerosis	disease	C14	DiseaseorSyndrome	0.6	0.974	1999	2019	2	0	CTD_human
1426	178	AGL	0.644	0.615	C0017922	GlycogenStorageDiseaseTypeIII	disease	C16;C18	DiseaseorSyndrome	1	0.988	1987	2020	8	124	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
1431	181	AGRP	0.488	0.769	C0028754	Obesity	disease	C23;C18	DiseaseorSyndrome	0.7	0.938	1997	2019	0	0	CTD_human
1445	182	JAG1	0.429	0.808	C0039685	TetralogyofFallot	disease	C16;C14	CongenitalAbnormality	0.8	1	1999	2018	3	3	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
1446	182	JAG1	0.429	0.808	C0085280	AlagilleSyndrome	disease	C16;C06;C14	CongenitalAbnormality	0.9	0.952	1997	2019	5	3	CTD_human;GENOMICS_ENGLAND
1460	182	JAG1	0.429	0.808	C1866053	Deafness,CongenitalHeartDefects,andPosteriorEmbryotoxon	disease	C23;C16;C10;C09;C14	DiseaseorSyndrome	0.6	1	2002	2010	2	2	GENOMICS_ENGLAND;UNIPROT
1461	182	JAG1	0.429	0.808	C1956125	AlagilleSyndrome1	disease	C16;C06;C14	DiseaseorSyndrome	0.71	1	1997	2016	19	48	CTD_human;GENOMICS_ENGLAND;UNIPROT
1475	183	AGT	0.367	0.923	C0004153	Atherosclerosis	disease	C14	DiseaseorSyndrome	0.6	1	1998	2019	2	0	CTD_human
1488	183	AGT	0.367	0.923	C0011884	DiabeticRetinopathy	disease	C11;C19;C14	DiseaseorSyndrome	0.58	1	2000	2018	1	0	CTD_human
1489	183	AGT	0.367	0.923	C0015934	FetalGrowthRetardation	phenotype	C23;C16;C13	DiseaseorSyndrome	0.6	1	1998	2019	1	0	CTD_human
1490	183	AGT	0.367	0.923	C0016059	Fibrosis	phenotype	C23	PathologicFunction	0.51	1	2002	2015	5	0	CTD_human
1491	183	AGT	0.367	0.923	C0017658	Glomerulonephritis	disease	C13;C12	DiseaseorSyndrome	0.55	1	1999	2019	1	0	CTD_human
1494	183	AGT	0.367	0.923	C0017668	Focalglomerulosclerosis	disease	C13;C12	DiseaseorSyndrome	0.54	0.833	1998	2011	1	0	CTD_human
1497	183	AGT	0.367	0.923	C0018801	Heartfailure	disease	C14	DiseaseorSyndrome	0.6	0.989	1992	2020	3	0	CTD_human
1498	183	AGT	0.367	0.923	C0018802	Congestiveheartfailure	disease	C14	DiseaseorSyndrome	0.6	0.991	1992	2020	3	0	CTD_human
1503	183	AGT	0.367	0.923	C0020538	Hypertensivedisease	group	C14	DiseaseorSyndrome	0.6	0.971	1979	2020	77	0	CTD_human
1513	183	AGT	0.367	0.923	C0023890	LiverCirrhosis	disease	C23;C06	DiseaseorSyndrome	0.56	1	2005	2018	1	0	CTD_human
1515	183	AGT	0.367	0.923	C0027051	MyocardialInfarction	disease	C23;C14	DiseaseorSyndrome	0.6	0.955	1991	2020	2	0	CTD_human
1526	183	AGT	0.367	0.923	C0034069	PulmonaryFibrosis	disease	C08	DiseaseorSyndrome	0.55	1	2007	2019	2	0	CTD_human
1536	183	AGT	0.367	0.923	C0085580	EssentialHypertension	disease	C14	DiseaseorSyndrome	0.6	0.932	1988	2020	1	0	CTD_human;GENOMICS_ENGLAND
1551	183	AGT	0.367	0.923	C0266313	AllansonPantzarMcLeodsyndrome	disease	C16;C13;C12	DiseaseorSyndrome	0.71	1	2005	2015	4	3	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
1617	185	AGTR1	0.423	0.846	C0018801	Heartfailure	disease	C14	DiseaseorSyndrome	0.6	0.963	1997	2019	3	0	CTD_human
1618	185	AGTR1	0.423	0.846	C0018802	Congestiveheartfailure	disease	C14	DiseaseorSyndrome	0.6	0.971	1997	2019	3	0	CTD_human
1619	185	AGTR1	0.423	0.846	C0020538	Hypertensivedisease	group	C14	DiseaseorSyndrome	0.6	0.944	1993	2020	4	0	CTD_human
1620	185	AGTR1	0.423	0.846	C0022658	KidneyDiseases	group	C13;C12	DiseaseorSyndrome	0.6	0.95	1997	2018	1	0	CTD_human
1626	185	AGTR1	0.423	0.846	C0085580	EssentialHypertension	disease	C14	DiseaseorSyndrome	0.6	0.941	1994	2019	1	0	CTD_human;GENOMICS_ENGLAND
1629	185	AGTR1	0.423	0.846	C0266313	AllansonPantzarMcLeodsyndrome	disease	C16;C13;C12	DiseaseorSyndrome	0.7	1	2005	2015	3	3	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
1639	186	AGTR2	0.496	0.808	C0020538	Hypertensivedisease	group	C14	DiseaseorSyndrome	0.6	1	2001	2019	1	0	CTD_human
1655	189	AGXT	0.593	0.731	C0268164	Primaryhyperoxaluria,typeI	disease	C16;C18;C13;C12	DiseaseorSyndrome	0.8	1	1973	2019	27	166	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
1660	190	NR0B1	0.494	0.808	C0342482	X-linkedAdrenalHypoplasia	disease	C19	DiseaseorSyndrome	1	1	1994	2019	19	58	CTD_human;GENOMICS_ENGLAND;UNIPROT
1664	190	NR0B1	0.494	0.808	C1848296	DOSAGE-SENSITIVESEXREVERSAL	disease	C16;C13;C12;C19	DiseaseorSyndrome	0.7	0.972	1997	2019	1	6	CTD_human;GENOMICS_ENGLAND
1682	191	AHCY	0.582	0.692	C3151058	S-adenosylhomocysteinehydrolasedeficiency	disease	C16;C18	DiseaseorSyndrome	0.7	1	1959	2018	13	5	CLINGEN;CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
1796	199	AIF1	0.521	0.808	C0020429	Hyperalgesia	phenotype	C23;C10	SignorSymptom	0.54	1	2007	2020	1	0	CTD_human
1814	203	AK1	0.711	0.5	C2675459	AdenylateKinaseDeficiency,HemolyticAnemiaDueTo	disease	C15	DiseaseorSyndrome	0.7	1	1989	2017	5	7	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
1820	204	AK2	0.678	0.423	C0272167	Reticulardysgenesis	disease	C16;C18;C20;C15	DiseaseorSyndrome	0.75	1	2009	2019	2	9	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
1840	274	BIN1	0.55	0.692	C0410204	Myopathy,Centronuclear,AutosomalRecessive	disease	C05;C10	DiseaseorSyndrome;CongenitalAbnormality	0.73	1	2007	2018	4	9	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
1854	341	APOC1	0.581	0.577	C0750900	AlzheimersDisease,FocalOnset	disease	C10;F03	MentalorBehavioralDysfunction	0.30	1	2018	2018	2	0	CTD_human
val	341	APOC1	0.581	0.577	C0750901	AlzheimerDisease,EarlyOnset	disease	C10;F03	DiseaseorSyndrome	0.30	1	2018	2018	2	0	CTD_human
val	341	APOC1	0.581	0.577	C1959583	MyocardialFailure	disease	C14	DiseaseorSyndrome	0.30	1	2016	2016	1	0	CTD_human
val	341	APOC1	0.581	0.577	C1961112	HeartDecompensation	phenotype	C14	PathologicFunction	0.30	1	2016	2016	1	0	CTD_human
val	343	AQP8	0.638	0.615	C0006142	Malignantneoplasmofbreast	disease	C04;C17	NeoplasticProcess	0.31	1	2018	2018	0	0	UNIPROT
val	344	APOC2	0.606	0.577	C0002726	Amyloidosis	disease	C18	DiseaseorSyndrome	0.30	1	2017	2017	1	0	GENOMICS_ENGLAND
val	344	APOC2	0.606	0.577	C0011609	DrugEruptions	group	C17;C20;C25	DiseaseorSyndrome	0.30	1	2010	2010	1	0	CTD_human
val	344	APOC2	0.606	0.577	C0019207	Hepatoma,Morris	disease	C06;C04	NeoplasticProcess;ExperimentalModelofDisease	0.30	1	2001	2001	1	0	CTD_human
val	344	APOC2	0.606	0.577	C0019208	Hepatoma,Novikoff	disease	C06;C04	NeoplasticProcess;ExperimentalModelofDisease	0.30	1	2001	2001	1	0	CTD_human
val	344	APOC2	0.606	0.577	C0023817	HyperlipoproteinemiaTypeI	disease	C16;C18	DiseaseorSyndrome	0.40	1	1981	2018	0	0	CTD_human
val	344	APOC2	0.606	0.577	C0023904	LiverNeoplasms,Experimental	phenotype	C06;C04	NeoplasticProcess;ExperimentalModelofDisease	0.30	1	2001	2001	1	0	CTD_human
val	344	APOC2	0.606	0.577	C0086404	ExperimentalHepatoma	disease	C06;C04	NeoplasticProcess;ExperimentalModelofDisease	0.30	1	2001	2001	1	0	CTD_human
val	344	APOC2	0.606	0.577	C0268199	FamilialapolipoproteinC-IIdeficiency	disease	C16;C18	DiseaseorSyndrome	0.33	1	1979	2018	1	0	ORPHANET
val	344	APOC2	0.606	0.577	C0406537	MorbilliformDrugReaction	disease	C17;C20;C25	DiseaseorSyndrome	0.30	1	2010	2010	1	0	CTD_human
val	344	APOC2	0.606	0.577	C1720779	ApolipoproteinC-IIDeficiency(disorder)	disease	C16;C18	DiseaseorSyndrome	0.75	1	1993	2017	4	0	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
val	345	APOC3	0.531	0.731	C0002726	Amyloidosis	disease	C18	DiseaseorSyndrome	0.31	0	2016	2016	1	0	GENOMICS_ENGLAND
val	345	APOC3	0.531	0.731	C0007222	CardiovascularDiseases	group	C14	DiseaseorSyndrome	0.40	1	2000	2020	1	0	CTD_human
val	345	APOC3	0.531	0.731	C0007570	CeliacDisease	disease	C06;C18	DiseaseorSyndrome	0.30	1	2018	2018	1	0	CTD_human
val	345	APOC3	0.531	0.731	C0010054	CoronaryArteriosclerosis	disease	C14	DiseaseorSyndrome	0.40	1	1997	2019	1	0	CTD_human
val	345	APOC3	0.531	0.731	C0011609	DrugEruptions	group	C17;C20;C25	DiseaseorSyndrome	0.30	1	2010	2010	1	0	CTD_human
val	345	APOC3	0.531	0.731	C0020443	Hypercholesterolemia	disease	C18	DiseaseorSyndrome	0.46	1	2001	2019	0	0	GENOMICS_ENGLAND
val	345	APOC3	0.531	0.731	C0020445	Hypercholesterolemia,Familial	disease	C16;C18	DiseaseorSyndrome	0.30	1	2005	2005	1	0	CTD_human
val	345	APOC3	0.531	0.731	C0020476	Hyperlipoproteinemias	disease	C18	DiseaseorSyndrome	0.30	1	1991	1991	1	0	CTD_human
val	345	APOC3	0.531	0.731	C0024121	LungNeoplasms	group	C04;C08	NeoplasticProcess	0.30	1	2009	2009	1	0	CTD_human
val	345	APOC3	0.531	0.731	C0242379	Malignantneoplasmoflung	disease	C04;C08	NeoplasticProcess	0.31	1	1999	2009	1	0	CTD_human
val	345	APOC3	0.531	0.731	C0342883	CholesterylEsterTransferProteinDeficiency	disease	C16;C18	DiseaseorSyndrome	0.32	1	1991	2014	1	0	ORPHANET
val	345	APOC3	0.531	0.731	C0406537	MorbilliformDrugReaction	disease	C17;C20;C25	DiseaseorSyndrome	0.30	1	2010	2010	1	0	CTD_human
val	345	APOC3	0.531	0.731	C0745103	HyperlipoproteinemiaTypeIIa	disease	C16;C18	DiseaseorSyndrome	0.30	1	2005	2005	1	0	CTD_human
val	345	APOC3	0.531	0.731	C1704417	HyperlipoproteinemiaTypeIIb	disease	C16;C18	DiseaseorSyndrome	0.30	1	2005	2005	1	0	CTD_human
val	345	APOC3	0.531	0.731	C1956346	CoronaryArteryDisease	disease	C14	DiseaseorSyndrome	0.40	1	1997	2019	1	0	CTD_human
val	345	APOC3	0.531	0.731	C3151467	ApolipoproteinC-IIIDeficiency	disease	C18	DiseaseorSyndrome	0.61	1	1991	2016	1	4	CTD_human;UNIPROT
val	346	APOC4	0.743	0.385	C0006142	Malignantneoplasmofbreast	disease	C04;C17	NeoplasticProcess	0.30				0	0	UNIPROT
val	347	APOD	0.584	0.577	C0005586	BipolarDisorder	disease	F03	MentalorBehavioralDysfunction	0.31	1	2003	2003	1	0	PSYGENET
val	347	APOD	0.584	0.577	C0017638	Glioma	disease	C04	NeoplasticProcess	0.31	1	2006	2006	1	0	CTD_human
val	347	APOD	0.584	0.577	C0023186	LearningDisorders	group	C23;C10;F03	MentalorBehavioralDysfunction	0.30	1	2008	2008	1	0	CTD_human
val	347	APOD	0.584	0.577	C0036341	Schizophrenia	disease	F03	MentalorBehavioralDysfunction	0.35	0.667	2002	2006	3	0	PSYGENET
val	347	APOD	0.584	0.577	C0086439	Hypokinesia	phenotype	C23;C10	Finding	0.30	1	2011	2011	1	0	CTD_human
val	347	APOD	0.584	0.577	C0233565	Bradykinesia	phenotype	C23;C10	SignorSymptom	0.30	1	2011	2011	1	0	CTD_human
val	347	APOD	0.584	0.577	C0242684	Hypodynamia	phenotype	C23;C10	OrganismFunction	0.30	1	2011	2011	1	0	CTD_human
val	347	APOD	0.584	0.577	C0259783	mixedgliomas	disease	C04	NeoplasticProcess	0.30	1	2006	2006	1	0	CTD_human
val	347	APOD	0.584	0.577	C0270715	DegenerativeDiseases,CentralNervousSystem	group	C10	DiseaseorSyndrome	0.30	1	2008	2008	1	0	CTD_human
val	347	APOD	0.584	0.577	C0524851	NeurodegenerativeDisorders	group	C10	DiseaseorSyndrome	0.31	1	2008	2018	1	0	CTD_human
val	347	APOD	0.584	0.577	C0555198	MalignantGlioma	disease	C04	NeoplasticProcess	0.30	1	2006	2006	1	0	CTD_human
val	347	APOD	0.584	0.577	C0751262	AdultLearningDisorders	group	C23;C10;F03	MentalorBehavioralDysfunction	0.30	1	2008	2008	1	0	CTD_human
val	347	APOD	0.584	0.577	C0751263	LearningDisturbance	disease	C23;C10;F03	MentalorBehavioralDysfunction	0.30	1	2008	2008	1	0	CTD_human
val	347	APOD	0.584	0.577	C0751265	LearningDisabilities	disease	C23;C10;F03	MentalorBehavioralDysfunction	0.30	1	2008	2008	1	0	CTD_human
val	347	APOD	0.584	0.577	C0751701	Hypokinesia,Antiorthostatic	phenotype	C23;C10	SignorSymptom	0.30	1	2011	2011	1	0	CTD_human
val	347	APOD	0.584	0.577	C0751733	DegenerativeDiseases,SpinalCord	group	C10	DiseaseorSyndrome	0.30	1	2008	2008	1	0	CTD_human
val	347	APOD	0.584	0.577	C1330966	DevelopmentalAcademicDisorder	phenotype	C23;C10;F03	Finding	0.30	1	2008	2008	1	0	CTD_human
val	348	APOE	0.338	0.962	C0000786	Spontaneousabortion	phenotype	C13	PathologicFunction	0.30	1	2012	2012	1	0	CTD_human
val	348	APOE	0.338	0.962	C0000822	Abortion,Tubal	phenotype	C13	PathologicFunction	0.30	1	2012	2012	1	0	CTD_human
val	348	APOE	0.338	0.962	C0001418	Adenocarcinoma	group	C04	NeoplasticProcess	0.31	0.5	2009	2011	1	0	CTD_human
val	348	APOE	0.338	0.962	C0001973	AlcoholicIntoxication,Chronic	disease	C25;F03	MentalorBehavioralDysfunction	0.34	0.75	2002	2008	4	0	PSYGENET
val	348	APOE	0.338	0.962	C0002395	AlzheimersDisease	disease	C10;F03	DiseaseorSyndrome	0.7	0.946	1991	2020	9	5	CTD_human
1863	348	APOE	0.338	0.962	C0010068	Coronaryheartdisease	disease	C14	DiseaseorSyndrome	0.7	0.966	1983	2019	1	1	CTD_human
1870	348	APOE	0.338	0.962	C0020443	Hypercholesterolemia	disease	C18	DiseaseorSyndrome	0.7	0.957	1985	2019	4	0	CTD_human
1872	348	APOE	0.338	0.962	C0020473	Hyperlipidemia	disease	C18	DiseaseorSyndrome	0.6	0.957	1979	2020	4	0	CTD_human
1873	348	APOE	0.338	0.962	C0020479	HyperlipoproteinemiaTypeIII	disease	C16;C18	DiseaseorSyndrome	0.8	0.977	1977	2020	16	10	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
1874	348	APOE	0.338	0.962	C0020538	Hypertensivedisease	group	C14	DiseaseorSyndrome	0.7	0.897	1994	2019	2	1	CTD_human
1886	348	APOE	0.338	0.962	C0036341	Schizophrenia	disease	F03	MentalorBehavioralDysfunction	0.6	0.78	1995	2019	1	0	CTD_human
1887	348	APOE	0.338	0.962	C0036489	Sea-BlueHistiocyteSyndrome	disease	C16;C18;C10;C15	DiseaseorSyndrome	0.7	1	2000	2014	2	1	CTD_human;GENOMICS_ENGLAND;ORPHANET
1923	348	APOE	0.338	0.962	C0745103	HyperlipoproteinemiaTypeIIa	disease	C16;C18	DiseaseorSyndrome	0.6	0.889	1989	2020	4	3	CTD_human;UNIPROT
1924	348	APOE	0.338	0.962	C0750900	AlzheimersDisease,FocalOnset	disease	C10;F03	MentalorBehavioralDysfunction	0.30	1	1993	2018	9	0	CTD_human
val	348	APOE	0.338	0.962	C0750901	AlzheimerDisease,EarlyOnset	disease	C10;F03	DiseaseorSyndrome	0.50	0.935	1993	2020	9	1	CTD_human
val	348	APOE	0.338	0.962	C0750986	InternalCarotidArteryDiseases	group	C10;C14	DiseaseorSyndrome	0.30	1	2008	2008	1	0	CTD_human
val	348	APOE	0.338	0.962	C0750987	ArterialDiseases,CommonCarotid	disease	C10;C14	DiseaseorSyndrome	0.30	1	2008	2008	1	0	CTD_human
val	348	APOE	0.338	0.962	C0751056	Non-epilepticconvulsion	phenotype	C23;C10	SignorSymptom	0.30	1	2013	2013	1	0	CTD_human
val	348	APOE	0.338	0.962	C0751110	SingleSeizure	disease	C23;C10	DiseaseorSyndrome	0.30	1	2013	2013	1	0	CTD_human
val	348	APOE	0.338	0.962	C0751123	AtonicAbsenceSeizures	phenotype	C23;C10	DiseaseorSyndrome	0.30	1	2013	2013	1	0	CTD_human
val	348	APOE	0.338	0.962	C0751324	MultipleSclerosis,AcuteFulminating	disease	C20;C10	DiseaseorSyndrome	0.30	1	2004	2004	1	0	CTD_human
val	348	APOE	0.338	0.962	C0751494	ConvulsiveSeizures	phenotype	C23;C10	SignorSymptom	0.30	1	2013	2013	1	0	CTD_human
val	348	APOE	0.338	0.962	C0751495	Seizures,Focal	phenotype	C23;C10	DiseaseorSyndrome	0.30	1	2013	2013	1	0	CTD_human
val	348	APOE	0.338	0.962	C0751496	Seizures,Sensory	phenotype	C23;C10	SignorSymptom	0.30	1	2013	2013	1	0	CTD_human
val	348	APOE	0.338	0.962	C0751633	CarotidArteryPlaque	disease	C10;C14	AcquiredAbnormality	0.32	1	2006	2019	1	0	CTD_human
val	348	APOE	0.338	0.962	C0751634	CarotidUlcer	phenotype	C10;C14	AcquiredAbnormality	0.30	1	2006	2006	1	0	CTD_human
val	348	APOE	0.338	0.962	C0751635	CommonCarotidArteryStenosis	disease	C10;C14	DiseaseorSyndrome	0.30	1	2006	2006	1	0	CTD_human
val	348	APOE	0.338	0.962	C0751636	ExternalCarotidArteryStenosis	disease	C10;C14	DiseaseorSyndrome	0.30	1	2006	2006	1	0	CTD_human
val	348	APOE	0.338	0.962	C0751967	MultipleSclerosis,Relapsing-Remitting	disease	C20;C10	DiseaseorSyndrome	0.32	1	2004	2009	1	0	CTD_human
val	348	APOE	0.338	0.962	C0860207	Drug-InducedLiverDisease	phenotype	C06;C25	DiseaseorSyndrome	0.31	1	2005	2012	1	0	CTD_human
val	348	APOE	0.338	0.962	C1262760	Hepatitis,Drug-Induced	disease	C06;C25	DiseaseorSyndrome	0.30	1	2005	2005	1	0	CTD_human
val	348	APOE	0.338	0.962	C1384666	hearingimpairment	phenotype	C23;C10;C09	DiseaseorSyndrome	0.33	1	2009	2019	1	0	CTD_human
val	348	APOE	0.338	0.962	C1527352	HepaticFormofWilsonDisease	disease	C16;C06;C18;C10	DiseaseorSyndrome	0.30	1	2000	2000	1	0	CTD_human
val	348	APOE	0.338	0.962	C1563937	Atherogenesis	phenotype	C14	PathologicFunction	0.30	1	1997	2018	29	0	CTD_human
val	348	APOE	0.338	0.962	C1565489	RenalInsufficiency	disease	C13;C12	DiseaseorSyndrome	0.44	0.8	2006	2019	1	0	CTD_human
val	348	APOE	0.338	0.962	C1704417	HyperlipoproteinemiaTypeIIb	disease	C16;C18	DiseaseorSyndrome	0.32	1	1985	2007	1	0	CTD_human
val	348	APOE	0.338	0.962	C1706412	Lipidemias	phenotype	C18	Finding	0.30	1	2002	2010	4	0	CTD_human
val	348	APOE	0.338	0.962	C1847200	ALZHEIMERDISEASE4	disease	C10;F03	DiseaseorSyndrome	0.30				0	0	CTD_human
val	348	APOE	0.338	0.962	C1863051	ALZHEIMERDISEASE2	disease	C10;F03	DiseaseorSyndrome	0.80	0.96	1985	2017	11	1	CTD_human;GENOMICS_ENGLAND;UNIPROT
val	348	APOE	0.338	0.962	C1864205	MacularDegeneration,Age-Related,1	disease	C11	DiseaseorSyndrome	0.30				0	0	CTD_human
val	348	APOE	0.338	0.962	C2673196	LIPOPROTEINGLOMERULOPATHY	disease	C13;C12	DiseaseorSyndrome	0.80	0.95	1997	2020	6	2	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
val	348	APOE	0.338	0.962	C2936350	Plaque,Atherosclerotic	phenotype	C23	BodySubstance	0.30	1	2007	2018	11	0	CTD_human
val	348	APOE	0.338	0.962	C2936351	Fibroatheroma	disease	C23	AcquiredAbnormality	0.30	1	2007	2018	11	0	CTD_human
val	348	APOE	0.338	0.962	C3495874	NonepilepticSeizures	phenotype	C23;C10	DiseaseorSyndrome	0.30	1	2013	2013	1	0	CTD_human
val	348	APOE	0.338	0.962	C3658290	Drug-InducedAcuteLiverInjury	disease	C06;C25	DiseaseorSyndrome	0.30	1	2005	2005	1	0	CTD_human
val	348	APOE	0.338	0.962	C3830362	EarlyPregnancyLoss	phenotype	C13	Finding	0.30	1	2012	2012	1	0	CTD_human
val	348	APOE	0.338	0.962	C4048158	Convulsions	phenotype	C23;C10	SignorSymptom	0.30	1	2013	2013	1	0	CTD_human
val	348	APOE	0.338	0.962	C4277682	ChemicalandDrugInducedLiverInjury	disease	C06;C25	DiseaseorSyndrome	0.30	1	2005	2005	1	0	CTD_human
val	348	APOE	0.338	0.962	C4279912	Chemically-InducedLiverToxicity	disease	C06;C25	DiseaseorSyndrome	0.30	1	2005	2005	1	0	CTD_human
val	348	APOE	0.338	0.962	C4316903	AbsenceSeizures	phenotype	C23;C10	DiseaseorSyndrome	0.30	1	2013	2013	1	0	CTD_human
val	348	APOE	0.338	0.962	C4317109	EpilepticSeizures	phenotype	C23;C10	DiseaseorSyndrome	0.30	1	2013	2013	1	0	CTD_human
val	348	APOE	0.338	0.962	C4317123	MyoclonicSeizures	phenotype	C23;C10	SignorSymptom	0.30	1	2013	2013	1	0	CTD_human
val	348	APOE	0.338	0.962	C4505436	GeneralizedAbsenceSeizures	phenotype	C23;C10	DiseaseorSyndrome	0.30	1	2013	2013	1	0	CTD_human
val	348	APOE	0.338	0.962	C4552766	Miscarriage	disease	C13	DiseaseorSyndrome	0.32	0.333	2012	2018	1	0	CTD_human
val	350	APOH	0.563	0.769	C0019193	Hepatitis,Toxic	disease	C06;C25	InjuryorPoisoning	0.30	1	2005	2005	1	0	CTD_human
val	350	APOH	0.563	0.769	C0036341	Schizophrenia	disease	F03	MentalorBehavioralDysfunction	0.31	1	2014	2019	1	0	PSYGENET
val	350	APOH	0.563	0.769	C0085278	AntiphospholipidSyndrome	disease	C20	DiseaseorSyndrome	0.40	1	1998	2020	1	0	GENOMICS_ENGLAND
val	350	APOH	0.563	0.769	C0860207	Drug-InducedLiverDisease	phenotype	C06;C25	DiseaseorSyndrome	0.30	1	2005	2005	1	0	CTD_human
val	350	APOH	0.563	0.769	C1262760	Hepatitis,Drug-Induced	disease	C06;C25	DiseaseorSyndrome	0.30	1	2005	2005	1	0	CTD_human
val	350	APOH	0.563	0.769	C3658290	Drug-InducedAcuteLiverInjury	disease	C06;C25	DiseaseorSyndrome	0.30	1	2005	2005	1	0	CTD_human
val	350	APOH	0.563	0.769	C4277682	ChemicalandDrugInducedLiverInjury	disease	C06;C25	DiseaseorSyndrome	0.50	1	2005	2013	1	0	CTD_human
val	350	APOH	0.563	0.769	C4279912	Chemically-InducedLiverToxicity	disease	C06;C25	DiseaseorSyndrome	0.30	1	2005	2005	1	0	CTD_human
val	351	APP	0.422	0.846	C0002395	AlzheimersDisease	disease	C10;F03	DiseaseorSyndrome	0.9	0.981	1987	2020	63	14	CTD_human;UNIPROT
1964	351	APP	0.422	0.846	C0338656	Impairedcognition	disease	F03	MentalorBehavioralDysfunction	0.6	0.98	1993	2020	1	0	CTD_human
1967	351	APP	0.422	0.846	C0497327	Dementia	disease	C10;F03	MentalorBehavioralDysfunction	0.7	0.964	1993	2020	3	0	CTD_human;GENOMICS_ENGLAND
1973	351	APP	0.422	0.846	C0750900	AlzheimersDisease,FocalOnset	disease	C10;F03	MentalorBehavioralDysfunction	0.30	1	1991	2018	35	0	CTD_human
val	351	APP	0.422	0.846	C0750901	AlzheimerDisease,EarlyOnset	disease	C10;F03	DiseaseorSyndrome	0.50	0.984	1991	2020	35	1	CTD_human
val	351	APP	0.422	0.846	C0750906	TactileAmnesia	phenotype	C23;C10;F03;F01	MentalorBehavioralDysfunction	0.30	1	2003	2003	1	0	CTD_human
val	351	APP	0.422	0.846	C0750907	AmnesticState	phenotype	C23;C10;F03;F01	MentalorBehavioralDysfunction	0.30	1	2003	2003	1	0	CTD_human
val	351	APP	0.422	0.846	C0751071	FamilialDementia	disease	C10;F03	MentalorBehavioralDysfunction	0.32	1	2005	2015	1	0	CTD_human
val	351	APP	0.422	0.846	C0751156	FRAXASyndrome	disease	C16;C10	DiseaseorSyndrome	0.30	1	2011	2011	1	0	CTD_human
val	351	APP	0.422	0.846	C0751157	FRAXESyndrome	disease	C16;C10	DiseaseorSyndrome	0.30	1	2011	2011	1	0	CTD_human
val	351	APP	0.422	0.846	C0751262	AdultLearningDisorders	group	C23;C10;F03	MentalorBehavioralDysfunction	0.30	1	2006	2018	8	0	CTD_human
val	351	APP	0.422	0.846	C0751263	LearningDisturbance	disease	C23;C10;F03	MentalorBehavioralDysfunction	0.30	1	2006	2018	8	0	CTD_human
val	351	APP	0.422	0.846	C0751265	LearningDisabilities	disease	C23;C10;F03	MentalorBehavioralDysfunction	0.30	1	2006	2018	8	0	CTD_human
val	351	APP	0.422	0.846	C0751292	Age-RelatedMemoryDisorders	group	C23;C10;F01	MentalorBehavioralDysfunction	0.30	1	2004	2018	16	0	CTD_human
val	351	APP	0.422	0.846	C0751293	MemoryDisorder,Semantic	phenotype	C23;C10;F01	MentalorBehavioralDysfunction	0.30	1	2004	2018	16	0	CTD_human
val	351	APP	0.422	0.846	C0751294	MemoryDisorder,Spatial	phenotype	C23;C10;F01	MentalorBehavioralDysfunction	0.30	1	2004	2018	16	0	CTD_human
val	351	APP	0.422	0.846	C0751295	MemoryLoss	phenotype	C23;C10;F01	SignorSymptom	0.40	1	1997	2020	16	0	CTD_human
val	351	APP	0.422	0.846	C0751733	DegenerativeDiseases,SpinalCord	group	C10	DiseaseorSyndrome	0.30	1	2005	2013	2	0	CTD_human
val	351	APP	0.422	0.846	C0878544	Cardiomyopathies	group	C14	DiseaseorSyndrome	0.30	1	2018	2018	1	0	CTD_human
val	351	APP	0.422	0.846	C0948008	Ischemicstroke	disease	C10;C14	DiseaseorSyndrome	0.31	1	2010	2020	1	0	GENOMICS_ENGLAND
val	351	APP	0.422	0.846	C1270972	Mildcognitivedisorder	disease	F03	MentalorBehavioralDysfunction	0.40	1	2003	2019	1	0	CTD_human
val	351	APP	0.422	0.846	C1279420	Anxietyneurosis(finding)	disease	F03	MentalorBehavioralDysfunction	0.30	1	2010	2010	1	0	CTD_human
val	351	APP	0.422	0.846	C1330966	DevelopmentalAcademicDisorder	phenotype	C23;C10;F03	Finding	0.30	1	2006	2018	8	0	CTD_human
val	351	APP	0.422	0.846	C2751494	CEREBRALAMYLOIDANGIOPATHY,APP-RELATED,ARCTICVARIANT	disease	C16;C18;C10;C14	DiseaseorSyndrome	0.30	1	1990	2000	2	0	CTD_human
val	351	APP	0.422	0.846	C2751536	CEREBRALAMYLOIDANGIOPATHY,APP-RELATED	disease	C16;C18;C10;C14	DiseaseorSyndrome	0.70	1	1990	2010	7	5	CTD_human;GENOMICS_ENGLAND;UNIPROT
val	351	APP	0.422	0.846	C2931672	Cerebralhemorrhagewithamyloidosis,hereditary,Dutchtype	disease	C16;C18;C10;C14	DiseaseorSyndrome	0.60	1	1990	2019	3	0	CTD_human;ORPHANET
val	351	APP	0.422	0.846	C2936349	Plaque,Amyloid	disease	C23	AcquiredAbnormality	0.40	0.973	1996	2019	2	0	CTD_human
val	351	APP	0.422	0.846	C3888307	CEREBRALAMYLOIDANGIOPATHY,APP-RELATED,FLEMISHVARIANT	disease	C16;C18;C10;C14	DiseaseorSyndrome	0.30	1	1990	2000	2	0	CTD_human
val	351	APP	0.422	0.846	C3888308	CEREBRALAMYLOIDANGIOPATHY,APP-RELATED,ITALIANVARIANT	disease	C16;C18;C10;C14	DiseaseorSyndrome	0.30	1	1990	2000	2	0	CTD_human
val	351	APP	0.422	0.846	C3888309	CEREBRALAMYLOIDANGIOPATHY,APP-RELATED,IOWAVARIANT	disease	C16;C18;C10;C14	DiseaseorSyndrome	0.30	1	1990	2000	2	0	CTD_human
val	353	APRT	0.423	0.846	C0006142	Malignantneoplasmofbreast	disease	C04;C17	NeoplasticProcess	0.40	1	1988	2018	1	0	CTD_human
val	353	APRT	0.423	0.846	C0007134	RenalCellCarcinoma	disease	C04;C13;C12	NeoplasticProcess	0.33	1	2002	2018	1	0	CTD_human
val	353	APRT	0.423	0.846	C0011570	MentalDepression	disease	F01	MentalorBehavioralDysfunction	0.33	1	1985	2019	5	0	PSYGENET
val	353	APRT	0.423	0.846	C0011581	Depressivedisorder	disease	F03	MentalorBehavioralDysfunction	0.33	1	1985	2019	5	0	PSYGENET
val	353	APRT	0.423	0.846	C0022661	KidneyFailure,Chronic	disease	C13;C12	DiseaseorSyndrome	0.31	1	2012	2019	1	0	GENOMICS_ENGLAND
val	353	APRT	0.423	0.846	C0027707	Nephritis,Interstitial	disease	C13;C12	DiseaseorSyndrome	0.30	1	2012	2012	1	0	GENOMICS_ENGLAND
val	353	APRT	0.423	0.846	C0041696	UnipolarDepression	disease	F03	MentalorBehavioralDysfunction	0.31	1	2000	2000	1	0	PSYGENET
val	353	APRT	0.423	0.846	C0268120	Adeninephosphoribosyltransferasedeficiency	disease	C16;C18;C13;C12	DiseaseorSyndrome	1.00	1	1986	2016	11	11	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
val	353	APRT	0.423	0.846	C0279702	Conventional(ClearCell)RenalCellCarcinoma	disease	C04;C13;C12	NeoplasticProcess	0.33	1	2002	2018	1	0	CTD_human
val	353	APRT	0.423	0.846	C0451641	Urolithiasis	disease	C13;C12	DiseaseorSyndrome	0.33	1	1976	2011	2	0	CTD_human
val	353	APRT	0.423	0.846	C0678222	BreastCarcinoma	disease	C04;C17	NeoplasticProcess	0.40	1	1988	2018	1	0	CTD_human
val	353	APRT	0.423	0.846	C1257931	MammaryNeoplasms,Human	disease	C04;C17	NeoplasticProcess	0.30	1	2008	2008	1	0	CTD_human
val	353	APRT	0.423	0.846	C1266042	ChromophobeRenalCellCarcinoma	disease	C04;C13;C12	NeoplasticProcess	0.30	1	2004	2004	1	0	CTD_human
val	353	APRT	0.423	0.846	C1266043	SarcomatoidRenalCellCarcinoma	disease	C04;C13;C12	NeoplasticProcess	0.30	1	2004	2004	1	0	CTD_human
val	353	APRT	0.423	0.846	C1266044	CollectingDuctCarcinomaoftheKidney	disease	C04;C13;C12	NeoplasticProcess	0.30	1	2004	2004	1	0	CTD_human
val	353	APRT	0.423	0.846	C1269683	MajorDepressiveDisorder	disease	F03	MentalorBehavioralDysfunction	0.31	1	2000	2000	1	0	PSYGENET
val	353	APRT	0.423	0.846	C1306837	PapillaryRenalCellCarcinoma	disease	C04;C13;C12	NeoplasticProcess	0.30	1	2004	2004	1	0	CTD_human
val	353	APRT	0.423	0.846	C1458155	MammaryNeoplasms	group	C04;C17	NeoplasticProcess	0.32	1	1996	2009	1	0	CTD_human
val	353	APRT	0.423	0.846	C1561643	ChronicKidneyDiseases	group	C13;C12	DiseaseorSyndrome	0.39	1	2012	2019	1	0	GENOMICS_ENGLAND
val	353	APRT	0.423	0.846	C3665382	2,8-DihydroxyadenineUrolithiasis	disease	C16;C18;C13;C12	DiseaseorSyndrome	0.80	1	1985	2012	1	0	CTD_human;ORPHANET
val	353	APRT	0.423	0.846	C4704874	MammaryCarcinoma,Human	disease	C04;C17	NeoplasticProcess	0.30	1	2008	2008	1	0	CTD_human
val	354	KLK3	0.443	0.885	C0005001	Benignprostatichypertrophy	phenotype	C12	PathologicFunction	0.30	1	2011	2011	1	0	CTD_human
val	354	KLK3	0.443	0.885	C0027643	NeoplasmRecurrence,Local	phenotype	C23;C04	NeoplasticProcess	0.30	1	2006	2006	1	0	CTD_human
val	354	KLK3	0.443	0.885	C0033578	ProstaticNeoplasms	group	C04;C12	NeoplasticProcess	0.40	0.988	1991	2019	11	0	CTD_human
val	354	KLK3	0.443	0.885	C0235874	DiseaseExacerbation	phenotype	C23	Finding	0.30	1	2003	2003	1	0	CTD_human
val	354	KLK3	0.443	0.885	C0376358	Malignantneoplasmofprostate	disease	C04;C12	NeoplasticProcess	0.50	0.958	1989	2020	11	2	CTD_human
val	354	KLK3	0.443	0.885	C0520477	ProstaticAdenoma	disease	C12	NeoplasticProcess	0.30	1	2011	2011	1	0	CTD_human
val	354	KLK3	0.443	0.885	C1334615	MalignantPhyllodesTumorofProstate	disease	C04;C12	NeoplasticProcess	0.30	1	2012	2012	1	0	CTD_human
val	354	KLK3	0.443	0.885	C1704272	BenignProstaticHyperplasia	disease	C12	DiseaseorSyndrome	0.40	0.927	1990	2020	1	0	CTD_human
val	354	KLK3	0.443	0.885	C1739363	ProstaticHypertrophy	disease	C12	DiseaseorSyndrome	0.31	1	2001	2011	1	0	CTD_human
val	354	KLK3	0.443	0.885	C2937421	ProstaticHyperplasia	disease	C12	DiseaseorSyndrome	0.37	1	2001	2019	1	0	CTD_human
val	355	FAS	0.372	0.923	C0002152	AlloxanDiabetes	disease	C18;C19	ExperimentalModelofDisease	0.30	1	2005	2005	1	0	CTD_human
val	355	FAS	0.372	0.923	C0002897	Anemia,Splenic	disease	C15	DiseaseorSyndrome	0.30	1	2005	2005	1	0	CTD_human
val	355	FAS	0.372	0.923	C0004364	AutoimmuneDiseases	group	C20	DiseaseorSyndrome	0.40	0.974	1989	2020	3	0	CTD_human
val	355	FAS	0.372	0.923	C0004943	BehcetSyndrome	disease	C16;C11;C17;C07;C14	DiseaseorSyndrome	0.33	1	2005	2015	1	0	ORPHANET
val	355	FAS	0.372	0.923	C0005684	Malignantneoplasmofurinarybladder	disease	C04;C13;C12	NeoplasticProcess	0.38	1	1997	2018	1	0	CTD_human
val	355	FAS	0.372	0.923	C0005695	BladderNeoplasm	disease	C04;C13;C12	NeoplasticProcess	0.37	1	1997	2018	1	0	CTD_human
val	355	FAS	0.372	0.923	C0007137	Squamouscellcarcinoma	disease	C04	NeoplasticProcess	0.60	0.917	1999	2014	0	3	CGI;UNIPROT
val	355	FAS	0.372	0.923	C0007193	Cardiomyopathy,Dilated	group	C14	DiseaseorSyndrome	0.51	1	1999	2007	1	0	CTD_human
val	355	FAS	0.372	0.923	C0011853	DiabetesMellitus,Experimental	disease	C18;C19	ExperimentalModelofDisease	0.50	1	2005	2009	1	0	CTD_human
val	355	FAS	0.372	0.923	C0011860	DiabetesMellitus,Non-Insulin-Dependent	disease	C18;C19	DiseaseorSyndrome	0.32	1	2005	2019	1	0	CTD_human
val	355	FAS	0.372	0.923	C0017658	Glomerulonephritis	disease	C13;C12	DiseaseorSyndrome	0.41	1	1999	2011	1	0	CTD_human
val	355	FAS	0.372	0.923	C0018939	HematologicalDisease	group	C15	DiseaseorSyndrome	0.30	1	2005	2005	1	0	CTD_human
val	355	FAS	0.372	0.923	C0019207	Hepatoma,Morris	disease	C06;C04	NeoplasticProcess;ExperimentalModelofDisease	0.30	1	2019	2019	1	0	CTD_human
val	355	FAS	0.372	0.923	C0019208	Hepatoma,Novikoff	disease	C06;C04	NeoplasticProcess;ExperimentalModelofDisease	0.30	1	2019	2019	1	0	CTD_human
val	355	FAS	0.372	0.923	C0020532	Hypersplenism	disease	C15	DiseaseorSyndrome	0.40	1	2005	2005	1	0	CTD_human
val	355	FAS	0.372	0.923	C0023467	Leukemia,Myelocytic,Acute	disease	C04	NeoplasticProcess	0.38	1	1995	2018	1	0	CTD_human
val	355	FAS	0.372	0.923	C0023893	LiverCirrhosis,Experimental	disease	C23;C06	ExperimentalModelofDisease	0.50	1	2006	2019	1	0	CTD_human
val	355	FAS	0.372	0.923	C0023904	LiverNeoplasms,Experimental	phenotype	C06;C04	NeoplasticProcess;ExperimentalModelofDisease	0.30	1	2019	2019	1	0	CTD_human
val	355	FAS	0.372	0.923	C0024121	LungNeoplasms	group	C04;C08	NeoplasticProcess	0.36	1	1998	2015	1	0	CTD_human
val	355	FAS	0.372	0.923	C0024299	Lymphoma	group	C04;C20;C15	NeoplasticProcess	0.40	1	1995	2016	0	0	GENOMICS_ENGLAND
val	355	FAS	0.372	0.923	C0024305	Lymphoma,Non-Hodgkin	disease	C04;C20;C15	NeoplasticProcess	0.54	1	1998	2010	0	2	CGI;UNIPROT
val	355	FAS	0.372	0.923	C0024535	Malaria,Falciparum	disease	C01	DiseaseorSyndrome	0.30	1	2011	2011	1	0	CTD_human
val	355	FAS	0.372	0.923	C0026896	MyastheniaGravis	disease	C04;C20;C10	DiseaseorSyndrome	0.30	1	2003	2003	1	0	CTD_human
val	355	FAS	0.372	0.923	C0026998	AcuteMyeloidLeukemia,M1	disease	C04	NeoplasticProcess	0.30	1	1995	1995	1	0	CTD_human
val	355	FAS	0.372	0.923	C0027540	Necrosis	phenotype	C23	OrganorTissueFunction	0.30	1	2005	2005	1	0	CTD_human
val	355	FAS	0.372	0.923	C0027697	Nephritis	disease	C13;C12	DiseaseorSyndrome	0.30	1	2015	2015	1	0	CTD_human
val	355	FAS	0.372	0.923	C0032963	PregnancyComplications,Cardiovascular	disease	C13;C14	DiseaseorSyndrome	0.30	1	2000	2000	1	0	CTD_human
val	355	FAS	0.372	0.923	C0033141	Cardiomyopathies,Primary	group	C14	DiseaseorSyndrome	0.30	1	2000	2007	3	0	CTD_human
val	355	FAS	0.372	0.923	C0033687	Proteinuria	phenotype	C23;C13;C12	Finding	0.30	1	2015	2015	1	0	CTD_human
val	355	FAS	0.372	0.923	C0036341	Schizophrenia	disease	F03	MentalorBehavioralDysfunction	0.31	1	2012	2012	1	0	PSYGENET
val	355	FAS	0.372	0.923	C0036529	MyocardialDiseases,Secondary	group	C14	DiseaseorSyndrome	0.30	1	2000	2007	3	0	CTD_human
val	355	FAS	0.372	0.923	C0038002	Splenomegaly	phenotype	C23	Finding	0.40	1	2011	2011	1	2	CTD_human
val	355	FAS	0.372	0.923	C0038433	StreptozotocinDiabetes	disease	C18;C19	ExperimentalModelofDisease	0.30	1	2005	2005	1	0	CTD_human
val	355	FAS	0.372	0.923	C0039338	TasteDisorders	group	C23;C10	DiseaseorSyndrome	0.30	1	2012	2012	1	0	CTD_human
val	355	FAS	0.372	0.923	C0042170	UveomeningoencephaliticSyndrome	disease	C11;C20;C10	DiseaseorSyndrome	0.31	1	2015	2015	1	0	ORPHANET
val	355	FAS	0.372	0.923	C0079744	DiffuseLargeB-CellLymphoma	disease	C04;C20;C15	NeoplasticProcess	0.37	1	2003	2018	1	0	CTD_human
val	355	FAS	0.372	0.923	C0079773	Lymphoma,T-Cell,Cutaneous	disease	C04;C20;C15	NeoplasticProcess	0.37	1	2002	2018	1	0	CTD_human
val	355	FAS	0.372	0.923	C0086404	ExperimentalHepatoma	disease	C06;C04	NeoplasticProcess;ExperimentalModelofDisease	0.30	1	2019	2019	1	0	CTD_human
val	355	FAS	0.372	0.923	C0162557	LiverFailure,Acute	disease	C06	DiseaseorSyndrome	0.35	1	1995	2019	1	0	CTD_human
val	355	FAS	0.372	0.923	C0234297	TasteDisorder,Primary	phenotype	C23;C10	DiseaseorSyndrome	0.30	1	2012	2012	1	0	CTD_human
val	355	FAS	0.372	0.923	C0234298	TasteDisorder,Primary,Sweet	phenotype	C23;C10	DiseaseorSyndrome	0.30	1	2012	2012	1	0	CTD_human
val	355	FAS	0.372	0.923	C0234299	TasteDisorder,Primary,Salt	phenotype	C23;C10	DiseaseorSyndrome	0.30	1	2012	2012	1	0	CTD_human
val	355	FAS	0.372	0.923	C0234300	TasteDisorder,Primary,Bitter	phenotype	C23;C10	DiseaseorSyndrome	0.30	1	2012	2012	1	0	CTD_human
val	355	FAS	0.372	0.923	C0234302	TasteDisorder,AnteriorTongue	phenotype	C23;C10	DiseaseorSyndrome	0.30	1	2012	2012	1	0	CTD_human
val	355	FAS	0.372	0.923	C0234303	TasteDisorder,Secondary	phenotype	C23;C10	DiseaseorSyndrome	0.30	1	2012	2012	1	0	CTD_human
val	355	FAS	0.372	0.923	C0234304	TasteDisorder,Secondary,Sweet	phenotype	C23;C10	DiseaseorSyndrome	0.30	1	2012	2012	1	0	CTD_human
val	355	FAS	0.372	0.923	C0234305	TasteDisorder,Secondary,Salt	phenotype	C23;C10	DiseaseorSyndrome	0.30	1	2012	2012	1	0	CTD_human
val	355	FAS	0.372	0.923	C0234306	TasteDisorder,Secondary,Bitter	phenotype	C23;C10	DiseaseorSyndrome	0.30	1	2012	2012	1	0	CTD_human
val	355	FAS	0.372	0.923	C0234319	TasteDisorder,PosteriorTongue	phenotype	C23;C10	DiseaseorSyndrome	0.30	1	2012	2012	1	0	CTD_human
val	355	FAS	0.372	0.923	C0240327	Taste,Metallic	phenotype	C23;C10	SignorSymptom	0.30	1	2012	2012	1	0	CTD_human
val	355	FAS	0.372	0.923	C0242379	Malignantneoplasmoflung	disease	C04;C08	NeoplasticProcess	0.40	0.923	1999	2017	1	0	CTD_human
val	355	FAS	0.372	0.923	C0242488	AcuteLungInjury	disease	C08	InjuryorPoisoning	0.30	1	2000	2000	1	0	CTD_human
val	355	FAS	0.372	0.923	C0242698	VentricularDysfunction,Left	phenotype	C14	PathologicFunction	0.30	1	2002	2002	1	0	CTD_human
val	355	FAS	0.372	0.923	C0376407	GranulomatousSlackSkin	disease	C04;C20;C15	NeoplasticProcess	0.30	1	2015	2015	1	0	CTD_human
val	355	FAS	0.372	0.923	C0400966	Non-alcoholicFattyLiverDisease	disease	C06	DiseaseorSyndrome	0.36	1	2011	2018	1	0	CTD_human
val	355	FAS	0.372	0.923	C0751339	MyastheniaGravis,Generalized	disease	C04;C20;C10	DiseaseorSyndrome	0.30	1	2003	2003	1	0	CTD_human
val	355	FAS	0.372	0.923	C0751340	MyastheniaGravis,Ocular	disease	C04;C20;C10	DiseaseorSyndrome	0.30	1	2003	2003	1	0	CTD_human
val	355	FAS	0.372	0.923	C0878544	Cardiomyopathies	group	C14	DiseaseorSyndrome	0.30	1	2000	2007	3	0	CTD_human
val	355	FAS	0.372	0.923	C1328840	AutoimmuneLymphoproliferativeSyndrome	disease	C16;C20;C15	DiseaseorSyndrome	1.00	1	1978	2018	18	10	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
val	355	FAS	0.372	0.923	C1449563	Cardiomyopathy,FamilialIdiopathic	disease	C14	DiseaseorSyndrome	0.31	1	2007	2016	1	0	CTD_human
val	355	FAS	0.372	0.923	C1704377	BrightDisease	disease	C13;C12	DiseaseorSyndrome	0.30	1	2011	2011	1	0	CTD_human
val	355	FAS	0.372	0.923	C1846545	AutoimmuneLymphoproliferativeSyndromeType2B	disease	C16;C20;C15	DiseaseorSyndrome	0.31	1	2005	2018	2	0	CTD_human
val	355	FAS	0.372	0.923	C1879321	AcuteMyeloidLeukemia(AML-M2)	disease	C04	NeoplasticProcess	0.31	1	1995	1999	1	0	CTD_human
val	355	FAS	0.372	0.923	C2717884	AutoimmuneLymphoproliferativeSyndromeType1,AutosomalDominant	disease	C16;C20;C15	DiseaseorSyndrome	0.30	1	2005	2007	2	0	CTD_human
val	355	FAS	0.372	0.923	C3241937	NonalcoholicSteatohepatitis	disease	C06	DiseaseorSyndrome	0.32	1	2013	2019	1	0	CTD_human
val	355	FAS	0.372	0.923	C3496549	MaleGermCellTumor	disease	C04;C12;C19	NeoplasticProcess	0.30				0	0	CGI
val	356	FASLG	0.43	0.885	C0003873	RheumatoidArthritis	disease	C17;C05;C20	DiseaseorSyndrome	0.34	1	2008	2015	1	0	CTD_human
val	356	FASLG	0.43	0.885	C0004153	Atherosclerosis	disease	C14	DiseaseorSyndrome	0.31	1	2004	2004	1	0	CTD_human
val	356	FASLG	0.43	0.885	C0007131	Non-SmallCellLungCarcinoma	disease	C04;C08	NeoplasticProcess	0.34	1	2008	2018	1	0	CTD_human
val	356	FASLG	0.43	0.885	C0007193	Cardiomyopathy,Dilated	group	C14	DiseaseorSyndrome	0.30	1	2007	2007	1	0	CTD_human
val	356	FASLG	0.43	0.885	C0007273	CarotidArteryDiseases	group	C10;C14	DiseaseorSyndrome	0.30	1	2004	2004	1	0	CTD_human
val	356	FASLG	0.43	0.885	C0011875	DiabeticAngiopathies	disease	C19;C14	DiseaseorSyndrome	0.30	1	2015	2015	1	0	CTD_human
val	356	FASLG	0.43	0.885	C0013182	DrugAllergy	group	C20;C25	PathologicFunction	0.30	1	2009	2009	1	0	CTD_human
val	356	FASLG	0.43	0.885	C0019158	Hepatitis	group	C06	DiseaseorSyndrome	0.40	1	2009	2009	1	0	CTD_human
val	356	FASLG	0.43	0.885	C0020474	Hyperlipidemia,FamilialCombined	disease	C16;C18	DiseaseorSyndrome	0.30	1	2004	2004	1	0	CTD_human
val	356	FASLG	0.43	0.885	C0024121	LungNeoplasms	group	C04;C08	NeoplasticProcess	0.33	1	2004	2007	0	0	CTD_human
val	356	FASLG	0.43	0.885	C0025202	melanoma	disease	C04	NeoplasticProcess	0.38	1	2001	2019	1	0	CTD_human
val	356	FASLG	0.43	0.885	C0025945	Microangiopathy,Diabetic	disease	C19;C14	DiseaseorSyndrome	0.30	1	2015	2015	1	0	CTD_human
val	356	FASLG	0.43	0.885	C0033141	Cardiomyopathies,Primary	group	C14	DiseaseorSyndrome	0.30	1	2006	2007	2	0	CTD_human
val	356	FASLG	0.43	0.885	C0033578	ProstaticNeoplasms	group	C04;C12	NeoplasticProcess	0.30	1	2007	2007	1	0	CTD_human
val	356	FASLG	0.43	0.885	C0036529	MyocardialDiseases,Secondary	group	C14	DiseaseorSyndrome	0.30	1	2006	2007	2	0	CTD_human
val	356	FASLG	0.43	0.885	C0039584	TesticularDiseases	group	C12;C19	DiseaseorSyndrome	0.31	1	2009	2019	1	0	CTD_human
val	356	FASLG	0.43	0.885	C0162557	LiverFailure,Acute	disease	C06	DiseaseorSyndrome	0.31	1	2009	2018	1	0	CTD_human
val	356	FASLG	0.43	0.885	C0242379	Malignantneoplasmoflung	disease	C04;C08	NeoplasticProcess	0.34	1	2002	2008	0	0	CTD_human
val	356	FASLG	0.43	0.885	C0242488	AcuteLungInjury	disease	C08	InjuryorPoisoning	0.30	1	2000	2000	1	0	CTD_human
val	356	FASLG	0.43	0.885	C0376358	Malignantneoplasmofprostate	disease	C04;C12	NeoplasticProcess	0.33	1	2001	2011	1	0	CTD_human
val	356	FASLG	0.43	0.885	C0577631	CarotidAtherosclerosis	disease	C10;C14	DiseaseorSyndrome	0.30	1	2004	2004	1	0	CTD_human
val	356	FASLG	0.43	0.885	C0600178	ExternalCarotidArteryDiseases	group	C10;C14	DiseaseorSyndrome	0.30	1	2004	2004	1	0	CTD_human
val	356	FASLG	0.43	0.885	C0750986	InternalCarotidArteryDiseases	group	C10;C14	DiseaseorSyndrome	0.30	1	2004	2004	1	0	CTD_human
val	356	FASLG	0.43	0.885	C0750987	ArterialDiseases,CommonCarotid	disease	C10;C14	DiseaseorSyndrome	0.30	1	2004	2004	1	0	CTD_human
val	356	FASLG	0.43	0.885	C0878544	Cardiomyopathies	group	C14	DiseaseorSyndrome	0.31	1	2006	2007	2	0	CTD_human
val	356	FASLG	0.43	0.885	C1328840	AutoimmuneLymphoproliferativeSyndrome	disease	C16;C20;C15	DiseaseorSyndrome	0.89	1	1984	2017	5	0	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
val	356	FASLG	0.43	0.885	C1449563	Cardiomyopathy,FamilialIdiopathic	disease	C14	DiseaseorSyndrome	0.30	1	2007	2007	1	0	CTD_human
val	356	FASLG	0.43	0.885	C1563937	Atherogenesis	phenotype	C14	PathologicFunction	0.30	1	2004	2004	1	0	CTD_human
val	356	FASLG	0.43	0.885	C1846545	AutoimmuneLymphoproliferativeSyndromeType2B	disease	C16;C20;C15	DiseaseorSyndrome	0.30				0	0	CTD_human
val	356	FASLG	0.43	0.885	C2717884	AutoimmuneLymphoproliferativeSyndromeType1,AutosomalDominant	disease	C16;C20;C15	DiseaseorSyndrome	0.30				0	0	CTD_human
val	357	SHROOM2	0.729	0.385	C0006142	Malignantneoplasmofbreast	disease	C04;C17	NeoplasticProcess	0.30				0	1	UNIPROT
val	358	AQP1	0.467	0.885	C0007097	Carcinoma	group	C04	NeoplasticProcess	0.32	1	2002	2018	1	0	CTD_human
val	358	AQP1	0.467	0.885	C0008340	CholedochalCyst	disease	C16;C06;C04	CongenitalAbnormality	0.30	1	2008	2008	1	0	CTD_human
val	358	AQP1	0.467	0.885	C0009439	CholedochalCyst,TypeI	disease	C16;C06;C04	CongenitalAbnormality	0.30	1	2008	2008	1	0	CTD_human
val	358	AQP1	0.467	0.885	C0010606	AdenoidCysticCarcinoma	disease	C04	NeoplasticProcess	0.31	1	2006	2014	1	0	CTD_human
val	358	AQP1	0.467	0.885	C0013608	Edema,Cardiac	disease	C23;C14	PathologicFunction	0.30	1	2013	2013	1	0	CTD_human
val	358	AQP1	0.467	0.885	C0020538	Hypertensivedisease	group	C14	DiseaseorSyndrome	0.55	1	2010	2019	1	0	CTD_human
val	358	AQP1	0.467	0.885	C0020550	Hyperthyroidism	disease	C19	DiseaseorSyndrome	0.30	1	2003	2003	1	0	CTD_human
val	358	AQP1	0.467	0.885	C0024667	AnimalMammaryNeoplasms	phenotype	C04;C22	NeoplasticProcess	0.30	1	2002	2002	1	0	CTD_human
val	358	AQP1	0.467	0.885	C0024668	MammaryNeoplasms,Experimental	phenotype	C04	NeoplasticProcess;ExperimentalModelofDisease	0.30	1	2002	2002	1	0	CTD_human
val	358	AQP1	0.467	0.885	C0030193	Pain	phenotype	C23	SignorSymptom	0.34	1	2010	2019	1	0	CTD_human
val	358	AQP1	0.467	0.885	C0036095	SalivaryGlandNeoplasms	group	C04;C07	NeoplasticProcess	0.30	1	2006	2006	1	0	CTD_human
val	358	AQP1	0.467	0.885	C0036981	Endotoxicshock	phenotype	C23;C01	PathologicFunction	0.30	1	2013	2013	1	0	CTD_human
val	358	AQP1	0.467	0.885	C0036983	SepticShock	phenotype	C23;C01	PathologicFunction	0.30	1	2013	2013	1	0	CTD_human
val	358	AQP1	0.467	0.885	C0085548	AutosomalRecessivePolycysticKidneyDisease	disease	C16;C13;C12	DiseaseorSyndrome	0.51	1	2008	2008	1	0	CTD_human
val	358	AQP1	0.467	0.885	C0205696	Anaplasticcarcinoma	disease	C04	NeoplasticProcess	0.30	1	2002	2002	1	0	CTD_human
val	358	AQP1	0.467	0.885	C0205697	Carcinoma,Spindle-Cell	disease	C04	NeoplasticProcess	0.30	1	2002	2002	1	0	CTD_human
val	358	AQP1	0.467	0.885	C0205698	Undifferentiatedcarcinoma	disease	C04	NeoplasticProcess	0.30	1	2002	2002	1	0	CTD_human
val	358	AQP1	0.467	0.885	C0205699	Carcinomatosis	phenotype	C04	NeoplasticProcess	0.30	1	2002	2002	1	0	CTD_human
val	358	AQP1	0.467	0.885	C0220636	Malignantneoplasmofsalivarygland	disease	C04;C07	NeoplasticProcess	0.30	1	2006	2006	1	0	CTD_human
val	358	AQP1	0.467	0.885	C0234230	Pain,Burning	phenotype	C23	SignorSymptom	0.30	1	2010	2010	1	0	CTD_human
val	358	AQP1	0.467	0.885	C0234238	Ache	phenotype	C23	SignorSymptom	0.30	1	2010	2010	1	0	CTD_human
val	358	AQP1	0.467	0.885	C0234254	Radiatingpain	phenotype	C23	SignorSymptom	0.30	1	2010	2010	1	0	CTD_human
val	358	AQP1	0.467	0.885	C0340543	Familialprimarypulmonaryhypertension	disease	C08	DiseaseorSyndrome	0.30	1	2018	2018	1	0	GENOMICS_ENGLAND
val	358	AQP1	0.467	0.885	C0458257	Pain,Splitting	phenotype	C23	SignorSymptom	0.30	1	2010	2010	1	0	CTD_human
val	358	AQP1	0.467	0.885	C0458259	Pain,Crushing	phenotype	C23	SignorSymptom	0.30	1	2010	2010	1	0	CTD_human
val	358	AQP1	0.467	0.885	C0600327	ToxicShockSyndrome	disease	C23;C01	DiseaseorSyndrome	0.30	1	2013	2013	1	0	CTD_human
val	358	AQP1	0.467	0.885	C0751407	Pain,Migratory	phenotype	C23	SignorSymptom	0.30	1	2010	2010	1	0	CTD_human
val	358	AQP1	0.467	0.885	C0751408	Suffering,Physical	phenotype	C23	SignorSymptom	0.30	1	2010	2010	1	0	CTD_human
val	358	AQP1	0.467	0.885	C1150929	2-oxo-hept-3-ene-1,7-dioatehydrataseactivity	phenotype		MolecularFunction	0.30	1	2018	2018	1	0	GENOMICS_ENGLAND
val	358	AQP1	0.467	0.885	C1257796	CholedochalCyst,TypeII	disease	C16;C06;C04	CongenitalAbnormality	0.30	1	2008	2008	1	0	CTD_human
val	358	AQP1	0.467	0.885	C1257797	CholedochalCyst,TypeIII	disease	C16;C06;C04	CongenitalAbnormality	0.30	1	2008	2008	1	0	CTD_human
val	358	AQP1	0.467	0.885	C1257798	CholedochalCyst,TypeIV	disease	C16;C06;C04	CongenitalAbnormality	0.30	1	2008	2008	1	0	CTD_human
val	358	AQP1	0.467	0.885	C1257799	CholedochalCyst,TypeV	disease	C16;C06;C04	CongenitalAbnormality	0.30	1	2008	2008	1	0	CTD_human
val	358	AQP1	0.467	0.885	C1257925	MammaryCarcinoma,Animal	disease	C04;C22	NeoplasticProcess	0.30	1	2002	2002	1	0	CTD_human
val	358	AQP1	0.467	0.885	C3714618	PrimaryHyperthyroidism	disease	C19	DiseaseorSyndrome	0.30	1	2003	2003	1	0	CTD_human
val	359	AQP2	0.581	0.769	C0033141	Cardiomyopathies,Primary	group	C14	DiseaseorSyndrome	0.30	1	2002	2002	1	0	CTD_human
val	359	AQP2	0.581	0.769	C0036529	MyocardialDiseases,Secondary	group	C14	DiseaseorSyndrome	0.30	1	2002	2002	1	0	CTD_human
val	359	AQP2	0.581	0.769	C0162283	NephrogenicDiabetesInsipidus	disease	C13;C12	DiseaseorSyndrome	0.90	1	1988	2020	5	4	CTD_human;GENOMICS_ENGLAND
val	359	AQP2	0.581	0.769	C0268443	AcquiredNephrogenicDiabetesInsipidus	disease	C13;C12	DiseaseorSyndrome	0.31	1	1998	2009	4	0	CTD_human
val	359	AQP2	0.581	0.769	C0677501	CongenitalNephrogenicDiabetesInsipidus	disease	C13;C12	DiseaseorSyndrome	0.40	1	1996	2019	4	0	CTD_human
val	359	AQP2	0.581	0.769	C0878544	Cardiomyopathies	group	C14	DiseaseorSyndrome	0.30	1	2002	2002	1	0	CTD_human
val	359	AQP2	0.581	0.769	C1563705	NephrogenicDiabetesInsipidus,TypeI	disease	C13;C12	DiseaseorSyndrome	0.40	0.968	1994	2020	4	0	CTD_human
val	359	AQP2	0.581	0.769	C1563706	NephrogenicDiabetesInsipidus,TypeII	disease	C13;C12	DiseaseorSyndrome	0.70	1	1994	2016	23	24	CTD_human;GENOMICS_ENGLAND;UNIPROT
val	359	AQP2	0.581	0.769	C3542500	ADH-ResistantDiabetesInsipidus	disease	C13;C12	DiseaseorSyndrome	0.30	1	2005	2009	4	0	CTD_human
val	360	AQP3	0.546	0.769	C0005684	Malignantneoplasmofurinarybladder	disease	C04;C13;C12	NeoplasticProcess	0.30	1	2012	2012	1	0	CTD_human
val	360	AQP3	0.546	0.769	C0005695	BladderNeoplasm	disease	C04;C13;C12	NeoplasticProcess	0.30	1	2012	2012	1	0	CTD_human
val	360	AQP3	0.546	0.769	C0007114	Malignantneoplasmofskin	disease	C04;C17	NeoplasticProcess	0.32	1	2011	2019	1	0	CTD_human
val	360	AQP3	0.546	0.769	C0007137	Squamouscellcarcinoma	disease	C04	NeoplasticProcess	0.33	1	2011	2019	1	0	CTD_human
val	360	AQP3	0.546	0.769	C0014859	EsophagealNeoplasms	group	C06;C04	NeoplasticProcess	0.30	1	2011	2011	1	0	CTD_human
val	360	AQP3	0.546	0.769	C0024232	LymphaticMetastasis	disease	C23;C04	NeoplasticProcess	0.31	1	2010	2011	1	0	CTD_human
val	360	AQP3	0.546	0.769	C0037286	SkinNeoplasms	group	C04;C17	NeoplasticProcess	0.33	1	2008	2019	1	0	CTD_human
val	360	AQP3	0.546	0.769	C0040411	TongueNeoplasms	group	C04;C07	NeoplasticProcess	0.30	1	2011	2011	1	0	CTD_human
val	360	AQP3	0.546	0.769	C0153349	Malignantneoplasmoftongue	disease	C04;C07	NeoplasticProcess	0.31	1	2011	2012	1	0	CTD_human
val	360	AQP3	0.546	0.769	C0546837	Malignantneoplasmofesophagus	disease	C06;C04	NeoplasticProcess	0.30	1	2011	2011	1	0	CTD_human
val	360	AQP3	0.546	0.769	C0919267	ovarianneoplasm	disease	C04;C13;C19	NeoplasticProcess	0.30	1	2008	2008	1	0	CTD_human
val	360	AQP3	0.546	0.769	C1140680	Malignantneoplasmofovary	disease	C04;C13;C19	NeoplasticProcess	0.30	1	2008	2008	1	0	CTD_human
val	361	AQP4	0.456	0.885	C0004352	AutisticDisorder	disease	F03	MentalorBehavioralDysfunction	0.31	1	2008	2008	1	0	CTD_human
val	361	AQP4	0.456	0.885	C0011570	MentalDepression	disease	F01	MentalorBehavioralDysfunction	0.31	1	2009	2017	2	0	PSYGENET
val	361	AQP4	0.456	0.885	C0011581	Depressivedisorder	disease	F03	MentalorBehavioralDysfunction	0.31	1	2014	2017	1	0	PSYGENET
val	361	AQP4	0.456	0.885	C0027873	NeuromyelitisOptica	disease	C11;C20;C10	DiseaseorSyndrome	0.40	0.963	2005	2020	2	0	CTD_human
val	361	AQP4	0.456	0.885	C0036341	Schizophrenia	disease	F03	MentalorBehavioralDysfunction	0.33	0.5	2005	2018	2	0	PSYGENET
val	361	AQP4	0.456	0.885	C0038220	StatusEpilepticus	disease	C23;C10	DiseaseorSyndrome	0.50	1	2010	2010	1	0	CTD_human
val	361	AQP4	0.456	0.885	C0038644	Suddeninfantdeathsyndrome	disease	C23	DiseaseorSyndrome	0.33	1	2010	2017	1	0	GENOMICS_ENGLAND
val	361	AQP4	0.456	0.885	C0152013	Adenocarcinomaoflung(disorder)	disease	C04	NeoplasticProcess	0.33	1	2011	2020	1	0	CTD_human
val	361	AQP4	0.456	0.885	C0270823	Petitmalstatus	disease	C23;C10	DiseaseorSyndrome	0.30	1	2010	2010	1	0	CTD_human
val	361	AQP4	0.456	0.885	C0311335	GrandMalStatusEpilepticus	disease	C23;C10	DiseaseorSyndrome	0.30	1	2010	2010	1	0	CTD_human
val	361	AQP4	0.456	0.885	C0338715	Drug-induceddepressivestate	disease	C25;F03	MentalorBehavioralDysfunction	0.30	1	2009	2014	2	0	PSYGENET
val	361	AQP4	0.456	0.885	C0393734	ComplexPartialStatusEpilepticus	disease	C23;C10	DiseaseorSyndrome	0.30	1	2010	2010	1	0	CTD_human
val	361	AQP4	0.456	0.885	C0751522	StatusEpilepticus,Subclinical	disease	C23;C10	DiseaseorSyndrome	0.30	1	2010	2010	1	0	CTD_human
val	361	AQP4	0.456	0.885	C0751523	Non-ConvulsiveStatusEpilepticus	disease	C23;C10	DiseaseorSyndrome	0.30	1	2010	2010	1	0	CTD_human
val	361	AQP4	0.456	0.885	C0751524	SimplePartialStatusEpilepticus	phenotype	C23;C10	DiseaseorSyndrome	0.30	1	2010	2010	1	0	CTD_human
val	362	AQP5	0.552	0.769	C0019284	DiaphragmaticHernia	phenotype	C23	DiseaseorSyndrome	0.30	1	2007	2007	2	0	CTD_human
val	362	AQP5	0.552	0.769	C1833030	PALMOPLANTARKERATODERMA,NONEPIDERMOLYTIC	disease	C16;C17	DiseaseorSyndrome	0.31	1	2013	2013	1	0	ORPHANET
val	362	AQP5	0.552	0.769	C1838359	Diffusepalmoplantarkeratoderma,Bothniantype	disease	C16;C17	DiseaseorSyndrome	0.70	1	1996	2016	5	5	CLINGEN;CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
val	362	AQP5	0.552	0.769	C4551675	Keratoderma,Palmoplantar	disease	C16;C17	DiseaseorSyndrome	0.31	1	2016	2016	0	0	GENOMICS_ENGLAND
val	364	AQP7	0.67	0.462	C0023893	LiverCirrhosis,Experimental	disease	C23;C06	ExperimentalModelofDisease	0.30	1	2006	2014	2	0	CTD_human
val	364	AQP7	0.67	0.462	C0028754	Obesity	disease	C23;C18	DiseaseorSyndrome	0.40	1	2006	2019	1	0	CTD_human
val	366	AQP9	0.565	0.808	C0023418	leukemia	disease	C04	NeoplasticProcess	0.30	1	2004	2004	1	0	CTD_human
val	366	AQP9	0.565	0.808	C0023467	Leukemia,Myelocytic,Acute	disease	C04	NeoplasticProcess	0.30	1	2007	2007	1	0	CTD_human
val	366	AQP9	0.565	0.808	C0023487	AcutePromyelocyticLeukemia	disease	C04	NeoplasticProcess	0.32	1	2002	2013	1	0	CTD_human
val	366	AQP9	0.565	0.808	C0026998	AcuteMyeloidLeukemia,M1	disease	C04	NeoplasticProcess	0.30	1	2007	2007	1	0	CTD_human
val	366	AQP9	0.565	0.808	C0087031	Juvenile-OnsetStillDisease	disease	C17;C05;C20	DiseaseorSyndrome	0.30	1	2009	2009	1	0	CTD_human
val	366	AQP9	0.565	0.808	C0274861	ArsenicPoisoning,Inorganic	disease	C10;C25	InjuryorPoisoning	0.30	1	2009	2009	1	0	CTD_human
val	366	AQP9	0.565	0.808	C0274862	NervousSystem,OrganicArsenicPoisoning	disease	C10;C25	InjuryorPoisoning	0.30	1	2009	2009	1	0	CTD_human
val	366	AQP9	0.565	0.808	C0311375	ArsenicPoisoning	disease	C10;C25	InjuryorPoisoning	0.30	1	2009	2009	1	0	CTD_human
val	366	AQP9	0.565	0.808	C0751851	ArsenicEncephalopathy	disease	C10;C25	DiseaseorSyndrome	0.30	1	2009	2009	1	0	CTD_human
val	366	AQP9	0.565	0.808	C0751852	ArsenicInducedPolyneuropathy	disease	C10;C25	InjuryorPoisoning	0.30	1	2009	2009	1	0	CTD_human
val	366	AQP9	0.565	0.808	C1879321	AcuteMyeloidLeukemia(AML-M2)	disease	C04	NeoplasticProcess	0.31	1	2007	2007	1	0	CTD_human
val	366	AQP9	0.565	0.808	C3495559	Juvenilearthritis	disease	C17;C05;C20	DiseaseorSyndrome	0.30	1	2009	2009	1	0	CTD_human
val	366	AQP9	0.565	0.808	C3714758	Juvenilepsoriaticarthritis	disease	C17;C05;C20	DiseaseorSyndrome	0.30	1	2009	2009	1	0	CTD_human
val	366	AQP9	0.565	0.808	C4552091	Polyarthritis,Juvenile,RheumatoidFactorNegative	disease	C17;C05;C20	DiseaseorSyndrome	0.30	1	2009	2009	1	0	CTD_human
val	366	AQP9	0.565	0.808	C4704862	Polyarthritis,Juvenile,RheumatoidFactorPositive	disease	C17;C05;C20	DiseaseorSyndrome	0.30	1	2009	2009	1	0	CTD_human
val	367	AR	0.351	0.846	C0001973	AlcoholicIntoxication,Chronic	disease	C25;F03	MentalorBehavioralDysfunction	0.31	1	2011	2014	2	0	PSYGENET
val	367	AR	0.351	0.846	C0002170	Alopecia	disease	C23;C17	DiseaseorSyndrome	0.39	1	2000	2016	1	0	CTD_human
val	367	AR	0.351	0.846	C0004114	Astrocytoma	disease	C04	NeoplasticProcess	0.30	1	2014	2014	1	0	CTD_human
val	367	AR	0.351	0.846	C0004352	AutisticDisorder	disease	F03	MentalorBehavioralDysfunction	0.34	1	2005	2013	1	0	CTD_human
val	367	AR	0.351	0.846	C0006142	Malignantneoplasmofbreast	disease	C04;C17	NeoplasticProcess	0.60	0.947	1990	2020	2	2	CTD_human;UNIPROT
val	367	AR	0.351	0.846	C0007112	Adenocarcinomaofprostate	disease	C04;C12	NeoplasticProcess	0.60	1	2002	2019	0	0	CGI
val	367	AR	0.351	0.846	C0011570	MentalDepression	disease	F01	MentalorBehavioralDysfunction	0.40	0.8	1994	2019	5	0	PSYGENET
val	367	AR	0.351	0.846	C0011581	Depressivedisorder	disease	F03	MentalorBehavioralDysfunction	0.40	0.8	1994	2019	5	0	PSYGENET
val	367	AR	0.351	0.846	C0017412	GenitalDiseases,Male	group	C12	DiseaseorSyndrome	0.30	1	2015	2015	1	0	CTD_human
val	367	AR	0.351	0.846	C0020538	Hypertensivedisease	group	C14	DiseaseorSyndrome	0.55	1	1999	2019	1	0	CTD_human
val	367	AR	0.351	0.846	C0021361	Femaleinfertility	phenotype	C13	PathologicFunction	0.30	1	2013	2013	1	0	CTD_human
val	367	AR	0.351	0.846	C0021364	Maleinfertility	phenotype	C12	DiseaseorSyndrome	0.40	0.918	1995	2019	3	0	CTD_human
val	367	AR	0.351	0.846	C0021655	InsulinResistance	phenotype	C18	PathologicFunction	0.30	1	2011	2011	1	0	CTD_human
val	367	AR	0.351	0.846	C0023418	leukemia	disease	C04	NeoplasticProcess	0.31	1	2009	2009	1	0	CTD_human
val	367	AR	0.351	0.846	C0027643	NeoplasmRecurrence,Local	phenotype	C23;C04	NeoplasticProcess	0.30	1	2001	2001	1	0	CTD_human
val	367	AR	0.351	0.846	C0033578	ProstaticNeoplasms	group	C04;C12	NeoplasticProcess	0.60	1	1990	2019	21	0	CTD_human
val	367	AR	0.351	0.846	C0038279	Sterility,Postpartum	phenotype	C13	PathologicFunction	0.30	1	2013	2013	1	0	CTD_human
val	367	AR	0.351	0.846	C0039585	Androgen-InsensitivitySyndrome	disease	C16;C13;C12;C19	DiseaseorSyndrome	1.00	0.966	1970	2019	74	98	CTD_human;GENOMICS_ENGLAND;UNIPROT
val	367	AR	0.351	0.846	C0085207	GestationalDiabetes	phenotype	C18;C13;C19	DiseaseorSyndrome	0.30	1	2010	2010	1	0	CTD_human
val	367	AR	0.351	0.846	C0086873	Pseudopelade	disease	C23;C17	DiseaseorSyndrome	0.30	1	2005	2005	1	0	CTD_human
val	367	AR	0.351	0.846	C0162311	AndrogeneticAlopecia	disease	C23;C17	DiseaseorSyndrome	0.40	0.9	1998	2019	1	0	CTD_human
val	367	AR	0.351	0.846	C0205768	SubependymalGiantCellAstrocytoma	disease	C04	NeoplasticProcess	0.30	1	2014	2014	1	0	CTD_human
val	367	AR	0.351	0.846	C0236663	Alcoholwithdrawalsyndrome	disease	C25;F03	DiseaseorSyndrome	0.34	1	2009	2011	3	0	PSYGENET
val	367	AR	0.351	0.846	C0238033	CarcinomaofMaleBreast	disease	C04;C17	NeoplasticProcess	0.40	0.958	1992	2019	2	0	CTD_human
val	367	AR	0.351	0.846	C0242788	BreastNeoplasms,Male	group	C04;C17	NeoplasticProcess	0.30	1	1992	1993	2	0	CTD_human
val	367	AR	0.351	0.846	C0263477	Femalepatternalopecia(disorder)	phenotype	C23;C17	DiseaseorSyndrome	0.30	1	2005	2005	1	0	CTD_human
val	367	AR	0.351	0.846	C0268301	ReifensteinSyndrome	disease	C16;C13;C12;C19	DiseaseorSyndrome	0.80	0.989	1984	2019	41	31	CTD_human;GENOMICS_ENGLAND;UNIPROT
val	367	AR	0.351	0.846	C0280783	JuvenilePilocyticAstrocytoma	disease	C04	NeoplasticProcess	0.30	1	2014	2014	1	0	CTD_human
val	367	AR	0.351	0.846	C0280785	DiffuseAstrocytoma	disease	C04	NeoplasticProcess	0.30	1	2014	2014	1	0	CTD_human
val	367	AR	0.351	0.846	C0282612	ProstaticIntraepithelialNeoplasias	disease	C04	NeoplasticProcess	0.40	1	1996	2017	1	0	CTD_human
val	367	AR	0.351	0.846	C0334579	Anaplasticastrocytoma	disease	C04	NeoplasticProcess	0.30	1	2014	2014	1	0	CTD_human
val	367	AR	0.351	0.846	C0334580	Protoplasmicastrocytoma	disease	C04	NeoplasticProcess	0.30	1	2014	2014	1	0	CTD_human
val	367	AR	0.351	0.846	C0334581	Gemistocyticastrocytoma	disease	C04	NeoplasticProcess	0.30	1	2014	2014	1	0	CTD_human
val	367	AR	0.351	0.846	C0334582	FibrillaryAstrocytoma	disease	C04	NeoplasticProcess	0.30	1	2014	2014	1	0	CTD_human
val	367	AR	0.351	0.846	C0334583	PilocyticAstrocytoma	disease	C04	NeoplasticProcess	0.30	1	2014	2014	1	0	CTD_human
val	367	AR	0.351	0.846	C0338070	ChildhoodCerebralAstrocytoma	disease	C04	NeoplasticProcess	0.30	1	2014	2014	1	0	CTD_human
val	367	AR	0.351	0.846	C0341869	Subfertility,Female	disease	C13	DiseaseorSyndrome	0.30	1	2013	2013	1	0	CTD_human
val	367	AR	0.351	0.846	C0376358	Malignantneoplasmofprostate	disease	C04;C12	NeoplasticProcess	1.00	0.982	1992	2020	21	16	CTD_human;GENOMICS_ENGLAND;UNIPROT
val	367	AR	0.351	0.846	C0393547	BulbospinalNeuronopathy	disease	C10	DiseaseorSyndrome	0.36	1	1990	2019	0	0	ORPHANET
val	367	AR	0.351	0.846	C0525045	MoodDisorders	group	F03	MentalorBehavioralDysfunction	0.32	1	2006	2017	1	0	PSYGENET
val	367	AR	0.351	0.846	C0547065	Mixedoligoastrocytoma	disease	C04	NeoplasticProcess	0.30	1	2014	2014	1	0	CTD_human
val	367	AR	0.351	0.846	C0556385	Cravingforalcohol	phenotype		Finding	0.30	1	2010	2010	1	0	PSYGENET
val	367	AR	0.351	0.846	C0678222	BreastCarcinoma	disease	C04;C17	NeoplasticProcess	0.40	0.947	1990	2020	2	0	CTD_human
val	367	AR	0.351	0.846	C0750935	CerebralAstrocytoma	disease	C04	NeoplasticProcess	0.30	1	2014	2014	1	0	CTD_human
val	367	AR	0.351	0.846	C0750936	IntracranialAstrocytoma	disease	C04	NeoplasticProcess	0.30	1	2014	2014	1	0	CTD_human
val	367	AR	0.351	0.846	C0752353	Atrophy,Muscular,Spinobulbar	disease	C16;C10	DiseaseorSyndrome	0.30				0	0	ORPHANET
val	367	AR	0.351	0.846	C0848676	Subfertility,Male	phenotype	C12	SignorSymptom	0.32	1	2002	2011	3	0	CTD_human
val	367	AR	0.351	0.846	C0917730	Femalesterility	phenotype	C13	Finding	0.30	1	2013	2013	1	0	CTD_human
val	367	AR	0.351	0.846	C0917731	Malesterility	phenotype	C12	Finding	0.30	1	2002	2010	3	0	CTD_human
val	367	AR	0.351	0.846	C0920563	InsulinSensitivity	phenotype	C18	PathologicFunction	0.30	1	2011	2011	1	0	CTD_human
val	367	AR	0.351	0.846	C0936016	TesticularFeminization	disease	C16;C13;C12;C19	DiseaseorSyndrome	0.60	0.955	1970	2019	2	0	CTD_human
val	367	AR	0.351	0.846	C1257931	MammaryNeoplasms,Human	disease	C04;C17	NeoplasticProcess	0.30	1	2011	2011	2	0	CTD_human
val	367	AR	0.351	0.846	C1458155	MammaryNeoplasms	group	C04;C17	NeoplasticProcess	0.40	1	2001	2019	2	0	CTD_human
val	367	AR	0.351	0.846	C1704230	GradeIAstrocytoma	disease	C04	NeoplasticProcess	0.30	1	2014	2014	1	0	CTD_human
val	367	AR	0.351	0.846	C1839259	Bulbo-SpinalAtrophy,X-Linked	disease	C16;C10	DiseaseorSyndrome	0.70	0.988	1990	2019	0	27	GENOMICS_ENGLAND;ORPHANET
val	367	AR	0.351	0.846	C2239176	Livercarcinoma	disease	C06;C04	NeoplasticProcess	0.40	1	1990	2020	1	0	CTD_human
val	367	AR	0.351	0.846	C2678098	Hypospadias1,X-Linked	disease	C16;C13;C12	DiseaseorSyndrome	0.60				0	3	CTD_human;GENOMICS_ENGLAND
val	367	AR	0.351	0.846	C2713546	AndrogenReceptorDeficiency	disease	C16;C13;C12;C19	DiseaseorSyndrome	0.32	0.75	1984	2018	2	0	CTD_human
val	367	AR	0.351	0.846	C2931395	Bulbospinalneuronopathy,X-linkedrecessive	disease	C16;C10	DiseaseorSyndrome	0.35	0.8	1992	1999	0	0	CTD_human
val	367	AR	0.351	0.846	C3658266	ProstaticCancer,Castration-Resistant	disease	C04;C12	NeoplasticProcess	0.30	1	2008	2017	4	0	CTD_human
val	367	AR	0.351	0.846	C3658267	ProstaticNeoplasms,Castration-Resistant	disease	C04;C12	NeoplasticProcess	0.30	1	2008	2017	4	0	CTD_human
val	367	AR	0.351	0.846	C4083212	Alopecia,MalePattern	disease	C23;C17	DiseaseorSyndrome	0.50	0.963	1998	2019	1	11	CTD_human
val	367	AR	0.351	0.846	C4704874	MammaryCarcinoma,Human	disease	C04;C17	NeoplasticProcess	0.30	1	2011	2011	2	0	CTD_human
val	368	ABCC6	0.54	0.654	C0009402	ColorectalCarcinoma	disease	C06;C04	NeoplasticProcess	0.30	1	2012	2012	1	0	CTD_human
val	368	ABCC6	0.54	0.654	C0009404	ColorectalNeoplasms	group	C06;C04	NeoplasticProcess	0.30	1	2012	2012	1	0	CTD_human
val	368	ABCC6	0.54	0.654	C0026654	MoyamoyaDisease	disease	C10;C14	DiseaseorSyndrome	0.30				0	0	GENOMICS_ENGLAND
val	368	ABCC6	0.54	0.654	C0033847	PseudoxanthomaElasticum	disease	C16;C17;C15;C14	DiseaseorSyndrome	1.00	0.982	1978	2020	26	312	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
val	368	ABCC6	0.54	0.654	C0235874	DiseaseExacerbation	phenotype	C23	Finding	0.30	1	2012	2012	1	0	CTD_human
val	368	ABCC6	0.54	0.654	C0264955	Idiopathicarterialcalcificationofinfancy	disease	C18;C14	DiseaseorSyndrome	0.30	1	2012	2012	1	0	ORPHANET
val	368	ABCC6	0.54	0.654	C0376359	Gronblad-StrandbergSyndrome	disease	C16;C17;C15;C14	DiseaseorSyndrome	0.30	1	2002	2015	8	0	CTD_human
val	368	ABCC6	0.54	0.654	C1859727	Arterialcalcificationofinfancy	disease	C18	DiseaseorSyndrome	0.58	1	2011	2020	2	0	CTD_human;ORPHANET
val	368	ABCC6	0.54	0.654	C1867450	PseudoxanthomaElasticum,Incomplete	disease	C16;C17;C15;C14	DiseaseorSyndrome	0.60	1	1978	2016	11	6	CTD_human;GENOMICS_ENGLAND
val	368	ABCC6	0.54	0.654	C3276161	ARTERIALCALCIFICATION,GENERALIZED,OFINFANCY,2	disease		DiseaseorSyndrome	0.60	1	2000	2012	2	16	GENOMICS_ENGLAND;UNIPROT
val	369	ARAF	0.619	0.654	C0006142	Malignantneoplasmofbreast	disease	C04;C17	NeoplasticProcess	0.30	1	2003	2003	1	0	CTD_human
val	369	ARAF	0.619	0.654	C0152013	Adenocarcinomaoflung(disorder)	disease	C04	NeoplasticProcess	0.41	1	2014	2016	0	2	CGI
val	369	ARAF	0.619	0.654	C0678222	BreastCarcinoma	disease	C04;C17	NeoplasticProcess	0.30	1	2003	2003	1	0	CTD_human
val	369	ARAF	0.619	0.654	C1257931	MammaryNeoplasms,Human	disease	C04;C17	NeoplasticProcess	0.30	1	2003	2003	1	0	CTD_human
val	369	ARAF	0.619	0.654	C1319315	Adenocarcinomaoflargeintestine	disease	C06;C04	NeoplasticProcess	0.30				0	0	UNIPROT
val	369	ARAF	0.619	0.654	C1458155	MammaryNeoplasms	group	C04;C17	NeoplasticProcess	0.30	1	2003	2003	1	0	CTD_human
val	369	ARAF	0.619	0.654	C4704874	MammaryCarcinoma,Human	disease	C04;C17	NeoplasticProcess	0.30	1	2003	2003	1	0	CTD_human
val	372	ARCN1	0.705	0.462	C0004134	Ataxia	phenotype	C23;C10	SignorSymptom	0.30	1	2010	2010	1	0	CTD_human
val	372	ARCN1	0.705	0.462	C0240991	Ataxia,Sensory	phenotype	C23;C10	SignorSymptom	0.30	1	2010	2010	1	0	CTD_human
val	372	ARCN1	0.705	0.462	C0278161	Ataxia,Motor	phenotype	C23;C10	Finding	0.30	1	2010	2010	1	0	CTD_human
val	372	ARCN1	0.705	0.462	C0427190	Ataxia,Truncal	phenotype	C23;C10	SignorSymptom	0.30	1	2010	2010	1	0	CTD_human
val	372	ARCN1	0.705	0.462	C0520966	Abnormalcoordination	phenotype	C23;C10	Finding	0.30	1	2010	2010	1	0	CTD_human
val	372	ARCN1	0.705	0.462	C0750937	Ataxia,Appendicular	phenotype	C23;C10	Finding	0.30	1	2010	2010	1	0	CTD_human
val	372	ARCN1	0.705	0.462	C0750940	Tremor,Rubral	disease	C23;C10	DiseaseorSyndrome	0.30	1	2010	2010	1	0	CTD_human
val	372	ARCN1	0.705	0.462	C4310686	SHORTSTATURE,RHIZOMELIC,WITHMICROCEPHALY,MICROGNATHIA,ANDDEVELOPMENTALDELAY	disease		DiseaseorSyndrome	0.40	1	2016	2016	1	3	GENOMICS_ENGLAND
val	374	AREG	0.487	0.769	C0004096	Asthma	disease	C08;C20	DiseaseorSyndrome	0.38	1	2005	2019	1	0	CTD_human
val	374	AREG	0.487	0.769	C0006142	Malignantneoplasmofbreast	disease	C04;C17	NeoplasticProcess	0.40	1	1993	2020	1	0	CTD_human
val	374	AREG	0.487	0.769	C0007131	Non-SmallCellLungCarcinoma	disease	C04;C08	NeoplasticProcess	0.39	1	2004	2019	2	0	CTD_human
val	374	AREG	0.487	0.769	C0007137	Squamouscellcarcinoma	disease	C04	NeoplasticProcess	0.34	1	2001	2019	1	0	CTD_human
val	374	AREG	0.487	0.769	C0014175	Endometriosis	disease	C13	DiseaseorSyndrome	0.30	1	2011	2011	1	0	CTD_human
val	374	AREG	0.487	0.769	C0018671	HeadandNeckNeoplasms	group	C04	NeoplasticProcess	0.30	1	2004	2004	1	0	CTD_human
val	374	AREG	0.487	0.769	C0018675	HeadNeoplasms	group	C04	NeoplasticProcess	0.30	1	2004	2004	1	0	CTD_human
val	374	AREG	0.487	0.769	C0024623	Malignantneoplasmofstomach	disease	C06;C04	NeoplasticProcess	0.36	1	2005	2019	3	0	CTD_human
val	374	AREG	0.487	0.769	C0027533	NeckNeoplasms	group	C04	NeoplasticProcess	0.30	1	2004	2004	1	0	CTD_human
val	374	AREG	0.487	0.769	C0034069	PulmonaryFibrosis	disease	C08	DiseaseorSyndrome	0.33	1	2005	2019	1	0	CTD_human
val	374	AREG	0.487	0.769	C0038356	StomachNeoplasms	group	C06;C04	NeoplasticProcess	0.30	1	2005	2006	3	0	CTD_human
val	374	AREG	0.487	0.769	C0087031	Juvenile-OnsetStillDisease	disease	C17;C05;C20	DiseaseorSyndrome	0.30	1	2009	2009	1	0	CTD_human
val	374	AREG	0.487	0.769	C0151744	MyocardialIschemia	disease	C14	DiseaseorSyndrome	0.32	1	2005	2020	1	0	CTD_human
val	374	AREG	0.487	0.769	C0162568	ErythropoieticProtoporphyria	disease	C16;C06;C18;C17	DiseaseorSyndrome	0.30	1	2009	2009	1	0	CTD_human
val	374	AREG	0.487	0.769	C0269102	Endometrioma	disease	C13	NeoplasticProcess	0.30	1	2011	2011	1	0	CTD_human
val	374	AREG	0.487	0.769	C0278996	MalignantHeadandNeckNeoplasm	disease	C04	NeoplasticProcess	0.31	1	2004	2009	1	0	CTD_human
val	374	AREG	0.487	0.769	C0349426	Ferrochelatasedeficiency	disease	C16;C06;C18;C17	DiseaseorSyndrome	0.30	1	2009	2009	1	0	CTD_human
val	374	AREG	0.487	0.769	C0678222	BreastCarcinoma	disease	C04;C17	NeoplasticProcess	0.40	1	1993	2020	1	0	CTD_human
val	374	AREG	0.487	0.769	C0746787	CancerofNeck	disease	C04	NeoplasticProcess	0.30	1	2004	2004	1	0	CTD_human
val	374	AREG	0.487	0.769	C0751177	CancerofHead	disease	C04	NeoplasticProcess	0.30	1	2004	2004	1	0	CTD_human
val	374	AREG	0.487	0.769	C0887900	UpperAerodigestiveTractNeoplasms	group	C04	NeoplasticProcess	0.30	1	2004	2004	1	0	CTD_human
val	374	AREG	0.487	0.769	C0919267	ovarianneoplasm	disease	C04;C13;C19	NeoplasticProcess	0.35	1	2002	2017	1	0	CTD_human
val	374	AREG	0.487	0.769	C1140680	Malignantneoplasmofovary	disease	C04;C13;C19	NeoplasticProcess	0.34	1	2002	2017	1	0	CTD_human
val	374	AREG	0.487	0.769	C1257931	MammaryNeoplasms,Human	disease	C04;C17	NeoplasticProcess	0.30	1	2001	2001	1	0	CTD_human
val	374	AREG	0.487	0.769	C1458155	MammaryNeoplasms	group	C04;C17	NeoplasticProcess	0.34	1	2001	2018	1	0	CTD_human
val	374	AREG	0.487	0.769	C1708349	HereditaryDiffuseGastricCancer	disease	C06;C04	NeoplasticProcess	0.30	1	2005	2006	3	0	CTD_human
val	374	AREG	0.487	0.769	C3495559	Juvenilearthritis	disease	C17;C05;C20	DiseaseorSyndrome	0.30	1	2009	2009	1	0	CTD_human
val	374	AREG	0.487	0.769	C3714758	Juvenilepsoriaticarthritis	disease	C17;C05;C20	DiseaseorSyndrome	0.30	1	2009	2009	1	0	CTD_human
val	374	AREG	0.487	0.769	C4552091	Polyarthritis,Juvenile,RheumatoidFactorNegative	disease	C17;C05;C20	DiseaseorSyndrome	0.30	1	2009	2009	1	0	CTD_human
val	374	AREG	0.487	0.769	C4704862	Polyarthritis,Juvenile,RheumatoidFactorPositive	disease	C17;C05;C20	DiseaseorSyndrome	0.30	1	2009	2009	1	0	CTD_human
val	374	AREG	0.487	0.769	C4704874	MammaryCarcinoma,Human	disease	C04;C17	NeoplasticProcess	0.30	1	2001	2001	1	0	CTD_human
val	374	AREG	0.487	0.769	C4721507	Alveolitis,Fibrosing	disease	C08	DiseaseorSyndrome	0.30	1	2016	2016	1	0	CTD_human
val	375	ARF1	0.626	0.615	C0006142	Malignantneoplasmofbreast	disease	C04;C17	NeoplasticProcess	0.32	1	2013	2016	1	0	CTD_human
val	375	ARF1	0.626	0.615	C0027626	NeoplasmInvasiveness	phenotype	C23;C04	PathologicFunction	0.30	1	2016	2016	1	0	CTD_human
val	375	ARF1	0.626	0.615	C0678222	BreastCarcinoma	disease	C04;C17	NeoplasticProcess	0.32	1	2013	2016	1	0	CTD_human
val	375	ARF1	0.626	0.615	C1257931	MammaryNeoplasms,Human	disease	C04;C17	NeoplasticProcess	0.30	1	2016	2016	1	0	CTD_human
val	375	ARF1	0.626	0.615	C1458155	MammaryNeoplasms	group	C04;C17	NeoplasticProcess	0.31	1	2008	2016	1	0	CTD_human
val	375	ARF1	0.626	0.615	C1868720	PeriventricularNodularHeterotopia	disease	C16;C10	DiseaseorSyndrome	0.41	1	2009	2016	1	0	ORPHANET
val	375	ARF1	0.626	0.615	C4704874	MammaryCarcinoma,Human	disease	C04;C17	NeoplasticProcess	0.30	1	2016	2016	1	0	CTD_human
val	375	ARF1	0.626	0.615	C4748602	PERIVENTRICULARNODULARHETEROTOPIA8	disease		DiseaseorSyndrome	0.40	1	2016	2016	1	3	UNIPROT
val	383	ARG1	0.476	0.846	C0002514	AminoAcidMetabolism,InbornErrors	group	C16;C18	DiseaseorSyndrome	0.30	1	2011	2011	1	0	CTD_human
val	383	ARG1	0.476	0.846	C0003949	Asbestosis	disease	C08;C24	DiseaseorSyndrome	0.30	1	2016	2016	1	0	CTD_human
val	383	ARG1	0.476	0.846	C0004096	Asthma	disease	C08;C20	DiseaseorSyndrome	0.40	0.909	2003	2018	2	0	CTD_human
val	383	ARG1	0.476	0.846	C0018500	HairDiseases	group	C17	DiseaseorSyndrome	0.30	1	2011	2011	1	0	CTD_human
val	383	ARG1	0.476	0.846	C0019193	Hepatitis,Toxic	disease	C06;C25	InjuryorPoisoning	0.30	1	2012	2012	1	0	CTD_human
val	383	ARG1	0.476	0.846	C0021053	ImmuneSystemDiseases	group	C20	DiseaseorSyndrome	0.30	1	2011	2011	1	0	CTD_human
val	383	ARG1	0.476	0.846	C0023281	Leishmaniasis	disease	C01;C17	DiseaseorSyndrome	0.31	1	2011	2018	1	0	CTD_human
val	383	ARG1	0.476	0.846	C0026848	Myopathy	group	C05;C10	DiseaseorSyndrome	0.30	1	2011	2011	1	0	CTD_human
val	383	ARG1	0.476	0.846	C0032927	PrecancerousConditions	group	C04	NeoplasticProcess	0.31	1	2012	2015	1	0	CTD_human
val	383	ARG1	0.476	0.846	C0037116	Silicosis	disease	C08;C24	DiseaseorSyndrome	0.50	1	2004	2007	1	0	CTD_human
val	383	ARG1	0.476	0.846	C0152013	Adenocarcinomaoflung(disorder)	disease	C04	NeoplasticProcess	0.31	1	2016	2019	1	0	CTD_human
val	383	ARG1	0.476	0.846	C0268548	Hyperargininemia	phenotype	C16;C18;C10	DiseaseorSyndrome	1.00	1	1944	2020	12	3	CLINGEN;CTD_human;GENOMICS_ENGLAND;UNIPROT
val	383	ARG1	0.476	0.846	C0282313	Condition,Preneoplastic	disease	C04	NeoplasticProcess	0.30	1	2012	2012	1	0	CTD_human
val	383	ARG1	0.476	0.846	C0750905	AminoAcidMetabolism,InheritedDisorders	disease	C16;C18	DiseaseorSyndrome	0.30	1	2011	2011	1	0	CTD_human
val	383	ARG1	0.476	0.846	C0860207	Drug-InducedLiverDisease	phenotype	C06;C25	DiseaseorSyndrome	0.30	1	2012	2012	1	0	CTD_human
val	383	ARG1	0.476	0.846	C1262760	Hepatitis,Drug-Induced	disease	C06;C25	DiseaseorSyndrome	0.30	1	2012	2012	1	0	CTD_human
val	383	ARG1	0.476	0.846	C2930617	PulmonaryFibrosis-fromAsbestosExposure	disease	C08;C24	DiseaseorSyndrome	0.30	1	2016	2016	1	0	CTD_human
val	383	ARG1	0.476	0.846	C3658290	Drug-InducedAcuteLiverInjury	disease	C06;C25	DiseaseorSyndrome	0.30	1	2012	2012	1	0	CTD_human
val	383	ARG1	0.476	0.846	C4277682	ChemicalandDrugInducedLiverInjury	disease	C06;C25	DiseaseorSyndrome	0.30	1	2012	2012	1	0	CTD_human
val	383	ARG1	0.476	0.846	C4279912	Chemically-InducedLiverToxicity	disease	C06;C25	DiseaseorSyndrome	0.30	1	2012	2012	1	0	CTD_human
val	384	ARG2	0.569	0.731	C0004096	Asthma	disease	C08;C20	DiseaseorSyndrome	0.39	1	2003	2017	1	0	CTD_human
val	384	ARG2	0.569	0.731	C0020542	PulmonaryHypertension	phenotype	C08	PathologicFunction	0.30	1	2014	2014	1	0	CTD_human
val	384	ARG2	0.569	0.731	C0027540	Necrosis	phenotype	C23	OrganorTissueFunction	0.30	1	2013	2013	1	0	CTD_human
val	384	ARG2	0.569	0.731	C0027746	NerveDegeneration	phenotype	C23	CellorMolecularDysfunction	0.30	1	2018	2018	1	0	CTD_human
val	384	ARG2	0.569	0.731	C0033578	ProstaticNeoplasms	group	C04;C12	NeoplasticProcess	0.31	1	2008	2013	1	0	CTD_human
val	384	ARG2	0.569	0.731	C0035304	RetinalDegeneration	phenotype	C11	PathologicFunction	0.30	1	2018	2018	1	0	CTD_human
val	384	ARG2	0.569	0.731	C0235874	DiseaseExacerbation	phenotype	C23	Finding	0.30	1	2013	2013	1	0	CTD_human
val	384	ARG2	0.569	0.731	C0376358	Malignantneoplasmofprostate	disease	C04;C12	NeoplasticProcess	0.32	1	2008	2013	1	0	CTD_human
val	384	ARG2	0.569	0.731	C0887833	Carcinoma,PancreaticDuctal	disease	C06;C04;C19	NeoplasticProcess	0.31	1	2013	2013	1	0	CTD_human
val	387	RHOA	0.502	0.808	C0000771	Abnormalities,Drug-Induced	group	C16	CongenitalAbnormality	0.30	1	2015	2015	1	0	CTD_human
val	387	RHOA	0.502	0.808	C0002170	Alopecia	disease	C23;C17	DiseaseorSyndrome	0.30	1	2019	2019	1	0	CTD_human
val	387	RHOA	0.502	0.808	C0005684	Malignantneoplasmofurinarybladder	disease	C04;C13;C12	NeoplasticProcess	0.30	1	2010	2010	1	0	CTD_human
val	387	RHOA	0.502	0.808	C0005695	BladderNeoplasm	disease	C04;C13;C12	NeoplasticProcess	0.30	1	2010	2010	1	0	CTD_human
val	387	RHOA	0.502	0.808	C0006413	BurkittLymphoma	disease	C04;C01;C20;C15	NeoplasticProcess	0.32	1	2014	2016	0	0	CGI
val	387	RHOA	0.502	0.808	C0007097	Carcinoma	group	C04	NeoplasticProcess	0.31	1	2014	2018	1	0	CTD_human
val	387	RHOA	0.502	0.808	C0009171	CocaineAbuse	disease	C25;F03	MentalorBehavioralDysfunction	0.30	1	2018	2018	1	0	CTD_human
val	387	RHOA	0.502	0.808	C0013575	EctodermalDysplasia	disease	C16;C17	DiseaseorSyndrome	0.30	1	2019	2019	1	0	CTD_human
val	387	RHOA	0.502	0.808	C0020981	AngioimmunoblasticLymphadenopathy	disease	C20;C15	NeoplasticProcess	0.40	1	2014	2019	2	0	CTD_human
val	387	RHOA	0.502	0.808	C0024299	Lymphoma	group	C04;C20;C15	NeoplasticProcess	0.34	1	2014	2019	0	0	CGI
val	387	RHOA	0.502	0.808	C0024623	Malignantneoplasmofstomach	disease	C06;C04	NeoplasticProcess	0.39	1	2004	2020	3	0	CTD_human
val	387	RHOA	0.502	0.808	C0027626	NeoplasmInvasiveness	phenotype	C23;C04	PathologicFunction	0.30	1	2010	2010	1	0	CTD_human
val	387	RHOA	0.502	0.808	C0033687	Proteinuria	phenotype	C23;C13;C12	Finding	0.30	1	2010	2010	1	0	CTD_human
val	387	RHOA	0.502	0.808	C0038356	StomachNeoplasms	group	C06;C04	NeoplasticProcess	0.32	1	2004	2014	3	0	CTD_human
val	387	RHOA	0.502	0.808	C0038587	SubstanceWithdrawalSyndrome	disease	C25;F03	MentalorBehavioralDysfunction	0.30	1	2018	2018	1	0	CTD_human
val	387	RHOA	0.502	0.808	C0040435	ToothDiseases	group	C07	DiseaseorSyndrome	0.30	1	2019	2019	1	0	CTD_human
val	387	RHOA	0.502	0.808	C0079772	T-CellLymphoma	disease	C04;C20;C15	NeoplasticProcess	0.32	1	2014	2017	1	0	CTD_human
val	387	RHOA	0.502	0.808	C0079773	Lymphoma,T-Cell,Cutaneous	disease	C04;C20;C15	NeoplasticProcess	0.30	1	2015	2015	1	0	CTD_human
val	387	RHOA	0.502	0.808	C0079774	PeripheralT-CellLymphoma	disease	C04;C20;C15	NeoplasticProcess	0.38	1	2014	2019	2	0	CTD_human
val	387	RHOA	0.502	0.808	C0086189	DrugWithdrawalSymptoms	phenotype	C25;F03	SignorSymptom	0.30	1	2018	2018	1	0	CTD_human
val	387	RHOA	0.502	0.808	C0086873	Pseudopelade	disease	C23;C17	DiseaseorSyndrome	0.30	1	2019	2019	1	0	CTD_human
val	387	RHOA	0.502	0.808	C0087169	WithdrawalSymptoms	phenotype	C25;F03	SignorSymptom	0.30	1	2018	2018	1	0	CTD_human
val	387	RHOA	0.502	0.808	C0162311	AndrogeneticAlopecia	disease	C23;C17	DiseaseorSyndrome	0.30	1	2019	2019	1	0	CTD_human
val	387	RHOA	0.502	0.808	C0162361	HidroticEctodermalDysplasia	disease	C16;C17	DiseaseorSyndrome	0.30	1	2019	2019	1	0	CTD_human
val	387	RHOA	0.502	0.808	C0162835	Hypopigmentationdisorder	disease	C17	DiseaseorSyndrome	0.31	1	2019	2019	1	0	CTD_human
val	387	RHOA	0.502	0.808	C0205696	Anaplasticcarcinoma	disease	C04	NeoplasticProcess	0.30	1	2014	2014	1	0	CTD_human
val	387	RHOA	0.502	0.808	C0205697	Carcinoma,Spindle-Cell	disease	C04	NeoplasticProcess	0.30	1	2014	2014	1	0	CTD_human
val	387	RHOA	0.502	0.808	C0205698	Undifferentiatedcarcinoma	disease	C04	NeoplasticProcess	0.30	1	2014	2014	1	0	CTD_human
val	387	RHOA	0.502	0.808	C0205699	Carcinomatosis	phenotype	C04	NeoplasticProcess	0.30	1	2014	2014	1	0	CTD_human
val	387	RHOA	0.502	0.808	C0235833	Congenitaldiaphragmatichernia	disease	C23;C16	CongenitalAbnormality	0.30	1	2015	2015	1	0	CTD_human
val	387	RHOA	0.502	0.808	C0236736	Cocaine-RelatedDisorders	group	C25;F03	MentalorBehavioralDysfunction	0.30	1	2018	2018	1	0	CTD_human
val	387	RHOA	0.502	0.808	C0238198	GastrointestinalStromalTumors	group	C06;C04	NeoplasticProcess	0.30				0	0	CGI
val	387	RHOA	0.502	0.808	C0263477	Femalepatternalopecia(disorder)	phenotype	C23;C17	DiseaseorSyndrome	0.30	1	2019	2019	1	0	CTD_human
val	387	RHOA	0.502	0.808	C0265316	NeurocutaneousSyndromes	disease	C16;C17;C10	DiseaseorSyndrome	0.30	1	2019	2019	1	0	CTD_human
val	387	RHOA	0.502	0.808	C0265699	CongenitalherniaofforamenofMorgagni	disease	C23;C16	CongenitalAbnormality	0.30	1	2015	2015	1	0	CTD_human
val	387	RHOA	0.502	0.808	C0265700	CongenitalherniaofforamenofBochdalek	disease	C23;C16	CongenitalAbnormality	0.30	1	2015	2015	1	0	CTD_human
val	387	RHOA	0.502	0.808	C0270612	Leukoencephalopathy	group	C10	DiseaseorSyndrome	0.30	1	2019	2019	1	0	CTD_human
val	387	RHOA	0.502	0.808	C0282160	AplasiaCutisCongenita	disease	C16;C17	CongenitalAbnormality	0.30	1	2019	2019	1	0	CTD_human
val	387	RHOA	0.502	0.808	C0376407	GranulomatousSlackSkin	disease	C04;C20;C15	NeoplasticProcess	0.30	1	2015	2015	1	0	CTD_human
val	387	RHOA	0.502	0.808	C0376634	CraniofacialAbnormalities	group	C16;C05	CongenitalAbnormality	0.30	1	2019	2019	1	0	CTD_human
val	387	RHOA	0.502	0.808	C0600427	CocaineDependence	disease	C25;F03	MentalorBehavioralDysfunction	0.30	1	2018	2018	1	0	CTD_human
val	387	RHOA	0.502	0.808	C1706004	AnhydroticEctodermalDysplasias	disease	C16;C17	CongenitalAbnormality	0.30	1	2019	2019	1	0	CTD_human
val	387	RHOA	0.502	0.808	C1708349	HereditaryDiffuseGastricCancer	disease	C06;C04	NeoplasticProcess	0.30	1	2004	2014	3	0	CTD_human
val	387	RHOA	0.502	0.808	C1744559	Congenitalectodermaldysplasiaofface	disease	C16;C17	DiseaseorSyndrome	0.30	1	2019	2019	1	0	CTD_human
val	387	RHOA	0.502	0.808	C1858991	ChildhoodAtaxiawithCentralNervousSystemHypomyelinization	disease	C10	DiseaseorSyndrome	0.30	1	2019	2019	1	0	CTD_human
val	387	RHOA	0.502	0.808	C4083212	Alopecia,MalePattern	disease	C23;C17	DiseaseorSyndrome	0.30	1	2019	2019	1	0	CTD_human
val	388	RHOB	0.653	0.423	C0036421	SystemicScleroderma	disease	C17	DiseaseorSyndrome	0.33	0.667	2011	2014	1	0	CTD_human
val	389	RHOC	0.641	0.308	C0027627	NeoplasmMetastasis	phenotype	C23;C04	NeoplasticProcess	0.40	1	2003	2019	1	0	CTD_human
val	389	RHOC	0.641	0.308	C0151744	MyocardialIschemia	disease	C14	DiseaseorSyndrome	0.30	1	2005	2005	1	0	CTD_human
val	390	RND3	0.656	0.385	C2239176	Livercarcinoma	disease	C06;C04	NeoplasticProcess	0.31	1	2012	2017	1	0	CTD_human
val	392	ARHGAP1	0.638	0.577	C0036341	Schizophrenia	disease	F03	MentalorBehavioralDysfunction	0.31	1	2012	2012	1	0	PSYGENET
val	393	ARHGAP4	0.736	0.5	C0019693	HIVInfections	group	C01;C20	DiseaseorSyndrome	0.30	1	2004	2004	1	0	CTD_human
val	393	ARHGAP4	0.736	0.5	C4505456	HIVCoinfection	disease	C01;C20	DiseaseorSyndrome	0.30	1	2004	2004	1	0	CTD_human
val	395	ARHGAP6	0.769	0.269	C2931456	Prostatecancer,familial	disease	C04;C12	NeoplasticProcess	0.30	1	2018	2018	1	0	CTD_human
val	395	ARHGAP6	0.769	0.269	C4722327	PROSTATECANCER,HEREDITARY,1	disease	C04;C12	NeoplasticProcess	0.30	1	2018	2018	1	0	CTD_human
val	396	ARHGDIA	0.663	0.577	C0006142	Malignantneoplasmofbreast	disease	C04;C17	NeoplasticProcess	0.32	1	2010	2014	1	0	CTD_human
val	396	ARHGDIA	0.663	0.577	C0019693	HIVInfections	group	C01;C20	DiseaseorSyndrome	0.30	1	2004	2004	1	0	CTD_human
val	396	ARHGDIA	0.663	0.577	C0022548	Keloid	disease	C23;C17	AcquiredAbnormality	0.30	1	2010	2010	1	0	CTD_human
val	396	ARHGDIA	0.663	0.577	C0027627	NeoplasmMetastasis	phenotype	C23;C04	NeoplasticProcess	0.35	1	2008	2016	1	0	CTD_human
val	396	ARHGDIA	0.663	0.577	C0678222	BreastCarcinoma	disease	C04;C17	NeoplasticProcess	0.32	1	2010	2014	1	0	CTD_human
val	396	ARHGDIA	0.663	0.577	C1257931	MammaryNeoplasms,Human	disease	C04;C17	NeoplasticProcess	0.30	1	2010	2010	1	0	CTD_human
val	396	ARHGDIA	0.663	0.577	C1458155	MammaryNeoplasms	group	C04;C17	NeoplasticProcess	0.31	1	2010	2015	1	0	CTD_human
val	396	ARHGDIA	0.663	0.577	C1868672	NEPHROTICSYNDROME,STEROID-RESISTANT,AUTOSOMALRECESSIVE	disease	C13;C12	DiseaseorSyndrome	0.30	1	2013	2013	1	0	ORPHANET
val	396	ARHGDIA	0.663	0.577	C3808874	ADVANCEDSLEEPPHASESYNDROME,FAMILIAL,2	disease		DiseaseorSyndrome	0.30	1	2019	2019	1	0	GENOMICS_ENGLAND
val	396	ARHGDIA	0.663	0.577	C3808953	NEPHROTICSYNDROME,TYPE8	disease		DiseaseorSyndrome	0.60				0	3	CTD_human;GENOMICS_ENGLAND
val	396	ARHGDIA	0.663	0.577	C4505456	HIVCoinfection	disease	C01;C20	DiseaseorSyndrome	0.30	1	2004	2004	1	0	CTD_human
val	396	ARHGDIA	0.663	0.577	C4704874	MammaryCarcinoma,Human	disease	C04;C17	NeoplasticProcess	0.30	1	2010	2010	1	0	CTD_human
val	397	ARHGDIB	0.633	0.654	C0019693	HIVInfections	group	C01;C20	DiseaseorSyndrome	0.30	1	2004	2004	1	0	CTD_human
val	397	ARHGDIB	0.633	0.654	C0023893	LiverCirrhosis,Experimental	disease	C23;C06	ExperimentalModelofDisease	0.30	1	2014	2014	1	0	CTD_human
val	397	ARHGDIB	0.633	0.654	C0948089	AcuteCoronarySyndrome	disease	C14	DiseaseorSyndrome	0.30	1	2011	2011	1	0	CTD_human
val	397	ARHGDIB	0.633	0.654	C4505456	HIVCoinfection	disease	C01;C20	DiseaseorSyndrome	0.30	1	2004	2004	1	0	CTD_human
val	399	RHOH	0.666	0.462	C0014522	EpidermodysplasiaVerruciformis	disease	C01;C17	NeoplasticProcess	0.32	1	2012	2013	1	0	GENOMICS_ENGLAND
val	399	RHOH	0.666	0.462	C0494261	Combinedimmunodeficiency	disease	C16;C18;C20	DiseaseorSyndrome	0.30	1	2013	2013	1	0	GENOMICS_ENGLAND
val	399	RHOH	0.666	0.462	C4749042	EPIDERMODYSPLASIAVERRUCIFORMIS,SUSCEPTIBILITYTO,4	phenotype		Finding	0.30	1	2012	2012	1	0	ORPHANET
val	401	PHOX2A	0.7	0.346	C1865915	FIBROSISOFEXTRAOCULARMUSCLES,CONGENITAL,2	disease	C23;C16;C11;C10	DiseaseorSyndrome	0.73	0.8	2001	2012	2	1	CTD_human;GENOMICS_ENGLAND;UNIPROT
val	402	ARL2	0.743	0.269	C0025202	melanoma	disease	C04	NeoplasticProcess	0.30	1	2012	2012	1	0	CTD_human
val	403	ARL3	0.603	0.615	C0035334	RetinitisPigmentosa	disease	C16;C11	DiseaseorSyndrome	0.34	1	2006	2019	1	0	ORPHANET
val	403	ARL3	0.603	0.615	C0431399	Familialaplasiaofthevermis	disease	C16;C13;C11;C12	DiseaseorSyndrome	0.33	1	2014	2018	1	0	ORPHANET
val	403	ARL3	0.603	0.615	C3553264	JOUBERTSYNDROME17	disease		DiseaseorSyndrome	0.30	1	2018	2018	1	0	GENOMICS_ENGLAND
val	403	ARL3	0.603	0.615	C4551568	Joubertsyndrome1	disease	C16;C13;C11;C12	DiseaseorSyndrome	0.30	1	2018	2018	1	0	ORPHANET
val	403	ARL3	0.603	0.615	C4748442	JOUBERTSYNDROME35	disease		DiseaseorSyndrome	0.40	1	2018	2018	1	2	UNIPROT
val	403	ARL3	0.603	0.615	C4748536	RETINITISPIGMENTOSA83	disease		DiseaseorSyndrome	0.30	1	2016	2016	1	0	UNIPROT
val	405	ARNT	0.575	0.692	C0000786	Spontaneousabortion	phenotype	C13	PathologicFunction	0.30	1	2008	2008	1	0	CTD_human
val	405	ARNT	0.575	0.692	C0000822	Abortion,Tubal	phenotype	C13	PathologicFunction	0.30	1	2008	2008	1	0	CTD_human
val	405	ARNT	0.575	0.692	C0009402	ColorectalCarcinoma	disease	C06;C04	NeoplasticProcess	0.33	1	2011	2015	1	0	CTD_human
val	405	ARNT	0.575	0.692	C0009404	ColorectalNeoplasms	group	C06;C04	NeoplasticProcess	0.30	1	2011	2011	1	0	CTD_human
val	405	ARNT	0.575	0.692	C0014175	Endometriosis	disease	C13	DiseaseorSyndrome	0.33	0.75	2002	2015	1	0	CTD_human
val	405	ARNT	0.575	0.692	C0019193	Hepatitis,Toxic	disease	C06;C25	InjuryorPoisoning	0.30	1	2010	2010	1	0	CTD_human
val	405	ARNT	0.575	0.692	C0023452	ChildhoodAcuteLymphoblasticLeukemia	disease	C04;C20;C15	NeoplasticProcess	0.30	1	2012	2012	1	0	CTD_human
val	405	ARNT	0.575	0.692	C0023453	L2AcuteLymphoblasticLeukemia	disease	C04;C20;C15	NeoplasticProcess	0.30	1	2012	2012	1	0	CTD_human
val	405	ARNT	0.575	0.692	C0023890	LiverCirrhosis	disease	C23;C06	DiseaseorSyndrome	0.30	1	2012	2012	1	0	CTD_human
val	405	ARNT	0.575	0.692	C0025202	melanoma	disease	C04	NeoplasticProcess	0.37	1	2006	2019	1	0	CTD_human
val	405	ARNT	0.575	0.692	C0027659	Neoplasms,Experimental	phenotype	C04	NeoplasticProcess;ExperimentalModelofDisease	0.30	1	1998	1998	1	0	CTD_human
val	405	ARNT	0.575	0.692	C0239946	Fibrosis,Liver	disease	C23;C06	DiseaseorSyndrome	0.30	1	2012	2012	1	0	CTD_human
val	405	ARNT	0.575	0.692	C0269102	Endometrioma	disease	C13	NeoplasticProcess	0.30	1	2012	2012	1	0	CTD_human
val	405	ARNT	0.575	0.692	C0860207	Drug-InducedLiverDisease	phenotype	C06;C25	DiseaseorSyndrome	0.30	1	2010	2010	1	0	CTD_human
val	405	ARNT	0.575	0.692	C1262760	Hepatitis,Drug-Induced	disease	C06;C25	DiseaseorSyndrome	0.30	1	2010	2010	1	0	CTD_human
val	405	ARNT	0.575	0.692	C1961102	PrecursorCellLymphoblasticLeukemiaLymphoma	disease	C04;C20;C15	NeoplasticProcess	0.31	1	2006	2012	1	0	CTD_human
val	405	ARNT	0.575	0.692	C3658290	Drug-InducedAcuteLiverInjury	disease	C06;C25	DiseaseorSyndrome	0.30	1	2010	2010	1	0	CTD_human
val	405	ARNT	0.575	0.692	C3830362	EarlyPregnancyLoss	phenotype	C13	Finding	0.30	1	2008	2008	1	0	CTD_human
val	405	ARNT	0.575	0.692	C4277682	ChemicalandDrugInducedLiverInjury	disease	C06;C25	DiseaseorSyndrome	0.30	1	2010	2010	1	0	CTD_human
val	405	ARNT	0.575	0.692	C4279912	Chemically-InducedLiverToxicity	disease	C06;C25	DiseaseorSyndrome	0.30	1	2010	2010	1	0	CTD_human
val	405	ARNT	0.575	0.692	C4552766	Miscarriage	disease	C13	DiseaseorSyndrome	0.31	1	2006	2008	1	0	CTD_human
val	406	ARNTL	0.51	0.885	C0000772	Multiplecongenitalanomalies	group	C16	CongenitalAbnormality	0.30	1	2014	2014	1	0	CTD_human
val	406	ARNTL	0.51	0.885	C0005586	BipolarDisorder	disease	F03	MentalorBehavioralDysfunction	0.37	1	2006	2019	5	0	PSYGENET
val	406	ARNTL	0.51	0.885	C0011570	MentalDepression	disease	F01	MentalorBehavioralDysfunction	0.36	1	2009	2018	3	0	PSYGENET
val	406	ARNTL	0.51	0.885	C0011581	Depressivedisorder	disease	F03	MentalorBehavioralDysfunction	0.36	1	2009	2018	3	0	PSYGENET
val	406	ARNTL	0.51	0.885	C0021361	Femaleinfertility	phenotype	C13	PathologicFunction	0.30	1	2010	2010	1	0	CTD_human
val	406	ARNTL	0.51	0.885	C0023473	MyeloidLeukemia,Chronic	disease	C04;C15	NeoplasticProcess	0.31	1	2006	2011	1	0	CTD_human
val	406	ARNTL	0.51	0.885	C0038279	Sterility,Postpartum	phenotype	C13	PathologicFunction	0.30	1	2010	2010	1	0	CTD_human
val	406	ARNTL	0.51	0.885	C0085159	SeasonalAffectiveDisorder	disease	F03	MentalorBehavioralDysfunction	0.32	1	2007	2015	1	0	PSYGENET
val	406	ARNTL	0.51	0.885	C0151744	MyocardialIschemia	disease	C14	DiseaseorSyndrome	0.30	1	2005	2005	1	0	CTD_human
val	406	ARNTL	0.51	0.885	C0268548	Hyperargininemia	phenotype	C16;C18;C10	DiseaseorSyndrome	0.30	1	2016	2016	1	0	CTD_human
val	406	ARNTL	0.51	0.885	C0341869	Subfertility,Female	disease	C13	DiseaseorSyndrome	0.30	1	2010	2010	1	0	CTD_human
val	406	ARNTL	0.51	0.885	C0525045	MoodDisorders	group	F03	MentalorBehavioralDysfunction	0.32	1	2009	2016	2	0	PSYGENET
val	406	ARNTL	0.51	0.885	C0917730	Femalesterility	phenotype	C13	Finding	0.30	1	2010	2010	1	0	CTD_human
val	407	ARR3	0.46	0.846	C4538795	MYOPIA26,X-LINKED,FEMALE-LIMITED	disease		DiseaseorSyndrome	0.40	1	2016	2016	1	3	UNIPROT
val	408	ARRB1	0.588	0.846	C0023890	LiverCirrhosis	disease	C23;C06	DiseaseorSyndrome	0.30	1	2016	2016	1	0	CTD_human
val	408	ARRB1	0.588	0.846	C0041696	UnipolarDepression	disease	F03	MentalorBehavioralDysfunction	0.31	1	2013	2015	1	0	PSYGENET
val	408	ARRB1	0.588	0.846	C0239946	Fibrosis,Liver	disease	C23;C06	DiseaseorSyndrome	0.32	1	2016	2019	1	0	CTD_human
val	408	ARRB1	0.588	0.846	C1269683	MajorDepressiveDisorder	disease	F03	MentalorBehavioralDysfunction	0.31	1	2013	2015	1	0	PSYGENET
val	408	ARRB1	0.588	0.846	C3178803	SocialAnhedonia	disease	C23;C10;F01	MentalorBehavioralDysfunction	0.30	1	2013	2013	1	0	PSYGENET
val	409	ARRB2	0.561	0.769	C0005586	BipolarDisorder	disease	F03	MentalorBehavioralDysfunction	0.30	1	2008	2008	1	0	PSYGENET
val	409	ARRB2	0.561	0.769	C0011570	MentalDepression	disease	F01	MentalorBehavioralDysfunction	0.30	1	2008	2008	1	0	PSYGENET
val	409	ARRB2	0.561	0.769	C0011581	Depressivedisorder	disease	F03	MentalorBehavioralDysfunction	0.30	1	2008	2008	1	0	PSYGENET
val	409	ARRB2	0.561	0.769	C0023893	LiverCirrhosis,Experimental	disease	C23;C06	ExperimentalModelofDisease	0.30	1	2014	2014	1	0	CTD_human
val	409	ARRB2	0.561	0.769	C0236733	Amphetamine-RelatedDisorders	group	C25;F03	MentalorBehavioralDysfunction	0.30	1	2007	2007	1	0	CTD_human
val	409	ARRB2	0.561	0.769	C0236804	AmphetamineAddiction	disease	C25;F03	MentalorBehavioralDysfunction	0.30	1	2007	2007	1	0	CTD_human
val	409	ARRB2	0.561	0.769	C0236807	AmphetamineAbuse	disease	C25;F03	MentalorBehavioralDysfunction	0.30	1	2007	2007	1	0	CTD_human
val	409	ARRB2	0.561	0.769	C0525045	MoodDisorders	group	F03	MentalorBehavioralDysfunction	0.31	1	2007	2007	1	0	PSYGENET
val	410	ARSA	0.448	0.923	C0001973	AlcoholicIntoxication,Chronic	disease	C25;F03	MentalorBehavioralDysfunction	0.33	1	1984	2002	4	0	PSYGENET
val	410	ARSA	0.448	0.923	C0013421	Dystonia	phenotype	C23;C10	SignorSymptom	0.40				0	0	GENOMICS_ENGLAND
val	410	ARSA	0.448	0.923	C0023522	Leukodystrophy,Metachromatic	disease	C16;C18;C10	DiseaseorSyndrome	1.00	0.978	1975	2019	44	142	CTD_human;GENOMICS_ENGLAND;UNIPROT
val	410	ARSA	0.448	0.923	C0041696	UnipolarDepression	disease	F03	MentalorBehavioralDysfunction	0.31	1	1996	1996	1	0	PSYGENET
val	410	ARSA	0.448	0.923	C0751276	Metachromaticleukodystrophy,juveniletype	disease	C16;C18;C10	DiseaseorSyndrome	0.43	1	1983	2006	0	5	CTD_human
val	410	ARSA	0.448	0.923	C0751278	MetachromaticLeukodystrophy,Infant	disease	C16;C18;C10	DiseaseorSyndrome	0.50	1	1991	2004	0	4	CTD_human
val	410	ARSA	0.448	0.923	C0751279	MetachromaticLeukodystrophy,Adult-Type(disorder)	disease	C16;C18;C10	DiseaseorSyndrome	0.45	1	1978	2011	0	7	CTD_human
val	410	ARSA	0.448	0.923	C1269683	MajorDepressiveDisorder	disease	F03	MentalorBehavioralDysfunction	0.31	1	1996	1996	1	0	PSYGENET
val	410	ARSA	0.448	0.923	C2713319	ArylsulfataseADeficiency	disease	C16;C18;C10	DiseaseorSyndrome	0.57	1	1980	2019	1	0	CTD_human;GENOMICS_ENGLAND
val	411	ARSB	0.595	0.692	C0026709	MucopolysaccharidosisVI	disease	C16;C18;C17	DiseaseorSyndrome	1.00	1	1979	2019	15	121	CTD_human;GENOMICS_ENGLAND;UNIPROT
val	411	ARSB	0.595	0.692	C1384666	hearingimpairment	phenotype	C23;C10;C09	DiseaseorSyndrome	0.40				0	0	GENOMICS_ENGLAND
val	412	STS	0.431	0.846	C0002152	AlloxanDiabetes	disease	C18;C19	ExperimentalModelofDisease	0.30	1	2014	2014	1	0	CTD_human
val	412	STS	0.431	0.846	C0003873	RheumatoidArthritis	disease	C17;C05;C20	DiseaseorSyndrome	0.32	1	2005	2019	1	0	CTD_human
val	412	STS	0.431	0.846	C0011853	DiabetesMellitus,Experimental	disease	C18;C19	ExperimentalModelofDisease	0.30	1	2014	2014	1	0	CTD_human
val	412	STS	0.431	0.846	C0015695	FattyLiver	disease	C06	DiseaseorSyndrome	0.30	1	2014	2014	1	0	CTD_human
val	412	STS	0.431	0.846	C0019187	Hepatitis,Alcoholic	disease	C06;C25	DiseaseorSyndrome	0.30	1	2016	2016	1	0	CTD_human
val	412	STS	0.431	0.846	C0021368	Inflammation	phenotype	C23	PathologicFunction	0.30	1	2014	2014	1	0	CTD_human
val	412	STS	0.431	0.846	C0021655	InsulinResistance	phenotype	C18	PathologicFunction	0.30	1	2014	2014	1	0	CTD_human
val	412	STS	0.431	0.846	C0028754	Obesity	disease	C23;C18	DiseaseorSyndrome	0.35	1	2014	2019	1	0	CTD_human
val	412	STS	0.431	0.846	C0038433	StreptozotocinDiabetes	disease	C18;C19	ExperimentalModelofDisease	0.30	1	2014	2014	1	0	CTD_human
val	412	STS	0.431	0.846	C0041671	AttentionDeficitDisorder	disease	F03	MentalorBehavioralDysfunction	0.30	1	2008	2008	1	0	CTD_human
val	412	STS	0.431	0.846	C0043094	WeightGain	phenotype	C23	Finding	0.30	1	2014	2014	1	0	CTD_human
val	412	STS	0.431	0.846	C0079588	Ichthyosis,X-Linked	disease	C16;C18;C17	DiseaseorSyndrome	0.80	0.974	1978	2019	8	5	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
val	412	STS	0.431	0.846	C0524610	ChronicAlcoholicHepatitis	disease	C06;C25	DiseaseorSyndrome	0.30	1	2016	2016	1	0	CTD_human
val	412	STS	0.431	0.846	C0920563	InsulinSensitivity	phenotype	C18	PathologicFunction	0.30	1	2014	2014	1	0	CTD_human
val	412	STS	0.431	0.846	C1263846	Attentiondeficithyperactivitydisorder	disease	F03	MentalorBehavioralDysfunction	0.46	1	2008	2017	1	0	CTD_human
val	412	STS	0.431	0.846	C1321905	MinimalBrainDysfunction	disease	F03	MentalorBehavioralDysfunction	0.30	1	2008	2008	1	0	CTD_human
val	412	STS	0.431	0.846	C2711227	Steatohepatitis	disease	C06	DiseaseorSyndrome	0.30	1	2014	2014	1	0	CTD_human
val	412	STS	0.431	0.846	C2717836	SteroidSulfataseDeficiencyDisease	disease	C16;C18;C17	DiseaseorSyndrome	0.60	0.909	1978	2018	5	0	CTD_human;ORPHANET
val	412	STS	0.431	0.846	C2720163	PlacentalSteroidSulfataseDeficiency	disease	C16;C18;C17	DiseaseorSyndrome	0.60	0.978	1979	2017	5	0	CTD_human;ORPHANET
val	412	STS	0.431	0.846	C4274085	SyndromicrecessiveX-linkedichthyosis	disease	C16;C18;C17	DiseaseorSyndrome	0.30	1	1988	2008	4	0	ORPHANET
val	415	ARSL	0.663	0.654	C0008445	ChondrodysplasiaPunctata	disease	C05	CongenitalAbnormality	0.40	0.875	1995	2017	1	0	GENOMICS_ENGLAND
val	415	ARSL	0.663	0.654	C1844853	BrachytelephalangicChondrodysplasiaPunctata	disease		DiseaseorSyndrome	0.63	1	1995	2013	3	11	GENOMICS_ENGLAND;UNIPROT
val	415	ARSL	0.663	0.654	C3669395	X-LinkedChondrodysplasiaPunctata1	disease	C16;C05	DiseaseorSyndrome	0.51	1	1995	2008	1	0	CTD_human;GENOMICS_ENGLAND
val	421	ARVCF	0.54	0.769	C0012236	DiGeorgeSyndrome	disease	C16;C05;C19;C15;C14	DiseaseorSyndrome	0.30				0	0	ORPHANET
val	421	ARVCF	0.54	0.769	C0036341	Schizophrenia	disease	F03	MentalorBehavioralDysfunction	0.46	1	2005	2019	4	0	PSYGENET
val	421	ARVCF	0.54	0.769	C0220704	Shprintzensyndrome	disease	C16;C05;C19;C15;C14	DiseaseorSyndrome	0.30				0	0	ORPHANET
val	421	ARVCF	0.54	0.769	C0431406	Asymmetriccryingfaceassociation	disease	C23;C10;C07	DiseaseorSyndrome	0.30				0	0	ORPHANET
val	421	ARVCF	0.54	0.769	C0795907	CONOTRUNCALANOMALYFACESYNDROME	disease	C16;C05;C19;C15;C14	DiseaseorSyndrome	0.30				0	0	ORPHANET
val	421	ARVCF	0.54	0.769	C0809983	Schizophreniaandrelateddisorders	group	F03	DiseaseorSyndrome	0.31	1	2010	2010	1	0	PSYGENET
val	421	ARVCF	0.54	0.769	C2936346	22q11DeletionSyndrome	disease	C16;C05;C19;C15;C14	DiseaseorSyndrome	0.30				0	0	ORPHANET
val	421	ARVCF	0.54	0.769	C3266101	22q11partialmonosomysyndrome	disease		DiseaseorSyndrome	0.30				0	0	ORPHANET
val	421	ARVCF	0.54	0.769	C3888239	HIRSCHSPRUNGDISEASE,SUSCEPTIBILITYTO,1	disease		Finding	0.30	1	2017	2017	1	0	GENOMICS_ENGLAND
val	427	ASAH1	0.526	0.808	C0004238	AtrialFibrillation	disease	C23;C14	DiseaseorSyndrome	0.40	1	2017	2018	2	1	CTD_human
val	427	ASAH1	0.526	0.808	C0020305	HydropsFetalis	disease	C23;C16;C13;C20;C15	DiseaseorSyndrome	0.30	1	2014	2014	1	0	GENOMICS_ENGLAND
val	427	ASAH1	0.526	0.808	C0023794	Lipoidosis	disease	C16;C18	DiseaseorSyndrome	0.30	1	2005	2006	2	0	CTD_human
val	427	ASAH1	0.526	0.808	C0023893	LiverCirrhosis,Experimental	disease	C23;C06	ExperimentalModelofDisease	0.30	1	2014	2014	1	0	CTD_human
val	427	ASAH1	0.526	0.808	C0036341	Schizophrenia	disease	F03	MentalorBehavioralDysfunction	0.31	1	2012	2012	1	0	PSYGENET
val	427	ASAH1	0.526	0.808	C0221765	Chronicschizophrenia	disease	F03	MentalorBehavioralDysfunction	0.31	1	2012	2012	1	0	PSYGENET
val	427	ASAH1	0.526	0.808	C0235480	Paroxysmalatrialfibrillation	disease	C23;C14	DiseaseorSyndrome	0.30	1	2018	2018	2	0	CTD_human
val	427	ASAH1	0.526	0.808	C0268255	FarberLipogranulomatosis	disease	C16;C18;C10	DiseaseorSyndrome	1.00	1	1989	2019	15	10	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
val	427	ASAH1	0.526	0.808	C0455988	HydropsFetalis,Non-Immune	disease	C23;C16;C13;C20;C15	DiseaseorSyndrome	0.30	1	1996	1996	1	0	GENOMICS_ENGLAND
val	427	ASAH1	0.526	0.808	C1834569	JankovicRiverasyndrome	disease	C23;C16;C05;C10	DiseaseorSyndrome	0.75	1	2012	2019	4	4	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
val	427	ASAH1	0.526	0.808	C2585653	Persistentatrialfibrillation	phenotype	C23;C14	PathologicFunction	0.30	1	2018	2018	2	0	CTD_human
val	427	ASAH1	0.526	0.808	C3468561	familialatrialfibrillation	phenotype	C23;C14	PathologicFunction	0.30	1	2018	2018	2	0	CTD_human
val	427	ASAH1	0.526	0.808	C3714756	IntellectualDisability	group	C23;C10;F03;F01	MentalorBehavioralDysfunction	0.41	1	2008	2014	1	0	GENOMICS_ENGLAND
val	429	ASCL1	0.552	0.692	C0020796	ProfoundMentalRetardation	disease	C23;C10;F03;F01	MentalorBehavioralDysfunction	0.30	1	2011	2011	1	0	CTD_human
val	429	ASCL1	0.552	0.692	C0025363	MentalRetardation,Psychosocial	phenotype	C23;C10;F03;F01	MentalorBehavioralDysfunction	0.30	1	2011	2011	1	0	CTD_human
val	429	ASCL1	0.552	0.692	C0027765	nervoussystemdisorder	group	C10	DiseaseorSyndrome	0.30	1	2013	2013	1	0	CTD_human
val	429	ASCL1	0.552	0.692	C0149925	Smallcellcarcinomaoflung	disease	C04;C08	NeoplasticProcess	0.40	1	1997	2020	1	0	CTD_human
val	429	ASCL1	0.552	0.692	C0242488	AcuteLungInjury	disease	C08	InjuryorPoisoning	0.30	1	2010	2010	1	0	CTD_human
val	429	ASCL1	0.552	0.692	C0917816	Mentaldeficiency	disease	C23;C10;F03;F01	MentalorBehavioralDysfunction	0.30	1	2011	2011	1	0	CTD_human
val	429	ASCL1	0.552	0.692	C1275808	Congenitalcentralhypoventilation	disease	C23;C08;C10	DiseaseorSyndrome	0.61	1	2003	2003	0	0	CTD_human;GENOMICS_ENGLAND
val	429	ASCL1	0.552	0.692	C1859049	CCHSWITHHIRSCHSPRUNGDISEASE	disease	C23;C08;C10	DiseaseorSyndrome;CongenitalAbnormality	0.50				0	0	CTD_human;ORPHANET
val	429	ASCL1	0.552	0.692	C3714756	IntellectualDisability	group	C23;C10;F03;F01	MentalorBehavioralDysfunction	0.40	1	2011	2011	1	0	CTD_human
val	430	ASCL2	0.691	0.423	C0007102	Malignanttumorofcolon	disease	C06;C04	NeoplasticProcess	0.35	0.833	2004	2019	1	0	CTD_human
val	430	ASCL2	0.691	0.423	C0009375	ColonicNeoplasms	group	C06;C04	NeoplasticProcess	0.30	1	2004	2004	1	0	CTD_human
val	434	ASIP	0.584	0.692	C0007114	Malignantneoplasmofskin	disease	C04;C17	NeoplasticProcess	0.31	1	2008	2009	1	0	CTD_human
val	434	ASIP	0.584	0.692	C0025202	melanoma	disease	C04	NeoplasticProcess	0.38	1	2002	2013	3	0	CTD_human
val	434	ASIP	0.584	0.692	C0037286	SkinNeoplasms	group	C04;C17	NeoplasticProcess	0.30	1	2008	2008	1	0	CTD_human
val	434	ASIP	0.584	0.692	C1368275	PigmentedBasalCellCarcinoma	disease	C04	NeoplasticProcess	0.30	1	2008	2008	1	0	CTD_human
val	434	ASIP	0.584	0.692	C4721806	Carcinoma,BasalCell	disease	C04	NeoplasticProcess	0.32	1	2008	2009	1	0	CTD_human
val	435	ASL	0.593	0.731	C0006142	Malignantneoplasmofbreast	disease	C04;C17	NeoplasticProcess	0.31	1	2015	2015	0	0	UNIPROT
val	435	ASL	0.593	0.731	C0268547	ArgininosuccinicAciduria	disease	C16;C18;C10	DiseaseorSyndrome	1.00	1	1976	2019	12	83	CLINGEN;CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
val	438	ASMT	0.691	0.346	C0004352	AutisticDisorder	disease	F03	MentalorBehavioralDysfunction	0.34	1	2008	2014	1	0	CTD_human
val	438	ASMT	0.691	0.346	C0005586	BipolarDisorder	disease	F03	MentalorBehavioralDysfunction	0.32	1	2012	2014	1	0	PSYGENET
val	438	ASMT	0.691	0.346	C0011570	MentalDepression	disease	F01	MentalorBehavioralDysfunction	0.31	1	2012	2014	2	0	PSYGENET
val	438	ASMT	0.691	0.346	C0011581	Depressivedisorder	disease	F03	MentalorBehavioralDysfunction	0.31	1	2012	2014	2	0	PSYGENET
val	438	ASMT	0.691	0.346	C0019202	HepatolenticularDegeneration	disease	C16;C06;C18;C10	DiseaseorSyndrome	0.30	1	2013	2013	1	0	CTD_human
val	438	ASMT	0.691	0.346	C1527352	HepaticFormofWilsonDisease	disease	C16;C06;C18;C10	DiseaseorSyndrome	0.30	1	2013	2013	1	0	CTD_human
val	440	ASNS	0.595	0.692	C0023794	Lipoidosis	disease	C16;C18	DiseaseorSyndrome	0.30	1	2007	2007	1	0	CTD_human
val	440	ASNS	0.595	0.692	C0023893	LiverCirrhosis,Experimental	disease	C23;C06	ExperimentalModelofDisease	0.30	1	2014	2014	1	0	CTD_human
val	440	ASNS	0.595	0.692	C0023903	Liverneoplasms	group	C06;C04	NeoplasticProcess	0.50	1	1976	2017	1	0	CTD_human
val	440	ASNS	0.595	0.692	C0345904	Malignantneoplasmofliver	disease	C06;C04	NeoplasticProcess	0.51	1	1976	2019	1	0	CTD_human
val	440	ASNS	0.595	0.692	C3809971	ASPARAGINESYNTHETASEDEFICIENCY	disease		DiseaseorSyndrome	0.73	1	1968	2019	16	12	CLINGEN;CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
val	443	ASPA	0.564	0.731	C0206307	CanavanDisease	disease	C16;C18;C10	DiseaseorSyndrome	1.00	0.967	1990	2020	17	0	CTD_human;GENOMICS_ENGLAND;UNIPROT
val	443	ASPA	0.564	0.731	C0751663	CanavanDisease,FamilialForm	disease	C16;C18;C10	DiseaseorSyndrome	0.40	1	1993	2013	2	0	CTD_human
val	443	ASPA	0.564	0.731	C0751664	CanavanDisease,Neonatal	disease	C16;C18;C10	DiseaseorSyndrome	0.50	1	2006	2011	3	0	CTD_human;ORPHANET
val	443	ASPA	0.564	0.731	C0751665	CanavanDisease,SporadicForm	disease	C16;C18;C10	DiseaseorSyndrome	0.30	1	2006	2007	2	0	CTD_human
val	443	ASPA	0.564	0.731	C0751666	CanavanDisease,Infantile	disease	C16;C18;C10	DiseaseorSyndrome	0.50	1	2006	2011	3	0	CTD_human;ORPHANET
val	443	ASPA	0.564	0.731	C0751667	CanavanDisease,Juvenile	disease	C16;C18;C10	DiseaseorSyndrome	0.50	1	2006	2011	3	0	CTD_human;ORPHANET
val	443	ASPA	0.564	0.731	C3542499	Aminoacylase2Deficiency	disease	C16;C18;C10	DiseaseorSyndrome	0.31	1	2005	2007	2	0	CTD_human
val	444	ASPH	0.61	0.615	C1832167	EctopiaLentis,SpontaneousFilteringBlebs,andCraniofacialDysmorphism	disease	C16;C11;C05	DiseaseorSyndrome	0.72	1	2014	2018	1	3	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
val	445	ASS1	0.523	0.731	C0011875	DiabeticAngiopathies	disease	C19;C14	DiseaseorSyndrome	0.30	1	2014	2014	1	0	CTD_human
val	445	ASS1	0.523	0.731	C0025945	Microangiopathy,Diabetic	disease	C19;C14	DiseaseorSyndrome	0.30	1	2014	2014	1	0	CTD_human
val	445	ASS1	0.523	0.731	C0175683	Citrullinemia	disease	C16;C18;C10	DiseaseorSyndrome	0.90	1	1982	2020	10	0	CLINGEN;CTD_human;GENOMICS_ENGLAND
val	445	ASS1	0.523	0.731	C0751750	ArgininosuccinicAcidSynthetaseDeficiencyDisease,Partial	disease	C16;C18;C10	DiseaseorSyndrome	0.30				0	0	CTD_human
val	445	ASS1	0.523	0.731	C0751751	ArgininosuccinicAcidSynthetaseDeficiency,Complete	disease	C16;C18;C10	DiseaseorSyndrome	0.55	1	1982	2017	9	0	CLINGEN;CTD_human
val	445	ASS1	0.523	0.731	C3714756	IntellectualDisability	group	C23;C10;F03;F01	MentalorBehavioralDysfunction	0.40	1	2009	2009	1	0	GENOMICS_ENGLAND
val	445	ASS1	0.523	0.731	C4721769	CitrullinemiaType1	disease	C16;C18;C10	DiseaseorSyndrome	0.80	1	1982	2019	22	85	CLINGEN;CTD_human;GENOMICS_ENGLAND;UNIPROT
val	460	ASTN1	0.736	0.308	C0001973	AlcoholicIntoxication,Chronic	disease	C25;F03	MentalorBehavioralDysfunction	0.31	1	2012	2012	1	0	PSYGENET
val	460	ASTN1	0.736	0.308	C0014544	Epilepsy	disease	C10	DiseaseorSyndrome	0.30	1	2015	2015	1	0	GENOMICS_ENGLAND
val	460	ASTN1	0.736	0.308	C0740858	Substanceabuseproblem	disease	C25;F03	MentalorBehavioralDysfunction	0.31	1	2012	2012	1	0	PSYGENET
val	460	ASTN1	0.736	0.308	C2748861	Corticalmalformations	phenotype		Finding	0.30	1	2015	2015	1	0	GENOMICS_ENGLAND
val	460	ASTN1	0.736	0.308	C3714756	IntellectualDisability	group	C23;C10;F03;F01	MentalorBehavioralDysfunction	0.30	1	2015	2015	1	0	GENOMICS_ENGLAND
val	462	SERPINC1	0.507	0.769	C0005779	BloodCoagulationDisorders	group	C15	DiseaseorSyndrome	0.30	1	1976	1976	1	0	CTD_human
val	462	SERPINC1	0.507	0.769	C0012739	DisseminatedIntravascularCoagulation	disease	C15	DiseaseorSyndrome	0.33	1	1984	2019	3	0	CTD_human
val	462	SERPINC1	0.507	0.769	C0027726	NephroticSyndrome	group	C13;C12	DiseaseorSyndrome	0.50	1	1994	2001	1	0	CTD_human
val	462	SERPINC1	0.507	0.769	C0035222	RespiratoryDistressSyndrome,Adult	disease	C08	DiseaseorSyndrome	0.30	1	1996	1996	1	0	CTD_human
val	462	SERPINC1	0.507	0.769	C0040053	Thrombosis	phenotype	C14	PathologicFunction	0.51	1	1983	2007	4	0	CTD_human
val	462	SERPINC1	0.507	0.769	C0042487	VenousThrombosis	phenotype	C14	PathologicFunction	0.34	1	1976	2007	3	0	CTD_human
val	462	SERPINC1	0.507	0.769	C0079102	CerebralThrombosis	disease	C10;C14	DiseaseorSyndrome	0.31	1	1980	1983	1	0	CTD_human
val	462	SERPINC1	0.507	0.769	C0087086	Thrombus	phenotype	C14	PathologicFunction	0.30	1	1983	2000	4	0	CTD_human
val	462	SERPINC1	0.507	0.769	C0149871	DeepVeinThrombosis	disease	C14	DiseaseorSyndrome	0.50	1	1976	2019	3	2	CTD_human
val	462	SERPINC1	0.507	0.769	C0162557	LiverFailure,Acute	disease	C06	DiseaseorSyndrome	0.31	1	1985	2017	1	0	CTD_human
val	462	SERPINC1	0.507	0.769	C0272375	AntithrombinIIIDeficiency	disease	C16;C15	DiseaseorSyndrome	1.00	0.987	1984	2019	38	43	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
val	462	SERPINC1	0.507	0.769	C0752143	IntracranialThrombosis	disease	C10;C14	DiseaseorSyndrome	0.30	1	1983	1983	1	0	CTD_human
val	462	SERPINC1	0.507	0.769	C0752144	BrainThrombosis	disease	C10;C14	DiseaseorSyndrome	0.30	1	1983	1983	1	0	CTD_human
val	462	SERPINC1	0.507	0.769	C0936261	BrainThrombus	disease	C10;C14	DiseaseorSyndrome	0.30	1	1983	1983	1	0	CTD_human
val	462	SERPINC1	0.507	0.769	C0936263	CerebralThrombus	disease	C10;C14	DiseaseorSyndrome	0.30	1	1983	1983	1	0	CTD_human
val	462	SERPINC1	0.507	0.769	C0948089	AcuteCoronarySyndrome	disease	C14	DiseaseorSyndrome	0.30	1	1994	1994	1	0	CTD_human
val	462	SERPINC1	0.507	0.769	C1861172	VenousThromboembolism	phenotype	C14	DiseaseorSyndrome	0.40	1	1979	2019	1	0	CTD_human
val	462	SERPINC1	0.507	0.769	C2937358	CerebralHemorrhage	phenotype	C23;C10;C14	PathologicFunction	0.30	1	1983	1983	1	0	CTD_human
val	462	SERPINC1	0.507	0.769	C3658294	HereditaryAntithrombinDeficiency	disease	C16;C15	DiseaseorSyndrome	0.34	1	1984	2019	1	0	CTD_human
val	463	ZFHX3	0.621	0.654	C0004238	AtrialFibrillation	disease	C23;C14	DiseaseorSyndrome	0.50	0.966	2009	2019	5	7	CTD_human
val	463	ZFHX3	0.621	0.654	C0028754	Obesity	disease	C23;C18	DiseaseorSyndrome	0.30	1	2018	2018	1	0	CTD_human
val	463	ZFHX3	0.621	0.654	C0033578	ProstaticNeoplasms	group	C04;C12	NeoplasticProcess	0.33	1	2005	2018	3	0	CTD_human
val	463	ZFHX3	0.621	0.654	C0038454	Cerebrovascularaccident	group	C10;C14	DiseaseorSyndrome	0.48	1	2012	2019	1	3	CTD_human
val	463	ZFHX3	0.621	0.654	C0235480	Paroxysmalatrialfibrillation	disease	C23;C14	DiseaseorSyndrome	0.31	1	2009	2018	5	0	CTD_human
val	463	ZFHX3	0.621	0.654	C0376358	Malignantneoplasmofprostate	disease	C04;C12	NeoplasticProcess	0.47	1	2005	2019	3	0	CTD_human
val	463	ZFHX3	0.621	0.654	C0751956	AcuteCerebrovascularAccidents	disease	C10;C14	DiseaseorSyndrome	0.30	1	2018	2018	1	0	CTD_human
val	463	ZFHX3	0.621	0.654	C2585653	Persistentatrialfibrillation	phenotype	C23;C14	PathologicFunction	0.30	1	2009	2018	5	0	CTD_human
val	463	ZFHX3	0.621	0.654	C3468561	familialatrialfibrillation	phenotype	C23;C14	PathologicFunction	0.30	1	2009	2018	5	0	CTD_human
val	465	ATD	0.656	0.731	C4551856	AsphyxiatingThoracicDystrophy1	disease	C16;C17;C05	DiseaseorSyndrome;CongenitalAbnormality	0.30				0	0	GENOMICS_ENGLAND
val	466	ATF1	0.588	0.577	C0032460	PolycysticOvarySyndrome	disease	C04;C13;C19	DiseaseorSyndrome	0.30	1	2011	2011	1	0	CTD_human
val	466	ATF1	0.588	0.577	C0206651	ClearCellSarcomaofSoftTissue	disease	C04	NeoplasticProcess	0.40	0.977	1993	2019	1	0	ORPHANET
val	466	ATF1	0.588	0.577	C1136382	SclerocysticOvaries	disease	C04;C13;C19	DiseaseorSyndrome	0.30	1	2011	2011	1	0	CTD_human
val	467	ATF3	0.494	0.885	C0002152	AlloxanDiabetes	disease	C18;C19	ExperimentalModelofDisease	0.30	1	2005	2005	1	0	CTD_human
val	467	ATF3	0.494	0.885	C0007131	Non-SmallCellLungCarcinoma	disease	C04;C08	NeoplasticProcess	0.32	1	2007	2016	1	0	CTD_human
val	467	ATF3	0.494	0.885	C0011570	MentalDepression	disease	F01	MentalorBehavioralDysfunction	0.31	1	2008	2018	1	0	PSYGENET
val	467	ATF3	0.494	0.885	C0011581	Depressivedisorder	disease	F03	MentalorBehavioralDysfunction	0.31	1	2008	2018	1	0	PSYGENET
val	467	ATF3	0.494	0.885	C0011853	DiabetesMellitus,Experimental	disease	C18;C19	ExperimentalModelofDisease	0.30	1	2005	2005	1	0	CTD_human
val	467	ATF3	0.494	0.885	C0011860	DiabetesMellitus,Non-Insulin-Dependent	disease	C18;C19	DiseaseorSyndrome	0.34	1	2005	2017	1	0	CTD_human
val	467	ATF3	0.494	0.885	C0021400	Influenza	disease	C01;C08	DiseaseorSyndrome	0.31	1	2007	2013	1	0	CTD_human
val	467	ATF3	0.494	0.885	C0023893	LiverCirrhosis,Experimental	disease	C23;C06	ExperimentalModelofDisease	0.30	1	2014	2014	1	0	CTD_human
val	467	ATF3	0.494	0.885	C0023903	Liverneoplasms	group	C06;C04	NeoplasticProcess	0.30	1	2010	2010	1	0	CTD_human
val	467	ATF3	0.494	0.885	C0027765	nervoussystemdisorder	group	C10	DiseaseorSyndrome	0.30	1	2008	2008	2	0	CTD_human
val	467	ATF3	0.494	0.885	C0033141	Cardiomyopathies,Primary	group	C14	DiseaseorSyndrome	0.30	1	2014	2014	1	0	CTD_human
val	467	ATF3	0.494	0.885	C0033578	ProstaticNeoplasms	group	C04;C12	NeoplasticProcess	0.31	1	2006	2008	1	0	CTD_human
val	467	ATF3	0.494	0.885	C0036529	MyocardialDiseases,Secondary	group	C14	DiseaseorSyndrome	0.30	1	2014	2014	1	0	CTD_human
val	467	ATF3	0.494	0.885	C0038433	StreptozotocinDiabetes	disease	C18;C19	ExperimentalModelofDisease	0.30	1	2005	2005	1	0	CTD_human
val	467	ATF3	0.494	0.885	C0238281	MiddleCerebralArterySyndrome	phenotype	C23;C10;C14	DiseaseorSyndrome	0.30	1	2002	2002	1	0	CTD_human
val	467	ATF3	0.494	0.885	C0345904	Malignantneoplasmofliver	disease	C06;C04	NeoplasticProcess	0.31	1	2010	2019	1	0	CTD_human
val	467	ATF3	0.494	0.885	C0376358	Malignantneoplasmofprostate	disease	C04;C12	NeoplasticProcess	0.35	1	2006	2016	1	0	CTD_human
val	467	ATF3	0.494	0.885	C0740376	MiddleCerebralArteryThrombosis	disease	C23;C10;C14	DiseaseorSyndrome	0.30	1	2002	2002	1	0	CTD_human
val	467	ATF3	0.494	0.885	C0740391	MiddleCerebralArteryOcclusion	disease	C23;C10;C14	AcquiredAbnormality	0.31	1	2002	2010	1	0	CTD_human
val	467	ATF3	0.494	0.885	C0740392	Infarction,MiddleCerebralArtery	disease	C23;C10;C14	DiseaseorSyndrome	0.30	1	2002	2002	1	0	CTD_human
val	467	ATF3	0.494	0.885	C0751845	MiddleCerebralArteryEmbolus	phenotype	C23;C10;C14	DiseaseorSyndrome	0.30	1	2002	2002	1	0	CTD_human
val	467	ATF3	0.494	0.885	C0751846	LeftMiddleCerebralArteryInfarction	phenotype	C23;C10;C14	DiseaseorSyndrome	0.30	1	2002	2002	1	0	CTD_human
val	467	ATF3	0.494	0.885	C0751847	EmbolicInfarction,MiddleCerebralArtery	phenotype	C23;C10;C14	DiseaseorSyndrome	0.30	1	2002	2002	1	0	CTD_human
val	467	ATF3	0.494	0.885	C0751848	ThromboticInfarction,MiddleCerebralArtery	phenotype	C23;C10;C14	DiseaseorSyndrome	0.30	1	2002	2002	1	0	CTD_human
val	467	ATF3	0.494	0.885	C0751849	RightMiddleCerebralArteryInfarction	phenotype	C23;C10;C14	DiseaseorSyndrome	0.30	1	2002	2002	1	0	CTD_human
val	467	ATF3	0.494	0.885	C0848558	Hypospadias	disease	C16;C13;C12	CongenitalAbnormality	0.37	1	2005	2018	1	0	CTD_human
val	467	ATF3	0.494	0.885	C0878544	Cardiomyopathies	group	C14	DiseaseorSyndrome	0.32	1	2014	2018	1	0	CTD_human
val	467	ATF3	0.494	0.885	C0919267	ovarianneoplasm	disease	C04;C13;C19	NeoplasticProcess	0.30	1	2005	2005	1	0	CTD_human
val	467	ATF3	0.494	0.885	C1140680	Malignantneoplasmofovary	disease	C04;C13;C19	NeoplasticProcess	0.30	1	2005	2005	1	0	CTD_human
val	467	ATF3	0.494	0.885	C4721453	PeripheralNervousSystemDiseases	group	C10	DiseaseorSyndrome	0.30	1	2007	2007	1	0	CTD_human
val	468	ATF4	0.507	0.769	C0003129	Anoxemia	phenotype	C23	SignorSymptom	0.30	1	2004	2004	1	0	CTD_human
val	468	ATF4	0.507	0.769	C0003130	Anoxia	phenotype	C23	PathologicFunction	0.30	1	2004	2004	1	0	CTD_human
val	468	ATF4	0.507	0.769	C0005586	BipolarDisorder	disease	F03	MentalorBehavioralDysfunction	0.31	1	2007	2008	2	0	PSYGENET
val	468	ATF4	0.507	0.769	C0011570	MentalDepression	disease	F01	MentalorBehavioralDysfunction	0.30	1	2008	2008	1	0	PSYGENET
val	468	ATF4	0.507	0.769	C0011581	Depressivedisorder	disease	F03	MentalorBehavioralDysfunction	0.30	1	2008	2008	1	0	PSYGENET
val	468	ATF4	0.507	0.769	C0015695	FattyLiver	disease	C06	DiseaseorSyndrome	0.33	1	2016	2019	1	0	CTD_human
val	468	ATF4	0.507	0.769	C0021367	MammaryDuctalCarcinoma	disease	C04;C17	NeoplasticProcess	0.30	1	2004	2004	1	0	CTD_human
val	468	ATF4	0.507	0.769	C0027540	Necrosis	phenotype	C23	OrganorTissueFunction	0.30	1	2004	2004	1	0	CTD_human
val	468	ATF4	0.507	0.769	C0036341	Schizophrenia	disease	F03	MentalorBehavioralDysfunction	0.32	1	2008	2020	1	0	PSYGENET
val	468	ATF4	0.507	0.769	C0242184	Hypoxia	phenotype	C23	PathologicFunction	0.30	1	2004	2004	1	0	CTD_human
val	468	ATF4	0.507	0.769	C0700292	Hypoxemia	phenotype	C23	Finding	0.30	1	2004	2004	1	0	CTD_human
val	468	ATF4	0.507	0.769	C1134719	InvasiveDuctalBreastCarcinoma	disease	C04;C17	NeoplasticProcess	0.30	1	2004	2004	1	0	CTD_human
val	468	ATF4	0.507	0.769	C2711227	Steatohepatitis	disease	C06	DiseaseorSyndrome	0.34	1	2016	2020	1	0	CTD_human
val	471	ATIC	0.576	0.731	C0001787	Osteoporosis,Age-Related	disease	C18;C05	DiseaseorSyndrome	0.30	1	2008	2008	1	0	CTD_human
val	471	ATIC	0.576	0.731	C0003873	RheumatoidArthritis	disease	C17;C05;C20	DiseaseorSyndrome	0.34	1	2004	2016	1	0	CTD_human
val	471	ATIC	0.576	0.731	C0013221	Drugtoxicity	group	C25	InjuryorPoisoning	0.30	1	2006	2006	1	0	CTD_human
val	471	ATIC	0.576	0.731	C0029456	Osteoporosis	disease	C18;C05	DiseaseorSyndrome	0.30	1	2008	2008	1	0	CTD_human
val	471	ATIC	0.576	0.731	C0029459	Osteoporosis,Senile	disease	C18;C05	DiseaseorSyndrome	0.30	1	2008	2008	1	0	CTD_human
val	471	ATIC	0.576	0.731	C0041755	Adversereactiontodrug	group	C25	PathologicFunction	0.30	1	2006	2006	1	0	CTD_human
val	471	ATIC	0.576	0.731	C0155003	Blindness,Transient	phenotype	C23;C11;C10	PathologicFunction	0.30	1	2004	2004	1	0	CTD_human
val	471	ATIC	0.576	0.731	C0221473	Blindness,Hysterical	phenotype	C23;C11;C10	MentalorBehavioralDysfunction	0.30	1	2004	2004	1	0	CTD_human
val	471	ATIC	0.576	0.731	C0271215	Blindness,Legal	disease	C23;C11;C10	DiseaseorSyndrome	0.30	1	2004	2004	1	0	CTD_human
val	471	ATIC	0.576	0.731	C0339730	Blindness,Acquired	disease	C23;C11;C10	DiseaseorSyndrome	0.30	1	2004	2004	1	0	CTD_human
val	471	ATIC	0.576	0.731	C0376288	Amaurosis	disease	C23;C11;C10	DiseaseorSyndrome	0.30	1	2004	2004	1	0	CTD_human
val	471	ATIC	0.576	0.731	C0456909	Blindness	phenotype	C23;C11;C10	DiseaseorSyndrome	0.30	1	2004	2004	1	0	CTD_human
val	471	ATIC	0.576	0.731	C0750958	Blindness,Monocular	disease	C23;C11;C10	DiseaseorSyndrome	0.30	1	2004	2004	1	0	CTD_human
val	471	ATIC	0.576	0.731	C0751406	Post-TraumaticOsteoporosis	disease	C18;C05	DiseaseorSyndrome	0.30	1	2008	2008	1	0	CTD_human
val	471	ATIC	0.576	0.731	C1837530	AICARTransformylaseInosineMonophosphateCyclohydrolaseDeficiency	disease	C23;C16;C10;F03;F01	DiseaseorSyndrome	0.70	1	2004	2004	1	1	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
val	471	ATIC	0.576	0.731	C1879328	BlindnessbotheyesNOS(disorder)	phenotype	C23;C11;C10	DiseaseorSyndrome	0.30	1	2004	2004	1	0	CTD_human
val	471	ATIC	0.576	0.731	C3714756	IntellectualDisability	group	C23;C10;F03;F01	MentalorBehavioralDysfunction	0.30	1	2016	2016	1	0	GENOMICS_ENGLAND
val	472	ATM	0.374	0.885	C0004135	AtaxiaTelangiectasia	disease	C16;C18;C20;C10;C14	DiseaseorSyndrome	1.00	0.982	1953	2020	37	414	CTD_human;GENOMICS_ENGLAND;UNIPROT
val	472	ATM	0.374	0.885	C0005684	Malignantneoplasmofurinarybladder	disease	C04;C13;C12	NeoplasticProcess	0.69	1	2008	2017	1	1	CGI;CTD_human
val	472	ATM	0.374	0.885	C0005695	BladderNeoplasm	disease	C04;C13;C12	NeoplasticProcess	0.58	1	2008	2017	1	0	CGI;CTD_human
val	472	ATM	0.374	0.885	C0006142	Malignantneoplasmofbreast	disease	C04;C17	NeoplasticProcess	0.70	0.932	1996	2020	1	22	CTD_human;GENOMICS_ENGLAND
val	472	ATM	0.374	0.885	C0006826	MalignantNeoplasms	group	C04	NeoplasticProcess	0.40	0.959	1995	2020	1	0	CTD_human
val	472	ATM	0.374	0.885	C0007112	Adenocarcinomaofprostate	disease	C04;C12	NeoplasticProcess	0.30				0	0	CGI
val	472	ATM	0.374	0.885	C0007137	Squamouscellcarcinoma	disease	C04	NeoplasticProcess	0.40	1	2004	2017	1	0	CTD_human
val	472	ATM	0.374	0.885	C0007193	Cardiomyopathy,Dilated	group	C14	DiseaseorSyndrome	0.30	1	2013	2013	1	0	CTD_human
val	472	ATM	0.374	0.885	C0009405	HereditaryNonpolyposisColorectalNeoplasms	group	C16;C06;C04;C18	NeoplasticProcess	0.30	1	2012	2017	6	0	CLINGEN
val	472	ATM	0.374	0.885	C0010606	AdenoidCysticCarcinoma	disease	C04	NeoplasticProcess	0.31	1	2013	2018	1	0	CTD_human
val	472	ATM	0.374	0.885	C0013421	Dystonia	phenotype	C23;C10	SignorSymptom	0.42	0.5	2012	2015	0	0	GENOMICS_ENGLAND
val	472	ATM	0.374	0.885	C0016059	Fibrosis	phenotype	C23	PathologicFunction	0.30	1	2013	2013	1	0	CTD_human
val	472	ATM	0.374	0.885	C0017638	Glioma	disease	C04	NeoplasticProcess	0.60	0.938	2001	2019	1	0	CGI;GENOMICS_ENGLAND
val	472	ATM	0.374	0.885	C0021051	ImmunologicDeficiencySyndromes	group	C20	DiseaseorSyndrome	0.42	1	2001	2016	1	1	GENOMICS_ENGLAND
val	472	ATM	0.374	0.885	C0023418	leukemia	disease	C04	NeoplasticProcess	0.90	1	1998	2018	1	0	CGI;GENOMICS_ENGLAND
val	472	ATM	0.374	0.885	C0023434	ChronicLymphocyticLeukemia	disease	C04;C20;C15	NeoplasticProcess	0.70	0.966	1998	2019	2	2	CTD_human;ORPHANET;UNIPROT
val	472	ATM	0.374	0.885	C0024299	Lymphoma	group	C04;C20;C15	NeoplasticProcess	0.90	0.955	1998	2020	1	0	CGI;GENOMICS_ENGLAND
val	472	ATM	0.374	0.885	C0024623	Malignantneoplasmofstomach	disease	C06;C04	NeoplasticProcess	0.60	1	1998	2019	1	0	CGI;CTD_human
val	472	ATM	0.374	0.885	C0025149	Medulloblastoma	disease	C04	NeoplasticProcess	0.51	0.5	2003	2017	1	0	CGI;GENOMICS_ENGLAND
val	472	ATM	0.374	0.885	C0025202	melanoma	disease	C04	NeoplasticProcess	0.50	1	2007	2019	1	2	CTD_human
val	472	ATM	0.374	0.885	C0027051	MyocardialInfarction	disease	C23;C14	DiseaseorSyndrome	0.38	1	1994	2019	1	0	CTD_human
val	472	ATM	0.374	0.885	C0027651	Neoplasms	group	C04	NeoplasticProcess	0.50	0.946	1995	2020	1	2	CTD_human
val	472	ATM	0.374	0.885	C0030297	PancreaticNeoplasm	disease	C06;C04;C19	NeoplasticProcess	0.33	1	2007	2019	2	0	CTD_human
val	472	ATM	0.374	0.885	C0033054	PrenatalExposureDelayedEffects	disease	C13	InjuryorPoisoning	0.30	1	2011	2011	1	0	CTD_human
val	472	ATM	0.374	0.885	C0033578	ProstaticNeoplasms	group	C04;C12	NeoplasticProcess	0.32	1	2004	2018	4	0	CTD_human
val	472	ATM	0.374	0.885	C0036341	Schizophrenia	disease	F03	MentalorBehavioralDysfunction	0.32	1	2008	2013	1	0	PSYGENET
val	472	ATM	0.374	0.885	C0038356	StomachNeoplasms	group	C06;C04	NeoplasticProcess	0.52	1	2001	2015	1	0	CGI;CTD_human
val	472	ATM	0.374	0.885	C0079773	Lymphoma,T-Cell,Cutaneous	disease	C04;C20;C15	NeoplasticProcess	0.30	1	2015	2015	1	0	CTD_human
val	472	ATM	0.374	0.885	C0079774	PeripheralT-CellLymphoma	disease	C04;C20;C15	NeoplasticProcess	0.33	1	2003	2015	1	0	CTD_human
val	472	ATM	0.374	0.885	C0086543	Cataract	disease	C11	AcquiredAbnormality	0.30	1	2006	2006	1	0	CTD_human
val	472	ATM	0.374	0.885	C0086692	BenignNeoplasm	group	C04	NeoplasticProcess	0.30	1	2011	2011	1	0	CTD_human
val	472	ATM	0.374	0.885	C0152013	Adenocarcinomaoflung(disorder)	disease	C04	NeoplasticProcess	0.40	0.9	2009	2019	0	1	UNIPROT
val	472	ATM	0.374	0.885	C0153943	Benignneoplasmofstomach	disease	C06;C04	NeoplasticProcess	0.30				0	0	CGI
val	472	ATM	0.374	0.885	C0154017	Benignneoplasmofbladder	disease	C04;C13;C12	NeoplasticProcess	0.30				0	0	CGI
val	472	ATM	0.374	0.885	C0154060	Carcinomainsituofstomach	disease	C06;C04	NeoplasticProcess	0.30				0	0	CGI
val	472	ATM	0.374	0.885	C0154091	Carcinomainsituofbladder	disease	C04;C13;C12	NeoplasticProcess	0.30				0	0	CGI
val	472	ATM	0.374	0.885	C0242698	VentricularDysfunction,Left	phenotype	C14	PathologicFunction	0.30	1	2013	2013	1	0	CTD_human
val	472	ATM	0.374	0.885	C0278701	GastricAdenocarcinoma	disease	C06;C04	NeoplasticProcess	0.30				0	0	UNIPROT
val	472	ATM	0.374	0.885	C0279702	Conventional(ClearCell)RenalCellCarcinoma	disease	C04;C13;C12	NeoplasticProcess	0.33	1	2013	2018	0	0	UNIPROT
val	472	ATM	0.374	0.885	C0334634	Malignantlymphoma,lymphocytic,intermediatedifferentiation,diffuse	disease	C04;C20;C15	NeoplasticProcess	0.80	1	1999	2017	1	1	CGI;GENOMICS_ENGLAND;UNIPROT
val	472	ATM	0.374	0.885	C0346153	BreastCancer,Familial	disease	C04;C17	NeoplasticProcess	0.40	1	1998	2019	5	0	CLINGEN
val	472	ATM	0.374	0.885	C0346647	Malignantneoplasmofpancreas	disease	C06;C04;C19	NeoplasticProcess	0.40	1	2004	2020	2	0	CTD_human
val	472	ATM	0.374	0.885	C0376358	Malignantneoplasmofprostate	disease	C04;C12	NeoplasticProcess	0.40	0.943	2000	2019	4	0	CTD_human
val	472	ATM	0.374	0.885	C0376407	GranulomatousSlackSkin	disease	C04;C20;C15	NeoplasticProcess	0.30	1	2015	2015	1	0	CTD_human
val	472	ATM	0.374	0.885	C0496905	Neoplasmofuncertainorunknownbehaviorofstomach	disease	C06;C04	NeoplasticProcess	0.30				0	0	CGI
val	472	ATM	0.374	0.885	C0496930	Neoplasmofuncertainorunknownbehaviorofbladder	disease	C04;C13;C12	NeoplasticProcess	0.30				0	0	CGI
val	472	ATM	0.374	0.885	C0524524	Pseudoaphakia	disease	C11	DiseaseorSyndrome	0.30	1	2006	2006	1	0	CTD_human
val	472	ATM	0.374	0.885	C0555202	Malignantlymphoma-lymphocytic,intermediatedifferentiation	disease		NeoplasticProcess	0.30	1	2000	2000	1	0	ORPHANET
val	472	ATM	0.374	0.885	C0598589	Inheritedneuropathies	disease	C10	DiseaseorSyndrome	0.30				0	0	GENOMICS_ENGLAND
val	472	ATM	0.374	0.885	C0678222	BreastCarcinoma	disease	C04;C17	NeoplasticProcess	0.50	0.934	1996	2020	0	3	CTD_human
val	472	ATM	0.374	0.885	C0699791	StomachCarcinoma	disease	C06;C04	NeoplasticProcess	0.40	1	1998	2019	0	0	CGI
val	472	ATM	0.374	0.885	C0699885	Carcinomaofbladder	disease	C04;C13;C12	NeoplasticProcess	0.39	1	2008	2017	0	0	CGI
val	472	ATM	0.374	0.885	C0855095	SmallLymphocyticLymphoma	disease	C04;C20;C15	NeoplasticProcess	0.31	0.5	1999	2014	1	0	ORPHANET
val	472	ATM	0.374	0.885	C1112155	Hereditarynon-polyposiscolorectalcancersyndrome	disease		CongenitalAbnormality	0.30	1	2012	2017	6	0	CLINGEN
val	472	ATM	0.374	0.885	C1257931	MammaryNeoplasms,Human	disease	C04;C17	NeoplasticProcess	0.30				0	0	CTD_human
val	472	ATM	0.374	0.885	C1319315	Adenocarcinomaoflargeintestine	disease	C06;C04	NeoplasticProcess	0.60				0	4	CGI;UNIPROT
val	472	ATM	0.374	0.885	C1333990	HereditaryNonpolyposisColorectalCancer	disease	C16;C06;C04;C18	NeoplasticProcess	0.33	1	2005	2018	6	0	CLINGEN
val	472	ATM	0.374	0.885	C1333991	HereditaryNon-PolyposisColonCancerType2	disease	C16;C04	NeoplasticProcess	0.30	1	2012	2017	6	0	CLINGEN
val	472	ATM	0.374	0.885	C1449563	Cardiomyopathy,FamilialIdiopathic	disease	C14	DiseaseorSyndrome	0.30	1	2013	2013	1	0	CTD_human
val	472	ATM	0.374	0.885	C1458155	MammaryNeoplasms	group	C04;C17	NeoplasticProcess	0.50	0.974	1996	2018	0	0	CTD_human
val	472	ATM	0.374	0.885	C1510497	LensOpacities	phenotype	C11	Finding	0.30	1	2006	2006	1	0	CTD_human
val	472	ATM	0.374	0.885	C1623038	Cirrhosis	disease	C23	DiseaseorSyndrome	0.30	1	2013	2013	1	0	CTD_human
val	472	ATM	0.374	0.885	C1708349	HereditaryDiffuseGastricCancer	disease	C06;C04	NeoplasticProcess	0.30	1	2015	2015	1	0	CTD_human
val	472	ATM	0.374	0.885	C1843542	T-CELLPROLYMPHOCYTICLEUKEMIA,SOMATIC	disease		DiseaseorSyndrome	0.30	1	2009	2009	1	0	GENOMICS_ENGLAND
val	472	ATM	0.374	0.885	C1868683	B-CELLMALIGNANCY,LOW-GRADE	disease		NeoplasticProcess	0.40	1	1998	2015	1	0	ORPHANET
val	472	ATM	0.374	0.885	C1876175	Ataxia-TelangiectasiaVariant	disease	C16;C18;C20;C10;C14	DiseaseorSyndrome	0.40	1	2013	2013	1	1	ORPHANET
val	472	ATM	0.374	0.885	C2239176	Livercarcinoma	disease	C06;C04	NeoplasticProcess	0.37	1	1995	2020	1	0	CTD_human
val	472	ATM	0.374	0.885	C2363142	T-CellProlymphocyticLeukemia	disease	C04;C20;C15	NeoplasticProcess	0.50	1	1997	2018	0	2	CGI
val	472	ATM	0.374	0.885	C2931456	Prostatecancer,familial	disease	C04;C12	NeoplasticProcess	0.30	1	2018	2018	1	0	CTD_human
val	472	ATM	0.374	0.885	C2936783	Colorectalcancer,hereditarynonpolyposis,type1	disease	C16;C06;C04;C18	NeoplasticProcess	0.30	1	2012	2017	6	0	CLINGEN
val	472	ATM	0.374	0.885	C4704874	MammaryCarcinoma,Human	disease	C04;C17	NeoplasticProcess	0.30				0	0	CTD_human
val	472	ATM	0.374	0.885	C4722327	PROSTATECANCER,HEREDITARY,1	disease	C04;C12	NeoplasticProcess	0.30	1	2018	2018	1	0	CTD_human
val	473	RERE	0.526	0.846	C0087031	Juvenile-OnsetStillDisease	disease	C17;C05;C20	DiseaseorSyndrome	0.30	1	2009	2009	1	0	CTD_human
val	473	RERE	0.526	0.846	C1842870	Chromosome1p36DeletionSyndrome	disease	C23;C16	DiseaseorSyndrome	0.31	1	2016	2016	1	0	ORPHANET
val	473	RERE	0.526	0.846	C3495559	Juvenilearthritis	disease	C17;C05;C20	DiseaseorSyndrome	0.30	1	2009	2009	1	0	CTD_human
val	473	RERE	0.526	0.846	C3714758	Juvenilepsoriaticarthritis	disease	C17;C05;C20	DiseaseorSyndrome	0.30	1	2009	2009	1	0	CTD_human
val	473	RERE	0.526	0.846	C4310772	NEURODEVELOPMENTALDISORDERWITHORWITHOUTANOMALIESOFTHEBRAIN,EYE,ORHEART	disease		DiseaseorSyndrome	0.71	1	2015	2018	3	11	CTD_human;GENOMICS_ENGLAND;UNIPROT
val	473	RERE	0.526	0.846	C4552091	Polyarthritis,Juvenile,RheumatoidFactorNegative	disease	C17;C05;C20	DiseaseorSyndrome	0.30	1	2009	2009	1	0	CTD_human
val	473	RERE	0.526	0.846	C4704862	Polyarthritis,Juvenile,RheumatoidFactorPositive	disease	C17;C05;C20	DiseaseorSyndrome	0.30	1	2009	2009	1	0	CTD_human
val	474	ATOH1	0.633	0.5	C0025149	Medulloblastoma	disease	C04	NeoplasticProcess	0.40	1	2007	2019	1	0	CTD_human
val	474	ATOH1	0.633	0.5	C0205833	Medullomyoblastoma	disease	C04	NeoplasticProcess	0.30	1	2008	2008	1	0	CTD_human
val	474	ATOH1	0.633	0.5	C0278510	ChildhoodMedulloblastoma	disease	C04	NeoplasticProcess	0.39	1	2008	2019	1	0	CTD_human
val	474	ATOH1	0.633	0.5	C0278876	AdultMedulloblastoma	disease	C04	NeoplasticProcess	0.39	1	2008	2019	1	0	CTD_human
val	474	ATOH1	0.633	0.5	C0751291	DesmoplasticMedulloblastoma	disease	C04	NeoplasticProcess	0.30	1	2008	2008	1	0	CTD_human
val	474	ATOH1	0.633	0.5	C1275668	Melanoticmedulloblastoma	disease	C04	NeoplasticProcess	0.30	1	2008	2008	1	0	CTD_human
val	474	ATOH1	0.633	0.5	C1879677	AlcoholToxicity	disease		InjuryorPoisoning	0.30	1	2008	2008	1	0	PSYGENET
val	475	ATOX1	0.656	0.5	C0019189	Hepatitis,Chronic	disease	C06	DiseaseorSyndrome	0.30	1	2015	2015	1	0	CTD_human
val	475	ATOX1	0.656	0.5	C0020538	Hypertensivedisease	group	C14	DiseaseorSyndrome	0.30	1	2012	2012	1	0	CTD_human
val	475	ATOX1	0.656	0.5	C0024121	LungNeoplasms	group	C04;C08	NeoplasticProcess	0.30	1	2013	2013	1	0	CTD_human
val	475	ATOX1	0.656	0.5	C0149519	ChronicPersistentHepatitis	disease	C06	DiseaseorSyndrome	0.30	1	2015	2015	1	0	CTD_human
val	475	ATOX1	0.656	0.5	C0242379	Malignantneoplasmoflung	disease	C04;C08	NeoplasticProcess	0.31	1	2013	2013	1	0	CTD_human
val	475	ATOX1	0.656	0.5	C0520463	Chronicactivehepatitis	disease	C06	DiseaseorSyndrome	0.30	1	2015	2015	1	0	CTD_human
val	475	ATOX1	0.656	0.5	C0524611	CryptogenicChronicHepatitis	disease	C06	DiseaseorSyndrome	0.30	1	2015	2015	1	0	CTD_human
val	476	ATP1A1	0.601	0.808	C0001430	Adenoma	group	C04	NeoplasticProcess	0.34	1	2013	2017	2	0	CTD_human
val	476	ATP1A1	0.601	0.808	C0005586	BipolarDisorder	disease	F03	MentalorBehavioralDysfunction	0.30	1	1998	1998	1	0	PSYGENET
val	476	ATP1A1	0.601	0.808	C0017162	Gastroenteritis,Transmissible,ofSwine	disease	C01;C22	DiseaseorSyndrome	0.30	1	2017	2017	1	0	CTD_human
val	476	ATP1A1	0.601	0.808	C0020428	Hyperaldosteronism	disease	C19	DiseaseorSyndrome	0.30	1	2013	2013	1	0	CTD_human
val	476	ATP1A1	0.601	0.808	C0020538	Hypertensivedisease	group	C14	DiseaseorSyndrome	0.56	1	1994	2015	1	0	CTD_human
val	476	ATP1A1	0.601	0.808	C0027051	MyocardialInfarction	disease	C23;C14	DiseaseorSyndrome	0.30	1	2018	2018	1	0	CTD_human
val	476	ATP1A1	0.601	0.808	C0027055	MyocardialReperfusionInjury	phenotype	C23;C14	PathologicFunction	0.30	1	2018	2018	1	0	CTD_human
val	476	ATP1A1	0.601	0.808	C0036572	Seizures	phenotype	C23;C10	SignorSymptom	0.31	1	2018	2020	1	0	GENOMICS_ENGLAND
val	476	ATP1A1	0.601	0.808	C0042594	VestibularDiseases	group	C09	DiseaseorSyndrome	0.30	1	2011	2011	1	0	CTD_human
val	476	ATP1A1	0.601	0.808	C0151723	Hypomagnesemia	phenotype	C18	DiseaseorSyndrome	0.42	1	2018	2020	1	0	GENOMICS_ENGLAND
val	476	ATP1A1	0.601	0.808	C0151744	MyocardialIschemia	disease	C14	DiseaseorSyndrome	0.30	1	2005	2005	1	0	CTD_human
val	476	ATP1A1	0.601	0.808	C0205646	Adenoma,BasalCell	disease	C04	NeoplasticProcess	0.30	1	2013	2013	2	0	CTD_human
val	476	ATP1A1	0.601	0.808	C0205647	Follicularadenoma	disease	C04	NeoplasticProcess	0.30	1	2013	2013	2	0	CTD_human
val	476	ATP1A1	0.601	0.808	C0205648	Adenoma,Microcystic	disease	C04	NeoplasticProcess	0.30	1	2013	2013	2	0	CTD_human
val	476	ATP1A1	0.601	0.808	C0205649	Adenoma,Monomorphic	disease	C04	NeoplasticProcess	0.30	1	2013	2013	2	0	CTD_human
val	476	ATP1A1	0.601	0.808	C0205650	Papillaryadenoma	disease	C04	NeoplasticProcess	0.30	1	2013	2013	2	0	CTD_human
val	476	ATP1A1	0.601	0.808	C0205651	Adenoma,Trabecular	disease	C04	NeoplasticProcess	0.30	1	2013	2013	2	0	CTD_human
val	476	ATP1A1	0.601	0.808	C0206667	AdrenalCorticalAdenoma	disease	C04;C19	NeoplasticProcess	0.31	1	2016	2016	0	0	CGI
val	476	ATP1A1	0.601	0.808	C1384514	ConnSyndrome	disease	C19	DiseaseorSyndrome	0.32	1	2013	2019	1	0	CTD_human
val	476	ATP1A1	0.601	0.808	C3714756	IntellectualDisability	group	C23;C10;F03;F01	MentalorBehavioralDysfunction	0.30	1	2018	2018	1	0	GENOMICS_ENGLAND
val	476	ATP1A1	0.601	0.808	C4552839	Hypomagnesemia,CTCAE	phenotype		Finding	0.40	1	2018	2018	1	0	GENOMICS_ENGLAND
val	476	ATP1A1	0.601	0.808	C4747974	CHARCOT-MARIE-TOOTHDISEASE,AXONAL,TYPE2DD	disease		DiseaseorSyndrome	0.70	1	2018	2018	2	1	GENOMICS_ENGLAND;ORPHANET;UNIPROT
val	477	ATP1A2	0.597	0.615	C0003886	Arthrogryposis	disease	C16;C05	DiseaseorSyndrome	0.40	1	2020	2020	1	2	GENOMICS_ENGLAND
val	477	ATP1A2	0.597	0.615	C0005586	BipolarDisorder	disease	F03	MentalorBehavioralDysfunction	0.31	1	2009	2009	1	0	PSYGENET
val	477	ATP1A2	0.597	0.615	C0009421	Comatose	phenotype	C23;C10	DiseaseorSyndrome	0.40	1	2009	2009	1	0	GENOMICS_ENGLAND
val	477	ATP1A2	0.597	0.615	C0013421	Dystonia	phenotype	C23;C10	SignorSymptom	0.40	1	2003	2003	2	0	GENOMICS_ENGLAND
val	477	ATP1A2	0.597	0.615	C0020305	HydropsFetalis	disease	C23;C16;C13;C20;C15	DiseaseorSyndrome	0.41	1	2020	2020	1	2	GENOMICS_ENGLAND
val	477	ATP1A2	0.597	0.615	C0020538	Hypertensivedisease	group	C14	DiseaseorSyndrome	0.50	1	2001	2005	2	0	CTD_human
val	477	ATP1A2	0.597	0.615	C0025958	Microcephaly	disease	C16;C05;C10	CongenitalAbnormality	0.30	1	2020	2020	1	0	GENOMICS_ENGLAND
val	477	ATP1A2	0.597	0.615	C0085584	Encephalopathies	group	C10	DiseaseorSyndrome	0.31	1	2009	2018	1	0	GENOMICS_ENGLAND
val	477	ATP1A2	0.597	0.615	C0149931	MigraineDisorders	group	C10	DiseaseorSyndrome	0.40	0.958	2003	2019	2	0	GENOMICS_ENGLAND
val	477	ATP1A2	0.597	0.615	C0220669	Familialbenignneonatalepilepsy	disease	C16;C10	DiseaseorSyndrome	0.32	1	2003	2004	1	0	GENOMICS_ENGLAND
val	477	ATP1A2	0.597	0.615	C0238358	Hypokalemicperiodicparalysis	disease	C16;C18;C05;C10	DiseaseorSyndrome	0.31	1	2007	2018	1	0	GENOMICS_ENGLAND
val	477	ATP1A2	0.597	0.615	C0270816	epilepsyandmigraine	disease		DiseaseorSyndrome	0.31	1	2003	2008	1	0	GENOMICS_ENGLAND
val	477	ATP1A2	0.597	0.615	C0338488	Alternatinghemiplegiaofchildhood	disease	C23;C10	DiseaseorSyndrome	0.54	1	2004	2019	1	0	CTD_human;ORPHANET
val	477	ATP1A2	0.597	0.615	C1865322	MIGRAINE,FAMILIALHEMIPLEGIC,2	disease	C10	DiseaseorSyndrome	0.80	1	2003	2020	9	13	CTD_human;GENOMICS_ENGLAND;UNIPROT
val	477	ATP1A2	0.597	0.615	C2733158	CerebralSmallVesselDiseases	group	C10;C14	DiseaseorSyndrome	0.30	1	2009	2009	1	0	GENOMICS_ENGLAND
val	477	ATP1A2	0.597	0.615	C3549447	ALTERNATINGHEMIPLEGIAOFCHILDHOOD1	disease		DiseaseorSyndrome	0.61	1	2003	2020	4	1	GENOMICS_ENGLAND;UNIPROT
val	478	ATP1A3	0.544	0.615	C0005586	BipolarDisorder	disease	F03	MentalorBehavioralDysfunction	0.52	0.5	1998	2001	2	0	PSYGENET
val	478	ATP1A3	0.544	0.615	C0011570	MentalDepression	disease	F01	MentalorBehavioralDysfunction	0.30	1	2011	2011	1	0	PSYGENET
val	478	ATP1A3	0.544	0.615	C0011581	Depressivedisorder	disease	F03	MentalorBehavioralDysfunction	0.40	1	2011	2011	1	0	PSYGENET
val	478	ATP1A3	0.544	0.615	C0013421	Dystonia	phenotype	C23;C10	SignorSymptom	0.50	1	1999	2016	1	2	CTD_human
val	478	ATP1A3	0.544	0.615	C0018801	Heartfailure	disease	C14	DiseaseorSyndrome	0.30	1	2008	2008	1	0	CTD_human
val	478	ATP1A3	0.544	0.615	C0018802	Congestiveheartfailure	disease	C14	DiseaseorSyndrome	0.30	1	2008	2008	1	0	CTD_human
val	478	ATP1A3	0.544	0.615	C0023212	Left-SidedHeartFailure	disease	C14	DiseaseorSyndrome	0.30	1	2008	2008	1	0	CTD_human
val	478	ATP1A3	0.544	0.615	C0029408	Degenerativepolyarthritis	disease	C05	DiseaseorSyndrome	0.30	1	2009	2009	1	0	CTD_human
val	478	ATP1A3	0.544	0.615	C0086743	OsteoarthrosisDeformans	disease	C05	DiseaseorSyndrome	0.30	1	2009	2009	1	0	CTD_human
val	478	ATP1A3	0.544	0.615	C0178417	Anhedonia	disease	C23;C10;F01	MentalorBehavioralDysfunction	0.30	1	2011	2011	1	0	PSYGENET
val	478	ATP1A3	0.544	0.615	C0235527	HeartFailure,Right-Sided	disease	C14	DiseaseorSyndrome	0.30	1	2008	2008	1	0	CTD_human
val	478	ATP1A3	0.544	0.615	C0242422	ParkinsonianDisorders	group	C10	DiseaseorSyndrome	0.48	1	2004	2016	1	0	CTD_human
val	478	ATP1A3	0.544	0.615	C0242423	RamsayHuntParalysisSyndrome	disease	C10	DiseaseorSyndrome	0.30	1	2004	2004	1	0	CTD_human
val	478	ATP1A3	0.544	0.615	C0242698	VentricularDysfunction,Left	phenotype	C14	PathologicFunction	0.30	1	2008	2008	1	0	CTD_human
val	478	ATP1A3	0.544	0.615	C0338488	Alternatinghemiplegiaofchildhood	disease	C23;C10	DiseaseorSyndrome	0.90	0.977	2009	2019	3	0	CTD_human;GENOMICS_ENGLAND;ORPHANET
val	478	ATP1A3	0.544	0.615	C0393588	Dystonia,Paroxysmal	phenotype	C23;C10	SignorSymptom	0.30	1	2004	2004	1	0	CTD_human
val	478	ATP1A3	0.544	0.615	C0393610	Dystonia,Diurnal	phenotype	C23;C10	SignorSymptom	0.30	1	2004	2004	1	0	CTD_human
val	478	ATP1A3	0.544	0.615	C0751093	Dystonia,Limb	phenotype	C23;C10	SignorSymptom	0.40	1	2004	2004	1	0	CTD_human
val	478	ATP1A3	0.544	0.615	C0752097	AutosomalDominantJuvenileParkinsonDisease	disease	C10	DiseaseorSyndrome	0.30	1	2004	2004	1	0	CTD_human
val	478	ATP1A3	0.544	0.615	C0752098	AutosomalDominantParkinsonism	disease	C10	DiseaseorSyndrome	0.30	1	2004	2004	1	0	CTD_human
val	478	ATP1A3	0.544	0.615	C0752100	AutosomalRecessiveParkinsonism	disease	C10	DiseaseorSyndrome	0.30	1	2004	2004	1	0	CTD_human
val	478	ATP1A3	0.544	0.615	C0752101	Parkinsonism,Experimental	disease	C10	ExperimentalModelofDisease	0.30	1	2004	2004	1	0	CTD_human
val	478	ATP1A3	0.544	0.615	C0752104	FamilialJuvenileParkinsonism	disease	C10	DiseaseorSyndrome	0.30	1	2004	2004	1	0	CTD_human
val	478	ATP1A3	0.544	0.615	C0752105	Parkinsonism,Juvenile	disease	C10	DiseaseorSyndrome	0.30	1	2004	2004	1	0	CTD_human
val	478	ATP1A3	0.544	0.615	C1832466	CAPOSsyndrome	disease	C23;C16;C11;C05;C10;C09	DiseaseorSyndrome	0.80	1	2012	2019	4	10	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
val	478	ATP1A3	0.544	0.615	C1868675	PARKINSONDISEASE2,AUTOSOMALRECESSIVEJUVENILE	disease	C10	DiseaseorSyndrome	0.30	1	2004	2004	1	0	CTD_human
val	478	ATP1A3	0.544	0.615	C1868681	DYSTONIA12	disease	C10	DiseaseorSyndrome	0.80	0.982	2004	2019	6	25	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
val	478	ATP1A3	0.544	0.615	C1959583	MyocardialFailure	disease	C14	DiseaseorSyndrome	0.30	1	2008	2008	1	0	CTD_human
val	478	ATP1A3	0.544	0.615	C1961112	HeartDecompensation	phenotype	C14	PathologicFunction	0.30	1	2008	2008	1	0	CTD_human
val	478	ATP1A3	0.544	0.615	C3549447	ALTERNATINGHEMIPLEGIAOFCHILDHOOD1	disease		DiseaseorSyndrome	0.30	1	2012	2012	1	0	GENOMICS_ENGLAND
val	478	ATP1A3	0.544	0.615	C3553788	ALTERNATINGHEMIPLEGIAOFCHILDHOOD2	disease		DiseaseorSyndrome	0.61	1	2004	2017	6	38	GENOMICS_ENGLAND;UNIPROT
val	480	ATP1A4	0.805	0.269	C0003165	Anthracosis	disease	C08	DiseaseorSyndrome	0.30	1	2018	2018	1	0	CTD_human
val	481	ATP1B1	0.7	0.462	C0013146	Drugabuse	group	C25;F03	MentalorBehavioralDysfunction	0.30	1	2010	2010	1	0	CTD_human
val	481	ATP1B1	0.7	0.462	C0013170	Drughabituation	phenotype	C25;F03	MentalorBehavioralDysfunction	0.30	1	2010	2010	1	0	CTD_human
val	481	ATP1B1	0.7	0.462	C0013222	DrugUseDisorders	group	C25;F03	MentalorBehavioralDysfunction	0.30	1	2010	2010	1	0	CTD_human
val	481	ATP1B1	0.7	0.462	C0023467	Leukemia,Myelocytic,Acute	disease	C04	NeoplasticProcess	0.30	1	2007	2007	1	0	CTD_human
val	481	ATP1B1	0.7	0.462	C0026998	AcuteMyeloidLeukemia,M1	disease	C04	NeoplasticProcess	0.30	1	2007	2007	1	0	CTD_human
val	481	ATP1B1	0.7	0.462	C0029231	OrganicMentalDisorders,Substance-Induced	disease	C25;F03	MentalorBehavioralDysfunction	0.30	1	2010	2010	1	0	CTD_human
val	481	ATP1B1	0.7	0.462	C0038580	SubstanceDependence	disease	C25;F03	MentalorBehavioralDysfunction	0.30	1	2010	2010	1	0	CTD_human
val	481	ATP1B1	0.7	0.462	C0038586	SubstanceUseDisorders	group	C25;F03	MentalorBehavioralDysfunction	0.30	1	2010	2010	1	0	CTD_human
val	481	ATP1B1	0.7	0.462	C0085580	EssentialHypertension	disease	C14	DiseaseorSyndrome	0.31	1	2009	2009	0	0	CTD_human
val	481	ATP1B1	0.7	0.462	C0236969	Substance-RelatedDisorders	group	C25;F03	MentalorBehavioralDysfunction	0.30	1	2010	2010	1	0	CTD_human
val	481	ATP1B1	0.7	0.462	C0740858	Substanceabuseproblem	disease	C25;F03	MentalorBehavioralDysfunction	0.30	1	2010	2010	1	0	CTD_human
val	481	ATP1B1	0.7	0.462	C1510472	DrugDependence	group	C25;F03	MentalorBehavioralDysfunction	0.30	1	2010	2010	1	0	CTD_human
val	481	ATP1B1	0.7	0.462	C1879321	AcuteMyeloidLeukemia(AML-M2)	disease	C04	NeoplasticProcess	0.30	1	2007	2007	1	0	CTD_human
val	481	ATP1B1	0.7	0.462	C4316881	PrescriptionDrugAbuse	phenotype	C25;F03	Finding	0.30	1	2010	2010	1	0	CTD_human
val	482	ATP1B2	0.705	0.308	C0017638	Glioma	disease	C04	NeoplasticProcess	0.32	1	2003	2006	1	0	CTD_human
val	482	ATP1B2	0.705	0.308	C0259783	mixedgliomas	disease	C04	NeoplasticProcess	0.30	1	2006	2006	1	0	CTD_human
val	482	ATP1B2	0.705	0.308	C0279626	Squamouscellcarcinomaofesophagus	disease	C06;C04	NeoplasticProcess	0.40	1	2014	2014	1	1	CTD_human
val	482	ATP1B2	0.705	0.308	C0555198	MalignantGlioma	disease	C04	NeoplasticProcess	0.31	1	2003	2006	1	0	CTD_human
val	486	FXYD2	0.78	0.346	C0020538	Hypertensivedisease	group	C14	DiseaseorSyndrome	0.30	1	2012	2012	1	0	CTD_human
val	486	FXYD2	0.78	0.346	C0023893	LiverCirrhosis,Experimental	disease	C23;C06	ExperimentalModelofDisease	0.30	1	2014	2014	1	0	CTD_human
val	486	FXYD2	0.78	0.346	C0024473	MagnesiumDeficiency	disease	C18	DiseaseorSyndrome	0.30	1	2000	2000	1	0	CTD_human
val	486	FXYD2	0.78	0.346	C0268448	Primaryhypomagnesemia(disorder)	disease	C23;C16;C18;C13;C12	DiseaseorSyndrome	0.30	1	2000	2000	1	0	CTD_human
val	486	FXYD2	0.78	0.346	C1835171	Hypomagnesemia2,renal	disease	C16;C18;C13;C12	DiseaseorSyndrome	0.70	1	2000	2016	4	0	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
val	487	ATP2A1	0.682	0.423	C0018801	Heartfailure	disease	C14	DiseaseorSyndrome	0.30	1	2009	2009	1	0	CTD_human
val	487	ATP2A1	0.682	0.423	C0018802	Congestiveheartfailure	disease	C14	DiseaseorSyndrome	0.30	1	2009	2009	1	0	CTD_human
val	487	ATP2A1	0.682	0.423	C0023212	Left-SidedHeartFailure	disease	C14	DiseaseorSyndrome	0.30	1	2009	2009	1	0	CTD_human
val	487	ATP2A1	0.682	0.423	C0235527	HeartFailure,Right-Sided	disease	C14	DiseaseorSyndrome	0.30	1	2009	2009	1	0	CTD_human
val	487	ATP2A1	0.682	0.423	C1832918	Brodymyopathy	disease	C16;C05;C10	DiseaseorSyndrome	0.80	1	1995	2014	3	11	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
val	487	ATP2A1	0.682	0.423	C1959583	MyocardialFailure	disease	C14	DiseaseorSyndrome	0.30	1	2009	2009	1	0	CTD_human
val	487	ATP2A1	0.682	0.423	C1961112	HeartDecompensation	phenotype	C14	PathologicFunction	0.30	1	2009	2009	1	0	CTD_human
val	488	ATP2A2	0.529	0.808	C0002152	AlloxanDiabetes	disease	C18;C19	ExperimentalModelofDisease	0.30	1	2005	2005	1	0	CTD_human
val	488	ATP2A2	0.529	0.808	C0011570	MentalDepression	disease	F01	MentalorBehavioralDysfunction	0.30	1	2001	2004	2	0	PSYGENET
val	488	ATP2A2	0.529	0.808	C0011581	Depressivedisorder	disease	F03	MentalorBehavioralDysfunction	0.30	1	2001	2004	2	0	PSYGENET
val	488	ATP2A2	0.529	0.808	C0011853	DiabetesMellitus,Experimental	disease	C18;C19	ExperimentalModelofDisease	0.50	1	2005	2017	1	0	CTD_human
val	488	ATP2A2	0.529	0.808	C0011860	DiabetesMellitus,Non-Insulin-Dependent	disease	C18;C19	DiseaseorSyndrome	0.51	1	2005	2016	1	0	CTD_human
val	488	ATP2A2	0.529	0.808	C0018799	HeartDiseases	group	C14	DiseaseorSyndrome	0.51	0.667	2009	2015	1	0	CTD_human
val	488	ATP2A2	0.529	0.808	C0018800	Cardiomegaly	phenotype	C23;C14	Finding	0.50	1	2001	2018	1	0	CTD_human
val	488	ATP2A2	0.529	0.808	C0018801	Heartfailure	disease	C14	DiseaseorSyndrome	0.60	0.929	1996	2019	1	0	CTD_human
val	488	ATP2A2	0.529	0.808	C0018802	Congestiveheartfailure	disease	C14	DiseaseorSyndrome	0.80	0.929	1996	2019	1	0	CTD_human;GENOMICS_ENGLAND
val	488	ATP2A2	0.529	0.808	C0022595	KeratosisFollicularis	disease	C16;C17	DiseaseorSyndrome	1.00	0.974	1999	2018	12	8	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
val	488	ATP2A2	0.529	0.808	C0023212	Left-SidedHeartFailure	disease	C14	DiseaseorSyndrome	0.30	1	2009	2009	1	0	CTD_human
val	488	ATP2A2	0.529	0.808	C0027055	MyocardialReperfusionInjury	phenotype	C23;C14	PathologicFunction	0.50	1	2000	2017	1	0	CTD_human
val	488	ATP2A2	0.529	0.808	C0036341	Schizophrenia	disease	F03	MentalorBehavioralDysfunction	0.43	1	2012	2019	1	1	PSYGENET
val	488	ATP2A2	0.529	0.808	C0038220	StatusEpilepticus	disease	C23;C10	DiseaseorSyndrome	0.30	1	2004	2004	1	0	CTD_human
val	488	ATP2A2	0.529	0.808	C0038433	StreptozotocinDiabetes	disease	C18;C19	ExperimentalModelofDisease	0.30	1	2005	2005	1	0	CTD_human
val	488	ATP2A2	0.529	0.808	C0206145	StunnedMyocardium	disease	C23;C14	DiseaseorSyndrome	0.30	1	2006	2006	1	0	CTD_human
val	488	ATP2A2	0.529	0.808	C0206146	MyocardialStunning	disease	C23;C14	DiseaseorSyndrome	0.30	1	2006	2006	1	0	CTD_human
val	488	ATP2A2	0.529	0.808	C0235527	HeartFailure,Right-Sided	disease	C14	DiseaseorSyndrome	0.30	1	2009	2009	1	0	CTD_human
val	488	ATP2A2	0.529	0.808	C0242698	VentricularDysfunction,Left	phenotype	C14	PathologicFunction	0.30	1	2011	2011	1	0	CTD_human
val	488	ATP2A2	0.529	0.808	C0264716	Chronicheartfailure	disease	C14	DiseaseorSyndrome	0.30				0	0	GENOMICS_ENGLAND
val	488	ATP2A2	0.529	0.808	C0265971	AcrokeratosisVerruciformisofHopf	disease	C16;C17	DiseaseorSyndrome;CongenitalAbnormality	0.74	1	2003	2017	3	2	CTD_human;ORPHANET;UNIPROT
val	488	ATP2A2	0.529	0.808	C0270823	Petitmalstatus	disease	C23;C10	DiseaseorSyndrome	0.30	1	2004	2004	1	0	CTD_human
val	488	ATP2A2	0.529	0.808	C0311335	GrandMalStatusEpilepticus	disease	C23;C10	DiseaseorSyndrome	0.30	1	2004	2004	1	0	CTD_human
val	488	ATP2A2	0.529	0.808	C0376416	Hibernation,Myocardial	disease	C23;C14	DiseaseorSyndrome	0.30	1	2006	2006	1	0	CTD_human
val	488	ATP2A2	0.529	0.808	C0393734	ComplexPartialStatusEpilepticus	disease	C23;C10	DiseaseorSyndrome	0.30	1	2004	2004	1	0	CTD_human
val	488	ATP2A2	0.529	0.808	C0473575	AcantholyticDyskeratoticEpidermalNevus	disease	C16;C17	NeoplasticProcess	0.30	1	2006	2010	2	0	CTD_human
val	488	ATP2A2	0.529	0.808	C0525045	MoodDisorders	group	F03	MentalorBehavioralDysfunction	0.32	1	2001	2002	2	0	PSYGENET
val	488	ATP2A2	0.529	0.808	C0751522	StatusEpilepticus,Subclinical	disease	C23;C10	DiseaseorSyndrome	0.30	1	2004	2004	1	0	CTD_human
val	488	ATP2A2	0.529	0.808	C0751523	Non-ConvulsiveStatusEpilepticus	disease	C23;C10	DiseaseorSyndrome	0.30	1	2004	2004	1	0	CTD_human
val	488	ATP2A2	0.529	0.808	C0751524	SimplePartialStatusEpilepticus	phenotype	C23;C10	DiseaseorSyndrome	0.30	1	2004	2004	1	0	CTD_human
val	488	ATP2A2	0.529	0.808	C0853897	DiabeticCardiomyopathies	disease	C19;C14	DiseaseorSyndrome	0.52	0.75	2002	2014	1	0	CTD_human
val	488	ATP2A2	0.529	0.808	C1383860	CardiacHypertrophy	phenotype	C23;C14	PathologicFunction	0.30	1	2001	2001	1	0	CTD_human
val	488	ATP2A2	0.529	0.808	C1959583	MyocardialFailure	disease	C14	DiseaseorSyndrome	0.30	1	2009	2009	1	0	CTD_human
val	488	ATP2A2	0.529	0.808	C1961112	HeartDecompensation	phenotype	C14	PathologicFunction	0.30	1	2009	2009	1	0	CTD_human
val	489	ATP2A3	0.617	0.577	C0001430	Adenoma	group	C04	NeoplasticProcess	0.32	1	2005	2014	1	0	CTD_human
val	489	ATP2A3	0.617	0.577	C0002152	AlloxanDiabetes	disease	C18;C19	ExperimentalModelofDisease	0.30	1	2005	2005	1	0	CTD_human
val	489	ATP2A3	0.617	0.577	C0006142	Malignantneoplasmofbreast	disease	C04;C17	NeoplasticProcess	0.35	1	2016	2019	0	1	UNIPROT
val	489	ATP2A3	0.617	0.577	C0011853	DiabetesMellitus,Experimental	disease	C18;C19	ExperimentalModelofDisease	0.50	1	2005	2010	1	0	CTD_human
val	489	ATP2A3	0.617	0.577	C0011860	DiabetesMellitus,Non-Insulin-Dependent	disease	C18;C19	DiseaseorSyndrome	0.32	1	1999	2019	1	0	CTD_human
val	489	ATP2A3	0.617	0.577	C0038433	StreptozotocinDiabetes	disease	C18;C19	ExperimentalModelofDisease	0.30	1	2005	2005	1	0	CTD_human
val	489	ATP2A3	0.617	0.577	C0205646	Adenoma,BasalCell	disease	C04	NeoplasticProcess	0.30	1	2013	2013	1	0	CTD_human
val	489	ATP2A3	0.617	0.577	C0205647	Follicularadenoma	disease	C04	NeoplasticProcess	0.30	1	2013	2013	1	0	CTD_human
val	489	ATP2A3	0.617	0.577	C0205648	Adenoma,Microcystic	disease	C04	NeoplasticProcess	0.30	1	2013	2013	1	0	CTD_human
val	489	ATP2A3	0.617	0.577	C0205649	Adenoma,Monomorphic	disease	C04	NeoplasticProcess	0.30	1	2013	2013	1	0	CTD_human
val	489	ATP2A3	0.617	0.577	C0205650	Papillaryadenoma	disease	C04	NeoplasticProcess	0.30	1	2013	2013	1	0	CTD_human
val	489	ATP2A3	0.617	0.577	C0205651	Adenoma,Trabecular	disease	C04	NeoplasticProcess	0.30	1	2013	2013	1	0	CTD_human
val	490	ATP2B1	0.666	0.5	C0010054	CoronaryArteriosclerosis	disease	C14	DiseaseorSyndrome	0.31	1	2012	2019	1	0	CTD_human
val	490	ATP2B1	0.666	0.5	C0020538	Hypertensivedisease	group	C14	DiseaseorSyndrome	0.70	0.966	1999	2019	1	9	CTD_human
val	490	ATP2B1	0.666	0.5	C0086543	Cataract	disease	C11	AcquiredAbnormality	0.30	1	2004	2004	1	0	CTD_human
val	490	ATP2B1	0.666	0.5	C0524524	Pseudoaphakia	disease	C11	DiseaseorSyndrome	0.30	1	2004	2004	1	0	CTD_human
val	490	ATP2B1	0.666	0.5	C1510497	LensOpacities	phenotype	C11	Finding	0.30	1	2004	2004	1	0	CTD_human
val	490	ATP2B1	0.666	0.5	C1956346	CoronaryArteryDisease	disease	C14	DiseaseorSyndrome	0.43	1	2012	2019	1	3	CTD_human
val	491	ATP2B2	0.659	0.731	C1832394	Deafness,AutosomalRecessive12	disease	C23;C10;C09	DiseaseorSyndrome	0.50	1	2007	2007	1	0	CTD_human;GENOMICS_ENGLAND
val	492	ATP2B3	0.631	0.692	C0001430	Adenoma	group	C04	NeoplasticProcess	0.31	1	2013	2013	1	0	CTD_human
val	492	ATP2B3	0.631	0.692	C0020428	Hyperaldosteronism	disease	C19	DiseaseorSyndrome	0.31	1	2013	2015	1	0	CTD_human
val	492	ATP2B3	0.631	0.692	C0020538	Hypertensivedisease	group	C14	DiseaseorSyndrome	0.31	1	2013	2017	1	0	CTD_human
val	492	ATP2B3	0.631	0.692	C0205646	Adenoma,BasalCell	disease	C04	NeoplasticProcess	0.30	1	2013	2013	1	0	CTD_human
val	492	ATP2B3	0.631	0.692	C0205647	Follicularadenoma	disease	C04	NeoplasticProcess	0.30	1	2013	2013	1	0	CTD_human
val	492	ATP2B3	0.631	0.692	C0205648	Adenoma,Microcystic	disease	C04	NeoplasticProcess	0.30	1	2013	2013	1	0	CTD_human
val	492	ATP2B3	0.631	0.692	C0205649	Adenoma,Monomorphic	disease	C04	NeoplasticProcess	0.30	1	2013	2013	1	0	CTD_human
val	492	ATP2B3	0.631	0.692	C0205650	Papillaryadenoma	disease	C04	NeoplasticProcess	0.30	1	2013	2013	1	0	CTD_human
val	492	ATP2B3	0.631	0.692	C0205651	Adenoma,Trabecular	disease	C04	NeoplasticProcess	0.30	1	2013	2013	1	0	CTD_human
val	492	ATP2B3	0.631	0.692	C0796205	SPINOCEREBELLARATAXIA,X-LINKED1	disease	C16;C10	DiseaseorSyndrome	0.70	1	2012	2012	1	1	CTD_human;GENOMICS_ENGLAND;UNIPROT
val	492	ATP2B3	0.631	0.692	C1384514	ConnSyndrome	disease	C19	DiseaseorSyndrome	0.31	1	2013	2015	1	0	CTD_human
val	492	ATP2B3	0.631	0.692	C4707849	X-linkednonprogressivecerebellarataxia	disease	C23;C16;C10	DiseaseorSyndrome	0.30				0	0	ORPHANET
val	498	ATP5F1A	0.604	0.731	C0002395	AlzheimersDisease	disease	C10;F03	DiseaseorSyndrome	0.54	1	2003	2017	1	0	CTD_human
1979	498	ATP5F1A	0.604	0.731	C0750900	AlzheimersDisease,FocalOnset	disease	C10;F03	MentalorBehavioralDysfunction	0.30	1	2009	2009	1	0	CTD_human
val	498	ATP5F1A	0.604	0.731	C0750901	AlzheimerDisease,EarlyOnset	disease	C10;F03	DiseaseorSyndrome	0.30	1	2009	2009	1	0	CTD_human
val	498	ATP5F1A	0.604	0.731	C3808899	MITOCHONDRIALCOMPLEXV(ATPSYNTHASE)DEFICIENCY,NUCLEARTYPE4	disease		DiseaseorSyndrome	0.70	1	2013	2013	2	1	CTD_human;GENOMICS_ENGLAND;UNIPROT
val	498	ATP5F1A	0.604	0.731	C4015062	COMBINEDOXIDATIVEPHOSPHORYLATIONDEFICIENCY22	disease		DiseaseorSyndrome	0.70	1	2013	2013	2	1	CTD_human;GENOMICS_ENGLAND;UNIPROT
val	498	ATP5F1A	0.604	0.731	C4757950	IsolatedATPsynthasedeficiency	disease		DiseaseorSyndrome	0.30	1	2013	2013	1	0	ORPHANET
val	501	ALDH7A1	0.551	0.769	C0005940	BoneDiseases	group	C05	DiseaseorSyndrome	0.30	1	2014	2014	1	0	CTD_human
val	501	ALDH7A1	0.551	0.769	C0009363	Congenitalocularcoloboma(disorder)	disease	C16;C11	CongenitalAbnormality	0.30	1	2014	2014	1	0	CTD_human
val	501	ALDH7A1	0.551	0.769	C0024623	Malignantneoplasmofstomach	disease	C06;C04	NeoplasticProcess	0.30	1	2011	2011	1	0	CTD_human
val	501	ALDH7A1	0.551	0.769	C0038356	StomachNeoplasms	group	C06;C04	NeoplasticProcess	0.30	1	2011	2011	1	0	CTD_human
val	501	ALDH7A1	0.551	0.769	C0235874	DiseaseExacerbation	phenotype	C23	Finding	0.30	1	2011	2011	1	0	CTD_human
val	501	ALDH7A1	0.551	0.769	C1708349	HereditaryDiffuseGastricCancer	disease	C06;C04	NeoplasticProcess	0.30	1	2011	2011	1	0	CTD_human
val	501	ALDH7A1	0.551	0.769	C1849508	EPILEPSY,PYRIDOXINE-DEPENDENT	disease	C10	DiseaseorSyndrome	0.80	1	2006	2020	9	25	CLINGEN;CTD_human;GENOMICS_ENGLAND;UNIPROT
val	501	ALDH7A1	0.551	0.769	C4554007	UveoretinalColoboma	disease	C16;C11	CongenitalAbnormality	0.30	1	2014	2014	1	0	CTD_human
val	506	ATP5F1B	0.626	0.654	C0003129	Anoxemia	phenotype	C23	SignorSymptom	0.30	1	2009	2009	1	0	CTD_human
val	506	ATP5F1B	0.626	0.654	C0003130	Anoxia	phenotype	C23	PathologicFunction	0.30	1	2009	2009	1	0	CTD_human
val	506	ATP5F1B	0.626	0.654	C0022660	KidneyFailure,Acute	disease	C13;C12	DiseaseorSyndrome	0.50	1	2015	2015	1	0	CTD_human
val	506	ATP5F1B	0.626	0.654	C0032927	PrecancerousConditions	group	C04	NeoplasticProcess	0.30	1	2012	2012	1	0	CTD_human
val	506	ATP5F1B	0.626	0.654	C0242184	Hypoxia	phenotype	C23	PathologicFunction	0.30	1	2009	2009	1	0	CTD_human
val	506	ATP5F1B	0.626	0.654	C0282313	Condition,Preneoplastic	disease	C04	NeoplasticProcess	0.30	1	2012	2012	1	0	CTD_human
val	506	ATP5F1B	0.626	0.654	C0700292	Hypoxemia	phenotype	C23	Finding	0.30	1	2009	2009	1	0	CTD_human
val	506	ATP5F1B	0.626	0.654	C1565662	AcuteKidneyInsufficiency	disease	C13;C12	DiseaseorSyndrome	0.50	1	2015	2015	1	0	CTD_human
val	506	ATP5F1B	0.626	0.654	C1846707	SPINOCEREBELLARATAXIA17	disease	C16;C10	DiseaseorSyndrome	0.30	1	2014	2014	1	0	CTD_human
val	506	ATP5F1B	0.626	0.654	C2609414	Acutekidneyinjury	disease	C13;C12	InjuryorPoisoning	0.50	1	2015	2015	1	0	CTD_human
val	513	ATP5F1D	0.674	0.5	C0005684	Malignantneoplasmofurinarybladder	disease	C04;C13;C12	NeoplasticProcess	0.30	1	2015	2015	1	0	CTD_human
val	513	ATP5F1D	0.674	0.5	C0005695	BladderNeoplasm	disease	C04;C13;C12	NeoplasticProcess	0.30	1	2015	2015	1	0	CTD_human
val	513	ATP5F1D	0.674	0.5	C4748269	MITOCHONDRIALCOMPLEXV(ATPSYNTHASE)DEFICIENCY,NUCLEARTYPE5	disease		DiseaseorSyndrome	0.60	1	2018	2018	1	2	GENOMICS_ENGLAND;UNIPROT
val	513	ATP5F1D	0.674	0.5	C4757950	IsolatedATPsynthasedeficiency	disease		DiseaseorSyndrome	0.30	1	2018	2018	1	0	ORPHANET
val	514	ATP5F1E	0.686	0.5	C3279708	MITOCHONDRIALCOMPLEXV(ATPSYNTHASE)DEFICIENCY,NUCLEARTYPE3	disease		DiseaseorSyndrome	0.70	1	2010	2016	3	1	CTD_human;GENOMICS_ENGLAND;UNIPROT
val	514	ATP5F1E	0.686	0.5	C4757950	IsolatedATPsynthasedeficiency	disease		DiseaseorSyndrome	0.30	1	2010	2010	1	0	ORPHANET
val	522	ATP5PF	0.716	0.538	C0018799	HeartDiseases	group	C14	DiseaseorSyndrome	0.30	1	2006	2006	1	0	CTD_human
val	523	ATP6V1A	0.579	0.615	C0268355	CutisLaxa,AutosomalRecessive,TypeIIA	disease	C16;C17	DiseaseorSyndrome	0.30	1	2017	2017	1	0	ORPHANET
val	523	ATP6V1A	0.579	0.615	C4479387	CUTISLAXA,AUTOSOMALRECESSIVE,TYPEIIC	disease		DiseaseorSyndrome	0.30	1	2017	2017	1	0	ORPHANET
val	523	ATP6V1A	0.579	0.615	C4479409	CUTISLAXA,AUTOSOMALRECESSIVE,TYPEIID	disease		DiseaseorSyndrome	0.70	1	2017	2017	1	2	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
val	523	ATP6V1A	0.579	0.615	C4693934	EPILEPTICENCEPHALOPATHY,INFANTILEOREARLYCHILDHOOD,3	disease		DiseaseorSyndrome	0.60	1	2017	2018	2	5	GENOMICS_ENGLAND;UNIPROT
val	525	ATP6V1B1	0.695	0.346	C0027707	Nephritis,Interstitial	disease	C13;C12	DiseaseorSyndrome	0.30				0	0	GENOMICS_ENGLAND
val	525	ATP6V1B1	0.695	0.346	C0041349	Nephritis,Tubulointerstitial	disease	C13;C12	DiseaseorSyndrome	0.30				0	0	GENOMICS_ENGLAND
val	525	ATP6V1B1	0.695	0.346	C0403554	RenalTubularAcidosis,Distal,withProgressiveNerveDeafness	disease	C23;C16;C18;C13;C12;C10;C09	DiseaseorSyndrome	0.70	1	1999	2017	4	0	CLINGEN;CTD_human;GENOMICS_ENGLAND;UNIPROT
val	525	ATP6V1B1	0.695	0.346	C1384666	hearingimpairment	phenotype	C23;C10;C09	DiseaseorSyndrome	0.30	1	1999	1999	1	0	GENOMICS_ENGLAND
val	525	ATP6V1B1	0.695	0.346	C1704380	DistalRenalTubularAcidosis	disease	C16;C18;C13;C12	DiseaseorSyndrome	0.40	1	2001	2020	0	0	GENOMICS_ENGLAND
val	525	ATP6V1B1	0.695	0.346	C1864498	RENALTUBULARACIDOSIS,DISTAL,AUTOSOMALRECESSIVE	disease	C16;C18;C13;C12	DiseaseorSyndrome	0.36	1	2002	2017	1	0	ORPHANET
val	525	ATP6V1B1	0.695	0.346	C4302514	Distalrenaltubularacidosisco-occurrentwithsensorineuraldeafness	phenotype	C23;C16;C18;C13;C12;C10;C09	DiseaseorSyndrome	0.30	1	1999	2017	2	0	CLINGEN
val	526	ATP6V1B2	0.606	0.577	C0024301	Lymphoma,Follicular	disease	C04;C20;C15	NeoplasticProcess	0.31	1	2016	2019	1	0	CTD_human
val	526	ATP6V1B2	0.606	0.577	C0029408	Degenerativepolyarthritis	disease	C05	DiseaseorSyndrome	0.30	1	2009	2009	1	0	CTD_human
val	526	ATP6V1B2	0.606	0.577	C0079745	Lymphoma,Large-Cell,Follicular	disease	C04;C20;C15	NeoplasticProcess	0.30	1	2016	2016	1	0	CTD_human
val	526	ATP6V1B2	0.606	0.577	C0079758	Lymphoma,Mixed-Cell,Follicular	disease	C04;C20;C15	NeoplasticProcess	0.30	1	2016	2016	1	0	CTD_human
val	526	ATP6V1B2	0.606	0.577	C0079765	Lymphoma,SmallCleaved-Cell,Follicular	disease	C04;C20;C15	NeoplasticProcess	0.30	1	2016	2016	1	0	CTD_human
val	526	ATP6V1B2	0.606	0.577	C0086743	OsteoarthrosisDeformans	disease	C05	DiseaseorSyndrome	0.30	1	2009	2009	1	0	CTD_human
val	526	ATP6V1B2	0.606	0.577	C0796013	ZimmermanLabandsyndrome	disease	C16;C05;C07	DiseaseorSyndrome	0.61	1	2015	2015	1	0	CTD_human;GENOMICS_ENGLAND;ORPHANET
val	526	ATP6V1B2	0.606	0.577	C1956130	Lymphoma,Follicular,Grade1	disease	C04;C20;C15	NeoplasticProcess	0.30	1	2016	2016	1	0	CTD_human
val	526	ATP6V1B2	0.606	0.577	C1956131	Lymphoma,Follicular,Grade3	disease	C04;C20;C15	NeoplasticProcess	0.30	1	2016	2016	1	0	CTD_human
val	526	ATP6V1B2	0.606	0.577	C1956132	Lymphoma,Follicular,Grade2	disease	C04;C20;C15	NeoplasticProcess	0.30	1	2016	2016	1	0	CTD_human
val	526	ATP6V1B2	0.606	0.577	C2675730	Deafness,Congenital,andOnychodystrophy,AutosomalDominant	disease	C23;C16;C10;C07;C09	DiseaseorSyndrome	0.62	1	2014	2019	1	1	CTD_human;ORPHANET
val	526	ATP6V1B2	0.606	0.577	C4225321	ZIMMERMANN-LABANDSYNDROME2	disease		DiseaseorSyndrome	0.41	1	2015	2019	1	2	UNIPROT
val	529	ATP6V1E1	0.61	0.769	C0009402	ColorectalCarcinoma	disease	C06;C04	NeoplasticProcess	0.30				0	0	UNIPROT
val	529	ATP6V1E1	0.61	0.769	C0268355	CutisLaxa,AutosomalRecessive,TypeIIA	disease	C16;C17	DiseaseorSyndrome	0.30	1	2017	2017	1	0	ORPHANET
val	529	ATP6V1E1	0.61	0.769	C4479387	CUTISLAXA,AUTOSOMALRECESSIVE,TYPEIIC	disease		DiseaseorSyndrome	0.70	1	2017	2017	1	2	CTD_human;ORPHANET;UNIPROT
val	529	ATP6V1E1	0.61	0.769	C4479409	CUTISLAXA,AUTOSOMALRECESSIVE,TYPEIID	disease		DiseaseorSyndrome	0.30	1	2017	2017	1	0	ORPHANET
val	533	ATP6V0B	0.931	0.115	C0006142	Malignantneoplasmofbreast	disease	C04;C17	NeoplasticProcess	0.30				0	1	UNIPROT
val	537	ATP6AP1	0.691	0.577	C0024301	Lymphoma,Follicular	disease	C04;C20;C15	NeoplasticProcess	0.30	1	2016	2016	1	0	CTD_human
val	537	ATP6AP1	0.691	0.577	C0079745	Lymphoma,Large-Cell,Follicular	disease	C04;C20;C15	NeoplasticProcess	0.30	1	2016	2016	1	0	CTD_human
val	537	ATP6AP1	0.691	0.577	C0079758	Lymphoma,Mixed-Cell,Follicular	disease	C04;C20;C15	NeoplasticProcess	0.30	1	2016	2016	1	0	CTD_human
val	537	ATP6AP1	0.691	0.577	C0079765	Lymphoma,SmallCleaved-Cell,Follicular	disease	C04;C20;C15	NeoplasticProcess	0.30	1	2016	2016	1	0	CTD_human
val	537	ATP6AP1	0.691	0.577	C1956130	Lymphoma,Follicular,Grade1	disease	C04;C20;C15	NeoplasticProcess	0.30	1	2016	2016	1	0	CTD_human
val	537	ATP6AP1	0.691	0.577	C1956131	Lymphoma,Follicular,Grade3	disease	C04;C20;C15	NeoplasticProcess	0.30	1	2016	2016	1	0	CTD_human
val	537	ATP6AP1	0.691	0.577	C1956132	Lymphoma,Follicular,Grade2	disease	C04;C20;C15	NeoplasticProcess	0.30	1	2016	2016	1	0	CTD_human
val	537	ATP6AP1	0.691	0.577	C4310819	IMMUNODEFICIENCY47	disease		DiseaseorSyndrome	0.70	1	2016	2018	1	5	CTD_human;GENOMICS_ENGLAND;UNIPROT
val	538	ATP7A	0.494	0.769	C0002871	Anemia	disease	C15	DiseaseorSyndrome	0.30	1	2013	2013	1	0	CTD_human
val	538	ATP7A	0.494	0.769	C0003496	AorticRupture	disease	C14;C26	DiseaseorSyndrome	0.30	1	1990	2015	2	0	CTD_human
val	538	ATP7A	0.494	0.769	C0004134	Ataxia	phenotype	C23;C10	SignorSymptom	0.30	1	2012	2012	1	0	CTD_human
val	538	ATP7A	0.494	0.769	C0007102	Malignanttumorofcolon	disease	C06;C04	NeoplasticProcess	0.31	1	2007	2007	1	0	CTD_human
val	538	ATP7A	0.494	0.769	C0009375	ColonicNeoplasms	group	C06;C04	NeoplasticProcess	0.30	1	2007	2007	1	0	CTD_human
val	538	ATP7A	0.494	0.769	C0010495	CutisLaxa	disease	C16;C17	DiseaseorSyndrome	0.40	1	2010	2010	1	0	GENOMICS_ENGLAND
val	538	ATP7A	0.494	0.769	C0018273	GrowthDisorders	group	C23	PathologicFunction	0.30	1	2012	2012	1	0	CTD_human
val	538	ATP7A	0.494	0.769	C0019054	Hemolysis(disorder)	phenotype	C23	PathologicFunction	0.30	1	2014	2014	1	0	CTD_human
val	538	ATP7A	0.494	0.769	C0019189	Hepatitis,Chronic	disease	C06	DiseaseorSyndrome	0.30	1	2015	2015	1	0	CTD_human
val	538	ATP7A	0.494	0.769	C0019207	Hepatoma,Morris	disease	C06;C04	NeoplasticProcess;ExperimentalModelofDisease	0.30	1	2013	2013	1	0	CTD_human
val	538	ATP7A	0.494	0.769	C0019208	Hepatoma,Novikoff	disease	C06;C04	NeoplasticProcess;ExperimentalModelofDisease	0.30	1	2013	2013	1	0	CTD_human
val	538	ATP7A	0.494	0.769	C0020542	PulmonaryHypertension	phenotype	C08	PathologicFunction	0.30	1	2014	2014	1	0	CTD_human
val	538	ATP7A	0.494	0.769	C0022333	JacksonianSeizure	disease	C23;C10	DiseaseorSyndrome	0.30	1	2012	2012	1	0	CTD_human
val	538	ATP7A	0.494	0.769	C0022716	MenkesKinkyHairSyndrome	disease	C16;C18;C17;C10	DiseaseorSyndrome	1.00	1	1953	2019	46	0	CLINGEN;CTD_human;GENOMICS_ENGLAND;UNIPROT
val	538	ATP7A	0.494	0.769	C0023904	LiverNeoplasms,Experimental	phenotype	C06;C04	NeoplasticProcess;ExperimentalModelofDisease	0.30	1	2013	2013	1	0	CTD_human
val	538	ATP7A	0.494	0.769	C0026654	MoyamoyaDisease	disease	C10;C14	DiseaseorSyndrome	0.30				0	0	GENOMICS_ENGLAND
val	538	ATP7A	0.494	0.769	C0027854	NeurologicManifestations	phenotype	C23;C10	Finding	0.30	1	2012	2012	2	0	CTD_human
val	538	ATP7A	0.494	0.769	C0036572	Seizures	phenotype	C23;C10	SignorSymptom	0.40	1	2012	2012	1	0	CTD_human
val	538	ATP7A	0.494	0.769	C0040822	Tremor	phenotype	C23;C10	SignorSymptom	0.30	1	2012	2012	1	0	CTD_human
val	538	ATP7A	0.494	0.769	C0040827	SaturnineTremor	phenotype	C23;C10	SignorSymptom	0.30	1	2012	2012	1	0	CTD_human
val	538	ATP7A	0.494	0.769	C0086404	ExperimentalHepatoma	disease	C06;C04	NeoplasticProcess;ExperimentalModelofDisease	0.30	1	2013	2013	1	0	CTD_human
val	538	ATP7A	0.494	0.769	C0149519	ChronicPersistentHepatitis	disease	C06	DiseaseorSyndrome	0.30	1	2015	2015	1	0	CTD_human
val	538	ATP7A	0.494	0.769	C0149840	SenileTremor	phenotype	C23;C10	SignorSymptom	0.30	1	2012	2012	1	0	CTD_human
val	538	ATP7A	0.494	0.769	C0149958	Complexpartialseizures	disease	C23;C10	DiseaseorSyndrome	0.30	1	2012	2012	1	0	CTD_human
val	538	ATP7A	0.494	0.769	C0234370	PersistentTremor	phenotype	C23;C10	SignorSymptom	0.30	1	2012	2012	1	0	CTD_human
val	538	ATP7A	0.494	0.769	C0234371	ContinuousTremor	phenotype	C23;C10	SignorSymptom	0.30	1	2012	2012	1	0	CTD_human
val	538	ATP7A	0.494	0.769	C0234372	IntermittentTremor	phenotype	C23;C10	SignorSymptom	0.30	1	2012	2012	1	0	CTD_human
val	538	ATP7A	0.494	0.769	C0234373	FineTremor	phenotype	C23;C10	SignorSymptom	0.30	1	2012	2012	1	0	CTD_human
val	538	ATP7A	0.494	0.769	C0234374	CoarseTremor	phenotype	C23;C10	SignorSymptom	0.30	1	2012	2012	1	0	CTD_human
val	538	ATP7A	0.494	0.769	C0234375	MassiveTremor	phenotype	C23;C10	SignorSymptom	0.30	1	2012	2012	1	0	CTD_human
val	538	ATP7A	0.494	0.769	C0234376	ActionTremor	phenotype	C23;C10	SignorSymptom	0.30	1	2012	2012	1	0	CTD_human
val	538	ATP7A	0.494	0.769	C0234377	PassiveTremor	phenotype	C23;C10	SignorSymptom	0.30	1	2012	2012	1	0	CTD_human
val	538	ATP7A	0.494	0.769	C0234378	StaticTremor	phenotype	C23;C10	SignorSymptom	0.30	1	2012	2012	1	0	CTD_human
val	538	ATP7A	0.494	0.769	C0234379	RestingTremor	phenotype	C23;C10	SignorSymptom	0.30	1	2012	2012	1	0	CTD_human
val	538	ATP7A	0.494	0.769	C0234381	DarknessTremor	phenotype	C23;C10	SignorSymptom	0.30	1	2012	2012	1	0	CTD_human
val	538	ATP7A	0.494	0.769	C0234533	Generalizedseizures	disease	C23;C10	DiseaseorSyndrome	0.30	1	2012	2012	1	0	CTD_human
val	538	ATP7A	0.494	0.769	C0234535	ClonicSeizures	disease	C23;C10	DiseaseorSyndrome	0.30	1	2012	2012	1	0	CTD_human
val	538	ATP7A	0.494	0.769	C0234544	ToddParalysis	phenotype	C23;C10	SignorSymptom	0.30	1	2012	2012	1	0	CTD_human
val	538	ATP7A	0.494	0.769	C0235031	NeurologicSymptoms	group	C23;C10	SignorSymptom	0.32	1	2011	2017	2	0	CTD_human
val	538	ATP7A	0.494	0.769	C0235078	Tremor,Perioral	phenotype	C23;C10	SignorSymptom	0.30	1	2012	2012	1	0	CTD_human
val	538	ATP7A	0.494	0.769	C0235081	Tremor,Limb	phenotype	C23;C10	SignorSymptom	0.30	1	2012	2012	1	0	CTD_human
val	538	ATP7A	0.494	0.769	C0235082	Tremor,Muscle	phenotype	C23;C10	SignorSymptom	0.30	1	2012	2012	1	0	CTD_human
val	538	ATP7A	0.494	0.769	C0235083	NerveTremors	phenotype	C23;C10	SignorSymptom	0.30	1	2012	2012	1	0	CTD_human
val	538	ATP7A	0.494	0.769	C0235574	Intravascularhemolysis	disease	C23	DiseaseorSyndrome	0.30	1	2014	2014	1	0	CTD_human
val	538	ATP7A	0.494	0.769	C0235843	Tremor,Neonatal	phenotype	C23;C10	SignorSymptom	0.30	1	2012	2012	1	0	CTD_human
val	538	ATP7A	0.494	0.769	C0240991	Ataxia,Sensory	phenotype	C23;C10	SignorSymptom	0.30	1	2012	2012	1	0	CTD_human
val	538	ATP7A	0.494	0.769	C0268353	Cutislaxa,x-linked	disease	C16;C17;C15;C14	CongenitalAbnormality	0.80	1	1996	2019	7	0	CTD_human;GENOMICS_ENGLAND;UNIPROT
val	538	ATP7A	0.494	0.769	C0270824	Visualseizure	disease	C23;C10	DiseaseorSyndrome	0.30	1	2012	2012	1	0	CTD_human
val	538	ATP7A	0.494	0.769	C0270844	TonicSeizures	phenotype	C23;C10	DiseaseorSyndrome	0.30	1	2012	2012	1	0	CTD_human
val	538	ATP7A	0.494	0.769	C0270846	Epilepticdropattack	disease	C23;C10	DiseaseorSyndrome	0.30	1	2012	2012	1	0	CTD_human
val	538	ATP7A	0.494	0.769	C0278161	Ataxia,Motor	phenotype	C23;C10	Finding	0.30	1	2012	2012	1	0	CTD_human
val	538	ATP7A	0.494	0.769	C0312854	ExtravascularHemolysis	disease	C23	PathologicFunction	0.30	1	2014	2014	1	0	CTD_human
val	538	ATP7A	0.494	0.769	C0422837	Neurologicalobservations	group	C23;C10	Finding	0.30	1	2012	2012	2	0	CTD_human
val	538	ATP7A	0.494	0.769	C0422850	Seizures,Somatosensory	phenotype	C23;C10	PathologicFunction	0.30	1	2012	2012	1	0	CTD_human
val	538	ATP7A	0.494	0.769	C0422852	Seizures,Auditory	phenotype	C23;C10	PathologicFunction	0.30	1	2012	2012	1	0	CTD_human
val	538	ATP7A	0.494	0.769	C0422853	Olfactoryseizure	phenotype	C23;C10	DiseaseorSyndrome	0.30	1	2012	2012	1	0	CTD_human
val	538	ATP7A	0.494	0.769	C0422854	Gustatoryseizure	phenotype	C23;C10	SignorSymptom	0.30	1	2012	2012	1	0	CTD_human
val	538	ATP7A	0.494	0.769	C0422855	Vertiginousseizure	phenotype	C23;C10	DiseaseorSyndrome	0.30	1	2012	2012	1	0	CTD_human
val	538	ATP7A	0.494	0.769	C0427190	Ataxia,Truncal	phenotype	C23;C10	SignorSymptom	0.30	1	2012	2012	1	0	CTD_human
val	538	ATP7A	0.494	0.769	C0494475	Tonic-clonicseizures	disease	C23;C10	DiseaseorSyndrome	0.30	1	2012	2012	1	0	CTD_human
val	538	ATP7A	0.494	0.769	C0520463	Chronicactivehepatitis	disease	C06	DiseaseorSyndrome	0.30	1	2015	2015	1	0	CTD_human
val	538	ATP7A	0.494	0.769	C0520966	Abnormalcoordination	phenotype	C23;C10	Finding	0.30	1	2012	2012	1	0	CTD_human
val	538	ATP7A	0.494	0.769	C0521654	NeurologicDeficits	group	C23;C10	Finding	0.30	1	2012	2012	2	0	CTD_human
val	538	ATP7A	0.494	0.769	C0522224	Paralysed	phenotype	C23;C10	Finding	0.30	1	2012	2012	1	0	CTD_human
val	538	ATP7A	0.494	0.769	C0524611	CryptogenicChronicHepatitis	disease	C06	DiseaseorSyndrome	0.30	1	2015	2015	1	0	CTD_human
val	538	ATP7A	0.494	0.769	C0598589	Inheritedneuropathies	disease	C10	DiseaseorSyndrome	0.30	1	2010	2010	1	0	GENOMICS_ENGLAND
val	538	ATP7A	0.494	0.769	C0741160	AorticAneurysm,Ruptured	disease	C14;C26	DiseaseorSyndrome	0.50	1	1990	2015	2	0	CTD_human
val	538	ATP7A	0.494	0.769	C0746857	FocalNeurologicDeficits	phenotype	C23;C10	Finding	0.30	1	2012	2012	2	0	CTD_human
val	538	ATP7A	0.494	0.769	C0750937	Ataxia,Appendicular	phenotype	C23;C10	Finding	0.30	1	2012	2012	1	0	CTD_human
val	538	ATP7A	0.494	0.769	C0750940	Tremor,Rubral	disease	C23;C10	DiseaseorSyndrome	0.30	1	2012	2012	1	0	CTD_human
val	538	ATP7A	0.494	0.769	C0751056	Non-epilepticconvulsion	phenotype	C23;C10	SignorSymptom	0.30	1	2012	2012	1	0	CTD_human
val	538	ATP7A	0.494	0.769	C0751110	SingleSeizure	disease	C23;C10	DiseaseorSyndrome	0.30	1	2012	2012	1	0	CTD_human
val	538	ATP7A	0.494	0.769	C0751123	AtonicAbsenceSeizures	phenotype	C23;C10	DiseaseorSyndrome	0.30	1	2012	2012	1	0	CTD_human
val	538	ATP7A	0.494	0.769	C0751377	NeurologicDysfunction	phenotype	C23;C10	Finding	0.30	1	2012	2012	2	0	CTD_human
val	538	ATP7A	0.494	0.769	C0751378	NeurologicSigns	phenotype	C23;C10	SignorSymptom	0.30	1	2012	2012	2	0	CTD_human
val	538	ATP7A	0.494	0.769	C0751494	ConvulsiveSeizures	phenotype	C23;C10	SignorSymptom	0.30	1	2012	2012	1	0	CTD_human
val	538	ATP7A	0.494	0.769	C0751495	Seizures,Focal	phenotype	C23;C10	DiseaseorSyndrome	0.30	1	2012	2012	1	0	CTD_human
val	538	ATP7A	0.494	0.769	C0751496	Seizures,Sensory	phenotype	C23;C10	SignorSymptom	0.30	1	2012	2012	1	0	CTD_human
val	538	ATP7A	0.494	0.769	C0751564	PillRollingTremor	phenotype	C23;C10	SignorSymptom	0.30	1	2012	2012	1	0	CTD_human
val	538	ATP7A	0.494	0.769	C0751565	Tremor,Semirhythmic	phenotype	C23;C10	Finding	0.30	1	2012	2012	1	0	CTD_human
val	538	ATP7A	0.494	0.769	C1527384	InvoluntaryQuiver	phenotype	C23;C10	SignorSymptom	0.30	1	2012	2012	1	0	CTD_human
val	538	ATP7A	0.494	0.769	C1845359	SpinalMuscularAtrophy,Distal,X-Linked3	disease	C16;C10	DiseaseorSyndrome	0.90	1	2004	2012	3	0	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
val	538	ATP7A	0.494	0.769	C2936380	Neointima	disease	C23	AcquiredAbnormality	0.30	1	2010	2010	1	0	CTD_human
val	538	ATP7A	0.494	0.769	C2936381	NeointimaFormation	phenotype	C23	PathologicFunction	0.30	1	2010	2010	1	0	CTD_human
val	538	ATP7A	0.494	0.769	C3495874	NonepilepticSeizures	phenotype	C23;C10	DiseaseorSyndrome	0.30	1	2012	2012	1	0	CTD_human
val	538	ATP7A	0.494	0.769	C4048158	Convulsions	phenotype	C23;C10	SignorSymptom	0.30	1	2012	2012	1	0	CTD_human
val	538	ATP7A	0.494	0.769	C4316903	AbsenceSeizures	phenotype	C23;C10	DiseaseorSyndrome	0.30	1	2012	2012	1	0	CTD_human
val	538	ATP7A	0.494	0.769	C4317109	EpilepticSeizures	phenotype	C23;C10	DiseaseorSyndrome	0.30	1	2012	2012	1	0	CTD_human
val	538	ATP7A	0.494	0.769	C4317123	MyoclonicSeizures	phenotype	C23;C10	SignorSymptom	0.30	1	2012	2012	1	0	CTD_human
val	538	ATP7A	0.494	0.769	C4505436	GeneralizedAbsenceSeizures	phenotype	C23;C10	DiseaseorSyndrome	0.30	1	2012	2012	1	0	CTD_human
val	540	ATP7B	0.529	0.654	C0006142	Malignantneoplasmofbreast	disease	C04;C17	NeoplasticProcess	0.30	1	2002	2002	1	0	CTD_human
val	540	ATP7B	0.529	0.654	C0007097	Carcinoma	group	C04	NeoplasticProcess	0.32	1	2002	2008	2	0	CTD_human
val	540	ATP7B	0.529	0.654	C0009402	ColorectalCarcinoma	disease	C06;C04	NeoplasticProcess	0.31	1	2009	2009	1	0	CTD_human
val	540	ATP7B	0.529	0.654	C0009404	ColorectalNeoplasms	group	C06;C04	NeoplasticProcess	0.31	1	2009	2009	1	0	CTD_human
val	540	ATP7B	0.529	0.654	C0015695	FattyLiver	disease	C06	DiseaseorSyndrome	0.41	1	2007	2017	1	0	CTD_human
val	540	ATP7B	0.529	0.654	C0019158	Hepatitis	group	C06	DiseaseorSyndrome	0.31	1	2003	2007	2	0	CTD_human
val	540	ATP7B	0.529	0.654	C0019202	HepatolenticularDegeneration	disease	C16;C06;C18;C10	DiseaseorSyndrome	1.00	0.98	1983	2020	136	318	CLINGEN;CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
val	540	ATP7B	0.529	0.654	C0019207	Hepatoma,Morris	disease	C06;C04	NeoplasticProcess;ExperimentalModelofDisease	0.30	1	2013	2013	1	0	CTD_human
val	540	ATP7B	0.529	0.654	C0019208	Hepatoma,Novikoff	disease	C06;C04	NeoplasticProcess;ExperimentalModelofDisease	0.30	1	2013	2013	1	0	CTD_human
val	540	ATP7B	0.529	0.654	C0021368	Inflammation	phenotype	C23	PathologicFunction	0.30	1	2013	2013	1	0	CTD_human
val	540	ATP7B	0.529	0.654	C0022665	KidneyNeoplasm	disease	C04;C13;C12	NeoplasticProcess	0.30	1	2001	2001	1	0	CTD_human
val	540	ATP7B	0.529	0.654	C0023890	LiverCirrhosis	disease	C23;C06	DiseaseorSyndrome	0.41	1	2014	2015	1	1	CTD_human
val	540	ATP7B	0.529	0.654	C0023895	Liverdiseases	group	C06	DiseaseorSyndrome	0.36	1	2010	2018	1	0	CTD_human
val	540	ATP7B	0.529	0.654	C0023903	Liverneoplasms	group	C06;C04	NeoplasticProcess	0.34	1	2001	2017	1	0	CTD_human
val	540	ATP7B	0.529	0.654	C0023904	LiverNeoplasms,Experimental	phenotype	C06;C04	NeoplasticProcess;ExperimentalModelofDisease	0.30	1	2013	2013	1	0	CTD_human
val	540	ATP7B	0.529	0.654	C0026640	MouthNeoplasms	group	C04;C07	NeoplasticProcess	0.30	1	2003	2003	1	0	CTD_human
val	540	ATP7B	0.529	0.654	C0033578	ProstaticNeoplasms	group	C04;C12	NeoplasticProcess	0.30	1	2014	2014	1	0	CTD_human
val	540	ATP7B	0.529	0.654	C0041696	UnipolarDepression	disease	F03	MentalorBehavioralDysfunction	0.31	1	2007	2007	1	0	PSYGENET
val	540	ATP7B	0.529	0.654	C0086404	ExperimentalHepatoma	disease	C06;C04	NeoplasticProcess;ExperimentalModelofDisease	0.30	1	2013	2013	1	0	CTD_human
val	540	ATP7B	0.529	0.654	C0086565	LiverDysfunction	phenotype	C06	Finding	0.30	1	2011	2011	1	0	CTD_human
val	540	ATP7B	0.529	0.654	C0153381	Malignantneoplasmofmouth	group	C04;C07	NeoplasticProcess	0.30	1	2003	2003	1	0	CTD_human
val	540	ATP7B	0.529	0.654	C0162557	LiverFailure,Acute	disease	C06	DiseaseorSyndrome	0.44	0.75	2000	2019	1	0	CTD_human
val	540	ATP7B	0.529	0.654	C0205696	Anaplasticcarcinoma	disease	C04	NeoplasticProcess	0.30	1	2002	2002	2	0	CTD_human
val	540	ATP7B	0.529	0.654	C0205697	Carcinoma,Spindle-Cell	disease	C04	NeoplasticProcess	0.30	1	2002	2002	2	0	CTD_human
val	540	ATP7B	0.529	0.654	C0205698	Undifferentiatedcarcinoma	disease	C04	NeoplasticProcess	0.30	1	2002	2002	2	0	CTD_human
val	540	ATP7B	0.529	0.654	C0205699	Carcinomatosis	phenotype	C04	NeoplasticProcess	0.30	1	2002	2002	2	0	CTD_human
val	540	ATP7B	0.529	0.654	C0235874	DiseaseExacerbation	phenotype	C23	Finding	0.30	1	2002	2009	3	0	CTD_human
val	540	ATP7B	0.529	0.654	C0239946	Fibrosis,Liver	disease	C23;C06	DiseaseorSyndrome	0.30	1	2014	2014	1	0	CTD_human
val	540	ATP7B	0.529	0.654	C0242339	Dyslipidemias	group	C18	DiseaseorSyndrome	0.30	1	2007	2007	1	0	CTD_human
val	540	ATP7B	0.529	0.654	C0345904	Malignantneoplasmofliver	disease	C06;C04	NeoplasticProcess	0.32	1	2001	2019	1	0	CTD_human
val	540	ATP7B	0.529	0.654	C0376358	Malignantneoplasmofprostate	disease	C04;C12	NeoplasticProcess	0.30	1	2014	2014	1	0	CTD_human
val	540	ATP7B	0.529	0.654	C0598784	Dyslipoproteinemias	phenotype	C18	PathologicFunction	0.30	1	2007	2007	1	0	CTD_human
val	540	ATP7B	0.529	0.654	C0678222	BreastCarcinoma	disease	C04;C17	NeoplasticProcess	0.31	1	2002	2002	1	0	CTD_human
val	540	ATP7B	0.529	0.654	C0740457	Malignantneoplasmofkidney	disease	C04;C13;C12	NeoplasticProcess	0.30	1	2001	2001	1	0	CTD_human
val	540	ATP7B	0.529	0.654	C0919267	ovarianneoplasm	disease	C04;C13;C19	NeoplasticProcess	0.32	1	2002	2015	1	0	CTD_human
val	540	ATP7B	0.529	0.654	C1140680	Malignantneoplasmofovary	disease	C04;C13;C19	NeoplasticProcess	0.33	1	2002	2015	1	0	CTD_human
val	540	ATP7B	0.529	0.654	C1168401	Squamouscellcarcinomaoftheheadandneck	disease	C04	NeoplasticProcess	0.32	1	2003	2019	1	0	CTD_human
val	540	ATP7B	0.529	0.654	C1257931	MammaryNeoplasms,Human	disease	C04;C17	NeoplasticProcess	0.30	1	2002	2002	1	0	CTD_human
val	540	ATP7B	0.529	0.654	C1269683	MajorDepressiveDisorder	disease	F03	MentalorBehavioralDysfunction	0.31	1	2007	2007	1	0	PSYGENET
val	540	ATP7B	0.529	0.654	C1458155	MammaryNeoplasms	group	C04;C17	NeoplasticProcess	0.30	1	2002	2002	1	0	CTD_human
val	540	ATP7B	0.529	0.654	C1527352	HepaticFormofWilsonDisease	disease	C16;C06;C18;C10	DiseaseorSyndrome	0.30	1	2000	2014	51	0	CTD_human
val	540	ATP7B	0.529	0.654	C2711227	Steatohepatitis	disease	C06	DiseaseorSyndrome	0.42	1	2007	2017	1	0	CTD_human
val	540	ATP7B	0.529	0.654	C4704874	MammaryCarcinoma,Human	disease	C04;C17	NeoplasticProcess	0.30	1	2002	2002	1	0	CTD_human
val	545	ATR	0.456	0.923	C0004681	Bagassosis	disease	C08;C24	DiseaseorSyndrome	0.30	1	2015	2015	1	0	CTD_human
val	545	ATR	0.456	0.923	C0006826	MalignantNeoplasms	group	C04	NeoplasticProcess	0.40	0.965	1999	2020	0	0	CGI
val	545	ATR	0.456	0.923	C0007103	Malignantneoplasmofendometrium	disease	C04;C13	NeoplasticProcess	0.31	1	2019	2019	0	0	CGI
val	545	ATR	0.456	0.923	C0017638	Glioma	disease	C04	NeoplasticProcess	0.31	1	2010	2010	0	0	CGI
val	545	ATR	0.456	0.923	C0024623	Malignantneoplasmofstomach	disease	C06;C04	NeoplasticProcess	0.32	1	1999	2005	0	0	CGI
val	545	ATR	0.456	0.923	C0029925	OvarianCarcinoma	disease	C04;C13;C19	NeoplasticProcess	0.30				0	0	CGI
val	545	ATR	0.456	0.923	C0032273	Pneumoconiosis	disease	C08;C24	DiseaseorSyndrome	0.30	1	2015	2015	1	0	CTD_human
val	545	ATR	0.456	0.923	C0033578	ProstaticNeoplasms	group	C04;C12	NeoplasticProcess	0.31	1	2014	2018	1	0	CTD_human
val	545	ATR	0.456	0.923	C0038356	StomachNeoplasms	group	C06;C04	NeoplasticProcess	0.30				0	0	CGI
val	545	ATR	0.456	0.923	C0042076	UrologicNeoplasms	group	C04;C13;C12	NeoplasticProcess	0.30	1	2013	2013	1	0	CTD_human
val	545	ATR	0.456	0.923	C0149782	Squamouscellcarcinomaoflung	disease	C04;C08	NeoplasticProcess	0.30				0	0	UNIPROT
val	545	ATR	0.456	0.923	C0152013	Adenocarcinomaoflung(disorder)	disease	C04	NeoplasticProcess	0.32	1	2017	2019	0	0	UNIPROT
val	545	ATR	0.456	0.923	C0153943	Benignneoplasmofstomach	disease	C06;C04	NeoplasticProcess	0.30				0	0	CGI
val	545	ATR	0.456	0.923	C0154060	Carcinomainsituofstomach	disease	C06;C04	NeoplasticProcess	0.30				0	0	CGI
val	545	ATR	0.456	0.923	C0265202	Seckelsyndrome	disease	C23;C16;C05;C10;C19	DiseaseorSyndrome	0.80	1	2003	2018	1	0	GENOMICS_ENGLAND;ORPHANET
val	545	ATR	0.456	0.923	C0280313	Squamouscellcarcinomaoforopharynx	disease	C04;C07;C09	NeoplasticProcess	0.30				0	0	CGI
val	545	ATR	0.456	0.923	C0345958	Largecellcarcinomaoflung	disease	C04;C08	NeoplasticProcess	0.30				0	0	UNIPROT
val	545	ATR	0.456	0.923	C0346191	Carcinomainsituofendometrium	disease	C04;C13	NeoplasticProcess	0.30				0	0	CGI
val	545	ATR	0.456	0.923	C0376358	Malignantneoplasmofprostate	disease	C04;C12	NeoplasticProcess	0.32	1	2014	2019	1	0	CTD_human
val	545	ATR	0.456	0.923	C0476089	EndometrialCarcinoma	disease	C04;C13	NeoplasticProcess	0.31	1	2019	2019	0	0	CGI
val	545	ATR	0.456	0.923	C0496905	Neoplasmofuncertainorunknownbehaviorofstomach	disease	C06;C04	NeoplasticProcess	0.30				0	0	CGI
val	545	ATR	0.456	0.923	C0496920	Neoplasmofuncertainorunknownbehaviorofovary	disease	C04;C13;C19	NeoplasticProcess	0.30				0	0	CGI
val	545	ATR	0.456	0.923	C0699791	StomachCarcinoma	disease	C06;C04	NeoplasticProcess	0.31	1	1999	1999	0	0	CGI
val	545	ATR	0.456	0.923	C0751571	CancerofUrinaryTract	disease	C04;C13;C12	NeoplasticProcess	0.30	1	2013	2013	1	0	CTD_human
val	545	ATR	0.456	0.923	C0919267	ovarianneoplasm	disease	C04;C13;C19	NeoplasticProcess	0.32	0.5	2005	2017	0	0	CGI
val	545	ATR	0.456	0.923	C1140680	Malignantneoplasmofovary	disease	C04;C13;C19	NeoplasticProcess	0.32	0.5	2005	2017	0	0	CGI
val	545	ATR	0.456	0.923	C1292778	Chronicmyeloproliferativedisorder	disease	C04;C15	NeoplasticProcess	0.30				0	0	GENOMICS_ENGLAND
val	545	ATR	0.456	0.923	C3165106	Infiltratingductcarcinomaoffemalebreast	disease	C04;C17	NeoplasticProcess	0.30				0	0	UNIPROT
val	545	ATR	0.456	0.923	C3281203	CUTANEOUSTELANGIECTASIAANDCANCERSYNDROME,FAMILIAL	disease		NeoplasticProcess	0.70	1	1990	2012	2	1	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
val	545	ATR	0.456	0.923	C4551474	Seckelsyndrome1	disease	C23;C16;C05;C10;C19	DiseaseorSyndrome	0.61	1	2003	2009	1	8	CTD_human;GENOMICS_ENGLAND
val	546	ATRX	0.452	0.808	C0010417	Cryptorchidism	disease	C16;C12;C19	CongenitalAbnormality	0.41	1	2009	2009	1	1	CTD_human
val	546	ATRX	0.452	0.808	C0010606	AdenoidCysticCarcinoma	disease	C04	NeoplasticProcess	0.30	1	2013	2013	1	0	CTD_human
val	546	ATRX	0.452	0.808	C0017638	Glioma	disease	C04	NeoplasticProcess	0.40	1	2012	2020	2	0	CTD_human
val	546	ATRX	0.452	0.808	C0018273	GrowthDisorders	group	C23	PathologicFunction	0.30	1	2009	2009	1	0	CTD_human
val	546	ATRX	0.452	0.808	C0027819	Neuroblastoma	disease	C04	NeoplasticProcess	0.40	1	2012	2019	2	0	CTD_human
val	546	ATRX	0.452	0.808	C0030297	PancreaticNeoplasm	disease	C06;C04;C19	NeoplasticProcess	0.30	1	2011	2011	1	0	CTD_human
val	546	ATRX	0.452	0.808	C0030846	PenileDiseases	group	C12	DiseaseorSyndrome	0.30	1	2009	2009	1	0	CTD_human
val	546	ATRX	0.452	0.808	C0039978	ThoracicDiseases	group	C08	DiseaseorSyndrome	0.30	1	2009	2009	1	0	CTD_human
val	546	ATRX	0.452	0.808	C0206754	NeuroendocrineTumors	group	C04	NeoplasticProcess	0.38	1	2011	2018	1	0	CTD_human
val	546	ATRX	0.452	0.808	C0259783	mixedgliomas	disease	C04	NeoplasticProcess	0.30	1	2013	2014	2	0	CTD_human
val	546	ATRX	0.452	0.808	C0346647	Malignantneoplasmofpancreas	disease	C06;C04;C19	NeoplasticProcess	0.30	1	2011	2011	1	0	CTD_human
val	546	ATRX	0.452	0.808	C0376634	CraniofacialAbnormalities	group	C16;C05	CongenitalAbnormality	0.30	1	2009	2009	1	0	CTD_human
val	546	ATRX	0.452	0.808	C0431663	BilateralCryptorchidism	disease	C16;C12;C19	CongenitalAbnormality	0.30	1	2009	2009	1	0	CTD_human
val	546	ATRX	0.452	0.808	C0431664	UnilateralCryptorchidism	disease	C16;C12;C19	CongenitalAbnormality	0.30	1	2009	2009	1	0	CTD_human
val	546	ATRX	0.452	0.808	C0555198	MalignantGlioma	disease	C04	NeoplasticProcess	0.32	1	2013	2019	2	0	CTD_human
val	546	ATRX	0.452	0.808	C0585216	Alpha-ThalassemiaMyelodysplasiaSyndrome	disease	C16;C15	NeoplasticProcess	0.71	1	2003	2006	1	3	CTD_human;GENOMICS_ENGLAND;ORPHANET
val	546	ATRX	0.452	0.808	C0796003	Juberg-Marsidisyndrome	disease	C23;C16;C10;C19;C09	DiseaseorSyndrome	0.72	1	1995	2020	17	10	CLINGEN;CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
val	546	ATRX	0.452	0.808	C0796159	MentalretardationSmithFinemanMyerstype	disease	C23;C10;F03;F01	DiseaseorSyndrome	0.31	1	2000	2000	1	0	ORPHANET
val	546	ATRX	0.452	0.808	C1136249	MentalRetardation,X-Linked	disease	C16;C10	DiseaseorSyndrome	0.40	1	1997	2011	1	0	CTD_human
val	546	ATRX	0.452	0.808	C1328479	PancreaticEndocrineCarcinoma	disease	C06;C04;C19	NeoplasticProcess	0.30				0	0	CGI
val	546	ATRX	0.452	0.808	C1563730	AbdominalCryptorchidism	disease	C16;C12;C19	CongenitalAbnormality	0.30	1	2009	2009	1	0	CTD_human
val	546	ATRX	0.452	0.808	C1563731	InguinalCryptorchidism	phenotype	C16;C12;C19	Finding	0.30	1	2009	2009	1	0	CTD_human
val	546	ATRX	0.452	0.808	C1621958	GlioblastomaMultiforme	disease	C04	NeoplasticProcess	0.38	1	2015	2018	0	0	CGI
val	546	ATRX	0.452	0.808	C1845055	ALPHA-THALASSEMIA/MENTALRETARDATIONSYNDROME,NONDELETIONTYPE,X-LINKED	disease	C16;C10;C15	DiseaseorSyndrome	1.00	0.982	1995	2019	16	22	CTD_human;GENOMICS_ENGLAND;UNIPROT
val	546	ATRX	0.452	0.808	C2713368	HematopoeticMyelodysplasia	phenotype	C15	PathologicFunction	0.30	1	2009	2009	1	0	CTD_human
val	546	ATRX	0.452	0.808	C3463824	MYELODYSPLASTICSYNDROME	group	C15	NeoplasticProcess	0.47	1	2003	2019	1	0	CTD_human
val	547	KIF1A	0.559	0.692	C0004352	AutisticDisorder	disease	F03	MentalorBehavioralDysfunction	0.30	1	2019	2019	1	0	CTD_human
val	547	KIF1A	0.559	0.692	C0008073	DevelopmentalDisabilities	group	F03	MentalorBehavioralDysfunction	0.30	1	2019	2019	1	0	CTD_human
val	547	KIF1A	0.559	0.692	C0011849	DiabetesMellitus	group	C18;C19	DiseaseorSyndrome	0.31	1	2013	2018	1	0	CTD_human
val	547	KIF1A	0.559	0.692	C0085996	ChildDevelopmentDeviations	disease	F03	MentalorBehavioralDysfunction	0.30	1	2019	2019	1	0	CTD_human
val	547	KIF1A	0.559	0.692	C0085997	ChildDevelopmentDisorders,Specific	disease	F03	MentalorBehavioralDysfunction	0.30	1	2019	2019	1	0	CTD_human
val	547	KIF1A	0.559	0.692	C0270914	HereditaryMotorandSensory-NeuropathyTypeII	disease	C16;C10	DiseaseorSyndrome	0.30	1	2011	2015	2	0	GENOMICS_ENGLAND
val	547	KIF1A	0.559	0.692	C1835896	SPASTICPARAPLEGIA30,AUTOSOMALRECESSIVE(disorder)	disease	C23;C10	DiseaseorSyndrome	0.93	1	2011	2020	4	22	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
val	547	KIF1A	0.559	0.692	C1850055	PEHOsyndrome	disease	C11;C10	DiseaseorSyndrome	0.42	1	2016	2019	1	3	ORPHANET
val	547	KIF1A	0.559	0.692	C2752089	Neuropathy,HereditarySensoryAndAutonomic,TypeIIA	disease	C16;C10	DiseaseorSyndrome	0.40				0	1	CTD_human
val	547	KIF1A	0.559	0.692	C3280168	NEUROPATHY,HEREDITARYSENSORY,TYPEIIC	disease		DiseaseorSyndrome	0.61	1	2011	2017	3	19	CTD_human;GENOMICS_ENGLAND
val	547	KIF1A	0.559	0.692	C3280283	MENTALRETARDATION,AUTOSOMALDOMINANT9	disease		DiseaseorSyndrome	0.70	1	2011	2017	6	37	CTD_human;GENOMICS_ENGLAND;UNIPROT
val	549	AUH	0.686	0.346	C0013421	Dystonia	phenotype	C23;C10	SignorSymptom	0.40	1	2010	2010	1	0	GENOMICS_ENGLAND
val	549	AUH	0.686	0.346	C0342727	3-@METHYLGLUTACONICACIDURIA,TYPEI	disease	C16;C18	DiseaseorSyndrome	0.75	1	1982	2017	11	3	CLINGEN;CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
val	549	AUH	0.686	0.346	C0342728	3-Methylglutaconicaciduriatype1	disease	C16;C18	DiseaseorSyndrome	0.61	1	2002	2017	9	0	CLINGEN;GENOMICS_ENGLAND;ORPHANET
val	551	AVP	0.437	0.846	C0002622	Amnesia	disease	C23;C10;F03;F01	MentalorBehavioralDysfunction	0.30	1	1995	1995	1	0	CTD_human
val	551	AVP	0.437	0.846	C0002962	AnginaPectoris	phenotype	C23;C14	SignorSymptom	0.30	1	2000	2002	2	0	CTD_human
val	551	AVP	0.437	0.846	C0003811	CardiacArrhythmia	phenotype	C23;C14	DiseaseorSyndrome	0.30	1	1982	1982	1	0	CTD_human
val	551	AVP	0.437	0.846	C0004352	AutisticDisorder	disease	F03	MentalorBehavioralDysfunction	0.40	1	1995	2019	1	0	CTD_human
val	551	AVP	0.437	0.846	C0005586	BipolarDisorder	disease	F03	MentalorBehavioralDysfunction	0.31	1	2013	2017	1	0	PSYGENET
val	551	AVP	0.437	0.846	C0009178	Cocainewithdrawal	disease	C25;F03	MentalorBehavioralDysfunction	0.30	1	2005	2005	1	0	PSYGENET
val	551	AVP	0.437	0.846	C0010398	Cruveilhier-BaumgartenSyndrome	disease	C06	DiseaseorSyndrome	0.30	1	1984	1984	1	0	CTD_human
val	551	AVP	0.437	0.846	C0011175	Dehydration	phenotype	C23;C18	DiseaseorSyndrome	0.60	1	1989	2019	1	0	CTD_human
val	551	AVP	0.437	0.846	C0011848	DiabetesInsipidus	disease	C13;C12;C19	DiseaseorSyndrome	0.70	1	1981	2020	3	0	CTD_human;ORPHANET
val	551	AVP	0.437	0.846	C0013390	Dysmenorrhea	phenotype	C23	DiseaseorSyndrome	0.30	1	1999	1999	1	0	CTD_human
val	551	AVP	0.437	0.846	C0017181	GastrointestinalHemorrhage	phenotype	C23;C06	PathologicFunction	0.30	1	1982	1982	1	0	CTD_human
val	551	AVP	0.437	0.846	C0018801	Heartfailure	disease	C14	DiseaseorSyndrome	0.40	1	1999	2020	1	0	CTD_human
val	551	AVP	0.437	0.846	C0018802	Congestiveheartfailure	disease	C14	DiseaseorSyndrome	0.40	1	1999	2020	1	0	CTD_human
val	551	AVP	0.437	0.846	C0018932	Hematochezia	phenotype	C23;C06	DiseaseorSyndrome	0.30	1	1982	1982	1	0	CTD_human
val	551	AVP	0.437	0.846	C0020429	Hyperalgesia	phenotype	C23;C10	SignorSymptom	0.31	1	1998	2017	1	0	CTD_human
val	551	AVP	0.437	0.846	C0020538	Hypertensivedisease	group	C14	DiseaseorSyndrome	0.60	1	1984	2020	5	0	CTD_human
val	551	AVP	0.437	0.846	C0020541	PortalHypertension	disease	C06	DiseaseorSyndrome	0.50	1	1984	2009	1	0	CTD_human
val	551	AVP	0.437	0.846	C0020625	Hyponatremia	phenotype	C18	DiseaseorSyndrome	0.40	0.921	1981	2019	1	0	CTD_human
val	551	AVP	0.437	0.846	C0020649	Hypotension	phenotype	C14	Finding	0.32	1	1985	2008	5	0	CTD_human
val	551	AVP	0.437	0.846	C0020683	HypovolemicShock	phenotype	C23	PathologicFunction	0.30	1	1999	1999	1	0	CTD_human
val	551	AVP	0.437	0.846	C0021141	InappropriateADHSyndrome	phenotype	C18;C10;C19	DiseaseorSyndrome	0.37	0.889	1979	2019	2	0	CTD_human
val	551	AVP	0.437	0.846	C0022116	Ischemia	phenotype	C23	PathologicFunction	0.30	1	1990	1999	2	0	CTD_human
val	551	AVP	0.437	0.846	C0022660	KidneyFailure,Acute	disease	C13;C12	DiseaseorSyndrome	0.34	1	1990	2017	1	0	CTD_human
val	551	AVP	0.437	0.846	C0023212	Left-SidedHeartFailure	disease	C14	DiseaseorSyndrome	0.30	1	2008	2008	1	0	CTD_human
val	551	AVP	0.437	0.846	C0025261	MemoryDisorders	disease	C23;C10;F01	MentalorBehavioralDysfunction	0.30	1	2001	2001	1	0	CTD_human
val	551	AVP	0.437	0.846	C0029944	DrugOverdose	disease	C25	InjuryorPoisoning	0.30	1	2002	2002	1	0	CTD_human
val	551	AVP	0.437	0.846	C0030193	Pain	phenotype	C23	SignorSymptom	0.35	1	1984	2019	2	0	CTD_human
val	551	AVP	0.437	0.846	C0032617	Polyuria	phenotype	C23;C13;C12	SignorSymptom	0.40	1	1999	2020	1	0	CTD_human
val	551	AVP	0.437	0.846	C0033141	Cardiomyopathies,Primary	group	C14	DiseaseorSyndrome	0.30	1	2002	2002	1	0	CTD_human
val	551	AVP	0.437	0.846	C0033958	Psychosis,BriefReactive	disease	F03	MentalorBehavioralDysfunction	0.30	1	1987	1987	1	0	CTD_human
val	551	AVP	0.437	0.846	C0033975	PsychoticDisorders	group	F03	MentalorBehavioralDysfunction	0.30	1	1987	1987	1	0	CTD_human
val	551	AVP	0.437	0.846	C0036337	SchizoaffectiveDisorder	disease	F03	MentalorBehavioralDysfunction	0.30	1	1987	1987	1	0	CTD_human
val	551	AVP	0.437	0.846	C0036341	Schizophrenia	disease	F03	MentalorBehavioralDysfunction	0.38	1	1987	2018	1	0	CTD_human
val	551	AVP	0.437	0.846	C0036358	SchizophreniformDisorders	group	F03	MentalorBehavioralDysfunction	0.30	1	1987	1987	1	0	CTD_human
val	551	AVP	0.437	0.846	C0036529	MyocardialDiseases,Secondary	group	C14	DiseaseorSyndrome	0.30	1	2002	2002	1	0	CTD_human
val	551	AVP	0.437	0.846	C0036974	Shock	phenotype	C23	PathologicFunction	0.30	1	1999	1999	1	0	CTD_human
val	551	AVP	0.437	0.846	C0037019	Shy-DragerSyndrome	disease	C10;C14	DiseaseorSyndrome	0.30	1	1983	1983	1	0	CTD_human
val	551	AVP	0.437	0.846	C0038587	SubstanceWithdrawalSyndrome	disease	C25;F03	MentalorBehavioralDysfunction	0.30	1	1985	1985	1	0	CTD_human
val	551	AVP	0.437	0.846	C0041696	UnipolarDepression	disease	F03	MentalorBehavioralDysfunction	0.31	1	2004	2006	1	0	PSYGENET
val	551	AVP	0.437	0.846	C0086132	DepressiveSymptoms	phenotype	F01	SignorSymptom	0.31	1	2011	2017	1	0	PSYGENET
val	551	AVP	0.437	0.846	C0086189	DrugWithdrawalSymptoms	phenotype	C25;F03	SignorSymptom	0.30	1	1985	1985	1	0	CTD_human
val	551	AVP	0.437	0.846	C0087169	WithdrawalSymptoms	phenotype	C25;F03	SignorSymptom	0.30	1	1985	1985	1	0	CTD_human
val	551	AVP	0.437	0.846	C0149925	Smallcellcarcinomaoflung	disease	C04;C08	NeoplasticProcess	0.39	1	1987	2017	1	0	CTD_human
val	551	AVP	0.437	0.846	C0233750	Hystericalamnesia	phenotype	C23;C10;F03;F01	MentalorBehavioralDysfunction	0.30	1	1995	1995	1	0	CTD_human
val	551	AVP	0.437	0.846	C0233794	Memoryimpairment	phenotype	C23;C10;F01	MentalorBehavioralDysfunction	0.32	1	2001	2020	1	0	CTD_human
val	551	AVP	0.437	0.846	C0233796	TemporaryAmnesia	phenotype	C23;C10;F03;F01	MentalorBehavioralDysfunction	0.30	1	1995	1995	1	0	CTD_human
val	551	AVP	0.437	0.846	C0234230	Pain,Burning	phenotype	C23	SignorSymptom	0.30	1	1984	1990	2	0	CTD_human
val	551	AVP	0.437	0.846	C0234238	Ache	phenotype	C23	SignorSymptom	0.30	1	1984	1990	2	0	CTD_human
val	551	AVP	0.437	0.846	C0234254	Radiatingpain	phenotype	C23	SignorSymptom	0.30	1	1984	1990	2	0	CTD_human
val	551	AVP	0.437	0.846	C0235527	HeartFailure,Right-Sided	disease	C14	DiseaseorSyndrome	0.30	1	2008	2008	1	0	CTD_human
val	551	AVP	0.437	0.846	C0236795	DissociativeAmnesia	phenotype	C23;C10;F03;F01	MentalorBehavioralDysfunction	0.30	1	1995	1995	1	0	CTD_human
val	551	AVP	0.437	0.846	C0262497	GlobalAmnesia	phenotype	C23;C10;F03;F01	MentalorBehavioralDysfunction	0.30	1	1995	1995	1	0	CTD_human
val	551	AVP	0.437	0.846	C0344315	Depressedmood	phenotype	F01	MentalorBehavioralDysfunction	0.40	1	2001	2019	1	0	PSYGENET
val	551	AVP	0.437	0.846	C0458247	Allodynia	phenotype	C23;C10	Finding	0.30	1	1998	1998	1	0	CTD_human
val	551	AVP	0.437	0.846	C0458257	Pain,Splitting	phenotype	C23	SignorSymptom	0.30	1	1984	1990	2	0	CTD_human
val	551	AVP	0.437	0.846	C0458259	Pain,Crushing	phenotype	C23	SignorSymptom	0.30	1	1984	1990	2	0	CTD_human
val	551	AVP	0.437	0.846	C0600427	CocaineDependence	disease	C25;F03	MentalorBehavioralDysfunction	0.30	1	2010	2011	2	0	PSYGENET
val	551	AVP	0.437	0.846	C0687720	CentralDiabetesInsipidus	disease	C13;C12;C19	DiseaseorSyndrome	1.00	0.988	1978	2020	28	17	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
val	551	AVP	0.437	0.846	C0750906	TactileAmnesia	phenotype	C23;C10;F03;F01	MentalorBehavioralDysfunction	0.30	1	1995	1995	1	0	CTD_human
val	551	AVP	0.437	0.846	C0750907	AmnesticState	phenotype	C23;C10;F03;F01	MentalorBehavioralDysfunction	0.30	1	1995	1995	1	0	CTD_human
val	551	AVP	0.437	0.846	C0751211	Hyperalgesia,Primary	phenotype	C23;C10	SignorSymptom	0.30	1	1998	1998	1	0	CTD_human
val	551	AVP	0.437	0.846	C0751212	Hyperalgesia,Secondary	phenotype	C23;C10	SignorSymptom	0.30	1	1998	1998	1	0	CTD_human
val	551	AVP	0.437	0.846	C0751213	TactileAllodynia	phenotype	C23;C10	SignorSymptom	0.30	1	1998	1998	1	0	CTD_human
val	551	AVP	0.437	0.846	C0751214	Hyperalgesia,Thermal	phenotype	C23;C10	SignorSymptom	0.30	1	1998	1998	1	0	CTD_human
val	551	AVP	0.437	0.846	C0751292	Age-RelatedMemoryDisorders	group	C23;C10;F01	MentalorBehavioralDysfunction	0.30	1	2001	2001	1	0	CTD_human
val	551	AVP	0.437	0.846	C0751293	MemoryDisorder,Semantic	phenotype	C23;C10;F01	MentalorBehavioralDysfunction	0.30	1	2001	2001	1	0	CTD_human
val	551	AVP	0.437	0.846	C0751294	MemoryDisorder,Spatial	phenotype	C23;C10;F01	MentalorBehavioralDysfunction	0.30	1	2001	2001	1	0	CTD_human
val	551	AVP	0.437	0.846	C0751295	MemoryLoss	phenotype	C23;C10;F01	SignorSymptom	0.30	1	2001	2001	1	0	CTD_human
val	551	AVP	0.437	0.846	C0751407	Pain,Migratory	phenotype	C23	SignorSymptom	0.30	1	1984	1990	2	0	CTD_human
val	551	AVP	0.437	0.846	C0751408	Suffering,Physical	phenotype	C23	SignorSymptom	0.30	1	1984	1990	2	0	CTD_human
val	551	AVP	0.437	0.846	C0878544	Cardiomyopathies	group	C14	DiseaseorSyndrome	0.30	1	2002	2002	1	0	CTD_human
val	551	AVP	0.437	0.846	C1136135	WaterStress	disease	C23;C18	DiseaseorSyndrome	0.30	1	1989	1989	1	0	CTD_human
val	551	AVP	0.437	0.846	C1269683	MajorDepressiveDisorder	disease	F03	MentalorBehavioralDysfunction	0.33	1	2004	2018	1	0	PSYGENET
val	551	AVP	0.437	0.846	C1565662	AcuteKidneyInsufficiency	disease	C13;C12	DiseaseorSyndrome	0.30	1	1990	1990	1	0	CTD_human
val	551	AVP	0.437	0.846	C1959583	MyocardialFailure	disease	C14	DiseaseorSyndrome	0.30	1	2008	2008	1	0	CTD_human
val	551	AVP	0.437	0.846	C1961112	HeartDecompensation	phenotype	C14	PathologicFunction	0.30	1	2008	2008	1	0	CTD_human
val	551	AVP	0.437	0.846	C2609414	Acutekidneyinjury	disease	C13;C12	InjuryorPoisoning	0.30	1	1990	1990	1	0	CTD_human
val	551	AVP	0.437	0.846	C2936719	MechanicalAllodynia	phenotype	C23;C10	SignorSymptom	0.31	1	1998	2019	1	0	CTD_human
val	552	AVPR1A	0.663	0.5	C0001627	Congenitaladrenalhyperplasia	disease	C16;C18;C13;C12;C19	DiseaseorSyndrome	0.30	1	2007	2007	1	0	CTD_human
val	552	AVPR1A	0.663	0.5	C0004352	AutisticDisorder	disease	F03	MentalorBehavioralDysfunction	0.39	1	2002	2017	1	0	CTD_human
val	552	AVPR1A	0.663	0.5	C0036341	Schizophrenia	disease	F03	MentalorBehavioralDysfunction	0.52	0.5	2007	2017	2	0	PSYGENET
val	552	AVPR1A	0.663	0.5	C1510586	AutismSpectrumDisorders	disease	F03	MentalorBehavioralDysfunction	0.40	1	2006	2019	1	0	CTD_human
val	553	AVPR1B	0.705	0.385	C0005586	BipolarDisorder	disease	F03	MentalorBehavioralDysfunction	0.33	0.5	2012	2013	2	0	PSYGENET
val	553	AVPR1B	0.705	0.385	C0525045	MoodDisorders	group	F03	MentalorBehavioralDysfunction	0.33	1	2004	2013	4	0	PSYGENET
val	554	AVPR2	0.568	0.769	C0001627	Congenitaladrenalhyperplasia	disease	C16;C18;C13;C12;C19	DiseaseorSyndrome	0.30	1	2007	2007	1	0	CTD_human
val	554	AVPR2	0.568	0.769	C0006142	Malignantneoplasmofbreast	disease	C04;C17	NeoplasticProcess	0.30				0	1	UNIPROT
val	554	AVPR2	0.568	0.769	C0018273	GrowthDisorders	group	C23	PathologicFunction	0.30	1	2010	2010	1	0	CTD_human
val	554	AVPR2	0.568	0.769	C0018801	Heartfailure	disease	C14	DiseaseorSyndrome	0.32	1	2002	2018	1	0	CTD_human
val	554	AVPR2	0.568	0.769	C0018802	Congestiveheartfailure	disease	C14	DiseaseorSyndrome	0.32	1	2002	2018	1	0	CTD_human
val	554	AVPR2	0.568	0.769	C0023212	Left-SidedHeartFailure	disease	C14	DiseaseorSyndrome	0.30	1	2002	2002	1	0	CTD_human
val	554	AVPR2	0.568	0.769	C0028961	Oliguria	phenotype	C23;C13;C12	DiseaseorSyndrome	0.30	1	1994	1994	1	0	CTD_human
val	554	AVPR2	0.568	0.769	C0033141	Cardiomyopathies,Primary	group	C14	DiseaseorSyndrome	0.30	1	2002	2002	1	0	CTD_human
val	554	AVPR2	0.568	0.769	C0036529	MyocardialDiseases,Secondary	group	C14	DiseaseorSyndrome	0.30	1	2002	2002	1	0	CTD_human
val	554	AVPR2	0.568	0.769	C0162283	NephrogenicDiabetesInsipidus	disease	C13;C12	DiseaseorSyndrome	0.90	1	1992	2019	6	30	CTD_human;GENOMICS_ENGLAND
val	554	AVPR2	0.568	0.769	C0235527	HeartFailure,Right-Sided	disease	C14	DiseaseorSyndrome	0.30	1	2002	2002	1	0	CTD_human
val	554	AVPR2	0.568	0.769	C0268443	AcquiredNephrogenicDiabetesInsipidus	disease	C13;C12	DiseaseorSyndrome	0.30	1	2002	2010	5	0	CTD_human
val	554	AVPR2	0.568	0.769	C0677501	CongenitalNephrogenicDiabetesInsipidus	disease	C13;C12	DiseaseorSyndrome	0.40	0.973	1994	2018	5	0	CTD_human
val	554	AVPR2	0.568	0.769	C0878544	Cardiomyopathies	group	C14	DiseaseorSyndrome	0.30	1	2002	2002	1	0	CTD_human
val	554	AVPR2	0.568	0.769	C1563705	NephrogenicDiabetesInsipidus,TypeI	disease	C13;C12	DiseaseorSyndrome	0.80	0.978	1989	2020	30	23	CTD_human;GENOMICS_ENGLAND;UNIPROT
val	554	AVPR2	0.568	0.769	C1563706	NephrogenicDiabetesInsipidus,TypeII	disease	C13;C12	DiseaseorSyndrome	0.30	1	2002	2010	5	0	CTD_human
val	554	AVPR2	0.568	0.769	C1845202	NephrogenicSyndromeofInappropriateAntidiuresis	disease	C16;C18;C10;C19	DiseaseorSyndrome	0.77	1	2005	2019	3	2	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
val	554	AVPR2	0.568	0.769	C1959583	MyocardialFailure	disease	C14	DiseaseorSyndrome	0.30	1	2002	2002	1	0	CTD_human
val	554	AVPR2	0.568	0.769	C1961112	HeartDecompensation	phenotype	C14	PathologicFunction	0.30	1	2002	2002	1	0	CTD_human
val	554	AVPR2	0.568	0.769	C3542500	ADH-ResistantDiabetesInsipidus	disease	C13;C12	DiseaseorSyndrome	0.30	1	2002	2010	5	0	CTD_human
val	558	AXL	0.489	0.615	C0007131	Non-SmallCellLungCarcinoma	disease	C04;C08	NeoplasticProcess	0.40	1	2011	2019	1	0	CTD_human
val	558	AXL	0.489	0.615	C0011881	DiabeticNephropathy	disease	C13;C12;C19	DiseaseorSyndrome	0.30	1	2003	2003	1	0	CTD_human
val	558	AXL	0.489	0.615	C0017667	Nodularglomerulosclerosis	disease	C13;C12;C19	DiseaseorSyndrome	0.30	1	2003	2003	1	0	CTD_human
val	558	AXL	0.489	0.615	C0022665	KidneyNeoplasm	disease	C04;C13;C12	NeoplasticProcess	0.30	1	2014	2014	1	0	CTD_human
val	558	AXL	0.489	0.615	C0023893	LiverCirrhosis,Experimental	disease	C23;C06	ExperimentalModelofDisease	0.30	1	2014	2014	1	0	CTD_human
val	558	AXL	0.489	0.615	C0027626	NeoplasmInvasiveness	phenotype	C23;C04	PathologicFunction	0.30	1	2015	2015	1	0	CTD_human
val	558	AXL	0.489	0.615	C0027627	NeoplasmMetastasis	phenotype	C23;C04	NeoplasticProcess	0.40	1	1999	2019	1	0	CTD_human
val	558	AXL	0.489	0.615	C0027659	Neoplasms,Experimental	phenotype	C04	NeoplasticProcess;ExperimentalModelofDisease	0.30	1	2015	2015	1	0	CTD_human
val	558	AXL	0.489	0.615	C0027809	Neurilemmoma	disease	C04	NeoplasticProcess	0.31	1	2014	2014	1	0	CTD_human
val	558	AXL	0.489	0.615	C0030297	PancreaticNeoplasm	disease	C06;C04;C19	NeoplasticProcess	0.30	1	2015	2015	1	0	CTD_human
val	558	AXL	0.489	0.615	C0206728	PlexiformNeurofibroma	disease	C04;C10	NeoplasticProcess	0.30	1	2014	2014	1	0	CTD_human
val	558	AXL	0.489	0.615	C0278701	GastricAdenocarcinoma	disease	C06;C04	NeoplasticProcess	0.30				0	1	UNIPROT
val	558	AXL	0.489	0.615	C0342384	Idiopathichypogonadotropichypogonadism	disease	C19	DiseaseorSyndrome	0.31	1	2014	2014	0	0	CTD_human
val	558	AXL	0.489	0.615	C0346647	Malignantneoplasmofpancreas	disease	C06;C04;C19	NeoplasticProcess	0.36	1	2009	2019	1	0	CTD_human
val	558	AXL	0.489	0.615	C0740457	Malignantneoplasmofkidney	disease	C04;C13;C12	NeoplasticProcess	0.31	1	2014	2017	1	0	CTD_human
val	558	AXL	0.489	0.615	C0751374	Schwannomatosis,Plexiform	disease	C04	NeoplasticProcess	0.30	1	2014	2014	1	0	CTD_human
val	563	AZGP1	0.566	0.769	C0001418	Adenocarcinoma	group	C04	NeoplasticProcess	0.32	1	2008	2008	1	0	CTD_human
val	563	AZGP1	0.566	0.769	C0024121	LungNeoplasms	group	C04;C08	NeoplasticProcess	0.30	1	2008	2008	1	0	CTD_human
val	563	AZGP1	0.566	0.769	C0032460	PolycysticOvarySyndrome	disease	C04;C13;C19	DiseaseorSyndrome	0.33	1	2011	2020	1	0	CTD_human
val	563	AZGP1	0.566	0.769	C0033578	ProstaticNeoplasms	group	C04;C12	NeoplasticProcess	0.31	1	2006	2007	1	0	CTD_human
val	563	AZGP1	0.566	0.769	C0037199	Sinusitis	disease	C01;C08;C09	DiseaseorSyndrome	0.30	1	2008	2008	1	0	CTD_human
val	563	AZGP1	0.566	0.769	C0205641	Adenocarcinoma,BasalCell	disease	C04	NeoplasticProcess	0.30	1	2008	2008	1	0	CTD_human
val	563	AZGP1	0.566	0.769	C0205642	Adenocarcinoma,Oxyphilic	disease	C04	NeoplasticProcess	0.30	1	2008	2008	1	0	CTD_human
val	563	AZGP1	0.566	0.769	C0205643	Carcinoma,Cribriform	disease	C04	NeoplasticProcess	0.30	1	2008	2008	1	0	CTD_human
val	563	AZGP1	0.566	0.769	C0205644	Carcinoma,GranularCell	disease	C04	NeoplasticProcess	0.30	1	2008	2008	1	0	CTD_human
val	563	AZGP1	0.566	0.769	C0205645	Adenocarcinoma,Tubular	disease	C04	NeoplasticProcess	0.30	1	2008	2008	1	0	CTD_human
val	563	AZGP1	0.566	0.769	C0242379	Malignantneoplasmoflung	disease	C04;C08	NeoplasticProcess	0.31	1	2008	2008	1	0	CTD_human
val	563	AZGP1	0.566	0.769	C0376358	Malignantneoplasmofprostate	disease	C04;C12	NeoplasticProcess	0.39	1	2006	2019	1	0	CTD_human
val	563	AZGP1	0.566	0.769	C1136382	SclerocysticOvaries	disease	C04;C13;C19	DiseaseorSyndrome	0.30	1	2011	2011	1	0	CTD_human
val	567	B2M	0.447	0.846	C0004364	AutoimmuneDiseases	group	C20	DiseaseorSyndrome	0.31	1	2006	2011	1	0	CTD_human
val	567	B2M	0.447	0.846	C0013221	Drugtoxicity	group	C25	InjuryorPoisoning	0.30	1	2017	2017	1	0	CTD_human
val	567	B2M	0.447	0.846	C0018799	HeartDiseases	group	C14	DiseaseorSyndrome	0.30	1	2006	2006	1	0	CTD_human
val	567	B2M	0.447	0.846	C0020455	Hypergammaglobulinemia	disease	C23;C20;C15	DiseaseorSyndrome	0.30	1	2011	2011	1	0	CTD_human
val	567	B2M	0.447	0.846	C0022658	KidneyDiseases	group	C13;C12	DiseaseorSyndrome	0.48	1	1990	2020	3	0	CTD_human
val	567	B2M	0.447	0.846	C0022660	KidneyFailure,Acute	disease	C13;C12	DiseaseorSyndrome	0.35	1	1989	2019	3	0	CTD_human
val	567	B2M	0.447	0.846	C0033578	ProstaticNeoplasms	group	C04;C12	NeoplasticProcess	0.31	1	2007	2008	1	0	CTD_human
val	567	B2M	0.447	0.846	C0041755	Adversereactiontodrug	group	C25	PathologicFunction	0.30	1	2017	2017	1	0	CTD_human
val	567	B2M	0.447	0.846	C0079744	DiffuseLargeB-CellLymphoma	disease	C04;C20;C15	NeoplasticProcess	0.35	1	1993	2020	1	0	CTD_human
val	567	B2M	0.447	0.846	C0079774	PeripheralT-CellLymphoma	disease	C04;C20;C15	NeoplasticProcess	0.31	1	2014	2019	1	0	CTD_human
val	567	B2M	0.447	0.846	C0268389	Amyloidosis,familialvisceral	disease	C16;C18	DiseaseorSyndrome	0.70	1	2012	2012	1	1	CTD_human;GENOMICS_ENGLAND;UNIPROT
val	567	B2M	0.447	0.846	C0279626	Squamouscellcarcinomaofesophagus	disease	C06;C04	NeoplasticProcess	0.31	1	2011	2018	1	0	CTD_human
val	567	B2M	0.447	0.846	C0376358	Malignantneoplasmofprostate	disease	C04;C12	NeoplasticProcess	0.33	1	2007	2015	1	0	CTD_human
val	567	B2M	0.447	0.846	C1565662	AcuteKidneyInsufficiency	disease	C13;C12	DiseaseorSyndrome	0.30	1	1989	2017	3	0	CTD_human
val	567	B2M	0.447	0.846	C1855796	Hypoproteinemia,Hypercatabolic	disease	C16;C18	DiseaseorSyndrome	0.71	1	2006	2015	2	2	CTD_human;GENOMICS_ENGLAND;UNIPROT
val	567	B2M	0.447	0.846	C1858266	BareLymphocyteSyndrome,TypeI	disease	C16;C18;C20	DiseaseorSyndrome	0.30	1	2015	2015	1	0	ORPHANET
val	567	B2M	0.447	0.846	C2609414	Acutekidneyinjury	disease	C13;C12	InjuryorPoisoning	0.50	1	1989	2017	3	0	CTD_human
val	567	B2M	0.447	0.846	C4302669	Autosomaldominantbeta2-microglobulinicamyloidosis	disease	C16;C18	DiseaseorSyndrome	0.30	1	2012	2012	1	0	ORPHANET
val	570	BAAT	0.578	0.654	C0008370	Cholestasis	disease	C06	DiseaseorSyndrome	0.30	1	2003	2013	2	0	GENOMICS_ENGLAND
val	570	BAAT	0.578	0.654	C1843139	Hypercholanemia,Familial	disease	C16;C18	DiseaseorSyndrome	0.71	1	2003	2013	2	1	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
val	570	BAAT	0.578	0.654	C4747366	Hypercholanemia	phenotype		Finding	0.30				0	0	GENOMICS_ENGLAND
val	572	BAD	0.553	0.769	C0007787	TransientIschemicAttack	disease	C10;C14	DiseaseorSyndrome	0.30	1	2003	2003	1	0	CTD_human
val	572	BAD	0.553	0.769	C0023418	leukemia	disease	C04	NeoplasticProcess	0.30	1	2003	2003	1	0	CTD_human
val	572	BAD	0.553	0.769	C0033578	ProstaticNeoplasms	group	C04;C12	NeoplasticProcess	0.35	1	2002	2013	2	0	CTD_human
val	572	BAD	0.553	0.769	C0376358	Malignantneoplasmofprostate	disease	C04;C12	NeoplasticProcess	0.32	1	2007	2017	2	0	CTD_human
val	572	BAD	0.553	0.769	C0472381	PosteriorCirculationTransientIschemicAttack	disease	C10;C14	DiseaseorSyndrome	0.30	1	2003	2003	1	0	CTD_human
val	572	BAD	0.553	0.769	C0751019	CarotidCirculationTransientIschemicAttack	disease	C10;C14	DiseaseorSyndrome	0.30	1	2003	2003	1	0	CTD_human
val	572	BAD	0.553	0.769	C0751020	TransientIschemicAttack,VertebrobasilarCirculation	disease	C10;C14	DiseaseorSyndrome	0.30	1	2003	2003	1	0	CTD_human
val	572	BAD	0.553	0.769	C0751021	CrescendoTransientIschemicAttacks	disease	C10;C14	DiseaseorSyndrome	0.30	1	2003	2003	1	0	CTD_human
val	572	BAD	0.553	0.769	C0751022	BrainStemIschemia,Transient	disease	C10;C14	DiseaseorSyndrome	0.30	1	2003	2003	1	0	CTD_human
val	572	BAD	0.553	0.769	C0917805	TransientCerebralIschemia	disease	C10;C14	DiseaseorSyndrome	0.30	1	2003	2003	1	0	CTD_human
val	572	BAD	0.553	0.769	C1527335	TransientIschemicAttack,AnteriorCirculation	disease	C10;C14	DiseaseorSyndrome	0.30	1	2003	2003	1	0	CTD_human
val	573	BAG1	0.538	0.769	C0005586	BipolarDisorder	disease	F03	MentalorBehavioralDysfunction	0.32	1	2005	2013	5	0	PSYGENET
val	573	BAG1	0.538	0.769	C0006142	Malignantneoplasmofbreast	disease	C04;C17	NeoplasticProcess	0.40	1	1999	2019	1	0	CTD_human
val	573	BAG1	0.538	0.769	C0011570	MentalDepression	disease	F01	MentalorBehavioralDysfunction	0.30	1	2008	2008	1	0	PSYGENET
val	573	BAG1	0.538	0.769	C0011581	Depressivedisorder	disease	F03	MentalorBehavioralDysfunction	0.30	1	2008	2008	1	0	PSYGENET
val	573	BAG1	0.538	0.769	C0021367	MammaryDuctalCarcinoma	disease	C04;C17	NeoplasticProcess	0.30	1	2009	2009	1	0	CTD_human
val	573	BAG1	0.538	0.769	C0036341	Schizophrenia	disease	F03	MentalorBehavioralDysfunction	0.36	1	2002	2013	1	0	PSYGENET
val	573	BAG1	0.538	0.769	C0678222	BreastCarcinoma	disease	C04;C17	NeoplasticProcess	0.40	1	1999	2019	1	0	CTD_human
val	573	BAG1	0.538	0.769	C1134719	InvasiveDuctalBreastCarcinoma	disease	C04;C17	NeoplasticProcess	0.31	1	2009	2009	1	0	CTD_human
val	573	BAG1	0.538	0.769	C1257931	MammaryNeoplasms,Human	disease	C04;C17	NeoplasticProcess	0.30	1	2009	2009	1	0	CTD_human
val	573	BAG1	0.538	0.769	C1458155	MammaryNeoplasms	group	C04;C17	NeoplasticProcess	0.34	1	2003	2016	1	0	CTD_human
val	573	BAG1	0.538	0.769	C4704874	MammaryCarcinoma,Human	disease	C04;C17	NeoplasticProcess	0.30	1	2009	2009	1	0	CTD_human
val	578	BAK1	0.555	0.769	C0007102	Malignanttumorofcolon	disease	C06;C04	NeoplasticProcess	0.30	1	2008	2008	1	0	CTD_human
val	578	BAK1	0.555	0.769	C0009375	ColonicNeoplasms	group	C06;C04	NeoplasticProcess	0.30	1	2008	2008	1	0	CTD_human
val	578	BAK1	0.555	0.769	C0019207	Hepatoma,Morris	disease	C06;C04	NeoplasticProcess;ExperimentalModelofDisease	0.30	1	2017	2017	1	0	CTD_human
val	578	BAK1	0.555	0.769	C0019208	Hepatoma,Novikoff	disease	C06;C04	NeoplasticProcess;ExperimentalModelofDisease	0.30	1	2017	2017	1	0	CTD_human
val	578	BAK1	0.555	0.769	C0023904	LiverNeoplasms,Experimental	phenotype	C06;C04	NeoplasticProcess;ExperimentalModelofDisease	0.30	1	2017	2017	1	0	CTD_human
val	578	BAK1	0.555	0.769	C0027051	MyocardialInfarction	disease	C23;C14	DiseaseorSyndrome	0.30	1	2018	2018	1	0	CTD_human
val	578	BAK1	0.555	0.769	C0027746	NerveDegeneration	phenotype	C23	CellorMolecularDysfunction	0.30	1	2009	2009	1	0	CTD_human
val	578	BAK1	0.555	0.769	C0086404	ExperimentalHepatoma	disease	C06;C04	NeoplasticProcess;ExperimentalModelofDisease	0.30	1	2017	2017	1	0	CTD_human
val	579	NKX3-2	0.736	0.308	C0152423	Congenitalsmallears	disease	C16;C09	CongenitalAbnormality	0.30	1	1997	1997	1	0	GENOMICS_ENGLAND
val	579	NKX3-2	0.736	0.308	C0878659	Disproportionateshortstature	phenotype	C16;C05;C19	Finding	0.30				0	0	GENOMICS_ENGLAND
val	579	NKX3-2	0.736	0.308	C2750066	Spondylo-Megaepiphyseal-MetaphysealDysplasia	disease	C16;C05	DiseaseorSyndrome	0.72	1	1997	2019	2	4	CTD_human;GENOMICS_ENGLAND;ORPHANET
val	580	BARD1	0.597	0.538	C0006142	Malignantneoplasmofbreast	disease	C04;C17	NeoplasticProcess	1.00	0.896	1996	2020	0	63	CTD_human;GENOMICS_ENGLAND;UNIPROT
val	580	BARD1	0.597	0.538	C0009405	HereditaryNonpolyposisColorectalNeoplasms	group	C16;C06;C04;C18	NeoplasticProcess	0.30	1	2001	2016	4	0	CLINGEN
val	580	BARD1	0.597	0.538	C0027819	Neuroblastoma	disease	C04	NeoplasticProcess	0.50	1	2009	2019	2	13	CTD_human
val	580	BARD1	0.597	0.538	C0153567	UterineCancer	disease	C04;C13	NeoplasticProcess	0.32	1	1998	2006	0	1	UNIPROT
val	580	BARD1	0.597	0.538	C0346153	BreastCancer,Familial	disease	C04;C17	NeoplasticProcess	0.35	0.938	2001	2019	11	0	CLINGEN
val	580	BARD1	0.597	0.538	C0677776	HereditaryBreastandOvarianCancerSyndrome	disease	C16;C04;C13;C17;C19	NeoplasticProcess	0.40	1	2004	2017	1	5	ORPHANET
val	580	BARD1	0.597	0.538	C0678222	BreastCarcinoma	disease	C04;C17	NeoplasticProcess	0.50	0.86	1996	2020	0	0	CTD_human
val	580	BARD1	0.597	0.538	C1112155	Hereditarynon-polyposiscolorectalcancersyndrome	disease		CongenitalAbnormality	0.30	1	2001	2016	4	0	CLINGEN
val	580	BARD1	0.597	0.538	C1257931	MammaryNeoplasms,Human	disease	C04;C17	NeoplasticProcess	0.30				0	0	CTD_human
val	580	BARD1	0.597	0.538	C1333990	HereditaryNonpolyposisColorectalCancer	disease	C16;C06;C04;C18	NeoplasticProcess	0.30	1	2001	2016	4	0	CLINGEN
val	580	BARD1	0.597	0.538	C1333991	HereditaryNon-PolyposisColonCancerType2	disease	C16;C04	NeoplasticProcess	0.30	1	2001	2016	4	0	CLINGEN
val	580	BARD1	0.597	0.538	C1458155	MammaryNeoplasms	group	C04;C17	NeoplasticProcess	0.45	1	2004	2008	0	1	CTD_human
val	580	BARD1	0.597	0.538	C1518693	Clearcelladenocarcinomaofovary	disease	C04	NeoplasticProcess	0.30				0	0	UNIPROT
val	580	BARD1	0.597	0.538	C2936783	Colorectalcancer,hereditarynonpolyposis,type1	disease	C16;C06;C04;C18	NeoplasticProcess	0.30	1	2001	2016	4	0	CLINGEN
val	580	BARD1	0.597	0.538	C4704874	MammaryCarcinoma,Human	disease	C04;C17	NeoplasticProcess	0.30				0	0	CTD_human
val	581	BAX	0.417	0.885	C0002152	AlloxanDiabetes	disease	C18;C19	ExperimentalModelofDisease	0.30	1	2013	2013	1	0	CTD_human
val	581	BAX	0.417	0.885	C0002395	AlzheimersDisease	disease	C10;F03	DiseaseorSyndrome	0.52	1	1997	2018	1	0	CTD_human
2080	595	CCND1	0.344	0.923	C0007138	Carcinoma,TransitionalCell	disease	C04	NeoplasticProcess	0.56	0.875	1997	2017	1	0	CTD_human
2092	595	CCND1	0.344	0.923	C0019562	VonHippel-LindauSyndrome	disease	C16;C10;C14	DiseaseorSyndrome	0.53	1	2002	2005	0	0	CTD_human;GENOMICS_ENGLAND
2106	595	CCND1	0.344	0.923	C0026764	MultipleMyeloma	disease	C04;C20;C15;C14	NeoplasticProcess	0.7	0.975	1992	2019	1	2	CTD_human;ORPHANET
2110	595	CCND1	0.344	0.923	C0033578	ProstaticNeoplasms	group	C04;C12	NeoplasticProcess	0.57	1	1999	2015	1	0	CTD_human
2141	595	CCND1	0.344	0.923	C0376358	Malignantneoplasmofprostate	disease	C04;C12	NeoplasticProcess	0.6	0.952	1998	2020	1	0	CTD_human
2183	596	BCL2	0.291	0.885	C0750900	AlzheimersDisease,FocalOnset	disease	C10;F03	MentalorBehavioralDysfunction	0.30	1	2008	2008	1	0	CTD_human
val	596	BCL2	0.291	0.885	C0750901	AlzheimerDisease,EarlyOnset	disease	C10;F03	DiseaseorSyndrome	0.30	1	2008	2008	1	0	CTD_human
val	596	BCL2	0.291	0.885	C0751177	CancerofHead	disease	C04	NeoplasticProcess	0.30	1	2008	2008	1	0	CTD_human
val	596	BCL2	0.291	0.885	C0751262	AdultLearningDisorders	group	C23;C10;F03	MentalorBehavioralDysfunction	0.30	1	2007	2007	1	0	CTD_human
val	596	BCL2	0.291	0.885	C0751263	LearningDisturbance	disease	C23;C10;F03	MentalorBehavioralDysfunction	0.30	1	2007	2007	1	0	CTD_human
val	596	BCL2	0.291	0.885	C0751265	LearningDisabilities	disease	C23;C10;F03	MentalorBehavioralDysfunction	0.30	1	2007	2007	1	0	CTD_human
val	596	BCL2	0.291	0.885	C0751292	Age-RelatedMemoryDisorders	group	C23;C10;F01	MentalorBehavioralDysfunction	0.30	1	2007	2007	1	0	CTD_human
val	596	BCL2	0.291	0.885	C0751293	MemoryDisorder,Semantic	phenotype	C23;C10;F01	MentalorBehavioralDysfunction	0.30	1	2007	2007	1	0	CTD_human
val	596	BCL2	0.291	0.885	C0751294	MemoryDisorder,Spatial	phenotype	C23;C10;F01	MentalorBehavioralDysfunction	0.30	1	2007	2007	1	0	CTD_human
val	596	BCL2	0.291	0.885	C0751295	MemoryLoss	phenotype	C23;C10;F01	SignorSymptom	0.30	1	2007	2007	1	0	CTD_human
val	596	BCL2	0.291	0.885	C0848676	Subfertility,Male	phenotype	C12	SignorSymptom	0.30	1	2014	2014	1	0	CTD_human
val	596	BCL2	0.291	0.885	C0853193	BipolarIdisorder	disease	F03	MentalorBehavioralDysfunction	0.32	1	2011	2013	2	0	PSYGENET
val	596	BCL2	0.291	0.885	C0887900	UpperAerodigestiveTractNeoplasms	group	C04	NeoplasticProcess	0.30	1	2008	2008	1	0	CTD_human
val	596	BCL2	0.291	0.885	C0917731	Malesterility	phenotype	C12	Finding	0.30	1	2014	2014	1	0	CTD_human
val	596	BCL2	0.291	0.885	C1136382	SclerocysticOvaries	disease	C04;C13;C19	DiseaseorSyndrome	0.30	1	2011	2011	1	0	CTD_human
val	596	BCL2	0.291	0.885	C1257931	MammaryNeoplasms,Human	disease	C04;C17	NeoplasticProcess	0.30	1	2003	2013	3	0	CTD_human
val	596	BCL2	0.291	0.885	C1330966	DevelopmentalAcademicDisorder	phenotype	C23;C10;F03	Finding	0.30	1	2007	2007	1	0	CTD_human
val	596	BCL2	0.291	0.885	C1458155	MammaryNeoplasms	group	C04;C17	NeoplasticProcess	0.40	0.978	1998	2019	3	0	CTD_human
val	596	BCL2	0.291	0.885	C1879321	AcuteMyeloidLeukemia(AML-M2)	disease	C04	NeoplasticProcess	0.31	1	1999	2013	1	0	CTD_human
val	596	BCL2	0.291	0.885	C1956130	Lymphoma,Follicular,Grade1	disease	C04;C20;C15	NeoplasticProcess	0.32	1	1988	2003	2	0	CTD_human
val	596	BCL2	0.291	0.885	C1956131	Lymphoma,Follicular,Grade3	disease	C04;C20;C15	NeoplasticProcess	0.32	1	1988	2013	2	0	CTD_human
val	596	BCL2	0.291	0.885	C1956132	Lymphoma,Follicular,Grade2	disease	C04;C20;C15	NeoplasticProcess	0.31	1	1988	2012	2	0	CTD_human
val	596	BCL2	0.291	0.885	C1961099	PrecursorT-CellLymphoblasticLeukemia-Lymphoma	disease	C04;C20;C15	NeoplasticProcess	0.40	1	1999	2020	1	0	CTD_human
val	596	BCL2	0.291	0.885	C2931456	Prostatecancer,familial	disease	C04;C12	NeoplasticProcess	0.30	1	2018	2018	1	0	CTD_human
val	596	BCL2	0.291	0.885	C2937358	CerebralHemorrhage	phenotype	C23;C10;C14	PathologicFunction	0.30	1	2003	2003	1	0	CTD_human
val	596	BCL2	0.291	0.885	C2985290	FetalAlcoholSpectrumDisorders	group	C16;C13;C25	DiseaseorSyndrome;CongenitalAbnormality	0.31	1	2012	2018	1	0	PSYGENET
val	596	BCL2	0.291	0.885	C3541456	SpondyloepiphysealDysplasiaTarda,X-Linked	disease	C16;C05	CongenitalAbnormality	0.30	1	2007	2007	1	0	CTD_human
val	596	BCL2	0.291	0.885	C3714542	Lymphoma,Diffuse	disease	C04;C20;C15	NeoplasticProcess	0.33	1	1988	2015	2	0	CTD_human
val	596	BCL2	0.291	0.885	C4551479	Schwartz-JampelSyndrome,Type1	disease	C16;C05	DiseaseorSyndrome	0.30	1	2007	2007	1	0	CTD_human
val	596	BCL2	0.291	0.885	C4704874	MammaryCarcinoma,Human	disease	C04;C17	NeoplasticProcess	0.30	1	2003	2013	3	0	CTD_human
val	596	BCL2	0.291	0.885	C4721532	Lymphoma,Non-Hodgkin,Familial	disease	C04;C20;C15	NeoplasticProcess	0.40	1	1988	2019	2	0	CTD_human
val	596	BCL2	0.291	0.885	C4722327	PROSTATECANCER,HEREDITARY,1	disease	C04;C12	NeoplasticProcess	0.30	1	2018	2018	1	0	CTD_human
val	597	BCL2A1	0.529	0.731	C0003873	RheumatoidArthritis	disease	C17;C05;C20	DiseaseorSyndrome	0.31	1	2009	2017	1	0	CTD_human
val	597	BCL2A1	0.529	0.731	C0006142	Malignantneoplasmofbreast	disease	C04;C17	NeoplasticProcess	0.35	1	2003	2019	2	0	CTD_human
val	597	BCL2A1	0.529	0.731	C0014859	EsophagealNeoplasms	group	C06;C04	NeoplasticProcess	0.30	1	2007	2007	1	0	CTD_human
val	597	BCL2A1	0.529	0.731	C0546837	Malignantneoplasmofesophagus	disease	C06;C04	NeoplasticProcess	0.30	1	2007	2007	1	0	CTD_human
val	597	BCL2A1	0.529	0.731	C0678222	BreastCarcinoma	disease	C04;C17	NeoplasticProcess	0.35	1	2003	2019	2	0	CTD_human
val	597	BCL2A1	0.529	0.731	C1257931	MammaryNeoplasms,Human	disease	C04;C17	NeoplasticProcess	0.30	1	2005	2008	2	0	CTD_human
val	597	BCL2A1	0.529	0.731	C1458155	MammaryNeoplasms	group	C04;C17	NeoplasticProcess	0.31	1	2003	2008	2	0	CTD_human
val	597	BCL2A1	0.529	0.731	C4704874	MammaryCarcinoma,Human	disease	C04;C17	NeoplasticProcess	0.30	1	2005	2008	2	0	CTD_human
val	598	BCL2L1	0.493	0.885	C0001430	Adenoma	group	C04	NeoplasticProcess	0.31	1	1999	2015	1	0	CTD_human
val	598	BCL2L1	0.493	0.885	C0002152	AlloxanDiabetes	disease	C18;C19	ExperimentalModelofDisease	0.30	1	2006	2006	1	0	CTD_human
val	598	BCL2L1	0.493	0.885	C0007097	Carcinoma	group	C04	NeoplasticProcess	0.33	1	1996	2005	1	0	CTD_human
val	598	BCL2L1	0.493	0.885	C0010417	Cryptorchidism	disease	C16;C12;C19	CongenitalAbnormality	0.30	1	2015	2015	1	0	CTD_human
val	598	BCL2L1	0.493	0.885	C0011853	DiabetesMellitus,Experimental	disease	C18;C19	ExperimentalModelofDisease	0.50	1	2006	2007	1	0	CTD_human
val	598	BCL2L1	0.493	0.885	C0011860	DiabetesMellitus,Non-Insulin-Dependent	disease	C18;C19	DiseaseorSyndrome	0.30	1	2006	2006	1	0	CTD_human
val	598	BCL2L1	0.493	0.885	C0018671	HeadandNeckNeoplasms	group	C04	NeoplasticProcess	0.31	1	2004	2008	1	0	CTD_human
val	598	BCL2L1	0.493	0.885	C0018675	HeadNeoplasms	group	C04	NeoplasticProcess	0.30	1	2008	2008	1	0	CTD_human
val	598	BCL2L1	0.493	0.885	C0019207	Hepatoma,Morris	disease	C06;C04	NeoplasticProcess;ExperimentalModelofDisease	0.30	1	1999	2017	2	0	CTD_human
val	598	BCL2L1	0.493	0.885	C0019208	Hepatoma,Novikoff	disease	C06;C04	NeoplasticProcess;ExperimentalModelofDisease	0.30	1	1999	2017	2	0	CTD_human
val	598	BCL2L1	0.493	0.885	C0023895	Liverdiseases	group	C06	DiseaseorSyndrome	0.30	1	2010	2010	1	0	CTD_human
val	598	BCL2L1	0.493	0.885	C0023904	LiverNeoplasms,Experimental	phenotype	C06;C04	NeoplasticProcess;ExperimentalModelofDisease	0.30	1	1999	2017	2	0	CTD_human
val	598	BCL2L1	0.493	0.885	C0024121	LungNeoplasms	group	C04;C08	NeoplasticProcess	0.33	1	2005	2013	1	0	CTD_human
val	598	BCL2L1	0.493	0.885	C0024623	Malignantneoplasmofstomach	disease	C06;C04	NeoplasticProcess	0.32	1	2015	2019	1	0	CTD_human
val	598	BCL2L1	0.493	0.885	C0026764	MultipleMyeloma	disease	C04;C20;C15;C14	NeoplasticProcess	0.36	1	1998	2014	1	0	CTD_human
val	598	BCL2L1	0.493	0.885	C0027051	MyocardialInfarction	disease	C23;C14	DiseaseorSyndrome	0.50	1	2007	2009	1	0	CTD_human
val	598	BCL2L1	0.493	0.885	C0027533	NeckNeoplasms	group	C04	NeoplasticProcess	0.30	1	2008	2008	1	0	CTD_human
val	598	BCL2L1	0.493	0.885	C0030297	PancreaticNeoplasm	disease	C06;C04;C19	NeoplasticProcess	0.30	1	2006	2006	1	0	CTD_human
val	598	BCL2L1	0.493	0.885	C0038356	StomachNeoplasms	group	C06;C04	NeoplasticProcess	0.30	1	2015	2015	1	0	CTD_human
val	598	BCL2L1	0.493	0.885	C0038433	StreptozotocinDiabetes	disease	C18;C19	ExperimentalModelofDisease	0.30	1	2006	2006	1	0	CTD_human
val	598	BCL2L1	0.493	0.885	C0086404	ExperimentalHepatoma	disease	C06;C04	NeoplasticProcess;ExperimentalModelofDisease	0.30	1	1999	2017	2	0	CTD_human
val	598	BCL2L1	0.493	0.885	C0086565	LiverDysfunction	phenotype	C06	Finding	0.30	1	2010	2010	1	0	CTD_human
val	598	BCL2L1	0.493	0.885	C0149504	Encephalopathy,Toxic	disease	C10;C25	InjuryorPoisoning	0.30	1	2010	2010	1	0	CTD_human
val	598	BCL2L1	0.493	0.885	C0154659	ToxicEncephalitis	disease	C10;C25	InjuryorPoisoning	0.30	1	2010	2010	1	0	CTD_human
val	598	BCL2L1	0.493	0.885	C0205646	Adenoma,BasalCell	disease	C04	NeoplasticProcess	0.30	1	1999	1999	1	0	CTD_human
val	598	BCL2L1	0.493	0.885	C0205647	Follicularadenoma	disease	C04	NeoplasticProcess	0.30	1	1999	1999	1	0	CTD_human
val	598	BCL2L1	0.493	0.885	C0205648	Adenoma,Microcystic	disease	C04	NeoplasticProcess	0.30	1	1999	1999	1	0	CTD_human
val	598	BCL2L1	0.493	0.885	C0205649	Adenoma,Monomorphic	disease	C04	NeoplasticProcess	0.30	1	1999	1999	1	0	CTD_human
val	598	BCL2L1	0.493	0.885	C0205650	Papillaryadenoma	disease	C04	NeoplasticProcess	0.30	1	1999	1999	1	0	CTD_human
val	598	BCL2L1	0.493	0.885	C0205651	Adenoma,Trabecular	disease	C04	NeoplasticProcess	0.30	1	1999	1999	1	0	CTD_human
val	598	BCL2L1	0.493	0.885	C0205696	Anaplasticcarcinoma	disease	C04	NeoplasticProcess	0.30	1	1999	1999	1	0	CTD_human
val	598	BCL2L1	0.493	0.885	C0205697	Carcinoma,Spindle-Cell	disease	C04	NeoplasticProcess	0.30	1	1999	1999	1	0	CTD_human
val	598	BCL2L1	0.493	0.885	C0205698	Undifferentiatedcarcinoma	disease	C04	NeoplasticProcess	0.30	1	1999	1999	1	0	CTD_human
val	598	BCL2L1	0.493	0.885	C0205699	Carcinomatosis	phenotype	C04	NeoplasticProcess	0.30	1	1999	1999	1	0	CTD_human
val	598	BCL2L1	0.493	0.885	C0235032	NeurotoxicitySyndromes	group	C10;C25	InjuryorPoisoning	0.30	1	2010	2010	1	0	CTD_human
val	598	BCL2L1	0.493	0.885	C0242350	Erectiledysfunction	disease	C12;F03	DiseaseorSyndrome	0.50	1	2002	2002	1	0	CTD_human
val	598	BCL2L1	0.493	0.885	C0242379	Malignantneoplasmoflung	disease	C04;C08	NeoplasticProcess	0.32	1	2005	2019	1	0	CTD_human
val	598	BCL2L1	0.493	0.885	C0278996	MalignantHeadandNeckNeoplasm	disease	C04	NeoplasticProcess	0.31	1	2008	2010	1	0	CTD_human
val	598	BCL2L1	0.493	0.885	C0346647	Malignantneoplasmofpancreas	disease	C06;C04;C19	NeoplasticProcess	0.30	1	2006	2006	1	0	CTD_human
val	598	BCL2L1	0.493	0.885	C0431663	BilateralCryptorchidism	disease	C16;C12;C19	CongenitalAbnormality	0.30	1	2015	2015	1	0	CTD_human
val	598	BCL2L1	0.493	0.885	C0431664	UnilateralCryptorchidism	disease	C16;C12;C19	CongenitalAbnormality	0.30	1	2015	2015	1	0	CTD_human
val	598	BCL2L1	0.493	0.885	C0746787	CancerofNeck	disease	C04	NeoplasticProcess	0.30	1	2008	2008	1	0	CTD_human
val	598	BCL2L1	0.493	0.885	C0751177	CancerofHead	disease	C04	NeoplasticProcess	0.30	1	2008	2008	1	0	CTD_human
val	598	BCL2L1	0.493	0.885	C0887900	UpperAerodigestiveTractNeoplasms	group	C04	NeoplasticProcess	0.30	1	2008	2008	1	0	CTD_human
val	598	BCL2L1	0.493	0.885	C1384666	hearingimpairment	phenotype	C23;C10;C09	DiseaseorSyndrome	0.30	1	2007	2007	1	0	CTD_human
val	598	BCL2L1	0.493	0.885	C1563730	AbdominalCryptorchidism	disease	C16;C12;C19	CongenitalAbnormality	0.30	1	2015	2015	1	0	CTD_human
val	598	BCL2L1	0.493	0.885	C1563731	InguinalCryptorchidism	phenotype	C16;C12;C19	Finding	0.30	1	2015	2015	1	0	CTD_human
val	598	BCL2L1	0.493	0.885	C1708349	HereditaryDiffuseGastricCancer	disease	C06;C04	NeoplasticProcess	0.30	1	2015	2015	1	0	CTD_human
val	598	BCL2L1	0.493	0.885	C1862939	AMYOTROPHICLATERALSCLEROSIS1	disease	C18;C10	DiseaseorSyndrome	0.30	1	2002	2002	1	0	CTD_human
val	598	BCL2L1	0.493	0.885	C1862941	AmyotrophicLateralSclerosis,Sporadic	disease	C18;C10	DiseaseorSyndrome	0.30	1	2002	2002	1	0	CTD_human
val	598	BCL2L1	0.493	0.885	C2239176	Livercarcinoma	disease	C06;C04	NeoplasticProcess	0.38	1	2000	2019	2	0	CTD_human
val	598	BCL2L1	0.493	0.885	C2937358	CerebralHemorrhage	phenotype	C23;C10;C14	PathologicFunction	0.30	1	2003	2003	1	0	CTD_human
val	598	BCL2L1	0.493	0.885	C4551993	AmyotrophicLateralSclerosis,Familial	disease	C18;C10	DiseaseorSyndrome	0.30	1	2002	2002	1	0	CTD_human
val	602	BCL3	0.541	0.731	C0004153	Atherosclerosis	disease	C14	DiseaseorSyndrome	0.31	1	2015	2015	1	0	CTD_human
val	602	BCL3	0.541	0.731	C0242339	Dyslipidemias	group	C18	DiseaseorSyndrome	0.31	1	2018	2018	1	0	CTD_human
val	602	BCL3	0.541	0.731	C0598784	Dyslipoproteinemias	phenotype	C18	PathologicFunction	0.30	1	2018	2018	1	0	CTD_human
val	602	BCL3	0.541	0.731	C1563937	Atherogenesis	phenotype	C14	PathologicFunction	0.30	1	2015	2015	1	0	CTD_human
val	604	BCL6	0.444	0.808	C0023434	ChronicLymphocyticLeukemia	disease	C04;C20;C15	NeoplasticProcess	0.40	0.933	1996	2020	0	0	CGI
val	604	BCL6	0.444	0.808	C0024301	Lymphoma,Follicular	disease	C04;C20;C15	NeoplasticProcess	0.40	0.961	1995	2020	1	0	ORPHANET
val	604	BCL6	0.444	0.808	C0024302	Reticulosarcoma	disease	C04;C20;C15	NeoplasticProcess	0.32	1	1997	2015	1	0	CTD_human
val	604	BCL6	0.444	0.808	C0024304	Lymphoma,Mixed-Cell	disease	C04;C20;C15	NeoplasticProcess	0.30	1	2015	2015	1	0	CTD_human
val	604	BCL6	0.444	0.808	C0024305	Lymphoma,Non-Hodgkin	disease	C04;C20;C15	NeoplasticProcess	0.60	0.956	1993	2015	1	0	CGI;CTD_human
val	604	BCL6	0.444	0.808	C0024306	Lymphoma,Undifferentiated	disease	C04;C20;C15	NeoplasticProcess	0.30	1	2015	2015	1	0	CTD_human
val	604	BCL6	0.444	0.808	C0079740	HighGradeLymphoma(neoplasm)	disease	C04;C20;C15	NeoplasticProcess	0.30	1	2015	2015	1	0	CTD_human
val	604	BCL6	0.444	0.808	C0079741	Lymphoma,Intermediate-Grade	disease	C04;C20;C15	NeoplasticProcess	0.30	1	2015	2015	1	0	CTD_human
val	604	BCL6	0.444	0.808	C0079747	LowGradeLymphoma(neoplasm)	disease	C04;C20;C15	NeoplasticProcess	0.30	1	2015	2015	1	0	CTD_human
val	604	BCL6	0.444	0.808	C0079757	DiffuseMixed-CellLymphoma	disease	C04;C20;C15	NeoplasticProcess	0.30	1	2015	2015	1	0	CTD_human
val	604	BCL6	0.444	0.808	C0079770	Lymphoma,SmallNoncleaved-Cell	disease	C04;C20;C15	NeoplasticProcess	0.33	1	1994	2015	1	0	CTD_human
val	604	BCL6	0.444	0.808	C0079772	T-CellLymphoma	disease	C04;C20;C15	NeoplasticProcess	0.34	1	2002	2015	1	0	CTD_human
val	604	BCL6	0.444	0.808	C0334660	Angioendotheliomatosis	disease	C04;C20;C15	NeoplasticProcess	0.31	1	2001	2001	0	0	ORPHANET
val	604	BCL6	0.444	0.808	C1292754	Mediastinal(Thymic)LargeB-CellLymphoma	disease	C04;C08;C20;C15	NeoplasticProcess	0.31	1	2006	2016	1	0	ORPHANET
val	604	BCL6	0.444	0.808	C3714542	Lymphoma,Diffuse	disease	C04;C20;C15	NeoplasticProcess	0.31	1	1997	2015	1	0	CTD_human
val	604	BCL6	0.444	0.808	C4721532	Lymphoma,Non-Hodgkin,Familial	disease	C04;C20;C15	NeoplasticProcess	0.40	0.935	1994	2015	1	0	CTD_human
val	607	BCL9	0.595	0.615	C0005586	BipolarDisorder	disease	F03	MentalorBehavioralDysfunction	0.31	1	2011	2011	1	0	PSYGENET
val	607	BCL9	0.595	0.615	C0033975	PsychoticDisorders	group	F03	MentalorBehavioralDysfunction	0.30	1	2011	2011	1	0	PSYGENET
val	607	BCL9	0.595	0.615	C0036341	Schizophrenia	disease	F03	MentalorBehavioralDysfunction	0.43	1	2011	2015	2	1	PSYGENET
val	607	BCL9	0.595	0.615	C0041696	UnipolarDepression	disease	F03	MentalorBehavioralDysfunction	0.31	1	2011	2011	1	0	PSYGENET
val	607	BCL9	0.595	0.615	C0919267	ovarianneoplasm	disease	C04;C13;C19	NeoplasticProcess	0.32	1	2011	2019	1	0	CTD_human
val	607	BCL9	0.595	0.615	C1140680	Malignantneoplasmofovary	disease	C04;C13;C19	NeoplasticProcess	0.32	1	2011	2019	1	0	CTD_human
val	607	BCL9	0.595	0.615	C1269683	MajorDepressiveDisorder	disease	F03	MentalorBehavioralDysfunction	0.31	1	2011	2011	1	0	PSYGENET
val	611	OPN1SW	0.519	0.769	C0004238	AtrialFibrillation	disease	C23;C14	DiseaseorSyndrome	0.30	1	2018	2018	1	0	CTD_human
val	611	OPN1SW	0.519	0.769	C0155017	ColorBlindness,Blue	disease	C23;C11;C10	DiseaseorSyndrome	0.74	0.667	1992	2018	3	4	CTD_human;ORPHANET;UNIPROT
val	611	OPN1SW	0.519	0.769	C0235480	Paroxysmalatrialfibrillation	disease	C23;C14	DiseaseorSyndrome	0.30	1	2018	2018	1	0	CTD_human
val	611	OPN1SW	0.519	0.769	C2585653	Persistentatrialfibrillation	phenotype	C23;C14	PathologicFunction	0.30	1	2018	2018	1	0	CTD_human
val	611	OPN1SW	0.519	0.769	C3468561	familialatrialfibrillation	phenotype	C23;C14	PathologicFunction	0.30	1	2018	2018	1	0	CTD_human
val	613	BCR	0.431	0.885	C0005586	BipolarDisorder	disease	F03	MentalorBehavioralDysfunction	0.32	1	2005	2008	4	0	PSYGENET
val	613	BCR	0.431	0.885	C0005699	BlastPhase	disease	C23;C04;C15	NeoplasticProcess	0.40	0.941	1975	2019	1	0	CTD_human
val	613	BCR	0.431	0.885	C0006413	BurkittLymphoma	disease	C04;C01;C20;C15	NeoplasticProcess	0.34	1	1985	2017	1	0	ORPHANET
val	613	BCR	0.431	0.885	C0023452	ChildhoodAcuteLymphoblasticLeukemia	disease	C04;C20;C15	NeoplasticProcess	0.40	0.948	1987	2019	0	0	CTD_human
val	613	BCR	0.431	0.885	C0023453	L2AcuteLymphoblasticLeukemia	disease	C04;C20;C15	NeoplasticProcess	0.30				0	0	CTD_human
val	613	BCR	0.431	0.885	C0023473	MyeloidLeukemia,Chronic	disease	C04;C15	NeoplasticProcess	0.70	0.969	1980	2020	3	0	CTD_human;ORPHANET
val	613	BCR	0.431	0.885	C0023893	LiverCirrhosis,Experimental	disease	C23;C06	ExperimentalModelofDisease	0.30	1	2014	2014	1	0	CTD_human
val	613	BCR	0.431	0.885	C0027022	Myeloproliferativedisease	group	C15	NeoplasticProcess	0.50	0.976	1979	2019	1	0	CTD_human
val	613	BCR	0.431	0.885	C0027540	Necrosis	phenotype	C23	OrganorTissueFunction	0.30	1	2013	2013	1	0	CTD_human
val	613	BCR	0.431	0.885	C0027659	Neoplasms,Experimental	phenotype	C04	NeoplasticProcess;ExperimentalModelofDisease	0.30	1	2009	2009	1	0	CTD_human
val	613	BCR	0.431	0.885	C0041696	UnipolarDepression	disease	F03	MentalorBehavioralDysfunction	0.31	1	2005	2005	1	0	PSYGENET
val	613	BCR	0.431	0.885	C0279680	Transitionalcellcarcinomaofbladder	disease	C04;C13;C12	NeoplasticProcess	0.30				0	0	UNIPROT
val	613	BCR	0.431	0.885	C1269683	MajorDepressiveDisorder	disease	F03	MentalorBehavioralDysfunction	0.31	1	2005	2005	1	0	PSYGENET
val	613	BCR	0.431	0.885	C1292769	PrecursorB-celllymphoblasticleukemia	disease	C04;C20;C15	NeoplasticProcess	0.40	0.92	1991	2019	1	0	ORPHANET
val	613	BCR	0.431	0.885	C1961099	PrecursorT-CellLymphoblasticLeukemia-Lymphoma	disease	C04;C20;C15	NeoplasticProcess	0.38	1	1989	2019	0	0	ORPHANET
val	613	BCR	0.431	0.885	C1961102	PrecursorCellLymphoblasticLeukemiaLymphoma	disease	C04;C20;C15	NeoplasticProcess	0.50	0.978	1988	2020	0	0	CTD_human
val	613	BCR	0.431	0.885	C2678480	Chromosome22q11.2DeletionSyndrome,Distal	disease	C23;C16;C05;C19;C15;C14	DiseaseorSyndrome	0.30				0	0	ORPHANET
val	617	BCS1L	0.534	0.808	C0008370	Cholestasis	disease	C06	DiseaseorSyndrome	0.40	1	1998	2002	2	0	GENOMICS_ENGLAND
val	617	BCS1L	0.534	0.808	C0023264	LeighDisease	disease	C16;C18;C10	DiseaseorSyndrome	0.70	1	1998	2017	10	3	CLINGEN;CTD_human;GENOMICS_ENGLAND
val	617	BCS1L	0.534	0.808	C0266006	Pilitorti-deafnesssyndrome	disease	C23;C18;C17;C10;C09	DiseaseorSyndrome	0.75	1	1998	2017	9	10	CLINGEN;CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
val	617	BCS1L	0.534	0.808	C0751267	Encephalopathy,SubacuteNecrotizing,Infantile	disease	C16;C18;C10	DiseaseorSyndrome	0.30				0	0	CTD_human
val	617	BCS1L	0.534	0.808	C0751268	Encephalopathy,SubacuteNecrotizing,Juvenile	disease	C16;C18;C10	DiseaseorSyndrome	0.30				0	0	CTD_human
val	617	BCS1L	0.534	0.808	C0751651	MitochondrialDiseases	group	C18	DiseaseorSyndrome	0.33	1	2007	2019	1	0	GENOMICS_ENGLAND
val	617	BCS1L	0.534	0.808	C1838951	LEIGHSYNDROMEDUETOMITOCHONDRIALCOMPLEXIDEFICIENCY	disease	C16;C18;C10	DiseaseorSyndrome	0.30	1	1999	2017	6	0	CLINGEN
val	617	BCS1L	0.534	0.808	C1850597	LeighSyndromeDueToMitochondrialComplexIIDeficiency	disease	C16;C18;C10	DiseaseorSyndrome	0.30	1	1999	2017	6	0	CLINGEN
val	617	BCS1L	0.534	0.808	C1850598	LeighSyndromeduetoMitochondrialComplexIIIDeficiency	disease	C16;C18;C10	DiseaseorSyndrome	0.40	1	1999	2017	6	1	CLINGEN
val	617	BCS1L	0.534	0.808	C1850599	LeighSyndromeduetoMitochondrialComplexIVDeficiency	disease	C16;C18;C10	DiseaseorSyndrome	0.30	1	1999	2017	6	0	CLINGEN
val	617	BCS1L	0.534	0.808	C1850600	LeighSyndromeduetoMitochondrialComplexVDeficiency	disease	C16;C18;C10	DiseaseorSyndrome	0.30	1	1999	2017	6	0	CLINGEN
val	617	BCS1L	0.534	0.808	C1864002	GRACILESYNDROME(disorder)	disease	C23;C16;C06;C18;C13;C12	DiseaseorSyndrome	0.77	1	1998	2019	7	27	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
val	617	BCS1L	0.534	0.808	C2931891	Necrotizingencephalopathy,infantilesubacute,ofLeigh	disease	C16;C18;C10	DiseaseorSyndrome	0.30	1	1999	2017	6	0	CLINGEN
val	617	BCS1L	0.534	0.808	C3541471	MITOCHONDRIALCOMPLEXIIIDEFICIENCY,NUCLEARTYPE1	disease		DiseaseorSyndrome	0.70	1	1998	2017	11	13	CTD_human;GENOMICS_ENGLAND;UNIPROT
val	622	BDH1	0.729	0.423	C0019193	Hepatitis,Toxic	disease	C06;C25	InjuryorPoisoning	0.30	1	2014	2014	1	0	CTD_human
val	622	BDH1	0.729	0.423	C0023893	LiverCirrhosis,Experimental	disease	C23;C06	ExperimentalModelofDisease	0.30	1	2006	2014	2	0	CTD_human
val	622	BDH1	0.729	0.423	C0860207	Drug-InducedLiverDisease	phenotype	C06;C25	DiseaseorSyndrome	0.30	1	2014	2014	1	0	CTD_human
val	622	BDH1	0.729	0.423	C1262760	Hepatitis,Drug-Induced	disease	C06;C25	DiseaseorSyndrome	0.30	1	2014	2014	1	0	CTD_human
val	622	BDH1	0.729	0.423	C3658290	Drug-InducedAcuteLiverInjury	disease	C06;C25	DiseaseorSyndrome	0.30	1	2014	2014	1	0	CTD_human
val	622	BDH1	0.729	0.423	C4277682	ChemicalandDrugInducedLiverInjury	disease	C06;C25	DiseaseorSyndrome	0.30	1	2014	2014	1	0	CTD_human
val	622	BDH1	0.729	0.423	C4279912	Chemically-InducedLiverToxicity	disease	C06;C25	DiseaseorSyndrome	0.30	1	2014	2014	1	0	CTD_human
val	623	BDKRB1	0.619	0.731	C0002152	AlloxanDiabetes	disease	C18;C19	ExperimentalModelofDisease	0.30	1	2011	2011	1	0	CTD_human
val	623	BDKRB1	0.619	0.731	C0011853	DiabetesMellitus,Experimental	disease	C18;C19	ExperimentalModelofDisease	0.50	1	2002	2011	1	0	CTD_human
val	623	BDKRB1	0.619	0.731	C0014556	Epilepsy,TemporalLobe	disease	C10	DiseaseorSyndrome	0.30	1	2004	2004	1	0	CTD_human
val	623	BDKRB1	0.619	0.731	C0014558	UncinateEpilepsy	disease	C10	DiseaseorSyndrome	0.30	1	2004	2004	1	0	CTD_human
val	623	BDKRB1	0.619	0.731	C0020429	Hyperalgesia	phenotype	C23;C10	SignorSymptom	0.50	1	2003	2010	3	0	CTD_human
val	623	BDKRB1	0.619	0.731	C0021368	Inflammation	phenotype	C23	PathologicFunction	0.31	1	2005	2010	1	0	CTD_human
val	623	BDKRB1	0.619	0.731	C0030193	Pain	phenotype	C23	SignorSymptom	0.50	1	2007	2010	1	0	CTD_human
val	623	BDKRB1	0.619	0.731	C0038002	Splenomegaly	phenotype	C23	Finding	0.30	1	2010	2010	1	0	CTD_human
val	623	BDKRB1	0.619	0.731	C0038433	StreptozotocinDiabetes	disease	C18;C19	ExperimentalModelofDisease	0.30	1	2011	2011	1	0	CTD_human
val	623	BDKRB1	0.619	0.731	C0234230	Pain,Burning	phenotype	C23	SignorSymptom	0.30	1	2010	2010	1	0	CTD_human
val	623	BDKRB1	0.619	0.731	C0234238	Ache	phenotype	C23	SignorSymptom	0.30	1	2010	2010	1	0	CTD_human
val	623	BDKRB1	0.619	0.731	C0234254	Radiatingpain	phenotype	C23	SignorSymptom	0.30	1	2010	2010	1	0	CTD_human
val	623	BDKRB1	0.619	0.731	C0393672	Epilepsy,BenignPsychomotor,Childhood	disease	C10	DiseaseorSyndrome	0.30	1	2004	2004	1	0	CTD_human
val	623	BDKRB1	0.619	0.731	C0393682	Epilepsy,LateralTemporal	disease	C10	DiseaseorSyndrome	0.30	1	2004	2004	1	0	CTD_human
val	623	BDKRB1	0.619	0.731	C0458247	Allodynia	phenotype	C23;C10	Finding	0.30	1	2008	2010	3	0	CTD_human
val	623	BDKRB1	0.619	0.731	C0458257	Pain,Splitting	phenotype	C23	SignorSymptom	0.30	1	2010	2010	1	0	CTD_human
val	623	BDKRB1	0.619	0.731	C0458259	Pain,Crushing	phenotype	C23	SignorSymptom	0.30	1	2010	2010	1	0	CTD_human
val	623	BDKRB1	0.619	0.731	C0751211	Hyperalgesia,Primary	phenotype	C23;C10	SignorSymptom	0.30	1	2008	2010	3	0	CTD_human
val	623	BDKRB1	0.619	0.731	C0751212	Hyperalgesia,Secondary	phenotype	C23;C10	SignorSymptom	0.30	1	2008	2010	3	0	CTD_human
val	623	BDKRB1	0.619	0.731	C0751213	TactileAllodynia	phenotype	C23;C10	SignorSymptom	0.30	1	2008	2010	3	0	CTD_human
val	623	BDKRB1	0.619	0.731	C0751214	Hyperalgesia,Thermal	phenotype	C23;C10	SignorSymptom	0.30	1	2008	2010	3	0	CTD_human
val	623	BDKRB1	0.619	0.731	C0751407	Pain,Migratory	phenotype	C23	SignorSymptom	0.30	1	2010	2010	1	0	CTD_human
val	623	BDKRB1	0.619	0.731	C0751408	Suffering,Physical	phenotype	C23	SignorSymptom	0.30	1	2010	2010	1	0	CTD_human
val	623	BDKRB1	0.619	0.731	C2936719	MechanicalAllodynia	phenotype	C23;C10	SignorSymptom	0.30	1	2008	2010	3	0	CTD_human
val	624	BDKRB2	0.585	0.808	C0003873	RheumatoidArthritis	disease	C17;C05;C20	DiseaseorSyndrome	0.30	1	2003	2003	1	0	CTD_human
val	624	BDKRB2	0.585	0.808	C0005586	BipolarDisorder	disease	F03	MentalorBehavioralDysfunction	0.30	1	2009	2009	1	0	PSYGENET
val	624	BDKRB2	0.585	0.808	C0014556	Epilepsy,TemporalLobe	disease	C10	DiseaseorSyndrome	0.30	1	2004	2004	1	0	CTD_human
val	624	BDKRB2	0.585	0.808	C0014558	UncinateEpilepsy	disease	C10	DiseaseorSyndrome	0.30	1	2004	2004	1	0	CTD_human
val	624	BDKRB2	0.585	0.808	C0015378	ExtravasationofContrastMedia	phenotype	C23;C26	PathologicFunction	0.30	1	1998	1998	1	0	CTD_human
val	624	BDKRB2	0.585	0.808	C0019080	Hemorrhage	phenotype	C23	PathologicFunction	0.30	1	2006	2006	1	0	CTD_human
val	624	BDKRB2	0.585	0.808	C0019193	Hepatitis,Toxic	disease	C06;C25	InjuryorPoisoning	0.30	1	2019	2019	1	0	CTD_human
val	624	BDKRB2	0.585	0.808	C0020429	Hyperalgesia	phenotype	C23;C10	SignorSymptom	0.50	1	1999	2010	3	0	CTD_human
val	624	BDKRB2	0.585	0.808	C0020452	Hyperemia	disease	C14	DiseaseorSyndrome	0.30	1	2002	2002	1	0	CTD_human
val	624	BDKRB2	0.585	0.808	C0020538	Hypertensivedisease	group	C14	DiseaseorSyndrome	0.57	1	1996	2016	1	0	CTD_human
val	624	BDKRB2	0.585	0.808	C0020649	Hypotension	phenotype	C14	Finding	0.30	1	1992	2005	2	0	CTD_human
val	624	BDKRB2	0.585	0.808	C0021368	Inflammation	phenotype	C23	PathologicFunction	0.51	1	1995	2010	1	0	CTD_human
val	624	BDKRB2	0.585	0.808	C0022660	KidneyFailure,Acute	disease	C13;C12	DiseaseorSyndrome	0.30	1	2014	2014	1	0	CTD_human
val	624	BDKRB2	0.585	0.808	C0028796	Dermatitis,Occupational	disease	C17;C24	DiseaseorSyndrome	0.30	1	2019	2019	1	0	CTD_human
val	624	BDKRB2	0.585	0.808	C0030193	Pain	phenotype	C23	SignorSymptom	0.30	1	2010	2010	1	0	CTD_human
val	624	BDKRB2	0.585	0.808	C0033141	Cardiomyopathies,Primary	group	C14	DiseaseorSyndrome	0.30	1	1999	1999	1	0	CTD_human
val	624	BDKRB2	0.585	0.808	C0036529	MyocardialDiseases,Secondary	group	C14	DiseaseorSyndrome	0.30	1	1999	1999	1	0	CTD_human
val	624	BDKRB2	0.585	0.808	C0040053	Thrombosis	phenotype	C14	PathologicFunction	0.30	1	2006	2006	1	0	CTD_human
val	624	BDKRB2	0.585	0.808	C0041696	UnipolarDepression	disease	F03	MentalorBehavioralDysfunction	0.31	1	2009	2009	1	0	PSYGENET
val	624	BDKRB2	0.585	0.808	C0042484	VenousEngorgement	phenotype	C14	PathologicFunction	0.30	1	2002	2002	1	0	CTD_human
val	624	BDKRB2	0.585	0.808	C0086457	IndustrialDermatosis	disease	C17;C24	DiseaseorSyndrome	0.30	1	2019	2019	1	0	CTD_human
val	624	BDKRB2	0.585	0.808	C0087086	Thrombus	phenotype	C14	PathologicFunction	0.30	1	2006	2006	1	0	CTD_human
val	624	BDKRB2	0.585	0.808	C0178824	ReactiveHyperemia	phenotype	C14	PathologicFunction	0.30	1	2002	2002	1	0	CTD_human
val	624	BDKRB2	0.585	0.808	C0234230	Pain,Burning	phenotype	C23	SignorSymptom	0.30	1	2010	2010	1	0	CTD_human
val	624	BDKRB2	0.585	0.808	C0234238	Ache	phenotype	C23	SignorSymptom	0.30	1	2010	2010	1	0	CTD_human
val	624	BDKRB2	0.585	0.808	C0234254	Radiatingpain	phenotype	C23	SignorSymptom	0.30	1	2010	2010	1	0	CTD_human
val	624	BDKRB2	0.585	0.808	C0333233	ActiveHyperemia	phenotype	C14	PathologicFunction	0.30	1	2002	2002	1	0	CTD_human
val	624	BDKRB2	0.585	0.808	C0393672	Epilepsy,BenignPsychomotor,Childhood	disease	C10	DiseaseorSyndrome	0.30	1	2004	2004	1	0	CTD_human
val	624	BDKRB2	0.585	0.808	C0393682	Epilepsy,LateralTemporal	disease	C10	DiseaseorSyndrome	0.30	1	2004	2004	1	0	CTD_human
val	624	BDKRB2	0.585	0.808	C0458247	Allodynia	phenotype	C23;C10	Finding	0.30	1	2008	2010	3	0	CTD_human
val	624	BDKRB2	0.585	0.808	C0458257	Pain,Splitting	phenotype	C23	SignorSymptom	0.30	1	2010	2010	1	0	CTD_human
val	624	BDKRB2	0.585	0.808	C0458259	Pain,Crushing	phenotype	C23	SignorSymptom	0.30	1	2010	2010	1	0	CTD_human
val	624	BDKRB2	0.585	0.808	C0751211	Hyperalgesia,Primary	phenotype	C23;C10	SignorSymptom	0.30	1	2008	2010	3	0	CTD_human
val	624	BDKRB2	0.585	0.808	C0751212	Hyperalgesia,Secondary	phenotype	C23;C10	SignorSymptom	0.30	1	2008	2010	3	0	CTD_human
val	624	BDKRB2	0.585	0.808	C0751213	TactileAllodynia	phenotype	C23;C10	SignorSymptom	0.30	1	2008	2010	3	0	CTD_human
val	624	BDKRB2	0.585	0.808	C0751214	Hyperalgesia,Thermal	phenotype	C23;C10	SignorSymptom	0.30	1	2008	2010	3	0	CTD_human
val	624	BDKRB2	0.585	0.808	C0751407	Pain,Migratory	phenotype	C23	SignorSymptom	0.30	1	2010	2010	1	0	CTD_human
val	624	BDKRB2	0.585	0.808	C0751408	Suffering,Physical	phenotype	C23	SignorSymptom	0.30	1	2010	2010	1	0	CTD_human
val	624	BDKRB2	0.585	0.808	C0860207	Drug-InducedLiverDisease	phenotype	C06;C25	DiseaseorSyndrome	0.30	1	2019	2019	1	0	CTD_human
val	624	BDKRB2	0.585	0.808	C0878544	Cardiomyopathies	group	C14	DiseaseorSyndrome	0.30	1	1999	1999	1	0	CTD_human
val	624	BDKRB2	0.585	0.808	C1262760	Hepatitis,Drug-Induced	disease	C06;C25	DiseaseorSyndrome	0.30	1	2019	2019	1	0	CTD_human
val	624	BDKRB2	0.585	0.808	C1269683	MajorDepressiveDisorder	disease	F03	MentalorBehavioralDysfunction	0.31	1	2009	2009	1	0	PSYGENET
val	624	BDKRB2	0.585	0.808	C1565662	AcuteKidneyInsufficiency	disease	C13;C12	DiseaseorSyndrome	0.30	1	2014	2014	1	0	CTD_human
val	624	BDKRB2	0.585	0.808	C2609414	Acutekidneyinjury	disease	C13;C12	InjuryorPoisoning	0.30	1	2014	2014	1	0	CTD_human
val	624	BDKRB2	0.585	0.808	C2936719	MechanicalAllodynia	phenotype	C23;C10	SignorSymptom	0.31	1	2008	2018	3	0	CTD_human
val	624	BDKRB2	0.585	0.808	C3658290	Drug-InducedAcuteLiverInjury	disease	C06;C25	DiseaseorSyndrome	0.30	1	2019	2019	1	0	CTD_human
val	624	BDKRB2	0.585	0.808	C4277682	ChemicalandDrugInducedLiverInjury	disease	C06;C25	DiseaseorSyndrome	0.30	1	2019	2019	1	0	CTD_human
val	624	BDKRB2	0.585	0.808	C4279912	Chemically-InducedLiverToxicity	disease	C06;C25	DiseaseorSyndrome	0.30	1	2019	2019	1	0	CTD_human
val	627	BDNF	0.345	0.923	C0001969	AlcoholicIntoxication	disease	C25;F03	MentalorBehavioralDysfunction	0.30	1	2001	2001	1	0	PSYGENET
val	627	BDNF	0.345	0.923	C0001973	AlcoholicIntoxication,Chronic	disease	C25;F03	MentalorBehavioralDysfunction	0.40	0.4	2004	2020	5	0	PSYGENET
val	627	BDNF	0.345	0.923	C0002395	AlzheimersDisease	disease	C10;F03	DiseaseorSyndrome	0.6	0.958	1991	2020	1	0	CTD_human
2187	627	BDNF	0.345	0.923	C0005586	BipolarDisorder	disease	F03	MentalorBehavioralDysfunction	0.6	1	2002	2019	7	0	CTD_human;PSYGENET
2195	627	BDNF	0.345	0.923	C0011570	MentalDepression	disease	F01	MentalorBehavioralDysfunction	0.6	1	2003	2020	5	0	PSYGENET
2197	627	BDNF	0.345	0.923	C0011581	Depressivedisorder	disease	F03	MentalorBehavioralDysfunction	0.6	1	2003	2020	7	0	CTD_human;PSYGENET
2203	627	BDNF	0.345	0.923	C0021368	Inflammation	phenotype	C23	PathologicFunction	0.53	1	2003	2010	1	0	CTD_human
2220	627	BDNF	0.345	0.923	C0038220	StatusEpilepticus	disease	C23;C10	DiseaseorSyndrome	0.56	1	1996	2019	2	0	CTD_human
2224	627	BDNF	0.345	0.923	C0041696	UnipolarDepression	disease	F03	MentalorBehavioralDysfunction	0.6	1	2005	2020	7	0	CTD_human;PSYGENET
2267	640	BLK	0.585	0.769	C0024141	LupusErythematosus,Systemic	disease	C17;C20	DiseaseorSyndrome	0.7	0.976	2008	2020	7	9	CTD_human;ORPHANET
2270	640	BLK	0.585	0.769	C0342276	Maturityonsetdiabetesmellitusinyoung	disease	C18;C19	DiseaseorSyndrome	0.62	1	2009	2013	1	0	GENOMICS_ENGLAND;ORPHANET
2271	640	BLK	0.585	0.769	C3150618	Maturity-onsetdiabetesoftheyoung,type11	disease	C18;C19	DiseaseorSyndrome	0.6	NA	NA	NA	0	1	CTD_human;GENOMICS_ENGLAND
2273	641	BLM	0.535	0.808	C0005859	BloomSyndrome	disease	C16;C18;C20	DiseaseorSyndrome	1	0.994	1994	2020	10	126	CLINGEN;CTD_human;GENOMICS_ENGLAND;UNIPROT
2278	641	BLM	0.535	0.808	C0023418	leukemia	disease	C04	NeoplasticProcess	0.61	1	2005	2017	1	0	CGI;GENOMICS_ENGLAND
2282	641	BLM	0.535	0.808	C0024299	Lymphoma	group	C04;C20;C15	NeoplasticProcess	0.61	1	2002	2017	1	0	CGI;GENOMICS_ENGLAND
2293	644	BLVRA	0.663	0.423	C3279964	Hyperbiliverdinemia	disease	C06	DiseaseorSyndrome	0.61	1	2009	2011	1	2	CTD_human;ORPHANET
2322	649	BMP1	0.554	0.769	C3553887	OSTEOGENESISIMPERFECTA,TYPEXIII	disease		DiseaseorSyndrome	0.71	1	2012	2019	4	6	CTD_human;GENOMICS_ENGLAND;UNIPROT
2346	650	BMP2	0.432	0.846	C1832702	BRACHYDACTYLY,TYPEA2	disease	C16;C05	CongenitalAbnormality	0.75	1	2005	2018	4	0	CTD_human;GENOMICS_ENGLAND;ORPHANET
2365	652	BMP4	0.422	0.808	C0033375	Prolactinoma	disease	C04;C10;C19	NeoplasticProcess	0.54	1	2003	2020	1	0	CTD_human
2379	652	BMP4	0.422	0.808	C1864689	MICROPHTHALMIA,SYNDROMIC6(disorder)	disease	C16;C13;C11;C05;C12;C10	DiseaseorSyndrome	0.7	1	1986	2013	4	2	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
2381	652	BMP4	0.422	0.808	C2677434	OROFACIALCLEFT11	disease	C16;C05;C07	DiseaseorSyndrome	0.71	1	1986	2009	3	5	CTD_human;GENOMICS_ENGLAND;UNIPROT
2413	657	BMPR1A	0.522	0.731	C0345893	Juvenilepolyposissyndrome	disease	C16;C06;C04	NeoplasticProcess	1	0.978	1993	2019	12	49	CLINGEN;CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
2417	657	BMPR1A	0.522	0.731	C1832940	JUVENILEPOLYPOSISOFSTOMACH	disease	C16;C06;C04	DiseaseorSyndrome	0.8	1	2001	2009	5	0	CLINGEN;CTD_human;ORPHANET
2419	657	BMPR1A	0.522	0.731	C1868081	JuvenilePolyposisColi	disease	C16;C06;C04	DiseaseorSyndrome	0.8	1	2001	2009	5	0	CLINGEN;CTD_human;ORPHANET
2437	658	BMPR1B	0.573	0.615	C1832702	BRACHYDACTYLY,TYPEA2	disease	C16;C05	CongenitalAbnormality	0.76	0.875	2003	2014	3	4	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
2444	658	BMPR1B	0.573	0.615	C4225183	BRACHYDACTYLY,TYPEA1,D	disease		DiseaseorSyndrome	0.7	1	2015	2015	1	3	CTD_human;GENOMICS_ENGLAND;UNIPROT
2445	658	BMPR1B	0.573	0.615	C4225404	ACROMESOMELICDYSPLASIA,DEMIRHANTYPE	disease		DiseaseorSyndrome	0.6	1	2005	2015	3	5	GENOMICS_ENGLAND;UNIPROT
2450	659	BMPR2	0.538	0.654	C0034091	PulmonaryVeno-OcclusiveDisease(disorder)	disease	C08;C14	DiseaseorSyndrome	0.72	1	2003	2016	3	1	CTD_human;GENOMICS_ENGLAND;ORPHANET
2451	659	BMPR2	0.538	0.654	C0152171	Idiopathicpulmonaryhypertension	disease	C08;C14	DiseaseorSyndrome	0.6	1	2000	2019	1	0	GENOMICS_ENGLAND
2453	659	BMPR2	0.538	0.654	C0340543	Familialprimarypulmonaryhypertension	disease	C08	DiseaseorSyndrome	0.7	1	1997	2019	4	0	CTD_human;GENOMICS_ENGLAND;ORPHANET
2463	659	BMPR2	0.538	0.654	C3203102	Idiopathicpulmonaryarterialhypertension	disease	C08	DiseaseorSyndrome	0.7	0.978	2000	2020	2	0	CTD_human;GENOMICS_ENGLAND
2467	659	BMPR2	0.538	0.654	C4552070	PulmonaryHypertension,Primary,1	disease	C08	DiseaseorSyndrome	0.7	1	2000	2018	12	308	CTD_human;GENOMICS_ENGLAND;UNIPROT
2479	667	DST	0.552	0.846	C3539003	NEUROPATHY,HEREDITARYSENSORYANDAUTONOMIC,TYPEVI	disease		DiseaseorSyndrome	0.71	1	2010	2017	2	10	CTD_human;GENOMICS_ENGLAND;ORPHANET
2480	667	DST	0.552	0.846	C3809470	EPIDERMOLYSISBULLOSASIMPLEX,AUTOSOMALRECESSIVE2	disease		DiseaseorSyndrome	0.6	1	2010	2015	3	6	GENOMICS_ENGLAND;ORPHANET
2484	668	FOXL2	0.542	0.692	C0220663	BLEPHAROPHIMOSIS,PTOSIS,ANDEPICANTHUSINVERSUS(disorder)	disease	C16;C13;C11;C17;C12	DiseaseorSyndrome	1	1	1995	2020	13	90	CTD_human;GENOMICS_ENGLAND;UNIPROT
2489	668	FOXL2	0.542	0.692	C1837008	PREMATUREOVARIANFAILURE3(disorder)	disease	C13;C19	DiseaseorSyndrome	0.7	1	2002	2009	2	4	CTD_human;GENOMICS_ENGLAND;UNIPROT
2496	669	BPGM	0.821	0.154	C1291620	Deficiencyofbisphosphoglyceratemutase	disease	C16;C18	DiseaseorSyndrome	0.7	1	1989	2004	3	3	CTD_human;ORPHANET;UNIPROT
2497	672	BRCA1	0.367	0.923	C0006142	Malignantneoplasmofbreast	disease	C04;C17	NeoplasticProcess	1	0.956	1992	2020	34	160	CGI;CTD_human;GENOMICS_ENGLAND;UNIPROT
2498	672	BRCA1	0.367	0.923	C0006826	MalignantNeoplasms	group	C04	NeoplasticProcess	0.6	0.968	1993	2020	1	0	CGI;CTD_human
2505	672	BRCA1	0.367	0.923	C0015625	FanconiAnemia	disease	C16;C18;C15	DiseaseorSyndrome	0.6	1	2001	2020	4	0	GENOMICS_ENGLAND;ORPHANET
2513	672	BRCA1	0.367	0.923	C0030297	PancreaticNeoplasm	disease	C06;C04;C19	NeoplasticProcess	0.62	1	2005	2015	1	0	CGI;CTD_human
2525	672	BRCA1	0.367	0.923	C0346647	Malignantneoplasmofpancreas	disease	C06;C04;C19	NeoplasticProcess	0.6	1	1997	2020	1	0	CGI;CTD_human
2531	672	BRCA1	0.367	0.923	C0677776	HereditaryBreastandOvarianCancerSyndrome	disease	C16;C04;C13;C17;C19	NeoplasticProcess	0.8	0.986	1990	2020	5	873	CTD_human;GENOMICS_ENGLAND;ORPHANET
2532	672	BRCA1	0.367	0.923	C0678222	BreastCarcinoma	disease	C04;C17	NeoplasticProcess	0.7	0.955	1992	2020	12	5	CGI;CTD_human
2534	672	BRCA1	0.367	0.923	C0919267	ovarianneoplasm	disease	C04;C13;C19	NeoplasticProcess	0.7	0.965	1992	2020	5	67	CGI;CTD_human
2535	672	BRCA1	0.367	0.923	C1140680	Malignantneoplasmofovary	disease	C04;C13;C19	NeoplasticProcess	0.8	0.965	1992	2020	9	15	CGI;CTD_human;GENOMICS_ENGLAND;UNIPROT
2541	672	BRCA1	0.367	0.923	C2676676	BREAST-OVARIANCANCER,FAMILIAL,SUSCEPTIBILITYTO,1	disease		Finding	0.7	1	1976	2019	16	2258	CLINGEN;CTD_human;GENOMICS_ENGLAND;UNIPROT
2551	672	BRCA1	0.367	0.923	C4554406	FANCONIANEMIA,COMPLEMENTATIONGROUPS	disease		DiseaseorSyndrome	0.7	1	2013	2019	7	28	CLINGEN;GENOMICS_ENGLAND;UNIPROT
2565	673	BRAF	0.319	0.846	C0009402	ColorectalCarcinoma	disease	C06;C04	NeoplasticProcess	0.7	0.976	2002	2020	8	5	CTD_human;UNIPROT
2567	673	BRAF	0.319	0.846	C0010276	Craniopharyngioma	disease	C04	NeoplasticProcess	0.6	1	2014	2019	1	0	CTD_human;ORPHANET
2569	673	BRAF	0.319	0.846	C0017638	Glioma	disease	C04	NeoplasticProcess	0.6	1	2005	2020	1	0	CGI;CTD_human
2571	673	BRAF	0.319	0.846	C0019621	Histiocytosis,Langerhans-Cell	disease	C08;C15	NeoplasticProcess	0.8	1	2010	2019	1	0	CGI;ORPHANET
2575	673	BRAF	0.319	0.846	C0023443	HairyCellLeukemia	disease	C04;C20;C15	NeoplasticProcess	0.6	0.938	2011	2020	2	0	CGI;ORPHANET
2578	673	BRAF	0.319	0.846	C0024121	LungNeoplasms	group	C04;C08	NeoplasticProcess	0.55	1	2004	2017	0	0	CGI;CTD_human
2584	673	BRAF	0.319	0.846	C0025202	melanoma	disease	C04	NeoplasticProcess	1	0.983	1986	2020	24	31	CGI;CTD_human;UNIPROT
2589	673	BRAF	0.319	0.846	C0028326	NoonanSyndrome	disease	C16;C17;C05;C14	DiseaseorSyndrome	0.77	1	2003	2019	8	18	CLINGEN;CTD_human;GENOMICS_ENGLAND;ORPHANET
2594	673	BRAF	0.319	0.846	C0040136	ThyroidNeoplasm	disease	C04;C19	NeoplasticProcess	0.7	0.99	2003	2020	6	3	CGI;CTD_human
2599	673	BRAF	0.319	0.846	C0152013	Adenocarcinomaoflung(disorder)	disease	C04	NeoplasticProcess	0.7	1	2002	2019	2	14	CGI;CTD_human
2603	673	BRAF	0.319	0.846	C0175704	LEOPARDSyndrome	disease	C16;C17;C05;C14	DiseaseorSyndrome	0.65	1	2009	2017	6	2	CLINGEN;GENOMICS_ENGLAND
2610	673	BRAF	0.319	0.846	C0238463	Papillarythyroidcarcinoma	disease	C04;C19	NeoplasticProcess	0.9	0.968	2003	2020	8	1	CTD_human;ORPHANET
2611	673	BRAF	0.319	0.846	C0242379	Malignantneoplasmoflung	disease	C04;C08	NeoplasticProcess	0.6	1	2002	2020	0	0	CGI;CTD_human
2617	673	BRAF	0.319	0.846	C0334579	Anaplasticastrocytoma	disease	C04	NeoplasticProcess	0.51	1	2013	2015	1	0	CGI;CTD_human
2621	673	BRAF	0.319	0.846	C0334583	PilocyticAstrocytoma	disease	C04	NeoplasticProcess	0.6	0.957	2008	2020	1	0	CGI;CTD_human
2633	673	BRAF	0.319	0.846	C0549473	Thyroidcarcinoma	disease	C04;C19	NeoplasticProcess	0.6	0.99	2003	2019	6	0	CGI;CTD_human
2635	673	BRAF	0.319	0.846	C0587248	Costellosyndrome(disorder)	disease	C16;C05	DiseaseorSyndrome	0.54	1	2006	2016	2	0	CLINGEN;CTD_human
2638	673	BRAF	0.319	0.846	C0684249	Carcinomaoflung	disease	C04;C08	NeoplasticProcess	0.7	1	2002	2019	1	12	CGI;UNIPROT
2650	673	BRAF	0.319	0.846	C1140680	Malignantneoplasmofovary	disease	C04;C13;C19	NeoplasticProcess	0.6	0.941	2003	2019	0	1	CGI;UNIPROT
2652	673	BRAF	0.319	0.846	C1275081	Cardio-facio-cutaneoussyndrome	disease	C23;C16;C17;C14	CongenitalAbnormality	1	0.972	2003	2019	14	48	CLINGEN;CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
2653	673	BRAF	0.319	0.846	C1319315	Adenocarcinomaoflargeintestine	disease	C06;C04	NeoplasticProcess	0.6	1	2011	2019	0	3	CGI;UNIPROT
2660	673	BRAF	0.319	0.846	C3150970	NOONANSYNDROME7	disease		DiseaseorSyndrome	0.7	1	2006	2017	5	8	CTD_human;GENOMICS_ENGLAND;UNIPROT
2661	673	BRAF	0.319	0.846	C3150971	LEOPARDSYNDROME3	disease		DiseaseorSyndrome	0.7	1	2006	2013	4	5	CTD_human;GENOMICS_ENGLAND;UNIPROT
2671	675	BRCA2	0.379	0.846	C0006142	Malignantneoplasmofbreast	disease	C04;C17	NeoplasticProcess	1	0.951	1994	2020	30	174	CGI;CTD_human;GENOMICS_ENGLAND;UNIPROT
2675	675	BRCA2	0.379	0.846	C0024121	LungNeoplasms	group	C04;C08	NeoplasticProcess	0.6	1	2014	2014	1	0	CGI;CTD_human
2676	675	BRCA2	0.379	0.846	C0025149	Medulloblastoma	disease	C04	NeoplasticProcess	0.63	1	2003	2018	3	22	CTD_human;GENOMICS_ENGLAND
2678	675	BRCA2	0.379	0.846	C0027708	Nephroblastoma	disease	C16;C04;C13;C12	NeoplasticProcess	0.72	1	2005	2018	4	22	CTD_human;GENOMICS_ENGLAND;ORPHANET
2680	675	BRCA2	0.379	0.846	C0030297	PancreaticNeoplasm	disease	C06;C04;C19	NeoplasticProcess	0.65	0.857	2003	2017	2	0	CGI;CTD_human
2682	675	BRCA2	0.379	0.846	C0033578	ProstaticNeoplasms	group	C04;C12	NeoplasticProcess	0.58	1	2000	2018	1	0	CTD_human
2686	675	BRCA2	0.379	0.846	C0242379	Malignantneoplasmoflung	disease	C04;C08	NeoplasticProcess	0.8	0.833	2007	2018	1	1	CGI;CTD_human;UNIPROT
2692	675	BRCA2	0.379	0.846	C0346647	Malignantneoplasmofpancreas	disease	C06;C04;C19	NeoplasticProcess	0.8	0.988	1996	2019	2	4	CGI;CTD_human;UNIPROT
2694	675	BRCA2	0.379	0.846	C0376358	Malignantneoplasmofprostate	disease	C04;C12	NeoplasticProcess	0.9	0.948	1996	2020	5	24	CTD_human;GENOMICS_ENGLAND
2698	675	BRCA2	0.379	0.846	C0677776	HereditaryBreastandOvarianCancerSyndrome	disease	C16;C04;C13;C17;C19	NeoplasticProcess	0.8	0.993	1990	2020	4	1160	CTD_human;GENOMICS_ENGLAND;ORPHANET
2699	675	BRCA2	0.379	0.846	C0678222	BreastCarcinoma	disease	C04;C17	NeoplasticProcess	0.7	0.95	1994	2020	3	9	CGI;CTD_human
2705	675	BRCA2	0.379	0.846	C0919267	ovarianneoplasm	disease	C04;C13;C19	NeoplasticProcess	0.9	0.947	1994	2020	1	38	CGI;CTD_human
2706	675	BRCA2	0.379	0.846	C1140680	Malignantneoplasmofovary	disease	C04;C13;C19	NeoplasticProcess	0.8	0.948	1994	2020	1	10	CGI;CTD_human;GENOMICS_ENGLAND;UNIPROT
2710	675	BRCA2	0.379	0.846	C1838457	FANCONIANEMIA,COMPLEMENTATIONGROUPD1	disease	C16;C18;C15	DiseaseorSyndrome	0.92	1	2002	2018	14	37	CLINGEN;CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
2712	675	BRCA2	0.379	0.846	C2675520	BREAST-OVARIANCANCER,FAMILIAL,SUSCEPTIBILITYTO,2	disease		Finding	0.7	1	1988	2019	13	2632	CLINGEN;CTD_human;GENOMICS_ENGLAND
2749	686	BTD	0.628	0.654	C0220754	BiotinidaseDeficiency	disease	C16;C18	DiseaseorSyndrome	1	0.988	1993	2019	13	187	CLINGEN;CTD_human;GENOMICS_ENGLAND;UNIPROT
2764	688	KLF5	0.534	0.769	C0009402	ColorectalCarcinoma	disease	C06;C04	NeoplasticProcess	0.64	1	2011	2019	1	1	CTD_human;UNIPROT
2785	695	BTK	0.464	0.808	C0221026	X-linkedagammaglobulinemia	disease	C16;C20;C15	DiseaseorSyndrome	1	0.964	1975	2020	27	68	CTD_human;GENOMICS_ENGLAND;UNIPROT
2787	695	BTK	0.464	0.808	C0472813	X-linkedagammaglobulinemiawithgrowthhormonedeficiency	disease	C16;C05;C20;C10;C19;C15	DiseaseorSyndrome	0.7	1	1994	2017	4	17	CTD_human;GENOMICS_ENGLAND;ORPHANET
2791	699	BUB1	0.528	0.731	C0009402	ColorectalCarcinoma	disease	C06;C04	NeoplasticProcess	0.7	1	2000	2018	0	4	CTD_human;UNIPROT
2797	701	BUB1B	0.502	0.808	C0009402	ColorectalCarcinoma	disease	C06;C04	NeoplasticProcess	0.54	1	2002	2016	0	1	CTD_human;UNIPROT
2811	701	BUB1B	0.502	0.808	C1850343	Mosaicvariegatedaneuploidysyndrome1	disease	C16	DiseaseorSyndrome	1	1	2004	2019	6	15	CLINGEN;CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
2812	701	BUB1B	0.502	0.808	C1864389	PREMATURECHROMATIDSEPARATIONTRAIT	disease		DiseaseorSyndrome	0.64	1	2006	2014	1	8	CTD_human;UNIPROT
2831	708	C1QBP	0.569	0.692	C4540209	COMBINEDOXIDATIVEPHOSPHORYLATIONDEFICIENCY33	disease		DiseaseorSyndrome	0.6	1	2017	2017	1	6	GENOMICS_ENGLAND;UNIPROT
2834	710	SERPING1	0.507	0.769	C0019243	Angioedemas,Hereditary	disease	C16;C17;C20;C14	DiseaseorSyndrome	0.6	0.991	1971	2020	7	0	CTD_human;GENOMICS_ENGLAND
2846	710	SERPING1	0.507	0.769	C1852700	ComplementComponent4,PartialDeficiencyOf	disease	C16;C20	DiseaseorSyndrome	0.6	1	1995	1995	1	0	CTD_human;GENOMICS_ENGLAND;ORPHANET
2849	710	SERPING1	0.507	0.769	C2717906	HereditaryAngioedemaTypeI	disease	C17;C20;C14	DiseaseorSyndrome	0.73	0.958	1988	2018	19	35	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
2859	712	C1QA	0.623	0.654	C0024141	LupusErythematosus,Systemic	disease	C17;C20	DiseaseorSyndrome	0.67	0.7	1996	2012	1	0	CTD_human
2865	712	C1QA	0.623	0.654	C3150902	C1qDEFICIENCY	disease		DiseaseorSyndrome	0.61	1	2012	2017	1	2	CTD_human;GENOMICS_ENGLAND
2880	713	C1QB	0.711	0.538	C3150902	C1qDEFICIENCY	disease		DiseaseorSyndrome	0.71	1	1997	2015	2	2	CTD_human;GENOMICS_ENGLAND;UNIPROT
2883	714	C1QC	0.751	0.423	C3150902	C1qDEFICIENCY	disease		DiseaseorSyndrome	0.7	1	1996	1996	1	4	CTD_human;GENOMICS_ENGLAND;UNIPROT
2890	715	C1R	0.638	0.654	C4551499	EHLERS-DANLOSSYNDROME,PERIODONTALTYPE,1	disease	C16;C17;C15;C14	DiseaseorSyndrome	0.6	1	2016	2017	2	12	GENOMICS_ENGLAND;UNIPROT
2900	716	C1S	0.705	0.462	C3151078	ComplementComponentC1sDeficiency	disease	C16;C20	DiseaseorSyndrome	0.6	1	2010	2010	1	1	CTD_human;GENOMICS_ENGLAND
2901	716	C1S	0.705	0.462	C4310681	EHLERS-DANLOSSYNDROME,PERIODONTALTYPE,2	disease		DiseaseorSyndrome	0.7	1	2016	2017	2	2	CTD_human;GENOMICS_ENGLAND;UNIPROT
2909	717	C2	0.617	0.692	C0242383	Agerelatedmaculardegeneration	disease	C11	DiseaseorSyndrome	0.68	1	2006	2018	1	0	CTD_human;GENOMICS_ENGLAND
2913	717	C2	0.617	0.692	C3150275	COMPLEMENTCOMPONENT2DEFICIENCY	disease		DiseaseorSyndrome	0.77	0.9	1975	2010	3	0	CTD_human;GENOMICS_ENGLAND;UNIPROT
2934	718	C3	0.445	0.885	C0242383	Agerelatedmaculardegeneration	disease	C11	DiseaseorSyndrome	0.7	1	2007	2020	4	2	CTD_human;GENOMICS_ENGLAND
2956	718	C3	0.445	0.885	C1332655	Complementcomponent3deficiency	disease		DiseaseorSyndrome	0.63	1	1972	2013	1	1	GENOMICS_ENGLAND
2962	718	C3	0.445	0.885	C2752037	HEMOLYTICUREMICSYNDROME,ATYPICAL,SUSCEPTIBILITYTO,5	disease		Finding	0.6	1	2005	2016	4	8	GENOMICS_ENGLAND;UNIPROT
2963	718	C3	0.445	0.885	C2931788	AtypicalHemolyticUremicSyndrome	disease	C13;C12;C15	DiseaseorSyndrome	0.6	1	2008	2019	1	0	CTD_human;GENOMICS_ENGLAND
2964	718	C3	0.445	0.885	C3151071	COMPLEMENTCOMPONENT3DEFICIENCY,AUTOSOMALRECESSIVE	disease	C16;C20	DiseaseorSyndrome	0.7	1	1972	2016	5	2	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
2972	720	C4A	0.563	0.769	C0024141	LupusErythematosus,Systemic	disease	C17;C20	DiseaseorSyndrome	0.7	0.957	1987	2018	6	0	ORPHANET
2974	720	C4A	0.563	0.769	C3280642	ComplementComponent4aDeficiency	disease	C16;C20	DiseaseorSyndrome	0.55	1	1990	2016	1	0	CTD_human;GENOMICS_ENGLAND
2979	721	C4B	0.603	0.808	C0024141	LupusErythematosus,Systemic	disease	C17;C20	DiseaseorSyndrome	0.6	0.944	1985	2019	7	0	ORPHANET
2982	721	C4B	0.603	0.808	C3280641	DecreasedserumcomplementC4b	disease		DiseaseorSyndrome	0.63	1	1992	2016	1	0	CTD_human;GENOMICS_ENGLAND
2983	726	CAPN5	0.663	0.615	C0242852	Proliferativevitreoretinopathy	disease	C11	DiseaseorSyndrome	0.71	1	2012	2019	1	3	CTD_human;ORPHANET;UNIPROT
2990	727	C5	0.55	0.731	C0343047	Complementcomponent5deficiency	disease	C16;C20	DiseaseorSyndrome	0.61	1	1977	2015	1	5	CTD_human;GENOMICS_ENGLAND
3002	729	C6	0.7	0.615	C2676232	ComplementComponent6Deficiency	disease	C16;C20	DiseaseorSyndrome	0.62	1	1987	2012	1	3	CTD_human;GENOMICS_ENGLAND
3005	730	C7	0.751	0.423	C1864694	ComplementComponent7Deficiency	disease	C16;C20	DiseaseorSyndrome	0.72	1	1989	2007	4	8	CTD_human;GENOMICS_ENGLAND;UNIPROT
3020	732	C8B	0.76	0.269	C3151080	COMPLEMENTCOMPONENT8DEFICIENCY,TYPEII	disease		DiseaseorSyndrome	0.62	1	1990	2009	1	7	CTD_human;GENOMICS_ENGLAND
3051	735	C9	0.619	0.692	C3151189	C9Deficiency	disease	C16;C20	DiseaseorSyndrome	0.75	1	1998	2017	2	5	CTD_human;GENOMICS_ENGLAND;UNIPROT
3052	735	C9	0.619	0.692	C3810042	MACULARDEGENERATION,AGE-RELATED,15	disease		DiseaseorSyndrome	0.6	1	2013	2013	1	1	CTD_human;UNIPROT
3060	745	MYRF	0.584	0.731	C4748946	CARDIAC-UROGENITALSYNDROME	disease		DiseaseorSyndrome	0.6	1	2018	2018	3	1	GENOMICS_ENGLAND;UNIPROT
3063	755	CFAP410	0.633	0.615	C0002736	AmyotrophicLateralSclerosis	disease	C18;C10	DiseaseorSyndrome	0.62	1	2016	2019	2	1	CTD_human;ORPHANET
3067	755	CFAP410	0.633	0.615	C1865695	Spondylometaphysealdysplasia,axial	disease	C16;C05	DiseaseorSyndrome	0.63	1	2013	2017	5	8	GENOMICS_ENGLAND;UNIPROT
3094	760	CA2	0.506	0.808	C0345407	OSTEOPETROSIS,AUTOSOMALRECESSIVE3	disease	C16;C18;C13;C05;C12;C10	DiseaseorSyndrome	0.99	1	1985	2020	6	5	CTD_human;GENOMICS_ENGLAND;UNIPROT
3113	762	CA4	0.674	0.577	C1833245	RetinitisPigmentosa17	disease	C16;C11	DiseaseorSyndrome	0.74	1	2000	2010	4	4	CTD_human;GENOMICS_ENGLAND;UNIPROT
3114	763	CA5A	0.686	0.5	C3810404	CARBONICANHYDRASEVADEFICIENCY,HYPERAMMONEMIADUETO	disease		DiseaseorSyndrome	0.7	1	1995	2016	4	4	CLINGEN;CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
3119	767	CA8	0.595	0.654	C2750509	CerebellarAtaxia,MentalRetardation,AndDysequilibriumSyndrome3	disease	C23;C10;F03;F01	DiseaseorSyndrome	0.9	1	2005	2016	3	4	CTD_human;GENOMICS_ENGLAND;UNIPROT
3134	771	CA12	0.592	0.731	C1840437	Isolatedhyperchlorhidrosis	phenotype		Finding	0.7	1	2010	2016	3	5	CTD_human;ORPHANET;UNIPROT
3139	773	CACNA1A	0.489	0.769	C0014553	AbsenceEpilepsy	disease	C10	DiseaseorSyndrome	0.76	1	1996	2020	2	0	CTD_human;GENOMICS_ENGLAND
3156	773	CACNA1A	0.489	0.769	C0752124	SpinocerebellarAtaxiaType6(disorder)	disease	C16;C10	DiseaseorSyndrome	1	0.986	1997	2019	12	11	CTD_human;GENOMICS_ENGLAND;UNIPROT
3158	773	CACNA1A	0.489	0.769	C1720416	Episodicataxiatype2(disorder)	disease	C23;C11;C10	DiseaseorSyndrome	1	0.988	1996	2019	21	60	CTD_human;GENOMICS_ENGLAND;UNIPROT
3159	773	CACNA1A	0.489	0.769	C1832884	Hemiplegicmigraine,familialtype1	disease	C23;C10	DiseaseorSyndrome	0.8	0.966	1996	2018	15	21	CTD_human;GENOMICS_ENGLAND;UNIPROT
3162	773	CACNA1A	0.489	0.769	C4310716	EPILEPTICENCEPHALOPATHY,EARLYINFANTILE,42	disease		DiseaseorSyndrome	0.7	1	1996	2017	4	28	CTD_human;GENOMICS_ENGLAND;UNIPROT
3179	775	CACNA1C	0.51	0.846	C0005586	BipolarDisorder	disease	F03	MentalorBehavioralDysfunction	0.7	0.8	2008	2020	9	6	CTD_human;PSYGENET
3208	775	CACNA1C	0.51	0.846	C1142166	BrugadaSyndrome(disorder)	disease	C16;C14	DiseaseorSyndrome	0.57	1	1993	2019	7	0	CLINGEN;GENOMICS_ENGLAND
3209	775	CACNA1C	0.51	0.846	C1269683	MajorDepressiveDisorder	disease	F03	MentalorBehavioralDysfunction	0.7	1	2010	2019	6	19	CTD_human;PSYGENET
3214	775	CACNA1C	0.51	0.846	C1832916	Timothysyndrome	disease	C23;C16;C05;F03;C14	DiseaseorSyndrome	1	0.969	2004	2019	8	5	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
3215	775	CACNA1C	0.51	0.846	C2678478	BrugadaSyndrome3	disease	C16;C14	DiseaseorSyndrome	0.7	1	2007	2018	5	2	CTD_human;GENOMICS_ENGLAND;UNIPROT
3242	776	CACNA1D	0.582	0.577	C3554018	SINOATRIALNODEDYSFUNCTIONANDDEAFNESS	disease	C23;C14	DiseaseorSyndrome	0.72	1	2004	2019	5	2	CLINGEN;GENOMICS_ENGLAND;ORPHANET
3244	776	CACNA1D	0.582	0.577	C3809609	PRIMARYALDOSTERONISM,SEIZURES,ANDNEUROLOGICABNORMALITIES	disease		DiseaseorSyndrome	0.71	1	2013	2018	2	2	GENOMICS_ENGLAND;ORPHANET;UNIPROT
3252	777	CACNA1E	0.65	0.577	C4748988	EPILEPTICENCEPHALOPATHY,EARLYINFANTILE,69	disease		DiseaseorSyndrome	0.6	1	2018	2018	1	8	GENOMICS_ENGLAND;UNIPROT
3255	778	CACNA1F	0.595	0.5	C0268505	Ocularalbinism,typeII	disease	C16;C18;C11;C17	DiseaseorSyndrome	0.76	1	1989	2019	3	3	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
3256	778	CACNA1F	0.595	0.5	C0339535	Nightblindness,congenitalstationary	disease	C16;C11	CongenitalAbnormality	0.7	1	1993	2018	0	12	CTD_human;GENOMICS_ENGLAND
3257	778	CACNA1F	0.595	0.5	C1845407	CONE-RODDYSTROPHY,X-LINKED,3	disease	C16;C11	DiseaseorSyndrome	0.61	1	2009	2015	1	3	CTD_human;GENOMICS_ENGLAND
3258	778	CACNA1F	0.595	0.5	C1848172	NIGHTBLINDNESS,CONGENITALSTATIONARY,TYPE2A	disease	C16;C11	DiseaseorSyndrome	1	1	1998	2019	8	9	CTD_human;GENOMICS_ENGLAND;UNIPROT
3269	779	CACNA1S	0.595	0.692	C0238358	Hypokalemicperiodicparalysis	disease	C16;C18;C05;C10	DiseaseorSyndrome	0.7	1	1994	2018	2	5	CTD_human
3273	779	CACNA1S	0.595	0.692	C1866077	MALIGNANTHYPERTHERMIA,SUSCEPTIBILITYTO,5	phenotype		Finding	0.6	1	1994	2015	2	11	GENOMICS_ENGLAND;UNIPROT
3274	779	CACNA1S	0.595	0.692	C2749982	THYROTOXICPERIODICPARALYSIS,SUSCEPTIBILITYTO,1	disease		Finding	0.6	NA	NA	NA	0	1	CTD_human;GENOMICS_ENGLAND
3276	779	CACNA1S	0.595	0.692	C3714580	Hypokalemicperiodicparalysistype1	disease		DiseaseorSyndrome	0.8	0.974	1994	2018	6	14	CTD_human;GENOMICS_ENGLAND;UNIPROT
3324	781	CACNA2D1	0.641	0.5	C1142166	BrugadaSyndrome(disorder)	disease	C16;C14	DiseaseorSyndrome	0.62	1	2005	2015	6	0	CLINGEN;GENOMICS_ENGLAND;ORPHANET
3339	783	CACNB2	0.659	0.538	C1142166	BrugadaSyndrome(disorder)	disease	C16;C14	DiseaseorSyndrome	0.51	1	2000	2012	7	0	CLINGEN;GENOMICS_ENGLAND
3341	783	CACNB2	0.659	0.538	C2678477	BrugadaSyndrome4	disease	C16;C14	DiseaseorSyndrome	0.7	1	2005	2016	3	2	CTD_human;GENOMICS_ENGLAND;UNIPROT
3354	785	CACNB4	0.653	0.231	C0270853	JuvenileMyoclonicEpilepsy	disease	C10	DiseaseorSyndrome	0.51	1	2000	2014	2	0	CTD_human;ORPHANET
3366	785	CACNB4	0.653	0.231	C1866039	EPISODICATAXIA,TYPE5	disease	C23;C10	DiseaseorSyndrome	0.7	1	2000	2008	2	1	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
3373	788	SLC25A20	0.563	0.769	C0342791	Carnitine-AcylcarnitineTranslocaseDeficiency	disease	C16;C18	DiseaseorSyndrome	0.77	1	1997	2019	12	15	CLINGEN;CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
3392	801	CALM1	0.472	0.808	C0750900	AlzheimersDisease,FocalOnset	disease	C10;F03	MentalorBehavioralDysfunction	0.30	1	2001	2001	1	0	CTD_human
val	801	CALM1	0.472	0.808	C0750901	AlzheimerDisease,EarlyOnset	disease	C10;F03	DiseaseorSyndrome	0.30	1	2001	2001	1	0	CTD_human
val	801	CALM1	0.472	0.808	C1631597	VENTRICULARTACHYCARDIA,CATECHOLAMINERGICPOLYMORPHIC,1(disorder)	disease	C23;C14	DiseaseorSyndrome	0.74	1	2009	2019	2	2	CTD_human;GENOMICS_ENGLAND;ORPHANET
val	801	CALM1	0.472	0.808	C2677794	Stress-inducedpolymorphicventriculartachycardia	disease	C23;C14	DiseaseorSyndrome	0.30				0	0	CTD_human
val	801	CALM1	0.472	0.808	C3554047	VENTRICULARTACHYCARDIA,CATECHOLAMINERGICPOLYMORPHIC,4	disease		DiseaseorSyndrome	0.60	1	2005	2016	6	3	GENOMICS_ENGLAND;UNIPROT
val	801	CALM1	0.472	0.808	C4015671	LONGQTSYNDROME14	disease		DiseaseorSyndrome	0.70	1	2005	2016	7	5	CTD_human;GENOMICS_ENGLAND;UNIPROT
val	805	CALM2	0.472	0.808	C0005586	BipolarDisorder	disease	F03	MentalorBehavioralDysfunction	0.31	1	2000	2013	2	0	PSYGENET
val	805	CALM2	0.472	0.808	C0006868	CannabisAbuse	disease	C25;F03	MentalorBehavioralDysfunction	0.30	1	2006	2006	1	0	CTD_human
val	805	CALM2	0.472	0.808	C0006870	CannabisDependence	disease	C25;F03	MentalorBehavioralDysfunction	0.30	1	2006	2006	1	0	CTD_human
val	805	CALM2	0.472	0.808	C0009171	CocaineAbuse	disease	C25;F03	MentalorBehavioralDysfunction	0.30	1	2006	2006	1	0	CTD_human
val	805	CALM2	0.472	0.808	C0011570	MentalDepression	disease	F01	MentalorBehavioralDysfunction	0.31	0.8	2005	2014	5	0	PSYGENET
val	805	CALM2	0.472	0.808	C0011581	Depressivedisorder	disease	F03	MentalorBehavioralDysfunction	0.31	0.8	2005	2014	5	0	PSYGENET
val	805	CALM2	0.472	0.808	C0018614	HashishAbuse	disease	C25;F03	DiseaseorSyndrome	0.30	1	2006	2006	1	0	CTD_human
val	805	CALM2	0.472	0.808	C0024809	MarijuanaAbuse	disease	C25;F03	MentalorBehavioralDysfunction	0.31	1	2006	2020	1	0	CTD_human
val	805	CALM2	0.472	0.808	C0031391	PhencyclidineAbuse	disease	C25;F03	MentalorBehavioralDysfunction	0.30	1	2006	2006	1	0	CTD_human
val	805	CALM2	0.472	0.808	C0035828	Romano-WardSyndrome	disease	C23;C16;C14	DiseaseorSyndrome	0.40	1	2013	2014	2	1	ORPHANET
val	805	CALM2	0.472	0.808	C0236735	Cannabis-RelatedDisorder	group	C25;F03	MentalorBehavioralDysfunction	0.30	1	2006	2006	1	0	CTD_human
val	805	CALM2	0.472	0.808	C0236736	Cocaine-RelatedDisorders	group	C25;F03	MentalorBehavioralDysfunction	0.30	1	2006	2006	1	0	CTD_human
val	805	CALM2	0.472	0.808	C0236742	Phencyclidine-RelatedDisorders	disease	C25;F03	MentalorBehavioralDysfunction	0.30	1	2006	2006	1	0	CTD_human
val	805	CALM2	0.472	0.808	C0588008	Severedepression	disease	F03	MentalorBehavioralDysfunction	0.30	1	2006	2006	1	0	PSYGENET
val	805	CALM2	0.472	0.808	C0600427	CocaineDependence	disease	C25;F03	MentalorBehavioralDysfunction	0.30	1	2006	2006	1	0	CTD_human
val	805	CALM2	0.472	0.808	C1142166	BrugadaSyndrome(disorder)	disease	C16;C14	DiseaseorSyndrome	0.30	1	2016	2016	1	0	ORPHANET
val	805	CALM2	0.472	0.808	C1631597	VENTRICULARTACHYCARDIA,CATECHOLAMINERGICPOLYMORPHIC,1(disorder)	disease	C23;C14	DiseaseorSyndrome	0.34	1	2014	2019	1	0	ORPHANET
val	805	CALM2	0.472	0.808	C4015695	LONGQTSYNDROME15	disease		DiseaseorSyndrome	0.70	1	2013	2016	6	6	CTD_human;GENOMICS_ENGLAND;UNIPROT
val	808	CALM3	0.485	0.846	C1631597	VENTRICULARTACHYCARDIA,CATECHOLAMINERGICPOLYMORPHIC,1(disorder)	disease	C23;C14	DiseaseorSyndrome	0.34	1	2016	2019	0	0	ORPHANET
val	810	CALML3	0.621	0.5	C0024121	LungNeoplasms	group	C04;C08	NeoplasticProcess	0.31	1	2017	2019	1	0	CTD_human
val	810	CALML3	0.621	0.5	C0242379	Malignantneoplasmoflung	disease	C04;C08	NeoplasticProcess	0.30	1	2017	2017	1	0	CTD_human
val	811	CALR	0.413	0.923	C0001815	PrimaryMyelofibrosis	disease	C15	NeoplasticProcess	0.80	0.929	2013	2020	2	1	CTD_human;GENOMICS_ENGLAND;ORPHANET
val	811	CALR	0.413	0.923	C0004565	Melanoma,B16	disease	C04	NeoplasticProcess;ExperimentalModelofDisease	0.31	1	2006	2006	1	0	CTD_human
val	811	CALR	0.413	0.923	C0005586	BipolarDisorder	disease	F03	MentalorBehavioralDysfunction	0.30	1	2009	2009	1	0	PSYGENET
val	811	CALR	0.413	0.923	C0009075	Melanoma,CloudmanS91	disease	C04	NeoplasticProcess;ExperimentalModelofDisease	0.30	1	2006	2006	1	0	CTD_human
val	811	CALR	0.413	0.923	C0009402	ColorectalCarcinoma	disease	C06;C04	NeoplasticProcess	0.40	0.909	2007	2020	1	0	CTD_human
val	811	CALR	0.413	0.923	C0009404	ColorectalNeoplasms	group	C06;C04	NeoplasticProcess	0.30	1	2007	2007	1	0	CTD_human
val	811	CALR	0.413	0.923	C0018598	Melanoma,Harding-Passey	disease	C04	NeoplasticProcess;ExperimentalModelofDisease	0.30	1	2006	2006	1	0	CTD_human
val	811	CALR	0.413	0.923	C0025205	Melanoma,Experimental	disease	C04	NeoplasticProcess;ExperimentalModelofDisease	0.30	1	2006	2006	1	0	CTD_human
val	811	CALR	0.413	0.923	C0026987	Myelofibrosis	disease	C23;C04;C15	NeoplasticProcess	0.60	0.933	2013	2020	2	0	GENOMICS_ENGLAND;ORPHANET
val	811	CALR	0.413	0.923	C0027022	Myeloproliferativedisease	group	C15	NeoplasticProcess	0.50	1	2013	2020	1	0	CTD_human
val	811	CALR	0.413	0.923	C0027626	NeoplasmInvasiveness	phenotype	C23;C04	PathologicFunction	0.30	1	2004	2004	1	0	CTD_human
val	811	CALR	0.413	0.923	C0033578	ProstaticNeoplasms	group	C04;C12	NeoplasticProcess	0.31	1	2007	2009	1	0	CTD_human
val	811	CALR	0.413	0.923	C0033937	Psychoses,Drug	disease	C25;F03	MentalorBehavioralDysfunction	0.30	1	2012	2012	1	0	PSYGENET
val	811	CALR	0.413	0.923	C0033975	PsychoticDisorders	group	F03	MentalorBehavioralDysfunction	0.33	1	2011	2012	2	0	PSYGENET
val	811	CALR	0.413	0.923	C0036337	SchizoaffectiveDisorder	disease	F03	MentalorBehavioralDysfunction	0.32	1	2008	2010	2	0	PSYGENET
val	811	CALR	0.413	0.923	C0036349	ParanoidSchizophrenia	disease	F03	MentalorBehavioralDysfunction	0.30	1	2008	2008	1	0	PSYGENET
val	811	CALR	0.413	0.923	C0036939	SharedParanoidDisorder	disease	F03	MentalorBehavioralDysfunction	0.31	1	2012	2012	1	0	PSYGENET
val	811	CALR	0.413	0.923	C0040028	Thrombocythemia,Essential	disease	C15	DiseaseorSyndrome	0.60	0.969	2013	2020	2	0	CTD_human;ORPHANET
val	811	CALR	0.413	0.923	C0151744	MyocardialIschemia	disease	C14	DiseaseorSyndrome	0.31	1	2005	2017	1	0	CTD_human
val	811	CALR	0.413	0.923	C0279626	Squamouscellcarcinomaofesophagus	disease	C06;C04	NeoplasticProcess	0.40	1	2009	2020	1	0	CTD_human
val	811	CALR	0.413	0.923	C0349204	Nonorganicpsychosis	disease	F03	MentalorBehavioralDysfunction	0.33	1	2011	2012	2	0	PSYGENET
val	811	CALR	0.413	0.923	C0376358	Malignantneoplasmofprostate	disease	C04;C12	NeoplasticProcess	0.40	0.923	2003	2020	1	0	CTD_human
val	811	CALR	0.413	0.923	C0376545	HematologicNeoplasms	group	C04;C15	NeoplasticProcess	0.43	1	2014	2018	0	0	CGI
val	811	CALR	0.413	0.923	C3277671	THROMBOCYTHEMIA1	disease		DiseaseorSyndrome	0.40	1	2013	2013	1	1	GENOMICS_ENGLAND
val	811	CALR	0.413	0.923	C3463824	MYELODYSPLASTICSYNDROME	group	C15	NeoplasticProcess	0.42	1	2015	2020	0	0	CGI
val	811	CALR	0.413	0.923	C3489628	Thrombocytosis,AutosomalDominant	disease	C15	DiseaseorSyndrome	0.30				0	0	CTD_human
val	813	CALU	0.7	0.385	C0004238	AtrialFibrillation	disease	C23;C14	DiseaseorSyndrome	0.30	1	2018	2018	1	0	CTD_human
val	813	CALU	0.7	0.385	C0027626	NeoplasmInvasiveness	phenotype	C23;C04	PathologicFunction	0.30	1	2004	2004	1	0	CTD_human
val	813	CALU	0.7	0.385	C0235480	Paroxysmalatrialfibrillation	disease	C23;C14	DiseaseorSyndrome	0.30	1	2018	2018	1	0	CTD_human
val	813	CALU	0.7	0.385	C2585653	Persistentatrialfibrillation	phenotype	C23;C14	PathologicFunction	0.30	1	2018	2018	1	0	CTD_human
val	813	CALU	0.7	0.385	C3468561	familialatrialfibrillation	phenotype	C23;C14	PathologicFunction	0.30	1	2018	2018	1	0	CTD_human
val	814	CAMK4	0.621	0.654	C0009171	CocaineAbuse	disease	C25;F03	MentalorBehavioralDysfunction	0.30	1	2008	2008	1	0	CTD_human
val	814	CAMK4	0.621	0.654	C0152013	Adenocarcinomaoflung(disorder)	disease	C04	NeoplasticProcess	0.30				0	0	UNIPROT
val	814	CAMK4	0.621	0.654	C0236736	Cocaine-RelatedDisorders	group	C25;F03	MentalorBehavioralDysfunction	0.30	1	2008	2008	1	0	CTD_human
val	814	CAMK4	0.621	0.654	C0345958	Largecellcarcinomaoflung	disease	C04;C08	NeoplasticProcess	0.30				0	1	UNIPROT
val	814	CAMK4	0.621	0.654	C0600427	CocaineDependence	disease	C25;F03	MentalorBehavioralDysfunction	0.51	1	2008	2008	1	0	CTD_human;PSYGENET
val	815	CAMK2A	0.612	0.538	C0001973	AlcoholicIntoxication,Chronic	disease	C25;F03	MentalorBehavioralDysfunction	0.31	1	2013	2013	1	0	PSYGENET
val	815	CAMK2A	0.612	0.538	C0005586	BipolarDisorder	disease	F03	MentalorBehavioralDysfunction	0.52	1	2011	2019	1	0	PSYGENET
val	815	CAMK2A	0.612	0.538	C0009171	CocaineAbuse	disease	C25;F03	MentalorBehavioralDysfunction	0.30	1	2004	2004	1	0	CTD_human
val	815	CAMK2A	0.612	0.538	C0011570	MentalDepression	disease	F01	MentalorBehavioralDysfunction	0.32	1	2006	2011	1	0	PSYGENET
val	815	CAMK2A	0.612	0.538	C0011581	Depressivedisorder	disease	F03	MentalorBehavioralDysfunction	0.32	1	2006	2011	1	0	PSYGENET
val	815	CAMK2A	0.612	0.538	C0019202	HepatolenticularDegeneration	disease	C16;C06;C18;C10	DiseaseorSyndrome	0.30	1	2013	2013	1	0	CTD_human
val	815	CAMK2A	0.612	0.538	C0019209	Hepatomegaly	phenotype	C23;C06	Finding	0.30	1	2017	2017	1	0	CTD_human
val	815	CAMK2A	0.612	0.538	C0020429	Hyperalgesia	phenotype	C23;C10	SignorSymptom	0.50	1	2007	2010	1	0	CTD_human
val	815	CAMK2A	0.612	0.538	C0041696	UnipolarDepression	disease	F03	MentalorBehavioralDysfunction	0.30	1	2008	2008	1	0	PSYGENET
val	815	CAMK2A	0.612	0.538	C0236736	Cocaine-RelatedDisorders	group	C25;F03	MentalorBehavioralDysfunction	0.30	1	2004	2004	1	0	CTD_human
val	815	CAMK2A	0.612	0.538	C0458247	Allodynia	phenotype	C23;C10	Finding	0.30	1	2010	2010	1	0	CTD_human
val	815	CAMK2A	0.612	0.538	C0600427	CocaineDependence	disease	C25;F03	MentalorBehavioralDysfunction	0.31	1	2004	2014	1	0	CTD_human
val	815	CAMK2A	0.612	0.538	C0751211	Hyperalgesia,Primary	phenotype	C23;C10	SignorSymptom	0.30	1	2010	2010	1	0	CTD_human
val	815	CAMK2A	0.612	0.538	C0751212	Hyperalgesia,Secondary	phenotype	C23;C10	SignorSymptom	0.30	1	2010	2010	1	0	CTD_human
val	815	CAMK2A	0.612	0.538	C0751213	TactileAllodynia	phenotype	C23;C10	SignorSymptom	0.30	1	2010	2010	1	0	CTD_human
val	815	CAMK2A	0.612	0.538	C0751214	Hyperalgesia,Thermal	phenotype	C23;C10	SignorSymptom	0.30	1	2010	2010	1	0	CTD_human
val	815	CAMK2A	0.612	0.538	C1269683	MajorDepressiveDisorder	disease	F03	MentalorBehavioralDysfunction	0.30	1	2008	2008	1	0	PSYGENET
val	815	CAMK2A	0.612	0.538	C1527352	HepaticFormofWilsonDisease	disease	C16;C06;C18;C10	DiseaseorSyndrome	0.30	1	2013	2013	1	0	CTD_human
val	815	CAMK2A	0.612	0.538	C2936719	MechanicalAllodynia	phenotype	C23;C10	SignorSymptom	0.30	1	2010	2010	1	0	CTD_human
val	815	CAMK2A	0.612	0.538	C3714756	IntellectualDisability	group	C23;C10;F03;F01	MentalorBehavioralDysfunction	0.43	1	2014	2018	2	0	GENOMICS_ENGLAND
val	815	CAMK2A	0.612	0.538	C4540481	MENTALRETARDATION,AUTOSOMALDOMINANT53	disease		MentalorBehavioralDysfunction	0.40	1	2015	2018	4	8	UNIPROT
val	815	CAMK2A	0.612	0.538	C4748167	MENTALRETARDATION,AUTOSOMALRECESSIVE63	disease		DiseaseorSyndrome	0.30	1	2018	2018	1	1	UNIPROT
val	816	CAMK2B	0.626	0.538	C0006868	CannabisAbuse	disease	C25;F03	MentalorBehavioralDysfunction	0.30	1	2006	2006	1	0	CTD_human
val	816	CAMK2B	0.626	0.538	C0006870	CannabisDependence	disease	C25;F03	MentalorBehavioralDysfunction	0.30	1	2006	2006	1	0	CTD_human
val	816	CAMK2B	0.626	0.538	C0009171	CocaineAbuse	disease	C25;F03	MentalorBehavioralDysfunction	0.30	1	2006	2006	1	0	CTD_human
val	816	CAMK2B	0.626	0.538	C0018614	HashishAbuse	disease	C25;F03	DiseaseorSyndrome	0.30	1	2006	2006	1	0	CTD_human
val	816	CAMK2B	0.626	0.538	C0024809	MarijuanaAbuse	disease	C25;F03	MentalorBehavioralDysfunction	0.30	1	2006	2006	1	0	CTD_human
val	816	CAMK2B	0.626	0.538	C0031391	PhencyclidineAbuse	disease	C25;F03	MentalorBehavioralDysfunction	0.30	1	2006	2006	1	0	CTD_human
val	816	CAMK2B	0.626	0.538	C0033937	Psychoses,Drug	disease	C25;F03	MentalorBehavioralDysfunction	0.30	1	2007	2007	1	0	CTD_human
val	816	CAMK2B	0.626	0.538	C0033941	Psychoses,Substance-Induced	disease	C25;F03	MentalorBehavioralDysfunction	0.30	1	2007	2007	1	0	CTD_human
val	816	CAMK2B	0.626	0.538	C0036341	Schizophrenia	disease	F03	MentalorBehavioralDysfunction	0.32	1	2000	2010	2	0	CTD_human
val	816	CAMK2B	0.626	0.538	C0236735	Cannabis-RelatedDisorder	group	C25;F03	MentalorBehavioralDysfunction	0.30	1	2006	2006	1	0	CTD_human
val	816	CAMK2B	0.626	0.538	C0236736	Cocaine-RelatedDisorders	group	C25;F03	MentalorBehavioralDysfunction	0.30	1	2006	2006	1	0	CTD_human
val	816	CAMK2B	0.626	0.538	C0236742	Phencyclidine-RelatedDisorders	disease	C25;F03	MentalorBehavioralDysfunction	0.30	1	2006	2006	1	0	CTD_human
val	816	CAMK2B	0.626	0.538	C0600427	CocaineDependence	disease	C25;F03	MentalorBehavioralDysfunction	0.30	1	2006	2006	1	0	CTD_human
val	816	CAMK2B	0.626	0.538	C1319315	Adenocarcinomaoflargeintestine	disease	C06;C04	NeoplasticProcess	0.30				0	1	UNIPROT
val	816	CAMK2B	0.626	0.538	C3714756	IntellectualDisability	group	C23;C10;F03;F01	MentalorBehavioralDysfunction	0.41	1	2017	2018	1	0	GENOMICS_ENGLAND
val	816	CAMK2B	0.626	0.538	C4540484	MENTALRETARDATION,AUTOSOMALDOMINANT54	disease		DiseaseorSyndrome	0.60	1	2017	2018	2	7	GENOMICS_ENGLAND;UNIPROT
val	817	CAMK2D	0.743	0.308	C0004238	AtrialFibrillation	disease	C23;C14	DiseaseorSyndrome	0.40	1	2018	2018	2	2	CTD_human
val	817	CAMK2D	0.743	0.308	C0023893	LiverCirrhosis,Experimental	disease	C23;C06	ExperimentalModelofDisease	0.30	1	2014	2014	1	0	CTD_human
val	817	CAMK2D	0.743	0.308	C0032460	PolycysticOvarySyndrome	disease	C04;C13;C19	DiseaseorSyndrome	0.30	1	2011	2011	1	0	CTD_human
val	817	CAMK2D	0.743	0.308	C0151744	MyocardialIschemia	disease	C14	DiseaseorSyndrome	0.30	1	2005	2005	1	0	CTD_human
val	817	CAMK2D	0.743	0.308	C0235480	Paroxysmalatrialfibrillation	disease	C23;C14	DiseaseorSyndrome	0.30	1	2018	2018	2	0	CTD_human
val	817	CAMK2D	0.743	0.308	C1136382	SclerocysticOvaries	disease	C04;C13;C19	DiseaseorSyndrome	0.30	1	2011	2011	1	0	CTD_human
val	817	CAMK2D	0.743	0.308	C2585653	Persistentatrialfibrillation	phenotype	C23;C14	PathologicFunction	0.30	1	2018	2018	2	0	CTD_human
val	817	CAMK2D	0.743	0.308	C3468561	familialatrialfibrillation	phenotype	C23;C14	PathologicFunction	0.30	1	2018	2018	2	0	CTD_human
val	818	CAMK2G	0.67	0.462	C4552072	X-linkedinfantilespasms	disease	C10	DiseaseorSyndrome	0.30	1	2017	2017	1	0	GENOMICS_ENGLAND
val	821	CANX	0.582	0.769	C0019193	Hepatitis,Toxic	disease	C06;C25	InjuryorPoisoning	0.30	1	2015	2015	1	0	CTD_human
val	821	CANX	0.582	0.769	C0151744	MyocardialIschemia	disease	C14	DiseaseorSyndrome	0.30	1	2005	2005	1	0	CTD_human
val	821	CANX	0.582	0.769	C0860207	Drug-InducedLiverDisease	phenotype	C06;C25	DiseaseorSyndrome	0.30	1	2015	2015	1	0	CTD_human
val	821	CANX	0.582	0.769	C1262760	Hepatitis,Drug-Induced	disease	C06;C25	DiseaseorSyndrome	0.30	1	2015	2015	1	0	CTD_human
val	821	CANX	0.582	0.769	C3658290	Drug-InducedAcuteLiverInjury	disease	C06;C25	DiseaseorSyndrome	0.30	1	2015	2015	1	0	CTD_human
val	821	CANX	0.582	0.769	C4277682	ChemicalandDrugInducedLiverInjury	disease	C06;C25	DiseaseorSyndrome	0.30	1	2015	2015	1	0	CTD_human
val	821	CANX	0.582	0.769	C4279912	Chemically-InducedLiverToxicity	disease	C06;C25	DiseaseorSyndrome	0.30	1	2015	2015	1	0	CTD_human
val	822	CAPG	0.548	0.731	C0007134	RenalCellCarcinoma	disease	C04;C13;C12	NeoplasticProcess	0.30	1	2004	2004	1	0	CTD_human
val	822	CAPG	0.548	0.731	C0022548	Keloid	disease	C23;C17	AcquiredAbnormality	0.30	1	2010	2010	1	0	CTD_human
val	822	CAPG	0.548	0.731	C0023467	Leukemia,Myelocytic,Acute	disease	C04	NeoplasticProcess	0.30	1	2008	2008	1	0	CTD_human
val	822	CAPG	0.548	0.731	C0023893	LiverCirrhosis,Experimental	disease	C23;C06	ExperimentalModelofDisease	0.30	1	2014	2014	1	0	CTD_human
val	822	CAPG	0.548	0.731	C0026998	AcuteMyeloidLeukemia,M1	disease	C04	NeoplasticProcess	0.30	1	2008	2008	1	0	CTD_human
val	822	CAPG	0.548	0.731	C0152013	Adenocarcinomaoflung(disorder)	disease	C04	NeoplasticProcess	0.30	1	2010	2010	1	0	CTD_human
val	822	CAPG	0.548	0.731	C0279702	Conventional(ClearCell)RenalCellCarcinoma	disease	C04;C13;C12	NeoplasticProcess	0.30	1	2004	2004	1	0	CTD_human
val	822	CAPG	0.548	0.731	C1266042	ChromophobeRenalCellCarcinoma	disease	C04;C13;C12	NeoplasticProcess	0.30	1	2004	2004	1	0	CTD_human
val	822	CAPG	0.548	0.731	C1266043	SarcomatoidRenalCellCarcinoma	disease	C04;C13;C12	NeoplasticProcess	0.30	1	2004	2004	1	0	CTD_human
val	822	CAPG	0.548	0.731	C1266044	CollectingDuctCarcinomaoftheKidney	disease	C04;C13;C12	NeoplasticProcess	0.30	1	2004	2004	1	0	CTD_human
val	822	CAPG	0.548	0.731	C1306837	PapillaryRenalCellCarcinoma	disease	C04;C13;C12	NeoplasticProcess	0.30	1	2004	2004	1	0	CTD_human
val	822	CAPG	0.548	0.731	C1879321	AcuteMyeloidLeukemia(AML-M2)	disease	C04	NeoplasticProcess	0.30	1	2008	2008	1	0	CTD_human
val	823	CAPN1	0.539	0.808	C0006826	MalignantNeoplasms	group	C04	NeoplasticProcess	0.32	1	1999	2019	1	0	CTD_human
val	823	CAPN1	0.539	0.808	C0025202	melanoma	disease	C04	NeoplasticProcess	0.32	1	2012	2019	1	0	CTD_human
val	823	CAPN1	0.539	0.808	C0027651	Neoplasms	group	C04	NeoplasticProcess	0.38	0.778	1999	2019	1	0	CTD_human
val	823	CAPN1	0.539	0.808	C0029134	OpticNeuritis	disease	C11;C10	DiseaseorSyndrome	0.30	1	2013	2013	1	0	CTD_human
val	823	CAPN1	0.539	0.808	C0085582	RetrobulbarNeuritis	disease	C11;C10	DiseaseorSyndrome	0.30	1	2013	2013	1	0	CTD_human
val	823	CAPN1	0.539	0.808	C0086692	BenignNeoplasm	group	C04	NeoplasticProcess	0.30	1	2008	2008	1	0	CTD_human
val	823	CAPN1	0.539	0.808	C0524679	Neuropapillitis	disease	C11;C10	DiseaseorSyndrome	0.30	1	2013	2013	1	0	CTD_human
val	823	CAPN1	0.539	0.808	C4310800	SPASTICPARAPLEGIA76,AUTOSOMALRECESSIVE	disease		DiseaseorSyndrome	0.71	1	2016	2019	2	4	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
val	824	CAPN2	0.59	0.692	C0023467	Leukemia,Myelocytic,Acute	disease	C04	NeoplasticProcess	0.30	1	2007	2007	1	0	CTD_human
val	824	CAPN2	0.59	0.692	C0026998	AcuteMyeloidLeukemia,M1	disease	C04	NeoplasticProcess	0.30	1	2007	2007	1	0	CTD_human
val	824	CAPN2	0.59	0.692	C1879321	AcuteMyeloidLeukemia(AML-M2)	disease	C04	NeoplasticProcess	0.30	1	2007	2007	1	0	CTD_human
val	825	CAPN3	0.564	0.615	C0686353	MuscularDystrophies,Limb-Girdle	group	C16;C05;C10	DiseaseorSyndrome	0.40	0.986	1993	2020	0	0	GENOMICS_ENGLAND
val	825	CAPN3	0.564	0.615	C1299884	Eosinophilicmyositis(disorder)	disease	C16;C05;C10	DiseaseorSyndrome	0.62	1	2000	2010	0	1	CTD_human
val	825	CAPN3	0.564	0.615	C1869123	Limb-girdlemusculardystrophytype2A	disease	C16;C05;C10	DiseaseorSyndrome	1.00	0.994	1995	2019	10	146	CTD_human;GENOMICS_ENGLAND;UNIPROT
val	826	CAPNS1	0.674	0.538	C0033578	ProstaticNeoplasms	group	C04;C12	NeoplasticProcess	0.30	1	2007	2007	1	0	CTD_human
val	826	CAPNS1	0.674	0.538	C0376358	Malignantneoplasmofprostate	disease	C04;C12	NeoplasticProcess	0.32	1	2007	2018	1	0	CTD_human
val	827	CAPN6	0.839	0.077	C0009402	ColorectalCarcinoma	disease	C06;C04	NeoplasticProcess	0.30				0	0	UNIPROT
val	829	CAPZA1	0.821	0.115	C0279626	Squamouscellcarcinomaofesophagus	disease	C06;C04	NeoplasticProcess	0.30	1	2011	2011	1	0	CTD_human
val	831	CAST	0.541	0.846	C0027540	Necrosis	phenotype	C23	OrganorTissueFunction	0.30	1	2007	2007	1	0	CTD_human
val	831	CAST	0.541	0.846	C0162557	LiverFailure,Acute	disease	C06	DiseaseorSyndrome	0.30	1	2006	2006	1	0	CTD_human
val	831	CAST	0.541	0.846	C4225381	PEELINGSKINWITHLEUKONYCHIA,ACRALPUNCTATEKERATOSES,CHEILITIS,ANDKNUCKLEPADS	disease		DiseaseorSyndrome	0.72	1	2015	2019	1	2	CTD_human;GENOMICS_ENGLAND;ORPHANET
val	832	CAPZB	0.729	0.308	C0007097	Carcinoma	group	C04	NeoplasticProcess	0.30	1	2005	2005	1	0	CTD_human
val	832	CAPZB	0.729	0.308	C0024667	AnimalMammaryNeoplasms	phenotype	C04;C22	NeoplasticProcess	0.30	1	2005	2005	1	0	CTD_human
val	832	CAPZB	0.729	0.308	C0024668	MammaryNeoplasms,Experimental	phenotype	C04	NeoplasticProcess;ExperimentalModelofDisease	0.30	1	2005	2005	1	0	CTD_human
val	832	CAPZB	0.729	0.308	C0205696	Anaplasticcarcinoma	disease	C04	NeoplasticProcess	0.30	1	2005	2005	1	0	CTD_human
val	832	CAPZB	0.729	0.308	C0205697	Carcinoma,Spindle-Cell	disease	C04	NeoplasticProcess	0.30	1	2005	2005	1	0	CTD_human
val	832	CAPZB	0.729	0.308	C0205698	Undifferentiatedcarcinoma	disease	C04	NeoplasticProcess	0.30	1	2005	2005	1	0	CTD_human
val	832	CAPZB	0.729	0.308	C0205699	Carcinomatosis	phenotype	C04	NeoplasticProcess	0.30	1	2005	2005	1	0	CTD_human
val	832	CAPZB	0.729	0.308	C0948089	AcuteCoronarySyndrome	disease	C14	DiseaseorSyndrome	0.30	1	2011	2011	1	0	CTD_human
val	832	CAPZB	0.729	0.308	C1257925	MammaryCarcinoma,Animal	disease	C04;C22	NeoplasticProcess	0.30	1	2005	2005	1	0	CTD_human
val	833	CARS1	0.722	0.538	C0001973	AlcoholicIntoxication,Chronic	disease	C25;F03	MentalorBehavioralDysfunction	0.30	1	2010	2010	1	0	PSYGENET
val	833	CARS1	0.722	0.538	C0025958	Microcephaly	disease	C16;C05;C10	CongenitalAbnormality	0.30	1	2019	2019	1	0	GENOMICS_ENGLAND
val	833	CARS1	0.722	0.538	C0263490	Brittlehair	disease		DiseaseorSyndrome	0.30	1	2019	2019	1	0	GENOMICS_ENGLAND
val	833	CARS1	0.722	0.538	C0334121	InflammatoryMyofibroblasticTumor	disease	C23	NeoplasticProcess	0.31	1	2002	2003	2	0	ORPHANET
val	833	CARS1	0.722	0.538	C1856963	Fragilenails	phenotype	C23	Finding	0.30	1	2019	2019	1	0	GENOMICS_ENGLAND
val	833	CARS1	0.722	0.538	C4022738	Neurodevelopmentaldelay	phenotype		Finding	0.30	1	2019	2019	1	0	GENOMICS_ENGLAND
val	834	CASP1	0.413	0.885	C0001925	Albuminuria	phenotype	C23;C13;C12	Finding	0.30	1	2012	2012	1	0	CTD_human
val	834	CASP1	0.413	0.885	C0020517	Hypersensitivity	group	C20	PathologicFunction	0.30	1	2011	2011	1	0	CTD_human
val	834	CASP1	0.413	0.885	C0021368	Inflammation	phenotype	C23	PathologicFunction	0.30	1	2012	2012	1	0	CTD_human
val	834	CASP1	0.413	0.885	C0021655	InsulinResistance	phenotype	C18	PathologicFunction	0.30	1	2012	2012	1	0	CTD_human
val	834	CASP1	0.413	0.885	C0022658	KidneyDiseases	group	C13;C12	DiseaseorSyndrome	0.32	1	2012	2019	1	0	CTD_human
val	834	CASP1	0.413	0.885	C0023893	LiverCirrhosis,Experimental	disease	C23;C06	ExperimentalModelofDisease	0.30	1	2014	2014	1	0	CTD_human
val	834	CASP1	0.413	0.885	C0026769	MultipleSclerosis	disease	C20;C10	DiseaseorSyndrome	0.36	1	1999	2018	1	0	CTD_human
val	834	CASP1	0.413	0.885	C0027055	MyocardialReperfusionInjury	phenotype	C23;C14	PathologicFunction	0.30	1	2004	2004	1	0	CTD_human
val	834	CASP1	0.413	0.885	C0028754	Obesity	disease	C23;C18	DiseaseorSyndrome	0.30	1	2012	2012	1	0	CTD_human
val	834	CASP1	0.413	0.885	C0032285	Pneumonia	disease	C01;C08	DiseaseorSyndrome	0.32	1	2011	2018	1	0	CTD_human
val	834	CASP1	0.413	0.885	C0032300	LobarPneumonia	disease	C01;C08	DiseaseorSyndrome	0.31	1	2011	2019	1	0	CTD_human
val	834	CASP1	0.413	0.885	C0038220	StatusEpilepticus	disease	C23;C10	DiseaseorSyndrome	0.30	1	2008	2008	1	0	CTD_human
val	834	CASP1	0.413	0.885	C0270823	Petitmalstatus	disease	C23;C10	DiseaseorSyndrome	0.30	1	2008	2008	1	0	CTD_human
val	834	CASP1	0.413	0.885	C0311335	GrandMalStatusEpilepticus	disease	C23;C10	DiseaseorSyndrome	0.30	1	2008	2008	1	0	CTD_human
val	834	CASP1	0.413	0.885	C0393734	ComplexPartialStatusEpilepticus	disease	C23;C10	DiseaseorSyndrome	0.30	1	2008	2008	1	0	CTD_human
val	834	CASP1	0.413	0.885	C0598608	Hyperhomocysteinemia	disease	C16;C18	DiseaseorSyndrome	0.31	1	2012	2017	1	0	CTD_human
val	834	CASP1	0.413	0.885	C0751324	MultipleSclerosis,AcuteFulminating	disease	C20;C10	DiseaseorSyndrome	0.30	1	2015	2015	1	0	CTD_human
val	834	CASP1	0.413	0.885	C0751522	StatusEpilepticus,Subclinical	disease	C23;C10	DiseaseorSyndrome	0.30	1	2008	2008	1	0	CTD_human
val	834	CASP1	0.413	0.885	C0751523	Non-ConvulsiveStatusEpilepticus	disease	C23;C10	DiseaseorSyndrome	0.30	1	2008	2008	1	0	CTD_human
val	834	CASP1	0.413	0.885	C0751524	SimplePartialStatusEpilepticus	phenotype	C23;C10	DiseaseorSyndrome	0.30	1	2008	2008	1	0	CTD_human
val	834	CASP1	0.413	0.885	C0887898	ExperimentalLungInflammation	disease	C01;C08	ExperimentalModelofDisease	0.30	1	2011	2011	1	0	CTD_human
val	834	CASP1	0.413	0.885	C0920563	InsulinSensitivity	phenotype	C18	PathologicFunction	0.30	1	2012	2012	1	0	CTD_human
val	834	CASP1	0.413	0.885	C1527304	AllergicReaction	phenotype	C20	PathologicFunction	0.30	1	2011	2011	1	0	CTD_human
val	834	CASP1	0.413	0.885	C1862939	AMYOTROPHICLATERALSCLEROSIS1	disease	C18;C10	DiseaseorSyndrome	0.31	1	2002	2002	1	0	CTD_human
val	834	CASP1	0.413	0.885	C1862941	AmyotrophicLateralSclerosis,Sporadic	disease	C18;C10	DiseaseorSyndrome	0.30	1	2002	2002	1	0	CTD_human
val	834	CASP1	0.413	0.885	C3714636	Pneumonitis	disease	C01;C08	DiseaseorSyndrome	0.31	1	2000	2011	1	0	CTD_human
val	834	CASP1	0.413	0.885	C4551993	AmyotrophicLateralSclerosis,Familial	disease	C18;C10	DiseaseorSyndrome	0.31	1	2002	2004	1	0	CTD_human
val	835	CASP2	0.565	0.731	C0007134	RenalCellCarcinoma	disease	C04;C13;C12	NeoplasticProcess	0.31	1	2010	2010	1	0	CTD_human
val	835	CASP2	0.565	0.731	C0020796	ProfoundMentalRetardation	disease	C23;C10;F03;F01	MentalorBehavioralDysfunction	0.30	1	2011	2011	1	0	CTD_human
val	835	CASP2	0.565	0.731	C0025363	MentalRetardation,Psychosocial	phenotype	C23;C10;F03;F01	MentalorBehavioralDysfunction	0.30	1	2011	2011	1	0	CTD_human
val	835	CASP2	0.565	0.731	C0279702	Conventional(ClearCell)RenalCellCarcinoma	disease	C04;C13;C12	NeoplasticProcess	0.31	1	2010	2010	1	0	CTD_human
val	835	CASP2	0.565	0.731	C0917816	Mentaldeficiency	disease	C23;C10;F03;F01	MentalorBehavioralDysfunction	0.30	1	2011	2011	1	0	CTD_human
val	835	CASP2	0.565	0.731	C1266042	ChromophobeRenalCellCarcinoma	disease	C04;C13;C12	NeoplasticProcess	0.30	1	2010	2010	1	0	CTD_human
val	835	CASP2	0.565	0.731	C1266043	SarcomatoidRenalCellCarcinoma	disease	C04;C13;C12	NeoplasticProcess	0.30	1	2010	2010	1	0	CTD_human
val	835	CASP2	0.565	0.731	C1266044	CollectingDuctCarcinomaoftheKidney	disease	C04;C13;C12	NeoplasticProcess	0.30	1	2010	2010	1	0	CTD_human
val	835	CASP2	0.565	0.731	C1306837	PapillaryRenalCellCarcinoma	disease	C04;C13;C12	NeoplasticProcess	0.30	1	2010	2010	1	0	CTD_human
val	835	CASP2	0.565	0.731	C3714756	IntellectualDisability	group	C23;C10;F03;F01	MentalorBehavioralDysfunction	0.30	1	2011	2011	1	0	CTD_human
val	836	CASP3	0.351	0.923	C0002152	AlloxanDiabetes	disease	C18;C19	ExperimentalModelofDisease	0.30	1	2010	2010	1	0	CTD_human
val	836	CASP3	0.351	0.923	C0002395	AlzheimersDisease	disease	C10;F03	DiseaseorSyndrome	0.6	0.98	1999	2020	1	0	CTD_human
3401	836	CASP3	0.351	0.923	C0011882	DiabeticNeuropathies	group	C10;C19	DiseaseorSyndrome	0.51	1	2003	2017	1	0	CTD_human
3402	836	CASP3	0.351	0.923	C0011884	DiabeticRetinopathy	disease	C11;C19;C14	DiseaseorSyndrome	0.51	0.667	2008	2019	1	0	CTD_human
3409	836	CASP3	0.351	0.923	C0027051	MyocardialInfarction	disease	C23;C14	DiseaseorSyndrome	0.6	1	2002	2019	1	0	CTD_human
3418	836	CASP3	0.351	0.923	C0038220	StatusEpilepticus	disease	C23;C10	DiseaseorSyndrome	0.57	1	2006	2019	2	0	CTD_human
3420	836	CASP3	0.351	0.923	C0038525	SubarachnoidHemorrhage	disease	C23;C10;C14	DiseaseorSyndrome	0.6	0.96	2014	2019	1	0	CTD_human
3426	836	CASP3	0.351	0.923	C0243026	Sepsis	disease	C23;C01	DiseaseorSyndrome	0.6	1	2005	2020	1	0	CTD_human
3469	1139	CHRNA7	0.532	0.654	C0036341	Schizophrenia	disease	F03	MentalorBehavioralDysfunction	0.7	0.75	1998	2019	4	0	PSYGENET
3549	1141	CHRNB2	0.617	0.308	C1854335	Epilepsy,NocturnalFrontalLobe,Type3	disease	C10	DiseaseorSyndrome	0.9	1	2000	2011	3	3	CTD_human;GENOMICS_ENGLAND;UNIPROT
3595	1144	CHRND	0.641	0.462	C0751882	MyasthenicSyndromes,Congenital	disease	C16;C10	DiseaseorSyndrome	0.52	1	2002	2017	1	0	CTD_human;GENOMICS_ENGLAND
3601	1144	CHRND	0.641	0.462	C1854678	MULTIPLEPTERYGIUMSYNDROME,LETHALTYPE	disease	C23;C16;C17	DiseaseorSyndrome	0.7	1	2006	2008	2	4	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
3603	1144	CHRND	0.641	0.462	C4225370	MYASTHENICSYNDROME,CONGENITAL,3C,ASSOCIATEDWITHACETYLCHOLINERECEPTORDEFICIENCY	disease		DiseaseorSyndrome	0.6	1	2001	2008	3	1	GENOMICS_ENGLAND;UNIPROT
3604	1144	CHRND	0.641	0.462	C4225371	MYASTHENICSYNDROME,CONGENITAL,3B,FAST-CHANNEL	disease		DiseaseorSyndrome	0.6	1	2001	2008	4	5	GENOMICS_ENGLAND;UNIPROT
3605	1144	CHRND	0.641	0.462	C4225372	MYASTHENICSYNDROME,CONGENITAL,3A,SLOW-CHANNEL	disease		DiseaseorSyndrome	0.8	1	1996	2006	4	2	GENOMICS_ENGLAND;UNIPROT
3606	1145	CHRNE	0.636	0.577	C1837091	MYASTHENICSYNDROME,CONGENITAL,ASSOCIATEDWITHACETYLCHOLINERECEPTORDEFICIENCY	disease	C16;C10	DiseaseorSyndrome	0.9	1	1996	2011	2	7	CTD_human;GENOMICS_ENGLAND;UNIPROT
3610	1145	CHRNE	0.636	0.577	C4225369	MYASTHENICSYNDROME,CONGENITAL,4B,FAST-CHANNEL	disease		DiseaseorSyndrome	0.6	1	1996	2012	4	2	GENOMICS_ENGLAND;UNIPROT
3611	1145	CHRNE	0.636	0.577	C4225413	MYASTHENICSYNDROME,CONGENITAL,4A,SLOW-CHANNEL	disease		DiseaseorSyndrome	0.8	1	1995	2016	6	6	GENOMICS_ENGLAND;UNIPROT
3614	1146	CHRNG	0.573	0.692	C0265261	Multiplepterygiumsyndrome	disease	C23;C16;C17	CongenitalAbnormality	0.78	1	2006	2019	4	11	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
3619	1146	CHRNG	0.573	0.692	C1854678	MULTIPLEPTERYGIUMSYNDROME,LETHALTYPE	disease	C23;C16;C17	DiseaseorSyndrome	0.71	1	2006	2019	3	5	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
3628	1147	CHUK	0.556	0.731	C3150891	COCOONSYNDROME	disease		DiseaseorSyndrome	0.92	1	1999	2015	1	1	CTD_human;GENOMICS_ENGLAND;ORPHANET
3677	1161	ERCC8	0.551	0.885	C0009207	CockayneSyndrome	disease	C16;C18;C05;C10	DiseaseorSyndrome	0.8	0.978	1996	2020	3	0	CTD_human;GENOMICS_ENGLAND
3680	1161	ERCC8	0.551	0.885	C0751039	CockayneSyndrome,TypeI	disease	C16;C18;C05;C10	DiseaseorSyndrome	0.8	1	1995	2019	8	26	CTD_human;GENOMICS_ENGLAND;UNIPROT
3681	1161	ERCC8	0.551	0.885	C1833561	UV-SensitiveSyndrome	disease	C17	DiseaseorSyndrome	0.62	1	2009	2017	2	0	CTD_human;GENOMICS_ENGLAND;ORPHANET
3682	1161	ERCC8	0.551	0.885	C3553298	UV-SENSITIVESYNDROME2	disease		DiseaseorSyndrome	0.6	1	2009	2009	1	2	GENOMICS_ENGLAND;UNIPROT
3694	1174	AP1S1	0.743	0.308	C1836330	ERYTHROKERATODERMIAVARIABILIS3(disorder)	disease	C16;C17	DiseaseorSyndrome	0.75	1	2005	2019	3	1	CTD_human;GENOMICS_ENGLAND;ORPHANET
3696	1175	AP2S1	0.705	0.346	C1833372	HYPOCALCIURICHYPERCALCEMIA,FAMILIAL,TYPEIII	disease	C18	DiseaseorSyndrome	0.7	1	2013	2016	4	2	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
3700	1180	CLCN1	0.641	0.423	C0027127	MyotoniaCongenita	disease	C16;C05;C10	DiseaseorSyndrome	0.9	0.968	1982	2019	2	27	CTD_human;GENOMICS_ENGLAND
3703	1180	CLCN1	0.641	0.423	C0751360	BeckerGeneralizedMyotonia	disease	C16;C05;C10	DiseaseorSyndrome	0.8	1	1992	2018	23	65	CTD_human;GENOMICS_ENGLAND;UNIPROT
3704	1180	CLCN1	0.641	0.423	C2936781	GeneralizedMyotoniaofThomsen	disease	C16;C05;C10	DiseaseorSyndrome	0.8	0.977	1992	2019	15	51	CTD_human;GENOMICS_ENGLAND;UNIPROT
3712	1181	CLCN2	0.626	0.462	C1854107	Hyperaldosteronism,Familial,TypeII	disease	C19	DiseaseorSyndrome	0.61	1	2018	2019	2	5	CTD_human;UNIPROT
3713	1181	CLCN2	0.626	0.462	C2750893	EPILEPSY,IDIOPATHICGENERALIZED,SUSCEPTIBILITYTO,11	disease		Finding	0.6	1	2009	2013	3	3	GENOMICS_ENGLAND;UNIPROT
3714	1181	CLCN2	0.626	0.462	C3810242	LEUKOENCEPHALOPATHYWITHATAXIA	disease		DiseaseorSyndrome	0.7	1	2003	2015	5	17	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
3724	1183	CLCN4	0.587	0.654	C0796221	MENTALRETARDATION,X-LINKED15	disease		DiseaseorSyndrome	0.7	1	2013	2016	2	6	CTD_human;GENOMICS_ENGLAND;UNIPROT
3734	1184	CLCN5	0.593	0.577	C0403720	X-linkedrecessivenephrolithiasiswithrenalfailure	disease	C16;C13;C12	DiseaseorSyndrome	0.62	1	1996	2013	4	1	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
3778	1200	TPP1	0.551	0.808	C0022340	Late-InfantileNeuronalCeroidLipfuscinosis	disease	C16;C18;C10	DiseaseorSyndrome	0.8	1	1993	2019	2	0	CTD_human;GENOMICS_ENGLAND
3780	1200	TPP1	0.551	0.808	C0027877	NeuronalCeroid-Lipofuscinoses	disease	C16;C18;C10	DiseaseorSyndrome	0.7	0.968	1991	2019	2	23	CTD_human
3787	1200	TPP1	0.551	0.808	C0750900	AlzheimersDisease,FocalOnset	disease	C10;F03	MentalorBehavioralDysfunction	0.30	1	1999	1999	1	0	CTD_human
val	1200	TPP1	0.551	0.808	C0750901	AlzheimerDisease,EarlyOnset	disease	C10;F03	DiseaseorSyndrome	0.30	1	1999	1999	1	0	CTD_human
val	1200	TPP1	0.551	0.808	C0751383	JuvenileNeuronalCeroidLipofuscinosis	disease	C16;C18;C10	DiseaseorSyndrome	0.60	1	1997	2019	2	0	CTD_human
val	1200	TPP1	0.551	0.808	C1834207	CeroidLipofuscinosis,Neuronal,ParryType	disease	C16;C18;C10	DiseaseorSyndrome	0.30	1	1999	2001	2	0	CTD_human
val	1200	TPP1	0.551	0.808	C1836474	SPINOCEREBELLARATAXIA,AUTOSOMALRECESSIVE7	disease	C16;C10	DiseaseorSyndrome	0.71	1	2013	2013	1	6	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
val	1200	TPP1	0.551	0.808	C1876161	CEROIDLIPOFUSCINOSIS,NEURONAL,2	disease	C16;C18;C10	DiseaseorSyndrome	1.00	1	1997	2019	16	66	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
val	1200	TPP1	0.551	0.808	C3714756	IntellectualDisability	group	C23;C10;F03;F01	MentalorBehavioralDysfunction	0.30	1	2016	2016	1	0	GENOMICS_ENGLAND
val	1201	CLN3	0.572	0.692	C0015397	Disorderofeye	group	C11	DiseaseorSyndrome	0.30				0	0	GENOMICS_ENGLAND
val	1201	CLN3	0.572	0.692	C0022340	Late-InfantileNeuronalCeroidLipfuscinosis	disease	C16;C18;C10	DiseaseorSyndrome	0.54	1	1994	2017	0	0	CTD_human
val	1201	CLN3	0.572	0.692	C0022797	AdultNeuronalCeroidLipofuscinosis	disease	C16;C18;C10	DiseaseorSyndrome	0.50	1	1999	2016	0	0	CTD_human
val	1201	CLN3	0.572	0.692	C0024623	Malignantneoplasmofstomach	disease	C06;C04	NeoplasticProcess	0.30	1	2011	2011	1	0	CTD_human
val	1201	CLN3	0.572	0.692	C0027877	NeuronalCeroid-Lipofuscinoses	disease	C16;C18;C10	DiseaseorSyndrome	0.70	0.957	1993	2019	0	12	CTD_human
val	1201	CLN3	0.572	0.692	C0035334	RetinitisPigmentosa	disease	C16;C11	DiseaseorSyndrome	0.41	1	2000	2014	0	4	GENOMICS_ENGLAND
val	1201	CLN3	0.572	0.692	C0038356	StomachNeoplasms	group	C06;C04	NeoplasticProcess	0.30	1	2011	2011	1	0	CTD_human
val	1201	CLN3	0.572	0.692	C0235874	DiseaseExacerbation	phenotype	C23	Finding	0.30	1	2011	2011	1	0	CTD_human
val	1201	CLN3	0.572	0.692	C0268281	Infantileneuronalceroidlipofuscinosis	disease	C16;C18;C10	DiseaseorSyndrome	0.30				0	0	CTD_human
val	1201	CLN3	0.572	0.692	C0751383	JuvenileNeuronalCeroidLipofuscinosis	disease	C16;C18;C10	DiseaseorSyndrome	1.00	0.994	1990	2019	7	72	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
val	1201	CLN3	0.572	0.692	C1708349	HereditaryDiffuseGastricCancer	disease	C06;C04	NeoplasticProcess	0.30	1	2011	2011	1	0	CTD_human
val	1201	CLN3	0.572	0.692	C1834207	CeroidLipofuscinosis,Neuronal,ParryType	disease	C16;C18;C10	DiseaseorSyndrome	0.30				0	0	CTD_human
val	1203	CLN5	0.705	0.269	C0015397	Disorderofeye	group	C11	DiseaseorSyndrome	0.30				0	0	GENOMICS_ENGLAND
val	1203	CLN5	0.705	0.269	C1850442	CEROIDLIPOFUSCINOSIS,NEURONAL,5	disease	C16;C18;C10	DiseaseorSyndrome	0.97	1	1998	2019	11	9	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
val	1207	CLNS1A	1	0.038	C0025202	melanoma	disease	C04	NeoplasticProcess	0.30	1	2012	2012	1	0	CTD_human
val	1209	CLPTM1	0.769	0.346	C0030297	PancreaticNeoplasm	disease	C06;C04;C19	NeoplasticProcess	0.30	1	2015	2015	1	0	CTD_human
val	1209	CLPTM1	0.769	0.346	C0346647	Malignantneoplasmofpancreas	disease	C06;C04;C19	NeoplasticProcess	0.30	1	2015	2015	1	0	CTD_human
val	1212	CLTB	0.821	0.231	C0024121	LungNeoplasms	group	C04;C08	NeoplasticProcess	0.30	1	2017	2017	1	0	CTD_human
val	1212	CLTB	0.821	0.231	C0242379	Malignantneoplasmoflung	disease	C04;C08	NeoplasticProcess	0.30	1	2017	2017	1	0	CTD_human
val	1213	CLTC	0.558	0.769	C0079744	DiffuseLargeB-CellLymphoma	disease	C04;C20;C15	NeoplasticProcess	0.31	1	2007	2012	1	0	CTD_human
val	1213	CLTC	0.558	0.769	C0334121	InflammatoryMyofibroblasticTumor	disease	C23	NeoplasticProcess	0.35	1	2001	2007	1	0	ORPHANET
val	1213	CLTC	0.558	0.769	C4518356	MiTfamilytranslocationrenalcellcarcinoma	disease	C04;C13;C12	NeoplasticProcess	0.30	1	2003	2010	2	0	ORPHANET
val	1213	CLTC	0.558	0.769	C4693389	MENTALRETARDATION,AUTOSOMALDOMINANT56	disease		MentalorBehavioralDysfunction	0.60	1	2016	2017	2	1	GENOMICS_ENGLAND;UNIPROT
val	1215	CMA1	0.514	0.692	C0020538	Hypertensivedisease	group	C14	DiseaseorSyndrome	0.33	1	2003	2018	1	0	CTD_human
val	1215	CMA1	0.514	0.692	C0034069	PulmonaryFibrosis	disease	C08	DiseaseorSyndrome	0.30	1	2004	2004	1	0	CTD_human
val	1215	CMA1	0.514	0.692	C0149721	LeftVentricularHypertrophy	disease	C23;C14	DiseaseorSyndrome	0.31	1	2003	2005	1	0	CTD_human
val	1215	CMA1	0.514	0.692	C4721507	Alveolitis,Fibrosing	disease	C08	DiseaseorSyndrome	0.30	1	2004	2004	1	0	CTD_human
val	1230	CCR1	0.531	0.769	C0004943	BehcetSyndrome	disease	C16;C11;C17;C07;C14	DiseaseorSyndrome	0.54	1	2012	2019	2	0	CTD_human;ORPHANET
val	1230	CCR1	0.531	0.769	C0011616	ContactDermatitis	disease	C17	DiseaseorSyndrome	0.30	1	2015	2015	1	0	CTD_human
val	1230	CCR1	0.531	0.769	C0020517	Hypersensitivity	group	C20	PathologicFunction	0.30	1	2011	2011	1	0	CTD_human
val	1230	CCR1	0.531	0.769	C0023895	Liverdiseases	group	C06	DiseaseorSyndrome	0.30	1	2010	2010	1	0	CTD_human
val	1230	CCR1	0.531	0.769	C0032285	Pneumonia	disease	C01;C08	DiseaseorSyndrome	0.30	1	2011	2011	1	0	CTD_human
val	1230	CCR1	0.531	0.769	C0032300	LobarPneumonia	disease	C01;C08	DiseaseorSyndrome	0.30	1	2011	2011	1	0	CTD_human
val	1230	CCR1	0.531	0.769	C0086565	LiverDysfunction	phenotype	C06	Finding	0.30	1	2010	2010	1	0	CTD_human
val	1230	CCR1	0.531	0.769	C0162351	Contacthypersensitivity	phenotype	C17	PathologicFunction	0.30	1	2015	2015	1	0	CTD_human
val	1230	CCR1	0.531	0.769	C0887898	ExperimentalLungInflammation	disease	C01;C08	ExperimentalModelofDisease	0.30	1	2011	2011	1	0	CTD_human
val	1230	CCR1	0.531	0.769	C1527304	AllergicReaction	phenotype	C20	PathologicFunction	0.30	1	2011	2011	1	0	CTD_human
val	1230	CCR1	0.531	0.769	C2239176	Livercarcinoma	disease	C06;C04	NeoplasticProcess	0.36	1	2003	2019	1	0	CTD_human
val	1230	CCR1	0.531	0.769	C3714636	Pneumonitis	disease	C01;C08	DiseaseorSyndrome	0.30	1	2011	2011	1	0	CTD_human
val	1232	CCR3	0.527	0.808	C0011615	Dermatitis,Atopic	disease	C16;C17;C20	DiseaseorSyndrome	0.34	1	1999	2018	1	0	CTD_human
val	1232	CCR3	0.527	0.808	C0019693	HIVInfections	group	C01;C20	DiseaseorSyndrome	0.32	1	1999	2017	1	0	CTD_human
val	1232	CCR3	0.527	0.808	C0034069	PulmonaryFibrosis	disease	C08	DiseaseorSyndrome	0.31	1	2005	2005	1	0	CTD_human
val	1232	CCR3	0.527	0.808	C0035228	RespiratoryHypersensitivity	phenotype	C08;C20	PathologicFunction	0.30	1	2010	2010	1	0	CTD_human
val	1232	CCR3	0.527	0.808	C0038220	StatusEpilepticus	disease	C23;C10	DiseaseorSyndrome	0.30	1	2009	2009	1	0	CTD_human
val	1232	CCR3	0.527	0.808	C0086196	Eczema,Infantile	disease	C16;C17;C20	DiseaseorSyndrome	0.30	1	2008	2008	1	0	CTD_human
val	1232	CCR3	0.527	0.808	C0270823	Petitmalstatus	disease	C23;C10	DiseaseorSyndrome	0.30	1	2009	2009	1	0	CTD_human
val	1232	CCR3	0.527	0.808	C0311335	GrandMalStatusEpilepticus	disease	C23;C10	DiseaseorSyndrome	0.30	1	2009	2009	1	0	CTD_human
val	1232	CCR3	0.527	0.808	C0393734	ComplexPartialStatusEpilepticus	disease	C23;C10	DiseaseorSyndrome	0.30	1	2009	2009	1	0	CTD_human
val	1232	CCR3	0.527	0.808	C0751522	StatusEpilepticus,Subclinical	disease	C23;C10	DiseaseorSyndrome	0.30	1	2009	2009	1	0	CTD_human
val	1232	CCR3	0.527	0.808	C0751523	Non-ConvulsiveStatusEpilepticus	disease	C23;C10	DiseaseorSyndrome	0.30	1	2009	2009	1	0	CTD_human
val	1232	CCR3	0.527	0.808	C0751524	SimplePartialStatusEpilepticus	phenotype	C23;C10	DiseaseorSyndrome	0.30	1	2009	2009	1	0	CTD_human
val	1232	CCR3	0.527	0.808	C1319853	Asthma,Aspirin-Induced	disease	C08;C20;C25	DiseaseorSyndrome	0.30	1	2010	2010	1	0	CTD_human
val	1232	CCR3	0.527	0.808	C4505456	HIVCoinfection	disease	C01;C20	DiseaseorSyndrome	0.30	1	1999	1999	1	0	CTD_human
val	1232	CCR3	0.527	0.808	C4721507	Alveolitis,Fibrosing	disease	C08	DiseaseorSyndrome	0.30	1	2005	2005	1	0	CTD_human
val	1233	CCR4	0.51	0.731	C0007570	CeliacDisease	disease	C06;C18	DiseaseorSyndrome	0.30	1	2010	2010	1	0	CTD_human
val	1233	CCR4	0.51	0.731	C0007786	BrainIschemia	disease	C10;C14	DiseaseorSyndrome	0.30	1	2005	2005	1	0	CTD_human
val	1233	CCR4	0.51	0.731	C0017638	Glioma	disease	C04	NeoplasticProcess	0.30	1	2008	2008	1	0	CTD_human
val	1233	CCR4	0.51	0.731	C0023493	AdultT-CellLymphoma/Leukemia	disease	C04;C20;C15	NeoplasticProcess	0.40	1	2002	2020	1	0	CTD_human
val	1233	CCR4	0.51	0.731	C0023903	Liverneoplasms	group	C06;C04	NeoplasticProcess	0.30	1	2009	2009	1	0	CTD_human
val	1233	CCR4	0.51	0.731	C0036920	SezarySyndrome	disease	C04;C20;C15	NeoplasticProcess	0.36	1	2005	2020	1	0	CTD_human
val	1233	CCR4	0.51	0.731	C0259783	mixedgliomas	disease	C04	NeoplasticProcess	0.30	1	2008	2008	1	0	CTD_human
val	1233	CCR4	0.51	0.731	C0345904	Malignantneoplasmofliver	disease	C06;C04	NeoplasticProcess	0.30	1	2009	2009	1	0	CTD_human
val	1233	CCR4	0.51	0.731	C0555198	MalignantGlioma	disease	C04	NeoplasticProcess	0.30	1	2008	2008	1	0	CTD_human
val	1233	CCR4	0.51	0.731	C0917798	CerebralIschemia	disease	C10;C14	PathologicFunction	0.30	1	2005	2005	1	0	CTD_human
val	1234	CCR5	0.398	0.885	C0011615	Dermatitis,Atopic	disease	C16;C17;C20	DiseaseorSyndrome	0.30	1	2008	2008	1	0	CTD_human
val	1234	CCR5	0.398	0.885	C0019196	HepatitisC	disease	C06;C01	DiseaseorSyndrome	0.40	0.839	2002	2019	0	0	CTD_human
val	1234	CCR5	0.398	0.885	C0022660	KidneyFailure,Acute	disease	C13;C12	DiseaseorSyndrome	0.30	1	2016	2016	1	0	CTD_human
val	1234	CCR5	0.398	0.885	C0027697	Nephritis	disease	C13;C12	DiseaseorSyndrome	0.30	1	2016	2016	1	0	CTD_human
val	1234	CCR5	0.398	0.885	C0036341	Schizophrenia	disease	F03	MentalorBehavioralDysfunction	0.33	1	2006	2016	1	0	PSYGENET
val	1234	CCR5	0.398	0.885	C0043124	WestNileFever	disease	C01;C10	DiseaseorSyndrome	0.36	0.833	2006	2016	0	0	CTD_human
val	1234	CCR5	0.398	0.885	C0086196	Eczema,Infantile	disease	C16;C17;C20	DiseaseorSyndrome	0.30	1	2008	2008	1	0	CTD_human
val	1234	CCR5	0.398	0.885	C0751583	Encephalitis,WestNileFever	disease	C01;C10	DiseaseorSyndrome	0.30				0	0	CTD_human
val	1234	CCR5	0.398	0.885	C0751584	WestNileFeverMeningitis	disease	C01;C10	DiseaseorSyndrome	0.30				0	0	CTD_human
val	1234	CCR5	0.398	0.885	C0751585	WestNileFeverMeningoencephalitis	disease	C01;C10	DiseaseorSyndrome	0.30				0	0	CTD_human
val	1234	CCR5	0.398	0.885	C0751586	WestNileFeverMyelitis	disease	C01;C10	DiseaseorSyndrome	0.30				0	0	CTD_human
val	1234	CCR5	0.398	0.885	C1565662	AcuteKidneyInsufficiency	disease	C13;C12	DiseaseorSyndrome	0.30	1	2016	2016	1	0	CTD_human
val	1234	CCR5	0.398	0.885	C2609414	Acutekidneyinjury	disease	C13;C12	InjuryorPoisoning	0.30	1	2016	2016	1	0	CTD_human
val	1234	CCR5	0.398	0.885	C2675864	DIABETESMELLITUS,INSULIN-DEPENDENT,22(disorder)	disease	C18;C20;C19	DiseaseorSyndrome	0.30				0	0	CTD_human
val	1235	CCR6	0.485	0.808	C0003873	RheumatoidArthritis	disease	C17;C05;C20	DiseaseorSyndrome	0.50	1	2001	2019	3	6	CTD_human
val	1235	CCR6	0.485	0.808	C0009324	UlcerativeColitis	disease	C06	DiseaseorSyndrome	0.35	1	2005	2019	1	0	CTD_human
val	1235	CCR6	0.485	0.808	C0020517	Hypersensitivity	group	C20	PathologicFunction	0.30	1	2011	2011	1	0	CTD_human
val	1235	CCR6	0.485	0.808	C0032285	Pneumonia	disease	C01;C08	DiseaseorSyndrome	0.30	1	2011	2011	1	0	CTD_human
val	1235	CCR6	0.485	0.808	C0032300	LobarPneumonia	disease	C01;C08	DiseaseorSyndrome	0.30	1	2011	2011	1	0	CTD_human
val	1235	CCR6	0.485	0.808	C0042900	Vitiligo	disease	C17	DiseaseorSyndrome	0.31	1	2010	2019	1	0	CTD_human
val	1235	CCR6	0.485	0.808	C0178417	Anhedonia	disease	C23;C10;F01	MentalorBehavioralDysfunction	0.30	1	2014	2014	1	0	PSYGENET
val	1235	CCR6	0.485	0.808	C0206138	CRESTSyndrome	disease	C06;C18;C17;C14	DiseaseorSyndrome	0.30	1	2013	2013	1	0	ORPHANET
val	1235	CCR6	0.485	0.808	C0748540	Scleroderma,Limited	disease	C17	DiseaseorSyndrome	0.30	1	2013	2013	1	0	ORPHANET
val	1235	CCR6	0.485	0.808	C0887898	ExperimentalLungInflammation	disease	C01;C08	ExperimentalModelofDisease	0.30	1	2011	2011	1	0	CTD_human
val	1235	CCR6	0.485	0.808	C1258104	DiffuseScleroderma	disease	C17	DiseaseorSyndrome	0.30	1	2013	2013	1	0	ORPHANET
val	1235	CCR6	0.485	0.808	C1527304	AllergicReaction	phenotype	C20	PathologicFunction	0.30	1	2011	2011	1	0	CTD_human
val	1235	CCR6	0.485	0.808	C3714636	Pneumonitis	disease	C01;C08	DiseaseorSyndrome	0.30	1	2011	2011	1	0	CTD_human
val	1236	CCR7	0.443	0.769	C0023493	AdultT-CellLymphoma/Leukemia	disease	C04;C20;C15	NeoplasticProcess	0.30	1	2015	2015	1	0	CTD_human
val	1236	CCR7	0.443	0.769	C0038220	StatusEpilepticus	disease	C23;C10	DiseaseorSyndrome	0.30	1	2007	2007	1	0	CTD_human
val	1236	CCR7	0.443	0.769	C0178417	Anhedonia	disease	C23;C10;F01	MentalorBehavioralDysfunction	0.30	1	2014	2014	1	0	PSYGENET
val	1236	CCR7	0.443	0.769	C0270823	Petitmalstatus	disease	C23;C10	DiseaseorSyndrome	0.30	1	2007	2007	1	0	CTD_human
val	1236	CCR7	0.443	0.769	C0311335	GrandMalStatusEpilepticus	disease	C23;C10	DiseaseorSyndrome	0.30	1	2007	2007	1	0	CTD_human
val	1236	CCR7	0.443	0.769	C0393734	ComplexPartialStatusEpilepticus	disease	C23;C10	DiseaseorSyndrome	0.30	1	2007	2007	1	0	CTD_human
val	1236	CCR7	0.443	0.769	C0751522	StatusEpilepticus,Subclinical	disease	C23;C10	DiseaseorSyndrome	0.30	1	2007	2007	1	0	CTD_human
val	1236	CCR7	0.443	0.769	C0751523	Non-ConvulsiveStatusEpilepticus	disease	C23;C10	DiseaseorSyndrome	0.30	1	2007	2007	1	0	CTD_human
val	1236	CCR7	0.443	0.769	C0751524	SimplePartialStatusEpilepticus	phenotype	C23;C10	DiseaseorSyndrome	0.30	1	2007	2007	1	0	CTD_human
val	1237	CCR8	0.597	0.692	C0038220	StatusEpilepticus	disease	C23;C10	DiseaseorSyndrome	0.30	1	2007	2007	1	0	CTD_human
val	1237	CCR8	0.597	0.692	C0270823	Petitmalstatus	disease	C23;C10	DiseaseorSyndrome	0.30	1	2007	2007	1	0	CTD_human
val	1237	CCR8	0.597	0.692	C0311335	GrandMalStatusEpilepticus	disease	C23;C10	DiseaseorSyndrome	0.30	1	2007	2007	1	0	CTD_human
val	1237	CCR8	0.597	0.692	C0393734	ComplexPartialStatusEpilepticus	disease	C23;C10	DiseaseorSyndrome	0.30	1	2007	2007	1	0	CTD_human
val	1237	CCR8	0.597	0.692	C0751522	StatusEpilepticus,Subclinical	disease	C23;C10	DiseaseorSyndrome	0.30	1	2007	2007	1	0	CTD_human
val	1237	CCR8	0.597	0.692	C0751523	Non-ConvulsiveStatusEpilepticus	disease	C23;C10	DiseaseorSyndrome	0.30	1	2007	2007	1	0	CTD_human
val	1237	CCR8	0.597	0.692	C0751524	SimplePartialStatusEpilepticus	phenotype	C23;C10	DiseaseorSyndrome	0.30	1	2007	2007	1	0	CTD_human
val	1240	CMKLR1	0.612	0.692	C0011570	MentalDepression	disease	F01	MentalorBehavioralDysfunction	0.31	1	2012	2018	1	0	PSYGENET
val	1240	CMKLR1	0.612	0.692	C0011581	Depressivedisorder	disease	F03	MentalorBehavioralDysfunction	0.31	1	2012	2018	1	0	PSYGENET
val	1240	CMKLR1	0.612	0.692	C0018206	granulosacelltumor	disease	C04;C13;C19	NeoplasticProcess	0.31	1	2018	2018	1	0	CTD_human
val	1240	CMKLR1	0.612	0.692	C1567257	GranulosaCellCancer	disease	C04;C13;C19	NeoplasticProcess	0.30	1	2018	2018	1	0	CTD_human
val	1241	LTB4R	0.576	0.692	C0002792	anaphylaxis	phenotype	C20	DiseaseorSyndrome	0.30	1	2000	2000	1	0	CTD_human
val	1241	LTB4R	0.576	0.692	C0021368	Inflammation	phenotype	C23	PathologicFunction	0.31	1	2000	2005	1	0	CTD_human
val	1241	LTB4R	0.576	0.692	C0023895	Liverdiseases	group	C06	DiseaseorSyndrome	0.30	1	2010	2010	1	0	CTD_human
val	1241	LTB4R	0.576	0.692	C0086565	LiverDysfunction	phenotype	C06	Finding	0.30	1	2010	2010	1	0	CTD_human
val	1244	ABCC2	0.483	0.808	C0002170	Alopecia	disease	C23;C17	DiseaseorSyndrome	0.31	1	2008	2008	1	0	CTD_human
val	1244	ABCC2	0.483	0.808	C0003873	RheumatoidArthritis	disease	C17;C05;C20	DiseaseorSyndrome	0.30	1	2013	2013	1	0	CTD_human
val	1244	ABCC2	0.483	0.808	C0008312	Primarybiliarycirrhosis	disease	C23;C06	DiseaseorSyndrome	0.52	1	2003	2005	1	0	CTD_human
val	1244	ABCC2	0.483	0.808	C0008370	Cholestasis	disease	C06	DiseaseorSyndrome	0.80	0.963	2000	2020	5	0	CTD_human;GENOMICS_ENGLAND
val	1244	ABCC2	0.483	0.808	C0009402	ColorectalCarcinoma	disease	C06;C04	NeoplasticProcess	0.34	1	2012	2015	1	0	CTD_human
val	1244	ABCC2	0.483	0.808	C0009404	ColorectalNeoplasms	group	C06;C04	NeoplasticProcess	0.31	1	2008	2012	1	0	CTD_human
val	1244	ABCC2	0.483	0.808	C0013182	DrugAllergy	group	C20;C25	PathologicFunction	0.30	1	2010	2010	1	0	CTD_human
val	1244	ABCC2	0.483	0.808	C0013221	Drugtoxicity	group	C25	InjuryorPoisoning	0.30	1	2010	2014	3	0	CTD_human
val	1244	ABCC2	0.483	0.808	C0017178	GastrointestinalDiseases	group	C06	DiseaseorSyndrome	0.30	1	2008	2008	1	0	CTD_human
val	1244	ABCC2	0.483	0.808	C0018799	HeartDiseases	group	C14	DiseaseorSyndrome	0.30	1	2005	2005	1	0	CTD_human
val	1244	ABCC2	0.483	0.808	C0019193	Hepatitis,Toxic	disease	C06;C25	InjuryorPoisoning	0.30	1	2008	2008	2	0	CTD_human
val	1244	ABCC2	0.483	0.808	C0020433	Hyperbilirubinemia	disease	C23	DiseaseorSyndrome	0.59	1	1996	2019	1	0	CTD_human
val	1244	ABCC2	0.483	0.808	C0022333	JacksonianSeizure	disease	C23;C10	DiseaseorSyndrome	0.30	1	2006	2006	1	0	CTD_human
val	1244	ABCC2	0.483	0.808	C0022350	Jaundice,ChronicIdiopathic	disease	C16;C18	DiseaseorSyndrome	1.00	1	1996	2020	11	10	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
val	1244	ABCC2	0.483	0.808	C0023892	Biliarycirrhosis	disease	C23;C06	DiseaseorSyndrome	0.50	1	2004	2005	1	0	CTD_human
val	1244	ABCC2	0.483	0.808	C0023893	LiverCirrhosis,Experimental	disease	C23;C06	ExperimentalModelofDisease	0.30	1	2014	2014	1	0	CTD_human
val	1244	ABCC2	0.483	0.808	C0027765	nervoussystemdisorder	group	C10	DiseaseorSyndrome	0.30	1	2011	2011	1	0	CTD_human
val	1244	ABCC2	0.483	0.808	C0036572	Seizures	phenotype	C23;C10	SignorSymptom	0.33	1	2006	2020	1	0	CTD_human
val	1244	ABCC2	0.483	0.808	C0038220	StatusEpilepticus	disease	C23;C10	DiseaseorSyndrome	0.50	1	2006	2006	1	0	CTD_human
val	1244	ABCC2	0.483	0.808	C0041755	Adversereactiontodrug	group	C25	PathologicFunction	0.30	1	2010	2014	3	0	CTD_human
val	1244	ABCC2	0.483	0.808	C0086873	Pseudopelade	disease	C23;C17	DiseaseorSyndrome	0.30	1	2008	2008	1	0	CTD_human
val	1244	ABCC2	0.483	0.808	C0149958	Complexpartialseizures	disease	C23;C10	DiseaseorSyndrome	0.31	1	2006	2013	1	0	CTD_human
val	1244	ABCC2	0.483	0.808	C0162311	AndrogeneticAlopecia	disease	C23;C17	DiseaseorSyndrome	0.30	1	2008	2008	1	0	CTD_human
val	1244	ABCC2	0.483	0.808	C0234533	Generalizedseizures	disease	C23;C10	DiseaseorSyndrome	0.30	1	2006	2006	1	0	CTD_human
val	1244	ABCC2	0.483	0.808	C0234535	ClonicSeizures	disease	C23;C10	DiseaseorSyndrome	0.30	1	2006	2006	1	0	CTD_human
val	1244	ABCC2	0.483	0.808	C0238065	SecondaryBiliaryCholangitis	disease	C23;C06	DiseaseorSyndrome	0.30	1	2004	2004	1	0	CTD_human
val	1244	ABCC2	0.483	0.808	C0263477	Femalepatternalopecia(disorder)	phenotype	C23;C17	DiseaseorSyndrome	0.30	1	2008	2008	1	0	CTD_human
val	1244	ABCC2	0.483	0.808	C0268318	Cholestasisofpregnancy	disease	C06;C13	DiseaseorSyndrome	0.35	1	2008	2018	2	0	GENOMICS_ENGLAND
val	1244	ABCC2	0.483	0.808	C0270823	Petitmalstatus	disease	C23;C10	DiseaseorSyndrome	0.30	1	2006	2006	1	0	CTD_human
val	1244	ABCC2	0.483	0.808	C0270824	Visualseizure	disease	C23;C10	DiseaseorSyndrome	0.50	1	2003	2006	1	0	CTD_human
val	1244	ABCC2	0.483	0.808	C0270844	TonicSeizures	phenotype	C23;C10	DiseaseorSyndrome	0.30	1	2006	2006	1	0	CTD_human
val	1244	ABCC2	0.483	0.808	C0270846	Epilepticdropattack	disease	C23;C10	DiseaseorSyndrome	0.30	1	2006	2006	1	0	CTD_human
val	1244	ABCC2	0.483	0.808	C0279626	Squamouscellcarcinomaofesophagus	disease	C06;C04	NeoplasticProcess	0.31	1	2011	2011	1	0	CTD_human
val	1244	ABCC2	0.483	0.808	C0311335	GrandMalStatusEpilepticus	disease	C23;C10	DiseaseorSyndrome	0.30	1	2006	2006	1	0	CTD_human
val	1244	ABCC2	0.483	0.808	C0393734	ComplexPartialStatusEpilepticus	disease	C23;C10	DiseaseorSyndrome	0.30	1	2006	2006	1	0	CTD_human
val	1244	ABCC2	0.483	0.808	C0400966	Non-alcoholicFattyLiverDisease	disease	C06	DiseaseorSyndrome	0.32	1	2009	2020	1	0	CTD_human
val	1244	ABCC2	0.483	0.808	C0422850	Seizures,Somatosensory	phenotype	C23;C10	PathologicFunction	0.30	1	2006	2006	1	0	CTD_human
val	1244	ABCC2	0.483	0.808	C0422852	Seizures,Auditory	phenotype	C23;C10	PathologicFunction	0.30	1	2006	2006	1	0	CTD_human
val	1244	ABCC2	0.483	0.808	C0422853	Olfactoryseizure	phenotype	C23;C10	DiseaseorSyndrome	0.30	1	2006	2006	1	0	CTD_human
val	1244	ABCC2	0.483	0.808	C0422854	Gustatoryseizure	phenotype	C23;C10	SignorSymptom	0.30	1	2006	2006	1	0	CTD_human
val	1244	ABCC2	0.483	0.808	C0422855	Vertiginousseizure	phenotype	C23;C10	DiseaseorSyndrome	0.30	1	2006	2006	1	0	CTD_human
val	1244	ABCC2	0.483	0.808	C0494475	Tonic-clonicseizures	disease	C23;C10	DiseaseorSyndrome	0.30	1	2006	2006	1	0	CTD_human
val	1244	ABCC2	0.483	0.808	C0559031	FunctionalGastrointestinalDisorders	disease	C06	DiseaseorSyndrome	0.30	1	2008	2008	1	0	CTD_human
val	1244	ABCC2	0.483	0.808	C0751056	Non-epilepticconvulsion	phenotype	C23;C10	SignorSymptom	0.30	1	2006	2006	1	0	CTD_human
val	1244	ABCC2	0.483	0.808	C0751110	SingleSeizure	disease	C23;C10	DiseaseorSyndrome	0.30	1	2006	2006	1	0	CTD_human
val	1244	ABCC2	0.483	0.808	C0751123	AtonicAbsenceSeizures	phenotype	C23;C10	DiseaseorSyndrome	0.30	1	2006	2006	1	0	CTD_human
val	1244	ABCC2	0.483	0.808	C0751494	ConvulsiveSeizures	phenotype	C23;C10	SignorSymptom	0.30	1	2006	2006	1	0	CTD_human
val	1244	ABCC2	0.483	0.808	C0751495	Seizures,Focal	phenotype	C23;C10	DiseaseorSyndrome	0.30	1	2006	2006	1	0	CTD_human
val	1244	ABCC2	0.483	0.808	C0751496	Seizures,Sensory	phenotype	C23;C10	SignorSymptom	0.30	1	2006	2006	1	0	CTD_human
val	1244	ABCC2	0.483	0.808	C0751522	StatusEpilepticus,Subclinical	disease	C23;C10	DiseaseorSyndrome	0.30	1	2006	2006	1	0	CTD_human
val	1244	ABCC2	0.483	0.808	C0751523	Non-ConvulsiveStatusEpilepticus	disease	C23;C10	DiseaseorSyndrome	0.30	1	2006	2006	1	0	CTD_human
val	1244	ABCC2	0.483	0.808	C0751524	SimplePartialStatusEpilepticus	phenotype	C23;C10	DiseaseorSyndrome	0.30	1	2006	2006	1	0	CTD_human
val	1244	ABCC2	0.483	0.808	C0860207	Drug-InducedLiverDisease	phenotype	C06;C25	DiseaseorSyndrome	0.36	0.875	2008	2020	2	0	CTD_human
val	1244	ABCC2	0.483	0.808	C1168401	Squamouscellcarcinomaoftheheadandneck	disease	C04	NeoplasticProcess	0.32	1	2014	2019	1	0	CTD_human
val	1244	ABCC2	0.483	0.808	C1262760	Hepatitis,Drug-Induced	disease	C06;C25	DiseaseorSyndrome	0.30	1	2008	2008	2	0	CTD_human
val	1244	ABCC2	0.483	0.808	C1565321	CholeraInfantum	disease	C06	DiseaseorSyndrome	0.30	1	2008	2008	1	0	CTD_human
val	1244	ABCC2	0.483	0.808	C3241937	NonalcoholicSteatohepatitis	disease	C06	DiseaseorSyndrome	0.30	1	2018	2018	1	0	CTD_human
val	1244	ABCC2	0.483	0.808	C3495874	NonepilepticSeizures	phenotype	C23;C10	DiseaseorSyndrome	0.30	1	2006	2006	1	0	CTD_human
val	1244	ABCC2	0.483	0.808	C3658290	Drug-InducedAcuteLiverInjury	disease	C06;C25	DiseaseorSyndrome	0.30	1	2008	2008	2	0	CTD_human
val	1244	ABCC2	0.483	0.808	C4048158	Convulsions	phenotype	C23;C10	SignorSymptom	0.31	1	2006	2020	1	0	CTD_human
val	1244	ABCC2	0.483	0.808	C4083212	Alopecia,MalePattern	disease	C23;C17	DiseaseorSyndrome	0.30	1	2008	2008	1	0	CTD_human
val	1244	ABCC2	0.483	0.808	C4277682	ChemicalandDrugInducedLiverInjury	disease	C06;C25	DiseaseorSyndrome	0.30	1	2008	2008	2	0	CTD_human
val	1244	ABCC2	0.483	0.808	C4279912	Chemically-InducedLiverToxicity	disease	C06;C25	DiseaseorSyndrome	0.30	1	2008	2008	2	0	CTD_human
val	1244	ABCC2	0.483	0.808	C4316903	AbsenceSeizures	phenotype	C23;C10	DiseaseorSyndrome	0.30	1	2006	2006	1	0	CTD_human
val	1244	ABCC2	0.483	0.808	C4317109	EpilepticSeizures	phenotype	C23;C10	DiseaseorSyndrome	0.30	1	2006	2006	1	0	CTD_human
val	1244	ABCC2	0.483	0.808	C4317123	MyoclonicSeizures	phenotype	C23;C10	SignorSymptom	0.30	1	2006	2006	1	0	CTD_human
val	1244	ABCC2	0.483	0.808	C4505436	GeneralizedAbsenceSeizures	phenotype	C23;C10	DiseaseorSyndrome	0.30	1	2006	2006	1	0	CTD_human
val	1244	ABCC2	0.483	0.808	C4551595	BiliaryCirrhosis,Primary,1	disease	C23;C06	DiseaseorSyndrome	0.30	1	2004	2004	1	0	CTD_human
val	1258	CNGB1	0.628	0.538	C0015397	Disorderofeye	group	C11	DiseaseorSyndrome	0.30				0	0	GENOMICS_ENGLAND
val	1258	CNGB1	0.628	0.538	C0035334	RetinitisPigmentosa	disease	C16;C11	DiseaseorSyndrome	0.68	1	2001	2019	1	12	CTD_human;GENOMICS_ENGLAND
val	1258	CNGB1	0.628	0.538	C3151066	RETINITISPIGMENTOSA45	disease		DiseaseorSyndrome	0.70	1	2001	2001	1	3	CTD_human;GENOMICS_ENGLAND;UNIPROT
val	1259	CNGA1	0.695	0.269	C0015397	Disorderofeye	group	C11	DiseaseorSyndrome	0.30				0	0	GENOMICS_ENGLAND
val	1259	CNGA1	0.695	0.269	C0035334	RetinitisPigmentosa	disease	C16;C11	DiseaseorSyndrome	0.64	1	1995	2019	1	0	CTD_human;GENOMICS_ENGLAND
val	1259	CNGA1	0.695	0.269	C3151059	RETINITISPIGMENTOSA49	disease		DiseaseorSyndrome	0.70	1	1995	2014	2	0	CTD_human;GENOMICS_ENGLAND;UNIPROT
val	1260	CNGA2	0.931	0.154	C0006142	Malignantneoplasmofbreast	disease	C04;C17	NeoplasticProcess	0.30				0	2	UNIPROT
val	1260	CNGA2	0.931	0.154	C0393778	Congenitalanosmia	disease	C23;C10	CongenitalAbnormality	0.32	1	2015	2017	1	0	ORPHANET
val	1261	CNGA3	0.65	0.154	C0009398	Colorvisiondefect	phenotype	C23;C11;C10	DiseaseorSyndrome	0.43	1	2004	2018	1	0	CTD_human
val	1261	CNGA3	0.65	0.154	C0015397	Disorderofeye	group	C11	DiseaseorSyndrome	0.31	1	2014	2017	1	0	GENOMICS_ENGLAND
val	1261	CNGA3	0.65	0.154	C0152200	Achromatopsia	disease	C23;C11;C10	DiseaseorSyndrome	0.80	0.982	2000	2019	1	17	CTD_human;GENOMICS_ENGLAND;ORPHANET
val	1261	CNGA3	0.65	0.154	C0155015	ColorBlindness,Red	disease	C23;C11;C10	DiseaseorSyndrome	0.30	1	2018	2018	1	0	CTD_human
val	1261	CNGA3	0.65	0.154	C0155016	ColorBlindness,Red-Green	disease	C23;C11;C10	DiseaseorSyndrome	0.30	1	2018	2018	1	0	CTD_human
val	1261	CNGA3	0.65	0.154	C0155017	ColorBlindness,Blue	disease	C23;C11;C10	DiseaseorSyndrome	0.30	1	2018	2018	1	0	CTD_human
val	1261	CNGA3	0.65	0.154	C0155018	ColorBlindness,Acquired	disease	C23;C11;C10	DiseaseorSyndrome	0.30	1	2018	2018	1	0	CTD_human
val	1261	CNGA3	0.65	0.154	C0239777	ColorBlindness,Green	phenotype	C23;C11;C10	DiseaseorSyndrome	0.30	1	2018	2018	1	0	CTD_human
val	1261	CNGA3	0.65	0.154	C0242225	Colorblindness	disease	C23;C11;C10	DiseaseorSyndrome	0.31	1	2008	2018	1	0	CTD_human
val	1261	CNGA3	0.65	0.154	C0751042	ColorBlindness,Inherited	disease	C23;C11;C10	DiseaseorSyndrome	0.30	1	2018	2018	1	0	CTD_human
val	1261	CNGA3	0.65	0.154	C0751043	Monochromatopsia	phenotype	C23;C11;C10	DiseaseorSyndrome	0.30	1	2018	2018	1	0	CTD_human
val	1261	CNGA3	0.65	0.154	C1857618	Achromatopsia2	disease	C23;C11;C10	DiseaseorSyndrome	0.94	1	1998	2019	9	43	CTD_human;GENOMICS_ENGLAND;UNIPROT
val	1261	CNGA3	0.65	0.154	C3489532	Cone-RodDystrophy2	disease	C16;C11	DiseaseorSyndrome	0.32	1	2015	2019	1	0	ORPHANET
val	1265	CNN2	0.666	0.538	C0007134	RenalCellCarcinoma	disease	C04;C13;C12	NeoplasticProcess	0.30	1	2004	2004	1	0	CTD_human
val	1265	CNN2	0.666	0.538	C0279702	Conventional(ClearCell)RenalCellCarcinoma	disease	C04;C13;C12	NeoplasticProcess	0.30	1	2004	2004	1	0	CTD_human
val	1265	CNN2	0.666	0.538	C1266042	ChromophobeRenalCellCarcinoma	disease	C04;C13;C12	NeoplasticProcess	0.30	1	2004	2004	1	0	CTD_human
val	1265	CNN2	0.666	0.538	C1266043	SarcomatoidRenalCellCarcinoma	disease	C04;C13;C12	NeoplasticProcess	0.30	1	2004	2004	1	0	CTD_human
val	1265	CNN2	0.666	0.538	C1266044	CollectingDuctCarcinomaoftheKidney	disease	C04;C13;C12	NeoplasticProcess	0.30	1	2004	2004	1	0	CTD_human
val	1265	CNN2	0.666	0.538	C1306837	PapillaryRenalCellCarcinoma	disease	C04;C13;C12	NeoplasticProcess	0.30	1	2004	2004	1	0	CTD_human
val	1266	CNN3	0.705	0.462	C0007097	Carcinoma	group	C04	NeoplasticProcess	0.30	1	2002	2002	1	0	CTD_human
val	1266	CNN3	0.705	0.462	C0024667	AnimalMammaryNeoplasms	phenotype	C04;C22	NeoplasticProcess	0.30	1	2002	2002	1	0	CTD_human
val	1266	CNN3	0.705	0.462	C0024668	MammaryNeoplasms,Experimental	phenotype	C04	NeoplasticProcess;ExperimentalModelofDisease	0.30	1	2002	2002	1	0	CTD_human
val	1266	CNN3	0.705	0.462	C0033578	ProstaticNeoplasms	group	C04;C12	NeoplasticProcess	0.30	1	2007	2007	1	0	CTD_human
val	1266	CNN3	0.705	0.462	C0205696	Anaplasticcarcinoma	disease	C04	NeoplasticProcess	0.30	1	2002	2002	1	0	CTD_human
val	1266	CNN3	0.705	0.462	C0205697	Carcinoma,Spindle-Cell	disease	C04	NeoplasticProcess	0.30	1	2002	2002	1	0	CTD_human
val	1266	CNN3	0.705	0.462	C0205698	Undifferentiatedcarcinoma	disease	C04	NeoplasticProcess	0.30	1	2002	2002	1	0	CTD_human
val	1266	CNN3	0.705	0.462	C0205699	Carcinomatosis	phenotype	C04	NeoplasticProcess	0.30	1	2002	2002	1	0	CTD_human
val	1266	CNN3	0.705	0.462	C0376358	Malignantneoplasmofprostate	disease	C04;C12	NeoplasticProcess	0.30	1	2007	2007	1	0	CTD_human
val	1266	CNN3	0.705	0.462	C1257925	MammaryCarcinoma,Animal	disease	C04;C22	NeoplasticProcess	0.30	1	2002	2002	1	0	CTD_human
val	1267	CNP	0.604	0.692	C0023893	LiverCirrhosis,Experimental	disease	C23;C06	ExperimentalModelofDisease	0.30	1	2014	2014	1	0	CTD_human
val	1267	CNP	0.604	0.692	C0036341	Schizophrenia	disease	F03	MentalorBehavioralDysfunction	0.40	0.4	2006	2018	5	0	PSYGENET
val	1267	CNP	0.604	0.692	C0041696	UnipolarDepression	disease	F03	MentalorBehavioralDysfunction	0.30	1	2011	2011	1	0	PSYGENET
val	1267	CNP	0.604	0.692	C1269683	MajorDepressiveDisorder	disease	F03	MentalorBehavioralDysfunction	0.31	1	2011	2015	1	0	PSYGENET
val	1268	CNR1	0.446	0.808	C0001973	AlcoholicIntoxication,Chronic	disease	C25;F03	MentalorBehavioralDysfunction	0.37	1	2002	2014	5	0	PSYGENET
val	1268	CNR1	0.446	0.808	C0003469	AnxietyDisorders	group	F03	MentalorBehavioralDysfunction	0.40	1	2004	2019	2	0	CTD_human
val	1268	CNR1	0.446	0.808	C0005586	BipolarDisorder	disease	F03	MentalorBehavioralDysfunction	0.32	0.5	2010	2013	2	0	PSYGENET
val	1268	CNR1	0.446	0.808	C0006868	CannabisAbuse	disease	C25;F03	MentalorBehavioralDysfunction	0.31	0.5	2009	2016	1	0	CTD_human
val	1268	CNR1	0.446	0.808	C0006870	CannabisDependence	disease	C25;F03	MentalorBehavioralDysfunction	0.37	1	2006	2016	1	0	CTD_human
val	1268	CNR1	0.446	0.808	C0007370	Catalepsy	disease	C23;C10	MentalorBehavioralDysfunction	0.30	1	1999	1999	1	0	CTD_human
val	1268	CNR1	0.446	0.808	C0009171	CocaineAbuse	disease	C25;F03	MentalorBehavioralDysfunction	0.31	1	2006	2017	3	0	CTD_human
val	1268	CNR1	0.446	0.808	C0011570	MentalDepression	disease	F01	MentalorBehavioralDysfunction	0.40	1	2005	2019	5	0	PSYGENET
val	1268	CNR1	0.446	0.808	C0011581	Depressivedisorder	disease	F03	MentalorBehavioralDysfunction	0.40	1	2005	2019	5	0	PSYGENET
val	1268	CNR1	0.446	0.808	C0013146	Drugabuse	group	C25;F03	MentalorBehavioralDysfunction	0.32	1	1999	2017	3	0	CTD_human
val	1268	CNR1	0.446	0.808	C0013170	Drughabituation	phenotype	C25;F03	MentalorBehavioralDysfunction	0.30	1	1999	2011	3	0	CTD_human
val	1268	CNR1	0.446	0.808	C0013222	DrugUseDisorders	group	C25;F03	MentalorBehavioralDysfunction	0.30	1	1999	2011	3	0	CTD_human
val	1268	CNR1	0.446	0.808	C0014175	Endometriosis	disease	C13	DiseaseorSyndrome	0.30	1	2011	2011	1	0	CTD_human
val	1268	CNR1	0.446	0.808	C0014556	Epilepsy,TemporalLobe	disease	C10	DiseaseorSyndrome	0.30	1	2010	2010	1	0	CTD_human
val	1268	CNR1	0.446	0.808	C0014558	UncinateEpilepsy	disease	C10	DiseaseorSyndrome	0.30	1	2010	2010	1	0	CTD_human
val	1268	CNR1	0.446	0.808	C0018614	HashishAbuse	disease	C25;F03	DiseaseorSyndrome	0.30	1	2009	2009	1	0	CTD_human
val	1268	CNR1	0.446	0.808	C0020179	HuntingtonDisease	disease	C16;C10;F03	DiseaseorSyndrome	0.36	1	2009	2019	1	0	CTD_human
val	1268	CNR1	0.446	0.808	C0020429	Hyperalgesia	phenotype	C23;C10	SignorSymptom	0.32	1	2007	2018	1	0	CTD_human
val	1268	CNR1	0.446	0.808	C0020649	Hypotension	phenotype	C14	Finding	0.50	1	1999	2009	1	0	CTD_human
val	1268	CNR1	0.446	0.808	C0020672	Hypothermia,natural	phenotype	C23	Finding	0.30	1	1999	1999	1	0	CTD_human
val	1268	CNR1	0.446	0.808	C0022333	JacksonianSeizure	disease	C23;C10	DiseaseorSyndrome	0.30	1	2003	2003	1	0	CTD_human
val	1268	CNR1	0.446	0.808	C0023890	LiverCirrhosis	disease	C23;C06	DiseaseorSyndrome	0.31	1	2001	2011	2	0	CTD_human
val	1268	CNR1	0.446	0.808	C0023893	LiverCirrhosis,Experimental	disease	C23;C06	ExperimentalModelofDisease	0.30	1	2006	2006	1	0	CTD_human
val	1268	CNR1	0.446	0.808	C0024809	MarijuanaAbuse	disease	C25;F03	MentalorBehavioralDysfunction	0.40	1	1997	2019	1	0	CTD_human
val	1268	CNR1	0.446	0.808	C0026650	MovementDisorders	group	C10	DiseaseorSyndrome	0.30	1	2000	2000	1	0	CTD_human
val	1268	CNR1	0.446	0.808	C0026769	MultipleSclerosis	disease	C20;C10	DiseaseorSyndrome	0.37	1	2003	2019	1	0	CTD_human
val	1268	CNR1	0.446	0.808	C0026838	MuscleSpasticity	phenotype	C23;C05;C10	SignorSymptom	0.30	1	2007	2007	1	0	CTD_human
val	1268	CNR1	0.446	0.808	C0027746	NerveDegeneration	phenotype	C23	CellorMolecularDysfunction	0.50	1	2001	2014	2	0	CTD_human
val	1268	CNR1	0.446	0.808	C0028754	Obesity	disease	C23;C18	DiseaseorSyndrome	0.60	0.982	2005	2020	1	0	CTD_human
val	1268	CNR1	0.446	0.808	C0029231	OrganicMentalDisorders,Substance-Induced	disease	C25;F03	MentalorBehavioralDysfunction	0.30	1	1999	2011	3	0	CTD_human
val	1268	CNR1	0.446	0.808	C0030193	Pain	phenotype	C23	SignorSymptom	0.60	1	2009	2020	1	0	CTD_human
val	1268	CNR1	0.446	0.808	C0030297	PancreaticNeoplasm	disease	C06;C04;C19	NeoplasticProcess	0.30	1	2006	2006	1	0	CTD_human
val	1268	CNR1	0.446	0.808	C0030305	Pancreatitis	disease	C06	DiseaseorSyndrome	0.30	1	2007	2007	1	0	CTD_human
val	1268	CNR1	0.446	0.808	C0035412	Rhabdomyosarcoma	disease	C04	NeoplasticProcess	0.31	1	2009	2009	1	0	CTD_human
val	1268	CNR1	0.446	0.808	C0036341	Schizophrenia	disease	F03	MentalorBehavioralDysfunction	0.60	0.951	2000	2019	1	0	CTD_human
val	1268	CNR1	0.446	0.808	C0036572	Seizures	phenotype	C23;C10	SignorSymptom	0.37	0.75	2003	2019	1	0	CTD_human
val	1268	CNR1	0.446	0.808	C0038220	StatusEpilepticus	disease	C23;C10	DiseaseorSyndrome	0.51	1	2009	2018	1	0	CTD_human
val	1268	CNR1	0.446	0.808	C0038580	SubstanceDependence	disease	C25;F03	MentalorBehavioralDysfunction	0.35	1	1999	2013	3	0	CTD_human
val	1268	CNR1	0.446	0.808	C0038586	SubstanceUseDisorders	group	C25;F03	MentalorBehavioralDysfunction	0.34	1	1999	2019	3	0	CTD_human
val	1268	CNR1	0.446	0.808	C0038587	SubstanceWithdrawalSyndrome	disease	C25;F03	MentalorBehavioralDysfunction	0.30	1	2008	2008	1	0	CTD_human
val	1268	CNR1	0.446	0.808	C0041671	AttentionDeficitDisorder	disease	F03	MentalorBehavioralDysfunction	0.30	1	2011	2011	1	0	CTD_human
val	1268	CNR1	0.446	0.808	C0041696	UnipolarDepression	disease	F03	MentalorBehavioralDysfunction	0.34	1	2008	2015	4	0	PSYGENET
val	1268	CNR1	0.446	0.808	C0043094	WeightGain	phenotype	C23	Finding	0.30	1	2010	2010	1	0	CTD_human
val	1268	CNR1	0.446	0.808	C0086189	DrugWithdrawalSymptoms	phenotype	C25;F03	SignorSymptom	0.30	1	2008	2008	1	0	CTD_human
val	1268	CNR1	0.446	0.808	C0087169	WithdrawalSymptoms	phenotype	C25;F03	SignorSymptom	0.30	1	2008	2008	1	0	CTD_human
val	1268	CNR1	0.446	0.808	C0149958	Complexpartialseizures	disease	C23;C10	DiseaseorSyndrome	0.30	1	2003	2003	1	0	CTD_human
val	1268	CNR1	0.446	0.808	C0151779	CutaneousMelanoma	disease	C04;C17	NeoplasticProcess	0.31	1	2017	2017	1	0	CTD_human
val	1268	CNR1	0.446	0.808	C0233612	Waxyflexibility	phenotype	C23;C10	SignorSymptom	0.30	1	1999	1999	1	0	CTD_human
val	1268	CNR1	0.446	0.808	C0234230	Pain,Burning	phenotype	C23	SignorSymptom	0.30	1	2009	2009	1	0	CTD_human
val	1268	CNR1	0.446	0.808	C0234238	Ache	phenotype	C23	SignorSymptom	0.30	1	2009	2009	1	0	CTD_human
val	1268	CNR1	0.446	0.808	C0234254	Radiatingpain	phenotype	C23	SignorSymptom	0.30	1	2009	2009	1	0	CTD_human
val	1268	CNR1	0.446	0.808	C0234533	Generalizedseizures	disease	C23;C10	DiseaseorSyndrome	0.30	1	2003	2003	1	0	CTD_human
val	1268	CNR1	0.446	0.808	C0234535	ClonicSeizures	disease	C23;C10	DiseaseorSyndrome	0.30	1	2003	2003	1	0	CTD_human
val	1268	CNR1	0.446	0.808	C0236735	Cannabis-RelatedDisorder	group	C25;F03	MentalorBehavioralDysfunction	0.30	1	2009	2009	1	0	CTD_human
val	1268	CNR1	0.446	0.808	C0236736	Cocaine-RelatedDisorders	group	C25;F03	MentalorBehavioralDysfunction	0.30	1	2006	2009	3	0	CTD_human
val	1268	CNR1	0.446	0.808	C0236969	Substance-RelatedDisorders	group	C25;F03	MentalorBehavioralDysfunction	0.30	1	1999	2011	3	0	CTD_human
val	1268	CNR1	0.446	0.808	C0239946	Fibrosis,Liver	disease	C23;C06	DiseaseorSyndrome	0.32	1	2001	2017	2	0	CTD_human
val	1268	CNR1	0.446	0.808	C0266487	EtatMarbre	disease	C10	DiseaseorSyndrome	0.30	1	2000	2000	1	0	CTD_human
val	1268	CNR1	0.446	0.808	C0269102	Endometrioma	disease	C13	NeoplasticProcess	0.30	1	2011	2011	1	0	CTD_human
val	1268	CNR1	0.446	0.808	C0270823	Petitmalstatus	disease	C23;C10	DiseaseorSyndrome	0.30	1	2009	2009	1	0	CTD_human
val	1268	CNR1	0.446	0.808	C0270824	Visualseizure	disease	C23;C10	DiseaseorSyndrome	0.30	1	2003	2003	1	0	CTD_human
val	1268	CNR1	0.446	0.808	C0270844	TonicSeizures	phenotype	C23;C10	DiseaseorSyndrome	0.30	1	2003	2003	1	0	CTD_human
val	1268	CNR1	0.446	0.808	C0270846	Epilepticdropattack	disease	C23;C10	DiseaseorSyndrome	0.30	1	2003	2003	1	0	CTD_human
val	1268	CNR1	0.446	0.808	C0277820	Clasp-KnifeSpasticity	phenotype	C23;C05;C10	SignorSymptom	0.30	1	2007	2007	1	0	CTD_human
val	1268	CNR1	0.446	0.808	C0311335	GrandMalStatusEpilepticus	disease	C23;C10	DiseaseorSyndrome	0.30	1	2009	2009	1	0	CTD_human
val	1268	CNR1	0.446	0.808	C0346647	Malignantneoplasmofpancreas	disease	C06;C04;C19	NeoplasticProcess	0.30	1	2006	2006	1	0	CTD_human
val	1268	CNR1	0.446	0.808	C0376280	AnxietyStates,Neurotic	disease	F03	MentalorBehavioralDysfunction	0.30	1	2004	2008	2	0	CTD_human
val	1268	CNR1	0.446	0.808	C0393574	HuntingtonDisease,LateOnset	disease	C16;C10;F03	DiseaseorSyndrome	0.30	1	2011	2011	1	0	CTD_human
val	1268	CNR1	0.446	0.808	C0393672	Epilepsy,BenignPsychomotor,Childhood	disease	C10	DiseaseorSyndrome	0.30	1	2010	2010	1	0	CTD_human
val	1268	CNR1	0.446	0.808	C0393682	Epilepsy,LateralTemporal	disease	C10	DiseaseorSyndrome	0.30	1	2010	2010	1	0	CTD_human
val	1268	CNR1	0.446	0.808	C0393734	ComplexPartialStatusEpilepticus	disease	C23;C10	DiseaseorSyndrome	0.30	1	2009	2009	1	0	CTD_human
val	1268	CNR1	0.446	0.808	C0422850	Seizures,Somatosensory	phenotype	C23;C10	PathologicFunction	0.30	1	2003	2003	1	0	CTD_human
val	1268	CNR1	0.446	0.808	C0422852	Seizures,Auditory	phenotype	C23;C10	PathologicFunction	0.30	1	2003	2003	1	0	CTD_human
val	1268	CNR1	0.446	0.808	C0422853	Olfactoryseizure	phenotype	C23;C10	DiseaseorSyndrome	0.30	1	2003	2003	1	0	CTD_human
val	1268	CNR1	0.446	0.808	C0422854	Gustatoryseizure	phenotype	C23;C10	SignorSymptom	0.30	1	2003	2003	1	0	CTD_human
val	1268	CNR1	0.446	0.808	C0422855	Vertiginousseizure	phenotype	C23;C10	DiseaseorSyndrome	0.30	1	2003	2003	1	0	CTD_human
val	1268	CNR1	0.446	0.808	C0443306	Spastic	disease	C23;C05;C10	MentalorBehavioralDysfunction	0.30	1	2007	2007	1	0	CTD_human
val	1268	CNR1	0.446	0.808	C0458247	Allodynia	phenotype	C23;C10	Finding	0.30	1	2007	2007	1	0	CTD_human
val	1268	CNR1	0.446	0.808	C0458257	Pain,Splitting	phenotype	C23	SignorSymptom	0.30	1	2009	2009	1	0	CTD_human
val	1268	CNR1	0.446	0.808	C0458259	Pain,Crushing	phenotype	C23	SignorSymptom	0.30	1	2009	2009	1	0	CTD_human
val	1268	CNR1	0.446	0.808	C0494475	Tonic-clonicseizures	disease	C23;C10	DiseaseorSyndrome	0.30	1	2003	2003	1	0	CTD_human
val	1268	CNR1	0.446	0.808	C0596170	Bingeeatingdisorder	phenotype	F03	MentalorBehavioralDysfunction	0.30	1	2013	2013	1	0	CTD_human
val	1268	CNR1	0.446	0.808	C0600427	CocaineDependence	disease	C25;F03	MentalorBehavioralDysfunction	0.53	1	2006	2013	4	0	CTD_human;PSYGENET
val	1268	CNR1	0.446	0.808	C0740858	Substanceabuseproblem	disease	C25;F03	MentalorBehavioralDysfunction	0.34	1	1999	2020	3	0	CTD_human
val	1268	CNR1	0.446	0.808	C0751056	Non-epilepticconvulsion	phenotype	C23;C10	SignorSymptom	0.30	1	2003	2003	1	0	CTD_human
val	1268	CNR1	0.446	0.808	C0751110	SingleSeizure	disease	C23;C10	DiseaseorSyndrome	0.30	1	2003	2003	1	0	CTD_human
val	1268	CNR1	0.446	0.808	C0751123	AtonicAbsenceSeizures	phenotype	C23;C10	DiseaseorSyndrome	0.30	1	2003	2003	1	0	CTD_human
val	1268	CNR1	0.446	0.808	C0751207	Akinetic-RigidVariantofHuntingtonDisease	disease	C16;C10;F03	DiseaseorSyndrome	0.30	1	2011	2011	1	0	CTD_human
val	1268	CNR1	0.446	0.808	C0751208	JuvenileHuntingtonDisease	disease	C16;C10;F03	DiseaseorSyndrome	0.30	1	2011	2011	1	0	CTD_human
val	1268	CNR1	0.446	0.808	C0751211	Hyperalgesia,Primary	phenotype	C23;C10	SignorSymptom	0.30	1	2007	2007	1	0	CTD_human
val	1268	CNR1	0.446	0.808	C0751212	Hyperalgesia,Secondary	phenotype	C23;C10	SignorSymptom	0.30	1	2007	2007	1	0	CTD_human
val	1268	CNR1	0.446	0.808	C0751213	TactileAllodynia	phenotype	C23;C10	SignorSymptom	0.30	1	2007	2007	1	0	CTD_human
val	1268	CNR1	0.446	0.808	C0751214	Hyperalgesia,Thermal	phenotype	C23;C10	SignorSymptom	0.30	1	2007	2007	1	0	CTD_human
val	1268	CNR1	0.446	0.808	C0751324	MultipleSclerosis,AcuteFulminating	disease	C20;C10	DiseaseorSyndrome	0.30	1	2003	2003	1	0	CTD_human
val	1268	CNR1	0.446	0.808	C0751407	Pain,Migratory	phenotype	C23	SignorSymptom	0.30	1	2009	2009	1	0	CTD_human
val	1268	CNR1	0.446	0.808	C0751408	Suffering,Physical	phenotype	C23	SignorSymptom	0.30	1	2009	2009	1	0	CTD_human
val	1268	CNR1	0.446	0.808	C0751494	ConvulsiveSeizures	phenotype	C23;C10	SignorSymptom	0.30	1	2003	2003	1	0	CTD_human
val	1268	CNR1	0.446	0.808	C0751495	Seizures,Focal	phenotype	C23;C10	DiseaseorSyndrome	0.30	1	2003	2003	1	0	CTD_human
val	1268	CNR1	0.446	0.808	C0751496	Seizures,Sensory	phenotype	C23;C10	SignorSymptom	0.30	1	2003	2003	1	0	CTD_human
val	1268	CNR1	0.446	0.808	C0751522	StatusEpilepticus,Subclinical	disease	C23;C10	DiseaseorSyndrome	0.30	1	2009	2009	1	0	CTD_human
val	1268	CNR1	0.446	0.808	C0751523	Non-ConvulsiveStatusEpilepticus	disease	C23;C10	DiseaseorSyndrome	0.30	1	2009	2009	1	0	CTD_human
val	1268	CNR1	0.446	0.808	C0751524	SimplePartialStatusEpilepticus	phenotype	C23;C10	DiseaseorSyndrome	0.30	1	2009	2009	1	0	CTD_human
val	1268	CNR1	0.446	0.808	C1263846	Attentiondeficithyperactivitydisorder	disease	F03	MentalorBehavioralDysfunction	0.33	1	2008	2019	1	0	CTD_human
val	1268	CNR1	0.446	0.808	C1269683	MajorDepressiveDisorder	disease	F03	MentalorBehavioralDysfunction	0.35	1	2008	2018	4	0	PSYGENET
val	1268	CNR1	0.446	0.808	C1279420	Anxietyneurosis(finding)	disease	F03	MentalorBehavioralDysfunction	0.30	1	2004	2008	2	0	CTD_human
val	1268	CNR1	0.446	0.808	C1321905	MinimalBrainDysfunction	disease	F03	MentalorBehavioralDysfunction	0.30	1	2011	2011	1	0	CTD_human
val	1268	CNR1	0.446	0.808	C1510472	DrugDependence	group	C25;F03	MentalorBehavioralDysfunction	0.38	1	1997	2019	3	0	CTD_human
val	1268	CNR1	0.446	0.808	C2936719	MechanicalAllodynia	phenotype	C23;C10	SignorSymptom	0.30	1	2007	2007	1	0	CTD_human
val	1268	CNR1	0.446	0.808	C3495874	NonepilepticSeizures	phenotype	C23;C10	DiseaseorSyndrome	0.30	1	2003	2003	1	0	CTD_human
val	1268	CNR1	0.446	0.808	C4048158	Convulsions	phenotype	C23;C10	SignorSymptom	0.31	0.5	2003	2019	1	0	CTD_human
val	1268	CNR1	0.446	0.808	C4316881	PrescriptionDrugAbuse	phenotype	C25;F03	Finding	0.30	1	1999	2011	3	0	CTD_human
val	1268	CNR1	0.446	0.808	C4316903	AbsenceSeizures	phenotype	C23;C10	DiseaseorSyndrome	0.30	1	2003	2003	1	0	CTD_human
val	1268	CNR1	0.446	0.808	C4317109	EpilepticSeizures	phenotype	C23;C10	DiseaseorSyndrome	0.31	1	2003	2019	1	0	CTD_human
val	1268	CNR1	0.446	0.808	C4317123	MyoclonicSeizures	phenotype	C23;C10	SignorSymptom	0.30	1	2003	2003	1	0	CTD_human
val	1268	CNR1	0.446	0.808	C4505436	GeneralizedAbsenceSeizures	phenotype	C23;C10	DiseaseorSyndrome	0.30	1	2003	2003	1	0	CTD_human
val	1269	CNR2	0.509	0.846	C0001973	AlcoholicIntoxication,Chronic	disease	C25;F03	MentalorBehavioralDysfunction	0.31	1	2007	2007	1	0	PSYGENET
val	1269	CNR2	0.509	0.846	C0004153	Atherosclerosis	disease	C14	DiseaseorSyndrome	0.36	1	2005	2019	1	0	CTD_human
val	1269	CNR2	0.509	0.846	C0005586	BipolarDisorder	disease	F03	MentalorBehavioralDysfunction	0.32	1	2011	2019	1	0	PSYGENET
val	1269	CNR2	0.509	0.846	C0006142	Malignantneoplasmofbreast	disease	C04;C17	NeoplasticProcess	0.33	1	2006	2017	1	0	CTD_human
val	1269	CNR2	0.509	0.846	C0011570	MentalDepression	disease	F01	MentalorBehavioralDysfunction	0.35	1	2006	2019	5	0	PSYGENET
val	1269	CNR2	0.509	0.846	C0011573	Endogenousdepression	disease	F03	MentalorBehavioralDysfunction	0.30	1	2008	2008	1	0	CTD_human
val	1269	CNR2	0.509	0.846	C0011581	Depressivedisorder	disease	F03	MentalorBehavioralDysfunction	0.55	1	2006	2019	5	0	CTD_human;PSYGENET
val	1269	CNR2	0.509	0.846	C0020429	Hyperalgesia	phenotype	C23;C10	SignorSymptom	0.31	1	2006	2008	2	0	CTD_human
val	1269	CNR2	0.509	0.846	C0021053	ImmuneSystemDiseases	group	C20	DiseaseorSyndrome	0.30	1	2006	2006	1	0	CTD_human
val	1269	CNR2	0.509	0.846	C0023467	Leukemia,Myelocytic,Acute	disease	C04	NeoplasticProcess	0.32	1	2003	2004	1	0	CTD_human
val	1269	CNR2	0.509	0.846	C0023890	LiverCirrhosis	disease	C23;C06	DiseaseorSyndrome	0.31	1	2005	2006	1	0	CTD_human
val	1269	CNR2	0.509	0.846	C0024809	MarijuanaAbuse	disease	C25;F03	MentalorBehavioralDysfunction	0.33	1	2014	2018	1	0	PSYGENET
val	1269	CNR2	0.509	0.846	C0025193	Melancholia	disease	F03	MentalorBehavioralDysfunction	0.30	1	2008	2008	1	0	CTD_human
val	1269	CNR2	0.509	0.846	C0026998	AcuteMyeloidLeukemia,M1	disease	C04	NeoplasticProcess	0.30	1	2004	2004	1	0	CTD_human
val	1269	CNR2	0.509	0.846	C0030297	PancreaticNeoplasm	disease	C06;C04;C19	NeoplasticProcess	0.30	1	2006	2006	1	0	CTD_human
val	1269	CNR2	0.509	0.846	C0030305	Pancreatitis	disease	C06	DiseaseorSyndrome	0.51	1	2007	2009	1	0	CTD_human
val	1269	CNR2	0.509	0.846	C0030569	SecondaryParkinsonDisease	disease	C10	DiseaseorSyndrome	0.30	1	2016	2016	1	0	CTD_human
val	1269	CNR2	0.509	0.846	C0036341	Schizophrenia	disease	F03	MentalorBehavioralDysfunction	0.34	0.75	2010	2017	4	0	PSYGENET
val	1269	CNR2	0.509	0.846	C0041696	UnipolarDepression	disease	F03	MentalorBehavioralDysfunction	0.30	1	2008	2008	1	0	CTD_human
val	1269	CNR2	0.509	0.846	C0085762	Alcoholabuse	disease	C25;F03	MentalorBehavioralDysfunction	0.31	1	2007	2007	1	0	PSYGENET
val	1269	CNR2	0.509	0.846	C0086133	DepressiveSyndrome	disease	F03	MentalorBehavioralDysfunction	0.30	1	2008	2008	1	0	CTD_human
val	1269	CNR2	0.509	0.846	C0239946	Fibrosis,Liver	disease	C23;C06	DiseaseorSyndrome	0.33	1	2005	2017	1	0	CTD_human
val	1269	CNR2	0.509	0.846	C0282126	Depression,Neurotic	disease	F03	MentalorBehavioralDysfunction	0.30	1	2008	2008	1	0	CTD_human
val	1269	CNR2	0.509	0.846	C0346647	Malignantneoplasmofpancreas	disease	C06;C04;C19	NeoplasticProcess	0.30	1	2006	2006	1	0	CTD_human
val	1269	CNR2	0.509	0.846	C0458247	Allodynia	phenotype	C23;C10	Finding	0.30	1	2007	2008	2	0	CTD_human
val	1269	CNR2	0.509	0.846	C0678222	BreastCarcinoma	disease	C04;C17	NeoplasticProcess	0.33	1	2006	2017	1	0	CTD_human
val	1269	CNR2	0.509	0.846	C0751211	Hyperalgesia,Primary	phenotype	C23;C10	SignorSymptom	0.30	1	2007	2008	2	0	CTD_human
val	1269	CNR2	0.509	0.846	C0751212	Hyperalgesia,Secondary	phenotype	C23;C10	SignorSymptom	0.30	1	2007	2008	2	0	CTD_human
val	1269	CNR2	0.509	0.846	C0751213	TactileAllodynia	phenotype	C23;C10	SignorSymptom	0.30	1	2007	2008	2	0	CTD_human
val	1269	CNR2	0.509	0.846	C0751214	Hyperalgesia,Thermal	phenotype	C23;C10	SignorSymptom	0.30	1	2007	2008	2	0	CTD_human
val	1269	CNR2	0.509	0.846	C0751414	ParkinsonDisease,SecondaryVascular	disease	C10	DiseaseorSyndrome	0.30	1	2016	2016	1	0	CTD_human
val	1269	CNR2	0.509	0.846	C0751415	AtheroscleroticParkinsonism	disease	C10	DiseaseorSyndrome	0.30	1	2016	2016	1	0	CTD_human
val	1269	CNR2	0.509	0.846	C1257931	MammaryNeoplasms,Human	disease	C04;C17	NeoplasticProcess	0.30	1	2006	2006	1	0	CTD_human
val	1269	CNR2	0.509	0.846	C1458155	MammaryNeoplasms	group	C04;C17	NeoplasticProcess	0.30	1	2006	2006	1	0	CTD_human
val	1269	CNR2	0.509	0.846	C1563937	Atherogenesis	phenotype	C14	PathologicFunction	0.30	1	2005	2005	1	0	CTD_human
val	1269	CNR2	0.509	0.846	C1879321	AcuteMyeloidLeukemia(AML-M2)	disease	C04	NeoplasticProcess	0.30	1	2004	2004	1	0	CTD_human
val	1269	CNR2	0.509	0.846	C2936719	MechanicalAllodynia	phenotype	C23;C10	SignorSymptom	0.32	1	2007	2019	2	0	CTD_human
val	1269	CNR2	0.509	0.846	C3160814	Cannabisuse	disease		MentalorBehavioralDysfunction	0.31	1	2014	2014	1	0	PSYGENET
val	1269	CNR2	0.509	0.846	C4704874	MammaryCarcinoma,Human	disease	C04;C17	NeoplasticProcess	0.30	1	2006	2006	1	0	CTD_human
val	1270	CNTF	0.561	0.615	C0011570	MentalDepression	disease	F01	MentalorBehavioralDysfunction	0.32	1	2004	2019	4	0	PSYGENET
val	1270	CNTF	0.561	0.615	C0011581	Depressivedisorder	disease	F03	MentalorBehavioralDysfunction	0.32	1	2004	2019	4	0	PSYGENET
val	1270	CNTF	0.561	0.615	C0027746	NerveDegeneration	phenotype	C23	CellorMolecularDysfunction	0.30	1	2004	2004	1	0	CTD_human
val	1270	CNTF	0.561	0.615	C0036341	Schizophrenia	disease	F03	MentalorBehavioralDysfunction	0.39	0.25	1996	2008	4	0	PSYGENET
val	1270	CNTF	0.561	0.615	C1862939	AMYOTROPHICLATERALSCLEROSIS1	disease	C18;C10	DiseaseorSyndrome	0.31	1	2002	2002	1	0	CTD_human
val	1270	CNTF	0.561	0.615	C1862941	AmyotrophicLateralSclerosis,Sporadic	disease	C18;C10	DiseaseorSyndrome	0.31	0	2002	2002	1	0	CTD_human
val	1270	CNTF	0.561	0.615	C2937358	CerebralHemorrhage	phenotype	C23;C10;C14	PathologicFunction	0.30	1	2001	2001	1	0	CTD_human
val	1270	CNTF	0.561	0.615	C4551993	AmyotrophicLateralSclerosis,Familial	disease	C18;C10	DiseaseorSyndrome	0.32	1	1995	2002	1	0	CTD_human
val	1272	CNTN1	0.599	0.577	C0009402	ColorectalCarcinoma	disease	C06;C04	NeoplasticProcess	0.30				0	0	UNIPROT
val	1272	CNTN1	0.599	0.577	C2675527	Myopathy,Congenital,Compton-North	disease	C16;C10	DiseaseorSyndrome	0.90	1	2008	2011	1	4	CTD_human;GENOMICS_ENGLAND;ORPHANET
val	1277	COL1A1	0.43	0.808	C0000786	Spontaneousabortion	phenotype	C13	PathologicFunction	0.30	1	2008	2008	1	0	CTD_human
val	1277	COL1A1	0.43	0.808	C0000822	Abortion,Tubal	phenotype	C13	PathologicFunction	0.30	1	2008	2008	1	0	CTD_human
val	1277	COL1A1	0.43	0.808	C0001787	Osteoporosis,Age-Related	disease	C18;C05	DiseaseorSyndrome	0.30				0	0	CTD_human
val	1277	COL1A1	0.43	0.808	C0002949	Aneurysm,Dissecting	disease	C14	DiseaseorSyndrome	0.40	1	1996	1996	1	0	CTD_human
val	1277	COL1A1	0.43	0.808	C0003504	AorticValveInsufficiency	disease	C14	DiseaseorSyndrome	0.30	1	2011	2011	1	0	CTD_human
val	1277	COL1A1	0.43	0.808	C0004364	AutoimmuneDiseases	group	C20	DiseaseorSyndrome	0.30	1	2014	2014	1	0	CTD_human
val	1277	COL1A1	0.43	0.808	C0005398	Cholestasis,Extrahepatic	disease	C06	DiseaseorSyndrome	0.30	1	2017	2017	1	0	CTD_human
val	1277	COL1A1	0.43	0.808	C0005779	BloodCoagulationDisorders	group	C15	DiseaseorSyndrome	0.30	1	2015	2015	1	0	GENOMICS_ENGLAND
val	1277	COL1A1	0.43	0.808	C0006663	Calcinosis	phenotype	C18	PathologicFunction	0.30	1	2011	2011	1	0	CTD_human
val	1277	COL1A1	0.43	0.808	C0008311	Cholangitis	disease	C06	DiseaseorSyndrome	0.30	1	2014	2014	1	0	CTD_human
val	1277	COL1A1	0.43	0.808	C0013720	Ehlers-DanlosSyndrome	disease	C16;C17;C15;C14	DiseaseorSyndrome	0.60	1	1991	2020	1	0	GENOMICS_ENGLAND
val	1277	COL1A1	0.43	0.808	C0016059	Fibrosis	phenotype	C23	PathologicFunction	0.30	1	2010	2010	1	0	CTD_human
val	1277	COL1A1	0.43	0.808	C0018824	Heartvalvedisease	group	C14	DiseaseorSyndrome	0.30	1	2011	2011	1	0	CTD_human
val	1277	COL1A1	0.43	0.808	C0020497	CorticalCongenitalHyperostosis	disease	C16;C05	DiseaseorSyndrome	0.77	1	1993	2019	3	8	CTD_human;GENOMICS_ENGLAND;UNIPROT
val	1277	COL1A1	0.43	0.808	C0020538	Hypertensivedisease	group	C14	DiseaseorSyndrome	0.40	1	2001	2001	1	0	CTD_human
val	1277	COL1A1	0.43	0.808	C0022548	Keloid	disease	C23;C17	AcquiredAbnormality	0.32	1	1993	2019	1	0	CTD_human
val	1277	COL1A1	0.43	0.808	C0023890	LiverCirrhosis	disease	C23;C06	DiseaseorSyndrome	0.32	1	2009	2018	4	0	CTD_human
val	1277	COL1A1	0.43	0.808	C0023893	LiverCirrhosis,Experimental	disease	C23;C06	ExperimentalModelofDisease	0.50	1	2005	2016	3	0	CTD_human
val	1277	COL1A1	0.43	0.808	C0023931	LobsteinDisease	disease	C16;C17;C05	DiseaseorSyndrome	1.00	0.976	1988	2019	15	191	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
val	1277	COL1A1	0.43	0.808	C0027719	Nephrosclerosis	disease	C13;C12	DiseaseorSyndrome	0.30	1	2019	2019	1	0	CTD_human
val	1277	COL1A1	0.43	0.808	C0027726	NephroticSyndrome	group	C13;C12	DiseaseorSyndrome	0.31	1	1992	2016	1	0	CTD_human
val	1277	COL1A1	0.43	0.808	C0029118	OpportunisticInfections	group	C01	DiseaseorSyndrome	0.30				0	0	GENOMICS_ENGLAND
val	1277	COL1A1	0.43	0.808	C0029172	OralSubmucousFibrosis	disease	C07	DiseaseorSyndrome	0.31	1	2002	2006	1	0	CTD_human
val	1277	COL1A1	0.43	0.808	C0029434	OsteogenesisImperfecta	disease	C16;C17;C05	DiseaseorSyndrome;CongenitalAbnormality	0.90	0.984	1985	2020	1	36	CTD_human;GENOMICS_ENGLAND
val	1277	COL1A1	0.43	0.808	C0029456	Osteoporosis	disease	C18;C05	DiseaseorSyndrome	0.70	1	1996	2017	0	0	CTD_human;GENOMICS_ENGLAND
val	1277	COL1A1	0.43	0.808	C0029459	Osteoporosis,Senile	disease	C18;C05	DiseaseorSyndrome	0.30				0	0	CTD_human
val	1277	COL1A1	0.43	0.808	C0149721	LeftVentricularHypertrophy	disease	C23;C14	DiseaseorSyndrome	0.30	1	2001	2001	1	0	CTD_human
val	1277	COL1A1	0.43	0.808	C0220679	Ehlers-DanlosSyndrome,AutosomalDominant,TypeUnspecified	disease	C16;C17;C15;C14	DiseaseorSyndrome	0.30	1	2000	2000	1	0	ORPHANET
val	1277	COL1A1	0.43	0.808	C0239946	Fibrosis,Liver	disease	C23;C06	DiseaseorSyndrome	0.40	0.929	2011	2019	4	0	CTD_human
val	1277	COL1A1	0.43	0.808	C0263628	Tumoralcalcinosis	disease	C18	DiseaseorSyndrome	0.30	1	2011	2011	1	0	CTD_human
val	1277	COL1A1	0.43	0.808	C0268345	EHLERS-DANLOSSYNDROME,ARTHROCHALASIATYPE	disease	C16;C18;C17;C15;C14	DiseaseorSyndrome	0.31	1	1991	1997	2	0	ORPHANET
val	1277	COL1A1	0.43	0.808	C0268358	Osteogenesisimperfecta,dominantperinatallethal	disease	C16;C17;C05	DiseaseorSyndrome;CongenitalAbnormality	0.89	1	1986	2019	38	61	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
val	1277	COL1A1	0.43	0.808	C0268362	OsteogenesisimperfectatypeIII(disorder)	disease	C16;C17;C05	DiseaseorSyndrome	0.99	1	1989	2018	17	31	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
val	1277	COL1A1	0.43	0.808	C0268363	OsteogenesisimperfectatypeIV(disorder)	disease		DiseaseorSyndrome;CongenitalAbnormality	0.97	1	1989	2018	12	33	GENOMICS_ENGLAND;ORPHANET;UNIPROT
val	1277	COL1A1	0.43	0.808	C0340643	Dissectionofaorta	disease	C14	DiseaseorSyndrome	0.30	1	1996	1996	1	0	CTD_human
val	1277	COL1A1	0.43	0.808	C0392784	DermatofibrosarcomaProtuberans	disease	C04	NeoplasticProcess	0.40	0.964	1997	2019	0	0	ORPHANET
val	1277	COL1A1	0.43	0.808	C0521174	Microcalcification	phenotype	C18	PathologicFunction	0.30	1	2011	2011	1	0	CTD_human
val	1277	COL1A1	0.43	0.808	C0751406	Post-TraumaticOsteoporosis	disease	C18;C05	DiseaseorSyndrome	0.30				0	0	CTD_human
val	1277	COL1A1	0.43	0.808	C0878659	Disproportionateshortstature	phenotype	C16;C05;C19	Finding	0.30				0	0	GENOMICS_ENGLAND
val	1277	COL1A1	0.43	0.808	C1458140	Bleedingtendency	phenotype	C15	PathologicFunction	0.30	1	2015	2015	1	0	GENOMICS_ENGLAND
val	1277	COL1A1	0.43	0.808	C1619692	NephrogenicFibrosingDermopathy	disease	C23;C17	DiseaseorSyndrome	0.30	1	2010	2010	1	0	CTD_human
val	1277	COL1A1	0.43	0.808	C1623038	Cirrhosis	disease	C23	DiseaseorSyndrome	0.31	1	2010	2018	1	0	CTD_human
val	1277	COL1A1	0.43	0.808	C1846545	AutoimmuneLymphoproliferativeSyndromeType2B	disease	C16;C20;C15	DiseaseorSyndrome	0.31	1	1991	2017	1	0	GENOMICS_ENGLAND
val	1277	COL1A1	0.43	0.808	C3830362	EarlyPregnancyLoss	phenotype	C13	Finding	0.30	1	2008	2008	1	0	CTD_human
val	1277	COL1A1	0.43	0.808	C4277533	Dissection,BloodVessel	phenotype	C14	PathologicFunction	0.30	1	1996	1996	1	0	CTD_human
val	1277	COL1A1	0.43	0.808	C4551623	EHLERS-DANLOSSYNDROME,ARTHROCHALASIATYPE,1	disease	C16;C17;C15;C14	DiseaseorSyndrome	0.60	1	1991	2016	4	11	CTD_human;GENOMICS_ENGLAND
val	1277	COL1A1	0.43	0.808	C4552122	EHLERS-DANLOSSYNDROME,CLASSICTYPE,1	disease		DiseaseorSyndrome	0.50	1	1991	2007	4	1	GENOMICS_ENGLAND;UNIPROT
val	1277	COL1A1	0.43	0.808	C4552766	Miscarriage	disease	C13	DiseaseorSyndrome	0.30	1	2008	2008	1	0	CTD_human
val	1277	COL1A1	0.43	0.808	C4707243	Familialthoracicaorticaneurysmandaorticdissection	disease		DiseaseorSyndrome	0.40				0	1	GENOMICS_ENGLAND
val	1278	COL1A2	0.486	0.846	C0000786	Spontaneousabortion	phenotype	C13	PathologicFunction	0.30	1	2008	2008	1	0	CTD_human
val	1278	COL1A2	0.486	0.846	C0000822	Abortion,Tubal	phenotype	C13	PathologicFunction	0.30	1	2008	2008	1	0	CTD_human
val	1278	COL1A2	0.486	0.846	C0001787	Osteoporosis,Age-Related	disease	C18;C05	DiseaseorSyndrome	0.30				0	0	CTD_human
val	1278	COL1A2	0.486	0.846	C0013720	Ehlers-DanlosSyndrome	disease	C16;C17;C15;C14	DiseaseorSyndrome	0.40	1	1987	2020	0	0	GENOMICS_ENGLAND
val	1278	COL1A2	0.486	0.846	C0016059	Fibrosis	phenotype	C23	PathologicFunction	0.30	1	2010	2010	1	0	CTD_human
val	1278	COL1A2	0.486	0.846	C0018824	Heartvalvedisease	group	C14	DiseaseorSyndrome	0.30	1	2004	2004	1	0	CTD_human
val	1278	COL1A2	0.486	0.846	C0023890	LiverCirrhosis	disease	C23;C06	DiseaseorSyndrome	0.31	1	2005	2016	1	0	CTD_human
val	1278	COL1A2	0.486	0.846	C0023893	LiverCirrhosis,Experimental	disease	C23;C06	ExperimentalModelofDisease	0.50	1	1993	2014	1	0	CTD_human
val	1278	COL1A2	0.486	0.846	C0023931	LobsteinDisease	disease	C16;C17;C05	DiseaseorSyndrome	0.89	1	1982	2019	6	64	ORPHANET;UNIPROT
val	1278	COL1A2	0.486	0.846	C0029172	OralSubmucousFibrosis	disease	C07	DiseaseorSyndrome	0.32	1	1995	2006	1	0	CTD_human
val	1278	COL1A2	0.486	0.846	C0029408	Degenerativepolyarthritis	disease	C05	DiseaseorSyndrome	0.31	1	2006	2009	1	0	CTD_human
val	1278	COL1A2	0.486	0.846	C0029434	OsteogenesisImperfecta	disease	C16;C17;C05	DiseaseorSyndrome;CongenitalAbnormality	0.70	0.977	1980	2020	0	15	GENOMICS_ENGLAND
val	1278	COL1A2	0.486	0.846	C0029456	Osteoporosis	disease	C18;C05	DiseaseorSyndrome	0.67	1	1985	2018	0	0	CTD_human;GENOMICS_ENGLAND
val	1278	COL1A2	0.486	0.846	C0029459	Osteoporosis,Senile	disease	C18;C05	DiseaseorSyndrome	0.30				0	0	CTD_human
val	1278	COL1A2	0.486	0.846	C0036421	SystemicScleroderma	disease	C17	DiseaseorSyndrome	0.40	1	1987	2014	1	0	CTD_human
val	1278	COL1A2	0.486	0.846	C0086743	OsteoarthrosisDeformans	disease	C05	DiseaseorSyndrome	0.30	1	2009	2009	1	0	CTD_human
val	1278	COL1A2	0.486	0.846	C0239946	Fibrosis,Liver	disease	C23;C06	DiseaseorSyndrome	0.34	1	1987	2019	1	0	CTD_human
val	1278	COL1A2	0.486	0.846	C0268345	EHLERS-DANLOSSYNDROME,ARTHROCHALASIATYPE	disease	C16;C18;C17;C15;C14	DiseaseorSyndrome	0.39	1	1987	2000	2	0	ORPHANET
val	1278	COL1A2	0.486	0.846	C0268358	Osteogenesisimperfecta,dominantperinatallethal	disease	C16;C17;C05	DiseaseorSyndrome;CongenitalAbnormality	0.66	1	1985	2011	16	29	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
val	1278	COL1A2	0.486	0.846	C0268362	OsteogenesisimperfectatypeIII(disorder)	disease	C16;C17;C05	DiseaseorSyndrome	0.95	1	1991	2018	16	34	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
val	1278	COL1A2	0.486	0.846	C0268363	OsteogenesisimperfectatypeIV(disorder)	disease		DiseaseorSyndrome;CongenitalAbnormality	0.80	1	1985	2015	11	26	GENOMICS_ENGLAND;ORPHANET;UNIPROT
val	1278	COL1A2	0.486	0.846	C0751406	Post-TraumaticOsteoporosis	disease	C18;C05	DiseaseorSyndrome	0.30				0	0	CTD_human
val	1278	COL1A2	0.486	0.846	C1623038	Cirrhosis	disease	C23	DiseaseorSyndrome	0.30	1	2010	2010	1	0	CTD_human
val	1278	COL1A2	0.486	0.846	C1857034	Ehlers-Danlossyndrome,cardiacvalvularform	disease	C16;C17;C15;C14	DiseaseorSyndrome	0.60	1	2004	2011	3	0	CTD_human;GENOMICS_ENGLAND;ORPHANET
val	1278	COL1A2	0.486	0.846	C3830362	EarlyPregnancyLoss	phenotype	C13	Finding	0.30	1	2008	2008	1	0	CTD_human
val	1278	COL1A2	0.486	0.846	C4303789	Ehlers-Danlossyndromecardiacvalvulartype	disease	C16;C17;C15;C14	DiseaseorSyndrome	0.40	1	2006	2006	1	3	GENOMICS_ENGLAND
val	1278	COL1A2	0.486	0.846	C4551623	EHLERS-DANLOSSYNDROME,ARTHROCHALASIATYPE,1	disease	C16;C17;C15;C14	DiseaseorSyndrome	0.40	1	2006	2006	1	4	GENOMICS_ENGLAND
val	1278	COL1A2	0.486	0.846	C4552766	Miscarriage	disease	C13	DiseaseorSyndrome	0.30	1	2008	2008	1	0	CTD_human
val	1278	COL1A2	0.486	0.846	C4707243	Familialthoracicaorticaneurysmandaorticdissection	disease		DiseaseorSyndrome	0.30				0	0	GENOMICS_ENGLAND
val	1280	COL2A1	0.444	0.846	C0003864	Arthritis	disease	C05	DiseaseorSyndrome	0.31	1	2007	2016	3	0	CTD_human
val	1280	COL2A1	0.444	0.846	C0003865	Arthritis,Adjuvant-Induced	disease	C05	ExperimentalModelofDisease	0.30	1	2005	2018	9	0	CTD_human
val	1280	COL2A1	0.444	0.846	C0003873	RheumatoidArthritis	disease	C17;C05;C20	DiseaseorSyndrome	0.35	0.857	1993	2018	2	0	CTD_human
val	1280	COL2A1	0.444	0.846	C0005974	BoneResorption	phenotype	C05	OrganorTissueFunction	0.30	1	2017	2017	1	0	CTD_human
val	1280	COL2A1	0.444	0.846	C0007302	CartilageDiseases	group	C17;C05	DiseaseorSyndrome	0.32	1	1995	2017	1	0	CTD_human
val	1280	COL2A1	0.444	0.846	C0008479	Chondrosarcoma	disease	C04	NeoplasticProcess	0.33	1	2013	2015	1	0	CTD_human
val	1280	COL2A1	0.444	0.846	C0008925	CleftPalate	disease	C16;C05;C07	CongenitalAbnormality	0.64	1	1991	2011	2	0	CTD_human;GENOMICS_ENGLAND
val	1280	COL2A1	0.444	0.846	C0013366	Dyschondroplasias	group	C16;C05	CongenitalAbnormality	0.30	1	1993	1993	1	0	CTD_human
val	1280	COL2A1	0.444	0.846	C0013604	Edema	phenotype	C23	PathologicFunction	0.40	1	2014	2018	4	0	CTD_human
val	1280	COL2A1	0.444	0.846	C0015397	Disorderofeye	group	C11	DiseaseorSyndrome	0.30	1	2008	2008	1	0	GENOMICS_ENGLAND
val	1280	COL2A1	0.444	0.846	C0015814	FemurHeadNecrosis	disease	C23;C05	DiseaseorSyndrome	0.50	1	2010	2010	0	0	CTD_human
val	1280	COL2A1	0.444	0.846	C0018784	SensorineuralHearingLoss(disorder)	disease	C23;C10;C09	DiseaseorSyndrome	0.42	1	2004	2008	1	0	CTD_human
val	1280	COL2A1	0.444	0.846	C0020507	Hyperplasia	phenotype	C23	PathologicFunction	0.30	1	2015	2015	1	0	CTD_human
val	1280	COL2A1	0.444	0.846	C0021368	Inflammation	phenotype	C23	PathologicFunction	0.30	1	2013	2017	2	0	CTD_human
val	1280	COL2A1	0.444	0.846	C0023234	Legg-Calve-PerthesDisease	disease	C05	DiseaseorSyndrome	0.74	1	2007	2014	3	4	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
val	1280	COL2A1	0.444	0.846	C0025202	melanoma	disease	C04	NeoplasticProcess	0.30	1	2006	2006	1	0	CTD_human
val	1280	COL2A1	0.444	0.846	C0025237	Melnick-NeedlesSyndrome	disease	C16;C05	DiseaseorSyndrome	0.30	1	1993	1993	1	0	CTD_human
val	1280	COL2A1	0.444	0.846	C0026760	MultipleEpiphysealDysplasia	disease	C16;C05	CongenitalAbnormality	0.41	1	1993	1993	1	1	CTD_human
val	1280	COL2A1	0.444	0.846	C0027092	Myopia	disease	C11	DiseaseorSyndrome	0.42	1	2007	2012	1	1	CTD_human
val	1280	COL2A1	0.444	0.846	C0029408	Degenerativepolyarthritis	disease	C05	DiseaseorSyndrome	0.50	0.941	1993	2020	2	1	CTD_human
val	1280	COL2A1	0.444	0.846	C0029422	Osteochondrodysplasias	group	C16;C05	DiseaseorSyndrome	0.44	1	1993	2017	1	0	CTD_human
val	1280	COL2A1	0.444	0.846	C0035305	RetinalDetachment	disease	C11	DiseaseorSyndrome	0.48	1	1993	2018	1	0	CTD_human
val	1280	COL2A1	0.444	0.846	C0036391	Schwartz-JampelSyndrome	disease	C16;C05	DiseaseorSyndrome	0.30	1	1993	1993	1	0	CTD_human
val	1280	COL2A1	0.444	0.846	C0038015	SpondyloepiphysealDysplasia	disease	C16;C05	DiseaseorSyndrome	0.50	1	1989	2019	1	0	CTD_human
val	1280	COL2A1	0.444	0.846	C0039103	Synovitis	disease	C05	DiseaseorSyndrome	0.31	1	2005	2014	1	0	CTD_human
val	1280	COL2A1	0.444	0.846	C0041834	Erythema	phenotype	C23;C17	DiseaseorSyndrome	0.30	1	2014	2017	2	0	CTD_human
val	1280	COL2A1	0.444	0.846	C0085700	Chondromalacia	disease	C17;C05	DiseaseorSyndrome	0.30	1	2017	2017	1	0	CTD_human
val	1280	COL2A1	0.444	0.846	C0086543	Cataract	disease	C11	AcquiredAbnormality	0.41	1	1993	1993	1	0	CTD_human
val	1280	COL2A1	0.444	0.846	C0086743	OsteoarthrosisDeformans	disease	C05	DiseaseorSyndrome	0.30	1	1997	2005	2	0	CTD_human
val	1280	COL2A1	0.444	0.846	C0151603	Anasarca	phenotype	C23	PathologicFunction	0.30	1	2014	2018	4	0	CTD_human
val	1280	COL2A1	0.444	0.846	C0162323	Polyarthritis	disease	C05	DiseaseorSyndrome	0.30	1	2007	2016	3	0	CTD_human
val	1280	COL2A1	0.444	0.846	C0220685	Achondrogenesistype2	disease	C16;C05	CongenitalAbnormality	1.00	1	1988	2012	13	12	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
val	1280	COL2A1	0.444	0.846	C0265279	Kniestdysplasia	disease	C16;C17;C05;C08;C19;C07	DiseaseorSyndrome	0.80	1	1989	2017	9	6	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
val	1280	COL2A1	0.444	0.846	C0339546	RetinalPigmentEpithelialDetachment	disease	C11	DiseaseorSyndrome	0.30	1	1993	1993	1	0	CTD_human
val	1280	COL2A1	0.444	0.846	C0376634	CraniofacialAbnormalities	group	C16;C05	CongenitalAbnormality	0.30	1	1997	2004	2	0	CTD_human
val	1280	COL2A1	0.444	0.846	C0410480	AvascularNecrosisofFemurHead	phenotype	C23;C05	DiseaseorSyndrome	0.65	1	2005	2018	1	0	CTD_human;GENOMICS_ENGLAND;ORPHANET
val	1280	COL2A1	0.444	0.846	C0410574	SynovialHypertrophy	disease	C05	DiseaseorSyndrome	0.30	1	2014	2014	1	0	CTD_human
val	1280	COL2A1	0.444	0.846	C0432214	Namaqualandhipdysplasia	disease	C16;C05	DiseaseorSyndrome	0.70	1	1990	2012	5	4	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
val	1280	COL2A1	0.444	0.846	C0432221	Spondylometaphysealdysplasia,cornerfracturetype	disease	C23;C16;C05;C26	DiseaseorSyndrome	0.30	1	2007	2007	1	0	ORPHANET
val	1280	COL2A1	0.444	0.846	C0432272	VanBuchemdisease	disease	C16;C05	DiseaseorSyndrome	0.30	1	1993	1993	1	0	CTD_human
val	1280	COL2A1	0.444	0.846	C0524524	Pseudoaphakia	disease	C11	DiseaseorSyndrome	0.30	1	1993	1993	1	0	CTD_human
val	1280	COL2A1	0.444	0.846	C0524595	AsepticNecrosisofFemurHead	phenotype	C23;C05	PathologicFunction	0.30				0	0	CTD_human
val	1280	COL2A1	0.444	0.846	C0542428	Hypochondrogenesis	disease	C16;C05	CongenitalAbnormality	0.66	1	1988	2003	1	3	ORPHANET
val	1280	COL2A1	0.444	0.846	C0700635	Strudwicksyndrome	disease	C16;C05	DiseaseorSyndrome	0.73	1	1989	2017	5	8	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
val	1280	COL2A1	0.444	0.846	C0796173	Spondyloperipheraldysplasiashortulna	disease	C16;C05	DiseaseorSyndrome	0.75	1	1989	2013	4	8	CTD_human;GENOMICS_ENGLAND;ORPHANET
val	1280	COL2A1	0.444	0.846	C0878659	Disproportionateshortstature	phenotype	C16;C05;C19	Finding	0.40				0	0	GENOMICS_ENGLAND
val	1280	COL2A1	0.444	0.846	C0971858	Arthritis,Collagen-Induced	disease	C05	ExperimentalModelofDisease	0.30	1	2005	2018	9	0	CTD_human
val	1280	COL2A1	0.444	0.846	C0993582	Arthritis,Experimental	disease	C05	ExperimentalModelofDisease	0.30	1	2005	2018	9	0	CTD_human
val	1280	COL2A1	0.444	0.846	C1262477	Weightdecreased	phenotype	C23	Finding	0.30	1	2015	2018	2	0	CTD_human
val	1280	COL2A1	0.444	0.846	C1510497	LensOpacities	phenotype	C11	Finding	0.30	1	1993	1993	1	0	CTD_human
val	1280	COL2A1	0.444	0.846	C1691779	Sensoryhearingloss	disease	C23;C10;C09	DiseaseorSyndrome	0.30	1	2005	2005	1	0	CTD_human
val	1280	COL2A1	0.444	0.846	C1835437	PlatyspondylicLethalSkeletalDysplasia,TorranceType	disease	C16;C05	DiseaseorSyndrome	0.73	1	1989	2016	6	4	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
val	1280	COL2A1	0.444	0.846	C1836080	SticklerSyndrome,TypeI,NonsyndromicOcular	disease	C16;C11	DiseaseorSyndrome	0.71	1	1989	2018	8	9	CTD_human;GENOMICS_ENGLAND;UNIPROT
val	1280	COL2A1	0.444	0.846	C1836081	RHEGMATOGENOUSRETINALDETACHMENT,AUTOSOMALDOMINANT	disease	C16;C11	DiseaseorSyndrome	0.41	1	2003	2005	1	2	ORPHANET
val	1280	COL2A1	0.444	0.846	C1836683	Czechdysplasia,metatarsaltype	disease	C16;C05	CongenitalAbnormality	0.73	1	1993	2016	6	4	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
val	1280	COL2A1	0.444	0.846	C1837218	Cleftpalate,isolated	disease	C16;C05;C07	CongenitalAbnormality	0.44	1	2003	2011	1	1	CTD_human
val	1280	COL2A1	0.444	0.846	C1840452	HyaloideoretinaldegenerationofWagner	disease	C11	DiseaseorSyndrome	0.36	1	1993	2003	1	0	CTD_human
val	1280	COL2A1	0.444	0.846	C1851536	EpiphysealDysplasia,Multiple,withMyopiaandConductiveDeafness	disease	C23;C16;C11;C05;C10;C09	DiseaseorSyndrome	0.70	1	1998	2012	3	4	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
val	1280	COL2A1	0.444	0.846	C1852989	VitreoretinopathywithPhalangealEpiphysealDysplasia	disease	C16;C11;C05	DiseaseorSyndrome	0.40	1	2008	2012	2	1	GENOMICS_ENGLAND
val	1280	COL2A1	0.444	0.846	C1855310	Megaepiphysealdwarfism	disease	C16;C05;C19	DiseaseorSyndrome	0.30	1	2005	2005	1	0	CTD_human
val	1280	COL2A1	0.444	0.846	C1861481	Sticklersyndrome,type3	disease	C17;C05	DiseaseorSyndrome	0.30	1	2005	2011	2	0	ORPHANET
val	1280	COL2A1	0.444	0.846	C1866688	Spondylometaphysealdysplasia,Algeriantype	disease	C16;C05	DiseaseorSyndrome	0.30	1	2013	2013	1	0	ORPHANET
val	1280	COL2A1	0.444	0.846	C2020284	Sticklersyndrome,type1	disease	C23;C11;C17;C05;C10;C09	DiseaseorSyndrome	0.80	0.968	1987	2019	6	23	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
val	1280	COL2A1	0.444	0.846	C2745959	Spondyloepiphysealdysplasia,congenita	disease	C16;C05	CongenitalAbnormality	1.00	0.981	1989	2020	12	14	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
val	1280	COL2A1	0.444	0.846	C3541456	SpondyloepiphysealDysplasiaTarda,X-Linked	disease	C16;C05	CongenitalAbnormality	0.31	1	1993	1994	1	0	CTD_human
val	1280	COL2A1	0.444	0.846	C4225273	SPONDYLOEPIPHYSEALDYSPLASIA,STANESCUTYPE	disease		DiseaseorSyndrome	0.71	1	1991	2016	5	5	CLINGEN;GENOMICS_ENGLAND;ORPHANET;UNIPROT
val	1280	COL2A1	0.444	0.846	C4302548	Dysspondyloenchondromatosis	disease	C05	DiseaseorSyndrome	0.32	1	2011	2015	2	0	ORPHANET
val	1280	COL2A1	0.444	0.846	C4479260	AVASCULARNECROSISOFFEMORALHEAD,PRIMARY,2	disease		DiseaseorSyndrome	0.30	1	2005	2005	1	0	ORPHANET
val	1280	COL2A1	0.444	0.846	C4520892	Otospondylomegaepiphysealdysplasia	disease	C16;C05;C19	DiseaseorSyndrome	0.61	1	2005	2012	2	1	CTD_human;GENOMICS_ENGLAND
val	1280	COL2A1	0.444	0.846	C4551479	Schwartz-JampelSyndrome,Type1	disease	C16;C05	DiseaseorSyndrome	0.30	1	1993	1993	1	0	CTD_human
val	1280	COL2A1	0.444	0.846	C4551562	AVASCULARNECROSISOFFEMORALHEAD,PRIMARY,1	disease	C23;C05	DiseaseorSyndrome	0.70	1	1989	2012	4	6	GENOMICS_ENGLAND;ORPHANET;UNIPROT
val	1281	COL3A1	0.477	0.808	C0003504	AorticValveInsufficiency	disease	C14	DiseaseorSyndrome	0.30	1	2011	2011	1	0	CTD_human
val	1281	COL3A1	0.477	0.808	C0005398	Cholestasis,Extrahepatic	disease	C06	DiseaseorSyndrome	0.30	1	2017	2017	1	0	CTD_human
val	1281	COL3A1	0.477	0.808	C0009402	ColorectalCarcinoma	disease	C06;C04	NeoplasticProcess	0.31	1	2016	2016	0	2	UNIPROT
val	1281	COL3A1	0.477	0.808	C0013720	Ehlers-DanlosSyndrome	disease	C16;C17;C15;C14	DiseaseorSyndrome	0.40	1	1986	2020	0	0	CTD_human
val	1281	COL3A1	0.477	0.808	C0015695	FattyLiver	disease	C06	DiseaseorSyndrome	0.30	1	2005	2005	1	0	CTD_human
val	1281	COL3A1	0.477	0.808	C0016059	Fibrosis	phenotype	C23	PathologicFunction	0.30	1	2010	2010	1	0	CTD_human
val	1281	COL3A1	0.477	0.808	C0019193	Hepatitis,Toxic	disease	C06;C25	InjuryorPoisoning	0.30	1	2006	2006	1	0	CTD_human
val	1281	COL3A1	0.477	0.808	C0020443	Hypercholesterolemia	disease	C18	DiseaseorSyndrome	0.30	1	2012	2012	1	0	CTD_human
val	1281	COL3A1	0.477	0.808	C0020456	Hyperglycemia	disease	C18	DiseaseorSyndrome	0.30	1	2010	2010	1	0	CTD_human
val	1281	COL3A1	0.477	0.808	C0020459	Hyperinsulinism	disease	C18	DiseaseorSyndrome	0.30	1	2010	2010	1	0	CTD_human
val	1281	COL3A1	0.477	0.808	C0020538	Hypertensivedisease	group	C14	DiseaseorSyndrome	0.41	1	2001	2017	1	0	CTD_human
val	1281	COL3A1	0.477	0.808	C0022548	Keloid	disease	C23;C17	AcquiredAbnormality	0.31	1	2010	2017	1	0	CTD_human
val	1281	COL3A1	0.477	0.808	C0023890	LiverCirrhosis	disease	C23;C06	DiseaseorSyndrome	0.31	1	1989	2008	5	0	CTD_human
val	1281	COL3A1	0.477	0.808	C0023891	LiverCirrhosis,Alcoholic	disease	C23;C06;C25	DiseaseorSyndrome	0.30	1	2013	2013	1	0	CTD_human
val	1281	COL3A1	0.477	0.808	C0023893	LiverCirrhosis,Experimental	disease	C23;C06	ExperimentalModelofDisease	0.30	1	2002	2014	2	0	CTD_human
val	1281	COL3A1	0.477	0.808	C0023895	Liverdiseases	group	C06	DiseaseorSyndrome	0.31	1	2001	2008	1	0	CTD_human
val	1281	COL3A1	0.477	0.808	C0027719	Nephrosclerosis	disease	C13;C12	DiseaseorSyndrome	0.30	1	2019	2019	1	0	CTD_human
val	1281	COL3A1	0.477	0.808	C0034069	PulmonaryFibrosis	disease	C08	DiseaseorSyndrome	0.32	1	2013	2018	1	0	CTD_human
val	1281	COL3A1	0.477	0.808	C0036341	Schizophrenia	disease	F03	MentalorBehavioralDysfunction	0.30	1	2011	2011	1	0	CTD_human
val	1281	COL3A1	0.477	0.808	C0038454	Cerebrovascularaccident	group	C10;C14	DiseaseorSyndrome	0.31	1	1995	2014	1	0	GENOMICS_ENGLAND
val	1281	COL3A1	0.477	0.808	C0041956	Ureteralobstruction	phenotype	C13;C12	DiseaseorSyndrome	0.30	1	2007	2007	1	0	CTD_human
val	1281	COL3A1	0.477	0.808	C0086565	LiverDysfunction	phenotype	C06	Finding	0.30	1	2001	2001	1	0	CTD_human
val	1281	COL3A1	0.477	0.808	C0149721	LeftVentricularHypertrophy	disease	C23;C14	DiseaseorSyndrome	0.30	1	2001	2001	1	0	CTD_human
val	1281	COL3A1	0.477	0.808	C0162871	AorticAneurysm,Abdominal	disease	C14	DiseaseorSyndrome	0.31	1	1990	2015	2	0	ORPHANET
val	1281	COL3A1	0.477	0.808	C0238288	MuscularDystrophy,Facioscapulohumeral	disease	C16;C05;C10	DiseaseorSyndrome	0.30	1	2003	2003	1	0	CTD_human
val	1281	COL3A1	0.477	0.808	C0238590	Acrogeria	disease	C23;C16;C18;C17	DiseaseorSyndrome	0.32	1	1996	2004	1	0	ORPHANET
val	1281	COL3A1	0.477	0.808	C0239946	Fibrosis,Liver	disease	C23;C06	DiseaseorSyndrome	0.30	1	1989	2006	5	0	CTD_human
val	1281	COL3A1	0.477	0.808	C0268338	Ehlers-DanlosSyndrome,TypeIV	disease	C16;C17;C15;C14	DiseaseorSyndrome	1.00	1	1980	2019	43	390	CLINGEN;CTD_human;GENOMICS_ENGLAND;UNIPROT
val	1281	COL3A1	0.477	0.808	C0338586	VertebralArteryDissection	disease	C10;C14;C26	DiseaseorSyndrome	0.30	1	1995	1995	1	0	GENOMICS_ENGLAND
val	1281	COL3A1	0.477	0.808	C0406584	Acrogeria,gottrontype	disease	C16;C18	DiseaseorSyndrome	0.30	1	2000	2000	1	0	ORPHANET
val	1281	COL3A1	0.477	0.808	C0553692	Brainhemorrhage	phenotype	C23;C10;C14	PathologicFunction	0.30	1	1995	1995	1	0	GENOMICS_ENGLAND
val	1281	COL3A1	0.477	0.808	C0553980	EndomyocardialFibrosis	phenotype	C14	PathologicFunction	0.30	1	2001	2001	1	0	CTD_human
val	1281	COL3A1	0.477	0.808	C0860207	Drug-InducedLiverDisease	phenotype	C06;C25	DiseaseorSyndrome	0.30	1	2006	2006	1	0	CTD_human
val	1281	COL3A1	0.477	0.808	C0948008	Ischemicstroke	disease	C10;C14	DiseaseorSyndrome	0.30	1	1995	1995	1	0	GENOMICS_ENGLAND
val	1281	COL3A1	0.477	0.808	C1257963	EndogenousHyperinsulinism	disease	C18	DiseaseorSyndrome	0.30	1	2010	2010	1	0	CTD_human
val	1281	COL3A1	0.477	0.808	C1257964	ExogenousHyperinsulinism	disease	C18	DiseaseorSyndrome	0.30	1	2010	2010	1	0	CTD_human
val	1281	COL3A1	0.477	0.808	C1257965	CompensatoryHyperinsulinemia	disease	C18	DiseaseorSyndrome	0.30	1	2010	2010	1	0	CTD_human
val	1281	COL3A1	0.477	0.808	C1262760	Hepatitis,Drug-Induced	disease	C06;C25	DiseaseorSyndrome	0.30	1	2006	2006	1	0	CTD_human
val	1281	COL3A1	0.477	0.808	C1623038	Cirrhosis	disease	C23	DiseaseorSyndrome	0.31	1	2008	2010	1	0	CTD_human
val	1281	COL3A1	0.477	0.808	C1853365	AORTICANEURYSM,FAMILIALABDOMINAL1	disease	C14	DiseaseorSyndrome	0.30	1	1990	1999	2	0	ORPHANET
val	1281	COL3A1	0.477	0.808	C1855520	Hyperglycemia,Postprandial	phenotype	C18	Finding	0.30	1	2010	2010	1	0	CTD_human
val	1281	COL3A1	0.477	0.808	C1862932	ANEURYSM,INTRACRANIALBERRY,1(disorder)	disease	C23;C10;C14	DiseaseorSyndrome	0.30	1	2012	2012	1	0	ORPHANET
val	1281	COL3A1	0.477	0.808	C2697932	Loeys-DietzSyndrome	disease	C16;C05;C14	DiseaseorSyndrome	0.41	1	1990	2016	2	1	GENOMICS_ENGLAND
val	1281	COL3A1	0.477	0.808	C2711227	Steatohepatitis	disease	C06	DiseaseorSyndrome	0.30	1	2005	2005	1	0	CTD_human
val	1281	COL3A1	0.477	0.808	C3658290	Drug-InducedAcuteLiverInjury	disease	C06;C25	DiseaseorSyndrome	0.30	1	2006	2006	1	0	CTD_human
val	1281	COL3A1	0.477	0.808	C4277682	ChemicalandDrugInducedLiverInjury	disease	C06;C25	DiseaseorSyndrome	0.30	1	2006	2006	1	0	CTD_human
val	1281	COL3A1	0.477	0.808	C4279912	Chemically-InducedLiverToxicity	disease	C06;C25	DiseaseorSyndrome	0.30	1	2006	2006	1	0	CTD_human
val	1281	COL3A1	0.477	0.808	C4707243	Familialthoracicaorticaneurysmandaorticdissection	disease		DiseaseorSyndrome	0.60	1	1988	2015	10	4	CLINGEN;GENOMICS_ENGLAND
val	1281	COL3A1	0.477	0.808	C4721507	Alveolitis,Fibrosing	disease	C08	DiseaseorSyndrome	0.30	1	2016	2016	1	0	CTD_human
val	1282	COL4A1	0.484	0.731	C0002878	Anemia,Hemolytic	disease	C15	DiseaseorSyndrome	0.42	1	2013	2016	1	0	CTD_human
val	1282	COL4A1	0.484	0.731	C0002879	Anemia,Hemolytic,Acquired	disease	C15	DiseaseorSyndrome	0.30	1	2013	2013	1	0	CTD_human
val	1282	COL4A1	0.484	0.731	C0002889	Anemia,Microangiopathic	disease	C15	DiseaseorSyndrome	0.30	1	2013	2013	1	0	CTD_human
val	1282	COL4A1	0.484	0.731	C0009691	Congenitalcataract	disease	C23;C16;C13;C11;C10	CongenitalAbnormality	0.32	1	2014	2019	0	0	GENOMICS_ENGLAND
val	1282	COL4A1	0.484	0.731	C0011881	DiabeticNephropathy	disease	C13;C12;C19	DiseaseorSyndrome	0.31	1	2009	2016	2	0	CTD_human
val	1282	COL4A1	0.484	0.731	C0015393	EyeAbnormalities	group	C16;C11	CongenitalAbnormality	0.30	1	2010	2010	1	0	CTD_human
val	1282	COL4A1	0.484	0.731	C0015397	Disorderofeye	group	C11	DiseaseorSyndrome	0.30				0	0	GENOMICS_ENGLAND
val	1282	COL4A1	0.484	0.731	C0017667	Nodularglomerulosclerosis	disease	C13;C12;C19	DiseaseorSyndrome	0.30	1	2009	2016	2	0	CTD_human
val	1282	COL4A1	0.484	0.731	C0017668	Focalglomerulosclerosis	disease	C13;C12	DiseaseorSyndrome	0.30	1	2005	2009	2	0	CTD_human
val	1282	COL4A1	0.484	0.731	C0018965	Hematuria	phenotype	C23;C13;C12	DiseaseorSyndrome	0.42	1	2007	2010	3	0	GENOMICS_ENGLAND
val	1282	COL4A1	0.484	0.731	C0023893	LiverCirrhosis,Experimental	disease	C23;C06	ExperimentalModelofDisease	0.30	1	2014	2014	1	0	CTD_human
val	1282	COL4A1	0.484	0.731	C0026848	Myopathy	group	C05;C10	DiseaseorSyndrome	0.37	1	2007	2020	1	0	GENOMICS_ENGLAND
val	1282	COL4A1	0.484	0.731	C0027726	NephroticSyndrome	group	C13;C12	DiseaseorSyndrome	0.31	1	1992	2019	1	0	CTD_human
val	1282	COL4A1	0.484	0.731	C0036572	Seizures	phenotype	C23;C10	SignorSymptom	0.40	1	2007	2007	1	1	GENOMICS_ENGLAND
val	1282	COL4A1	0.484	0.731	C0038454	Cerebrovascularaccident	group	C10;C14	DiseaseorSyndrome	0.50	1	2006	2020	1	1	GENOMICS_ENGLAND
val	1282	COL4A1	0.484	0.731	C0086432	Hyalinosis,SegmentalGlomerular	disease	C13;C12	DiseaseorSyndrome	0.30	1	2005	2009	2	0	CTD_human
val	1282	COL4A1	0.484	0.731	C0149931	MigraineDisorders	group	C10	DiseaseorSyndrome	0.40	1	2007	2007	1	0	GENOMICS_ENGLAND
val	1282	COL4A1	0.484	0.731	C0221021	Microangiopathichemolyticanemia	disease	C15	DiseaseorSyndrome	0.30	1	2013	2013	1	0	CTD_human
val	1282	COL4A1	0.484	0.731	C0265221	Walker-Warburgcongenitalmusculardystrophy	disease	C16;C11;C10	DiseaseorSyndrome	0.52	1	2011	2015	1	0	ORPHANET
val	1282	COL4A1	0.484	0.731	C0265341	Riegersyndrome	disease	C16;C11	DiseaseorSyndrome	0.30	1	2007	2010	2	0	CTD_human
val	1282	COL4A1	0.484	0.731	C0266484	Schizencephaly	disease	C16;C10	CongenitalAbnormality	0.75	1	2013	2019	2	2	CTD_human;GENOMICS_ENGLAND;UNIPROT
val	1282	COL4A1	0.484	0.731	C0266548	Axenfeldanomaly(disorder)	disease	C16;C11	CongenitalAbnormality	0.51	1	2007	2010	3	0	CTD_human;GENOMICS_ENGLAND
val	1282	COL4A1	0.484	0.731	C0270612	Leukoencephalopathy	group	C10	DiseaseorSyndrome	0.48	0.889	2007	2019	1	0	CTD_human
val	1282	COL4A1	0.484	0.731	C0302892	Congenitalporencephaly	disease	C16;C05;C10	CongenitalAbnormality	0.60	1	1977	2020	2	0	CTD_human
val	1282	COL4A1	0.484	0.731	C0338656	Impairedcognition	disease	F03	MentalorBehavioralDysfunction	0.30	1	2007	2007	1	0	GENOMICS_ENGLAND
val	1282	COL4A1	0.484	0.731	C0424605	Developmentaldelay(disorder)	phenotype	F03	MentalorBehavioralDysfunction	0.32	1	2007	2017	1	0	GENOMICS_ENGLAND
val	1282	COL4A1	0.484	0.731	C0497327	Dementia	disease	C10;F03	MentalorBehavioralDysfunction	0.31	1	2007	2016	1	0	GENOMICS_ENGLAND
val	1282	COL4A1	0.484	0.731	C0557874	Globaldevelopmentaldelay	disease		MentalorBehavioralDysfunction	0.42	1	2007	2017	1	0	GENOMICS_ENGLAND
val	1282	COL4A1	0.484	0.731	C1135196	HeartFailure,Diastolic	disease	C14	DiseaseorSyndrome	0.30	1	2018	2018	1	0	CTD_human
val	1282	COL4A1	0.484	0.731	C1280768	Axenfeldsyndrome	disease	C16;C11	DiseaseorSyndrome	0.30	1	2007	2010	2	0	CTD_human
val	1282	COL4A1	0.484	0.731	C1843512	BRAINSMALLVESSELDISEASEWITHHEMORRHAGE	disease		DiseaseorSyndrome	0.82	1	2005	2013	4	0	CTD_human;GENOMICS_ENGLAND;ORPHANET
val	1282	COL4A1	0.484	0.731	C1858991	ChildhoodAtaxiawithCentralNervousSystemHypomyelinization	disease	C10	DiseaseorSyndrome	0.30	1	2010	2010	1	0	CTD_human
val	1282	COL4A1	0.484	0.731	C1860475	Retinalvasculartortuosity	phenotype		Finding	0.40	1	2007	2010	3	0	GENOMICS_ENGLAND
val	1282	COL4A1	0.484	0.731	C1867327	RETINALARTERIES,TORTUOSITYOF	phenotype		Finding	0.70	1	2014	2014	1	1	CTD_human;ORPHANET;UNIPROT
val	1282	COL4A1	0.484	0.731	C1867983	PORENCEPHALY,FAMILIAL	disease	C16;C05;C10	DiseaseorSyndrome	0.83	1	1977	2016	2	1	CTD_human;ORPHANET
val	1282	COL4A1	0.484	0.731	C2673195	Angiopathy,Hereditary,WithNephropathy,Aneurysms,AndMuscleCramps	disease	C23;C05;C10;C14	DiseaseorSyndrome	0.77	0.909	2007	2019	6	17	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
val	1282	COL4A1	0.484	0.731	C2675650	BrainSmallVesselDiseaseWithAxenfeld-RiegerAnomaly	disease		DiseaseorSyndrome	0.30	1	2006	2007	2	0	CTD_human
val	1282	COL4A1	0.484	0.731	C2678503	AXENFELD-RIEGERSYNDROME,TYPE3	disease	C16;C11	DiseaseorSyndrome	0.30	1	2007	2010	2	0	CTD_human
val	1282	COL4A1	0.484	0.731	C2733158	CerebralSmallVesselDiseases	group	C10;C14	DiseaseorSyndrome	0.40	1	2007	2020	1	0	GENOMICS_ENGLAND
val	1282	COL4A1	0.484	0.731	C2930808	Familialvascularleukoencephalopathy	disease	C23;C16;C10;C14	DiseaseorSyndrome	0.50	1	2005	2013	1	0	ORPHANET
val	1282	COL4A1	0.484	0.731	C2931870	Familialschizencephaly	disease	C16;C10	DiseaseorSyndrome	0.30	1	2015	2015	1	0	ORPHANET
val	1282	COL4A1	0.484	0.731	C2937358	CerebralHemorrhage	phenotype	C23;C10;C14	PathologicFunction	0.40				0	0	CTD_human
val	1282	COL4A1	0.484	0.731	C3281105	HEMORRHAGE,INTRACEREBRAL,SUSCEPTIBILITYTO	disease		Finding	0.60	1	2007	2012	2	2	GENOMICS_ENGLAND;UNIPROT
val	1282	COL4A1	0.484	0.731	C3495488	Axenfeld-Riegersyndrome	disease	C16;C11	DiseaseorSyndrome	0.30	1	2007	2010	2	0	CTD_human
val	1282	COL4A1	0.484	0.731	C3698507	Post-traumaticPorencephaly	phenotype	C16;C05;C10	AcquiredAbnormality	0.50	1	1977	2013	2	0	CTD_human
val	1282	COL4A1	0.484	0.731	C3714873	Axenfeld-RiegerSyndrome,Type1	disease	C16;C11	DiseaseorSyndrome	0.30	1	2007	2010	2	0	CTD_human
val	1282	COL4A1	0.484	0.731	C4013035	BRAINSMALLVESSELDISEASEWITHORWITHOUTOCULARANOMALIES	disease		DiseaseorSyndrome	0.40	1	2006	2018	1	2	GENOMICS_ENGLAND
val	1282	COL4A1	0.484	0.731	C4082173	Porencephaly	disease	C16;C05;C10	DiseaseorSyndrome	0.40	1	1977	2020	2	0	CTD_human
val	1282	COL4A1	0.484	0.731	C4082301	DevelopmentalPorencephaly	disease	C16;C05;C10	CongenitalAbnormality	0.30	1	1977	2013	2	0	CTD_human
val	1282	COL4A1	0.484	0.731	C4551998	Porencephaly,Type1,AutosomalDominant	disease	C16;C05;C10	DiseaseorSyndrome	0.90	1	1977	2018	18	15	CTD_human;GENOMICS_ENGLAND;UNIPROT
val	1282	COL4A1	0.484	0.731	C4707243	Familialthoracicaorticaneurysmandaorticdissection	disease		DiseaseorSyndrome	0.30				0	0	GENOMICS_ENGLAND
val	1284	COL4A2	0.563	0.654	C0023893	LiverCirrhosis,Experimental	disease	C23;C06	ExperimentalModelofDisease	0.30	1	2014	2014	1	0	CTD_human
val	1284	COL4A2	0.563	0.654	C0027726	NephroticSyndrome	group	C13;C12	DiseaseorSyndrome	0.30	1	1992	1992	1	0	CTD_human
val	1284	COL4A2	0.563	0.654	C0149925	Smallcellcarcinomaoflung	disease	C04;C08	NeoplasticProcess	0.30	1	2012	2012	1	0	CTD_human
val	1284	COL4A2	0.563	0.654	C0302892	Congenitalporencephaly	disease	C16;C05;C10	CongenitalAbnormality	0.36	0.833	2012	2016	0	0	CTD_human
val	1284	COL4A2	0.563	0.654	C1867983	PORENCEPHALY,FAMILIAL	disease	C16;C05;C10	DiseaseorSyndrome	0.51	1	2012	2012	0	0	CTD_human;ORPHANET
val	1284	COL4A2	0.563	0.654	C2937358	CerebralHemorrhage	phenotype	C23;C10;C14	PathologicFunction	0.30				0	0	CTD_human
val	1284	COL4A2	0.563	0.654	C3280970	PORENCEPHALY2	disease		DiseaseorSyndrome	0.60	1	2012	2018	4	4	GENOMICS_ENGLAND;UNIPROT
val	1284	COL4A2	0.563	0.654	C3281105	HEMORRHAGE,INTRACEREBRAL,SUSCEPTIBILITYTO	disease		Finding	0.30	1	2012	2012	1	0	GENOMICS_ENGLAND
val	1284	COL4A2	0.563	0.654	C3698507	Post-traumaticPorencephaly	phenotype	C16;C05;C10	AcquiredAbnormality	0.30				0	0	CTD_human
val	1284	COL4A2	0.563	0.654	C4082173	Porencephaly	disease	C16;C05;C10	DiseaseorSyndrome	0.56	0.857	2012	2016	1	0	CTD_human;GENOMICS_ENGLAND
val	1284	COL4A2	0.563	0.654	C4082301	DevelopmentalPorencephaly	disease	C16;C05;C10	CongenitalAbnormality	0.30				0	0	CTD_human
val	1284	COL4A2	0.563	0.654	C4551998	Porencephaly,Type1,AutosomalDominant	disease	C16;C05;C10	DiseaseorSyndrome	0.30				0	0	CTD_human
val	1285	COL4A3	0.552	0.692	C0027706	Hereditarynephritis	disease	C16;C13;C17;C12	DiseaseorSyndrome	0.39	1	1989	2018	1	0	CTD_human
val	1285	COL4A3	0.552	0.692	C0241908	Hematuria,BenignFamilial	disease	C23;C13;C12	DiseaseorSyndrome	0.80	1	1996	2019	3	0	CTD_human;GENOMICS_ENGLAND;UNIPROT
val	1285	COL4A3	0.552	0.692	C0268731	Renalglomerulardisease	group	C23;C13;C12	DiseaseorSyndrome	0.32	1	2007	2017	0	0	GENOMICS_ENGLAND
val	1285	COL4A3	0.552	0.692	C0403440	Thinbasementmembranedisease	disease	C23;C13;C12	DiseaseorSyndrome	0.60	1	2001	2018	0	0	CTD_human;GENOMICS_ENGLAND
val	1285	COL4A3	0.552	0.692	C0848548	hypertensivenephropathy	disease	C13;C12;C14	DiseaseorSyndrome	0.30				0	0	GENOMICS_ENGLAND
val	1285	COL4A3	0.552	0.692	C1567741	AlportSyndrome	disease	C16;C13;C17;C12	DiseaseorSyndrome	0.70	0.982	1986	2020	2	0	CTD_human;GENOMICS_ENGLAND
val	1285	COL4A3	0.552	0.692	C1567742	AlportSyndrome,X-Linked	disease	C16;C13;C17;C12	DiseaseorSyndrome	0.60	1	1994	2019	2	0	CTD_human;GENOMICS_ENGLAND
val	1285	COL4A3	0.552	0.692	C1567743	AlportSyndrome,AutosomalDominant	disease	C16;C13;C17;C12	DiseaseorSyndrome	0.53	1	1997	2019	2	0	CTD_human;GENOMICS_ENGLAND
val	1285	COL4A3	0.552	0.692	C1567744	AlportSyndrome,AutosomalRecessive	disease	C16;C13;C17;C12	DiseaseorSyndrome	0.80	1	1994	2017	2	0	CTD_human;GENOMICS_ENGLAND
val	1285	COL4A3	0.552	0.692	C1868672	NEPHROTICSYNDROME,STEROID-RESISTANT,AUTOSOMALRECESSIVE	disease	C13;C12	DiseaseorSyndrome	0.30	1	2015	2015	1	0	ORPHANET
val	1285	COL4A3	0.552	0.692	C2931253	Alportsyndrome,dominanttype	disease	C16;C13;C17;C12	DiseaseorSyndrome	0.30				0	0	CTD_human
val	1285	COL4A3	0.552	0.692	C2931254	Alportsyndrome,recessivetype	disease	C16;C13;C17;C12	DiseaseorSyndrome	0.50	1	1996	2014	0	0	CTD_human
val	1285	COL4A3	0.552	0.692	C2931861	Hemorrhagichereditarynephritis	disease	C16;C13;C17;C12	DiseaseorSyndrome	0.30	1	2003	2003	1	0	CTD_human
val	1285	COL4A3	0.552	0.692	C4521256	GlomerulopathyAssessment	phenotype		DiagnosticProcedure	0.30				0	0	GENOMICS_ENGLAND
val	1285	COL4A3	0.552	0.692	C4746547	ALPORTSYNDROME3,AUTOSOMALDOMINANT	disease		DiseaseorSyndrome	0.60	1	1997	2019	5	0	GENOMICS_ENGLAND;UNIPROT
val	1285	COL4A3	0.552	0.692	C4746745	ALPORTSYNDROME2,AUTOSOMALRECESSIVE	disease		DiseaseorSyndrome	0.80	1	1994	2017	5	3	GENOMICS_ENGLAND;UNIPROT
val	1286	COL4A4	0.644	0.5	C0241908	Hematuria,BenignFamilial	disease	C23;C13;C12	DiseaseorSyndrome	0.80	1	1982	2018	4	9	CTD_human;GENOMICS_ENGLAND;UNIPROT
val	1286	COL4A4	0.644	0.5	C0268731	Renalglomerulardisease	group	C23;C13;C12	DiseaseorSyndrome	0.31	1	2011	2011	0	0	GENOMICS_ENGLAND
val	1286	COL4A4	0.644	0.5	C0403440	Thinbasementmembranedisease	disease	C23;C13;C12	DiseaseorSyndrome	0.60	1	2001	2019	0	0	CTD_human;GENOMICS_ENGLAND
val	1286	COL4A4	0.644	0.5	C0848548	hypertensivenephropathy	disease	C13;C12;C14	DiseaseorSyndrome	0.30				0	0	GENOMICS_ENGLAND
val	1286	COL4A4	0.644	0.5	C1567741	AlportSyndrome	disease	C16;C13;C17;C12	DiseaseorSyndrome	0.40	1	1995	2020	1	0	GENOMICS_ENGLAND
val	1286	COL4A4	0.644	0.5	C1567742	AlportSyndrome,X-Linked	disease	C16;C13;C17;C12	DiseaseorSyndrome	0.40	1	2001	2019	1	0	GENOMICS_ENGLAND
val	1286	COL4A4	0.644	0.5	C1567743	AlportSyndrome,AutosomalDominant	disease	C16;C13;C17;C12	DiseaseorSyndrome	0.53	1	1997	2018	5	0	GENOMICS_ENGLAND;ORPHANET
val	1286	COL4A4	0.644	0.5	C1567744	AlportSyndrome,AutosomalRecessive	disease	C16;C13;C17;C12	DiseaseorSyndrome	0.60	1	1997	2019	1	0	GENOMICS_ENGLAND
val	1286	COL4A4	0.644	0.5	C2931253	Alportsyndrome,dominanttype	disease	C16;C13;C17;C12	DiseaseorSyndrome	0.30	1	1997	2009	4	0	ORPHANET
val	1286	COL4A4	0.644	0.5	C2931254	Alportsyndrome,recessivetype	disease	C16;C13;C17;C12	DiseaseorSyndrome	0.50	1	2011	2014	0	0	CTD_human
val	1286	COL4A4	0.644	0.5	C4521256	GlomerulopathyAssessment	phenotype		DiagnosticProcedure	0.30				0	0	GENOMICS_ENGLAND
val	1286	COL4A4	0.644	0.5	C4746745	ALPORTSYNDROME2,AUTOSOMALRECESSIVE	disease		DiseaseorSyndrome	0.80	1	1994	2017	4	62	GENOMICS_ENGLAND;UNIPROT
val	1287	COL4A5	0.553	0.654	C0017668	Focalglomerulosclerosis	disease	C13;C12	DiseaseorSyndrome	0.31	1	2017	2019	1	0	GENOMICS_ENGLAND
val	1287	COL4A5	0.553	0.654	C0018965	Hematuria	phenotype	C23;C13;C12	DiseaseorSyndrome	0.48	1	2001	2019	1	3	GENOMICS_ENGLAND
val	1287	COL4A5	0.553	0.654	C0033687	Proteinuria	phenotype	C23;C13;C12	Finding	0.40	1	2017	2017	1	4	GENOMICS_ENGLAND
val	1287	COL4A5	0.553	0.654	C0086533	Leiomyoma,Epithelioid	disease	C04	NeoplasticProcess	0.30	1	2006	2006	1	0	CTD_human
val	1287	COL4A5	0.553	0.654	C0241908	Hematuria,BenignFamilial	disease	C23;C13;C12	DiseaseorSyndrome	0.34	1	2003	2014	1	0	GENOMICS_ENGLAND
val	1287	COL4A5	0.553	0.654	C0268731	Renalglomerulardisease	group	C23;C13;C12	DiseaseorSyndrome	0.44	1	2011	2018	0	1	GENOMICS_ENGLAND
val	1287	COL4A5	0.553	0.654	C1384666	hearingimpairment	phenotype	C23;C10;C09	DiseaseorSyndrome	0.41	1	1995	1997	1	1	GENOMICS_ENGLAND
val	1287	COL4A5	0.553	0.654	C1567741	AlportSyndrome	disease	C16;C13;C17;C12	DiseaseorSyndrome	0.70	0.977	1990	2020	12	307	CLINGEN;GENOMICS_ENGLAND
val	1287	COL4A5	0.553	0.654	C1567742	AlportSyndrome,X-Linked	disease	C16;C13;C17;C12	DiseaseorSyndrome	0.60	0.96	1992	2020	1	0	GENOMICS_ENGLAND
val	1287	COL4A5	0.553	0.654	C1567743	AlportSyndrome,AutosomalDominant	disease	C16;C13;C17;C12	DiseaseorSyndrome	0.30	1	2003	2003	1	0	GENOMICS_ENGLAND
val	1287	COL4A5	0.553	0.654	C1567744	AlportSyndrome,AutosomalRecessive	disease	C16;C13;C17;C12	DiseaseorSyndrome	0.31	1	2003	2005	1	0	GENOMICS_ENGLAND
val	1287	COL4A5	0.553	0.654	C1839884	Leiomyomatosis,esophagealandvulval,withnephropathy	disease	C16;C04;C13;C17;C12	DiseaseorSyndrome	0.32	1	1992	2013	1	0	ORPHANET
val	1287	COL4A5	0.553	0.654	C4049702	FocalSegmentalGlomerulosclerosis,NotOtherwiseSpecified	disease	C13;C12	DiseaseorSyndrome	0.30	1	2017	2017	1	0	GENOMICS_ENGLAND
val	1287	COL4A5	0.553	0.654	C4521256	GlomerulopathyAssessment	phenotype		DiagnosticProcedure	0.30				0	0	GENOMICS_ENGLAND
val	1287	COL4A5	0.553	0.654	C4707243	Familialthoracicaorticaneurysmandaorticdissection	disease		DiseaseorSyndrome	0.30				0	0	GENOMICS_ENGLAND
val	1287	COL4A5	0.553	0.654	C4746986	ALPORTSYNDROME1,X-LINKED	disease		DiseaseorSyndrome	0.90	1	1991	2017	24	450	CTD_human;GENOMICS_ENGLAND;UNIPROT
val	1288	COL4A6	0.686	0.423	C0000786	Spontaneousabortion	phenotype	C13	PathologicFunction	0.30	1	2008	2008	1	0	CTD_human
val	1288	COL4A6	0.686	0.423	C0000822	Abortion,Tubal	phenotype	C13	PathologicFunction	0.30	1	2008	2008	1	0	CTD_human
val	1288	COL4A6	0.686	0.423	C0009402	ColorectalCarcinoma	disease	C06;C04	NeoplasticProcess	0.30				0	0	UNIPROT
val	1288	COL4A6	0.686	0.423	C0086533	Leiomyoma,Epithelioid	disease	C04	NeoplasticProcess	0.30	1	2006	2006	1	0	CTD_human
val	1288	COL4A6	0.686	0.423	C1839884	Leiomyomatosis,esophagealandvulval,withnephropathy	disease	C16;C04;C13;C17;C12	DiseaseorSyndrome	0.51	1	1998	2013	2	0	GENOMICS_ENGLAND;ORPHANET
val	1288	COL4A6	0.686	0.423	C3806737	DEAFNESS,X-LINKED6	disease		DiseaseorSyndrome	0.70	1	1998	2015	3	1	CLINGEN;CTD_human;GENOMICS_ENGLAND;UNIPROT
val	1288	COL4A6	0.686	0.423	C3830362	EarlyPregnancyLoss	phenotype	C13	Finding	0.30	1	2008	2008	1	0	CTD_human
val	1288	COL4A6	0.686	0.423	C4552766	Miscarriage	disease	C13	DiseaseorSyndrome	0.30	1	2008	2008	1	0	CTD_human
val	1289	COL5A1	0.536	0.769	C0000786	Spontaneousabortion	phenotype	C13	PathologicFunction	0.30	1	2008	2008	1	0	CTD_human
val	1289	COL5A1	0.536	0.769	C0000822	Abortion,Tubal	phenotype	C13	PathologicFunction	0.30	1	2008	2008	1	0	CTD_human
val	1289	COL5A1	0.536	0.769	C0005779	BloodCoagulationDisorders	group	C15	DiseaseorSyndrome	0.30	1	2015	2015	1	0	GENOMICS_ENGLAND
val	1289	COL5A1	0.536	0.769	C0007097	Carcinoma	group	C04	NeoplasticProcess	0.30	1	2002	2002	1	0	CTD_human
val	1289	COL5A1	0.536	0.769	C0022548	Keloid	disease	C23;C17	AcquiredAbnormality	0.30	1	2010	2010	1	0	CTD_human
val	1289	COL5A1	0.536	0.769	C0023893	LiverCirrhosis,Experimental	disease	C23;C06	ExperimentalModelofDisease	0.30	1	2014	2014	1	0	CTD_human
val	1289	COL5A1	0.536	0.769	C0024667	AnimalMammaryNeoplasms	phenotype	C04;C22	NeoplasticProcess	0.30	1	2002	2002	1	0	CTD_human
val	1289	COL5A1	0.536	0.769	C0024668	MammaryNeoplasms,Experimental	phenotype	C04	NeoplasticProcess;ExperimentalModelofDisease	0.30	1	2002	2002	1	0	CTD_human
val	1289	COL5A1	0.536	0.769	C0033578	ProstaticNeoplasms	group	C04;C12	NeoplasticProcess	0.30	1	2018	2018	1	0	CTD_human
val	1289	COL5A1	0.536	0.769	C0205696	Anaplasticcarcinoma	disease	C04	NeoplasticProcess	0.30	1	2002	2002	1	0	CTD_human
val	1289	COL5A1	0.536	0.769	C0205697	Carcinoma,Spindle-Cell	disease	C04	NeoplasticProcess	0.30	1	2002	2002	1	0	CTD_human
val	1289	COL5A1	0.536	0.769	C0205698	Undifferentiatedcarcinoma	disease	C04	NeoplasticProcess	0.30	1	2002	2002	1	0	CTD_human
val	1289	COL5A1	0.536	0.769	C0205699	Carcinomatosis	phenotype	C04	NeoplasticProcess	0.30	1	2002	2002	1	0	CTD_human
val	1289	COL5A1	0.536	0.769	C0220679	Ehlers-DanlosSyndrome,AutosomalDominant,TypeUnspecified	disease	C16;C17;C15;C14	DiseaseorSyndrome	0.30	1	2005	2012	2	0	ORPHANET
val	1289	COL5A1	0.536	0.769	C0268335	Ehlers-Danlossyndrometype1	disease	C16;C17;C15;C14	DiseaseorSyndrome	0.73	1	1996	2010	3	0	CTD_human;GENOMICS_ENGLAND
val	1289	COL5A1	0.536	0.769	C0268336	Ehlers-Danlossyndrometype2	disease	C16;C17;C15;C14	DiseaseorSyndrome	0.53	1	1995	1998	2	0	CTD_human;GENOMICS_ENGLAND
val	1289	COL5A1	0.536	0.769	C0376358	Malignantneoplasmofprostate	disease	C04;C12	NeoplasticProcess	0.30	1	2018	2018	1	0	CTD_human
val	1289	COL5A1	0.536	0.769	C1257925	MammaryCarcinoma,Animal	disease	C04;C22	NeoplasticProcess	0.30	1	2002	2002	1	0	CTD_human
val	1289	COL5A1	0.536	0.769	C1458140	Bleedingtendency	phenotype	C15	PathologicFunction	0.30	1	2015	2015	1	0	GENOMICS_ENGLAND
val	1289	COL5A1	0.536	0.769	C1846545	AutoimmuneLymphoproliferativeSyndromeType2B	disease	C16;C20;C15	DiseaseorSyndrome	0.30	1	1997	1997	1	0	GENOMICS_ENGLAND
val	1289	COL5A1	0.536	0.769	C3830362	EarlyPregnancyLoss	phenotype	C13	Finding	0.30	1	2008	2008	1	0	CTD_human
val	1289	COL5A1	0.536	0.769	C4225429	Ehlers-Danlossyndromeclassictype	disease	C16;C17;C15;C14	DiseaseorSyndrome	0.30	1	2015	2015	1	0	GENOMICS_ENGLAND
val	1289	COL5A1	0.536	0.769	C4552122	EHLERS-DANLOSSYNDROME,CLASSICTYPE,1	disease		DiseaseorSyndrome	0.60	1	1993	2018	7	38	GENOMICS_ENGLAND;UNIPROT
val	1289	COL5A1	0.536	0.769	C4552766	Miscarriage	disease	C13	DiseaseorSyndrome	0.30	1	2008	2008	1	0	CTD_human
val	1289	COL5A1	0.536	0.769	C4707243	Familialthoracicaorticaneurysmandaorticdissection	disease		DiseaseorSyndrome	0.40				0	1	GENOMICS_ENGLAND
val	1290	COL5A2	0.568	0.731	C0000786	Spontaneousabortion	phenotype	C13	PathologicFunction	0.30	1	2008	2008	1	0	CTD_human
val	1290	COL5A2	0.568	0.731	C0000822	Abortion,Tubal	phenotype	C13	PathologicFunction	0.30	1	2008	2008	1	0	CTD_human
val	1290	COL5A2	0.568	0.731	C0005779	BloodCoagulationDisorders	group	C15	DiseaseorSyndrome	0.30	1	1998	1998	1	0	GENOMICS_ENGLAND
val	1290	COL5A2	0.568	0.731	C0023890	LiverCirrhosis	disease	C23;C06	DiseaseorSyndrome	0.30	1	2016	2016	1	0	CTD_human
val	1290	COL5A2	0.568	0.731	C0023893	LiverCirrhosis,Experimental	disease	C23;C06	ExperimentalModelofDisease	0.30	1	2014	2014	1	0	CTD_human
val	1290	COL5A2	0.568	0.731	C0220679	Ehlers-DanlosSyndrome,AutosomalDominant,TypeUnspecified	disease	C16;C17;C15;C14	DiseaseorSyndrome	0.30	1	2005	2012	2	0	ORPHANET
val	1290	COL5A2	0.568	0.731	C0239946	Fibrosis,Liver	disease	C23;C06	DiseaseorSyndrome	0.30	1	2016	2016	1	0	CTD_human
val	1290	COL5A2	0.568	0.731	C0268335	Ehlers-Danlossyndrometype1	disease	C16;C17;C15;C14	DiseaseorSyndrome	0.50	1	1998	2015	1	0	GENOMICS_ENGLAND
val	1290	COL5A2	0.568	0.731	C0268336	Ehlers-Danlossyndrometype2	disease	C16;C17;C15;C14	DiseaseorSyndrome	0.31	1	1998	1998	1	0	GENOMICS_ENGLAND
val	1290	COL5A2	0.568	0.731	C1458140	Bleedingtendency	phenotype	C15	PathologicFunction	0.30	1	1998	1998	1	0	GENOMICS_ENGLAND
val	1290	COL5A2	0.568	0.731	C1846545	AutoimmuneLymphoproliferativeSyndromeType2B	disease	C16;C20;C15	DiseaseorSyndrome	0.30	1	1998	1998	1	0	GENOMICS_ENGLAND
val	1290	COL5A2	0.568	0.731	C3151201	MULTISYSTEMICSMOOTHMUSCLEDYSFUNCTIONSYNDROME	disease		DiseaseorSyndrome	0.30	1	2017	2018	2	0	GENOMICS_ENGLAND
val	1290	COL5A2	0.568	0.731	C3830362	EarlyPregnancyLoss	phenotype	C13	Finding	0.30	1	2008	2008	1	0	CTD_human
val	1290	COL5A2	0.568	0.731	C4225429	Ehlers-Danlossyndromeclassictype	disease	C16;C17;C15;C14	DiseaseorSyndrome	0.30	1	1998	1998	1	0	GENOMICS_ENGLAND
val	1290	COL5A2	0.568	0.731	C4538407	EHLERS-DANLOSSYNDROME,CLASSICTYPE,2	disease		DiseaseorSyndrome	0.60	1	1993	2016	4	11	GENOMICS_ENGLAND;UNIPROT
val	1290	COL5A2	0.568	0.731	C4552122	EHLERS-DANLOSSYNDROME,CLASSICTYPE,1	disease		DiseaseorSyndrome	0.40	1	1998	2018	3	3	GENOMICS_ENGLAND
val	1290	COL5A2	0.568	0.731	C4552766	Miscarriage	disease	C13	DiseaseorSyndrome	0.30	1	2008	2008	1	0	CTD_human
val	1290	COL5A2	0.568	0.731	C4707243	Familialthoracicaorticaneurysmandaorticdissection	disease		DiseaseorSyndrome	0.40				0	2	GENOMICS_ENGLAND
val	1291	COL6A1	0.587	0.731	C0000786	Spontaneousabortion	phenotype	C13	PathologicFunction	0.30	1	2008	2008	1	0	CTD_human
val	1291	COL6A1	0.587	0.731	C0000822	Abortion,Tubal	phenotype	C13	PathologicFunction	0.30	1	2008	2008	1	0	CTD_human
val	1291	COL6A1	0.587	0.731	C0023893	LiverCirrhosis,Experimental	disease	C23;C06	ExperimentalModelofDisease	0.30	1	2014	2014	1	0	CTD_human
val	1291	COL6A1	0.587	0.731	C0024121	LungNeoplasms	group	C04;C08	NeoplasticProcess	0.30	1	2013	2013	1	0	CTD_human
val	1291	COL6A1	0.587	0.731	C0026850	MuscularDystrophy	disease	C16;C05;C10	DiseaseorSyndrome	0.48	1	2002	2019	1	0	CTD_human
val	1291	COL6A1	0.587	0.731	C0242379	Malignantneoplasmoflung	disease	C04;C08	NeoplasticProcess	0.30	1	2013	2013	1	0	CTD_human
val	1291	COL6A1	0.587	0.731	C0410179	Ullrichcongenitalmusculardystrophy1	disease	C23;C16;C05;C10	DiseaseorSyndrome	0.80	0.96	2003	2018	6	10	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
val	1291	COL6A1	0.587	0.731	C1135196	HeartFailure,Diastolic	disease	C14	DiseaseorSyndrome	0.30	1	2018	2018	1	0	CTD_human
val	1291	COL6A1	0.587	0.731	C1834674	BETHLEMMYOPATHY1	disease	C16;C05;C10	DiseaseorSyndrome	1.00	1	1993	2019	7	33	CTD_human;GENOMICS_ENGLAND;UNIPROT
val	1291	COL6A1	0.587	0.731	C3830362	EarlyPregnancyLoss	phenotype	C13	Finding	0.30	1	2008	2008	1	0	CTD_human
val	1291	COL6A1	0.587	0.731	C4552766	Miscarriage	disease	C13	DiseaseorSyndrome	0.30	1	2008	2008	1	0	CTD_human
val	1292	COL6A2	0.599	0.692	C0023893	LiverCirrhosis,Experimental	disease	C23;C06	ExperimentalModelofDisease	0.50	1	1995	2014	1	0	CTD_human
val	1292	COL6A2	0.599	0.692	C0029408	Degenerativepolyarthritis	disease	C05	DiseaseorSyndrome	0.30	1	2009	2009	1	0	CTD_human
val	1292	COL6A2	0.599	0.692	C0086743	OsteoarthrosisDeformans	disease	C05	DiseaseorSyndrome	0.30	1	2009	2009	1	0	CTD_human
val	1292	COL6A2	0.599	0.692	C0410179	Ullrichcongenitalmusculardystrophy1	disease	C23;C16;C05;C10	DiseaseorSyndrome	0.80	1	2001	2017	5	12	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
val	1292	COL6A2	0.599	0.692	C1611706	Myosclerosis	disease	C16	DiseaseorSyndrome	0.31	1	2008	2008	1	0	ORPHANET
val	1292	COL6A2	0.599	0.692	C1834674	BETHLEMMYOPATHY1	disease	C16;C05;C10	DiseaseorSyndrome	0.79	1	1993	2016	5	36	CTD_human;GENOMICS_ENGLAND;UNIPROT
val	1292	COL6A2	0.599	0.692	C1850671	Myosclerosis,AutosomalRecessive	disease	C05;C10	DiseaseorSyndrome	0.61	1	2001	2014	1	3	CTD_human;GENOMICS_ENGLAND
val	1293	COL6A3	0.563	0.769	C0000786	Spontaneousabortion	phenotype	C13	PathologicFunction	0.30	1	2008	2008	1	0	CTD_human
val	1293	COL6A3	0.563	0.769	C0000822	Abortion,Tubal	phenotype	C13	PathologicFunction	0.30	1	2008	2008	1	0	CTD_human
val	1293	COL6A3	0.563	0.769	C0013421	Dystonia	phenotype	C23;C10	SignorSymptom	0.34	1	2016	2018	0	0	CTD_human
val	1293	COL6A3	0.563	0.769	C0027708	Nephroblastoma	disease	C16;C04;C13;C12	NeoplasticProcess	0.30	1	2017	2017	1	0	CTD_human
val	1293	COL6A3	0.563	0.769	C0393588	Dystonia,Paroxysmal	phenotype	C23;C10	SignorSymptom	0.30				0	0	CTD_human
val	1293	COL6A3	0.563	0.769	C0393610	Dystonia,Diurnal	phenotype	C23;C10	SignorSymptom	0.30				0	0	CTD_human
val	1293	COL6A3	0.563	0.769	C0410179	Ullrichcongenitalmusculardystrophy1	disease	C23;C16;C05;C10	DiseaseorSyndrome	1.00	1	2002	2018	4	10	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
val	1293	COL6A3	0.563	0.769	C0751093	Dystonia,Limb	phenotype	C23;C10	SignorSymptom	0.40				0	0	CTD_human
val	1293	COL6A3	0.563	0.769	C1834674	BETHLEMMYOPATHY1	disease	C16;C05;C10	DiseaseorSyndrome	0.80	1	1993	2018	5	37	CTD_human;GENOMICS_ENGLAND;UNIPROT
val	1293	COL6A3	0.563	0.769	C2930471	BilateralWilmsTumor	disease	C16;C04;C13;C12	DiseaseorSyndrome	0.30	1	2017	2017	1	0	CTD_human
val	1293	COL6A3	0.563	0.769	C3830362	EarlyPregnancyLoss	phenotype	C13	Finding	0.30	1	2008	2008	1	0	CTD_human
val	1293	COL6A3	0.563	0.769	C4225336	DYSTONIA27	disease		DiseaseorSyndrome	0.72	1	2002	2018	2	7	GENOMICS_ENGLAND;ORPHANET;UNIPROT
val	1293	COL6A3	0.563	0.769	C4552766	Miscarriage	disease	C13	DiseaseorSyndrome	0.30	1	2008	2008	1	0	CTD_human
val	1294	COL7A1	0.545	0.808	C0006142	Malignantneoplasmofbreast	disease	C04;C17	NeoplasticProcess	0.50	1	2008	2008	1	1	CTD_human;UNIPROT
val	1294	COL7A1	0.545	0.808	C0007131	Non-SmallCellLungCarcinoma	disease	C04;C08	NeoplasticProcess	0.30	1	2018	2018	1	0	CTD_human
val	1294	COL7A1	0.545	0.808	C0009402	ColorectalCarcinoma	disease	C06;C04	NeoplasticProcess	0.30	1	2008	2008	1	0	CTD_human
val	1294	COL7A1	0.545	0.808	C0009404	ColorectalNeoplasms	group	C06;C04	NeoplasticProcess	0.30	1	2008	2008	1	0	CTD_human
val	1294	COL7A1	0.545	0.808	C0079136	Cockayne-TouraineDisease	disease	C16;C17	DiseaseorSyndrome	0.40	0.957	1991	2017	0	0	CTD_human
val	1294	COL7A1	0.545	0.808	C0079294	EpidermolysisBullosaDystrophica	disease	C16;C17	DiseaseorSyndrome	0.90	1	1992	2019	2	9	CTD_human;GENOMICS_ENGLAND
val	1294	COL7A1	0.545	0.808	C0079474	Hallopeau-SiemensDisease	disease	C16;C17	DiseaseorSyndrome	1.00	0.983	1993	2020	16	51	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
val	1294	COL7A1	0.545	0.808	C0235874	DiseaseExacerbation	phenotype	C23	Finding	0.30	1	2018	2018	1	0	CTD_human
val	1294	COL7A1	0.545	0.808	C0268371	EpidermolysisBullosaWithCongenitalLocalizedAbsenceOfSkinAndDeformityOfNails	disease	C16;C17	CongenitalAbnormality	0.60	1	2002	2013	2	10	CTD_human;GENOMICS_ENGLAND
val	1294	COL7A1	0.545	0.808	C0432321	Epidermolysisbullosa,pretibial	disease	C16;C17	CongenitalAbnormality	0.75	1	1995	2018	3	10	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
val	1294	COL7A1	0.545	0.808	C0432322	Dominantdystrophicepidermolysisbullosa,albopapulartype(disorder)	disease	C16;C17	CongenitalAbnormality	0.78	1	1989	2017	18	24	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
val	1294	COL7A1	0.545	0.808	C0678222	BreastCarcinoma	disease	C04;C17	NeoplasticProcess	0.30	1	2008	2008	1	0	CTD_human
val	1294	COL7A1	0.545	0.808	C1257931	MammaryNeoplasms,Human	disease	C04;C17	NeoplasticProcess	0.30	1	2008	2008	1	0	CTD_human
val	1294	COL7A1	0.545	0.808	C1275114	EpidermolysisBullosaPruriginosa	disease	C16;C17	DiseaseorSyndrome	0.80	0.933	1999	2018	2	10	CTD_human;ORPHANET;UNIPROT
val	1294	COL7A1	0.545	0.808	C1458155	MammaryNeoplasms	group	C04;C17	NeoplasticProcess	0.30	1	2008	2008	1	0	CTD_human
val	1294	COL7A1	0.545	0.808	C1843477	EpidermolysisBullosaSimplexSuperficialis	disease	C16;C17	DiseaseorSyndrome	0.30	1	2002	2002	1	0	ORPHANET
val	1294	COL7A1	0.545	0.808	C1843761	TOENAILDYSTROPHY,ISOLATED	disease	C23;C17	DiseaseorSyndrome	0.60	1	2002	2002	1	13	CTD_human;UNIPROT
val	1294	COL7A1	0.545	0.808	C1851573	Transientbullousdermolysisofthenewborn	disease	C16;C17	DiseaseorSyndrome	0.73	1	1997	2013	3	13	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
val	1294	COL7A1	0.545	0.808	C2673611	EpidermolysisBullosaDystrophica,AutosomalRecessive,LocalisataVariant	disease	C16;C17	DiseaseorSyndrome	0.60	1	1999	2009	0	1	ORPHANET
val	1294	COL7A1	0.545	0.808	C2673612	EpidermolysisBullosaDystrophicaInversa,AutosomalRecessive	disease	C16;C17	DiseaseorSyndrome	0.60	1	1999	2009	0	4	ORPHANET
val	1294	COL7A1	0.545	0.808	C4511056	Centripetalisrecessivedystrophicepidermolysisbullosa	disease	C16;C17	DiseaseorSyndrome	0.30				0	0	ORPHANET
val	1294	COL7A1	0.545	0.808	C4518087	Acraldystrophicepidermolysisbullosa	disease		DiseaseorSyndrome	0.30				0	0	ORPHANET
val	1294	COL7A1	0.545	0.808	C4704874	MammaryCarcinoma,Human	disease	C04;C17	NeoplasticProcess	0.30	1	2008	2008	1	0	CTD_human
val	1295	COL8A1	0.678	0.538	C0000768	CongenitalAbnormality	group	C16	CongenitalAbnormality	0.30	1	2008	2008	1	0	CTD_human
val	1295	COL8A1	0.678	0.538	C1135196	HeartFailure,Diastolic	disease	C14	DiseaseorSyndrome	0.30	1	2018	2018	1	0	CTD_human
val	1296	COL8A2	0.67	0.423	C0016781	FuchsEndothelialDystrophy	disease	C16;C11	DiseaseorSyndrome	0.60	0.938	2004	2018	1	0	ORPHANET
val	1296	COL8A2	0.67	0.423	C0339284	Polymorphouscornealdystrophy	disease	C16;C11	DiseaseorSyndrome	0.34	1	2001	2019	1	0	ORPHANET
val	1296	COL8A2	0.67	0.423	C1850959	Cornealdystrophy,Fuchsendothelial,1	disease	C16;C11	DiseaseorSyndrome	0.72	1	2001	2019	2	7	CTD_human;GENOMICS_ENGLAND;UNIPROT
3788	1296	COL8A2	0.67	0.423	C1852795	CORNEALDYSTROPHY,POSTERIORPOLYMORPHOUS,2	disease	C16;C11	DiseaseorSyndrome	0.7	1	2001	2001	1	2	CTD_human;GENOMICS_ENGLAND;UNIPROT
3794	1297	COL9A1	0.566	0.731	C0026760	MultipleEpiphysealDysplasia	disease	C16;C05	CongenitalAbnormality	0.7	1	2001	2019	3	0	CTD_human;GENOMICS_ENGLAND
3805	1297	COL9A1	0.566	0.731	C3279941	STICKLERSYNDROME,TYPEIV	disease		DiseaseorSyndrome	0.6	1	2001	2006	2	2	CTD_human;GENOMICS_ENGLAND
3815	1298	COL9A2	0.572	0.769	C0158252	Intervertebraldiscdisorder	group	C23;C05	DiseaseorSyndrome	0.55	1	1999	2016	3	1	GENOMICS_ENGLAND;UNIPROT
3820	1298	COL9A2	0.572	0.769	C3280342	STICKLERSYNDROME,TYPEV	disease		DiseaseorSyndrome	0.6	1	2002	2011	3	1	CTD_human;GENOMICS_ENGLAND
3827	1299	COL9A3	0.569	0.769	C0158252	Intervertebraldiscdisorder	group	C23;C05	DiseaseorSyndrome	0.55	0.8	2004	2018	0	0	CTD_human;GENOMICS_ENGLAND
3831	1299	COL9A3	0.569	0.769	C1832998	EPIPHYSEALDYSPLASIA,MULTIPLE,3	disease	C16;C05	DiseaseorSyndrome	0.7	1	1999	2014	5	6	CTD_human;GENOMICS_ENGLAND;UNIPROT
3834	1300	COL10A1	0.619	0.5	C0265289	MetaphysealchondrodysplasiaSchmidtype	disease	C16;C05	DiseaseorSyndrome	0.95	1	1994	2019	10	0	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
3850	1301	COL11A1	0.495	0.846	C0158252	Intervertebraldiscdisorder	group	C23;C05	DiseaseorSyndrome	0.51	1	1996	2014	1	0	CTD_human;GENOMICS_ENGLAND
3852	1301	COL11A1	0.495	0.846	C0265235	Marshallsyndrome	disease	C23;C16;C11;C05;C10;C09	DiseaseorSyndrome	0.73	1	1996	2014	3	3	CTD_human;GENOMICS_ENGLAND;ORPHANET
3853	1301	COL11A1	0.495	0.846	C0265282	Fibrochondrogenesis	disease	C23;C16;C05;C19	CongenitalAbnormality	0.63	1	2010	2013	1	0	CTD_human;GENOMICS_ENGLAND;ORPHANET
3858	1301	COL11A1	0.495	0.846	C1858084	STICKLERSYNDROME,TYPEII(disorder)	disease	C11;C17	DiseaseorSyndrome	0.98	1	1971	2020	4	9	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
3859	1301	COL11A1	0.495	0.846	C2020284	Sticklersyndrome,type1	disease	C23;C11;C17;C05;C10;C09	DiseaseorSyndrome	0.6	1	1971	2017	0	0	GENOMICS_ENGLAND
3861	1301	COL11A1	0.495	0.846	C3278138	FIBROCHONDROGENESIS1	disease		DiseaseorSyndrome	0.6	1	1996	2010	2	4	GENOMICS_ENGLAND;UNIPROT
3872	1302	COL11A2	0.435	0.846	C0265282	Fibrochondrogenesis	disease	C23;C16;C05;C19	CongenitalAbnormality	0.51	1	2012	2012	1	0	CTD_human;ORPHANET
3877	1302	COL11A2	0.435	0.846	C1848488	PierreRobinsyndromewithfetalchondrodysplasia	disease	C16;C05;C07	DiseaseorSyndrome	0.82	1	1964	2015	17	1	CLINGEN;CTD_human;GENOMICS_ENGLAND;UNIPROT
3879	1302	COL11A2	0.435	0.846	C1861481	Sticklersyndrome,type3	disease	C17;C05	DiseaseorSyndrome	0.6	1	2004	2004	1	4	GENOMICS_ENGLAND;ORPHANET
3880	1302	COL11A2	0.435	0.846	C1864746	Deafness,AutosomalRecessive53	disease	C23;C10;C09	DiseaseorSyndrome	0.71	1	1964	2015	4	4	CTD_human;GENOMICS_ENGLAND;UNIPROT
3881	1302	COL11A2	0.435	0.846	C1866095	Deafness,AutosomalDominant13	disease	C23;C10;C09	DiseaseorSyndrome	0.93	1	1964	2016	3	3	CTD_human;GENOMICS_ENGLAND;UNIPROT
3884	1302	COL11A2	0.435	0.846	C4520892	Otospondylomegaepiphysealdysplasia	disease	C16;C05;C19	DiseaseorSyndrome	1	1	1964	2015	18	4	CLINGEN;CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
3888	1303	COL12A1	0.615	0.692	C1834674	BETHLEMMYOPATHY1	disease	C16;C05;C10	DiseaseorSyndrome	0.61	1	2014	2018	2	0	CTD_human;GENOMICS_ENGLAND;ORPHANET
3890	1303	COL12A1	0.615	0.692	C4225313	BETHLEMMYOPATHY2	disease		DiseaseorSyndrome	0.6	1	2014	2017	3	7	GENOMICS_ENGLAND;UNIPROT
3899	1305	COL13A1	0.608	0.654	C4225235	MYASTHENICSYNDROME,CONGENITAL,19	disease		DiseaseorSyndrome	0.6	1	2015	2017	1	3	GENOMICS_ENGLAND
3906	1308	COL17A1	0.545	0.769	C0268374	Adultjunctionalepidermolysisbullosa(disorder)	disease	C16;C17	DiseaseorSyndrome	0.7	1	1996	2014	7	13	CTD_human;GENOMICS_ENGLAND;UNIPROT
3907	1308	COL17A1	0.545	0.769	C1852551	EpithelialRecurrentErosionDystrophy	disease	C16;C11	DiseaseorSyndrome	0.75	1	2003	2019	2	2	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
3917	1311	COMP	0.503	0.808	C0410538	Pseudoachondroplasia	disease	C16;C05	CongenitalAbnormality	1	0.974	1995	2019	14	15	CTD_human;GENOMICS_ENGLAND;UNIPROT
3919	1311	COMP	0.503	0.808	C1838280	Epiphysealdysplasia,multiple,1	disease	C16;C05	DiseaseorSyndrome	0.74	1	1995	2016	11	13	CTD_human;GENOMICS_ENGLAND;UNIPROT
3927	1312	COMT	0.4	0.923	C0005586	BipolarDisorder	disease	F03	MentalorBehavioralDysfunction	0.7	1	1997	2019	6	0	CTD_human;PSYGENET
3928	1312	COMT	0.4	0.923	C0005587	Depression,Bipolar	disease	F03	MentalorBehavioralDysfunction	0.51	0.5	2002	2006	3	0	CTD_human;PSYGENET
3934	1312	COMT	0.4	0.923	C0012236	DiGeorgeSyndrome	disease	C16;C05;C19;C15;C14	DiseaseorSyndrome	0.6	0.929	1996	2008	1	0	CTD_human;ORPHANET
3942	1312	COMT	0.4	0.923	C0030193	Pain	phenotype	C23	SignorSymptom	0.6	0.958	2003	2020	1	0	CTD_human
3954	1312	COMT	0.4	0.923	C0220704	Shprintzensyndrome	disease	C16;C05;C19;C15;C14	DiseaseorSyndrome	0.6	0.9	1996	2012	1	0	CTD_human;ORPHANET
3973	1312	COMT	0.4	0.923	C0600427	CocaineDependence	disease	C25;F03	MentalorBehavioralDysfunction	0.52	1	2008	2010	3	0	CTD_human;PSYGENET
4009	1314	COPA	0.7	0.385	C4225334	AUTOIMMUNEINTERSTITIALLUNG,JOINT,ANDKIDNEYDISEASE	disease		DiseaseorSyndrome	0.71	1	2015	2017	2	5	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
4013	1316	KLF6	0.501	0.846	C0024623	Malignantneoplasmofstomach	disease	C06;C04	NeoplasticProcess	0.66	1	2005	2019	0	0	CGI;CTD_human
4015	1316	KLF6	0.501	0.846	C0038356	StomachNeoplasms	group	C06;C04	NeoplasticProcess	0.61	1	2005	2005	0	1	CGI;CTD_human
4047	1337	COX6A1	0.78	0.154	C4015029	CHARCOT-MARIE-TOOTHDISEASE,RECESSIVEINTERMEDIATED	disease		DiseaseorSyndrome	0.9	1	2014	2014	1	1	CTD_human;GENOMICS_ENGLAND;ORPHANET
4048	1340	COX6B1	0.7	0.577	C0268237	Cytochrome-cOxidaseDeficiency	disease	C16;C18	DiseaseorSyndrome;CongenitalAbnormality	0.7	1	2008	2016	3	2	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
4050	1349	COX7B	0.595	0.654	C0796070	MICROPHTHALMIA,SYNDROMIC7	disease	C16;C11;C17	DiseaseorSyndrome;CongenitalAbnormality	0.52	1	2012	2015	1	0	CTD_human;ORPHANET
4051	1349	COX7B	0.595	0.654	C3550921	LINEARSKINDEFECTSWITHMULTIPLECONGENITALANOMALIES2	disease		DiseaseorSyndrome	0.6	1	1998	2016	3	3	CTD_human;GENOMICS_ENGLAND
4054	1351	COX8A	0.4	0.846	C0268237	Cytochrome-cOxidaseDeficiency	disease	C16;C18	DiseaseorSyndrome;CongenitalAbnormality	0.75	1	1997	2016	1	1	CTD_human;GENOMICS_ENGLAND;ORPHANET
4055	1352	COX10	0.623	0.654	C0023264	LeighDisease	disease	C16;C18;C10	DiseaseorSyndrome	0.61	1	1990	2015	9	0	CLINGEN;CTD_human;GENOMICS_ENGLAND
4056	1352	COX10	0.623	0.654	C0268237	Cytochrome-cOxidaseDeficiency	disease	C16;C18	DiseaseorSyndrome;CongenitalAbnormality	0.94	1	1999	2016	5	6	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
4066	1355	COX15	0.638	0.538	C0023264	LeighDisease	disease	C16;C18;C10	DiseaseorSyndrome	0.74	1	2002	2016	8	0	CLINGEN;CTD_human;GENOMICS_ENGLAND;UNIPROT
4078	1355	COX15	0.638	0.538	C3554534	CARDIOENCEPHALOMYOPATHY,FATALINFANTILE,DUETOCYTOCHROMEcOXIDASEDEFICIENCY2	disease		DiseaseorSyndrome	0.6	1	2003	2016	4	0	GENOMICS_ENGLAND;UNIPROT
4089	1356	CP	0.466	0.846	C0012715	IronMetabolismDisorders	group	C18	DiseaseorSyndrome	0.53	1	1998	2006	1	0	CTD_human
4140	1356	CP	0.466	0.846	C0878682	Ceruloplasmindeficiency	disease	C18;C10	DiseaseorSyndrome	0.9	1	1987	2019	6	51	CTD_human;GENOMICS_ENGLAND
4154	1357	CPA1	0.65	0.577	C0149521	Pancreatitis,Chronic	disease	C06	DiseaseorSyndrome	0.63	1	2013	2017	2	0	CTD_human;GENOMICS_ENGLAND
4155	1357	CPA1	0.65	0.577	C0238339	Hereditarypancreatitis	disease	C06	DiseaseorSyndrome	0.51	1	2013	2019	3	0	GENOMICS_ENGLAND;ORPHANET
4167	1363	CPE	0.584	0.692	C0028754	Obesity	disease	C23;C18	DiseaseorSyndrome	0.73	0.923	1991	2013	2	0	CTD_human;GENOMICS_ENGLAND
4193	1371	CPOX	0.488	0.846	C0162531	HereditaryCoproporphyria	disease	C16;C06;C18;C17	DiseaseorSyndrome	1	0.938	1983	2019	12	10	CTD_human;GENOMICS_ENGLAND;UNIPROT
4203	1373	CPS1	0.59	0.615	C0751753	Carbamoyl-PhosphateSynthaseIDeficiencyDisease	disease	C16;C18;C10	DiseaseorSyndrome	0.87	1	1986	2019	13	0	CLINGEN;CTD_human;ORPHANET
4208	1373	CPS1	0.59	0.615	C3714958	PULMONARYHYPERTENSION,NEONATAL,SUSCEPTIBILITYTO	phenotype		Finding	0.6	NA	NA	NA	0	3	CTD_human;GENOMICS_ENGLAND
4209	1373	CPS1	0.59	0.615	C4082171	HyperammonemiaDuetoCarbamoylPhosphateSynthetase1Deficiency	disease	C16;C18;C10	DiseaseorSyndrome	0.71	1	1993	2018	19	112	CTD_human;GENOMICS_ENGLAND;UNIPROT
4217	1374	CPT1A	0.555	0.808	C0011860	DiabetesMellitus,Non-Insulin-Dependent	disease	C18;C19	DiseaseorSyndrome	0.56	1	2005	2019	1	0	CTD_human
4224	1374	CPT1A	0.555	0.808	C1829703	Carnitinepalmitoyltransferase1Adeficiency	disease	C16;C18	DiseaseorSyndrome	0.9	1	1981	2016	13	55	CLINGEN;CTD_human;GENOMICS_ENGLAND;UNIPROT
4246	1376	CPT2	0.542	0.769	C1833508	CARNITINEPALMITOYLTRANSFERASEIIDEFICIENCY,LATE-ONSET	disease	C16;C18;C05;C10	DiseaseorSyndrome	0.7	1	1992	2015	14	36	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
4247	1376	CPT2	0.542	0.769	C1833511	CARNITINEPALMITOYLTRANSFERASEIIDEFICIENCY,INFANTILE	disease	C16;C06;C18	DiseaseorSyndrome	0.71	1	1992	2016	5	54	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
4248	1376	CPT2	0.542	0.769	C1833518	CARNITINEPALMITOYLTRANSFERASEIIDEFICIENCY,LETHALNEONATAL	disease	C16;C18	DiseaseorSyndrome	0.7	1	1998	2016	3	24	CTD_human;GENOMICS_ENGLAND;ORPHANET
4254	1380	CR2	0.556	0.654	C0009447	CommonVariableImmunodeficiency	disease	C20	DiseaseorSyndrome	0.6	1	2009	2019	1	0	CTD_human;ORPHANET
4257	1380	CR2	0.556	0.654	C0024141	LupusErythematosus,Systemic	disease	C17;C20	DiseaseorSyndrome	0.69	1	2006	2020	3	0	CTD_human;GENOMICS_ENGLAND;ORPHANET
4277	1384	CRAT	0.656	0.577	C4693587	NEURODEGENERATIONWITHBRAINIRONACCUMULATION8	disease		DiseaseorSyndrome	0.6	1	2018	2018	1	1	GENOMICS_ENGLAND;UNIPROT
4296	1385	CREB1	0.463	0.885	C0600427	CocaineDependence	disease	C25;F03	MentalorBehavioralDysfunction	0.51	1	2001	2009	4	0	CTD_human;PSYGENET
4310	1387	CREBBP	0.428	0.808	C0023467	Leukemia,Myelocytic,Acute	disease	C04	NeoplasticProcess	0.6	1	1996	2019	0	0	CGI
4314	1387	CREBBP	0.428	0.808	C0035934	Rubinstein-TaybiSyndrome	disease	C16;C05;C10	DiseaseorSyndrome	0.9	0.988	1997	2019	6	86	CLINGEN;CTD_human
4333	1387	CREBBP	0.428	0.808	C4551859	RUBINSTEIN-TAYBISYNDROME1	disease	C16;C05;C10	DiseaseorSyndrome	0.7	1	1997	2016	12	37	CLINGEN;GENOMICS_ENGLAND;UNIPROT
4378	1393	CRHBP	0.659	0.5	C0011570	MentalDepression	disease	F01	MentalorBehavioralDysfunction	0.52	1	1996	2010	2	0	PSYGENET
4392	1394	CRHR1	0.517	0.769	C0011570	MentalDepression	disease	F01	MentalorBehavioralDysfunction	0.6	1	2004	2019	5	0	PSYGENET
4416	1394	CRHR1	0.517	0.769	C1269683	MajorDepressiveDisorder	disease	F03	MentalorBehavioralDysfunction	0.6	1	2006	2019	5	0	CTD_human;PSYGENET
4424	1395	CRHR2	0.584	0.731	C0003123	Anorexia	disease	C23	DiseaseorSyndrome	0.54	1	1999	2019	1	0	CTD_human
4428	1395	CRHR2	0.584	0.731	C0011570	MentalDepression	disease	F01	MentalorBehavioralDysfunction	0.52	1	2003	2019	4	0	PSYGENET
4441	1399	CRKL	0.553	0.769	C0012236	DiGeorgeSyndrome	disease	C16;C05;C19;C15;C14	DiseaseorSyndrome	0.52	1	2001	2019	1	0	CTD_human
4449	1401	CRP	0.299	0.962	C0003873	RheumatoidArthritis	disease	C17;C05;C20	DiseaseorSyndrome	0.6	0.955	1989	2020	1	0	CTD_human
4461	1401	CRP	0.299	0.962	C0020538	Hypertensivedisease	group	C14	DiseaseorSyndrome	0.6	0.944	2003	2020	4	0	CTD_human
4463	1401	CRP	0.299	0.962	C0021368	Inflammation	phenotype	C23	PathologicFunction	0.6	1	2001	2011	3	0	CTD_human
4475	1401	CRP	0.299	0.962	C0028754	Obesity	disease	C23;C18	DiseaseorSyndrome	0.6	0.98	2001	2020	1	0	CTD_human
4490	1401	CRP	0.299	0.962	C0151744	MyocardialIschemia	disease	C14	DiseaseorSyndrome	0.6	0.938	2000	2019	1	0	CTD_human
4531	1406	CRX	0.565	0.692	C0035334	RetinitisPigmentosa	disease	C16;C11	DiseaseorSyndrome	0.8	1	1997	2018	3	5	CTD_human;GENOMICS_ENGLAND;UNIPROT
4532	1406	CRX	0.565	0.692	C0339527	LeberCongenitalAmaurosis	disease	C11	DiseaseorSyndrome	0.8	0.955	1998	2019	3	2	CTD_human;GENOMICS_ENGLAND;ORPHANET
4533	1406	CRX	0.565	0.692	C3151192	LEBERCONGENITALAMAUROSIS7	disease		DiseaseorSyndrome	0.9	1	1998	2014	5	4	CTD_human;GENOMICS_ENGLAND;UNIPROT
4534	1406	CRX	0.565	0.692	C3489532	Cone-RodDystrophy2	disease	C16;C11	DiseaseorSyndrome	0.8	1	1997	2019	6	6	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
4556	1409	CRYAA	0.653	0.385	C0009691	Congenitalcataract	disease	C23;C16;C13;C11;C10	CongenitalAbnormality	0.7	1	1996	2018	0	4	GENOMICS_ENGLAND
4560	1409	CRYAA	0.653	0.385	C0392557	Nuclearcataract	disease	C11	DiseaseorSyndrome	0.52	1	2007	2014	3	0	GENOMICS_ENGLAND;ORPHANET
4565	1409	CRYAA	0.653	0.385	C1858679	CATARACT,AUTOSOMALDOMINANT	disease	C11	DiseaseorSyndrome	0.9	1	1996	2013	8	8	CTD_human;GENOMICS_ENGLAND;UNIPROT
4597	1410	CRYAB	0.515	0.731	C1837317	Alpha-BCrystallinopathy	disease	C11;C05;C10;C14	DiseaseorSyndrome	0.9	1	1998	2012	6	4	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
4600	1410	CRYAB	0.515	0.731	C3151236	MYOPATHY,MYOFIBRILLAR,FATALINFANTILEHYPERTONIC,ALPHA-BCRYSTALLIN-RELATED	disease		DiseaseorSyndrome	0.7	1	2011	2011	1	1	CTD_human;GENOMICS_ENGLAND;ORPHANET
4601	1410	CRYAB	0.515	0.731	C3554649	CARDIOMYOPATHY,DILATED,1II	disease		DiseaseorSyndrome	0.7	1	2006	2017	2	4	CTD_human;GENOMICS_ENGLAND;UNIPROT
4602	1410	CRYAB	0.515	0.731	C3808377	CATARACT16,MULTIPLETYPES	disease		DiseaseorSyndrome	0.8	1	2001	2013	2	4	CTD_human;GENOMICS_ENGLAND
4606	1411	CRYBA1	0.716	0.269	C1833229	Cataract,CongenitalZonular,withSuturalOpacities	disease	C11	DiseaseorSyndrome	0.8	1	1998	2015	2	4	CTD_human;GENOMICS_ENGLAND
4613	1413	CRYBA4	0.716	0.269	C3808012	CATARACT23,MULTIPLETYPES	disease		DiseaseorSyndrome	0.7	1	2006	2010	2	3	CTD_human;GENOMICS_ENGLAND;UNIPROT
4624	1414	CRYBB1	0.686	0.231	C3888124	CATARACT17,MULTIPLETYPES	disease		DiseaseorSyndrome	0.6	1	2002	2017	4	3	GENOMICS_ENGLAND;UNIPROT
4628	1415	CRYBB2	0.623	0.462	C0344523	Cataract,congenital,ceruleantype1	disease	C11	CongenitalAbnormality	0.63	1	1997	2019	2	0	CTD_human;ORPHANET
4631	1415	CRYBB2	0.623	0.462	C1832175	Cataract,Congenital,CeruleanType,2	disease	C11	DiseaseorSyndrome	0.8	1	1980	2017	2	5	CTD_human;GENOMICS_ENGLAND
4633	1415	CRYBB2	0.623	0.462	C1852438	CATARACT,COPPOCK-LIKE	disease	C11	DiseaseorSyndrome	0.61	1	2000	2000	1	0	GENOMICS_ENGLAND;ORPHANET
4641	1417	CRYBB3	0.769	0.269	C1857853	Cataract,CongenitalNuclear,AutosomalRecessive2	disease	C16;C11	DiseaseorSyndrome	0.7	1	2005	2013	2	2	CTD_human;GENOMICS_ENGLAND;UNIPROT
4644	1419	CRYGB	0.78	0.269	C3808800	CATARACT39,MULTIPLETYPES	disease		DiseaseorSyndrome	0.8	1	1984	2012	1	2	CTD_human;GENOMICS_ENGLAND
4651	1420	CRYGC	0.612	0.577	C1852438	CATARACT,COPPOCK-LIKE	disease	C11	DiseaseorSyndrome	0.82	1	1999	2017	2	1	CTD_human;ORPHANET
4654	1420	CRYGC	0.612	0.577	C4721890	CATARACT2,MULTIPLETYPES	disease		DiseaseorSyndrome	0.8	1	1999	2014	8	6	GENOMICS_ENGLAND;UNIPROT
4656	1421	CRYGD	0.51	0.808	C0086543	Cataract	disease	C11	AcquiredAbnormality	0.7	0.96	1999	2019	2	0	CTD_human;GENOMICS_ENGLAND
4667	1421	CRYGD	0.51	0.808	C3540850	CATARACT4,MULTIPLETYPES	disease		DiseaseorSyndrome	0.9	1	1999	2011	11	6	CTD_human;GENOMICS_ENGLAND;UNIPROT
4672	1427	CRYGS	0.743	0.192	C3805410	CATARACT20,MULTIPLETYPES	disease		DiseaseorSyndrome	0.9	1	1983	2005	1	2	CTD_human;GENOMICS_ENGLAND;UNIPROT
4674	1428	CRYM	0.769	0.346	C4084708	DEAFNESS,AUTOSOMALDOMINANT40	disease		DiseaseorSyndrome	0.7	1	1997	2016	7	2	CLINGEN;CTD_human;GENOMICS_ENGLAND;UNIPROT
4722	1436	CSF1R	0.448	0.808	C0006826	MalignantNeoplasms	group	C04	NeoplasticProcess	0.6	1	1992	2020	1	0	CGI;CTD_human
4739	1436	CSF1R	0.448	0.808	C3711381	HereditaryDiffuseLeukoencephalopathywithSpheroids	disease	C10	DiseaseorSyndrome	0.8	1	1989	2020	3	44	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
4777	1437	CSF2	0.33	0.962	C0034069	PulmonaryFibrosis	disease	C08	DiseaseorSyndrome	0.51	1	1998	2007	1	0	CTD_human
4845	1438	CSF2RA	0.67	0.615	C0034050	PulmonaryAlveolarProteinosis	disease	C08	DiseaseorSyndrome	0.7	1	2008	2019	3	0	CTD_human;GENOMICS_ENGLAND
4847	1438	CSF2RA	0.67	0.615	C2677877	SurfactantMetabolismDysfunction,Pulmonary,4	disease	C16;C08	DiseaseorSyndrome	0.7	1	2008	2014	4	1	CTD_human;GENOMICS_ENGLAND;UNIPROT
4848	1438	CSF2RA	0.67	0.615	C2931035	Pulmonaryalveolarproteinosis,congenital	disease	C08	DiseaseorSyndrome	0.51	1	2008	2013	2	0	GENOMICS_ENGLAND;ORPHANET
4850	1439	CSF2RB	0.705	0.423	C0034050	PulmonaryAlveolarProteinosis	disease	C08	DiseaseorSyndrome	0.64	1	1995	2019	2	0	GENOMICS_ENGLAND
4855	1439	CSF2RB	0.705	0.423	C3280574	SURFACTANTMETABOLISMDYSFUNCTION,PULMONARY,5	disease		DiseaseorSyndrome	0.6	1	2004	2011	2	1	CTD_human;GENOMICS_ENGLAND
5027	1441	CSF3R	0.55	0.692	C0023481	ChronicNeutrophilicLeukemia	disease	C15	NeoplasticProcess	0.6	0.935	2013	2020	1	0	CGI;ORPHANET
5032	1441	CSF3R	0.55	0.692	C0543669	Neutrophilia,Hereditary	disease	C15	DiseaseorSyndrome	0.83	1	1998	2014	1	1	ORPHANET;UNIPROT
5033	1441	CSF3R	0.55	0.692	C1292772	Leukemia,Myeloid,Chronic,Atypical,BCR-ABLNegative	disease	C04;C15	NeoplasticProcess	0.59	1	2013	2020	1	0	CGI;ORPHANET
5035	1441	CSF3R	0.55	0.692	C4310764	NEUTROPENIA,SEVERECONGENITAL,7,AUTOSOMALRECESSIVE	disease		DiseaseorSyndrome	0.7	1	2009	2015	3	7	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
5065	1453	CSNK1D	0.65	0.615	C1858496	AdvancedSleep-PhaseSyndrome,Familial	disease	C10;F03;C24	DiseaseorSyndrome	0.51	1	2005	2005	1	0	CTD_human;ORPHANET
5066	1453	CSNK1D	0.65	0.615	C3808874	ADVANCEDSLEEPPHASESYNDROME,FAMILIAL,2	disease		DiseaseorSyndrome	0.6	1	2005	2015	3	2	GENOMICS_ENGLAND;UNIPROT
5075	1457	CSNK2A1	0.597	0.731	C4310739	OKUR-CHUNGNEURODEVELOPMENTALSYNDROME	disease		DiseaseorSyndrome	0.72	1	2016	2020	1	9	CTD_human;GENOMICS_ENGLAND;UNIPROT
5089	1462	VCAN	0.497	0.808	C1840452	HyaloideoretinaldegenerationofWagner	disease	C11	DiseaseorSyndrome	0.7	0.938	1999	2018	0	0	CTD_human;GENOMICS_ENGLAND
5091	1463	NCAN	0.67	0.5	C0005586	BipolarDisorder	disease	F03	MentalorBehavioralDysfunction	0.68	1	2011	2019	6	2	CTD_human;PSYGENET
5132	1471	CST3	0.436	0.808	C1527338	HereditaryCerebralAmyloidAngiopathy,IcelandicType	disease	C16;C18;C10;C14	DiseaseorSyndrome	0.77	1	1987	2013	5	1	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
5141	1471	CST3	0.436	0.808	C2677774	Age-RelatedMacularDegenerationtype11	disease	C11	DiseaseorSyndrome	0.6	1	1989	2009	3	1	CTD_human;UNIPROT
5185	1476	CSTB	0.53	0.692	C0751785	Unverricht-LundborgSyndrome	disease	C16;C10	DiseaseorSyndrome	1	0.984	1994	2019	7	13	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
5204	1482	NKX2-5	0.533	0.692	C0039685	TetralogyofFallot	disease	C16;C14	CongenitalAbnormality	0.96	0.909	1999	2018	4	0	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
5207	1482	NKX2-5	0.533	0.692	C0152101	HypoplasticLeftHeartSyndrome	disease	C16;C14	DiseaseorSyndrome	0.81	1	2003	2017	3	0	CTD_human;ORPHANET
5220	1482	NKX2-5	0.533	0.692	C1857586	CONOTRUNCALHEARTMALFORMATIONS(disorder)	disease	C16;C14	DiseaseorSyndrome	0.6	1	2003	2012	3	0	CTD_human;GENOMICS_ENGLAND;UNIPROT
5223	1482	NKX2-5	0.533	0.692	C2673630	HYPOTHYROIDISM,CONGENITAL,NONGOITROUS,5(disorder)	disease	C16;C05;C19	DiseaseorSyndrome	0.6	1	2006	2006	1	0	CTD_human;GENOMICS_ENGLAND;UNIPROT
5226	1482	NKX2-5	0.533	0.692	C3276096	ATRIALSEPTALDEFECT7WITHORWITHOUTATRIOVENTRICULARCONDUCTIONDEFECTS	disease		DiseaseorSyndrome	0.8	1	1998	2017	6	0	CTD_human;GENOMICS_ENGLAND;UNIPROT
5230	1482	NKX2-5	0.533	0.692	C3502353	AtrialSeptalDefectwithAtrioventricularConductionDefects	disease	C23;C16;C14	DiseaseorSyndrome	0.7	1	2008	2017	2	0	GENOMICS_ENGLAND;ORPHANET
5237	1487	CTBP1	0.559	0.692	C4693578	HYPOTONIA,ATAXIA,DEVELOPMENTALDELAY,ANDTOOTHENAMELDEFECTSYNDROME	disease		DiseaseorSyndrome	0.6	1	2016	2019	3	0	GENOMICS_ENGLAND;UNIPROT
5268	1490	CCN2	0.399	0.846	C0034069	PulmonaryFibrosis	disease	C08	DiseaseorSyndrome	0.7	0.963	2001	2019	4	0	CTD_human
5296	1491	CTH	0.578	0.615	C0220993	Cystathioninuria	phenotype	C16;C18	DiseaseorSyndrome	0.94	1	1986	2019	8	3	CLINGEN;GENOMICS_ENGLAND;ORPHANET;UNIPROT
5297	1491	CTH	0.578	0.615	C0268616	Gamma-cystathionasedeficiency	disease	C16;C18	DiseaseorSyndrome	0.94	1	1986	2019	6	0	CLINGEN;CTD_human;ORPHANET
5310	1493	CTLA4	0.369	0.923	C0024141	LupusErythematosus,Systemic	disease	C17;C20	DiseaseorSyndrome	0.7	0.829	1998	2020	1	0	CTD_human;ORPHANET
5331	1493	CTLA4	0.369	0.923	C4015214	CTLA4Haploinsufficiency	disease	C20	DiseaseorSyndrome	0.75	1	2014	2019	2	5	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
5345	1495	CTNNA1	0.584	0.538	C1837029	MacularDystrophy,Butterfly-ShapedPigmentary,2	disease	C11	DiseaseorSyndrome	0.8	1	2016	2016	1	4	CTD_human;UNIPROT
5364	1497	CTNS	0.628	0.538	C0268626	Juvenilenephropathiccystinosis(disorder)	disease	C16;C18;C13;C12	DiseaseorSyndrome;CongenitalAbnormality	0.71	1	1998	2017	6	13	CTD_human;GENOMICS_ENGLAND;UNIPROT
5366	1497	CTNS	0.628	0.538	C2931013	Cystinosis,benign,nonnephropathic	disease	C16;C18	DiseaseorSyndrome	0.7	1	1998	2017	4	12	CTD_human;GENOMICS_ENGLAND;UNIPROT
5367	1497	CTNS	0.628	0.538	C2931187	Nephropathiccystinosis	disease	C16;C18	DiseaseorSyndrome	1	0.98	1998	2019	14	54	CTD_human;GENOMICS_ENGLAND;UNIPROT
5383	1499	CTNNB1	0.303	0.885	C0009402	ColorectalCarcinoma	disease	C06;C04	NeoplasticProcess	0.7	0.983	1997	2020	5	3	CTD_human;UNIPROT
5384	1499	CTNNB1	0.303	0.885	C0009404	ColorectalNeoplasms	group	C06;C04	NeoplasticProcess	0.7	0.985	1997	2019	4	6	CTD_human
5385	1499	CTNNB1	0.303	0.885	C0010276	Craniopharyngioma	disease	C04	NeoplasticProcess	0.7	1	2004	2019	1	3	CTD_human;ORPHANET
5397	1499	CTNNB1	0.303	0.885	C0025149	Medulloblastoma	disease	C04	NeoplasticProcess	0.8	0.979	1998	2020	2	9	CGI;CTD_human;UNIPROT
5407	1499	CTNNB1	0.303	0.885	C0033578	ProstaticNeoplasms	group	C04;C12	NeoplasticProcess	0.6	1	2002	2020	2	0	CTD_human
5411	1499	CTNNB1	0.303	0.885	C0079218	Fibromatosis,Aggressive	disease	C04	NeoplasticProcess	0.7	0.974	1996	2019	0	0	CGI;ORPHANET
5431	1499	CTNNB1	0.303	0.885	C0206624	Hepatoblastoma	disease	C04	NeoplasticProcess	0.7	0.981	1999	2019	1	3	CGI;CTD_human
5435	1499	CTNNB1	0.303	0.885	C0206711	Pilomatrixoma	disease	C04	NeoplasticProcess	0.8	1	1999	2019	3	8	CTD_human;ORPHANET;UNIPROT
5459	1499	CTNNB1	0.303	0.885	C0376358	Malignantneoplasmofprostate	disease	C04;C12	NeoplasticProcess	0.6	0.979	1998	2020	2	0	CTD_human
5474	1499	CTNNB1	0.303	0.885	C0919267	ovarianneoplasm	disease	C04;C13;C19	NeoplasticProcess	0.9	1	1999	2019	1	4	CGI;CTD_human
5475	1499	CTNNB1	0.303	0.885	C1140680	Malignantneoplasmofovary	disease	C04;C13;C19	NeoplasticProcess	0.9	1	1998	2019	2	2	CGI;CTD_human;UNIPROT
5487	1499	CTNNB1	0.303	0.885	C2239176	Livercarcinoma	disease	C06;C04	NeoplasticProcess	0.8	0.982	1998	2020	5	16	CGI;CTD_human;GENOMICS_ENGLAND;UNIPROT
5490	1499	CTNNB1	0.303	0.885	C3554449	MENTALRETARDATION,AUTOSOMALDOMINANT19	disease		DiseaseorSyndrome	0.7	1	1989	2017	6	21	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
5497	1499	CTNNB1	0.303	0.885	C4539767	EXUDATIVEVITREORETINOPATHY7	disease		DiseaseorSyndrome	0.6	1	2017	2017	2	3	GENOMICS_ENGLAND;UNIPROT
5513	1503	CTPS1	0.736	0.269	C4014617	IMMUNODEFICIENCY24	disease		DiseaseorSyndrome	0.7	1	1998	2016	2	1	CTD_human;GENOMICS_ENGLAND;ORPHANET
5531	1508	CTSB	0.457	0.846	C0406756	Keratolyticwintererythema	disease	C23;C16;C17	DiseaseorSyndrome;CongenitalAbnormality	0.52	1	2012	2017	1	0	CTD_human;ORPHANET
5554	1509	CTSD	0.478	0.846	C1864669	NEURONALCEROIDLIPOFUSCINOSISDUETOCATHEPSINDDEFICIENCY	disease	C16;C18;C10	DiseaseorSyndrome	0.93	1	1995	2018	4	6	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
5580	1513	CTSK	0.497	0.808	C0238402	Pycnodysostosis	disease	C16;C18;C05	DiseaseorSyndrome	0.8	0.979	1996	2019	11	35	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
5651	1528	CYB5A	0.601	0.654	C4285231	METHEMOGLOBINEMIAANDAMBIGUOUSGENITALIA	disease		DiseaseorSyndrome	0.6	1	1994	2012	3	3	GENOMICS_ENGLAND;UNIPROT
5660	1535	CYBA	0.52	0.769	C0020538	Hypertensivedisease	group	C14	DiseaseorSyndrome	0.6	0.964	2002	2017	3	0	CTD_human
5661	1535	CYBA	0.52	0.769	C0022661	KidneyFailure,Chronic	disease	C13;C12	DiseaseorSyndrome	0.55	1	2005	2016	1	0	CTD_human
5670	1535	CYBA	0.52	0.769	C1856255	GranulomatousDisease,Chronic,AutosomalRecessive,CytochromeB-Negative	disease	C16;C20;C15	DiseaseorSyndrome	0.7	1	1990	2016	11	15	CTD_human;GENOMICS_ENGLAND;UNIPROT
5675	1536	CYBB	0.452	0.885	C0018203	Chronicgranulomatousdisease	group	C16;C20;C15	DiseaseorSyndrome	0.9	0.986	1987	2020	2	2	CTD_human;GENOMICS_ENGLAND
5678	1536	CYBB	0.452	0.885	C0020538	Hypertensivedisease	group	C14	DiseaseorSyndrome	0.6	0.812	2003	2020	4	0	CTD_human
5680	1536	CYBB	0.452	0.885	C0022661	KidneyFailure,Chronic	disease	C13;C12	DiseaseorSyndrome	0.51	1	2005	2017	1	0	CTD_human
5694	1536	CYBB	0.452	0.885	C1844376	GranulomatousDisease,Chronic,X-Linked	disease	C16;C20;C15	DiseaseorSyndrome	0.8	0.991	1976	2020	25	71	CTD_human;GENOMICS_ENGLAND;UNIPROT
5698	1536	CYBB	0.452	0.885	C1970859	AtypicalMycobacteriosis,Familial,X-Linked2	disease	C16;C01	DiseaseorSyndrome	0.7	1	2007	2011	2	2	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
5701	1537	CYC1	0.656	0.462	C3809553	MITOCHONDRIALCOMPLEXIIIDEFICIENCY,NUCLEARTYPE6	disease		DiseaseorSyndrome	0.6	1	2013	2013	1	2	GENOMICS_ENGLAND;UNIPROT
5709	1540	CYLD	0.498	0.846	C1275122	Familialmultipletrichoepitheliomata	disease	C16;C04;C17	NeoplasticProcess	0.8	1	2003	2019	5	2	CTD_human;ORPHANET;UNIPROT
5712	1540	CYLD	0.498	0.846	C1857941	Brooke-Spieglersyndrome	disease	C16;C04;C17	DiseaseorSyndrome	0.8	0.938	2000	2019	13	7	CLINGEN;CTD_human;UNIPROT
5855	1545	CYP1B1	0.457	0.769	C1856439	GLAUCOMA3,PRIMARYCONGENITAL,A	disease	C11	DiseaseorSyndrome;CongenitalAbnormality	0.7	1	1997	2016	22	17	CTD_human;GENOMICS_ENGLAND;UNIPROT
6021	1571	CYP2E1	0.459	0.885	C0001973	AlcoholicIntoxication,Chronic	disease	C25;F03	MentalorBehavioralDysfunction	0.6	1	1995	2018	6	0	CTD_human;PSYGENET
6025	1571	CYP2E1	0.459	0.885	C0015695	FattyLiver	disease	C06	DiseaseorSyndrome	0.55	1	2003	2018	1	0	CTD_human
6026	1571	CYP2E1	0.459	0.885	C0015696	FattyLiver,Alcoholic	disease	C06;C25	DiseaseorSyndrome	0.52	1	2009	2018	1	0	CTD_human
6043	1571	CYP2E1	0.459	0.885	C0028754	Obesity	disease	C23;C18	DiseaseorSyndrome	0.58	1	1998	2019	1	0	CTD_human
6053	1571	CYP2E1	0.459	0.885	C0085762	Alcoholabuse	disease	C25;F03	MentalorBehavioralDysfunction	0.74	1	1992	2013	6	0	CTD_human;PSYGENET
6111	1581	CYP7A1	0.576	0.615	C0008370	Cholestasis	disease	C06	DiseaseorSyndrome	0.65	1	1998	2018	2	0	CTD_human
6112	1581	CYP7A1	0.576	0.615	C0020443	Hypercholesterolemia	disease	C18	DiseaseorSyndrome	0.7	1	1993	2020	1	0	CTD_human
6148	1583	CYP11A1	0.547	0.731	C3151055	ADRENALINSUFFICIENCY,CONGENITAL,WITH46,XYSEXREVERSAL,PARTIALORCOMPLETE	disease		DiseaseorSyndrome	0.72	1	2001	2017	7	8	GENOMICS_ENGLAND;ORPHANET;UNIPROT
6160	1584	CYP11B1	0.563	0.615	C0268292	Congenitaladrenalhyperplasiadueto11-Beta-hydroxylasedeficiency	disease	C16;C18;C13;C12;C19	DiseaseorSyndrome	0.8	1	1991	2019	13	0	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
6161	1584	CYP11B1	0.563	0.615	C1260386	Glucocorticoid-remediablealdosteronism	disease	C19	DiseaseorSyndrome	0.8	1	1992	2019	3	0	CTD_human;GENOMICS_ENGLAND;ORPHANET
6167	1585	CYP11B2	0.553	0.615	C0268293	CorticosteroneMethylOxidaseTypeIDeficiency	disease	C19	DiseaseorSyndrome	0.71	1	1997	2014	3	0	CTD_human;GENOMICS_ENGLAND;UNIPROT
6172	1585	CYP11B2	0.553	0.615	C3463917	CorticosteroneMethylOxidaseTypeIIDeficiency	disease		DiseaseorSyndrome	0.61	1	1992	2014	6	0	GENOMICS_ENGLAND;UNIPROT
6174	1586	CYP17A1	0.462	0.769	C0001627	Congenitaladrenalhyperplasia	disease	C16;C18;C13;C12;C19	DiseaseorSyndrome	0.7	1	1989	2019	1	0	CTD_human;GENOMICS_ENGLAND
6201	1586	CYP17A1	0.462	0.769	C0268285	Adrenalhyperplasia,congenital,type5	disease	C16;C18;C13;C12;C19	DiseaseorSyndrome	0.8	0.978	1988	2018	19	7	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
6230	1588	CYP19A1	0.41	0.885	C0014175	Endometriosis	disease	C13	DiseaseorSyndrome	0.6	0.956	1996	2020	2	0	CTD_human
6241	1588	CYP19A1	0.41	0.885	C0032460	PolycysticOvarySyndrome	disease	C04;C13;C19	DiseaseorSyndrome	0.6	0.915	1993	2020	4	0	CTD_human
6270	1588	CYP19A1	0.41	0.885	C1960539	Aromatasedeficiency	disease	C16;C18;C13;C17;C12;C19	DiseaseorSyndrome	0.8	1	1993	2019	7	10	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
6271	1588	CYP19A1	0.41	0.885	C1970109	AROMATASEEXCESSSYNDROME	disease	C16;C18;C13;C17;C12;C19	DiseaseorSyndrome	0.8	1	1998	2019	3	0	GENOMICS_ENGLAND;ORPHANET
6278	1589	CYP21A2	0.525	0.769	C2936858	Congenitaladrenalhyperplasiadueto21hydroxylasedeficiency	disease	C16;C18;C13;C12;C19	CongenitalAbnormality	0.8	0.976	1980	2020	54	51	CTD_human;GENOMICS_ENGLAND;UNIPROT
6293	1591	CYP24A1	0.518	0.692	C0475732	Hypercalcemia,Infantile	phenotype	C18	Finding	0.6	NA	NA	NA	0	0	CTD_human;GENOMICS_ENGLAND
6300	1591	CYP24A1	0.518	0.692	C4310232	Hypercalcemia,Infantile,1	disease	C18	DiseaseorSyndrome	0.7	1	2011	2018	3	10	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
6330	1593	CYP27A1	0.538	0.731	C0238052	Xanthomatosis,Cerebrotendinous	disease	C16;C18	DiseaseorSyndrome	0.8	0.985	1975	2019	18	69	CTD_human;GENOMICS_ENGLAND;UNIPROT
6336	1594	CYP27B1	0.502	0.769	C0035579	Rickets	disease	C18;C05	DiseaseorSyndrome	0.7	1	1998	2018	1	0	CTD_human
6339	1594	CYP27B1	0.502	0.769	C0268689	VitaminD-dependentrickets,type1	disease	C16;C18;C13;C05;C12	DiseaseorSyndrome	0.8	1	1997	2020	6	20	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
6342	1600	DAB1	0.626	0.615	C3889636	SPINOCEREBELLARATAXIA37	disease	C16;C10	DiseaseorSyndrome	0.53	1	2017	2019	2	0	GENOMICS_ENGLAND;ORPHANET
6345	1604	CD55	0.51	0.808	C0033680	Protein-LosingEnteropathies	group	C06	DiseaseorSyndrome	0.54	1	2017	2019	1	0	CTD_human;GENOMICS_ENGLAND
6356	1605	DAG1	0.498	0.808	C0265221	Walker-Warburgcongenitalmusculardystrophy	disease	C16;C11;C10	DiseaseorSyndrome	0.7	0.955	1998	2017	3	0	CTD_human;GENOMICS_ENGLAND;ORPHANET
6364	1605	DAG1	0.498	0.808	C3151184	MUSCULARDYSTROPHY-DYSTROGLYCANOPATHY(LIMB-GIRDLE),TYPEC,9	disease		DiseaseorSyndrome	0.91	1	2003	2019	6	5	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
6365	1605	DAG1	0.498	0.808	C4225291	MUSCULARDYSTROPHY-DYSTROGLYCANOPATHY(CONGENITALWITHBRAINANDEYEANOMALIES),TYPEA,9	disease		DiseaseorSyndrome	0.6	1	2012	2015	4	4	GENOMICS_ENGLAND;UNIPROT
6376	1609	DGKQ	0.736	0.423	C1527336	SjogrensSyndrome	disease	C11;C17;C05;C20;C07	DiseaseorSyndrome	0.30	1	2013	2013	1	0	CTD_human
val	1610	DAO	0.636	0.615	C0002736	AmyotrophicLateralSclerosis	disease	C18;C10	DiseaseorSyndrome	0.67	1	2010	2018	2	0	GENOMICS_ENGLAND;ORPHANET
val	1610	DAO	0.636	0.615	C0004352	AutisticDisorder	disease	F03	MentalorBehavioralDysfunction	0.30	1	2007	2007	1	0	CTD_human
val	1610	DAO	0.636	0.615	C0005586	BipolarDisorder	disease	F03	MentalorBehavioralDysfunction	0.36	0.8	2004	2012	5	0	PSYGENET
val	1610	DAO	0.636	0.615	C0023893	LiverCirrhosis,Experimental	disease	C23;C06	ExperimentalModelofDisease	0.30	1	2014	2014	1	0	CTD_human
val	1610	DAO	0.636	0.615	C0036341	Schizophrenia	disease	F03	MentalorBehavioralDysfunction	0.40	0.92	2002	2019	1	0	CTD_human
val	1610	DAO	0.636	0.615	C0086132	DepressiveSymptoms	phenotype	F01	SignorSymptom	0.31	1	2007	2007	1	0	PSYGENET
val	1610	DAO	0.636	0.615	C0525045	MoodDisorders	group	F03	MentalorBehavioralDysfunction	0.31	1	2007	2007	1	0	PSYGENET
val	1610	DAO	0.636	0.615	C0853193	BipolarIdisorder	disease	F03	MentalorBehavioralDysfunction	0.31	1	2005	2005	1	0	PSYGENET
val	1610	DAO	0.636	0.615	C1839839	MAJORAFFECTIVEDISORDER2	disease	C16;F03	MentalorBehavioralDysfunction	0.33	1	2004	2008	1	0	PSYGENET
val	1611	DAP	0.53	0.808	C0009324	UlcerativeColitis	disease	C06	DiseaseorSyndrome	0.40	1	2011	2016	1	3	CTD_human
val	1612	DAPK1	0.472	0.808	C0001418	Adenocarcinoma	group	C04	NeoplasticProcess	0.34	0.8	2004	2018	1	0	CTD_human
val	1612	DAPK1	0.472	0.808	C0006118	BrainNeoplasms	group	C04;C10	NeoplasticProcess	0.30	1	2007	2007	1	0	CTD_human
val	1612	DAPK1	0.472	0.808	C0007131	Non-SmallCellLungCarcinoma	disease	C04;C08	NeoplasticProcess	0.39	0.9	2001	2018	1	0	CTD_human
val	1612	DAPK1	0.472	0.808	C0007134	RenalCellCarcinoma	disease	C04;C13;C12	NeoplasticProcess	0.34	1	2003	2015	1	0	CTD_human
val	1612	DAPK1	0.472	0.808	C0007138	Carcinoma,TransitionalCell	disease	C04	NeoplasticProcess	0.34	1	2006	2011	1	0	CTD_human
val	1612	DAPK1	0.472	0.808	C0009759	ConjunctivalDiseases	group	C11	DiseaseorSyndrome	0.30	1	2013	2013	1	0	CTD_human
val	1612	DAPK1	0.472	0.808	C0010606	AdenoidCysticCarcinoma	disease	C04	NeoplasticProcess	0.31	1	2005	2006	1	0	CTD_human
val	1612	DAPK1	0.472	0.808	C0023467	Leukemia,Myelocytic,Acute	disease	C04	NeoplasticProcess	0.35	1	2002	2014	1	0	CTD_human
val	1612	DAPK1	0.472	0.808	C0024121	LungNeoplasms	group	C04;C08	NeoplasticProcess	0.33	1	2004	2012	1	0	CTD_human
val	1612	DAPK1	0.472	0.808	C0026998	AcuteMyeloidLeukemia,M1	disease	C04	NeoplasticProcess	0.30	1	2010	2010	1	0	CTD_human
val	1612	DAPK1	0.472	0.808	C0027627	NeoplasmMetastasis	phenotype	C23;C04	NeoplasticProcess	0.40	0.917	2006	2019	1	0	CTD_human
val	1612	DAPK1	0.472	0.808	C0035242	RespiratoryTractDiseases	group	C08	DiseaseorSyndrome	0.30	1	2013	2013	1	0	CTD_human
val	1612	DAPK1	0.472	0.808	C0036095	SalivaryGlandNeoplasms	group	C04;C07	NeoplasticProcess	0.31	1	2006	2006	1	0	CTD_human
val	1612	DAPK1	0.472	0.808	C0085183	Neoplasms,SecondPrimary	phenotype	C04	NeoplasticProcess	0.30	1	2010	2010	1	0	CTD_human
val	1612	DAPK1	0.472	0.808	C0086696	Neoplasms,Therapy-Associated	phenotype	C04	NeoplasticProcess	0.30	1	2010	2010	1	0	CTD_human
val	1612	DAPK1	0.472	0.808	C0087031	Juvenile-OnsetStillDisease	disease	C17;C05;C20	DiseaseorSyndrome	0.30	1	2009	2009	1	0	CTD_human
val	1612	DAPK1	0.472	0.808	C0153633	Malignantneoplasmofbrain	disease	C04;C10	NeoplasticProcess	0.30	1	2007	2007	1	0	CTD_human
val	1612	DAPK1	0.472	0.808	C0205641	Adenocarcinoma,BasalCell	disease	C04	NeoplasticProcess	0.30	1	2004	2004	1	0	CTD_human
val	1612	DAPK1	0.472	0.808	C0205642	Adenocarcinoma,Oxyphilic	disease	C04	NeoplasticProcess	0.30	1	2004	2004	1	0	CTD_human
val	1612	DAPK1	0.472	0.808	C0205643	Carcinoma,Cribriform	disease	C04	NeoplasticProcess	0.30	1	2004	2004	1	0	CTD_human
val	1612	DAPK1	0.472	0.808	C0205644	Carcinoma,GranularCell	disease	C04	NeoplasticProcess	0.30	1	2004	2004	1	0	CTD_human
val	1612	DAPK1	0.472	0.808	C0205645	Adenocarcinoma,Tubular	disease	C04	NeoplasticProcess	0.30	1	2004	2004	1	0	CTD_human
val	1612	DAPK1	0.472	0.808	C0220636	Malignantneoplasmofsalivarygland	disease	C04;C07	NeoplasticProcess	0.30	1	2006	2006	1	0	CTD_human
val	1612	DAPK1	0.472	0.808	C0242379	Malignantneoplasmoflung	disease	C04;C08	NeoplasticProcess	0.36	1	2004	2015	1	0	CTD_human
val	1612	DAPK1	0.472	0.808	C0279702	Conventional(ClearCell)RenalCellCarcinoma	disease	C04;C13;C12	NeoplasticProcess	0.36	1	2003	2019	1	0	CTD_human
val	1612	DAPK1	0.472	0.808	C0496899	Benignneoplasmofbrain,unspecified	disease	C04;C10	NeoplasticProcess	0.30	1	2007	2007	1	0	CTD_human
val	1612	DAPK1	0.472	0.808	C0750974	BrainTumor,Primary	disease	C04;C10	NeoplasticProcess	0.30	1	2007	2007	1	0	CTD_human
val	1612	DAPK1	0.472	0.808	C0750977	RecurrentBrainNeoplasm	disease	C04;C10	NeoplasticProcess	0.30	1	2007	2007	1	0	CTD_human
val	1612	DAPK1	0.472	0.808	C0750979	Primarymalignantneoplasmofbrain	disease	C04;C10	NeoplasticProcess	0.30	1	2007	2007	1	0	CTD_human
val	1612	DAPK1	0.472	0.808	C0877578	Treatmentrelatedsecondarymalignancy	disease	C04	NeoplasticProcess	0.30	1	2010	2010	1	0	CTD_human
val	1612	DAPK1	0.472	0.808	C1266042	ChromophobeRenalCellCarcinoma	disease	C04;C13;C12	NeoplasticProcess	0.30	1	2006	2006	1	0	CTD_human
val	1612	DAPK1	0.472	0.808	C1266043	SarcomatoidRenalCellCarcinoma	disease	C04;C13;C12	NeoplasticProcess	0.30	1	2006	2006	1	0	CTD_human
val	1612	DAPK1	0.472	0.808	C1266044	CollectingDuctCarcinomaoftheKidney	disease	C04;C13;C12	NeoplasticProcess	0.30	1	2006	2006	1	0	CTD_human
val	1612	DAPK1	0.472	0.808	C1306837	PapillaryRenalCellCarcinoma	disease	C04;C13;C12	NeoplasticProcess	0.30	1	2006	2006	1	0	CTD_human
val	1612	DAPK1	0.472	0.808	C1527390	Neoplasms,Intracranial	group	C04;C10	NeoplasticProcess	0.30	1	2007	2007	1	0	CTD_human
val	1612	DAPK1	0.472	0.808	C1879321	AcuteMyeloidLeukemia(AML-M2)	disease	C04	NeoplasticProcess	0.30	1	2010	2010	1	0	CTD_human
val	1612	DAPK1	0.472	0.808	C2713368	HematopoeticMyelodysplasia	phenotype	C15	PathologicFunction	0.30	1	2010	2010	1	0	CTD_human
val	1612	DAPK1	0.472	0.808	C3463824	MYELODYSPLASTICSYNDROME	group	C15	NeoplasticProcess	0.35	1	2010	2015	1	0	CTD_human
val	1612	DAPK1	0.472	0.808	C3495559	Juvenilearthritis	disease	C17;C05;C20	DiseaseorSyndrome	0.30	1	2009	2009	1	0	CTD_human
val	1612	DAPK1	0.472	0.808	C3714758	Juvenilepsoriaticarthritis	disease	C17;C05;C20	DiseaseorSyndrome	0.30	1	2009	2009	1	0	CTD_human
val	1612	DAPK1	0.472	0.808	C4552091	Polyarthritis,Juvenile,RheumatoidFactorNegative	disease	C17;C05;C20	DiseaseorSyndrome	0.30	1	2009	2009	1	0	CTD_human
val	1612	DAPK1	0.472	0.808	C4704862	Polyarthritis,Juvenile,RheumatoidFactorPositive	disease	C17;C05;C20	DiseaseorSyndrome	0.30	1	2009	2009	1	0	CTD_human
val	1612	DAPK1	0.472	0.808	C4721453	PeripheralNervousSystemDiseases	group	C10	DiseaseorSyndrome	0.30	1	2013	2013	1	0	CTD_human
val	1613	DAPK3	0.612	0.654	C1319315	Adenocarcinomaoflargeintestine	disease	C06;C04	NeoplasticProcess	0.30				0	0	UNIPROT
val	1613	DAPK3	0.612	0.654	C1335167	OvarianMucinousAdenocarcinoma	disease	C04	NeoplasticProcess	0.30				0	0	UNIPROT
val	1615	DARS1	0.711	0.5	C1271100	Lowerlimbspasticity	phenotype	C23;C05;C10	Finding	0.30	1	2015	2015	1	0	GENOMICS_ENGLAND
val	1615	DARS1	0.711	0.5	C3809008	HYPOMYELINATIONWITHBRAINSTEMANDSPINALCORDINVOLVEMENTANDLEGSPASTICITY	disease		DiseaseorSyndrome	0.73	1	2013	2018	3	10	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
val	1616	DAXX	0.544	0.692	C0017636	Glioblastoma	disease	C04	NeoplasticProcess	0.33	1	2015	2018	0	0	CGI
val	1616	DAXX	0.544	0.692	C0030297	PancreaticNeoplasm	disease	C06;C04;C19	NeoplasticProcess	0.31	1	2011	2014	1	0	CTD_human
val	1616	DAXX	0.544	0.692	C0206686	Adrenocorticalcarcinoma	disease	C04;C19	NeoplasticProcess	0.30	1	2014	2014	1	0	CTD_human
val	1616	DAXX	0.544	0.692	C0206754	NeuroendocrineTumors	group	C04	NeoplasticProcess	0.38	1	2011	2019	1	0	CTD_human
val	1616	DAXX	0.544	0.692	C0346647	Malignantneoplasmofpancreas	disease	C06;C04;C19	NeoplasticProcess	0.31	1	2011	2015	1	0	CTD_human
val	1616	DAXX	0.544	0.692	C1328479	PancreaticEndocrineCarcinoma	disease	C06;C04;C19	NeoplasticProcess	0.30				0	0	CGI
val	1617	DAZ1	0.705	0.385	C1507149	PartialchromosomeYdeletion	phenotype	C23;C16;C13;C12;C19	CellorMolecularDysfunction	0.30	1	2002	2010	2	0	ORPHANET
val	1617	DAZ1	0.705	0.385	C1839071	SpermatogenicFailure,Nonobstructive,Y-Linked	disease	C16;C12	DiseaseorSyndrome	0.30				0	0	CTD_human
val	1617	DAZ1	0.705	0.385	C2931163	MalesterilityduetoY-chromosomedeletions	phenotype	C23;C16;C13;C12;C19	DiseaseorSyndrome	0.30	1	2002	2010	2	0	ORPHANET
val	1618	DAZL	0.78	0.154	C1336708	TesticularGermCellTumor	disease	C04;C12;C19	NeoplasticProcess	0.30	1	2013	2013	1	0	CTD_human
val	1620	BRINP1	0.615	0.615	C0009402	ColorectalCarcinoma	disease	C06;C04	NeoplasticProcess	0.33	1	2014	2018	0	0	UNIPROT
val	1621	DBH	0.511	0.846	C0001973	AlcoholicIntoxication,Chronic	disease	C25;F03	MentalorBehavioralDysfunction	0.40	1	1981	2014	5	0	PSYGENET
val	1621	DBH	0.511	0.846	C0005586	BipolarDisorder	disease	F03	MentalorBehavioralDysfunction	0.33	1	1994	2013	5	0	PSYGENET
val	1621	DBH	0.511	0.846	C0011570	MentalDepression	disease	F01	MentalorBehavioralDysfunction	0.53	1	1993	2013	5	0	PSYGENET
val	1621	DBH	0.511	0.846	C0011581	Depressivedisorder	disease	F03	MentalorBehavioralDysfunction	0.34	1	1993	2013	5	0	PSYGENET
val	1621	DBH	0.511	0.846	C0027819	Neuroblastoma	disease	C04	NeoplasticProcess	0.37	1	1989	2015	1	0	CTD_human
val	1621	DBH	0.511	0.846	C0031511	Pheochromocytoma	disease	C04	NeoplasticProcess	0.34	1	1978	2015	1	0	CTD_human
val	1621	DBH	0.511	0.846	C0041696	UnipolarDepression	disease	F03	MentalorBehavioralDysfunction	0.33	1	2002	2015	3	0	PSYGENET
val	1621	DBH	0.511	0.846	C0342687	dopaminebetahydroxylasedeficiency	disease	C10	DiseaseorSyndrome	0.71	1	1995	2011	0	0	CTD_human;GENOMICS_ENGLAND
val	1621	DBH	0.511	0.846	C0525045	MoodDisorders	group	F03	MentalorBehavioralDysfunction	0.34	1	1982	2009	4	0	PSYGENET
val	1621	DBH	0.511	0.846	C0600427	CocaineDependence	disease	C25;F03	MentalorBehavioralDysfunction	0.39	1	2009	2019	5	0	PSYGENET
val	1621	DBH	0.511	0.846	C1257877	Pheochromocytoma,Extra-Adrenal	disease	C04	NeoplasticProcess	0.30	1	2012	2012	1	0	CTD_human
val	1621	DBH	0.511	0.846	C1269683	MajorDepressiveDisorder	disease	F03	MentalorBehavioralDysfunction	0.33	1	2002	2015	3	0	PSYGENET
val	1621	DBH	0.511	0.846	C1306067	Drug-inducedparanoidstate	disease		MentalorBehavioralDysfunction	0.30	1	2000	2014	3	0	PSYGENET
val	1621	DBH	0.511	0.846	C1456784	Paranoia	disease	F03	MentalorBehavioralDysfunction	0.35	1	2000	2014	3	0	CTD_human
val	1621	DBH	0.511	0.846	C2239176	Livercarcinoma	disease	C06;C04	NeoplasticProcess	0.30	1	2017	2017	1	0	CTD_human
val	1621	DBH	0.511	0.846	C4746777	ORTHOSTATICHYPOTENSION1	disease		DiseaseorSyndrome	0.60	1	2002	2017	4	7	GENOMICS_ENGLAND;UNIPROT
val	1622	DBI	0.65	0.654	C0007097	Carcinoma	group	C04	NeoplasticProcess	0.30	1	2002	2002	1	0	CTD_human
val	1622	DBI	0.65	0.654	C0024667	AnimalMammaryNeoplasms	phenotype	C04;C22	NeoplasticProcess	0.30	1	2002	2002	1	0	CTD_human
val	1622	DBI	0.65	0.654	C0024668	MammaryNeoplasms,Experimental	phenotype	C04	NeoplasticProcess;ExperimentalModelofDisease	0.30	1	2002	2002	1	0	CTD_human
val	1622	DBI	0.65	0.654	C0205696	Anaplasticcarcinoma	disease	C04	NeoplasticProcess	0.30	1	2002	2002	1	0	CTD_human
val	1622	DBI	0.65	0.654	C0205697	Carcinoma,Spindle-Cell	disease	C04	NeoplasticProcess	0.30	1	2002	2002	1	0	CTD_human
val	1622	DBI	0.65	0.654	C0205698	Undifferentiatedcarcinoma	disease	C04	NeoplasticProcess	0.30	1	2002	2002	1	0	CTD_human
val	1622	DBI	0.65	0.654	C0205699	Carcinomatosis	phenotype	C04	NeoplasticProcess	0.30	1	2002	2002	1	0	CTD_human
val	1622	DBI	0.65	0.654	C1257925	MammaryCarcinoma,Animal	disease	C04;C22	NeoplasticProcess	0.30	1	2002	2002	1	0	CTD_human
val	1627	DBN1	0.633	0.538	C0005586	BipolarDisorder	disease	F03	MentalorBehavioralDysfunction	0.30	1	2012	2012	1	0	PSYGENET
val	1627	DBN1	0.633	0.538	C0006142	Malignantneoplasmofbreast	disease	C04;C17	NeoplasticProcess	0.30				0	0	UNIPROT
val	1627	DBN1	0.633	0.538	C0036341	Schizophrenia	disease	F03	MentalorBehavioralDysfunction	0.31	1	2004	2013	3	0	PSYGENET
val	1628	DBP	0.556	0.731	C4707243	Familialthoracicaorticaneurysmandaorticdissection	disease		DiseaseorSyndrome	0.30				0	0	GENOMICS_ENGLAND
val	1629	DBT	0.638	0.462	C0019193	Hepatitis,Toxic	disease	C06;C25	InjuryorPoisoning	0.30	1	2015	2015	1	0	CTD_human
val	1629	DBT	0.638	0.462	C0024776	MapleSyrupUrineDisease	disease	C16;C18;C10	DiseaseorSyndrome	1.00	1	1991	2020	13	25	CLINGEN;CTD_human;GENOMICS_ENGLAND;UNIPROT
val	1629	DBT	0.638	0.462	C0036572	Seizures	phenotype	C23;C10	SignorSymptom	0.40	1	2019	2019	1	0	GENOMICS_ENGLAND
val	1629	DBT	0.638	0.462	C0268568	ClassicMapleSyrupUrineDisease	disease	C16;C18;C10	DiseaseorSyndrome	0.30				0	0	CTD_human
val	1629	DBT	0.638	0.462	C0268569	IntermittentMapleSyrupUrineDisease	disease	C16;C18;C10	DiseaseorSyndrome	0.30				0	0	CTD_human
val	1629	DBT	0.638	0.462	C0751285	MapleSyrupUrineDisease,ThiamineResponsive	disease	C16;C18;C10	DiseaseorSyndrome	0.31	1	1991	1991	0	0	CTD_human
val	1629	DBT	0.638	0.462	C0860207	Drug-InducedLiverDisease	phenotype	C06;C25	DiseaseorSyndrome	0.30	1	2015	2015	1	0	CTD_human
val	1629	DBT	0.638	0.462	C1262760	Hepatitis,Drug-Induced	disease	C06;C25	DiseaseorSyndrome	0.30	1	2015	2015	1	0	CTD_human
val	1629	DBT	0.638	0.462	C1621920	IntermediateMapleSyrupUrineDisease	disease	C16;C18;C10	DiseaseorSyndrome	0.30				0	0	CTD_human
val	1629	DBT	0.638	0.462	C1855371	MAPLESYRUPURINEDISEASE,TYPEII	disease	C16;C18;C10	DiseaseorSyndrome	0.40	1	2016	2016	1	3	GENOMICS_ENGLAND
val	1629	DBT	0.638	0.462	C3658290	Drug-InducedAcuteLiverInjury	disease	C06;C25	DiseaseorSyndrome	0.30	1	2015	2015	1	0	CTD_human
val	1629	DBT	0.638	0.462	C4048158	Convulsions	phenotype	C23;C10	SignorSymptom	0.30	1	2019	2019	1	0	GENOMICS_ENGLAND
val	1629	DBT	0.638	0.462	C4277682	ChemicalandDrugInducedLiverInjury	disease	C06;C25	DiseaseorSyndrome	0.30	1	2015	2015	1	0	CTD_human
val	1629	DBT	0.638	0.462	C4279912	Chemically-InducedLiverToxicity	disease	C06;C25	DiseaseorSyndrome	0.30	1	2015	2015	1	0	CTD_human
val	1630	DCC	0.471	0.808	C0009402	ColorectalCarcinoma	disease	C06;C04	NeoplasticProcess	0.70	0.946	1990	2019	1	0	CTD_human;UNIPROT
val	1630	DCC	0.471	0.808	C0009404	ColorectalNeoplasms	group	C06;C04	NeoplasticProcess	0.38	1	1992	2007	1	0	CTD_human
val	1630	DCC	0.471	0.808	C0014859	EsophagealNeoplasms	group	C06;C04	NeoplasticProcess	0.51	1	1992	1992	0	0	CGI;CTD_human
val	1630	DCC	0.471	0.808	C0020796	ProfoundMentalRetardation	disease	C23;C10;F03;F01	MentalorBehavioralDysfunction	0.30	1	2017	2017	1	0	CTD_human
val	1630	DCC	0.471	0.808	C0025202	melanoma	disease	C04	NeoplasticProcess	0.30	1	2012	2012	1	0	CTD_human
val	1630	DCC	0.471	0.808	C0025363	MentalRetardation,Psychosocial	phenotype	C23;C10;F03;F01	MentalorBehavioralDysfunction	0.30	1	2017	2017	1	0	CTD_human
val	1630	DCC	0.471	0.808	C0036341	Schizophrenia	disease	F03	MentalorBehavioralDysfunction	0.43	1	2012	2019	1	2	PSYGENET
val	1630	DCC	0.471	0.808	C0152018	Esophagealcarcinoma	disease	C06;C04	NeoplasticProcess	0.50				0	1	CGI;UNIPROT
val	1630	DCC	0.471	0.808	C0153942	Benignneoplasmofesophagus	disease	C06;C04	NeoplasticProcess	0.30				0	0	CGI
val	1630	DCC	0.471	0.808	C0154059	Carcinomainsituofesophagus	disease	C06;C04	NeoplasticProcess	0.30				0	0	CGI
val	1630	DCC	0.471	0.808	C0162809	KallmannSyndrome	disease	C16;C13;C12;C19	DiseaseorSyndrome	0.30	1	2018	2018	1	0	ORPHANET
val	1630	DCC	0.471	0.808	C0175754	Agenesisofcorpuscallosum	disease	C23;C16;C10	CongenitalAbnormality	0.43	1	2017	2020	1	9	CTD_human
val	1630	DCC	0.471	0.808	C0546837	Malignantneoplasmofesophagus	disease	C06;C04	NeoplasticProcess	0.50				0	0	CGI;CTD_human
val	1630	DCC	0.471	0.808	C0917816	Mentaldeficiency	disease	C23;C10;F03;F01	MentalorBehavioralDysfunction	0.30	1	2017	2017	1	0	CTD_human
val	1630	DCC	0.471	0.808	C1319315	Adenocarcinomaoflargeintestine	disease	C06;C04	NeoplasticProcess	0.31	1	2003	2003	0	0	CGI
val	1630	DCC	0.471	0.808	C1834870	MIRRORMOVEMENTS1	phenotype		Finding	0.70	1	2010	2017	2	9	CTD_human;GENOMICS_ENGLAND;UNIPROT
val	1630	DCC	0.471	0.808	C1846496	GazePalsy,FamilialHorizontal,withProgressiveScoliosis	disease	C05	DiseaseorSyndrome	0.30	1	2017	2017	1	0	ORPHANET
val	1630	DCC	0.471	0.808	C3179058	CorpusCallosumMalformation	disease	C23;C16;C10	CongenitalAbnormality	0.30	1	2017	2017	1	0	CTD_human
val	1630	DCC	0.471	0.808	C3714756	IntellectualDisability	group	C23;C10;F03;F01	MentalorBehavioralDysfunction	0.41	1	2017	2017	1	0	CTD_human
val	1630	DCC	0.471	0.808	C4479640	GAZEPALSY,FAMILIALHORIZONTAL,WITHPROGRESSIVESCOLIOSIS,2	disease		DiseaseorSyndrome	0.50	1	2017	2017	1	1	GENOMICS_ENGLAND;UNIPROT
val	1630	DCC	0.471	0.808	C4551964	GAZEPALSY,FAMILIALHORIZONTAL,WITHPROGRESSIVESCOLIOSIS,1	disease	C23;C18;C11;C05;C10	DiseaseorSyndrome	0.30	1	2017	2017	1	0	CTD_human
val	1634	DCN	0.457	0.808	C0014170	EndometrialNeoplasms	group	C04;C13	NeoplasticProcess	0.30	1	2006	2006	1	0	CTD_human
val	1634	DCN	0.457	0.808	C0016059	Fibrosis	phenotype	C23	PathologicFunction	0.50	1	2005	2005	1	0	CTD_human
val	1634	DCN	0.457	0.808	C0027707	Nephritis,Interstitial	disease	C13;C12	DiseaseorSyndrome	0.30	1	2005	2005	1	0	CTD_human
val	1634	DCN	0.457	0.808	C0041349	Nephritis,Tubulointerstitial	disease	C13;C12	DiseaseorSyndrome	0.30	1	2005	2005	1	0	CTD_human
val	1634	DCN	0.457	0.808	C0151744	MyocardialIschemia	disease	C14	DiseaseorSyndrome	0.30	1	2005	2005	1	0	CTD_human
val	1634	DCN	0.457	0.808	C0238288	MuscularDystrophy,Facioscapulohumeral	disease	C16;C05;C10	DiseaseorSyndrome	0.30	1	2003	2003	1	0	CTD_human
val	1634	DCN	0.457	0.808	C0476089	EndometrialCarcinoma	disease	C04;C13	NeoplasticProcess	0.32	1	2000	2011	1	0	CTD_human
val	1634	DCN	0.457	0.808	C1623038	Cirrhosis	disease	C23	DiseaseorSyndrome	0.31	1	2001	2005	1	0	CTD_human
val	1634	DCN	0.457	0.808	C1864738	CornealDystrophy,CongenitalStromal	disease	C16;C11	DiseaseorSyndrome	0.95	1	2005	2015	2	4	CTD_human;GENOMICS_ENGLAND;ORPHANET
val	1634	DCN	0.457	0.808	C2239176	Livercarcinoma	disease	C06;C04	NeoplasticProcess	0.34	1	2002	2018	1	0	CTD_human
val	1636	ACE	0.328	0.923	C0001418	Adenocarcinoma	group	C04	NeoplasticProcess	0.30	1	2011	2011	1	0	CTD_human
val	1636	ACE	0.328	0.923	C0001925	Albuminuria	phenotype	C23;C13;C12	Finding	0.51	1	2006	2013	1	0	CTD_human
val	1636	ACE	0.328	0.923	C0001973	AlcoholicIntoxication,Chronic	disease	C25;F03	MentalorBehavioralDysfunction	0.32	1	2005	2013	3	0	PSYGENET
val	1636	ACE	0.328	0.923	C0002152	AlloxanDiabetes	disease	C18;C19	ExperimentalModelofDisease	0.30	1	2012	2012	1	0	CTD_human
val	1636	ACE	0.328	0.923	C0002395	AlzheimersDisease	disease	C10;F03	DiseaseorSyndrome	0.9	0.915	1998	2020	5	1	CTD_human;GENOMICS_ENGLAND
6381	1636	ACE	0.328	0.923	C0005586	BipolarDisorder	disease	F03	MentalorBehavioralDysfunction	0.57	0.5	2000	2019	4	0	PSYGENET
6392	1636	ACE	0.328	0.923	C0011881	DiabeticNephropathy	disease	C13;C12;C19	DiseaseorSyndrome	0.6	0.914	1994	2019	4	0	CTD_human
6398	1636	ACE	0.328	0.923	C0018801	Heartfailure	disease	C14	DiseaseorSyndrome	0.6	0.981	1992	2020	1	0	CTD_human
6399	1636	ACE	0.328	0.923	C0018802	Congestiveheartfailure	disease	C14	DiseaseorSyndrome	0.6	0.984	1992	2020	1	0	CTD_human
6400	1636	ACE	0.328	0.923	C0020538	Hypertensivedisease	group	C14	DiseaseorSyndrome	0.6	0.921	1986	2020	3	0	CTD_human
6406	1636	ACE	0.328	0.923	C0022661	KidneyFailure,Chronic	disease	C13;C12	DiseaseorSyndrome	0.6	0.878	1995	2020	2	0	CTD_human
6408	1636	ACE	0.328	0.923	C0024115	Lungdiseases	group	C08	DiseaseorSyndrome	0.56	0.889	1997	2019	1	0	CTD_human
6412	1636	ACE	0.328	0.923	C0027051	MyocardialInfarction	disease	C23;C14	DiseaseorSyndrome	0.6	0.921	1992	2020	2	0	CTD_human
6425	1636	ACE	0.328	0.923	C0038454	Cerebrovascularaccident	group	C10;C14	DiseaseorSyndrome	0.6	0.844	1994	2020	1	0	CTD_human
6429	1636	ACE	0.328	0.923	C0149721	LeftVentricularHypertrophy	disease	C23;C14	DiseaseorSyndrome	0.6	0.867	1993	2019	1	0	CTD_human
6439	1636	ACE	0.328	0.923	C0266313	AllansonPantzarMcLeodsyndrome	disease	C16;C13;C12	DiseaseorSyndrome	0.76	1	2005	2019	3	7	CTD_human;GENOMICS_ENGLAND;ORPHANET
6464	1723	DHODH	0.576	0.769	C0265257	Genee-Wiedemannsyndrome	disease	C16;C11;C05;C07	DiseaseorSyndrome	0.75	1	2010	2016	3	8	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
6474	1727	CYB5R3	0.638	0.654	C0025637	Methemoglobinemia	disease	C15	DiseaseorSyndrome	0.7	1	1979	2008	2	0	CTD_human;GENOMICS_ENGLAND
6475	1727	CYB5R3	0.638	0.654	C0268193	NADHcytochromeB5reductasedeficiency	disease	C15	DiseaseorSyndrome	0.71	1	1991	2018	12	10	CTD_human;GENOMICS_ENGLAND;UNIPROT
6483	1728	NQO1	0.434	0.885	C0005684	Malignantneoplasmofurinarybladder	disease	C04;C13;C12	NeoplasticProcess	0.6	0.947	1996	2017	1	0	CTD_human
6484	1728	NQO1	0.434	0.885	C0005695	BladderNeoplasm	disease	C04;C13;C12	NeoplasticProcess	0.6	0.95	1996	2017	1	0	CTD_human
6485	1728	NQO1	0.434	0.885	C0006142	Malignantneoplasmofbreast	disease	C04;C17	NeoplasticProcess	0.6	0.833	2002	2019	1	0	CTD_human
6536	1729	DIAPH1	0.623	0.654	C1852282	DEAFNESS,AUTOSOMALDOMINANT1(disorder)	disease	C23;C10;C09	DiseaseorSyndrome	0.61	1	1997	2017	10	0	CLINGEN;CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
6538	1729	DIAPH1	0.623	0.654	C4225261	SEIZURES,CORTICALBLINDNESS,ANDMICROCEPHALYSYNDROME	disease		DiseaseorSyndrome	0.7	1	1989	2016	4	4	CTD_human;GENOMICS_ENGLAND;ORPHANET
6561	1736	DKC1	0.547	0.769	C0265965	DyskeratosisCongenita	disease	C16;C17;C15	DiseaseorSyndrome	0.9	0.969	1998	2019	6	35	CTD_human;GENOMICS_ENGLAND
6562	1736	DKC1	0.547	0.769	C1148551	X-LinkedDyskeratosisCongenita	disease	C16;C17;C15	DiseaseorSyndrome	0.8	1	1998	2019	16	31	CTD_human;GENOMICS_ENGLAND;UNIPROT
6563	1736	DKC1	0.547	0.769	C1846142	HOYERAAL-HREIDARSSONSYNDROME	disease	C23;C16;C13;C17;C05;C10;F03;C15;F01	DiseaseorSyndrome	0.55	1	1999	2016	1	0	GENOMICS_ENGLAND;ORPHANET
6572	1737	DLAT	0.576	0.731	C1855565	PyruvateDehydrogenaseE2Deficiency	disease	C16;C18;C10	DiseaseorSyndrome	0.7	1	2005	2016	4	2	CTD_human;GENOMICS_ENGLAND;ORPHANET
6578	1738	DLD	0.517	0.769	C0268193	NADHcytochromeB5reductasedeficiency	disease	C15	DiseaseorSyndrome	0.8	1	1981	2018	18	33	CLINGEN;GENOMICS_ENGLAND;ORPHANET;UNIPROT
6597	1741	DLG3	0.544	0.615	C2931498	MentalRetardation,X-Linked1	disease	C16;C10	DiseaseorSyndrome	0.55	1	1998	2016	1	0	ORPHANET
6598	1741	DLG3	0.544	0.615	C3275443	MENTALRETARDATION,X-LINKED90(disorder)	disease		DiseaseorSyndrome	0.8	1	2016	2016	0	5	CTD_human;GENOMICS_ENGLAND
6606	1742	DLG4	0.595	0.654	C0175702	WilliamsSyndrome	disease	C16;C10;C14	DiseaseorSyndrome	0.51	1	2010	2010	1	0	CTD_human
6610	1742	DLG4	0.595	0.654	C1510586	AutismSpectrumDisorders	disease	F03	MentalorBehavioralDysfunction	0.55	1	2010	2019	1	0	CTD_human
6623	1747	DLX3	0.601	0.692	C0265333	Tricho-dento-osseoussyndrome(disorder)	disease	C16;C17;C05;C07	DiseaseorSyndrome	0.8	1	1998	2019	4	4	CTD_human;GENOMICS_ENGLAND;ORPHANET
6625	1747	DLX3	0.601	0.692	C1863012	AmelogenesisImperfecta,TypeIV	disease	C16;C07	DiseaseorSyndrome	0.71	1	2005	2016	3	3	CTD_human;GENOMICS_ENGLAND;ORPHANET
6628	1748	DLX4	0.585	0.654	C4225209	OROFACIALCLEFT15	disease		CongenitalAbnormality	0.6	1	2015	2015	1	1	CTD_human;GENOMICS_ENGLAND
6630	1749	DLX5	0.604	0.692	C0265554	Ectrodactyly	disease	C16;C05	CongenitalAbnormality	0.53	1	2002	2014	1	0	ORPHANET
6632	1749	DLX5	0.604	0.692	C1857344	Split-Hand-FootMalformationWithSensorineuralHearingLoss	disease	C23;C16;C05;C10;C09	DiseaseorSyndrome;CongenitalAbnormality	0.7	1	2012	2016	2	1	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
6633	1750	DLX6	0.659	0.615	C0265554	Ectrodactyly	disease	C16;C05	CongenitalAbnormality	0.52	1	2002	2017	1	0	ORPHANET
6636	1750	DLX6	0.659	0.615	C2931019	Splithandfootdeformity1	disease	C16;C05	CongenitalAbnormality	0.55	1	2002	2017	1	0	GENOMICS_ENGLAND
6642	1756	DMD	0.423	0.923	C0007193	Cardiomyopathy,Dilated	group	C14	DiseaseorSyndrome	0.7	0.929	1993	2015	1	1	CTD_human
6644	1756	DMD	0.423	0.923	C0013264	MuscularDystrophy,Duchenne	disease	C16;C05;C10	DiseaseorSyndrome	1	0.98	1981	2020	18	151	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
6655	1756	DMD	0.423	0.923	C0038220	StatusEpilepticus	disease	C23;C10	DiseaseorSyndrome	0.51	1	2010	2019	1	0	CTD_human
6671	1756	DMD	0.423	0.923	C0878544	Cardiomyopathies	group	C14	DiseaseorSyndrome	0.7	0.962	1993	2020	3	1	CTD_human;GENOMICS_ENGLAND
6672	1756	DMD	0.423	0.923	C0917713	BeckerMuscularDystrophy	disease	C16;C05;C10	DiseaseorSyndrome	0.8	0.971	1984	2020	13	29	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
6679	1756	DMD	0.423	0.923	C3668940	Dmd-AssociatedDilatedCardiomyopathy	disease	C14	DiseaseorSyndrome	0.8	1	1992	2018	4	164	CTD_human;GENOMICS_ENGLAND;UNIPROT
6684	1757	SARDH	0.523	0.846	C0268563	Sarcosinemia	phenotype	C16;C18	DiseaseorSyndrome	0.73	1	1986	2016	4	4	CLINGEN;CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
6688	1758	DMP1	0.556	0.615	C0342643	AutosomalrecessivehypophosphatemicvitaminDrefractoryrickets	disease	C16;C18;C13;C05;C12	DiseaseorSyndrome	0.8	1	2006	2020	0	0	CTD_human;ORPHANET
6696	1758	DMP1	0.556	0.615	C4551495	HypophosphatemicRickets,AutosomalRecessive,1	disease	C16;C18;C13;C05;C12	DiseaseorSyndrome	0.8	1	2006	2011	1	4	CTD_human;GENOMICS_ENGLAND
6707	1759	DNM1	0.595	0.692	C4225357	EPILEPTICENCEPHALOPATHY,EARLYINFANTILE,31	disease		DiseaseorSyndrome	0.7	1	2014	2017	4	12	CTD_human;GENOMICS_ENGLAND;UNIPROT
6709	1760	DMPK	0.603	0.692	C0027125	Myotonia	phenotype	C23;C10	Finding	0.6	1	2013	2013	1	0	CTD_human;GENOMICS_ENGLAND
6710	1760	DMPK	0.603	0.692	C0027126	MyotonicDystrophy	disease	C16;C05;C10	DiseaseorSyndrome	0.6	0.981	1992	2020	1	0	CTD_human
6716	1760	DMPK	0.603	0.692	C3250443	MYOTONICDYSTROPHY1	disease	C16;C05;C10	DiseaseorSyndrome	0.7	0.981	1992	2019	4	1	GENOMICS_ENGLAND;ORPHANET
6730	1763	DNA2	0.626	0.731	C3554599	PROGRESSIVEEXTERNALOPHTHALMOPLEGIAWITHMITOCHONDRIALDNADELETIONS,AUTOSOMALDOMINANT,6	disease		DiseaseorSyndrome	0.7	1	2013	2013	1	4	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
6736	1767	DNAH5	0.59	0.692	C1837618	CILIARYDYSKINESIA,PRIMARY,3	disease	C16;C08;C09;C14	DiseaseorSyndrome	0.9	1	2000	2016	5	26	CTD_human;GENOMICS_ENGLAND;UNIPROT
6763	1770	DNAH9	0.716	0.5	C4551720	PrimaryCiliaryDyskinesia	disease	C16;C08;C09	DiseaseorSyndrome	0.54	1	2001	2018	2	0	GENOMICS_ENGLAND;ORPHANET
6766	1773	DNASE1	0.505	0.846	C0024141	LupusErythematosus,Systemic	disease	C17;C20	DiseaseorSyndrome	0.9	0.955	2000	2020	1	0	CTD_human;ORPHANET
6798	1778	DYNC1H1	0.547	0.769	C1834690	SpinalMuscularAtrophy,Childhood,Proximal,AutosomalDominant	disease	C16;C10	DiseaseorSyndrome	0.72	1	2012	2018	8	9	GENOMICS_ENGLAND;ORPHANET;UNIPROT
6803	1778	DYNC1H1	0.547	0.769	C3280220	CHARCOT-MARIE-TOOTHDISEASE,AXONAL,TYPE2O	disease		DiseaseorSyndrome	0.9	1	2011	2018	5	7	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
6804	1778	DYNC1H1	0.547	0.769	C3281202	MENTALRETARDATION,AUTOSOMALDOMINANT13	disease		MentalorBehavioralDysfunction	0.7	1	2010	2018	7	20	CTD_human;GENOMICS_ENGLAND;UNIPROT
6815	1785	DNM2	0.542	0.769	C0175709	Centronuclearmyopathy	disease	C05;C10	DiseaseorSyndrome	0.9	0.982	2005	2019	2	9	CTD_human;GENOMICS_ENGLAND
6820	1785	DNM2	0.542	0.769	C1834558	Myopathy,Centronuclear,AutosomalDominant	disease	C05;C10	DiseaseorSyndrome	0.7	0.958	2005	2019	7	0	CLINGEN;CTD_human;ORPHANET
6821	1785	DNM2	0.542	0.769	C1847902	CHARCOT-MARIE-TOOTHDISEASE,DOMINANTINTERMEDIATEB(disorder)	disease	C16;C10	DiseaseorSyndrome	0.71	1	2005	2017	8	13	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
6825	1785	DNM2	0.542	0.769	C3809272	LETHALCONGENITALCONTRACTURESYNDROME5	disease		DiseaseorSyndrome	0.71	1	2005	2018	2	1	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
6826	1785	DNM2	0.542	0.769	C4551952	Myopathy,Centronuclear,1	disease	C05;C10	DiseaseorSyndrome	0.71	1	2005	2016	13	11	CTD_human;GENOMICS_ENGLAND;UNIPROT
6835	1786	DNMT1	0.406	0.885	C0009375	ColonicNeoplasms	group	C06;C04	NeoplasticProcess	0.52	1	2009	2019	1	0	CTD_human
6876	1786	DNMT1	0.406	0.885	C1384666	hearingimpairment	phenotype	C23;C10;C09	DiseaseorSyndrome	0.51	1	1998	2019	2	0	CTD_human;GENOMICS_ENGLAND
6881	1786	DNMT1	0.406	0.885	C3279885	HereditarySensoryandAutonomicNeuropathyTypeIe	disease	C16;C10	DiseaseorSyndrome	0.72	1	1998	2018	5	3	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
6882	1786	DNMT1	0.406	0.885	C3807295	CEREBELLARATAXIA,DEAFNESS,ANDNARCOLEPSY,AUTOSOMALDOMINANT	disease		DiseaseorSyndrome	0.77	1	1998	2016	11	3	CLINGEN;GENOMICS_ENGLAND;ORPHANET;UNIPROT
6891	1788	DNMT3A	0.445	0.846	C0023467	Leukemia,Myelocytic,Acute	disease	C04	NeoplasticProcess	0.8	0.955	2009	2019	0	4	CGI;CTD_human;GENOMICS_ENGLAND
6920	1788	DNMT3A	0.445	0.846	C4014545	TattonBrownRahmansyndrome	disease	C23;C10;F03;F01	DiseaseorSyndrome	0.78	1	2014	2020	4	28	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
6946	1789	DNMT3B	0.453	0.846	C4551557	IMMUNODEFICIENCY-CENTROMERICINSTABILITY-FACIALANOMALIESSYNDROME1	disease	C16;C20	DiseaseorSyndrome	0.92	1	1999	2016	11	15	CTD_human;GENOMICS_ENGLAND;UNIPROT
6961	1794	DOCK2	0.674	0.462	C4225328	IMMUNODEFICIENCY40	disease		DiseaseorSyndrome	0.7	1	2015	2018	2	4	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
6963	1795	DOCK3	0.619	0.692	C4749014	NEURODEVELOPMENTALDISORDERWITHIMPAIREDINTELLECTUALDEVELOPMENT,HYPOTONIA,ANDATAXIA	disease		DiseaseorSyndrome	0.6	1	2017	2019	3	4	GENOMICS_ENGLAND;UNIPROT
6980	1798	DPAGT1	0.621	0.538	C2931004	Congenitaldisorderofglycosylationtype1J	disease	C16;C18	DiseaseorSyndrome	0.73	1	2003	2019	6	9	CTD_human;GENOMICS_ENGLAND;UNIPROT
6981	1798	DPAGT1	0.621	0.538	C3553645	MYASTHENICSYNDROME,CONGENITAL,13	disease		DiseaseorSyndrome	0.6	1	2012	2019	6	9	GENOMICS_ENGLAND;UNIPROT
6986	1801	DPH1	0.653	0.538	C4310801	DEVELOPMENTALDELAYWITHSHORTSTATURE,DYSMORPHICFEATURES,ANDSPARSEHAIR	disease		DiseaseorSyndrome	0.7	1	2015	2015	2	3	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
6999	1804	DPP6	0.603	0.692	C4225375	MENTALRETARDATION,AUTOSOMALDOMINANT33	disease		MentalorBehavioralDysfunction	0.7	1	2013	2013	1	1	CTD_human;GENOMICS_ENGLAND;UNIPROT
7007	1806	DPYD	0.493	0.846	C0009404	ColorectalNeoplasms	group	C06;C04	NeoplasticProcess	0.6	0.952	1999	2016	5	0	CTD_human
7040	1806	DPYD	0.493	0.846	C1959620	DihydropyrimidineDehydrogenaseDeficiency	disease	C16;C18	DiseaseorSyndrome	0.8	0.941	1988	2019	7	55	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
7047	1807	DPYS	0.621	0.577	C0342803	Dihydropyrimidinasedeficiency	disease	C16;C18	DiseaseorSyndrome	0.71	1	1998	2017	2	6	CTD_human;ORPHANET;UNIPROT
7053	1811	SLC26A3	0.554	0.692	C0267662	Congenitalchloridediarrhea	disease	C23;C16;C18	DiseaseorSyndrome	1	0.964	1996	2019	11	55	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
7056	1812	DRD1	0.529	0.808	C0005586	BipolarDisorder	disease	F03	MentalorBehavioralDysfunction	0.6	1	1992	2015	6	0	CTD_human;PSYGENET
7060	1812	DRD1	0.529	0.808	C0011570	MentalDepression	disease	F01	MentalorBehavioralDysfunction	0.53	1	2007	2018	3	0	PSYGENET
7067	1812	DRD1	0.529	0.808	C0030567	ParkinsonDisease	disease	C10	DiseaseorSyndrome	0.57	1	1996	2020	1	0	CTD_human
7113	1813	DRD2	0.436	0.846	C0009171	CocaineAbuse	disease	C25;F03	MentalorBehavioralDysfunction	0.54	1	2000	2014	14	0	CTD_human;PSYGENET
7116	1813	DRD2	0.436	0.846	C0011570	MentalDepression	disease	F01	MentalorBehavioralDysfunction	0.6	1	2001	2016	5	0	PSYGENET
7124	1813	DRD2	0.436	0.846	C0019337	HeroinDependence	disease	C25;F03	MentalorBehavioralDysfunction	0.6	1	2002	2019	1	0	CTD_human
7125	1813	DRD2	0.436	0.846	C0020514	Hyperprolactinemia	disease	C10;C19	DiseaseorSyndrome	0.6	0.923	2004	2020	2	0	CTD_human
7139	1813	DRD2	0.436	0.846	C0030567	ParkinsonDisease	disease	C10	DiseaseorSyndrome	0.6	0.931	1995	2020	1	0	CTD_human
7153	1813	DRD2	0.436	0.846	C0085762	Alcoholabuse	disease	C25;F03	MentalorBehavioralDysfunction	0.57	1	1994	2015	5	0	PSYGENET
7199	1813	DRD2	0.436	0.846	C0600427	CocaineDependence	disease	C25;F03	MentalorBehavioralDysfunction	0.8	1	1993	2019	15	0	CTD_human;PSYGENET
7228	1813	DRD2	0.436	0.846	C1834570	Myoclonicdystonia	disease	C10	DiseaseorSyndrome	0.57	1	1999	2009	0	0	GENOMICS_ENGLAND;ORPHANET
7282	1814	DRD3	0.529	0.692	C0600427	CocaineDependence	disease	C25;F03	MentalorBehavioralDysfunction	0.52	0.667	1999	2010	7	0	CTD_human;PSYGENET
7339	1816	DRD5	0.603	0.423	C0005586	BipolarDisorder	disease	F03	MentalorBehavioralDysfunction	0.53	1	1998	2014	6	0	CTD_human;PSYGENET
7375	1822	ATN1	0.409	0.885	C0751781	Dentatorubral-PallidoluysianAtrophy	disease	C10	DiseaseorSyndrome	0.7	1	1995	2020	0	0	CTD_human;GENOMICS_ENGLAND;ORPHANET
7384	1824	DSC2	0.61	0.538	C1864850	ArrhythmogenicRightVentricularDysplasia,Familial,11	disease	C16;C14	DiseaseorSyndrome	0.7	1	2006	2018	7	14	CTD_human;GENOMICS_ENGLAND;UNIPROT
7392	1825	DSC3	0.57	0.808	C2751292	HypotrichosisAndRecurrentSkinVesicles	disease	C23;C17	DiseaseorSyndrome;CongenitalAbnormality	0.71	1	2009	2009	1	1	CTD_human;GENOMICS_ENGLAND;ORPHANET
7423	1828	DSG1	0.606	0.538	C2931122	Keratosispalmoplantarisstriata1	disease	C16;C17	DiseaseorSyndrome	0.6	1	2017	2017	1	8	CTD_human;GENOMICS_ENGLAND
7424	1828	DSG1	0.606	0.538	C3809719	Severedermatitis,multipleallergies,metabolicwastingsyndrome	disease	C16;C17	DiseaseorSyndrome	0.8	1	2013	2020	2	1	CTD_human;GENOMICS_ENGLAND;ORPHANET
7431	1829	DSG2	0.601	0.692	C1857777	ArrhythmogenicRightVentricularDysplasia,Familial,10	disease	C16;C14	DiseaseorSyndrome	0.7	1	2006	2018	6	20	CTD_human;GENOMICS_ENGLAND;UNIPROT
7432	1829	DSG2	0.601	0.692	C2752072	Cardiomyopathy,Dilated,1BB	disease	C14	DiseaseorSyndrome	0.6	1	2017	2018	2	2	CTD_human;GENOMICS_ENGLAND
7450	1832	DSP	0.514	0.808	C1800706	IdiopathicPulmonaryFibrosis	disease	C08	DiseaseorSyndrome	0.66	1	2013	2019	1	1	CTD_human;ORPHANET
7451	1832	DSP	0.514	0.808	C1843292	SkinFragility-WoollyHairSyndrome	disease	C16;C17	DiseaseorSyndrome	0.72	1	2002	2019	6	7	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
7452	1832	DSP	0.514	0.808	C1843896	ArrhythmogenicRightVentricularDysplasia,Familial,8	disease	C16;C14	DiseaseorSyndrome	0.9	1	1999	2019	8	69	CTD_human;GENOMICS_ENGLAND;UNIPROT
7453	1832	DSP	0.514	0.808	C1852127	KERATOSISPALMOPLANTARISSTRIATAII	disease	C16;C17	DiseaseorSyndrome	0.6	1	2011	2019	5	4	CTD_human;GENOMICS_ENGLAND
7454	1832	DSP	0.514	0.808	C1854063	CardiomyopathydilatedwithWoollyhairandkeratoderma	disease	C16;C17;C14	DiseaseorSyndrome	0.96	0.971	1999	2019	7	54	CTD_human;GENOMICS_ENGLAND;ORPHANET
7456	1832	DSP	0.514	0.808	C1864826	Epidermolysisbullosa,lethalacantholytic	disease	C16;C17	DiseaseorSyndrome	0.74	1	2005	2019	7	5	CTD_human;GENOMICS_ENGLAND;ORPHANET
7458	1832	DSP	0.514	0.808	C4014393	CARDIOMYOPATHY,DILATED,WITHWOOLLYHAIR,KERATODERMA,ANDTOOTHAGENESIS	disease		DiseaseorSyndrome	0.7	1	2006	2019	6	8	CTD_human;GENOMICS_ENGLAND;UNIPROT
7465	1834	DSPP	0.556	0.769	C0011436	DentinogenesisImperfecta	disease	C16;C07	CongenitalAbnormality	0.7	1	1992	2019	8	0	CLINGEN;CTD_human
7514	1889	ECE1	0.541	0.769	C0020538	Hypertensivedisease	group	C14	DiseaseorSyndrome	0.63	1	2000	2014	1	0	CTD_human
7524	1889	ECE1	0.541	0.769	C3151237	HirschsprungDisease,CardiacDefects,andAutonomicDysfunction	disease	C16;C06;C10;C14	DiseaseorSyndrome	0.6	1	1999	1999	1	1	CTD_human;GENOMICS_ENGLAND;UNIPROT
7544	1890	TYMP	0.495	0.769	C0872218	MITOCHONDRIALNEUROGASTROINTESTINALENCEPHALOPATHYSYNDROME	disease		DiseaseorSyndrome	0.6	1	2001	2019	2	0	GENOMICS_ENGLAND;ORPHANET
7548	1890	TYMP	0.495	0.769	C4551995	MitochondrialDNADepletionSyndrome1	disease		DiseaseorSyndrome	0.7	1	1999	2015	5	43	CTD_human;GENOMICS_ENGLAND;UNIPROT
7561	1892	ECHS1	0.601	0.654	C4225391	MITOCHONDRIALSHORT-CHAINENOYL-CoAHYDRATASE1DEFICIENCY	disease		DiseaseorSyndrome	0.7	1	1993	2017	9	24	CLINGEN;CTD_human;GENOMICS_ENGLAND;UNIPROT
7567	1893	ECM1	0.576	0.731	C0023795	LipoidProteinosisofUrbachandWiethe	disease	C16;C08	DiseaseorSyndrome	0.8	1	2002	2018	5	12	CTD_human;ORPHANET;UNIPROT
7580	1896	EDA	0.553	0.808	C0162359	Christ-Siemens-Tourainesyndrome	disease	C16;C17	DiseaseorSyndrome	0.8	0.99	1992	2019	27	78	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
7582	1896	EDA	0.553	0.808	C1970757	ToothAgenesis,Selective,X-Linked,1	disease	C16;C07	DiseaseorSyndrome	0.7	1	2006	2016	7	9	CTD_human;GENOMICS_ENGLAND;UNIPROT
7627	1906	EDN1	0.38	0.846	C0011860	DiabetesMellitus,Non-Insulin-Dependent	disease	C18;C19	DiseaseorSyndrome	0.6	1	1999	2019	1	0	CTD_human
7631	1906	EDN1	0.38	0.846	C0018800	Cardiomegaly	phenotype	C23;C14	Finding	0.51	1	1995	2012	1	0	CTD_human
7632	1906	EDN1	0.38	0.846	C0018801	Heartfailure	disease	C14	DiseaseorSyndrome	0.6	0.971	1994	2020	7	0	CTD_human
7633	1906	EDN1	0.38	0.846	C0018802	Congestiveheartfailure	disease	C14	DiseaseorSyndrome	0.6	0.976	1994	2020	7	0	CTD_human
7638	1906	EDN1	0.38	0.846	C0020538	Hypertensivedisease	group	C14	DiseaseorSyndrome	0.6	0.983	1993	2020	14	0	CTD_human
7639	1906	EDN1	0.38	0.846	C0020542	PulmonaryHypertension	phenotype	C08	PathologicFunction	0.53	1	1994	2010	5	0	CTD_human
7655	1906	EDN1	0.38	0.846	C0034069	PulmonaryFibrosis	disease	C08	DiseaseorSyndrome	0.6	1	1997	2019	1	0	CTD_human
7658	1906	EDN1	0.38	0.846	C0035222	RespiratoryDistressSyndrome,Adult	disease	C08	DiseaseorSyndrome	0.51	1	1992	2017	1	0	CTD_human
7667	1906	EDN1	0.38	0.846	C0149721	LeftVentricularHypertrophy	disease	C23;C14	DiseaseorSyndrome	0.55	1	1997	2016	2	0	CTD_human
7670	1906	EDN1	0.38	0.846	C0151744	MyocardialIschemia	disease	C14	DiseaseorSyndrome	0.56	1	1999	2019	3	0	CTD_human
7678	1906	EDN1	0.38	0.846	C0242350	Erectiledysfunction	disease	C12;F03	DiseaseorSyndrome	0.52	1	1996	2017	1	0	CTD_human
7718	1906	EDN1	0.38	0.846	C1865295	Auriculo-condylarsyndrome	disease	C09	DiseaseorSyndrome	0.62	1	2013	2017	1	0	CTD_human;GENOMICS_ENGLAND;ORPHANET
7727	1906	EDN1	0.38	0.846	C4551996	Auriculocondylarsyndrome1	disease	C09	DiseaseorSyndrome	0.61	1	2013	2018	1	0	CTD_human;GENOMICS_ENGLAND
7731	1908	EDN3	0.608	0.577	C0019569	HirschsprungDisease	disease	C16;C06	DiseaseorSyndrome	0.7	1	1964	2011	4	0	CTD_human
7735	1908	EDN3	0.608	0.577	C0085758	Aganglionosis,Colonic	disease	C16;C06	CongenitalAbnormality	0.52	1	1996	2009	5	0	CTD_human;GENOMICS_ENGLAND
7738	1908	EDN3	0.608	0.577	C1275808	Congenitalcentralhypoventilation	disease	C23;C08;C10	DiseaseorSyndrome	0.6	1	1996	1998	2	0	CTD_human;GENOMICS_ENGLAND;ORPHANET
7739	1908	EDN3	0.608	0.577	C1848519	WAARDENBURGSYNDROME,TYPE4A	disease	C16;C06	DiseaseorSyndrome	0.56	1	1996	2011	4	0	CTD_human;ORPHANET
7741	1908	EDN3	0.608	0.577	C2750457	WaardenburgSyndrome,Type4b	disease	C16;C06	DiseaseorSyndrome	0.9	1	1994	2017	11	9	CLINGEN;CTD_human;GENOMICS_ENGLAND;UNIPROT
7742	1908	EDN3	0.608	0.577	C3150975	HIRSCHSPRUNGDISEASE,SUSCEPTIBILITYTO,4	disease		Finding	0.6	1	1998	2009	2	3	GENOMICS_ENGLAND;UNIPROT
7743	1908	EDN3	0.608	0.577	C3266898	WaardenburgSyndrome	disease	C16	DiseaseorSyndrome	0.54	1	1996	2020	2	0	GENOMICS_ENGLAND;ORPHANET
7748	1909	EDNRA	0.426	0.885	C0011860	DiabetesMellitus,Non-Insulin-Dependent	disease	C18;C19	DiseaseorSyndrome	0.6	1	2006	2018	1	0	CTD_human
7753	1909	EDNRA	0.426	0.885	C0020538	Hypertensivedisease	group	C14	DiseaseorSyndrome	0.6	1	1996	2019	1	0	CTD_human
7756	1909	EDNRA	0.426	0.885	C0038454	Cerebrovascularaccident	group	C10;C14	DiseaseorSyndrome	0.51	1	2007	2019	1	0	CTD_human
7764	1909	EDNRA	0.426	0.885	C0520679	SleepApnea,Obstructive	disease	C08;C10	DiseaseorSyndrome	0.53	1	2009	2018	1	0	CTD_human
7772	1909	EDNRA	0.426	0.885	C4225349	MANDIBULOFACIALDYSOSTOSISWITHALOPECIA	disease		DiseaseorSyndrome	0.91	1	2010	2016	2	2	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
7774	1910	EDNRB	0.47	0.846	C0011860	DiabetesMellitus,Non-Insulin-Dependent	disease	C18;C19	DiseaseorSyndrome	0.51	1	2006	2009	1	0	CTD_human
7778	1910	EDNRB	0.47	0.846	C0019569	HirschsprungDisease	disease	C16;C06	DiseaseorSyndrome	0.7	1	1966	2019	1	0	CTD_human
7784	1910	EDNRB	0.47	0.846	C0085758	Aganglionosis,Colonic	disease	C16;C06	CongenitalAbnormality	0.65	1	1996	2015	2	2	CTD_human;GENOMICS_ENGLAND
7794	1910	EDNRB	0.47	0.846	C1838099	ABCDsyndrome	disease	C16	DiseaseorSyndrome	0.61	1	1995	2015	3	1	CTD_human;GENOMICS_ENGLAND
7795	1910	EDNRB	0.47	0.846	C1838564	HIRSCHSPRUNGDISEASE,SUSCEPTIBILITYTO,2	disease		Finding	0.6	1	1994	2017	7	6	GENOMICS_ENGLAND;UNIPROT
7796	1910	EDNRB	0.47	0.846	C1848519	WAARDENBURGSYNDROME,TYPE4A	disease	C16;C06	DiseaseorSyndrome	1	1	1994	2018	11	7	CLINGEN;CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
7800	1910	EDNRB	0.47	0.846	C3266898	WaardenburgSyndrome	disease	C16	DiseaseorSyndrome	0.53	0.667	1999	2017	1	0	GENOMICS_ENGLAND;ORPHANET
7813	1911	PHC1	0.644	0.692	C3809431	MICROCEPHALY11,PRIMARY,AUTOSOMALRECESSIVE	disease		DiseaseorSyndrome	0.7	1	2013	2015	3	1	CTD_human;GENOMICS_ENGLAND;UNIPROT
7833	1917	EEF1A2	0.554	0.808	C4225337	EPILEPTICENCEPHALOPATHY,EARLYINFANTILE,33	disease		DiseaseorSyndrome	0.7	1	1988	2018	3	9	CTD_human;GENOMICS_ENGLAND;UNIPROT
7834	1917	EEF1A2	0.554	0.808	C4225343	MENTALRETARDATION,AUTOSOMALDOMINANT38	disease		DiseaseorSyndrome	0.6	1	2015	2015	1	4	CTD_human;UNIPROT
7867	1938	EEF2	0.599	0.731	C1836395	SPINOCEREBELLARATAXIA26	disease	C16;C10	DiseaseorSyndrome	0.7	1	2012	2012	1	1	CTD_human;ORPHANET;UNIPROT
7880	1947	EFNB1	0.561	0.769	C0220767	Craniofrontonasaldysplasia	disease	C16;C05	DiseaseorSyndrome	1	0.958	2004	2019	3	18	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
7938	1950	EGF	0.357	0.923	C2673648	Hypomagnesemia4,Renal	disease	C16;C18;C13;C12	DiseaseorSyndrome	0.6	1	2007	2007	1	1	CTD_human;GENOMICS_ENGLAND;UNIPROT
7954	1954	MEGF8	0.584	0.538	C1275078	Acrocephalopolysyndactylytype2	disease	C16;C05	DiseaseorSyndrome	0.82	1	2012	2018	1	0	CTD_human;GENOMICS_ENGLAND;ORPHANET
7955	1954	MEGF8	0.584	0.538	C3554247	CARPENTERSYNDROME2	disease		DiseaseorSyndrome	0.6	1	2012	2012	1	4	GENOMICS_ENGLAND;UNIPROT
7971	1956	EGFR	0.295	0.885	C0007131	Non-SmallCellLungCarcinoma	disease	C04;C08	NeoplasticProcess	0.7	0.976	1989	2020	16	20	CGI;CTD_human
7981	1956	EGFR	0.295	0.885	C0014859	EsophagealNeoplasms	group	C06;C04	NeoplasticProcess	0.6	1	1988	2019	3	0	CGI;CTD_human
7983	1956	EGFR	0.295	0.885	C0017636	Glioblastoma	disease	C04	NeoplasticProcess	0.7	0.975	1988	2020	3	10	CGI;CTD_human
7985	1956	EGFR	0.295	0.885	C0018671	HeadandNeckNeoplasms	group	C04	NeoplasticProcess	0.63	0.889	2003	2017	3	3	CGI;CTD_human
7989	1956	EGFR	0.295	0.885	C0024121	LungNeoplasms	group	C04;C08	NeoplasticProcess	0.6	0.984	1994	2019	7	0	CGI;CTD_human
8012	1956	EGFR	0.295	0.885	C0152013	Adenocarcinomaoflung(disorder)	disease	C04	NeoplasticProcess	0.7	0.978	1990	2020	2	6	CGI;CTD_human
8034	1956	EGFR	0.295	0.885	C0242379	Malignantneoplasmoflung	disease	C04;C08	NeoplasticProcess	0.6	0.983	1988	2020	7	0	CGI;CTD_human
8037	1956	EGFR	0.295	0.885	C0278996	MalignantHeadandNeckNeoplasm	disease	C04	NeoplasticProcess	0.6	0.965	1989	2019	3	0	CGI;CTD_human
8038	1956	EGFR	0.295	0.885	C0279626	Squamouscellcarcinomaofesophagus	disease	C06;C04	NeoplasticProcess	0.7	1	1994	2020	1	1	CGI;CTD_human
8048	1956	EGFR	0.295	0.885	C0546837	Malignantneoplasmofesophagus	disease	C06;C04	NeoplasticProcess	0.6	1	1988	2020	3	0	CGI;CTD_human
8077	1956	EGFR	0.295	0.885	C4015130	INFLAMMATORYSKINANDBOWELDISEASE,NEONATAL,2	disease		DiseaseorSyndrome	0.7	1	2014	2015	2	1	CTD_human;GENOMICS_ENGLAND;UNIPROT
8115	1959	EGR2	0.547	0.769	C0011195	Dejerine-SottasDisease(disorder)	disease	C16;C10	DiseaseorSyndrome	0.94	1	1999	2019	2	1	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
8123	1959	EGR2	0.547	0.769	C1843247	Charcot-Marie-Toothdisease,Type1D(disorder)	disease	C16;C10	DiseaseorSyndrome	0.71	1	1998	2012	7	4	CTD_human;GENOMICS_ENGLAND;UNIPROT
8125	1959	EGR2	0.547	0.769	C4721436	NEUROPATHY,CONGENITALHYPOMYELINATING,1,AUTOSOMALRECESSIVE	disease	C16;C10	DiseaseorSyndrome	0.8	1	1998	2012	2	1	GENOMICS_ENGLAND;UNIPROT
8149	1962	EHHADH	0.67	0.5	C0341703	AdultFanconisyndrome	disease	C16;C13;C12	DiseaseorSyndrome	0.52	1	2014	2015	1	0	CTD_human;ORPHANET
8156	1962	EHHADH	0.67	0.5	C3810100	FANCONIRENOTUBULARSYNDROME3	disease		DiseaseorSyndrome	0.6	1	2014	2014	1	1	GENOMICS_ENGLAND;UNIPROT
8168	1967	EIF2B1	0.663	0.538	C1847967	OVARIOLEUKODYSTROPHY	disease	C13;C10;C19	DiseaseorSyndrome	0.55	1	2004	2008	1	0	CTD_human;ORPHANET
8169	1967	EIF2B1	0.663	0.538	C1858991	ChildhoodAtaxiawithCentralNervousSystemHypomyelinization	disease	C10	DiseaseorSyndrome	0.8	0.906	2001	2020	6	8	GENOMICS_ENGLAND;ORPHANET;UNIPROT
8176	1968	EIF2S3	0.604	0.731	C1846278	MENTALRETARDATION,EPILEPTICSEIZURES,HYPOGONADISMANDHYPOGENITALISM,MICROCEPHALY,ANDOBESITY(disorder)	disease	C23;C16;C18;C05;C10;C19	DiseaseorSyndrome	0.75	1	1998	2020	4	5	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
8193	1969	EPHA2	0.501	0.731	C1861825	CATARACT,POSTERIORPOLAR,1	disease	C11	DiseaseorSyndrome	0.9	1	2006	2013	4	4	CTD_human;GENOMICS_ENGLAND;UNIPROT
8228	1981	EIF4G1	0.553	0.808	C3280271	PARKINSONDISEASE18	disease		DiseaseorSyndrome	0.7	1	2011	2016	3	2	CTD_human;GENOMICS_ENGLAND;UNIPROT
8249	1991	ELANE	0.447	0.846	C0221023	Cyclicneutropenia	disease	C15	DiseaseorSyndrome	0.8	1	1999	2019	6	13	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
8251	1991	ELANE	0.447	0.846	C1859966	Neutropenia,SevereCongenital,AutosomalDominant1	disease	C15	DiseaseorSyndrome	0.7	1	1999	2016	14	25	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
8275	2006	ELN	0.415	0.885	C0003499	Supravalvularaorticstenosis	disease	C14	DiseaseorSyndrome	0.8	1	1993	2019	7	33	CTD_human;GENOMICS_ENGLAND;ORPHANET
8276	2006	ELN	0.415	0.885	C0010495	CutisLaxa	disease	C16;C17	DiseaseorSyndrome	0.7	1	1980	2020	2	0	CTD_human;GENOMICS_ENGLAND
8277	2006	ELN	0.415	0.885	C0019284	DiaphragmaticHernia	phenotype	C23	DiseaseorSyndrome	0.51	1	1999	2002	1	0	CTD_human
8289	2006	ELN	0.415	0.885	C0268350	CutisLaxa,AutosomalDominant	disease	C16;C17	DiseaseorSyndrome	0.67	1	1997	2018	2	1	CTD_human;ORPHANET
8301	2009	EML1	0.705	0.462	C4284594	BANDHETEROTOPIA	disease		DiseaseorSyndrome	0.6	1	2014	2017	2	4	GENOMICS_ENGLAND;UNIPROT
8304	2010	EMD	0.542	0.731	C0751337	X-LinkedEmery-DreifussMuscularDystrophy	disease	C16;C05;C10	DiseaseorSyndrome	0.8	1	1994	2019	6	20	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
8322	2013	EMP2	0.65	0.692	C4014507	NEPHROTICSYNDROME,TYPE10	disease		DiseaseorSyndrome	0.7	1	2014	2014	1	3	CTD_human;GENOMICS_ENGLAND;UNIPROT
8348	2020	EN2	0.674	0.462	C1510586	AutismSpectrumDisorders	disease	F03	MentalorBehavioralDysfunction	0.59	1	2004	2019	1	0	CTD_human
8352	2022	ENG	0.446	0.846	C0039445	Hereditaryhemorrhagictelangiectasia	disease	C16;C15;C14	DiseaseorSyndrome	1	0.991	1994	2019	13	81	CLINGEN;CTD_human;GENOMICS_ENGLAND
8353	2022	ENG	0.446	0.846	C0340543	Familialprimarypulmonaryhypertension	disease	C08	DiseaseorSyndrome	0.52	1	2004	2017	5	0	GENOMICS_ENGLAND;ORPHANET
8354	2022	ENG	0.446	0.846	C0345893	Juvenilepolyposissyndrome	disease	C16;C06;C04	NeoplasticProcess	0.63	1	2005	2016	5	0	CLINGEN;GENOMICS_ENGLAND;ORPHANET
8363	2022	ENG	0.446	0.846	C4551861	Telangiectasia,HereditaryHemorrhagic,Type1	disease	C16;C15;C14	DiseaseorSyndrome	0.76	1	1994	2018	18	28	CTD_human;GENOMICS_ENGLAND;UNIPROT
8402	2027	ENO3	0.769	0.308	C2752027	GlycogenStorageDiseaseXIII	disease	C16;C18	DiseaseorSyndrome	0.7	1	2001	2014	2	2	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
8408	2030	SLC29A1	0.587	0.731	C0001973	AlcoholicIntoxication,Chronic	disease	C25;F03	MentalorBehavioralDysfunction	0.52	1	2004	2018	2	0	PSYGENET
8422	2033	EP300	0.459	0.846	C0006142	Malignantneoplasmofbreast	disease	C04;C17	NeoplasticProcess	0.7	1	2004	2020	1	1	CGI;CTD_human;UNIPROT
8425	2033	EP300	0.459	0.846	C0009402	ColorectalCarcinoma	disease	C06;C04	NeoplasticProcess	0.64	1	1996	2017	0	3	CTD_human;UNIPROT
8434	2033	EP300	0.459	0.846	C0035934	Rubinstein-TaybiSyndrome	disease	C16;C05;C10	DiseaseorSyndrome	0.6	0.969	2005	2019	0	0	CTD_human;GENOMICS_ENGLAND
8442	2033	EP300	0.459	0.846	C0346647	Malignantneoplasmofpancreas	disease	C06;C04;C19	NeoplasticProcess	0.51	1	2004	2004	0	0	CGI;UNIPROT
8447	2033	EP300	0.459	0.846	C0678222	BreastCarcinoma	disease	C04;C17	NeoplasticProcess	0.6	1	2004	2020	1	0	CGI;CTD_human
8460	2034	EPAS1	0.454	0.731	C0007134	RenalCellCarcinoma	disease	C04;C13;C12	NeoplasticProcess	0.7	0.974	2001	2019	1	18	CTD_human
8470	2034	EPAS1	0.454	0.731	C2673187	Erythrocytosis,Familial,4	disease	C15	DiseaseorSyndrome	0.7	1	2008	2012	4	2	CTD_human;GENOMICS_ENGLAND;UNIPROT
8473	2035	EPB41	0.691	0.5	C0013902	Elliptocytosis,Hereditary	disease	C16;C15	DiseaseorSyndrome	0.83	1	1988	2016	3	1	GENOMICS_ENGLAND;ORPHANET
8476	2035	EPB41	0.691	0.5	C2678497	Elliptocytosis1	disease	C16;C15	DiseaseorSyndrome	0.6	1	1988	1992	2	1	CTD_human;GENOMICS_ENGLAND
8477	2036	EPB41L1	0.839	0.192	C3280285	MENTALRETARDATION,AUTOSOMALDOMINANT11	disease		DiseaseorSyndrome	0.6	1	2011	2015	2	0	CTD_human;GENOMICS_ENGLAND;UNIPROT
8484	2038	EPB42	0.729	0.269	C2675192	Spherocytosis,Type5	disease	C16;C15	DiseaseorSyndrome	0.7	1	1992	1999	6	9	CTD_human;GENOMICS_ENGLAND;UNIPROT
8535	2050	EPHB4	0.524	0.692	C4310629	LYMPHATICMALFORMATION7	disease		DiseaseorSyndrome	0.7	1	2016	2018	2	3	CTD_human;GENOMICS_ENGLAND;UNIPROT
8537	2050	EPHB4	0.524	0.692	C4748670	CAPILLARYMALFORMATION-ARTERIOVENOUSMALFORMATION2	disease		DiseaseorSyndrome	0.61	1	2017	2019	5	14	GENOMICS_ENGLAND;UNIPROT
8593	2052	EPHX1	0.5	0.846	C1843139	Hypercholanemia,Familial	disease	C16;C18	DiseaseorSyndrome	0.6	1	2003	2015	3	0	CTD_human;GENOMICS_ENGLAND;ORPHANET
8615	2053	EPHX2	0.568	0.654	C0745103	HyperlipoproteinemiaTypeIIa	disease	C16;C18	DiseaseorSyndrome	0.61	1	2004	2004	0	1	CTD_human;GENOMICS_ENGLAND
8625	2055	CLN8	0.682	0.423	C1838570	CEROIDLIPOFUSCINOSIS,NEURONAL,8	disease	C16;C18;C10	DiseaseorSyndrome	0.94	1	1986	2019	9	43	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
8626	2055	CLN8	0.682	0.423	C1864923	Northernepilepsysyndrome	disease	C16;C18;C10	DiseaseorSyndrome	0.76	1	1999	2017	4	2	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
8671	2099	ESR1	0.324	0.962	C0919267	ovarianneoplasm	disease	C04;C13;C19	NeoplasticProcess	0.6	0.95	1995	2019	0	0	CGI
8672	2099	ESR1	0.324	0.962	C1140680	Malignantneoplasmofovary	disease	C04;C13;C19	NeoplasticProcess	0.6	0.947	1990	2019	0	0	CGI
8684	2099	ESR1	0.324	0.962	C3809250	ESTROGENRESISTANCE	disease		DiseaseorSyndrome	0.79	1	1994	2018	3	4	GENOMICS_ENGLAND;ORPHANET;UNIPROT
8696	2100	ESR2	0.4	0.923	C0006142	Malignantneoplasmofbreast	disease	C04;C17	NeoplasticProcess	0.6	0.97	1996	2020	3	0	CTD_human
8774	2103	ESRRB	0.565	0.846	C1837857	DEAFNESS,AUTOSOMALRECESSIVE35	disease	C23;C10;C09	DiseaseorSyndrome	0.7	1	1997	2008	2	5	CTD_human;GENOMICS_ENGLAND;UNIPROT
8778	2108	ETFA	0.508	0.731	C0268596	MultipleAcylCoenzymeADehydrogenaseDeficiency	disease	C16;C18	DiseaseorSyndrome	0.79	1	1991	2019	11	4	CLINGEN;CTD_human;GENOMICS_ENGLAND;UNIPROT
8788	2109	ETFB	0.711	0.538	C0268596	MultipleAcylCoenzymeADehydrogenaseDeficiency	disease	C16;C18	DiseaseorSyndrome	0.65	1	1993	2019	10	2	CLINGEN;CTD_human;GENOMICS_ENGLAND;UNIPROT
8798	2110	ETFDH	0.678	0.462	C0268596	MultipleAcylCoenzymeADehydrogenaseDeficiency	disease	C16;C18	DiseaseorSyndrome	0.8	1	1985	2019	18	26	CLINGEN;CTD_human;GENOMICS_ENGLAND;UNIPROT
8807	2113	ETS1	0.444	0.731	C0024141	LupusErythematosus,Systemic	disease	C17;C20	DiseaseorSyndrome	0.7	0.957	2000	2019	3	1	CTD_human;ORPHANET
8843	2120	ETV6	0.477	0.731	C0023467	Leukemia,Myelocytic,Acute	disease	C04	NeoplasticProcess	0.8	0.981	1995	2019	1	2	CGI;CTD_human;GENOMICS_ENGLAND
8850	2120	ETV6	0.477	0.731	C0040034	Thrombocytopenia	phenotype	C15	DiseaseorSyndrome	0.69	1	2015	2019	3	5	CTD_human;GENOMICS_ENGLAND
8866	2120	ETV6	0.477	0.731	C4015537	THROMBOCYTOPENIA5	disease		DiseaseorSyndrome	0.7	1	2015	2017	4	5	CTD_human;GENOMICS_ENGLAND;UNIPROT
8870	2121	EVC	0.587	0.577	C0013903	Ellis-VanCreveldSyndrome	disease	C16;C17;C05	DiseaseorSyndrome	0.96	1	2000	2018	9	21	CLINGEN;CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
8873	2121	EVC	0.587	0.577	C0457013	Weyersacrofacialdysostosis	disease	C16;C05;C07	DiseaseorSyndrome	0.72	1	2000	2018	2	4	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
8895	2122	MECOM	0.513	0.731	C1854273	RadioulnarSynostosiswithAmegakaryocyticThrombocytopenia	disease	C16;C05;C15	DiseaseorSyndrome	0.51	1	2015	2015	1	0	GENOMICS_ENGLAND;ORPHANET
8899	2122	MECOM	0.513	0.731	C4225221	RADIOULNARSYNOSTOSISWITHAMEGAKARYOCYTICTHROMBOCYTOPENIA2	disease		DiseaseorSyndrome	0.6	1	2015	2018	3	3	GENOMICS_ENGLAND;UNIPROT
8912	2147	F2	0.415	0.885	C0012739	DisseminatedIntravascularCoagulation	disease	C15	DiseaseorSyndrome	0.6	0.941	1991	2019	1	0	CTD_human
8916	2147	F2	0.415	0.885	C0020640	InheritedFactorIIdeficiency	disease	C16;C15	DiseaseorSyndrome	0.8	0.964	1983	2019	14	10	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
8921	2147	F2	0.415	0.885	C0028754	Obesity	disease	C23;C18	DiseaseorSyndrome	0.54	1	2007	2015	1	0	CTD_human
8927	2147	F2	0.415	0.885	C0040053	Thrombosis	phenotype	C14	PathologicFunction	0.58	1	1992	2013	4	0	CTD_human
8928	2147	F2	0.415	0.885	C0042487	VenousThrombosis	phenotype	C14	PathologicFunction	0.57	1	1999	2013	3	0	CTD_human
8938	2147	F2	0.415	0.885	C0398623	Thrombophilia	disease	C15	DiseaseorSyndrome	0.6	0.956	1992	2019	1	0	CTD_human
8945	2213	FCGR2B	0.522	0.846	C0024141	LupusErythematosus,Systemic	disease	C17;C20	DiseaseorSyndrome	0.9	0.98	1995	2019	3	0	CTD_human;ORPHANET
8946	2213	FCGR2B	0.522	0.846	C0024530	Malaria	disease	C01	DiseaseorSyndrome	0.53	1	2007	2014	0	0	CTD_human
8954	2214	FCGR3A	0.432	0.962	C3810342	IMMUNODEFICIENCY20	disease		DiseaseorSyndrome	0.6	1	1996	2012	4	1	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
8972	2218	FKTN	0.511	0.692	C0265221	Walker-Warburgcongenitalmusculardystrophy	disease	C16;C11;C10	DiseaseorSyndrome	0.66	1	1998	2016	2	9	CTD_human;ORPHANET
8974	2218	FKTN	0.511	0.692	C0410174	FukuyamaTypeCongenitalMuscularDystrophy	disease	C16;C11;C10	DiseaseorSyndrome	1	1	1992	2019	13	28	CTD_human;GENOMICS_ENGLAND;UNIPROT
8975	2218	FKTN	0.511	0.692	C0457133	Muscleeyebraindisease	disease	C16;C11;C10	DiseaseorSyndrome	0.52	1	2003	2011	1	0	CTD_human;ORPHANET
8979	2218	FKTN	0.511	0.692	C1969024	CARDIOMYOPATHY,DILATED,1X	disease	C14	DiseaseorSyndrome	0.7	1	2006	2016	3	3	CTD_human;GENOMICS_ENGLAND;UNIPROT
8980	2218	FKTN	0.511	0.692	C1969040	MUSCULARDYSTROPHY,LIMB-GIRDLE,TYPE2M	disease	C16;C05;C10	DiseaseorSyndrome	0.7	1	2001	2016	5	7	CTD_human;GENOMICS_ENGLAND;UNIPROT
8981	2218	FKTN	0.511	0.692	C2751052	MUSCULARDYSTROPHY-DYSTROGLYCANOPATHY(CONGENITALWITHOUTMENTALRETARDATION),TYPEB,4	disease		DiseaseorSyndrome	0.9	1	2001	2016	7	3	CTD_human;GENOMICS_ENGLAND;UNIPROT
9009	2224	FDPS	0.599	0.769	C4225262	POROKERATOSIS9,MULTIPLETYPES	disease		DiseaseorSyndrome	0.7	1	2015	2016	2	0	CTD_human;GENOMICS_ENGLAND;UNIPROT
9010	2232	FDXR	0.566	0.808	C4521678	AUDITORYNEUROPATHYANDOPTICATROPHY	disease		DiseaseorSyndrome	0.7	1	2017	2017	1	4	GENOMICS_ENGLAND;ORPHANET;UNIPROT
9013	2235	FECH	0.585	0.577	C0162568	ErythropoieticProtoporphyria	disease	C16;C06;C18;C17	DiseaseorSyndrome	0.8	0.992	1977	2020	6	0	CTD_human;GENOMICS_ENGLAND
9016	2235	FECH	0.585	0.577	C4692546	PROTOPORPHYRIA,ERYTHROPOIETIC,1	disease		DiseaseorSyndrome	0.6	1	1991	2017	16	25	GENOMICS_ENGLAND;UNIPROT
9023	2239	GPC4	0.547	0.769	C0796154	SIMPSON-GOLABI-BEHMELSYNDROME,TYPE1	disease	C23;C16;C05;C10;C19;F03;F01;C14	DiseaseorSyndrome	0.57	0.875	1998	2020	1	0	CTD_human;ORPHANET
9043	2243	FGA	0.573	0.769	C0268389	Amyloidosis,familialvisceral	disease	C16;C18	DiseaseorSyndrome	0.7	1	1993	2015	3	4	CTD_human;GENOMICS_ENGLAND;UNIPROT
9044	2243	FGA	0.573	0.769	C0272350	Dysfibrinogenemia,Congenital	disease	C16;C15	DiseaseorSyndrome	0.62	1	1993	2018	5	2	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
9053	2243	FGA	0.573	0.769	C2584774	Congenitalhypofibrinogenemia	disease	C16;C15	DiseaseorSyndrome	0.79	0.933	1992	2020	8	1	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
9058	2243	FGA	0.573	0.769	C4316812	FibrinogenDeficiency	disease	C16;C15	DiseaseorSyndrome	0.62	1	1992	2010	4	0	CTD_human;GENOMICS_ENGLAND
9064	2244	FGB	0.584	0.692	C0272350	Dysfibrinogenemia,Congenital	disease	C16;C15	DiseaseorSyndrome	0.61	1	1992	2015	4	1	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
9066	2244	FGB	0.584	0.692	C2584774	Congenitalhypofibrinogenemia	disease	C16;C15	DiseaseorSyndrome	0.76	1	2000	2017	7	6	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
9067	2244	FGB	0.584	0.692	C4316812	FibrinogenDeficiency	disease	C16;C15	DiseaseorSyndrome	0.63	1	2013	2019	0	0	CTD_human;GENOMICS_ENGLAND
9072	2245	FGD1	0.573	0.731	C0175701	Aarskogsyndrome	disease	C16;C05;C19;C14	DiseaseorSyndrome	0.8	0.935	1994	2017	11	11	CLINGEN;CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
9099	2247	FGF2	0.383	0.923	C0021368	Inflammation	phenotype	C23	PathologicFunction	0.51	1	2002	2010	1	0	CTD_human
9170	2248	FGF3	0.505	0.808	C0006142	Malignantneoplasmofbreast	disease	C04;C17	NeoplasticProcess	0.6	0.96	1988	2015	1	0	CGI;CTD_human
9177	2248	FGF3	0.505	0.808	C0678222	BreastCarcinoma	disease	C04;C17	NeoplasticProcess	0.6	0.968	1989	2015	1	0	CGI;CTD_human
9186	2248	FGF3	0.505	0.808	C1853144	Deafness,Congenital,withInnerEarAgenesis,Microtia,andMicrodontia	disease	C23;C16;C10;C07;C09	DiseaseorSyndrome	0.73	1	1987	2018	10	14	CLINGEN;CTD_human;GENOMICS_ENGLAND;UNIPROT
9190	2249	FGF4	0.588	0.577	C0006142	Malignantneoplasmofbreast	disease	C04;C17	NeoplasticProcess	0.56	1	1989	2011	1	0	CGI;CTD_human
9192	2249	FGF4	0.588	0.577	C0678222	BreastCarcinoma	disease	C04;C17	NeoplasticProcess	0.6	1	1989	2011	1	0	CGI;CTD_human
9231	2253	FGF8	0.507	0.769	C0162809	KallmannSyndrome	disease	C16;C13;C12;C19	DiseaseorSyndrome	0.56	1	2008	2019	2	0	CTD_human;ORPHANET
9244	2253	FGF8	0.507	0.769	C3552574	HYPOGONADOTROPICHYPOGONADISM6WITHORWITHOUTANOSMIA	disease		DiseaseorSyndrome	0.6	1	2008	2014	5	9	GENOMICS_ENGLAND;UNIPROT
9260	2254	FGF9	0.528	0.846	C2751826	MultipleSynostosesSyndrome3	disease	C16;C05	DiseaseorSyndrome	0.92	1	2009	2017	1	2	CTD_human;GENOMICS_ENGLAND;UNIPROT
9267	2255	FGF10	0.53	0.692	C0158667	AplasiaofLacrimalandSalivaryGlands	disease	C11;C07	CongenitalAbnormality	0.75	1	2006	2017	1	4	CTD_human;GENOMICS_ENGLAND;ORPHANET
9268	2255	FGF10	0.53	0.692	C0265269	Lacrimoauriculodentodigitalsyndrome	disease	C23;C16;C11;C05;C10;C07;C09	DiseaseorSyndrome	0.93	1	1999	2016	3	10	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
9278	2257	FGF12	0.619	0.615	C4310685	EPILEPTICENCEPHALOPATHY,EARLYINFANTILE,47	disease		DiseaseorSyndrome	0.7	1	2016	2016	3	2	CTD_human;GENOMICS_ENGLAND;UNIPROT
9286	2259	FGF14	0.619	0.692	C1836383	SPINOCEREBELLARATAXIA27	disease	C16;C10	DiseaseorSyndrome	0.95	1	2002	2019	4	3	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
9289	2260	FGFR1	0.362	0.885	C0006142	Malignantneoplasmofbreast	disease	C04;C17	NeoplasticProcess	0.6	0.976	1999	2020	2	0	CGI;CTD_human
9295	2260	FGFR1	0.362	0.885	C0010278	Craniosynostosis	disease	C16;C05	DiseaseorSyndrome	0.7	0.941	1995	2018	1	0	CTD_human;GENOMICS_ENGLAND
9298	2260	FGFR1	0.362	0.885	C0011581	Depressivedisorder	disease	F03	MentalorBehavioralDysfunction	0.62	1	2003	2018	5	0	CTD_human;PSYGENET
9308	2260	FGFR1	0.362	0.885	C0041696	UnipolarDepression	disease	F03	MentalorBehavioralDysfunction	0.51	0.667	2006	2017	4	0	CTD_human;PSYGENET
9314	2260	FGFR1	0.362	0.885	C0162809	KallmannSyndrome	disease	C16;C13;C12;C19	DiseaseorSyndrome	0.6	0.979	2003	2019	2	0	CTD_human;ORPHANET
9317	2260	FGFR1	0.362	0.885	C0220658	PfeifferSyndrome	disease	C16;C05	DiseaseorSyndrome	0.9	1	1994	2020	5	5	GENOMICS_ENGLAND;UNIPROT
9322	2260	FGFR1	0.362	0.885	C0265535	Trigonocephaly	disease	C16;C05	CongenitalAbnormality	0.64	0.75	2000	2019	1	0	CTD_human;ORPHANET
9338	2260	FGFR1	0.362	0.885	C0406612	Encephalocraniocutaneouslipomatosis	disease	C16;C18;C11;C17;C10	CongenitalAbnormality	0.74	1	2009	2020	4	3	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
9340	2260	FGFR1	0.362	0.885	C0432122	Interfrontalcraniofaciosynostosis	disease	C16;C05	CongenitalAbnormality	0.61	1	2000	2006	2	2	GENOMICS_ENGLAND;UNIPROT
9341	2260	FGFR1	0.362	0.885	C0432283	Osteoglophonicdwarfism	disease	C16;C05	CongenitalAbnormality	0.73	1	2003	2020	5	4	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
9345	2260	FGFR1	0.362	0.885	C0678222	BreastCarcinoma	disease	C04;C17	NeoplasticProcess	0.6	0.977	1994	2020	2	0	CGI;CTD_human
9349	2260	FGFR1	0.362	0.885	C0795998	JACKSON-WEISSSYNDROME	disease	C16;C05	DiseaseorSyndrome	0.71	1	2000	2017	3	2	CTD_human;GENOMICS_ENGLAND;UNIPROT
9357	2260	FGFR1	0.362	0.885	C1563720	KallmannSyndrome2(disorder)	disease	C16;C13;C12;C19	DiseaseorSyndrome	0.72	0.971	1994	2017	18	42	CTD_human;GENOMICS_ENGLAND;UNIPROT
9361	2260	FGFR1	0.362	0.885	C1845146	Holoprosencephaly,Ectrodactyly,andBilateralCleftLip-Palate	disease	C23;C16;C05;C10;F03;C07;F01	CongenitalAbnormality	0.75	0.889	2003	2019	6	16	GENOMICS_ENGLAND;ORPHANET;UNIPROT
9374	2261	FGFR3	0.391	0.846	C0001080	Achondroplasia	disease	C16;C05	CongenitalAbnormality	1	0.974	1994	2020	13	9	CLINGEN;CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
9375	2261	FGFR3	0.391	0.846	C0005684	Malignantneoplasmofurinarybladder	disease	C04;C13;C12	NeoplasticProcess	0.8	0.979	1999	2019	6	8	CGI;CTD_human;UNIPROT
9376	2261	FGFR3	0.391	0.846	C0005695	BladderNeoplasm	disease	C04;C13;C12	NeoplasticProcess	0.6	0.981	2001	2019	4	0	CGI;CTD_human
9379	2261	FGFR3	0.391	0.846	C0007873	UterineCervicalNeoplasm	disease	C04;C13	NeoplasticProcess	0.51	1	2005	2005	0	0	CGI;CTD_human
9382	2261	FGFR3	0.391	0.846	C0009402	ColorectalCarcinoma	disease	C06;C04	NeoplasticProcess	0.66	1	2000	2018	0	8	CTD_human;UNIPROT
9387	2261	FGFR3	0.391	0.846	C0026764	MultipleMyeloma	disease	C04;C20;C15;C14	NeoplasticProcess	0.7	0.971	1997	2019	1	2	CGI;CTD_human
9389	2261	FGFR3	0.391	0.846	C0039743	ThanatophoricDysplasia	disease	C16;C05	CongenitalAbnormality	0.6	1	1995	2019	1	0	CTD_human
9391	2261	FGFR3	0.391	0.846	C0152013	Adenocarcinomaoflung(disorder)	disease	C04	NeoplasticProcess	0.65	1	2013	2018	0	1	CGI;UNIPROT
9399	2261	FGFR3	0.391	0.846	C0265269	Lacrimoauriculodentodigitalsyndrome	disease	C23;C16;C11;C05;C10;C07;C09	DiseaseorSyndrome	0.72	1	1995	2017	2	9	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
9402	2261	FGFR3	0.391	0.846	C0334082	NEVUS,EPIDERMAL(disorder)	disease	C04	DiseaseorSyndrome	0.69	1	2006	2017	1	7	CTD_human;UNIPROT
9405	2261	FGFR3	0.391	0.846	C0410529	Hypochondroplasia(disorder)	disease	C16;C05;C19	CongenitalAbnormality	0.8	0.972	1995	2020	10	21	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
9411	2261	FGFR3	0.391	0.846	C1300257	Thanatophoricdysplasia,type2	disease	C16;C05	DiseaseorSyndrome	0.8	0.941	1995	2018	4	14	CTD_human;GENOMICS_ENGLAND;UNIPROT
9416	2261	FGFR3	0.391	0.846	C1864436	MuenkeSyndrome	disease	C16;C05	DiseaseorSyndrome	1	1	1994	2019	9	7	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
9417	2261	FGFR3	0.391	0.846	C1864852	CATSHLsyndrome	disease	C23;C16;C05;C10;C09	DiseaseorSyndrome	0.71	1	1995	2016	4	10	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
9418	2261	FGFR3	0.391	0.846	C1868678	THANATOPHORICDYSPLASIA,TYPEI(disorder)	disease	C16;C05	DiseaseorSyndrome	0.8	1	1994	2019	9	12	CTD_human;GENOMICS_ENGLAND;UNIPROT
9419	2261	FGFR3	0.391	0.846	C2674173	Achondroplasia,Severe,WithDevelopmentalDelayAndAcanthosisNigricans	disease	C16;C05	CongenitalAbnormality	0.8	1	1996	2018	3	7	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
9420	2261	FGFR3	0.391	0.846	C2677099	CROUZONSYNDROMEWITHACANTHOSISNIGRICANS(disorder)	disease	C16;C17;C05	DiseaseorSyndrome	0.78	1	1994	2018	7	8	CTD_human;GENOMICS_ENGLAND;UNIPROT
9422	2261	FGFR3	0.391	0.846	C4048328	cervicalcancer	disease	C04;C13	NeoplasticProcess	0.54	1	1999	2019	1	1	CTD_human;UNIPROT
9426	2263	FGFR2	0.38	0.808	C0001193	Apertsyndrome	disease	C16;C05	CongenitalAbnormality	0.8	0.976	1994	2019	19	14	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
9429	2263	FGFR2	0.38	0.808	C0006142	Malignantneoplasmofbreast	disease	C04;C17	NeoplasticProcess	0.7	0.942	1991	2020	3	11	CTD_human;UNIPROT
9434	2263	FGFR2	0.38	0.808	C0010273	CraniofacialDysostosis	disease	C16;C05	DiseaseorSyndrome	0.7	1	1994	2019	1	0	CTD_human
9435	2263	FGFR2	0.38	0.808	C0010278	Craniosynostosis	disease	C16;C05	DiseaseorSyndrome	0.7	0.956	1995	2019	4	7	CTD_human;GENOMICS_ENGLAND
9445	2263	FGFR2	0.38	0.808	C0024623	Malignantneoplasmofstomach	disease	C06;C04	NeoplasticProcess	0.7	0.957	1996	2019	2	0	CGI;CTD_human
9454	2263	FGFR2	0.38	0.808	C0038356	StomachNeoplasms	group	C06;C04	NeoplasticProcess	0.62	1	2007	2012	2	9	CGI;CTD_human
9457	2263	FGFR2	0.38	0.808	C0149782	Squamouscellcarcinomaoflung	disease	C04;C08	NeoplasticProcess	0.63	0.75	2013	2016	0	3	CGI;UNIPROT
9463	2263	FGFR2	0.38	0.808	C0175699	Saethre-ChotzenSyndrome	disease	C16;C05	DiseaseorSyndrome	0.74	1	1997	2016	8	9	CTD_human;GENOMICS_ENGLAND;ORPHANET
9466	2263	FGFR2	0.38	0.808	C0220658	PfeifferSyndrome	disease	C16;C05	DiseaseorSyndrome	1	0.983	1994	2019	21	26	CTD_human;GENOMICS_ENGLAND;UNIPROT
9470	2263	FGFR2	0.38	0.808	C0265269	Lacrimoauriculodentodigitalsyndrome	disease	C23;C16;C11;C05;C10;C07;C09	DiseaseorSyndrome	0.73	1	1996	2019	5	13	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
9481	2263	FGFR2	0.38	0.808	C0476089	EndometrialCarcinoma	disease	C04;C13	NeoplasticProcess	0.7	0.964	2007	2019	1	2	CGI;CTD_human
9486	2263	FGFR2	0.38	0.808	C0699791	StomachCarcinoma	disease	C06;C04	NeoplasticProcess	0.6	0.957	1996	2019	1	0	CGI;GENOMICS_ENGLAND
9487	2263	FGFR2	0.38	0.808	C0795998	JACKSON-WEISSSYNDROME	disease	C16;C05	DiseaseorSyndrome	0.76	1	1994	2017	10	13	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
9495	2263	FGFR2	0.38	0.808	C1510455	Acrocephalosyndactylia	disease	C16;C05	CongenitalAbnormality	0.88	1	1997	2013	6	1	CTD_human;ORPHANET
9499	2263	FGFR2	0.38	0.808	C1852406	CutisGyrataSyndromeofBeareAndStevenson	disease	C16;C17;C05	DiseaseorSyndrome	0.97	1	1994	2017	8	13	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
9503	2263	FGFR2	0.38	0.808	C1865070	SCAPHOCEPHALY,MAXILLARYRETRUSION,ANDMENTALRETARDATION	disease	C23;C16;C05;C10;F03;C07;F01	DiseaseorSyndrome	0.7	1	1996	2016	4	9	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
9508	2263	FGFR2	0.38	0.808	C2931196	Craniofacialdysostosistype1	disease	C16;C05	DiseaseorSyndrome	0.8	1	1994	2019	23	36	CTD_human;GENOMICS_ENGLAND;UNIPROT
9510	2263	FGFR2	0.38	0.808	C2936791	Antley-BixlerSyndrome,AutosomalDominant	disease	C16;C18;C05	DiseaseorSyndrome	0.74	1	1996	2017	7	10	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
9512	2263	FGFR2	0.38	0.808	C3281247	BENTBONEDYSPLASIASYNDROME	disease		DiseaseorSyndrome	0.73	1	2006	2019	3	10	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
9523	2264	FGFR4	0.49	0.769	C0376358	Malignantneoplasmofprostate	disease	C04;C12	NeoplasticProcess	0.6	0.929	2004	2016	5	1	CTD_human;UNIPROT
9524	2266	FGG	0.633	0.615	C0001733	Afibrinogenemia	disease	C16;C15	DiseaseorSyndrome	0.53	1	2000	2004	0	0	CTD_human
9528	2266	FGG	0.633	0.615	C0272350	Dysfibrinogenemia,Congenital	disease	C16;C15	DiseaseorSyndrome	0.61	1	1986	2018	6	4	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
9531	2266	FGG	0.633	0.615	C2584774	Congenitalhypofibrinogenemia	disease	C16;C15	DiseaseorSyndrome	0.74	1	2000	2018	5	3	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
9532	2266	FGG	0.633	0.615	C4316812	FibrinogenDeficiency	disease	C16;C15	DiseaseorSyndrome	0.7	1	2005	2018	0	0	CTD_human;GENOMICS_ENGLAND
9537	2271	FH	0.489	0.846	C0342770	Fumarasedeficiency	disease	C23;C16;C18;C10;F01	DiseaseorSyndrome	0.74	1	1990	2019	3	90	CTD_human;GENOMICS_ENGLAND;UNIPROT
9539	2271	FH	0.489	0.846	C0740457	Malignantneoplasmofkidney	disease	C04;C13;C12	NeoplasticProcess	0.6	0.971	2002	2020	0	0	CGI;GENOMICS_ENGLAND
9541	2271	FH	0.489	0.846	C1708350	HereditaryLeiomyomatosisandRenalCellCancer	disease	C16;C04;C13;C17	NeoplasticProcess	0.8	0.972	1994	2020	10	53	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
9552	2272	FHIT	0.444	0.846	C0023903	Liverneoplasms	group	C06;C04	NeoplasticProcess	0.51	1	2002	2009	1	0	CTD_human
9571	2272	FHIT	0.444	0.846	C0345904	Malignantneoplasmofliver	disease	C06;C04	NeoplasticProcess	0.53	1	1998	2017	1	0	CTD_human
9587	2273	FHL1	0.532	0.731	C2678055	MYOPATHY,X-LINKED,WITHPOSTURALMUSCLEATROPHY(disorder)	disease	C16;C05;C10	DiseaseorSyndrome	0.78	1	2008	2018	5	11	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
9588	2273	FHL1	0.532	0.731	C2678061	SCAPULOPERONEALMYOPATHY,X-LINKEDDOMINANT	disease	C16;C05;C10	DiseaseorSyndrome	0.71	1	2008	2018	3	1	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
9590	2273	FHL1	0.532	0.731	C4225159	REDUCINGBODYMYOPATHY,X-LINKED1B,WITHLATECHILDHOODORADULTONSET	disease		DiseaseorSyndrome	0.6	1	1995	2018	6	3	GENOMICS_ENGLAND;UNIPROT
9591	2273	FHL1	0.532	0.731	C4225423	REDUCINGBODYMYOPATHY,X-LINKED1A,SEVERE,WITHINFANTILEOREARLYCHILDHOODONSET	disease		DiseaseorSyndrome	0.6	1	2008	2018	4	5	GENOMICS_ENGLAND;UNIPROT
9630	2289	FKBP5	0.524	0.769	C1269683	MajorDepressiveDisorder	disease	F03	MentalorBehavioralDysfunction	0.6	0.8	2009	2020	5	0	CTD_human;PSYGENET
9668	2290	FOXG1	0.522	0.692	C3150705	FOXG1syndrome	disease	C16;C10;F03	DiseaseorSyndrome	0.79	1	2008	2019	6	46	CTD_human;GENOMICS_ENGLAND;UNIPROT
9680	2294	FOXF1	0.54	0.692	C0031190	PersistentFetalCirculationSyndrome	disease	C16;C08	DiseaseorSyndrome	0.7	1	2009	2019	5	4	GENOMICS_ENGLAND;UNIPROT
9686	2294	FOXF1	0.54	0.692	C2677362	Alveolarcapillarydysplasia	disease	C16;C08	CongenitalAbnormality	0.57	1	2009	2019	2	0	CTD_human;ORPHANET
9692	2296	FOXC1	0.483	0.846	C0010964	Dandy-WalkerSyndrome	disease	C16;C10	DiseaseorSyndrome	0.52	1	2009	2013	2	0	CTD_human;GENOMICS_ENGLAND
9703	2296	FOXC1	0.483	0.846	C0344559	Irido-corneo-trabeculardysgenesis(disorder)	disease	C16;C11	CongenitalAbnormality	0.62	1	1998	2008	4	0	GENOMICS_ENGLAND;ORPHANET
9712	2296	FOXC1	0.483	0.846	C1839928	IRISHYPOPLASIAWITHGLAUCOMA	disease	C11	DiseaseorSyndrome	0.51	1	1998	2013	8	5	GENOMICS_ENGLAND;UNIPROT
9714	2296	FOXC1	0.483	0.846	C2678503	AXENFELD-RIEGERSYNDROME,TYPE3	disease	C16;C11	DiseaseorSyndrome	0.7	1	1998	2017	23	27	CTD_human;GENOMICS_ENGLAND;UNIPROT
9722	2313	FLI1	0.468	0.692	C0553580	Ewingssarcoma	disease	C04	NeoplasticProcess	0.6	0.988	1993	2019	3	0	CTD_human;ORPHANET
9728	2313	FLI1	0.468	0.692	C4479515	BLEEDINGDISORDER,PLATELET-TYPE,21	disease		DiseaseorSyndrome	0.7	1	2013	2017	3	6	CTD_human;GENOMICS_ENGLAND;UNIPROT
9742	2316	FLNA	0.419	0.846	C0025237	Melnick-NeedlesSyndrome	disease	C16;C05	DiseaseorSyndrome	0.68	1	2003	2018	7	0	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
9750	2316	FLNA	0.419	0.846	C0262436	Cardiacvalvulardysplasia,X-linked	disease	C16;C04;C14	CongenitalAbnormality	0.61	1	2006	2007	2	0	CTD_human;GENOMICS_ENGLAND;UNIPROT
9751	2316	FLNA	0.419	0.846	C0265251	Oto-Palato-digitalsyndrometype1	disease	C16;C05	DiseaseorSyndrome	0.62	1	2003	2017	6	0	CTD_human;GENOMICS_ENGLAND;UNIPROT
9752	2316	FLNA	0.419	0.846	C0265293	Frontometaphysealdysplasia	disease	C16;C05	CongenitalAbnormality	0.7	1	2003	2018	5	0	CTD_human;GENOMICS_ENGLAND;ORPHANET
9762	2316	FLNA	0.419	0.846	C1844696	OTOPALATODIGITALSYNDROME,TYPEII	disease	C16;C05	DiseaseorSyndrome	0.7	0.923	2003	2017	6	0	CTD_human;GENOMICS_ENGLAND;UNIPROT
9766	2316	FLNA	0.419	0.846	C1845902	FGSYNDROME2	disease	C23;C16;C06;C10	DiseaseorSyndrome	0.6	1	2004	2007	2	0	CTD_human;GENOMICS_ENGLAND;UNIPROT
9767	2316	FLNA	0.419	0.846	C1846129	TerminalOsseousDysplasiaandPigmentaryDefects	disease	C23;C16;C17;C05	DiseaseorSyndrome	0.61	1	2003	2017	4	0	CTD_human;GENOMICS_ENGLAND;ORPHANET
9768	2316	FLNA	0.419	0.846	C1848213	PeriventricularHeterotopia,X-Linked	disease	C16;C10	DiseaseorSyndrome	0.81	1	1998	2013	9	0	CTD_human;GENOMICS_ENGLAND;UNIPROT
9770	2316	FLNA	0.419	0.846	C1868720	PeriventricularNodularHeterotopia	disease	C16;C10	DiseaseorSyndrome	0.7	0.978	1998	2019	2	0	CTD_human
9771	2316	FLNA	0.419	0.846	C2746068	Congenitalidiopathicintestinalpseudoobstruction	disease	C16;C06	DiseaseorSyndrome	0.51	1	2004	2009	2	0	CTD_human;GENOMICS_ENGLAND
9774	2316	FLNA	0.419	0.846	C4281559	FRONTOMETAPHYSEALDYSPLASIA1	disease	C16;C05	CongenitalAbnormality	0.59	1	2003	2018	4	0	GENOMICS_ENGLAND;UNIPROT
9780	2317	FLNB	0.458	0.923	C0175778	Larsensyndrome	disease	C16;C05	DiseaseorSyndrome	0.8	1	2004	2017	2	12	GENOMICS_ENGLAND;ORPHANET;UNIPROT
9781	2317	FLNB	0.458	0.923	C0265283	Atelosteogenesis,type1	disease	C16;C05	CongenitalAbnormality	0.76	1	2004	2017	1	23	CTD_human;GENOMICS_ENGLAND;UNIPROT
9782	2317	FLNB	0.458	0.923	C0432201	Boomerangdysplasia	disease	C23;C16;C05;C19	DiseaseorSyndrome	0.75	1	2004	2018	2	9	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
9784	2317	FLNB	0.458	0.923	C1848934	SPONDYLOCARPOTARSALSYNOSTOSISSYNDROME	disease	C16;C05	DiseaseorSyndrome	0.87	1	2004	2018	1	9	CTD_human;GENOMICS_ENGLAND
9785	2317	FLNB	0.458	0.923	C2931648	Larsensyndrome,dominanttype	disease	C16;C05;C07;C26	DiseaseorSyndrome	0.51	1	2004	2007	1	0	CTD_human;ORPHANET
9786	2317	FLNB	0.458	0.923	C3668942	AtelosteogenesisType3	disease	C16;C05	CongenitalAbnormality	0.71	1	2004	2006	1	2	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
9790	2318	FLNC	0.568	0.615	C1836050	Filaminopathy,autosomaldominant	disease	C16;C05;C10	DiseaseorSyndrome	0.91	1	1998	2018	16	38	CLINGEN;CTD_human;GENOMICS_ENGLAND;ORPHANET
9791	2318	FLNC	0.568	0.615	C3279722	MYOPATHY,DISTAL,4	disease		DiseaseorSyndrome	0.7	1	2005	2016	3	38	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
9792	2318	FLNC	0.568	0.615	C4310749	CARDIOMYOPATHY,FAMILIALHYPERTROPHIC,26	disease		DiseaseorSyndrome	0.7	1	2011	2016	3	43	CTD_human;GENOMICS_ENGLAND;UNIPROT
9793	2321	FLT1	0.419	0.846	C0006142	Malignantneoplasmofbreast	disease	C04;C17	NeoplasticProcess	0.6	1	1999	2019	2	0	CTD_human
9799	2321	FLT1	0.419	0.846	C0023890	LiverCirrhosis	disease	C23;C06	DiseaseorSyndrome	0.51	1	2002	2007	1	0	CTD_human
9805	2321	FLT1	0.419	0.846	C0032914	Pre-Eclampsia	phenotype	C13	PathologicFunction	0.6	1	2004	2017	2	0	CTD_human;ORPHANET
9835	2322	FLT3	0.462	0.654	C0023467	Leukemia,Myelocytic,Acute	disease	C04	NeoplasticProcess	1	0.985	1992	2020	13	28	CGI;CTD_human;UNIPROT
9839	2322	FLT3	0.462	0.654	C0026998	AcuteMyeloidLeukemia,M1	disease	C04	NeoplasticProcess	0.52	1	2002	2017	14	0	CTD_human;ORPHANET
9846	2322	FLT3	0.462	0.654	C1879321	AcuteMyeloidLeukemia(AML-M2)	disease	C04	NeoplasticProcess	0.52	1	2006	2017	14	0	CTD_human;ORPHANET
9848	2322	FLT3	0.462	0.654	C1961102	PrecursorCellLymphoblasticLeukemiaLymphoma	disease	C04;C20;C15	NeoplasticProcess	0.8	1	2004	2020	0	4	CGI;CTD_human;UNIPROT
9857	2324	FLT4	0.457	0.808	C0039685	TetralogyofFallot	disease	C16;C14	CongenitalAbnormality	0.54	1	2013	2019	1	0	CTD_human;GENOMICS_ENGLAND
9863	2324	FLT4	0.457	0.808	C1704423	MilroyDisease	disease	C15	DiseaseorSyndrome	0.8	1	1998	2019	11	10	CTD_human;GENOMICS_ENGLAND;UNIPROT
9864	2324	FLT4	0.457	0.808	C1865871	HEMANGIOMA,CAPILLARYINFANTILE	disease	C16;C04	DiseaseorSyndrome	0.6	1	2002	2002	1	1	CTD_human;GENOMICS_ENGLAND;UNIPROT
9876	2328	FMO3	0.638	0.5	C0342739	Trimethylaminuria	disease	C16;C18	DiseaseorSyndrome	0.8	0.972	1997	2020	9	14	CTD_human;GENOMICS_ENGLAND;UNIPROT
9888	2332	FMR1	0.473	0.769	C0016667	FragileXSyndrome	disease	C16;C10	DiseaseorSyndrome	1	0.985	1991	2020	37	6	CLINGEN;CTD_human;GENOMICS_ENGLAND;UNIPROT
9907	2332	FMR1	0.473	0.769	C1839780	FRAGILEXTREMOR/ATAXIASYNDROME	disease	C23;C16;C10	DiseaseorSyndrome	0.9	0.995	2003	2019	2	0	CTD_human;GENOMICS_ENGLAND;ORPHANET
9912	2332	FMR1	0.473	0.769	C4552079	PrematureOvarianFailure1	disease	C13;C19	DiseaseorSyndrome	0.6	1	2003	2019	1	0	CTD_human;GENOMICS_ENGLAND
9915	2334	AFF2	0.636	0.538	C0751157	FRAXESyndrome	disease	C16;C10	DiseaseorSyndrome	0.74	1	1993	2013	11	1	CLINGEN;CTD_human;GENOMICS_ENGLAND;ORPHANET
9919	2335	FN1	0.365	0.962	C0006142	Malignantneoplasmofbreast	disease	C04;C17	NeoplasticProcess	0.6	1	1997	2020	1	1	CTD_human;UNIPROT
9925	2335	FN1	0.365	0.962	C0011881	DiabeticNephropathy	disease	C13;C12;C19	DiseaseorSyndrome	0.6	0.958	1996	2019	1	0	CTD_human
9941	2335	FN1	0.365	0.962	C0432221	Spondylometaphysealdysplasia,cornerfracturetype	disease	C23;C16;C05;C26	DiseaseorSyndrome	0.7	1	2017	2019	2	5	GENOMICS_ENGLAND;ORPHANET;UNIPROT
9949	2335	FN1	0.365	0.962	C1866075	GLOMERULOPATHYWITHFIBRONECTINDEPOSITS2(disorder)	disease	C13;C12;C20	DiseaseorSyndrome	0.7	1	2008	2008	1	5	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
9951	2335	FN1	0.365	0.962	C3888104	Glomerulopathywithfibronectindeposits	disease	C13;C12;C20	DiseaseorSyndrome	0.57	1	1998	2019	1	0	CTD_human;ORPHANET
9995	2348	FOLR1	0.522	0.885	C2751584	NeurodegenerationDueToCerebralFolateTransportDeficiency	phenotype	C10	DiseaseorSyndrome	0.79	0.952	1991	2019	16	4	CLINGEN;CTD_human;GENOMICS_ENGLAND;ORPHANET
10020	2353	FOS	0.411	0.885	C0020429	Hyperalgesia	phenotype	C23;C10	SignorSymptom	0.51	1	2012	2018	1	0	CTD_human
10021	2353	FOS	0.411	0.885	C0020538	Hypertensivedisease	group	C14	DiseaseorSyndrome	0.51	1	2002	2013	2	0	CTD_human
10173	2395	FXN	0.51	0.654	C0016719	FriedreichAtaxia	disease	C16;C18;C10	DiseaseorSyndrome	0.9	0.997	1976	2020	18	0	CLINGEN;CTD_human;GENOMICS_ENGLAND;ORPHANET
10175	2395	FXN	0.51	0.654	C1856689	FRIEDREICHATAXIA1	disease	C16;C18;C10	DiseaseorSyndrome	0.8	0.983	1997	2020	10	14	CTD_human;GENOMICS_ENGLAND;UNIPROT
10191	2475	MTOR	0.343	0.885	C0020538	Hypertensivedisease	group	C14	DiseaseorSyndrome	0.54	1	2009	2019	1	0	CTD_human
10195	2475	MTOR	0.343	0.885	C0036341	Schizophrenia	disease	F03	MentalorBehavioralDysfunction	0.53	1	2011	2019	1	0	CTD_human
10198	2475	MTOR	0.343	0.885	C0149721	LeftVentricularHypertrophy	disease	C23;C14	DiseaseorSyndrome	0.52	1	2004	2018	1	0	CTD_human
10211	2475	MTOR	0.343	0.885	C0279702	Conventional(ClearCell)RenalCellCarcinoma	disease	C04;C13;C12	NeoplasticProcess	0.6	0.984	2005	2020	1	0	CGI;CTD_human
10234	2475	MTOR	0.343	0.885	C1621958	GlioblastomaMultiforme	disease	C04	NeoplasticProcess	0.6	0.967	2005	2019	1	0	CTD_human;UNIPROT
10235	2475	MTOR	0.343	0.885	C1846385	FOCALCORTICALDYSPLASIAOFTAYLOR	disease	C16;C10	DiseaseorSyndrome	0.74	1	2015	2018	5	8	CTD_human;GENOMICS_ENGLAND;UNIPROT
10243	2475	MTOR	0.343	0.885	C4225259	SMITH-KINGSMORESYNDROME	disease		DiseaseorSyndrome	0.72	1	2015	2019	5	7	GENOMICS_ENGLAND;ORPHANET;UNIPROT
10271	2488	FSHB	0.631	0.577	C1856716	Follicle-stimulatinghormonedeficiency,isolated	disease	C12	DiseaseorSyndrome	0.71	1	1993	2017	5	5	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
10274	2492	FSHR	0.539	0.654	C0085083	OvarianHyperstimulationSyndrome	disease	C13;C19	DiseaseorSyndrome	0.8	0.96	2003	2019	9	5	CTD_human;ORPHANET;UNIPROT
10277	2492	FSHR	0.539	0.654	C0949595	GonadalDysgenesis,46,XX	disease	C16;C13;C12;C19	CongenitalAbnormality	0.75	1	1995	2016	7	11	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
10319	2495	FTH1	0.559	0.731	C1851316	IronOverload,AutosomalDominant	disease	C18	DiseaseorSyndrome	0.7	1	2001	2001	1	1	CTD_human;GENOMICS_ENGLAND;ORPHANET
10337	2512	FTL	0.559	0.692	C1833213	Hyperferritinemia,hereditary,withcongenitalcataracts	disease	C18;C11	DiseaseorSyndrome	0.8	1	1990	2019	3	9	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
10338	2512	FTL	0.559	0.692	C1853578	Neuroferritinopathy	disease	C18;C10	DiseaseorSyndrome	0.8	0.967	1990	2019	3	5	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
10339	2512	FTL	0.559	0.692	C3810090	L-FERRITINDEFICIENCY	disease		DiseaseorSyndrome	0.7	1	2009	2013	2	1	CTD_human;GENOMICS_ENGLAND;ORPHANET
10357	2516	NR5A1	0.479	0.731	C0949595	GonadalDysgenesis,46,XX	disease	C16;C13;C12;C19	CongenitalAbnormality	0.51	1	2009	2012	1	0	CTD_human;ORPHANET
10361	2516	NR5A1	0.479	0.731	C2751825	PREMATUREOVARIANFAILURE7(disorder)	disease	C13;C19	DiseaseorSyndrome	0.7	1	2000	2016	5	9	CTD_human;GENOMICS_ENGLAND;UNIPROT
10364	2516	NR5A1	0.479	0.731	C3151406	SPERMATOGENICFAILURE8	disease		DiseaseorSyndrome	0.7	1	2010	2015	3	6	CTD_human;GENOMICS_ENGLAND;UNIPROT
10365	2516	NR5A1	0.479	0.731	C3489793	46,XYSexReversal3	disease	C16;C13;C12;C19	CongenitalAbnormality	0.7	1	1999	2017	10	20	CTD_human;GENOMICS_ENGLAND;UNIPROT
10370	2517	FUCA1	0.623	0.577	C0016788	FucosidaseDeficiencyDisease	disease	C16;C18;C10	DiseaseorSyndrome	1	1	1988	2019	8	13	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
10396	2521	FUS	0.47	0.846	C0002736	AmyotrophicLateralSclerosis	disease	C18;C10	DiseaseorSyndrome	0.7	0.981	2009	2020	2	0	CTD_human;ORPHANET
10398	2521	FUS	0.47	0.846	C0206634	Liposarcoma,Myxoid	disease	C04	NeoplasticProcess	0.6	1	1993	2019	2	0	CTD_human;ORPHANET
10405	2521	FUS	0.47	0.846	C3539195	TREMOR,HEREDITARYESSENTIAL,4	disease		DiseaseorSyndrome	0.6	1	2009	2014	1	4	CTD_human;UNIPROT
10423	2530	FUT8	0.603	0.692	C4693905	CONGENITALDISORDEROFGLYCOSYLATIONWITHDEFECTIVEFUCOSYLATION	disease		DiseaseorSyndrome	0.61	1	2005	2019	3	4	GENOMICS_ENGLAND;UNIPROT
10433	2531	KDSR	0.674	0.538	C4479620	ERYTHROKERATODERMIAVARIABILISETPROGRESSIVA4	disease		DiseaseorSyndrome	0.6	1	2017	2017	1	4	GENOMICS_ENGLAND;UNIPROT
10437	2533	FYB1	0.711	0.538	C2678311	Thrombocytopenia3	disease	C15	DiseaseorSyndrome	0.6	1	2015	2015	1	2	CTD_human;GENOMICS_ENGLAND
10458	2535	FZD2	0.558	0.654	C2750355	Omodysplasia2	disease	C23;C16;C05	DiseaseorSyndrome	0.71	1	2015	2018	4	2	GENOMICS_ENGLAND;ORPHANET;UNIPROT
10470	2538	G6PC	0.56	0.692	C0017920	GlycogenStorageDiseaseTypeI	disease	C16;C18	DiseaseorSyndrome	0.9	1	1983	2020	26	30	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
10472	2538	G6PC	0.56	0.692	C2919796	GlycogenstoragediseasetypeIa	disease	C16;C18	DiseaseorSyndrome	0.7	1	1993	2020	0	44	CTD_human;ORPHANET
10473	2539	G6PD	0.424	0.846	C0002878	Anemia,Hemolytic	disease	C15	DiseaseorSyndrome	0.6	1	1973	2019	4	0	CTD_human;GENOMICS_ENGLAND
10480	2539	G6PD	0.424	0.846	C0015702	Favism	disease	C16;C25;C15	DiseaseorSyndrome	0.6	1	1971	2018	2	0	CTD_human
10494	2539	G6PD	0.424	0.846	C2720289	ANEMIA,NONSPHEROCYTICHEMOLYTIC,DUETOG6PDDEFICIENCY	disease	C16;C18;C15	DiseaseorSyndrome	0.7	1	1969	2019	21	51	CTD_human;GENOMICS_ENGLAND;UNIPROT
10499	2542	SLC37A4	0.617	0.654	C0017920	GlycogenStorageDiseaseTypeI	disease	C16;C18	DiseaseorSyndrome	0.57	1	1998	2018	1	0	GENOMICS_ENGLAND
10501	2542	SLC37A4	0.617	0.654	C0268146	Glucose-6-phosphatetransportdefect	disease	C16;C18	DiseaseorSyndrome	0.8	1	1997	2020	22	51	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
10502	2542	SLC37A4	0.617	0.654	C0342749	GLYCOGENSTORAGEDISEASEIc	disease	C16;C18	DiseaseorSyndrome	0.71	1	1998	2016	3	2	CTD_human;GENOMICS_ENGLAND;UNIPROT
10515	2548	GAA	0.631	0.577	C0017921	GlycogenstoragediseasetypeII	disease	C16;C18;C10	DiseaseorSyndrome	1	0.994	1965	2019	57	196	CLINGEN;CTD_human;GENOMICS_ENGLAND;UNIPROT
10519	2548	GAA	0.631	0.577	C0342751	Generalizedglycogenstoragediseaseofinfants	disease	C16;C18;C10	DiseaseorSyndrome	0.6	0.982	1976	2019	5	0	CTD_human;GENOMICS_ENGLAND
10521	2548	GAA	0.631	0.577	C0751173	GlycogenStorageDiseaseTypeII,Infantile	disease	C16;C18;C10	DiseaseorSyndrome	0.61	1	2001	2011	5	4	CTD_human;ORPHANET
10527	2548	GAA	0.631	0.577	C3888925	Pompesdiseaseadultonset	disease		DiseaseorSyndrome	0.30				0	0	ORPHANET
val	2548	GAA	0.631	0.577	C4551472	Hypertrophicobstructivecardiomyopathy	disease	C14	DiseaseorSyndrome	0.30	1	2001	2001	1	0	CTD_human
val	2549	GAB1	0.584	0.654	C0006142	Malignantneoplasmofbreast	disease	C04;C17	NeoplasticProcess	0.34	1	2003	2019	0	0	UNIPROT
val	2549	GAB1	0.584	0.654	C0032460	PolycysticOvarySyndrome	disease	C04;C13;C19	DiseaseorSyndrome	0.32	1	2011	2014	1	0	CTD_human
val	2549	GAB1	0.584	0.654	C1136382	SclerocysticOvaries	disease	C04;C13;C19	DiseaseorSyndrome	0.30	1	2011	2011	1	0	CTD_human
val	2549	GAB1	0.584	0.654	C1854275	DEAFNESS,AUTOSOMALRECESSIVE26	disease	C23;C10;C09	DiseaseorSyndrome	0.60	1	2018	2018	1	1	CTD_human;UNIPROT
val	2550	GABBR1	0.587	0.769	C0001956	AlcoholUseDisorder	disease	C25;F03	MentalorBehavioralDysfunction	0.31	1	2012	2018	1	0	CTD_human
val	2550	GABBR1	0.587	0.769	C0001973	AlcoholicIntoxication,Chronic	disease	C25;F03	MentalorBehavioralDysfunction	0.56	0.5	1999	2018	5	0	CTD_human;PSYGENET
val	2550	GABBR1	0.587	0.769	C0004352	AutisticDisorder	disease	F03	MentalorBehavioralDysfunction	0.31	1	2006	2009	2	0	CTD_human
val	2550	GABBR1	0.587	0.769	C0009171	CocaineAbuse	disease	C25;F03	MentalorBehavioralDysfunction	0.30	1	2012	2012	1	0	CTD_human
val	2550	GABBR1	0.587	0.769	C0036341	Schizophrenia	disease	F03	MentalorBehavioralDysfunction	0.46	1	2002	2017	2	1	PSYGENET
val	2550	GABBR1	0.587	0.769	C0085762	Alcoholabuse	disease	C25;F03	MentalorBehavioralDysfunction	0.30	1	2012	2012	1	0	CTD_human
val	2550	GABBR1	0.587	0.769	C0236736	Cocaine-RelatedDisorders	group	C25;F03	MentalorBehavioralDysfunction	0.30	1	2012	2012	1	0	CTD_human
val	2550	GABBR1	0.587	0.769	C0600427	CocaineDependence	disease	C25;F03	MentalorBehavioralDysfunction	0.30	1	2012	2012	1	0	CTD_human
val	2550	GABBR1	0.587	0.769	C0751217	Hyperkinesia,Generalized	phenotype	C23;C10	SignorSymptom	0.30	1	2006	2006	1	0	CTD_human
val	2550	GABBR1	0.587	0.769	C3887506	Hyperkinesia	phenotype	C23;C10	DiseaseorSyndrome	0.30	1	2006	2006	1	0	CTD_human
val	2551	GABPA	0.379	0.885	C0011581	Depressivedisorder	disease	F03	MentalorBehavioralDysfunction	0.36	1	2013	2019	1	0	PSYGENET
val	2551	GABPA	0.379	0.885	C0015923	FetalAlcoholSyndrome	disease	C16;C13;C25	DiseaseorSyndrome	0.30	1	2008	2008	1	0	PSYGENET
val	2551	GABPA	0.379	0.885	C2985290	FetalAlcoholSpectrumDisorders	group	C16;C13;C25	DiseaseorSyndrome;CongenitalAbnormality	0.30	1	2008	2008	1	0	PSYGENET
val	2553	GABPB1	0.743	0.346	C0009402	ColorectalCarcinoma	disease	C06;C04	NeoplasticProcess	0.30				0	0	UNIPROT
val	2554	GABRA1	0.563	0.577	C0001969	AlcoholicIntoxication	disease	C25;F03	MentalorBehavioralDysfunction	0.30	1	2006	2006	1	0	PSYGENET
val	2554	GABRA1	0.563	0.577	C0001973	AlcoholicIntoxication,Chronic	disease	C25;F03	MentalorBehavioralDysfunction	0.34	0.667	2003	2019	3	0	PSYGENET
val	2554	GABRA1	0.563	0.577	C0004134	Ataxia	phenotype	C23;C10	SignorSymptom	0.40	1	2002	2002	1	0	CTD_human
val	2554	GABRA1	0.563	0.577	C0004352	AutisticDisorder	disease	F03	MentalorBehavioralDysfunction	0.30	1	2009	2009	1	0	CTD_human
val	2554	GABRA1	0.563	0.577	C0005586	BipolarDisorder	disease	F03	MentalorBehavioralDysfunction	0.31	1	2004	2004	1	0	PSYGENET
val	2554	GABRA1	0.563	0.577	C0010093	CorpusLuteumCyst	disease	C04;C13;C19	DiseaseorSyndrome	0.30	1	2011	2011	1	0	CTD_human
val	2554	GABRA1	0.563	0.577	C0019147	HepaticComa	disease	C06;C18;C10	DiseaseorSyndrome	0.30	1	2005	2005	1	0	CTD_human
val	2554	GABRA1	0.563	0.577	C0019151	HepaticEncephalopathy	disease	C06;C18;C10	DiseaseorSyndrome	0.51	1	2005	2014	1	0	CTD_human
val	2554	GABRA1	0.563	0.577	C0029927	OvarianCysts	disease	C04;C13;C19	DiseaseorSyndrome	0.30	1	2011	2011	1	0	CTD_human
val	2554	GABRA1	0.563	0.577	C0036341	Schizophrenia	disease	F03	MentalorBehavioralDysfunction	0.35	0.5	2005	2017	4	0	PSYGENET
val	2554	GABRA1	0.563	0.577	C0085762	Alcoholabuse	disease	C25;F03	MentalorBehavioralDysfunction	0.30	1	2008	2008	1	0	PSYGENET
val	2554	GABRA1	0.563	0.577	C0240991	Ataxia,Sensory	phenotype	C23;C10	SignorSymptom	0.30	1	2002	2002	1	0	CTD_human
val	2554	GABRA1	0.563	0.577	C0270736	EssentialTremor	disease	C10	DiseaseorSyndrome	0.32	1	2005	2011	1	0	CTD_human
val	2554	GABRA1	0.563	0.577	C0270853	JuvenileMyoclonicEpilepsy	disease	C10	DiseaseorSyndrome	0.67	1	2002	2019	2	0	CTD_human;GENOMICS_ENGLAND;ORPHANET
val	2554	GABRA1	0.563	0.577	C0278161	Ataxia,Motor	phenotype	C23;C10	Finding	0.30	1	2002	2002	1	0	CTD_human
val	2554	GABRA1	0.563	0.577	C0393615	FamilialTremor	disease	C10	DiseaseorSyndrome	0.30	1	2005	2005	1	0	CTD_human
val	2554	GABRA1	0.563	0.577	C0427190	Ataxia,Truncal	phenotype	C23;C10	SignorSymptom	0.30	1	2002	2002	1	0	CTD_human
val	2554	GABRA1	0.563	0.577	C0520966	Abnormalcoordination	phenotype	C23;C10	Finding	0.30	1	2002	2002	1	0	CTD_human
val	2554	GABRA1	0.563	0.577	C0525045	MoodDisorders	group	F03	MentalorBehavioralDysfunction	0.34	0.75	1998	2004	4	0	PSYGENET
val	2554	GABRA1	0.563	0.577	C0543888	Epilepticencephalopathy	disease	C10	DiseaseorSyndrome	0.41	1	2013	2019	1	1	GENOMICS_ENGLAND
val	2554	GABRA1	0.563	0.577	C0750937	Ataxia,Appendicular	phenotype	C23;C10	Finding	0.30	1	2002	2002	1	0	CTD_human
val	2554	GABRA1	0.563	0.577	C0750940	Tremor,Rubral	disease	C23;C10	DiseaseorSyndrome	0.30	1	2002	2002	1	0	CTD_human
val	2554	GABRA1	0.563	0.577	C0751122	InfantileSevereMyoclonicEpilepsy	disease	C10	DiseaseorSyndrome	0.33	1	2010	2016	1	0	ORPHANET
val	2554	GABRA1	0.563	0.577	C0751197	FulminantHepaticFailurewithCerebralEdema	disease	C06;C18;C10	DiseaseorSyndrome	0.30	1	2005	2005	1	0	CTD_human
val	2554	GABRA1	0.563	0.577	C0751198	HepaticStupor	disease	C06;C18;C10	DiseaseorSyndrome	0.30	1	2005	2005	1	0	CTD_human
val	2554	GABRA1	0.563	0.577	C1838604	EPILEPSY,CHILDHOODABSENCE,1	disease		DiseaseorSyndrome	0.30	1	2006	2006	1	0	ORPHANET
val	2554	GABRA1	0.563	0.577	C1862939	AMYOTROPHICLATERALSCLEROSIS1	disease	C18;C10	DiseaseorSyndrome	0.30	1	2002	2002	1	0	CTD_human
val	2554	GABRA1	0.563	0.577	C1862941	AmyotrophicLateralSclerosis,Sporadic	disease	C18;C10	DiseaseorSyndrome	0.30	1	2002	2002	1	0	CTD_human
val	2554	GABRA1	0.563	0.577	C3810400	EPILEPTICENCEPHALOPATHY,EARLYINFANTILE,19	disease	C10	DiseaseorSyndrome	0.60	1	2014	2017	2	9	CTD_human;UNIPROT
val	2554	GABRA1	0.563	0.577	C4013473	EPILEPSY,IDIOPATHICGENERALIZED,SUSCEPTIBILITYTO,13	disease		Finding	0.60	1	2002	2019	5	6	GENOMICS_ENGLAND;UNIPROT
val	2554	GABRA1	0.563	0.577	C4551857	JuvenileMyoclonicEpilepsyofJanz	disease	C10	DiseaseorSyndrome	0.30				0	0	CTD_human
val	2554	GABRA1	0.563	0.577	C4551993	AmyotrophicLateralSclerosis,Familial	disease	C18;C10	DiseaseorSyndrome	0.30	1	2002	2002	1	0	CTD_human
val	2554	GABRA1	0.563	0.577	C4552768	MyoclonicEpilepsy,Adolescent	disease	C10	DiseaseorSyndrome	0.30				0	0	CTD_human
val	2554	GABRA1	0.563	0.577	C4553087	MyoclonicEpilepsy,Juvenile,1	disease	C10	DiseaseorSyndrome	0.30				0	0	CTD_human
val	2554	GABRA1	0.563	0.577	C4553298	ImpulsivePetitMalEpilepsy	disease	C10	DiseaseorSyndrome	0.30				0	0	CTD_human
val	2555	GABRA2	0.641	0.346	C0001956	AlcoholUseDisorder	disease	C25;F03	MentalorBehavioralDysfunction	0.40	0.857	2009	2019	1	0	CTD_human
val	2555	GABRA2	0.641	0.346	C0001973	AlcoholicIntoxication,Chronic	disease	C25;F03	MentalorBehavioralDysfunction	0.70	0.8	2004	2017	6	0	CTD_human;PSYGENET
val	2555	GABRA2	0.641	0.346	C0003469	AnxietyDisorders	group	F03	MentalorBehavioralDysfunction	0.32	1	2006	2018	1	0	CTD_human
val	2555	GABRA2	0.641	0.346	C0004352	AutisticDisorder	disease	F03	MentalorBehavioralDysfunction	0.30	1	2009	2009	1	0	CTD_human
val	2555	GABRA2	0.641	0.346	C0006870	CannabisDependence	disease	C25;F03	MentalorBehavioralDysfunction	0.32	1	2006	2009	1	0	PSYGENET
val	2555	GABRA2	0.641	0.346	C0009171	CocaineAbuse	disease	C25;F03	MentalorBehavioralDysfunction	0.30	1	2010	2010	2	0	CTD_human
val	2555	GABRA2	0.641	0.346	C0019337	HeroinDependence	disease	C25;F03	MentalorBehavioralDysfunction	0.30	1	2010	2010	1	0	CTD_human
val	2555	GABRA2	0.641	0.346	C0085762	Alcoholabuse	disease	C25;F03	MentalorBehavioralDysfunction	0.32	1	2012	2014	1	0	CTD_human
val	2555	GABRA2	0.641	0.346	C0236736	Cocaine-RelatedDisorders	group	C25;F03	MentalorBehavioralDysfunction	0.30	1	2010	2010	2	0	CTD_human
val	2555	GABRA2	0.641	0.346	C0376280	AnxietyStates,Neurotic	disease	F03	MentalorBehavioralDysfunction	0.30	1	2008	2008	1	0	CTD_human
val	2555	GABRA2	0.641	0.346	C0424605	Developmentaldelay(disorder)	phenotype	F03	MentalorBehavioralDysfunction	0.31	1	1978	2018	1	0	GENOMICS_ENGLAND
val	2555	GABRA2	0.641	0.346	C0557874	Globaldevelopmentaldelay	disease		MentalorBehavioralDysfunction	0.31	1	1978	2018	1	0	GENOMICS_ENGLAND
val	2555	GABRA2	0.641	0.346	C0600241	heroinabuse	disease	C25;F03	MentalorBehavioralDysfunction	0.30	1	2010	2010	1	0	CTD_human
val	2555	GABRA2	0.641	0.346	C0600427	CocaineDependence	disease	C25;F03	MentalorBehavioralDysfunction	0.55	1	2010	2019	3	0	CTD_human;PSYGENET
val	2555	GABRA2	0.641	0.346	C1279420	Anxietyneurosis(finding)	disease	F03	MentalorBehavioralDysfunction	0.30	1	2008	2008	1	0	CTD_human
val	2555	GABRA2	0.641	0.346	C3160814	Cannabisuse	disease		MentalorBehavioralDysfunction	0.31	1	2008	2008	1	0	PSYGENET
val	2555	GABRA2	0.641	0.346	C3714756	IntellectualDisability	group	C23;C10;F03;F01	MentalorBehavioralDysfunction	0.30	1	1978	1978	1	0	GENOMICS_ENGLAND
val	2555	GABRA2	0.641	0.346	C4505390	HeroinSmoking	disease	C25;F03	MentalorBehavioralDysfunction	0.30	1	2010	2010	1	0	CTD_human
val	2556	GABRA3	0.636	0.577	C0004352	AutisticDisorder	disease	F03	MentalorBehavioralDysfunction	0.30	1	2009	2009	1	0	CTD_human
val	2556	GABRA3	0.636	0.577	C0005586	BipolarDisorder	disease	F03	MentalorBehavioralDysfunction	0.33	1	1989	2004	5	0	PSYGENET
val	2556	GABRA3	0.636	0.577	C0011570	MentalDepression	disease	F01	MentalorBehavioralDysfunction	0.30	1	2010	2010	1	0	PSYGENET
val	2556	GABRA3	0.636	0.577	C0011581	Depressivedisorder	disease	F03	MentalorBehavioralDysfunction	0.30	1	2010	2010	1	0	PSYGENET
val	2556	GABRA3	0.636	0.577	C0268446	Thyrotoxicperiodicparalysis	disease	C16;C18;C05;C10	DiseaseorSyndrome	0.30	1	2008	2008	1	0	ORPHANET
val	2557	GABRA4	0.751	0.308	C0004134	Ataxia	phenotype	C23;C10	SignorSymptom	0.30	1	2005	2005	1	0	CTD_human
val	2557	GABRA4	0.751	0.308	C0004352	AutisticDisorder	disease	F03	MentalorBehavioralDysfunction	0.33	1	2005	2015	2	0	CTD_human
val	2557	GABRA4	0.751	0.308	C0006142	Malignantneoplasmofbreast	disease	C04;C17	NeoplasticProcess	0.30				0	0	UNIPROT
val	2557	GABRA4	0.751	0.308	C0036341	Schizophrenia	disease	F03	MentalorBehavioralDysfunction	0.30	1	2010	2010	1	0	PSYGENET
val	2557	GABRA4	0.751	0.308	C0240991	Ataxia,Sensory	phenotype	C23;C10	SignorSymptom	0.30	1	2005	2005	1	0	CTD_human
val	2557	GABRA4	0.751	0.308	C0270496	Schizoaffectivedisorder,bipolartype	disease	F03	MentalorBehavioralDysfunction	0.30	1	2010	2010	1	0	PSYGENET
val	2557	GABRA4	0.751	0.308	C0278161	Ataxia,Motor	phenotype	C23;C10	Finding	0.30	1	2005	2005	1	0	CTD_human
val	2557	GABRA4	0.751	0.308	C0427190	Ataxia,Truncal	phenotype	C23;C10	SignorSymptom	0.30	1	2005	2005	1	0	CTD_human
val	2557	GABRA4	0.751	0.308	C0520966	Abnormalcoordination	phenotype	C23;C10	Finding	0.30	1	2005	2005	1	0	CTD_human
val	2557	GABRA4	0.751	0.308	C0750937	Ataxia,Appendicular	phenotype	C23;C10	Finding	0.30	1	2005	2005	1	0	CTD_human
val	2557	GABRA4	0.751	0.308	C0750940	Tremor,Rubral	disease	C23;C10	DiseaseorSyndrome	0.30	1	2005	2005	1	0	CTD_human
val	2558	GABRA5	0.621	0.385	C0001973	AlcoholicIntoxication,Chronic	disease	C25;F03	MentalorBehavioralDysfunction	0.31	1	2003	2003	1	0	PSYGENET
val	2558	GABRA5	0.621	0.385	C0004352	AutisticDisorder	disease	F03	MentalorBehavioralDysfunction	0.33	1	2001	2007	1	0	CTD_human
val	2558	GABRA5	0.621	0.385	C0005586	BipolarDisorder	disease	F03	MentalorBehavioralDysfunction	0.33	1	1998	2010	5	0	PSYGENET
val	2558	GABRA5	0.621	0.385	C0022333	JacksonianSeizure	disease	C23;C10	DiseaseorSyndrome	0.30	1	1996	1996	1	0	CTD_human
val	2558	GABRA5	0.621	0.385	C0025261	MemoryDisorders	disease	C23;C10;F01	MentalorBehavioralDysfunction	0.30	1	2010	2010	1	0	CTD_human
val	2558	GABRA5	0.621	0.385	C0036341	Schizophrenia	disease	F03	MentalorBehavioralDysfunction	0.31	1	2001	2001	1	0	PSYGENET
val	2558	GABRA5	0.621	0.385	C0036572	Seizures	phenotype	C23;C10	SignorSymptom	0.30	1	1996	1996	1	0	CTD_human
val	2558	GABRA5	0.621	0.385	C0149958	Complexpartialseizures	disease	C23;C10	DiseaseorSyndrome	0.30	1	1996	1996	1	0	CTD_human
val	2558	GABRA5	0.621	0.385	C0150080	SocialCommunicationDisorder	disease	F03	MentalorBehavioralDysfunction	0.30	1	2016	2016	1	0	CTD_human
val	2558	GABRA5	0.621	0.385	C0233794	Memoryimpairment	phenotype	C23;C10;F01	MentalorBehavioralDysfunction	0.30	1	2010	2010	1	0	CTD_human
val	2558	GABRA5	0.621	0.385	C0234533	Generalizedseizures	disease	C23;C10	DiseaseorSyndrome	0.30	1	1996	1996	1	0	CTD_human
val	2558	GABRA5	0.621	0.385	C0234535	ClonicSeizures	disease	C23;C10	DiseaseorSyndrome	0.30	1	1996	1996	1	0	CTD_human
val	2558	GABRA5	0.621	0.385	C0270824	Visualseizure	disease	C23;C10	DiseaseorSyndrome	0.30	1	1996	1996	1	0	CTD_human
val	2558	GABRA5	0.621	0.385	C0270844	TonicSeizures	phenotype	C23;C10	DiseaseorSyndrome	0.30	1	1996	1996	1	0	CTD_human
val	2558	GABRA5	0.621	0.385	C0270846	Epilepticdropattack	disease	C23;C10	DiseaseorSyndrome	0.30	1	1996	1996	1	0	CTD_human
val	2558	GABRA5	0.621	0.385	C0422850	Seizures,Somatosensory	phenotype	C23;C10	PathologicFunction	0.30	1	1996	1996	1	0	CTD_human
val	2558	GABRA5	0.621	0.385	C0422852	Seizures,Auditory	phenotype	C23;C10	PathologicFunction	0.30	1	1996	1996	1	0	CTD_human
val	2558	GABRA5	0.621	0.385	C0422853	Olfactoryseizure	phenotype	C23;C10	DiseaseorSyndrome	0.30	1	1996	1996	1	0	CTD_human
val	2558	GABRA5	0.621	0.385	C0422854	Gustatoryseizure	phenotype	C23;C10	SignorSymptom	0.30	1	1996	1996	1	0	CTD_human
val	2558	GABRA5	0.621	0.385	C0422855	Vertiginousseizure	phenotype	C23;C10	DiseaseorSyndrome	0.30	1	1996	1996	1	0	CTD_human
val	2558	GABRA5	0.621	0.385	C0424605	Developmentaldelay(disorder)	phenotype	F03	MentalorBehavioralDysfunction	0.31	1	2018	2019	1	0	GENOMICS_ENGLAND
val	2558	GABRA5	0.621	0.385	C0494475	Tonic-clonicseizures	disease	C23;C10	DiseaseorSyndrome	0.30	1	1996	1996	1	0	CTD_human
val	2558	GABRA5	0.621	0.385	C0525045	MoodDisorders	group	F03	MentalorBehavioralDysfunction	0.31	1	1998	1998	1	0	PSYGENET
val	2558	GABRA5	0.621	0.385	C0557874	Globaldevelopmentaldelay	disease		MentalorBehavioralDysfunction	0.31	1	2018	2019	1	0	GENOMICS_ENGLAND
val	2558	GABRA5	0.621	0.385	C0751056	Non-epilepticconvulsion	phenotype	C23;C10	SignorSymptom	0.30	1	1996	1996	1	0	CTD_human
val	2558	GABRA5	0.621	0.385	C0751110	SingleSeizure	disease	C23;C10	DiseaseorSyndrome	0.30	1	1996	1996	1	0	CTD_human
val	2558	GABRA5	0.621	0.385	C0751123	AtonicAbsenceSeizures	phenotype	C23;C10	DiseaseorSyndrome	0.30	1	1996	1996	1	0	CTD_human
val	2558	GABRA5	0.621	0.385	C0751292	Age-RelatedMemoryDisorders	group	C23;C10;F01	MentalorBehavioralDysfunction	0.30	1	2010	2010	1	0	CTD_human
val	2558	GABRA5	0.621	0.385	C0751293	MemoryDisorder,Semantic	phenotype	C23;C10;F01	MentalorBehavioralDysfunction	0.30	1	2010	2010	1	0	CTD_human
val	2558	GABRA5	0.621	0.385	C0751294	MemoryDisorder,Spatial	phenotype	C23;C10;F01	MentalorBehavioralDysfunction	0.30	1	2010	2010	1	0	CTD_human
val	2558	GABRA5	0.621	0.385	C0751295	MemoryLoss	phenotype	C23;C10;F01	SignorSymptom	0.31	1	2010	2017	1	0	CTD_human
val	2558	GABRA5	0.621	0.385	C0751494	ConvulsiveSeizures	phenotype	C23;C10	SignorSymptom	0.30	1	1996	1996	1	0	CTD_human
val	2558	GABRA5	0.621	0.385	C0751495	Seizures,Focal	phenotype	C23;C10	DiseaseorSyndrome	0.30	1	1996	1996	1	0	CTD_human
val	2558	GABRA5	0.621	0.385	C0751496	Seizures,Sensory	phenotype	C23;C10	SignorSymptom	0.30	1	1996	1996	1	0	CTD_human
val	2558	GABRA5	0.621	0.385	C1510586	AutismSpectrumDisorders	disease	F03	MentalorBehavioralDysfunction	0.30	1	2016	2016	1	0	CTD_human
val	2558	GABRA5	0.621	0.385	C3495874	NonepilepticSeizures	phenotype	C23;C10	DiseaseorSyndrome	0.30	1	1996	1996	1	0	CTD_human
val	2558	GABRA5	0.621	0.385	C3711376	IsodicentricChromosome15Syndrome	disease	C16	DiseaseorSyndrome	0.30	1	2013	2013	1	0	CTD_human
val	2558	GABRA5	0.621	0.385	C4048158	Convulsions	phenotype	C23;C10	SignorSymptom	0.30	1	1996	1996	1	0	CTD_human
val	2558	GABRA5	0.621	0.385	C4316903	AbsenceSeizures	phenotype	C23;C10	DiseaseorSyndrome	0.30	1	1996	1996	1	0	CTD_human
val	2558	GABRA5	0.621	0.385	C4317109	EpilepticSeizures	phenotype	C23;C10	DiseaseorSyndrome	0.30	1	1996	1996	1	0	CTD_human
val	2558	GABRA5	0.621	0.385	C4317123	MyoclonicSeizures	phenotype	C23;C10	SignorSymptom	0.30	1	1996	1996	1	0	CTD_human
val	2558	GABRA5	0.621	0.385	C4505436	GeneralizedAbsenceSeizures	phenotype	C23;C10	DiseaseorSyndrome	0.30	1	1996	1996	1	0	CTD_human
val	2559	GABRA6	0.678	0.423	C0001973	AlcoholicIntoxication,Chronic	disease	C25;F03	MentalorBehavioralDysfunction	0.34	0.667	1999	2019	3	0	PSYGENET
val	2559	GABRA6	0.678	0.423	C0009402	ColorectalCarcinoma	disease	C06;C04	NeoplasticProcess	0.30				0	0	UNIPROT
val	2559	GABRA6	0.678	0.423	C0011570	MentalDepression	disease	F01	MentalorBehavioralDysfunction	0.31	1	2006	2017	1	0	PSYGENET
val	2559	GABRA6	0.678	0.423	C0011581	Depressivedisorder	disease	F03	MentalorBehavioralDysfunction	0.31	1	2006	2017	1	0	PSYGENET
val	2559	GABRA6	0.678	0.423	C0036341	Schizophrenia	disease	F03	MentalorBehavioralDysfunction	0.32	1	2005	2013	1	0	CTD_human
val	2559	GABRA6	0.678	0.423	C0238281	MiddleCerebralArterySyndrome	phenotype	C23;C10;C14	DiseaseorSyndrome	0.30	1	2014	2014	1	0	CTD_human
val	2559	GABRA6	0.678	0.423	C0525045	MoodDisorders	group	F03	MentalorBehavioralDysfunction	0.31	1	2003	2003	1	0	PSYGENET
val	2559	GABRA6	0.678	0.423	C0740376	MiddleCerebralArteryThrombosis	disease	C23;C10;C14	DiseaseorSyndrome	0.30	1	2014	2014	1	0	CTD_human
val	2559	GABRA6	0.678	0.423	C0740391	MiddleCerebralArteryOcclusion	disease	C23;C10;C14	AcquiredAbnormality	0.30	1	2014	2014	1	0	CTD_human
val	2559	GABRA6	0.678	0.423	C0740392	Infarction,MiddleCerebralArtery	disease	C23;C10;C14	DiseaseorSyndrome	0.30	1	2014	2014	1	0	CTD_human
val	2559	GABRA6	0.678	0.423	C0751845	MiddleCerebralArteryEmbolus	phenotype	C23;C10;C14	DiseaseorSyndrome	0.30	1	2014	2014	1	0	CTD_human
val	2559	GABRA6	0.678	0.423	C0751846	LeftMiddleCerebralArteryInfarction	phenotype	C23;C10;C14	DiseaseorSyndrome	0.30	1	2014	2014	1	0	CTD_human
val	2559	GABRA6	0.678	0.423	C0751847	EmbolicInfarction,MiddleCerebralArtery	phenotype	C23;C10;C14	DiseaseorSyndrome	0.30	1	2014	2014	1	0	CTD_human
val	2559	GABRA6	0.678	0.423	C0751848	ThromboticInfarction,MiddleCerebralArtery	phenotype	C23;C10;C14	DiseaseorSyndrome	0.30	1	2014	2014	1	0	CTD_human
val	2559	GABRA6	0.678	0.423	C0751849	RightMiddleCerebralArteryInfarction	phenotype	C23;C10;C14	DiseaseorSyndrome	0.30	1	2014	2014	1	0	CTD_human
val	2560	GABRB1	0.686	0.5	C0001973	AlcoholicIntoxication,Chronic	disease	C25;F03	MentalorBehavioralDysfunction	0.34	1	1999	2006	5	0	PSYGENET
val	2560	GABRB1	0.686	0.5	C0004352	AutisticDisorder	disease	F03	MentalorBehavioralDysfunction	0.33	1	2005	2013	2	0	CTD_human
val	2560	GABRB1	0.686	0.5	C0005586	BipolarDisorder	disease	F03	MentalorBehavioralDysfunction	0.31	1	2010	2010	2	0	PSYGENET
val	2560	GABRB1	0.686	0.5	C0019147	HepaticComa	disease	C06;C18;C10	DiseaseorSyndrome	0.30	1	2005	2005	1	0	CTD_human
val	2560	GABRB1	0.686	0.5	C0019151	HepaticEncephalopathy	disease	C06;C18;C10	DiseaseorSyndrome	0.50	1	2005	2005	1	0	CTD_human
val	2560	GABRB1	0.686	0.5	C0035222	RespiratoryDistressSyndrome,Adult	disease	C08	DiseaseorSyndrome	0.30	1	2014	2014	1	0	CTD_human
val	2560	GABRB1	0.686	0.5	C0036341	Schizophrenia	disease	F03	MentalorBehavioralDysfunction	0.32	1	2010	2014	2	0	PSYGENET
val	2560	GABRB1	0.686	0.5	C0270496	Schizoaffectivedisorder,bipolartype	disease	F03	MentalorBehavioralDysfunction	0.31	1	2010	2010	1	0	PSYGENET
val	2560	GABRB1	0.686	0.5	C0751197	FulminantHepaticFailurewithCerebralEdema	disease	C06;C18;C10	DiseaseorSyndrome	0.30	1	2005	2005	1	0	CTD_human
val	2560	GABRB1	0.686	0.5	C0751198	HepaticStupor	disease	C06;C18;C10	DiseaseorSyndrome	0.30	1	2005	2005	1	0	CTD_human
val	2560	GABRB1	0.686	0.5	C4310691	EPILEPTICENCEPHALOPATHY,EARLYINFANTILE,45	disease		DiseaseorSyndrome	0.70	1	2013	2016	3	3	CTD_human;GENOMICS_ENGLAND;UNIPROT
val	2561	GABRB2	0.619	0.5	C0001973	AlcoholicIntoxication,Chronic	disease	C25;F03	MentalorBehavioralDysfunction	0.32	0.667	2005	2010	3	0	PSYGENET
val	2561	GABRB2	0.619	0.5	C0005586	BipolarDisorder	disease	F03	MentalorBehavioralDysfunction	0.31	1	2009	2009	1	0	PSYGENET
val	2561	GABRB2	0.619	0.5	C0014544	Epilepsy	disease	C10	DiseaseorSyndrome	0.34	1	2011	2018	1	0	CTD_human
val	2561	GABRB2	0.619	0.5	C0036341	Schizophrenia	disease	F03	MentalorBehavioralDysfunction	0.40	0.955	2004	2019	1	0	CTD_human
val	2561	GABRB2	0.619	0.5	C0086237	Epilepsy,Cryptogenic	disease	C10	DiseaseorSyndrome	0.30	1	2018	2018	1	0	CTD_human
val	2561	GABRB2	0.619	0.5	C0236018	Aura	phenotype	C10	Finding	0.30	1	2018	2018	1	0	CTD_human
val	2561	GABRB2	0.619	0.5	C0525045	MoodDisorders	group	F03	MentalorBehavioralDysfunction	0.31	1	2012	2012	1	0	PSYGENET
val	2561	GABRB2	0.619	0.5	C0751111	AwakeningEpilepsy	disease	C10	DiseaseorSyndrome	0.30	1	2018	2018	1	0	CTD_human
val	2561	GABRB2	0.619	0.5	C1535926	NeurodevelopmentalDisorders	group	F03	MentalorBehavioralDysfunction	0.32	1	2014	2018	1	0	CTD_human
val	2561	GABRB2	0.619	0.5	C3714756	IntellectualDisability	group	C23;C10;F03;F01	MentalorBehavioralDysfunction	0.41	1	2014	2017	1	0	GENOMICS_ENGLAND
val	2561	GABRB2	0.619	0.5	C4693362	EPILEPTICENCEPHALOPATHY,INFANTILEOREARLYCHILDHOOD,2	disease		DiseaseorSyndrome	0.50	1	2014	2017	3	0	GENOMICS_ENGLAND;UNIPROT
val	2562	GABRB3	0.546	0.615	C0001890	AkineticPetitMal	disease	C10	DiseaseorSyndrome	0.30	1	2008	2008	1	0	CTD_human
val	2562	GABRB3	0.546	0.615	C0001973	AlcoholicIntoxication,Chronic	disease	C25;F03	MentalorBehavioralDysfunction	0.34	1	1998	2013	4	0	PSYGENET
val	2562	GABRB3	0.546	0.615	C0004352	AutisticDisorder	disease	F03	MentalorBehavioralDysfunction	0.40	0.867	1998	2018	2	0	CTD_human
val	2562	GABRB3	0.546	0.615	C0005586	BipolarDisorder	disease	F03	MentalorBehavioralDysfunction	0.31	1	2001	2010	2	0	PSYGENET
val	2562	GABRB3	0.546	0.615	C0011570	MentalDepression	disease	F01	MentalorBehavioralDysfunction	0.33	1	2001	2012	5	0	PSYGENET
val	2562	GABRB3	0.546	0.615	C0011581	Depressivedisorder	disease	F03	MentalorBehavioralDysfunction	0.43	1	2001	2012	5	0	PSYGENET
val	2562	GABRB3	0.546	0.615	C0014544	Epilepsy	disease	C10	DiseaseorSyndrome	0.39	1	1998	2019	2	0	CTD_human
val	2562	GABRB3	0.546	0.615	C0014553	AbsenceEpilepsy	disease	C10	DiseaseorSyndrome	0.50	0.917	1999	2019	1	0	CTD_human
val	2562	GABRB3	0.546	0.615	C0021603	SleepInitiationandMaintenanceDisorders	disease	C10;F03	DiseaseorSyndrome	0.30	1	2002	2002	1	0	CTD_human
val	2562	GABRB3	0.546	0.615	C0033139	PrimaryInsomnia	disease	C10;F03	DiseaseorSyndrome	0.30	1	2002	2002	1	0	CTD_human
val	2562	GABRB3	0.546	0.615	C0036341	Schizophrenia	disease	F03	MentalorBehavioralDysfunction	0.37	1	2005	2019	2	0	PSYGENET
val	2562	GABRB3	0.546	0.615	C0086237	Epilepsy,Cryptogenic	disease	C10	DiseaseorSyndrome	0.30	1	2005	2018	2	0	CTD_human
val	2562	GABRB3	0.546	0.615	C0162635	AngelmanSyndrome	disease	C16;C10	DiseaseorSyndrome	0.40	1	1991	2019	1	0	CTD_human
val	2562	GABRB3	0.546	0.615	C0236018	Aura	phenotype	C10	Finding	0.30	1	2005	2018	2	0	CTD_human
val	2562	GABRB3	0.546	0.615	C0238111	Lennox-Gastautsyndrome	disease	C16;C10	DiseaseorSyndrome	0.34	1	2013	2019	2	0	ORPHANET
val	2562	GABRB3	0.546	0.615	C0270541	ReboundInsomnia	phenotype	C10;F03	SignorSymptom	0.30	1	2002	2002	1	0	CTD_human
val	2562	GABRB3	0.546	0.615	C0349255	NonorganicInsomnia	disease	C10;F03	DiseaseorSyndrome	0.30	1	2002	2002	1	0	CTD_human
val	2562	GABRB3	0.546	0.615	C0376634	CraniofacialAbnormalities	group	C16;C05	CongenitalAbnormality	0.30	1	2005	2005	1	0	CTD_human
val	2562	GABRB3	0.546	0.615	C0393759	TransientInsomnia	phenotype	C10;F03	SignorSymptom	0.30	1	2002	2002	1	0	CTD_human
val	2562	GABRB3	0.546	0.615	C0541798	EarlyAwakening	phenotype	C10;F03	MentalorBehavioralDysfunction	0.30	1	2002	2002	1	0	CTD_human
val	2562	GABRB3	0.546	0.615	C0751111	AwakeningEpilepsy	disease	C10	DiseaseorSyndrome	0.30	1	2005	2018	2	0	CTD_human
val	2562	GABRB3	0.546	0.615	C0751124	Epilepsy,Absence,Atypical	disease	C10	DiseaseorSyndrome	0.30	1	2008	2008	1	0	CTD_human
val	2562	GABRB3	0.546	0.615	C0751249	ChronicInsomnia	disease	C10;F03	DiseaseorSyndrome	0.30	1	2002	2002	1	0	CTD_human
val	2562	GABRB3	0.546	0.615	C0751250	PsychophysiologicalInsomnia	disease	C10;F03	DiseaseorSyndrome	0.30	1	2002	2002	1	0	CTD_human
val	2562	GABRB3	0.546	0.615	C0751251	SecondaryInsomnia	phenotype	C10;F03	SignorSymptom	0.30	1	2002	2002	1	0	CTD_human
val	2562	GABRB3	0.546	0.615	C0751252	SleepInitiationDysfunction	disease	C10;F03	DiseaseorSyndrome	0.30	1	2002	2002	1	0	CTD_human
val	2562	GABRB3	0.546	0.615	C0917801	Sleeplessness	phenotype	C10;F03	SignorSymptom	0.30	1	2002	2002	1	0	CTD_human
val	2562	GABRB3	0.546	0.615	C1510586	AutismSpectrumDisorders	disease	F03	MentalorBehavioralDysfunction	0.54	1	2005	2018	1	0	CTD_human
val	2562	GABRB3	0.546	0.615	C1535926	NeurodevelopmentalDisorders	group	F03	MentalorBehavioralDysfunction	0.32	1	1999	2018	1	0	CTD_human
val	2562	GABRB3	0.546	0.615	C1838604	EPILEPSY,CHILDHOODABSENCE,1	disease		DiseaseorSyndrome	0.40	1	2008	2017	1	3	ORPHANET
val	2562	GABRB3	0.546	0.615	C2677087	EPILEPSY,CHILDHOODABSENCE,SUSCEPTIBILITYTO,5	phenotype		Finding	0.60	1	2008	2017	3	6	GENOMICS_ENGLAND;UNIPROT
val	2562	GABRB3	0.546	0.615	C3711376	IsodicentricChromosome15Syndrome	disease	C16	DiseaseorSyndrome	0.31	1	2013	2013	1	0	CTD_human
val	2562	GABRB3	0.546	0.615	C4281785	ChildhoodAbsenceEpilepsy	disease	C10	DiseaseorSyndrome	0.40	0.9	1999	2019	1	0	CTD_human
val	2562	GABRB3	0.546	0.615	C4310712	EPILEPTICENCEPHALOPATHY,EARLYINFANTILE,43	disease		DiseaseorSyndrome	0.60	1	2013	2017	6	8	CTD_human;UNIPROT
val	2562	GABRB3	0.546	0.615	C4317339	JuvenileAbsenceEpilepsy	disease	C10	DiseaseorSyndrome	0.31	1	2008	2019	1	0	CTD_human
val	2562	GABRB3	0.546	0.615	C4552765	Epilepsy,Minor	disease	C10	DiseaseorSyndrome	0.30	1	2008	2008	1	0	CTD_human
val	2562	GABRB3	0.546	0.615	C4553705	AbsenceSeizureDisorder	disease	C10	DiseaseorSyndrome	0.30	1	2008	2008	1	0	CTD_human
val	2563	GABRD	0.558	0.692	C0036341	Schizophrenia	disease	F03	MentalorBehavioralDysfunction	0.30	1	2008	2008	1	0	CTD_human
val	2563	GABRD	0.558	0.692	C0270850	Idiopathicgeneralizedepilepsy	disease	C10	DiseaseorSyndrome	0.30				0	0	CTD_human
val	2563	GABRD	0.558	0.692	C0270853	JuvenileMyoclonicEpilepsy	disease	C10	DiseaseorSyndrome	0.32	1	2010	2018	1	0	ORPHANET
val	2563	GABRD	0.558	0.692	C0525045	MoodDisorders	group	F03	MentalorBehavioralDysfunction	0.31	1	2010	2010	1	0	PSYGENET
val	2563	GABRD	0.558	0.692	C1842870	Chromosome1p36DeletionSyndrome	disease	C23;C16	DiseaseorSyndrome	0.30	1	2012	2012	1	0	ORPHANET
val	2563	GABRD	0.558	0.692	C2239176	Livercarcinoma	disease	C06;C04	NeoplasticProcess	0.30	1	2017	2017	1	0	CTD_human
val	2563	GABRD	0.558	0.692	C2751603	EPILEPSY,IDIOPATHICGENERALIZED,SUSCEPTIBILITYTO,10	disease		Finding	0.50	1	2004	2018	2	2	GENOMICS_ENGLAND;UNIPROT
val	2563	GABRD	0.558	0.692	C3502809	GeneralizedEpilepsywithFebrileSeizuresPlus	disease	C23;C10	DiseaseorSyndrome	0.33	1	2004	2010	0	0	ORPHANET
val	2565	GABRG1	0.78	0.192	C0001973	AlcoholicIntoxication,Chronic	disease	C25;F03	MentalorBehavioralDysfunction	0.33	1	2008	2014	4	0	PSYGENET
val	2565	GABRG1	0.78	0.192	C0005586	BipolarDisorder	disease	F03	MentalorBehavioralDysfunction	0.30	1	2009	2009	1	0	PSYGENET
val	2566	GABRG2	0.548	0.654	C0001956	AlcoholUseDisorder	disease	C25;F03	MentalorBehavioralDysfunction	0.31	1	2012	2014	1	0	CTD_human
val	2566	GABRG2	0.548	0.654	C0001973	AlcoholicIntoxication,Chronic	disease	C25;F03	MentalorBehavioralDysfunction	0.53	1	2005	2018	3	0	CTD_human;PSYGENET
val	2566	GABRG2	0.548	0.654	C0009171	CocaineAbuse	disease	C25;F03	MentalorBehavioralDysfunction	0.30	1	2012	2012	1	0	CTD_human
val	2566	GABRG2	0.548	0.654	C0009952	FebrileConvulsions	disease	C23;C10	DiseaseorSyndrome	0.50	0.85	2002	2019	1	0	CTD_human
val	2566	GABRG2	0.548	0.654	C0014544	Epilepsy	disease	C10	DiseaseorSyndrome	0.40	0.844	2001	2019	8	0	CLINGEN
val	2566	GABRG2	0.548	0.654	C0019147	HepaticComa	disease	C06;C18;C10	DiseaseorSyndrome	0.30	1	2005	2005	1	0	CTD_human
val	2566	GABRG2	0.548	0.654	C0019151	HepaticEncephalopathy	disease	C06;C18;C10	DiseaseorSyndrome	0.51	1	2005	2014	1	0	CTD_human
val	2566	GABRG2	0.548	0.654	C0036341	Schizophrenia	disease	F03	MentalorBehavioralDysfunction	0.34	0.5	2005	2014	4	0	PSYGENET
val	2566	GABRG2	0.548	0.654	C0085762	Alcoholabuse	disease	C25;F03	MentalorBehavioralDysfunction	0.30	1	2012	2012	1	0	CTD_human
val	2566	GABRG2	0.548	0.654	C0149886	Seizure,Febrile,Simple	disease	C23;C10	DiseaseorSyndrome	0.31	1	2012	2014	1	0	CTD_human
val	2566	GABRG2	0.548	0.654	C0236733	Amphetamine-RelatedDisorders	group	C25;F03	MentalorBehavioralDysfunction	0.30	1	2005	2005	1	0	CTD_human
val	2566	GABRG2	0.548	0.654	C0236736	Cocaine-RelatedDisorders	group	C25;F03	MentalorBehavioralDysfunction	0.30	1	2012	2012	1	0	CTD_human
val	2566	GABRG2	0.548	0.654	C0236804	AmphetamineAddiction	disease	C25;F03	MentalorBehavioralDysfunction	0.30	1	2005	2005	1	0	CTD_human
val	2566	GABRG2	0.548	0.654	C0236807	AmphetamineAbuse	disease	C25;F03	MentalorBehavioralDysfunction	0.30	1	2005	2005	1	0	CTD_human
val	2566	GABRG2	0.548	0.654	C0376532	Epilepsy,Rolandic	disease	C10	DiseaseorSyndrome	0.31	1	2015	2015	1	0	ORPHANET
val	2566	GABRG2	0.548	0.654	C0600427	CocaineDependence	disease	C25;F03	MentalorBehavioralDysfunction	0.30	1	2012	2012	1	0	CTD_human
val	2566	GABRG2	0.548	0.654	C0751057	Seizure,Febrile,Complex	disease	C23;C10	DiseaseorSyndrome	0.30	1	2014	2014	1	0	CTD_human
val	2566	GABRG2	0.548	0.654	C0751122	InfantileSevereMyoclonicEpilepsy	disease	C10	DiseaseorSyndrome	0.40	0.941	2002	2017	3	0	ORPHANET
val	2566	GABRG2	0.548	0.654	C0751197	FulminantHepaticFailurewithCerebralEdema	disease	C06;C18;C10	DiseaseorSyndrome	0.30	1	2005	2005	1	0	CTD_human
val	2566	GABRG2	0.548	0.654	C0751198	HepaticStupor	disease	C06;C18;C10	DiseaseorSyndrome	0.30	1	2005	2005	1	0	CTD_human
val	2566	GABRG2	0.548	0.654	C1838604	EPILEPSY,CHILDHOODABSENCE,1	disease		DiseaseorSyndrome	0.30				0	0	ORPHANET
val	2566	GABRG2	0.548	0.654	C1843244	EPILEPSY,CHILDHOODABSENCE,SUSCEPTIBILITYTO,2	disease		DiseaseorSyndrome	0.60	1	2001	2018	5	0	CTD_human;GENOMICS_ENGLAND;UNIPROT
val	2566	GABRG2	0.548	0.654	C1858674	GENERALIZEDEPILEPSYWITHFEBRILESEIZURESPLUS,TYPE3	disease	C23;C10	DiseaseorSyndrome	0.50	1	2001	2018	5	0	GENOMICS_ENGLAND;UNIPROT
val	2566	GABRG2	0.548	0.654	C2363129	BenignRolandicEpilepsy	disease	C10	DiseaseorSyndrome	0.30	1	2015	2015	1	0	ORPHANET
val	2566	GABRG2	0.548	0.654	C3502809	GeneralizedEpilepsywithFebrileSeizuresPlus	disease	C23;C10	DiseaseorSyndrome	0.38	1	2002	2014	0	0	ORPHANET
val	2567	GABRG3	0.711	0.423	C0001973	AlcoholicIntoxication,Chronic	disease	C25;F03	MentalorBehavioralDysfunction	0.32	1	2004	2015	1	0	PSYGENET
val	2567	GABRG3	0.711	0.423	C3711376	IsodicentricChromosome15Syndrome	disease	C16	DiseaseorSyndrome	0.30	1	2013	2013	1	0	CTD_human
val	2568	GABRP	0.736	0.462	C0006142	Malignantneoplasmofbreast	disease	C04;C17	NeoplasticProcess	0.33	1	2005	2019	0	1	UNIPROT
val	2569	GABRR1	0.839	0.115	C0001973	AlcoholicIntoxication,Chronic	disease	C25;F03	MentalorBehavioralDysfunction	0.31	1	2010	2010	1	0	PSYGENET
val	2569	GABRR1	0.839	0.115	C0005586	BipolarDisorder	disease	F03	MentalorBehavioralDysfunction	0.30	1	2010	2010	2	0	PSYGENET
val	2569	GABRR1	0.839	0.115	C0036341	Schizophrenia	disease	F03	MentalorBehavioralDysfunction	0.31	1	2010	2010	1	0	PSYGENET
val	2570	GABRR2	0.805	0.115	C0001973	AlcoholicIntoxication,Chronic	disease	C25;F03	MentalorBehavioralDysfunction	0.31	1	2010	2010	1	0	PSYGENET
val	2570	GABRR2	0.805	0.115	C0005586	BipolarDisorder	disease	F03	MentalorBehavioralDysfunction	0.30	1	2010	2010	1	0	PSYGENET
val	2570	GABRR2	0.805	0.115	C0023895	Liverdiseases	group	C06	DiseaseorSyndrome	0.30	1	2010	2010	1	0	CTD_human
val	2570	GABRR2	0.805	0.115	C0086565	LiverDysfunction	phenotype	C06	Finding	0.30	1	2010	2010	1	0	CTD_human
val	2570	GABRR2	0.805	0.115	C0149504	Encephalopathy,Toxic	disease	C10;C25	InjuryorPoisoning	0.30	1	2010	2010	1	0	CTD_human
val	2570	GABRR2	0.805	0.115	C0154659	ToxicEncephalitis	disease	C10;C25	InjuryorPoisoning	0.30	1	2010	2010	1	0	CTD_human
val	2570	GABRR2	0.805	0.115	C0235032	NeurotoxicitySyndromes	group	C10;C25	InjuryorPoisoning	0.30	1	2010	2010	1	0	CTD_human
val	2571	GAD1	0.486	0.885	C0001973	AlcoholicIntoxication,Chronic	disease	C25;F03	MentalorBehavioralDysfunction	0.35	1	1988	2018	5	0	PSYGENET
val	2571	GAD1	0.486	0.885	C0004352	AutisticDisorder	disease	F03	MentalorBehavioralDysfunction	0.36	1	2004	2018	1	0	CTD_human
val	2571	GAD1	0.486	0.885	C0005586	BipolarDisorder	disease	F03	MentalorBehavioralDysfunction	0.60	1	2000	2017	6	0	CTD_human;PSYGENET
val	2571	GAD1	0.486	0.885	C0005587	Depression,Bipolar	disease	F03	MentalorBehavioralDysfunction	0.30	1	2005	2005	1	0	CTD_human
val	2571	GAD1	0.486	0.885	C0009171	CocaineAbuse	disease	C25;F03	MentalorBehavioralDysfunction	0.30	1	2012	2012	1	0	CTD_human
val	2571	GAD1	0.486	0.885	C0011570	MentalDepression	disease	F01	MentalorBehavioralDysfunction	0.40	1	2008	2020	4	0	PSYGENET
val	2571	GAD1	0.486	0.885	C0011574	InvolutionalDepression	disease	F03	MentalorBehavioralDysfunction	0.30	1	2005	2005	1	0	CTD_human
val	2571	GAD1	0.486	0.885	C0011581	Depressivedisorder	disease	F03	MentalorBehavioralDysfunction	0.40	1	2008	2020	4	0	PSYGENET
val	2571	GAD1	0.486	0.885	C0013386	Dyskinesia,Drug-Induced	disease	C23;C10;C25	DiseaseorSyndrome	0.30	1	1998	1998	1	0	CTD_human
val	2571	GAD1	0.486	0.885	C0020514	Hyperprolactinemia	disease	C10;C19	DiseaseorSyndrome	0.30	1	1982	1982	1	0	CTD_human
val	2571	GAD1	0.486	0.885	C0024713	ManicDisorder	disease	F03	MentalorBehavioralDysfunction	0.30	1	2005	2005	1	0	CTD_human
val	2571	GAD1	0.486	0.885	C0036341	Schizophrenia	disease	F03	MentalorBehavioralDysfunction	0.40	0.956	2000	2019	4	0	CTD_human
val	2571	GAD1	0.486	0.885	C0041696	UnipolarDepression	disease	F03	MentalorBehavioralDysfunction	0.33	1	2004	2014	5	0	PSYGENET
val	2571	GAD1	0.486	0.885	C0236736	Cocaine-RelatedDisorders	group	C25;F03	MentalorBehavioralDysfunction	0.30	1	2012	2012	1	0	CTD_human
val	2571	GAD1	0.486	0.885	C0338831	Manic	disease	F03	MentalorBehavioralDysfunction	0.30	1	2005	2005	1	0	CTD_human
val	2571	GAD1	0.486	0.885	C0525045	MoodDisorders	group	F03	MentalorBehavioralDysfunction	0.32	1	2005	2011	1	0	PSYGENET
val	2571	GAD1	0.486	0.885	C0600427	CocaineDependence	disease	C25;F03	MentalorBehavioralDysfunction	0.30	1	2012	2012	1	0	CTD_human
val	2571	GAD1	0.486	0.885	C0751088	Dyskinesia,Medication-Induced	phenotype	C23;C10;C25	DiseaseorSyndrome	0.30	1	1998	1998	1	0	CTD_human
val	2571	GAD1	0.486	0.885	C1269683	MajorDepressiveDisorder	disease	F03	MentalorBehavioralDysfunction	0.53	1	2005	2014	6	0	CTD_human;PSYGENET
val	2571	GAD1	0.486	0.885	C1571983	Involutionalparaphrenia	disease	F03	MentalorBehavioralDysfunction	0.30	1	2005	2005	1	0	CTD_human
val	2571	GAD1	0.486	0.885	C1571984	Psychosis,Involutional	disease	F03	MentalorBehavioralDysfunction	0.30	1	2005	2005	1	0	CTD_human
val	2571	GAD1	0.486	0.885	C2751938	CerebralPalsy,SpasticQuadriplegic,1	disease	C10	DiseaseorSyndrome	0.70	1	2004	2004	1	2	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
val	2572	GAD2	0.529	0.731	C0005586	BipolarDisorder	disease	F03	MentalorBehavioralDysfunction	0.30	1	2005	2005	1	0	CTD_human
val	2572	GAD2	0.529	0.731	C0005587	Depression,Bipolar	disease	F03	MentalorBehavioralDysfunction	0.30	1	2005	2005	1	0	CTD_human
val	2572	GAD2	0.529	0.731	C0009171	CocaineAbuse	disease	C25;F03	MentalorBehavioralDysfunction	0.30	1	2012	2012	1	0	CTD_human
val	2572	GAD2	0.529	0.731	C0011574	InvolutionalDepression	disease	F03	MentalorBehavioralDysfunction	0.30	1	2005	2005	1	0	CTD_human
val	2572	GAD2	0.529	0.731	C0011884	DiabeticRetinopathy	disease	C11;C19;C14	DiseaseorSyndrome	0.30	1	2011	2011	1	0	CTD_human
val	2572	GAD2	0.529	0.731	C0022333	JacksonianSeizure	disease	C23;C10	DiseaseorSyndrome	0.30	1	1996	1996	2	0	CTD_human
val	2572	GAD2	0.529	0.731	C0024713	ManicDisorder	disease	F03	MentalorBehavioralDysfunction	0.30	1	2005	2005	1	0	CTD_human
val	2572	GAD2	0.529	0.731	C0036341	Schizophrenia	disease	F03	MentalorBehavioralDysfunction	0.38	0.9	2004	2017	2	0	CTD_human
val	2572	GAD2	0.529	0.731	C0036572	Seizures	phenotype	C23;C10	SignorSymptom	0.34	1	1996	2018	2	0	CTD_human
val	2572	GAD2	0.529	0.731	C0149958	Complexpartialseizures	disease	C23;C10	DiseaseorSyndrome	0.30	1	1996	1996	2	0	CTD_human
val	2572	GAD2	0.529	0.731	C0234533	Generalizedseizures	disease	C23;C10	DiseaseorSyndrome	0.30	1	1996	1996	2	0	CTD_human
val	2572	GAD2	0.529	0.731	C0234535	ClonicSeizures	disease	C23;C10	DiseaseorSyndrome	0.30	1	1996	1996	2	0	CTD_human
val	2572	GAD2	0.529	0.731	C0236736	Cocaine-RelatedDisorders	group	C25;F03	MentalorBehavioralDysfunction	0.30	1	2012	2012	1	0	CTD_human
val	2572	GAD2	0.529	0.731	C0270824	Visualseizure	disease	C23;C10	DiseaseorSyndrome	0.30	1	1996	1996	2	0	CTD_human
val	2572	GAD2	0.529	0.731	C0270844	TonicSeizures	phenotype	C23;C10	DiseaseorSyndrome	0.30	1	1996	1996	2	0	CTD_human
val	2572	GAD2	0.529	0.731	C0270846	Epilepticdropattack	disease	C23;C10	DiseaseorSyndrome	0.30	1	1996	1996	2	0	CTD_human
val	2572	GAD2	0.529	0.731	C0338831	Manic	disease	F03	MentalorBehavioralDysfunction	0.30	1	2005	2005	1	0	CTD_human
val	2572	GAD2	0.529	0.731	C0422850	Seizures,Somatosensory	phenotype	C23;C10	PathologicFunction	0.30	1	1996	1996	2	0	CTD_human
val	2572	GAD2	0.529	0.731	C0422852	Seizures,Auditory	phenotype	C23;C10	PathologicFunction	0.30	1	1996	1996	2	0	CTD_human
val	2572	GAD2	0.529	0.731	C0422853	Olfactoryseizure	phenotype	C23;C10	DiseaseorSyndrome	0.30	1	1996	1996	2	0	CTD_human
val	2572	GAD2	0.529	0.731	C0422854	Gustatoryseizure	phenotype	C23;C10	SignorSymptom	0.30	1	1996	1996	2	0	CTD_human
val	2572	GAD2	0.529	0.731	C0422855	Vertiginousseizure	phenotype	C23;C10	DiseaseorSyndrome	0.30	1	1996	1996	2	0	CTD_human
val	2572	GAD2	0.529	0.731	C0494475	Tonic-clonicseizures	disease	C23;C10	DiseaseorSyndrome	0.30	1	1996	1996	2	0	CTD_human
val	2572	GAD2	0.529	0.731	C0525045	MoodDisorders	group	F03	MentalorBehavioralDysfunction	0.32	1	2009	2016	1	0	PSYGENET
val	2572	GAD2	0.529	0.731	C0600427	CocaineDependence	disease	C25;F03	MentalorBehavioralDysfunction	0.30	1	2012	2012	1	0	CTD_human
val	2572	GAD2	0.529	0.731	C0751056	Non-epilepticconvulsion	phenotype	C23;C10	SignorSymptom	0.30	1	1996	1996	2	0	CTD_human
val	2572	GAD2	0.529	0.731	C0751110	SingleSeizure	disease	C23;C10	DiseaseorSyndrome	0.30	1	1996	1996	2	0	CTD_human
val	2572	GAD2	0.529	0.731	C0751123	AtonicAbsenceSeizures	phenotype	C23;C10	DiseaseorSyndrome	0.30	1	1996	1996	2	0	CTD_human
val	2572	GAD2	0.529	0.731	C0751494	ConvulsiveSeizures	phenotype	C23;C10	SignorSymptom	0.30	1	1996	1996	2	0	CTD_human
val	2572	GAD2	0.529	0.731	C0751495	Seizures,Focal	phenotype	C23;C10	DiseaseorSyndrome	0.30	1	1996	1996	2	0	CTD_human
val	2572	GAD2	0.529	0.731	C0751496	Seizures,Sensory	phenotype	C23;C10	SignorSymptom	0.30	1	1996	1996	2	0	CTD_human
val	2572	GAD2	0.529	0.731	C1269683	MajorDepressiveDisorder	disease	F03	MentalorBehavioralDysfunction	0.33	1	2005	2018	1	0	CTD_human
val	2572	GAD2	0.529	0.731	C1571983	Involutionalparaphrenia	disease	F03	MentalorBehavioralDysfunction	0.30	1	2005	2005	1	0	CTD_human
val	2572	GAD2	0.529	0.731	C1571984	Psychosis,Involutional	disease	F03	MentalorBehavioralDysfunction	0.30	1	2005	2005	1	0	CTD_human
val	2572	GAD2	0.529	0.731	C3495874	NonepilepticSeizures	phenotype	C23;C10	DiseaseorSyndrome	0.30	1	1996	1996	2	0	CTD_human
val	2572	GAD2	0.529	0.731	C4048158	Convulsions	phenotype	C23;C10	SignorSymptom	0.30	1	1996	1996	2	0	CTD_human
val	2572	GAD2	0.529	0.731	C4316903	AbsenceSeizures	phenotype	C23;C10	DiseaseorSyndrome	0.30	1	1996	1996	2	0	CTD_human
val	2572	GAD2	0.529	0.731	C4317109	EpilepticSeizures	phenotype	C23;C10	DiseaseorSyndrome	0.30	1	1996	1996	2	0	CTD_human
val	2572	GAD2	0.529	0.731	C4317123	MyoclonicSeizures	phenotype	C23;C10	SignorSymptom	0.30	1	1996	1996	2	0	CTD_human
val	2572	GAD2	0.529	0.731	C4505436	GeneralizedAbsenceSeizures	phenotype	C23;C10	DiseaseorSyndrome	0.30	1	1996	1996	2	0	CTD_human
val	2580	GAK	0.805	0.231	C0030567	ParkinsonDisease	disease	C10	DiseaseorSyndrome	0.50	1	2009	2020	1	3	CTD_human
val	2581	GALC	0.604	0.615	C0023521	Globoidcellleukodystrophy	disease	C16;C18;C10	DiseaseorSyndrome	1.00	1	1970	2020	14	106	CTD_human;GENOMICS_ENGLAND;UNIPROT
val	2581	GALC	0.604	0.615	C0023893	LiverCirrhosis,Experimental	disease	C23;C06	ExperimentalModelofDisease	0.30	1	2014	2014	1	0	CTD_human
val	2581	GALC	0.604	0.615	C0036572	Seizures	phenotype	C23;C10	SignorSymptom	0.40	1	2010	2010	1	2	GENOMICS_ENGLAND
val	2581	GALC	0.604	0.615	C0268252	Late-OnsetGloboidCellLeukodystrophy	disease	C16;C18;C10	DiseaseorSyndrome	0.56	1	1981	2019	1	0	CTD_human;ORPHANET
val	2581	GALC	0.604	0.615	C0751273	InfantileGloboidCellLeukodystrophy	disease	C16;C18;C10	DiseaseorSyndrome	0.59	0.9	1995	2019	1	0	CTD_human;ORPHANET
val	2582	GALE	0.722	0.385	C0016952	Galactosemias	disease	C16;C18;C10	DiseaseorSyndrome	0.40	1	1998	2019	1	0	CTD_human
val	2582	GALE	0.722	0.385	C0268151	Classicalgalactosemia	disease	C16;C18;C10	DiseaseorSyndrome	0.40	1	1995	2019	1	0	CTD_human
val	2582	GALE	0.722	0.385	C0268155	Deficiencyofgalactokinase	disease	C16;C18;C10	DiseaseorSyndrome	0.30	1	2015	2015	1	0	CTD_human
val	2582	GALE	0.722	0.385	C0751161	UDPglucose4-epimerasedeficiencydisease	disease	C16;C18;C10	DiseaseorSyndrome	0.72	1	1995	2015	9	16	CTD_human;GENOMICS_ENGLAND;UNIPROT
val	2582	GALE	0.722	0.385	C3714756	IntellectualDisability	group	C23;C10;F03;F01	MentalorBehavioralDysfunction	0.40	1	2016	2016	1	0	GENOMICS_ENGLAND
val	2583	B4GALNT1	0.644	0.615	C1441613	Immunediffusion	phenotype		LaboratoryProcedure	0.30				0	0	GENOMICS_ENGLAND
val	2583	B4GALNT1	0.644	0.615	C1836632	SPASTICPARAPLEGIA26,AUTOSOMALRECESSIVE(disorder)	disease	C16;C10	DiseaseorSyndrome	0.70	1	2013	2014	2	6	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
val	2584	GALK1	0.682	0.346	C0016952	Galactosemias	disease	C16;C18;C10	DiseaseorSyndrome	0.40	0.933	1988	2019	1	0	CTD_human
val	2584	GALK1	0.682	0.346	C0086543	Cataract	disease	C11	AcquiredAbnormality	0.50	0.909	1986	2018	1	0	CTD_human
val	2584	GALK1	0.682	0.346	C0268151	Classicalgalactosemia	disease	C16;C18;C10	DiseaseorSyndrome	0.40	0.923	1988	2019	1	0	CTD_human
val	2584	GALK1	0.682	0.346	C0268155	Deficiencyofgalactokinase	disease	C16;C18;C10	DiseaseorSyndrome	0.80	1	1986	2018	8	22	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
val	2584	GALK1	0.682	0.346	C0524524	Pseudoaphakia	disease	C11	DiseaseorSyndrome	0.30	1	1995	1995	1	0	CTD_human
val	2584	GALK1	0.682	0.346	C0751161	UDPglucose4-epimerasedeficiencydisease	disease	C16;C18;C10	DiseaseorSyndrome	0.32	1	1995	2017	1	0	CTD_human
val	2584	GALK1	0.682	0.346	C1510497	LensOpacities	phenotype	C11	Finding	0.30	1	1995	1995	1	0	CTD_human
val	2587	GALR1	0.656	0.5	C0011574	InvolutionalDepression	disease	F03	MentalorBehavioralDysfunction	0.30	1	2016	2016	1	0	CTD_human
val	2587	GALR1	0.656	0.5	C0600427	CocaineDependence	disease	C25;F03	MentalorBehavioralDysfunction	0.31	1	2014	2014	1	0	PSYGENET
val	2587	GALR1	0.656	0.5	C1269683	MajorDepressiveDisorder	disease	F03	MentalorBehavioralDysfunction	0.30	1	2016	2016	1	0	CTD_human
val	2587	GALR1	0.656	0.5	C1571983	Involutionalparaphrenia	disease	F03	MentalorBehavioralDysfunction	0.30	1	2016	2016	1	0	CTD_human
val	2587	GALR1	0.656	0.5	C1571984	Psychosis,Involutional	disease	F03	MentalorBehavioralDysfunction	0.30	1	2016	2016	1	0	CTD_human
val	2588	GALNS	0.56	0.808	C0009402	ColorectalCarcinoma	disease	C06;C04	NeoplasticProcess	0.30				0	0	UNIPROT
val	2588	GALNS	0.56	0.808	C0021368	Inflammation	phenotype	C23	PathologicFunction	0.30	1	1994	1994	1	0	CTD_human
val	2588	GALNS	0.56	0.808	C0026707	MucopolysaccharidosisIV	disease	C16;C18;C17	DiseaseorSyndrome	0.90	1	1980	2016	2	7	CTD_human;GENOMICS_ENGLAND
val	2588	GALNS	0.56	0.808	C0086651	Mucopolysaccharidosis,MPS-IV-A	disease	C16;C18;C17	DiseaseorSyndrome	0.80	1	1988	2019	14	82	CTD_human;GENOMICS_ENGLAND;UNIPROT
val	2588	GALNS	0.56	0.808	C0086652	MucopolysaccharidosistypeIVB	disease	C16;C18;C17	DiseaseorSyndrome	0.30				0	0	CTD_human
val	2588	GALNS	0.56	0.808	C3179194	GALNSDeficiency	disease	C16;C18;C17	DiseaseorSyndrome	0.33	1	1999	2019	0	0	CTD_human
val	2591	GALNT3	0.603	0.769	C0006663	Calcinosis	phenotype	C18	PathologicFunction	0.43	1	2004	2008	1	0	CTD_human
val	2591	GALNT3	0.603	0.769	C0033578	ProstaticNeoplasms	group	C04;C12	NeoplasticProcess	0.30	1	2007	2007	1	0	CTD_human
val	2591	GALNT3	0.603	0.769	C0085681	Hyperphosphatemia(disorder)	disease	C18	DiseaseorSyndrome	0.48	1	2007	2017	1	0	CTD_human
val	2591	GALNT3	0.603	0.769	C0263628	Tumoralcalcinosis	disease	C18	DiseaseorSyndrome	0.38	1	2005	2015	1	0	CTD_human
val	2591	GALNT3	0.603	0.769	C0376358	Malignantneoplasmofprostate	disease	C04;C12	NeoplasticProcess	0.31	1	2005	2007	1	0	CTD_human
val	2591	GALNT3	0.603	0.769	C0521174	Microcalcification	phenotype	C18	PathologicFunction	0.30	1	2007	2007	1	0	CTD_human
val	2591	GALNT3	0.603	0.769	C1876187	TUMORALCALCINOSIS,HYPERPHOSPHATEMIC,FAMILIAL	disease	C16;C18;C05	DiseaseorSyndrome	0.80	1	2004	2019	2	0	CTD_human;ORPHANET
val	2591	GALNT3	0.603	0.769	C4692564	TUMORALCALCINOSIS,HYPERPHOSPHATEMIC,FAMILIAL,1	disease		DiseaseorSyndrome	0.80	1	2004	2016	3	14	GENOMICS_ENGLAND;ORPHANET
val	2592	GALT	0.612	0.654	C0016952	Galactosemias	disease	C16;C18;C10	DiseaseorSyndrome	0.80	0.963	1970	2019	2	0	CTD_human;GENOMICS_ENGLAND
val	2592	GALT	0.612	0.654	C0086543	Cataract	disease	C11	AcquiredAbnormality	0.42	1	2008	2016	1	0	GENOMICS_ENGLAND
val	2592	GALT	0.612	0.654	C0268151	Classicalgalactosemia	disease	C16;C18;C10	DiseaseorSyndrome	0.80	0.993	1970	2020	29	223	CTD_human;GENOMICS_ENGLAND;UNIPROT
val	2592	GALT	0.612	0.654	C0268155	Deficiencyofgalactokinase	disease	C16;C18;C10	DiseaseorSyndrome	0.30	1	2013	2013	1	0	CTD_human
val	2592	GALT	0.612	0.654	C0751161	UDPglucose4-epimerasedeficiencydisease	disease	C16;C18;C10	DiseaseorSyndrome	0.31	1	2001	2013	1	0	CTD_human
val	2592	GALT	0.612	0.654	C3714756	IntellectualDisability	group	C23;C10;F03;F01	MentalorBehavioralDysfunction	0.40	1	2016	2016	1	0	GENOMICS_ENGLAND
val	2593	GAMT	0.691	0.269	C0002514	AminoAcidMetabolism,InbornErrors	group	C16;C18	DiseaseorSyndrome	0.30	1	2005	2005	1	0	CTD_human
val	2593	GAMT	0.691	0.269	C0013421	Dystonia	phenotype	C23;C10	SignorSymptom	0.40	1	2014	2014	1	0	GENOMICS_ENGLAND
val	2593	GAMT	0.691	0.269	C0020796	ProfoundMentalRetardation	disease	C23;C10;F03;F01	MentalorBehavioralDysfunction	0.30	1	2005	2005	1	0	CTD_human
val	2593	GAMT	0.691	0.269	C0022333	JacksonianSeizure	disease	C23;C10	DiseaseorSyndrome	0.30	1	2005	2005	1	0	CTD_human
val	2593	GAMT	0.691	0.269	C0025363	MentalRetardation,Psychosocial	phenotype	C23;C10;F03;F01	MentalorBehavioralDysfunction	0.30	1	2005	2005	1	0	CTD_human
val	2593	GAMT	0.691	0.269	C0036572	Seizures	phenotype	C23;C10	SignorSymptom	0.60	1	2005	2014	2	0	CTD_human;GENOMICS_ENGLAND
val	2593	GAMT	0.691	0.269	C0149958	Complexpartialseizures	disease	C23;C10	DiseaseorSyndrome	0.40	1	2005	2005	1	0	CTD_human
val	2593	GAMT	0.691	0.269	C0234533	Generalizedseizures	disease	C23;C10	DiseaseorSyndrome	0.30	1	2005	2005	1	0	CTD_human
val	2593	GAMT	0.691	0.269	C0234535	ClonicSeizures	disease	C23;C10	DiseaseorSyndrome	0.30	1	2005	2005	1	0	CTD_human
val	2593	GAMT	0.691	0.269	C0270824	Visualseizure	disease	C23;C10	DiseaseorSyndrome	0.30	1	2005	2005	1	0	CTD_human
val	2593	GAMT	0.691	0.269	C0270844	TonicSeizures	phenotype	C23;C10	DiseaseorSyndrome	0.30	1	2005	2005	1	0	CTD_human
val	2593	GAMT	0.691	0.269	C0270846	Epilepticdropattack	disease	C23;C10	DiseaseorSyndrome	0.40	1	2005	2005	1	0	CTD_human
val	2593	GAMT	0.691	0.269	C0422850	Seizures,Somatosensory	phenotype	C23;C10	PathologicFunction	0.30	1	2005	2005	1	0	CTD_human
val	2593	GAMT	0.691	0.269	C0422852	Seizures,Auditory	phenotype	C23;C10	PathologicFunction	0.30	1	2005	2005	1	0	CTD_human
val	2593	GAMT	0.691	0.269	C0422853	Olfactoryseizure	phenotype	C23;C10	DiseaseorSyndrome	0.30	1	2005	2005	1	0	CTD_human
val	2593	GAMT	0.691	0.269	C0422854	Gustatoryseizure	phenotype	C23;C10	SignorSymptom	0.30	1	2005	2005	1	0	CTD_human
val	2593	GAMT	0.691	0.269	C0422855	Vertiginousseizure	phenotype	C23;C10	DiseaseorSyndrome	0.30	1	2005	2005	1	0	CTD_human
val	2593	GAMT	0.691	0.269	C0494475	Tonic-clonicseizures	disease	C23;C10	DiseaseorSyndrome	0.40	1	2005	2005	1	0	CTD_human
val	2593	GAMT	0.691	0.269	C0574080	Guanidinoacetatemethyltransferasedeficiency	disease	C23;C10	DiseaseorSyndrome	0.94	1	1940	2017	21	18	CLINGEN;CTD_human;GENOMICS_ENGLAND;UNIPROT
val	2593	GAMT	0.691	0.269	C0750905	AminoAcidMetabolism,InheritedDisorders	disease	C16;C18	DiseaseorSyndrome	0.30	1	2005	2005	1	0	CTD_human
val	2593	GAMT	0.691	0.269	C0751056	Non-epilepticconvulsion	phenotype	C23;C10	SignorSymptom	0.30	1	2005	2005	1	0	CTD_human
val	2593	GAMT	0.691	0.269	C0751110	SingleSeizure	disease	C23;C10	DiseaseorSyndrome	0.30	1	2005	2005	1	0	CTD_human
val	2593	GAMT	0.691	0.269	C0751123	AtonicAbsenceSeizures	phenotype	C23;C10	DiseaseorSyndrome	0.30	1	2005	2005	1	0	CTD_human
val	2593	GAMT	0.691	0.269	C0751494	ConvulsiveSeizures	phenotype	C23;C10	SignorSymptom	0.30	1	2005	2005	1	0	CTD_human
val	2593	GAMT	0.691	0.269	C0751495	Seizures,Focal	phenotype	C23;C10	DiseaseorSyndrome	0.30	1	2005	2005	1	0	CTD_human
val	2593	GAMT	0.691	0.269	C0751496	Seizures,Sensory	phenotype	C23;C10	SignorSymptom	0.30	1	2005	2005	1	0	CTD_human
val	2593	GAMT	0.691	0.269	C0917816	Mentaldeficiency	disease	C23;C10;F03;F01	MentalorBehavioralDysfunction	0.30	1	2005	2005	1	0	CTD_human
val	2593	GAMT	0.691	0.269	C3495874	NonepilepticSeizures	phenotype	C23;C10	DiseaseorSyndrome	0.30	1	2005	2005	1	0	CTD_human
val	2593	GAMT	0.691	0.269	C3714756	IntellectualDisability	group	C23;C10;F03;F01	MentalorBehavioralDysfunction	0.60	1	1996	2005	2	0	CTD_human;GENOMICS_ENGLAND
val	2593	GAMT	0.691	0.269	C4048158	Convulsions	phenotype	C23;C10	SignorSymptom	0.30	1	2005	2005	1	0	CTD_human
val	2593	GAMT	0.691	0.269	C4316903	AbsenceSeizures	phenotype	C23;C10	DiseaseorSyndrome	0.30	1	2005	2005	1	0	CTD_human
val	2593	GAMT	0.691	0.269	C4317109	EpilepticSeizures	phenotype	C23;C10	DiseaseorSyndrome	0.30	1	2005	2005	1	0	CTD_human
val	2593	GAMT	0.691	0.269	C4317123	MyoclonicSeizures	phenotype	C23;C10	SignorSymptom	0.30	1	2005	2005	1	0	CTD_human
val	2593	GAMT	0.691	0.269	C4505436	GeneralizedAbsenceSeizures	phenotype	C23;C10	DiseaseorSyndrome	0.30	1	2005	2005	1	0	CTD_human
val	2596	GAP43	0.564	0.731	C0001973	AlcoholicIntoxication,Chronic	disease	C25;F03	MentalorBehavioralDysfunction	0.31	1	2006	2006	1	0	PSYGENET
val	2596	GAP43	0.564	0.731	C0005586	BipolarDisorder	disease	F03	MentalorBehavioralDysfunction	0.30	1	2001	2001	1	0	PSYGENET
val	2596	GAP43	0.564	0.731	C0007102	Malignanttumorofcolon	disease	C06;C04	NeoplasticProcess	0.30	1	2004	2004	1	0	CTD_human
val	2596	GAP43	0.564	0.731	C0009375	ColonicNeoplasms	group	C06;C04	NeoplasticProcess	0.30	1	2004	2004	1	0	CTD_human
val	2596	GAP43	0.564	0.731	C0011570	MentalDepression	disease	F01	MentalorBehavioralDysfunction	0.33	1	1998	2020	1	0	PSYGENET
val	2596	GAP43	0.564	0.731	C0011581	Depressivedisorder	disease	F03	MentalorBehavioralDysfunction	0.33	1	1998	2020	1	0	PSYGENET
val	2596	GAP43	0.564	0.731	C0013415	DysthymicDisorder	disease	F03	MentalorBehavioralDysfunction	0.31	1	2000	2000	1	0	PSYGENET
val	2596	GAP43	0.564	0.731	C0017181	GastrointestinalHemorrhage	phenotype	C23;C06	PathologicFunction	0.30	1	2012	2012	1	0	GENOMICS_ENGLAND
val	2596	GAP43	0.564	0.731	C0019569	HirschsprungDisease	disease	C16;C06	DiseaseorSyndrome	0.31	1	2012	2018	1	0	GENOMICS_ENGLAND
val	2596	GAP43	0.564	0.731	C0019829	HodgkinDisease	disease	C04;C20;C15	NeoplasticProcess	0.30	1	2012	2012	1	0	GENOMICS_ENGLAND
val	2596	GAP43	0.564	0.731	C0020179	HuntingtonDisease	disease	C16;C10;F03	DiseaseorSyndrome	0.30	1	2012	2012	1	0	GENOMICS_ENGLAND
val	2596	GAP43	0.564	0.731	C0036341	Schizophrenia	disease	F03	MentalorBehavioralDysfunction	0.35	1	1998	2012	4	0	PSYGENET
val	2596	GAP43	0.564	0.731	C0038220	StatusEpilepticus	disease	C23;C10	DiseaseorSyndrome	0.31	1	1999	2017	1	0	CTD_human
val	2596	GAP43	0.564	0.731	C0270823	Petitmalstatus	disease	C23;C10	DiseaseorSyndrome	0.30	1	1999	1999	1	0	CTD_human
val	2596	GAP43	0.564	0.731	C0311335	GrandMalStatusEpilepticus	disease	C23;C10	DiseaseorSyndrome	0.30	1	1999	1999	1	0	CTD_human
val	2596	GAP43	0.564	0.731	C0393734	ComplexPartialStatusEpilepticus	disease	C23;C10	DiseaseorSyndrome	0.30	1	1999	1999	1	0	CTD_human
val	2596	GAP43	0.564	0.731	C0525045	MoodDisorders	group	F03	MentalorBehavioralDysfunction	0.30	1	2009	2009	1	0	PSYGENET
val	2596	GAP43	0.564	0.731	C0751522	StatusEpilepticus,Subclinical	disease	C23;C10	DiseaseorSyndrome	0.30	1	1999	1999	1	0	CTD_human
val	2596	GAP43	0.564	0.731	C0751523	Non-ConvulsiveStatusEpilepticus	disease	C23;C10	DiseaseorSyndrome	0.30	1	1999	1999	1	0	CTD_human
val	2596	GAP43	0.564	0.731	C0751524	SimplePartialStatusEpilepticus	phenotype	C23;C10	DiseaseorSyndrome	0.30	1	1999	1999	1	0	CTD_human
val	2597	GAPDH	0.447	0.808	C0001787	Osteoporosis,Age-Related	disease	C18;C05	DiseaseorSyndrome	0.30	1	2008	2008	1	0	CTD_human
val	2597	GAPDH	0.447	0.808	C0001973	AlcoholicIntoxication,Chronic	disease	C25;F03	MentalorBehavioralDysfunction	0.31	1	2010	2010	1	0	PSYGENET
val	2597	GAPDH	0.447	0.808	C0003129	Anoxemia	phenotype	C23	SignorSymptom	0.30	1	2009	2009	1	0	CTD_human
val	2597	GAPDH	0.447	0.808	C0003130	Anoxia	phenotype	C23	PathologicFunction	0.30	1	2009	2009	1	0	CTD_human
val	2597	GAPDH	0.447	0.808	C0007137	Squamouscellcarcinoma	disease	C04	NeoplasticProcess	0.33	1	2003	2015	1	0	CTD_human
val	2597	GAPDH	0.447	0.808	C0009402	ColorectalCarcinoma	disease	C06;C04	NeoplasticProcess	0.34	1	2006	2019	1	0	CTD_human
val	2597	GAPDH	0.447	0.808	C0009404	ColorectalNeoplasms	group	C06;C04	NeoplasticProcess	0.30	1	2015	2015	1	0	CTD_human
val	2597	GAPDH	0.447	0.808	C0014859	EsophagealNeoplasms	group	C06;C04	NeoplasticProcess	0.30	1	2005	2005	1	0	CTD_human
val	2597	GAPDH	0.447	0.808	C0026640	MouthNeoplasms	group	C04;C07	NeoplasticProcess	0.30	1	2004	2004	1	0	CTD_human
val	2597	GAPDH	0.447	0.808	C0027540	Necrosis	phenotype	C23	OrganorTissueFunction	0.30	1	2015	2015	1	0	CTD_human
val	2597	GAPDH	0.447	0.808	C0029408	Degenerativepolyarthritis	disease	C05	DiseaseorSyndrome	0.30	1	2009	2009	1	0	CTD_human
val	2597	GAPDH	0.447	0.808	C0029456	Osteoporosis	disease	C18;C05	DiseaseorSyndrome	0.31	1	2008	2017	1	0	CTD_human
val	2597	GAPDH	0.447	0.808	C0029459	Osteoporosis,Senile	disease	C18;C05	DiseaseorSyndrome	0.30	1	2008	2008	1	0	CTD_human
val	2597	GAPDH	0.447	0.808	C0086743	OsteoarthrosisDeformans	disease	C05	DiseaseorSyndrome	0.30	1	2009	2009	1	0	CTD_human
val	2597	GAPDH	0.447	0.808	C0152013	Adenocarcinomaoflung(disorder)	disease	C04	NeoplasticProcess	0.32	1	2004	2019	1	0	CTD_human
val	2597	GAPDH	0.447	0.808	C0153381	Malignantneoplasmofmouth	group	C04;C07	NeoplasticProcess	0.30	1	2004	2004	1	0	CTD_human
val	2597	GAPDH	0.447	0.808	C0242184	Hypoxia	phenotype	C23	PathologicFunction	0.30	1	2009	2009	1	0	CTD_human
val	2597	GAPDH	0.447	0.808	C0546837	Malignantneoplasmofesophagus	disease	C06;C04	NeoplasticProcess	0.31	1	2005	2005	1	0	CTD_human
val	2597	GAPDH	0.447	0.808	C0700292	Hypoxemia	phenotype	C23	Finding	0.30	1	2009	2009	1	0	CTD_human
val	2597	GAPDH	0.447	0.808	C0751406	Post-TraumaticOsteoporosis	disease	C18;C05	DiseaseorSyndrome	0.30	1	2008	2008	1	0	CTD_human
val	2597	GAPDH	0.447	0.808	C0948089	AcuteCoronarySyndrome	disease	C14	DiseaseorSyndrome	0.30	1	2011	2011	1	0	CTD_human
val	2597	GAPDH	0.447	0.808	C2239176	Livercarcinoma	disease	C06;C04	NeoplasticProcess	0.40	1	1988	2019	2	0	CTD_human
val	2617	GARS1	0.623	0.5	C1832274	Charcot-Marie-Toothdisease,Type2D	disease	C16;C10	DiseaseorSyndrome	0.90	1	2003	2019	9	9	CTD_human;UNIPROT
val	2617	GARS1	0.623	0.5	C1833308	NEURONOPATHY,DISTALHEREDITARYMOTOR,TYPEV	disease	C10	DiseaseorSyndrome	0.80	1	2000	2018	5	8	CTD_human;ORPHANET;UNIPROT
val	2618	GART	0.631	0.615	C0003873	RheumatoidArthritis	disease	C17;C05;C20	DiseaseorSyndrome	0.30	1	2013	2013	1	0	CTD_human
val	2618	GART	0.631	0.615	C0152013	Adenocarcinomaoflung(disorder)	disease	C04	NeoplasticProcess	0.30	1	2016	2016	1	0	CTD_human
val	2619	GAS1	0.587	0.654	C0078982	Arhinencephaly	disease	C16;C05;C10	CongenitalAbnormality	0.30	1	2007	2007	1	0	CTD_human
val	2619	GAS1	0.587	0.654	C0079541	Holoprosencephaly	disease	C16;C05;C10	CongenitalAbnormality	0.43	1	2007	2012	1	0	CTD_human
val	2619	GAS1	0.587	0.654	C0431362	LobarHoloprosencephaly	disease	C16;C05;C10	CongenitalAbnormality	0.50	1	2007	2007	1	0	CTD_human;ORPHANET
val	2619	GAS1	0.587	0.654	C0431363	AlobarHoloprosencephaly	disease	C16;C05;C10	CongenitalAbnormality	0.50	1	2007	2007	1	0	CTD_human;ORPHANET
val	2619	GAS1	0.587	0.654	C0751617	SemilobarHoloprosencephaly	disease	C16;C05;C10	CongenitalAbnormality	0.50	1	2007	2007	1	0	CTD_human;ORPHANET
val	2620	GAS2	0.792	0.269	C0010606	AdenoidCysticCarcinoma	disease	C04	NeoplasticProcess	0.30	1	2006	2006	1	0	CTD_human
val	2620	GAS2	0.792	0.269	C0036095	SalivaryGlandNeoplasms	group	C04;C07	NeoplasticProcess	0.30	1	2006	2006	1	0	CTD_human
val	2620	GAS2	0.792	0.269	C0220636	Malignantneoplasmofsalivarygland	disease	C04;C07	NeoplasticProcess	0.30	1	2006	2006	1	0	CTD_human
val	2621	GAS6	0.5	0.769	C0010606	AdenoidCysticCarcinoma	disease	C04	NeoplasticProcess	0.30	1	2006	2006	1	0	CTD_human
val	2621	GAS6	0.5	0.769	C0011881	DiabeticNephropathy	disease	C13;C12;C19	DiseaseorSyndrome	0.34	1	2003	2018	1	0	CTD_human
val	2621	GAS6	0.5	0.769	C0017667	Nodularglomerulosclerosis	disease	C13;C12;C19	DiseaseorSyndrome	0.30	1	2003	2003	1	0	CTD_human
val	2621	GAS6	0.5	0.769	C0018800	Cardiomegaly	phenotype	C23;C14	Finding	0.30	1	2009	2009	1	0	CTD_human
val	2621	GAS6	0.5	0.769	C0022660	KidneyFailure,Acute	disease	C13;C12	DiseaseorSyndrome	0.31	1	2009	2019	1	0	CTD_human
val	2621	GAS6	0.5	0.769	C0036095	SalivaryGlandNeoplasms	group	C04;C07	NeoplasticProcess	0.30	1	2006	2006	1	0	CTD_human
val	2621	GAS6	0.5	0.769	C0040038	Thromboembolism	phenotype	C14	PathologicFunction	0.30	1	2006	2006	1	0	CTD_human
val	2621	GAS6	0.5	0.769	C0040053	Thrombosis	phenotype	C14	PathologicFunction	0.31	1	2001	2006	4	0	CTD_human
val	2621	GAS6	0.5	0.769	C0087086	Thrombus	phenotype	C14	PathologicFunction	0.30	1	2001	2006	4	0	CTD_human
val	2621	GAS6	0.5	0.769	C0220636	Malignantneoplasmofsalivarygland	disease	C04;C07	NeoplasticProcess	0.30	1	2006	2006	1	0	CTD_human
val	2621	GAS6	0.5	0.769	C1383860	CardiacHypertrophy	phenotype	C23;C14	PathologicFunction	0.30	1	2009	2009	1	0	CTD_human
val	2621	GAS6	0.5	0.769	C1565662	AcuteKidneyInsufficiency	disease	C13;C12	DiseaseorSyndrome	0.30	1	2009	2009	1	0	CTD_human
val	2621	GAS6	0.5	0.769	C2609414	Acutekidneyinjury	disease	C13;C12	InjuryorPoisoning	0.30	1	2009	2009	1	0	CTD_human
val	2622	GAS8	0.636	0.654	C0022521	KartagenerSyndrome	disease	C16;C08;C09;C14	DiseaseorSyndrome	0.31	1	2015	2015	1	0	ORPHANET
val	2622	GAS8	0.636	0.654	C4225230	CILIARYDYSKINESIA,PRIMARY,33	disease		DiseaseorSyndrome	0.90	1	2015	2016	3	2	CTD_human;GENOMICS_ENGLAND;UNIPROT
val	2622	GAS8	0.636	0.654	C4317124	PolynesianBronchiectasis	disease	C16;C08;C09;C14	DiseaseorSyndrome	0.30	1	2015	2015	1	0	ORPHANET
val	2622	GAS8	0.636	0.654	C4551720	PrimaryCiliaryDyskinesia	disease	C16;C08;C09	DiseaseorSyndrome	0.53	1	2015	2019	2	0	GENOMICS_ENGLAND;ORPHANET
val	2622	GAS8	0.636	0.654	C4551906	CiliaryDyskinesia,Primary,1,WithOrWithoutSitusInversus	disease	C16;C08;C09;C14	DiseaseorSyndrome	0.30	1	2015	2015	1	0	ORPHANET
val	2623	GATA1	0.483	0.808	C0002871	Anemia	disease	C15	DiseaseorSyndrome	0.50	1	2000	2019	1	0	GENOMICS_ENGLAND
val	2623	GATA1	0.483	0.808	C0013080	DownSyndrome	disease	C16;C10	DiseaseorSyndrome	0.40	0.981	2002	2020	0	0	CTD_human
val	2623	GATA1	0.483	0.808	C0023437	AcuteBasophilicLeukemia	disease	C04	NeoplasticProcess	0.32	1	2011	2019	1	0	ORPHANET
val	2623	GATA1	0.483	0.808	C0023462	AcuteMegakaryocyticLeukemias	disease	C04	NeoplasticProcess	0.50	0.955	2002	2018	0	1	CGI
val	2623	GATA1	0.483	0.808	C0027947	Neutropenia	disease	C15	DiseaseorSyndrome	0.40	1	2012	2012	1	0	GENOMICS_ENGLAND
val	2623	GATA1	0.483	0.808	C0040034	Thrombocytopenia	phenotype	C15	DiseaseorSyndrome	0.90	0.947	1995	2020	3	2	CTD_human;GENOMICS_ENGLAND
val	2623	GATA1	0.483	0.808	C0162530	Porphyria,Erythropoietic	disease	C16;C18;C17	DiseaseorSyndrome	0.55	1	2001	2019	1	0	GENOMICS_ENGLAND;ORPHANET
val	2623	GATA1	0.483	0.808	C0432416	DownSyndrome,PartialTrisomy21	disease	C16;C10	DiseaseorSyndrome	0.30				0	0	CTD_human
val	2623	GATA1	0.483	0.808	C0432417	Trisomy21,MeioticNondisjunction	disease	C16;C10	DiseaseorSyndrome	0.30				0	0	CTD_human
val	2623	GATA1	0.483	0.808	C0751081	Trisomy21,MitoticNondisjunction	disease	C16;C10	DiseaseorSyndrome	0.30				0	0	CTD_human
val	2623	GATA1	0.483	0.808	C1260899	Anemia,Diamond-Blackfan	disease	C16;C15	DiseaseorSyndrome	0.70	1	1996	2019	6	4	GENOMICS_ENGLAND;ORPHANET
val	2623	GATA1	0.483	0.808	C1834582	MYELOPROLIFERATIVESYNDROME,TRANSIENT	disease	C16;C10;C15	NeoplasticProcess	0.40	0.97	2003	2020	1	0	ORPHANET
val	2623	GATA1	0.483	0.808	C1839161	Thrombocytopenia,PlateletDysfunction,Hemolysis,andImbalancedGlobinSynthesis	disease	C23;C16;C15	DiseaseorSyndrome	0.70	1	1977	2014	2	12	CTD_human;GENOMICS_ENGLAND;UNIPROT
val	2623	GATA1	0.483	0.808	C1845837	DyserythropoieticAnemiawithThrombocytopenia	disease	C16;C15	DiseaseorSyndrome	0.43	1	1996	2014	0	2	ORPHANET
val	2623	GATA1	0.483	0.808	C1860788	TransientMyeloproliferativeDisorderofDownSyndrome	disease	C16;C10;C15	DiseaseorSyndrome	0.31	1	2003	2013	1	0	CTD_human
val	2623	GATA1	0.483	0.808	C2713368	HematopoeticMyelodysplasia	phenotype	C15	PathologicFunction	0.50	1	1998	2017	1	0	CTD_human
val	2623	GATA1	0.483	0.808	C2718078	DeficiencyofUroporphyrinogenIIISynthase	disease	C16;C18;C17	DiseaseorSyndrome	0.30	1	2007	2007	1	0	ORPHANET
val	2623	GATA1	0.483	0.808	C2931850	AaseSmithsyndrome2	disease	C16;C15	DiseaseorSyndrome	0.30	1	2012	2014	2	0	ORPHANET
val	2623	GATA1	0.483	0.808	C3463824	MYELODYSPLASTICSYNDROME	group	C15	NeoplasticProcess	0.40	1	1999	2020	1	0	CTD_human
val	2623	GATA1	0.483	0.808	C3550789	THROMBOCYTOPENIA,X-LINKED,WITHORWITHOUTDYSERYTHROPOIETICANEMIA	disease		DiseaseorSyndrome	0.70	1	2000	2018	8	5	CTD_human;GENOMICS_ENGLAND;UNIPROT
val	2623	GATA1	0.483	0.808	C3550856	ANEMIA,X-LINKED,WITHORWITHOUTNEUTROPENIAAND/ORPLATELETABNORMALITIES	disease		DiseaseorSyndrome	0.70	1	2000	2018	6	3	CTD_human;GENOMICS_ENGLAND;ORPHANET
val	2623	GATA1	0.483	0.808	C4228778	Abnormalityofradialray	phenotype		Finding	0.30				0	0	GENOMICS_ENGLAND
val	2624	GATA2	0.496	0.654	C0007302	CartilageDiseases	group	C17;C05	DiseaseorSyndrome	0.30	1	2010	2010	1	0	CTD_human
val	2624	GATA2	0.496	0.654	C0023467	Leukemia,Myelocytic,Acute	disease	C04	NeoplasticProcess	0.80	0.974	1994	2020	4	2	CGI;CTD_human;GENOMICS_ENGLAND
val	2624	GATA2	0.496	0.654	C0024236	Lymphedema	disease	C15	PathologicFunction	0.40	1	2011	2011	1	0	CTD_human
val	2624	GATA2	0.496	0.654	C0026985	Myelodysplasia	disease		CongenitalAbnormality	0.47	1	2011	2019	1	0	ORPHANET
val	2624	GATA2	0.496	0.654	C0026998	AcuteMyeloidLeukemia,M1	disease	C04	NeoplasticProcess	0.31	1	2011	2015	2	0	CTD_human
val	2624	GATA2	0.496	0.654	C0085700	Chondromalacia	disease	C17;C05	DiseaseorSyndrome	0.30	1	2010	2010	1	0	CTD_human
val	2624	GATA2	0.496	0.654	C0243050	CardiovascularAbnormalities	group	C16;C14	CongenitalAbnormality	0.30	1	2010	2010	1	0	CTD_human
val	2624	GATA2	0.496	0.654	C0340970	Congenitalneutropenia	disease	C16;C15	CongenitalAbnormality	0.33	1	2015	2018	1	0	GENOMICS_ENGLAND
val	2624	GATA2	0.496	0.654	C0349639	JuvenileMyelomonocyticLeukemia	disease	C04;C15	NeoplasticProcess	0.32	1	2015	2019	1	0	CTD_human
val	2624	GATA2	0.496	0.654	C0376634	CraniofacialAbnormalities	group	C16;C05	CongenitalAbnormality	0.30	1	2010	2010	1	0	CTD_human
val	2624	GATA2	0.496	0.654	C1704423	MilroyDisease	disease	C15	DiseaseorSyndrome	0.34	1	2011	2017	1	0	CTD_human
val	2624	GATA2	0.496	0.654	C1879321	AcuteMyeloidLeukemia(AML-M2)	disease	C04	NeoplasticProcess	0.30	1	2011	2011	2	0	CTD_human
val	2624	GATA2	0.496	0.654	C2713368	HematopoeticMyelodysplasia	phenotype	C15	PathologicFunction	0.30	1	2011	2017	3	0	CTD_human
val	2624	GATA2	0.496	0.654	C3279664	EmbergerSyndrome	disease	C16	DiseaseorSyndrome	0.77	1	2010	2018	4	15	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
val	2624	GATA2	0.496	0.654	C3280030	GATA2Deficiency	disease	C16	DiseaseorSyndrome	0.80	1	1994	2019	13	18	CLINGEN;CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
val	2624	GATA2	0.496	0.654	C3463824	MYELODYSPLASTICSYNDROME	group	C15	NeoplasticProcess	0.80	0.976	2002	2019	5	1	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
val	2624	GATA2	0.496	0.654	C4707228	Inheritedacutemyeloidleukemia	disease	C04	NeoplasticProcess	0.30	1	2011	2015	2	0	ORPHANET
val	2625	GATA3	0.415	0.846	C0003873	RheumatoidArthritis	disease	C17;C05;C20	DiseaseorSyndrome	0.43	1	2005	2019	1	2	CTD_human
val	2625	GATA3	0.415	0.846	C0006142	Malignantneoplasmofbreast	disease	C04;C17	NeoplasticProcess	0.60	0.95	1999	2020	0	0	CGI;UNIPROT
val	2625	GATA3	0.415	0.846	C0006413	BurkittLymphoma	disease	C04;C01;C20;C15	NeoplasticProcess	0.30	1	2013	2013	3	0	ORPHANET
val	2625	GATA3	0.415	0.846	C0007097	Carcinoma	group	C04	NeoplasticProcess	0.40	1	2005	2019	1	0	CTD_human
val	2625	GATA3	0.415	0.846	C0014457	Eosinophilia	disease	C15	DiseaseorSyndrome	0.33	0.75	2008	2018	1	0	CTD_human
val	2625	GATA3	0.415	0.846	C0014458	Eosinophilia,Tropical	disease	C15	DiseaseorSyndrome	0.30	1	2017	2017	1	0	CTD_human
val	2625	GATA3	0.415	0.846	C0019829	HodgkinDisease	disease	C04;C20;C15	NeoplasticProcess	0.46	1	2005	2019	1	1	CTD_human
val	2625	GATA3	0.415	0.846	C0021368	Inflammation	phenotype	C23	PathologicFunction	0.30	1	2012	2012	1	0	CTD_human
val	2625	GATA3	0.415	0.846	C0023485	PrecursorB-CellLymphoblasticLeukemia-Lymphoma	disease	C04;C20;C15	NeoplasticProcess	0.40	1	2013	2018	1	1	CTD_human
val	2625	GATA3	0.415	0.846	C0023493	AdultT-CellLymphoma/Leukemia	disease	C04;C20;C15	NeoplasticProcess	0.31	1	2000	2015	1	0	CTD_human
val	2625	GATA3	0.415	0.846	C0024667	AnimalMammaryNeoplasms	phenotype	C04;C22	NeoplasticProcess	0.30	1	2005	2005	1	0	CTD_human
val	2625	GATA3	0.415	0.846	C0024668	MammaryNeoplasms,Experimental	phenotype	C04	NeoplasticProcess;ExperimentalModelofDisease	0.30	1	2005	2005	1	0	CTD_human
val	2625	GATA3	0.415	0.846	C0025568	Metaplasia	phenotype	C23	CellorMolecularDysfunction	0.30	1	2017	2017	1	0	CTD_human
val	2625	GATA3	0.415	0.846	C0027819	Neuroblastoma	disease	C04	NeoplasticProcess	0.36	1	2010	2019	1	0	CTD_human
val	2625	GATA3	0.415	0.846	C0152266	MixedCellularityHodgkinLymphoma	disease	C04;C20;C15	NeoplasticProcess	0.30	1	2010	2010	1	0	CTD_human
val	2625	GATA3	0.415	0.846	C0152267	Hodgkinlymphoma,lymphocytedepletion	disease	C04;C20;C15	NeoplasticProcess	0.30	1	2010	2010	1	0	CTD_human
val	2625	GATA3	0.415	0.846	C0205696	Anaplasticcarcinoma	disease	C04	NeoplasticProcess	0.30	1	2005	2005	1	0	CTD_human
val	2625	GATA3	0.415	0.846	C0205697	Carcinoma,Spindle-Cell	disease	C04	NeoplasticProcess	0.30	1	2005	2005	1	0	CTD_human
val	2625	GATA3	0.415	0.846	C0205698	Undifferentiatedcarcinoma	disease	C04	NeoplasticProcess	0.30	1	2005	2005	1	0	CTD_human
val	2625	GATA3	0.415	0.846	C0205699	Carcinomatosis	phenotype	C04	NeoplasticProcess	0.30	1	2005	2005	1	0	CTD_human
val	2625	GATA3	0.415	0.846	C0220597	AdultHodgkinLymphoma	disease	C04;C20;C15	NeoplasticProcess	0.36	1	2005	2019	1	0	CTD_human
val	2625	GATA3	0.415	0.846	C0496956	Neoplasmofuncertainorunknownbehaviorofbreast	disease	C04;C17	NeoplasticProcess	0.30				0	0	CGI
val	2625	GATA3	0.415	0.846	C0678222	BreastCarcinoma	disease	C04;C17	NeoplasticProcess	0.40	0.94	1999	2020	0	0	CGI
val	2625	GATA3	0.415	0.846	C0858252	Breastadenocarcinoma	disease	C04;C17	NeoplasticProcess	0.31	1	2016	2016	0	0	CGI
val	2625	GATA3	0.415	0.846	C1257925	MammaryCarcinoma,Animal	disease	C04;C22	NeoplasticProcess	0.30	1	2005	2005	1	0	CTD_human
val	2625	GATA3	0.415	0.846	C1266194	LymphocyteRichClassicalHodgkinLymphoma	disease	C04;C20;C15	NeoplasticProcess	0.30	1	2010	2010	1	0	CTD_human
val	2625	GATA3	0.415	0.846	C1292769	PrecursorB-celllymphoblasticleukemia	disease	C04;C20;C15	NeoplasticProcess	0.30	1	2013	2013	3	0	ORPHANET
val	2625	GATA3	0.415	0.846	C1334968	NodularLymphocytePredominantHodgkinLymphoma	disease	C04;C20;C15	NeoplasticProcess	0.31	1	2010	2019	1	0	CTD_human
val	2625	GATA3	0.415	0.846	C1840333	Barakatsyndrome	disease	C23;C13;C12;C10;C19;C09	DiseaseorSyndrome	1.00	0.957	1995	2019	16	8	CLINGEN;CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
val	2625	GATA3	0.415	0.846	C2930967	Gastro-enteropancreaticneuroendocrinetumor	disease	C06;C04;C19	NeoplasticProcess	0.30	1	2018	2018	1	0	CTD_human
val	2626	GATA4	0.458	0.846	C0001956	AlcoholUseDisorder	disease	C25;F03	MentalorBehavioralDysfunction	0.31	1	2011	2018	1	0	CTD_human
val	2626	GATA4	0.458	0.846	C0001973	AlcoholicIntoxication,Chronic	disease	C25;F03	MentalorBehavioralDysfunction	0.35	0.8	2011	2016	1	0	CTD_human
val	2626	GATA4	0.458	0.846	C0004238	AtrialFibrillation	disease	C23;C14	DiseaseorSyndrome	0.34	1	2010	2018	1	0	CTD_human
val	2626	GATA4	0.458	0.846	C0009402	ColorectalCarcinoma	disease	C06;C04	NeoplasticProcess	0.32	1	2003	2009	1	0	CTD_human
val	2626	GATA4	0.458	0.846	C0009404	ColorectalNeoplasms	group	C06;C04	NeoplasticProcess	0.31	1	2003	2009	1	0	CTD_human
val	2626	GATA4	0.458	0.846	C0018800	Cardiomegaly	phenotype	C23;C14	Finding	0.30	1	2005	2008	2	0	CTD_human
val	2626	GATA4	0.458	0.846	C0018818	VentricularSeptalDefects	group	C16;C14	CongenitalAbnormality	0.50	0.95	2006	2018	0	0	CTD_human
val	2626	GATA4	0.458	0.846	C0019284	DiaphragmaticHernia	phenotype	C23	DiseaseorSyndrome	0.50	1	2007	2008	1	0	CTD_human
val	2626	GATA4	0.458	0.846	C0027051	MyocardialInfarction	disease	C23;C14	DiseaseorSyndrome	0.55	1	2010	2019	1	0	CTD_human
val	2626	GATA4	0.458	0.846	C0039685	TetralogyofFallot	disease	C16;C14	CongenitalAbnormality	0.80	0.952	2006	2018	3	4	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
val	2626	GATA4	0.458	0.846	C0085762	Alcoholabuse	disease	C25;F03	MentalorBehavioralDysfunction	0.30	1	2011	2011	1	0	CTD_human
val	2626	GATA4	0.458	0.846	C0158981	Neonataldiabetesmellitus	disease	C16;C18;C19	DiseaseorSyndrome	0.31	1	2010	2014	1	0	GENOMICS_ENGLAND
val	2626	GATA4	0.458	0.846	C0235480	Paroxysmalatrialfibrillation	disease	C23;C14	DiseaseorSyndrome	0.30	1	2018	2018	1	0	CTD_human
val	2626	GATA4	0.458	0.846	C0235833	Congenitaldiaphragmatichernia	disease	C23;C16	CongenitalAbnormality	0.46	1	2008	2013	1	0	CTD_human
val	2626	GATA4	0.458	0.846	C0265699	CongenitalherniaofforamenofMorgagni	disease	C23;C16	CongenitalAbnormality	0.30	1	2013	2013	1	0	CTD_human
val	2626	GATA4	0.458	0.846	C0265700	CongenitalherniaofforamenofBochdalek	disease	C23;C16	CongenitalAbnormality	0.30	1	2013	2013	1	0	CTD_human
val	2626	GATA4	0.458	0.846	C0344724	Ostiumsecundumatrialseptaldefect	disease	C16;C14	CongenitalAbnormality	0.41	1	2003	2011	3	1	ORPHANET
val	2626	GATA4	0.458	0.846	C0344735	Partialatrioventricularcanal	disease	C16;C14	CongenitalAbnormality	0.40	1	2003	2009	3	0	ORPHANET
val	2626	GATA4	0.458	0.846	C0600519	VentricularRemodeling	phenotype	C23	OrganorTissueFunction	0.30	1	2018	2018	1	0	CTD_human
val	2626	GATA4	0.458	0.846	C0600520	LeftVentricleRemodeling	phenotype	C23	OrganorTissueFunction	0.30	1	2018	2018	1	0	CTD_human
val	2626	GATA4	0.458	0.846	C1383860	CardiacHypertrophy	phenotype	C23;C14	PathologicFunction	0.30	1	2005	2008	2	0	CTD_human
val	2626	GATA4	0.458	0.846	C1389016	ATRIOVENTRICULARCANALDEFECT	disease	C16;C14	AnatomicalAbnormality	0.45	1	2007	2017	0	0	CTD_human
val	2626	GATA4	0.458	0.846	C1389018	AtrioventricularSeptalDefect	disease	C16;C14	CongenitalAbnormality	0.32	1	2016	2016	0	0	CTD_human
val	2626	GATA4	0.458	0.846	C1842778	Atrialseptaldefect2	disease	C16;C14	DiseaseorSyndrome;CongenitalAbnormality	0.90	1	2003	2016	7	9	CTD_human;GENOMICS_ENGLAND;UNIPROT
val	2626	GATA4	0.458	0.846	C1843687	ATRIALFIBRILLATION,FAMILIAL,1(disorder)	disease	C23;C14	DiseaseorSyndrome	0.30	1	2011	2012	3	0	ORPHANET
val	2626	GATA4	0.458	0.846	C2585653	Persistentatrialfibrillation	phenotype	C23;C14	PathologicFunction	0.30	1	2018	2018	1	0	CTD_human
val	2626	GATA4	0.458	0.846	C2931638	Chromosome8,monosomy8p231	disease	C23	DiseaseorSyndrome	0.30	1	1999	2009	2	0	ORPHANET
val	2626	GATA4	0.458	0.846	C3280777	VENTRICULARSEPTALDEFECT1	disease		DiseaseorSyndrome;CongenitalAbnormality	0.60	1	2009	2012	4	7	GENOMICS_ENGLAND;UNIPROT
val	2626	GATA4	0.458	0.846	C3280781	ATRIOVENTRICULARSEPTALDEFECT4	disease		DiseaseorSyndrome;CongenitalAbnormality	0.60	1	2003	2007	1	3	GENOMICS_ENGLAND;UNIPROT
val	2626	GATA4	0.458	0.846	C3468561	familialatrialfibrillation	phenotype	C23;C14	PathologicFunction	0.30	1	2018	2018	1	0	CTD_human
val	2626	GATA4	0.458	0.846	C3809858	TESTICULARANOMALIESWITHORWITHOUTCONGENITALHEARTDISEASE	disease		DiseaseorSyndrome	0.70	1	2011	2011	1	1	CTD_human;GENOMICS_ENGLAND;UNIPROT
val	2626	GATA4	0.458	0.846	C4510744	46,XYpartialgonadaldysgenesis	disease		DiseaseorSyndrome	0.30	1	2011	2011	1	0	ORPHANET
val	2627	GATA6	0.478	0.808	C0019284	DiaphragmaticHernia	phenotype	C23	DiseaseorSyndrome	0.51	1	2008	2019	1	0	CTD_human
val	2627	GATA6	0.478	0.808	C0024121	LungNeoplasms	group	C04;C08	NeoplasticProcess	0.30	1	2005	2005	1	0	CTD_human
val	2627	GATA6	0.478	0.808	C0039685	TetralogyofFallot	disease	C16;C14	CongenitalAbnormality	0.73	1	2010	2014	2	3	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
val	2627	GATA6	0.478	0.808	C0158981	Neonataldiabetesmellitus	disease	C16;C18;C19	DiseaseorSyndrome	0.36	1	2012	2019	1	0	GENOMICS_ENGLAND
val	2627	GATA6	0.478	0.808	C0235833	Congenitaldiaphragmatichernia	disease	C23;C16	CongenitalAbnormality	0.43	1	2014	2019	1	3	ORPHANET
val	2627	GATA6	0.478	0.808	C0242379	Malignantneoplasmoflung	disease	C04;C08	NeoplasticProcess	0.34	1	2004	2020	1	0	CTD_human
val	2627	GATA6	0.478	0.808	C0344724	Ostiumsecundumatrialseptaldefect	disease	C16;C14	CongenitalAbnormality	0.40	1	2010	2010	1	0	ORPHANET
val	2627	GATA6	0.478	0.808	C0344735	Partialatrioventricularcanal	disease	C16;C14	CongenitalAbnormality	0.30	1	2010	2010	1	0	ORPHANET
val	2627	GATA6	0.478	0.808	C1389016	ATRIOVENTRICULARCANALDEFECT	disease	C16;C14	AnatomicalAbnormality	0.41	1	2017	2017	0	0	CTD_human
val	2627	GATA6	0.478	0.808	C1389018	AtrioventricularSeptalDefect	disease	C16;C14	CongenitalAbnormality	0.40				0	0	CTD_human
val	2627	GATA6	0.478	0.808	C1843687	ATRIALFIBRILLATION,FAMILIAL,1(disorder)	disease	C23;C14	DiseaseorSyndrome	0.30	1	2012	2012	3	0	ORPHANET
val	2627	GATA6	0.478	0.808	C1857586	CONOTRUNCALHEARTMALFORMATIONS(disorder)	disease	C16;C14	DiseaseorSyndrome	0.60	1	2009	2016	2	1	CTD_human;GENOMICS_ENGLAND;UNIPROT
val	2627	GATA6	0.478	0.808	C2931296	YorifujiOkunosyndrome	disease	C23;C18;C13;C12;C10;C19;F03;F01;C14	DiseaseorSyndrome	0.30	1	2011	2012	2	0	ORPHANET
val	2627	GATA6	0.478	0.808	C3280939	ATRIOVENTRICULARSEPTALDEFECT5	disease		DiseaseorSyndrome;CongenitalAbnormality	0.50	1	2010	2010	2	1	GENOMICS_ENGLAND;UNIPROT
val	2627	GATA6	0.478	0.808	C3280943	ATRIALSEPTALDEFECT9	disease		DiseaseorSyndrome;CongenitalAbnormality	0.60	1	2010	2010	1	1	CTD_human;GENOMICS_ENGLAND;UNIPROT
val	2627	GATA6	0.478	0.808	C3888085	PANCREATICAGENESISANDCONGENITALHEARTDEFECTS	disease		DiseaseorSyndrome	0.31	1	2011	2017	3	0	GENOMICS_ENGLAND
val	2627	GATA6	0.478	0.808	C3888631	Monogenicdiabetes	disease	C18;C19	DiseaseorSyndrome	0.31	1	2013	2013	0	0	GENOMICS_ENGLAND
val	2627	GATA6	0.478	0.808	C4012454	HEARTDEFECTS,CONGENITAL,ANDOTHERCONGENITALANOMALIES	disease		DiseaseorSyndrome	0.70	1	2010	2017	3	10	CTD_human;GENOMICS_ENGLAND;UNIPROT
val	2628	GATM	0.666	0.615	C0007097	Carcinoma	group	C04	NeoplasticProcess	0.30	1	2005	2005	1	0	CTD_human
val	2628	GATM	0.666	0.615	C0018801	Heartfailure	disease	C14	DiseaseorSyndrome	0.31	1	2006	2006	1	0	CTD_human
val	2628	GATM	0.666	0.615	C0018802	Congestiveheartfailure	disease	C14	DiseaseorSyndrome	0.31	1	2006	2006	1	0	CTD_human
val	2628	GATM	0.666	0.615	C0022658	KidneyDiseases	group	C13;C12	DiseaseorSyndrome	0.30	1	2012	2012	1	0	CTD_human
val	2628	GATM	0.666	0.615	C0023212	Left-SidedHeartFailure	disease	C14	DiseaseorSyndrome	0.30	1	2006	2006	1	0	CTD_human
val	2628	GATM	0.666	0.615	C0024667	AnimalMammaryNeoplasms	phenotype	C04;C22	NeoplasticProcess	0.30	1	2005	2005	1	0	CTD_human
val	2628	GATM	0.666	0.615	C0024668	MammaryNeoplasms,Experimental	phenotype	C04	NeoplasticProcess;ExperimentalModelofDisease	0.30	1	2005	2005	1	0	CTD_human
val	2628	GATM	0.666	0.615	C0027540	Necrosis	phenotype	C23	OrganorTissueFunction	0.30	1	2012	2012	1	0	CTD_human
val	2628	GATM	0.666	0.615	C0151744	MyocardialIschemia	disease	C14	DiseaseorSyndrome	0.30	1	2005	2005	1	0	CTD_human
val	2628	GATM	0.666	0.615	C0205696	Anaplasticcarcinoma	disease	C04	NeoplasticProcess	0.30	1	2005	2005	1	0	CTD_human
val	2628	GATM	0.666	0.615	C0205697	Carcinoma,Spindle-Cell	disease	C04	NeoplasticProcess	0.30	1	2005	2005	1	0	CTD_human
val	2628	GATM	0.666	0.615	C0205698	Undifferentiatedcarcinoma	disease	C04	NeoplasticProcess	0.30	1	2005	2005	1	0	CTD_human
val	2628	GATM	0.666	0.615	C0205699	Carcinomatosis	phenotype	C04	NeoplasticProcess	0.30	1	2005	2005	1	0	CTD_human
val	2628	GATM	0.666	0.615	C0235527	HeartFailure,Right-Sided	disease	C14	DiseaseorSyndrome	0.30	1	2006	2006	1	0	CTD_human
val	2628	GATM	0.666	0.615	C1257925	MammaryCarcinoma,Animal	disease	C04;C22	NeoplasticProcess	0.30	1	2005	2005	1	0	CTD_human
val	2628	GATM	0.666	0.615	C1959583	MyocardialFailure	disease	C14	DiseaseorSyndrome	0.30	1	2006	2006	1	0	CTD_human
val	2628	GATM	0.666	0.615	C1961112	HeartDecompensation	phenotype	C14	PathologicFunction	0.30	1	2006	2006	1	0	CTD_human
val	2628	GATM	0.666	0.615	C2675179	Arginine:GlycineAmidinotransferaseDeficiency	disease	C23;C16;C18;C10;F03;F01	DiseaseorSyndrome	0.76	1	1940	2018	17	18	CLINGEN;CTD_human;GENOMICS_ENGLAND;UNIPROT
val	2629	GBA	0.5	0.808	C0017205	GaucherDisease	disease	C16;C18;C10	DiseaseorSyndrome	0.90	0.985	1973	2020	10	40	CTD_human;GENOMICS_ENGLAND
val	2629	GBA	0.5	0.808	C0020542	PulmonaryHypertension	phenotype	C08	PathologicFunction	0.30	1	2003	2003	1	0	CTD_human
val	2629	GBA	0.5	0.808	C0030567	ParkinsonDisease	disease	C10	DiseaseorSyndrome	0.50	0.989	2004	2020	2	1	CTD_human
val	2629	GBA	0.5	0.808	C0036572	Seizures	phenotype	C23;C10	SignorSymptom	0.40	1	1997	1997	1	0	GENOMICS_ENGLAND
val	2629	GBA	0.5	0.808	C0242422	ParkinsonianDisorders	group	C10	DiseaseorSyndrome	0.50	1	2004	2020	1	2	CTD_human
val	2629	GBA	0.5	0.808	C0242423	RamsayHuntParalysisSyndrome	disease	C10	DiseaseorSyndrome	0.30	1	2015	2015	1	0	CTD_human
val	2629	GBA	0.5	0.808	C0268250	GaucherDisease,Type2(disorder)	disease	C16;C18;C10	DiseaseorSyndrome	0.93	1	1984	2019	21	34	CTD_human;GENOMICS_ENGLAND;UNIPROT
val	2629	GBA	0.5	0.808	C0268251	GaucherDisease,Type3(disorder)	disease	C16;C18;C10	DiseaseorSyndrome	0.77	1	1984	2019	15	26	CTD_human;GENOMICS_ENGLAND;UNIPROT
val	2629	GBA	0.5	0.808	C0752097	AutosomalDominantJuvenileParkinsonDisease	disease	C10	DiseaseorSyndrome	0.30	1	2015	2015	1	0	CTD_human
val	2629	GBA	0.5	0.808	C0752098	AutosomalDominantParkinsonism	disease	C10	DiseaseorSyndrome	0.30	1	2015	2015	1	0	CTD_human
val	2629	GBA	0.5	0.808	C0752100	AutosomalRecessiveParkinsonism	disease	C10	DiseaseorSyndrome	0.30	1	2015	2015	1	0	CTD_human
val	2629	GBA	0.5	0.808	C0752101	Parkinsonism,Experimental	disease	C10	ExperimentalModelofDisease	0.30	1	2015	2015	1	0	CTD_human
val	2629	GBA	0.5	0.808	C0752104	FamilialJuvenileParkinsonism	disease	C10	DiseaseorSyndrome	0.30	1	2015	2015	1	0	CTD_human
val	2629	GBA	0.5	0.808	C0752105	Parkinsonism,Juvenile	disease	C10	DiseaseorSyndrome	0.30	1	2015	2015	1	0	CTD_human
val	2629	GBA	0.5	0.808	C0752347	LewyBodyDisease	disease	C10;F03	DiseaseorSyndrome	0.50	1	2008	2020	1	7	CTD_human
val	2629	GBA	0.5	0.808	C1842704	GAUCHERDISEASE,PERINATALLETHAL	disease	C16;C18;C10	DiseaseorSyndrome	0.70	1	1984	2016	8	16	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
val	2629	GBA	0.5	0.808	C1856476	GaucherDisease,TypeIiic	disease	C16;C18;C10	DiseaseorSyndrome	0.70	1	1984	2016	6	19	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
val	2629	GBA	0.5	0.808	C1868675	PARKINSONDISEASE2,AUTOSOMALRECESSIVEJUVENILE	disease	C10	DiseaseorSyndrome	0.30	1	2015	2015	1	0	CTD_human
val	2629	GBA	0.5	0.808	C1961835	GaucherDisease,Type1	disease	C16;C18;C10	DiseaseorSyndrome	1.00	0.984	1983	2020	62	113	CTD_human;GENOMICS_ENGLAND;UNIPROT
val	2629	GBA	0.5	0.808	C2931585	Gaucher-likedisease	disease	C16;C18;C10	DiseaseorSyndrome	0.30	1	2000	2000	1	0	ORPHANET
val	2629	GBA	0.5	0.808	C3160718	PARKINSONDISEASE,LATE-ONSET	disease		DiseaseorSyndrome	0.69	1	2012	2020	3	11	CTD_human;GENOMICS_ENGLAND
val	2632	GBE1	0.612	0.654	C0017919	GlycogenStorageDisease	group	C16;C18	DiseaseorSyndrome	0.36	1	1999	2016	1	0	GENOMICS_ENGLAND
val	2632	GBE1	0.612	0.654	C0017922	GlycogenStorageDiseaseTypeIII	disease	C16;C18	DiseaseorSyndrome	0.31	1	2000	2000	0	0	ORPHANET
val	2632	GBE1	0.612	0.654	C0017923	GlycogenStorageDiseaseTypeIV	disease	C16;C18	DiseaseorSyndrome	1.00	1	1996	2017	7	20	CTD_human;GENOMICS_ENGLAND;UNIPROT
val	2632	GBE1	0.612	0.654	C1276035	Pena-ShokeirsyndrometypeI	disease	C16;C05	DiseaseorSyndrome	0.31	1	2004	2011	1	0	GENOMICS_ENGLAND
val	2632	GBE1	0.612	0.654	C1449563	Cardiomyopathy,FamilialIdiopathic	disease	C14	DiseaseorSyndrome	0.30	1	2016	2016	1	0	GENOMICS_ENGLAND
val	2632	GBE1	0.612	0.654	C1849722	PolyglucosanBodyDisease,AdultForm	disease	C16;C18;C10	DiseaseorSyndrome	0.80	1	1998	2018	5	6	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
val	2632	GBE1	0.612	0.654	C1856303	GSDIV,NeuromuscularForm,FatalPerinatal	disease	C16;C18;C10	DiseaseorSyndrome	0.30				0	0	ORPHANET
val	2632	GBE1	0.612	0.654	C1856304	GSDIV,NeuromuscularForm,Congenital	disease	C16;C18;C10	DiseaseorSyndrome	0.40				0	6	ORPHANET
val	2632	GBE1	0.612	0.654	C1856305	GSDIV,NeuromuscularForm,Childhood	disease	C16;C18;C10	DiseaseorSyndrome	0.40				0	1	ORPHANET
val	2632	GBE1	0.612	0.654	C1856309	Fetalhydrops(inperinatalorcongenitalneuromuscularforms)	phenotype		Finding	0.30	1	2012	2012	1	0	GENOMICS_ENGLAND
val	2633	GBP1	0.626	0.731	C0021400	Influenza	disease	C01;C08	DiseaseorSyndrome	0.30	1	2013	2013	1	0	CTD_human
val	2634	GBP2	0.751	0.385	C0023893	LiverCirrhosis,Experimental	disease	C23;C06	ExperimentalModelofDisease	0.30	1	2014	2014	1	0	CTD_human
val	2634	GBP2	0.751	0.385	C0151744	MyocardialIschemia	disease	C14	DiseaseorSyndrome	0.30	1	2005	2005	1	0	CTD_human
val	2637	GBX2	0.751	0.385	C1862939	AMYOTROPHICLATERALSCLEROSIS1	disease	C18;C10	DiseaseorSyndrome	0.30	1	2002	2002	1	0	CTD_human
val	2637	GBX2	0.751	0.385	C1862941	AmyotrophicLateralSclerosis,Sporadic	disease	C18;C10	DiseaseorSyndrome	0.30	1	2002	2002	1	0	CTD_human
val	2637	GBX2	0.751	0.385	C4551993	AmyotrophicLateralSclerosis,Familial	disease	C18;C10	DiseaseorSyndrome	0.30	1	2002	2002	1	0	CTD_human
val	2638	GC	0.489	0.885	C0003873	RheumatoidArthritis	disease	C17;C05;C20	DiseaseorSyndrome	0.35	0.8	1985	2019	1	0	CTD_human
val	2638	GC	0.489	0.885	C0005944	MetabolicBoneDisorder	group	C18;C05	DiseaseorSyndrome	0.30	1	2014	2014	1	0	CTD_human
val	2638	GC	0.489	0.885	C0013221	Drugtoxicity	group	C25	InjuryorPoisoning	0.30	1	2017	2017	1	0	CTD_human
val	2638	GC	0.489	0.885	C0018213	GravesDisease	disease	C11;C20;C19	DiseaseorSyndrome	0.32	1	2002	2014	1	0	CTD_human
val	2638	GC	0.489	0.885	C0019147	HepaticComa	disease	C06;C18;C10	DiseaseorSyndrome	0.30	1	2001	2001	1	0	CTD_human
val	2638	GC	0.489	0.885	C0019151	HepaticEncephalopathy	disease	C06;C18;C10	DiseaseorSyndrome	0.30	1	2001	2001	1	0	CTD_human
val	2638	GC	0.489	0.885	C0019193	Hepatitis,Toxic	disease	C06;C25	InjuryorPoisoning	0.30	1	2005	2005	1	0	CTD_human
val	2638	GC	0.489	0.885	C0022660	KidneyFailure,Acute	disease	C13;C12	DiseaseorSyndrome	0.30	1	2017	2017	1	0	CTD_human
val	2638	GC	0.489	0.885	C0023890	LiverCirrhosis	disease	C23;C06	DiseaseorSyndrome	0.32	1	2014	2019	1	0	CTD_human
val	2638	GC	0.489	0.885	C0023893	LiverCirrhosis,Experimental	disease	C23;C06	ExperimentalModelofDisease	0.30	1	2014	2014	1	0	CTD_human
val	2638	GC	0.489	0.885	C0024121	LungNeoplasms	group	C04;C08	NeoplasticProcess	0.30	1	2007	2007	1	0	CTD_human
val	2638	GC	0.489	0.885	C0026769	MultipleSclerosis	disease	C20;C10	DiseaseorSyndrome	0.37	0.75	1988	2018	1	0	CTD_human
val	2638	GC	0.489	0.885	C0029453	Osteopenia	disease	C18;C05	DiseaseorSyndrome	0.30	1	2014	2014	1	0	CTD_human
val	2638	GC	0.489	0.885	C0036341	Schizophrenia	disease	F03	MentalorBehavioralDysfunction	0.32	1	1982	2015	1	0	CTD_human
val	2638	GC	0.489	0.885	C0036981	Endotoxicshock	phenotype	C23;C01	PathologicFunction	0.30	1	2007	2007	1	0	CTD_human
val	2638	GC	0.489	0.885	C0036983	SepticShock	phenotype	C23;C01	PathologicFunction	0.30	1	2007	2007	1	0	CTD_human
val	2638	GC	0.489	0.885	C0041755	Adversereactiontodrug	group	C25	PathologicFunction	0.30	1	2017	2017	1	0	CTD_human
val	2638	GC	0.489	0.885	C0162557	LiverFailure,Acute	disease	C06	DiseaseorSyndrome	0.33	1	1996	2019	2	0	CTD_human
val	2638	GC	0.489	0.885	C0239946	Fibrosis,Liver	disease	C23;C06	DiseaseorSyndrome	0.31	1	2014	2017	1	0	CTD_human
val	2638	GC	0.489	0.885	C0242379	Malignantneoplasmoflung	disease	C04;C08	NeoplasticProcess	0.31	1	2007	2018	1	0	CTD_human
val	2638	GC	0.489	0.885	C0600327	ToxicShockSyndrome	disease	C23;C01	DiseaseorSyndrome	0.30	1	2007	2007	1	0	CTD_human
val	2638	GC	0.489	0.885	C0751197	FulminantHepaticFailurewithCerebralEdema	disease	C06;C18;C10	DiseaseorSyndrome	0.30	1	2001	2001	1	0	CTD_human
val	2638	GC	0.489	0.885	C0751198	HepaticStupor	disease	C06;C18;C10	DiseaseorSyndrome	0.30	1	2001	2001	1	0	CTD_human
val	2638	GC	0.489	0.885	C0751324	MultipleSclerosis,AcuteFulminating	disease	C20;C10	DiseaseorSyndrome	0.30	1	2015	2015	1	0	CTD_human
val	2638	GC	0.489	0.885	C0860207	Drug-InducedLiverDisease	phenotype	C06;C25	DiseaseorSyndrome	0.30	1	2005	2005	1	0	CTD_human
val	2638	GC	0.489	0.885	C1262760	Hepatitis,Drug-Induced	disease	C06;C25	DiseaseorSyndrome	0.30	1	2005	2005	1	0	CTD_human
val	2638	GC	0.489	0.885	C1565662	AcuteKidneyInsufficiency	disease	C13;C12	DiseaseorSyndrome	0.30	1	2017	2017	1	0	CTD_human
val	2638	GC	0.489	0.885	C2609414	Acutekidneyinjury	disease	C13;C12	InjuryorPoisoning	0.30	1	2017	2017	1	0	CTD_human
val	2638	GC	0.489	0.885	C3658290	Drug-InducedAcuteLiverInjury	disease	C06;C25	DiseaseorSyndrome	0.30	1	2005	2005	1	0	CTD_human
val	2638	GC	0.489	0.885	C4277682	ChemicalandDrugInducedLiverInjury	disease	C06;C25	DiseaseorSyndrome	0.30	1	2005	2005	1	0	CTD_human
val	2638	GC	0.489	0.885	C4279912	Chemically-InducedLiverToxicity	disease	C06;C25	DiseaseorSyndrome	0.30	1	2005	2005	1	0	CTD_human
val	2639	GCDH	0.691	0.385	C0013421	Dystonia	phenotype	C23;C10	SignorSymptom	0.43	1	1995	2015	2	1	GENOMICS_ENGLAND
val	2639	GCDH	0.691	0.385	C0268595	Glutaricaciduria,type1	disease	C16;C18;C10	DiseaseorSyndrome	1.00	1	1988	2020	20	104	CLINGEN;CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
val	2641	GCG	0.431	0.885	C0003123	Anorexia	disease	C23	DiseaseorSyndrome	0.38	1	2017	2019	1	0	CTD_human
val	2641	GCG	0.431	0.885	C0007102	Malignanttumorofcolon	disease	C06;C04	NeoplasticProcess	0.32	0.667	2008	2017	1	0	CTD_human
val	2641	GCG	0.431	0.885	C0007370	Catalepsy	disease	C23;C10	MentalorBehavioralDysfunction	0.30	1	1999	1999	1	0	CTD_human
val	2641	GCG	0.431	0.885	C0009319	Colitis	disease	C06	DiseaseorSyndrome	0.36	1	2012	2019	1	0	CTD_human
val	2641	GCG	0.431	0.885	C0009375	ColonicNeoplasms	group	C06;C04	NeoplasticProcess	0.30	1	2012	2012	1	0	CTD_human
val	2641	GCG	0.431	0.885	C0009421	Comatose	phenotype	C23;C10	DiseaseorSyndrome	0.30	1	1999	1999	1	0	CTD_human
val	2641	GCG	0.431	0.885	C0009806	Constipation	phenotype	C23	SignorSymptom	0.31	1	2002	2020	1	0	CTD_human
val	2641	GCG	0.431	0.885	C0011860	DiabetesMellitus,Non-Insulin-Dependent	disease	C18;C19	DiseaseorSyndrome	0.40	0.99	1986	2020	1	0	CTD_human
val	2641	GCG	0.431	0.885	C0018799	HeartDiseases	group	C14	DiseaseorSyndrome	0.31	1	1988	2017	1	0	CTD_human
val	2641	GCG	0.431	0.885	C0018801	Heartfailure	disease	C14	DiseaseorSyndrome	0.40	0.919	1995	2020	1	0	CTD_human
val	2641	GCG	0.431	0.885	C0018802	Congestiveheartfailure	disease	C14	DiseaseorSyndrome	0.40	0.919	1995	2020	1	0	CTD_human
val	2641	GCG	0.431	0.885	C0020456	Hyperglycemia	disease	C18	DiseaseorSyndrome	0.40	0.966	1975	2020	2	0	CTD_human
val	2641	GCG	0.431	0.885	C0020459	Hyperinsulinism	disease	C18	DiseaseorSyndrome	0.40	0.878	1979	2019	1	0	CTD_human
val	2641	GCG	0.431	0.885	C0020473	Hyperlipidemia	disease	C18	DiseaseorSyndrome	0.34	1	1977	2019	1	0	CTD_human
val	2641	GCG	0.431	0.885	C0020538	Hypertensivedisease	group	C14	DiseaseorSyndrome	0.39	1	2001	2020	1	0	CTD_human
val	2641	GCG	0.431	0.885	C0020649	Hypotension	phenotype	C14	Finding	0.30	1	1988	1993	2	0	CTD_human
val	2641	GCG	0.431	0.885	C0020672	Hypothermia,natural	phenotype	C23	Finding	0.30	1	1999	1999	1	0	CTD_human
val	2641	GCG	0.431	0.885	C0023212	Left-SidedHeartFailure	disease	C14	DiseaseorSyndrome	0.30	1	1995	1995	1	0	CTD_human
val	2641	GCG	0.431	0.885	C0028754	Obesity	disease	C23;C18	DiseaseorSyndrome	0.40	0.992	1996	2020	1	0	CTD_human
val	2641	GCG	0.431	0.885	C0037763	Spasm	phenotype	C23;C10	SignorSymptom	0.30	1	1980	1980	1	0	CTD_human
val	2641	GCG	0.431	0.885	C0038354	StomachDiseases	group	C06	DiseaseorSyndrome	0.30	1	2007	2007	1	0	CTD_human
val	2641	GCG	0.431	0.885	C0039231	Tachycardia	phenotype	C23;C14	Finding	0.30	1	1995	1995	1	0	CTD_human
val	2641	GCG	0.431	0.885	C0039239	SinusTachycardia	disease	C23;C14	DiseaseorSyndrome	0.30	1	1980	1980	1	0	CTD_human
val	2641	GCG	0.431	0.885	C0042373	VascularDiseases	group	C14	DiseaseorSyndrome	0.31	1	1999	2020	1	0	CTD_human
val	2641	GCG	0.431	0.885	C0080203	Tachyarrhythmia	phenotype	C23;C14	Finding	0.30	1	1995	1995	1	0	CTD_human
val	2641	GCG	0.431	0.885	C0151911	GeneralizedSpasms	phenotype	C23;C10	Finding	0.30	1	1980	1980	1	0	CTD_human
val	2641	GCG	0.431	0.885	C0233612	Waxyflexibility	phenotype	C23;C10	SignorSymptom	0.30	1	1999	1999	1	0	CTD_human
val	2641	GCG	0.431	0.885	C0235229	CiliaryBodySpasm	phenotype	C23;C10	Finding	0.30	1	1980	1980	1	0	CTD_human
val	2641	GCG	0.431	0.885	C0235527	HeartFailure,Right-Sided	disease	C14	DiseaseorSyndrome	0.30	1	1995	1995	1	0	CTD_human
val	2641	GCG	0.431	0.885	C0237326	Dyschezia	phenotype	C23	SignorSymptom	0.30	1	2002	2002	1	0	CTD_human
val	2641	GCG	0.431	0.885	C0428977	Bradycardia	phenotype	C23;C14	Finding	0.30	1	1984	1998	5	0	CTD_human
val	2641	GCG	0.431	0.885	C0751217	Hyperkinesia,Generalized	phenotype	C23;C10	SignorSymptom	0.30	1	1999	1999	1	0	CTD_human
val	2641	GCG	0.431	0.885	C0860634	Psychogeniccoma	phenotype	C23;C10	MentalorBehavioralDysfunction	0.30	1	1999	1999	1	0	CTD_human
val	2641	GCG	0.431	0.885	C1257861	ColonicInertia	phenotype	C23	SignorSymptom	0.30	1	2002	2002	1	0	CTD_human
val	2641	GCG	0.431	0.885	C1257963	EndogenousHyperinsulinism	disease	C18	DiseaseorSyndrome	0.30	1	1986	1986	1	0	CTD_human
val	2641	GCG	0.431	0.885	C1257964	ExogenousHyperinsulinism	disease	C18	DiseaseorSyndrome	0.30	1	1986	1986	1	0	CTD_human
val	2641	GCG	0.431	0.885	C1257965	CompensatoryHyperinsulinemia	disease	C18	DiseaseorSyndrome	0.30	1	1986	1986	1	0	CTD_human
val	2641	GCG	0.431	0.885	C1706412	Lipidemias	phenotype	C18	Finding	0.30	1	1977	1977	1	0	CTD_human
val	2641	GCG	0.431	0.885	C1855520	Hyperglycemia,Postprandial	phenotype	C18	Finding	0.30	1	1986	2008	2	0	CTD_human
val	2641	GCG	0.431	0.885	C1879526	AberrantCryptFoci	phenotype	C04	Finding	0.30	1	2012	2012	1	0	CTD_human
val	2641	GCG	0.431	0.885	C1959583	MyocardialFailure	disease	C14	DiseaseorSyndrome	0.30	1	1995	1995	1	0	CTD_human
val	2641	GCG	0.431	0.885	C1961112	HeartDecompensation	phenotype	C14	PathologicFunction	0.30	1	1995	1995	1	0	CTD_human
val	2641	GCG	0.431	0.885	C3887506	Hyperkinesia	phenotype	C23;C10	DiseaseorSyndrome	0.30	1	1999	1999	1	0	CTD_human
val	2642	GCGR	0.656	0.308	C0011860	DiabetesMellitus,Non-Insulin-Dependent	disease	C18;C19	DiseaseorSyndrome	0.50	0.891	1995	2020	0	0	CTD_human
val	2642	GCGR	0.656	0.308	C1857451	Acth-IndependentMacronodularAdrenalHyperplasia	disease	C19	DiseaseorSyndrome	0.30	1	2010	2010	1	0	CTD_human
val	2643	GCH1	0.511	0.846	C0013386	Dyskinesia,Drug-Induced	disease	C23;C10;C25	DiseaseorSyndrome	0.30	1	2005	2005	1	0	CTD_human
val	2643	GCH1	0.511	0.846	C0013421	Dystonia	phenotype	C23;C10	SignorSymptom	0.70	0.982	1991	2019	2	2	CTD_human;GENOMICS_ENGLAND
val	2643	GCH1	0.511	0.846	C0020538	Hypertensivedisease	group	C14	DiseaseorSyndrome	0.42	1	2003	2018	1	0	CTD_human
val	2643	GCH1	0.511	0.846	C0026837	MuscleRigidity	phenotype	C23;C05;C10	SignorSymptom	0.40	1	2007	2007	1	1	CTD_human
val	2643	GCH1	0.511	0.846	C0026858	MusculoskeletalPain	phenotype	C23;C05	Finding	0.30	1	2014	2014	1	0	CTD_human
val	2643	GCH1	0.511	0.846	C0030193	Pain	phenotype	C23	SignorSymptom	0.40	0.885	2007	2019	1	0	CTD_human
val	2643	GCH1	0.511	0.846	C0033975	PsychoticDisorders	group	F03	MentalorBehavioralDysfunction	0.33	1	2014	2019	1	0	PSYGENET
val	2643	GCH1	0.511	0.846	C0036341	Schizophrenia	disease	F03	MentalorBehavioralDysfunction	0.32	1	2014	2018	1	0	PSYGENET
val	2643	GCH1	0.511	0.846	C0036572	Seizures	phenotype	C23;C10	SignorSymptom	0.40	1	2008	2008	1	0	GENOMICS_ENGLAND
val	2643	GCH1	0.511	0.846	C0037772	SpasticParaplegia	disease	C23;C10	DiseaseorSyndrome	0.31	1	2001	2011	1	0	GENOMICS_ENGLAND
val	2643	GCH1	0.511	0.846	C0086439	Hypokinesia	phenotype	C23;C10	Finding	0.30	1	2007	2007	1	0	CTD_human
val	2643	GCH1	0.511	0.846	C0151564	CogwheelRigidity	phenotype	C23;C05;C10	SignorSymptom	0.30	1	2007	2007	1	0	CTD_human
val	2643	GCH1	0.511	0.846	C0151744	MyocardialIschemia	disease	C14	DiseaseorSyndrome	0.30	1	2005	2005	1	0	CTD_human
val	2643	GCH1	0.511	0.846	C0231519	Gegenhalten	phenotype	C23;C05;C10	Finding	0.30	1	2007	2007	1	0	CTD_human
val	2643	GCH1	0.511	0.846	C0233565	Bradykinesia	phenotype	C23;C10	SignorSymptom	0.40	1	2007	2007	1	0	CTD_human
val	2643	GCH1	0.511	0.846	C0233608	CatatonicRigidity	phenotype	C23;C05;C10	SignorSymptom	0.30	1	2007	2007	1	0	CTD_human
val	2643	GCH1	0.511	0.846	C0234230	Pain,Burning	phenotype	C23	SignorSymptom	0.30	1	2009	2009	1	0	CTD_human
val	2643	GCH1	0.511	0.846	C0234238	Ache	phenotype	C23	SignorSymptom	0.30	1	2009	2009	1	0	CTD_human
val	2643	GCH1	0.511	0.846	C0234254	Radiatingpain	phenotype	C23	SignorSymptom	0.30	1	2009	2009	1	0	CTD_human
val	2643	GCH1	0.511	0.846	C0239325	ExtensorRigidity	phenotype	C23;C05;C10	SignorSymptom	0.30	1	2007	2007	1	0	CTD_human
val	2643	GCH1	0.511	0.846	C0242684	Hypodynamia	phenotype	C23;C10	OrganismFunction	0.30	1	2007	2007	1	0	CTD_human
val	2643	GCH1	0.511	0.846	C0268467	Hyperphenylalaninemia,BH4-Deficient,B	disease	C16;C18;C10	DiseaseorSyndrome	0.75	1	1994	2019	8	13	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
val	2643	GCH1	0.511	0.846	C0277821	ExtrapyramidalRigidity	phenotype	C23;C05;C10	SignorSymptom	0.30	1	2007	2007	1	0	CTD_human
val	2643	GCH1	0.511	0.846	C0349204	Nonorganicpsychosis	disease	F03	MentalorBehavioralDysfunction	0.33	1	2014	2019	1	0	PSYGENET
val	2643	GCH1	0.511	0.846	C0393588	Dystonia,Paroxysmal	phenotype	C23;C10	SignorSymptom	0.30	1	2004	2004	1	0	CTD_human
val	2643	GCH1	0.511	0.846	C0393610	Dystonia,Diurnal	phenotype	C23;C10	SignorSymptom	0.32	1	2000	2004	1	0	CTD_human
val	2643	GCH1	0.511	0.846	C0458257	Pain,Splitting	phenotype	C23	SignorSymptom	0.30	1	2009	2009	1	0	CTD_human
val	2643	GCH1	0.511	0.846	C0458259	Pain,Crushing	phenotype	C23	SignorSymptom	0.30	1	2009	2009	1	0	CTD_human
val	2643	GCH1	0.511	0.846	C0751088	Dyskinesia,Medication-Induced	phenotype	C23;C10;C25	DiseaseorSyndrome	0.30	1	2005	2005	1	0	CTD_human
val	2643	GCH1	0.511	0.846	C0751093	Dystonia,Limb	phenotype	C23;C10	SignorSymptom	0.43	1	2004	2017	1	0	CTD_human
val	2643	GCH1	0.511	0.846	C0751407	Pain,Migratory	phenotype	C23	SignorSymptom	0.30	1	2009	2009	1	0	CTD_human
val	2643	GCH1	0.511	0.846	C0751408	Suffering,Physical	phenotype	C23	SignorSymptom	0.30	1	2009	2009	1	0	CTD_human
val	2643	GCH1	0.511	0.846	C0751701	Hypokinesia,Antiorthostatic	phenotype	C23;C10	SignorSymptom	0.30	1	2007	2007	1	0	CTD_human
val	2643	GCH1	0.511	0.846	C1320474	NuchalRigidity	phenotype	C23;C05;C10	Finding	0.30	1	2007	2007	1	0	CTD_human
val	2643	GCH1	0.511	0.846	C1851920	Dopa-ResponsiveDystonia	disease	C10	DiseaseorSyndrome	0.80	0.939	1989	2019	19	26	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
val	2643	GCH1	0.511	0.846	C1855483	Progressivespasticparaplegia	phenotype	C23;C10	Finding	0.30	1	2011	2011	1	0	GENOMICS_ENGLAND
val	2644	GCHFR	0.579	0.808	C0023893	LiverCirrhosis,Experimental	disease	C23;C06	ExperimentalModelofDisease	0.30	1	2014	2014	1	0	CTD_human
val	2645	GCK	0.523	0.808	C0002152	AlloxanDiabetes	disease	C18;C19	ExperimentalModelofDisease	0.30	1	2005	2005	1	0	CTD_human
val	2645	GCK	0.523	0.808	C0011853	DiabetesMellitus,Experimental	disease	C18;C19	ExperimentalModelofDisease	0.50	1	1990	2005	1	0	CTD_human
val	2645	GCK	0.523	0.808	C0011860	DiabetesMellitus,Non-Insulin-Dependent	disease	C18;C19	DiseaseorSyndrome	0.90	0.953	1992	2020	4	7	CTD_human;GENOMICS_ENGLAND
val	2645	GCK	0.523	0.808	C0020456	Hyperglycemia	disease	C18	DiseaseorSyndrome	0.50	1	1992	2020	1	14	CTD_human
val	2645	GCK	0.523	0.808	C0023893	LiverCirrhosis,Experimental	disease	C23;C06	ExperimentalModelofDisease	0.30	1	2006	2006	1	0	CTD_human
val	2645	GCK	0.523	0.808	C0038433	StreptozotocinDiabetes	disease	C18;C19	ExperimentalModelofDisease	0.30	1	2005	2005	1	0	CTD_human
val	2645	GCK	0.523	0.808	C0158981	Neonataldiabetesmellitus	disease	C16;C18;C19	DiseaseorSyndrome	0.40	1	2003	2018	0	0	GENOMICS_ENGLAND
val	2645	GCK	0.523	0.808	C0342276	Maturityonsetdiabetesmellitusinyoung	disease	C18;C19	DiseaseorSyndrome	0.70	0.978	1992	2020	2	6	GENOMICS_ENGLAND;ORPHANET
val	2645	GCK	0.523	0.808	C0342277	DiabetesmellitusautosomaldominanttypeII(disorder)	disease	C18;C19	DiseaseorSyndrome	1.00	1	1992	2019	21	137	CTD_human;GENOMICS_ENGLAND;UNIPROT
val	2645	GCK	0.523	0.808	C1833104	DIABETESMELLITUS,PERMANENTNEONATAL	disease	C18;C19	DiseaseorSyndrome	0.80	1	2001	2019	4	17	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
val	2645	GCK	0.523	0.808	C1855520	Hyperglycemia,Postprandial	phenotype	C18	Finding	0.30	1	2008	2008	1	0	CTD_human
val	2645	GCK	0.523	0.808	C1865290	Hyperinsulinemichypoglycemia,familial,3	disease	C18	DiseaseorSyndrome	0.70	1	1998	2017	9	11	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
val	2645	GCK	0.523	0.808	C2609269	Fastinghyperglycaemia	phenotype		Finding	0.30				0	0	GENOMICS_ENGLAND
val	2645	GCK	0.523	0.808	C2931832	Hyperinsulinemichypoglycemia,familial,1	disease	C16;C06;C18	DiseaseorSyndrome	0.30	1	2004	2004	1	0	CTD_human
val	2645	GCK	0.523	0.808	C2931833	Hyperinsulinemichypoglycemia,familial,2	disease	C16;C06;C18	DiseaseorSyndrome	0.30	1	2004	2004	1	0	CTD_human
val	2645	GCK	0.523	0.808	C3888018	CongenitalHyperinsulinism	disease	C16;C06;C18	DiseaseorSyndrome	0.50	0.958	1997	2019	1	0	CTD_human
val	2645	GCK	0.523	0.808	C3888631	Monogenicdiabetes	disease	C18;C19	DiseaseorSyndrome	0.50	0.977	2002	2019	0	8	GENOMICS_ENGLAND
val	2646	GCKR	0.604	0.615	C0011860	DiabetesMellitus,Non-Insulin-Dependent	disease	C18;C19	DiseaseorSyndrome	0.50	0.957	2005	2020	1	3	CTD_human
val	2646	GCKR	0.604	0.615	C0020557	Hypertriglyceridemia	phenotype	C18	DiseaseorSyndrome	0.49	0.909	2010	2019	1	3	CTD_human
val	2647	BLOC1S1	1	0.038	C0036341	Schizophrenia	disease	F03	MentalorBehavioralDysfunction	0.30	1	2015	2015	1	0	PSYGENET
val	2650	GCNT1	0.716	0.346	C0023893	LiverCirrhosis,Experimental	disease	C23;C06	ExperimentalModelofDisease	0.30	1	2014	2014	1	0	CTD_human
val	2650	GCNT1	0.716	0.346	C0033578	ProstaticNeoplasms	group	C04;C12	NeoplasticProcess	0.32	1	2005	2005	1	0	CTD_human
val	2650	GCNT1	0.716	0.346	C0376358	Malignantneoplasmofprostate	disease	C04;C12	NeoplasticProcess	0.32	1	2005	2014	1	0	CTD_human
val	2651	GCNT2	0.65	0.538	C0266539	Congenitaltotalcataract	disease	C16;C11	CongenitalAbnormality	0.30	1	2012	2015	2	0	ORPHANET
val	2651	GCNT2	0.65	0.538	C3805373	CATARACT13WITHADULTiPHENOTYPE	disease		DiseaseorSyndrome	0.70	1	2001	2001	1	4	CTD_human;GENOMICS_ENGLAND;UNIPROT
val	2652	OPN1MW	0.572	0.769	C0339537	Conemonochromatism	disease	C23;C11;C10	DiseaseorSyndrome	0.77	1	1995	2019	3	2	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
val	2652	OPN1MW	0.572	0.769	C2931753	Achromatopsiaincomplete,X-linked	disease	C23;C16;C11;C10	DiseaseorSyndrome	0.30	1	2004	2004	1	0	ORPHANET
val	2652	OPN1MW	0.572	0.769	C3159311	BORNHOLMEYEDISEASE	disease	C16;C11	DiseaseorSyndrome	0.30	1	2013	2013	1	0	ORPHANET
val	2652	OPN1MW	0.572	0.769	C3489532	Cone-RodDystrophy2	disease	C16;C11	DiseaseorSyndrome	0.30	1	2010	2010	1	0	ORPHANET
val	2652	OPN1MW	0.572	0.769	C3887938	Deuteranomaly	disease	C23;C11;C10	DiseaseorSyndrome	0.62	1	1992	2016	2	3	CTD_human;UNIPROT
val	2653	GCSH	0.76	0.385	C0268560	Hyperglycinemia,TransientNeonatal	disease	C16;C18;C10	DiseaseorSyndrome	0.31	1	2002	2006	1	0	GENOMICS_ENGLAND
val	2653	GCSH	0.76	0.385	C0268561	Hyperglycinemia,Nonketotic,TypeI	disease	C16;C18;C10	DiseaseorSyndrome	0.30				0	0	CTD_human
val	2653	GCSH	0.76	0.385	C0268562	Hyperglycinemia,Nonketotic,TypeII	disease	C16;C18;C10	DiseaseorSyndrome	0.30				0	0	CTD_human
val	2653	GCSH	0.76	0.385	C0751747	Hyperglycinemia,Nonketotic,TypeIII	disease	C16;C18;C10	DiseaseorSyndrome	0.30				0	0	CTD_human
val	2653	GCSH	0.76	0.385	C0751748	NonketoticHyperglycinemia	disease	C16;C18;C10	DiseaseorSyndrome	0.69	1	1990	2016	1	1	CTD_human;GENOMICS_ENGLAND
val	2657	GDF1	0.529	0.692	C0013069	DoubleOutletRightVentricle	disease	C16;C14	CongenitalAbnormality	0.40	1	2007	2007	1	0	CTD_human
val	2657	GDF1	0.529	0.692	C0018798	CongenitalHeartDefects	group	C16;C14	CongenitalAbnormality	0.43	1	1997	2017	1	0	CTD_human
val	2657	GDF1	0.529	0.692	C0039685	TetralogyofFallot	disease	C16;C14	CongenitalAbnormality	0.71	1	2007	2017	2	0	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
val	2657	GDF1	0.529	0.692	C0040761	TranspositionofGreatVessels	disease	C16;C14	CongenitalAbnormality	0.41	1	2007	2007	1	0	CTD_human
val	2657	GDF1	0.529	0.692	C0175707	AspleniaSyndrome	disease	C16;C15;C14	DiseaseorSyndrome	0.60	1	2010	2010	1	0	CTD_human;ORPHANET
val	2657	GDF1	0.529	0.692	C0265357	PolyspleniaSyndrome	disease	C16;C15;C14	CongenitalAbnormality	0.30				0	0	CTD_human
val	2657	GDF1	0.529	0.692	C0266642	Situsambiguus	disease	C16;C15;C14	CongenitalAbnormality	0.30				0	0	CTD_human
val	2657	GDF1	0.529	0.692	C1857586	CONOTRUNCALHEARTMALFORMATIONS(disorder)	disease	C16;C14	DiseaseorSyndrome	0.50	1	2006	2017	3	0	GENOMICS_ENGLAND;UNIPROT
val	2657	GDF1	0.529	0.692	C1956410	DoubleOutletRightVentricle,NoncommittedVSD	disease	C16;C14	CongenitalAbnormality	0.30	1	2007	2007	1	0	CTD_human
val	2657	GDF1	0.529	0.692	C1956411	DoubleOutletRightVentricle,SubaorticVSD	disease	C16;C14	DiseaseorSyndrome;CongenitalAbnormality	0.30	1	2007	2007	1	0	CTD_human
val	2657	GDF1	0.529	0.692	C1956412	DoubleOutletRightVentricle,SubpulmonaryVSD	disease	C16;C14	CongenitalAbnormality	0.30	1	2007	2007	1	0	CTD_human
val	2657	GDF1	0.529	0.692	C1956413	Taussig-BingAnomaly	disease	C16;C14	CongenitalAbnormality	0.30	1	2007	2007	1	0	CTD_human
val	2657	GDF1	0.529	0.692	C3151221	CONGENITALHEARTDEFECTS,MULTIPLETYPES,6	disease	C16;C14	CongenitalAbnormality	0.70	1	2007	2017	2	0	CTD_human;GENOMICS_ENGLAND;UNIPROT
val	2657	GDF1	0.529	0.692	C3178805	HeterotaxySyndrome	disease	C16;C15;C14	DiseaseorSyndrome	0.40	1	2010	2017	0	0	CTD_human
val	2657	GDF1	0.529	0.692	C3178806	RightAtrialIsomerism	disease	C16;C15;C14	CongenitalAbnormality	0.62	1	2010	2018	1	0	CTD_human;GENOMICS_ENGLAND
val	2657	GDF1	0.529	0.692	C3178807	LeftAtrialIsomerism	disease	C16;C15;C14	CongenitalAbnormality	0.30				0	0	CTD_human
val	2657	GDF1	0.529	0.692	C4277690	Ciliopathies	disease	C16	CongenitalAbnormality	0.30				0	0	GENOMICS_ENGLAND
val	2658	GDF2	0.529	0.731	C0020542	PulmonaryHypertension	phenotype	C08	PathologicFunction	0.30	1	2016	2016	1	0	CTD_human
val	2658	GDF2	0.529	0.731	C0039445	Hereditaryhemorrhagictelangiectasia	disease	C16;C15;C14	DiseaseorSyndrome	0.54	1	2012	2018	2	0	CTD_human;ORPHANET
val	2658	GDF2	0.529	0.731	C0340543	Familialprimarypulmonaryhypertension	disease	C08	DiseaseorSyndrome	0.30	1	2016	2016	1	0	GENOMICS_ENGLAND
val	2658	GDF2	0.529	0.731	C1150929	2-oxo-hept-3-ene-1,7-dioatehydrataseactivity	phenotype		MolecularFunction	0.30	1	2016	2016	1	0	GENOMICS_ENGLAND
val	2658	GDF2	0.529	0.731	C2239176	Livercarcinoma	disease	C06;C04	NeoplasticProcess	0.32	0.75	2013	2017	2	0	CTD_human
val	2658	GDF2	0.529	0.731	C3809710	TELANGIECTASIA,HEREDITARYHEMORRHAGIC,TYPE5	disease		DiseaseorSyndrome	0.70	1	2013	2015	2	3	CTD_human;GENOMICS_ENGLAND;UNIPROT
val	2658	GDF2	0.529	0.731	C4551861	Telangiectasia,HereditaryHemorrhagic,Type1	disease	C16;C15;C14	DiseaseorSyndrome	0.30	1	2016	2016	1	0	CTD_human
val	2660	MSTN	0.528	0.731	C0018801	Heartfailure	disease	C14	DiseaseorSyndrome	0.54	1	2006	2019	1	0	CTD_human
val	2660	MSTN	0.528	0.731	C0018802	Congestiveheartfailure	disease	C14	DiseaseorSyndrome	0.57	1	2006	2019	1	0	CTD_human
val	2660	MSTN	0.528	0.731	C0023212	Left-SidedHeartFailure	disease	C14	DiseaseorSyndrome	0.30	1	2006	2006	1	0	CTD_human
val	2660	MSTN	0.528	0.731	C0235527	HeartFailure,Right-Sided	disease	C14	DiseaseorSyndrome	0.30	1	2006	2006	1	0	CTD_human
val	2660	MSTN	0.528	0.731	C0236033	Musclehypertrophy	phenotype	C23;C05;C10	OrganorTissueFunction	0.40				0	0	CTD_human
val	2660	MSTN	0.528	0.731	C1959583	MyocardialFailure	disease	C14	DiseaseorSyndrome	0.30	1	2006	2006	1	0	CTD_human
val	2660	MSTN	0.528	0.731	C1961112	HeartDecompensation	phenotype	C14	PathologicFunction	0.30	1	2006	2006	1	0	CTD_human
val	2660	MSTN	0.528	0.731	C2931112	Myostatin-relatedmusclehypertrophy	disease	C23;C05;C10	CongenitalAbnormality	0.60	1	1997	2009	2	0	CTD_human
val	2661	GDF9	0.644	0.385	C0032460	PolycysticOvarySyndrome	disease	C04;C13;C19	DiseaseorSyndrome	0.40	1	2000	2019	1	0	CTD_human
val	2661	GDF9	0.644	0.385	C0085215	OvarianFailure,Premature	disease	C13;C19	DiseaseorSyndrome	0.40	0.938	2000	2019	1	0	GENOMICS_ENGLAND
val	2661	GDF9	0.644	0.385	C1136382	SclerocysticOvaries	disease	C04;C13;C19	DiseaseorSyndrome	0.30	1	2012	2012	1	0	CTD_human
val	2661	GDF9	0.644	0.385	C4693941	PREMATUREOVARIANFAILURE14	disease		DiseaseorSyndrome	0.30	1	2006	2018	7	5	UNIPROT
val	2662	GDF10	0.628	0.654	C0006142	Malignantneoplasmofbreast	disease	C04;C17	NeoplasticProcess	0.30	1	2013	2013	1	0	CTD_human
val	2662	GDF10	0.628	0.654	C0025500	Mesothelioma	disease	C04	NeoplasticProcess	0.31	1	2008	2008	1	0	CTD_human
val	2662	GDF10	0.628	0.654	C0678222	BreastCarcinoma	disease	C04;C17	NeoplasticProcess	0.30	1	2013	2013	1	0	CTD_human
val	2662	GDF10	0.628	0.654	C1257931	MammaryNeoplasms,Human	disease	C04;C17	NeoplasticProcess	0.30	1	2013	2013	1	0	CTD_human
val	2662	GDF10	0.628	0.654	C1458155	MammaryNeoplasms	group	C04;C17	NeoplasticProcess	0.30	1	2013	2013	1	0	CTD_human
val	2662	GDF10	0.628	0.654	C4704874	MammaryCarcinoma,Human	disease	C04;C17	NeoplasticProcess	0.30	1	2013	2013	1	0	CTD_human
val	2664	GDI1	0.572	0.654	C0019193	Hepatitis,Toxic	disease	C06;C25	InjuryorPoisoning	0.30	1	2015	2015	1	0	CTD_human
val	2664	GDI1	0.572	0.654	C0860207	Drug-InducedLiverDisease	phenotype	C06;C25	DiseaseorSyndrome	0.30	1	2015	2015	1	0	CTD_human
val	2664	GDI1	0.572	0.654	C1136249	MentalRetardation,X-Linked	disease	C16;C10	DiseaseorSyndrome	0.32	1	1996	2002	2	0	CTD_human
val	2664	GDI1	0.572	0.654	C1262760	Hepatitis,Drug-Induced	disease	C06;C25	DiseaseorSyndrome	0.30	1	2015	2015	1	0	CTD_human
val	2664	GDI1	0.572	0.654	C1862939	AMYOTROPHICLATERALSCLEROSIS1	disease	C18;C10	DiseaseorSyndrome	0.30	1	2002	2002	1	0	CTD_human
val	2664	GDI1	0.572	0.654	C1862941	AmyotrophicLateralSclerosis,Sporadic	disease	C18;C10	DiseaseorSyndrome	0.30	1	2002	2002	1	0	CTD_human
val	2664	GDI1	0.572	0.654	C2931498	MentalRetardation,X-Linked1	disease	C16;C10	DiseaseorSyndrome	0.50	1	2009	2011	1	0	ORPHANET
val	2664	GDI1	0.572	0.654	C3501611	MentalRetardation,X-LinkedNonsyndromic	disease	C16;C10	DiseaseorSyndrome	0.30	1	1997	2012	6	0	CLINGEN
val	2664	GDI1	0.572	0.654	C3658290	Drug-InducedAcuteLiverInjury	disease	C06;C25	DiseaseorSyndrome	0.30	1	2015	2015	1	0	CTD_human
val	2664	GDI1	0.572	0.654	C3887939	MENTALRETARDATION,X-LINKED41	disease		DiseaseorSyndrome	0.90	1	1998	2009	2	4	CTD_human;GENOMICS_ENGLAND;UNIPROT
val	2664	GDI1	0.572	0.654	C4277682	ChemicalandDrugInducedLiverInjury	disease	C06;C25	DiseaseorSyndrome	0.30	1	2015	2015	1	0	CTD_human
val	2664	GDI1	0.572	0.654	C4279912	Chemically-InducedLiverToxicity	disease	C06;C25	DiseaseorSyndrome	0.30	1	2015	2015	1	0	CTD_human
val	2664	GDI1	0.572	0.654	C4551993	AmyotrophicLateralSclerosis,Familial	disease	C18;C10	DiseaseorSyndrome	0.30	1	2002	2002	1	0	CTD_human
val	2665	GDI2	0.76	0.308	C0279626	Squamouscellcarcinomaofesophagus	disease	C06;C04	NeoplasticProcess	0.30	1	2011	2011	1	0	CTD_human
val	2668	GDNF	0.434	0.885	C0005586	BipolarDisorder	disease	F03	MentalorBehavioralDysfunction	0.33	0.5	2008	2017	2	0	PSYGENET
val	2668	GDNF	0.434	0.885	C0009171	CocaineAbuse	disease	C25;F03	MentalorBehavioralDysfunction	0.30	1	2003	2005	2	0	CTD_human
val	2668	GDNF	0.434	0.885	C0013386	Dyskinesia,Drug-Induced	disease	C23;C10;C25	DiseaseorSyndrome	0.30	1	2001	2001	1	0	CTD_human
val	2668	GDNF	0.434	0.885	C0014474	Ependymoma	disease	C04	NeoplasticProcess	0.31	1	2004	2009	1	0	CTD_human
val	2668	GDNF	0.434	0.885	C0017636	Glioblastoma	disease	C04	NeoplasticProcess	0.37	1	1999	2018	1	0	CTD_human
val	2668	GDNF	0.434	0.885	C0017638	Glioma	disease	C04	NeoplasticProcess	0.40	1	1999	2019	1	0	CTD_human
val	2668	GDNF	0.434	0.885	C0019569	HirschsprungDisease	disease	C16;C06	DiseaseorSyndrome	0.70	1	1996	2013	2	0	CTD_human
val	2668	GDNF	0.434	0.885	C0020179	HuntingtonDisease	disease	C16;C10;F03	DiseaseorSyndrome	0.34	1	2005	2016	1	0	CTD_human
val	2668	GDNF	0.434	0.885	C0020429	Hyperalgesia	phenotype	C23;C10	SignorSymptom	0.32	1	2010	2018	1	0	CTD_human
val	2668	GDNF	0.434	0.885	C0024115	Lungdiseases	group	C08	DiseaseorSyndrome	0.30				0	0	GENOMICS_ENGLAND
val	2668	GDNF	0.434	0.885	C0027854	NeurologicManifestations	phenotype	C23;C10	Finding	0.30	1	2010	2010	1	0	CTD_human
val	2668	GDNF	0.434	0.885	C0028945	oligodendroglioma	disease	C04	NeoplasticProcess	0.30	1	2009	2009	1	0	CTD_human
val	2668	GDNF	0.434	0.885	C0030567	ParkinsonDisease	disease	C10	DiseaseorSyndrome	0.40	0.983	1993	2020	2	0	CTD_human
val	2668	GDNF	0.434	0.885	C0030569	SecondaryParkinsonDisease	disease	C10	DiseaseorSyndrome	0.30	1	2010	2010	1	0	CTD_human
val	2668	GDNF	0.434	0.885	C0031511	Pheochromocytoma	disease	C04	NeoplasticProcess	0.65	0.8	1997	2013	1	0	CTD_human;UNIPROT
val	2668	GDNF	0.434	0.885	C0035304	RetinalDegeneration	phenotype	C11	PathologicFunction	0.31	1	2007	2007	1	0	CTD_human
val	2668	GDNF	0.434	0.885	C0036341	Schizophrenia	disease	F03	MentalorBehavioralDysfunction	0.40	0.5	2001	2019	4	0	PSYGENET
val	2668	GDNF	0.434	0.885	C0038220	StatusEpilepticus	disease	C23;C10	DiseaseorSyndrome	0.30	1	1994	2003	2	0	CTD_human
val	2668	GDNF	0.434	0.885	C0041696	UnipolarDepression	disease	F03	MentalorBehavioralDysfunction	0.34	1	2008	2019	4	0	PSYGENET
val	2668	GDNF	0.434	0.885	C0085758	Aganglionosis,Colonic	disease	C16;C06	CongenitalAbnormality	0.30	1	1996	1996	2	0	CTD_human
val	2668	GDNF	0.434	0.885	C0205769	Myxopapillaryependymoma	disease	C04	NeoplasticProcess	0.30	1	2009	2009	1	0	CTD_human
val	2668	GDNF	0.434	0.885	C0235031	NeurologicSymptoms	group	C23;C10	SignorSymptom	0.30	1	2010	2010	1	0	CTD_human
val	2668	GDNF	0.434	0.885	C0236733	Amphetamine-RelatedDisorders	group	C25;F03	MentalorBehavioralDysfunction	0.30	1	2007	2007	1	0	CTD_human
val	2668	GDNF	0.434	0.885	C0236736	Cocaine-RelatedDisorders	group	C25;F03	MentalorBehavioralDysfunction	0.30	1	2003	2005	2	0	CTD_human
val	2668	GDNF	0.434	0.885	C0236804	AmphetamineAddiction	disease	C25;F03	MentalorBehavioralDysfunction	0.30	1	2007	2007	1	0	CTD_human
val	2668	GDNF	0.434	0.885	C0236807	AmphetamineAbuse	disease	C25;F03	MentalorBehavioralDysfunction	0.30	1	2007	2007	1	0	CTD_human
val	2668	GDNF	0.434	0.885	C0242422	ParkinsonianDisorders	group	C10	DiseaseorSyndrome	0.53	1	1997	2018	2	0	CTD_human
val	2668	GDNF	0.434	0.885	C0242423	RamsayHuntParalysisSyndrome	disease	C10	DiseaseorSyndrome	0.30	1	1997	2002	2	0	CTD_human
val	2668	GDNF	0.434	0.885	C0259783	mixedgliomas	disease	C04	NeoplasticProcess	0.30	1	2009	2009	1	0	CTD_human
val	2668	GDNF	0.434	0.885	C0270715	DegenerativeDiseases,CentralNervousSystem	group	C10	DiseaseorSyndrome	0.30	1	2001	2001	1	0	CTD_human
val	2668	GDNF	0.434	0.885	C0270823	Petitmalstatus	disease	C23;C10	DiseaseorSyndrome	0.30	1	1994	2003	2	0	CTD_human
val	2668	GDNF	0.434	0.885	C0279070	AdultOligodendroglioma	disease	C04	NeoplasticProcess	0.30	1	2009	2009	1	0	CTD_human
val	2668	GDNF	0.434	0.885	C0280475	ChildhoodOligodendroglioma	disease	C04	NeoplasticProcess	0.30	1	2009	2009	1	0	CTD_human
val	2668	GDNF	0.434	0.885	C0280788	AnaplasticEpendymoma	disease	C04	NeoplasticProcess	0.30	1	2009	2009	1	0	CTD_human
val	2668	GDNF	0.434	0.885	C0280793	MixedOligodendroglioma-Astrocytoma	disease	C04	NeoplasticProcess	0.30	1	2009	2009	1	0	CTD_human
val	2668	GDNF	0.434	0.885	C0311335	GrandMalStatusEpilepticus	disease	C23;C10	DiseaseorSyndrome	0.30	1	1994	2003	2	0	CTD_human
val	2668	GDNF	0.434	0.885	C0334578	Papillaryependymoma	disease	C04	NeoplasticProcess	0.30	1	2009	2009	1	0	CTD_human
val	2668	GDNF	0.434	0.885	C0334588	GiantCellGlioblastoma	disease	C04	NeoplasticProcess	0.30	1	2009	2009	1	0	CTD_human
val	2668	GDNF	0.434	0.885	C0334590	AnaplasticOligodendroglioma	disease	C04	NeoplasticProcess	0.30	1	2009	2009	1	0	CTD_human
val	2668	GDNF	0.434	0.885	C0344461	Oligodendroblastoma	disease	C04	NeoplasticProcess	0.30	1	2009	2009	1	0	CTD_human
val	2668	GDNF	0.434	0.885	C0393574	HuntingtonDisease,LateOnset	disease	C16;C10;F03	DiseaseorSyndrome	0.30	1	2007	2007	1	0	CTD_human
val	2668	GDNF	0.434	0.885	C0393734	ComplexPartialStatusEpilepticus	disease	C23;C10	DiseaseorSyndrome	0.30	1	1994	2003	2	0	CTD_human
val	2668	GDNF	0.434	0.885	C0422837	Neurologicalobservations	group	C23;C10	Finding	0.30	1	2010	2010	1	0	CTD_human
val	2668	GDNF	0.434	0.885	C0458247	Allodynia	phenotype	C23;C10	Finding	0.30	1	2010	2010	1	0	CTD_human
val	2668	GDNF	0.434	0.885	C0521654	NeurologicDeficits	group	C23;C10	Finding	0.30	1	2010	2010	1	0	CTD_human
val	2668	GDNF	0.434	0.885	C0524851	NeurodegenerativeDisorders	group	C10	DiseaseorSyndrome	0.38	1	1998	2019	1	0	CTD_human
val	2668	GDNF	0.434	0.885	C0555198	MalignantGlioma	disease	C04	NeoplasticProcess	0.33	1	2009	2017	1	0	CTD_human
val	2668	GDNF	0.434	0.885	C0600427	CocaineDependence	disease	C25;F03	MentalorBehavioralDysfunction	0.30	1	2003	2005	2	0	CTD_human
val	2668	GDNF	0.434	0.885	C0683357	Excessivedrinking	phenotype		MentalorBehavioralDysfunction	0.30	1	2014	2014	1	0	PSYGENET
val	2668	GDNF	0.434	0.885	C0746857	FocalNeurologicDeficits	phenotype	C23;C10	Finding	0.30	1	2010	2010	1	0	CTD_human
val	2668	GDNF	0.434	0.885	C0751088	Dyskinesia,Medication-Induced	phenotype	C23;C10;C25	DiseaseorSyndrome	0.30	1	2001	2001	1	0	CTD_human
val	2668	GDNF	0.434	0.885	C0751207	Akinetic-RigidVariantofHuntingtonDisease	disease	C16;C10;F03	DiseaseorSyndrome	0.30	1	2007	2007	1	0	CTD_human
val	2668	GDNF	0.434	0.885	C0751208	JuvenileHuntingtonDisease	disease	C16;C10;F03	DiseaseorSyndrome	0.30	1	2007	2007	1	0	CTD_human
val	2668	GDNF	0.434	0.885	C0751211	Hyperalgesia,Primary	phenotype	C23;C10	SignorSymptom	0.30	1	2010	2010	1	0	CTD_human
val	2668	GDNF	0.434	0.885	C0751212	Hyperalgesia,Secondary	phenotype	C23;C10	SignorSymptom	0.30	1	2010	2010	1	0	CTD_human
val	2668	GDNF	0.434	0.885	C0751213	TactileAllodynia	phenotype	C23;C10	SignorSymptom	0.30	1	2010	2010	1	0	CTD_human
val	2668	GDNF	0.434	0.885	C0751214	Hyperalgesia,Thermal	phenotype	C23;C10	SignorSymptom	0.31	1	2010	2014	1	0	CTD_human
val	2668	GDNF	0.434	0.885	C0751377	NeurologicDysfunction	phenotype	C23;C10	Finding	0.30	1	2010	2010	1	0	CTD_human
val	2668	GDNF	0.434	0.885	C0751378	NeurologicSigns	phenotype	C23;C10	SignorSymptom	0.30	1	2010	2010	1	0	CTD_human
val	2668	GDNF	0.434	0.885	C0751395	MixedOligodendroglioma-Ependymoma	disease	C04	NeoplasticProcess	0.30	1	2009	2009	1	0	CTD_human
val	2668	GDNF	0.434	0.885	C0751396	WellDifferentiatedOligodendroglioma	disease	C04	NeoplasticProcess	0.30	1	2009	2009	1	0	CTD_human
val	2668	GDNF	0.434	0.885	C0751414	ParkinsonDisease,SecondaryVascular	disease	C10	DiseaseorSyndrome	0.30	1	2010	2010	1	0	CTD_human
val	2668	GDNF	0.434	0.885	C0751415	AtheroscleroticParkinsonism	disease	C10	DiseaseorSyndrome	0.30	1	2010	2010	1	0	CTD_human
val	2668	GDNF	0.434	0.885	C0751522	StatusEpilepticus,Subclinical	disease	C23;C10	DiseaseorSyndrome	0.30	1	1994	2003	2	0	CTD_human
val	2668	GDNF	0.434	0.885	C0751523	Non-ConvulsiveStatusEpilepticus	disease	C23;C10	DiseaseorSyndrome	0.30	1	1994	2003	2	0	CTD_human
val	2668	GDNF	0.434	0.885	C0751524	SimplePartialStatusEpilepticus	phenotype	C23;C10	DiseaseorSyndrome	0.30	1	1994	2003	2	0	CTD_human
val	2668	GDNF	0.434	0.885	C0751733	DegenerativeDiseases,SpinalCord	group	C10	DiseaseorSyndrome	0.30	1	2001	2001	1	0	CTD_human
val	2668	GDNF	0.434	0.885	C0752097	AutosomalDominantJuvenileParkinsonDisease	disease	C10	DiseaseorSyndrome	0.30	1	1997	2002	2	0	CTD_human
val	2668	GDNF	0.434	0.885	C0752098	AutosomalDominantParkinsonism	disease	C10	DiseaseorSyndrome	0.30	1	1997	2002	2	0	CTD_human
val	2668	GDNF	0.434	0.885	C0752100	AutosomalRecessiveParkinsonism	disease	C10	DiseaseorSyndrome	0.30	1	1997	2002	2	0	CTD_human
val	2668	GDNF	0.434	0.885	C0752101	Parkinsonism,Experimental	disease	C10	ExperimentalModelofDisease	0.30	1	1997	2002	2	0	CTD_human
val	2668	GDNF	0.434	0.885	C0752104	FamilialJuvenileParkinsonism	disease	C10	DiseaseorSyndrome	0.30	1	1997	2002	2	0	CTD_human
val	2668	GDNF	0.434	0.885	C0752105	Parkinsonism,Juvenile	disease	C10	DiseaseorSyndrome	0.30	1	1997	2002	2	0	CTD_human
val	2668	GDNF	0.434	0.885	C1257840	Aganglionosis,RectosigmoidColon	disease	C16;C06	CongenitalAbnormality	0.30	1	1996	1996	2	0	CTD_human
val	2668	GDNF	0.434	0.885	C1257877	Pheochromocytoma,Extra-Adrenal	disease	C04	NeoplasticProcess	0.30	1	1997	1997	1	0	CTD_human
val	2668	GDNF	0.434	0.885	C1269683	MajorDepressiveDisorder	disease	F03	MentalorBehavioralDysfunction	0.37	1	2008	2019	4	0	PSYGENET
val	2668	GDNF	0.434	0.885	C1275808	Congenitalcentralhypoventilation	disease	C23;C08;C10	DiseaseorSyndrome	0.60	1	1998	1998	1	0	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
val	2668	GDNF	0.434	0.885	C1384403	CellularEpendymoma	disease	C04	NeoplasticProcess	0.30	1	2009	2009	1	0	CTD_human
val	2668	GDNF	0.434	0.885	C1621958	GlioblastomaMultiforme	disease	C04	NeoplasticProcess	0.37	1	1999	2018	1	0	CTD_human
val	2668	GDNF	0.434	0.885	C1708353	HereditaryParaganglioma-PheochromocytomaSyndrome	disease	C16;C04	DiseaseorSyndrome	0.30	1	1997	1997	1	0	CLINGEN
val	2668	GDNF	0.434	0.885	C1859049	CCHSWITHHIRSCHSPRUNGDISEASE	disease	C23;C08;C10	DiseaseorSyndrome;CongenitalAbnormality	0.30	1	1998	1998	1	0	CTD_human
val	2668	GDNF	0.434	0.885	C1868675	PARKINSONDISEASE2,AUTOSOMALRECESSIVEJUVENILE	disease	C10	DiseaseorSyndrome	0.30	1	1997	2002	2	0	CTD_human
val	2668	GDNF	0.434	0.885	C2936719	MechanicalAllodynia	phenotype	C23;C10	SignorSymptom	0.31	1	2010	2018	1	0	CTD_human
val	2668	GDNF	0.434	0.885	C3150974	HIRSCHSPRUNGDISEASE,SUSCEPTIBILITYTO,3	disease		Finding	0.60	1	1996	2002	5	0	GENOMICS_ENGLAND;UNIPROT
val	2668	GDNF	0.434	0.885	C3661523	CongenitalIntestinalAganglionosis	disease	C16;C06	DiseaseorSyndrome	0.30	1	1996	1996	2	0	CTD_human
val	2670	GFAP	0.421	0.885	C0001973	AlcoholicIntoxication,Chronic	disease	C25;F03	MentalorBehavioralDysfunction	0.30	1	2005	2005	1	0	PSYGENET
val	2670	GFAP	0.421	0.885	C0002736	AmyotrophicLateralSclerosis	disease	C18;C10	DiseaseorSyndrome	0.40	1	2001	2019	1	0	CTD_human
val	2670	GFAP	0.421	0.885	C0005586	BipolarDisorder	disease	F03	MentalorBehavioralDysfunction	0.32	0.5	2005	2010	2	0	PSYGENET
val	2670	GFAP	0.421	0.885	C0011570	MentalDepression	disease	F01	MentalorBehavioralDysfunction	0.36	1	2002	2019	3	0	PSYGENET
val	2670	GFAP	0.421	0.885	C0011581	Depressivedisorder	disease	F03	MentalorBehavioralDysfunction	0.36	1	2002	2019	3	0	PSYGENET
val	2670	GFAP	0.421	0.885	C0014544	Epilepsy	disease	C10	DiseaseorSyndrome	0.40	1	1999	2020	1	0	CTD_human
val	2670	GFAP	0.421	0.885	C0017639	Gliosis	phenotype	C23	PathologicFunction	0.31	1	2002	2005	1	0	CTD_human
val	2670	GFAP	0.421	0.885	C0020429	Hyperalgesia	phenotype	C23;C10	SignorSymptom	0.50	1	2005	2016	1	0	CTD_human
val	2670	GFAP	0.421	0.885	C0027765	nervoussystemdisorder	group	C10	DiseaseorSyndrome	0.40	1	1997	2019	3	0	CTD_human
val	2670	GFAP	0.421	0.885	C0027873	NeuromyelitisOptica	disease	C11;C20;C10	DiseaseorSyndrome	0.38	1	2008	2019	1	0	CTD_human
val	2670	GFAP	0.421	0.885	C0030567	ParkinsonDisease	disease	C10	DiseaseorSyndrome	0.40	1	1999	2020	1	0	CTD_human
val	2670	GFAP	0.421	0.885	C0036341	Schizophrenia	disease	F03	MentalorBehavioralDysfunction	0.39	1	2005	2017	2	0	PSYGENET
val	2670	GFAP	0.421	0.885	C0036572	Seizures	phenotype	C23;C10	SignorSymptom	0.46	1	2006	2019	1	1	GENOMICS_ENGLAND
val	2670	GFAP	0.421	0.885	C0037917	SpinaBifidaCystica	disease	C16;C10	CongenitalAbnormality	0.30	1	1993	1993	1	0	CTD_human
val	2670	GFAP	0.421	0.885	C0040997	TrigeminalNeuralgia	disease	C10;C07	DiseaseorSyndrome	0.30	1	2016	2016	1	0	CTD_human
val	2670	GFAP	0.421	0.885	C0041696	UnipolarDepression	disease	F03	MentalorBehavioralDysfunction	0.31	1	2008	2017	2	0	PSYGENET
val	2670	GFAP	0.421	0.885	C0086237	Epilepsy,Cryptogenic	disease	C10	DiseaseorSyndrome	0.30	1	2010	2010	1	0	CTD_human
val	2670	GFAP	0.421	0.885	C0236018	Aura	phenotype	C10	Finding	0.30	1	2010	2010	1	0	CTD_human
val	2670	GFAP	0.421	0.885	C0270726	AlexanderDisease	disease	C16;C18;C10	DiseaseorSyndrome	1.00	0.972	1976	2020	30	90	CTD_human;GENOMICS_ENGLAND;UNIPROT
val	2670	GFAP	0.421	0.885	C0393554	AmyotrophicLateralSclerosisWithDementia	disease	C18;C10	DiseaseorSyndrome	0.30	1	2001	2001	1	0	CTD_human
val	2670	GFAP	0.421	0.885	C0393786	TrigeminalNeuralgia,Idiopathic	disease	C10;C07	DiseaseorSyndrome	0.31	1	2016	2019	1	0	CTD_human
val	2670	GFAP	0.421	0.885	C0393787	SecondaryTrigeminalNeuralgia	disease	C10;C07	DiseaseorSyndrome	0.30	1	2016	2016	1	0	CTD_human
val	2670	GFAP	0.421	0.885	C0458247	Allodynia	phenotype	C23;C10	Finding	0.30	1	2016	2016	1	0	CTD_human
val	2670	GFAP	0.421	0.885	C0543859	AmyotrophicLateralSclerosis,GuamForm	disease	C18;C10	DiseaseorSyndrome	0.30	1	2001	2001	1	0	CTD_human
val	2670	GFAP	0.421	0.885	C0751111	AwakeningEpilepsy	disease	C10	DiseaseorSyndrome	0.30	1	2010	2010	1	0	CTD_human
val	2670	GFAP	0.421	0.885	C0751211	Hyperalgesia,Primary	phenotype	C23;C10	SignorSymptom	0.30	1	2016	2016	1	0	CTD_human
val	2670	GFAP	0.421	0.885	C0751212	Hyperalgesia,Secondary	phenotype	C23;C10	SignorSymptom	0.30	1	2016	2016	1	0	CTD_human
val	2670	GFAP	0.421	0.885	C0751213	TactileAllodynia	phenotype	C23;C10	SignorSymptom	0.30	1	2016	2016	1	0	CTD_human
val	2670	GFAP	0.421	0.885	C0751214	Hyperalgesia,Thermal	phenotype	C23;C10	SignorSymptom	0.30	1	2016	2016	1	0	CTD_human
val	2670	GFAP	0.421	0.885	C0752347	LewyBodyDisease	disease	C10;F03	DiseaseorSyndrome	0.32	1	2009	2018	1	0	CTD_human
val	2670	GFAP	0.421	0.885	C0917813	SpinaBifida,Open	disease	C16;C10	CongenitalAbnormality	0.30	1	1993	1993	1	0	CTD_human
val	2670	GFAP	0.421	0.885	C1269683	MajorDepressiveDisorder	disease	F03	MentalorBehavioralDysfunction	0.33	1	2004	2018	2	0	PSYGENET
val	2670	GFAP	0.421	0.885	C1862939	AMYOTROPHICLATERALSCLEROSIS1	disease	C18;C10	DiseaseorSyndrome	0.30	1	2002	2002	1	0	CTD_human
val	2670	GFAP	0.421	0.885	C1862941	AmyotrophicLateralSclerosis,Sporadic	disease	C18;C10	DiseaseorSyndrome	0.30	1	2002	2002	1	0	CTD_human
val	2670	GFAP	0.421	0.885	C2931673	Ceroidlipofuscinosis,neuronal1,infantile	disease	C16;C18;C10	DiseaseorSyndrome	0.30	1	2011	2011	1	0	CTD_human
val	2670	GFAP	0.421	0.885	C2936719	MechanicalAllodynia	phenotype	C23;C10	SignorSymptom	0.37	1	2016	2019	1	0	CTD_human
val	2670	GFAP	0.421	0.885	C3887640	Astrocytosis	phenotype	C23	PathologicFunction	0.30	1	2002	2002	1	0	CTD_human
val	2670	GFAP	0.421	0.885	C4551993	AmyotrophicLateralSclerosis,Familial	disease	C18;C10	DiseaseorSyndrome	0.30	1	2002	2002	1	0	CTD_human
val	2670	GFAP	0.421	0.885	C4721453	PeripheralNervousSystemDiseases	group	C10	DiseaseorSyndrome	0.32	1	1999	2019	1	0	CTD_human
val	2671	GFER	0.56	0.846	C0022660	KidneyFailure,Acute	disease	C13;C12	DiseaseorSyndrome	0.35	1	2009	2019	1	0	CTD_human
val	2671	GFER	0.56	0.846	C0162557	LiverFailure,Acute	disease	C06	DiseaseorSyndrome	0.32	1	2005	2017	1	0	CTD_human
val	2671	GFER	0.56	0.846	C0392622	Toxiceffectofcarbontetrachloride	disease	C25	InjuryorPoisoning	0.30	1	2005	2005	1	0	CTD_human
val	2671	GFER	0.56	0.846	C1565662	AcuteKidneyInsufficiency	disease	C13;C12	DiseaseorSyndrome	0.30	1	2009	2009	1	0	CTD_human
val	2671	GFER	0.56	0.846	C2609414	Acutekidneyinjury	disease	C13;C12	InjuryorPoisoning	0.50	1	2009	2009	1	0	CTD_human
val	2671	GFER	0.56	0.846	C2751320	Myopathy,MitochondrialProgressive,WithCongenitalCataract,HearingLoss,AndDevelopmentalDelay	disease	C23;C18;C11;C05;C10;F03;C09	DiseaseorSyndrome	0.71	1	2009	2017	4	2	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
val	2671	GFER	0.56	0.846	C3714756	IntellectualDisability	group	C23;C10;F03;F01	MentalorBehavioralDysfunction	0.30	1	2017	2017	1	0	GENOMICS_ENGLAND
val	2672	GFI1	0.546	0.769	C0023467	Leukemia,Myelocytic,Acute	disease	C04	NeoplasticProcess	0.50	1	2007	2020	1	0	CTD_human
val	2672	GFI1	0.546	0.769	C0026998	AcuteMyeloidLeukemia,M1	disease	C04	NeoplasticProcess	0.30	1	2007	2007	1	0	CTD_human
val	2672	GFI1	0.546	0.769	C0087012	Ataxia,Spinocerebellar	disease	C16;C10	DiseaseorSyndrome	0.30	1	2005	2005	1	0	CTD_human
val	2672	GFI1	0.546	0.769	C0340970	Congenitalneutropenia	disease	C16;C15	CongenitalAbnormality	0.37	1	2003	2018	0	0	GENOMICS_ENGLAND
val	2672	GFI1	0.546	0.769	C0752120	SpinocerebellarAtaxiaType1	disease	C16;C10	DiseaseorSyndrome	0.30	1	2005	2005	1	0	CTD_human
val	2672	GFI1	0.546	0.769	C0752121	SpinocerebellarAtaxiaType2	disease	C16;C10	DiseaseorSyndrome	0.30	1	2005	2005	1	0	CTD_human
val	2672	GFI1	0.546	0.769	C0752122	SpinocerebellarAtaxiaType4	disease	C16;C10	DiseaseorSyndrome	0.30	1	2005	2005	1	0	CTD_human
val	2672	GFI1	0.546	0.769	C0752123	SpinocerebellarAtaxiaType5	disease	C16;C10	DiseaseorSyndrome	0.30	1	2005	2005	1	0	CTD_human
val	2672	GFI1	0.546	0.769	C0752124	SpinocerebellarAtaxiaType6(disorder)	disease	C16;C10	DiseaseorSyndrome	0.30	1	2005	2005	1	0	CTD_human
val	2672	GFI1	0.546	0.769	C0752125	SpinocerebellarAtaxiaType7	disease	C16;C10	DiseaseorSyndrome	0.30	1	2005	2005	1	0	CTD_human
val	2672	GFI1	0.546	0.769	C1842930	Neutropenia,NonimmuneChronicIdiopathic,Adult	disease	C16;C15	DiseaseorSyndrome	0.60	1	2003	2003	2	1	CTD_human;GENOMICS_ENGLAND;UNIPROT
val	2672	GFI1	0.546	0.769	C1859966	Neutropenia,SevereCongenital,AutosomalDominant1	disease	C15	DiseaseorSyndrome	0.30	1	2003	2003	1	0	ORPHANET
val	2672	GFI1	0.546	0.769	C1879321	AcuteMyeloidLeukemia(AML-M2)	disease	C04	NeoplasticProcess	0.30	1	2007	2007	1	0	CTD_human
val	2672	GFI1	0.546	0.769	C2751288	Neutropenia,SevereCongenital,AutosomalDominant2	disease	C15	DiseaseorSyndrome	0.70	1	2003	2003	2	1	CTD_human;GENOMICS_ENGLAND;UNIPROT
val	2672	GFI1	0.546	0.769	C2930967	Gastro-enteropancreaticneuroendocrinetumor	disease	C06;C04;C19	NeoplasticProcess	0.30	1	2018	2018	1	0	CTD_human
val	2673	GFPT1	0.612	0.654	C0026848	Myopathy	group	C05;C10	DiseaseorSyndrome	0.42	1	2018	2019	1	0	CTD_human
val	2673	GFPT1	0.612	0.654	C0028754	Obesity	disease	C23;C18	DiseaseorSyndrome	0.30	1	2011	2011	1	0	CTD_human
val	2673	GFPT1	0.612	0.654	C0333768	Tubularaggregates	phenotype		CellorMolecularDysfunction	0.30	1	2013	2013	1	0	GENOMICS_ENGLAND
val	2673	GFPT1	0.612	0.654	C0751882	MyasthenicSyndromes,Congenital	disease	C16;C10	DiseaseorSyndrome	0.70	1	2011	2019	2	1	CTD_human;GENOMICS_ENGLAND
val	2673	GFPT1	0.612	0.654	C0751883	CongenitalMyasthenicSyndromes,Postsynaptic	disease	C16;C10	DiseaseorSyndrome	0.30	1	2018	2018	1	0	CTD_human
val	2673	GFPT1	0.612	0.654	C0751884	CongenitalMyasthenicSyndromes,Presynaptic	disease	C16;C10	DiseaseorSyndrome	0.30	1	2018	2018	1	0	CTD_human
val	2673	GFPT1	0.612	0.654	C0751885	MyasthenicSyndromes,Congenital,SlowChannel	disease	C16;C10	DiseaseorSyndrome	0.30	1	2018	2018	1	0	CTD_human
val	2673	GFPT1	0.612	0.654	C1837091	MYASTHENICSYNDROME,CONGENITAL,ASSOCIATEDWITHACETYLCHOLINERECEPTORDEFICIENCY	disease	C16;C10	DiseaseorSyndrome	0.30				0	0	CTD_human
val	2673	GFPT1	0.612	0.654	C3552335	MYASTHENICSYNDROME,CONGENITAL,12	disease		DiseaseorSyndrome	0.80	1	2011	2017	3	16	GENOMICS_ENGLAND;UNIPROT
val	2674	GFRA1	0.619	0.615	C0023893	LiverCirrhosis,Experimental	disease	C23;C06	ExperimentalModelofDisease	0.30	1	2014	2014	1	0	CTD_human
val	2674	GFRA1	0.619	0.615	C0027796	Neuralgia	phenotype	C23;C10	SignorSymptom	0.30	1	2008	2008	1	0	CTD_human
val	2674	GFRA1	0.619	0.615	C0036341	Schizophrenia	disease	F03	MentalorBehavioralDysfunction	0.31	1	2010	2010	1	0	PSYGENET
val	2674	GFRA1	0.619	0.615	C0038870	Neuralgia,Supraorbital	phenotype	C23;C10	DiseaseorSyndrome	0.30	1	2008	2008	1	0	CTD_human
val	2674	GFRA1	0.619	0.615	C0042656	Neuralgia,Vidian	phenotype	C23;C10	DiseaseorSyndrome	0.30	1	2008	2008	1	0	CTD_human
val	2674	GFRA1	0.619	0.615	C0234247	Neuralgia,Atypical	phenotype	C23;C10	DiseaseorSyndrome	0.30	1	2008	2008	1	0	CTD_human
val	2674	GFRA1	0.619	0.615	C0234249	Neuralgia,Stump	phenotype	C23;C10	DiseaseorSyndrome	0.30	1	2008	2008	1	0	CTD_human
val	2674	GFRA1	0.619	0.615	C0423711	Neuralgia,Perineal	phenotype	C23;C10	DiseaseorSyndrome	0.30	1	2008	2008	1	0	CTD_human
val	2674	GFRA1	0.619	0.615	C0423712	Neuralgia,IliohypogastricNerve	phenotype	C23;C10	DiseaseorSyndrome	0.30	1	2008	2008	1	0	CTD_human
val	2674	GFRA1	0.619	0.615	C0751371	Neuralgia,Ilioinguinal	phenotype	C23;C10	SignorSymptom	0.30	1	2008	2008	1	0	CTD_human
val	2674	GFRA1	0.619	0.615	C0751372	NervePain	phenotype	C23;C10	SignorSymptom	0.30	1	2008	2008	1	0	CTD_human
val	2674	GFRA1	0.619	0.615	C0751373	ParoxysmalNervePain	phenotype	C23;C10	SignorSymptom	0.30	1	2008	2008	1	0	CTD_human
val	2676	GFRA3	0.736	0.346	C0036341	Schizophrenia	disease	F03	MentalorBehavioralDysfunction	0.31	1	2010	2010	1	0	PSYGENET
val	2677	GGCX	0.678	0.538	C0005779	BloodCoagulationDisorders	group	C15	DiseaseorSyndrome	0.32	1	2000	2016	1	0	CTD_human
val	2677	GGCX	0.678	0.538	C0451641	Urolithiasis	disease	C13;C12	DiseaseorSyndrome	0.50	1	1998	1998	1	0	CTD_human
val	2677	GGCX	0.678	0.538	C1835813	PseudoxanthomaElasticum-LikeDisorderwithMultipleCoagulationFactorDeficiency	disease	C16;C17;C15;C14	DiseaseorSyndrome	0.70	1	2007	2009	2	8	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
val	2677	GGCX	0.678	0.538	C1848534	VITAMINK-DEPENDENTCLOTTINGFACTORS,COMBINEDDEFICIENCYOF,1	disease	C16;C15	DiseaseorSyndrome	0.74	1	1998	2019	6	4	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
val	2678	GGT1	0.496	0.885	C0001956	AlcoholUseDisorder	disease	C25;F03	MentalorBehavioralDysfunction	0.30	1	2003	2003	1	0	CTD_human
val	2678	GGT1	0.496	0.885	C0001973	AlcoholicIntoxication,Chronic	disease	C25;F03	MentalorBehavioralDysfunction	0.51	1	1980	2003	1	0	CTD_human
val	2678	GGT1	0.496	0.885	C0007097	Carcinoma	group	C04	NeoplasticProcess	0.31	1	1998	2002	1	0	CTD_human
val	2678	GGT1	0.496	0.885	C0023895	Liverdiseases	group	C06	DiseaseorSyndrome	0.38	1	2000	2020	1	0	CTD_human
val	2678	GGT1	0.496	0.885	C0024667	AnimalMammaryNeoplasms	phenotype	C04;C22	NeoplasticProcess	0.30	1	2002	2002	1	0	CTD_human
val	2678	GGT1	0.496	0.885	C0024668	MammaryNeoplasms,Experimental	phenotype	C04	NeoplasticProcess;ExperimentalModelofDisease	0.30	1	2002	2002	1	0	CTD_human
val	2678	GGT1	0.496	0.885	C0027051	MyocardialInfarction	disease	C23;C14	DiseaseorSyndrome	0.30	1	2009	2009	1	0	CTD_human
val	2678	GGT1	0.496	0.885	C0031051	Pericementitis	disease	C07	DiseaseorSyndrome	0.30	1	2003	2003	1	0	CTD_human
val	2678	GGT1	0.496	0.885	C0031099	Periodontitis	disease	C07	DiseaseorSyndrome	0.30	1	2003	2003	1	0	CTD_human
val	2678	GGT1	0.496	0.885	C0033578	ProstaticNeoplasms	group	C04;C12	NeoplasticProcess	0.30	1	2007	2007	1	0	CTD_human
val	2678	GGT1	0.496	0.885	C0085762	Alcoholabuse	disease	C25;F03	MentalorBehavioralDysfunction	0.30	1	2003	2003	1	0	CTD_human
val	2678	GGT1	0.496	0.885	C0086565	LiverDysfunction	phenotype	C06	Finding	0.30	1	2010	2010	1	0	CTD_human
val	2678	GGT1	0.496	0.885	C0205696	Anaplasticcarcinoma	disease	C04	NeoplasticProcess	0.30	1	2002	2002	1	0	CTD_human
val	2678	GGT1	0.496	0.885	C0205697	Carcinoma,Spindle-Cell	disease	C04	NeoplasticProcess	0.30	1	2002	2002	1	0	CTD_human
val	2678	GGT1	0.496	0.885	C0205698	Undifferentiatedcarcinoma	disease	C04	NeoplasticProcess	0.30	1	2002	2002	1	0	CTD_human
val	2678	GGT1	0.496	0.885	C0205699	Carcinomatosis	phenotype	C04	NeoplasticProcess	0.30	1	2002	2002	1	0	CTD_human
val	2678	GGT1	0.496	0.885	C0268524	gamma-Glutamyltransferasedeficiency	disease	C16;C18	DiseaseorSyndrome	0.60	1	2014	2018	2	0	CTD_human;GENOMICS_ENGLAND;ORPHANET
val	2678	GGT1	0.496	0.885	C0376358	Malignantneoplasmofprostate	disease	C04;C12	NeoplasticProcess	0.32	1	2007	2019	1	0	CTD_human
val	2678	GGT1	0.496	0.885	C1257925	MammaryCarcinoma,Animal	disease	C04;C22	NeoplasticProcess	0.30	1	2002	2002	1	0	CTD_human
val	2683	B4GALT1	0.674	0.538	C2931009	Congenitaldisorderofglycosylationtype2D	disease	C16;C18	DiseaseorSyndrome	0.60	1	2002	2016	3	1	CTD_human;GENOMICS_ENGLAND
val	2688	GH1	0.373	0.923	C0001206	Acromegaly	disease	C05;C10;C19	DiseaseorSyndrome	0.40	0.982	1978	2020	7	0	CTD_human
val	2688	GH1	0.373	0.923	C0001973	AlcoholicIntoxication,Chronic	disease	C25;F03	MentalorBehavioralDysfunction	0.33	1	1991	2010	5	0	PSYGENET
val	2688	GH1	0.373	0.923	C0007222	CardiovascularDiseases	group	C14	DiseaseorSyndrome	0.40	0.923	2003	2019	1	0	CTD_human
val	2688	GH1	0.373	0.923	C0011570	MentalDepression	disease	F01	MentalorBehavioralDysfunction	0.32	0.667	1996	2019	3	0	PSYGENET
val	2688	GH1	0.373	0.923	C0011581	Depressivedisorder	disease	F03	MentalorBehavioralDysfunction	0.32	0.667	1996	2019	3	0	PSYGENET
val	2688	GH1	0.373	0.923	C0018273	GrowthDisorders	group	C23	PathologicFunction	0.30	1	2004	2004	1	0	CTD_human
val	2688	GH1	0.373	0.923	C0021655	InsulinResistance	phenotype	C18	PathologicFunction	0.30	1	2011	2011	1	0	CTD_human
val	2688	GH1	0.373	0.923	C0023893	LiverCirrhosis,Experimental	disease	C23;C06	ExperimentalModelofDisease	0.30	1	2004	2004	1	0	CTD_human
val	2688	GH1	0.373	0.923	C0024668	MammaryNeoplasms,Experimental	phenotype	C04	NeoplasticProcess;ExperimentalModelofDisease	0.50	1	1984	2007	2	0	CTD_human
val	2688	GH1	0.373	0.923	C0026846	MuscularAtrophy	phenotype	C23;C10	PathologicFunction	0.31	1	1996	2008	1	0	CTD_human
val	2688	GH1	0.373	0.923	C0028754	Obesity	disease	C23;C18	DiseaseorSyndrome	0.40	1	1982	2019	1	0	CTD_human
val	2688	GH1	0.373	0.923	C0032000	PituitaryAdenoma	disease	C04;C10;C19	NeoplasticProcess	0.40	1	1998	2019	1	0	CTD_human
val	2688	GH1	0.373	0.923	C0032019	PituitaryNeoplasms	group	C04;C10;C19	NeoplasticProcess	0.40	1	1986	2019	1	0	CTD_human
val	2688	GH1	0.373	0.923	C0032461	Polycythemia	disease	C15	DiseaseorSyndrome	0.31	1	2004	2017	1	0	CTD_human
val	2688	GH1	0.373	0.923	C0041408	TurnerSyndrome	disease	C16;C13;C12;C19;C14	DiseaseorSyndrome	0.40	0.938	1979	2019	1	0	CTD_human
val	2688	GH1	0.373	0.923	C0043094	WeightGain	phenotype	C23	Finding	0.30	1	2007	2007	1	0	CTD_human
val	2688	GH1	0.373	0.923	C0242526	GonadalDysgenesis,45,X	disease	C16;C13;C12;C19;C14	DiseaseorSyndrome	0.31	1	1979	2004	1	0	CTD_human
val	2688	GH1	0.373	0.923	C0242528	Azotemia	disease	C23;C13;C12	DiseaseorSyndrome	0.30	1	2003	2003	1	0	CTD_human
val	2688	GH1	0.373	0.923	C0270948	NeurogenicMuscularAtrophy	phenotype	C23;C10	PathologicFunction	0.30	1	1996	1996	1	0	CTD_human
val	2688	GH1	0.373	0.923	C0271561	Somatotropindeficiency	disease	C16;C05;C10;C19	DiseaseorSyndrome	0.50	0.958	1984	2020	0	0	GENOMICS_ENGLAND
val	2688	GH1	0.373	0.923	C0271567	IsolatedGrowthHormoneDeficiency,TypeII	disease	C05;C10;C19	DiseaseorSyndrome	0.75	1	1996	2019	4	0	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
val	2688	GH1	0.373	0.923	C0342573	PITUITARYDWARFISMI	disease	C05;C10;C19	CongenitalAbnormality	0.72	1	1993	2012	2	0	CTD_human;GENOMICS_ENGLAND;ORPHANET
val	2688	GH1	0.373	0.923	C0346300	Pituitarycarcinoma	disease	C04;C10;C19	NeoplasticProcess	0.30	1	2009	2009	1	0	CTD_human
val	2688	GH1	0.373	0.923	C0346302	GrowthHormone-SecretingPituitaryAdenoma	disease	C04;C10;C19	NeoplasticProcess	0.40	0.952	1991	2019	2	0	CTD_human
val	2688	GH1	0.373	0.923	C0920563	InsulinSensitivity	phenotype	C18	PathologicFunction	0.30	1	2011	2011	1	0	CTD_human
val	2688	GH1	0.373	0.923	C1527168	Bonnevie-UllrichSyndrome	disease	C16;C13;C12;C19;C14	DiseaseorSyndrome	0.30	1	2004	2004	1	0	CTD_human
val	2688	GH1	0.373	0.923	C1527405	Erythrocytosis	phenotype	C15	Finding	0.30	1	2004	2004	1	0	CTD_human
val	2688	GH1	0.373	0.923	C1849779	Kowarskisyndrome	disease	C05;C10;C19	DiseaseorSyndrome	0.71	1	1996	2007	4	0	CTD_human;ORPHANET;UNIPROT
val	2688	GH1	0.373	0.923	C2748571	IsolatedGrowthHormoneDeficiency,TypeIB	disease	C16;C05;C10;C19	DiseaseorSyndrome	0.60	1	2003	2012	3	0	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
val	2688	GH1	0.373	0.923	C3489630	Somatotrophinoma,Familial	disease	C04;C10;C19	NeoplasticProcess	0.30	1	1991	1992	2	0	CTD_human
val	2688	GH1	0.373	0.923	C3714796	Isolatedsomatotropindeficiency	disease		DiseaseorSyndrome	0.50	0.952	1982	2020	0	0	GENOMICS_ENGLAND
val	2688	GH1	0.373	0.923	C4748435	ISOLATEDGROWTHHORMONEDEFICIENCY,TYPEV	disease		DiseaseorSyndrome	0.30	1	2009	2012	2	0	ORPHANET
val	2689	GH2	0.769	0.5	C0175693	Russell-Silversyndrome	disease	C16;C05	DiseaseorSyndrome	0.30	1	2003	2003	1	0	CTD_human
val	2690	GHR	0.49	0.846	C0004352	AutisticDisorder	disease	F03	MentalorBehavioralDysfunction	0.30	1	2007	2007	1	0	CTD_human
val	2690	GHR	0.49	0.846	C0023893	LiverCirrhosis,Experimental	disease	C23;C06	ExperimentalModelofDisease	0.50	1	2003	2014	2	0	CTD_human
val	2690	GHR	0.49	0.846	C0033578	ProstaticNeoplasms	group	C04;C12	NeoplasticProcess	0.31	1	2004	2007	1	0	CTD_human
val	2690	GHR	0.49	0.846	C0151744	MyocardialIschemia	disease	C14	DiseaseorSyndrome	0.30	1	2005	2005	1	0	CTD_human
val	2690	GHR	0.49	0.846	C0271568	LaronSyndrome	disease	C16;C05;C19	DiseaseorSyndrome	1.00	0.98	1987	2020	12	21	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
val	2690	GHR	0.49	0.846	C0376358	Malignantneoplasmofprostate	disease	C04;C12	NeoplasticProcess	0.34	0.5	2002	2013	1	0	CTD_human
val	2690	GHR	0.49	0.846	C0745103	HyperlipoproteinemiaTypeIIa	disease	C16;C18	DiseaseorSyndrome	0.51	1	2003	2003	0	0	CTD_human;GENOMICS_ENGLAND
val	2690	GHR	0.49	0.846	C1858656	ShortStature,Idiopathic,Autosomal	disease	C05;C10;C19	DiseaseorSyndrome	0.72	0.667	1995	2000	1	5	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
val	2690	GHR	0.49	0.846	C2239176	Livercarcinoma	disease	C06;C04	NeoplasticProcess	0.35	1	1994	2017	1	0	CTD_human
val	2690	GHR	0.49	0.846	C3888131	INCREASEDRESPONSIVENESSTOGROWTHHORMONE	phenotype		Finding	0.50				0	0	GENOMICS_ENGLAND;ORPHANET
val	2691	GHRH	0.503	0.769	C0034063	PulmonaryEdema	phenotype	C08	PathologicFunction	0.30	1	2012	2012	1	0	CTD_human
val	2692	GHRHR	0.568	0.692	C0009402	ColorectalCarcinoma	disease	C06;C04	NeoplasticProcess	0.31	1	2016	2016	0	0	UNIPROT
val	2692	GHRHR	0.568	0.692	C0271561	Somatotropindeficiency	disease	C16;C05;C10;C19	DiseaseorSyndrome	0.38	1	1997	2016	0	0	GENOMICS_ENGLAND
val	2692	GHRHR	0.568	0.692	C2748571	IsolatedGrowthHormoneDeficiency,TypeIB	disease	C16;C05;C10;C19	DiseaseorSyndrome	0.35	1	1998	2018	2	0	ORPHANET
val	2692	GHRHR	0.568	0.692	C3714796	Isolatedsomatotropindeficiency	disease		DiseaseorSyndrome	0.40	1	1995	2019	0	0	GENOMICS_ENGLAND
val	2692	GHRHR	0.568	0.692	C4722273	ISOLATEDGROWTHHORMONEDEFICIENCY,TYPEIV	disease		DiseaseorSyndrome	0.61	1	1996	2003	5	9	GENOMICS_ENGLAND;UNIPROT
val	2693	GHSR	0.528	0.769	C0001956	AlcoholUseDisorder	disease	C25;F03	MentalorBehavioralDysfunction	0.33	1	2013	2019	1	0	CTD_human
val	2693	GHSR	0.528	0.769	C0001973	AlcoholicIntoxication,Chronic	disease	C25;F03	MentalorBehavioralDysfunction	0.31	1	2013	2019	1	0	CTD_human
val	2693	GHSR	0.528	0.769	C0012243	DigestiveSystemNeoplasms	group	C06;C04	NeoplasticProcess	0.30	1	2007	2007	1	0	CTD_human
val	2693	GHSR	0.528	0.769	C0085762	Alcoholabuse	disease	C25;F03	MentalorBehavioralDysfunction	0.30	1	2013	2013	1	0	CTD_human
val	2693	GHSR	0.528	0.769	C0751075	CancerofDigestiveSystem	disease	C06;C04	NeoplasticProcess	0.30	1	2007	2007	1	0	CTD_human
val	2693	GHSR	0.528	0.769	C1858656	ShortStature,Idiopathic,Autosomal	disease	C05;C10;C19	DiseaseorSyndrome	0.70	1	2006	2009	2	3	GENOMICS_ENGLAND;ORPHANET;UNIPROT
val	2694	CBLIF	0.507	0.808	C0005586	BipolarDisorder	disease	F03	MentalorBehavioralDysfunction	0.31	1	2015	2015	1	0	PSYGENET
val	2694	CBLIF	0.507	0.808	C0036341	Schizophrenia	disease	F03	MentalorBehavioralDysfunction	0.30	1	2011	2011	1	0	CTD_human
val	2694	CBLIF	0.507	0.808	C0340957	Congenitaldeficiencyofintrinsicfactor	disease	C16;C18;C15	CongenitalAbnormality	0.41	1	2004	2017	1	2	ORPHANET
val	2694	CBLIF	0.507	0.808	C1394891	IntrinsicFactorDeficiency	disease	C18;C15	DiseaseorSyndrome	0.72	1	2004	2015	2	3	CTD_human;ORPHANET;UNIPROT
val	2695	GIP	0.57	0.654	C0003123	Anorexia	disease	C23	DiseaseorSyndrome	0.33	1	2017	2018	3	0	CTD_human
val	2696	GIPR	0.67	0.538	C0005910	BodyWeight	phenotype	C23	OrganismAttribute	0.30	1	2012	2012	1	0	CTD_human
val	2696	GIPR	0.67	0.538	C0007131	Non-SmallCellLungCarcinoma	disease	C04;C08	NeoplasticProcess	0.31	1	2006	2017	1	0	CTD_human
val	2697	GJA1	0.393	0.885	C0001430	Adenoma	group	C04	NeoplasticProcess	0.30	1	2006	2006	1	0	CTD_human
val	2697	GJA1	0.393	0.885	C0003811	CardiacArrhythmia	phenotype	C23;C14	DiseaseorSyndrome	0.70	0.969	2006	2019	2	0	CTD_human
val	2697	GJA1	0.393	0.885	C0004352	AutisticDisorder	disease	F03	MentalorBehavioralDysfunction	0.31	1	2008	2008	1	0	CTD_human
val	2697	GJA1	0.393	0.885	C0006142	Malignantneoplasmofbreast	disease	C04;C17	NeoplasticProcess	0.40	1	2000	2019	1	0	CTD_human
val	2697	GJA1	0.393	0.885	C0007114	Malignantneoplasmofskin	disease	C04;C17	NeoplasticProcess	0.30	1	1995	1995	1	0	CTD_human
val	2697	GJA1	0.393	0.885	C0010051	CoronaryAneurysm	disease	C14	DiseaseorSyndrome	0.30	1	2004	2004	1	0	CTD_human
val	2697	GJA1	0.393	0.885	C0018522	HallermannsSyndrome	disease	C16;C05	DiseaseorSyndrome	0.52	1	2004	2012	2	1	GENOMICS_ENGLAND;UNIPROT
10529	2697	GJA1	0.393	0.885	C0020538	Hypertensivedisease	group	C14	DiseaseorSyndrome	0.61	1	2006	2017	1	0	CTD_human
10536	2697	GJA1	0.393	0.885	C0152101	HypoplasticLeftHeartSyndrome	disease	C16;C14	DiseaseorSyndrome	0.7	1	2001	2009	3	0	CTD_human;GENOMICS_ENGLAND;ORPHANET
10551	2697	GJA1	0.393	0.885	C0812437	Oculo-dento-digitalsyndrome	disease	C16;C11;C05;C07	CongenitalAbnormality	1	1	1975	2019	8	17	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
10557	2697	GJA1	0.393	0.885	C1861366	SYNDACTYLY,TYPEIII	disease	C16;C05	DiseaseorSyndrome	0.72	1	2003	2013	3	1	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
10559	2697	GJA1	0.393	0.885	C2749477	OculodentodigitalDysplasia,AutosomalRecessive	disease	C16;C11;C05;C07	DiseaseorSyndrome	0.6	1	2007	2016	2	6	CTD_human;GENOMICS_ENGLAND
10560	2697	GJA1	0.393	0.885	C2931244	Craniometaphysealdysplasia,autosomalrecessivetype	disease	C16;C05	DiseaseorSyndrome	0.7	1	2013	2013	1	1	CTD_human;GENOMICS_ENGLAND;UNIPROT
10562	2697	GJA1	0.393	0.885	C3151468	PALMOPLANTARKERATODERMAANDCONGENITALALOPECIA1	disease		DiseaseorSyndrome	0.62	1	2006	2019	3	1	GENOMICS_ENGLAND;UNIPROT
10565	2697	GJA1	0.393	0.885	C4479619	ERYTHROKERATODERMIAVARIABILISETPROGRESSIVA3	disease		DiseaseorSyndrome	0.6	1	2006	2015	2	2	GENOMICS_ENGLAND;UNIPROT
10568	2697	GJA1	0.393	0.885	C4551854	HYPOPLASTICLEFTHEARTSYNDROME1	disease	C16;C14	DiseaseorSyndrome	0.6	1	2001	2011	2	2	GENOMICS_ENGLAND;UNIPROT
10575	2700	GJA3	0.647	0.346	C1866078	Cataract,ZonularPulverulent3	disease	C11	DiseaseorSyndrome	0.9	1	1999	2018	22	10	CTD_human;GENOMICS_ENGLAND;UNIPROT
10580	2702	GJA5	0.575	0.577	C0020538	Hypertensivedisease	group	C14	DiseaseorSyndrome	0.55	1	2002	2018	1	0	CTD_human
10581	2702	GJA5	0.575	0.577	C0039685	TetralogyofFallot	disease	C16;C14	CongenitalAbnormality	0.62	1	2003	2013	1	0	ORPHANET
10587	2702	GJA5	0.575	0.577	C3279693	ATRIALFIBRILLATION,FAMILIAL,11	disease		DiseaseorSyndrome	0.6	1	2010	2010	1	5	CTD_human;UNIPROT
10600	2703	GJA8	0.587	0.577	C1861828	Cataract,ZonularPulverulent1	disease	C11	DiseaseorSyndrome	0.93	1	1998	2016	11	9	CTD_human;GENOMICS_ENGLAND;UNIPROT
10601	2703	GJA8	0.587	0.577	C1861829	Cataractmicrocorneasyndrome	disease	C11	DiseaseorSyndrome	0.61	1	2006	2010	3	0	CTD_human;GENOMICS_ENGLAND;ORPHANET
10606	2705	GJB1	0.514	0.731	C0011195	Dejerine-SottasDisease(disorder)	disease	C16;C10	DiseaseorSyndrome	0.63	1	1996	2005	1	1	UNIPROT
10626	2705	GJB1	0.514	0.731	C0393808	Charcot-Marie-Toothdisease,X-linked,1	disease	C16;C10	DiseaseorSyndrome	1	1	1993	2019	61	82	CTD_human;GENOMICS_ENGLAND;UNIPROT
10636	2706	GJB2	0.441	0.846	C0018784	SensorineuralHearingLoss(disorder)	disease	C23;C10;C09	DiseaseorSyndrome	0.7	0.973	1994	2020	1	4	CTD_human
10649	2706	GJB2	0.441	0.846	C0265336	Sentersyndrome	disease	C23;C16;C11;C17;C10;C09	DiseaseorSyndrome	1	1	1991	2019	5	23	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
10650	2706	GJB2	0.441	0.846	C0265964	Mutilatingkeratoderma	disease	C23;C16;C17;C05;C10;C09	CongenitalAbnormality	0.8	1	1997	2019	9	21	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
10651	2706	GJB2	0.441	0.846	C0266004	Knucklepads,leuconychiaandsensorineuraldeafness	disease	C23;C16;C17;C10;C09	CongenitalAbnormality	0.72	1	1997	2019	5	21	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
10658	2706	GJB2	0.441	0.846	C1835672	PalmoplantarKeratodermawithDeafness	disease	C23;C16;C17;C10;C09	DiseaseorSyndrome	0.73	1	1997	2019	10	26	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
10661	2706	GJB2	0.441	0.846	C1865234	ICHTHYOSIS,HYSTRIX-LIKE,WITHDEAFNESS	disease	C23;C16;C17;C10;C09	DiseaseorSyndrome	0.71	1	1997	2019	4	20	CTD_human;GENOMICS_ENGLAND;UNIPROT
10662	2706	GJB2	0.441	0.846	C2673759	DEAFNESS,AUTOSOMALRECESSIVE1A(disorder)	disease	C23;C10;C09	DiseaseorSyndrome	0.9	1	1997	2019	9	95	CTD_human;GENOMICS_ENGLAND;UNIPROT
10663	2706	GJB2	0.441	0.846	C2673760	DEAFNESS,DIGENIC,GJB2/GJB6(disorder)	disease	C23;C10;C09	DiseaseorSyndrome	0.6	NA	NA	NA	0	1	CTD_human
10664	2706	GJB2	0.441	0.846	C2673761	DEAFNESS,DIGENIC,GJB2/GJB3(disorder)	disease	C23;C10;C09	DiseaseorSyndrome	0.6	NA	NA	NA	0	1	CTD_human
10665	2706	GJB2	0.441	0.846	C2675750	DEAFNESS,AUTOSOMALDOMINANT3A(disorder)	disease	C23;C10;C09	DiseaseorSyndrome	0.7	1	1997	2019	8	49	CTD_human;GENOMICS_ENGLAND;UNIPROT
10667	2706	GJB2	0.441	0.846	C3665333	Keratitis-Ichthyosis-DeafnessSyndrome	disease	C11	DiseaseorSyndrome	0.6	1	1990	2019	0	0	ORPHANET
10677	2707	GJB3	0.621	0.462	C0265961	Erythrokeratodermiavariabilis	disease	C16;C17	DiseaseorSyndrome	0.9	0.967	1998	2019	17	0	CLINGEN;CTD_human;GENOMICS_ENGLAND;ORPHANET
10685	2707	GJB3	0.621	0.462	C2673759	DEAFNESS,AUTOSOMALRECESSIVE1A(disorder)	disease	C23;C10;C09	DiseaseorSyndrome	0.6	1	1998	1998	1	0	CTD_human;GENOMICS_ENGLAND
10688	2707	GJB3	0.621	0.462	C2675236	Deafness,AutosomalDominant2B	disease	C23;C10;C09	DiseaseorSyndrome	0.7	1	1998	1998	1	0	CTD_human;GENOMICS_ENGLAND;UNIPROT
10694	2707	GJB3	0.621	0.462	C4551486	ERYTHROKERATODERMIAVARIABILISETPROGRESSIVA1	disease	C16;C17	DiseaseorSyndrome	0.6	1	1998	2000	4	0	GENOMICS_ENGLAND;UNIPROT
10695	2707	GJB3	0.621	0.462	C4721453	PeripheralNervousSystemDiseases	group	C10	DiseaseorSyndrome	0.54	1	1999	2009	2	0	CTD_human;GENOMICS_ENGLAND
10700	2710	GK	0.656	0.577	C0268418	Deficiencyofglycerolkinase	disease		DiseaseorSyndrome	0.8	1	1988	2009	3	5	CTD_human;GENOMICS_ENGLAND;UNIPROT
10702	2717	GLA	0.537	0.769	C0002986	FabryDisease	disease	C16;C18;C10;C14	DiseaseorSyndrome	1	0.992	1967	2020	57	0	CLINGEN;CTD_human;GENOMICS_ENGLAND;UNIPROT
10717	2719	GPC3	0.466	0.808	C0027708	Nephroblastoma	disease	C16;C04;C13;C12	NeoplasticProcess	0.8	0.938	1997	2019	2	7	CGI;CTD_human;GENOMICS_ENGLAND;ORPHANET
10719	2719	GPC3	0.466	0.808	C0796154	SIMPSON-GOLABI-BEHMELSYNDROME,TYPE1	disease	C23;C16;C05;C10;C19;F03;F01;C14	DiseaseorSyndrome	1	0.956	1995	2019	6	10	CLINGEN;CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
10720	2719	GPC3	0.466	0.808	C2239176	Livercarcinoma	disease	C06;C04	NeoplasticProcess	0.6	0.984	1997	2020	2	0	CTD_human
10728	2720	GLB1	0.448	0.808	C0026707	MucopolysaccharidosisIV	disease	C16;C18;C17	DiseaseorSyndrome	0.52	1	1977	2019	4	0	CTD_human;GENOMICS_ENGLAND
10734	2720	GLB1	0.448	0.808	C0085131	GangliosidosisGM1	disease	C16;C18;C10	DiseaseorSyndrome	0.7	0.99	1975	2019	0	19	CTD_human
10737	2720	GLB1	0.448	0.808	C0086652	MucopolysaccharidosistypeIVB	disease	C16;C18;C17	DiseaseorSyndrome	0.8	1	1977	2018	12	68	CTD_human;GENOMICS_ENGLAND;UNIPROT
10739	2720	GLB1	0.448	0.808	C0268271	Gangliosidosis,GeneralizedGM1,Type1(disorder)	disease	C16;C18;C10	DiseaseorSyndrome	0.76	0.982	1979	2017	21	76	CTD_human;GENOMICS_ENGLAND;UNIPROT
10740	2720	GLB1	0.448	0.808	C0268272	Gangliosidosis,GeneralizedGM1,Type2	disease	C16;C18;C10	DiseaseorSyndrome	0.73	1	1991	2018	14	59	CTD_human;GENOMICS_ENGLAND;UNIPROT
10741	2720	GLB1	0.448	0.808	C0268273	Gangliosidosis,GeneralizedGM1,Type3	disease	C16;C18;C10	DiseaseorSyndrome	0.72	1	1984	2017	13	52	CTD_human;GENOMICS_ENGLAND;UNIPROT
10770	2729	GCLC	0.509	0.885	C1856603	Gamma-GlutamylcysteineSynthetaseDeficiency,HemolyticAnemiadueto	disease	C15	DiseaseorSyndrome	0.7	1	1996	2016	6	2	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
10789	2731	GLDC	0.628	0.577	C0751748	NonketoticHyperglycinemia	disease	C16;C18;C10	DiseaseorSyndrome	1	0.982	1990	2020	18	136	CLINGEN;CTD_human;GENOMICS_ENGLAND;UNIPROT
10791	2733	GLE1	0.628	0.577	C1854664	LETHALCONGENITALCONTRACTURESYNDROME1	disease	C16;C05	DiseaseorSyndrome	0.74	0.857	2006	2018	3	2	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
10792	2733	GLE1	0.628	0.577	C2678471	LethalArthrogryposisWithAnteriorHornCellDisease	disease	C16;C05;C10	DiseaseorSyndrome	0.72	1	2006	2018	3	7	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
10800	2735	GLI1	0.431	0.846	C1395852	Polydactylypreaxialtype1	disease	C16;C05	CongenitalAbnormality	0.7	1	2019	2019	1	0	GENOMICS_ENGLAND;ORPHANET;UNIPROT
10811	2736	GLI2	0.446	0.846	C0079541	Holoprosencephaly	disease	C16;C05;C10	CongenitalAbnormality	0.7	1	2003	2019	1	0	CTD_human;GENOMICS_ENGLAND
10814	2736	GLI2	0.446	0.846	C0431362	LobarHoloprosencephaly	disease	C16;C05;C10	CongenitalAbnormality	0.51	1	2006	2016	1	0	CTD_human;ORPHANET
10818	2736	GLI2	0.446	0.846	C1835819	PITUITARYANOMALIESWITHHOLOPROSENCEPHALY-LIKEFEATURES(disorder)	disease	C16;C05;C10;C19	DiseaseorSyndrome	0.7	1	2003	2015	4	12	CTD_human;GENOMICS_ENGLAND;UNIPROT
10822	2736	GLI2	0.446	0.846	C4014479	CULLER-JONESSYNDROME	disease		DiseaseorSyndrome	0.71	1	2003	2019	7	10	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
10833	2737	GLI3	0.436	0.846	C0152427	Polydactyly	disease	C16;C05	CongenitalAbnormality	0.7	1	1999	2019	2	0	CTD_human;GENOMICS_ENGLAND
10837	2737	GLI3	0.436	0.846	C0265220	Pallister-Hallsyndrome	disease	C16;C04;C05;C10	DiseaseorSyndrome	0.9	1	1997	2019	6	39	CTD_human;GENOMICS_ENGLAND
10838	2737	GLI3	0.436	0.846	C0265306	Greigcephalopolysyndactylysyndrome	disease	C16;C05	CongenitalAbnormality	1	0.917	1991	2019	13	19	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
10842	2737	GLI3	0.436	0.846	C0342418	Hypothalamichamartomas	disease	C04;C10	CongenitalAbnormality	0.63	1	2008	2019	1	0	CTD_human;GENOMICS_ENGLAND
10848	2737	GLI3	0.436	0.846	C1868111	Polydactyly,preaxial4	disease	C16;C05	DiseaseorSyndrome	0.7	1	2015	2019	2	1	CTD_human;GENOMICS_ENGLAND;ORPHANET
10852	2737	GLI3	0.436	0.846	C3495676	AnorectalMalformations	group	C16;C06	AnatomicalAbnormality	0.51	1	2008	2019	1	0	GENOMICS_ENGLAND
10853	2737	GLI3	0.436	0.846	C3887487	PostaxialpolydactylytypeA	disease	C16;C05	DiseaseorSyndrome	0.62	1	1999	2015	2	0	CTD_human;GENOMICS_ENGLAND;ORPHANET
10854	2737	GLI3	0.436	0.846	C4282400	Polydactyly,Postaxial,TypeA1	disease	C16;C05	DiseaseorSyndrome	0.71	1	1997	2019	2	3	CTD_human;GENOMICS_ENGLAND;UNIPROT
10860	2739	GLO1	0.537	0.769	C0011581	Depressivedisorder	disease	F03	MentalorBehavioralDysfunction	0.52	1	2005	2019	2	0	CTD_human;PSYGENET
10873	2740	GLP1R	0.471	0.846	C0020538	Hypertensivedisease	group	C14	DiseaseorSyndrome	0.56	1	2002	2020	1	0	CTD_human
10876	2741	GLRA1	0.628	0.5	C0234166	Hyperexplexia	phenotype	C10	SignorSymptom	0.7	0.979	1992	2019	2	13	GENOMICS_ENGLAND
10903	2775	GNAO1	0.523	0.808	C0393706	Earlyinfantileepilepticencephalopathywithsuppressionbursts	disease	C10	DiseaseorSyndrome	0.51	1	1997	2019	13	0	CLINGEN;ORPHANET
10909	2775	GNAO1	0.523	0.808	C3809606	EPILEPTICENCEPHALOPATHY,EARLYINFANTILE,17	disease		DiseaseorSyndrome	0.91	1	2013	2019	5	13	CTD_human;GENOMICS_ENGLAND;UNIPROT
10910	2775	GNAO1	0.523	0.808	C4479569	NEURODEVELOPMENTALDISORDERWITHINVOLUNTARYMOVEMENTS	disease		DiseaseorSyndrome	0.61	1	2013	2018	6	10	GENOMICS_ENGLAND;UNIPROT
10916	2776	GNAQ	0.516	0.808	C0025202	melanoma	disease	C04	NeoplasticProcess	0.7	0.967	1989	2019	1	1	CGI;CTD_human
10917	2776	GNAQ	0.516	0.808	C0038505	Sturge-WeberSyndrome	disease	C04;C10;C14	DiseaseorSyndrome	0.8	1	2013	2019	3	1	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
10920	2776	GNAQ	0.516	0.808	C0220633	Uvealmelanoma	disease	C04;C11	NeoplasticProcess	0.8	0.984	2008	2019	5	2	CGI;CTD_human;ORPHANET
10921	2776	GNAQ	0.516	0.808	C0235752	Port-WineStain	disease	C16;C17	CongenitalAbnormality	0.66	1	2013	2020	1	1	CTD_human;ORPHANET
10923	2776	GNAQ	0.516	0.808	C0340803	Capillarymalformation(disorder)	disease	C16;C14	CongenitalAbnormality	0.66	0.833	2016	2020	0	1	CTD_human;GENOMICS_ENGLAND
10941	2778	GNAS	0.42	0.885	C0016065	Polyostoticfibrousdysplasia	disease	C05	CongenitalAbnormality	0.65	1	1991	2017	5	0	CTD_human;ORPHANET
10954	2778	GNAS	0.42	0.885	C0033806	Pseudohypoparathyroidism	disease	C16;C18;C05	DiseaseorSyndrome	0.7	0.963	1991	2019	3	0	CTD_human
10955	2778	GNAS	0.42	0.885	C0033835	Pseudopseudohypoparathyroidism	disease	C16;C18;C05	DiseaseorSyndrome	1	1	1998	2018	1	11	CTD_human;GENOMICS_ENGLAND;ORPHANET
10958	2778	GNAS	0.42	0.885	C0036341	Schizophrenia	disease	F03	MentalorBehavioralDysfunction	0.51	1	2006	2006	1	0	PSYGENET
10970	2778	GNAS	0.42	0.885	C0242292	McCune-AlbrightSyndrome	disease	C05	DiseaseorSyndrome	0.8	0.966	1991	2019	7	8	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
10973	2778	GNAS	0.42	0.885	C0334041	Osteomacutis	disease	C23;C16;C18;C17;C05	DiseaseorSyndrome	0.8	0.955	2000	2019	3	3	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
10986	2778	GNAS	0.42	0.885	C1857451	Acth-IndependentMacronodularAdrenalHyperplasia	disease	C19	DiseaseorSyndrome	0.7	1	1997	2003	2	4	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
10987	2778	GNAS	0.42	0.885	C1864100	PSEUDOHYPOPARATHYROIDISM,TYPEIB	disease	C16;C18;C05	DiseaseorSyndrome	0.8	0.96	1997	2017	5	2	CTD_human;GENOMICS_ENGLAND;ORPHANET
10989	2778	GNAS	0.42	0.885	C2931404	Albrightshereditaryosteodystrophy	disease	C16;C18;C05	DiseaseorSyndrome	0.80	0.939	1990	2019	4	0	CTD_human;GENOMICS_ENGLAND
val	2778	GNAS	0.42	0.885	C2932715	PseudohypoparathyroidismType1B	disease	C16;C18;C05	DiseaseorSyndrome	0.70	1	2002	2019	1	0	CTD_human;GENOMICS_ENGLAND;ORPHANET
val	2778	GNAS	0.42	0.885	C2932716	PseudohypoparathyroidismType1C	disease	C16;C18;C05	DiseaseorSyndrome	0.73	1	2002	2017	2	5	GENOMICS_ENGLAND;ORPHANET;UNIPROT
val	2778	GNAS	0.42	0.885	C3489630	Somatotrophinoma,Familial	disease	C04;C10;C19	NeoplasticProcess	0.30	1	2001	2001	1	0	CTD_human
val	2778	GNAS	0.42	0.885	C3494506	Pseudohypoparathyroidism,TypeIa	disease	C16;C18;C05	DiseaseorSyndrome	0.80	0.957	1991	2019	17	13	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
val	2778	GNAS	0.42	0.885	C3697137	Fibrousdysplasiaofbonewithintramuscularmyxoma	disease	C05	DiseaseorSyndrome	0.31	1	2012	2019	1	0	ORPHANET
val	2778	GNAS	0.42	0.885	C3714756	IntellectualDisability	group	C23;C10;F03;F01	MentalorBehavioralDysfunction	0.41	1	2001	2004	1	0	CTD_human
val	2778	GNAS	0.42	0.885	C3805278	ExtrahepaticCholangiocarcinoma	disease	C04	NeoplasticProcess	0.30	1	2012	2012	1	0	CTD_human
val	2779	GNAT1	0.666	0.308	C0015397	Disorderofeye	group	C11	DiseaseorSyndrome	0.30				0	0	GENOMICS_ENGLAND
val	2779	GNAT1	0.666	0.308	C0339535	Nightblindness,congenitalstationary	disease	C16;C11	CongenitalAbnormality	0.73	1	1996	2016	2	0	CTD_human;GENOMICS_ENGLAND;ORPHANET
val	2779	GNAT1	0.666	0.308	C1848172	NIGHTBLINDNESS,CONGENITALSTATIONARY,TYPE2A	disease	C16;C11	DiseaseorSyndrome	0.30				0	0	CTD_human
val	2779	GNAT1	0.666	0.308	C1850362	NIGHTBLINDNESS,CONGENITALSTATIONARY,TYPE1B	disease	C16;C11	DiseaseorSyndrome	0.30				0	0	CTD_human
val	2779	GNAT1	0.666	0.308	C1864870	NightBlindness,CongenitalStationary,AutosomalDominant3	disease	C16;C11	DiseaseorSyndrome	0.70	1	1996	2007	2	2	CTD_human;GENOMICS_ENGLAND;UNIPROT
val	2779	GNAT1	0.666	0.308	C1864877	NIGHTBLINDNESS,CONGENITALSTATIONARY,TYPE2B(disorder)	disease	C16;C11	DiseaseorSyndrome	0.30				0	0	CTD_human
val	2779	GNAT1	0.666	0.308	C3495587	NightBlindness,CongenitalStationary,Type1A	disease	C16;C11	DiseaseorSyndrome	0.30				0	0	CTD_human
val	2779	GNAT1	0.666	0.308	C3501847	Nightblindness,congenitalstationary,type1	disease	C16;C11	DiseaseorSyndrome	0.30				0	0	CTD_human
val	2779	GNAT1	0.666	0.308	C3711543	X-LinkedCsnb	disease	C16;C11	DiseaseorSyndrome	0.30				0	0	CTD_human
val	2779	GNAT1	0.666	0.308	C4041558	Cone-rodsynapticdisorder,congenitalnonprogressive	disease	C16;C11	DiseaseorSyndrome	0.30				0	0	CTD_human
val	2779	GNAT1	0.666	0.308	C4225345	NIGHTBLINDNESS,CONGENITALSTATIONARY,TYPE1G	disease		DiseaseorSyndrome	0.60	1	2012	2012	1	1	GENOMICS_ENGLAND;UNIPROT
val	2780	GNAT2	0.674	0.231	C0009398	Colorvisiondefect	phenotype	C23;C11;C10	DiseaseorSyndrome	0.41	1	2002	2002	1	0	CTD_human
val	2780	GNAT2	0.674	0.231	C0015397	Disorderofeye	group	C11	DiseaseorSyndrome	0.30				0	0	GENOMICS_ENGLAND
val	2780	GNAT2	0.674	0.231	C0152200	Achromatopsia	disease	C23;C11;C10	DiseaseorSyndrome	0.79	1	2002	2019	1	1	CTD_human;GENOMICS_ENGLAND;ORPHANET
val	2780	GNAT2	0.674	0.231	C0155015	ColorBlindness,Red	disease	C23;C11;C10	DiseaseorSyndrome	0.30	1	2002	2002	1	0	CTD_human
val	2780	GNAT2	0.674	0.231	C0155016	ColorBlindness,Red-Green	disease	C23;C11;C10	DiseaseorSyndrome	0.30	1	2002	2002	1	0	CTD_human
val	2780	GNAT2	0.674	0.231	C0155017	ColorBlindness,Blue	disease	C23;C11;C10	DiseaseorSyndrome	0.30	1	2002	2002	1	0	CTD_human
val	2780	GNAT2	0.674	0.231	C0155018	ColorBlindness,Acquired	disease	C23;C11;C10	DiseaseorSyndrome	0.30	1	2002	2002	1	0	CTD_human
val	2780	GNAT2	0.674	0.231	C0239777	ColorBlindness,Green	phenotype	C23;C11;C10	DiseaseorSyndrome	0.30	1	2002	2002	1	0	CTD_human
val	2780	GNAT2	0.674	0.231	C0242225	Colorblindness	disease	C23;C11;C10	DiseaseorSyndrome	0.30	1	2002	2002	1	0	CTD_human
val	2780	GNAT2	0.674	0.231	C0271092	Progressiveconedystrophy(withoutrodinvolvement)	disease	C11	DiseaseorSyndrome	0.30	1	2003	2003	1	0	ORPHANET
val	2780	GNAT2	0.674	0.231	C0751042	ColorBlindness,Inherited	disease	C23;C11;C10	DiseaseorSyndrome	0.30	1	2002	2002	1	0	CTD_human
val	2780	GNAT2	0.674	0.231	C0751043	Monochromatopsia	phenotype	C23;C11;C10	DiseaseorSyndrome	0.30	1	2002	2002	1	0	CTD_human
val	2780	GNAT2	0.674	0.231	C1841721	ACHROMATOPSIA4	disease	C23;C16;C11;C10	DiseaseorSyndrome	0.81	1	2002	2013	0	13	CTD_human;GENOMICS_ENGLAND
val	2781	GNAZ	0.722	0.346	C2239176	Livercarcinoma	disease	C06;C04	NeoplasticProcess	0.31	0.5	2006	2017	1	0	CTD_human
val	2782	GNB1	0.617	0.731	C0003469	AnxietyDisorders	group	F03	MentalorBehavioralDysfunction	0.30	1	2012	2012	1	0	CTD_human
val	2782	GNB1	0.617	0.731	C0011573	Endogenousdepression	disease	F03	MentalorBehavioralDysfunction	0.30	1	2012	2012	1	0	CTD_human
val	2782	GNB1	0.617	0.731	C0011581	Depressivedisorder	disease	F03	MentalorBehavioralDysfunction	0.30	1	2012	2012	1	0	CTD_human
val	2782	GNB1	0.617	0.731	C0023452	ChildhoodAcuteLymphoblasticLeukemia	disease	C04;C20;C15	NeoplasticProcess	0.30				0	0	CTD_human
val	2782	GNB1	0.617	0.731	C0023453	L2AcuteLymphoblasticLeukemia	disease	C04;C20;C15	NeoplasticProcess	0.30				0	0	CTD_human
val	2782	GNB1	0.617	0.731	C0025193	Melancholia	disease	F03	MentalorBehavioralDysfunction	0.30	1	2012	2012	1	0	CTD_human
val	2782	GNB1	0.617	0.731	C0036572	Seizures	phenotype	C23;C10	SignorSymptom	0.41	1	2015	2016	1	8	GENOMICS_ENGLAND
val	2782	GNB1	0.617	0.731	C0041696	UnipolarDepression	disease	F03	MentalorBehavioralDysfunction	0.30	1	2012	2012	1	0	CTD_human
val	2782	GNB1	0.617	0.731	C0086133	DepressiveSyndrome	disease	F03	MentalorBehavioralDysfunction	0.30	1	2012	2012	1	0	CTD_human
val	2782	GNB1	0.617	0.731	C0282126	Depression,Neurotic	disease	F03	MentalorBehavioralDysfunction	0.30	1	2012	2012	1	0	CTD_human
val	2782	GNB1	0.617	0.731	C0376280	AnxietyStates,Neurotic	disease	F03	MentalorBehavioralDysfunction	0.30	1	2012	2012	1	0	CTD_human
val	2782	GNB1	0.617	0.731	C0424605	Developmentaldelay(disorder)	phenotype	F03	MentalorBehavioralDysfunction	0.31	1	2017	2019	1	0	GENOMICS_ENGLAND
val	2782	GNB1	0.617	0.731	C0557874	Globaldevelopmentaldelay	disease		MentalorBehavioralDysfunction	0.42	1	2016	2019	1	9	GENOMICS_ENGLAND
val	2782	GNB1	0.617	0.731	C1279420	Anxietyneurosis(finding)	disease	F03	MentalorBehavioralDysfunction	0.30	1	2012	2012	1	0	CTD_human
val	2782	GNB1	0.617	0.731	C1961102	PrecursorCellLymphoblasticLeukemiaLymphoma	disease	C04;C20;C15	NeoplasticProcess	0.40				0	1	CTD_human
val	2782	GNB1	0.617	0.731	C3714756	IntellectualDisability	group	C23;C10;F03;F01	MentalorBehavioralDysfunction	0.40	1	2017	2017	1	0	GENOMICS_ENGLAND
val	2782	GNB1	0.617	0.731	C4310774	MENTALRETARDATION,AUTOSOMALDOMINANT42	disease		DiseaseorSyndrome	0.70	1	2015	2018	5	12	CTD_human;GENOMICS_ENGLAND;UNIPROT
val	2784	GNB3	0.518	0.808	C0005586	BipolarDisorder	disease	F03	MentalorBehavioralDysfunction	0.30	1	2010	2010	1	0	PSYGENET
val	2784	GNB3	0.518	0.808	C0010054	CoronaryArteriosclerosis	disease	C14	DiseaseorSyndrome	0.35	1	2000	2014	1	0	CTD_human
val	2784	GNB3	0.518	0.808	C0011570	MentalDepression	disease	F01	MentalorBehavioralDysfunction	0.34	1	2004	2018	5	0	PSYGENET
val	2784	GNB3	0.518	0.808	C0011581	Depressivedisorder	disease	F03	MentalorBehavioralDysfunction	0.36	1	2002	2018	5	0	PSYGENET
val	2784	GNB3	0.518	0.808	C0011860	DiabetesMellitus,Non-Insulin-Dependent	disease	C18;C19	DiseaseorSyndrome	0.40	0.923	1999	2018	1	0	CTD_human
val	2784	GNB3	0.518	0.808	C0020538	Hypertensivedisease	group	C14	DiseaseorSyndrome	0.40	0.938	1998	2018	2	0	CTD_human
val	2784	GNB3	0.518	0.808	C0022333	JacksonianSeizure	disease	C23;C10	DiseaseorSyndrome	0.30	1	2008	2008	1	0	CTD_human
val	2784	GNB3	0.518	0.808	C0028754	Obesity	disease	C23;C18	DiseaseorSyndrome	0.40	0.939	1999	2018	2	0	CTD_human
val	2784	GNB3	0.518	0.808	C0036341	Schizophrenia	disease	F03	MentalorBehavioralDysfunction	0.32	1	2005	2007	1	0	PSYGENET
val	2784	GNB3	0.518	0.808	C0036572	Seizures	phenotype	C23;C10	SignorSymptom	0.30	1	2008	2008	1	0	CTD_human
val	2784	GNB3	0.518	0.808	C0041696	UnipolarDepression	disease	F03	MentalorBehavioralDysfunction	0.37	0.6	2007	2017	5	0	PSYGENET
val	2784	GNB3	0.518	0.808	C0043094	WeightGain	phenotype	C23	Finding	0.30	1	2005	2005	1	0	CTD_human
val	2784	GNB3	0.518	0.808	C0085580	EssentialHypertension	disease	C14	DiseaseorSyndrome	0.40	0.909	1998	2017	0	0	CTD_human
val	2784	GNB3	0.518	0.808	C0149958	Complexpartialseizures	disease	C23;C10	DiseaseorSyndrome	0.30	1	2008	2008	1	0	CTD_human
val	2784	GNB3	0.518	0.808	C0234533	Generalizedseizures	disease	C23;C10	DiseaseorSyndrome	0.30	1	2008	2008	1	0	CTD_human
val	2784	GNB3	0.518	0.808	C0234535	ClonicSeizures	disease	C23;C10	DiseaseorSyndrome	0.30	1	2008	2008	1	0	CTD_human
val	2784	GNB3	0.518	0.808	C0270824	Visualseizure	disease	C23;C10	DiseaseorSyndrome	0.30	1	2008	2008	1	0	CTD_human
val	2784	GNB3	0.518	0.808	C0270844	TonicSeizures	phenotype	C23;C10	DiseaseorSyndrome	0.30	1	2008	2008	1	0	CTD_human
val	2784	GNB3	0.518	0.808	C0270846	Epilepticdropattack	disease	C23;C10	DiseaseorSyndrome	0.30	1	2008	2008	1	0	CTD_human
val	2784	GNB3	0.518	0.808	C0339535	Nightblindness,congenitalstationary	disease	C16;C11	CongenitalAbnormality	0.51	0.5	2015	2016	1	0	CTD_human;ORPHANET
val	2784	GNB3	0.518	0.808	C0422850	Seizures,Somatosensory	phenotype	C23;C10	PathologicFunction	0.30	1	2008	2008	1	0	CTD_human
val	2784	GNB3	0.518	0.808	C0422852	Seizures,Auditory	phenotype	C23;C10	PathologicFunction	0.30	1	2008	2008	1	0	CTD_human
val	2784	GNB3	0.518	0.808	C0422853	Olfactoryseizure	phenotype	C23;C10	DiseaseorSyndrome	0.30	1	2008	2008	1	0	CTD_human
val	2784	GNB3	0.518	0.808	C0422854	Gustatoryseizure	phenotype	C23;C10	SignorSymptom	0.30	1	2008	2008	1	0	CTD_human
val	2784	GNB3	0.518	0.808	C0422855	Vertiginousseizure	phenotype	C23;C10	DiseaseorSyndrome	0.30	1	2008	2008	1	0	CTD_human
val	2784	GNB3	0.518	0.808	C0494475	Tonic-clonicseizures	disease	C23;C10	DiseaseorSyndrome	0.30	1	2008	2008	1	0	CTD_human
val	2784	GNB3	0.518	0.808	C0525045	MoodDisorders	group	F03	MentalorBehavioralDysfunction	0.33	1	2001	2003	2	0	PSYGENET
val	2784	GNB3	0.518	0.808	C0751056	Non-epilepticconvulsion	phenotype	C23;C10	SignorSymptom	0.30	1	2008	2008	1	0	CTD_human
val	2784	GNB3	0.518	0.808	C0751110	SingleSeizure	disease	C23;C10	DiseaseorSyndrome	0.30	1	2008	2008	1	0	CTD_human
val	2784	GNB3	0.518	0.808	C0751123	AtonicAbsenceSeizures	phenotype	C23;C10	DiseaseorSyndrome	0.30	1	2008	2008	1	0	CTD_human
val	2784	GNB3	0.518	0.808	C0751494	ConvulsiveSeizures	phenotype	C23;C10	SignorSymptom	0.30	1	2008	2008	1	0	CTD_human
val	2784	GNB3	0.518	0.808	C0751495	Seizures,Focal	phenotype	C23;C10	DiseaseorSyndrome	0.30	1	2008	2008	1	0	CTD_human
val	2784	GNB3	0.518	0.808	C0751496	Seizures,Sensory	phenotype	C23;C10	SignorSymptom	0.30	1	2008	2008	1	0	CTD_human
val	2784	GNB3	0.518	0.808	C1269683	MajorDepressiveDisorder	disease	F03	MentalorBehavioralDysfunction	0.38	0.6	2004	2017	5	0	PSYGENET
val	2784	GNB3	0.518	0.808	C1848172	NIGHTBLINDNESS,CONGENITALSTATIONARY,TYPE2A	disease	C16;C11	DiseaseorSyndrome	0.30				0	0	CTD_human
val	2784	GNB3	0.518	0.808	C1850362	NIGHTBLINDNESS,CONGENITALSTATIONARY,TYPE1B	disease	C16;C11	DiseaseorSyndrome	0.30				0	0	CTD_human
val	2784	GNB3	0.518	0.808	C1864877	NIGHTBLINDNESS,CONGENITALSTATIONARY,TYPE2B(disorder)	disease	C16;C11	DiseaseorSyndrome	0.30				0	0	CTD_human
val	2784	GNB3	0.518	0.808	C1956346	CoronaryArteryDisease	disease	C14	DiseaseorSyndrome	0.38	1	2000	2017	1	0	CTD_human
val	2784	GNB3	0.518	0.808	C3495587	NightBlindness,CongenitalStationary,Type1A	disease	C16;C11	DiseaseorSyndrome	0.30				0	0	CTD_human
val	2784	GNB3	0.518	0.808	C3495874	NonepilepticSeizures	phenotype	C23;C10	DiseaseorSyndrome	0.30	1	2008	2008	1	0	CTD_human
val	2784	GNB3	0.518	0.808	C3501847	Nightblindness,congenitalstationary,type1	disease	C16;C11	DiseaseorSyndrome	0.30				0	0	CTD_human
val	2784	GNB3	0.518	0.808	C3711543	X-LinkedCsnb	disease	C16;C11	DiseaseorSyndrome	0.30				0	0	CTD_human
val	2784	GNB3	0.518	0.808	C4041558	Cone-rodsynapticdisorder,congenitalnonprogressive	disease	C16;C11	DiseaseorSyndrome	0.30				0	0	CTD_human
val	2784	GNB3	0.518	0.808	C4048158	Convulsions	phenotype	C23;C10	SignorSymptom	0.30	1	2008	2008	1	0	CTD_human
val	2784	GNB3	0.518	0.808	C4310758	NIGHTBLINDNESS,CONGENITALSTATIONARY,TYPE1H	disease		DiseaseorSyndrome	0.40	1	2016	2016	1	2	UNIPROT
val	2784	GNB3	0.518	0.808	C4316903	AbsenceSeizures	phenotype	C23;C10	DiseaseorSyndrome	0.30	1	2008	2008	1	0	CTD_human
val	2784	GNB3	0.518	0.808	C4317109	EpilepticSeizures	phenotype	C23;C10	DiseaseorSyndrome	0.30	1	2008	2008	1	0	CTD_human
val	2784	GNB3	0.518	0.808	C4317123	MyoclonicSeizures	phenotype	C23;C10	SignorSymptom	0.30	1	2008	2008	1	0	CTD_human
val	2784	GNB3	0.518	0.808	C4505436	GeneralizedAbsenceSeizures	phenotype	C23;C10	DiseaseorSyndrome	0.30	1	2008	2008	1	0	CTD_human
val	2787	GNG5	0.89	0.231	C0033578	ProstaticNeoplasms	group	C04;C12	NeoplasticProcess	0.30	1	2007	2007	1	0	CTD_human
val	2787	GNG5	0.89	0.231	C0376358	Malignantneoplasmofprostate	disease	C04;C12	NeoplasticProcess	0.30	1	2007	2007	1	0	CTD_human
val	2788	GNG7	0.76	0.269	C0014859	EsophagealNeoplasms	group	C06;C04	NeoplasticProcess	0.30	1	2008	2008	1	0	CTD_human
val	2788	GNG7	0.76	0.269	C0546837	Malignantneoplasmofesophagus	disease	C06;C04	NeoplasticProcess	0.31	1	2008	2008	1	0	CTD_human
val	2791	GNG11	0.76	0.231	C0087031	Juvenile-OnsetStillDisease	disease	C17;C05;C20	DiseaseorSyndrome	0.30	1	2009	2009	1	0	CTD_human
val	2791	GNG11	0.76	0.231	C0152013	Adenocarcinomaoflung(disorder)	disease	C04	NeoplasticProcess	0.30	1	2014	2014	1	0	CTD_human
val	2791	GNG11	0.76	0.231	C3495559	Juvenilearthritis	disease	C17;C05;C20	DiseaseorSyndrome	0.30	1	2009	2009	1	0	CTD_human
val	2791	GNG11	0.76	0.231	C3714758	Juvenilepsoriaticarthritis	disease	C17;C05;C20	DiseaseorSyndrome	0.30	1	2009	2009	1	0	CTD_human
val	2791	GNG11	0.76	0.231	C4552091	Polyarthritis,Juvenile,RheumatoidFactorNegative	disease	C17;C05;C20	DiseaseorSyndrome	0.30	1	2009	2009	1	0	CTD_human
val	2791	GNG11	0.76	0.231	C4704862	Polyarthritis,Juvenile,RheumatoidFactorPositive	disease	C17;C05;C20	DiseaseorSyndrome	0.30	1	2009	2009	1	0	CTD_human
val	2793	GNGT2	0.805	0.154	C0023893	LiverCirrhosis,Experimental	disease	C23;C06	ExperimentalModelofDisease	0.30	1	2014	2014	1	0	CTD_human
val	2796	GNRH1	0.524	0.731	C0001624	AdrenalGlandNeoplasms	group	C04;C19	NeoplasticProcess	0.30	1	2009	2009	1	0	CTD_human
val	2796	GNRH1	0.524	0.731	C0018681	Headache	phenotype	C23	SignorSymptom	0.30	1	2003	2003	1	0	CTD_human
val	2796	GNRH1	0.524	0.731	C0020514	Hyperprolactinemia	disease	C10;C19	DiseaseorSyndrome	0.30	1	1990	1990	1	0	CTD_human
val	2796	GNRH1	0.524	0.731	C0020538	Hypertensivedisease	group	C14	DiseaseorSyndrome	0.30	1	1983	1983	1	0	CTD_human
val	2796	GNRH1	0.524	0.731	C0020619	Hypogonadism	disease	C19	DiseaseorSyndrome	0.34	1	2008	2019	1	0	CTD_human
val	2796	GNRH1	0.524	0.731	C0020672	Hypothermia,natural	phenotype	C23	Finding	0.30	1	1983	1983	1	0	CTD_human
val	2796	GNRH1	0.524	0.731	C0021364	Maleinfertility	phenotype	C12	DiseaseorSyndrome	0.30	1	2010	2010	1	0	CTD_human
val	2796	GNRH1	0.524	0.731	C0028838	OcularHeadache	phenotype	C23	SignorSymptom	0.30	1	2003	2003	1	0	CTD_human
val	2796	GNRH1	0.524	0.731	C0034013	PrecociousPuberty	disease	C19	DiseaseorSyndrome	0.31	1	1993	2008	1	0	CTD_human
val	2796	GNRH1	0.524	0.731	C0035222	RespiratoryDistressSyndrome,Adult	disease	C08	DiseaseorSyndrome	0.30	1	2014	2014	1	0	CTD_human
val	2796	GNRH1	0.524	0.731	C0039231	Tachycardia	phenotype	C23;C14	Finding	0.30	1	1983	1983	1	0	CTD_human
val	2796	GNRH1	0.524	0.731	C0042963	Vomiting	phenotype	C23	SignorSymptom	0.30	1	2003	2003	1	0	CTD_human
val	2796	GNRH1	0.524	0.731	C0080203	Tachyarrhythmia	phenotype	C23;C14	Finding	0.30	1	1983	1983	1	0	CTD_human
val	2796	GNRH1	0.524	0.731	C0271527	Cryptogenicsexualprecocity	phenotype	C19	DiseaseorSyndrome	0.30	1	2008	2008	1	0	CTD_human
val	2796	GNRH1	0.524	0.731	C0271623	Hypogonadotropichypogonadism	disease	C19	DiseaseorSyndrome	0.65	1	1977	2019	1	0	CTD_human
val	2796	GNRH1	0.524	0.731	C0342384	Idiopathichypogonadotropichypogonadism	disease	C19	DiseaseorSyndrome	0.38	0.875	1989	2016	1	0	CTD_human
val	2796	GNRH1	0.524	0.731	C0342543	CentralPrecociousPuberty	disease	C19	DiseaseorSyndrome	0.30	1	2008	2008	1	0	CTD_human
val	2796	GNRH1	0.524	0.731	C0423618	ThrobbingHeadache	phenotype	C23	SignorSymptom	0.30	1	2003	2003	1	0	CTD_human
val	2796	GNRH1	0.524	0.731	C0423623	BilateralHeadache	phenotype	C23	SignorSymptom	0.30	1	2003	2003	1	0	CTD_human
val	2796	GNRH1	0.524	0.731	C0428977	Bradycardia	phenotype	C23;C14	Finding	0.30	1	1983	1983	1	0	CTD_human
val	2796	GNRH1	0.524	0.731	C0474366	GeneralizedHeadache	phenotype	C23	SignorSymptom	0.30	1	2003	2003	1	0	CTD_human
val	2796	GNRH1	0.524	0.731	C0750887	AdrenalCancer	disease	C04;C19	NeoplasticProcess	0.30	1	2009	2009	1	0	CTD_human
val	2796	GNRH1	0.524	0.731	C0751186	OrthostaticHeadache	phenotype	C23	SignorSymptom	0.30	1	2003	2003	1	0	CTD_human
val	2796	GNRH1	0.524	0.731	C0751187	PeriorbitalHeadache	phenotype	C23	SignorSymptom	0.30	1	2003	2003	1	0	CTD_human
val	2796	GNRH1	0.524	0.731	C0751189	Retro-OcularHeadache	phenotype	C23	SignorSymptom	0.30	1	2003	2003	1	0	CTD_human
val	2796	GNRH1	0.524	0.731	C0751190	SharpHeadache	phenotype	C23	SignorSymptom	0.30	1	2003	2003	1	0	CTD_human
val	2796	GNRH1	0.524	0.731	C0751192	VertexHeadache	phenotype	C23	SignorSymptom	0.30	1	2003	2003	1	0	CTD_human
val	2796	GNRH1	0.524	0.731	C0848676	Subfertility,Male	phenotype	C12	SignorSymptom	0.30	1	2010	2010	1	0	CTD_human
val	2796	GNRH1	0.524	0.731	C0877781	Hemicrania	phenotype	C23	SignorSymptom	0.30	1	2003	2003	1	0	CTD_human
val	2796	GNRH1	0.524	0.731	C0917731	Malesterility	phenotype	C12	Finding	0.30	1	2010	2010	1	0	CTD_human
val	2796	GNRH1	0.524	0.731	C0948896	Primaryhypogonadism	disease	C19	DiseaseorSyndrome	0.30	1	2010	2010	1	0	CTD_human
val	2796	GNRH1	0.524	0.731	C1504412	Testotoxicosis	disease	C19	DiseaseorSyndrome	0.30	1	2008	2008	1	0	CTD_human
val	2796	GNRH1	0.524	0.731	C1856897	Eunuchoidism,familialhypogonadotropic	disease	C19	DiseaseorSyndrome	0.90	1	1977	2013	3	1	CTD_human;GENOMICS_ENGLAND;UNIPROT
val	2796	GNRH1	0.524	0.731	C3489396	Hypogonadism,IsolatedHypogonadotropic	disease	C19	DiseaseorSyndrome	0.31	1	2010	2010	1	0	CTD_human
val	2798	GNRHR	0.54	0.654	C0001624	AdrenalGlandNeoplasms	group	C04;C19	NeoplasticProcess	0.30	1	2009	2009	1	0	CTD_human
val	2798	GNRHR	0.54	0.654	C0020619	Hypogonadism	disease	C19	DiseaseorSyndrome	0.39	1	1999	2017	1	0	CTD_human
val	2798	GNRHR	0.54	0.654	C0271623	Hypogonadotropichypogonadism	disease	C19	DiseaseorSyndrome	0.70	0.971	1999	2018	1	0	CTD_human
val	2798	GNRHR	0.54	0.654	C0342384	Idiopathichypogonadotropichypogonadism	disease	C19	DiseaseorSyndrome	1.00	0.981	1997	2018	12	0	CTD_human;GENOMICS_ENGLAND;UNIPROT
val	2798	GNRHR	0.54	0.654	C0750887	AdrenalCancer	disease	C04;C19	NeoplasticProcess	0.30	1	2009	2009	1	0	CTD_human
val	2798	GNRHR	0.54	0.654	C0948896	Primaryhypogonadism	disease	C19	DiseaseorSyndrome	0.30	1	2005	2005	1	0	CTD_human
val	2798	GNRHR	0.54	0.654	C3489396	Hypogonadism,IsolatedHypogonadotropic	disease	C19	DiseaseorSyndrome	0.56	1	2001	2016	1	0	CTD_human
val	2799	GNS	0.705	0.538	C0026706	MucopolysaccharidosisIII	disease	C16;C18;C17	DiseaseorSyndrome	0.72	1	1988	2017	2	0	CTD_human;GENOMICS_ENGLAND
val	2799	GNS	0.705	0.538	C0086647	MucopolysaccharidosisTypeIIIA	disease	C16;C18;C17	DiseaseorSyndrome	0.34	1	1988	2019	1	0	CTD_human
val	2799	GNS	0.705	0.538	C0086648	MPSIIIB	disease	C16;C18;C17	DiseaseorSyndrome	0.30	1	1988	1988	1	0	CTD_human
val	2799	GNS	0.705	0.538	C0086649	MPSIIIC	disease	C16;C18;C17	DiseaseorSyndrome	0.31	1	1988	2016	1	0	CTD_human
val	2799	GNS	0.705	0.538	C0086650	MPSIIID	disease	C16;C18;C17	DiseaseorSyndrome	0.77	1	1988	2016	6	5	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
val	2803	GOLGA4	0.656	0.692	C0033578	ProstaticNeoplasms	group	C04;C12	NeoplasticProcess	0.30	1	2007	2007	1	0	CTD_human
val	2803	GOLGA4	0.656	0.692	C0037274	Dermatologicdisorders	group	C17	DiseaseorSyndrome	0.30	1	2006	2006	1	0	CTD_human
val	2803	GOLGA4	0.656	0.692	C0274861	ArsenicPoisoning,Inorganic	disease	C10;C25	InjuryorPoisoning	0.30	1	2006	2006	1	0	CTD_human
val	2803	GOLGA4	0.656	0.692	C0274862	NervousSystem,OrganicArsenicPoisoning	disease	C10;C25	InjuryorPoisoning	0.30	1	2006	2006	1	0	CTD_human
val	2803	GOLGA4	0.656	0.692	C0311375	ArsenicPoisoning	disease	C10;C25	InjuryorPoisoning	0.30	1	2006	2006	1	0	CTD_human
val	2803	GOLGA4	0.656	0.692	C0376358	Malignantneoplasmofprostate	disease	C04;C12	NeoplasticProcess	0.30	1	2007	2007	1	0	CTD_human
val	2803	GOLGA4	0.656	0.692	C0751851	ArsenicEncephalopathy	disease	C10;C25	DiseaseorSyndrome	0.30	1	2006	2006	1	0	CTD_human
val	2803	GOLGA4	0.656	0.692	C0751852	ArsenicInducedPolyneuropathy	disease	C10;C25	InjuryorPoisoning	0.30	1	2006	2006	1	0	CTD_human
val	2804	GOLGB1	0.695	0.615	C0006142	Malignantneoplasmofbreast	disease	C04;C17	NeoplasticProcess	0.30				0	0	UNIPROT
val	2805	GOT1	0.601	0.692	C0019193	Hepatitis,Toxic	disease	C06;C25	InjuryorPoisoning	0.30	1	2014	2014	1	0	CTD_human
val	2805	GOT1	0.601	0.692	C0023893	LiverCirrhosis,Experimental	disease	C23;C06	ExperimentalModelofDisease	0.30	1	2006	2006	1	0	CTD_human
val	2805	GOT1	0.601	0.692	C0860207	Drug-InducedLiverDisease	phenotype	C06;C25	DiseaseorSyndrome	0.30	1	2014	2014	1	0	CTD_human
val	2805	GOT1	0.601	0.692	C1262760	Hepatitis,Drug-Induced	disease	C06;C25	DiseaseorSyndrome	0.30	1	2014	2014	1	0	CTD_human
val	2805	GOT1	0.601	0.692	C3658290	Drug-InducedAcuteLiverInjury	disease	C06;C25	DiseaseorSyndrome	0.30	1	2014	2014	1	0	CTD_human
val	2805	GOT1	0.601	0.692	C4277682	ChemicalandDrugInducedLiverInjury	disease	C06;C25	DiseaseorSyndrome	0.30	1	2014	2014	1	0	CTD_human
val	2805	GOT1	0.601	0.692	C4279912	Chemically-InducedLiverToxicity	disease	C06;C25	DiseaseorSyndrome	0.30	1	2014	2014	1	0	CTD_human
val	2806	GOT2	0.529	0.731	C0015544	FailuretoThrive	disease	C23	DiseaseorSyndrome	0.30	1	2019	2019	1	0	GENOMICS_ENGLAND
val	2806	GOT2	0.529	0.731	C0025958	Microcephaly	disease	C16;C05;C10	CongenitalAbnormality	0.30	1	2019	2019	1	0	GENOMICS_ENGLAND
val	2806	GOT2	0.529	0.731	C0036572	Seizures	phenotype	C23;C10	SignorSymptom	0.30	1	2019	2019	1	0	GENOMICS_ENGLAND
val	2806	GOT2	0.529	0.731	C0220994	Hyperammonemia	phenotype	C23	DiseaseorSyndrome	0.30	1	2019	2019	1	0	GENOMICS_ENGLAND
val	2806	GOT2	0.529	0.731	C0232466	Feedingdifficulties	phenotype		Finding	0.30	1	2019	2019	1	0	GENOMICS_ENGLAND
val	2806	GOT2	0.529	0.731	C0557874	Globaldevelopmentaldelay	disease		MentalorBehavioralDysfunction	0.30	1	2019	2019	1	0	GENOMICS_ENGLAND
val	2806	GOT2	0.529	0.731	C1836440	Increasedserumlactate	phenotype	C18	Finding	0.30	1	2019	2019	1	0	GENOMICS_ENGLAND
val	2806	GOT2	0.529	0.731	C3714756	IntellectualDisability	group	C23;C10;F03;F01	MentalorBehavioralDysfunction	0.30	1	2019	2019	1	0	GENOMICS_ENGLAND
val	2806	GOT2	0.529	0.731	C4022810	Abnormalityofnervoussystemmorphology	disease	C16;C10	AnatomicalAbnormality	0.30	1	2019	2019	1	0	GENOMICS_ENGLAND
val	2810	SFN	0.561	0.769	C0007137	Squamouscellcarcinoma	disease	C04	NeoplasticProcess	0.35	1	2004	2008	1	0	CTD_human
val	2810	SFN	0.561	0.769	C0014859	EsophagealNeoplasms	group	C06;C04	NeoplasticProcess	0.31	1	2005	2010	1	0	CTD_human
val	2810	SFN	0.561	0.769	C0022548	Keloid	disease	C23;C17	AcquiredAbnormality	0.30	1	2010	2010	1	0	CTD_human
val	2810	SFN	0.561	0.769	C0024232	LymphaticMetastasis	disease	C23;C04	NeoplasticProcess	0.31	1	2010	2010	1	0	CTD_human
val	2810	SFN	0.561	0.769	C0026640	MouthNeoplasms	group	C04;C07	NeoplasticProcess	0.31	1	2004	2007	1	0	CTD_human
val	2810	SFN	0.561	0.769	C0152013	Adenocarcinomaoflung(disorder)	disease	C04	NeoplasticProcess	0.38	1	2010	2019	1	0	CTD_human
val	2810	SFN	0.561	0.769	C0153381	Malignantneoplasmofmouth	group	C04;C07	NeoplasticProcess	0.30	1	2004	2004	1	0	CTD_human
val	2810	SFN	0.561	0.769	C0279626	Squamouscellcarcinomaofesophagus	disease	C06;C04	NeoplasticProcess	0.32	1	2010	2011	1	0	CTD_human
val	2810	SFN	0.561	0.769	C0546837	Malignantneoplasmofesophagus	disease	C06;C04	NeoplasticProcess	0.31	1	2005	2010	1	0	CTD_human
val	2810	SFN	0.561	0.769	C2239176	Livercarcinoma	disease	C06;C04	NeoplasticProcess	0.32	1	2000	2019	1	0	CTD_human
val	2811	GP1BA	0.565	0.692	C0005129	Bernard-SoulierSyndrome	disease	C16;C15	DiseaseorSyndrome	1.00	1	1990	2020	9	0	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
val	2811	GP1BA	0.565	0.692	C0020538	Hypertensivedisease	group	C14	DiseaseorSyndrome	0.30	1	2012	2012	1	0	CTD_human
val	2811	GP1BA	0.565	0.692	C0040053	Thrombosis	phenotype	C14	PathologicFunction	0.31	1	2007	2007	1	0	CTD_human
val	2811	GP1BA	0.565	0.692	C0087086	Thrombus	phenotype	C14	PathologicFunction	0.30	1	2007	2007	1	0	CTD_human
val	2811	GP1BA	0.565	0.692	C1280798	VonWillebranddisease,platelettype	disease	C16;C15	DiseaseorSyndrome	0.80	1	1991	2019	5	0	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
val	2811	GP1BA	0.565	0.692	C1319466	BarberSaysyndrome	disease	C23;C16;C11;C17;C05;C07	DiseaseorSyndrome	0.30	1	2011	2011	1	0	GENOMICS_ENGLAND
val	2811	GP1BA	0.565	0.692	C1847711	NONARTERITICANTERIORISCHEMICOPTICNEUROPATHY,SUSCEPTIBILITYTO	phenotype		Finding	0.30				0	0	CTD_human
val	2811	GP1BA	0.565	0.692	C1857941	Brooke-Spieglersyndrome	disease	C16;C04;C17	DiseaseorSyndrome	0.31	1	2011	2018	1	0	GENOMICS_ENGLAND
val	2811	GP1BA	0.565	0.692	C2713537	DeficiencyofPlateletGlycoprotein1b	disease	C16;C15	DiseaseorSyndrome	0.30				0	0	CTD_human
val	2811	GP1BA	0.565	0.692	C3277076	BERNARD-SOULIERSYNDROME,TYPEA2,AUTOSOMALDOMINANT	disease		DiseaseorSyndrome	0.60	1	2001	2001	1	0	CTD_human;UNIPROT
val	2811	GP1BA	0.565	0.692	C3853779	NeonatalAlloimmuneThrombocytopenia	disease	C16;C15	DiseaseorSyndrome	0.40				0	0	ORPHANET
val	2811	GP1BA	0.565	0.692	C3854603	FNAITP	disease		DiseaseorSyndrome	0.31	1	2013	2013	0	0	ORPHANET
val	2812	GP1BB	0.524	0.769	C0005129	Bernard-SoulierSyndrome	disease	C16;C15	DiseaseorSyndrome	1.00	1	1988	2019	15	1	CLINGEN;CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
val	2812	GP1BB	0.524	0.769	C0012236	DiGeorgeSyndrome	disease	C16;C05;C19;C15;C14	DiseaseorSyndrome	0.31	1	2007	2007	0	0	ORPHANET
val	2812	GP1BB	0.524	0.769	C0018798	CongenitalHeartDefects	group	C16;C14	CongenitalAbnormality	0.30	1	2004	2004	1	0	CTD_human
val	2812	GP1BB	0.524	0.769	C0032460	PolycysticOvarySyndrome	disease	C04;C13;C19	DiseaseorSyndrome	0.30	1	2011	2011	1	0	CTD_human
val	2812	GP1BB	0.524	0.769	C0040034	Thrombocytopenia	phenotype	C15	DiseaseorSyndrome	0.40	1	2004	2019	1	0	CTD_human
val	2812	GP1BB	0.524	0.769	C0087031	Juvenile-OnsetStillDisease	disease	C17;C05;C20	DiseaseorSyndrome	0.30	1	2009	2009	1	0	CTD_human
val	2812	GP1BB	0.524	0.769	C0220704	Shprintzensyndrome	disease	C16;C05;C19;C15;C14	DiseaseorSyndrome	0.30				0	0	ORPHANET
val	2812	GP1BB	0.524	0.769	C0376634	CraniofacialAbnormalities	group	C16;C05	CongenitalAbnormality	0.30	1	2004	2004	1	0	CTD_human
val	2812	GP1BB	0.524	0.769	C0431406	Asymmetriccryingfaceassociation	disease	C23;C10;C07	DiseaseorSyndrome	0.30				0	0	ORPHANET
val	2812	GP1BB	0.524	0.769	C0795907	CONOTRUNCALANOMALYFACESYNDROME	disease	C16;C05;C19;C15;C14	DiseaseorSyndrome	0.30				0	0	ORPHANET
val	2812	GP1BB	0.524	0.769	C1136382	SclerocysticOvaries	disease	C04;C13;C19	DiseaseorSyndrome	0.30	1	2011	2011	1	0	CTD_human
val	2812	GP1BB	0.524	0.769	C1319466	BarberSaysyndrome	disease	C23;C16;C11;C17;C05;C07	DiseaseorSyndrome	0.30	1	2011	2011	1	0	GENOMICS_ENGLAND
val	2812	GP1BB	0.524	0.769	C1857941	Brooke-Spieglersyndrome	disease	C16;C04;C17	DiseaseorSyndrome	0.30	1	2011	2011	1	0	GENOMICS_ENGLAND
val	2812	GP1BB	0.524	0.769	C2713537	DeficiencyofPlateletGlycoprotein1b	disease	C16;C15	DiseaseorSyndrome	0.30				0	0	CTD_human
val	2812	GP1BB	0.524	0.769	C2936346	22q11DeletionSyndrome	disease	C16;C05;C19;C15;C14	DiseaseorSyndrome	0.31	1	2019	2019	0	0	ORPHANET
val	2812	GP1BB	0.524	0.769	C3266101	22q11partialmonosomysyndrome	disease		DiseaseorSyndrome	0.30				0	0	ORPHANET
val	2812	GP1BB	0.524	0.769	C3495559	Juvenilearthritis	disease	C17;C05;C20	DiseaseorSyndrome	0.30	1	2009	2009	1	0	CTD_human
val	2812	GP1BB	0.524	0.769	C3714758	Juvenilepsoriaticarthritis	disease	C17;C05;C20	DiseaseorSyndrome	0.30	1	2009	2009	1	0	CTD_human
val	2812	GP1BB	0.524	0.769	C3853779	NeonatalAlloimmuneThrombocytopenia	disease	C16;C15	DiseaseorSyndrome	0.40				0	0	ORPHANET
val	2812	GP1BB	0.524	0.769	C3854603	FNAITP	disease		DiseaseorSyndrome	0.30				0	0	ORPHANET
val	2812	GP1BB	0.524	0.769	C4304021	Autosomaldominantmacrothrombocytopenia	disease	C16	DiseaseorSyndrome	0.31	1	2017	2017	1	0	ORPHANET
val	2812	GP1BB	0.524	0.769	C4552091	Polyarthritis,Juvenile,RheumatoidFactorNegative	disease	C17;C05;C20	DiseaseorSyndrome	0.30	1	2009	2009	1	0	CTD_human
val	2812	GP1BB	0.524	0.769	C4704862	Polyarthritis,Juvenile,RheumatoidFactorPositive	disease	C17;C05;C20	DiseaseorSyndrome	0.30	1	2009	2009	1	0	CTD_human
val	2813	GP2	0.67	0.5	C0005910	BodyWeight	phenotype	C23	OrganismAttribute	0.30	1	2012	2012	1	0	CTD_human
val	2813	GP2	0.67	0.5	C0011860	DiabetesMellitus,Non-Insulin-Dependent	disease	C18;C19	DiseaseorSyndrome	0.40	1	2019	2019	1	1	CTD_human
val	2815	GP9	0.695	0.5	C0005129	Bernard-SoulierSyndrome	disease	C16;C15	DiseaseorSyndrome	0.80	0.981	1983	2019	20	6	CLINGEN;CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
val	2815	GP9	0.695	0.5	C0040034	Thrombocytopenia	phenotype	C15	DiseaseorSyndrome	0.46	1	1998	2020	1	1	CTD_human
val	2815	GP9	0.695	0.5	C1319466	BarberSaysyndrome	disease	C23;C16;C11;C17;C05;C07	DiseaseorSyndrome	0.30	1	2011	2011	1	0	GENOMICS_ENGLAND
val	2815	GP9	0.695	0.5	C1856448	Bernard-SoulierSyndrome,TypeC	disease	C16;C15	DiseaseorSyndrome	0.41	1	2019	2019	0	6	GENOMICS_ENGLAND
val	2815	GP9	0.695	0.5	C1857941	Brooke-Spieglersyndrome	disease	C16;C04;C17	DiseaseorSyndrome	0.30	1	2011	2011	1	0	GENOMICS_ENGLAND
val	2815	GP9	0.695	0.5	C2713537	DeficiencyofPlateletGlycoprotein1b	disease	C16;C15	DiseaseorSyndrome	0.30				0	0	CTD_human
val	2817	GPC1	0.587	0.731	C0005411	BiliaryAtresia	disease	C16;C06	CongenitalAbnormality	0.32	1	2013	2016	1	0	ORPHANET
val	2817	GPC1	0.587	0.731	C0006142	Malignantneoplasmofbreast	disease	C04;C17	NeoplasticProcess	0.33	1	2001	2018	0	0	UNIPROT
val	2819	GPD1	0.67	0.5	C0019193	Hepatitis,Toxic	disease	C06;C25	InjuryorPoisoning	0.30	1	2015	2015	1	0	CTD_human
val	2819	GPD1	0.67	0.5	C0020443	Hypercholesterolemia	disease	C18	DiseaseorSyndrome	0.31	1	1994	1994	0	0	GENOMICS_ENGLAND
val	2819	GPD1	0.67	0.5	C0860207	Drug-InducedLiverDisease	phenotype	C06;C25	DiseaseorSyndrome	0.30	1	2015	2015	1	0	CTD_human
val	2819	GPD1	0.67	0.5	C1262760	Hepatitis,Drug-Induced	disease	C06;C25	DiseaseorSyndrome	0.30	1	2015	2015	1	0	CTD_human
val	2819	GPD1	0.67	0.5	C3280953	HYPERTRIGLYCERIDEMIA,TRANSIENTINFANTILE	disease		DiseaseorSyndrome	0.72	1	2012	2018	2	2	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
val	2819	GPD1	0.67	0.5	C3658290	Drug-InducedAcuteLiverInjury	disease	C06;C25	DiseaseorSyndrome	0.30	1	2015	2015	1	0	CTD_human
val	2819	GPD1	0.67	0.5	C4277682	ChemicalandDrugInducedLiverInjury	disease	C06;C25	DiseaseorSyndrome	0.30	1	2015	2015	1	0	CTD_human
val	2819	GPD1	0.67	0.5	C4279912	Chemically-InducedLiverToxicity	disease	C06;C25	DiseaseorSyndrome	0.30	1	2015	2015	1	0	CTD_human
val	2820	GPD2	0.678	0.538	C0001787	Osteoporosis,Age-Related	disease	C18;C05	DiseaseorSyndrome	0.30	1	2008	2008	1	0	CTD_human
val	2820	GPD2	0.678	0.538	C0002152	AlloxanDiabetes	disease	C18;C19	ExperimentalModelofDisease	0.30	1	2005	2005	1	0	CTD_human
val	2820	GPD2	0.678	0.538	C0011853	DiabetesMellitus,Experimental	disease	C18;C19	ExperimentalModelofDisease	0.30	1	2005	2005	1	0	CTD_human
val	2820	GPD2	0.678	0.538	C0011860	DiabetesMellitus,Non-Insulin-Dependent	disease	C18;C19	DiseaseorSyndrome	0.45	0.833	1996	2005	1	1	CTD_human
val	2820	GPD2	0.678	0.538	C0029456	Osteoporosis	disease	C18;C05	DiseaseorSyndrome	0.30	1	2008	2008	1	0	CTD_human
val	2820	GPD2	0.678	0.538	C0029459	Osteoporosis,Senile	disease	C18;C05	DiseaseorSyndrome	0.30	1	2008	2008	1	0	CTD_human
val	2820	GPD2	0.678	0.538	C0038433	StreptozotocinDiabetes	disease	C18;C19	ExperimentalModelofDisease	0.30	1	2005	2005	1	0	CTD_human
val	2820	GPD2	0.678	0.538	C0268583	Methylmalonicacidemia	phenotype	C16;C18	DiseaseorSyndrome	0.30	1	2006	2006	1	0	CTD_human
val	2820	GPD2	0.678	0.538	C0751406	Post-TraumaticOsteoporosis	disease	C18;C05	DiseaseorSyndrome	0.30	1	2008	2008	1	0	CTD_human
val	2820	GPD2	0.678	0.538	C1855119	Methylmalonicaciduria	disease	C16;C18	DiseaseorSyndrome	0.30	1	2006	2006	1	0	CTD_human
val	2821	GPI	0.491	0.769	C0002878	Anemia,Hemolytic	disease	C15	DiseaseorSyndrome	0.39	1	1978	2019	1	0	CTD_human
val	2821	GPI	0.491	0.769	C0002879	Anemia,Hemolytic,Acquired	disease	C15	DiseaseorSyndrome	0.30	1	1996	1996	1	0	CTD_human
val	2821	GPI	0.491	0.769	C0002889	Anemia,Microangiopathic	disease	C15	DiseaseorSyndrome	0.30	1	1996	1996	1	0	CTD_human
val	2821	GPI	0.491	0.769	C0006142	Malignantneoplasmofbreast	disease	C04;C17	NeoplasticProcess	0.38	1	2000	2017	1	0	CTD_human
val	2821	GPI	0.491	0.769	C0221021	Microangiopathichemolyticanemia	disease	C15	DiseaseorSyndrome	0.30	1	1996	1996	1	0	CTD_human
val	2821	GPI	0.491	0.769	C0678222	BreastCarcinoma	disease	C04;C17	NeoplasticProcess	0.40	1	2000	2017	1	0	CTD_human
val	2821	GPI	0.491	0.769	C1257931	MammaryNeoplasms,Human	disease	C04;C17	NeoplasticProcess	0.30	1	2008	2008	1	0	CTD_human
val	2821	GPI	0.491	0.769	C1458155	MammaryNeoplasms	group	C04;C17	NeoplasticProcess	0.31	1	2003	2008	1	0	CTD_human
val	2821	GPI	0.491	0.769	C3150730	HEMOLYTICANEMIA,NONSPHEROCYTIC,DUETOGLUCOSEPHOSPHATEISOMERASEDEFICIENCY	disease		DiseaseorSyndrome	0.70	1	1977	2018	10	24	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
val	2821	GPI	0.491	0.769	C4704874	MammaryCarcinoma,Human	disease	C04;C17	NeoplasticProcess	0.30	1	2008	2008	1	0	CTD_human
val	2823	GPM6A	0.729	0.423	C0036341	Schizophrenia	disease	F03	MentalorBehavioralDysfunction	0.42	1	2008	2019	1	4	PSYGENET
val	2823	GPM6A	0.729	0.423	C2239176	Livercarcinoma	disease	C06;C04	NeoplasticProcess	0.30	1	2017	2017	1	0	CTD_human
val	2826	CCR10	0.626	0.654	C0038220	StatusEpilepticus	disease	C23;C10	DiseaseorSyndrome	0.30	1	2007	2007	1	0	CTD_human
val	2826	CCR10	0.626	0.654	C0270823	Petitmalstatus	disease	C23;C10	DiseaseorSyndrome	0.30	1	2007	2007	1	0	CTD_human
val	2826	CCR10	0.626	0.654	C0311335	GrandMalStatusEpilepticus	disease	C23;C10	DiseaseorSyndrome	0.30	1	2007	2007	1	0	CTD_human
val	2826	CCR10	0.626	0.654	C0393734	ComplexPartialStatusEpilepticus	disease	C23;C10	DiseaseorSyndrome	0.30	1	2007	2007	1	0	CTD_human
val	2826	CCR10	0.626	0.654	C0751522	StatusEpilepticus,Subclinical	disease	C23;C10	DiseaseorSyndrome	0.30	1	2007	2007	1	0	CTD_human
val	2826	CCR10	0.626	0.654	C0751523	Non-ConvulsiveStatusEpilepticus	disease	C23;C10	DiseaseorSyndrome	0.30	1	2007	2007	1	0	CTD_human
val	2826	CCR10	0.626	0.654	C0751524	SimplePartialStatusEpilepticus	phenotype	C23;C10	DiseaseorSyndrome	0.30	1	2007	2007	1	0	CTD_human
val	2831	NPBWR1	0.89	0.115	C0006142	Malignantneoplasmofbreast	disease	C04;C17	NeoplasticProcess	0.30				0	1	UNIPROT
val	2832	NPBWR2	0.931	0.192	C0009402	ColorectalCarcinoma	disease	C06;C04	NeoplasticProcess	0.30				0	0	UNIPROT
val	2833	CXCR3	0.436	0.808	C0002171	AlopeciaAreata	disease	C17	DiseaseorSyndrome	0.30	1	2012	2012	1	0	CTD_human
val	2833	CXCR3	0.436	0.808	C0004364	AutoimmuneDiseases	group	C20	DiseaseorSyndrome	0.39	1	2002	2019	1	0	CTD_human
val	2833	CXCR3	0.436	0.808	C0011615	Dermatitis,Atopic	disease	C16;C17;C20	DiseaseorSyndrome	0.32	1	2000	2019	1	0	CTD_human
val	2833	CXCR3	0.436	0.808	C0011616	ContactDermatitis	disease	C17	DiseaseorSyndrome	0.30	1	2015	2015	1	0	CTD_human
val	2833	CXCR3	0.436	0.808	C0017658	Glomerulonephritis	disease	C13;C12	DiseaseorSyndrome	0.30	1	2003	2003	1	0	CTD_human
val	2833	CXCR3	0.436	0.808	C0020517	Hypersensitivity	group	C20	PathologicFunction	0.30	1	2011	2011	1	0	CTD_human
val	2833	CXCR3	0.436	0.808	C0021368	Inflammation	phenotype	C23	PathologicFunction	0.31	1	2003	2004	1	0	CTD_human
val	2833	CXCR3	0.436	0.808	C0022116	Ischemia	phenotype	C23	PathologicFunction	0.30	1	2003	2003	1	0	CTD_human
val	2833	CXCR3	0.436	0.808	C0032226	PleuralDiseases	group	C08	DiseaseorSyndrome	0.30	1	2011	2011	1	0	CTD_human
val	2833	CXCR3	0.436	0.808	C0032285	Pneumonia	disease	C01;C08	DiseaseorSyndrome	0.31	1	2008	2011	1	0	CTD_human
val	2833	CXCR3	0.436	0.808	C0032300	LobarPneumonia	disease	C01;C08	DiseaseorSyndrome	0.30	1	2011	2011	1	0	CTD_human
val	2833	CXCR3	0.436	0.808	C0038454	Cerebrovascularaccident	group	C10;C14	DiseaseorSyndrome	0.31	1	2000	2002	1	0	CTD_human
val	2833	CXCR3	0.436	0.808	C0086196	Eczema,Infantile	disease	C16;C17;C20	DiseaseorSyndrome	0.30	1	2008	2008	1	0	CTD_human
val	2833	CXCR3	0.436	0.808	C0162351	Contacthypersensitivity	phenotype	C17	PathologicFunction	0.30	1	2015	2015	1	0	CTD_human
val	2833	CXCR3	0.436	0.808	C0751956	AcuteCerebrovascularAccidents	disease	C10;C14	DiseaseorSyndrome	0.30	1	2002	2002	1	0	CTD_human
val	2833	CXCR3	0.436	0.808	C0887898	ExperimentalLungInflammation	disease	C01;C08	ExperimentalModelofDisease	0.30	1	2011	2011	1	0	CTD_human
val	2833	CXCR3	0.436	0.808	C1527304	AllergicReaction	phenotype	C20	PathologicFunction	0.30	1	2011	2011	1	0	CTD_human
val	2833	CXCR3	0.436	0.808	C1704377	BrightDisease	disease	C13;C12	DiseaseorSyndrome	0.30	1	2003	2003	1	0	CTD_human
val	2833	CXCR3	0.436	0.808	C3714636	Pneumonitis	disease	C01;C08	DiseaseorSyndrome	0.31	1	2008	2011	1	0	CTD_human
val	2837	UTS2R	0.566	0.692	C0006142	Malignantneoplasmofbreast	disease	C04;C17	NeoplasticProcess	0.32	1	2014	2016	0	1	UNIPROT
val	2840	GPR17	0.686	0.615	C0393953	AnteriorCerebralCirculationInfarction	phenotype	C23;C10;C14	DiseaseorSyndrome	0.30	1	2008	2008	1	0	CTD_human
val	2840	GPR17	0.686	0.615	C0751952	AnteriorCirculationBrainInfarction	phenotype	C23;C10;C14	DiseaseorSyndrome	0.30	1	2008	2008	1	0	CTD_human
val	2840	GPR17	0.686	0.615	C0751953	BrainInfarction,PosteriorCirculation	phenotype	C23;C10;C14	DiseaseorSyndrome	0.30	1	2008	2008	1	0	CTD_human
val	2840	GPR17	0.686	0.615	C0751954	VenousInfarction,Brain	phenotype	C23;C10;C14	DiseaseorSyndrome	0.30	1	2008	2008	1	0	CTD_human
val	2840	GPR17	0.686	0.615	C0751955	BrainInfarction	disease	C23;C10;C14	DiseaseorSyndrome	0.30	1	2008	2008	1	0	CTD_human
val	2846	LPAR4	0.769	0.346	C0238463	Papillarythyroidcarcinoma	disease	C04;C19	NeoplasticProcess	0.31	1	2016	2016	1	0	ORPHANET
val	2847	MCHR1	0.65	0.5	C0005586	BipolarDisorder	disease	F03	MentalorBehavioralDysfunction	0.31	1	2006	2009	2	0	PSYGENET
val	2847	MCHR1	0.65	0.5	C0011570	MentalDepression	disease	F01	MentalorBehavioralDysfunction	0.33	1	2005	2019	5	0	PSYGENET
val	2847	MCHR1	0.65	0.5	C0011581	Depressivedisorder	disease	F03	MentalorBehavioralDysfunction	0.33	1	2005	2019	5	0	PSYGENET
val	2847	MCHR1	0.65	0.5	C0036341	Schizophrenia	disease	F03	MentalorBehavioralDysfunction	0.34	1	2006	2020	3	0	PSYGENET
val	2847	MCHR1	0.65	0.5	C0525045	MoodDisorders	group	F03	MentalorBehavioralDysfunction	0.33	1	2006	2009	2	0	PSYGENET
val	2850	GPR27	1	0.077	C0345967	Malignantmesothelioma	disease	C04;C08	NeoplasticProcess	0.30	1	2015	2015	1	0	CTD_human
val	2852	GPER1	0.505	0.731	C0000772	Multiplecongenitalanomalies	group	C16	CongenitalAbnormality	0.30	1	2012	2012	1	0	CTD_human
val	2852	GPER1	0.505	0.731	C0006142	Malignantneoplasmofbreast	disease	C04;C17	NeoplasticProcess	0.40	0.982	1997	2020	1	0	CTD_human
val	2852	GPER1	0.505	0.731	C0678222	BreastCarcinoma	disease	C04;C17	NeoplasticProcess	0.40	0.982	1997	2020	1	0	CTD_human
val	2852	GPER1	0.505	0.731	C1257931	MammaryNeoplasms,Human	disease	C04;C17	NeoplasticProcess	0.30	1	2014	2014	1	0	CTD_human
val	2852	GPER1	0.505	0.731	C1458155	MammaryNeoplasms	group	C04;C17	NeoplasticProcess	0.40	1	2000	2019	1	0	CTD_human
val	2852	GPER1	0.505	0.731	C1800706	IdiopathicPulmonaryFibrosis	disease	C08	DiseaseorSyndrome	0.30	1	2018	2018	1	0	CTD_human
val	2852	GPER1	0.505	0.731	C4704874	MammaryCarcinoma,Human	disease	C04;C17	NeoplasticProcess	0.30	1	2014	2014	1	0	CTD_human
val	2852	GPER1	0.505	0.731	C4721508	Hamman-RichDisease	disease	C08	DiseaseorSyndrome	0.30	1	2018	2018	1	0	CTD_human
val	2852	GPER1	0.505	0.731	C4721509	UsualInterstitialPneumonia	disease	C08	DiseaseorSyndrome	0.30	1	2018	2018	1	0	CTD_human
val	2852	GPER1	0.505	0.731	C4721952	FamilialIdiopathicPulmonaryFibrosis	disease	C08	DiseaseorSyndrome	0.30	1	2018	2018	1	0	CTD_human
val	2857	GPR34	0.743	0.346	C0010093	CorpusLuteumCyst	disease	C04;C13;C19	DiseaseorSyndrome	0.30	1	2011	2011	1	0	CTD_human
val	2857	GPR34	0.743	0.346	C0029927	OvarianCysts	disease	C04;C13;C19	DiseaseorSyndrome	0.30	1	2011	2011	1	0	CTD_human
val	2859	GPR35	0.587	0.654	C0566602	Primarysclerosingcholangitis	disease	C06	DiseaseorSyndrome	0.31	1	2013	2013	1	0	ORPHANET
val	2861	GPR37	0.716	0.385	C0345967	Malignantmesothelioma	disease	C04;C08	NeoplasticProcess	0.30	1	2015	2015	1	0	CTD_human
val	2868	GRK4	0.716	0.5	C0019193	Hepatitis,Toxic	disease	C06;C25	InjuryorPoisoning	0.30	1	2015	2015	1	0	CTD_human
val	2868	GRK4	0.716	0.5	C0860207	Drug-InducedLiverDisease	phenotype	C06;C25	DiseaseorSyndrome	0.30	1	2015	2015	1	0	CTD_human
val	2868	GRK4	0.716	0.5	C1262760	Hepatitis,Drug-Induced	disease	C06;C25	DiseaseorSyndrome	0.30	1	2015	2015	1	0	CTD_human
val	2868	GRK4	0.716	0.5	C3658290	Drug-InducedAcuteLiverInjury	disease	C06;C25	DiseaseorSyndrome	0.30	1	2015	2015	1	0	CTD_human
val	2868	GRK4	0.716	0.5	C4277682	ChemicalandDrugInducedLiverInjury	disease	C06;C25	DiseaseorSyndrome	0.30	1	2015	2015	1	0	CTD_human
val	2868	GRK4	0.716	0.5	C4279912	Chemically-InducedLiverToxicity	disease	C06;C25	DiseaseorSyndrome	0.30	1	2015	2015	1	0	CTD_human
val	2869	GRK5	0.588	0.769	C0007222	CardiovascularDiseases	group	C14	DiseaseorSyndrome	0.32	1	2015	2019	1	0	CTD_human
val	2869	GRK5	0.588	0.769	C0023895	Liverdiseases	group	C06	DiseaseorSyndrome	0.30	1	2010	2010	1	0	CTD_human
val	2869	GRK5	0.588	0.769	C0086565	LiverDysfunction	phenotype	C06	Finding	0.30	1	2010	2010	1	0	CTD_human
val	2870	GRK6	0.67	0.654	C0003873	RheumatoidArthritis	disease	C17;C05;C20	DiseaseorSyndrome	0.31	1	1999	1999	1	0	CTD_human
val	2870	GRK6	0.67	0.654	C0036341	Schizophrenia	disease	F03	MentalorBehavioralDysfunction	0.31	0.5	2006	2014	2	0	PSYGENET
val	2870	GRK6	0.67	0.654	C0278701	GastricAdenocarcinoma	disease	C06;C04	NeoplasticProcess	0.30				0	1	UNIPROT
val	2870	GRK6	0.67	0.654	C3165106	Infiltratingductcarcinomaoffemalebreast	disease	C04;C17	NeoplasticProcess	0.30				0	0	UNIPROT
val	2873	GPS1	0.769	0.346	C0036341	Schizophrenia	disease	F03	MentalorBehavioralDysfunction	0.31	1	2008	2008	1	0	PSYGENET
val	2875	GPT	0.403	0.923	C0015695	FattyLiver	disease	C06	DiseaseorSyndrome	0.40	0.943	2000	2020	1	0	CTD_human
val	2875	GPT	0.403	0.923	C0019193	Hepatitis,Toxic	disease	C06;C25	InjuryorPoisoning	0.30	1	1977	2009	2	0	CTD_human
val	2875	GPT	0.403	0.923	C0023893	LiverCirrhosis,Experimental	disease	C23;C06	ExperimentalModelofDisease	0.50	1	2006	2012	1	0	CTD_human
val	2875	GPT	0.403	0.923	C0023895	Liverdiseases	group	C06	DiseaseorSyndrome	0.40	0.985	1993	2020	1	0	CTD_human
val	2875	GPT	0.403	0.923	C0035126	ReperfusionInjury	disease	C23;C14	InjuryorPoisoning	0.30	1	1993	1993	1	0	CTD_human
val	2875	GPT	0.403	0.923	C0086565	LiverDysfunction	phenotype	C06	Finding	0.30	1	2014	2014	1	0	CTD_human
val	2875	GPT	0.403	0.923	C0860207	Drug-InducedLiverDisease	phenotype	C06;C25	DiseaseorSyndrome	0.40	1	1977	2020	2	0	CTD_human
val	2875	GPT	0.403	0.923	C1262760	Hepatitis,Drug-Induced	disease	C06;C25	DiseaseorSyndrome	0.30	1	1977	2009	2	0	CTD_human
val	2875	GPT	0.403	0.923	C2711227	Steatohepatitis	disease	C06	DiseaseorSyndrome	0.40	0.955	2000	2020	1	0	CTD_human
val	2875	GPT	0.403	0.923	C3658290	Drug-InducedAcuteLiverInjury	disease	C06;C25	DiseaseorSyndrome	0.30	1	1977	2009	2	0	CTD_human
val	2875	GPT	0.403	0.923	C4277682	ChemicalandDrugInducedLiverInjury	disease	C06;C25	DiseaseorSyndrome	0.50	1	1977	2016	2	0	CTD_human
val	2875	GPT	0.403	0.923	C4279912	Chemically-InducedLiverToxicity	disease	C06;C25	DiseaseorSyndrome	0.30	1	1977	2009	2	0	CTD_human
val	2876	GPX1	0.458	0.923	C0001787	Osteoporosis,Age-Related	disease	C18;C05	DiseaseorSyndrome	0.30	1	2008	2008	1	0	CTD_human
val	2876	GPX1	0.458	0.923	C0002152	AlloxanDiabetes	disease	C18;C19	ExperimentalModelofDisease	0.30	1	2005	2005	1	0	CTD_human
val	2876	GPX1	0.458	0.923	C0004352	AutisticDisorder	disease	F03	MentalorBehavioralDysfunction	0.31	1	2010	2010	1	0	CTD_human
val	2876	GPX1	0.458	0.923	C0005684	Malignantneoplasmofurinarybladder	disease	C04;C13;C12	NeoplasticProcess	0.40	0.909	2004	2017	1	0	CTD_human
val	2876	GPX1	0.458	0.923	C0005695	BladderNeoplasm	disease	C04;C13;C12	NeoplasticProcess	0.40	0.909	2004	2017	1	0	CTD_human
val	2876	GPX1	0.458	0.923	C0006142	Malignantneoplasmofbreast	disease	C04;C17	NeoplasticProcess	0.40	0.833	1995	2019	1	0	CTD_human
val	2876	GPX1	0.458	0.923	C0007137	Squamouscellcarcinoma	disease	C04	NeoplasticProcess	0.33	1	2002	2017	1	0	CTD_human
val	2876	GPX1	0.458	0.923	C0007138	Carcinoma,TransitionalCell	disease	C04	NeoplasticProcess	0.30	1	2004	2004	1	0	CTD_human
val	2876	GPX1	0.458	0.923	C0007193	Cardiomyopathy,Dilated	group	C14	DiseaseorSyndrome	0.31	1	2009	2009	1	0	CTD_human
val	2876	GPX1	0.458	0.923	C0007222	CardiovascularDiseases	group	C14	DiseaseorSyndrome	0.36	1	2003	2019	1	0	CTD_human
val	2876	GPX1	0.458	0.923	C0007786	BrainIschemia	disease	C10;C14	DiseaseorSyndrome	0.30	1	2002	2002	1	0	CTD_human
val	2876	GPX1	0.458	0.923	C0011570	MentalDepression	disease	F01	MentalorBehavioralDysfunction	0.32	1	2013	2017	1	0	PSYGENET
val	2876	GPX1	0.458	0.923	C0011581	Depressivedisorder	disease	F03	MentalorBehavioralDysfunction	0.32	1	2013	2017	1	0	PSYGENET
val	2876	GPX1	0.458	0.923	C0011853	DiabetesMellitus,Experimental	disease	C18;C19	ExperimentalModelofDisease	0.50	1	2004	2015	1	0	CTD_human
val	2876	GPX1	0.458	0.923	C0011860	DiabetesMellitus,Non-Insulin-Dependent	disease	C18;C19	DiseaseorSyndrome	0.37	1	2005	2018	2	0	CTD_human
val	2876	GPX1	0.458	0.923	C0014544	Epilepsy	disease	C10	DiseaseorSyndrome	0.31	1	2009	2017	1	0	CTD_human
val	2876	GPX1	0.458	0.923	C0015695	FattyLiver	disease	C06	DiseaseorSyndrome	0.30	1	2000	2000	1	0	CTD_human
val	2876	GPX1	0.458	0.923	C0018671	HeadandNeckNeoplasms	group	C04	NeoplasticProcess	0.30	1	2004	2004	1	0	CTD_human
val	2876	GPX1	0.458	0.923	C0018675	HeadNeoplasms	group	C04	NeoplasticProcess	0.30	1	2004	2004	1	0	CTD_human
val	2876	GPX1	0.458	0.923	C0019189	Hepatitis,Chronic	disease	C06	DiseaseorSyndrome	0.30	1	2015	2015	1	0	CTD_human
val	2876	GPX1	0.458	0.923	C0020456	Hyperglycemia	disease	C18	DiseaseorSyndrome	0.31	1	2004	2010	1	0	CTD_human
val	2876	GPX1	0.458	0.923	C0020459	Hyperinsulinism	disease	C18	DiseaseorSyndrome	0.32	1	2004	2019	2	0	CTD_human
val	2876	GPX1	0.458	0.923	C0020538	Hypertensivedisease	group	C14	DiseaseorSyndrome	0.52	1	2010	2017	1	0	CTD_human
val	2876	GPX1	0.458	0.923	C0020550	Hyperthyroidism	disease	C19	DiseaseorSyndrome	0.51	1	2010	2019	1	0	CTD_human
val	2876	GPX1	0.458	0.923	C0024121	LungNeoplasms	group	C04;C08	NeoplasticProcess	0.35	1	1994	2008	1	0	CTD_human
val	2876	GPX1	0.458	0.923	C0027533	NeckNeoplasms	group	C04	NeoplasticProcess	0.30	1	2004	2004	1	0	CTD_human
val	2876	GPX1	0.458	0.923	C0028754	Obesity	disease	C23;C18	DiseaseorSyndrome	0.32	1	2004	2020	1	0	CTD_human
val	2876	GPX1	0.458	0.923	C0029456	Osteoporosis	disease	C18;C05	DiseaseorSyndrome	0.31	1	2008	2010	1	0	CTD_human
val	2876	GPX1	0.458	0.923	C0029459	Osteoporosis,Senile	disease	C18;C05	DiseaseorSyndrome	0.30	1	2008	2008	1	0	CTD_human
val	2876	GPX1	0.458	0.923	C0030567	ParkinsonDisease	disease	C10	DiseaseorSyndrome	0.31	1	2005	2009	1	0	CTD_human
val	2876	GPX1	0.458	0.923	C0035126	ReperfusionInjury	disease	C23;C14	InjuryorPoisoning	0.30	1	2013	2013	1	0	CTD_human
val	2876	GPX1	0.458	0.923	C0038433	StreptozotocinDiabetes	disease	C18;C19	ExperimentalModelofDisease	0.30	1	2005	2005	1	0	CTD_human
val	2876	GPX1	0.458	0.923	C0086237	Epilepsy,Cryptogenic	disease	C10	DiseaseorSyndrome	0.30	1	2009	2009	1	0	CTD_human
val	2876	GPX1	0.458	0.923	C0149519	ChronicPersistentHepatitis	disease	C06	DiseaseorSyndrome	0.30	1	2015	2015	1	0	CTD_human
val	2876	GPX1	0.458	0.923	C0236018	Aura	phenotype	C10	Finding	0.30	1	2009	2009	1	0	CTD_human
val	2876	GPX1	0.458	0.923	C0242379	Malignantneoplasmoflung	disease	C04;C08	NeoplasticProcess	0.38	0.889	1994	2015	1	0	CTD_human
val	2876	GPX1	0.458	0.923	C0278996	MalignantHeadandNeckNeoplasm	disease	C04	NeoplasticProcess	0.33	1	2004	2017	1	0	CTD_human
val	2876	GPX1	0.458	0.923	C0398747	Gluthathioneperoxidasedeficiency	disease		DiseaseorSyndrome	0.30	1	1975	1975	1	0	GENOMICS_ENGLAND
val	2876	GPX1	0.458	0.923	C0520463	Chronicactivehepatitis	disease	C06	DiseaseorSyndrome	0.30	1	2015	2015	1	0	CTD_human
val	2876	GPX1	0.458	0.923	C0524611	CryptogenicChronicHepatitis	disease	C06	DiseaseorSyndrome	0.30	1	2015	2015	1	0	CTD_human
val	2876	GPX1	0.458	0.923	C0678222	BreastCarcinoma	disease	C04;C17	NeoplasticProcess	0.40	0.889	1995	2019	1	0	CTD_human
val	2876	GPX1	0.458	0.923	C0746787	CancerofNeck	disease	C04	NeoplasticProcess	0.30	1	2004	2004	1	0	CTD_human
val	2876	GPX1	0.458	0.923	C0751111	AwakeningEpilepsy	disease	C10	DiseaseorSyndrome	0.30	1	2009	2009	1	0	CTD_human
val	2876	GPX1	0.458	0.923	C0751177	CancerofHead	disease	C04	NeoplasticProcess	0.30	1	2004	2004	1	0	CTD_human
val	2876	GPX1	0.458	0.923	C0751406	Post-TraumaticOsteoporosis	disease	C18;C05	DiseaseorSyndrome	0.30	1	2008	2008	1	0	CTD_human
val	2876	GPX1	0.458	0.923	C0887900	UpperAerodigestiveTractNeoplasms	group	C04	NeoplasticProcess	0.30	1	2004	2004	1	0	CTD_human
val	2876	GPX1	0.458	0.923	C0917798	CerebralIschemia	disease	C10;C14	PathologicFunction	0.30	1	2002	2002	1	0	CTD_human
val	2876	GPX1	0.458	0.923	C1257931	MammaryNeoplasms,Human	disease	C04;C17	NeoplasticProcess	0.30	1	2003	2003	1	0	CTD_human
val	2876	GPX1	0.458	0.923	C1257963	EndogenousHyperinsulinism	disease	C18	DiseaseorSyndrome	0.30	1	2004	2008	2	0	CTD_human
val	2876	GPX1	0.458	0.923	C1257964	ExogenousHyperinsulinism	disease	C18	DiseaseorSyndrome	0.30	1	2004	2008	2	0	CTD_human
val	2876	GPX1	0.458	0.923	C1257965	CompensatoryHyperinsulinemia	disease	C18	DiseaseorSyndrome	0.30	1	2004	2008	2	0	CTD_human
val	2876	GPX1	0.458	0.923	C1449563	Cardiomyopathy,FamilialIdiopathic	disease	C14	DiseaseorSyndrome	0.30	1	2009	2009	1	0	CTD_human
val	2876	GPX1	0.458	0.923	C1458155	MammaryNeoplasms	group	C04;C17	NeoplasticProcess	0.34	1	2002	2008	1	0	CTD_human
val	2876	GPX1	0.458	0.923	C1855520	Hyperglycemia,Postprandial	phenotype	C18	Finding	0.30	1	2004	2004	1	0	CTD_human
val	2876	GPX1	0.458	0.923	C2711227	Steatohepatitis	disease	C06	DiseaseorSyndrome	0.30	1	2000	2000	1	0	CTD_human
val	2876	GPX1	0.458	0.923	C3501647	GlutathionePeroxidaseDeficiency,HemolyticAnemiapossiblydueto	disease	C15	DiseaseorSyndrome	0.30				0	0	CTD_human
val	2876	GPX1	0.458	0.923	C3714618	PrimaryHyperthyroidism	disease	C19	DiseaseorSyndrome	0.30	1	2010	2010	1	0	CTD_human
val	2876	GPX1	0.458	0.923	C4704874	MammaryCarcinoma,Human	disease	C04;C17	NeoplasticProcess	0.30	1	2003	2003	1	0	CTD_human
val	2877	GPX2	0.619	0.5	C0006142	Malignantneoplasmofbreast	disease	C04;C17	NeoplasticProcess	0.34	1	1999	2019	1	0	CTD_human
val	2877	GPX2	0.619	0.5	C0023903	Liverneoplasms	group	C06;C04	NeoplasticProcess	0.30	1	2017	2017	1	0	CTD_human
val	2877	GPX2	0.619	0.5	C0027627	NeoplasmMetastasis	phenotype	C23;C04	NeoplasticProcess	0.35	0.8	2013	2019	1	0	CTD_human
val	2877	GPX2	0.619	0.5	C0345904	Malignantneoplasmofliver	disease	C06;C04	NeoplasticProcess	0.30	1	2017	2017	1	0	CTD_human
val	2877	GPX2	0.619	0.5	C0678222	BreastCarcinoma	disease	C04;C17	NeoplasticProcess	0.34	1	1999	2019	1	0	CTD_human
val	2877	GPX2	0.619	0.5	C1257931	MammaryNeoplasms,Human	disease	C04;C17	NeoplasticProcess	0.30	1	2007	2007	1	0	CTD_human
val	2877	GPX2	0.619	0.5	C1458155	MammaryNeoplasms	group	C04;C17	NeoplasticProcess	0.30	1	2007	2007	1	0	CTD_human
val	2877	GPX2	0.619	0.5	C4704874	MammaryCarcinoma,Human	disease	C04;C17	NeoplasticProcess	0.30	1	2007	2007	1	0	CTD_human
val	2878	GPX3	0.522	0.769	C0001418	Adenocarcinoma	group	C04	NeoplasticProcess	0.34	1	2005	2018	1	0	CTD_human
val	2878	GPX3	0.522	0.769	C0006826	MalignantNeoplasms	group	C04	NeoplasticProcess	0.40	0.917	2010	2019	1	0	CTD_human
val	2878	GPX3	0.522	0.769	C0014175	Endometriosis	disease	C13	DiseaseorSyndrome	0.30	1	2011	2011	2	0	CTD_human
val	2878	GPX3	0.522	0.769	C0015624	FanconiSyndrome	disease	C16;C13;C12	DiseaseorSyndrome	0.30	1	1998	1998	1	0	CTD_human
val	2878	GPX3	0.522	0.769	C0021655	InsulinResistance	phenotype	C18	PathologicFunction	0.30	1	2009	2009	1	0	CTD_human
val	2878	GPX3	0.522	0.769	C0023903	Liverneoplasms	group	C06;C04	NeoplasticProcess	0.30	1	2010	2010	1	0	CTD_human
val	2878	GPX3	0.522	0.769	C0024121	LungNeoplasms	group	C04;C08	NeoplasticProcess	0.30	1	2009	2011	2	0	CTD_human
val	2878	GPX3	0.522	0.769	C0027651	Neoplasms	group	C04	NeoplasticProcess	0.40	1	2001	2019	1	0	CTD_human
val	2878	GPX3	0.522	0.769	C0028754	Obesity	disease	C23;C18	DiseaseorSyndrome	0.52	1	2001	2018	2	0	CTD_human
val	2878	GPX3	0.522	0.769	C0033578	ProstaticNeoplasms	group	C04;C12	NeoplasticProcess	0.30	1	2007	2007	1	0	CTD_human
val	2878	GPX3	0.522	0.769	C0086692	BenignNeoplasm	group	C04	NeoplasticProcess	0.30	1	2011	2011	1	0	CTD_human
val	2878	GPX3	0.522	0.769	C0205641	Adenocarcinoma,BasalCell	disease	C04	NeoplasticProcess	0.30	1	2011	2011	1	0	CTD_human
val	2878	GPX3	0.522	0.769	C0205642	Adenocarcinoma,Oxyphilic	disease	C04	NeoplasticProcess	0.30	1	2011	2011	1	0	CTD_human
val	2878	GPX3	0.522	0.769	C0205643	Carcinoma,Cribriform	disease	C04	NeoplasticProcess	0.30	1	2011	2011	1	0	CTD_human
val	2878	GPX3	0.522	0.769	C0205644	Carcinoma,GranularCell	disease	C04	NeoplasticProcess	0.30	1	2011	2011	1	0	CTD_human
val	2878	GPX3	0.522	0.769	C0205645	Adenocarcinoma,Tubular	disease	C04	NeoplasticProcess	0.30	1	2011	2011	1	0	CTD_human
val	2878	GPX3	0.522	0.769	C0242379	Malignantneoplasmoflung	disease	C04;C08	NeoplasticProcess	0.33	1	2009	2019	2	0	CTD_human
val	2878	GPX3	0.522	0.769	C0269102	Endometrioma	disease	C13	NeoplasticProcess	0.30	1	2011	2011	2	0	CTD_human
val	2878	GPX3	0.522	0.769	C0270715	DegenerativeDiseases,CentralNervousSystem	group	C10	DiseaseorSyndrome	0.30	1	2005	2005	1	0	CTD_human
val	2878	GPX3	0.522	0.769	C0341703	AdultFanconisyndrome	disease	C16;C13;C12	DiseaseorSyndrome	0.30	1	1998	1998	1	0	CTD_human
val	2878	GPX3	0.522	0.769	C0345904	Malignantneoplasmofliver	disease	C06;C04	NeoplasticProcess	0.30	1	2010	2010	1	0	CTD_human
val	2878	GPX3	0.522	0.769	C0376358	Malignantneoplasmofprostate	disease	C04;C12	NeoplasticProcess	0.36	1	2007	2018	1	0	CTD_human
val	2878	GPX3	0.522	0.769	C0524851	NeurodegenerativeDisorders	group	C10	DiseaseorSyndrome	0.30	1	2005	2005	1	0	CTD_human
val	2878	GPX3	0.522	0.769	C0751733	DegenerativeDiseases,SpinalCord	group	C10	DiseaseorSyndrome	0.30	1	2005	2005	1	0	CTD_human
val	2878	GPX3	0.522	0.769	C0920563	InsulinSensitivity	phenotype	C18	PathologicFunction	0.30	1	2009	2009	1	0	CTD_human
val	2878	GPX3	0.522	0.769	C1857395	DeToni-Debre-FanconiSyndrome	disease	C16;C13;C12	DiseaseorSyndrome	0.30	1	1998	1998	1	0	CTD_human
val	2878	GPX3	0.522	0.769	C3495427	Fanconi-BickelSyndrome	disease	C16;C13;C12	DiseaseorSyndrome	0.30	1	1998	1998	1	0	CTD_human
val	2879	GPX4	0.516	0.808	C0006142	Malignantneoplasmofbreast	disease	C04;C17	NeoplasticProcess	0.35	1	2001	2019	1	0	CTD_human
val	2879	GPX4	0.516	0.808	C0006635	Cadmiumpoisoning	disease	C25	InjuryorPoisoning	0.30	1	2010	2010	1	0	CTD_human
val	2879	GPX4	0.516	0.808	C0009402	ColorectalCarcinoma	disease	C06;C04	NeoplasticProcess	0.32	1	2007	2018	1	0	CTD_human
val	2879	GPX4	0.516	0.808	C0009404	ColorectalNeoplasms	group	C06;C04	NeoplasticProcess	0.30	1	2007	2007	1	0	CTD_human
val	2879	GPX4	0.516	0.808	C0010417	Cryptorchidism	disease	C16;C12;C19	CongenitalAbnormality	0.30	1	2015	2015	1	0	CTD_human
val	2879	GPX4	0.516	0.808	C0012684	BlastocystDisintegration	phenotype	C23;C13	PathologicFunction	0.30	1	2003	2003	1	0	CTD_human
val	2879	GPX4	0.516	0.808	C0013937	EmbryoResorption	phenotype	C23;C13	OrganismFunction	0.30	1	2003	2003	1	0	CTD_human
val	2879	GPX4	0.516	0.808	C0015695	FattyLiver	disease	C06	DiseaseorSyndrome	0.30	1	2015	2015	1	0	CTD_human
val	2879	GPX4	0.516	0.808	C0016059	Fibrosis	phenotype	C23	PathologicFunction	0.30	1	2015	2015	1	0	CTD_human
val	2879	GPX4	0.516	0.808	C0018801	Heartfailure	disease	C14	DiseaseorSyndrome	0.30	1	2010	2010	1	0	CTD_human
val	2879	GPX4	0.516	0.808	C0018802	Congestiveheartfailure	disease	C14	DiseaseorSyndrome	0.30	1	2010	2010	1	0	CTD_human
val	2879	GPX4	0.516	0.808	C0021364	Maleinfertility	phenotype	C12	DiseaseorSyndrome	0.31	1	2003	2009	2	0	CTD_human
val	2879	GPX4	0.516	0.808	C0023212	Left-SidedHeartFailure	disease	C14	DiseaseorSyndrome	0.30	1	2010	2010	1	0	CTD_human
val	2879	GPX4	0.516	0.808	C0235527	HeartFailure,Right-Sided	disease	C14	DiseaseorSyndrome	0.30	1	2010	2010	1	0	CTD_human
val	2879	GPX4	0.516	0.808	C0271650	Impairedglucosetolerance	phenotype	C18	DiseaseorSyndrome	0.30	1	2015	2015	1	0	CTD_human
val	2879	GPX4	0.516	0.808	C0431663	BilateralCryptorchidism	disease	C16;C12;C19	CongenitalAbnormality	0.30	1	2015	2015	1	0	CTD_human
val	2879	GPX4	0.516	0.808	C0431664	UnilateralCryptorchidism	disease	C16;C12;C19	CongenitalAbnormality	0.30	1	2015	2015	1	0	CTD_human
val	2879	GPX4	0.516	0.808	C0678222	BreastCarcinoma	disease	C04;C17	NeoplasticProcess	0.35	1	2001	2019	1	0	CTD_human
val	2879	GPX4	0.516	0.808	C0752350	EmbryoDeath	phenotype	C23;C13	PathologicFunction	0.30	1	2003	2003	1	0	CTD_human
val	2879	GPX4	0.516	0.808	C0752351	EmbryoLoss	phenotype	C23;C13	PathologicFunction	0.30	1	2003	2003	1	0	CTD_human
val	2879	GPX4	0.516	0.808	C0848676	Subfertility,Male	phenotype	C12	SignorSymptom	0.30	1	2009	2009	2	0	CTD_human
val	2879	GPX4	0.516	0.808	C0917731	Malesterility	phenotype	C12	Finding	0.30	1	2009	2009	2	0	CTD_human
val	2879	GPX4	0.516	0.808	C1136082	EmbryoDisintegration	phenotype	C23;C13	PathologicFunction	0.30	1	2003	2003	1	0	CTD_human
val	2879	GPX4	0.516	0.808	C1257931	MammaryNeoplasms,Human	disease	C04;C17	NeoplasticProcess	0.30	1	2007	2007	1	0	CTD_human
val	2879	GPX4	0.516	0.808	C1458155	MammaryNeoplasms	group	C04;C17	NeoplasticProcess	0.32	1	2001	2007	1	0	CTD_human
val	2879	GPX4	0.516	0.808	C1563730	AbdominalCryptorchidism	disease	C16;C12;C19	CongenitalAbnormality	0.30	1	2015	2015	1	0	CTD_human
val	2879	GPX4	0.516	0.808	C1563731	InguinalCryptorchidism	phenotype	C16;C12;C19	Finding	0.30	1	2015	2015	1	0	CTD_human
val	2879	GPX4	0.516	0.808	C1623038	Cirrhosis	disease	C23	DiseaseorSyndrome	0.30	1	2015	2015	1	0	CTD_human
val	2879	GPX4	0.516	0.808	C1855229	Spondylometaphysealdysplasia,Sedaghatiantype	disease	C16;C05	DiseaseorSyndrome	0.72	1	2014	2018	1	2	CTD_human;GENOMICS_ENGLAND;ORPHANET
val	2879	GPX4	0.516	0.808	C1959583	MyocardialFailure	disease	C14	DiseaseorSyndrome	0.30	1	2010	2010	1	0	CTD_human
val	2879	GPX4	0.516	0.808	C1961112	HeartDecompensation	phenotype	C14	PathologicFunction	0.30	1	2010	2010	1	0	CTD_human
val	2879	GPX4	0.516	0.808	C2711227	Steatohepatitis	disease	C06	DiseaseorSyndrome	0.30	1	2015	2015	1	0	CTD_human
val	2879	GPX4	0.516	0.808	C4704874	MammaryCarcinoma,Human	disease	C04;C17	NeoplasticProcess	0.30	1	2007	2007	1	0	CTD_human
val	2885	GRB2	0.546	0.769	C0036341	Schizophrenia	disease	F03	MentalorBehavioralDysfunction	0.32	0.5	2008	2019	2	0	PSYGENET
val	2886	GRB7	0.603	0.462	C0001418	Adenocarcinoma	group	C04	NeoplasticProcess	0.30	1	2011	2011	1	0	CTD_human
val	2886	GRB7	0.603	0.462	C0006142	Malignantneoplasmofbreast	disease	C04;C17	NeoplasticProcess	0.40	1	1994	2019	2	0	CTD_human
val	2886	GRB7	0.603	0.462	C0007134	RenalCellCarcinoma	disease	C04;C13;C12	NeoplasticProcess	0.30	1	2013	2013	1	0	CTD_human
val	2886	GRB7	0.603	0.462	C0024121	LungNeoplasms	group	C04;C08	NeoplasticProcess	0.30	1	2011	2011	1	0	CTD_human
val	2886	GRB7	0.603	0.462	C0033578	ProstaticNeoplasms	group	C04;C12	NeoplasticProcess	0.30	1	2007	2007	1	0	CTD_human
val	2886	GRB7	0.603	0.462	C0205641	Adenocarcinoma,BasalCell	disease	C04	NeoplasticProcess	0.30	1	2011	2011	1	0	CTD_human
val	2886	GRB7	0.603	0.462	C0205642	Adenocarcinoma,Oxyphilic	disease	C04	NeoplasticProcess	0.30	1	2011	2011	1	0	CTD_human
val	2886	GRB7	0.603	0.462	C0205643	Carcinoma,Cribriform	disease	C04	NeoplasticProcess	0.30	1	2011	2011	1	0	CTD_human
val	2886	GRB7	0.603	0.462	C0205644	Carcinoma,GranularCell	disease	C04	NeoplasticProcess	0.30	1	2011	2011	1	0	CTD_human
val	2886	GRB7	0.603	0.462	C0205645	Adenocarcinoma,Tubular	disease	C04	NeoplasticProcess	0.30	1	2011	2011	1	0	CTD_human
val	2886	GRB7	0.603	0.462	C0242379	Malignantneoplasmoflung	disease	C04;C08	NeoplasticProcess	0.30	1	2011	2011	1	0	CTD_human
val	2886	GRB7	0.603	0.462	C0279702	Conventional(ClearCell)RenalCellCarcinoma	disease	C04;C13;C12	NeoplasticProcess	0.30	1	2013	2013	1	0	CTD_human
val	2886	GRB7	0.603	0.462	C0376358	Malignantneoplasmofprostate	disease	C04;C12	NeoplasticProcess	0.30	1	2007	2007	1	0	CTD_human
val	2886	GRB7	0.603	0.462	C0678222	BreastCarcinoma	disease	C04;C17	NeoplasticProcess	0.40	1	1994	2019	2	0	CTD_human
val	2886	GRB7	0.603	0.462	C1257931	MammaryNeoplasms,Human	disease	C04;C17	NeoplasticProcess	0.30	1	2007	2009	2	0	CTD_human
val	2886	GRB7	0.603	0.462	C1266042	ChromophobeRenalCellCarcinoma	disease	C04;C13;C12	NeoplasticProcess	0.30	1	2013	2013	1	0	CTD_human
val	2886	GRB7	0.603	0.462	C1266043	SarcomatoidRenalCellCarcinoma	disease	C04;C13;C12	NeoplasticProcess	0.30	1	2013	2013	1	0	CTD_human
val	2886	GRB7	0.603	0.462	C1266044	CollectingDuctCarcinomaoftheKidney	disease	C04;C13;C12	NeoplasticProcess	0.30	1	2013	2013	1	0	CTD_human
val	2886	GRB7	0.603	0.462	C1306837	PapillaryRenalCellCarcinoma	disease	C04;C13;C12	NeoplasticProcess	0.30	1	2013	2013	1	0	CTD_human
val	2886	GRB7	0.603	0.462	C1458155	MammaryNeoplasms	group	C04;C17	NeoplasticProcess	0.32	1	1994	2009	2	0	CTD_human
val	2886	GRB7	0.603	0.462	C4704874	MammaryCarcinoma,Human	disease	C04;C17	NeoplasticProcess	0.30	1	2007	2009	2	0	CTD_human
val	2887	GRB10	0.628	0.615	C0036341	Schizophrenia	disease	F03	MentalorBehavioralDysfunction	0.31	1	2014	2014	1	0	PSYGENET
val	2888	GRB14	0.743	0.346	C0011860	DiabetesMellitus,Non-Insulin-Dependent	disease	C18;C19	DiseaseorSyndrome	0.43	1	2011	2019	1	1	CTD_human
val	2888	GRB14	0.743	0.346	C0043094	WeightGain	phenotype	C23	Finding	0.30	1	2008	2008	1	0	CTD_human
val	2890	GRIA1	0.57	0.577	C0004352	AutisticDisorder	disease	F03	MentalorBehavioralDysfunction	0.31	1	2001	2017	1	0	CTD_human
val	2890	GRIA1	0.57	0.577	C0005586	BipolarDisorder	disease	F03	MentalorBehavioralDysfunction	0.32	0.5	2007	2012	4	0	PSYGENET
val	2890	GRIA1	0.57	0.577	C0009171	CocaineAbuse	disease	C25;F03	MentalorBehavioralDysfunction	0.30	1	2003	2008	5	0	CTD_human
val	2890	GRIA1	0.57	0.577	C0011570	MentalDepression	disease	F01	MentalorBehavioralDysfunction	0.38	0.6	2012	2020	5	0	PSYGENET
val	2890	GRIA1	0.57	0.577	C0011581	Depressivedisorder	disease	F03	MentalorBehavioralDysfunction	0.38	0.6	2012	2020	5	0	PSYGENET
val	2890	GRIA1	0.57	0.577	C0016722	Frigidity	disease	F03	MentalorBehavioralDysfunction	0.30	1	2009	2009	1	0	CTD_human
val	2890	GRIA1	0.57	0.577	C0020594	HypoactiveSexualDesireDisorder	disease	F03	MentalorBehavioralDysfunction	0.30	1	2009	2009	1	0	CTD_human
val	2890	GRIA1	0.57	0.577	C0020649	Hypotension	phenotype	C14	Finding	0.30	1	2008	2008	1	0	CTD_human
val	2890	GRIA1	0.57	0.577	C0023186	LearningDisorders	group	C23;C10;F03	MentalorBehavioralDysfunction	0.30	1	2007	2007	1	0	CTD_human
val	2890	GRIA1	0.57	0.577	C0026552	MorphineDependence	disease	C25;F03	MentalorBehavioralDysfunction	0.31	1	2001	2019	1	0	CTD_human
val	2890	GRIA1	0.57	0.577	C0029261	OrgasmicDisorder	disease	F03	MentalorBehavioralDysfunction	0.30	1	2009	2009	1	0	CTD_human
val	2890	GRIA1	0.57	0.577	C0033953	PsychosexualDisorders	group	F03	MentalorBehavioralDysfunction	0.30	1	2009	2009	1	0	CTD_human
val	2890	GRIA1	0.57	0.577	C0036337	SchizoaffectiveDisorder	disease	F03	MentalorBehavioralDysfunction	0.50	1	2012	2012	1	0	PSYGENET
val	2890	GRIA1	0.57	0.577	C0036341	Schizophrenia	disease	F03	MentalorBehavioralDysfunction	0.50	1	1995	2019	2	2	PSYGENET
val	2890	GRIA1	0.57	0.577	C0036902	SexualArousalDisorder	disease	F03	MentalorBehavioralDysfunction	0.30	1	2009	2009	1	0	CTD_human
val	2890	GRIA1	0.57	0.577	C0038587	SubstanceWithdrawalSyndrome	disease	C25;F03	MentalorBehavioralDysfunction	0.30	1	2001	2003	2	0	CTD_human
val	2890	GRIA1	0.57	0.577	C0086189	DrugWithdrawalSymptoms	phenotype	C25;F03	SignorSymptom	0.30	1	2001	2003	2	0	CTD_human
val	2890	GRIA1	0.57	0.577	C0087169	WithdrawalSymptoms	phenotype	C25;F03	SignorSymptom	0.30	1	2001	2003	2	0	CTD_human
val	2890	GRIA1	0.57	0.577	C0236736	Cocaine-RelatedDisorders	group	C25;F03	MentalorBehavioralDysfunction	0.30	1	2003	2008	5	0	CTD_human
val	2890	GRIA1	0.57	0.577	C0600272	MorphineAbuse	disease	C25;F03	MentalorBehavioralDysfunction	0.30	1	2001	2001	1	0	CTD_human
val	2890	GRIA1	0.57	0.577	C0600427	CocaineDependence	disease	C25;F03	MentalorBehavioralDysfunction	0.30	1	2003	2008	5	0	CTD_human
val	2890	GRIA1	0.57	0.577	C0751217	Hyperkinesia,Generalized	phenotype	C23;C10	SignorSymptom	0.30	1	2008	2008	2	0	CTD_human
val	2890	GRIA1	0.57	0.577	C0751262	AdultLearningDisorders	group	C23;C10;F03	MentalorBehavioralDysfunction	0.30	1	2007	2007	1	0	CTD_human
val	2890	GRIA1	0.57	0.577	C0751263	LearningDisturbance	disease	C23;C10;F03	MentalorBehavioralDysfunction	0.30	1	2007	2007	1	0	CTD_human
val	2890	GRIA1	0.57	0.577	C0751265	LearningDisabilities	disease	C23;C10;F03	MentalorBehavioralDysfunction	0.31	1	2007	2017	1	0	CTD_human
val	2890	GRIA1	0.57	0.577	C1330966	DevelopmentalAcademicDisorder	phenotype	C23;C10;F03	Finding	0.30	1	2007	2007	1	0	CTD_human
val	2890	GRIA1	0.57	0.577	C3714756	IntellectualDisability	group	C23;C10;F03;F01	MentalorBehavioralDysfunction	0.30	1	2014	2014	1	0	GENOMICS_ENGLAND
val	2890	GRIA1	0.57	0.577	C3887506	Hyperkinesia	phenotype	C23;C10	DiseaseorSyndrome	0.30	1	2008	2008	2	0	CTD_human
val	2891	GRIA2	0.573	0.692	C0005586	BipolarDisorder	disease	F03	MentalorBehavioralDysfunction	0.32	0.667	2007	2020	3	0	PSYGENET
val	2891	GRIA2	0.573	0.692	C0009171	CocaineAbuse	disease	C25;F03	MentalorBehavioralDysfunction	0.30	1	2008	2008	1	0	CTD_human
val	2891	GRIA2	0.573	0.692	C0036341	Schizophrenia	disease	F03	MentalorBehavioralDysfunction	0.36	0.5	1995	2020	2	0	PSYGENET
val	2891	GRIA2	0.573	0.692	C0036572	Seizures	phenotype	C23;C10	SignorSymptom	0.36	1	2001	2019	1	0	GENOMICS_ENGLAND
val	2891	GRIA2	0.573	0.692	C0038220	StatusEpilepticus	disease	C23;C10	DiseaseorSyndrome	0.72	1	2009	2019	2	0	CTD_human;GENOMICS_ENGLAND
val	2891	GRIA2	0.573	0.692	C0038587	SubstanceWithdrawalSyndrome	disease	C25;F03	MentalorBehavioralDysfunction	0.30	1	2003	2003	1	0	CTD_human
val	2891	GRIA2	0.573	0.692	C0041696	UnipolarDepression	disease	F03	MentalorBehavioralDysfunction	0.32	0.5	2012	2013	2	0	PSYGENET
val	2891	GRIA2	0.573	0.692	C0086189	DrugWithdrawalSymptoms	phenotype	C25;F03	SignorSymptom	0.30	1	2003	2003	1	0	CTD_human
val	2891	GRIA2	0.573	0.692	C0087169	WithdrawalSymptoms	phenotype	C25;F03	SignorSymptom	0.30	1	2003	2003	1	0	CTD_human
val	2891	GRIA2	0.573	0.692	C0236736	Cocaine-RelatedDisorders	group	C25;F03	MentalorBehavioralDysfunction	0.30	1	2008	2008	1	0	CTD_human
val	2891	GRIA2	0.573	0.692	C0270823	Petitmalstatus	disease	C23;C10	DiseaseorSyndrome	0.30	1	2009	2009	1	0	CTD_human
val	2891	GRIA2	0.573	0.692	C0311335	GrandMalStatusEpilepticus	disease	C23;C10	DiseaseorSyndrome	0.30	1	2009	2009	1	0	CTD_human
val	2891	GRIA2	0.573	0.692	C0393734	ComplexPartialStatusEpilepticus	disease	C23;C10	DiseaseorSyndrome	0.30	1	2009	2009	1	0	CTD_human
val	2891	GRIA2	0.573	0.692	C0494475	Tonic-clonicseizures	disease	C23;C10	DiseaseorSyndrome	0.30	1	2019	2019	1	0	GENOMICS_ENGLAND
val	2891	GRIA2	0.573	0.692	C0600427	CocaineDependence	disease	C25;F03	MentalorBehavioralDysfunction	0.30	1	2008	2008	1	0	CTD_human
val	2891	GRIA2	0.573	0.692	C0751217	Hyperkinesia,Generalized	phenotype	C23;C10	SignorSymptom	0.30	1	2008	2008	1	0	CTD_human
val	2891	GRIA2	0.573	0.692	C0751495	Seizures,Focal	phenotype	C23;C10	DiseaseorSyndrome	0.30	1	2019	2019	1	0	GENOMICS_ENGLAND
val	2891	GRIA2	0.573	0.692	C0751522	StatusEpilepticus,Subclinical	disease	C23;C10	DiseaseorSyndrome	0.30	1	2009	2009	1	0	CTD_human
val	2891	GRIA2	0.573	0.692	C0751523	Non-ConvulsiveStatusEpilepticus	disease	C23;C10	DiseaseorSyndrome	0.30	1	2009	2009	1	0	CTD_human
val	2891	GRIA2	0.573	0.692	C0751524	SimplePartialStatusEpilepticus	phenotype	C23;C10	DiseaseorSyndrome	0.30	1	2009	2009	1	0	CTD_human
val	2891	GRIA2	0.573	0.692	C1269683	MajorDepressiveDisorder	disease	F03	MentalorBehavioralDysfunction	0.32	0.5	2012	2013	2	0	PSYGENET
val	2891	GRIA2	0.573	0.692	C3714756	IntellectualDisability	group	C23;C10;F03;F01	MentalorBehavioralDysfunction	0.32	0.5	2013	2019	1	0	GENOMICS_ENGLAND
val	2891	GRIA2	0.573	0.692	C3887506	Hyperkinesia	phenotype	C23;C10	DiseaseorSyndrome	0.30	1	2008	2008	1	0	CTD_human
val	2891	GRIA2	0.573	0.692	C4317123	MyoclonicSeizures	phenotype	C23;C10	SignorSymptom	0.30	1	2019	2019	1	0	GENOMICS_ENGLAND
val	2892	GRIA3	0.566	0.692	C0005586	BipolarDisorder	disease	F03	MentalorBehavioralDysfunction	0.32	1	1999	2010	5	0	PSYGENET
val	2892	GRIA3	0.566	0.692	C0011570	MentalDepression	disease	F01	MentalorBehavioralDysfunction	0.32	1	2010	2017	2	0	PSYGENET
val	2892	GRIA3	0.566	0.692	C0011581	Depressivedisorder	disease	F03	MentalorBehavioralDysfunction	0.32	1	2010	2017	3	0	PSYGENET
val	2892	GRIA3	0.566	0.692	C0016722	Frigidity	disease	F03	MentalorBehavioralDysfunction	0.30	1	2009	2009	1	0	CTD_human
val	2892	GRIA3	0.566	0.692	C0020594	HypoactiveSexualDesireDisorder	disease	F03	MentalorBehavioralDysfunction	0.30	1	2009	2009	1	0	CTD_human
val	2892	GRIA3	0.566	0.692	C0029261	OrgasmicDisorder	disease	F03	MentalorBehavioralDysfunction	0.30	1	2009	2009	1	0	CTD_human
val	2892	GRIA3	0.566	0.692	C0033953	PsychosexualDisorders	group	F03	MentalorBehavioralDysfunction	0.30	1	2009	2009	1	0	CTD_human
val	2892	GRIA3	0.566	0.692	C0036341	Schizophrenia	disease	F03	MentalorBehavioralDysfunction	0.32	1	2008	2013	2	0	PSYGENET
val	2892	GRIA3	0.566	0.692	C0036902	SexualArousalDisorder	disease	F03	MentalorBehavioralDysfunction	0.30	1	2009	2009	1	0	CTD_human
val	2892	GRIA3	0.566	0.692	C0796250	PARTINGTONX-LINKEDMENTALRETARDATIONSYNDROME	disease	C23;C16;C10	DiseaseorSyndrome	0.30	1	1999	2014	6	0	CLINGEN
val	2892	GRIA3	0.566	0.692	C1862939	AMYOTROPHICLATERALSCLEROSIS1	disease	C18;C10	DiseaseorSyndrome	0.30	1	2004	2004	1	0	CTD_human
val	2892	GRIA3	0.566	0.692	C1862941	AmyotrophicLateralSclerosis,Sporadic	disease	C18;C10	DiseaseorSyndrome	0.30	1	2004	2004	1	0	CTD_human
val	2892	GRIA3	0.566	0.692	C2678051	MENTALRETARDATION,X-LINKED94(disorder)	disease	C16;C10	DiseaseorSyndrome	0.70	1	2007	2007	1	7	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
val	2892	GRIA3	0.566	0.692	C4551993	AmyotrophicLateralSclerosis,Familial	disease	C18;C10	DiseaseorSyndrome	0.30	1	2004	2004	1	0	CTD_human
val	2893	GRIA4	0.631	0.615	C0013146	Drugabuse	group	C25;F03	MentalorBehavioralDysfunction	0.30	1	2010	2010	1	0	CTD_human
val	2893	GRIA4	0.631	0.615	C0013170	Drughabituation	phenotype	C25;F03	MentalorBehavioralDysfunction	0.30	1	2010	2010	1	0	CTD_human
val	2893	GRIA4	0.631	0.615	C0013222	DrugUseDisorders	group	C25;F03	MentalorBehavioralDysfunction	0.30	1	2010	2010	1	0	CTD_human
val	2893	GRIA4	0.631	0.615	C0027092	Myopia	disease	C11	DiseaseorSyndrome	0.40	1	2013	2016	1	1	CTD_human
val	2893	GRIA4	0.631	0.615	C0029231	OrganicMentalDisorders,Substance-Induced	disease	C25;F03	MentalorBehavioralDysfunction	0.30	1	2010	2010	1	0	CTD_human
val	2893	GRIA4	0.631	0.615	C0036341	Schizophrenia	disease	F03	MentalorBehavioralDysfunction	0.35	0.25	2003	2012	4	0	PSYGENET
val	2893	GRIA4	0.631	0.615	C0038580	SubstanceDependence	disease	C25;F03	MentalorBehavioralDysfunction	0.30	1	2010	2010	1	0	CTD_human
val	2893	GRIA4	0.631	0.615	C0038586	SubstanceUseDisorders	group	C25;F03	MentalorBehavioralDysfunction	0.30	1	2010	2010	1	0	CTD_human
val	2893	GRIA4	0.631	0.615	C0236969	Substance-RelatedDisorders	group	C25;F03	MentalorBehavioralDysfunction	0.30	1	2010	2010	1	0	CTD_human
val	2893	GRIA4	0.631	0.615	C0740858	Substanceabuseproblem	disease	C25;F03	MentalorBehavioralDysfunction	0.30	1	2010	2010	1	0	CTD_human
val	2893	GRIA4	0.631	0.615	C1510472	DrugDependence	group	C25;F03	MentalorBehavioralDysfunction	0.30	1	2010	2010	1	0	CTD_human
val	2893	GRIA4	0.631	0.615	C4316881	PrescriptionDrugAbuse	phenotype	C25;F03	Finding	0.30	1	2010	2010	1	0	CTD_human
val	2893	GRIA4	0.631	0.615	C4693391	NEURODEVELOPMENTALDISORDERWITHORWITHOUTSEIZURESANDGAITABNORMALITIES	disease		DiseaseorSyndrome	0.50	1	2008	2017	2	4	GENOMICS_ENGLAND;UNIPROT
val	2894	GRID1	0.743	0.385	C0005586	BipolarDisorder	disease	F03	MentalorBehavioralDysfunction	0.30	1	2012	2012	1	0	PSYGENET
val	2894	GRID1	0.743	0.385	C0009402	ColorectalCarcinoma	disease	C06;C04	NeoplasticProcess	0.30	1	2011	2011	1	0	CTD_human
val	2894	GRID1	0.743	0.385	C0009404	ColorectalNeoplasms	group	C06;C04	NeoplasticProcess	0.30	1	2011	2011	1	0	CTD_human
val	2894	GRID1	0.743	0.385	C0011570	MentalDepression	disease	F01	MentalorBehavioralDysfunction	0.30	1	2012	2013	3	0	PSYGENET
val	2894	GRID1	0.743	0.385	C0011581	Depressivedisorder	disease	F03	MentalorBehavioralDysfunction	0.30	1	2012	2013	3	0	PSYGENET
val	2894	GRID1	0.743	0.385	C0036341	Schizophrenia	disease	F03	MentalorBehavioralDysfunction	0.36	1	2005	2018	5	0	PSYGENET
val	2895	GRID2	0.67	0.5	C0009402	ColorectalCarcinoma	disease	C06;C04	NeoplasticProcess	0.30				0	0	UNIPROT
val	2895	GRID2	0.67	0.5	C0087012	Ataxia,Spinocerebellar	disease	C16;C10	DiseaseorSyndrome	0.30				0	0	CTD_human
val	2895	GRID2	0.67	0.5	C0752120	SpinocerebellarAtaxiaType1	disease	C16;C10	DiseaseorSyndrome	0.30				0	0	CTD_human
val	2895	GRID2	0.67	0.5	C0752121	SpinocerebellarAtaxiaType2	disease	C16;C10	DiseaseorSyndrome	0.30				0	0	CTD_human
val	2895	GRID2	0.67	0.5	C0752122	SpinocerebellarAtaxiaType4	disease	C16;C10	DiseaseorSyndrome	0.30				0	0	CTD_human
val	2895	GRID2	0.67	0.5	C0752123	SpinocerebellarAtaxiaType5	disease	C16;C10	DiseaseorSyndrome	0.30				0	0	CTD_human
val	2895	GRID2	0.67	0.5	C0752124	SpinocerebellarAtaxiaType6(disorder)	disease	C16;C10	DiseaseorSyndrome	0.30				0	0	CTD_human
val	2895	GRID2	0.67	0.5	C0752125	SpinocerebellarAtaxiaType7	disease	C16;C10	DiseaseorSyndrome	0.30				0	0	CTD_human
val	2895	GRID2	0.67	0.5	C4015505	SPINOCEREBELLARATAXIA,AUTOSOMALRECESSIVE18	disease		DiseaseorSyndrome	0.90	1	2010	2016	5	2	GENOMICS_ENGLAND;ORPHANET;UNIPROT
val	2896	GRN	0.435	0.846	C0005586	BipolarDisorder	disease	F03	MentalorBehavioralDysfunction	0.34	1	2012	2017	2	0	PSYGENET
val	2896	GRN	0.435	0.846	C0011570	MentalDepression	disease	F01	MentalorBehavioralDysfunction	0.30	1	2010	2012	3	0	PSYGENET
val	2896	GRN	0.435	0.846	C0011581	Depressivedisorder	disease	F03	MentalorBehavioralDysfunction	0.40	1	2010	2012	3	0	PSYGENET
val	2896	GRN	0.435	0.846	C0015397	Disorderofeye	group	C11	DiseaseorSyndrome	0.30				0	0	GENOMICS_ENGLAND
val	2896	GRN	0.435	0.846	C0023893	LiverCirrhosis,Experimental	disease	C23;C06	ExperimentalModelofDisease	0.30	1	2014	2014	1	0	CTD_human
val	2896	GRN	0.435	0.846	C0027746	NerveDegeneration	phenotype	C23	CellorMolecularDysfunction	0.30	1	2011	2011	1	0	CTD_human
val	2896	GRN	0.435	0.846	C0036341	Schizophrenia	disease	F03	MentalorBehavioralDysfunction	0.33	1	2010	2012	2	0	PSYGENET
val	2896	GRN	0.435	0.846	C0338451	Frontotemporaldementia	disease	C18;C10;F03	DiseaseorSyndrome	0.90	0.976	2006	2020	3	15	CTD_human;GENOMICS_ENGLAND
val	2896	GRN	0.435	0.846	C0338462	SemanticDementia	disease	C18;C10;F03	MentalorBehavioralDysfunction	0.53	1	2010	2018	3	0	CTD_human;ORPHANET
val	2896	GRN	0.435	0.846	C0338630	SenileParanoidDementia	disease	C10;F03	MentalorBehavioralDysfunction	0.30	1	2007	2008	2	0	CTD_human
val	2896	GRN	0.435	0.846	C0497327	Dementia	disease	C10;F03	MentalorBehavioralDysfunction	0.50	1	2006	2019	2	0	CTD_human
val	2896	GRN	0.435	0.846	C0751071	FamilialDementia	disease	C10;F03	MentalorBehavioralDysfunction	0.30	1	2007	2008	2	0	CTD_human
val	2896	GRN	0.435	0.846	C0751072	FrontotemporalLobarDegeneration	disease	C18;C10;F03	MentalorBehavioralDysfunction	0.40	0.989	2006	2020	1	0	CTD_human
val	2896	GRN	0.435	0.846	C0751706	PrimaryProgressiveNonfluentAphasia	disease	C23;C18;C10;F03	MentalorBehavioralDysfunction	0.40	0.917	2006	2018	1	0	ORPHANET
val	2896	GRN	0.435	0.846	C1843792	FRONTOTEMPORALLOBARDEGENERATIONWITHTDP43INCLUSIONS,GRN-RELATED	disease		DiseaseorSyndrome	0.98	1	2006	2018	3	22	CTD_human;GENOMICS_ENGLAND;UNIPROT
val	2896	GRN	0.435	0.846	C1850792	Congenitalmyasthenicsyndromeib	disease	C16;C10	DiseaseorSyndrome	0.30				0	0	GENOMICS_ENGLAND
val	2896	GRN	0.435	0.846	C3539123	CEROIDLIPOFUSCINOSIS,NEURONAL,11	disease		DiseaseorSyndrome	0.70	1	2006	2017	1	8	CTD_human;GENOMICS_ENGLAND;ORPHANET
val	2896	GRN	0.435	0.846	C4011788	Behavioralvariantoffrontotemporaldementia	disease	C18;C10;F03	DiseaseorSyndrome	0.39	1	2007	2019	2	0	ORPHANET
val	2897	GRIK1	0.641	0.462	C0001969	AlcoholicIntoxication	disease	C25;F03	MentalorBehavioralDysfunction	0.30	1	2014	2014	1	0	PSYGENET
val	2897	GRIK1	0.641	0.462	C0001973	AlcoholicIntoxication,Chronic	disease	C25;F03	MentalorBehavioralDysfunction	0.32	1	2009	2015	1	0	PSYGENET
val	2897	GRIK1	0.641	0.462	C0005586	BipolarDisorder	disease	F03	MentalorBehavioralDysfunction	0.32	1	2007	2009	1	0	PSYGENET
val	2897	GRIK1	0.641	0.462	C0022333	JacksonianSeizure	disease	C23;C10	DiseaseorSyndrome	0.30	1	2002	2002	1	0	CTD_human
val	2897	GRIK1	0.641	0.462	C0036341	Schizophrenia	disease	F03	MentalorBehavioralDysfunction	0.36	0.5	1994	2012	2	0	PSYGENET
val	2897	GRIK1	0.641	0.462	C0036572	Seizures	phenotype	C23;C10	SignorSymptom	0.31	1	2001	2002	1	0	CTD_human
val	2897	GRIK1	0.641	0.462	C0149958	Complexpartialseizures	disease	C23;C10	DiseaseorSyndrome	0.30	1	2002	2002	1	0	CTD_human
val	2897	GRIK1	0.641	0.462	C0234533	Generalizedseizures	disease	C23;C10	DiseaseorSyndrome	0.30	1	2002	2002	1	0	CTD_human
val	2897	GRIK1	0.641	0.462	C0234535	ClonicSeizures	disease	C23;C10	DiseaseorSyndrome	0.30	1	2002	2002	1	0	CTD_human
val	2897	GRIK1	0.641	0.462	C0270824	Visualseizure	disease	C23;C10	DiseaseorSyndrome	0.30	1	2002	2002	1	0	CTD_human
val	2897	GRIK1	0.641	0.462	C0270844	TonicSeizures	phenotype	C23;C10	DiseaseorSyndrome	0.30	1	2002	2002	1	0	CTD_human
val	2897	GRIK1	0.641	0.462	C0270846	Epilepticdropattack	disease	C23;C10	DiseaseorSyndrome	0.30	1	2002	2002	1	0	CTD_human
val	2897	GRIK1	0.641	0.462	C0422850	Seizures,Somatosensory	phenotype	C23;C10	PathologicFunction	0.30	1	2002	2002	1	0	CTD_human
val	2897	GRIK1	0.641	0.462	C0422852	Seizures,Auditory	phenotype	C23;C10	PathologicFunction	0.30	1	2002	2002	1	0	CTD_human
val	2897	GRIK1	0.641	0.462	C0422853	Olfactoryseizure	phenotype	C23;C10	DiseaseorSyndrome	0.30	1	2002	2002	1	0	CTD_human
val	2897	GRIK1	0.641	0.462	C0422854	Gustatoryseizure	phenotype	C23;C10	SignorSymptom	0.30	1	2002	2002	1	0	CTD_human
val	2897	GRIK1	0.641	0.462	C0422855	Vertiginousseizure	phenotype	C23;C10	DiseaseorSyndrome	0.30	1	2002	2002	1	0	CTD_human
val	2897	GRIK1	0.641	0.462	C0494475	Tonic-clonicseizures	disease	C23;C10	DiseaseorSyndrome	0.30	1	2002	2002	1	0	CTD_human
val	2897	GRIK1	0.641	0.462	C0573196	Overdoseofcocaine	disease		InjuryorPoisoning	0.30	1	2003	2003	1	0	PSYGENET
val	2897	GRIK1	0.641	0.462	C0687132	heavydrinking	disease		MentalorBehavioralDysfunction	0.32	1	2014	2014	2	0	PSYGENET
val	2897	GRIK1	0.641	0.462	C0751056	Non-epilepticconvulsion	phenotype	C23;C10	SignorSymptom	0.30	1	2002	2002	1	0	CTD_human
val	2897	GRIK1	0.641	0.462	C0751110	SingleSeizure	disease	C23;C10	DiseaseorSyndrome	0.30	1	2002	2002	1	0	CTD_human
val	2897	GRIK1	0.641	0.462	C0751123	AtonicAbsenceSeizures	phenotype	C23;C10	DiseaseorSyndrome	0.30	1	2002	2002	1	0	CTD_human
val	2897	GRIK1	0.641	0.462	C0751494	ConvulsiveSeizures	phenotype	C23;C10	SignorSymptom	0.30	1	2002	2002	1	0	CTD_human
val	2897	GRIK1	0.641	0.462	C0751495	Seizures,Focal	phenotype	C23;C10	DiseaseorSyndrome	0.30	1	2002	2002	1	0	CTD_human
val	2897	GRIK1	0.641	0.462	C0751496	Seizures,Sensory	phenotype	C23;C10	SignorSymptom	0.30	1	2002	2002	1	0	CTD_human
val	2897	GRIK1	0.641	0.462	C3495874	NonepilepticSeizures	phenotype	C23;C10	DiseaseorSyndrome	0.30	1	2002	2002	1	0	CTD_human
val	2897	GRIK1	0.641	0.462	C3496069	cocaineuse	disease		MentalorBehavioralDysfunction	0.30	1	2003	2003	1	0	PSYGENET
val	2897	GRIK1	0.641	0.462	C4048158	Convulsions	phenotype	C23;C10	SignorSymptom	0.30	1	2002	2002	1	0	CTD_human
val	2897	GRIK1	0.641	0.462	C4316903	AbsenceSeizures	phenotype	C23;C10	DiseaseorSyndrome	0.30	1	2002	2002	1	0	CTD_human
val	2897	GRIK1	0.641	0.462	C4317109	EpilepticSeizures	phenotype	C23;C10	DiseaseorSyndrome	0.30	1	2002	2002	1	0	CTD_human
val	2897	GRIK1	0.641	0.462	C4317123	MyoclonicSeizures	phenotype	C23;C10	SignorSymptom	0.30	1	2002	2002	1	0	CTD_human
val	2897	GRIK1	0.641	0.462	C4505436	GeneralizedAbsenceSeizures	phenotype	C23;C10	DiseaseorSyndrome	0.30	1	2002	2002	1	0	CTD_human
val	2898	GRIK2	0.561	0.769	C0004352	AutisticDisorder	disease	F03	MentalorBehavioralDysfunction	0.38	1	2002	2010	2	0	CTD_human
val	2898	GRIK2	0.561	0.769	C0005586	BipolarDisorder	disease	F03	MentalorBehavioralDysfunction	0.51	1	2007	2009	3	0	CTD_human;PSYGENET
val	2898	GRIK2	0.561	0.769	C0005587	Depression,Bipolar	disease	F03	MentalorBehavioralDysfunction	0.30	1	2008	2008	1	0	CTD_human
val	2898	GRIK2	0.561	0.769	C0006142	Malignantneoplasmofbreast	disease	C04;C17	NeoplasticProcess	0.51	1	2019	2019	1	0	CTD_human;UNIPROT
val	2898	GRIK2	0.561	0.769	C0007102	Malignanttumorofcolon	disease	C06;C04	NeoplasticProcess	0.30	1	2019	2019	1	0	CTD_human
val	2898	GRIK2	0.561	0.769	C0007131	Non-SmallCellLungCarcinoma	disease	C04;C08	NeoplasticProcess	0.30	1	2019	2019	1	0	CTD_human
val	2898	GRIK2	0.561	0.769	C0009375	ColonicNeoplasms	group	C06;C04	NeoplasticProcess	0.30	1	2019	2019	1	0	CTD_human
val	2898	GRIK2	0.561	0.769	C0013146	Drugabuse	group	C25;F03	MentalorBehavioralDysfunction	0.30	1	2010	2010	1	0	CTD_human
val	2898	GRIK2	0.561	0.769	C0013170	Drughabituation	phenotype	C25;F03	MentalorBehavioralDysfunction	0.30	1	2010	2010	1	0	CTD_human
val	2898	GRIK2	0.561	0.769	C0013222	DrugUseDisorders	group	C25;F03	MentalorBehavioralDysfunction	0.30	1	2010	2010	1	0	CTD_human
val	2898	GRIK2	0.561	0.769	C0014859	EsophagealNeoplasms	group	C06;C04	NeoplasticProcess	0.30	1	2019	2019	1	0	CTD_human
val	2898	GRIK2	0.561	0.769	C0016722	Frigidity	disease	F03	MentalorBehavioralDysfunction	0.30	1	2009	2009	1	0	CTD_human
val	2898	GRIK2	0.561	0.769	C0017636	Glioblastoma	disease	C04	NeoplasticProcess	0.30	1	2019	2019	1	0	CTD_human
val	2898	GRIK2	0.561	0.769	C0020594	HypoactiveSexualDesireDisorder	disease	F03	MentalorBehavioralDysfunction	0.30	1	2009	2009	1	0	CTD_human
val	2898	GRIK2	0.561	0.769	C0023903	Liverneoplasms	group	C06;C04	NeoplasticProcess	0.30	1	2019	2019	1	0	CTD_human
val	2898	GRIK2	0.561	0.769	C0024232	LymphaticMetastasis	disease	C23;C04	NeoplasticProcess	0.30	1	2019	2019	1	0	CTD_human
val	2898	GRIK2	0.561	0.769	C0024713	ManicDisorder	disease	F03	MentalorBehavioralDysfunction	0.30	1	2008	2008	1	0	CTD_human
val	2898	GRIK2	0.561	0.769	C0029231	OrganicMentalDisorders,Substance-Induced	disease	C25;F03	MentalorBehavioralDysfunction	0.30	1	2010	2010	1	0	CTD_human
val	2898	GRIK2	0.561	0.769	C0029261	OrgasmicDisorder	disease	F03	MentalorBehavioralDysfunction	0.30	1	2009	2009	1	0	CTD_human
val	2898	GRIK2	0.561	0.769	C0033953	PsychosexualDisorders	group	F03	MentalorBehavioralDysfunction	0.30	1	2009	2009	1	0	CTD_human
val	2898	GRIK2	0.561	0.769	C0036341	Schizophrenia	disease	F03	MentalorBehavioralDysfunction	0.35	0.667	1996	2017	1	0	CTD_human
val	2898	GRIK2	0.561	0.769	C0036902	SexualArousalDisorder	disease	F03	MentalorBehavioralDysfunction	0.30	1	2009	2009	1	0	CTD_human
val	2898	GRIK2	0.561	0.769	C0038580	SubstanceDependence	disease	C25;F03	MentalorBehavioralDysfunction	0.30	1	2010	2010	1	0	CTD_human
val	2898	GRIK2	0.561	0.769	C0038586	SubstanceUseDisorders	group	C25;F03	MentalorBehavioralDysfunction	0.30	1	2010	2010	1	0	CTD_human
val	2898	GRIK2	0.561	0.769	C0236969	Substance-RelatedDisorders	group	C25;F03	MentalorBehavioralDysfunction	0.30	1	2010	2010	1	0	CTD_human
val	2898	GRIK2	0.561	0.769	C0334588	GiantCellGlioblastoma	disease	C04	NeoplasticProcess	0.30	1	2019	2019	1	0	CTD_human
val	2898	GRIK2	0.561	0.769	C0338831	Manic	disease	F03	MentalorBehavioralDysfunction	0.31	1	2008	2019	1	0	CTD_human
val	2898	GRIK2	0.561	0.769	C0345904	Malignantneoplasmofliver	disease	C06;C04	NeoplasticProcess	0.30	1	2019	2019	1	0	CTD_human
val	2898	GRIK2	0.561	0.769	C0525045	MoodDisorders	group	F03	MentalorBehavioralDysfunction	0.32	1	2012	2017	1	0	PSYGENET
val	2898	GRIK2	0.561	0.769	C0546837	Malignantneoplasmofesophagus	disease	C06;C04	NeoplasticProcess	0.30	1	2019	2019	1	0	CTD_human
val	2898	GRIK2	0.561	0.769	C0678222	BreastCarcinoma	disease	C04;C17	NeoplasticProcess	0.31	1	2019	2019	1	0	CTD_human
val	2898	GRIK2	0.561	0.769	C0740858	Substanceabuseproblem	disease	C25;F03	MentalorBehavioralDysfunction	0.30	1	2010	2010	1	0	CTD_human
val	2898	GRIK2	0.561	0.769	C0919267	ovarianneoplasm	disease	C04;C13;C19	NeoplasticProcess	0.30	1	2019	2019	1	0	CTD_human
val	2898	GRIK2	0.561	0.769	C1140680	Malignantneoplasmofovary	disease	C04;C13;C19	NeoplasticProcess	0.30	1	2019	2019	1	0	CTD_human
val	2898	GRIK2	0.561	0.769	C1257931	MammaryNeoplasms,Human	disease	C04;C17	NeoplasticProcess	0.30	1	2019	2019	1	0	CTD_human
val	2898	GRIK2	0.561	0.769	C1458155	MammaryNeoplasms	group	C04;C17	NeoplasticProcess	0.30	1	2019	2019	1	0	CTD_human
val	2898	GRIK2	0.561	0.769	C1510472	DrugDependence	group	C25;F03	MentalorBehavioralDysfunction	0.30	1	2010	2010	1	0	CTD_human
val	2898	GRIK2	0.561	0.769	C1621958	GlioblastomaMultiforme	disease	C04	NeoplasticProcess	0.30	1	2019	2019	1	0	CTD_human
val	2898	GRIK2	0.561	0.769	C1970198	MENTALRETARDATION,AUTOSOMALRECESSIVE6	disease	C23;C10;F03;F01	DiseaseorSyndrome	0.60	1	2007	2007	1	1	CTD_human;GENOMICS_ENGLAND
val	2898	GRIK2	0.561	0.769	C4316881	PrescriptionDrugAbuse	phenotype	C25;F03	Finding	0.30	1	2010	2010	1	0	CTD_human
val	2898	GRIK2	0.561	0.769	C4704874	MammaryCarcinoma,Human	disease	C04;C17	NeoplasticProcess	0.30	1	2019	2019	1	0	CTD_human
val	2899	GRIK3	0.674	0.538	C0001973	AlcoholicIntoxication,Chronic	disease	C25;F03	MentalorBehavioralDysfunction	0.32	0.5	2006	2013	2	0	PSYGENET
val	2899	GRIK3	0.674	0.538	C0006142	Malignantneoplasmofbreast	disease	C04;C17	NeoplasticProcess	0.31	1	2019	2019	0	0	UNIPROT
val	2899	GRIK3	0.674	0.538	C0009402	ColorectalCarcinoma	disease	C06;C04	NeoplasticProcess	0.30				0	1	UNIPROT
val	2899	GRIK3	0.674	0.538	C0011570	MentalDepression	disease	F01	MentalorBehavioralDysfunction	0.31	1	2010	2010	1	0	PSYGENET
val	2899	GRIK3	0.674	0.538	C0011581	Depressivedisorder	disease	F03	MentalorBehavioralDysfunction	0.31	1	2010	2010	1	0	PSYGENET
val	2899	GRIK3	0.674	0.538	C0033975	PsychoticDisorders	group	F03	MentalorBehavioralDysfunction	0.31	1	2009	2009	1	0	PSYGENET
val	2899	GRIK3	0.674	0.538	C0036341	Schizophrenia	disease	F03	MentalorBehavioralDysfunction	0.37	0.6	2002	2010	5	0	PSYGENET
val	2899	GRIK3	0.674	0.538	C0149925	Smallcellcarcinomaoflung	disease	C04;C08	NeoplasticProcess	0.30	1	2012	2012	1	0	CTD_human
val	2900	GRIK4	0.678	0.423	C0005586	BipolarDisorder	disease	F03	MentalorBehavioralDysfunction	0.35	1	2006	2019	5	0	PSYGENET
val	2900	GRIK4	0.678	0.423	C0005587	Depression,Bipolar	disease	F03	MentalorBehavioralDysfunction	0.30	1	2012	2012	1	0	PSYGENET
val	2900	GRIK4	0.678	0.423	C0033975	PsychoticDisorders	group	F03	MentalorBehavioralDysfunction	0.31	1	2007	2008	1	0	PSYGENET
val	2900	GRIK4	0.678	0.423	C0036341	Schizophrenia	disease	F03	MentalorBehavioralDysfunction	0.35	0.5	2006	2018	4	0	PSYGENET
val	2900	GRIK4	0.678	0.423	C0041696	UnipolarDepression	disease	F03	MentalorBehavioralDysfunction	0.32	1	2012	2017	1	0	PSYGENET
val	2900	GRIK4	0.678	0.423	C0349204	Nonorganicpsychosis	disease	F03	MentalorBehavioralDysfunction	0.31	1	2007	2008	1	0	PSYGENET
val	2900	GRIK4	0.678	0.423	C1269683	MajorDepressiveDisorder	disease	F03	MentalorBehavioralDysfunction	0.33	1	2012	2019	1	0	PSYGENET
val	2901	GRIK5	0.792	0.231	C0005586	BipolarDisorder	disease	F03	MentalorBehavioralDysfunction	0.30	1	2009	2009	1	0	PSYGENET
val	2901	GRIK5	0.792	0.231	C0036341	Schizophrenia	disease	F03	MentalorBehavioralDysfunction	0.31	1	2006	2008	1	0	CTD_human
val	2902	GRIN1	0.561	0.692	C0001973	AlcoholicIntoxication,Chronic	disease	C25;F03	MentalorBehavioralDysfunction	0.33	1	2003	2013	3	0	PSYGENET
val	2902	GRIN1	0.561	0.692	C0005586	BipolarDisorder	disease	F03	MentalorBehavioralDysfunction	0.34	0.5	2003	2012	2	0	PSYGENET
val	2902	GRIN1	0.561	0.692	C0009171	CocaineAbuse	disease	C25;F03	MentalorBehavioralDysfunction	0.30	1	2005	2010	2	0	CTD_human
val	2902	GRIN1	0.561	0.692	C0020429	Hyperalgesia	phenotype	C23;C10	SignorSymptom	0.31	1	2016	2017	1	0	CTD_human
val	2902	GRIN1	0.561	0.692	C0030193	Pain	phenotype	C23	SignorSymptom	0.31	1	2008	2017	1	0	CTD_human
val	2902	GRIN1	0.561	0.692	C0033958	Psychosis,BriefReactive	disease	F03	MentalorBehavioralDysfunction	0.30	1	2004	2004	1	0	CTD_human
val	2902	GRIN1	0.561	0.692	C0033975	PsychoticDisorders	group	F03	MentalorBehavioralDysfunction	0.32	1	2001	2013	1	0	CTD_human
val	2902	GRIN1	0.561	0.692	C0036337	SchizoaffectiveDisorder	disease	F03	MentalorBehavioralDysfunction	0.30	1	2004	2004	1	0	CTD_human
val	2902	GRIN1	0.561	0.692	C0036358	SchizophreniformDisorders	group	F03	MentalorBehavioralDysfunction	0.30	1	2004	2004	1	0	CTD_human
val	2902	GRIN1	0.561	0.692	C0040997	TrigeminalNeuralgia	disease	C10;C07	DiseaseorSyndrome	0.30	1	2016	2016	1	0	CTD_human
val	2902	GRIN1	0.561	0.692	C0234230	Pain,Burning	phenotype	C23	SignorSymptom	0.30	1	2008	2008	1	0	CTD_human
val	2902	GRIN1	0.561	0.692	C0234238	Ache	phenotype	C23	SignorSymptom	0.30	1	2008	2008	1	0	CTD_human
val	2902	GRIN1	0.561	0.692	C0234254	Radiatingpain	phenotype	C23	SignorSymptom	0.30	1	2008	2008	1	0	CTD_human
val	2902	GRIN1	0.561	0.692	C0236736	Cocaine-RelatedDisorders	group	C25;F03	MentalorBehavioralDysfunction	0.30	1	2005	2010	2	0	CTD_human
val	2902	GRIN1	0.561	0.692	C0393786	TrigeminalNeuralgia,Idiopathic	disease	C10;C07	DiseaseorSyndrome	0.30	1	2016	2016	1	0	CTD_human
val	2902	GRIN1	0.561	0.692	C0393787	SecondaryTrigeminalNeuralgia	disease	C10;C07	DiseaseorSyndrome	0.30	1	2016	2016	1	0	CTD_human
val	2902	GRIN1	0.561	0.692	C0427086	InvoluntaryMovements	phenotype	C23;C10	SignorSymptom	0.41	1	2015	2017	1	0	GENOMICS_ENGLAND
val	2902	GRIN1	0.561	0.692	C0458247	Allodynia	phenotype	C23;C10	Finding	0.30	1	2016	2016	1	0	CTD_human
val	2902	GRIN1	0.561	0.692	C0458257	Pain,Splitting	phenotype	C23	SignorSymptom	0.30	1	2008	2008	1	0	CTD_human
val	2902	GRIN1	0.561	0.692	C0458259	Pain,Crushing	phenotype	C23	SignorSymptom	0.30	1	2008	2008	1	0	CTD_human
val	2902	GRIN1	0.561	0.692	C0543888	Epilepticencephalopathy	disease	C10	DiseaseorSyndrome	0.44	1	2013	2019	3	0	GENOMICS_ENGLAND
val	2902	GRIN1	0.561	0.692	C0600427	CocaineDependence	disease	C25;F03	MentalorBehavioralDysfunction	0.30	1	2005	2010	2	0	CTD_human
val	2902	GRIN1	0.561	0.692	C0751211	Hyperalgesia,Primary	phenotype	C23;C10	SignorSymptom	0.30	1	2016	2016	1	0	CTD_human
val	2902	GRIN1	0.561	0.692	C0751212	Hyperalgesia,Secondary	phenotype	C23;C10	SignorSymptom	0.30	1	2016	2016	1	0	CTD_human
val	2902	GRIN1	0.561	0.692	C0751213	TactileAllodynia	phenotype	C23;C10	SignorSymptom	0.30	1	2016	2016	1	0	CTD_human
val	2902	GRIN1	0.561	0.692	C0751214	Hyperalgesia,Thermal	phenotype	C23;C10	SignorSymptom	0.30	1	2016	2016	1	0	CTD_human
val	2902	GRIN1	0.561	0.692	C0751407	Pain,Migratory	phenotype	C23	SignorSymptom	0.30	1	2008	2008	1	0	CTD_human
val	2902	GRIN1	0.561	0.692	C0751408	Suffering,Physical	phenotype	C23	SignorSymptom	0.30	1	2008	2008	1	0	CTD_human
val	2902	GRIN1	0.561	0.692	C2936719	MechanicalAllodynia	phenotype	C23;C10	SignorSymptom	0.34	1	2016	2019	1	0	CTD_human
val	2902	GRIN1	0.561	0.692	C3280282	NEURODEVELOPMENTALDISORDERWITHORWITHOUTHYPERKINETICMOVEMENTSANDSEIZURES,AUTOSOMALDOMINANT	disease		DiseaseorSyndrome	0.70	1	2011	2017	9	16	CTD_human;GENOMICS_ENGLAND;UNIPROT
val	2902	GRIN1	0.561	0.692	C3714756	IntellectualDisability	group	C23;C10;F03;F01	MentalorBehavioralDysfunction	0.43	1	2015	2017	1	0	GENOMICS_ENGLAND
val	2902	GRIN1	0.561	0.692	C4693325	NEURODEVELOPMENTALDISORDERWITHORWITHOUTHYPERKINETICMOVEMENTSANDSEIZURES,AUTOSOMALRECESSIVE	disease		DiseaseorSyndrome	0.60	1	2013	2017	3	2	GENOMICS_ENGLAND;UNIPROT
val	2903	GRIN2A	0.522	0.808	C0001973	AlcoholicIntoxication,Chronic	disease	C25;F03	MentalorBehavioralDysfunction	0.34	1	2008	2015	4	0	PSYGENET
val	2903	GRIN2A	0.522	0.808	C0004352	AutisticDisorder	disease	F03	MentalorBehavioralDysfunction	0.31	1	2005	2005	1	0	CTD_human
val	2903	GRIN2A	0.522	0.808	C0005586	BipolarDisorder	disease	F03	MentalorBehavioralDysfunction	0.58	0.8	2005	2019	6	0	CTD_human;PSYGENET
val	2903	GRIN2A	0.522	0.808	C0005587	Depression,Bipolar	disease	F03	MentalorBehavioralDysfunction	0.30	1	2019	2019	1	0	CTD_human
val	2903	GRIN2A	0.522	0.808	C0009090	Cluttering	phenotype	C23;C10	SignorSymptom	0.30	1	2013	2013	1	0	CTD_human
val	2903	GRIN2A	0.522	0.808	C0009402	ColorectalCarcinoma	disease	C06;C04	NeoplasticProcess	0.31	1	2008	2008	1	0	CTD_human
val	2903	GRIN2A	0.522	0.808	C0009404	ColorectalNeoplasms	group	C06;C04	NeoplasticProcess	0.31	1	2008	2008	1	0	CTD_human
val	2903	GRIN2A	0.522	0.808	C0011570	MentalDepression	disease	F01	MentalorBehavioralDysfunction	0.33	1	2006	2019	4	0	PSYGENET
val	2903	GRIN2A	0.522	0.808	C0011581	Depressivedisorder	disease	F03	MentalorBehavioralDysfunction	0.43	1	2006	2019	4	0	PSYGENET
val	2903	GRIN2A	0.522	0.808	C0014544	Epilepsy	disease	C10	DiseaseorSyndrome	0.40	0.96	1999	2019	2	0	CTD_human
val	2903	GRIN2A	0.522	0.808	C0023012	LanguageDelay	phenotype	C23;C10	Finding	0.30	1	2013	2013	1	0	CTD_human
val	2903	GRIN2A	0.522	0.808	C0023014	LanguageDevelopmentDisorders	group	C23;C10	MentalorBehavioralDysfunction	0.30	1	2013	2013	1	0	CTD_human
val	2903	GRIN2A	0.522	0.808	C0024713	ManicDisorder	disease	F03	MentalorBehavioralDysfunction	0.30	1	2019	2019	1	0	CTD_human
val	2903	GRIN2A	0.522	0.808	C0025202	melanoma	disease	C04	NeoplasticProcess	0.33	1	2011	2017	1	0	CTD_human
val	2903	GRIN2A	0.522	0.808	C0026552	MorphineDependence	disease	C25;F03	MentalorBehavioralDysfunction	0.30	1	2003	2003	1	0	CTD_human
val	2903	GRIN2A	0.522	0.808	C0036341	Schizophrenia	disease	F03	MentalorBehavioralDysfunction	0.40	0.6	2003	2020	5	0	PSYGENET
val	2903	GRIN2A	0.522	0.808	C0037822	SpeechDisorders	group	C23;C10	DiseaseorSyndrome	0.31	1	2013	2013	1	0	CTD_human
val	2903	GRIN2A	0.522	0.808	C0038587	SubstanceWithdrawalSyndrome	disease	C25;F03	MentalorBehavioralDysfunction	0.30	1	2003	2003	1	0	CTD_human
val	2903	GRIN2A	0.522	0.808	C0086189	DrugWithdrawalSymptoms	phenotype	C25;F03	SignorSymptom	0.30	1	2003	2003	1	0	CTD_human
val	2903	GRIN2A	0.522	0.808	C0086237	Epilepsy,Cryptogenic	disease	C10	DiseaseorSyndrome	0.30	1	2010	2013	2	0	CTD_human
val	2903	GRIN2A	0.522	0.808	C0087169	WithdrawalSymptoms	phenotype	C25;F03	SignorSymptom	0.30	1	2003	2003	1	0	CTD_human
val	2903	GRIN2A	0.522	0.808	C0233726	Aprosodia	phenotype	C23;C10	SignorSymptom	0.30	1	2013	2013	1	0	CTD_human
val	2903	GRIN2A	0.522	0.808	C0236018	Aura	phenotype	C10	Finding	0.30	1	2010	2013	2	0	CTD_human
val	2903	GRIN2A	0.522	0.808	C0241210	SpeechDelay	disease	C23;C10	MentalorBehavioralDysfunction	0.30	1	2013	2013	1	0	CTD_human
val	2903	GRIN2A	0.522	0.808	C0282512	Landau-KleffnerSyndrome	disease	C10	MentalorBehavioralDysfunction	0.64	1	2013	2018	3	0	CTD_human;GENOMICS_ENGLAND;ORPHANET
val	2903	GRIN2A	0.522	0.808	C0338831	Manic	disease	F03	MentalorBehavioralDysfunction	0.30	1	2019	2019	1	0	CTD_human
val	2903	GRIN2A	0.522	0.808	C0376532	Epilepsy,Rolandic	disease	C10	DiseaseorSyndrome	0.53	1	2012	2018	1	0	CTD_human;ORPHANET
val	2903	GRIN2A	0.522	0.808	C0454655	Semantic-PragmaticDisorder	phenotype	C23;C10	MentalorBehavioralDysfunction	0.30	1	2013	2013	1	0	CTD_human
val	2903	GRIN2A	0.522	0.808	C0525045	MoodDisorders	group	F03	MentalorBehavioralDysfunction	0.33	1	2003	2017	3	0	PSYGENET
val	2903	GRIN2A	0.522	0.808	C0600272	MorphineAbuse	disease	C25;F03	MentalorBehavioralDysfunction	0.30	1	2003	2003	1	0	CTD_human
val	2903	GRIN2A	0.522	0.808	C0751111	AwakeningEpilepsy	disease	C10	DiseaseorSyndrome	0.30	1	2010	2013	2	0	CTD_human
val	2903	GRIN2A	0.522	0.808	C0751257	AuditoryProcessingDisorder,Central	disease	C23;C10	DiseaseorSyndrome	0.30	1	2013	2013	1	0	CTD_human
val	2903	GRIN2A	0.522	0.808	C0751512	Dysglossia	phenotype	C23;C10	SignorSymptom	0.30	1	2013	2013	1	0	CTD_human
val	2903	GRIN2A	0.522	0.808	C0751513	Rhinolalia	phenotype	C23;C10	SignorSymptom	0.30	1	2013	2013	1	0	CTD_human
val	2903	GRIN2A	0.522	0.808	C0751514	VerbalFluencyDisorders	phenotype	C23;C10	DiseaseorSyndrome	0.30	1	2013	2013	1	0	CTD_human
val	2903	GRIN2A	0.522	0.808	C2363129	BenignRolandicEpilepsy	disease	C10	DiseaseorSyndrome	0.52	1	2013	2018	1	0	CTD_human;ORPHANET
val	2903	GRIN2A	0.522	0.808	C3495145	Dyslalia	disease	C23;C10	MentalorBehavioralDysfunction	0.30	1	2013	2013	1	0	CTD_human
val	2903	GRIN2A	0.522	0.808	C3806402	EPILEPSY,FOCAL,WITHSPEECHDISORDERANDWITHORWITHOUTMENTALRETARDATION	disease		DiseaseorSyndrome	0.60	1	2010	2017	12	0	CTD_human;GENOMICS_ENGLAND;UNIPROT
val	2903	GRIN2A	0.522	0.808	C4749281	Early-onsetepilepticencephalopathyandintellectualdisabilityduetoGRIN2Amutation	phenotype	C23;C10;F03;F01	DiseaseorSyndrome	0.30	1	2010	2010	1	0	ORPHANET
val	2904	GRIN2B	0.51	0.692	C0001973	AlcoholicIntoxication,Chronic	disease	C25;F03	MentalorBehavioralDysfunction	0.38	0.8	2003	2017	5	0	PSYGENET
val	2904	GRIN2B	0.51	0.692	C0004352	AutisticDisorder	disease	F03	MentalorBehavioralDysfunction	0.43	1	2013	2018	1	2	GENOMICS_ENGLAND
val	2904	GRIN2B	0.51	0.692	C0005586	BipolarDisorder	disease	F03	MentalorBehavioralDysfunction	0.39	0.8	2005	2020	5	0	PSYGENET
val	2904	GRIN2B	0.51	0.692	C0011570	MentalDepression	disease	F01	MentalorBehavioralDysfunction	0.40	0.8	2009	2019	5	0	PSYGENET
val	2904	GRIN2B	0.51	0.692	C0011581	Depressivedisorder	disease	F03	MentalorBehavioralDysfunction	0.40	0.8	2009	2019	5	0	PSYGENET
val	2904	GRIN2B	0.51	0.692	C0014544	Epilepsy	disease	C10	DiseaseorSyndrome	0.65	0.875	2004	2018	2	1	CTD_human
val	2904	GRIN2B	0.51	0.692	C0020429	Hyperalgesia	phenotype	C23;C10	SignorSymptom	0.56	1	2009	2020	1	0	CTD_human
val	2904	GRIN2B	0.51	0.692	C0020649	Hypotension	phenotype	C14	Finding	0.30	1	2008	2008	1	0	CTD_human
val	2904	GRIN2B	0.51	0.692	C0020796	ProfoundMentalRetardation	disease	C23;C10;F03;F01	MentalorBehavioralDysfunction	0.30	1	2010	2010	1	0	CTD_human
val	2904	GRIN2B	0.51	0.692	C0025363	MentalRetardation,Psychosocial	phenotype	C23;C10;F03;F01	MentalorBehavioralDysfunction	0.30	1	2010	2010	1	0	CTD_human
val	2904	GRIN2B	0.51	0.692	C0036341	Schizophrenia	disease	F03	MentalorBehavioralDysfunction	0.70	0.972	2000	2020	1	1	CTD_human
val	2904	GRIN2B	0.51	0.692	C0037769	WestSyndrome	disease	C10	DiseaseorSyndrome	0.42	1	2014	2017	1	0	ORPHANET
val	2904	GRIN2B	0.51	0.692	C0086237	Epilepsy,Cryptogenic	disease	C10	DiseaseorSyndrome	0.30	1	2006	2018	2	0	CTD_human
val	2904	GRIN2B	0.51	0.692	C0236018	Aura	phenotype	C10	Finding	0.30	1	2006	2018	2	0	CTD_human
val	2904	GRIN2B	0.51	0.692	C0458247	Allodynia	phenotype	C23;C10	Finding	0.30	1	2009	2009	1	0	CTD_human
val	2904	GRIN2B	0.51	0.692	C0543888	Epilepticencephalopathy	disease	C10	DiseaseorSyndrome	0.41	1	2013	2016	1	0	GENOMICS_ENGLAND
val	2904	GRIN2B	0.51	0.692	C0751111	AwakeningEpilepsy	disease	C10	DiseaseorSyndrome	0.30	1	2006	2018	2	0	CTD_human
val	2904	GRIN2B	0.51	0.692	C0751211	Hyperalgesia,Primary	phenotype	C23;C10	SignorSymptom	0.30	1	2009	2009	1	0	CTD_human
val	2904	GRIN2B	0.51	0.692	C0751212	Hyperalgesia,Secondary	phenotype	C23;C10	SignorSymptom	0.30	1	2009	2009	1	0	CTD_human
val	2904	GRIN2B	0.51	0.692	C0751213	TactileAllodynia	phenotype	C23;C10	SignorSymptom	0.30	1	2009	2009	1	0	CTD_human
val	2904	GRIN2B	0.51	0.692	C0751214	Hyperalgesia,Thermal	phenotype	C23;C10	SignorSymptom	0.30	1	2009	2009	1	0	CTD_human
val	2904	GRIN2B	0.51	0.692	C0917816	Mentaldeficiency	disease	C23;C10;F03;F01	MentalorBehavioralDysfunction	0.30	1	2010	2010	1	0	CTD_human
val	2904	GRIN2B	0.51	0.692	C1510586	AutismSpectrumDisorders	disease	F03	MentalorBehavioralDysfunction	0.38	1	2011	2019	1	0	CTD_human
val	2904	GRIN2B	0.51	0.692	C1535926	NeurodevelopmentalDisorders	group	F03	MentalorBehavioralDysfunction	0.34	1	2012	2018	2	0	CTD_human
val	2904	GRIN2B	0.51	0.692	C2936719	MechanicalAllodynia	phenotype	C23;C10	SignorSymptom	0.36	1	2009	2019	1	0	CTD_human
val	2904	GRIN2B	0.51	0.692	C3151411	MENTALRETARDATION,AUTOSOMALDOMINANT6	disease		MentalorBehavioralDysfunction	0.70	1	2010	2017	8	21	CTD_human;GENOMICS_ENGLAND;UNIPROT
val	2904	GRIN2B	0.51	0.692	C3714756	IntellectualDisability	group	C23;C10;F03;F01	MentalorBehavioralDysfunction	0.47	1	2010	2018	1	0	CTD_human
val	2904	GRIN2B	0.51	0.692	C4015316	EPILEPTICENCEPHALOPATHY,EARLYINFANTILE,27	disease		DiseaseorSyndrome	0.70	1	2014	2017	3	12	CTD_human;GENOMICS_ENGLAND;UNIPROT
val	2905	GRIN2C	0.792	0.269	C0036341	Schizophrenia	disease	F03	MentalorBehavioralDysfunction	0.34	0.75	2003	2014	4	0	PSYGENET
val	2906	GRIN2D	0.65	0.538	C0006142	Malignantneoplasmofbreast	disease	C04;C17	NeoplasticProcess	0.30				0	1	UNIPROT
val	2906	GRIN2D	0.65	0.538	C0027746	NerveDegeneration	phenotype	C23	CellorMolecularDysfunction	0.30	1	2010	2010	1	0	CTD_human
val	2906	GRIN2D	0.65	0.538	C0036341	Schizophrenia	disease	F03	MentalorBehavioralDysfunction	0.34	1	2005	2019	1	0	CTD_human
val	2906	GRIN2D	0.65	0.538	C3714756	IntellectualDisability	group	C23;C10;F03;F01	MentalorBehavioralDysfunction	0.40	1	2018	2018	1	0	GENOMICS_ENGLAND
val	2906	GRIN2D	0.65	0.538	C4310687	EPILEPTICENCEPHALOPATHY,EARLYINFANTILE,46	disease		DiseaseorSyndrome	0.70	1	2016	2018	2	4	CTD_human;GENOMICS_ENGLAND;UNIPROT
val	2908	NR3C1	0.393	0.885	C0001969	AlcoholicIntoxication	disease	C25;F03	MentalorBehavioralDysfunction	0.31	1	2011	2012	2	0	PSYGENET
val	2908	NR3C1	0.393	0.885	C0004238	AtrialFibrillation	disease	C23;C14	DiseaseorSyndrome	0.30	1	2018	2018	1	0	CTD_human
val	2908	NR3C1	0.393	0.885	C0005586	BipolarDisorder	disease	F03	MentalorBehavioralDysfunction	0.60	1	2004	2017	6	0	CTD_human;PSYGENET
val	2908	NR3C1	0.393	0.885	C0005587	Depression,Bipolar	disease	F03	MentalorBehavioralDysfunction	0.30	1	2004	2004	1	0	CTD_human
val	2908	NR3C1	0.393	0.885	C0009171	CocaineAbuse	disease	C25;F03	MentalorBehavioralDysfunction	0.30	1	2003	2009	2	0	CTD_human
val	2908	NR3C1	0.393	0.885	C0011570	MentalDepression	disease	F01	MentalorBehavioralDysfunction	0.60	0.8	1999	2020	5	0	PSYGENET
val	2908	NR3C1	0.393	0.885	C0011573	Endogenousdepression	disease	F03	MentalorBehavioralDysfunction	0.30	1	2004	2004	1	0	CTD_human
val	2908	NR3C1	0.393	0.885	C0011581	Depressivedisorder	disease	F03	MentalorBehavioralDysfunction	0.60	0.8	1999	2020	6	0	CTD_human;PSYGENET
val	2908	NR3C1	0.393	0.885	C0013221	Drugtoxicity	group	C25	InjuryorPoisoning	0.30	1	2018	2018	1	0	CTD_human
val	2908	NR3C1	0.393	0.885	C0014175	Endometriosis	disease	C13	DiseaseorSyndrome	0.32	1	2012	2018	1	0	CTD_human
val	2908	NR3C1	0.393	0.885	C0017614	Glaucoma,Suspect	disease	C11	DiseaseorSyndrome	0.30	1	2007	2007	1	0	CTD_human
val	2908	NR3C1	0.393	0.885	C0020538	Hypertensivedisease	group	C14	DiseaseorSyndrome	0.70	0.824	1993	2018	2	0	CTD_human
val	2908	NR3C1	0.393	0.885	C0020621	Hypokalemia	phenotype	C18	Finding	0.40	1	2002	2002	1	0	CTD_human
val	2908	NR3C1	0.393	0.885	C0024713	ManicDisorder	disease	F03	MentalorBehavioralDysfunction	0.30	1	2004	2004	1	0	CTD_human
val	2908	NR3C1	0.393	0.885	C0025193	Melancholia	disease	F03	MentalorBehavioralDysfunction	0.31	1	2004	2013	1	0	CTD_human
val	2908	NR3C1	0.393	0.885	C0028840	OcularHypertension	disease	C11	DiseaseorSyndrome	0.34	0.75	2007	2019	1	0	CTD_human
val	2908	NR3C1	0.393	0.885	C0033578	ProstaticNeoplasms	group	C04;C12	NeoplasticProcess	0.31	1	2007	2015	1	0	CTD_human
val	2908	NR3C1	0.393	0.885	C0033958	Psychosis,BriefReactive	disease	F03	MentalorBehavioralDysfunction	0.30	1	2004	2004	1	0	CTD_human
val	2908	NR3C1	0.393	0.885	C0033975	PsychoticDisorders	group	F03	MentalorBehavioralDysfunction	0.33	1	2004	2015	1	0	CTD_human
val	2908	NR3C1	0.393	0.885	C0036337	SchizoaffectiveDisorder	disease	F03	MentalorBehavioralDysfunction	0.30	1	2004	2004	1	0	CTD_human
val	2908	NR3C1	0.393	0.885	C0036341	Schizophrenia	disease	F03	MentalorBehavioralDysfunction	0.40	0.929	2000	2019	2	0	CTD_human
val	2908	NR3C1	0.393	0.885	C0036358	SchizophreniformDisorders	group	F03	MentalorBehavioralDysfunction	0.30	1	2004	2004	1	0	CTD_human
val	2908	NR3C1	0.393	0.885	C0041696	UnipolarDepression	disease	F03	MentalorBehavioralDysfunction	0.60	1	2004	2020	6	0	CTD_human;PSYGENET
val	2908	NR3C1	0.393	0.885	C0041755	Adversereactiontodrug	group	C25	PathologicFunction	0.30	1	2018	2018	1	0	CTD_human
val	2908	NR3C1	0.393	0.885	C0086133	DepressiveSyndrome	disease	F03	MentalorBehavioralDysfunction	0.30	1	2004	2004	1	0	CTD_human
val	2908	NR3C1	0.393	0.885	C0235480	Paroxysmalatrialfibrillation	disease	C23;C14	DiseaseorSyndrome	0.30	1	2018	2018	1	0	CTD_human
val	2908	NR3C1	0.393	0.885	C0236736	Cocaine-RelatedDisorders	group	C25;F03	MentalorBehavioralDysfunction	0.30	1	2003	2009	2	0	CTD_human
val	2908	NR3C1	0.393	0.885	C0238394	FemalePseudohermaphroditism	disease	C16;C13;C12;C19	CongenitalAbnormality	0.41	1	2002	2006	1	0	CTD_human
val	2908	NR3C1	0.393	0.885	C0269102	Endometrioma	disease	C13	NeoplasticProcess	0.30	1	2012	2012	1	0	CTD_human
val	2908	NR3C1	0.393	0.885	C0282126	Depression,Neurotic	disease	F03	MentalorBehavioralDysfunction	0.30	1	2004	2004	1	0	CTD_human
val	2908	NR3C1	0.393	0.885	C0338831	Manic	disease	F03	MentalorBehavioralDysfunction	0.32	1	2004	2011	1	0	CTD_human
val	2908	NR3C1	0.393	0.885	C0376358	Malignantneoplasmofprostate	disease	C04;C12	NeoplasticProcess	0.40	1	1997	2020	1	0	CTD_human
val	2908	NR3C1	0.393	0.885	C0525045	MoodDisorders	group	F03	MentalorBehavioralDysfunction	0.60	0.8	2002	2018	6	0	CTD_human;PSYGENET
val	2908	NR3C1	0.393	0.885	C0600260	LungDiseases,Obstructive	group	C08	DiseaseorSyndrome	0.31	1	1998	2007	1	0	CTD_human
val	2908	NR3C1	0.393	0.885	C0600427	CocaineDependence	disease	C25;F03	MentalorBehavioralDysfunction	0.33	1	2003	2017	2	0	CTD_human
val	2908	NR3C1	0.393	0.885	C1257958	GlucoseMetabolismDisorders	group	C18	DiseaseorSyndrome	0.30	1	2018	2018	1	0	CTD_human
val	2908	NR3C1	0.393	0.885	C1269683	MajorDepressiveDisorder	disease	F03	MentalorBehavioralDysfunction	0.40	1	2006	2020	5	0	PSYGENET
val	2908	NR3C1	0.393	0.885	C1841972	GlucocorticoidReceptorDeficiency	disease	C16;C18	DiseaseorSyndrome	0.80	0.953	1991	2020	16	9	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
val	2908	NR3C1	0.393	0.885	C1841973	Pseudohermaphroditism,Female,WithHypokalemia,DueToGlucocorticoidResistance	disease	C16;C18	DiseaseorSyndrome	0.40				0	1	CTD_human
val	2908	NR3C1	0.393	0.885	C1841982	BODYCOMPOSITION,BENEFICIAL	phenotype	C16;C18	Finding	0.30				0	0	CTD_human
val	2908	NR3C1	0.393	0.885	C2585653	Persistentatrialfibrillation	phenotype	C23;C14	PathologicFunction	0.30	1	2018	2018	1	0	CTD_human
val	2908	NR3C1	0.393	0.885	C2936403	46,XXDisordersofSexDevelopment	group	C16;C13;C12;C19	CongenitalAbnormality	0.30	1	2002	2002	1	0	CTD_human
val	2908	NR3C1	0.393	0.885	C3468561	familialatrialfibrillation	phenotype	C23;C14	PathologicFunction	0.30	1	2018	2018	1	0	CTD_human
val	2909	ARHGAP35	0.751	0.269	C0152013	Adenocarcinomaoflung(disorder)	disease	C04	NeoplasticProcess	0.31	1	2016	2018	1	0	CTD_human
val	2911	GRM1	0.528	0.808	C0001973	AlcoholicIntoxication,Chronic	disease	C25;F03	MentalorBehavioralDysfunction	0.32	1	2014	2020	1	0	PSYGENET
val	2911	GRM1	0.528	0.808	C0009402	ColorectalCarcinoma	disease	C06;C04	NeoplasticProcess	0.30				0	1	UNIPROT
val	2911	GRM1	0.528	0.808	C0011570	MentalDepression	disease	F01	MentalorBehavioralDysfunction	0.30	1	2001	2014	5	0	PSYGENET
val	2911	GRM1	0.528	0.808	C0011581	Depressivedisorder	disease	F03	MentalorBehavioralDysfunction	0.30	1	2001	2014	5	0	PSYGENET
val	2911	GRM1	0.528	0.808	C0014544	Epilepsy	disease	C10	DiseaseorSyndrome	0.34	1	2010	2019	1	0	CTD_human
val	2911	GRM1	0.528	0.808	C0014556	Epilepsy,TemporalLobe	disease	C10	DiseaseorSyndrome	0.52	1	2000	2005	1	0	CTD_human
val	2911	GRM1	0.528	0.808	C0014558	UncinateEpilepsy	disease	C10	DiseaseorSyndrome	0.30	1	2005	2005	1	0	CTD_human
val	2911	GRM1	0.528	0.808	C0016045	fibroma	disease	C04	NeoplasticProcess	0.30	1	2014	2014	1	0	CTD_human
val	2911	GRM1	0.528	0.808	C0016048	Fibromatosis	disease	C04	NeoplasticProcess	0.30	1	2014	2014	1	0	CTD_human
val	2911	GRM1	0.528	0.808	C0036341	Schizophrenia	disease	F03	MentalorBehavioralDysfunction	0.36	1	2005	2019	2	0	PSYGENET
val	2911	GRM1	0.528	0.808	C0038220	StatusEpilepticus	disease	C23;C10	DiseaseorSyndrome	0.30	1	2004	2007	2	0	CTD_human
val	2911	GRM1	0.528	0.808	C0041671	AttentionDeficitDisorder	disease	F03	MentalorBehavioralDysfunction	0.30	1	2011	2011	1	0	CTD_human
val	2911	GRM1	0.528	0.808	C0041696	UnipolarDepression	disease	F03	MentalorBehavioralDysfunction	0.31	1	2012	2012	1	0	PSYGENET
val	2911	GRM1	0.528	0.808	C0086237	Epilepsy,Cryptogenic	disease	C10	DiseaseorSyndrome	0.30	1	2010	2010	1	0	CTD_human
val	2911	GRM1	0.528	0.808	C0087012	Ataxia,Spinocerebellar	disease	C16;C10	DiseaseorSyndrome	0.32	1	2015	2017	0	0	CTD_human
val	2911	GRM1	0.528	0.808	C0205766	Myxofibroma	disease	C04	NeoplasticProcess	0.30	1	2014	2014	1	0	CTD_human
val	2911	GRM1	0.528	0.808	C0206639	Neoplasms,BoneTissue	group	C04	NeoplasticProcess	0.30	1	2014	2014	1	0	CTD_human
val	2911	GRM1	0.528	0.808	C0221290	Chondromyxoidfibroma	disease	C04	NeoplasticProcess	0.32	1	2014	2019	1	0	ORPHANET
val	2911	GRM1	0.528	0.808	C0236018	Aura	phenotype	C10	Finding	0.30	1	2010	2010	1	0	CTD_human
val	2911	GRM1	0.528	0.808	C0270823	Petitmalstatus	disease	C23;C10	DiseaseorSyndrome	0.30	1	2004	2007	2	0	CTD_human
val	2911	GRM1	0.528	0.808	C0311335	GrandMalStatusEpilepticus	disease	C23;C10	DiseaseorSyndrome	0.30	1	2004	2007	2	0	CTD_human
val	2911	GRM1	0.528	0.808	C0393672	Epilepsy,BenignPsychomotor,Childhood	disease	C10	DiseaseorSyndrome	0.30	1	2005	2005	1	0	CTD_human
val	2911	GRM1	0.528	0.808	C0393682	Epilepsy,LateralTemporal	disease	C10	DiseaseorSyndrome	0.30	1	2005	2005	1	0	CTD_human
val	2911	GRM1	0.528	0.808	C0393734	ComplexPartialStatusEpilepticus	disease	C23;C10	DiseaseorSyndrome	0.30	1	2004	2007	2	0	CTD_human
val	2911	GRM1	0.528	0.808	C0751111	AwakeningEpilepsy	disease	C10	DiseaseorSyndrome	0.30	1	2010	2010	1	0	CTD_human
val	2911	GRM1	0.528	0.808	C0751522	StatusEpilepticus,Subclinical	disease	C23;C10	DiseaseorSyndrome	0.30	1	2004	2007	2	0	CTD_human
val	2911	GRM1	0.528	0.808	C0751523	Non-ConvulsiveStatusEpilepticus	disease	C23;C10	DiseaseorSyndrome	0.30	1	2004	2007	2	0	CTD_human
val	2911	GRM1	0.528	0.808	C0751524	SimplePartialStatusEpilepticus	phenotype	C23;C10	DiseaseorSyndrome	0.30	1	2004	2007	2	0	CTD_human
val	2911	GRM1	0.528	0.808	C0752120	SpinocerebellarAtaxiaType1	disease	C16;C10	DiseaseorSyndrome	0.31	1	2017	2017	0	0	CTD_human
val	2911	GRM1	0.528	0.808	C0752121	SpinocerebellarAtaxiaType2	disease	C16;C10	DiseaseorSyndrome	0.32	1	2015	2017	0	0	CTD_human
val	2911	GRM1	0.528	0.808	C0752122	SpinocerebellarAtaxiaType4	disease	C16;C10	DiseaseorSyndrome	0.30				0	0	CTD_human
val	2911	GRM1	0.528	0.808	C0752123	SpinocerebellarAtaxiaType5	disease	C16;C10	DiseaseorSyndrome	0.30				0	0	CTD_human
val	2911	GRM1	0.528	0.808	C0752124	SpinocerebellarAtaxiaType6(disorder)	disease	C16;C10	DiseaseorSyndrome	0.30				0	0	CTD_human
val	2911	GRM1	0.528	0.808	C0752125	SpinocerebellarAtaxiaType7	disease	C16;C10	DiseaseorSyndrome	0.30				0	0	CTD_human
val	2911	GRM1	0.528	0.808	C0852975	Congenitalcerebellarataxia	disease		DiseaseorSyndrome	0.31	1	2012	2012	0	0	GENOMICS_ENGLAND
val	2911	GRM1	0.528	0.808	C1263846	Attentiondeficithyperactivitydisorder	disease	F03	MentalorBehavioralDysfunction	0.30	1	2011	2011	1	0	CTD_human
val	2911	GRM1	0.528	0.808	C1321905	MinimalBrainDysfunction	disease	F03	MentalorBehavioralDysfunction	0.30	1	2011	2011	1	0	CTD_human
val	2911	GRM1	0.528	0.808	C3553816	SPINOCEREBELLARATAXIA,AUTOSOMALRECESSIVE13	disease		DiseaseorSyndrome	0.90	1	2006	2015	2	1	GENOMICS_ENGLAND;ORPHANET;UNIPROT
val	2911	GRM1	0.528	0.808	C4521563	SPINOCEREBELLARATAXIA44	disease		DiseaseorSyndrome	0.61	1	2017	2019	1	3	GENOMICS_ENGLAND;UNIPROT
val	2912	GRM2	0.582	0.577	C0001973	AlcoholicIntoxication,Chronic	disease	C25;F03	MentalorBehavioralDysfunction	0.31	1	2013	2013	1	0	PSYGENET
val	2912	GRM2	0.582	0.577	C0014556	Epilepsy,TemporalLobe	disease	C10	DiseaseorSyndrome	0.31	1	2001	2008	1	0	CTD_human
val	2912	GRM2	0.582	0.577	C0014558	UncinateEpilepsy	disease	C10	DiseaseorSyndrome	0.30	1	2008	2008	1	0	CTD_human
val	2912	GRM2	0.582	0.577	C0033937	Psychoses,Drug	disease	C25;F03	MentalorBehavioralDysfunction	0.30	1	2010	2010	1	0	CTD_human
val	2912	GRM2	0.582	0.577	C0033941	Psychoses,Substance-Induced	disease	C25;F03	MentalorBehavioralDysfunction	0.30	1	2010	2010	1	0	CTD_human
val	2912	GRM2	0.582	0.577	C0036341	Schizophrenia	disease	F03	MentalorBehavioralDysfunction	0.40	0.893	1995	2019	1	0	CTD_human
val	2912	GRM2	0.582	0.577	C0236733	Amphetamine-RelatedDisorders	group	C25;F03	MentalorBehavioralDysfunction	0.30	1	2010	2010	1	0	CTD_human
val	2912	GRM2	0.582	0.577	C0236804	AmphetamineAddiction	disease	C25;F03	MentalorBehavioralDysfunction	0.30	1	2010	2010	1	0	CTD_human
val	2912	GRM2	0.582	0.577	C0236807	AmphetamineAbuse	disease	C25;F03	MentalorBehavioralDysfunction	0.30	1	2010	2010	1	0	CTD_human
val	2912	GRM2	0.582	0.577	C0393672	Epilepsy,BenignPsychomotor,Childhood	disease	C10	DiseaseorSyndrome	0.30	1	2008	2008	1	0	CTD_human
val	2912	GRM2	0.582	0.577	C0393682	Epilepsy,LateralTemporal	disease	C10	DiseaseorSyndrome	0.30	1	2008	2008	1	0	CTD_human
val	2912	GRM2	0.582	0.577	C0858355	Addictedtococaine	phenotype		MentalorBehavioralDysfunction	0.30	1	2013	2013	1	0	PSYGENET
val	2913	GRM3	0.606	0.538	C0001973	AlcoholicIntoxication,Chronic	disease	C25;F03	MentalorBehavioralDysfunction	0.31	1	2014	2014	1	0	PSYGENET
val	2913	GRM3	0.606	0.538	C0005586	BipolarDisorder	disease	F03	MentalorBehavioralDysfunction	0.35	0.8	2002	2017	5	0	PSYGENET
val	2913	GRM3	0.606	0.538	C0014556	Epilepsy,TemporalLobe	disease	C10	DiseaseorSyndrome	0.30	1	2008	2008	1	0	CTD_human
val	2913	GRM3	0.606	0.538	C0014558	UncinateEpilepsy	disease	C10	DiseaseorSyndrome	0.30	1	2008	2008	1	0	CTD_human
val	2913	GRM3	0.606	0.538	C0025202	melanoma	disease	C04	NeoplasticProcess	0.32	1	2011	2018	2	0	CTD_human
val	2913	GRM3	0.606	0.538	C0036341	Schizophrenia	disease	F03	MentalorBehavioralDysfunction	0.50	0.885	2002	2019	1	0	CTD_human
val	2913	GRM3	0.606	0.538	C0393672	Epilepsy,BenignPsychomotor,Childhood	disease	C10	DiseaseorSyndrome	0.30	1	2008	2008	1	0	CTD_human
val	2913	GRM3	0.606	0.538	C0393682	Epilepsy,LateralTemporal	disease	C10	DiseaseorSyndrome	0.30	1	2008	2008	1	0	CTD_human
val	2913	GRM3	0.606	0.538	C0525045	MoodDisorders	group	F03	MentalorBehavioralDysfunction	0.32	1	2009	2013	2	0	PSYGENET
val	2913	GRM3	0.606	0.538	C0858355	Addictedtococaine	phenotype		MentalorBehavioralDysfunction	0.30	1	2013	2013	1	0	PSYGENET
val	2914	GRM4	0.636	0.5	C0005586	BipolarDisorder	disease	F03	MentalorBehavioralDysfunction	0.30	1	2005	2007	2	0	PSYGENET
val	2914	GRM4	0.636	0.5	C0014556	Epilepsy,TemporalLobe	disease	C10	DiseaseorSyndrome	0.30	1	2005	2005	1	0	CTD_human
val	2914	GRM4	0.636	0.5	C0014558	UncinateEpilepsy	disease	C10	DiseaseorSyndrome	0.30	1	2005	2005	1	0	CTD_human
val	2914	GRM4	0.636	0.5	C0027746	NerveDegeneration	phenotype	C23	CellorMolecularDysfunction	0.30	1	2007	2007	1	0	CTD_human
val	2914	GRM4	0.636	0.5	C0029463	Osteosarcoma	disease	C04	NeoplasticProcess	0.45	1	2013	2020	1	1	CTD_human
val	2914	GRM4	0.636	0.5	C0036341	Schizophrenia	disease	F03	MentalorBehavioralDysfunction	0.32	0.333	2001	2013	3	0	PSYGENET
val	2914	GRM4	0.636	0.5	C0393672	Epilepsy,BenignPsychomotor,Childhood	disease	C10	DiseaseorSyndrome	0.30	1	2005	2005	1	0	CTD_human
val	2914	GRM4	0.636	0.5	C0393682	Epilepsy,LateralTemporal	disease	C10	DiseaseorSyndrome	0.30	1	2005	2005	1	0	CTD_human
val	2915	GRM5	0.525	0.846	C0005586	BipolarDisorder	disease	F03	MentalorBehavioralDysfunction	0.32	1	2013	2018	1	0	PSYGENET
val	2915	GRM5	0.525	0.846	C0009171	CocaineAbuse	disease	C25;F03	MentalorBehavioralDysfunction	0.31	1	2010	2019	1	0	CTD_human
val	2915	GRM5	0.525	0.846	C0011882	DiabeticNeuropathies	group	C10;C19	DiseaseorSyndrome	0.30	1	2010	2010	1	0	CTD_human
val	2915	GRM5	0.525	0.846	C0013146	Drugabuse	group	C25;F03	MentalorBehavioralDysfunction	0.32	1	2010	2019	1	0	CTD_human
val	2915	GRM5	0.525	0.846	C0013170	Drughabituation	phenotype	C25;F03	MentalorBehavioralDysfunction	0.31	1	2010	2020	1	0	CTD_human
val	2915	GRM5	0.525	0.846	C0013222	DrugUseDisorders	group	C25;F03	MentalorBehavioralDysfunction	0.30	1	2010	2010	1	0	CTD_human
val	2915	GRM5	0.525	0.846	C0014556	Epilepsy,TemporalLobe	disease	C10	DiseaseorSyndrome	0.33	1	2000	2019	1	0	CTD_human
val	2915	GRM5	0.525	0.846	C0014558	UncinateEpilepsy	disease	C10	DiseaseorSyndrome	0.30	1	2005	2005	1	0	CTD_human
val	2915	GRM5	0.525	0.846	C0027796	Neuralgia	phenotype	C23;C10	SignorSymptom	0.40	1	2010	2019	1	0	CTD_human
val	2915	GRM5	0.525	0.846	C0029231	OrganicMentalDisorders,Substance-Induced	disease	C25;F03	MentalorBehavioralDysfunction	0.30	1	2010	2010	1	0	CTD_human
val	2915	GRM5	0.525	0.846	C0036341	Schizophrenia	disease	F03	MentalorBehavioralDysfunction	0.60	1	2001	2020	3	0	PSYGENET
val	2915	GRM5	0.525	0.846	C0038220	StatusEpilepticus	disease	C23;C10	DiseaseorSyndrome	0.31	1	2007	2019	2	0	CTD_human
val	2915	GRM5	0.525	0.846	C0038580	SubstanceDependence	disease	C25;F03	MentalorBehavioralDysfunction	0.30	1	2010	2010	1	0	CTD_human
val	2915	GRM5	0.525	0.846	C0038586	SubstanceUseDisorders	group	C25;F03	MentalorBehavioralDysfunction	0.30	1	2010	2010	1	0	CTD_human
val	2915	GRM5	0.525	0.846	C0038870	Neuralgia,Supraorbital	phenotype	C23;C10	DiseaseorSyndrome	0.30	1	2010	2010	1	0	CTD_human
val	2915	GRM5	0.525	0.846	C0041671	AttentionDeficitDisorder	disease	F03	MentalorBehavioralDysfunction	0.30	1	2010	2011	2	0	CTD_human
val	2915	GRM5	0.525	0.846	C0041696	UnipolarDepression	disease	F03	MentalorBehavioralDysfunction	0.34	1	2010	2019	3	0	PSYGENET
val	2915	GRM5	0.525	0.846	C0042656	Neuralgia,Vidian	phenotype	C23;C10	DiseaseorSyndrome	0.30	1	2010	2010	1	0	CTD_human
val	2915	GRM5	0.525	0.846	C0234247	Neuralgia,Atypical	phenotype	C23;C10	DiseaseorSyndrome	0.30	1	2010	2010	1	0	CTD_human
val	2915	GRM5	0.525	0.846	C0234249	Neuralgia,Stump	phenotype	C23;C10	DiseaseorSyndrome	0.30	1	2010	2010	1	0	CTD_human
val	2915	GRM5	0.525	0.846	C0236736	Cocaine-RelatedDisorders	group	C25;F03	MentalorBehavioralDysfunction	0.30	1	2010	2010	1	0	CTD_human
val	2915	GRM5	0.525	0.846	C0236969	Substance-RelatedDisorders	group	C25;F03	MentalorBehavioralDysfunction	0.30	1	2010	2010	1	0	CTD_human
val	2915	GRM5	0.525	0.846	C0270823	Petitmalstatus	disease	C23;C10	DiseaseorSyndrome	0.30	1	2007	2008	2	0	CTD_human
val	2915	GRM5	0.525	0.846	C0271673	SymmetricDiabeticProximalMotorNeuropathy	disease	C10;C19	DiseaseorSyndrome	0.30	1	2010	2010	1	0	CTD_human
val	2915	GRM5	0.525	0.846	C0271674	AsymmetricDiabeticProximalMotorNeuropathy	disease	C10;C19	DiseaseorSyndrome	0.30	1	2010	2010	1	0	CTD_human
val	2915	GRM5	0.525	0.846	C0271678	DiabeticMononeuropathy	disease	C10;C19	DiseaseorSyndrome	0.30	1	2010	2010	1	0	CTD_human
val	2915	GRM5	0.525	0.846	C0271680	DiabeticPolyneuropathies	group	C10;C19	DiseaseorSyndrome	0.30	1	2010	2010	1	0	CTD_human
val	2915	GRM5	0.525	0.846	C0271685	DiabeticAmyotrophy	disease	C10;C19	DiseaseorSyndrome	0.30	1	2010	2010	1	0	CTD_human
val	2915	GRM5	0.525	0.846	C0271686	DiabeticAutonomicNeuropathy	disease	C10;C19	DiseaseorSyndrome	0.30	1	2010	2010	1	0	CTD_human
val	2915	GRM5	0.525	0.846	C0311335	GrandMalStatusEpilepticus	disease	C23;C10	DiseaseorSyndrome	0.30	1	2007	2008	2	0	CTD_human
val	2915	GRM5	0.525	0.846	C0393672	Epilepsy,BenignPsychomotor,Childhood	disease	C10	DiseaseorSyndrome	0.30	1	2005	2005	1	0	CTD_human
val	2915	GRM5	0.525	0.846	C0393682	Epilepsy,LateralTemporal	disease	C10	DiseaseorSyndrome	0.30	1	2005	2005	1	0	CTD_human
val	2915	GRM5	0.525	0.846	C0393734	ComplexPartialStatusEpilepticus	disease	C23;C10	DiseaseorSyndrome	0.30	1	2007	2008	2	0	CTD_human
val	2915	GRM5	0.525	0.846	C0393835	DiabeticAsymmetricPolyneuropathy	disease	C10;C19	DiseaseorSyndrome	0.30	1	2010	2010	1	0	CTD_human
val	2915	GRM5	0.525	0.846	C0423711	Neuralgia,Perineal	phenotype	C23;C10	DiseaseorSyndrome	0.30	1	2010	2010	1	0	CTD_human
val	2915	GRM5	0.525	0.846	C0423712	Neuralgia,IliohypogastricNerve	phenotype	C23;C10	DiseaseorSyndrome	0.30	1	2010	2010	1	0	CTD_human
val	2915	GRM5	0.525	0.846	C0600427	CocaineDependence	disease	C25;F03	MentalorBehavioralDysfunction	0.32	1	2010	2018	1	0	CTD_human
val	2915	GRM5	0.525	0.846	C0740858	Substanceabuseproblem	disease	C25;F03	MentalorBehavioralDysfunction	0.31	1	2010	2019	1	0	CTD_human
val	2915	GRM5	0.525	0.846	C0751074	DiabeticNeuralgia	disease	C10;C19	DiseaseorSyndrome	0.30	1	2010	2010	1	0	CTD_human
val	2915	GRM5	0.525	0.846	C0751371	Neuralgia,Ilioinguinal	phenotype	C23;C10	SignorSymptom	0.30	1	2010	2010	1	0	CTD_human
val	2915	GRM5	0.525	0.846	C0751372	NervePain	phenotype	C23;C10	SignorSymptom	0.30	1	2010	2010	1	0	CTD_human
val	2915	GRM5	0.525	0.846	C0751373	ParoxysmalNervePain	phenotype	C23;C10	SignorSymptom	0.30	1	2010	2010	1	0	CTD_human
val	2915	GRM5	0.525	0.846	C0751522	StatusEpilepticus,Subclinical	disease	C23;C10	DiseaseorSyndrome	0.30	1	2007	2008	2	0	CTD_human
val	2915	GRM5	0.525	0.846	C0751523	Non-ConvulsiveStatusEpilepticus	disease	C23;C10	DiseaseorSyndrome	0.30	1	2007	2008	2	0	CTD_human
val	2915	GRM5	0.525	0.846	C0751524	SimplePartialStatusEpilepticus	phenotype	C23;C10	DiseaseorSyndrome	0.30	1	2007	2008	2	0	CTD_human
val	2915	GRM5	0.525	0.846	C1263846	Attentiondeficithyperactivitydisorder	disease	F03	MentalorBehavioralDysfunction	0.45	1	2010	2015	2	1	CTD_human
val	2915	GRM5	0.525	0.846	C1269683	MajorDepressiveDisorder	disease	F03	MentalorBehavioralDysfunction	0.49	1	2010	2019	3	4	PSYGENET
val	2915	GRM5	0.525	0.846	C1321905	MinimalBrainDysfunction	disease	F03	MentalorBehavioralDysfunction	0.30	1	2010	2011	2	0	CTD_human
val	2915	GRM5	0.525	0.846	C1510472	DrugDependence	group	C25;F03	MentalorBehavioralDysfunction	0.30	1	2010	2010	1	0	CTD_human
val	2915	GRM5	0.525	0.846	C4316881	PrescriptionDrugAbuse	phenotype	C25;F03	Finding	0.30	1	2010	2010	1	0	CTD_human
val	2916	GRM6	0.7	0.308	C0006142	Malignantneoplasmofbreast	disease	C04;C17	NeoplasticProcess	0.30				0	0	UNIPROT
val	2916	GRM6	0.7	0.308	C0015397	Disorderofeye	group	C11	DiseaseorSyndrome	0.30				0	0	GENOMICS_ENGLAND
val	2916	GRM6	0.7	0.308	C0339535	Nightblindness,congenitalstationary	disease	C16;C11	CongenitalAbnormality	0.80	1	2005	2019	1	3	CTD_human;GENOMICS_ENGLAND;ORPHANET
val	2916	GRM6	0.7	0.308	C1848172	NIGHTBLINDNESS,CONGENITALSTATIONARY,TYPE2A	disease	C16;C11	DiseaseorSyndrome	0.30				0	0	CTD_human
val	2916	GRM6	0.7	0.308	C1850362	NIGHTBLINDNESS,CONGENITALSTATIONARY,TYPE1B	disease	C16;C11	DiseaseorSyndrome	0.91	1	2005	2017	3	8	CTD_human;GENOMICS_ENGLAND;UNIPROT
val	2916	GRM6	0.7	0.308	C1864877	NIGHTBLINDNESS,CONGENITALSTATIONARY,TYPE2B(disorder)	disease	C16;C11	DiseaseorSyndrome	0.30				0	0	CTD_human
val	2916	GRM6	0.7	0.308	C3495587	NightBlindness,CongenitalStationary,Type1A	disease	C16;C11	DiseaseorSyndrome	0.30				0	0	CTD_human
val	2916	GRM6	0.7	0.308	C3501847	Nightblindness,congenitalstationary,type1	disease	C16;C11	DiseaseorSyndrome	0.30				0	0	CTD_human
val	2916	GRM6	0.7	0.308	C3711543	X-LinkedCsnb	disease	C16;C11	DiseaseorSyndrome	0.30				0	0	CTD_human
val	2916	GRM6	0.7	0.308	C4041558	Cone-rodsynapticdisorder,congenitalnonprogressive	disease	C16;C11	DiseaseorSyndrome	0.30				0	0	CTD_human
val	2917	GRM7	0.628	0.538	C0001973	AlcoholicIntoxication,Chronic	disease	C25;F03	MentalorBehavioralDysfunction	0.31	1	2013	2013	1	0	PSYGENET
val	2917	GRM7	0.628	0.538	C0005586	BipolarDisorder	disease	F03	MentalorBehavioralDysfunction	0.33	0.667	2007	2014	3	0	PSYGENET
val	2917	GRM7	0.628	0.538	C0011570	MentalDepression	disease	F01	MentalorBehavioralDysfunction	0.33	1	2010	2018	5	0	PSYGENET
val	2917	GRM7	0.628	0.538	C0011581	Depressivedisorder	disease	F03	MentalorBehavioralDysfunction	0.33	1	2010	2018	5	0	PSYGENET
val	2917	GRM7	0.628	0.538	C0013146	Drugabuse	group	C25;F03	MentalorBehavioralDysfunction	0.30	1	2010	2010	1	0	CTD_human
val	2917	GRM7	0.628	0.538	C0013170	Drughabituation	phenotype	C25;F03	MentalorBehavioralDysfunction	0.30	1	2010	2010	1	0	CTD_human
val	2917	GRM7	0.628	0.538	C0013222	DrugUseDisorders	group	C25;F03	MentalorBehavioralDysfunction	0.30	1	2010	2010	1	0	CTD_human
val	2917	GRM7	0.628	0.538	C0029231	OrganicMentalDisorders,Substance-Induced	disease	C25;F03	MentalorBehavioralDysfunction	0.30	1	2010	2010	1	0	CTD_human
val	2917	GRM7	0.628	0.538	C0036341	Schizophrenia	disease	F03	MentalorBehavioralDysfunction	0.40	1	2000	2019	4	0	PSYGENET
val	2917	GRM7	0.628	0.538	C0038580	SubstanceDependence	disease	C25;F03	MentalorBehavioralDysfunction	0.30	1	2010	2010	1	0	CTD_human
val	2917	GRM7	0.628	0.538	C0038586	SubstanceUseDisorders	group	C25;F03	MentalorBehavioralDysfunction	0.31	1	2010	2016	1	0	CTD_human
val	2917	GRM7	0.628	0.538	C0041671	AttentionDeficitDisorder	disease	F03	MentalorBehavioralDysfunction	0.31	1	2011	2019	1	0	CTD_human
val	2917	GRM7	0.628	0.538	C0041696	UnipolarDepression	disease	F03	MentalorBehavioralDysfunction	0.34	0.8	2010	2018	5	0	PSYGENET
val	2917	GRM7	0.628	0.538	C0236969	Substance-RelatedDisorders	group	C25;F03	MentalorBehavioralDysfunction	0.30	1	2010	2010	1	0	CTD_human
val	2917	GRM7	0.628	0.538	C0740858	Substanceabuseproblem	disease	C25;F03	MentalorBehavioralDysfunction	0.30	1	2010	2010	1	0	CTD_human
val	2917	GRM7	0.628	0.538	C1263846	Attentiondeficithyperactivitydisorder	disease	F03	MentalorBehavioralDysfunction	0.36	1	2011	2019	1	0	CTD_human
val	2917	GRM7	0.628	0.538	C1269683	MajorDepressiveDisorder	disease	F03	MentalorBehavioralDysfunction	0.49	0.8	2010	2019	5	1	PSYGENET
val	2917	GRM7	0.628	0.538	C1321905	MinimalBrainDysfunction	disease	F03	MentalorBehavioralDysfunction	0.30	1	2011	2011	1	0	CTD_human
val	2917	GRM7	0.628	0.538	C1510472	DrugDependence	group	C25;F03	MentalorBehavioralDysfunction	0.31	1	2010	2016	1	0	CTD_human
val	2917	GRM7	0.628	0.538	C4316881	PrescriptionDrugAbuse	phenotype	C25;F03	Finding	0.30	1	2010	2010	1	0	CTD_human
val	2918	GRM8	0.636	0.577	C0001973	AlcoholicIntoxication,Chronic	disease	C25;F03	MentalorBehavioralDysfunction	0.33	1	2009	2017	1	0	PSYGENET
val	2918	GRM8	0.636	0.577	C0003469	AnxietyDisorders	group	F03	MentalorBehavioralDysfunction	0.31	0	2007	2007	1	0	CTD_human
val	2918	GRM8	0.636	0.577	C0004352	AutisticDisorder	disease	F03	MentalorBehavioralDysfunction	0.31	1	2003	2008	1	0	CTD_human
val	2918	GRM8	0.636	0.577	C0017639	Gliosis	phenotype	C23	PathologicFunction	0.30	1	2001	2001	1	0	CTD_human
val	2918	GRM8	0.636	0.577	C0036341	Schizophrenia	disease	F03	MentalorBehavioralDysfunction	0.36	0.333	2001	2018	3	0	PSYGENET
val	2918	GRM8	0.636	0.577	C0041671	AttentionDeficitDisorder	disease	F03	MentalorBehavioralDysfunction	0.30	1	2011	2011	1	0	CTD_human
val	2918	GRM8	0.636	0.577	C0149925	Smallcellcarcinomaoflung	disease	C04;C08	NeoplasticProcess	0.30	1	2012	2012	1	0	CTD_human
val	2918	GRM8	0.636	0.577	C0376280	AnxietyStates,Neurotic	disease	F03	MentalorBehavioralDysfunction	0.30	1	2007	2007	1	0	CTD_human
val	2918	GRM8	0.636	0.577	C1263846	Attentiondeficithyperactivitydisorder	disease	F03	MentalorBehavioralDysfunction	0.32	1	2011	2015	1	0	CTD_human
val	2918	GRM8	0.636	0.577	C1279420	Anxietyneurosis(finding)	disease	F03	MentalorBehavioralDysfunction	0.30	1	2007	2007	1	0	CTD_human
val	2918	GRM8	0.636	0.577	C1321905	MinimalBrainDysfunction	disease	F03	MentalorBehavioralDysfunction	0.30	1	2011	2011	1	0	CTD_human
val	2918	GRM8	0.636	0.577	C3887640	Astrocytosis	phenotype	C23	PathologicFunction	0.30	1	2001	2001	1	0	CTD_human
val	2919	CXCL1	0.449	0.923	C0019193	Hepatitis,Toxic	disease	C06;C25	InjuryorPoisoning	0.30	1	2005	2005	1	0	CTD_human
val	2919	CXCL1	0.449	0.923	C0020517	Hypersensitivity	group	C20	PathologicFunction	0.30	1	2011	2011	1	0	CTD_human
val	2919	CXCL1	0.449	0.923	C0023893	LiverCirrhosis,Experimental	disease	C23;C06	ExperimentalModelofDisease	0.30	1	2014	2014	1	0	CTD_human
val	2919	CXCL1	0.449	0.923	C0024117	ChronicObstructiveAirwayDisease	disease	C08	DiseaseorSyndrome	0.34	1	2013	2019	1	0	CTD_human
val	2919	CXCL1	0.449	0.923	C0032285	Pneumonia	disease	C01;C08	DiseaseorSyndrome	0.58	1	1996	2019	1	0	CTD_human
val	2919	CXCL1	0.449	0.923	C0032300	LobarPneumonia	disease	C01;C08	DiseaseorSyndrome	0.30	1	2011	2011	1	0	CTD_human
val	2919	CXCL1	0.449	0.923	C0035126	ReperfusionInjury	disease	C23;C14	InjuryorPoisoning	0.50	1	2000	2006	1	0	CTD_human
val	2919	CXCL1	0.449	0.923	C0035228	RespiratoryHypersensitivity	phenotype	C08;C20	PathologicFunction	0.30	1	2012	2012	1	0	CTD_human
val	2919	CXCL1	0.449	0.923	C0036982	Shock,Hemorrhagic	phenotype	C23	PathologicFunction	0.50	1	2011	2011	1	0	CTD_human
val	2919	CXCL1	0.449	0.923	C0085129	BronchialHyperreactivity	disease	C08	DiseaseorSyndrome	0.30	1	2003	2003	1	0	CTD_human
val	2919	CXCL1	0.449	0.923	C0087031	Juvenile-OnsetStillDisease	disease	C17;C05;C20	DiseaseorSyndrome	0.30	1	2009	2009	1	0	CTD_human
val	2919	CXCL1	0.449	0.923	C0241910	AutoimmuneChronicHepatitis	disease	C06;C20	DiseaseorSyndrome	0.30	1	2011	2011	1	0	CTD_human
val	2919	CXCL1	0.449	0.923	C0860207	Drug-InducedLiverDisease	phenotype	C06;C25	DiseaseorSyndrome	0.30	1	2005	2005	1	0	CTD_human
val	2919	CXCL1	0.449	0.923	C0887898	ExperimentalLungInflammation	disease	C01;C08	ExperimentalModelofDisease	0.30	1	2011	2011	1	0	CTD_human
val	2919	CXCL1	0.449	0.923	C1262760	Hepatitis,Drug-Induced	disease	C06;C25	DiseaseorSyndrome	0.30	1	2005	2005	1	0	CTD_human
val	2919	CXCL1	0.449	0.923	C1527303	ChronicAirflowObstruction	disease	C08	DiseaseorSyndrome	0.30	1	2013	2013	1	0	CTD_human
val	2919	CXCL1	0.449	0.923	C1527304	AllergicReaction	phenotype	C20	PathologicFunction	0.30	1	2011	2011	1	0	CTD_human
val	2919	CXCL1	0.449	0.923	C3495559	Juvenilearthritis	disease	C17;C05;C20	DiseaseorSyndrome	0.31	1	2009	2017	1	0	CTD_human
val	2919	CXCL1	0.449	0.923	C3658290	Drug-InducedAcuteLiverInjury	disease	C06;C25	DiseaseorSyndrome	0.30	1	2005	2005	1	0	CTD_human
val	2919	CXCL1	0.449	0.923	C3714636	Pneumonitis	disease	C01;C08	DiseaseorSyndrome	0.35	1	1996	2018	1	0	CTD_human
val	2919	CXCL1	0.449	0.923	C3714758	Juvenilepsoriaticarthritis	disease	C17;C05;C20	DiseaseorSyndrome	0.30	1	2009	2009	1	0	CTD_human
val	2919	CXCL1	0.449	0.923	C4277682	ChemicalandDrugInducedLiverInjury	disease	C06;C25	DiseaseorSyndrome	0.30	1	2005	2005	1	0	CTD_human
val	2919	CXCL1	0.449	0.923	C4279912	Chemically-InducedLiverToxicity	disease	C06;C25	DiseaseorSyndrome	0.30	1	2005	2005	1	0	CTD_human
val	2919	CXCL1	0.449	0.923	C4552091	Polyarthritis,Juvenile,RheumatoidFactorNegative	disease	C17;C05;C20	DiseaseorSyndrome	0.30	1	2009	2009	1	0	CTD_human
val	2919	CXCL1	0.449	0.923	C4704862	Polyarthritis,Juvenile,RheumatoidFactorPositive	disease	C17;C05;C20	DiseaseorSyndrome	0.30	1	2009	2009	1	0	CTD_human
val	2920	CXCL2	0.513	0.885	C0003873	RheumatoidArthritis	disease	C17;C05;C20	DiseaseorSyndrome	0.32	1	2004	2017	1	0	CTD_human
val	2920	CXCL2	0.513	0.885	C0005974	BoneResorption	phenotype	C05	OrganorTissueFunction	0.30	1	2011	2011	1	0	CTD_human
val	2920	CXCL2	0.513	0.885	C0006142	Malignantneoplasmofbreast	disease	C04;C17	NeoplasticProcess	0.30	1	2005	2005	1	0	CTD_human
val	2920	CXCL2	0.513	0.885	C0008370	Cholestasis	disease	C06	DiseaseorSyndrome	0.30	1	2011	2011	1	0	CTD_human
val	2920	CXCL2	0.513	0.885	C0014859	EsophagealNeoplasms	group	C06;C04	NeoplasticProcess	0.31	1	2011	2011	1	0	CTD_human
val	2920	CXCL2	0.513	0.885	C0018801	Heartfailure	disease	C14	DiseaseorSyndrome	0.30	1	2012	2012	1	0	CTD_human
val	2920	CXCL2	0.513	0.885	C0018802	Congestiveheartfailure	disease	C14	DiseaseorSyndrome	0.30	1	2012	2012	1	0	CTD_human
val	2920	CXCL2	0.513	0.885	C0020538	Hypertensivedisease	group	C14	DiseaseorSyndrome	0.30	1	2012	2012	1	0	CTD_human
val	2920	CXCL2	0.513	0.885	C0021368	Inflammation	phenotype	C23	PathologicFunction	0.30	1	2013	2013	1	0	CTD_human
val	2920	CXCL2	0.513	0.885	C0023212	Left-SidedHeartFailure	disease	C14	DiseaseorSyndrome	0.30	1	2012	2012	1	0	CTD_human
val	2920	CXCL2	0.513	0.885	C0024117	ChronicObstructiveAirwayDisease	disease	C08	DiseaseorSyndrome	0.31	1	2013	2016	1	0	CTD_human
val	2920	CXCL2	0.513	0.885	C0029408	Degenerativepolyarthritis	disease	C05	DiseaseorSyndrome	0.33	1	2004	2014	1	0	CTD_human
val	2920	CXCL2	0.513	0.885	C0034069	PulmonaryFibrosis	disease	C08	DiseaseorSyndrome	0.30	1	2006	2006	1	0	CTD_human
val	2920	CXCL2	0.513	0.885	C0035126	ReperfusionInjury	disease	C23;C14	InjuryorPoisoning	0.50	1	2000	2010	1	0	CTD_human
val	2920	CXCL2	0.513	0.885	C0036982	Shock,Hemorrhagic	phenotype	C23	PathologicFunction	0.30	1	2011	2011	1	0	CTD_human
val	2920	CXCL2	0.513	0.885	C0037274	Dermatologicdisorders	group	C17	DiseaseorSyndrome	0.30	1	2006	2006	1	0	CTD_human
val	2920	CXCL2	0.513	0.885	C0086743	OsteoarthrosisDeformans	disease	C05	DiseaseorSyndrome	0.30	1	2004	2004	1	0	CTD_human
val	2920	CXCL2	0.513	0.885	C0151744	MyocardialIschemia	disease	C14	DiseaseorSyndrome	0.30	1	2005	2005	1	0	CTD_human
val	2920	CXCL2	0.513	0.885	C0162820	Dermatitis,AllergicContact	disease	C17;C20	DiseaseorSyndrome	0.30	1	2013	2013	1	0	CTD_human
val	2920	CXCL2	0.513	0.885	C0235527	HeartFailure,Right-Sided	disease	C14	DiseaseorSyndrome	0.30	1	2012	2012	1	0	CTD_human
val	2920	CXCL2	0.513	0.885	C0238281	MiddleCerebralArterySyndrome	phenotype	C23;C10;C14	DiseaseorSyndrome	0.30	1	2002	2002	1	0	CTD_human
val	2920	CXCL2	0.513	0.885	C0242488	AcuteLungInjury	disease	C08	InjuryorPoisoning	0.50	1	2009	2016	1	0	CTD_human
val	2920	CXCL2	0.513	0.885	C0274861	ArsenicPoisoning,Inorganic	disease	C10;C25	InjuryorPoisoning	0.30	1	2006	2006	1	0	CTD_human
val	2920	CXCL2	0.513	0.885	C0274862	NervousSystem,OrganicArsenicPoisoning	disease	C10;C25	InjuryorPoisoning	0.30	1	2006	2006	1	0	CTD_human
val	2920	CXCL2	0.513	0.885	C0311375	ArsenicPoisoning	disease	C10;C25	InjuryorPoisoning	0.30	1	2006	2006	1	0	CTD_human
val	2920	CXCL2	0.513	0.885	C0546837	Malignantneoplasmofesophagus	disease	C06;C04	NeoplasticProcess	0.31	1	2011	2011	1	0	CTD_human
val	2920	CXCL2	0.513	0.885	C0678222	BreastCarcinoma	disease	C04;C17	NeoplasticProcess	0.30	1	2005	2005	1	0	CTD_human
val	2920	CXCL2	0.513	0.885	C0740376	MiddleCerebralArteryThrombosis	disease	C23;C10;C14	DiseaseorSyndrome	0.30	1	2002	2002	1	0	CTD_human
val	2920	CXCL2	0.513	0.885	C0740391	MiddleCerebralArteryOcclusion	disease	C23;C10;C14	AcquiredAbnormality	0.30	1	2002	2002	1	0	CTD_human
val	2920	CXCL2	0.513	0.885	C0740392	Infarction,MiddleCerebralArtery	disease	C23;C10;C14	DiseaseorSyndrome	0.30	1	2002	2002	1	0	CTD_human
val	2920	CXCL2	0.513	0.885	C0751845	MiddleCerebralArteryEmbolus	phenotype	C23;C10;C14	DiseaseorSyndrome	0.30	1	2002	2002	1	0	CTD_human
val	2920	CXCL2	0.513	0.885	C0751846	LeftMiddleCerebralArteryInfarction	phenotype	C23;C10;C14	DiseaseorSyndrome	0.30	1	2002	2002	1	0	CTD_human
val	2920	CXCL2	0.513	0.885	C0751847	EmbolicInfarction,MiddleCerebralArtery	phenotype	C23;C10;C14	DiseaseorSyndrome	0.30	1	2002	2002	1	0	CTD_human
val	2920	CXCL2	0.513	0.885	C0751848	ThromboticInfarction,MiddleCerebralArtery	phenotype	C23;C10;C14	DiseaseorSyndrome	0.30	1	2002	2002	1	0	CTD_human
val	2920	CXCL2	0.513	0.885	C0751849	RightMiddleCerebralArteryInfarction	phenotype	C23;C10;C14	DiseaseorSyndrome	0.30	1	2002	2002	1	0	CTD_human
val	2920	CXCL2	0.513	0.885	C0751851	ArsenicEncephalopathy	disease	C10;C25	DiseaseorSyndrome	0.30	1	2006	2006	1	0	CTD_human
val	2920	CXCL2	0.513	0.885	C0751852	ArsenicInducedPolyneuropathy	disease	C10;C25	InjuryorPoisoning	0.30	1	2006	2006	1	0	CTD_human
val	2920	CXCL2	0.513	0.885	C1257931	MammaryNeoplasms,Human	disease	C04;C17	NeoplasticProcess	0.30	1	2005	2005	1	0	CTD_human
val	2920	CXCL2	0.513	0.885	C1458155	MammaryNeoplasms	group	C04;C17	NeoplasticProcess	0.31	1	2005	2008	1	0	CTD_human
val	2920	CXCL2	0.513	0.885	C1527303	ChronicAirflowObstruction	disease	C08	DiseaseorSyndrome	0.30	1	2013	2013	1	0	CTD_human
val	2920	CXCL2	0.513	0.885	C1959583	MyocardialFailure	disease	C14	DiseaseorSyndrome	0.30	1	2012	2012	1	0	CTD_human
val	2920	CXCL2	0.513	0.885	C1961112	HeartDecompensation	phenotype	C14	PathologicFunction	0.30	1	2012	2012	1	0	CTD_human
val	2920	CXCL2	0.513	0.885	C4704874	MammaryCarcinoma,Human	disease	C04;C17	NeoplasticProcess	0.30	1	2005	2005	1	0	CTD_human
val	2920	CXCL2	0.513	0.885	C4721507	Alveolitis,Fibrosing	disease	C08	DiseaseorSyndrome	0.30	1	2006	2006	1	0	CTD_human
val	2921	CXCL3	0.65	0.692	C0006142	Malignantneoplasmofbreast	disease	C04;C17	NeoplasticProcess	0.31	1	2005	2014	1	0	CTD_human
val	2921	CXCL3	0.65	0.692	C0037274	Dermatologicdisorders	group	C17	DiseaseorSyndrome	0.30	1	2006	2006	1	0	CTD_human
val	2921	CXCL3	0.65	0.692	C0274861	ArsenicPoisoning,Inorganic	disease	C10;C25	InjuryorPoisoning	0.30	1	2006	2006	1	0	CTD_human
val	2921	CXCL3	0.65	0.692	C0274862	NervousSystem,OrganicArsenicPoisoning	disease	C10;C25	InjuryorPoisoning	0.30	1	2006	2006	1	0	CTD_human
val	2921	CXCL3	0.65	0.692	C0311375	ArsenicPoisoning	disease	C10;C25	InjuryorPoisoning	0.30	1	2006	2006	1	0	CTD_human
val	2921	CXCL3	0.65	0.692	C0678222	BreastCarcinoma	disease	C04;C17	NeoplasticProcess	0.31	1	2005	2014	1	0	CTD_human
val	2921	CXCL3	0.65	0.692	C0751851	ArsenicEncephalopathy	disease	C10;C25	DiseaseorSyndrome	0.30	1	2006	2006	1	0	CTD_human
val	2921	CXCL3	0.65	0.692	C0751852	ArsenicInducedPolyneuropathy	disease	C10;C25	InjuryorPoisoning	0.30	1	2006	2006	1	0	CTD_human
val	2921	CXCL3	0.65	0.692	C1135196	HeartFailure,Diastolic	disease	C14	DiseaseorSyndrome	0.30	1	2018	2018	1	0	CTD_human
val	2921	CXCL3	0.65	0.692	C1257931	MammaryNeoplasms,Human	disease	C04;C17	NeoplasticProcess	0.30	1	2005	2005	1	0	CTD_human
val	2921	CXCL3	0.65	0.692	C1458155	MammaryNeoplasms	group	C04;C17	NeoplasticProcess	0.31	1	2005	2014	1	0	CTD_human
val	2921	CXCL3	0.65	0.692	C4704874	MammaryCarcinoma,Human	disease	C04;C17	NeoplasticProcess	0.30	1	2005	2005	1	0	CTD_human
val	2922	GRP	0.524	0.769	C0002622	Amnesia	disease	C23;C10;F03;F01	MentalorBehavioralDysfunction	0.30	1	2001	2001	1	0	CTD_human
val	2922	GRP	0.524	0.769	C0018671	HeadandNeckNeoplasms	group	C04	NeoplasticProcess	0.30	1	2004	2004	1	0	CTD_human
val	2922	GRP	0.524	0.769	C0018675	HeadNeoplasms	group	C04	NeoplasticProcess	0.30	1	2004	2004	1	0	CTD_human
val	2922	GRP	0.524	0.769	C0019207	Hepatoma,Morris	disease	C06;C04	NeoplasticProcess;ExperimentalModelofDisease	0.30	1	1989	1989	1	0	CTD_human
val	2922	GRP	0.524	0.769	C0019208	Hepatoma,Novikoff	disease	C06;C04	NeoplasticProcess;ExperimentalModelofDisease	0.30	1	1989	1989	1	0	CTD_human
val	2922	GRP	0.524	0.769	C0023904	LiverNeoplasms,Experimental	phenotype	C06;C04	NeoplasticProcess;ExperimentalModelofDisease	0.30	1	1989	1989	1	0	CTD_human
val	2922	GRP	0.524	0.769	C0027533	NeckNeoplasms	group	C04	NeoplasticProcess	0.30	1	2004	2004	1	0	CTD_human
val	2922	GRP	0.524	0.769	C0086404	ExperimentalHepatoma	disease	C06;C04	NeoplasticProcess;ExperimentalModelofDisease	0.30	1	1989	1989	1	0	CTD_human
val	2922	GRP	0.524	0.769	C0233750	Hystericalamnesia	phenotype	C23;C10;F03;F01	MentalorBehavioralDysfunction	0.30	1	2001	2001	1	0	CTD_human
val	2922	GRP	0.524	0.769	C0233796	TemporaryAmnesia	phenotype	C23;C10;F03;F01	MentalorBehavioralDysfunction	0.30	1	2001	2001	1	0	CTD_human
val	2922	GRP	0.524	0.769	C0236795	DissociativeAmnesia	phenotype	C23;C10;F03;F01	MentalorBehavioralDysfunction	0.30	1	2001	2001	1	0	CTD_human
val	2922	GRP	0.524	0.769	C0262497	GlobalAmnesia	phenotype	C23;C10;F03;F01	MentalorBehavioralDysfunction	0.30	1	2001	2001	1	0	CTD_human
val	2922	GRP	0.524	0.769	C0278996	MalignantHeadandNeckNeoplasm	disease	C04	NeoplasticProcess	0.30	1	2004	2004	1	0	CTD_human
val	2922	GRP	0.524	0.769	C0746787	CancerofNeck	disease	C04	NeoplasticProcess	0.30	1	2004	2004	1	0	CTD_human
val	2922	GRP	0.524	0.769	C0750906	TactileAmnesia	phenotype	C23;C10;F03;F01	MentalorBehavioralDysfunction	0.30	1	2001	2001	1	0	CTD_human
val	2922	GRP	0.524	0.769	C0750907	AmnesticState	phenotype	C23;C10;F03;F01	MentalorBehavioralDysfunction	0.30	1	2001	2001	1	0	CTD_human
val	2922	GRP	0.524	0.769	C0751177	CancerofHead	disease	C04	NeoplasticProcess	0.30	1	2004	2004	1	0	CTD_human
val	2922	GRP	0.524	0.769	C0887900	UpperAerodigestiveTractNeoplasms	group	C04	NeoplasticProcess	0.30	1	2004	2004	1	0	CTD_human
val	2923	PDIA3	0.566	0.769	C0006826	MalignantNeoplasms	group	C04	NeoplasticProcess	0.37	0.875	2007	2019	1	0	CTD_human
val	2923	PDIA3	0.566	0.769	C0027651	Neoplasms	group	C04	NeoplasticProcess	0.34	0.8	2007	2015	1	0	CTD_human
val	2923	PDIA3	0.566	0.769	C0033578	ProstaticNeoplasms	group	C04;C12	NeoplasticProcess	0.30	1	2007	2007	1	0	CTD_human
val	2923	PDIA3	0.566	0.769	C0086692	BenignNeoplasm	group	C04	NeoplasticProcess	0.30	1	2007	2007	1	0	CTD_human
val	2923	PDIA3	0.566	0.769	C0376358	Malignantneoplasmofprostate	disease	C04;C12	NeoplasticProcess	0.32	1	2007	2016	1	0	CTD_human
val	2923	PDIA3	0.566	0.769	C0948089	AcuteCoronarySyndrome	disease	C14	DiseaseorSyndrome	0.30	1	2011	2011	1	0	CTD_human
val	2923	PDIA3	0.566	0.769	C1846707	SPINOCEREBELLARATAXIA17	disease	C16;C10	DiseaseorSyndrome	0.30	1	2014	2014	1	0	CTD_human
val	2923	PDIA3	0.566	0.769	C2239176	Livercarcinoma	disease	C06;C04	NeoplasticProcess	0.34	1	2006	2019	1	0	CTD_human
val	2925	GRPR	0.595	0.538	C0011570	MentalDepression	disease	F01	MentalorBehavioralDysfunction	0.30	1	2011	2011	1	0	PSYGENET
val	2925	GRPR	0.595	0.538	C0011581	Depressivedisorder	disease	F03	MentalorBehavioralDysfunction	0.30	1	2011	2011	1	0	PSYGENET
val	2925	GRPR	0.595	0.538	C0025261	MemoryDisorders	disease	C23;C10;F01	MentalorBehavioralDysfunction	0.30	1	2007	2007	1	0	CTD_human
val	2925	GRPR	0.595	0.538	C0033578	ProstaticNeoplasms	group	C04;C12	NeoplasticProcess	0.36	0.857	2002	2019	1	0	CTD_human
val	2925	GRPR	0.595	0.538	C0233794	Memoryimpairment	phenotype	C23;C10;F01	MentalorBehavioralDysfunction	0.30	1	2007	2007	1	0	CTD_human
val	2925	GRPR	0.595	0.538	C0376358	Malignantneoplasmofprostate	disease	C04;C12	NeoplasticProcess	0.40	0.973	2000	2020	1	0	CTD_human
val	2925	GRPR	0.595	0.538	C0751292	Age-RelatedMemoryDisorders	group	C23;C10;F01	MentalorBehavioralDysfunction	0.30	1	2007	2007	1	0	CTD_human
val	2925	GRPR	0.595	0.538	C0751293	MemoryDisorder,Semantic	phenotype	C23;C10;F01	MentalorBehavioralDysfunction	0.30	1	2007	2007	1	0	CTD_human
val	2925	GRPR	0.595	0.538	C0751294	MemoryDisorder,Spatial	phenotype	C23;C10;F01	MentalorBehavioralDysfunction	0.30	1	2007	2007	1	0	CTD_human
val	2925	GRPR	0.595	0.538	C0751295	MemoryLoss	phenotype	C23;C10;F01	SignorSymptom	0.30	1	2007	2007	1	0	CTD_human
val	2931	GSK3A	0.644	0.538	C0005586	BipolarDisorder	disease	F03	MentalorBehavioralDysfunction	0.30	1	2010	2010	1	0	CTD_human
val	2931	GSK3A	0.644	0.538	C0005587	Depression,Bipolar	disease	F03	MentalorBehavioralDysfunction	0.30	1	2010	2010	1	0	CTD_human
val	2931	GSK3A	0.644	0.538	C0011573	Endogenousdepression	disease	F03	MentalorBehavioralDysfunction	0.30	1	2010	2010	1	0	CTD_human
val	2931	GSK3A	0.644	0.538	C0011581	Depressivedisorder	disease	F03	MentalorBehavioralDysfunction	0.30	1	2010	2010	1	0	CTD_human
val	2931	GSK3A	0.644	0.538	C0024713	ManicDisorder	disease	F03	MentalorBehavioralDysfunction	0.30	1	2010	2010	1	0	CTD_human
val	2931	GSK3A	0.644	0.538	C0025193	Melancholia	disease	F03	MentalorBehavioralDysfunction	0.30	1	2010	2010	1	0	CTD_human
val	2931	GSK3A	0.644	0.538	C0036341	Schizophrenia	disease	F03	MentalorBehavioralDysfunction	0.32	1	2005	2014	1	0	CTD_human
val	2931	GSK3A	0.644	0.538	C0041696	UnipolarDepression	disease	F03	MentalorBehavioralDysfunction	0.30	1	2010	2010	1	0	CTD_human
val	2931	GSK3A	0.644	0.538	C0086133	DepressiveSyndrome	disease	F03	MentalorBehavioralDysfunction	0.30	1	2010	2010	1	0	CTD_human
val	2931	GSK3A	0.644	0.538	C0282126	Depression,Neurotic	disease	F03	MentalorBehavioralDysfunction	0.30	1	2010	2010	1	0	CTD_human
val	2931	GSK3A	0.644	0.538	C0338831	Manic	disease	F03	MentalorBehavioralDysfunction	0.30	1	2010	2010	1	0	CTD_human
val	2932	GSK3B	0.43	0.846	C0000772	Multiplecongenitalanomalies	group	C16	CongenitalAbnormality	0.30	1	2012	2012	1	0	CTD_human
val	2932	GSK3B	0.43	0.846	C0002395	AlzheimersDisease	disease	C10;F03	DiseaseorSyndrome	0.7	0.982	2000	2020	2	1	CTD_human
10991	2932	GSK3B	0.43	0.846	C0005586	BipolarDisorder	disease	F03	MentalorBehavioralDysfunction	0.6	0.8	2004	2019	6	0	CTD_human;PSYGENET
10996	2932	GSK3B	0.43	0.846	C0011570	MentalDepression	disease	F01	MentalorBehavioralDysfunction	0.58	1	2007	2019	3	0	PSYGENET
10998	2932	GSK3B	0.43	0.846	C0011581	Depressivedisorder	disease	F03	MentalorBehavioralDysfunction	0.57	1	2007	2019	5	0	CTD_human;PSYGENET
11002	2932	GSK3B	0.43	0.846	C0020538	Hypertensivedisease	group	C14	DiseaseorSyndrome	0.51	1	2012	2018	1	0	CTD_human
11008	2932	GSK3B	0.43	0.846	C0027051	MyocardialInfarction	disease	C23;C14	DiseaseorSyndrome	0.56	1	2006	2018	1	0	CTD_human
11011	2932	GSK3B	0.43	0.846	C0036341	Schizophrenia	disease	F03	MentalorBehavioralDysfunction	0.6	0.88	2003	2020	2	0	CTD_human
11032	2972	BRF1	0.7	0.462	C4015495	CEREBELLOFACIODENTALSYNDROME	disease		DiseaseorSyndrome	0.71	1	2015	2017	1	4	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
11045	2978	GUCA1A	0.647	0.5	C1865869	CONEDYSTROPHY3(disorder)	disease	C16;C11	DiseaseorSyndrome	0.72	1	1998	2011	8	6	CTD_human;GENOMICS_ENGLAND;UNIPROT
11048	2979	GUCA1B	0.682	0.423	C0035334	RetinitisPigmentosa	disease	C16;C11	DiseaseorSyndrome	0.52	1	2004	2011	2	0	CTD_human;GENOMICS_ENGLAND
11049	2979	GUCA1B	0.682	0.423	C3151190	RETINITISPIGMENTOSA48	disease		DiseaseorSyndrome	0.61	1	2005	2011	2	1	CTD_human;GENOMICS_ENGLAND;UNIPROT
11064	2982	GUCY1A1	0.686	0.577	C3810403	MOYAMOYADISEASE6WITHORWITHOUTACHALASIA	disease		DiseaseorSyndrome	0.7	1	2014	2016	2	5	CTD_human;GENOMICS_ENGLAND;ORPHANET
11071	2984	GUCY2C	0.599	0.577	C2939175	Meconiumileus	disease	C06	DiseaseorSyndrome	0.73	0.75	2012	2019	2	3	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
11072	2984	GUCY2C	0.599	0.577	C3553270	DIARRHEA6	disease		DiseaseorSyndrome	0.7	1	2012	2016	2	0	GENOMICS_ENGLAND;ORPHANET;UNIPROT
11080	2990	GUSB	0.53	0.846	C0085132	MucopolysaccharidosisVII	disease	C16;C18;C17	DiseaseorSyndrome	1	1	1973	2019	17	34	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
11082	2992	GYG1	0.722	0.308	C0017919	GlycogenStorageDisease	group	C16;C18	DiseaseorSyndrome	0.55	1	2010	2017	1	0	CTD_human;GENOMICS_ENGLAND
11085	2992	GYG1	0.722	0.308	C3150754	GLYCOGENSTORAGEDISEASEXV	disease		DiseaseorSyndrome	0.71	1	2010	2020	4	3	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
11086	2992	GYG1	0.722	0.308	C4015452	POLYGLUCOSANBODYMYOPATHY2	disease		DiseaseorSyndrome	0.71	1	2010	2018	3	7	GENOMICS_ENGLAND;ORPHANET;UNIPROT
11100	2997	GYS1	0.722	0.385	C1969054	GlycogenStorageDisease0,Muscle	disease	C16;C18	DiseaseorSyndrome	0.7	1	2007	2015	3	4	CTD_human;GENOMICS_ENGLAND;ORPHANET
11102	2998	GYS2	0.686	0.462	C1855861	GlycogenStorageDisease0,Liver	disease	C16;C06;C18	DiseaseorSyndrome	0.72	1	1998	2018	2	16	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
11105	3000	GUCY2D	0.57	0.769	C0035334	RetinitisPigmentosa	disease	C16;C11	DiseaseorSyndrome	0.68	0.875	2005	2016	1	0	CTD_human;GENOMICS_ENGLAND
11109	3000	GUCY2D	0.57	0.769	C1536451	Centralareolarchoroidalsclerosis	disease	C11	DiseaseorSyndrome	0.61	1	2012	2012	1	1	CTD_human;ORPHANET
11110	3000	GUCY2D	0.57	0.769	C1866293	Retinalconedystrophy2	disease	C16;C11	DiseaseorSyndrome	0.98	1	1996	2020	14	10	CTD_human;GENOMICS_ENGLAND;UNIPROT
11111	3000	GUCY2D	0.57	0.769	C2931258	AmaurosiscongenitaofLeber,type1	disease	C11	DiseaseorSyndrome	1	0.984	1995	2020	9	26	CTD_human;GENOMICS_ENGLAND;UNIPROT
11114	3000	GUCY2D	0.57	0.769	C4551884	ChoroidalDystrophy,CentralAreolar1	disease	C11	DiseaseorSyndrome	0.6	1	2012	2012	1	1	CTD_human;UNIPROT
11175	3026	HABP2	0.593	0.615	C4225292	THYROIDCANCER,NONMEDULLARY,5	disease		NeoplasticProcess	0.6	1	2003	2017	3	1	CTD_human;GENOMICS_ENGLAND;UNIPROT
11179	3028	HSD17B10	0.656	0.538	C3266731	2-methyl-3-hydroxybutyricaciduria	phenotype	C23;C16;C10	DiseaseorSyndrome	0.75	1	1999	2019	17	10	CLINGEN;CTD_human;GENOMICS_ENGLAND;UNIPROT
11191	3030	HADHA	0.569	0.769	C1969443	TrifunctionalProteinDeficiencyWithMyopathyAndNeuropathy	disease	C16;C18;C05;C10;C14	DiseaseorSyndrome	0.8	1	1994	2019	3	17	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
11193	3030	HADHA	0.569	0.769	C3711645	Longchain3-hydroxyacyl-CoAdehydrogenasedeficiency	disease	C16;C18;C05;C10;C14	DiseaseorSyndrome	0.8	1	1994	2019	9	48	CLINGEN;CTD_human;GENOMICS_ENGLAND;UNIPROT
11206	3032	HADHB	0.619	0.692	C1969443	TrifunctionalProteinDeficiencyWithMyopathyAndNeuropathy	disease	C16;C18;C05;C10;C14	DiseaseorSyndrome	0.78	1	1996	2019	7	16	CLINGEN;CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
11211	3033	HADH	0.65	0.538	C0028754	Obesity	disease	C23;C18	DiseaseorSyndrome	0.51	1	2005	2017	1	0	CTD_human
11214	3033	HADH	0.65	0.538	C1291230	3-Hydroxyacyl-CoADehydrogenaseDeficiency	disease	C16;C18	DiseaseorSyndrome	0.7	1	2001	2016	7	3	CLINGEN;CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
11215	3033	HADH	0.65	0.538	C1864948	HyperinsulinemicHypoglycemia,Familial,4	disease	C18	DiseaseorSyndrome	0.7	1	2001	2016	2	3	CTD_human;GENOMICS_ENGLAND;UNIPROT
11217	3034	HAL	0.641	0.538	C0220992	Histidinemia	phenotype	C16;C18	DiseaseorSyndrome	0.73	1	1991	2005	1	4	CTD_human;ORPHANET;UNIPROT
11228	3035	HARS1	0.569	0.808	C3281066	USHERSYNDROME,TYPEIIIB	disease		DiseaseorSyndrome	0.71	1	1995	2017	2	2	CTD_human;GENOMICS_ENGLAND;UNIPROT
11229	3035	HARS1	0.569	0.808	C4225265	CHARCOT-MARIE-TOOTHDISEASE,AXONAL,TYPE2W	disease		DiseaseorSyndrome	0.7	1	2013	2018	3	9	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
11232	3039	HBA1	0.508	0.808	C0002312	alpha-Thalassemia	disease	C16;C15	DiseaseorSyndrome	0.8	0.985	1979	2019	3	1	CTD_human;GENOMICS_ENGLAND;ORPHANET
11257	3040	HBA2	0.512	0.808	C0700299	HeinzBodyAnemias	disease	C16;C15	DiseaseorSyndrome	0.6	1	1991	1991	1	1	CTD_human;GENOMICS_ENGLAND
11261	3040	HBA2	0.512	0.808	C3161174	HemoglobinHDisease	disease	C16;C15	DiseaseorSyndrome	0.6	0.971	1979	2018	2	0	GENOMICS_ENGLAND;ORPHANET
11266	3043	HBB	0.494	0.808	C0002875	Cooleysanemia	disease	C16;C15	DiseaseorSyndrome	0.70	1	1979	2019	7	7	CTD_human;ORPHANET
val	3043	HBB	0.494	0.808	C0002895	Anemia,SickleCell	disease	C16;C15	DiseaseorSyndrome	0.80	0.994	1957	2020	8	36	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
val	3043	HBB	0.494	0.808	C0005283	betaThalassemia	disease	C16;C15	DiseaseorSyndrome	0.80	0.994	1961	2019	13	87	CTD_human;GENOMICS_ENGLAND;UNIPROT
val	3043	HBB	0.494	0.808	C0010520	Cyanosis	phenotype	C23	SignorSymptom	0.30	1	2005	2005	1	0	CTD_human
val	3043	HBB	0.494	0.808	C0013502	Echinococcosis	disease	C01	DiseaseorSyndrome	0.30	1	2014	2014	1	0	CTD_human
val	3043	HBB	0.494	0.808	C0019021	HemoglobinCDisease	disease	C16;C15	DiseaseorSyndrome	0.30	1	2011	2011	1	0	ORPHANET
val	3043	HBB	0.494	0.808	C0019025	HemoglobinFDisease	disease	C16;C15	DiseaseorSyndrome	0.60	0.962	1979	2017	7	0	CTD_human;ORPHANET
val	3043	HBB	0.494	0.808	C0019045	Hemoglobinopathies	group	C16;C15	DiseaseorSyndrome	0.50	1	1969	2019	1	35	CTD_human
val	3043	HBB	0.494	0.808	C0024530	Malaria	disease	C01	DiseaseorSyndrome	0.50	0.846	1999	2018	0	2	CTD_human
val	3043	HBB	0.494	0.808	C0024535	Malaria,Falciparum	disease	C01	DiseaseorSyndrome	0.33	0.75	1999	2010	1	0	CTD_human
val	3043	HBB	0.494	0.808	C0025637	Methemoglobinemia	disease	C15	DiseaseorSyndrome	0.31	1	2005	2017	1	0	CTD_human
val	3043	HBB	0.494	0.808	C0032461	Polycythemia	disease	C15	DiseaseorSyndrome	0.30	1	1975	1982	2	0	CTD_human
val	3043	HBB	0.494	0.808	C0032463	PolycythemiaVera	disease	C04;C15	NeoplasticProcess	0.30	1	1969	1969	1	0	CTD_human
val	3043	HBB	0.494	0.808	C0038002	Splenomegaly	phenotype	C23	Finding	0.40	1	2018	2018	1	0	CTD_human
val	3043	HBB	0.494	0.808	C0085578	ThalassemiaMinor	disease	C16;C15	DiseaseorSyndrome	0.30	1	1979	2014	6	0	CTD_human
val	3043	HBB	0.494	0.808	C0238159	HemoglobinEdisease	disease	C16;C15	DiseaseorSyndrome	0.40	1	2011	2016	1	1	ORPHANET
val	3043	HBB	0.494	0.808	C0263454	Chloracne	disease	C17	DiseaseorSyndrome	0.30	1	2007	2007	1	0	CTD_human
val	3043	HBB	0.494	0.808	C0271979	ThalassemiaIntermedia	disease	C16;C15	DiseaseorSyndrome	0.40	1	1979	2017	6	0	CTD_human
val	3043	HBB	0.494	0.808	C0271985	Delta-BetaThalassemia	disease	C16;C15	DiseaseorSyndrome	0.40	0.941	1983	2008	1	0	ORPHANET
val	3043	HBB	0.494	0.808	C0272080	HemoglobinDdisease	disease	C16;C15	DiseaseorSyndrome	0.30	1	2001	2014	2	0	ORPHANET
val	3043	HBB	0.494	0.808	C0472767	Betathalassemiaintermedia	disease	C16;C15	DiseaseorSyndrome	0.50	1	1985	2019	1	7	ORPHANET
val	3043	HBB	0.494	0.808	C0472777	HemoglobinE/betathalassemiadisease	disease	C16;C15	DiseaseorSyndrome	0.40	1	2011	2011	1	1	ORPHANET
val	3043	HBB	0.494	0.808	C0700299	HeinzBodyAnemias	disease	C16;C15	DiseaseorSyndrome	0.60	1	2010	2010	1	17	CTD_human;GENOMICS_ENGLAND
val	3043	HBB	0.494	0.808	C1527405	Erythrocytosis	phenotype	C15	Finding	0.40	1	1975	1982	2	1	CTD_human
val	3043	HBB	0.494	0.808	C1841621	FETALHEMOGLOBINQUANTITATIVETRAITLOCUS1	phenotype		Finding	0.40	1	2010	2010	1	12	GENOMICS_ENGLAND
val	3043	HBB	0.494	0.808	C1858990	BetaThalassemia,DominantInclusionBodyType	disease	C16;C15	DiseaseorSyndrome	0.70	1	2010	2011	2	14	CTD_human;GENOMICS_ENGLAND;ORPHANET
val	3043	HBB	0.494	0.808	C3665425	HemoglobinMDisease	disease	C15	DiseaseorSyndrome	0.30	1	1993	1993	1	0	ORPHANET
val	3043	HBB	0.494	0.808	C3889261	OtherLicenseStatus	phenotype		Finding	0.30				0	0	GENOMICS_ENGLAND
val	3043	HBB	0.494	0.808	C4551637	Erythrocytosisfamilial,1	disease	C15	DiseaseorSyndrome	0.32	1	2005	2014	1	0	GENOMICS_ENGLAND
val	3043	HBB	0.494	0.808	C4553297	CysticEchinocccosis	disease	C01	DiseaseorSyndrome	0.30	1	2014	2014	1	0	CTD_human
val	3045	HBD	0.659	0.231	C0022548	Keloid	disease	C23;C17	AcquiredAbnormality	0.30	1	2010	2010	1	0	CTD_human
val	3045	HBD	0.659	0.231	C0263454	Chloracne	disease	C17	DiseaseorSyndrome	0.30	1	2007	2007	1	0	CTD_human
val	3045	HBD	0.659	0.231	C0271985	Delta-BetaThalassemia	disease	C16;C15	DiseaseorSyndrome	0.35	1	1982	1992	1	0	ORPHANET
val	3047	HBG1	0.615	0.538	C0019025	HemoglobinFDisease	disease	C16;C15	DiseaseorSyndrome	0.40	0.978	1982	2019	2	0	ORPHANET
val	3047	HBG1	0.615	0.538	C0030567	ParkinsonDisease	disease	C10	DiseaseorSyndrome	0.30	1	2015	2015	1	0	CTD_human
val	3047	HBG1	0.615	0.538	C0033578	ProstaticNeoplasms	group	C04;C12	NeoplasticProcess	0.30	1	2009	2009	1	0	CTD_human
val	3047	HBG1	0.615	0.538	C0263454	Chloracne	disease	C17	DiseaseorSyndrome	0.30	1	2007	2007	1	0	CTD_human
val	3047	HBG1	0.615	0.538	C0271985	Delta-BetaThalassemia	disease	C16;C15	DiseaseorSyndrome	0.35	0.833	1982	2008	1	0	ORPHANET
val	3047	HBG1	0.615	0.538	C0376358	Malignantneoplasmofprostate	disease	C04;C12	NeoplasticProcess	0.30	1	2009	2009	1	0	CTD_human
val	3047	HBG1	0.615	0.538	C1841621	FETALHEMOGLOBINQUANTITATIVETRAITLOCUS1	phenotype		Finding	0.30	1	2015	2015	1	0	GENOMICS_ENGLAND
val	3048	HBG2	0.565	0.692	C0019025	HemoglobinFDisease	disease	C16;C15	DiseaseorSyndrome	0.40	1	1982	2019	3	0	ORPHANET
val	3048	HBG2	0.565	0.692	C0022660	KidneyFailure,Acute	disease	C13;C12	DiseaseorSyndrome	0.30	1	1977	1977	2	0	CTD_human
val	3048	HBG2	0.565	0.692	C0028961	Oliguria	phenotype	C23;C13;C12	DiseaseorSyndrome	0.30	1	1977	1977	1	0	CTD_human
val	3048	HBG2	0.565	0.692	C0033578	ProstaticNeoplasms	group	C04;C12	NeoplasticProcess	0.30	1	2009	2009	1	0	CTD_human
val	3048	HBG2	0.565	0.692	C0376358	Malignantneoplasmofprostate	disease	C04;C12	NeoplasticProcess	0.30	1	2009	2009	1	0	CTD_human
val	3048	HBG2	0.565	0.692	C1565662	AcuteKidneyInsufficiency	disease	C13;C12	DiseaseorSyndrome	0.30	1	1977	1977	2	0	CTD_human
val	3048	HBG2	0.565	0.692	C1841621	FETALHEMOGLOBINQUANTITATIVETRAITLOCUS1	phenotype		Finding	0.40	1	2015	2015	1	3	GENOMICS_ENGLAND
val	3048	HBG2	0.565	0.692	C2609414	Acutekidneyinjury	disease	C13;C12	InjuryorPoisoning	0.30	1	1977	1977	2	0	CTD_human
val	3048	HBG2	0.565	0.692	C3151421	CYANOSIS,TRANSIENTNEONATAL	disease		DiseaseorSyndrome	0.71	1	1989	2015	7	4	CTD_human;GENOMICS_ENGLAND;UNIPROT
val	3050	HBZ	0.686	0.346	C3278365	HEMOGLOBINHHYDROPSFETALISSYNDROME	disease		DiseaseorSyndrome	0.30	1	1997	1997	1	0	GENOMICS_ENGLAND
val	3052	HCCS	0.559	0.731	C0015397	Disorderofeye	group	C11	DiseaseorSyndrome	0.30				0	0	GENOMICS_ENGLAND
val	3052	HCCS	0.559	0.731	C0796070	MICROPHTHALMIA,SYNDROMIC7	disease	C16;C11;C17	DiseaseorSyndrome;CongenitalAbnormality	0.80	1	1998	2016	2	1	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
val	3053	SERPIND1	0.619	0.654	C0007274	CarotidArteryThrombosis	disease	C10;C14	DiseaseorSyndrome	0.30	1	2002	2002	1	0	CTD_human
val	3053	SERPIND1	0.619	0.654	C0025472	MesentericVascularOcclusion	disease	C06;C14	DiseaseorSyndrome	0.30	1	1991	1991	1	0	CTD_human
val	3053	SERPIND1	0.619	0.654	C0398623	Thrombophilia	disease	C15	DiseaseorSyndrome	0.32	1	1987	1999	1	0	CTD_human
val	3053	SERPIND1	0.619	0.654	C0398626	HeparincofactorIIdeficiency(disorder)	disease	C14	DiseaseorSyndrome	0.70	1	1989	2004	4	0	CTD_human;GENOMICS_ENGLAND;UNIPROT
val	3053	SERPIND1	0.619	0.654	C0750988	CommonCarotidArteryThrombosis	disease	C10;C14	DiseaseorSyndrome	0.30	1	2002	2002	1	0	CTD_human
val	3053	SERPIND1	0.619	0.654	C0750989	ExternalCarotidArteryThrombosis	disease	C10;C14	DiseaseorSyndrome	0.30	1	2002	2002	1	0	CTD_human
val	3053	SERPIND1	0.619	0.654	C0750990	InternalCarotidArteryThrombosis	disease	C10;C14	DiseaseorSyndrome	0.30	1	2002	2002	1	0	CTD_human
val	3053	SERPIND1	0.619	0.654	C1861172	VenousThromboembolism	phenotype	C14	DiseaseorSyndrome	0.30	1	1991	1991	1	0	CTD_human
val	3054	HCFC1	0.601	0.692	C0023903	Liverneoplasms	group	C06;C04	NeoplasticProcess	0.31	1	2009	2009	1	0	CTD_human
val	3054	HCFC1	0.601	0.692	C0345904	Malignantneoplasmofliver	disease	C06;C04	NeoplasticProcess	0.31	1	2009	2009	1	0	CTD_human
val	3054	HCFC1	0.601	0.692	C0796208	MENTALRETARDATION,X-LINKED3	disease	C16;C10	DiseaseorSyndrome	0.70	1	2012	2013	2	6	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
val	3054	HCFC1	0.601	0.692	C2931498	MentalRetardation,X-Linked1	disease	C16;C10	DiseaseorSyndrome	0.31	1	1992	2012	1	0	ORPHANET
val	3055	HCK	0.663	0.5	C0023452	ChildhoodAcuteLymphoblasticLeukemia	disease	C04;C20;C15	NeoplasticProcess	0.30	1	2007	2007	1	0	CTD_human
val	3055	HCK	0.663	0.5	C0023453	L2AcuteLymphoblasticLeukemia	disease	C04;C20;C15	NeoplasticProcess	0.30	1	2007	2007	1	0	CTD_human
val	3055	HCK	0.663	0.5	C0023893	LiverCirrhosis,Experimental	disease	C23;C06	ExperimentalModelofDisease	0.30	1	2014	2014	1	0	CTD_human
val	3055	HCK	0.663	0.5	C1335167	OvarianMucinousAdenocarcinoma	disease	C04	NeoplasticProcess	0.30				0	0	UNIPROT
val	3055	HCK	0.663	0.5	C1961102	PrecursorCellLymphoblasticLeukemiaLymphoma	disease	C04;C20;C15	NeoplasticProcess	0.30	1	2007	2007	1	0	CTD_human
val	3059	HCLS1	0.539	0.846	C0003873	RheumatoidArthritis	disease	C17;C05;C20	DiseaseorSyndrome	0.31	1	1992	2003	1	0	CTD_human
val	3060	HCRT	0.5	0.808	C0006870	CannabisDependence	disease	C25;F03	MentalorBehavioralDysfunction	0.31	1	2012	2012	1	0	PSYGENET
val	3060	HCRT	0.5	0.808	C0009171	CocaineAbuse	disease	C25;F03	MentalorBehavioralDysfunction	0.31	1	2005	2018	1	0	CTD_human
val	3060	HCRT	0.5	0.808	C0011570	MentalDepression	disease	F01	MentalorBehavioralDysfunction	0.40	1	2009	2020	5	0	PSYGENET
val	3060	HCRT	0.5	0.808	C0011581	Depressivedisorder	disease	F03	MentalorBehavioralDysfunction	0.40	1	2009	2020	5	0	PSYGENET
val	3060	HCRT	0.5	0.808	C0024809	MarijuanaAbuse	disease	C25;F03	MentalorBehavioralDysfunction	0.31	1	2012	2012	1	0	PSYGENET
val	3060	HCRT	0.5	0.808	C0027404	Narcolepsy	disease	C10;F03	DiseaseorSyndrome	0.70	0.959	1999	2019	2	0	ORPHANET
val	3060	HCRT	0.5	0.808	C0030193	Pain	phenotype	C23	SignorSymptom	0.40	1	2005	2019	1	0	CTD_human
val	3060	HCRT	0.5	0.808	C0038587	SubstanceWithdrawalSyndrome	disease	C25;F03	MentalorBehavioralDysfunction	0.31	1	2010	2017	1	0	CTD_human
val	3060	HCRT	0.5	0.808	C0086189	DrugWithdrawalSymptoms	phenotype	C25;F03	SignorSymptom	0.30	1	2010	2010	1	0	CTD_human
val	3060	HCRT	0.5	0.808	C0087169	WithdrawalSymptoms	phenotype	C25;F03	SignorSymptom	0.30	1	2010	2010	1	0	CTD_human
val	3060	HCRT	0.5	0.808	C0234230	Pain,Burning	phenotype	C23	SignorSymptom	0.30	1	2005	2005	1	0	CTD_human
val	3060	HCRT	0.5	0.808	C0234238	Ache	phenotype	C23	SignorSymptom	0.30	1	2005	2005	1	0	CTD_human
val	3060	HCRT	0.5	0.808	C0234254	Radiatingpain	phenotype	C23	SignorSymptom	0.30	1	2005	2005	1	0	CTD_human
val	3060	HCRT	0.5	0.808	C0236736	Cocaine-RelatedDisorders	group	C25;F03	MentalorBehavioralDysfunction	0.30	1	2005	2005	1	0	CTD_human
val	3060	HCRT	0.5	0.808	C0270715	DegenerativeDiseases,CentralNervousSystem	group	C10	DiseaseorSyndrome	0.30	1	2013	2013	1	0	CTD_human
val	3060	HCRT	0.5	0.808	C0338715	Drug-induceddepressivestate	disease	C25;F03	MentalorBehavioralDysfunction	0.30	1	2009	2009	1	0	PSYGENET
val	3060	HCRT	0.5	0.808	C0458257	Pain,Splitting	phenotype	C23	SignorSymptom	0.30	1	2005	2005	1	0	CTD_human
val	3060	HCRT	0.5	0.808	C0458259	Pain,Crushing	phenotype	C23	SignorSymptom	0.30	1	2005	2005	1	0	CTD_human
val	3060	HCRT	0.5	0.808	C0524851	NeurodegenerativeDisorders	group	C10	DiseaseorSyndrome	0.37	1	2010	2019	1	0	CTD_human
val	3060	HCRT	0.5	0.808	C0600427	CocaineDependence	disease	C25;F03	MentalorBehavioralDysfunction	0.32	1	2005	2019	1	0	CTD_human
val	3060	HCRT	0.5	0.808	C0751362	Narcolepsy-CataplexySyndrome	disease	C10;F03	DiseaseorSyndrome	0.40	1	2000	2019	2	0	ORPHANET
val	3060	HCRT	0.5	0.808	C0751407	Pain,Migratory	phenotype	C23	SignorSymptom	0.30	1	2005	2005	1	0	CTD_human
val	3060	HCRT	0.5	0.808	C0751408	Suffering,Physical	phenotype	C23	SignorSymptom	0.30	1	2005	2005	1	0	CTD_human
val	3060	HCRT	0.5	0.808	C0751733	DegenerativeDiseases,SpinalCord	group	C10	DiseaseorSyndrome	0.30	1	2013	2013	1	0	CTD_human
val	3060	HCRT	0.5	0.808	C1834372	Narcolepsy1	disease	C10;F03	DiseaseorSyndrome	0.70	1	2000	2000	1	1	CTD_human;GENOMICS_ENGLAND;UNIPROT
val	3061	HCRTR1	0.623	0.654	C0009171	CocaineAbuse	disease	C25;F03	MentalorBehavioralDysfunction	0.30	1	2005	2010	3	0	CTD_human
val	3061	HCRTR1	0.623	0.654	C0011570	MentalDepression	disease	F01	MentalorBehavioralDysfunction	0.30	1	2011	2012	2	0	PSYGENET
val	3061	HCRTR1	0.623	0.654	C0011581	Depressivedisorder	disease	F03	MentalorBehavioralDysfunction	0.30	1	2011	2012	2	0	PSYGENET
val	3061	HCRTR1	0.623	0.654	C0036341	Schizophrenia	disease	F03	MentalorBehavioralDysfunction	0.32	1	2005	2007	2	0	PSYGENET
val	3061	HCRTR1	0.623	0.654	C0038587	SubstanceWithdrawalSyndrome	disease	C25;F03	MentalorBehavioralDysfunction	0.31	1	2010	2017	1	0	CTD_human
val	3061	HCRTR1	0.623	0.654	C0086189	DrugWithdrawalSymptoms	phenotype	C25;F03	SignorSymptom	0.30	1	2010	2010	1	0	CTD_human
val	3061	HCRTR1	0.623	0.654	C0087169	WithdrawalSymptoms	phenotype	C25;F03	SignorSymptom	0.30	1	2010	2010	1	0	CTD_human
val	3061	HCRTR1	0.623	0.654	C0236736	Cocaine-RelatedDisorders	group	C25;F03	MentalorBehavioralDysfunction	0.30	1	2005	2010	3	0	CTD_human
val	3061	HCRTR1	0.623	0.654	C0525045	MoodDisorders	group	F03	MentalorBehavioralDysfunction	0.32	1	2011	2019	1	0	PSYGENET
val	3061	HCRTR1	0.623	0.654	C0600427	CocaineDependence	disease	C25;F03	MentalorBehavioralDysfunction	0.31	1	2005	2020	3	0	CTD_human
val	3062	HCRTR2	0.7	0.577	C0027404	Narcolepsy	disease	C10;F03	DiseaseorSyndrome	0.60	0.941	1999	2018	1	0	CTD_human
val	3062	HCRTR2	0.7	0.577	C0751362	Narcolepsy-CataplexySyndrome	disease	C10;F03	DiseaseorSyndrome	0.30	1	2007	2007	1	0	CTD_human
val	3064	HTT	0.548	0.654	C0006635	Cadmiumpoisoning	disease	C25	InjuryorPoisoning	0.30	1	2010	2010	1	0	CTD_human
val	3064	HTT	0.548	0.654	C0011570	MentalDepression	disease	F01	MentalorBehavioralDysfunction	0.32	1	2004	2017	4	0	PSYGENET
val	3064	HTT	0.548	0.654	C0011581	Depressivedisorder	disease	F03	MentalorBehavioralDysfunction	0.42	1	2004	2017	4	0	PSYGENET
val	3064	HTT	0.548	0.654	C0020179	HuntingtonDisease	disease	C16;C10;F03	DiseaseorSyndrome	1.00	0.987	1993	2020	12	17	CTD_human;GENOMICS_ENGLAND;ORPHANET
val	3064	HTT	0.548	0.654	C0026650	MovementDisorders	group	C10	DiseaseorSyndrome	0.44	1	2004	2016	1	0	CTD_human
val	3064	HTT	0.548	0.654	C0266487	EtatMarbre	disease	C10	DiseaseorSyndrome	0.30	1	2011	2011	1	0	CTD_human
val	3064	HTT	0.548	0.654	C0393574	HuntingtonDisease,LateOnset	disease	C16;C10;F03	DiseaseorSyndrome	0.30	1	2004	2017	11	0	CTD_human
val	3064	HTT	0.548	0.654	C0525045	MoodDisorders	group	F03	MentalorBehavioralDysfunction	0.30	1	2013	2013	2	0	PSYGENET
val	3064	HTT	0.548	0.654	C0677050	ManganesePoisoning	disease	C10;C25	InjuryorPoisoning	0.30	1	2010	2010	1	0	CTD_human
val	3064	HTT	0.548	0.654	C0751207	Akinetic-RigidVariantofHuntingtonDisease	disease	C16;C10;F03	DiseaseorSyndrome	0.30	1	2004	2017	11	0	CTD_human
val	3064	HTT	0.548	0.654	C0751208	JuvenileHuntingtonDisease	disease	C16;C10;F03	DiseaseorSyndrome	0.53	1	2004	2019	12	0	CTD_human;ORPHANET
val	3064	HTT	0.548	0.654	C3714756	IntellectualDisability	group	C23;C10;F03;F01	MentalorBehavioralDysfunction	0.30	1	2016	2016	1	0	GENOMICS_ENGLAND
val	3064	HTT	0.548	0.654	C4479476	MENTALRETARDATION,AUTOSOMALRECESSIVE60	disease		MentalorBehavioralDysfunction	0.30				0	0	GENOMICS_ENGLAND
val	3064	HTT	0.548	0.654	C4479491	LOPES-MACIEL-RODANSYNDROME	disease		DiseaseorSyndrome	0.60	1	2016	2016	2	4	GENOMICS_ENGLAND;UNIPROT
val	3065	HDAC1	0.46	0.846	C0007137	Squamouscellcarcinoma	disease	C04	NeoplasticProcess	0.32	1	2003	2011	1	0	CTD_human
val	3065	HDAC1	0.46	0.846	C0014175	Endometriosis	disease	C13	DiseaseorSyndrome	0.31	1	2012	2012	1	0	CTD_human
val	3065	HDAC1	0.46	0.846	C0018799	HeartDiseases	group	C14	DiseaseorSyndrome	0.30	1	2008	2008	1	0	CTD_human
val	3065	HDAC1	0.46	0.846	C0036341	Schizophrenia	disease	F03	MentalorBehavioralDysfunction	0.36	1	2008	2017	2	0	PSYGENET
val	3065	HDAC1	0.46	0.846	C0269102	Endometrioma	disease	C13	NeoplasticProcess	0.31	1	2012	2013	1	0	CTD_human
val	3065	HDAC1	0.46	0.846	C0340543	Familialprimarypulmonaryhypertension	disease	C08	DiseaseorSyndrome	0.30	1	2012	2012	1	0	CTD_human
val	3065	HDAC1	0.46	0.846	C0525045	MoodDisorders	group	F03	MentalorBehavioralDysfunction	0.30	1	2013	2013	1	0	PSYGENET
val	3065	HDAC1	0.46	0.846	C1969342	PULMONARYHYPERTENSION,PRIMARY,DEXFENFLURAMINE-ASSOCIATED	disease	C08	DiseaseorSyndrome	0.30	1	2012	2012	1	0	CTD_human
val	3065	HDAC1	0.46	0.846	C1969343	PulmonaryHypertension,Primary,Fenfluramine-Associated	disease	C08	DiseaseorSyndrome	0.30	1	2012	2012	1	0	CTD_human
val	3065	HDAC1	0.46	0.846	C2713368	HematopoeticMyelodysplasia	phenotype	C15	PathologicFunction	0.30	1	2017	2017	1	0	CTD_human
val	3065	HDAC1	0.46	0.846	C3203102	Idiopathicpulmonaryarterialhypertension	disease	C08	DiseaseorSyndrome	0.30	1	2012	2012	1	0	CTD_human
val	3065	HDAC1	0.46	0.846	C3463824	MYELODYSPLASTICSYNDROME	group	C15	NeoplasticProcess	0.31	1	2017	2017	1	0	CTD_human
val	3065	HDAC1	0.46	0.846	C3714844	PulmonaryHypertension,Primary,1,WithHereditaryHemorrhagicTelangiectasia	disease	C08	DiseaseorSyndrome	0.30	1	2012	2012	1	0	CTD_human
val	3065	HDAC1	0.46	0.846	C4552070	PulmonaryHypertension,Primary,1	disease	C08	DiseaseorSyndrome	0.30	1	2012	2012	1	0	CTD_human
val	3066	HDAC2	0.476	0.846	C0001973	AlcoholicIntoxication,Chronic	disease	C25;F03	MentalorBehavioralDysfunction	0.30	1	2013	2013	1	0	PSYGENET
val	3066	HDAC2	0.476	0.846	C0007112	Adenocarcinomaofprostate	disease	C04;C12	NeoplasticProcess	0.30				0	0	CGI
val	3066	HDAC2	0.476	0.846	C0007137	Squamouscellcarcinoma	disease	C04	NeoplasticProcess	0.32	1	2011	2011	1	0	CTD_human
val	3066	HDAC2	0.476	0.846	C0011570	MentalDepression	disease	F01	MentalorBehavioralDysfunction	0.33	1	2010	2019	1	0	PSYGENET
val	3066	HDAC2	0.476	0.846	C0014175	Endometriosis	disease	C13	DiseaseorSyndrome	0.51	1	2011	2012	1	0	CTD_human
val	3066	HDAC2	0.476	0.846	C0018800	Cardiomegaly	phenotype	C23;C14	Finding	0.30	1	2008	2008	1	0	CTD_human
val	3066	HDAC2	0.476	0.846	C0023466	Leukemia,Monocytic,Chronic	disease	C04	NeoplasticProcess	0.30	1	2011	2011	1	0	CTD_human
val	3066	HDAC2	0.476	0.846	C0023470	MyeloidLeukemia	disease	C04	NeoplasticProcess	0.31	1	2011	2011	1	0	CTD_human
val	3066	HDAC2	0.476	0.846	C0023890	LiverCirrhosis	disease	C23;C06	DiseaseorSyndrome	0.30	1	2016	2016	1	0	CTD_human
val	3066	HDAC2	0.476	0.846	C0024117	ChronicObstructiveAirwayDisease	disease	C08	DiseaseorSyndrome	0.60	1	2004	2019	2	0	CTD_human
val	3066	HDAC2	0.476	0.846	C0025202	melanoma	disease	C04	NeoplasticProcess	0.30	1	2012	2012	1	0	CTD_human
val	3066	HDAC2	0.476	0.846	C0033975	PsychoticDisorders	group	F03	MentalorBehavioralDysfunction	0.30	1	2012	2012	1	0	PSYGENET
val	3066	HDAC2	0.476	0.846	C0036341	Schizophrenia	disease	F03	MentalorBehavioralDysfunction	0.36	1	2012	2019	1	0	PSYGENET
val	3066	HDAC2	0.476	0.846	C0239946	Fibrosis,Liver	disease	C23;C06	DiseaseorSyndrome	0.31	1	2016	2016	1	0	CTD_human
val	3066	HDAC2	0.476	0.846	C0269102	Endometrioma	disease	C13	NeoplasticProcess	0.30	1	2012	2012	1	0	CTD_human
val	3066	HDAC2	0.476	0.846	C0349204	Nonorganicpsychosis	disease	F03	MentalorBehavioralDysfunction	0.30	1	2012	2012	1	0	PSYGENET
val	3066	HDAC2	0.476	0.846	C0525045	MoodDisorders	group	F03	MentalorBehavioralDysfunction	0.30	1	2010	2013	2	0	PSYGENET
val	3066	HDAC2	0.476	0.846	C0920269	MicrosatelliteInstability	phenotype	C23	CellorMolecularDysfunction	0.30	1	2015	2015	1	0	CTD_human
val	3066	HDAC2	0.476	0.846	C1383860	CardiacHypertrophy	phenotype	C23;C14	PathologicFunction	0.30	1	2008	2008	1	0	CTD_human
val	3066	HDAC2	0.476	0.846	C1527303	ChronicAirflowObstruction	disease	C08	DiseaseorSyndrome	0.30	1	2004	2008	2	0	CTD_human
val	3066	HDAC2	0.476	0.846	C1721098	ReplicationErrorPhenotype	phenotype	C23	CellorMolecularDysfunction	0.30	1	2015	2015	1	0	CTD_human
val	3067	HDC	0.584	0.692	C0009402	ColorectalCarcinoma	disease	C06;C04	NeoplasticProcess	0.31	1	2017	2017	0	1	UNIPROT
val	3067	HDC	0.584	0.692	C0019209	Hepatomegaly	phenotype	C23;C06	Finding	0.30	1	2017	2017	1	0	CTD_human
val	3067	HDC	0.584	0.692	C0040517	GillesdelaTourettesyndrome	disease	C16;C10;F03	DiseaseorSyndrome	0.68	0.9	2001	2020	0	1	CTD_human
val	3068	HDGF	0.575	0.654	C0019693	HIVInfections	group	C01;C20	DiseaseorSyndrome	0.30	1	2004	2004	1	0	CTD_human
val	3068	HDGF	0.575	0.654	C4505456	HIVCoinfection	disease	C01;C20	DiseaseorSyndrome	0.30	1	2004	2004	1	0	CTD_human
val	3069	HDLBP	0.636	0.731	C0004352	AutisticDisorder	disease	F03	MentalorBehavioralDysfunction	0.31	1	2009	2009	1	0	CTD_human
val	3069	HDLBP	0.636	0.731	C0006142	Malignantneoplasmofbreast	disease	C04;C17	NeoplasticProcess	0.33	1	2011	2019	0	0	UNIPROT
val	3069	HDLBP	0.636	0.731	C2931817	Chromosome2q37deletionsyndrome	disease	C23	DiseaseorSyndrome	0.30	1	2009	2009	1	0	CTD_human
val	3070	HELLS	0.603	0.731	C0023893	LiverCirrhosis,Experimental	disease	C23;C06	ExperimentalModelofDisease	0.30	1	2014	2014	1	0	CTD_human
val	3070	HELLS	0.603	0.731	C0032460	PolycysticOvarySyndrome	disease	C04;C13;C19	DiseaseorSyndrome	0.30	1	2011	2011	1	0	CTD_human
val	3070	HELLS	0.603	0.731	C0152013	Adenocarcinomaoflung(disorder)	disease	C04	NeoplasticProcess	0.31	1	2015	2016	1	0	CTD_human
val	3070	HELLS	0.603	0.731	C0398788	Immunodeficiencysyndrome,variable	disease	C16;C20	DiseaseorSyndrome	0.31	1	2006	2015	1	0	GENOMICS_ENGLAND
val	3070	HELLS	0.603	0.731	C1136382	SclerocysticOvaries	disease	C04;C13;C19	DiseaseorSyndrome	0.30	1	2011	2011	1	0	CTD_human
val	3070	HELLS	0.603	0.731	C4310798	IMMUNODEFICIENCY-CENTROMERICINSTABILITY-FACIALANOMALIESSYNDROME4	disease		DiseaseorSyndrome	0.70	1	2006	2015	2	6	CTD_human;GENOMICS_ENGLAND;UNIPROT
val	3071	NCKAP1L	0.839	0.269	C0023893	LiverCirrhosis,Experimental	disease	C23;C06	ExperimentalModelofDisease	0.30	1	2014	2014	1	0	CTD_human
val	3073	HEXA	0.633	0.615	C0020796	ProfoundMentalRetardation	disease	C23;C10;F03;F01	MentalorBehavioralDysfunction	0.30	1	2011	2011	1	0	CTD_human
val	3073	HEXA	0.633	0.615	C0025363	MentalRetardation,Psychosocial	phenotype	C23;C10;F03;F01	MentalorBehavioralDysfunction	0.30	1	2011	2011	1	0	CTD_human
val	3073	HEXA	0.633	0.615	C0039373	Tay-SachsDisease	disease	C16;C18;C10	DiseaseorSyndrome	1.00	1	1982	2019	31	118	CTD_human;GENOMICS_ENGLAND;UNIPROT
val	3073	HEXA	0.633	0.615	C0282220	AmauroticFamilialIdiocy	disease	C16;C18;C10	DiseaseorSyndrome	0.30	1	2001	2001	1	0	CTD_human
val	3073	HEXA	0.633	0.615	C0917816	Mentaldeficiency	disease	C23;C10;F03;F01	MentalorBehavioralDysfunction	0.30	1	2011	2011	1	0	CTD_human
val	3073	HEXA	0.633	0.615	C1848914	HexosaminidaseADeficiency,AdultType	disease	C16;C18;C10	DiseaseorSyndrome	0.30				0	0	ORPHANET
val	3073	HEXA	0.633	0.615	C1848916	Tay-SachsDisease,VariantB1	disease	C16;C18;C10	DiseaseorSyndrome	0.41	1	2017	2017	0	4	ORPHANET
val	3073	HEXA	0.633	0.615	C1848922	Hexosaminidasealpha-SubunitDeficiency(VariantB)	disease	C16;C18;C10	DiseaseorSyndrome	0.30	1	2001	2001	1	0	CTD_human
val	3073	HEXA	0.633	0.615	C2749283	Gm2-Gangliosidosis,VariantB1	disease	C16;C18;C10	DiseaseorSyndrome	0.40				0	1	ORPHANET
val	3073	HEXA	0.633	0.615	C3714756	IntellectualDisability	group	C23;C10;F03;F01	MentalorBehavioralDysfunction	0.30	1	2011	2011	1	0	CTD_human
val	3074	HEXB	0.644	0.654	C0014550	MyoclonicEpilepsy	disease	C10	DiseaseorSyndrome	0.30	1	1995	1995	1	0	GENOMICS_ENGLAND
val	3074	HEXB	0.644	0.654	C0022660	KidneyFailure,Acute	disease	C13;C12	DiseaseorSyndrome	0.30	1	2011	2011	1	0	CTD_human
val	3074	HEXB	0.644	0.654	C0036161	SandhoffDisease	disease	C16;C18;C10	DiseaseorSyndrome	1.00	0.987	1989	2020	12	45	CTD_human;GENOMICS_ENGLAND;UNIPROT
val	3074	HEXB	0.644	0.654	C0036572	Seizures	phenotype	C23;C10	SignorSymptom	0.30	1	1995	1995	1	0	GENOMICS_ENGLAND
val	3074	HEXB	0.644	0.654	C0751489	AdultSandhoffDisease	disease	C16;C18;C10	DiseaseorSyndrome	0.52	1	1998	2010	1	0	CTD_human;ORPHANET
val	3074	HEXB	0.644	0.654	C0751490	InfantileSandhoffDisease	disease	C16;C18;C10	DiseaseorSyndrome	0.63	1	1992	2010	1	1	CTD_human;ORPHANET
val	3074	HEXB	0.644	0.654	C0751491	JuvenileSandhoffDisease	disease	C16;C18;C10	DiseaseorSyndrome	0.53	1	1992	2010	1	0	CTD_human;ORPHANET
val	3074	HEXB	0.644	0.654	C1565662	AcuteKidneyInsufficiency	disease	C13;C12	DiseaseorSyndrome	0.30	1	2011	2011	1	0	CTD_human
val	3074	HEXB	0.644	0.654	C1849320	SandhoffDisease,AdultType	disease	C16;C18;C10	DiseaseorSyndrome	0.40	1	2010	2010	1	2	ORPHANET
val	3074	HEXB	0.644	0.654	C1849321	SandhoffDisease,JuvenileType	disease	C16;C18;C10	DiseaseorSyndrome	0.40	1	2010	2010	1	1	ORPHANET
val	3074	HEXB	0.644	0.654	C1849322	SandhoffDisease,InfantileType	disease	C16;C18;C10	DiseaseorSyndrome	0.30	1	2010	2010	1	0	ORPHANET
val	3074	HEXB	0.644	0.654	C2609414	Acutekidneyinjury	disease	C13;C12	InjuryorPoisoning	0.30	1	2011	2011	1	0	CTD_human
val	3074	HEXB	0.644	0.654	C2713499	TotalHexosaminidaseDeficiency	disease	C16;C18;C10	DiseaseorSyndrome	0.30				0	0	CTD_human
val	3075	CFH	0.441	0.885	C0003257	AntibodyDeficiencySyndrome	disease	C20	DiseaseorSyndrome	0.30	1	2004	2004	1	0	CTD_human
val	3075	CFH	0.441	0.885	C0017662	Glomerulonephritis,Membranoproliferative	disease	C13;C12;C20	DiseaseorSyndrome	0.60	1	1994	2015	1	0	CTD_human
val	3075	CFH	0.441	0.885	C0019193	Hepatitis,Toxic	disease	C06;C25	InjuryorPoisoning	0.30	1	2015	2015	1	0	CTD_human
val	3075	CFH	0.441	0.885	C0021051	ImmunologicDeficiencySyndromes	group	C20	DiseaseorSyndrome	0.30	1	2004	2004	1	0	CTD_human
val	3075	CFH	0.441	0.885	C0025303	MeningococcalInfections	group	C01	DiseaseorSyndrome	0.40	1	2006	2019	1	0	CTD_human
val	3075	CFH	0.441	0.885	C0162739	HELLPSyndrome	disease	C13	DiseaseorSyndrome	0.32	1	2008	2012	2	0	ORPHANET
val	3075	CFH	0.441	0.885	C0242383	Agerelatedmaculardegeneration	disease	C11	DiseaseorSyndrome	0.50	0.961	2005	2019	6	69	CTD_human
val	3075	CFH	0.441	0.885	C0268742	MembranoproliferativeGlomerulonephritis,TypeI	disease	C13;C12;C20	DiseaseorSyndrome	0.52	1	2004	2017	2	0	CTD_human;ORPHANET
val	3075	CFH	0.441	0.885	C0268743	MembranoproliferativeGlomerulonephritis,TypeII	disease	C13;C12;C20	DiseaseorSyndrome	0.70	1	1994	2016	3	0	CTD_human;GENOMICS_ENGLAND;ORPHANET
val	3075	CFH	0.441	0.885	C0272242	Complementdeficiencydisease	group	C20;C15	DiseaseorSyndrome	0.30	1	2014	2014	1	0	GENOMICS_ENGLAND
val	3075	CFH	0.441	0.885	C0398777	ComplementFactorHDeficiency	disease	C16;C13;C12;C20	DiseaseorSyndrome	0.80	0.947	1990	2016	9	9	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
val	3075	CFH	0.441	0.885	C0730295	BASALLAMINARDRUSEN(disorder)	disease	C16;C11	DiseaseorSyndrome	0.65	1	2007	2016	0	4	CTD_human;GENOMICS_ENGLAND
val	3075	CFH	0.441	0.885	C0860207	Drug-InducedLiverDisease	phenotype	C06;C25	DiseaseorSyndrome	0.30	1	2015	2015	1	0	CTD_human
val	3075	CFH	0.441	0.885	C1262760	Hepatitis,Drug-Induced	disease	C06;C25	DiseaseorSyndrome	0.30	1	2015	2015	1	0	CTD_human
val	3075	CFH	0.441	0.885	C1720821	MembranoproliferativeGlomerulonephritis,TypeIII	disease	C13;C12;C20	DiseaseorSyndrome	0.50	1	2004	2011	2	0	CTD_human;ORPHANET
val	3075	CFH	0.441	0.885	C1832174	DOYNEHONEYCOMBRETINALDYSTROPHY	disease	C11;C10	DiseaseorSyndrome	0.30	1	2008	2008	1	0	ORPHANET
val	3075	CFH	0.441	0.885	C1852020	MalattiaLeventinese	disease	C11;C10	DiseaseorSyndrome	0.30	1	2008	2008	1	0	ORPHANET
val	3075	CFH	0.441	0.885	C1852021	Drusen,Radial,AutosomalDominant	disease	C16;C11	DiseaseorSyndrome	0.30	1	2008	2008	1	0	ORPHANET
val	3075	CFH	0.441	0.885	C1853147	MACULARDEGENERATION,AGE-RELATED,4(disorder)	disease	C11	DiseaseorSyndrome	0.90	1	2003	2015	1	5	CTD_human;GENOMICS_ENGLAND;UNIPROT
val	3075	CFH	0.441	0.885	C2749604	HEMOLYTICUREMICSYNDROME,ATYPICAL,SUSCEPTIBILITYTO,1	disease		Finding	0.60	1	1998	2016	11	23	GENOMICS_ENGLAND;UNIPROT
val	3075	CFH	0.441	0.885	C2931788	AtypicalHemolyticUremicSyndrome	disease	C13;C12;C15	DiseaseorSyndrome	0.70	0.983	1999	2019	2	2	CTD_human
val	3075	CFH	0.441	0.885	C3658290	Drug-InducedAcuteLiverInjury	disease	C06;C25	DiseaseorSyndrome	0.30	1	2015	2015	1	0	CTD_human
val	3075	CFH	0.441	0.885	C4087273	C3glomerulopathy	disease		DiseaseorSyndrome	0.40	1	2012	2018	1	0	GENOMICS_ENGLAND
val	3075	CFH	0.441	0.885	C4277682	ChemicalandDrugInducedLiverInjury	disease	C06;C25	DiseaseorSyndrome	0.30	1	2015	2015	1	0	CTD_human
val	3075	CFH	0.441	0.885	C4279912	Chemically-InducedLiverToxicity	disease	C06;C25	DiseaseorSyndrome	0.30	1	2015	2015	1	0	CTD_human
val	3077	HFE	0.436	0.846	C0002395	AlzheimersDisease	disease	C10;F03	DiseaseorSyndrome	0.7	0.963	2001	2018	2	1	CTD_human;GENOMICS_ENGLAND
11269	3077	HFE	0.436	0.846	C0018995	Hemochromatosis	disease	C16;C18	DiseaseorSyndrome	0.6	0.979	1987	2019	15	0	CTD_human;GENOMICS_ENGLAND
11276	3077	HFE	0.436	0.846	C0162566	PorphyriaCutaneaTarda	disease	C16;C06;C18;C17	DiseaseorSyndrome	0.6	0.967	1996	2019	0	0	CTD_human;GENOMICS_ENGLAND
11279	3077	HFE	0.436	0.846	C0392514	Hereditaryhemochromatosis	disease	C16;C18	DiseaseorSyndrome	0.7	0.975	1991	2020	14	5	CTD_human
11303	3162	HMOX1	0.381	0.923	C0009319	Colitis	disease	C06	DiseaseorSyndrome	0.57	1	2005	2019	2	0	CTD_human
11308	3162	HMOX1	0.381	0.923	C0011860	DiabetesMellitus,Non-Insulin-Dependent	disease	C18;C19	DiseaseorSyndrome	0.6	0.95	2002	2019	3	0	CTD_human
11315	3162	HMOX1	0.381	0.923	C0018801	Heartfailure	disease	C14	DiseaseorSyndrome	0.55	1	2005	2019	1	0	CTD_human
11316	3162	HMOX1	0.381	0.923	C0018802	Congestiveheartfailure	disease	C14	DiseaseorSyndrome	0.56	1	2005	2019	1	0	CTD_human
11323	3162	HMOX1	0.381	0.923	C0020538	Hypertensivedisease	group	C14	DiseaseorSyndrome	0.6	0.947	1997	2019	3	0	CTD_human
11335	3162	HMOX1	0.381	0.923	C0024117	ChronicObstructiveAirwayDisease	disease	C08	DiseaseorSyndrome	0.7	0.9	2005	2020	0	0	CTD_human
11350	3162	HMOX1	0.381	0.923	C0035126	ReperfusionInjury	disease	C23;C14	InjuryorPoisoning	0.51	1	2002	2015	6	0	CTD_human
11353	3162	HMOX1	0.381	0.923	C0038220	StatusEpilepticus	disease	C23;C10	DiseaseorSyndrome	0.51	1	2011	2018	1	0	CTD_human
11360	3162	HMOX1	0.381	0.923	C0151744	MyocardialIschemia	disease	C14	DiseaseorSyndrome	0.52	1	2004	2005	1	0	CTD_human
11411	3417	IDH1	0.424	0.808	C0014084	Enchondromatosis	disease	C05	DiseaseorSyndrome	0.79	1	2011	2019	2	0	CTD_human;GENOMICS_ENGLAND;ORPHANET
11412	3417	IDH1	0.424	0.808	C0017638	Glioma	disease	C04	NeoplasticProcess	0.7	0.984	2008	2020	5	2	CGI;CTD_human;UNIPROT
11416	3417	IDH1	0.424	0.808	C0023467	Leukemia,Myelocytic,Acute	disease	C04	NeoplasticProcess	0.7	0.969	2009	2020	2	2	CGI;CTD_human
11418	3417	IDH1	0.424	0.808	C0024454	MaffucciSyndrome	disease	C05	DiseaseorSyndrome	0.7	1	2011	2019	2	0	CTD_human;GENOMICS_ENGLAND;ORPHANET
11426	3417	IDH1	0.424	0.808	C0206698	Cholangiocarcinoma	disease	C04	NeoplasticProcess	0.6	1	2012	2020	1	0	CGI;CTD_human
11450	3417	IDH1	0.424	0.808	C3553958	METAPHYSEALENCHONDROMATOSISWITHD-2-HYDROXYGLUTARICACIDURIA	disease		DiseaseorSyndrome	0.61	1	2011	2011	2	1	GENOMICS_ENGLAND;ORPHANET
11457	3418	IDH2	0.434	0.808	C0014084	Enchondromatosis	disease	C05	DiseaseorSyndrome	0.77	1	2011	2019	2	0	CTD_human;GENOMICS_ENGLAND;ORPHANET
11464	3418	IDH2	0.434	0.808	C0023467	Leukemia,Myelocytic,Acute	disease	C04	NeoplasticProcess	0.7	0.961	2010	2019	2	5	CGI;CTD_human
11466	3418	IDH2	0.434	0.808	C0024454	MaffucciSyndrome	disease	C05	DiseaseorSyndrome	0.65	1	2011	2016	2	0	CTD_human;GENOMICS_ENGLAND;ORPHANET
11469	3418	IDH2	0.434	0.808	C0028945	oligodendroglioma	disease	C04	NeoplasticProcess	0.6	1	2009	2019	8	0	CTD_human;ORPHANET
11480	3418	IDH2	0.434	0.808	C0206698	Cholangiocarcinoma	disease	C04	NeoplasticProcess	0.56	1	2012	2018	1	0	CGI;CTD_human
11489	3418	IDH2	0.434	0.808	C0280793	MixedOligodendroglioma-Astrocytoma	disease	C04	NeoplasticProcess	0.51	1	2009	2015	7	0	CTD_human;ORPHANET
11494	3418	IDH2	0.434	0.808	C0334590	AnaplasticOligodendroglioma	disease	C04	NeoplasticProcess	0.58	0.933	2009	2019	8	0	CTD_human;ORPHANET
11525	3418	IDH2	0.434	0.808	C3150909	D-2-HYDROXYGLUTARICACIDURIA2	disease		DiseaseorSyndrome	0.61	1	2010	2018	3	2	GENOMICS_ENGLAND;UNIPROT
11537	3419	IDH3A	0.705	0.385	C0035334	RetinitisPigmentosa	disease	C16;C11	DiseaseorSyndrome	0.51	1	2017	2018	2	0	GENOMICS_ENGLAND;ORPHANET
11542	3420	IDH3B	0.7	0.462	C0035334	RetinitisPigmentosa	disease	C16;C11	DiseaseorSyndrome	0.51	1	2008	2008	1	0	CTD_human;GENOMICS_ENGLAND
11546	3420	IDH3B	0.7	0.462	C2675496	RetinitisPigmentosa46	disease	C16;C11	DiseaseorSyndrome	0.7	1	2008	2008	1	1	CTD_human;GENOMICS_ENGLAND;UNIPROT
11548	3423	IDS	0.559	0.769	C0026705	MucopolysaccharidosisII	disease	C16;C18;C17;C10	DiseaseorSyndrome	1	0.994	1991	2019	41	68	CLINGEN;CTD_human;GENOMICS_ENGLAND;UNIPROT
11551	3425	IDUA	0.499	0.846	C0023786	MucopolysaccharidosisI	disease	C16;C18;C17	DiseaseorSyndrome	0.9	1	1992	2020	6	21	CTD_human;GENOMICS_ENGLAND
11552	3425	IDUA	0.499	0.846	C0026708	MucopolysaccharidosisV	disease	C16;C18;C17	DiseaseorSyndrome	0.76	1	1992	2020	17	10	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
11553	3425	IDUA	0.499	0.846	C0086431	Hurler-ScheieSyndrome	disease	C16;C18;C17	DiseaseorSyndrome	0.77	1	1992	2020	15	16	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
11554	3425	IDUA	0.499	0.846	C0086795	Pfaundler-HurlerSyndrome	disease	C16;C18;C17	DiseaseorSyndrome	0.8	0.992	1973	2020	23	72	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
11562	3426	CFI	0.569	0.731	C2752039	HEMOLYTICUREMICSYNDROME,ATYPICAL,SUSCEPTIBILITYTO,3	disease		Finding	0.6	1	2004	2016	7	13	GENOMICS_ENGLAND;UNIPROT
11564	3426	CFI	0.569	0.731	C3463916	ComplementFactorI(C3inactivator)deficiency	disease	C16;C20	DiseaseorSyndrome	0.72	1	1996	2017	4	3	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
11565	3426	CFI	0.569	0.731	C3809523	MACULARDEGENERATION,AGE-RELATED,13	disease		DiseaseorSyndrome	0.6	1	2013	2013	2	1	CTD_human;GENOMICS_ENGLAND;UNIPROT
11578	3431	SP110	0.656	0.5	C1856128	Hepaticvenoocclusivediseasewithimmunodeficiency	disease	C06;C20;C14	DiseaseorSyndrome	0.72	0.75	2006	2017	1	1	CTD_human;GENOMICS_ENGLAND;ORPHANET
11793	3455	IFNAR2	0.585	0.731	C4225252	IMMUNODEFICIENCY45	disease		DiseaseorSyndrome	0.7	1	2015	2015	1	1	CTD_human;GENOMICS_ENGLAND;ORPHANET
11800	3456	IFNB1	0.421	0.846	C0006142	Malignantneoplasmofbreast	disease	C04;C17	NeoplasticProcess	0.56	1	2008	2019	1	0	CTD_human;UNIPROT
11846	3458	IFNG	0.288	0.962	C0002874	AplasticAnemia	disease	C15	DiseaseorSyndrome	0.9	1	1992	2020	1	0	CTD_human;GENOMICS_ENGLAND
11869	3458	IFNG	0.288	0.962	C0011854	DiabetesMellitus,Insulin-Dependent	disease	C18;C20;C19	DiseaseorSyndrome	0.6	1	1994	2019	1	0	CTD_human
11901	3458	IFNG	0.288	0.962	C0243026	Sepsis	disease	C23;C01	DiseaseorSyndrome	0.6	1	1998	2019	1	0	CTD_human
11910	3479	IGF1	0.318	0.885	C0006142	Malignantneoplasmofbreast	disease	C04;C17	NeoplasticProcess	0.6	0.955	1986	2020	2	0	CTD_human
11913	3479	IGF1	0.318	0.885	C0008370	Cholestasis	disease	C06	DiseaseorSyndrome	0.51	1	2003	2008	1	0	CTD_human
11931	3479	IGF1	0.318	0.885	C0020538	Hypertensivedisease	group	C14	DiseaseorSyndrome	0.6	0.931	1993	2020	2	0	CTD_human
11944	3479	IGF1	0.318	0.885	C0033578	ProstaticNeoplasms	group	C04;C12	NeoplasticProcess	0.6	1	2002	2019	3	0	CTD_human
11951	3479	IGF1	0.318	0.885	C0151744	MyocardialIschemia	disease	C14	DiseaseorSyndrome	0.55	1	2003	2011	1	0	CTD_human
11969	3479	IGF1	0.318	0.885	C0750900	AlzheimersDisease,FocalOnset	disease	C10;F03	MentalorBehavioralDysfunction	0.30	1	2005	2005	1	0	CTD_human
val	3479	IGF1	0.318	0.885	C0750901	AlzheimerDisease,EarlyOnset	disease	C10;F03	DiseaseorSyndrome	0.30	1	2005	2005	1	0	CTD_human
val	3479	IGF1	0.318	0.885	C0751211	Hyperalgesia,Primary	phenotype	C23;C10	SignorSymptom	0.30	1	1997	1997	1	0	CTD_human
val	3479	IGF1	0.318	0.885	C0751212	Hyperalgesia,Secondary	phenotype	C23;C10	SignorSymptom	0.30	1	1997	1997	1	0	CTD_human
val	3479	IGF1	0.318	0.885	C0751213	TactileAllodynia	phenotype	C23;C10	SignorSymptom	0.30	1	1997	1997	1	0	CTD_human
val	3479	IGF1	0.318	0.885	C0751214	Hyperalgesia,Thermal	phenotype	C23;C10	SignorSymptom	0.30	1	1997	1997	1	0	CTD_human
val	3479	IGF1	0.318	0.885	C0751845	MiddleCerebralArteryEmbolus	phenotype	C23;C10;C14	DiseaseorSyndrome	0.30	1	2014	2014	1	0	CTD_human
val	3479	IGF1	0.318	0.885	C0751846	LeftMiddleCerebralArteryInfarction	phenotype	C23;C10;C14	DiseaseorSyndrome	0.30	1	2014	2014	1	0	CTD_human
val	3479	IGF1	0.318	0.885	C0751847	EmbolicInfarction,MiddleCerebralArtery	phenotype	C23;C10;C14	DiseaseorSyndrome	0.30	1	2014	2014	1	0	CTD_human
val	3479	IGF1	0.318	0.885	C0751848	ThromboticInfarction,MiddleCerebralArtery	phenotype	C23;C10;C14	DiseaseorSyndrome	0.30	1	2014	2014	1	0	CTD_human
val	3479	IGF1	0.318	0.885	C0751849	RightMiddleCerebralArteryInfarction	phenotype	C23;C10;C14	DiseaseorSyndrome	0.30	1	2014	2014	1	0	CTD_human
val	3479	IGF1	0.318	0.885	C0853897	DiabeticCardiomyopathies	disease	C19;C14	DiseaseorSyndrome	0.30	1	2001	2001	1	0	CTD_human
val	3479	IGF1	0.318	0.885	C0860207	Drug-InducedLiverDisease	phenotype	C06;C25	DiseaseorSyndrome	0.30	1	2013	2014	2	0	CTD_human
val	3479	IGF1	0.318	0.885	C0949272	IIeocolitis	disease	C06	DiseaseorSyndrome	0.30	1	2010	2010	1	0	CTD_human
val	3479	IGF1	0.318	0.885	C1168401	Squamouscellcarcinomaoftheheadandneck	disease	C04	NeoplasticProcess	0.37	1	2006	2018	1	0	CTD_human
val	3479	IGF1	0.318	0.885	C1257931	MammaryNeoplasms,Human	disease	C04;C17	NeoplasticProcess	0.30	1	2007	2008	2	0	CTD_human
val	3479	IGF1	0.318	0.885	C1262760	Hepatitis,Drug-Induced	disease	C06;C25	DiseaseorSyndrome	0.30	1	2013	2014	2	0	CTD_human
val	3479	IGF1	0.318	0.885	C1292778	Chronicmyeloproliferativedisorder	disease	C04;C15	NeoplasticProcess	0.30	1	1996	1996	1	0	GENOMICS_ENGLAND
val	3479	IGF1	0.318	0.885	C1383860	CardiacHypertrophy	phenotype	C23;C14	PathologicFunction	0.30	1	1999	1999	1	0	CTD_human
val	3479	IGF1	0.318	0.885	C1458155	MammaryNeoplasms	group	C04;C17	NeoplasticProcess	0.40	1	1990	2019	2	0	CTD_human
val	3479	IGF1	0.318	0.885	C1504412	Testotoxicosis	disease	C19	DiseaseorSyndrome	0.30	1	2011	2011	1	0	CTD_human
val	3479	IGF1	0.318	0.885	C1565662	AcuteKidneyInsufficiency	disease	C13;C12	DiseaseorSyndrome	0.30	1	1995	1995	1	0	CTD_human
val	3479	IGF1	0.318	0.885	C1720887	FemaleUrogenitalDiseases	group	C13	DiseaseorSyndrome	0.30	1	2005	2005	1	0	CTD_human
val	3479	IGF1	0.318	0.885	C1837475	Insulin-LikeGrowthFactorIDeficiency	disease	C23;C10;C09	DiseaseorSyndrome	0.80	1	1993	2020	3	0	CTD_human;GENOMICS_ENGLAND;ORPHANET
val	3479	IGF1	0.318	0.885	C2239176	Livercarcinoma	disease	C06;C04	NeoplasticProcess	0.40	0.962	1989	2019	1	0	CTD_human
val	3479	IGF1	0.318	0.885	C2350037	ClinicallyIsolatedSyndrome,CNSDemyelinating	disease	C10	DiseaseorSyndrome	0.30	1	1997	1997	1	0	CTD_human
val	3479	IGF1	0.318	0.885	C2609414	Acutekidneyinjury	disease	C13;C12	InjuryorPoisoning	0.30	1	1995	1995	1	0	CTD_human
val	3479	IGF1	0.318	0.885	C2936719	MechanicalAllodynia	phenotype	C23;C10	SignorSymptom	0.30	1	1997	1997	1	0	CTD_human
val	3479	IGF1	0.318	0.885	C3658290	Drug-InducedAcuteLiverInjury	disease	C06;C25	DiseaseorSyndrome	0.30	1	2013	2014	2	0	CTD_human
val	3479	IGF1	0.318	0.885	C3830362	EarlyPregnancyLoss	phenotype	C13	Finding	0.30	1	2008	2008	1	0	CTD_human
val	3479	IGF1	0.318	0.885	C3837958	DiabetesMellitus,Ketosis-Prone	disease	C18;C20;C19	DiseaseorSyndrome	0.30	1	2014	2014	1	0	CTD_human
val	3479	IGF1	0.318	0.885	C4277682	ChemicalandDrugInducedLiverInjury	disease	C06;C25	DiseaseorSyndrome	0.30	1	2013	2014	2	0	CTD_human
val	3479	IGF1	0.318	0.885	C4279912	Chemically-InducedLiverToxicity	disease	C06;C25	DiseaseorSyndrome	0.30	1	2013	2014	2	0	CTD_human
val	3479	IGF1	0.318	0.885	C4552766	Miscarriage	disease	C13	DiseaseorSyndrome	0.30	1	2008	2008	1	0	CTD_human
val	3479	IGF1	0.318	0.885	C4554117	DiabetesMellitus,Sudden-Onset	disease	C18;C20;C19	DiseaseorSyndrome	0.30	1	2014	2014	1	0	CTD_human
val	3479	IGF1	0.318	0.885	C4704874	MammaryCarcinoma,Human	disease	C04;C17	NeoplasticProcess	0.30	1	2007	2008	2	0	CTD_human
val	3479	IGF1	0.318	0.885	C4721453	PeripheralNervousSystemDiseases	group	C10	DiseaseorSyndrome	0.32	1	1996	2019	2	0	CTD_human
val	3479	IGF1	0.318	0.885	C4721507	Alveolitis,Fibrosing	disease	C08	DiseaseorSyndrome	0.30	1	2004	2004	1	0	CTD_human
val	3480	IGF1R	0.399	0.885	C0002395	AlzheimersDisease	disease	C10;F03	DiseaseorSyndrome	0.56	1	2005	2020	1	0	CTD_human
11976	3480	IGF1R	0.399	0.885	C0015934	FetalGrowthRetardation	phenotype	C23;C16;C13	DiseaseorSyndrome	0.7	1	1991	2019	1	0	CTD_human
11979	3480	IGF1R	0.399	0.885	C0030567	ParkinsonDisease	disease	C10	DiseaseorSyndrome	0.51	1	2009	2019	1	0	CTD_human
11997	3480	IGF1R	0.399	0.885	C0750900	AlzheimersDisease,FocalOnset	disease	C10;F03	MentalorBehavioralDysfunction	0.30	1	2005	2005	1	0	CTD_human
val	3480	IGF1R	0.399	0.885	C0750901	AlzheimerDisease,EarlyOnset	disease	C10;F03	DiseaseorSyndrome	0.30	1	2005	2005	1	0	CTD_human
val	3480	IGF1R	0.399	0.885	C0752347	LewyBodyDisease	disease	C10;F03	DiseaseorSyndrome	0.30	1	2009	2009	1	0	CTD_human
val	3480	IGF1R	0.399	0.885	C1145670	RespiratoryFailure	disease	C08	DiseaseorSyndrome	0.31	1	2010	2015	1	0	CTD_human
val	3480	IGF1R	0.399	0.885	C1257931	MammaryNeoplasms,Human	disease	C04;C17	NeoplasticProcess	0.30	1	2011	2011	1	0	CTD_human
val	3480	IGF1R	0.399	0.885	C1458155	MammaryNeoplasms	group	C04;C17	NeoplasticProcess	0.40	1	1992	2019	1	0	CTD_human
val	3480	IGF1R	0.399	0.885	C1849157	ResistancetoInsulin-LikeGrowthFactorI	disease	C23;C16	DiseaseorSyndrome	0.70	0.977	2001	2019	5	4	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
val	3480	IGF1R	0.399	0.885	C2239176	Livercarcinoma	disease	C06;C04	NeoplasticProcess	0.40	1	1996	2020	2	0	CTD_human
val	3480	IGF1R	0.399	0.885	C2585653	Persistentatrialfibrillation	phenotype	C23;C14	PathologicFunction	0.30	1	2018	2018	2	0	CTD_human
val	3480	IGF1R	0.399	0.885	C3468561	familialatrialfibrillation	phenotype	C23;C14	PathologicFunction	0.30	1	2018	2018	2	0	CTD_human
val	3480	IGF1R	0.399	0.885	C3495559	Juvenilearthritis	disease	C17;C05;C20	DiseaseorSyndrome	0.30	1	2009	2009	1	0	CTD_human
val	3480	IGF1R	0.399	0.885	C3714758	Juvenilepsoriaticarthritis	disease	C17;C05;C20	DiseaseorSyndrome	0.30	1	2009	2009	1	0	CTD_human
val	3480	IGF1R	0.399	0.885	C4552091	Polyarthritis,Juvenile,RheumatoidFactorNegative	disease	C17;C05;C20	DiseaseorSyndrome	0.30	1	2009	2009	1	0	CTD_human
val	3480	IGF1R	0.399	0.885	C4704862	Polyarthritis,Juvenile,RheumatoidFactorPositive	disease	C17;C05;C20	DiseaseorSyndrome	0.30	1	2009	2009	1	0	CTD_human
val	3480	IGF1R	0.399	0.885	C4704874	MammaryCarcinoma,Human	disease	C04;C17	NeoplasticProcess	0.30	1	2011	2011	1	0	CTD_human
val	3480	IGF1R	0.399	0.885	C4721453	PeripheralNervousSystemDiseases	group	C10	DiseaseorSyndrome	0.30	1	2010	2010	1	0	CTD_human
val	3481	IGF2	0.39	0.885	C0000786	Spontaneousabortion	phenotype	C13	PathologicFunction	0.31	1	2008	2008	1	0	CTD_human
val	3481	IGF2	0.39	0.885	C0000822	Abortion,Tubal	phenotype	C13	PathologicFunction	0.30	1	2008	2008	1	0	CTD_human
val	3481	IGF2	0.39	0.885	C0002395	AlzheimersDisease	disease	C10;F03	DiseaseorSyndrome	0.57	1	2002	2019	1	0	CTD_human
12001	3481	IGF2	0.39	0.885	C0004903	Beckwith-WiedemannSyndrome	disease	C16	DiseaseorSyndrome	0.6	0.959	1986	2019	4	0	CTD_human;GENOMICS_ENGLAND
12009	3481	IGF2	0.39	0.885	C0015934	FetalGrowthRetardation	phenotype	C23;C16;C13	DiseaseorSyndrome	0.9	1	1992	2019	3	0	CTD_human;GENOMICS_ENGLAND
12014	3481	IGF2	0.39	0.885	C0023903	Liverneoplasms	group	C06;C04	NeoplasticProcess	0.54	1	1990	2016	1	0	CTD_human
12024	3481	IGF2	0.39	0.885	C0175693	Russell-Silversyndrome	disease	C16;C05	DiseaseorSyndrome	0.7	1	2006	2020	2	0	CTD_human;GENOMICS_ENGLAND
12025	3481	IGF2	0.39	0.885	C0206624	Hepatoblastoma	disease	C04	NeoplasticProcess	0.7	1	1993	2013	1	0	CTD_human
12033	3481	IGF2	0.39	0.885	C0345904	Malignantneoplasmofliver	disease	C06;C04	NeoplasticProcess	0.54	1	1988	2007	1	0	CTD_human
12053	3482	IGF2R	0.518	0.731	C0750900	AlzheimersDisease,FocalOnset	disease	C10;F03	MentalorBehavioralDysfunction	0.30	1	2005	2005	1	0	CTD_human
val	3482	IGF2R	0.518	0.731	C0750901	AlzheimerDisease,EarlyOnset	disease	C10;F03	DiseaseorSyndrome	0.30	1	2005	2005	1	0	CTD_human
val	3482	IGF2R	0.518	0.731	C0752347	LewyBodyDisease	disease	C10;F03	DiseaseorSyndrome	0.30	1	2009	2009	1	0	CTD_human
val	3482	IGF2R	0.518	0.731	C2239176	Livercarcinoma	disease	C06;C04	NeoplasticProcess	0.70	1	1995	2019	1	2	CGI;CTD_human
val	3483	IGFALS	0.511	0.846	C0013336	Dwarfism	disease	C16;C05;C19	CongenitalAbnormality	0.35	1	2004	2020	1	0	GENOMICS_ENGLAND
val	3483	IGFALS	0.511	0.846	C0018273	GrowthDisorders	group	C23	PathologicFunction	0.30	1	2004	2007	2	0	CTD_human
val	3483	IGFALS	0.511	0.846	C0021655	InsulinResistance	phenotype	C18	PathologicFunction	0.40	1	2007	2007	1	0	CTD_human
val	3483	IGFALS	0.511	0.846	C0023893	LiverCirrhosis,Experimental	disease	C23;C06	ExperimentalModelofDisease	0.30	1	2014	2014	1	0	CTD_human
val	3483	IGFALS	0.511	0.846	C0034012	DelayedPuberty	phenotype	C19	PathologicFunction	0.60	1	2004	2007	2	0	CTD_human;GENOMICS_ENGLAND
val	3483	IGFALS	0.511	0.846	C0349588	Shortstature	phenotype		Finding	0.30	1	2004	2004	1	0	GENOMICS_ENGLAND
val	3483	IGFALS	0.511	0.846	C0920563	InsulinSensitivity	phenotype	C18	PathologicFunction	0.30	1	2007	2007	1	0	CTD_human
val	3483	IGFALS	0.511	0.846	C2239176	Livercarcinoma	disease	C06;C04	NeoplasticProcess	0.30	1	2017	2017	1	0	CTD_human
val	3483	IGFALS	0.511	0.846	C2919142	ShortStature,CTCAE	phenotype		Finding	0.30	1	2004	2004	1	0	GENOMICS_ENGLAND
val	3483	IGFALS	0.511	0.846	C3900122	Acid-LabileSubunitDeficiency	disease		LaboratoryorTestResult	0.70	1	2004	2016	8	0	CTD_human;ORPHANET;UNIPROT
val	3484	IGFBP1	0.502	0.808	C0000786	Spontaneousabortion	phenotype	C13	PathologicFunction	0.30	1	2008	2008	1	0	CTD_human
val	3484	IGFBP1	0.502	0.808	C0000822	Abortion,Tubal	phenotype	C13	PathologicFunction	0.30	1	2008	2008	1	0	CTD_human
val	3484	IGFBP1	0.502	0.808	C0007102	Malignanttumorofcolon	disease	C06;C04	NeoplasticProcess	0.30	1	2004	2004	1	0	CTD_human
val	3484	IGFBP1	0.502	0.808	C0008312	Primarybiliarycirrhosis	disease	C23;C06	DiseaseorSyndrome	0.30	1	2008	2008	1	0	CTD_human
val	3484	IGFBP1	0.502	0.808	C0009375	ColonicNeoplasms	group	C06;C04	NeoplasticProcess	0.30	1	2004	2004	1	0	CTD_human
val	3484	IGFBP1	0.502	0.808	C0013221	Drugtoxicity	group	C25	InjuryorPoisoning	0.30	1	2005	2005	1	0	CTD_human
val	3484	IGFBP1	0.502	0.808	C0014175	Endometriosis	disease	C13	DiseaseorSyndrome	0.36	1	2003	2012	1	0	CTD_human
val	3484	IGFBP1	0.502	0.808	C0022660	KidneyFailure,Acute	disease	C13;C12	DiseaseorSyndrome	0.30	1	1995	1995	1	0	CTD_human
val	3484	IGFBP1	0.502	0.808	C0023890	LiverCirrhosis	disease	C23;C06	DiseaseorSyndrome	0.33	0.75	1994	2018	1	0	CTD_human
val	3484	IGFBP1	0.502	0.808	C0023892	Biliarycirrhosis	disease	C23;C06	DiseaseorSyndrome	0.30	1	2008	2008	1	0	CTD_human
val	3484	IGFBP1	0.502	0.808	C0023893	LiverCirrhosis,Experimental	disease	C23;C06	ExperimentalModelofDisease	0.30	1	2006	2014	2	0	CTD_human
val	3484	IGFBP1	0.502	0.808	C0032927	PrecancerousConditions	group	C04	NeoplasticProcess	0.30	1	2003	2003	1	0	CTD_human
val	3484	IGFBP1	0.502	0.808	C0041755	Adversereactiontodrug	group	C25	PathologicFunction	0.30	1	2005	2005	1	0	CTD_human
val	3484	IGFBP1	0.502	0.808	C0175693	Russell-Silversyndrome	disease	C16;C05	DiseaseorSyndrome	0.33	1	1999	1999	1	0	GENOMICS_ENGLAND
val	3484	IGFBP1	0.502	0.808	C0238065	SecondaryBiliaryCholangitis	disease	C23;C06	DiseaseorSyndrome	0.30	1	2008	2008	1	0	CTD_human
val	3484	IGFBP1	0.502	0.808	C0239946	Fibrosis,Liver	disease	C23;C06	DiseaseorSyndrome	0.30	1	2016	2016	1	0	CTD_human
val	3484	IGFBP1	0.502	0.808	C0269102	Endometrioma	disease	C13	NeoplasticProcess	0.32	0.667	2010	2012	1	0	CTD_human
val	3484	IGFBP1	0.502	0.808	C0282313	Condition,Preneoplastic	disease	C04	NeoplasticProcess	0.30	1	2003	2003	1	0	CTD_human
val	3484	IGFBP1	0.502	0.808	C1565662	AcuteKidneyInsufficiency	disease	C13;C12	DiseaseorSyndrome	0.30	1	1995	1995	1	0	CTD_human
val	3484	IGFBP1	0.502	0.808	C2609414	Acutekidneyinjury	disease	C13;C12	InjuryorPoisoning	0.30	1	1995	1995	1	0	CTD_human
val	3484	IGFBP1	0.502	0.808	C3830362	EarlyPregnancyLoss	phenotype	C13	Finding	0.30	1	2008	2008	1	0	CTD_human
val	3484	IGFBP1	0.502	0.808	C4551595	BiliaryCirrhosis,Primary,1	disease	C23;C06	DiseaseorSyndrome	0.30	1	2008	2008	1	0	CTD_human
val	3484	IGFBP1	0.502	0.808	C4552766	Miscarriage	disease	C13	DiseaseorSyndrome	0.31	1	2008	2011	1	0	CTD_human
val	3485	IGFBP2	0.478	0.769	C0005586	BipolarDisorder	disease	F03	MentalorBehavioralDysfunction	0.35	0.667	2005	2018	3	0	PSYGENET
val	3485	IGFBP2	0.478	0.769	C0010606	AdenoidCysticCarcinoma	disease	C04	NeoplasticProcess	0.31	1	2006	2018	1	0	CTD_human
val	3485	IGFBP2	0.478	0.769	C0011616	ContactDermatitis	disease	C17	DiseaseorSyndrome	0.30	1	2015	2015	1	0	CTD_human
val	3485	IGFBP2	0.478	0.769	C0021655	InsulinResistance	phenotype	C18	PathologicFunction	0.30	1	2012	2012	1	0	CTD_human
val	3485	IGFBP2	0.478	0.769	C0023890	LiverCirrhosis	disease	C23;C06	DiseaseorSyndrome	0.30	1	2016	2016	1	0	CTD_human
val	3485	IGFBP2	0.478	0.769	C0023893	LiverCirrhosis,Experimental	disease	C23;C06	ExperimentalModelofDisease	0.30	1	2006	2014	2	0	CTD_human
val	3485	IGFBP2	0.478	0.769	C0028754	Obesity	disease	C23;C18	DiseaseorSyndrome	0.34	1	2010	2019	1	0	CTD_human
val	3485	IGFBP2	0.478	0.769	C0036095	SalivaryGlandNeoplasms	group	C04;C07	NeoplasticProcess	0.30	1	2006	2006	1	0	CTD_human
val	3485	IGFBP2	0.478	0.769	C0162351	Contacthypersensitivity	phenotype	C17	PathologicFunction	0.30	1	2015	2015	1	0	CTD_human
val	3485	IGFBP2	0.478	0.769	C0220636	Malignantneoplasmofsalivarygland	disease	C04;C07	NeoplasticProcess	0.30	1	2006	2006	1	0	CTD_human
val	3485	IGFBP2	0.478	0.769	C0239946	Fibrosis,Liver	disease	C23;C06	DiseaseorSyndrome	0.30	1	2016	2016	1	0	CTD_human
val	3485	IGFBP2	0.478	0.769	C0920563	InsulinSensitivity	phenotype	C18	PathologicFunction	0.30	1	2012	2012	1	0	CTD_human
val	3486	IGFBP3	0.439	0.808	C0000786	Spontaneousabortion	phenotype	C13	PathologicFunction	0.30	1	2008	2008	1	0	CTD_human
val	3486	IGFBP3	0.439	0.808	C0000822	Abortion,Tubal	phenotype	C13	PathologicFunction	0.30	1	2008	2008	1	0	CTD_human
val	3486	IGFBP3	0.439	0.808	C0003873	RheumatoidArthritis	disease	C17;C05;C20	DiseaseorSyndrome	0.34	0.75	2007	2019	1	0	CTD_human
val	3486	IGFBP3	0.439	0.808	C0004352	AutisticDisorder	disease	F03	MentalorBehavioralDysfunction	0.30	1	2007	2007	1	0	CTD_human
val	3486	IGFBP3	0.439	0.808	C0005684	Malignantneoplasmofurinarybladder	disease	C04;C13;C12	NeoplasticProcess	0.32	1	2011	2012	1	0	CTD_human
val	3486	IGFBP3	0.439	0.808	C0005695	BladderNeoplasm	disease	C04;C13;C12	NeoplasticProcess	0.33	1	2006	2011	1	0	CTD_human
val	3486	IGFBP3	0.439	0.808	C0007138	Carcinoma,TransitionalCell	disease	C04	NeoplasticProcess	0.31	1	2007	2011	1	0	CTD_human
val	3486	IGFBP3	0.439	0.808	C0009402	ColorectalCarcinoma	disease	C06;C04	NeoplasticProcess	0.60	0.815	2004	2019	1	1	CTD_human;UNIPROT
val	3486	IGFBP3	0.439	0.808	C0009404	ColorectalNeoplasms	group	C06;C04	NeoplasticProcess	0.32	1	2005	2011	1	0	CTD_human
val	3486	IGFBP3	0.439	0.808	C0023893	LiverCirrhosis,Experimental	disease	C23;C06	ExperimentalModelofDisease	0.30	1	2014	2014	1	0	CTD_human
val	3486	IGFBP3	0.439	0.808	C0024623	Malignantneoplasmofstomach	disease	C06;C04	NeoplasticProcess	0.37	1	2004	2017	1	0	CTD_human
val	3486	IGFBP3	0.439	0.808	C0033578	ProstaticNeoplasms	group	C04;C12	NeoplasticProcess	0.40	1	2002	2014	3	0	CTD_human
val	3486	IGFBP3	0.439	0.808	C0038356	StomachNeoplasms	group	C06;C04	NeoplasticProcess	0.32	1	2002	2008	1	0	CTD_human
val	3486	IGFBP3	0.439	0.808	C0151744	MyocardialIschemia	disease	C14	DiseaseorSyndrome	0.32	1	2000	2005	1	0	CTD_human
val	3486	IGFBP3	0.439	0.808	C0175693	Russell-Silversyndrome	disease	C16;C05	DiseaseorSyndrome	0.34	1	1999	2017	1	0	GENOMICS_ENGLAND
val	3486	IGFBP3	0.439	0.808	C0376358	Malignantneoplasmofprostate	disease	C04;C12	NeoplasticProcess	0.40	0.943	1996	2018	3	0	CTD_human
val	3486	IGFBP3	0.439	0.808	C1708349	HereditaryDiffuseGastricCancer	disease	C06;C04	NeoplasticProcess	0.30	1	2006	2006	1	0	CTD_human
val	3486	IGFBP3	0.439	0.808	C3830362	EarlyPregnancyLoss	phenotype	C13	Finding	0.30	1	2008	2008	1	0	CTD_human
val	3486	IGFBP3	0.439	0.808	C4552766	Miscarriage	disease	C13	DiseaseorSyndrome	0.30	1	2008	2008	1	0	CTD_human
val	3488	IGFBP5	0.544	0.692	C0005684	Malignantneoplasmofurinarybladder	disease	C04;C13;C12	NeoplasticProcess	0.32	1	2015	2017	1	0	CTD_human
val	3488	IGFBP5	0.544	0.692	C0005695	BladderNeoplasm	disease	C04;C13;C12	NeoplasticProcess	0.32	1	2015	2017	1	0	CTD_human
val	3488	IGFBP5	0.544	0.692	C0006142	Malignantneoplasmofbreast	disease	C04;C17	NeoplasticProcess	0.40	0.941	1996	2018	1	0	CTD_human
val	3488	IGFBP5	0.544	0.692	C0043094	WeightGain	phenotype	C23	Finding	0.30	1	2008	2008	1	0	CTD_human
val	3488	IGFBP5	0.544	0.692	C0678222	BreastCarcinoma	disease	C04;C17	NeoplasticProcess	0.40	0.938	1993	2018	1	0	CTD_human
val	3488	IGFBP5	0.544	0.692	C1257931	MammaryNeoplasms,Human	disease	C04;C17	NeoplasticProcess	0.30	1	2010	2010	1	0	CTD_human
val	3488	IGFBP5	0.544	0.692	C1458155	MammaryNeoplasms	group	C04;C17	NeoplasticProcess	0.33	1	2003	2010	1	0	CTD_human
val	3488	IGFBP5	0.544	0.692	C4704874	MammaryCarcinoma,Human	disease	C04;C17	NeoplasticProcess	0.30	1	2010	2010	1	0	CTD_human
val	3489	IGFBP6	0.601	0.692	C0000786	Spontaneousabortion	phenotype	C13	PathologicFunction	0.30	1	2008	2008	1	0	CTD_human
val	3489	IGFBP6	0.601	0.692	C0000822	Abortion,Tubal	phenotype	C13	PathologicFunction	0.30	1	2008	2008	1	0	CTD_human
val	3489	IGFBP6	0.601	0.692	C0011616	ContactDermatitis	disease	C17	DiseaseorSyndrome	0.30	1	2015	2015	1	0	CTD_human
val	3489	IGFBP6	0.601	0.692	C0014175	Endometriosis	disease	C13	DiseaseorSyndrome	0.30	1	2011	2011	1	0	CTD_human
val	3489	IGFBP6	0.601	0.692	C0033578	ProstaticNeoplasms	group	C04;C12	NeoplasticProcess	0.30	1	2005	2005	1	0	CTD_human
val	3489	IGFBP6	0.601	0.692	C0035222	RespiratoryDistressSyndrome,Adult	disease	C08	DiseaseorSyndrome	0.30	1	2014	2014	1	0	CTD_human
val	3489	IGFBP6	0.601	0.692	C0162351	Contacthypersensitivity	phenotype	C17	PathologicFunction	0.30	1	2015	2015	1	0	CTD_human
val	3489	IGFBP6	0.601	0.692	C0269102	Endometrioma	disease	C13	NeoplasticProcess	0.30	1	2011	2011	1	0	CTD_human
val	3489	IGFBP6	0.601	0.692	C0376358	Malignantneoplasmofprostate	disease	C04;C12	NeoplasticProcess	0.31	1	2005	2005	1	0	CTD_human
val	3489	IGFBP6	0.601	0.692	C3830362	EarlyPregnancyLoss	phenotype	C13	Finding	0.30	1	2008	2008	1	0	CTD_human
val	3489	IGFBP6	0.601	0.692	C4552766	Miscarriage	disease	C13	DiseaseorSyndrome	0.30	1	2008	2008	1	0	CTD_human
val	3490	IGFBP7	0.476	0.769	C0006142	Malignantneoplasmofbreast	disease	C04;C17	NeoplasticProcess	0.40	1	1998	2017	1	0	CTD_human
val	3490	IGFBP7	0.476	0.769	C0023893	LiverCirrhosis,Experimental	disease	C23;C06	ExperimentalModelofDisease	0.30	1	2014	2014	1	0	CTD_human
val	3490	IGFBP7	0.476	0.769	C0024623	Malignantneoplasmofstomach	disease	C06;C04	NeoplasticProcess	0.34	1	2006	2018	1	0	CTD_human
val	3490	IGFBP7	0.476	0.769	C0033578	ProstaticNeoplasms	group	C04;C12	NeoplasticProcess	0.32	1	2003	2003	1	0	CTD_human
val	3490	IGFBP7	0.476	0.769	C0038356	StomachNeoplasms	group	C06;C04	NeoplasticProcess	0.30	1	2006	2006	1	0	CTD_human
val	3490	IGFBP7	0.476	0.769	C0376358	Malignantneoplasmofprostate	disease	C04;C12	NeoplasticProcess	0.37	1	1999	2012	1	0	CTD_human
val	3490	IGFBP7	0.476	0.769	C0678222	BreastCarcinoma	disease	C04;C17	NeoplasticProcess	0.38	1	1998	2017	1	0	CTD_human
val	3490	IGFBP7	0.476	0.769	C1257931	MammaryNeoplasms,Human	disease	C04;C17	NeoplasticProcess	0.30	1	2003	2003	1	0	CTD_human
val	3490	IGFBP7	0.476	0.769	C1458155	MammaryNeoplasms	group	C04;C17	NeoplasticProcess	0.34	1	2002	2018	1	0	CTD_human
val	3490	IGFBP7	0.476	0.769	C1708349	HereditaryDiffuseGastricCancer	disease	C06;C04	NeoplasticProcess	0.30	1	2006	2006	1	0	CTD_human
val	3490	IGFBP7	0.476	0.769	C3280205	RETINALARTERIALMACROANEURYSMWITHSUPRAVALVULARPULMONICSTENOSIS	disease		DiseaseorSyndrome	0.51	1	2002	2020	2	0	GENOMICS_ENGLAND;ORPHANET
val	3490	IGFBP7	0.476	0.769	C4704874	MammaryCarcinoma,Human	disease	C04;C17	NeoplasticProcess	0.30	1	2003	2003	1	0	CTD_human
val	3491	CCN1	0.473	0.731	C0003873	RheumatoidArthritis	disease	C17;C05;C20	DiseaseorSyndrome	0.40	0.929	2006	2019	1	0	CTD_human
val	3491	CCN1	0.473	0.731	C0024121	LungNeoplasms	group	C04;C08	NeoplasticProcess	0.31	1	2007	2017	1	0	CTD_human
val	3491	CCN1	0.473	0.731	C0036421	SystemicScleroderma	disease	C17	DiseaseorSyndrome	0.33	1	1998	2019	1	0	CTD_human
val	3491	CCN1	0.473	0.731	C0242379	Malignantneoplasmoflung	disease	C04;C08	NeoplasticProcess	0.33	1	2007	2018	1	0	CTD_human
val	3491	CCN1	0.473	0.731	C2239176	Livercarcinoma	disease	C06;C04	NeoplasticProcess	0.38	1	2004	2018	1	0	CTD_human
val	3492	IGH	0.473	0.654	C0006413	BurkittLymphoma	disease	C04;C01;C20;C15	NeoplasticProcess	0.40	1	1991	2020	1	0	ORPHANET
val	3492	IGH	0.473	0.654	C0024301	Lymphoma,Follicular	disease	C04;C20;C15	NeoplasticProcess	0.40	0.935	1990	2020	1	0	ORPHANET
val	3492	IGH	0.473	0.654	C0242647	Mucosa-AssociatedLymphoidTissueLymphoma	disease	C04;C20;C15	NeoplasticProcess	0.40	0.97	1996	2019	1	0	ORPHANET
val	3492	IGH	0.473	0.654	C0555202	Malignantlymphoma-lymphocytic,intermediatedifferentiation	disease		NeoplasticProcess	0.30	1	2001	2002	2	0	ORPHANET
val	3492	IGH	0.473	0.654	C1292769	PrecursorB-celllymphoblasticleukemia	disease	C04;C20;C15	NeoplasticProcess	0.40	1	1991	2019	1	0	ORPHANET
val	3500	IGHG1	0.7	0.5	C0023434	ChronicLymphocyticLeukemia	disease	C04;C20;C15	NeoplasticProcess	0.30				0	0	ORPHANET
val	3500	IGHG1	0.7	0.5	C0027121	Myositis	disease	C05;C10	DiseaseorSyndrome	0.30	1	2008	2008	1	0	CTD_human
val	3500	IGHG1	0.7	0.5	C0032460	PolycysticOvarySyndrome	disease	C04;C13;C19	DiseaseorSyndrome	0.30	1	2011	2011	1	0	CTD_human
val	3500	IGHG1	0.7	0.5	C0158353	InfectiousMyositis	disease	C05;C10	DiseaseorSyndrome	0.30	1	2008	2008	1	0	CTD_human
val	3500	IGHG1	0.7	0.5	C0544796	Myositis,Proliferative	disease	C05;C10	DiseaseorSyndrome	0.30	1	2008	2008	1	0	CTD_human
val	3500	IGHG1	0.7	0.5	C0751356	IdiopathicInflammatoryMyopathies	disease	C05;C10	DiseaseorSyndrome	0.30	1	2008	2008	1	0	CTD_human
val	3500	IGHG1	0.7	0.5	C0751357	Myositis,Focal	disease	C05;C10	DiseaseorSyndrome	0.30	1	2008	2008	1	0	CTD_human
val	3500	IGHG1	0.7	0.5	C0855095	SmallLymphocyticLymphoma	disease	C04;C20;C15	NeoplasticProcess	0.30				0	0	ORPHANET
val	3500	IGHG1	0.7	0.5	C1136382	SclerocysticOvaries	disease	C04;C13;C19	DiseaseorSyndrome	0.30	1	2011	2011	1	0	CTD_human
val	3500	IGHG1	0.7	0.5	C1868683	B-CELLMALIGNANCY,LOW-GRADE	disease		NeoplasticProcess	0.30				0	0	ORPHANET
val	3501	IGHG2	0.76	0.192	C0027121	Myositis	disease	C05;C10	DiseaseorSyndrome	0.30	1	2008	2008	1	0	CTD_human
val	3501	IGHG2	0.76	0.192	C0158353	InfectiousMyositis	disease	C05;C10	DiseaseorSyndrome	0.30	1	2008	2008	1	0	CTD_human
val	3501	IGHG2	0.76	0.192	C0162539	IgGDeficiencydisorder	disease	C20;C15	DiseaseorSyndrome	0.30	1	1998	1998	1	0	ORPHANET
val	3501	IGHG2	0.76	0.192	C0544796	Myositis,Proliferative	disease	C05;C10	DiseaseorSyndrome	0.30	1	2008	2008	1	0	CTD_human
val	3501	IGHG2	0.76	0.192	C0751356	IdiopathicInflammatoryMyopathies	disease	C05;C10	DiseaseorSyndrome	0.30	1	2008	2008	1	0	CTD_human
val	3501	IGHG2	0.76	0.192	C0751357	Myositis,Focal	disease	C05;C10	DiseaseorSyndrome	0.30	1	2008	2008	1	0	CTD_human
val	3501	IGHG2	0.76	0.192	C3279824	Kappa-ChainDeficiency	disease	C20	DiseaseorSyndrome	0.30	1	1998	1998	1	0	ORPHANET
val	3507	IGHM	0.644	0.654	C0001768	Agammaglobulinemia	disease	C20;C15	DiseaseorSyndrome	0.60	1	2002	2002	1	0	CTD_human;GENOMICS_ENGLAND
val	3507	IGHM	0.644	0.654	C0086438	Hypogammaglobulinemia	disease	C20;C15	DiseaseorSyndrome	0.31	1	2002	2002	0	0	CTD_human
val	3507	IGHM	0.644	0.654	C1832241	Agammaglobulinemia,non-Brutontype	disease	C20;C15	DiseaseorSyndrome	0.30	1	1996	1996	1	0	ORPHANET
val	3507	IGHM	0.644	0.654	C3152144	AGAMMAGLOBULINEMIA1,AUTOSOMALRECESSIVE	disease		DiseaseorSyndrome	0.40	1	2002	2002	1	1	GENOMICS_ENGLAND
val	3507	IGHM	0.644	0.654	C4016215	AGAMMAGLOBULINEMIA1	phenotype		Finding	0.30	1	2002	2002	1	0	GENOMICS_ENGLAND
val	3508	IGHMBP2	0.636	0.615	C1858517	SPINALMUSCULARATROPHYWITHRESPIRATORYDISTRESS1	disease	C16;C08;C10	DiseaseorSyndrome	1.00	0.957	1975	2020	8	48	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
val	3508	IGHMBP2	0.636	0.615	C4015349	CHARCOT-MARIE-TOOTHDISEASE,AXONAL,TYPE2S	disease		DiseaseorSyndrome	0.70	1	1975	2017	2	32	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
val	3514	IGKC	0.7	0.423	C0013374	Dysgammaglobulinemia	disease	C20;C15	DiseaseorSyndrome	0.30	1	1985	1985	1	0	CTD_human
val	3514	IGKC	0.7	0.423	C0019209	Hepatomegaly	phenotype	C23;C06	Finding	0.30	1	2017	2017	1	0	CTD_human
val	3514	IGKC	0.7	0.423	C0027121	Myositis	disease	C05;C10	DiseaseorSyndrome	0.30	1	2008	2008	1	0	CTD_human
val	3514	IGKC	0.7	0.423	C0158353	InfectiousMyositis	disease	C05;C10	DiseaseorSyndrome	0.30	1	2008	2008	1	0	CTD_human
val	3514	IGKC	0.7	0.423	C0162539	IgGDeficiencydisorder	disease	C20;C15	DiseaseorSyndrome	0.30				0	0	ORPHANET
val	3514	IGKC	0.7	0.423	C0231221	Asymptomatic	phenotype		Finding	0.30	1	1969	1969	1	0	GENOMICS_ENGLAND
val	3514	IGKC	0.7	0.423	C0544796	Myositis,Proliferative	disease	C05;C10	DiseaseorSyndrome	0.30	1	2008	2008	1	0	CTD_human
val	3514	IGKC	0.7	0.423	C0751356	IdiopathicInflammatoryMyopathies	disease	C05;C10	DiseaseorSyndrome	0.30	1	2008	2008	1	0	CTD_human
val	3514	IGKC	0.7	0.423	C0751357	Myositis,Focal	disease	C05;C10	DiseaseorSyndrome	0.30	1	2008	2008	1	0	CTD_human
val	3514	IGKC	0.7	0.423	C3279824	Kappa-ChainDeficiency	disease	C20	DiseaseorSyndrome	0.60	1	1969	1985	2	0	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
val	3516	RBPJ	0.518	0.808	C0003873	RheumatoidArthritis	disease	C17;C05;C20	DiseaseorSyndrome	0.32	1	2010	2016	2	0	CTD_human
val	3516	RBPJ	0.518	0.808	C0014175	Endometriosis	disease	C13	DiseaseorSyndrome	0.30	1	2012	2012	1	0	CTD_human
val	3516	RBPJ	0.518	0.808	C0026769	MultipleSclerosis	disease	C20;C10	DiseaseorSyndrome	0.31	1	2011	2015	1	0	CTD_human
val	3516	RBPJ	0.518	0.808	C0265268	AdamsOliversyndrome	disease	C16;C17	DiseaseorSyndrome	0.30	1	2012	2012	1	0	ORPHANET
val	3516	RBPJ	0.518	0.808	C0269102	Endometrioma	disease	C13	NeoplasticProcess	0.30	1	2012	2012	1	0	CTD_human
val	3516	RBPJ	0.518	0.808	C0751324	MultipleSclerosis,AcuteFulminating	disease	C20;C10	DiseaseorSyndrome	0.30	1	2015	2015	1	0	CTD_human
val	3516	RBPJ	0.518	0.808	C2931779	Congenitaldefectofskullandscalp	disease	C16;C17;C05	CongenitalAbnormality	0.30				0	0	CTD_human
val	3516	RBPJ	0.518	0.808	C3553748	ADAMS-OLIVERSYNDROME3	disease		DiseaseorSyndrome	0.60	1	2012	2018	3	5	GENOMICS_ENGLAND;UNIPROT
val	3516	RBPJ	0.518	0.808	C4551482	Adams-Oliversyndrome1	disease	C16;C17;C05	DiseaseorSyndrome	0.51	1	2012	2018	2	0	CTD_human;GENOMICS_ENGLAND
val	3543	IGLL1	0.678	0.538	C0001768	Agammaglobulinemia	disease	C20;C15	DiseaseorSyndrome	0.60	1	2016	2016	1	0	CTD_human;GENOMICS_ENGLAND
val	3543	IGLL1	0.678	0.538	C0086438	Hypogammaglobulinemia	disease	C20;C15	DiseaseorSyndrome	0.30				0	0	CTD_human
val	3543	IGLL1	0.678	0.538	C1832241	Agammaglobulinemia,non-Brutontype	disease	C20;C15	DiseaseorSyndrome	0.30	1	1998	1998	1	0	ORPHANET
val	3543	IGLL1	0.678	0.538	C3150750	AGAMMAGLOBULINEMIA2,AUTOSOMALRECESSIVE	disease		DiseaseorSyndrome	0.60	1	1998	2016	2	2	GENOMICS_ENGLAND;UNIPROT
val	3547	IGSF1	0.608	0.5	C0010308	CongenitalHypothyroidism	disease	C16;C05;C19	DiseaseorSyndrome	0.50	1	2012	2012	1	0	CTD_human
val	3547	IGSF1	0.608	0.5	C0039584	TesticularDiseases	group	C12;C19	DiseaseorSyndrome	0.30	1	2012	2012	1	0	CTD_human
val	3547	IGSF1	0.608	0.5	C0271586	ProlactinDeficiency,Isolated	phenotype	C16;C13;C17	Finding	0.30	1	2013	2013	1	0	GENOMICS_ENGLAND
val	3547	IGSF1	0.608	0.5	C0271801	Centralhypothyroidism	disease	C19	DiseaseorSyndrome	0.40	1	2012	2020	1	0	GENOMICS_ENGLAND
val	3547	IGSF1	0.608	0.5	C0342200	EndemicCretinism	disease	C16;C05;C19	DiseaseorSyndrome	0.30	1	2012	2012	1	0	CTD_human
val	3547	IGSF1	0.608	0.5	C1263023	Macroorchidism	disease		Finding	0.30	1	2013	2013	1	0	GENOMICS_ENGLAND
val	3547	IGSF1	0.608	0.5	C1578691	Myxedema,Congenital	disease	C16;C05;C19	DiseaseorSyndrome;CongenitalAbnormality	0.30	1	2012	2012	1	0	CTD_human
val	3547	IGSF1	0.608	0.5	C3550963	HYPOTHYROIDISM,CENTRAL,ANDTESTICULARENLARGEMENT	disease	C23	DiseaseorSyndrome	0.90	1	2012	2015	3	5	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
val	3547	IGSF1	0.608	0.5	C3714796	Isolatedsomatotropindeficiency	disease		DiseaseorSyndrome	0.30	1	2013	2013	1	0	GENOMICS_ENGLAND
val	3549	IHH	0.573	0.538	C0010093	CorpusLuteumCyst	disease	C04;C13;C19	DiseaseorSyndrome	0.30	1	2011	2011	1	0	CTD_human
val	3549	IHH	0.573	0.538	C0014175	Endometriosis	disease	C13	DiseaseorSyndrome	0.30	1	2011	2011	1	0	CTD_human
val	3549	IHH	0.573	0.538	C0029927	OvarianCysts	disease	C04;C13;C19	DiseaseorSyndrome	0.30	1	2011	2011	1	0	CTD_human
val	3549	IHH	0.573	0.538	C0238198	GastrointestinalStromalTumors	group	C06;C04	NeoplasticProcess	0.30	1	2016	2016	1	0	CTD_human
val	3549	IHH	0.573	0.538	C0269102	Endometrioma	disease	C13	NeoplasticProcess	0.30	1	2011	2011	1	0	CTD_human
val	3549	IHH	0.573	0.538	C0878659	Disproportionateshortstature	phenotype	C16;C05;C19	Finding	0.40				0	0	GENOMICS_ENGLAND
val	3549	IHH	0.573	0.538	C1843096	AcrocapitofemoralDysplasia	disease	C23;C16;C05	DiseaseorSyndrome	0.71	1	2003	2015	3	2	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
val	3549	IHH	0.573	0.538	C1861380	Syndactyly,TypeI	disease	C16;C05	DiseaseorSyndrome	0.30	1	2011	2011	1	0	GENOMICS_ENGLAND
val	3549	IHH	0.573	0.538	C1862151	BRACHYDACTYLY,TYPEA1(disorder)	disease	C16;C05	DiseaseorSyndrome	0.96	0.9	2001	2019	6	8	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
val	3549	IHH	0.573	0.538	C1863307	AcropectorovertebralDysplasia,F-Form	disease	C16;C05	DiseaseorSyndrome	0.30	1	2015	2015	1	0	GENOMICS_ENGLAND
val	3549	IHH	0.573	0.538	C3179349	GastrointestinalStromalSarcoma	disease	C06;C04	NeoplasticProcess	0.30	1	2016	2016	1	0	CTD_human
val	3551	IKBKB	0.506	0.846	C0006142	Malignantneoplasmofbreast	disease	C04;C17	NeoplasticProcess	0.38	1	2011	2019	0	0	UNIPROT
val	3551	IKBKB	0.506	0.846	C0020538	Hypertensivedisease	group	C14	DiseaseorSyndrome	0.50	1	2009	2016	1	0	CTD_human
val	3551	IKBKB	0.506	0.846	C0024305	Lymphoma,Non-Hodgkin	disease	C04;C20;C15	NeoplasticProcess	0.30				0	0	CGI
val	3551	IKBKB	0.506	0.846	C0032285	Pneumonia	disease	C01;C08	DiseaseorSyndrome	0.54	1	2010	2019	1	0	CTD_human
val	3551	IKBKB	0.506	0.846	C0032300	LobarPneumonia	disease	C01;C08	DiseaseorSyndrome	0.30	1	2019	2019	1	0	CTD_human
val	3551	IKBKB	0.506	0.846	C0271650	Impairedglucosetolerance	phenotype	C18	DiseaseorSyndrome	0.32	1	2017	2019	1	0	CTD_human
val	3551	IKBKB	0.506	0.846	C0494261	Combinedimmunodeficiency	disease	C16;C18;C20	DiseaseorSyndrome	0.31	1	2014	2014	1	0	GENOMICS_ENGLAND
val	3551	IKBKB	0.506	0.846	C0857007	Hyperbilirubinemia,Neonatal	disease	C23;C16	DiseaseorSyndrome	0.30	1	2017	2017	1	0	CTD_human
val	3551	IKBKB	0.506	0.846	C0887898	ExperimentalLungInflammation	disease	C01;C08	ExperimentalModelofDisease	0.30	1	2019	2019	1	0	CTD_human
val	3551	IKBKB	0.506	0.846	C1565885	DirectHyperbilirubinemia,Neonatal	phenotype	C23;C16	DiseaseorSyndrome	0.30	1	2017	2017	1	0	CTD_human
val	3551	IKBKB	0.506	0.846	C1565886	IndirectHyperbilirubinemia,Neonatal	disease	C23;C16	DiseaseorSyndrome	0.30	1	2017	2017	1	0	CTD_human
val	3551	IKBKB	0.506	0.846	C3714636	Pneumonitis	disease	C01;C08	DiseaseorSyndrome	0.33	1	2017	2019	1	0	CTD_human
val	3551	IKBKB	0.506	0.846	C4747743	IMMUNODEFICIENCY15B	disease		DiseaseorSyndrome	0.60	1	2013	2014	2	0	CTD_human;GENOMICS_ENGLAND;ORPHANET
val	3551	IKBKB	0.506	0.846	C4748694	IMMUNODEFICIENCY15A	disease		DiseaseorSyndrome	0.40	1	2018	2018	1	1	UNIPROT
val	3552	IL1A	0.333	0.962	C0002622	Amnesia	disease	C23;C10;F03;F01	MentalorBehavioralDysfunction	0.30	1	1993	1993	1	0	CTD_human
val	3552	IL1A	0.333	0.962	C0002631	Infectionofamnioticcavity	disease	C16;C13	DiseaseorSyndrome	0.30	1	2011	2011	1	0	CTD_human
val	3552	IL1A	0.333	0.962	C0003165	Anthracosis	disease	C08	DiseaseorSyndrome	0.31	1	2011	2011	1	0	CTD_human
val	3552	IL1A	0.333	0.962	C0007114	Malignantneoplasmofskin	disease	C04;C17	NeoplasticProcess	0.30	1	1993	1993	1	0	CTD_human
val	3552	IL1A	0.333	0.962	C0007786	BrainIschemia	disease	C10;C14	DiseaseorSyndrome	0.30	1	2005	2005	1	0	CTD_human
val	3552	IL1A	0.333	0.962	C0008495	Chorioamnionitis	phenotype	C16;C13	DiseaseorSyndrome	0.32	1	2011	2018	1	0	CTD_human
val	3552	IL1A	0.333	0.962	C0011570	MentalDepression	disease	F01	MentalorBehavioralDysfunction	0.39	0.8	1999	2019	5	0	PSYGENET
val	3552	IL1A	0.333	0.962	C0011581	Depressivedisorder	disease	F03	MentalorBehavioralDysfunction	0.39	0.8	1999	2019	5	0	PSYGENET
val	3552	IL1A	0.333	0.962	C0011633	Dermatomyositis	disease	C17;C05;C10	DiseaseorSyndrome	0.32	1	2007	2008	1	0	CTD_human
val	3552	IL1A	0.333	0.962	C0011991	Diarrhea	phenotype	C23	SignorSymptom	0.31	1	1997	2018	1	0	CTD_human
val	3552	IL1A	0.333	0.962	C0015967	Fever	phenotype	C23	SignorSymptom	0.40	0.955	1986	2019	1	0	CTD_human
val	3552	IL1A	0.333	0.962	C0019061	Hemolytic-UremicSyndrome	disease	C13;C12;C15	DiseaseorSyndrome	0.30	1	2004	2004	1	0	CTD_human
val	3552	IL1A	0.333	0.962	C0019193	Hepatitis,Toxic	disease	C06;C25	InjuryorPoisoning	0.30	1	1993	1993	1	0	CTD_human
val	3552	IL1A	0.333	0.962	C0020429	Hyperalgesia	phenotype	C23;C10	SignorSymptom	0.32	1	2003	2018	1	0	CTD_human
val	3552	IL1A	0.333	0.962	C0020649	Hypotension	phenotype	C14	Finding	0.30	1	2004	2004	1	0	CTD_human
val	3552	IL1A	0.333	0.962	C0021368	Inflammation	phenotype	C23	PathologicFunction	0.30	1	2011	2011	2	0	CTD_human
val	3552	IL1A	0.333	0.962	C0022541	Kearns-Sayresyndrome	disease	C23;C18;C11;C05;C10;C14	DiseaseorSyndrome	0.30	1	1994	1994	1	0	CTD_human
val	3552	IL1A	0.333	0.962	C0033141	Cardiomyopathies,Primary	group	C14	DiseaseorSyndrome	0.30	1	1994	1994	1	0	CTD_human
val	3552	IL1A	0.333	0.962	C0035126	ReperfusionInjury	disease	C23;C14	InjuryorPoisoning	0.30	1	2014	2014	1	0	CTD_human
val	3552	IL1A	0.333	0.962	C0036529	MyocardialDiseases,Secondary	group	C14	DiseaseorSyndrome	0.30	1	1994	1994	1	0	CTD_human
val	3552	IL1A	0.333	0.962	C0037274	Dermatologicdisorders	group	C17	DiseaseorSyndrome	0.38	0.9	2006	2019	2	0	CTD_human
val	3552	IL1A	0.333	0.962	C0037286	SkinNeoplasms	group	C04;C17	NeoplasticProcess	0.30	1	1993	1993	1	0	CTD_human
val	3552	IL1A	0.333	0.962	C0042900	Vitiligo	disease	C17	DiseaseorSyndrome	0.31	1	2009	2017	1	0	CTD_human
val	3552	IL1A	0.333	0.962	C0085655	Polymyositis	disease	C05;C10	DiseaseorSyndrome	0.31	1	1994	2007	1	0	CTD_human
val	3552	IL1A	0.333	0.962	C0151744	MyocardialIschemia	disease	C14	DiseaseorSyndrome	0.32	1	2000	2017	1	0	CTD_human
val	3552	IL1A	0.333	0.962	C0162668	MegaconialMyopathies	disease	C18;C05;C10	DiseaseorSyndrome	0.30	1	1994	1994	1	0	CTD_human
val	3552	IL1A	0.333	0.962	C0162669	PleoconialMyopathies	disease	C18;C05;C10	DiseaseorSyndrome	0.30	1	1994	1994	1	0	CTD_human
val	3552	IL1A	0.333	0.962	C0162670	MitochondrialMyopathies	group	C18;C05;C10	DiseaseorSyndrome	0.30	1	1994	1994	1	0	CTD_human
val	3552	IL1A	0.333	0.962	C0162671	MELASSyndrome	disease	C16;C18;C05;C10;C14	DiseaseorSyndrome	0.30	1	1994	1994	1	0	CTD_human
val	3552	IL1A	0.333	0.962	C0162672	MERRFSyndrome	disease	C16;C18;C05;C10	DiseaseorSyndrome	0.30	1	1994	1994	1	0	CTD_human
val	3552	IL1A	0.333	0.962	C0162674	Chronicprogressiveexternalophthalmoplegia	disease	C23;C18;C11;C05;C10	DiseaseorSyndrome	0.30	1	1994	1994	1	0	CTD_human
val	3552	IL1A	0.333	0.962	C0162820	Dermatitis,AllergicContact	disease	C17;C20	DiseaseorSyndrome	0.31	0.5	2013	2017	1	0	CTD_human
val	3552	IL1A	0.333	0.962	C0206637	MesenchymalChondrosarcoma	disease	C04	NeoplasticProcess	0.30	1	2003	2003	1	0	CTD_human
val	3552	IL1A	0.333	0.962	C0221056	Adulttypedermatomyositis	disease	C17;C05;C10	DiseaseorSyndrome	0.31	1	2007	2008	1	0	CTD_human
val	3552	IL1A	0.333	0.962	C0233750	Hystericalamnesia	phenotype	C23;C10;F03;F01	MentalorBehavioralDysfunction	0.30	1	1993	1993	1	0	CTD_human
val	3552	IL1A	0.333	0.962	C0233796	TemporaryAmnesia	phenotype	C23;C10;F03;F01	MentalorBehavioralDysfunction	0.30	1	1993	1993	1	0	CTD_human
val	3552	IL1A	0.333	0.962	C0235874	DiseaseExacerbation	phenotype	C23	Finding	0.30	1	2016	2016	1	0	CTD_human
val	3552	IL1A	0.333	0.962	C0236795	DissociativeAmnesia	phenotype	C23;C10;F03;F01	MentalorBehavioralDysfunction	0.30	1	1993	1993	1	0	CTD_human
val	3552	IL1A	0.333	0.962	C0262497	GlobalAmnesia	phenotype	C23;C10;F03;F01	MentalorBehavioralDysfunction	0.30	1	1993	1993	1	0	CTD_human
val	3552	IL1A	0.333	0.962	C0263666	Dermatomyositis,ChildhoodType	disease	C17;C05;C10	DiseaseorSyndrome	0.31	1	2008	2008	1	0	CTD_human
val	3552	IL1A	0.333	0.962	C0263984	PolymyositisOssificans	disease	C05;C10	DiseaseorSyndrome	0.30	1	1994	1994	1	0	CTD_human
val	3552	IL1A	0.333	0.962	C0274861	ArsenicPoisoning,Inorganic	disease	C10;C25	InjuryorPoisoning	0.30	1	2006	2006	1	0	CTD_human
val	3552	IL1A	0.333	0.962	C0274862	NervousSystem,OrganicArsenicPoisoning	disease	C10;C25	InjuryorPoisoning	0.30	1	2006	2006	1	0	CTD_human
val	3552	IL1A	0.333	0.962	C0311375	ArsenicPoisoning	disease	C10;C25	InjuryorPoisoning	0.30	1	2006	2006	1	0	CTD_human
val	3552	IL1A	0.333	0.962	C0343755	HIVWastingSyndrome	disease	C18;C01;C20	DiseaseorSyndrome	0.30	1	1994	1994	1	0	CTD_human
val	3552	IL1A	0.333	0.962	C0345967	Malignantmesothelioma	disease	C04;C08	NeoplasticProcess	0.31	1	2014	2015	1	0	CTD_human
val	3552	IL1A	0.333	0.962	C0400966	Non-alcoholicFattyLiverDisease	disease	C06	DiseaseorSyndrome	0.33	1	2011	2019	1	0	CTD_human
val	3552	IL1A	0.333	0.962	C0458247	Allodynia	phenotype	C23;C10	Finding	0.30	1	2003	2003	1	0	CTD_human
val	3552	IL1A	0.333	0.962	C0554591	Polymyositis,Idiopathic	disease	C05;C10	DiseaseorSyndrome	0.30	1	1994	1994	1	0	CTD_human
val	3552	IL1A	0.333	0.962	C0750906	TactileAmnesia	phenotype	C23;C10;F03;F01	MentalorBehavioralDysfunction	0.30	1	1993	1993	1	0	CTD_human
val	3552	IL1A	0.333	0.962	C0750907	AmnesticState	phenotype	C23;C10;F03;F01	MentalorBehavioralDysfunction	0.30	1	1993	1993	1	0	CTD_human
val	3552	IL1A	0.333	0.962	C0751211	Hyperalgesia,Primary	phenotype	C23;C10	SignorSymptom	0.30	1	2003	2003	1	0	CTD_human
val	3552	IL1A	0.333	0.962	C0751212	Hyperalgesia,Secondary	phenotype	C23;C10	SignorSymptom	0.30	1	2003	2003	1	0	CTD_human
val	3552	IL1A	0.333	0.962	C0751213	TactileAllodynia	phenotype	C23;C10	SignorSymptom	0.30	1	2003	2003	1	0	CTD_human
val	3552	IL1A	0.333	0.962	C0751214	Hyperalgesia,Thermal	phenotype	C23;C10	SignorSymptom	0.30	1	2003	2003	1	0	CTD_human
val	3552	IL1A	0.333	0.962	C0751851	ArsenicEncephalopathy	disease	C10;C25	DiseaseorSyndrome	0.30	1	2006	2006	1	0	CTD_human
val	3552	IL1A	0.333	0.962	C0751852	ArsenicInducedPolyneuropathy	disease	C10;C25	InjuryorPoisoning	0.30	1	2006	2006	1	0	CTD_human
val	3552	IL1A	0.333	0.962	C0860207	Drug-InducedLiverDisease	phenotype	C06;C25	DiseaseorSyndrome	0.32	1	1993	2017	1	0	CTD_human
val	3552	IL1A	0.333	0.962	C0878544	Cardiomyopathies	group	C14	DiseaseorSyndrome	0.32	1	1994	2007	1	0	CTD_human
val	3552	IL1A	0.333	0.962	C0917796	OpticAtrophy,Hereditary,Leber	disease	C16;C18;C11;C10	DiseaseorSyndrome	0.30	1	1994	1994	1	0	CTD_human
val	3552	IL1A	0.333	0.962	C0917798	CerebralIschemia	disease	C10;C14	PathologicFunction	0.30	1	2005	2005	1	0	CTD_human
val	3552	IL1A	0.333	0.962	C0949496	LuftDisease	disease	C18;C05;C10	DiseaseorSyndrome	0.30	1	1994	1994	1	0	CTD_human
val	3552	IL1A	0.333	0.962	C1168401	Squamouscellcarcinomaoftheheadandneck	disease	C04	NeoplasticProcess	0.36	1	1996	2019	1	0	CTD_human
val	3552	IL1A	0.333	0.962	C1262760	Hepatitis,Drug-Induced	disease	C06;C25	DiseaseorSyndrome	0.30	1	1993	1993	1	0	CTD_human
val	3552	IL1A	0.333	0.962	C1275592	Funisitis(disorder)	disease	C16;C13	DiseaseorSyndrome	0.30	1	2011	2011	1	0	CTD_human
val	3552	IL1A	0.333	0.962	C2936719	MechanicalAllodynia	phenotype	C23;C10	SignorSymptom	0.30	1	2003	2003	1	0	CTD_human
val	3552	IL1A	0.333	0.962	C3241937	NonalcoholicSteatohepatitis	disease	C06	DiseaseorSyndrome	0.31	1	2011	2011	1	0	CTD_human
val	3552	IL1A	0.333	0.962	C3658290	Drug-InducedAcuteLiverInjury	disease	C06;C25	DiseaseorSyndrome	0.30	1	1993	1993	1	0	CTD_human
val	3552	IL1A	0.333	0.962	C4277682	ChemicalandDrugInducedLiverInjury	disease	C06;C25	DiseaseorSyndrome	0.30	1	1993	1993	1	0	CTD_human
val	3552	IL1A	0.333	0.962	C4279912	Chemically-InducedLiverToxicity	disease	C06;C25	DiseaseorSyndrome	0.30	1	1993	1993	1	0	CTD_human
val	3553	IL1B	0.276	0.962	C0000786	Spontaneousabortion	phenotype	C13	PathologicFunction	0.30	1	2008	2008	1	0	CTD_human
val	3553	IL1B	0.276	0.962	C0000822	Abortion,Tubal	phenotype	C13	PathologicFunction	0.30	1	2008	2008	1	0	CTD_human
val	3553	IL1B	0.276	0.962	C0001418	Adenocarcinoma	group	C04	NeoplasticProcess	0.35	1	1995	2018	1	0	CTD_human
val	3553	IL1B	0.276	0.962	C0001973	AlcoholicIntoxication,Chronic	disease	C25;F03	MentalorBehavioralDysfunction	0.33	0.75	2005	2018	4	0	PSYGENET
val	3553	IL1B	0.276	0.962	C0002152	AlloxanDiabetes	disease	C18;C19	ExperimentalModelofDisease	0.30	1	2002	2002	1	0	CTD_human
val	3553	IL1B	0.276	0.962	C0002395	AlzheimersDisease	disease	C10;F03	DiseaseorSyndrome	0.6	0.966	1989	2020	1	0	CTD_human
12054	3553	IL1B	0.276	0.962	C0003123	Anorexia	disease	C23	DiseaseorSyndrome	0.53	1	2012	2017	1	0	CTD_human
12067	3553	IL1B	0.276	0.962	C0009319	Colitis	disease	C06	DiseaseorSyndrome	0.6	1	2000	2020	2	0	CTD_human
12068	3553	IL1B	0.276	0.962	C0009324	UlcerativeColitis	disease	C06	DiseaseorSyndrome	0.6	0.959	1992	2020	4	0	CTD_human
12071	3553	IL1B	0.276	0.962	C0011570	MentalDepression	disease	F01	MentalorBehavioralDysfunction	0.6	0.8	1999	2020	5	0	PSYGENET
12077	3553	IL1B	0.276	0.962	C0015967	Fever	phenotype	C23	SignorSymptom	0.6	0.98	1986	2019	5	0	CTD_human
12081	3553	IL1B	0.276	0.962	C0017658	Glomerulonephritis	disease	C13;C12	DiseaseorSyndrome	0.55	1	1993	2017	2	0	CTD_human
12089	3553	IL1B	0.276	0.962	C0020429	Hyperalgesia	phenotype	C23;C10	SignorSymptom	0.6	1	1995	2019	6	0	CTD_human
12092	3553	IL1B	0.276	0.962	C0020538	Hypertensivedisease	group	C14	DiseaseorSyndrome	0.6	0.964	1994	2019	3	0	CTD_human
12095	3553	IL1B	0.276	0.962	C0021368	Inflammation	phenotype	C23	PathologicFunction	0.57	1	1999	2017	9	0	CTD_human
12113	3553	IL1B	0.276	0.962	C0027051	MyocardialInfarction	disease	C23;C14	DiseaseorSyndrome	0.6	1	2001	2020	3	0	CTD_human
12123	3553	IL1B	0.276	0.962	C0032285	Pneumonia	disease	C01;C08	DiseaseorSyndrome	0.6	0.975	1995	2020	1	0	CTD_human
12127	3553	IL1B	0.276	0.962	C0034069	PulmonaryFibrosis	disease	C08	DiseaseorSyndrome	0.6	1	2005	2019	2	0	CTD_human
12239	3586	IL10	0.281	0.923	C0243026	Sepsis	disease	C23;C01	DiseaseorSyndrome	0.6	0.975	2000	2019	1	0	CTD_human
12247	3593	IL12B	0.48	0.885	C0010346	CrohnDisease	disease	C06	DiseaseorSyndrome	0.6	1	2004	2018	1	0	CTD_human;GENOMICS_ENGLAND
12267	3593	IL12B	0.48	0.885	C4013948	IMMUNODEFICIENCY29	disease		DiseaseorSyndrome	0.7	1	2014	2014	1	3	CTD_human;GENOMICS_ENGLAND;ORPHANET
12272	3594	IL12RB1	0.555	0.731	C0008312	Primarybiliarycirrhosis	disease	C23;C06	DiseaseorSyndrome	0.52	1	2013	2017	0	0	ORPHANET
12274	3594	IL12RB1	0.555	0.731	C4013949	IMMUNODEFICIENCY30	disease		DiseaseorSyndrome	0.75	1	1998	2019	2	8	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
12276	3596	IL13	0.386	0.846	C0004096	Asthma	disease	C08;C20	DiseaseorSyndrome	0.7	0.982	1995	2020	1	0	CTD_human
12280	3596	IL13	0.386	0.846	C0011615	Dermatitis,Atopic	disease	C16;C17;C20	DiseaseorSyndrome	0.7	0.99	1996	2020	2	0	CTD_human
12292	3596	IL13	0.386	0.846	C0034069	PulmonaryFibrosis	disease	C08	DiseaseorSyndrome	0.56	1	1998	2019	1	0	CTD_human
12338	3605	IL17A	0.324	0.923	C0007786	BrainIschemia	disease	C10;C14	DiseaseorSyndrome	0.51	1	2005	2005	1	0	CTD_human
12339	3605	IL17A	0.324	0.923	C0009319	Colitis	disease	C06	DiseaseorSyndrome	0.6	0.979	2007	2020	1	0	CTD_human
12355	3605	IL17A	0.324	0.923	C0549463	X-LinkedLymphoproliferativeDisorder	disease	C20;C15	NeoplasticProcess	0.51	1	2010	2012	1	0	CTD_human;GENOMICS_ENGLAND
12372	3606	IL18	0.365	0.923	C0007786	BrainIschemia	disease	C10;C14	DiseaseorSyndrome	0.51	1	2002	2020	1	0	CTD_human
12388	3606	IL18	0.365	0.923	C0032285	Pneumonia	disease	C01;C08	DiseaseorSyndrome	0.51	1	2001	2019	1	0	CTD_human
12403	3606	IL18	0.365	0.923	C0524620	MetabolicSyndromeX	disease	C18	DiseaseorSyndrome	0.6	1	2006	2018	1	0	CTD_human
12477	3614	IMPDH1	0.623	0.462	C0035334	RetinitisPigmentosa	disease	C16;C11	DiseaseorSyndrome	0.7	1	2002	2020	2	1	CTD_human;GENOMICS_ENGLAND
12478	3614	IMPDH1	0.623	0.462	C0339527	LeberCongenitalAmaurosis	disease	C11	DiseaseorSyndrome	0.63	1	2006	2015	2	0	CTD_human;GENOMICS_ENGLAND;ORPHANET
12479	3614	IMPDH1	0.623	0.462	C1840284	LEBERCONGENITALAMAUROSIS11	disease	C11	DiseaseorSyndrome	0.7	1	2006	2006	1	1	CTD_human;GENOMICS_ENGLAND;UNIPROT
12480	3614	IMPDH1	0.623	0.462	C1867299	RetinitisPigmentosa10	disease	C16;C11	DiseaseorSyndrome	0.72	1	2002	2008	3	4	CTD_human;GENOMICS_ENGLAND;UNIPROT
12487	3617	IMPG1	0.722	0.154	C4015342	MACULARDYSTROPHY,VITELLIFORM,4	disease		DiseaseorSyndrome	0.6	1	2013	2013	1	4	GENOMICS_ENGLAND;UNIPROT
12519	3621	ING1	0.573	0.692	C1168401	Squamouscellcarcinomaoftheheadandneck	disease	C04	NeoplasticProcess	0.71	1	2000	2000	1	3	CGI;CTD_human;UNIPROT
12540	3627	CXCL10	0.378	0.885	C0007786	BrainIschemia	disease	C10;C14	DiseaseorSyndrome	0.51	1	2005	2018	1	0	CTD_human
12598	3630	INS	0.445	0.923	C1833104	DIABETESMELLITUS,PERMANENTNEONATAL	disease	C18;C19	DiseaseorSyndrome	1	0.955	1998	2019	6	2	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
12599	3630	INS	0.445	0.923	C1852092	DIABETESMELLITUS,INSULIN-DEPENDENT,2	disease	C18;C20;C19	DiseaseorSyndrome	0.7	1	2007	2008	2	0	CTD_human;GENOMICS_ENGLAND;UNIPROT
12606	3630	INS	0.445	0.923	C3150617	Maturity-onsetdiabetesoftheyoung,type10	disease	C18;C19	DiseaseorSyndrome	0.7	1	2007	2015	5	0	CTD_human;GENOMICS_ENGLAND;UNIPROT
12636	3636	INPPL1	0.59	0.769	C0432219	Opsismodysplasia	disease	C16;C05	DiseaseorSyndrome	0.76	1	2013	2017	3	12	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
12646	3640	INSL3	0.604	0.538	C0010417	Cryptorchidism	disease	C16;C12;C19	CongenitalAbnormality	0.9	0.857	1999	2019	5	5	CTD_human;UNIPROT
12667	3643	INSR	0.432	0.846	C1864952	HyperinsulinemicHypoglycemia,Familial,5	disease	C18	DiseaseorSyndrome	0.7	1	1994	2004	2	2	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
12677	3651	PDX1	0.53	0.654	C0011860	DiabetesMellitus,Non-Insulin-Dependent	disease	C18;C19	DiseaseorSyndrome	0.7	0.956	1998	2019	2	5	CTD_human
12681	3651	PDX1	0.53	0.654	C0342276	Maturityonsetdiabetesmellitusinyoung	disease	C18;C19	DiseaseorSyndrome	0.9	0.97	1998	2019	2	1	GENOMICS_ENGLAND;ORPHANET
12683	3651	PDX1	0.53	0.654	C1833104	DIABETESMELLITUS,PERMANENTNEONATAL	disease	C18;C19	DiseaseorSyndrome	0.61	1	2003	2017	1	4	CTD_human;ORPHANET
12684	3651	PDX1	0.53	0.654	C1833382	MATURITY-ONSETDIABETESOFTHEYOUNG,TYPEIV(disorder)	disease	C18;C19	DiseaseorSyndrome	0.83	1	1998	2018	1	6	CTD_human;GENOMICS_ENGLAND
12712	3655	ITGA6	0.539	0.769	C1856934	Epidermolysisbullosawithpyloricatresia	disease	C16;C17	DiseaseorSyndrome	0.68	1	1997	2017	2	0	CTD_human;GENOMICS_ENGLAND;ORPHANET
12717	3659	IRF1	0.468	0.769	C0024623	Malignantneoplasmofstomach	disease	C06;C04	NeoplasticProcess	0.66	1	1998	2019	0	0	CGI;CTD_human
12718	3659	IRF1	0.468	0.769	C0038356	StomachNeoplasms	group	C06;C04	NeoplasticProcess	0.6	NA	NA	NA	0	1	CGI;CTD_human
12726	3659	IRF1	0.468	0.769	C0699791	StomachCarcinoma	disease	C06;C04	NeoplasticProcess	0.65	1	1998	2019	2	2	CGI;GENOMICS_ENGLAND;UNIPROT
12733	3661	IRF3	0.517	0.808	C4225294	ENCEPHALOPATHY,ACUTE,INFECTION-INDUCED(HERPES-SPECIFIC),SUSCEPTIBILITYTO,7	phenotype		Finding	0.6	1	2015	2015	2	1	GENOMICS_ENGLAND;UNIPROT
12741	3663	IRF5	0.489	0.731	C0009324	UlcerativeColitis	disease	C06	DiseaseorSyndrome	0.57	1	2007	2019	1	0	CTD_human;GENOMICS_ENGLAND
12742	3663	IRF5	0.489	0.731	C0024141	LupusErythematosus,Systemic	disease	C17;C20	DiseaseorSyndrome	0.7	0.949	2005	2020	6	4	CTD_human;ORPHANET
12749	3664	IRF6	0.486	0.769	C0008924	Cleftupperlip	disease	C16;C07	CongenitalAbnormality	0.9	0.923	2003	2019	4	5	CTD_human;ORPHANET
12750	3664	IRF6	0.486	0.769	C0008925	CleftPalate	disease	C16;C05;C07	CongenitalAbnormality	0.7	0.952	1999	2019	1	1	CTD_human;GENOMICS_ENGLAND
12754	3664	IRF6	0.486	0.769	C0175697	VanderWoudesyndrome	disease	C23;C16;C04;C05;C07	DiseaseorSyndrome	0.9	0.966	1999	2019	3	0	CTD_human;GENOMICS_ENGLAND;ORPHANET
12756	3664	IRF6	0.486	0.769	C0265259	Poplitealpterygiumsyndrome	disease	C16;C13;C11;C05;C12;C07	DiseaseorSyndrome	1	0.969	2002	2018	4	13	CTD_human;GENOMICS_ENGLAND;UNIPROT
12763	3664	IRF6	0.486	0.769	C1837213	OROFACIALCLEFT6,SUSCEPTIBILITYTO	disease		Finding	0.7	1	2002	2017	2	8	CTD_human;GENOMICS_ENGLAND;UNIPROT
12766	3664	IRF6	0.486	0.769	C4551864	VANDERWOUDESYNDROME1	disease	C23;C16;C04;C05;C07	DiseaseorSyndrome	0.61	1	2002	2017	9	27	GENOMICS_ENGLAND;UNIPROT
12771	3665	IRF7	0.547	0.846	C4225358	IMMUNODEFICIENCY39	disease		DiseaseorSyndrome	0.7	1	1997	2015	2	2	CTD_human;GENOMICS_ENGLAND;UNIPROT
12778	3667	IRS1	0.488	0.769	C0011860	DiabetesMellitus,Non-Insulin-Dependent	disease	C18;C19	DiseaseorSyndrome	0.9	0.939	1993	2019	9	2	CTD_human;UNIPROT
12782	3667	IRS1	0.488	0.769	C0028754	Obesity	disease	C23;C18	DiseaseorSyndrome	0.6	0.969	1995	2019	1	0	CTD_human
12824	3674	ITGA2B	0.493	0.692	C0038454	Cerebrovascularaccident	group	C10;C14	DiseaseorSyndrome	0.57	0.667	1997	2017	1	0	CTD_human
12825	3674	ITGA2B	0.493	0.692	C0040015	Thrombasthenia	disease	C16;C15	DiseaseorSyndrome	0.8	0.977	1982	2020	27	27	CLINGEN;CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
12832	3674	ITGA2B	0.493	0.692	C1861195	GlanzmannThrombasthenia,AutosomalDominant	disease	C16;C15	DiseaseorSyndrome	0.9	1	1998	2013	3	2	CTD_human;GENOMICS_ENGLAND;UNIPROT
12843	3675	ITGA3	0.573	0.731	C3553636	INTERSTITIALLUNGDISEASE,NEPHROTICSYNDROME,ANDEPIDERMOLYSISBULLOSA,CONGENITAL	disease		DiseaseorSyndrome	0.72	1	2012	2018	3	6	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
12860	3679	ITGA7	0.588	0.654	C0546264	CongenitalFiberTypeDisproportion	disease	C05;C10	CongenitalAbnormality	0.51	1	1997	2013	1	0	ORPHANET
12863	3679	ITGA7	0.588	0.654	C2750786	MuscularDystrophy,Congenital,DueToIntegrinAlpha-7Deficiency	disease	C16;C05;C10	DiseaseorSyndrome	0.9	1	1997	2015	2	10	CTD_human;GENOMICS_ENGLAND;ORPHANET
12878	3684	ITGAM	0.443	0.808	C0024141	LupusErythematosus,Systemic	disease	C17;C20	DiseaseorSyndrome	0.7	1	2008	2019	5	10	CTD_human;ORPHANET
12935	3689	ITGB2	0.444	0.923	C0398738	Leukocyteadhesiondeficiencytype1	disease	C16;C20	DiseaseorSyndrome	1	1	1990	2019	12	23	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
12954	3690	ITGB3	0.485	0.846	C0038454	Cerebrovascularaccident	group	C10;C14	DiseaseorSyndrome	0.59	1	1998	2019	1	0	CTD_human
12955	3690	ITGB3	0.485	0.846	C0040015	Thrombasthenia	disease	C16;C15	DiseaseorSyndrome	1	1	1982	2020	29	22	CLINGEN;CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
12966	3690	ITGB3	0.485	0.846	C1861195	GlanzmannThrombasthenia,AutosomalDominant	disease	C16;C15	DiseaseorSyndrome	0.9	1	1999	2018	4	3	CTD_human;GENOMICS_ENGLAND;UNIPROT
12969	3690	ITGB3	0.485	0.846	C3853779	NeonatalAlloimmuneThrombocytopenia	disease	C16;C15	DiseaseorSyndrome	0.77	1	1990	2019	3	0	CTD_human;GENOMICS_ENGLAND;ORPHANET
12972	3690	ITGB3	0.485	0.846	C4304021	Autosomaldominantmacrothrombocytopenia	disease	C16	DiseaseorSyndrome	0.51	1	1999	2018	2	0	ORPHANET
12986	3691	ITGB4	0.525	0.731	C0079301	JunctionalEpidermolysisBullosa	disease	C16;C17	DiseaseorSyndrome	0.57	1	1995	2018	1	0	CTD_human
12992	3691	ITGB4	0.525	0.731	C0268374	Adultjunctionalepidermolysisbullosa(disorder)	disease	C16;C17	DiseaseorSyndrome	0.9	1	1996	2002	2	1	CTD_human;GENOMICS_ENGLAND;UNIPROT
12993	3691	ITGB4	0.525	0.731	C0282160	AplasiaCutisCongenita	disease	C16;C17	CongenitalAbnormality	0.61	1	2008	2019	2	0	CTD_human;ORPHANET
12995	3691	ITGB4	0.525	0.731	C1856934	Epidermolysisbullosawithpyloricatresia	disease	C16;C17	DiseaseorSyndrome	1	1	1995	2017	11	12	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
13030	3694	ITGB6	0.597	0.692	C4015557	AMELOGENESISIMPERFECTA,TYPEIH	disease		DiseaseorSyndrome	0.7	1	2014	2016	3	4	CTD_human;GENOMICS_ENGLAND;UNIPROT
13037	3697	ITIH1	0.691	0.462	C0005586	BipolarDisorder	disease	F03	MentalorBehavioralDysfunction	0.6	1	2009	2019	3	3	CTD_human;PSYGENET
13050	3766	KCNJ10	0.599	0.654	C2748572	SeSAMEsyndrome	disease	C23;C10;F03;C09;F01	DiseaseorSyndrome	1	1	1997	2019	6	12	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
13051	3766	KCNJ10	0.599	0.654	C3538946	DEAFNESS,AUTOSOMALRECESSIVE4,WITHENLARGEDVESTIBULARAQUEDUCT	disease	C23;C10;C09	DiseaseorSyndrome	0.6	1	1997	2009	1	2	CTD_human;GENOMICS_ENGLAND
13055	3767	KCNJ11	0.529	0.615	C0011860	DiabetesMellitus,Non-Insulin-Dependent	disease	C18;C19	DiseaseorSyndrome	0.9	0.943	1996	2019	2	4	CTD_human;GENOMICS_ENGLAND
13068	3767	KCNJ11	0.529	0.615	C0342276	Maturityonsetdiabetesmellitusinyoung	disease	C18;C19	DiseaseorSyndrome	0.66	1	2009	2019	1	0	GENOMICS_ENGLAND;ORPHANET
13084	3767	KCNJ11	0.529	0.615	C1833104	DIABETESMELLITUS,PERMANENTNEONATAL	disease	C18;C19	DiseaseorSyndrome	1	0.984	2001	2018	19	33	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
13085	3767	KCNJ11	0.529	0.615	C1853564	DevelopmentalDelay,Epilepsy,andNeonatalDiabetes	disease	C23;C16;C18;C10;C19;F01	DiseaseorSyndrome	0.57	1	2006	2018	6	0	ORPHANET
13086	3767	KCNJ11	0.529	0.615	C1864623	DIABETESMELLITUS,TRANSIENTNEONATAL,3(disorder)	disease	C18;C19	DiseaseorSyndrome	0.7	1	2001	2016	2	15	CTD_human;GENOMICS_ENGLAND;UNIPROT
13088	3767	KCNJ11	0.529	0.615	C2931833	Hyperinsulinemichypoglycemia,familial,2	disease	C16;C06;C18	DiseaseorSyndrome	0.7	1	1995	2016	12	28	CTD_human;GENOMICS_ENGLAND;UNIPROT
13091	3767	KCNJ11	0.529	0.615	C3888018	CongenitalHyperinsulinism	disease	C16;C06;C18	DiseaseorSyndrome	0.7	1	2001	2019	2	0	CTD_human;GENOMICS_ENGLAND
13094	3767	KCNJ11	0.529	0.615	C4225365	MATURITY-ONSETDIABETESOFTHEYOUNG,TYPE13	disease		DiseaseorSyndrome	0.61	1	2011	2017	1	5	CTD_human;UNIPROT
13103	3769	KCNJ13	0.659	0.308	C0339527	LeberCongenitalAmaurosis	disease	C11	DiseaseorSyndrome	0.65	1	2011	2019	2	0	GENOMICS_ENGLAND;ORPHANET
13104	3769	KCNJ13	0.659	0.308	C1860405	Snowflakevitreoretinaldegeneration	disease	C11	DiseaseorSyndrome	0.78	1	2008	2019	1	0	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
13105	3769	KCNJ13	0.659	0.308	C3280062	LEBERCONGENITALAMAUROSIS16	disease		DiseaseorSyndrome	0.72	1	2011	2019	1	0	CTD_human;GENOMICS_ENGLAND;UNIPROT
13116	3776	KCNK2	0.626	0.654	C0011581	Depressivedisorder	disease	F03	MentalorBehavioralDysfunction	0.6	1	2007	2019	6	0	CTD_human;PSYGENET
13126	3777	KCNK3	0.584	0.654	C0340543	Familialprimarypulmonaryhypertension	disease	C08	DiseaseorSyndrome	0.64	1	2013	2019	3	0	CTD_human;GENOMICS_ENGLAND;ORPHANET
13133	3777	KCNK3	0.584	0.654	C3203102	Idiopathicpulmonaryarterialhypertension	disease	C08	DiseaseorSyndrome	0.7	0.952	2012	2020	1	0	CTD_human;GENOMICS_ENGLAND
13135	3777	KCNK3	0.584	0.654	C3809198	PULMONARYHYPERTENSION,PRIMARY,4	disease		DiseaseorSyndrome	0.6	1	2013	2017	2	7	GENOMICS_ENGLAND;UNIPROT
13162	3778	KCNMA1	0.518	0.846	C1836173	GeneralizedEpilepsyandParoxysmalDyskinesia	disease	C23;C10	DiseaseorSyndrome	0.73	1	2005	2019	3	2	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
13164	3779	KCNMB1	0.716	0.423	C0020538	Hypertensivedisease	group	C14	DiseaseorSyndrome	0.55	1	2003	2010	1	0	CTD_human
13179	3782	KCNN3	0.621	0.615	C0796013	ZimmermanLabandsyndrome	disease	C16;C05;C07	DiseaseorSyndrome	0.51	1	2019	2019	1	0	GENOMICS_ENGLAND;ORPHANET
13182	3783	KCNN4	0.653	0.577	C0272051	Xerocytosis	disease	C23;C16;C13;C20;C15	DiseaseorSyndrome	0.65	0.833	2015	2019	2	0	CTD_human;GENOMICS_ENGLAND;ORPHANET
13183	3783	KCNN4	0.653	0.577	C4225242	DEHYDRATEDHEREDITARYSTOMATOCYTOSIS2	disease		DiseaseorSyndrome	0.6	1	2015	2015	3	3	GENOMICS_ENGLAND;UNIPROT
13186	3784	KCNQ1	0.485	0.769	C0007194	HypertrophicCardiomyopathy	disease	C14	DiseaseorSyndrome	0.52	1	2014	2016	1	0	CLINGEN;GENOMICS_ENGLAND
13190	3784	KCNQ1	0.485	0.769	C0022387	Jervell-LangeNielsenSyndrome	disease	C16;C14	DiseaseorSyndrome	1	1	1997	2019	10	6	CLINGEN;CTD_human;ORPHANET
13191	3784	KCNQ1	0.485	0.769	C0023976	LongQTSyndrome	disease	C23;C16;C14	DiseaseorSyndrome	0.7	0.98	1993	2020	7	96	CTD_human;GENOMICS_ENGLAND
13201	3784	KCNQ1	0.485	0.769	C1837014	AtrialFibrillation,Familial,3	disease	C23;C14	DiseaseorSyndrome	0.7	1	1996	2018	3	10	CTD_human;GENOMICS_ENGLAND;UNIPROT
13203	3784	KCNQ1	0.485	0.769	C1865019	SHORTQTSYNDROME2(disorder)	disease	C23;C16;C14	DiseaseorSyndrome	0.72	1	1996	2018	3	9	CTD_human;GENOMICS_ENGLAND;UNIPROT
13206	3784	KCNQ1	0.485	0.769	C4551509	JervellAndLange-NielsenSyndrome1	disease	C16;C14	DiseaseorSyndrome	0.7	1	1996	2018	9	21	CTD_human;GENOMICS_ENGLAND;UNIPROT
13207	3784	KCNQ1	0.485	0.769	C4551647	LongQTSyndrome1	disease	C23;C16;C14	DiseaseorSyndrome	1	0.99	1996	2019	44	220	CTD_human;GENOMICS_ENGLAND;UNIPROT
13222	3785	KCNQ2	0.537	0.654	C0220669	Familialbenignneonatalepilepsy	disease	C16;C10	DiseaseorSyndrome	0.6	0.946	1994	2020	4	0	CTD_human;ORPHANET
13229	3785	KCNQ2	0.537	0.654	C0270851	Benignneonatalepilepsy	disease	C16;C10	DiseaseorSyndrome	0.59	1	2000	2019	2	0	CTD_human
13248	3785	KCNQ2	0.537	0.654	C3149074	SEIZURES,BENIGNFAMILIALNEONATAL,1	disease		DiseaseorSyndrome	0.7	1	1998	2016	9	104	CTD_human;GENOMICS_ENGLAND;UNIPROT
13249	3785	KCNQ2	0.537	0.654	C3150986	EPILEPTICENCEPHALOPATHY,EARLYINFANTILE,7	disease		DiseaseorSyndrome	0.7	1	1998	2018	9	91	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
13261	3786	KCNQ3	0.604	0.462	C1852581	EPILEPSY,BENIGNNEONATAL,2	disease	C16;C10	DiseaseorSyndrome	0.8	0.941	1998	2018	5	10	CTD_human;GENOMICS_ENGLAND;UNIPROT
13268	3791	KDR	0.378	0.885	C0009402	ColorectalCarcinoma	disease	C06;C04	NeoplasticProcess	0.6	0.964	2002	2019	1	0	CTD_human;UNIPROT
13276	3791	KDR	0.378	0.885	C0018923	Hemangiosarcoma	disease	C04	NeoplasticProcess	0.59	1	2007	2019	1	0	CGI;CTD_human
13311	3791	KDR	0.378	0.885	C1865871	HEMANGIOMA,CAPILLARYINFANTILE	disease	C16;C04	DiseaseorSyndrome	0.7	1	2002	2008	3	2	CTD_human;GENOMICS_ENGLAND;UNIPROT
13317	3795	KHK	0.7	0.346	C0268160	Deficiencyoffructokinase	disease	C16;C18	DiseaseorSyndrome	0.74	1	1994	2018	4	2	CTD_human;ORPHANET;UNIPROT
13323	3796	KIF2A	0.59	0.731	C3809414	CORTICALDYSPLASIA,COMPLEX,WITHOTHERBRAINMALFORMATIONS3	disease		DiseaseorSyndrome	0.7	1	2013	2016	2	0	CTD_human;GENOMICS_ENGLAND;UNIPROT
13335	3798	KIF5A	0.593	0.731	C1858712	Spasticparaplegia10,autosomaldominant	disease	C16;C10	DiseaseorSyndrome	0.76	1	2002	2018	12	10	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
13337	3798	KIF5A	0.593	0.731	C4310658	MYOCLONUS,INTRACTABLE,NEONATAL	disease		DiseaseorSyndrome	0.6	1	2017	2018	2	2	CTD_human;GENOMICS_ENGLAND
13338	3798	KIF5A	0.593	0.731	C4693609	AMYOTROPHICLATERALSCLEROSIS,SUSCEPTIBILITYTO,25	phenotype		Finding	0.6	1	2018	2018	3	8	GENOMICS_ENGLAND;UNIPROT
13346	3800	KIF5C	0.686	0.346	C3809013	CORTICALDYSPLASIA,COMPLEX,WITHOTHERBRAINMALFORMATIONS2	disease		DiseaseorSyndrome	0.7	1	2012	2017	4	2	CTD_human;GENOMICS_ENGLAND;UNIPROT
13356	3814	KISS1	0.507	0.808	C3541462	HYPOGONADOTROPICHYPOGONADISM13WITHORWITHOUTANOSMIA	disease		DiseaseorSyndrome	0.9	1	2007	2012	1	1	CTD_human;GENOMICS_ENGLAND;UNIPROT
13361	3815	KIT	0.366	0.808	C0023461	Leukemia,Mast-Cell	disease	C04	NeoplasticProcess	0.6	1	1993	2019	0	1	CGI;UNIPROT
13362	3815	KIT	0.366	0.808	C0023467	Leukemia,Myelocytic,Acute	disease	C04	NeoplasticProcess	0.8	0.955	1989	2019	0	3	CGI;CTD_human;GENOMICS_ENGLAND
13366	3815	KIT	0.366	0.808	C0024899	Mastocytosis	disease	C04;C17;C20	DiseaseorSyndrome	1	0.989	1992	2020	2	0	CGI;CTD_human;GENOMICS_ENGLAND
13373	3815	KIT	0.366	0.808	C0080024	Piebaldism	disease	C16;C18;C17	CongenitalAbnormality	1	1	1991	2018	11	11	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
13377	3815	KIT	0.366	0.808	C0221013	Mastocytosis,Systemic	disease	C04;C20	NeoplasticProcess	0.7	0.984	1998	2020	1	1	CGI;CTD_human
13378	3815	KIT	0.366	0.808	C0238198	GastrointestinalStromalTumors	group	C06;C04	NeoplasticProcess	1	0.951	1995	2020	19	40	CGI;CLINGEN;CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
13387	3815	KIT	0.366	0.808	C1136033	CutaneousMastocytosis	disease	C04;C17	NeoplasticProcess	0.68	1	1992	2019	6	6	GENOMICS_ENGLAND;UNIPROT
13392	3815	KIT	0.366	0.808	C1336708	TesticularGermCellTumor	disease	C04;C12;C19	NeoplasticProcess	0.63	1	2008	2016	0	2	CTD_human;GENOMICS_ENGLAND;UNIPROT
13395	3815	KIT	0.366	0.808	C3179349	GastrointestinalStromalSarcoma	disease	C06;C04	NeoplasticProcess	0.67	1	1998	2016	17	0	CLINGEN;CTD_human;ORPHANET
13405	3816	KLK1	0.533	0.769	C0020538	Hypertensivedisease	group	C14	DiseaseorSyndrome	0.6	1	1995	2018	1	0	CTD_human
13420	3818	KLKB1	0.604	0.692	C0272339	Prekallikreindeficiency	disease	C15	DiseaseorSyndrome	0.74	0.9	1974	2019	5	6	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
13437	3827	KNG1	0.481	0.885	C0020429	Hyperalgesia	phenotype	C23;C10	SignorSymptom	0.56	0.958	1988	2019	17	0	CTD_human
13458	3827	KNG1	0.481	0.885	C0272340	Highmolecularweightkininogendeficiency	disease	C15	DiseaseorSyndrome	0.77	0.889	1976	2019	3	3	CTD_human;GENOMICS_ENGLAND;ORPHANET
13488	3832	KIF11	0.56	0.769	C1835265	Lymphedema,microcephalyandchorioretinopathysyndrome	disease	C23;C16;C11;C05;C10;C15	DiseaseorSyndrome	0.74	1	2012	2016	2	23	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
13493	3835	KIF22	0.552	0.654	C1863732	Spondyloepimetaphysealdysplasiawithmultipledislocations	disease	C16;C05;C26	DiseaseorSyndrome	0.73	1	2011	2015	3	3	GENOMICS_ENGLAND;ORPHANET;UNIPROT
13510	3845	KRAS	0.32	0.923	C0005684	Malignantneoplasmofurinarybladder	disease	C04;C13;C12	NeoplasticProcess	0.7	1	2000	2019	1	2	CTD_human;UNIPROT
13512	3845	KRAS	0.32	0.923	C0006142	Malignantneoplasmofbreast	disease	C04;C17	NeoplasticProcess	0.7	0.947	2005	2020	0	1	CGI;CTD_human
13513	3845	KRAS	0.32	0.923	C0006826	MalignantNeoplasms	group	C04	NeoplasticProcess	0.6	0.972	1987	2020	2	0	CGI;CTD_human
13517	3845	KRAS	0.32	0.923	C0007131	Non-SmallCellLungCarcinoma	disease	C04;C08	NeoplasticProcess	0.7	0.979	1989	2020	7	10	CGI;CTD_human
13525	3845	KRAS	0.32	0.923	C0009402	ColorectalCarcinoma	disease	C06;C04	NeoplasticProcess	0.6	0.963	1990	2020	3	4	CTD_human;UNIPROT
13527	3845	KRAS	0.32	0.923	C0014175	Endometriosis	disease	C13	DiseaseorSyndrome	0.6	0.917	2005	2019	1	0	CTD_human
13529	3845	KRAS	0.32	0.923	C0018923	Hemangiosarcoma	disease	C04	NeoplasticProcess	0.64	1	1997	2016	4	1	CGI;CTD_human
13532	3845	KRAS	0.32	0.923	C0023467	Leukemia,Myelocytic,Acute	disease	C04	NeoplasticProcess	0.7	0.939	1987	2020	0	7	CGI;CTD_human
13535	3845	KRAS	0.32	0.923	C0023903	Liverneoplasms	group	C06;C04	NeoplasticProcess	0.66	1	1993	2017	2	0	CTD_human
13537	3845	KRAS	0.32	0.923	C0024121	LungNeoplasms	group	C04;C08	NeoplasticProcess	0.6	0.974	1991	2019	33	0	CGI;CTD_human
13547	3845	KRAS	0.32	0.923	C0028326	NoonanSyndrome	disease	C16;C17;C05;C14	DiseaseorSyndrome	1	0.985	1993	2019	13	14	CLINGEN;CTD_human;GENOMICS_ENGLAND;ORPHANET
13549	3845	KRAS	0.32	0.923	C0030297	PancreaticNeoplasm	disease	C06;C04;C19	NeoplasticProcess	0.7	0.974	1997	2019	6	0	CGI;CTD_human
13554	3845	KRAS	0.32	0.923	C0040136	ThyroidNeoplasm	disease	C04;C19	NeoplasticProcess	0.68	1	1988	2016	1	8	CGI;CTD_human
13563	3845	KRAS	0.32	0.923	C0152013	Adenocarcinomaoflung(disorder)	disease	C04	NeoplasticProcess	0.7	0.967	1990	2020	5	2	CGI;CTD_human
13589	3845	KRAS	0.32	0.923	C0235974	Pancreaticcarcinoma	disease	C06;C04;C19	NeoplasticProcess	0.7	0.983	1985	2020	0	2	CGI
13592	3845	KRAS	0.32	0.923	C0242379	Malignantneoplasmoflung	disease	C04;C08	NeoplasticProcess	0.7	0.974	1990	2020	33	1	CGI;CTD_human;UNIPROT
13593	3845	KRAS	0.32	0.923	C0265329	OrganoidNevusPhakomatosis	disease	C16;C04;C10	DiseaseorSyndrome	0.75	1	2012	2019	1	2	CTD_human;GENOMICS_ENGLAND;ORPHANET
13605	3845	KRAS	0.32	0.923	C0334583	PilocyticAstrocytoma	disease	C04	NeoplasticProcess	0.62	1	2007	2013	1	1	CGI;CTD_human
13607	3845	KRAS	0.32	0.923	C0345904	Malignantneoplasmofliver	disease	C06;C04	NeoplasticProcess	0.52	1	1993	2020	2	0	CTD_human
13608	3845	KRAS	0.32	0.923	C0345905	IntrahepaticCholangiocarcinoma	disease	C04	NeoplasticProcess	0.6	0.957	1994	2019	2	0	CTD_human
13609	3845	KRAS	0.32	0.923	C0346647	Malignantneoplasmofpancreas	disease	C06;C04;C19	NeoplasticProcess	0.6	0.985	1985	2020	6	0	CGI;CTD_human
13611	3845	KRAS	0.32	0.923	C0349639	JuvenileMyelomonocyticLeukemia	disease	C04;C15	NeoplasticProcess	1	1	1994	2019	4	4	CTD_human;ORPHANET;UNIPROT
13613	3845	KRAS	0.32	0.923	C0376358	Malignantneoplasmofprostate	disease	C04;C12	NeoplasticProcess	0.6	1	2005	2018	1	0	CTD_human
13620	3845	KRAS	0.32	0.923	C0549473	Thyroidcarcinoma	disease	C04;C19	NeoplasticProcess	0.59	1	1988	2016	1	0	CGI;CTD_human
13621	3845	KRAS	0.32	0.923	C0587248	Costellosyndrome(disorder)	disease	C16;C05	DiseaseorSyndrome	0.6	1	2006	2018	4	0	CLINGEN;CTD_human
13623	3845	KRAS	0.32	0.923	C0678222	BreastCarcinoma	disease	C04;C17	NeoplasticProcess	0.7	0.95	1987	2020	0	0	CGI;CTD_human
13624	3845	KRAS	0.32	0.923	C0684249	Carcinomaoflung	disease	C04;C08	NeoplasticProcess	0.7	0.98	1985	2020	0	4	CGI;UNIPROT
13634	3845	KRAS	0.32	0.923	C0919267	ovarianneoplasm	disease	C04;C13;C19	NeoplasticProcess	0.7	0.903	1991	2019	1	3	CGI;CTD_human
13636	3845	KRAS	0.32	0.923	C1140680	Malignantneoplasmofovary	disease	C04;C13;C19	NeoplasticProcess	0.7	0.909	1986	2019	1	0	CGI;CTD_human
13638	3845	KRAS	0.32	0.923	C1275081	Cardio-facio-cutaneoussyndrome	disease	C23;C16;C17;C14	CongenitalAbnormality	0.8	1	1993	2019	12	8	CLINGEN;CTD_human;GENOMICS_ENGLAND;ORPHANET
13648	3845	KRAS	0.32	0.923	C1860991	NOONANSYNDROME3	disease	C16;C17;C05;C14	DiseaseorSyndrome	0.9	1	2006	2014	9	11	CTD_human;GENOMICS_ENGLAND;UNIPROT
13650	3845	KRAS	0.32	0.923	C2239176	Livercarcinoma	disease	C06;C04	NeoplasticProcess	0.7	0.92	1985	2020	2	2	CTD_human
13651	3845	KRAS	0.32	0.923	C2674723	RAS-ASSOCIATEDAUTOIMMUNELEUKOPROLIFERATIVEDISORDER	disease	C16;C04;C20;C15	DiseaseorSyndrome	0.63	1	2006	2019	2	6	GENOMICS_ENGLAND;ORPHANET
13662	3845	KRAS	0.32	0.923	C3809005	CARDIOFACIOCUTANEOUSSYNDROME2	disease		DiseaseorSyndrome	0.6	1	2006	2014	10	9	GENOMICS_ENGLAND;UNIPROT
13667	3845	KRAS	0.32	0.923	C4552097	NevusSebaceusofJadassohn	disease	C16;C04;C10	DiseaseorSyndrome	0.62	1	2012	2017	1	2	CTD_human;GENOMICS_ENGLAND
13674	3848	KRT1	0.575	0.654	C0079153	Hyperkeratosis,Epidermolytic	disease	C16;C17	CongenitalAbnormality	1	0.951	1992	2019	15	17	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
13677	3848	KRT1	0.575	0.654	C1721006	Keratoderma,Palmoplantar,Epidermolytic	disease	C16;C17	DiseaseorSyndrome	0.67	1	2001	2018	1	0	CTD_human;ORPHANET
13678	3848	KRT1	0.575	0.654	C1833030	PALMOPLANTARKERATODERMA,NONEPIDERMOLYTIC	disease	C16;C17	DiseaseorSyndrome	0.72	1	1994	2018	3	1	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
13681	3848	KRT1	0.575	0.654	C1840296	Ichthyosishystrix,CurthMacklintype	disease	C16;C17	DiseaseorSyndrome	0.61	1	1994	2006	2	0	CTD_human;GENOMICS_ENGLAND;ORPHANET
13682	3848	KRT1	0.575	0.654	C1843463	Ichthyosis,Cyclic,withEpidermolyticHyperkeratosis	disease	C16;C17	DiseaseorSyndrome	0.71	1	1994	2018	4	2	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
13691	3849	KRT2	0.76	0.154	C0432306	IchthyosisBullosaofSiemens	disease	C16;C17	CongenitalAbnormality	0.8	1	1994	2005	15	12	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
13694	3850	KRT3	0.751	0.385	C0339277	CornealDystrophy,JuvenileEpithelialofMeesmann	disease	C16;C11	CongenitalAbnormality	0.67	1	1997	2016	2	2	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
13698	3851	KRT4	0.736	0.423	C1721005	Leukokeratosis,HereditaryMucosal	disease	C16;C17	DiseaseorSyndrome	0.78	1	1998	2019	3	0	CTD_human;ORPHANET
13708	3852	KRT5	0.512	0.731	C0079295	EpidermolysisBullosaHerpetiformisDowling-Meara	disease	C16;C17	DiseaseorSyndrome	0.95	1	1992	2019	10	15	CTD_human;GENOMICS_ENGLAND;UNIPROT
13709	3852	KRT5	0.512	0.731	C0079298	EpidermolysisBullosaSimplex	disease	C16;C17	DiseaseorSyndrome	0.9	0.985	1991	2019	0	4	CTD_human;GENOMICS_ENGLAND
13710	3852	KRT5	0.512	0.731	C0079299	EpidermolysisBullosaSimplexKobner	disease	C16;C17	CongenitalAbnormality	0.73	1	1993	2019	7	11	CTD_human;GENOMICS_ENGLAND;UNIPROT
13711	3852	KRT5	0.512	0.731	C0080333	Weber-CockayneSyndrome	disease	C16;C17	DiseaseorSyndrome	0.76	1	1993	2019	15	24	CTD_human;GENOMICS_ENGLAND;UNIPROT
13718	3852	KRT5	0.512	0.731	C0432316	Epidermolysisbullosasimplexwithmottledpigmentation	disease	C16;C17	CongenitalAbnormality	0.78	1	1996	2014	4	2	CTD_human;GENOMICS_ENGLAND;UNIPROT
13725	3852	KRT5	0.512	0.731	C1836284	EpidermolysisBullosaSimplexwithMigratoryCircinateErythema	disease	C23;C16;C17	DiseaseorSyndrome	0.62	1	2003	2006	1	2	CTD_human;ORPHANET
13726	3852	KRT5	0.512	0.731	C3714534	dowling-degosdisease	disease	C16;C17	DiseaseorSyndrome	0.7	1	2006	2019	1	0	CTD_human;GENOMICS_ENGLAND;ORPHANET
13728	3852	KRT5	0.512	0.731	C4552092	Dowling-Degosdisease1	disease	C16;C17	DiseaseorSyndrome	0.6	1	2006	2006	1	3	CTD_human;GENOMICS_ENGLAND
13732	3853	KRT6A	0.61	0.692	C1706595	PachyonychiaCongenita,JadassohnLewandowskyType	disease	C16;C17	DiseaseorSyndrome	0.53	1	1999	2013	1	0	CTD_human;GENOMICS_ENGLAND
13741	3854	KRT6B	0.663	0.577	C3714949	PACHYONYCHIACONGENITA4	disease		DiseaseorSyndrome	0.6	1	1998	2011	4	1	GENOMICS_ENGLAND;UNIPROT
13796	3857	KRT9	0.678	0.346	C1721006	Keratoderma,Palmoplantar,Epidermolytic	disease	C16;C17	DiseaseorSyndrome	0.8	1	1992	2019	26	14	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
13804	3858	KRT10	0.579	0.692	C0079153	Hyperkeratosis,Epidermolytic	disease	C16;C17	CongenitalAbnormality	0.8	0.98	1992	2020	10	0	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
13813	3858	KRT10	0.579	0.692	C1843463	Ichthyosis,Cyclic,withEpidermolyticHyperkeratosis	disease	C16;C17	DiseaseorSyndrome	0.73	1	1997	1999	2	0	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
13814	3858	KRT10	0.579	0.692	C3665704	Congenitalreticularichthyosiformerythroderma	disease	C16;C17	DiseaseorSyndrome	0.79	1	1994	2019	2	2	CTD_human;GENOMICS_ENGLAND;ORPHANET
13816	3859	KRT12	0.751	0.192	C0339277	CornealDystrophy,JuvenileEpithelialofMeesmann	disease	C16;C11	CongenitalAbnormality	0.7	1	1996	2019	16	15	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
13818	3860	KRT13	0.631	0.692	C1721005	Leukokeratosis,HereditaryMucosal	disease	C16;C17	DiseaseorSyndrome	0.54	1	1995	2018	4	0	CTD_human;ORPHANET
13827	3861	KRT14	0.53	0.731	C0079295	EpidermolysisBullosaHerpetiformisDowling-Meara	disease	C16;C17	DiseaseorSyndrome	0.98	1	1991	2019	18	14	CTD_human;GENOMICS_ENGLAND;UNIPROT
13828	3861	KRT14	0.53	0.731	C0079298	EpidermolysisBullosaSimplex	disease	C16;C17	DiseaseorSyndrome	0.7	1	1991	2019	0	4	CTD_human
13829	3861	KRT14	0.53	0.731	C0079299	EpidermolysisBullosaSimplexKobner	disease	C16;C17	CongenitalAbnormality	0.75	1	1991	2019	10	10	CTD_human;GENOMICS_ENGLAND;UNIPROT
13830	3861	KRT14	0.53	0.731	C0080333	Weber-CockayneSyndrome	disease	C16;C17	DiseaseorSyndrome	0.7	1	1993	2006	14	16	CTD_human;GENOMICS_ENGLAND;UNIPROT
13833	3861	KRT14	0.53	0.731	C0343111	Naegelisyndrome	disease	C16;C17	DiseaseorSyndrome	0.72	1	1995	2008	4	2	CTD_human;GENOMICS_ENGLAND;ORPHANET
13834	3861	KRT14	0.53	0.731	C0406778	Dermatopathiapigmentosareticularis	disease	C23;C04;C17	CongenitalAbnormality	0.62	1	1995	2009	4	0	CTD_human;GENOMICS_ENGLAND;ORPHANET
13841	3861	KRT14	0.53	0.731	C3715082	EPIDERMOLYSISBULLOSASIMPLEX,AUTOSOMALRECESSIVE1	disease		DiseaseorSyndrome	0.7	1	1993	2005	3	6	GENOMICS_ENGLAND;ORPHANET;UNIPROT
13850	3868	KRT16	0.565	0.769	C0265334	PachyonychiaCongenita	disease	C16;C17	DiseaseorSyndrome	0.6	1	2001	2020	0	0	CTD_human
13852	3868	KRT16	0.565	0.769	C1706595	PachyonychiaCongenita,JadassohnLewandowskyType	disease	C16;C17	DiseaseorSyndrome	0.95	1	1995	2013	12	12	CTD_human;GENOMICS_ENGLAND;UNIPROT
13856	3868	KRT16	0.565	0.769	C4552049	PALMOPLANTARKERATODERMA,NONEPIDERMOLYTIC,FOCAL1	disease	C16;C04;C17	DiseaseorSyndrome	0.7	1	1995	2011	3	3	CTD_human;GENOMICS_ENGLAND;UNIPROT
13859	3872	KRT17	0.531	0.654	C0259771	Steatocystomamultiplex	disease	C16;C17	NeoplasticProcess	0.75	1	1997	2019	6	4	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
13861	3872	KRT17	0.531	0.654	C0265334	PachyonychiaCongenita	disease	C16;C17	DiseaseorSyndrome	0.7	1	1995	2020	0	1	CTD_human;GENOMICS_ENGLAND
13865	3872	KRT17	0.531	0.654	C1721007	PachyonychiaCongenita,Type2(disorder)	disease	C16;C17	DiseaseorSyndrome	0.78	1	1994	2013	21	13	CTD_human;GENOMICS_ENGLAND;UNIPROT
13905	3887	KRT81	0.659	0.462	C0546966	Monilethrix	disease	C16;C17	CongenitalAbnormality	0.72	1	1997	2015	3	4	CTD_human;ORPHANET;UNIPROT
13907	3889	KRT83	0.716	0.269	C0546966	Monilethrix	disease	C16;C17	CongenitalAbnormality	0.72	1	2005	2015	2	2	CTD_human;ORPHANET;UNIPROT
13908	3891	KRT85	0.751	0.115	C1865951	EctodermalDysplasia,PureHair-NailType	disease	C16;C17	DiseaseorSyndrome	0.7	1	2006	2010	2	2	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
13909	3892	KRT86	0.736	0.308	C0546966	Monilethrix	disease	C16;C17	CongenitalAbnormality	0.65	1	1997	2015	7	0	CTD_human;ORPHANET;UNIPROT
13937	3897	L1CAM	0.475	0.769	C0265216	X-linkedhydrocephalussyndrome	disease	C16;C10	DiseaseorSyndrome	1	0.984	1986	2020	27	18	CTD_human;GENOMICS_ENGLAND;UNIPROT
13957	3897	L1CAM	0.475	0.769	C0795953	MASASYNDROME(disorder)	disease	C23;C16;C10;F03;F01	DiseaseorSyndrome	1	1	1986	2019	24	12	CLINGEN;CTD_human;GENOMICS_ENGLAND;UNIPROT
13963	3897	L1CAM	0.475	0.769	C1839909	CORPUSCALLOSUM,PARTIALAGENESISOF,X-LINKED	disease	C23;C16;C10	DiseaseorSyndrome	0.7	1	1986	2006	2	2	CTD_human;GENOMICS_ENGLAND;UNIPROT
13985	3908	LAMA2	0.553	0.692	C1263858	Musculardystrophycongenital,merosinnegative	disease	C16;C05;C10	DiseaseorSyndrome	1	1	1955	2018	6	109	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
13990	3909	LAMA3	0.576	0.731	C0079301	JunctionalEpidermolysisBullosa	disease	C16;C17	DiseaseorSyndrome	0.8	1	1992	2018	3	0	CTD_human;GENOMICS_ENGLAND
13991	3909	LAMA3	0.576	0.731	C0079683	HerlitzDisease	disease	C16;C17	DiseaseorSyndrome	0.61	1	1992	2016	4	76	CTD_human;GENOMICS_ENGLAND
13992	3909	LAMA3	0.576	0.731	C0268374	Adultjunctionalepidermolysisbullosa(disorder)	disease	C16;C17	DiseaseorSyndrome	0.8	1	1995	2016	3	3	CTD_human;GENOMICS_ENGLAND
13994	3909	LAMA3	0.576	0.731	C1328355	Laryngoonychocutaneoussyndrome	disease	C11;C08;C09	DiseaseorSyndrome	0.71	1	1995	2016	5	2	CTD_human;GENOMICS_ENGLAND;ORPHANET
14000	3910	LAMA4	0.682	0.577	C3808935	CARDIOMYOPATHY,DILATED,1JJ	disease		DiseaseorSyndrome	0.6	1	2007	2007	1	1	CTD_human;UNIPROT
14013	3912	LAMB1	0.615	0.654	C3554657	LISSENCEPHALY5	disease		DiseaseorSyndrome	0.7	1	2007	2015	3	5	CLINGEN;GENOMICS_ENGLAND;ORPHANET
14021	3913	LAMB2	0.601	0.654	C1836876	Piersonsyndrome	disease	C23;C16;C13;C11;C12;C10	DiseaseorSyndrome	1	1	1995	2018	6	12	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
14022	3913	LAMB2	0.601	0.654	C3280113	NEPHROTICSYNDROME,TYPE5,WITHORWITHOUTOCULARABNORMALITIES	disease		DiseaseorSyndrome	0.7	1	2010	2018	4	10	CTD_human;GENOMICS_ENGLAND;UNIPROT
14027	3914	LAMB3	0.558	0.692	C0079301	JunctionalEpidermolysisBullosa	disease	C16;C17	DiseaseorSyndrome	0.8	1	1994	2019	1	0	CTD_human;GENOMICS_ENGLAND
14028	3914	LAMB3	0.558	0.692	C0079683	HerlitzDisease	disease	C16;C17	DiseaseorSyndrome	0.92	1	1994	2018	2	66	CTD_human;GENOMICS_ENGLAND;UNIPROT
14029	3914	LAMB3	0.558	0.692	C0268374	Adultjunctionalepidermolysisbullosa(disorder)	disease	C16;C17	DiseaseorSyndrome	0.9	1	1997	2016	4	14	CTD_human;GENOMICS_ENGLAND;UNIPROT
14030	3914	LAMB3	0.558	0.692	C0399367	Amelogenesisimperfectalocalhypoplasticform	disease	C16;C07	CongenitalAbnormality	0.52	1	2014	2015	1	0	CTD_human;ORPHANET
14043	3918	LAMC2	0.389	0.923	C0079301	JunctionalEpidermolysisBullosa	disease	C16;C17	DiseaseorSyndrome	0.8	1	1992	2018	2	0	CTD_human;GENOMICS_ENGLAND
14044	3918	LAMC2	0.389	0.923	C0079683	HerlitzDisease	disease	C16;C17	DiseaseorSyndrome	0.81	1	1992	2017	3	54	CTD_human;GENOMICS_ENGLAND
14047	3918	LAMC2	0.389	0.923	C0268374	Adultjunctionalepidermolysisbullosa(disorder)	disease	C16;C17	DiseaseorSyndrome	0.8	1	1994	2017	4	3	CTD_human;GENOMICS_ENGLAND
14049	3918	LAMC2	0.389	0.923	C2673609	Epidermolysisbullosainversadystrophica	disease	C16;C17	DiseaseorSyndrome	0.51	1	1994	2010	0	0	ORPHANET
14059	3920	LAMP2	0.552	0.731	C0878677	GlycogenStorageDiseaseTypeIIb	disease	C16;C18;C10;C14	DiseaseorSyndrome	1	1	1995	2020	15	37	CLINGEN;CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
14062	3921	RPSA	0.485	0.769	C0685889	SplenicHypoplasia	disease	C16;C20	CongenitalAbnormality	0.74	1	2013	2019	1	6	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
14092	3929	LBP	0.525	0.808	C0028754	Obesity	disease	C23;C18	DiseaseorSyndrome	0.6	1	2010	2019	1	0	CTD_human
14104	3930	LBR	0.473	0.808	C0030779	Pelger-HuetAnomaly	disease	C16;C15	DiseaseorSyndrome	1	0.944	2002	2019	2	6	CTD_human;GENOMICS_ENGLAND;UNIPROT
14107	3930	LBR	0.473	0.808	C0748397	Reynoldssyndrome	disease	C23;C06;C17	DiseaseorSyndrome	0.71	1	2010	2013	2	1	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
14109	3930	LBR	0.473	0.808	C2931048	HEMdysplasia	disease	C16;C05	DiseaseorSyndrome	0.8	0.933	1993	2019	6	5	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
14111	3930	LBR	0.473	0.808	C4747922	PELGER-HUETANOMALYWITHMILDSKELETALANOMALIES	disease		DiseaseorSyndrome	0.7	1	2003	2015	5	4	CLINGEN;GENOMICS_ENGLAND;ORPHANET;UNIPROT
14113	3931	LCAT	0.588	0.654	C0023195	LecithinAcyltransferaseDeficiency	disease	C16;C18	DiseaseorSyndrome	1	0.974	1967	2019	18	19	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
14114	3931	LCAT	0.588	0.654	C0342895	Fish-EyeDisease	disease	C16;C18	DiseaseorSyndrome	0.8	1	1987	2019	10	11	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
14117	3932	LCK	0.564	0.769	C4014233	IMMUNODEFICIENCY22	disease		DiseaseorSyndrome	0.7	1	2001	2012	2	1	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
14118	3934	LCN2	0.405	0.885	C0002875	Cooleysanemia	disease	C16;C15	DiseaseorSyndrome	0.32	1	2006	2019	1	0	CTD_human
val	3934	LCN2	0.405	0.885	C0003873	RheumatoidArthritis	disease	C17;C05;C20	DiseaseorSyndrome	0.30	1	1995	1995	1	0	CTD_human
val	3934	LCN2	0.405	0.885	C0005283	betaThalassemia	disease	C16;C15	DiseaseorSyndrome	0.32	1	2006	2008	1	0	CTD_human
val	3934	LCN2	0.405	0.885	C0006663	Calcinosis	phenotype	C18	PathologicFunction	0.30	1	2011	2011	1	0	CTD_human
val	3934	LCN2	0.405	0.885	C0006826	MalignantNeoplasms	group	C04	NeoplasticProcess	0.40	1	2005	2019	1	0	CTD_human
val	3934	LCN2	0.405	0.885	C0007570	CeliacDisease	disease	C06;C18	DiseaseorSyndrome	0.30	1	2018	2018	1	0	CTD_human
val	3934	LCN2	0.405	0.885	C0011616	ContactDermatitis	disease	C17	DiseaseorSyndrome	0.31	0.5	2002	2015	1	0	CTD_human
val	3934	LCN2	0.405	0.885	C0013221	Drugtoxicity	group	C25	InjuryorPoisoning	0.30	1	2017	2017	1	0	CTD_human
val	3934	LCN2	0.405	0.885	C0018824	Heartvalvedisease	group	C14	DiseaseorSyndrome	0.30	1	2011	2011	1	0	CTD_human
val	3934	LCN2	0.405	0.885	C0019025	HemoglobinFDisease	disease	C16;C15	DiseaseorSyndrome	0.30	1	2006	2006	1	0	CTD_human
val	3934	LCN2	0.405	0.885	C0019188	Hepatitis,Animal	disease	C06;C01;C22	DiseaseorSyndrome	0.30	1	2008	2008	1	0	CTD_human
val	3934	LCN2	0.405	0.885	C0019193	Hepatitis,Toxic	disease	C06;C25	InjuryorPoisoning	0.30	1	2010	2011	2	0	CTD_human
val	3934	LCN2	0.405	0.885	C0021368	Inflammation	phenotype	C23	PathologicFunction	0.31	1	2005	2010	1	0	CTD_human
val	3934	LCN2	0.405	0.885	C0022658	KidneyDiseases	group	C13;C12	DiseaseorSyndrome	0.40	1	2006	2019	4	0	CTD_human
val	3934	LCN2	0.405	0.885	C0022660	KidneyFailure,Acute	disease	C13;C12	DiseaseorSyndrome	0.40	0.982	2003	2020	5	0	CTD_human
val	3934	LCN2	0.405	0.885	C0023893	LiverCirrhosis,Experimental	disease	C23;C06	ExperimentalModelofDisease	0.30	1	2006	2014	2	0	CTD_human
val	3934	LCN2	0.405	0.885	C0027627	NeoplasmMetastasis	phenotype	C23;C04	NeoplasticProcess	0.40	0.971	2005	2019	1	0	CTD_human
val	3934	LCN2	0.405	0.885	C0027651	Neoplasms	group	C04	NeoplasticProcess	0.40	0.98	2005	2019	1	0	CTD_human
val	3934	LCN2	0.405	0.885	C0035222	RespiratoryDistressSyndrome,Adult	disease	C08	DiseaseorSyndrome	0.30	1	2014	2014	1	0	CTD_human
val	3934	LCN2	0.405	0.885	C0036341	Schizophrenia	disease	F03	MentalorBehavioralDysfunction	0.31	1	2012	2018	1	0	PSYGENET
val	3934	LCN2	0.405	0.885	C0041755	Adversereactiontodrug	group	C25	PathologicFunction	0.30	1	2017	2017	1	0	CTD_human
val	3934	LCN2	0.405	0.885	C0085578	ThalassemiaMinor	disease	C16;C15	DiseaseorSyndrome	0.30	1	2006	2006	1	0	CTD_human
val	3934	LCN2	0.405	0.885	C0086692	BenignNeoplasm	group	C04	NeoplasticProcess	0.30	1	2006	2006	1	0	CTD_human
val	3934	LCN2	0.405	0.885	C0162351	Contacthypersensitivity	phenotype	C17	PathologicFunction	0.30	1	2015	2015	1	0	CTD_human
val	3934	LCN2	0.405	0.885	C0263628	Tumoralcalcinosis	disease	C18	DiseaseorSyndrome	0.30	1	2011	2011	1	0	CTD_human
val	3934	LCN2	0.405	0.885	C0271979	ThalassemiaIntermedia	disease	C16;C15	DiseaseorSyndrome	0.30	1	2006	2006	1	0	CTD_human
val	3934	LCN2	0.405	0.885	C0403447	ChronicKidneyInsufficiency	disease	C13;C12	DiseaseorSyndrome	0.30	1	2015	2015	1	0	CTD_human
val	3934	LCN2	0.405	0.885	C0521174	Microcalcification	phenotype	C18	PathologicFunction	0.30	1	2011	2011	1	0	CTD_human
val	3934	LCN2	0.405	0.885	C0860207	Drug-InducedLiverDisease	phenotype	C06;C25	DiseaseorSyndrome	0.30	1	2010	2011	2	0	CTD_human
val	3934	LCN2	0.405	0.885	C1262760	Hepatitis,Drug-Induced	disease	C06;C25	DiseaseorSyndrome	0.30	1	2010	2011	2	0	CTD_human
val	3934	LCN2	0.405	0.885	C1561643	ChronicKidneyDiseases	group	C13;C12	DiseaseorSyndrome	0.40	0.935	2010	2019	1	0	CTD_human
val	3934	LCN2	0.405	0.885	C1565662	AcuteKidneyInsufficiency	disease	C13;C12	DiseaseorSyndrome	0.30	1	2011	2017	5	0	CTD_human
val	3934	LCN2	0.405	0.885	C2609414	Acutekidneyinjury	disease	C13;C12	InjuryorPoisoning	0.50	1	2011	2017	5	0	CTD_human
val	3934	LCN2	0.405	0.885	C3658290	Drug-InducedAcuteLiverInjury	disease	C06;C25	DiseaseorSyndrome	0.30	1	2010	2011	2	0	CTD_human
val	3934	LCN2	0.405	0.885	C4277682	ChemicalandDrugInducedLiverInjury	disease	C06;C25	DiseaseorSyndrome	0.30	1	2010	2011	2	0	CTD_human
val	3934	LCN2	0.405	0.885	C4279912	Chemically-InducedLiverToxicity	disease	C06;C25	DiseaseorSyndrome	0.30	1	2010	2011	2	0	CTD_human
val	3936	LCP1	0.663	0.654	C0023893	LiverCirrhosis,Experimental	disease	C23;C06	ExperimentalModelofDisease	0.30	1	2014	2014	1	0	CTD_human
val	3936	LCP1	0.663	0.654	C0028043	NicotineDependence	disease	C25;F03	MentalorBehavioralDysfunction	0.30	1	2008	2008	1	0	CTD_human
val	3936	LCP1	0.663	0.654	C0040332	TobaccoDependence	disease	C25;F03	MentalorBehavioralDysfunction	0.30	1	2008	2008	1	0	CTD_human
val	3936	LCP1	0.663	0.654	C0376384	NicotineUseDisorder	phenotype	C25;F03	MentalorBehavioralDysfunction	0.30	1	2008	2008	1	0	CTD_human
val	3937	LCP2	0.716	0.308	C0023893	LiverCirrhosis,Experimental	disease	C23;C06	ExperimentalModelofDisease	0.30	1	2014	2014	1	0	CTD_human
val	3938	LCT	0.581	0.808	C0035222	RespiratoryDistressSyndrome,Adult	disease	C08	DiseaseorSyndrome	0.30	1	2014	2014	1	0	CTD_human
val	3938	LCT	0.581	0.808	C0268179	LactaseDeficiency,Congenital	phenotype	C16;C18	PathologicFunction	0.70	1	2006	2016	2	9	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
val	3939	LDHA	0.507	0.808	C0005586	BipolarDisorder	disease	F03	MentalorBehavioralDysfunction	0.30	1	2013	2013	1	0	PSYGENET
val	3939	LDHA	0.507	0.808	C0011570	MentalDepression	disease	F01	MentalorBehavioralDysfunction	0.31	1	2013	2019	1	0	PSYGENET
val	3939	LDHA	0.507	0.808	C0017919	GlycogenStorageDisease	group	C16;C18	DiseaseorSyndrome	0.30	1	1984	2016	2	0	GENOMICS_ENGLAND
val	3939	LDHA	0.507	0.808	C0027051	MyocardialInfarction	disease	C23;C14	DiseaseorSyndrome	0.30	1	1988	1988	1	0	CTD_human
val	3939	LDHA	0.507	0.808	C0027080	Myoglobinuria	phenotype	C05	Finding	0.40	1	2011	2011	1	0	CTD_human
val	3939	LDHA	0.507	0.808	C0030297	PancreaticNeoplasm	disease	C06;C04;C19	NeoplasticProcess	0.31	1	2014	2018	1	0	CTD_human
val	3939	LDHA	0.507	0.808	C0033141	Cardiomyopathies,Primary	group	C14	DiseaseorSyndrome	0.30	1	2004	2004	1	0	CTD_human
val	3939	LDHA	0.507	0.808	C0036529	MyocardialDiseases,Secondary	group	C14	DiseaseorSyndrome	0.30	1	2004	2004	1	0	CTD_human
val	3939	LDHA	0.507	0.808	C0041696	UnipolarDepression	disease	F03	MentalorBehavioralDysfunction	0.30	1	2013	2013	1	0	PSYGENET
val	3939	LDHA	0.507	0.808	C0152013	Adenocarcinomaoflung(disorder)	disease	C04	NeoplasticProcess	0.32	1	2016	2019	1	0	CTD_human
val	3939	LDHA	0.507	0.808	C0346647	Malignantneoplasmofpancreas	disease	C06;C04;C19	NeoplasticProcess	0.38	0.889	2013	2020	1	0	CTD_human
val	3939	LDHA	0.507	0.808	C0525045	MoodDisorders	group	F03	MentalorBehavioralDysfunction	0.30	1	2013	2013	1	0	PSYGENET
val	3939	LDHA	0.507	0.808	C0878544	Cardiomyopathies	group	C14	DiseaseorSyndrome	0.30	1	2004	2004	1	0	CTD_human
val	3939	LDHA	0.507	0.808	C1269683	MajorDepressiveDisorder	disease	F03	MentalorBehavioralDysfunction	0.31	1	2013	2013	1	0	PSYGENET
val	3939	LDHA	0.507	0.808	C2931743	LactatedehydrogenasedeficiencytypeA	disease	C16;C18	DiseaseorSyndrome	0.60	1	1984	2016	3	0	CTD_human;GENOMICS_ENGLAND;ORPHANET
val	3945	LDHB	0.604	0.615	C0006142	Malignantneoplasmofbreast	disease	C04;C17	NeoplasticProcess	0.34	1	2012	2018	1	0	CTD_human
val	3945	LDHB	0.604	0.615	C0007124	NoninfiltratingIntraductalCarcinoma	disease	C04	NeoplasticProcess	0.30	1	2013	2013	1	0	CTD_human
val	3945	LDHB	0.604	0.615	C0007134	RenalCellCarcinoma	disease	C04;C13;C12	NeoplasticProcess	0.30	1	2004	2004	1	0	CTD_human
val	3945	LDHB	0.604	0.615	C0023893	LiverCirrhosis,Experimental	disease	C23;C06	ExperimentalModelofDisease	0.30	1	2014	2014	1	0	CTD_human
val	3945	LDHB	0.604	0.615	C0025521	InbornErrorsofMetabolism	group	C16;C18	DiseaseorSyndrome;CongenitalAbnormality	0.30	1	1990	1990	1	0	CTD_human
val	3945	LDHB	0.604	0.615	C0027626	NeoplasmInvasiveness	phenotype	C23;C04	PathologicFunction	0.30	1	2004	2004	1	0	CTD_human
val	3945	LDHB	0.604	0.615	C0033578	ProstaticNeoplasms	group	C04;C12	NeoplasticProcess	0.30	1	2007	2007	1	0	CTD_human
val	3945	LDHB	0.604	0.615	C0279702	Conventional(ClearCell)RenalCellCarcinoma	disease	C04;C13;C12	NeoplasticProcess	0.30	1	2004	2004	1	0	CTD_human
val	3945	LDHB	0.604	0.615	C0376358	Malignantneoplasmofprostate	disease	C04;C12	NeoplasticProcess	0.32	1	2006	2018	1	0	CTD_human
val	3945	LDHB	0.604	0.615	C0678222	BreastCarcinoma	disease	C04;C17	NeoplasticProcess	0.34	1	2012	2018	1	0	CTD_human
val	3945	LDHB	0.604	0.615	C0948089	AcuteCoronarySyndrome	disease	C14	DiseaseorSyndrome	0.30	1	2011	2011	1	0	CTD_human
val	3945	LDHB	0.604	0.615	C1257931	MammaryNeoplasms,Human	disease	C04;C17	NeoplasticProcess	0.30	1	2013	2013	1	0	CTD_human
val	3945	LDHB	0.604	0.615	C1266042	ChromophobeRenalCellCarcinoma	disease	C04;C13;C12	NeoplasticProcess	0.30	1	2004	2004	1	0	CTD_human
val	3945	LDHB	0.604	0.615	C1266043	SarcomatoidRenalCellCarcinoma	disease	C04;C13;C12	NeoplasticProcess	0.30	1	2004	2004	1	0	CTD_human
val	3945	LDHB	0.604	0.615	C1266044	CollectingDuctCarcinomaoftheKidney	disease	C04;C13;C12	NeoplasticProcess	0.30	1	2004	2004	1	0	CTD_human
val	3945	LDHB	0.604	0.615	C1306837	PapillaryRenalCellCarcinoma	disease	C04;C13;C12	NeoplasticProcess	0.30	1	2004	2004	1	0	CTD_human
val	3945	LDHB	0.604	0.615	C1332347	AtypicalDuctalBreastHyperplasia	disease	C04	NeoplasticProcess	0.30	1	2013	2013	1	0	CTD_human
val	3945	LDHB	0.604	0.615	C1458155	MammaryNeoplasms	group	C04;C17	NeoplasticProcess	0.30	1	2013	2013	1	0	CTD_human
val	3945	LDHB	0.604	0.615	C3279904	LactateDehydrogenaseBDeficiency	disease	C16;C18	DiseaseorSyndrome	0.70	1	1990	2001	8	5	CTD_human;ORPHANET;UNIPROT
val	3945	LDHB	0.604	0.615	C4704874	MammaryCarcinoma,Human	disease	C04;C17	NeoplasticProcess	0.30	1	2013	2013	1	0	CTD_human
val	3948	LDHC	0.711	0.5	C0021364	Maleinfertility	phenotype	C12	DiseaseorSyndrome	0.30	1	2011	2013	2	0	CTD_human
val	3948	LDHC	0.711	0.5	C0024115	Lungdiseases	group	C08	DiseaseorSyndrome	0.30	1	2011	2011	1	0	CTD_human
val	3948	LDHC	0.711	0.5	C0848676	Subfertility,Male	phenotype	C12	SignorSymptom	0.30	1	2011	2013	2	0	CTD_human
val	3948	LDHC	0.711	0.5	C0917731	Malesterility	phenotype	C12	Finding	0.30	1	2011	2013	2	0	CTD_human
val	3949	LDLR	0.449	0.885	C0004153	Atherosclerosis	disease	C14	DiseaseorSyndrome	0.70	0.984	1980	2020	5	1	CTD_human
val	3949	LDLR	0.449	0.885	C0010054	CoronaryArteriosclerosis	disease	C14	DiseaseorSyndrome	0.40	0.986	1988	2020	2	0	CTD_human
val	3949	LDLR	0.449	0.885	C0010068	Coronaryheartdisease	disease	C14	DiseaseorSyndrome	0.50	0.967	1986	2020	1	2	CTD_human
val	3949	LDLR	0.449	0.885	C0015695	FattyLiver	disease	C06	DiseaseorSyndrome	0.64	1	1997	2019	1	0	CTD_human
val	3949	LDLR	0.449	0.885	C0020443	Hypercholesterolemia	disease	C18	DiseaseorSyndrome	0.90	0.977	1982	2020	6	9	CTD_human;GENOMICS_ENGLAND
val	3949	LDLR	0.449	0.885	C0020445	Hypercholesterolemia,Familial	disease	C16;C18	DiseaseorSyndrome	0.90	0.982	1964	2020	9	1252	CTD_human;GENOMICS_ENGLAND
val	3949	LDLR	0.449	0.885	C0020473	Hyperlipidemia	disease	C18	DiseaseorSyndrome	0.50	1	1990	2020	2	0	CTD_human
val	3949	LDLR	0.449	0.885	C0020507	Hyperplasia	phenotype	C23	PathologicFunction	0.30	1	1997	1997	1	0	CTD_human
val	3949	LDLR	0.449	0.885	C0028754	Obesity	disease	C23;C18	DiseaseorSyndrome	0.40	1	1992	2018	1	0	CTD_human
val	3949	LDLR	0.449	0.885	C0034362	QFever	disease	C01	DiseaseorSyndrome	0.30	1	2006	2006	1	0	CTD_human
val	3949	LDLR	0.449	0.885	C0085762	Alcoholabuse	disease	C25;F03	MentalorBehavioralDysfunction	0.31	1	2006	2006	1	0	PSYGENET
val	3949	LDLR	0.449	0.885	C0242339	Dyslipidemias	group	C18	DiseaseorSyndrome	0.40	0.917	1996	2019	1	0	CTD_human
val	3949	LDLR	0.449	0.885	C0400966	Non-alcoholicFattyLiverDisease	disease	C06	DiseaseorSyndrome	0.37	1	2009	2016	3	0	CTD_human
val	3949	LDLR	0.449	0.885	C0519066	AcuteQfever	disease	C01	DiseaseorSyndrome	0.30	1	2006	2006	1	0	CTD_human
val	3949	LDLR	0.449	0.885	C0598784	Dyslipoproteinemias	phenotype	C18	PathologicFunction	0.30	1	2010	2010	1	0	CTD_human
val	3949	LDLR	0.449	0.885	C0745103	HyperlipoproteinemiaTypeIIa	disease	C16;C18	DiseaseorSyndrome	0.80	0.977	1975	2020	61	548	CTD_human;GENOMICS_ENGLAND;UNIPROT
val	3949	LDLR	0.449	0.885	C1443892	ChronicQFever	disease	C01	DiseaseorSyndrome	0.30	1	2006	2006	1	0	CTD_human
val	3949	LDLR	0.449	0.885	C1563937	Atherogenesis	phenotype	C14	PathologicFunction	0.30	1	2002	2017	5	0	CTD_human
val	3949	LDLR	0.449	0.885	C1704417	HyperlipoproteinemiaTypeIIb	disease	C16;C18	DiseaseorSyndrome	0.40	1	1990	2017	7	0	CTD_human
val	3949	LDLR	0.449	0.885	C1706412	Lipidemias	phenotype	C18	Finding	0.30	1	2002	2015	2	0	CTD_human
val	3949	LDLR	0.449	0.885	C1862939	AMYOTROPHICLATERALSCLEROSIS1	disease	C18;C10	DiseaseorSyndrome	0.30	1	2002	2002	1	0	CTD_human
val	3949	LDLR	0.449	0.885	C1862941	AmyotrophicLateralSclerosis,Sporadic	disease	C18;C10	DiseaseorSyndrome	0.30	1	2002	2002	1	0	CTD_human
val	3949	LDLR	0.449	0.885	C1956346	CoronaryArteryDisease	disease	C14	DiseaseorSyndrome	0.50	0.989	1986	2020	2	2	CTD_human
val	3949	LDLR	0.449	0.885	C2711227	Steatohepatitis	disease	C06	DiseaseorSyndrome	0.43	1	2011	2019	1	0	CTD_human
val	3949	LDLR	0.449	0.885	C2973787	CoxiellaburnetiiInfection	disease	C01	DiseaseorSyndrome	0.30	1	2006	2006	1	0	CTD_human
val	3949	LDLR	0.449	0.885	C3241937	NonalcoholicSteatohepatitis	disease	C06	DiseaseorSyndrome	0.32	1	2010	2020	3	0	CTD_human
val	3949	LDLR	0.449	0.885	C4551993	AmyotrophicLateralSclerosis,Familial	disease	C18;C10	DiseaseorSyndrome	0.30	1	2002	2002	1	0	CTD_human
val	3950	LECT2	0.653	0.5	C0024121	LungNeoplasms	group	C04;C08	NeoplasticProcess	0.30	1	2018	2018	1	0	CTD_human
val	3950	LECT2	0.653	0.5	C0027627	NeoplasmMetastasis	phenotype	C23;C04	NeoplasticProcess	0.31	1	2018	2018	1	0	CTD_human
val	3950	LECT2	0.653	0.5	C0027659	Neoplasms,Experimental	phenotype	C04	NeoplasticProcess;ExperimentalModelofDisease	0.30	1	2018	2018	1	0	CTD_human
val	3950	LECT2	0.653	0.5	C0242379	Malignantneoplasmoflung	disease	C04;C08	NeoplasticProcess	0.31	1	2018	2018	1	0	CTD_human
val	3950	LECT2	0.653	0.5	C0243038	Carcinoma,LewisLung	disease	C04	NeoplasticProcess;ExperimentalModelofDisease	0.31	1	2018	2018	1	0	CTD_human
val	3952	LEP	0.349	0.846	C0001973	AlcoholicIntoxication,Chronic	disease	C25;F03	MentalorBehavioralDysfunction	0.33	1	2015	2019	1	0	PSYGENET
val	3952	LEP	0.349	0.846	C0002152	AlloxanDiabetes	disease	C18;C19	ExperimentalModelofDisease	0.30	1	2017	2017	1	0	CTD_human
val	3952	LEP	0.349	0.846	C0002395	AlzheimersDisease	disease	C10;F03	DiseaseorSyndrome	0.6	0.944	2004	2019	1	0	CTD_human
14129	3952	LEP	0.349	0.846	C0011860	DiabetesMellitus,Non-Insulin-Dependent	disease	C18;C19	DiseaseorSyndrome	0.6	0.952	1996	2020	1	0	CTD_human
14130	3952	LEP	0.349	0.846	C0015695	FattyLiver	disease	C06	DiseaseorSyndrome	0.6	1	2003	2020	6	0	CTD_human
14133	3952	LEP	0.349	0.846	C0020443	Hypercholesterolemia	disease	C18	DiseaseorSyndrome	0.54	1	2012	2017	1	0	CTD_human
14135	3952	LEP	0.349	0.846	C0020459	Hyperinsulinism	disease	C18	DiseaseorSyndrome	0.7	0.976	1997	2020	1	0	CTD_human
14138	3952	LEP	0.349	0.846	C0020538	Hypertensivedisease	group	C14	DiseaseorSyndrome	0.6	0.972	1998	2020	4	0	CTD_human
14139	3952	LEP	0.349	0.846	C0020619	Hypogonadism	disease	C19	DiseaseorSyndrome	0.65	1	1998	2017	2	0	CTD_human
14146	3952	LEP	0.349	0.846	C0028754	Obesity	disease	C23;C18	DiseaseorSyndrome	0.7	0.952	1973	2020	14	0	CTD_human
14170	3952	LEP	0.349	0.846	C0271650	Impairedglucosetolerance	phenotype	C18	DiseaseorSyndrome	0.6	0.944	1996	2020	2	0	CTD_human
14183	3952	LEP	0.349	0.846	C0524620	MetabolicSyndromeX	disease	C18	DiseaseorSyndrome	0.6	0.992	1976	2019	2	0	CTD_human
14206	4129	MAOB	0.533	0.808	C0030567	ParkinsonDisease	disease	C10	DiseaseorSyndrome	0.6	0.991	1993	2020	1	0	CTD_human
14217	4129	MAOB	0.533	0.808	C0750900	AlzheimersDisease,FocalOnset	disease	C10;F03	MentalorBehavioralDysfunction	0.30	1	1994	2011	2	0	CTD_human
val	4129	MAOB	0.533	0.808	C0750901	AlzheimerDisease,EarlyOnset	disease	C10;F03	DiseaseorSyndrome	0.30	1	1994	2011	2	0	CTD_human
val	4129	MAOB	0.533	0.808	C0751197	FulminantHepaticFailurewithCerebralEdema	disease	C06;C18;C10	DiseaseorSyndrome	0.30	1	1999	1999	1	0	CTD_human
val	4129	MAOB	0.533	0.808	C0751198	HepaticStupor	disease	C06;C18;C10	DiseaseorSyndrome	0.30	1	1999	1999	1	0	CTD_human
val	4129	MAOB	0.533	0.808	C0751207	Akinetic-RigidVariantofHuntingtonDisease	disease	C16;C10;F03	DiseaseorSyndrome	0.30	1	2011	2011	1	0	CTD_human
val	4129	MAOB	0.533	0.808	C0751208	JuvenileHuntingtonDisease	disease	C16;C10;F03	DiseaseorSyndrome	0.30	1	2011	2011	1	0	CTD_human
val	4129	MAOB	0.533	0.808	C1257877	Pheochromocytoma,Extra-Adrenal	disease	C04	NeoplasticProcess	0.30	1	2012	2012	1	0	CTD_human
val	4129	MAOB	0.533	0.808	C1269683	MajorDepressiveDisorder	disease	F03	MentalorBehavioralDysfunction	0.35	1	2007	2019	2	0	PSYGENET
val	4129	MAOB	0.533	0.808	C2936349	Plaque,Amyloid	disease	C23	AcquiredAbnormality	0.30	1	1994	1994	1	0	CTD_human
val	4131	MAP1B	0.628	0.5	C0009402	ColorectalCarcinoma	disease	C06;C04	NeoplasticProcess	0.30				0	2	UNIPROT
val	4131	MAP1B	0.628	0.5	C1868720	PeriventricularNodularHeterotopia	disease	C16;C10	DiseaseorSyndrome	0.42	1	2018	2019	1	4	ORPHANET
val	4131	MAP1B	0.628	0.5	C3714756	IntellectualDisability	group	C23;C10;F03;F01	MentalorBehavioralDysfunction	0.33	1	2015	2019	1	0	GENOMICS_ENGLAND
val	4133	MAP2	0.537	0.692	C0000786	Spontaneousabortion	phenotype	C13	PathologicFunction	0.30	1	2008	2008	1	0	CTD_human
val	4133	MAP2	0.537	0.692	C0000822	Abortion,Tubal	phenotype	C13	PathologicFunction	0.30	1	2008	2008	1	0	CTD_human
val	4133	MAP2	0.537	0.692	C0005586	BipolarDisorder	disease	F03	MentalorBehavioralDysfunction	0.30	1	2004	2004	1	0	PSYGENET
val	4133	MAP2	0.537	0.692	C0009402	ColorectalCarcinoma	disease	C06;C04	NeoplasticProcess	0.30				0	1	UNIPROT
val	4133	MAP2	0.537	0.692	C0030567	ParkinsonDisease	disease	C10	DiseaseorSyndrome	0.30	1	2019	2019	1	0	CTD_human
val	4133	MAP2	0.537	0.692	C0041696	UnipolarDepression	disease	F03	MentalorBehavioralDysfunction	0.30	1	2004	2004	1	0	PSYGENET
val	4133	MAP2	0.537	0.692	C0087031	Juvenile-OnsetStillDisease	disease	C17;C05;C20	DiseaseorSyndrome	0.30	1	2009	2009	1	0	CTD_human
val	4133	MAP2	0.537	0.692	C0525045	MoodDisorders	group	F03	MentalorBehavioralDysfunction	0.32	1	2004	2017	1	0	PSYGENET
val	4133	MAP2	0.537	0.692	C0752347	LewyBodyDisease	disease	C10;F03	DiseaseorSyndrome	0.30	1	2019	2019	1	0	CTD_human
val	4133	MAP2	0.537	0.692	C1269683	MajorDepressiveDisorder	disease	F03	MentalorBehavioralDysfunction	0.30	1	2004	2004	1	0	PSYGENET
val	4133	MAP2	0.537	0.692	C3495559	Juvenilearthritis	disease	C17;C05;C20	DiseaseorSyndrome	0.30	1	2009	2009	1	0	CTD_human
val	4133	MAP2	0.537	0.692	C3714758	Juvenilepsoriaticarthritis	disease	C17;C05;C20	DiseaseorSyndrome	0.30	1	2009	2009	1	0	CTD_human
val	4133	MAP2	0.537	0.692	C3830362	EarlyPregnancyLoss	phenotype	C13	Finding	0.30	1	2008	2008	1	0	CTD_human
val	4133	MAP2	0.537	0.692	C4552091	Polyarthritis,Juvenile,RheumatoidFactorNegative	disease	C17;C05;C20	DiseaseorSyndrome	0.30	1	2009	2009	1	0	CTD_human
val	4133	MAP2	0.537	0.692	C4552766	Miscarriage	disease	C13	DiseaseorSyndrome	0.30	1	2008	2008	1	0	CTD_human
val	4133	MAP2	0.537	0.692	C4704862	Polyarthritis,Juvenile,RheumatoidFactorPositive	disease	C17;C05;C20	DiseaseorSyndrome	0.30	1	2009	2009	1	0	CTD_human
val	4134	MAP4	0.682	0.5	C0043094	WeightGain	phenotype	C23	Finding	0.30	1	2008	2008	1	0	CTD_human
val	4135	MAP6	0.578	0.769	C0036341	Schizophrenia	disease	F03	MentalorBehavioralDysfunction	0.57	1	2002	2018	4	0	PSYGENET
val	4135	MAP6	0.578	0.769	C0085633	Moodswings	disease	C10;F03;F01	MentalorBehavioralDysfunction	0.30	1	2012	2012	1	0	PSYGENET
val	4135	MAP6	0.578	0.769	C0751217	Hyperkinesia,Generalized	phenotype	C23;C10	SignorSymptom	0.30	1	2005	2005	1	0	CTD_human
val	4135	MAP6	0.578	0.769	C2678117	Schizophrenia-likesymptoms(uncommon)	phenotype		Finding	0.30	1	2010	2010	1	0	PSYGENET
val	4135	MAP6	0.578	0.769	C3887506	Hyperkinesia	phenotype	C23;C10	DiseaseorSyndrome	0.30	1	2005	2005	1	0	CTD_human
val	4137	MAPT	0.446	0.923	C0002395	AlzheimersDisease	disease	C10;F03	DiseaseorSyndrome	0.7	0.99	1988	2020	7	1	CTD_human
14230	4137	MAPT	0.446	0.923	C0038868	Progressivesupranuclearpalsy	disease	C23;C11;C10	DiseaseorSyndrome	0.7	0.953	1995	2019	4	2	CTD_human;ORPHANET
14235	4137	MAPT	0.446	0.923	C0236642	PickDiseaseoftheBrain	disease	C10;F03	DiseaseorSyndrome	0.8	0.975	1998	2020	6	7	CTD_human;GENOMICS_ENGLAND;UNIPROT
14236	4137	MAPT	0.446	0.923	C0242422	ParkinsonianDisorders	group	C10	DiseaseorSyndrome	0.7	1	1998	2019	2	0	CTD_human
14240	4137	MAPT	0.446	0.923	C0338451	Frontotemporaldementia	disease	C18;C10;F03	DiseaseorSyndrome	0.8	0.978	1997	2020	27	20	CTD_human;GENOMICS_ENGLAND;UNIPROT
14241	4137	MAPT	0.446	0.923	C0338462	SemanticDementia	disease	C18;C10;F03	MentalorBehavioralDysfunction	0.56	1	1998	2017	7	0	CTD_human;ORPHANET
14291	4353	MPO	0.377	0.923	C0398595	MyeloperoxidaseDeficiency	disease	C16;C18	DiseaseorSyndrome	0.8	0.824	1979	2019	5	9	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
14302	4524	MTHFR	0.337	0.885	C0005586	BipolarDisorder	disease	F03	MentalorBehavioralDysfunction	0.6	1	2006	2015	6	0	CTD_human;PSYGENET
14322	4524	MTHFR	0.337	0.885	C0011581	Depressivedisorder	disease	F03	MentalorBehavioralDysfunction	0.6	1	1997	2019	6	0	CTD_human;PSYGENET
14376	4524	MTHFR	0.337	0.885	C0041696	UnipolarDepression	disease	F03	MentalorBehavioralDysfunction	0.6	1	1997	2020	6	0	CTD_human;PSYGENET
14425	4609	MYC	0.344	0.923	C0345904	Malignantneoplasmofliver	disease	C06;C04	NeoplasticProcess	0.59	1	1996	2019	2	0	CTD_human
14441	4609	MYC	0.344	0.923	C2239176	Livercarcinoma	disease	C06;C04	NeoplasticProcess	0.6	1	1985	2020	4	0	CTD_human
14467	4613	MYCN	0.454	0.808	C0027819	Neuroblastoma	disease	C04	NeoplasticProcess	0.7	0.971	1984	2020	14	0	CGI;CTD_human;ORPHANET
14473	4613	MYCN	0.454	0.808	C0796068	Oculodigitoesophagoduodenalsyndrome	disease	C23;C16;C06;C05;C08;C10;F03;F01	DiseaseorSyndrome	0.65	1	1997	2012	4	1	CTD_human;ORPHANET
14480	4613	MYCN	0.454	0.808	C4551774	FEINGOLDSYNDROME1	disease	C23;C16;C06;C05;C08;C10;F03;F01	DiseaseorSyndrome	0.71	0.75	2005	2018	3	11	GENOMICS_ENGLAND;ORPHANET;UNIPROT
14490	4615	MYD88	0.414	0.923	C0024419	WaldenstromMacroglobulinemia	disease	C04;C20;C15;C14	NeoplasticProcess	0.7	0.965	2012	2019	3	0	CGI;CTD_human;ORPHANET
14496	4615	MYD88	0.414	0.923	C0079744	DiffuseLargeB-CellLymphoma	disease	C04;C20;C15	NeoplasticProcess	0.6	0.953	2012	2020	1	0	CGI;CTD_human
14509	4615	MYD88	0.414	0.923	C2677092	MYD88Deficiency	disease	C16;C20	DiseaseorSyndrome	0.76	0.909	2008	2019	5	4	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
14534	4846	NOS3	0.378	0.885	C0011860	DiabetesMellitus,Non-Insulin-Dependent	disease	C18;C19	DiseaseorSyndrome	0.6	0.9	1999	2019	2	0	CTD_human
14535	4846	NOS3	0.378	0.885	C0011875	DiabeticAngiopathies	disease	C19;C14	DiseaseorSyndrome	0.52	1	2002	2017	1	0	CTD_human
14536	4846	NOS3	0.378	0.885	C0011881	DiabeticNephropathy	disease	C13;C12;C19	DiseaseorSyndrome	0.6	0.941	2000	2019	1	0	CTD_human
14538	4846	NOS3	0.378	0.885	C0015934	FetalGrowthRetardation	phenotype	C23;C16;C13	DiseaseorSyndrome	0.69	0.917	2009	2019	1	0	CTD_human
14541	4846	NOS3	0.378	0.885	C0018800	Cardiomegaly	phenotype	C23;C14	Finding	0.51	1	2001	2018	4	0	CTD_human
14542	4846	NOS3	0.378	0.885	C0018801	Heartfailure	disease	C14	DiseaseorSyndrome	0.6	0.9	2004	2018	2	0	CTD_human
14543	4846	NOS3	0.378	0.885	C0018802	Congestiveheartfailure	disease	C14	DiseaseorSyndrome	0.6	0.926	2003	2019	2	0	CTD_human
14548	4846	NOS3	0.378	0.885	C0020473	Hyperlipidemia	disease	C18	DiseaseorSyndrome	0.53	1	2001	2018	1	0	CTD_human
14549	4846	NOS3	0.378	0.885	C0020538	Hypertensivedisease	group	C14	DiseaseorSyndrome	0.7	0.942	1996	2019	5	1	CTD_human
14550	4846	NOS3	0.378	0.885	C0020541	PortalHypertension	disease	C06	DiseaseorSyndrome	0.51	1	2000	2017	1	0	CTD_human
14564	4846	NOS3	0.378	0.885	C0027051	MyocardialInfarction	disease	C23;C14	DiseaseorSyndrome	0.6	0.915	1998	2019	2	0	CTD_human
14568	4846	NOS3	0.378	0.885	C0032914	Pre-Eclampsia	phenotype	C13	PathologicFunction	0.68	1	2001	2017	0	0	CTD_human
14570	4846	NOS3	0.378	0.885	C0034063	PulmonaryEdema	phenotype	C08	PathologicFunction	0.51	1	2002	2006	1	0	CTD_human
14581	4846	NOS3	0.378	0.885	C0085580	EssentialHypertension	disease	C14	DiseaseorSyndrome	0.6	0.917	1995	2018	0	0	CTD_human
14595	4846	NOS3	0.378	0.885	C0242350	Erectiledysfunction	disease	C12;F03	DiseaseorSyndrome	0.6	1	1999	2019	2	0	CTD_human
14605	4846	NOS3	0.378	0.885	C0524620	MetabolicSyndromeX	disease	C18	DiseaseorSyndrome	0.6	1	2003	2019	3	0	CTD_human
14610	4846	NOS3	0.378	0.885	C0750900	AlzheimersDisease,FocalOnset	disease	C10;F03	MentalorBehavioralDysfunction	0.30	1	1999	2006	2	0	CTD_human
val	4846	NOS3	0.378	0.885	C0750901	AlzheimerDisease,EarlyOnset	disease	C10;F03	DiseaseorSyndrome	0.30	1	1999	2006	2	0	CTD_human
val	4846	NOS3	0.378	0.885	C0751010	CerebralInfarction,LeftHemisphere	phenotype	C23;C10;C14	DiseaseorSyndrome	0.30				0	0	CTD_human
val	4846	NOS3	0.378	0.885	C0751011	CerebralInfarction,RightHemisphere	phenotype	C23;C10;C14	DiseaseorSyndrome	0.30				0	0	CTD_human
val	4846	NOS3	0.378	0.885	C0751012	AnteriorChoroidalArteryInfarction	phenotype	C23;C10;C14	DiseaseorSyndrome	0.30				0	0	CTD_human
val	4846	NOS3	0.378	0.885	C0751014	SubcorticalInfarction	disease	C23;C10;C14	DiseaseorSyndrome	0.30				0	0	CTD_human
val	4846	NOS3	0.378	0.885	C0848676	Subfertility,Male	phenotype	C12	SignorSymptom	0.30	1	2014	2014	1	0	CTD_human
val	4846	NOS3	0.378	0.885	C0852036	Pregnancyassociatedhypertension	phenotype	C13;C14	DiseaseorSyndrome	0.40	0.846	1997	2017	1	0	CTD_human
val	4846	NOS3	0.378	0.885	C0887799	PosteriorChoroidalArteryInfarction	phenotype	C23;C10;C14	DiseaseorSyndrome	0.30				0	0	CTD_human
val	4846	NOS3	0.378	0.885	C0917731	Malesterility	phenotype	C12	Finding	0.30	1	2014	2014	1	0	CTD_human
val	4846	NOS3	0.378	0.885	C0920563	InsulinSensitivity	phenotype	C18	PathologicFunction	0.30	1	2001	2009	4	0	CTD_human
val	4846	NOS3	0.378	0.885	C1257931	MammaryNeoplasms,Human	disease	C04;C17	NeoplasticProcess	0.30	1	2004	2009	2	0	CTD_human
val	4846	NOS3	0.378	0.885	C1257963	EndogenousHyperinsulinism	disease	C18	DiseaseorSyndrome	0.30	1	2009	2009	1	0	CTD_human
val	4846	NOS3	0.378	0.885	C1257964	ExogenousHyperinsulinism	disease	C18	DiseaseorSyndrome	0.30	1	2009	2009	1	0	CTD_human
val	4846	NOS3	0.378	0.885	C1257965	CompensatoryHyperinsulinemia	disease	C18	DiseaseorSyndrome	0.30	1	2009	2009	1	0	CTD_human
val	4846	NOS3	0.378	0.885	C1306571	HepaticInsufficiency	phenotype	C06	PathologicFunction	0.30	1	2018	2018	1	0	CTD_human
val	4846	NOS3	0.378	0.885	C1383860	CardiacHypertrophy	phenotype	C23;C14	PathologicFunction	0.30	1	2001	2006	4	0	CTD_human
val	4846	NOS3	0.378	0.885	C1458155	MammaryNeoplasms	group	C04;C17	NeoplasticProcess	0.36	1	2004	2009	2	0	CTD_human
val	4846	NOS3	0.378	0.885	C1527303	ChronicAirflowObstruction	disease	C08	DiseaseorSyndrome	0.30	1	2012	2012	1	0	CTD_human
val	4846	NOS3	0.378	0.885	C1563937	Atherogenesis	phenotype	C14	PathologicFunction	0.30	1	2002	2010	2	0	CTD_human
val	4846	NOS3	0.378	0.885	C1565662	AcuteKidneyInsufficiency	disease	C13;C12	DiseaseorSyndrome	0.30	1	1998	1998	1	0	CTD_human
val	4846	NOS3	0.378	0.885	C1706412	Lipidemias	phenotype	C18	Finding	0.30	1	2001	2001	1	0	CTD_human
val	4846	NOS3	0.378	0.885	C1708349	HereditaryDiffuseGastricCancer	disease	C06;C04	NeoplasticProcess	0.30	1	2006	2006	1	0	CTD_human
val	4846	NOS3	0.378	0.885	C1719672	SevereSepsis	disease	C23;C01	DiseaseorSyndrome	0.31	1	2010	2011	1	0	CTD_human
val	4846	NOS3	0.378	0.885	C1837218	Cleftpalate,isolated	disease	C16;C05;C07	CongenitalAbnormality	0.30	1	2011	2011	1	0	CTD_human
val	4846	NOS3	0.378	0.885	C1855520	Hyperglycemia,Postprandial	phenotype	C18	Finding	0.30	1	2001	2001	1	0	CTD_human
val	4846	NOS3	0.378	0.885	C1956346	CoronaryArteryDisease	disease	C14	DiseaseorSyndrome	0.50	0.918	1996	2020	4	1	CTD_human
val	4846	NOS3	0.378	0.885	C1959583	MyocardialFailure	disease	C14	DiseaseorSyndrome	0.30	1	2009	2010	2	0	CTD_human
val	4846	NOS3	0.378	0.885	C1961112	HeartDecompensation	phenotype	C14	PathologicFunction	0.30	1	2009	2010	2	0	CTD_human
val	4846	NOS3	0.378	0.885	C2585653	Persistentatrialfibrillation	phenotype	C23;C14	PathologicFunction	0.30	1	2001	2001	1	0	CTD_human
val	4846	NOS3	0.378	0.885	C2609414	Acutekidneyinjury	disease	C13;C12	InjuryorPoisoning	0.50	1	1998	2017	1	0	CTD_human
val	4846	NOS3	0.378	0.885	C3468561	familialatrialfibrillation	phenotype	C23;C14	PathologicFunction	0.30	1	2001	2001	1	0	CTD_human
val	4846	NOS3	0.378	0.885	C3837958	DiabetesMellitus,Ketosis-Prone	disease	C18;C20;C19	DiseaseorSyndrome	0.30	1	2011	2011	1	0	CTD_human
val	4846	NOS3	0.378	0.885	C4551595	BiliaryCirrhosis,Primary,1	disease	C23;C06	DiseaseorSyndrome	0.30	1	2018	2018	1	0	CTD_human
val	4846	NOS3	0.378	0.885	C4554117	DiabetesMellitus,Sudden-Onset	disease	C18;C20;C19	DiseaseorSyndrome	0.30	1	2011	2011	1	0	CTD_human
val	4846	NOS3	0.378	0.885	C4704874	MammaryCarcinoma,Human	disease	C04;C17	NeoplasticProcess	0.30	1	2004	2009	2	0	CTD_human
val	4849	CNOT3	0.686	0.615	C0033578	ProstaticNeoplasms	group	C04;C12	NeoplasticProcess	0.30	1	2018	2018	2	0	CTD_human
val	4849	CNOT3	0.686	0.615	C0376358	Malignantneoplasmofprostate	disease	C04;C12	NeoplasticProcess	0.30	1	2018	2018	2	0	CTD_human
val	4849	CNOT3	0.686	0.615	C1961099	PrecursorT-CellLymphoblasticLeukemia-Lymphoma	disease	C04;C20;C15	NeoplasticProcess	0.64	0.75	2013	2019	1	0	CGI;CTD_human;ORPHANET
val	4851	NOTCH1	0.369	0.885	C0000768	CongenitalAbnormality	group	C16	CongenitalAbnormality	0.40	1	2005	2019	1	0	CTD_human
val	4851	NOTCH1	0.369	0.885	C0004114	Astrocytoma	disease	C04	NeoplasticProcess	0.32	1	2010	2013	1	0	CTD_human
val	4851	NOTCH1	0.369	0.885	C0005684	Malignantneoplasmofurinarybladder	disease	C04;C13;C12	NeoplasticProcess	0.37	1	2014	2019	0	0	CGI
val	4851	NOTCH1	0.369	0.885	C0005695	BladderNeoplasm	disease	C04;C13;C12	NeoplasticProcess	0.36	1	2014	2019	0	0	CGI
val	4851	NOTCH1	0.369	0.885	C0006142	Malignantneoplasmofbreast	disease	C04;C17	NeoplasticProcess	0.60	1	2004	2020	2	0	CGI;CTD_human
val	4851	NOTCH1	0.369	0.885	C0006663	Calcinosis	phenotype	C18	PathologicFunction	0.30	1	2011	2011	1	0	CTD_human
val	4851	NOTCH1	0.369	0.885	C0006826	MalignantNeoplasms	group	C04	NeoplasticProcess	0.40	0.943	1999	2019	0	0	CGI
val	4851	NOTCH1	0.369	0.885	C0007102	Malignanttumorofcolon	disease	C06;C04	NeoplasticProcess	0.36	1	2009	2017	1	0	CTD_human
val	4851	NOTCH1	0.369	0.885	C0007114	Malignantneoplasmofskin	disease	C04;C17	NeoplasticProcess	0.33	1	2008	2018	1	0	CTD_human
val	4851	NOTCH1	0.369	0.885	C0007137	Squamouscellcarcinoma	disease	C04	NeoplasticProcess	0.60	0.935	2007	2019	1	0	CGI;CTD_human
val	4851	NOTCH1	0.369	0.885	C0007621	NeoplasticCellTransformation	phenotype	C23;C04	NeoplasticProcess	0.30	1	2012	2012	1	0	CTD_human
val	4851	NOTCH1	0.369	0.885	C0007873	UterineCervicalNeoplasm	disease	C04;C13	NeoplasticProcess	0.30	1	2014	2014	1	0	CTD_human
val	4851	NOTCH1	0.369	0.885	C0009375	ColonicNeoplasms	group	C06;C04	NeoplasticProcess	0.30	1	2009	2009	1	0	CTD_human
val	4851	NOTCH1	0.369	0.885	C0009782	ConnectiveTissueDiseases	group	C17	DiseaseorSyndrome	0.40	1	2006	2006	1	1	GENOMICS_ENGLAND
val	4851	NOTCH1	0.369	0.885	C0010606	AdenoidCysticCarcinoma	disease	C04	NeoplasticProcess	0.44	1	2013	2018	1	2	CTD_human
val	4851	NOTCH1	0.369	0.885	C0017636	Glioblastoma	disease	C04	NeoplasticProcess	0.40	0.929	2010	2019	1	0	CTD_human
val	4851	NOTCH1	0.369	0.885	C0018824	Heartvalvedisease	group	C14	DiseaseorSyndrome	0.30	1	2011	2011	1	0	CTD_human
val	4851	NOTCH1	0.369	0.885	C0019193	Hepatitis,Toxic	disease	C06;C25	InjuryorPoisoning	0.30	1	2019	2019	1	0	CTD_human
val	4851	NOTCH1	0.369	0.885	C0023449	Acutelymphocyticleukemia	disease	C04;C20;C15	NeoplasticProcess	0.40	1	2005	2019	1	0	GENOMICS_ENGLAND
val	4851	NOTCH1	0.369	0.885	C0023452	ChildhoodAcuteLymphoblasticLeukemia	disease	C04;C20;C15	NeoplasticProcess	0.36	1	2009	2017	1	0	GENOMICS_ENGLAND
val	4851	NOTCH1	0.369	0.885	C0023492	Leukemia,T-Cell	disease	C04;C20;C15	NeoplasticProcess	0.40	1	2006	2019	1	0	CTD_human
val	4851	NOTCH1	0.369	0.885	C0024299	Lymphoma	group	C04;C20;C15	NeoplasticProcess	0.40	1	1998	2019	1	0	CTD_human
val	4851	NOTCH1	0.369	0.885	C0027765	nervoussystemdisorder	group	C10	DiseaseorSyndrome	0.31	1	1998	2013	1	0	CTD_human
val	4851	NOTCH1	0.369	0.885	C0036439	Scoliosis,unspecified	disease	C05	DiseaseorSyndrome	0.30	1	2007	2007	1	0	CTD_human
val	4851	NOTCH1	0.369	0.885	C0037286	SkinNeoplasms	group	C04;C17	NeoplasticProcess	0.31	1	2012	2017	1	0	CTD_human
val	4851	NOTCH1	0.369	0.885	C0038002	Splenomegaly	phenotype	C23	Finding	0.30	1	2015	2015	1	0	CTD_human
val	4851	NOTCH1	0.369	0.885	C0149630	Bicuspidaorticvalve	disease	C14	CongenitalAbnormality	0.70	0.955	2005	2019	2	0	CTD_human;ORPHANET
val	4851	NOTCH1	0.369	0.885	C0149782	Squamouscellcarcinomaoflung	disease	C04;C08	NeoplasticProcess	0.31	1	2019	2019	0	0	CGI
val	4851	NOTCH1	0.369	0.885	C0154017	Benignneoplasmofbladder	disease	C04;C13;C12	NeoplasticProcess	0.30				0	0	CGI
val	4851	NOTCH1	0.369	0.885	C0154091	Carcinomainsituofbladder	disease	C04;C13;C12	NeoplasticProcess	0.30				0	0	CGI
val	4851	NOTCH1	0.369	0.885	C0205768	SubependymalGiantCellAstrocytoma	disease	C04	NeoplasticProcess	0.30	1	2010	2010	1	0	CTD_human
val	4851	NOTCH1	0.369	0.885	C0263628	Tumoralcalcinosis	disease	C18	DiseaseorSyndrome	0.30	1	2011	2011	1	0	CTD_human
val	4851	NOTCH1	0.369	0.885	C0265268	AdamsOliversyndrome	disease	C16;C17	DiseaseorSyndrome	0.34	1	2014	2019	1	0	ORPHANET
val	4851	NOTCH1	0.369	0.885	C0279626	Squamouscellcarcinomaofesophagus	disease	C06;C04	NeoplasticProcess	0.39	0.8	2011	2019	1	0	CTD_human
val	4851	NOTCH1	0.369	0.885	C0280783	JuvenilePilocyticAstrocytoma	disease	C04	NeoplasticProcess	0.30	1	2010	2010	1	0	CTD_human
val	4851	NOTCH1	0.369	0.885	C0280785	DiffuseAstrocytoma	disease	C04	NeoplasticProcess	0.30	1	2010	2010	1	0	CTD_human
val	4851	NOTCH1	0.369	0.885	C0334579	Anaplasticastrocytoma	disease	C04	NeoplasticProcess	0.30	1	2010	2010	1	0	CTD_human
val	4851	NOTCH1	0.369	0.885	C0334580	Protoplasmicastrocytoma	disease	C04	NeoplasticProcess	0.30	1	2010	2010	1	0	CTD_human
val	4851	NOTCH1	0.369	0.885	C0334581	Gemistocyticastrocytoma	disease	C04	NeoplasticProcess	0.30	1	2010	2010	1	0	CTD_human
val	4851	NOTCH1	0.369	0.885	C0334582	FibrillaryAstrocytoma	disease	C04	NeoplasticProcess	0.30	1	2010	2010	1	0	CTD_human
val	4851	NOTCH1	0.369	0.885	C0334583	PilocyticAstrocytoma	disease	C04	NeoplasticProcess	0.30	1	2010	2010	1	0	CTD_human
val	4851	NOTCH1	0.369	0.885	C0334588	GiantCellGlioblastoma	disease	C04	NeoplasticProcess	0.30	1	2010	2010	1	0	CTD_human
val	4851	NOTCH1	0.369	0.885	C0334634	Malignantlymphoma,lymphocytic,intermediatedifferentiation,diffuse	disease	C04;C20;C15	NeoplasticProcess	0.33	1	2012	2019	0	0	CGI
val	4851	NOTCH1	0.369	0.885	C0338070	ChildhoodCerebralAstrocytoma	disease	C04	NeoplasticProcess	0.30	1	2010	2010	1	0	CTD_human
val	4851	NOTCH1	0.369	0.885	C0344917	Leftventricularoutflowtractobstruction	disease		CongenitalAbnormality	0.30				0	0	GENOMICS_ENGLAND
val	4851	NOTCH1	0.369	0.885	C0345050	Congenitalaneurysmofascendingaorta	disease	C14	CongenitalAbnormality	0.30	1	2006	2006	1	0	GENOMICS_ENGLAND
val	4851	NOTCH1	0.369	0.885	C0376634	CraniofacialAbnormalities	group	C16;C05	CongenitalAbnormality	0.30	1	2007	2007	1	0	CTD_human
val	4851	NOTCH1	0.369	0.885	C0428791	Aorticvalvecalcification	disease	C18;C14	DiseaseorSyndrome	0.65	1	2005	2020	1	0	CTD_human;ORPHANET
val	4851	NOTCH1	0.369	0.885	C0496930	Neoplasmofuncertainorunknownbehaviorofbladder	disease	C04;C13;C12	NeoplasticProcess	0.30				0	0	CGI
val	4851	NOTCH1	0.369	0.885	C0496956	Neoplasmofuncertainorunknownbehaviorofbreast	disease	C04;C17	NeoplasticProcess	0.30				0	0	CGI
val	4851	NOTCH1	0.369	0.885	C0521174	Microcalcification	phenotype	C18	PathologicFunction	0.30	1	2011	2011	1	0	CTD_human
val	4851	NOTCH1	0.369	0.885	C0547065	Mixedoligoastrocytoma	disease	C04	NeoplasticProcess	0.30	1	2010	2010	1	0	CTD_human
val	4851	NOTCH1	0.369	0.885	C0678222	BreastCarcinoma	disease	C04;C17	NeoplasticProcess	0.60	1	2004	2020	2	0	CGI;CTD_human
val	4851	NOTCH1	0.369	0.885	C0699885	Carcinomaofbladder	disease	C04;C13;C12	NeoplasticProcess	0.37	1	2013	2019	0	0	CGI
val	4851	NOTCH1	0.369	0.885	C0750935	CerebralAstrocytoma	disease	C04	NeoplasticProcess	0.30	1	2010	2010	1	0	CTD_human
val	4851	NOTCH1	0.369	0.885	C0750936	IntracranialAstrocytoma	disease	C04	NeoplasticProcess	0.30	1	2010	2010	1	0	CTD_human
val	4851	NOTCH1	0.369	0.885	C0751606	AdultAcuteLymphocyticLeukemia	disease		NeoplasticProcess	0.35	1	2009	2017	1	0	GENOMICS_ENGLAND
val	4851	NOTCH1	0.369	0.885	C0858252	Breastadenocarcinoma	disease	C04;C17	NeoplasticProcess	0.30				0	0	CGI
val	4851	NOTCH1	0.369	0.885	C0860207	Drug-InducedLiverDisease	phenotype	C06;C25	DiseaseorSyndrome	0.30	1	2019	2019	1	0	CTD_human
val	4851	NOTCH1	0.369	0.885	C0887833	Carcinoma,PancreaticDuctal	disease	C06;C04;C19	NeoplasticProcess	0.30	1	2009	2009	1	0	CTD_human
val	4851	NOTCH1	0.369	0.885	C1168401	Squamouscellcarcinomaoftheheadandneck	disease	C04	NeoplasticProcess	0.40	1	2011	2019	0	0	CGI
val	4851	NOTCH1	0.369	0.885	C1257931	MammaryNeoplasms,Human	disease	C04;C17	NeoplasticProcess	0.30	1	2010	2011	2	0	CTD_human
val	4851	NOTCH1	0.369	0.885	C1260873	Aorticvalvedisorder	disease	C14	DiseaseorSyndrome	0.36	1	2005	2016	1	0	ORPHANET
val	4851	NOTCH1	0.369	0.885	C1262760	Hepatitis,Drug-Induced	disease	C06;C25	DiseaseorSyndrome	0.30	1	2019	2019	1	0	CTD_human
val	4851	NOTCH1	0.369	0.885	C1458155	MammaryNeoplasms	group	C04;C17	NeoplasticProcess	0.38	1	2004	2018	2	0	CTD_human
val	4851	NOTCH1	0.369	0.885	C1621958	GlioblastomaMultiforme	disease	C04	NeoplasticProcess	0.40	0.952	2007	2019	1	0	CTD_human
val	4851	NOTCH1	0.369	0.885	C1704230	GradeIAstrocytoma	disease	C04	NeoplasticProcess	0.30	1	2010	2010	1	0	CTD_human
val	4851	NOTCH1	0.369	0.885	C1961099	PrecursorT-CellLymphoblasticLeukemia-Lymphoma	disease	C04;C20;C15	NeoplasticProcess	0.60	0.978	1998	2020	5	0	CGI;CTD_human
val	4851	NOTCH1	0.369	0.885	C2931779	Congenitaldefectofskullandscalp	disease	C16;C17;C05	CongenitalAbnormality	0.31	1	2014	2014	0	0	CTD_human
val	4851	NOTCH1	0.369	0.885	C3658290	Drug-InducedAcuteLiverInjury	disease	C06;C25	DiseaseorSyndrome	0.30	1	2019	2019	1	0	CTD_human
val	4851	NOTCH1	0.369	0.885	C3887892	AorticValveDisease1	disease	C16;C14	DiseaseorSyndrome	0.70	1	2005	2016	4	7	CTD_human;GENOMICS_ENGLAND;ORPHANET
val	4851	NOTCH1	0.369	0.885	C4014970	ADAMS-OLIVERSYNDROME5	disease		DiseaseorSyndrome	0.60	1	2014	2018	1	27	GENOMICS_ENGLAND;UNIPROT
val	4851	NOTCH1	0.369	0.885	C4048328	cervicalcancer	disease	C04;C13	NeoplasticProcess	0.37	1	2007	2019	1	0	CTD_human
val	4851	NOTCH1	0.369	0.885	C4277682	ChemicalandDrugInducedLiverInjury	disease	C06;C25	DiseaseorSyndrome	0.30	1	2019	2019	1	0	CTD_human
val	4851	NOTCH1	0.369	0.885	C4279912	Chemically-InducedLiverToxicity	disease	C06;C25	DiseaseorSyndrome	0.30	1	2019	2019	1	0	CTD_human
val	4851	NOTCH1	0.369	0.885	C4551482	Adams-Oliversyndrome1	disease	C16;C17;C05	DiseaseorSyndrome	0.56	1	2014	2019	1	0	CTD_human;GENOMICS_ENGLAND
val	4851	NOTCH1	0.369	0.885	C4704874	MammaryCarcinoma,Human	disease	C04;C17	NeoplasticProcess	0.30	1	2010	2011	2	0	CTD_human
val	4851	NOTCH1	0.369	0.885	C4707243	Familialthoracicaorticaneurysmandaorticdissection	disease		DiseaseorSyndrome	0.60	1	2005	2016	4	1	CLINGEN;GENOMICS_ENGLAND
val	4852	NPY	0.447	0.846	C0001956	AlcoholUseDisorder	disease	C25;F03	MentalorBehavioralDysfunction	0.31	1	2007	2017	1	0	CTD_human
val	4852	NPY	0.447	0.846	C0001973	AlcoholicIntoxication,Chronic	disease	C25;F03	MentalorBehavioralDysfunction	0.60	1	2001	2017	6	0	CTD_human;PSYGENET
val	4852	NPY	0.447	0.846	C0002395	AlzheimersDisease	disease	C10;F03	DiseaseorSyndrome	0.6	0.833	2000	2018	1	0	CTD_human
14611	4852	NPY	0.447	0.846	C0003123	Anorexia	disease	C23	DiseaseorSyndrome	0.57	1	2001	2019	3	0	CTD_human
14619	4852	NPY	0.447	0.846	C0011570	MentalDepression	disease	F01	MentalorBehavioralDysfunction	0.6	1	2002	2019	5	0	PSYGENET
14621	4852	NPY	0.447	0.846	C0011581	Depressivedisorder	disease	F03	MentalorBehavioralDysfunction	0.6	1	1998	2019	7	0	CTD_human;PSYGENET
14642	4852	NPY	0.447	0.846	C0041696	UnipolarDepression	disease	F03	MentalorBehavioralDysfunction	0.56	1	1998	2017	7	0	CTD_human;PSYGENET
14644	4852	NPY	0.447	0.846	C0085762	Alcoholabuse	disease	C25;F03	MentalorBehavioralDysfunction	0.72	1	2003	2017	3	0	CTD_human;PSYGENET
14679	4852	NPY	0.447	0.846	C0600427	CocaineDependence	disease	C25;F03	MentalorBehavioralDysfunction	0.51	1	2008	2009	2	0	CTD_human;PSYGENET
14688	4901	NRL	0.647	0.462	C0035334	RetinitisPigmentosa	disease	C16;C11	DiseaseorSyndrome	0.67	0.75	1999	2017	2	1	CTD_human;GENOMICS_ENGLAND
14689	4901	NRL	0.647	0.462	C1834329	RETINITISPIGMENTOSA27	disease	C16;C11	DiseaseorSyndrome	0.7	1	1999	2012	8	10	CTD_human;GENOMICS_ENGLAND;UNIPROT
14708	4907	NT5E	0.436	0.885	C1859372	CalcificationofJointsandArteries	disease	C18;C05;C14	DiseaseorSyndrome	0.73	1	2011	2016	2	3	CTD_human;ORPHANET;UNIPROT
14752	4909	NTF4	0.644	0.692	C2751294	GLAUCOMA1,OPENANGLE,O	disease	C11	DiseaseorSyndrome	0.7	1	2009	2010	2	5	CTD_human;GENOMICS_ENGLAND;UNIPROT
14758	4913	NTHL1	0.623	0.615	C4225157	FAMILIALADENOMATOUSPOLYPOSIS3	disease		DiseaseorSyndrome	0.7	1	2015	2017	4	2	CLINGEN;GENOMICS_ENGLAND;ORPHANET
14765	4914	NTRK1	0.422	0.808	C0020074	HSANTypeIV	disease	C16;C10	DiseaseorSyndrome	0.8	1	1996	2020	17	32	CTD_human;GENOMICS_ENGLAND;UNIPROT
14766	4914	NTRK1	0.422	0.808	C0020075	HereditarySensoryAutonomicNeuropathy,Type5	disease	C16;C10	DiseaseorSyndrome	0.52	1	2001	2002	1	0	CTD_human;ORPHANET
14789	4914	NTRK1	0.422	0.808	C0699739	SensoryNeuropathy,Hereditary	disease	C16;C10	DiseaseorSyndrome	0.51	1	2006	2006	0	0	CTD_human
14796	4914	NTRK1	0.422	0.808	C1833921	Familialmedullarythyroidcarcinoma	disease	C16;C04;C19	NeoplasticProcess	0.75	1	1995	2005	1	1	CTD_human;GENOMICS_ENGLAND;ORPHANET
14801	4915	NTRK2	0.479	0.808	C0005586	BipolarDisorder	disease	F03	MentalorBehavioralDysfunction	0.52	1	2008	2016	3	0	CTD_human;PSYGENET
14805	4915	NTRK2	0.479	0.808	C0011570	MentalDepression	disease	F01	MentalorBehavioralDysfunction	0.6	1	2009	2020	5	0	PSYGENET
14853	4915	NTRK2	0.479	0.808	C3151303	Obesity,Hyperphagia,andDevelopmentalDelay	disease	C23;C18;F03	DiseaseorSyndrome	0.7	1	2004	2017	4	3	CTD_human;GENOMICS_ENGLAND;UNIPROT
14855	4915	NTRK2	0.479	0.808	C4693367	EPILEPTICENCEPHALOPATHY,EARLYINFANTILE,58	disease		DiseaseorSyndrome	0.6	1	2004	2017	3	1	GENOMICS_ENGLAND;UNIPROT
14884	4919	ROR1	0.552	0.731	C0006142	Malignantneoplasmofbreast	disease	C04;C17	NeoplasticProcess	0.6	1	2012	2020	1	1	CTD_human;UNIPROT
14899	4920	ROR2	0.498	0.731	C1849334	Robinowsyndrome,autosomalrecessive	disease	C16;C05;C07	DiseaseorSyndrome	1	1	2000	2020	5	8	CTD_human;GENOMICS_ENGLAND;UNIPROT
14900	4920	ROR2	0.498	0.731	C1862112	BRACHYDACTYLY,TYPEB1	disease	C16;C05	CongenitalAbnormality	0.7	0.941	2000	2019	2	6	CTD_human;GENOMICS_ENGLAND
14909	4921	DDR2	0.541	0.769	C1849011	SPONDYLOMETAEPIPHYSEALDYSPLASIA,SHORTLIMB-HANDTYPE	disease	C16;C05;C19	DiseaseorSyndrome	0.73	1	1993	2018	4	4	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
14946	4926	NUMA1	0.644	0.577	C0023487	AcutePromyelocyticLeukemia	disease	C04	NeoplasticProcess	0.62	1	1997	2017	1	0	CTD_human;ORPHANET
14970	4929	NR4A2	0.529	0.846	C0036341	Schizophrenia	disease	F03	MentalorBehavioralDysfunction	0.6	0.8	1999	2020	5	0	PSYGENET
14989	4935	GPR143	0.659	0.385	C0342684	Ocularalbinism,typeI	disease	C16;C18;C11;C17	DiseaseorSyndrome	0.8	0.974	1995	2020	14	24	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
14991	4935	GPR143	0.659	0.385	C3151752	NYSTAGMUS6,CONGENITAL,X-LINKED	disease		DiseaseorSyndrome	0.7	1	2007	2011	3	2	CTD_human;GENOMICS_ENGLAND;UNIPROT
15004	4942	OAT	0.593	0.731	C0018425	GyrateAtrophy	disease	C16;C11	DiseaseorSyndrome	1	0.962	1981	2019	18	34	CLINGEN;CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
15009	4942	OAT	0.593	0.731	C0599035	Hyperornithinemia	phenotype	C16;C11	DiseaseorSyndrome	0.67	1	1981	2017	1	61	CTD_human;ORPHANET
15013	4948	OCA2	0.539	0.808	C0078918	Albinism,Oculocutaneous	disease	C16;C18;C11;C17	CongenitalAbnormality	0.6	0.974	1994	2019	1	0	GENOMICS_ENGLAND
15014	4948	OCA2	0.539	0.808	C0268495	Oculocutaneousalbinismtype2	disease	C16;C18;C11;C17	DiseaseorSyndrome	0.8	1	1994	2017	12	49	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
15017	4952	OCRL	0.553	0.731	C0028860	OculocerebrorenalSyndrome	disease	C16;C18;C13;C12;C10	DiseaseorSyndrome	0.8	1	1993	2020	15	42	CTD_human;GENOMICS_ENGLAND;UNIPROT
15018	4952	OCRL	0.553	0.731	C1845167	DentDisease2	disease	C16;C13;C12	DiseaseorSyndrome	0.7	1	1999	2016	5	6	CTD_human;GENOMICS_ENGLAND;UNIPROT
15040	4967	OGDH	0.653	0.538	C2752074	ALPHA-KETOGLUTARATEDEHYDROGENASEDEFICIENCY	disease	C16;C18	DiseaseorSyndrome	0.6	1	2016	2016	1	0	CTD_human;GENOMICS_ENGLAND;ORPHANET
15047	4968	OGG1	0.453	0.808	C0007134	RenalCellCarcinoma	disease	C04;C13;C12	NeoplasticProcess	0.62	1	2003	2011	0	0	CTD_human
15075	4968	OGG1	0.453	0.808	C0279702	Conventional(ClearCell)RenalCellCarcinoma	disease	C04;C13;C12	NeoplasticProcess	0.64	1	2003	2011	0	1	CGI;CTD_human
15092	4973	OLR1	0.544	0.769	C0020538	Hypertensivedisease	group	C14	DiseaseorSyndrome	0.54	1	1998	2019	1	0	CTD_human
15110	4976	OPA1	0.51	0.846	C0221061	Behrsyndrome	disease	C23;C11;C10;F03;C09;F01	DiseaseorSyndrome	0.74	1	2011	2019	3	5	CTD_human;GENOMICS_ENGLAND;UNIPROT
15111	4976	OPA1	0.51	0.846	C0338508	OpticAtrophy1	disease	C16;C18;C11;C10	DiseaseorSyndrome	0.8	0.989	1997	2019	24	30	CTD_human;GENOMICS_ENGLAND;UNIPROT
15117	4976	OPA1	0.51	0.846	C3276549	OPTICATROPHYWITHORWITHOUTDEAFNESS,OPHTHALMOPLEGIA,MYOPATHY,ATAXIA,ANDNEUROPATHY	disease		DiseaseorSyndrome	0.7	1	1999	2019	11	21	GENOMICS_ENGLAND;UNIPROT
15123	4978	OPCML	0.606	0.654	C0919267	ovarianneoplasm	disease	C04;C13;C19	NeoplasticProcess	0.63	1	2003	2014	0	1	CGI;CTD_human
15124	4978	OPCML	0.606	0.654	C1140680	Malignantneoplasmofovary	disease	C04;C13;C19	NeoplasticProcess	0.61	1	2003	2014	1	1	CGI;CTD_human;UNIPROT
15137	4982	TNFRSF11B	0.422	0.808	C0268414	Hyperphosphatasemiawithbonedisease	disease	C05	DiseaseorSyndrome	0.8	1	2002	2020	1	4	CTD_human;GENOMICS_ENGLAND;ORPHANET
15154	4983	OPHN1	0.633	0.538	C1845366	Mentalretardation,X-linked,withcerebellarhypoplasiaanddistinctivefacialappearance	disease	C16;C10	DiseaseorSyndrome	0.7	1	1998	2018	3	6	CTD_human;GENOMICS_ENGLAND;ORPHANET
15206	4986	OPRK1	0.555	0.615	C0600427	CocaineDependence	disease	C25;F03	MentalorBehavioralDysfunction	0.55	1	1996	2019	7	0	CTD_human;PSYGENET
15235	4988	OPRM1	0.457	0.808	C0001973	AlcoholicIntoxication,Chronic	disease	C25;F03	MentalorBehavioralDysfunction	0.6	0.8	1998	2019	6	0	CTD_human;PSYGENET
15268	4988	OPRM1	0.457	0.808	C0085762	Alcoholabuse	disease	C25;F03	MentalorBehavioralDysfunction	0.51	1	2003	2014	3	0	CTD_human;PSYGENET
15308	4988	OPRM1	0.457	0.808	C0600427	CocaineDependence	disease	C25;F03	MentalorBehavioralDysfunction	0.55	1	2000	2019	6	0	CTD_human;PSYGENET
15345	4990	SIX6	0.588	0.654	C4225424	OPTICDISCANOMALIESWITHRETINALAND/ORMACULARDYSTROPHY	disease		DiseaseorSyndrome	0.6	1	2004	2015	3	0	GENOMICS_ENGLAND;ORPHANET
15353	4998	ORC1	0.595	0.654	C1868684	EAR,PATELLA,SHORTSTATURESYNDROME	disease	C23;C16;C05;C07;C09	DiseaseorSyndrome	0.65	1	2011	2017	2	1	CTD_human;ORPHANET
15357	4998	ORC1	0.595	0.654	C4552001	MEIER-GORLINSYNDROME1	disease	C23;C16;C05;C07;C09	DiseaseorSyndrome	0.6	1	1996	2015	5	7	GENOMICS_ENGLAND;UNIPROT
15361	5000	ORC4	0.612	0.654	C1868684	EAR,PATELLA,SHORTSTATURESYNDROME	disease	C23;C16;C05;C07;C09	DiseaseorSyndrome	0.52	1	2011	2017	3	0	CTD_human;ORPHANET
15362	5000	ORC4	0.612	0.654	C3151097	MEIER-GORLINSYNDROME2	disease		DiseaseorSyndrome	0.6	1	1998	2015	5	4	GENOMICS_ENGLAND;UNIPROT
15371	5002	SLC22A18	0.595	0.692	C0684249	Carcinomaoflung	disease	C04;C08	NeoplasticProcess	0.6	1	1998	1998	1	1	CGI;UNIPROT
15399	5009	OTC	0.565	0.846	C0268542	Ornithinecarbamoyltransferasedeficiency	disease	C16;C18;C10	DiseaseorSyndrome	1	1	1976	2018	42	133	CLINGEN;CTD_human;GENOMICS_ENGLAND;UNIPROT
15421	5015	OTX2	0.514	0.808	C1864690	Microphthalmia,Syndromic5	disease	C16;C11	DiseaseorSyndrome	0.7	1	1997	2014	10	16	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
15425	5015	OTX2	0.514	0.808	C3151440	PITUITARYHORMONEDEFICIENCY,COMBINED,6	disease		DiseaseorSyndrome	0.6	1	2008	2015	4	2	GENOMICS_ENGLAND;UNIPROT
15438	5019	OXCT1	0.686	0.423	C0342792	Succinyl-CoA:3-oxoacidCoAtransferasedeficiency	disease	C18	DiseaseorSyndrome	0.7	1	1998	2019	4	11	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
15587	5027	P2RX7	0.45	0.808	C0023434	ChronicLymphocyticLeukemia	disease	C04;C20;C15	NeoplasticProcess	0.59	0.7	2000	2016	2	0	CTD_human;ORPHANET
15597	5032	P2RY11	0.705	0.538	C0027404	Narcolepsy	disease	C10;F03	DiseaseorSyndrome	0.58	1	2011	2019	2	0	CTD_human;ORPHANET
15598	5032	P2RY11	0.705	0.538	C0751362	Narcolepsy-CataplexySyndrome	disease	C10;F03	DiseaseorSyndrome	0.51	1	2011	2017	2	0	CTD_human;ORPHANET
15611	5034	P4HB	0.488	0.808	C1862178	ColeCarpentersyndrome	disease	C16;C11;C17;C05;C10	DiseaseorSyndrome	0.63	1	2015	2018	1	0	CTD_human;GENOMICS_ENGLAND;ORPHANET
15615	5034	P4HB	0.488	0.808	C4317154	COLE-CARPENTERSYNDROME1	disease	C16;C11;C17;C05;C10	DiseaseorSyndrome	0.61	1	2015	2017	2	1	GENOMICS_ENGLAND;UNIPROT
15661	5048	PAFAH1B1	0.504	0.769	C0265219	MillerDiekersyndrome	disease	C16;C10	DiseaseorSyndrome	0.6	0.968	1994	2019	1	0	ORPHANET
15662	5048	PAFAH1B1	0.504	0.769	C0266463	Lissencephaly	disease	C16;C10	CongenitalAbnormality	0.7	1	1984	2019	0	0	CTD_human
15663	5048	PAFAH1B1	0.504	0.769	C0266483	Pachygyria	disease	C16;C10	CongenitalAbnormality	0.65	1	1998	2018	0	0	CTD_human
15664	5048	PAFAH1B1	0.504	0.769	C0431375	ClassicalLissencephaly	disease	C16;C10	DiseaseorSyndrome	0.8	1	1993	2018	9	97	GENOMICS_ENGLAND;ORPHANET;UNIPROT
15666	5048	PAFAH1B1	0.504	0.769	C1848201	SubcorticalBandHeterotopia	disease	C16;C10	DiseaseorSyndrome	0.7	1	2000	2017	1	3	GENOMICS_ENGLAND;ORPHANET
15688	5053	PAH	0.516	0.769	C0031485	Phenylketonurias	group	C16;C18;C10	DiseaseorSyndrome	0.8	0.985	1977	2020	1	0	CTD_human;GENOMICS_ENGLAND
15691	5053	PAH	0.516	0.769	C0085547	Phenylketonuria,Maternal	disease	C16;C18;C13;C10	DiseaseorSyndrome	0.59	0.929	1987	2018	1	0	ORPHANET
15693	5053	PAH	0.516	0.769	C0751434	Classicalphenylketonuria	disease	C16;C18;C10	DiseaseorSyndrome	0.8	0.996	1975	2019	47	381	CTD_human;GENOMICS_ENGLAND;UNIPROT
15708	5054	SERPINE1	0.359	0.885	C0011881	DiabeticNephropathy	disease	C13;C12;C19	DiseaseorSyndrome	0.6	0.889	1996	2019	1	0	CTD_human
15714	5054	SERPINE1	0.359	0.885	C0020538	Hypertensivedisease	group	C14	DiseaseorSyndrome	0.6	0.889	1998	2019	2	0	CTD_human
15715	5054	SERPINE1	0.359	0.885	C0022661	KidneyFailure,Chronic	disease	C13;C12	DiseaseorSyndrome	0.51	1	2003	2016	1	0	CTD_human
15744	5054	SERPINE1	0.359	0.885	C2750067	PlasminogenActivatorInhibitor-1Deficiency	disease	C15	DiseaseorSyndrome	0.7	1	1992	2011	1	2	CTD_human;GENOMICS_ENGLAND;ORPHANET
15772	5058	PAK1	0.494	0.808	C4748428	INTELLECTUALDEVELOPMENTALDISORDERWITHMACROCEPHALY,SEIZURES,ANDSPEECHDELAY	disease		DiseaseorSyndrome	0.6	1	2018	2019	2	2	GENOMICS_ENGLAND;UNIPROT
15780	5063	PAK3	0.569	0.731	C0796237	MentalRetardation,X-Linked30	disease	C16;C10	DiseaseorSyndrome	0.7	1	1998	2003	3	6	CTD_human;GENOMICS_ENGLAND;UNIPROT
15840	5071	PRKN	0.431	0.846	C0030567	ParkinsonDisease	disease	C10	DiseaseorSyndrome	0.6	0.974	1998	2020	13	0	CTD_human
15863	5071	PRKN	0.431	0.846	C0752105	Parkinsonism,Juvenile	disease	C10	DiseaseorSyndrome	0.59	1	1998	2018	10	0	CTD_human;GENOMICS_ENGLAND
15865	5071	PRKN	0.431	0.846	C1140680	Malignantneoplasmofovary	disease	C04;C13;C19	NeoplasticProcess	0.55	1	2011	2019	0	0	CTD_human;GENOMICS_ENGLAND
15869	5071	PRKN	0.431	0.846	C1868675	PARKINSONDISEASE2,AUTOSOMALRECESSIVEJUVENILE	disease	C10	DiseaseorSyndrome	1	0.994	1998	2019	37	27	CTD_human;GENOMICS_ENGLAND;UNIPROT
15872	5073	PARN	0.575	0.769	C0265965	DyskeratosisCongenita	disease	C16;C17;C15	DiseaseorSyndrome	0.67	1	2015	2019	2	2	GENOMICS_ENGLAND;ORPHANET
15873	5073	PARN	0.575	0.769	C1800706	IdiopathicPulmonaryFibrosis	disease	C08	DiseaseorSyndrome	0.55	0.833	2015	2019	1	0	CTD_human;ORPHANET
15875	5073	PARN	0.575	0.769	C4225347	PULMONARYFIBROSISAND/ORBONEMARROWFAILURE,TELOMERE-RELATED,4	disease		DiseaseorSyndrome	0.7	1	2015	2015	4	4	CTD_human;GENOMICS_ENGLAND;UNIPROT
15876	5073	PARN	0.575	0.769	C4225356	DYSKERATOSISCONGENITA,AUTOSOMALRECESSIVE6	disease		DiseaseorSyndrome	0.7	1	2015	2019	3	9	CTD_human;GENOMICS_ENGLAND;UNIPROT
15894	5075	PAX1	0.593	0.654	C1833691	OtofaciocervicalSyndrome	disease	C16	DiseaseorSyndrome	0.53	1	2013	2018	1	0	CTD_human;ORPHANET
15902	5076	PAX2	0.495	0.731	C0431692	Bilateralrenalhypoplasia	disease		CongenitalAbnormality	0.51	1	1995	2018	4	0	ORPHANET
15904	5076	PAX2	0.495	0.731	C1852759	Papillorenalsyndrome	disease	C16;C13;C11;C12	DiseaseorSyndrome	1	1	1995	2019	9	11	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
15907	5076	PAX2	0.495	0.731	C4014925	FOCALSEGMENTALGLOMERULOSCLEROSIS7	disease		DiseaseorSyndrome	0.6	1	1999	2015	3	6	GENOMICS_ENGLAND;UNIPROT
15916	5077	PAX3	0.481	0.769	C0079661	KleinsSyndrome	disease	C16	DiseaseorSyndrome	0.75	1	1993	2018	16	5	CLINGEN;CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
val	5077	PAX3	0.481	0.769	C0080178	SpinaBifida	disease	C16;C10	CongenitalAbnormality	0.48	0.909	1984	2017	4	0	CTD_human
val	5077	PAX3	0.481	0.769	C0080218	TetheredCordSyndrome	disease	C16;C10	DiseaseorSyndrome	0.30	1	1988	2003	3	0	CTD_human
val	5077	PAX3	0.481	0.769	C0086395	HearingLoss,Extreme	phenotype	C23;C10;C09	SignorSymptom	0.30	1	2003	2003	1	0	CTD_human
val	5077	PAX3	0.481	0.769	C0152234	Iniencephaly	disease	C16;C10	CongenitalAbnormality	0.30	1	1988	2003	3	0	CTD_human
val	5077	PAX3	0.481	0.769	C0152426	Craniorachischisis	disease	C16;C10	CongenitalAbnormality	0.30	1	1988	2003	3	0	CTD_human
val	5077	PAX3	0.481	0.769	C0205944	Sarcoma,Epithelioid	disease	C04	NeoplasticProcess	0.30	1	2014	2014	1	0	CTD_human
val	5077	PAX3	0.481	0.769	C0205945	Sarcoma,SpindleCell	disease	C04	NeoplasticProcess	0.30	1	2014	2014	1	0	CTD_human
val	5077	PAX3	0.481	0.769	C0206655	Alveolarrhabdomyosarcoma	disease	C04	NeoplasticProcess	1.00	0.983	1993	2019	2	0	CTD_human;GENOMICS_ENGLAND;ORPHANET
val	5077	PAX3	0.481	0.769	C0265541	Cranioschisis	disease	C16;C10	CongenitalAbnormality	0.30	1	1995	1995	1	0	CTD_human
val	5077	PAX3	0.481	0.769	C0266453	Exencephaly	disease	C16;C10	CongenitalAbnormality	0.31	1	1988	2017	3	0	CTD_human
val	5077	PAX3	0.481	0.769	C0266508	Rachischisis	disease	C16;C10	CongenitalAbnormality	0.30	1	1984	2007	4	0	CTD_human
val	5077	PAX3	0.481	0.769	C0344479	SpinalCordMyelodysplasia	disease	C16;C10	CongenitalAbnormality	0.30	1	1988	2003	3	0	CTD_human
val	5077	PAX3	0.481	0.769	C0376634	CraniofacialAbnormalities	group	C16;C05	CongenitalAbnormality	0.30	1	2003	2003	1	0	CTD_human
val	5077	PAX3	0.481	0.769	C0497552	Congenitalneurologicanomalies	group	C16;C10	CongenitalAbnormality	0.30	1	1995	1995	1	0	CTD_human
val	5077	PAX3	0.481	0.769	C0581883	CompleteHearingLoss	phenotype	C23;C10;C09	Finding	0.30	1	2003	2003	1	0	CTD_human
val	5077	PAX3	0.481	0.769	C0599973	WaardenburgAnophthalmiaSyndrome	disease	C16	DiseaseorSyndrome	0.30	1	1993	2003	3	0	ORPHANET
val	5077	PAX3	0.481	0.769	C0702169	Acrania	disease	C16;C10	CongenitalAbnormality	0.30	1	1988	2003	3	0	CTD_human
val	5077	PAX3	0.481	0.769	C0751068	Deafness,Acquired	disease	C23;C10;C09	DiseaseorSyndrome	0.30	1	2003	2003	1	0	CTD_human
val	5077	PAX3	0.481	0.769	C1261473	Sarcoma	group	C04	NeoplasticProcess	0.38	1	1995	2018	1	0	CTD_human
val	5077	PAX3	0.481	0.769	C1710096	Sinonasalundifferentiatedcarcinoma	disease	C04;C08;C09	NeoplasticProcess	0.30	1	2014	2014	1	0	CTD_human
val	5077	PAX3	0.481	0.769	C1847800	WaardenburgSyndromeType1	disease	C16	DiseaseorSyndrome	1.00	0.987	1983	2019	33	43	CLINGEN;CTD_human;GENOMICS_ENGLAND;UNIPROT
val	5077	PAX3	0.481	0.769	C1852510	Craniofacialdeafnesshandsyndrome	disease	C23;C16;C05;C10;C09	DiseaseorSyndrome	0.71	1	1983	2018	5	1	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
val	5077	PAX3	0.481	0.769	C3266898	WaardenburgSyndrome	disease	C16	DiseaseorSyndrome	0.80	1	1992	2018	12	2	CLINGEN;CTD_human;GENOMICS_ENGLAND
val	5077	PAX3	0.481	0.769	C3665473	BilateralDeafness	phenotype	C23;C10;C09	Finding	0.30	1	2003	2003	1	0	CTD_human
val	5077	PAX3	0.481	0.769	C4082305	DeafMutism	disease	C23;C10;C09	DiseaseorSyndrome	0.30	1	2003	2003	1	0	CTD_human
val	5078	PAX4	0.644	0.423	C0011854	DiabetesMellitus,Insulin-Dependent	disease	C18;C20;C19	DiseaseorSyndrome	0.37	0.571	2004	2018	0	0	CTD_human
val	5078	PAX4	0.644	0.423	C0011860	DiabetesMellitus,Non-Insulin-Dependent	disease	C18;C19	DiseaseorSyndrome	1.00	0.857	1999	2019	1	2	CTD_human;GENOMICS_ENGLAND;UNIPROT
val	5078	PAX4	0.644	0.423	C0025202	melanoma	disease	C04	NeoplasticProcess	0.31	1	2008	2008	1	0	CTD_human
val	5078	PAX4	0.644	0.423	C0205734	Diabetes,Autoimmune	disease	C18;C20;C19	DiseaseorSyndrome	0.30				0	0	CTD_human
val	5078	PAX4	0.644	0.423	C0342276	Maturityonsetdiabetesmellitusinyoung	disease	C18;C19	DiseaseorSyndrome	0.66	0.857	1999	2019	4	0	GENOMICS_ENGLAND;ORPHANET
val	5078	PAX4	0.644	0.423	C0342302	Brittlediabetes	disease	C18;C20;C19	DiseaseorSyndrome	0.30				0	0	CTD_human
val	5078	PAX4	0.644	0.423	C2677132	MATURITY-ONSETDIABETESOFTHEYOUNG,TYPE9(disorder)	disease	C18;C19	DiseaseorSyndrome	0.71	1	2007	2016	1	2	CTD_human;GENOMICS_ENGLAND;UNIPROT
val	5078	PAX4	0.644	0.423	C3837958	DiabetesMellitus,Ketosis-Prone	disease	C18;C20;C19	DiseaseorSyndrome	0.61	0	2004	2004	1	1	CTD_human;GENOMICS_ENGLAND;UNIPROT
val	5078	PAX4	0.644	0.423	C3888631	Monogenicdiabetes	disease	C18;C19	DiseaseorSyndrome	0.30				0	0	GENOMICS_ENGLAND
val	5078	PAX4	0.644	0.423	C4554117	DiabetesMellitus,Sudden-Onset	disease	C18;C20;C19	DiseaseorSyndrome	0.30				0	0	CTD_human
val	5079	PAX5	0.487	0.654	C0006413	BurkittLymphoma	disease	C04;C01;C20;C15	NeoplasticProcess	0.35	1	2003	2019	4	0	ORPHANET
val	5079	PAX5	0.487	0.654	C0023452	ChildhoodAcuteLymphoblasticLeukemia	disease	C04;C20;C15	NeoplasticProcess	0.40	0.923	2001	2019	1	0	CTD_human
val	5079	PAX5	0.487	0.654	C0023453	L2AcuteLymphoblasticLeukemia	disease	C04;C20;C15	NeoplasticProcess	0.30	1	2015	2015	1	0	CTD_human
val	5079	PAX5	0.487	0.654	C0023485	PrecursorB-CellLymphoblasticLeukemia-Lymphoma	disease	C04;C20;C15	NeoplasticProcess	0.33	1	2012	2019	2	0	CTD_human
val	5079	PAX5	0.487	0.654	C0024305	Lymphoma,Non-Hodgkin	disease	C04;C20;C15	NeoplasticProcess	0.32	1	1998	2016	0	0	CGI
val	5079	PAX5	0.487	0.654	C1292769	PrecursorB-celllymphoblasticleukemia	disease	C04;C20;C15	NeoplasticProcess	0.40	1	2006	2019	4	0	ORPHANET
val	5079	PAX5	0.487	0.654	C1535926	NeurodevelopmentalDisorders	group	F03	MentalorBehavioralDysfunction	0.30	1	2017	2017	1	0	CTD_human
val	5079	PAX5	0.487	0.654	C1961102	PrecursorCellLymphoblasticLeukemiaLymphoma	disease	C04;C20;C15	NeoplasticProcess	0.70	0.96	2001	2019	2	1	CGI;CTD_human;UNIPROT
val	5080	PAX6	0.45	0.769	C0002152	AlloxanDiabetes	disease	C18;C19	ExperimentalModelofDisease	0.30	1	2005	2005	1	0	CTD_human
val	5080	PAX6	0.45	0.769	C0003076	Aniridia	disease	C16;C11	CongenitalAbnormality	1.00	0.984	1978	2020	25	18	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
val	5080	PAX6	0.45	0.769	C0003119	Anophthalmos	disease	C16;C11	CongenitalAbnormality	0.32	1	1995	2015	1	0	GENOMICS_ENGLAND
val	5080	PAX6	0.45	0.769	C0004352	AutisticDisorder	disease	F03	MentalorBehavioralDysfunction	0.53	1	2008	2014	1	0	CTD_human
val	5080	PAX6	0.45	0.769	C0009363	Congenitalocularcoloboma(disorder)	disease	C16;C11	CongenitalAbnormality	0.75	0.875	1988	2020	3	2	CTD_human;GENOMICS_ENGLAND;UNIPROT
val	5080	PAX6	0.45	0.769	C0011847	Diabetes	disease	C19	DiseaseorSyndrome	0.35	1	2002	2019	0	0	GENOMICS_ENGLAND
val	5080	PAX6	0.45	0.769	C0011849	DiabetesMellitus	group	C18;C19	DiseaseorSyndrome	0.38	1	2002	2019	0	0	GENOMICS_ENGLAND
val	5080	PAX6	0.45	0.769	C0011853	DiabetesMellitus,Experimental	disease	C18;C19	ExperimentalModelofDisease	0.30	1	2005	2005	1	0	CTD_human
val	5080	PAX6	0.45	0.769	C0011860	DiabetesMellitus,Non-Insulin-Dependent	disease	C18;C19	DiseaseorSyndrome	0.31	1	2005	2014	1	0	CTD_human
val	5080	PAX6	0.45	0.769	C0015397	Disorderofeye	group	C11	DiseaseorSyndrome	0.38	1	1999	2017	0	0	GENOMICS_ENGLAND
val	5080	PAX6	0.45	0.769	C0020796	ProfoundMentalRetardation	disease	C23;C10;F03;F01	MentalorBehavioralDysfunction	0.30	1	2008	2008	1	0	CTD_human
val	5080	PAX6	0.45	0.769	C0024623	Malignantneoplasmofstomach	disease	C06;C04	NeoplasticProcess	0.33	1	2006	2019	1	0	CTD_human
val	5080	PAX6	0.45	0.769	C0025202	melanoma	disease	C04	NeoplasticProcess	0.30	1	2006	2006	1	0	CTD_human
val	5080	PAX6	0.45	0.769	C0025363	MentalRetardation,Psychosocial	phenotype	C23;C10;F03;F01	MentalorBehavioralDysfunction	0.30	1	2008	2008	1	0	CTD_human
val	5080	PAX6	0.45	0.769	C0027626	NeoplasmInvasiveness	phenotype	C23;C04	PathologicFunction	0.30	1	2015	2015	1	0	CTD_human
val	5080	PAX6	0.45	0.769	C0029132	Disorderoftheopticnerve	group	C11;C10	DiseaseorSyndrome	0.30	1	2003	2003	1	0	CTD_human
val	5080	PAX6	0.45	0.769	C0033578	ProstaticNeoplasms	group	C04;C12	NeoplasticProcess	0.30	1	2018	2018	1	0	CTD_human
val	5080	PAX6	0.45	0.769	C0036341	Schizophrenia	disease	F03	MentalorBehavioralDysfunction	0.33	1	1999	2020	1	0	PSYGENET
val	5080	PAX6	0.45	0.769	C0038356	StomachNeoplasms	group	C06;C04	NeoplasticProcess	0.30	1	2006	2006	1	0	CTD_human
val	5080	PAX6	0.45	0.769	C0038433	StreptozotocinDiabetes	disease	C18;C19	ExperimentalModelofDisease	0.30	1	2005	2005	1	0	CTD_human
val	5080	PAX6	0.45	0.769	C0040427	ToothAbnormalities	group	C16;C07	AnatomicalAbnormality	0.30	1	1995	1997	2	0	CTD_human
val	5080	PAX6	0.45	0.769	C0086543	Cataract	disease	C11	AcquiredAbnormality	0.46	1	2000	2018	1	0	CTD_human
val	5080	PAX6	0.45	0.769	C0152112	Foster-KennedySyndrome	disease	C11;C10	DiseaseorSyndrome	0.30	1	2003	2003	1	0	CTD_human
val	5080	PAX6	0.45	0.769	C0155299	Colobomaofopticdisc	disease	C16;C11	DiseaseorSyndrome	0.71	1	1988	2019	5	3	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
val	5080	PAX6	0.45	0.769	C0206115	WAGRSyndrome	disease	C16;C04;C13;C11;C12;C10;C19	DiseaseorSyndrome	0.80	0.933	1988	2017	1	1	CTD_human;GENOMICS_ENGLAND;ORPHANET
val	5080	PAX6	0.45	0.769	C0265541	Cranioschisis	disease	C16;C10	CongenitalAbnormality	0.30	1	2009	2009	1	0	CTD_human
val	5080	PAX6	0.45	0.769	C0266551	Congenitalcolobomaofiris	disease	C16;C11	CongenitalAbnormality	0.31	1	2003	2012	2	0	ORPHANET
val	5080	PAX6	0.45	0.769	C0338502	Hypoplasiaoftheopticnerve	disease	C16;C11;C10	DiseaseorSyndrome	0.40	1	2003	2003	1	0	ORPHANET
val	5080	PAX6	0.45	0.769	C0344516	Colobomaoflens	disease	C16;C11	CongenitalAbnormality	0.30	1	2003	2006	2	0	ORPHANET
val	5080	PAX6	0.45	0.769	C0344559	Irido-corneo-trabeculardysgenesis(disorder)	disease	C16;C11	CongenitalAbnormality	1.00	0.938	1983	2011	3	0	CTD_human;GENOMICS_ENGLAND;ORPHANET
val	5080	PAX6	0.45	0.769	C0376358	Malignantneoplasmofprostate	disease	C04;C12	NeoplasticProcess	0.31	1	2010	2018	1	0	CTD_human
val	5080	PAX6	0.45	0.769	C0376634	CraniofacialAbnormalities	group	C16;C05	CongenitalAbnormality	0.30	1	1995	1997	3	0	CTD_human
val	5080	PAX6	0.45	0.769	C0431401	Gillespiesyndrome	disease	C23;C16;C11;C10;F03;F01	DiseaseorSyndrome	0.53	0.857	1988	2016	4	0	GENOMICS_ENGLAND;ORPHANET
val	5080	PAX6	0.45	0.769	C0497552	Congenitalneurologicanomalies	group	C16;C10	CongenitalAbnormality	0.30	1	2009	2009	1	0	CTD_human
val	5080	PAX6	0.45	0.769	C0521573	Colobomaofeyelid	phenotype	C16;C11	DiseaseorSyndrome	0.30	1	2003	2006	2	0	ORPHANET
val	5080	PAX6	0.45	0.769	C0524524	Pseudoaphakia	disease	C11	DiseaseorSyndrome	0.30	1	2018	2018	1	0	CTD_human
val	5080	PAX6	0.45	0.769	C0524730	Odontome	disease	C16;C07	CongenitalAbnormality	0.30	1	1995	1997	2	0	CTD_human
val	5080	PAX6	0.45	0.769	C0549307	Morningglorysyndrome	disease	C23;C16;C13;C11;C10	DiseaseorSyndrome	0.31	1	2003	2008	1	0	ORPHANET
val	5080	PAX6	0.45	0.769	C0751402	OpticDiskDisorders	group	C11;C10	DiseaseorSyndrome	0.30	1	2003	2003	1	0	CTD_human
val	5080	PAX6	0.45	0.769	C0917816	Mentaldeficiency	disease	C23;C10;F03;F01	MentalorBehavioralDysfunction	0.30	1	2008	2008	1	0	CTD_human
val	5080	PAX6	0.45	0.769	C1510497	LensOpacities	phenotype	C11	Finding	0.30	1	2018	2018	1	0	CTD_human
val	5080	PAX6	0.45	0.769	C1708349	HereditaryDiffuseGastricCancer	disease	C06;C04	NeoplasticProcess	0.30	1	2006	2006	1	0	CTD_human
val	5080	PAX6	0.45	0.769	C1833797	OpticNerveHypoplasia,Bilateral	disease	C11;C10	DiseaseorSyndrome	0.70	1	1988	2006	4	3	CTD_human;GENOMICS_ENGLAND;UNIPROT
val	5080	PAX6	0.45	0.769	C1835698	Keratitis,hereditary	disease	C11	DiseaseorSyndrome	0.70	1	1988	2006	4	1	CTD_human;GENOMICS_ENGLAND;ORPHANET
val	5080	PAX6	0.45	0.769	C1840452	HyaloideoretinaldegenerationofWagner	disease	C11	DiseaseorSyndrome	0.30				0	0	GENOMICS_ENGLAND
val	5080	PAX6	0.45	0.769	C1852767	Hereditarymacularcoloboma	disease	C16;C11	CongenitalAbnormality	0.30	1	2003	2006	2	0	ORPHANET
val	5080	PAX6	0.45	0.769	C2673946	Fovealhypoplasia(finding)	phenotype		Finding	0.40				0	0	GENOMICS_ENGLAND
val	5080	PAX6	0.45	0.769	C2931644	ODonnellPappassyndrome	disease	C16;C11;C10	DiseaseorSyndrome	0.6	1	1999	1999	1	0	CTD_human;GENOMICS_ENGLAND;ORPHANET
15920	5080	PAX6	0.45	0.769	C3805604	FOVEALHYPOPLASIA1	disease		DiseaseorSyndrome	0.6	1	1988	2006	5	3	GENOMICS_ENGLAND;UNIPROT
15921	5080	PAX6	0.45	0.769	C4310809	ANTERIORSEGMENTDYSGENESIS5	disease		DiseaseorSyndrome	0.6	1	1988	2018	6	24	GENOMICS_ENGLAND;UNIPROT
15928	5081	PAX7	0.597	0.538	C0206655	Alveolarrhabdomyosarcoma	disease	C04	NeoplasticProcess	0.8	0.976	1995	2019	1	0	CTD_human;GENOMICS_ENGLAND;ORPHANET
15932	5083	PAX9	0.636	0.538	C1970291	ToothAgenesis,Selective,3	disease	C16;C07	DiseaseorSyndrome	0.7	1	2003	2017	1	9	CTD_human;GENOMICS_ENGLAND;UNIPROT
15952	5092	PCBD1	0.623	0.769	C1849700	Hyperphenylalaninemiawithprimapterinuria	disease	C16;C18;C10	DiseaseorSyndrome	0.71	1	1993	2017	5	7	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
15953	5095	PCCA	0.682	0.538	C0268579	Propionicacidemia	disease	C16;C18	DiseaseorSyndrome	0.8	1	1993	2019	8	56	CTD_human;GENOMICS_ENGLAND;UNIPROT
15956	5096	PCCB	0.695	0.577	C0268579	Propionicacidemia	disease	C16;C18	DiseaseorSyndrome	0.8	1	1990	2019	11	62	CTD_human;GENOMICS_ENGLAND;UNIPROT
15979	5105	PCK1	0.608	0.538	C0268194	Phosphoenolpyruvatecarboxykinasedeficiency	disease	C16;C06;C18	DiseaseorSyndrome	0.61	1	2014	2017	3	2	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
16012	5111	PCNA	0.382	0.846	C0206624	Hepatoblastoma	disease	C04	NeoplasticProcess	0.51	1	2002	2013	1	0	CTD_human
16020	5111	PCNA	0.382	0.846	C4014676	ATAXIA-TELANGIECTASIA-LIKEDISORDER2	disease		DiseaseorSyndrome	0.6	1	2014	2014	1	1	ORPHANET;UNIPROT
16026	5116	PCNT	0.564	0.808	C0265202	Seckelsyndrome	disease	C23;C16;C05;C10;C19	DiseaseorSyndrome	0.55	1	2008	2011	1	0	GENOMICS_ENGLAND;ORPHANET
16028	5116	PCNT	0.564	0.808	C0432246	MicrocephalicOsteodysplasticPrimordialDwarfism,TypeII	disease	C23;C16;C13;C05;C10;C19	CongenitalAbnormality	0.8	1	2004	2019	4	32	CTD_human;GENOMICS_ENGLAND;ORPHANET
16044	5119	CHMP1A	0.695	0.5	C3554209	Congenitalpontocerebellarhypoplasiatype8	disease	C10	DiseaseorSyndrome	0.7	1	2012	2012	1	2	CTD_human;GENOMICS_ENGLAND;ORPHANET
16048	5122	PCSK1	0.548	0.615	C0028754	Obesity	disease	C23;C18	DiseaseorSyndrome	0.7	0.857	1997	2018	1	0	CTD_human
16049	5122	PCSK1	0.548	0.615	C1833053	ProproteinConvertase13Deficiency	disease	C23;C18;C19	DiseaseorSyndrome	0.71	1	1997	2019	3	4	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
16083	5130	PCYT1A	0.485	0.885	C1837073	SpondylometaphysealDysplasiawithCone-RodDystrophy	disease	C16;C11;C05	DiseaseorSyndrome	0.71	1	2014	2014	3	4	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
16087	5133	PDCD1	0.402	0.846	C0024141	LupusErythematosus,Systemic	disease	C17;C20	DiseaseorSyndrome	0.8	0.949	1998	2020	1	0	CTD_human;ORPHANET
16114	5139	PDE3A	0.67	0.577	C1862170	Brachydactylywithhypertension	disease	C16;C05;C14	DiseaseorSyndrome	0.77	1	1998	2020	2	5	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
16127	5142	PDE4B	0.566	0.731	C0005586	BipolarDisorder	disease	F03	MentalorBehavioralDysfunction	0.53	1	2007	2010	4	0	CTD_human;PSYGENET
16153	5144	PDE4D	0.519	0.846	C0220659	Acrodysostosis	disease	C23;C16;C05;C10;F03;F01	DiseaseorSyndrome	0.7	0.867	2012	2019	2	0	CTD_human;GENOMICS_ENGLAND;ORPHANET
16159	5144	PDE4D	0.519	0.846	C3553250	ACRODYSOSTOSIS2WITHORWITHOUTHORMONERESISTANCE	disease	C23;C16;C05;C10;F03;F01	DiseaseorSyndrome	0.71	1	2012	2017	4	10	CTD_human;GENOMICS_ENGLAND;UNIPROT
16162	5145	PDE6A	0.691	0.269	C0035334	RetinitisPigmentosa	disease	C16;C11	DiseaseorSyndrome	0.9	1	1995	2019	2	7	CTD_human;GENOMICS_ENGLAND
16163	5145	PDE6A	0.691	0.269	C3151139	RETINITISPIGMENTOSA43	disease		DiseaseorSyndrome	0.7	1	1995	1999	2	9	CTD_human;GENOMICS_ENGLAND;UNIPROT
16165	5146	PDE6C	0.7	0.269	C0152200	Achromatopsia	disease	C23;C11;C10	DiseaseorSyndrome	0.87	1	2009	2019	1	13	GENOMICS_ENGLAND;ORPHANET
16170	5146	PDE6C	0.7	0.269	C2751308	CONEDYSTROPHY4(disorder)	disease	C16;C11	DiseaseorSyndrome	0.7	1	2009	2017	3	8	CTD_human;GENOMICS_ENGLAND;UNIPROT
16175	5148	PDE6G	0.695	0.308	C0035334	RetinitisPigmentosa	disease	C16;C11	DiseaseorSyndrome	0.72	1	1997	2010	0	0	CTD_human;GENOMICS_ENGLAND
16179	5149	PDE6H	0.7	0.269	C0152200	Achromatopsia	disease	C23;C11;C10	DiseaseorSyndrome	0.72	1	2012	2015	2	1	CTD_human;GENOMICS_ENGLAND;ORPHANET
16188	5149	PDE6H	0.7	0.269	C1864900	RetinalConeDystrophy3A	disease	C16;C11	DiseaseorSyndrome	0.6	1	2012	2015	2	1	CTD_human;GENOMICS_ENGLAND
16241	5156	PDGFRA	0.415	0.808	C0238198	GastrointestinalStromalTumors	group	C06;C04	NeoplasticProcess	0.8	0.954	2003	2020	10	13	CGI;CLINGEN;CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
16251	5156	PDGFRA	0.415	0.808	C1540912	Hypereosinophilicsyndrome	disease	C15	DiseaseorSyndrome	0.6	0.958	2003	2019	2	0	CGI;CTD_human
16258	5156	PDGFRA	0.415	0.808	C3179349	GastrointestinalStromalSarcoma	disease	C06;C04	NeoplasticProcess	0.61	1	2003	2018	9	0	CLINGEN;CTD_human;ORPHANET
16266	5158	PDE6B	0.626	0.346	C0035334	RetinitisPigmentosa	disease	C16;C11	DiseaseorSyndrome	0.9	1	1992	2019	1	18	CTD_human;GENOMICS_ENGLAND
16267	5158	PDE6B	0.626	0.346	C0339535	Nightblindness,congenitalstationary	disease	C16;C11	CongenitalAbnormality	0.72	1	1994	2007	1	0	CTD_human;GENOMICS_ENGLAND;ORPHANET
16271	5158	PDE6B	0.626	0.346	C1876182	NIGHTBLINDNESS,CONGENITALSTATIONARY,AUTOSOMALDOMINANT2	disease	C16;C11	DiseaseorSyndrome	0.9	1	1924	2007	1	1	CTD_human;GENOMICS_ENGLAND;UNIPROT
16272	5158	PDE6B	0.626	0.346	C3151107	RETINITISPIGMENTOSA40(disorder)	disease		DiseaseorSyndrome	0.9	1	1993	2016	7	22	CTD_human;GENOMICS_ENGLAND;UNIPROT
16288	5159	PDGFRB	0.416	0.846	C0393590	Fahrssyndrome(disorder)	disease	C18;C10;C14	DiseaseorSyndrome	0.71	1	2013	2015	3	0	GENOMICS_ENGLAND;ORPHANET
val	5159	PDGFRB	0.416	0.846	C0432284	Infantilemyofibromatosis	disease	C04	DiseaseorSyndrome	1.00	1	2013	2019	2	6	CTD_human;GENOMICS_ENGLAND;ORPHANET
val	5159	PDGFRB	0.416	0.846	C0521174	Microcalcification	phenotype	C18	PathologicFunction	0.30	1	2015	2015	1	0	CTD_human
val	5159	PDGFRB	0.416	0.846	C0750951	LenticulostriateDisorders	disease	C10	DiseaseorSyndrome	0.30	1	2015	2015	1	0	CTD_human
val	5159	PDGFRB	0.416	0.846	C1333046	MyeloproliferativeNeoplasm,Unclassifiable	disease		NeoplasticProcess	0.30	1	2007	2007	1	0	ORPHANET
val	5159	PDGFRB	0.416	0.846	C1851585	MYELOPROLIFERATIVEDISORDER,CHRONIC,WITHEOSINOPHILIA	disease	C15	DiseaseorSyndrome	0.40				0	0	CTD_human
val	5159	PDGFRB	0.416	0.846	C1866182	Penttinen-Aulasyndrome	disease	C16;C18;C05	DiseaseorSyndrome	0.71	1	2015	2019	1	1	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
val	5159	PDGFRB	0.416	0.846	C3165106	Infiltratingductcarcinomaoffemalebreast	disease	C04;C17	NeoplasticProcess	0.30				0	0	UNIPROT
val	5159	PDGFRB	0.416	0.846	C3472621	Myeloidneoplasmwithbeta-typeplatelet-derivedgrowthfactorreceptorgenerearrangement	disease		NeoplasticProcess	0.30	1	2013	2013	1	0	ORPHANET
val	5159	PDGFRB	0.416	0.846	C3554321	BASALGANGLIACALCIFICATION,IDIOPATHIC,4	disease		DiseaseorSyndrome	0.70	1	2013	2015	6	3	CTD_human;GENOMICS_ENGLAND;UNIPROT
val	5159	PDGFRB	0.416	0.846	C3714756	IntellectualDisability	group	C23;C10;F03;F01	MentalorBehavioralDysfunction	0.30	1	2017	2017	1	0	GENOMICS_ENGLAND
val	5159	PDGFRB	0.416	0.846	C4225270	Kosakiovergrowthsyndrome	disease		DiseaseorSyndrome	0.73	1	2015	2019	3	1	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
val	5159	PDGFRB	0.416	0.846	C4551572	MYOFIBROMATOSIS,INFANTILE,1	disease	C04	DiseaseorSyndrome	0.80	1	2013	2017	3	5	GENOMICS_ENGLAND;UNIPROT
val	5159	PDGFRB	0.416	0.846	C4551624	Idiopathicbasalgangliacalcification1	disease	C18;C10	DiseaseorSyndrome	0.30				0	0	CTD_human
val	5160	PDHA1	0.581	0.538	C0001125	Acidosis,Lactic	phenotype	C18	DiseaseorSyndrome	0.43	1	1989	2017	1	1	CTD_human
val	5160	PDHA1	0.581	0.538	C0023264	LeighDisease	disease	C16;C18;C10	DiseaseorSyndrome	0.31	1	1993	2017	8	0	CLINGEN
val	5160	PDHA1	0.581	0.538	C0024623	Malignantneoplasmofstomach	disease	C06;C04	NeoplasticProcess	0.32	1	2011	2019	1	0	CTD_human
val	5160	PDHA1	0.581	0.538	C0029408	Degenerativepolyarthritis	disease	C05	DiseaseorSyndrome	0.30	1	2009	2009	1	0	CTD_human
val	5160	PDHA1	0.581	0.538	C0033578	ProstaticNeoplasms	group	C04;C12	NeoplasticProcess	0.31	1	2007	2018	2	0	CTD_human
val	5160	PDHA1	0.581	0.538	C0034345	PyruvateDehydrogenaseComplexDeficiencyDisease	disease	C16;C18;C10	DiseaseorSyndrome	0.90	1	1990	2015	4	2	CTD_human;ORPHANET
val	5160	PDHA1	0.581	0.538	C0034350	PyruvateMetabolism,InbornErrors	disease	C16;C18	DiseaseorSyndrome	0.30	1	1990	1990	1	0	CTD_human
val	5160	PDHA1	0.581	0.538	C0038356	StomachNeoplasms	group	C06;C04	NeoplasticProcess	0.30	1	2011	2011	1	0	CTD_human
val	5160	PDHA1	0.581	0.538	C0086743	OsteoarthrosisDeformans	disease	C05	DiseaseorSyndrome	0.30	1	2009	2009	1	0	CTD_human
val	5160	PDHA1	0.581	0.538	C0151744	MyocardialIschemia	disease	C14	DiseaseorSyndrome	0.30	1	2005	2005	1	0	CTD_human
val	5160	PDHA1	0.581	0.538	C0235874	DiseaseExacerbation	phenotype	C23	Finding	0.30	1	2011	2011	1	0	CTD_human
val	5160	PDHA1	0.581	0.538	C0376358	Malignantneoplasmofprostate	disease	C04;C12	NeoplasticProcess	0.33	1	2007	2018	2	0	CTD_human
val	5160	PDHA1	0.581	0.538	C0751595	JuvenilePyruvateDehydrogenaseComplexDeficiencyDisease	disease	C16;C18;C10	DiseaseorSyndrome	0.30	1	1990	1990	1	0	CTD_human
val	5160	PDHA1	0.581	0.538	C0751596	PyruvateDehydrogenaseComplexDeficiencyDisease,Neonatal	disease	C16;C18;C10	DiseaseorSyndrome	0.30	1	1990	1990	1	0	CTD_human
val	5160	PDHA1	0.581	0.538	C0751597	AtaxiawithLacticAcidosis,TypeI	disease	C16;C18;C10	DiseaseorSyndrome	0.30	1	1990	1990	1	0	CTD_human
val	5160	PDHA1	0.581	0.538	C1708349	HereditaryDiffuseGastricCancer	disease	C06;C04	NeoplasticProcess	0.30	1	2011	2011	1	0	CTD_human
val	5160	PDHA1	0.581	0.538	C1838951	LEIGHSYNDROMEDUETOMITOCHONDRIALCOMPLEXIDEFICIENCY	disease	C16;C18;C10	DiseaseorSyndrome	0.30	1	1993	2017	8	0	CLINGEN
val	5160	PDHA1	0.581	0.538	C1839413	PyruvateDehydrogenaseE1AlphaDeficiency	disease	C18	DiseaseorSyndrome	0.70	1	1991	2017	24	42	GENOMICS_ENGLAND;ORPHANET;UNIPROT
val	5160	PDHA1	0.581	0.538	C1850597	LeighSyndromeDueToMitochondrialComplexIIDeficiency	disease	C16;C18;C10	DiseaseorSyndrome	0.30	1	1993	2017	8	0	CLINGEN
val	5160	PDHA1	0.581	0.538	C1850598	LeighSyndromeduetoMitochondrialComplexIIIDeficiency	disease	C16;C18;C10	DiseaseorSyndrome	0.30	1	1993	2017	8	0	CLINGEN
val	5160	PDHA1	0.581	0.538	C1850599	LeighSyndromeduetoMitochondrialComplexIVDeficiency	disease	C16;C18;C10	DiseaseorSyndrome	0.30	1	1993	2017	8	0	CLINGEN
val	5160	PDHA1	0.581	0.538	C1850600	LeighSyndromeduetoMitochondrialComplexVDeficiency	disease	C16;C18;C10	DiseaseorSyndrome	0.30	1	1993	2017	8	0	CLINGEN
val	5160	PDHA1	0.581	0.538	C2931891	Necrotizingencephalopathy,infantilesubacute,ofLeigh	disease	C16;C18;C10	DiseaseorSyndrome	0.30	1	1993	2017	8	0	CLINGEN
val	5162	PDHB	0.711	0.385	C0007134	RenalCellCarcinoma	disease	C04;C13;C12	NeoplasticProcess	0.30	1	2015	2015	1	0	CTD_human
val	5162	PDHB	0.711	0.385	C0034345	PyruvateDehydrogenaseComplexDeficiencyDisease	disease	C16;C18;C10	DiseaseorSyndrome	0.31	1	2004	2008	1	0	CTD_human
val	5162	PDHB	0.711	0.385	C0279702	Conventional(ClearCell)RenalCellCarcinoma	disease	C04;C13;C12	NeoplasticProcess	0.30	1	2015	2015	1	0	CTD_human
val	5162	PDHB	0.711	0.385	C0751595	JuvenilePyruvateDehydrogenaseComplexDeficiencyDisease	disease	C16;C18;C10	DiseaseorSyndrome	0.30	1	2004	2004	1	0	CTD_human
val	5162	PDHB	0.711	0.385	C0751596	PyruvateDehydrogenaseComplexDeficiencyDisease,Neonatal	disease	C16;C18;C10	DiseaseorSyndrome	0.30	1	2004	2004	1	0	CTD_human
val	5162	PDHB	0.711	0.385	C0751597	AtaxiawithLacticAcidosis,TypeI	disease	C16;C18;C10	DiseaseorSyndrome	0.30	1	2004	2004	1	0	CTD_human
val	5162	PDHB	0.711	0.385	C1266042	ChromophobeRenalCellCarcinoma	disease	C04;C13;C12	NeoplasticProcess	0.30	1	2015	2015	1	0	CTD_human
val	5162	PDHB	0.711	0.385	C1266043	SarcomatoidRenalCellCarcinoma	disease	C04;C13;C12	NeoplasticProcess	0.30	1	2015	2015	1	0	CTD_human
val	5162	PDHB	0.711	0.385	C1266044	CollectingDuctCarcinomaoftheKidney	disease	C04;C13;C12	NeoplasticProcess	0.30	1	2015	2015	1	0	CTD_human
val	5162	PDHB	0.711	0.385	C1306837	PapillaryRenalCellCarcinoma	disease	C04;C13;C12	NeoplasticProcess	0.30	1	2015	2015	1	0	CTD_human
val	5162	PDHB	0.711	0.385	C3279841	PyruvateDehydrogenaseE1-BetaDeficiency	disease	C16;C18;C10	DiseaseorSyndrome	0.70	1	2004	2016	5	2	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
val	5164	PDK2	0.751	0.269	C0033141	Cardiomyopathies,Primary	group	C14	DiseaseorSyndrome	0.30	1	2010	2010	1	0	CTD_human
val	5164	PDK2	0.751	0.269	C0036529	MyocardialDiseases,Secondary	group	C14	DiseaseorSyndrome	0.30	1	2010	2010	1	0	CTD_human
val	5164	PDK2	0.751	0.269	C0878544	Cardiomyopathies	group	C14	DiseaseorSyndrome	0.30	1	2010	2010	1	0	CTD_human
val	5164	PDK2	0.751	0.269	C1621958	GlioblastomaMultiforme	disease	C04	NeoplasticProcess	0.30				0	1	UNIPROT
val	5165	PDK3	0.678	0.5	C3806702	CHARCOT-MARIE-TOOTHDISEASE,X-LINKEDDOMINANT,6	disease		DiseaseorSyndrome	0.73	1	2013	2016	1	1	GENOMICS_ENGLAND;ORPHANET;UNIPROT
val	5166	PDK4	0.578	0.577	C0002152	AlloxanDiabetes	disease	C18;C19	ExperimentalModelofDisease	0.30	1	2004	2004	1	0	CTD_human
val	5166	PDK4	0.578	0.577	C0011853	DiabetesMellitus,Experimental	disease	C18;C19	ExperimentalModelofDisease	0.30	1	2004	2004	1	0	CTD_human
val	5166	PDK4	0.578	0.577	C0019193	Hepatitis,Toxic	disease	C06;C25	InjuryorPoisoning	0.30	1	2011	2011	1	0	CTD_human
val	5166	PDK4	0.578	0.577	C0038433	StreptozotocinDiabetes	disease	C18;C19	ExperimentalModelofDisease	0.30	1	2004	2004	1	0	CTD_human
val	5166	PDK4	0.578	0.577	C0151744	MyocardialIschemia	disease	C14	DiseaseorSyndrome	0.30	1	2005	2005	1	0	CTD_human
val	5166	PDK4	0.578	0.577	C0400966	Non-alcoholicFattyLiverDisease	disease	C06	DiseaseorSyndrome	0.31	1	2018	2018	1	0	CTD_human
val	5166	PDK4	0.578	0.577	C0860207	Drug-InducedLiverDisease	phenotype	C06;C25	DiseaseorSyndrome	0.30	1	2011	2011	1	0	CTD_human
val	5166	PDK4	0.578	0.577	C1262760	Hepatitis,Drug-Induced	disease	C06;C25	DiseaseorSyndrome	0.30	1	2011	2011	1	0	CTD_human
val	5166	PDK4	0.578	0.577	C2239176	Livercarcinoma	disease	C06;C04	NeoplasticProcess	0.34	1	2015	2019	1	0	CTD_human
val	5166	PDK4	0.578	0.577	C3241937	NonalcoholicSteatohepatitis	disease	C06	DiseaseorSyndrome	0.31	1	2018	2018	1	0	CTD_human
val	5166	PDK4	0.578	0.577	C3658290	Drug-InducedAcuteLiverInjury	disease	C06;C25	DiseaseorSyndrome	0.30	1	2011	2011	1	0	CTD_human
val	5166	PDK4	0.578	0.577	C4277682	ChemicalandDrugInducedLiverInjury	disease	C06;C25	DiseaseorSyndrome	0.30	1	2011	2011	1	0	CTD_human
val	5166	PDK4	0.578	0.577	C4279912	Chemically-InducedLiverToxicity	disease	C06;C25	DiseaseorSyndrome	0.30	1	2011	2011	1	0	CTD_human
val	5167	ENPP1	0.498	0.808	C0011860	DiabetesMellitus,Non-Insulin-Dependent	disease	C18;C19	DiseaseorSyndrome	0.70	0.814	2000	2019	0	0	CTD_human;GENOMICS_ENGLAND
val	5167	ENPP1	0.498	0.808	C0014175	Endometriosis	disease	C13	DiseaseorSyndrome	0.31	1	2011	2018	1	0	CTD_human
val	5167	ENPP1	0.498	0.808	C0028754	Obesity	disease	C23;C18	DiseaseorSyndrome	0.70	0.786	2001	2019	0	0	CTD_human;GENOMICS_ENGLAND
val	5167	ENPP1	0.498	0.808	C0033847	PseudoxanthomaElasticum	disease	C16;C17;C15;C14	DiseaseorSyndrome	0.40	1	2012	2019	1	0	ORPHANET
val	5167	ENPP1	0.498	0.808	C0269102	Endometrioma	disease	C13	NeoplasticProcess	0.31	1	2011	2018	1	0	CTD_human
val	5167	ENPP1	0.498	0.808	C0342643	AutosomalrecessivehypophosphatemicvitaminDrefractoryrickets	disease	C16;C18;C13;C05;C12	DiseaseorSyndrome	0.37	1	2010	2020	0	0	ORPHANET
val	5167	ENPP1	0.498	0.808	C1859727	Arterialcalcificationofinfancy	disease	C18	DiseaseorSyndrome	0.70	1	2003	2018	0	1	CTD_human
val	5167	ENPP1	0.498	0.808	C1865343	OSSIFICATIONOFTHEPOSTERIORLONGITUDINALLIGAMENTOFSPINE	disease	C23;C05	DiseaseorSyndrome	0.70	1	1981	1999	1	1	GENOMICS_ENGLAND;UNIPROT
val	5167	ENPP1	0.498	0.808	C2750078	HypophosphatemicRickets,AutosomalRecessive,2	disease	C16;C18;C13;C05;C12	DiseaseorSyndrome	0.70	1	2005	2015	4	7	CTD_human;GENOMICS_ENGLAND;UNIPROT
val	5167	ENPP1	0.498	0.808	C3809781	Coledisease	disease		DiseaseorSyndrome	0.72	1	2009	2018	4	3	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
val	5167	ENPP1	0.498	0.808	C4551985	ARTERIALCALCIFICATION,GENERALIZED,OFINFANCY,1	disease	C18	DiseaseorSyndrome	0.60	1	2003	2016	7	28	GENOMICS_ENGLAND;UNIPROT
val	5168	ENPP2	0.582	0.769	C0005612	BirthWeight	phenotype	C23	OrganismAttribute	0.40	1	2013	2019	1	1	CTD_human
val	5168	ENPP2	0.582	0.769	C0019158	Hepatitis	group	C06	DiseaseorSyndrome	0.30	1	2007	2007	1	0	CTD_human
val	5168	ENPP2	0.582	0.769	C0023893	LiverCirrhosis,Experimental	disease	C23;C06	ExperimentalModelofDisease	0.50	1	2006	2012	1	0	CTD_human
val	5168	ENPP2	0.582	0.769	C0027627	NeoplasmMetastasis	phenotype	C23;C04	NeoplasticProcess	0.34	1	1999	2018	1	0	CTD_human
val	5168	ENPP2	0.582	0.769	C0040136	ThyroidNeoplasm	disease	C04;C19	NeoplasticProcess	0.32	1	2004	2015	1	0	CTD_human
val	5168	ENPP2	0.582	0.769	C0151468	ThyroidGlandFollicularAdenoma	disease	C04;C19	NeoplasticProcess	0.30	1	2015	2015	1	0	CTD_human
val	5168	ENPP2	0.582	0.769	C0549473	Thyroidcarcinoma	disease	C04;C19	NeoplasticProcess	0.32	1	2004	2015	1	0	CTD_human
val	5170	PDPK1	0.588	0.808	C0006142	Malignantneoplasmofbreast	disease	C04;C17	NeoplasticProcess	0.55	1	2005	2019	1	0	CGI;CTD_human
val	5170	PDPK1	0.588	0.808	C0018801	Heartfailure	disease	C14	DiseaseorSyndrome	0.30	1	2009	2009	1	0	CTD_human
val	5170	PDPK1	0.588	0.808	C0018802	Congestiveheartfailure	disease	C14	DiseaseorSyndrome	0.30	1	2009	2009	1	0	CTD_human
val	5170	PDPK1	0.588	0.808	C0023212	Left-SidedHeartFailure	disease	C14	DiseaseorSyndrome	0.30	1	2009	2009	1	0	CTD_human
val	5170	PDPK1	0.588	0.808	C0079744	DiffuseLargeB-CellLymphoma	disease	C04;C20;C15	NeoplasticProcess	0.31	1	2011	2018	1	0	CTD_human
val	5170	PDPK1	0.588	0.808	C0235527	HeartFailure,Right-Sided	disease	C14	DiseaseorSyndrome	0.30	1	2009	2009	1	0	CTD_human
val	5170	PDPK1	0.588	0.808	C0496956	Neoplasmofuncertainorunknownbehaviorofbreast	disease	C04;C17	NeoplasticProcess	0.30				0	0	CGI
val	5170	PDPK1	0.588	0.808	C0678222	BreastCarcinoma	disease	C04;C17	NeoplasticProcess	0.55	1	2005	2019	1	0	CGI;CTD_human
val	5170	PDPK1	0.588	0.808	C0858252	Breastadenocarcinoma	disease	C04;C17	NeoplasticProcess	0.30				0	0	CGI
val	5170	PDPK1	0.588	0.808	C1257931	MammaryNeoplasms,Human	disease	C04;C17	NeoplasticProcess	0.30	1	2014	2014	1	0	CTD_human
val	5170	PDPK1	0.588	0.808	C1458155	MammaryNeoplasms	group	C04;C17	NeoplasticProcess	0.31	1	2005	2014	1	0	CTD_human
val	5170	PDPK1	0.588	0.808	C1959583	MyocardialFailure	disease	C14	DiseaseorSyndrome	0.30	1	2009	2009	1	0	CTD_human
val	5170	PDPK1	0.588	0.808	C1961112	HeartDecompensation	phenotype	C14	PathologicFunction	0.30	1	2009	2009	1	0	CTD_human
val	5170	PDPK1	0.588	0.808	C4704874	MammaryCarcinoma,Human	disease	C04;C17	NeoplasticProcess	0.30	1	2014	2014	1	0	CTD_human
val	5172	SLC26A4	0.507	0.885	C0018021	Goiter	phenotype	C19	DiseaseorSyndrome	0.70	0.972	1996	2017	4	0	CTD_human;GENOMICS_ENGLAND
val	5172	SLC26A4	0.507	0.885	C0018784	SensorineuralHearingLoss(disorder)	disease	C23;C10;C09	DiseaseorSyndrome	0.70	1	1996	2019	4	0	CTD_human;GENOMICS_ENGLAND
val	5172	SLC26A4	0.507	0.885	C0033578	ProstaticNeoplasms	group	C04;C12	NeoplasticProcess	0.30	1	2007	2007	1	0	CTD_human
val	5172	SLC26A4	0.507	0.885	C0151516	ThyroidHypoplasia	disease	C16;C19	DiseaseorSyndrome	0.41	1	2014	2014	1	0	ORPHANET
val	5172	SLC26A4	0.507	0.885	C0271829	Pendredssyndrome	disease	C23;C10;C19;C09	DiseaseorSyndrome	1	1	1996	2019	28	125	CLINGEN;CTD_human;GENOMICS_ENGLAND;UNIPROT
16292	5172	SLC26A4	0.507	0.885	C1384666	hearingimpairment	phenotype	C23;C10;C09	DiseaseorSyndrome	0.7	1	1999	2018	3	36	CTD_human;GENOMICS_ENGLAND
16295	5172	SLC26A4	0.507	0.885	C3538946	DEAFNESS,AUTOSOMALRECESSIVE4,WITHENLARGEDVESTIBULARAQUEDUCT	disease	C23;C10;C09	DiseaseorSyndrome	0.73	1	1998	2019	13	73	CTD_human;GENOMICS_ENGLAND;UNIPROT
16297	5173	PDYN	0.535	0.577	C0001973	AlcoholicIntoxication,Chronic	disease	C25;F03	MentalorBehavioralDysfunction	0.6	0.8	1997	2018	7	0	CTD_human;PSYGENET
16362	5173	PDYN	0.535	0.577	C0600427	CocaineDependence	disease	C25;F03	MentalorBehavioralDysfunction	0.54	1	2002	2014	7	0	CTD_human;PSYGENET
16389	5173	PDYN	0.535	0.577	C1853250	SPINOCEREBELLARATAXIA23	disease	C16;C10	DiseaseorSyndrome	0.74	1	2010	2013	4	0	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
16419	5176	SERPINF1	0.46	0.846	C0029434	OsteogenesisImperfecta	disease	C16;C17;C05	DiseaseorSyndrome;CongenitalAbnormality	0.6	1	2011	2018	1	0	GENOMICS_ENGLAND
16427	5176	SERPINF1	0.46	0.846	C3279564	OsteogenesisImperfecta,TypeVI	disease	C16;C17;C05	DiseaseorSyndrome	0.9	1	2011	2019	1	6	CTD_human;GENOMICS_ENGLAND
16466	5184	PEPD	0.621	0.769	C0268532	Deficiencyofprolidase	disease	C16	DiseaseorSyndrome	0.76	1	1990	2017	9	12	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
16485	5189	PEX1	0.538	0.769	C0043459	ZellwegerSyndrome	disease	C16;C06;C18;C13;C12;C10	DiseaseorSyndrome	0.8	1	1997	2020	5	0	CTD_human;GENOMICS_ENGLAND
16488	5189	PEX1	0.538	0.769	C0282527	InfantileRefsumDisease(disorder)	disease	C16;C18;C10	DiseaseorSyndrome	0.72	1	1997	2017	9	57	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
16490	5189	PEX1	0.538	0.769	C1832200	Peroxisomebiogenesisdisorders	group	C16;C18	DiseaseorSyndrome	0.7	1	1997	2016	4	8	CTD_human;GENOMICS_ENGLAND
16491	5189	PEX1	0.538	0.769	C1856186	Deafnessenamelhypoplasianaildefects	disease	C23;C16;C10;C07;C09	DiseaseorSyndrome	0.53	1	2015	2018	1	0	CTD_human;ORPHANET
16496	5189	PEX1	0.538	0.769	C4551980	HEIMLERSYNDROME1	disease	C23;C16;C10;C07;C09	DiseaseorSyndrome	0.6	1	1997	2017	3	12	GENOMICS_ENGLAND;UNIPROT
16497	5189	PEX1	0.538	0.769	C4721541	PEROXISOMEBIOGENESISDISORDER1A(ZELLWEGER)	disease	C16;C06;C18;C13;C12;C10	DiseaseorSyndrome	0.6	1	1997	2017	9	96	GENOMICS_ENGLAND;UNIPROT
16500	5190	PEX6	0.547	0.731	C0043459	ZellwegerSyndrome	disease	C16;C06;C18;C13;C12;C10	DiseaseorSyndrome	0.56	1	1996	2017	2	0	CTD_human;GENOMICS_ENGLAND
16505	5190	PEX6	0.547	0.731	C1832200	Peroxisomebiogenesisdisorders	group	C16;C18	DiseaseorSyndrome	0.68	1	1996	2019	3	13	CTD_human;GENOMICS_ENGLAND
16507	5190	PEX6	0.547	0.731	C1856186	Deafnessenamelhypoplasianaildefects	disease	C23;C16;C10;C07;C09	DiseaseorSyndrome	0.51	1	2015	2018	1	0	CTD_human;ORPHANET
16508	5190	PEX6	0.547	0.731	C3553936	PEROXISOMEBIOGENESISDISORDER4A(ZELLWEGER)	disease	C16;C18	DiseaseorSyndrome	0.7	1	1996	2016	10	38	CTD_human;GENOMICS_ENGLAND;UNIPROT
16509	5190	PEX6	0.547	0.731	C3553937	PEROXISOMEBIOGENESISDISORDER4B	disease	C16;C18	DiseaseorSyndrome	0.6	1	1996	2016	5	35	CTD_human;GENOMICS_ENGLAND
16512	5190	PEX6	0.547	0.731	C4225267	HEIMLERSYNDROME2	disease		DiseaseorSyndrome	0.6	1	2002	2016	4	12	GENOMICS_ENGLAND;UNIPROT
16515	5191	PEX7	0.603	0.615	C0034960	RefsumDisease	disease	C16;C18;C10	DiseaseorSyndrome	0.66	1	1997	2012	2	2	CTD_human;GENOMICS_ENGLAND
16516	5191	PEX7	0.603	0.615	C0282529	ChondrodysplasiaPunctata,Rhizomelic	disease	C16;C18;C05	DiseaseorSyndrome	0.6	0.95	1997	2017	1	0	CTD_human
16520	5191	PEX7	0.603	0.615	C1859133	RHIZOMELICCHONDRODYSPLASIAPUNCTATA,TYPE1	disease	C16;C18;C05	DiseaseorSyndrome	0.98	0.964	1995	2017	8	42	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
16521	5191	PEX7	0.603	0.615	C2749346	RefsumDisease,Adult,2	disease	C16;C18;C10	DiseaseorSyndrome	0.7	1	1997	2016	3	13	CTD_human;GENOMICS_ENGLAND;UNIPROT
16522	5192	PEX10	0.584	0.654	C0043459	ZellwegerSyndrome	disease	C16;C06;C18;C13;C12;C10	DiseaseorSyndrome	0.52	1	1998	2017	5	0	CTD_human;GENOMICS_ENGLAND
16523	5192	PEX10	0.584	0.654	C0282525	Adrenoleukodystrophy,Neonatal	disease	C16;C18	DiseaseorSyndrome	0.52	1	1998	2017	0	0	GENOMICS_ENGLAND;ORPHANET
16526	5192	PEX10	0.584	0.654	C1832200	Peroxisomebiogenesisdisorders	group	C16;C18	DiseaseorSyndrome	0.67	1	1998	2019	4	2	CTD_human;GENOMICS_ENGLAND
16528	5192	PEX10	0.584	0.654	C3553947	PEROXISOMEBIOGENESISDISORDER6A(ZELLWEGER)	disease	C16;C18	DiseaseorSyndrome	0.6	1	1995	2017	3	23	CTD_human;GENOMICS_ENGLAND
16529	5192	PEX10	0.584	0.654	C3553948	PEROXISOMEBIOGENESISDISORDER6B	disease	C16;C18	DiseaseorSyndrome	0.7	1	1995	2016	4	26	CTD_human;GENOMICS_ENGLAND;UNIPROT
16532	5193	PEX12	0.601	0.615	C0043459	ZellwegerSyndrome	disease	C16;C06;C18;C13;C12;C10	DiseaseorSyndrome	0.53	1	1997	2015	2	0	CTD_human;GENOMICS_ENGLAND
16536	5193	PEX12	0.601	0.615	C1832200	Peroxisomebiogenesisdisorders	group	C16;C18	DiseaseorSyndrome	0.65	1	1997	2018	2	7	CTD_human;GENOMICS_ENGLAND
16537	5193	PEX12	0.601	0.615	C3550693	PEROXISOMEBIOGENESISDISORDER3B	disease	C16;C18	DiseaseorSyndrome	0.6	1	1997	2017	4	34	GENOMICS_ENGLAND;UNIPROT
16538	5193	PEX12	0.601	0.615	C3553929	PEROXISOMEBIOGENESISDISORDER3A(ZELLWEGER)	disease	C16;C18	DiseaseorSyndrome	0.7	1	1997	2017	6	38	CTD_human;GENOMICS_ENGLAND;UNIPROT
16543	5194	PEX13	0.597	0.654	C0282525	Adrenoleukodystrophy,Neonatal	disease	C16;C18	DiseaseorSyndrome	0.51	1	2005	2005	0	0	GENOMICS_ENGLAND;ORPHANET
16547	5194	PEX13	0.597	0.654	C1832200	Peroxisomebiogenesisdisorders	group	C16;C18	DiseaseorSyndrome	0.54	1	1998	2017	4	0	CTD_human;GENOMICS_ENGLAND
16549	5194	PEX13	0.597	0.654	C3554000	PEROXISOMEBIOGENESISDISORDER11A(ZELLWEGER)	disease		DiseaseorSyndrome	0.6	1	2009	2016	5	4	CTD_human;GENOMICS_ENGLAND
16550	5194	PEX13	0.597	0.654	C3554001	PEROXISOMEBIOGENESISDISORDER11B	disease		DiseaseorSyndrome	0.7	1	1999	2015	6	2	CTD_human;GENOMICS_ENGLAND;UNIPROT
16554	5195	PEX14	0.592	0.692	C0043459	ZellwegerSyndrome	disease	C16;C06;C18;C13;C12;C10	DiseaseorSyndrome	0.52	1	2004	2008	2	0	CTD_human;GENOMICS_ENGLAND
16558	5195	PEX14	0.592	0.692	C1832200	Peroxisomebiogenesisdisorders	group	C16;C18	DiseaseorSyndrome	0.52	1	2004	2016	4	0	CTD_human;GENOMICS_ENGLAND
16559	5195	PEX14	0.592	0.692	C3554004	PEROXISOMEBIOGENESISDISORDER13A(ZELLWEGER)	disease		DiseaseorSyndrome	0.6	1	2004	2016	5	1	CTD_human;GENOMICS_ENGLAND
16576	5199	CFP	0.573	0.692	C0398762	Properdindeficiencydisease	disease		DiseaseorSyndrome	0.51	1	1980	2006	2	0	GENOMICS_ENGLAND;ORPHANET
16582	5199	CFP	0.573	0.692	C1839454	PROPERDINDEFICIENCY,X-LINKED	disease	C16;C20	DiseaseorSyndrome	0.7	1	1995	2019	7	5	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
16587	5205	ATP8B1	0.61	0.5	C0268318	Cholestasisofpregnancy	disease	C06;C13	DiseaseorSyndrome	0.58	1	2003	2017	1	0	CTD_human;ORPHANET
16589	5205	ATP8B1	0.61	0.5	C3549845	CHOLESTASIS,INTRAHEPATIC,OFPREGNANCY,1	disease		DiseaseorSyndrome	0.6	1	2005	2016	4	4	GENOMICS_ENGLAND;UNIPROT
16590	5205	ATP8B1	0.61	0.5	C4551898	Cholestasis,progressivefamilialintrahepatic1	disease	C06	DiseaseorSyndrome	0.8	0.978	1996	2018	7	13	CTD_human;GENOMICS_ENGLAND;UNIPROT
16591	5205	ATP8B1	0.61	0.5	C4551899	Cholestasis,benignrecurrentintrahepatic1	disease	C06	DiseaseorSyndrome	0.7	1	1998	2016	5	9	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
16612	5213	PFKM	0.666	0.5	C0017926	GlycogenStorageDiseaseTypeVII	disease	C16;C18;C05;C10	DiseaseorSyndrome	0.94	1	1990	2016	11	9	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
16620	5216	PFN1	0.565	0.769	C3553719	AMYOTROPHICLATERALSCLEROSIS18	disease		DiseaseorSyndrome	0.7	1	2012	2012	1	4	CTD_human;GENOMICS_ENGLAND;UNIPROT
16648	5224	PGAM2	0.792	0.308	C0268149	GlycogenstoragediseasetypeX	disease	C13;C05;C12;C10	DiseaseorSyndrome	0.73	1	1993	2017	4	0	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
16665	5230	PGK1	0.542	0.769	C1970848	PhosphoglycerateKinase1Deficiency	disease	C16;C18	DiseaseorSyndrome	0.77	1	1980	2019	11	14	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
16675	5236	PGM1	0.628	0.577	C2752015	GlycogenStorageDiseaseXIV	disease	C16;C18	DiseaseorSyndrome	0.7	1	2009	2016	8	13	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
16682	5238	PGM3	0.61	0.769	C4014371	IMMUNODEFICIENCY23	disease		DiseaseorSyndrome	0.7	1	2014	2015	4	9	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
16692	5241	PGR	0.426	0.885	C0014175	Endometriosis	disease	C13	DiseaseorSyndrome	0.6	0.966	1995	2020	2	0	CTD_human
16750	5243	ABCB1	0.344	0.885	C0009402	ColorectalCarcinoma	disease	C06;C04	NeoplasticProcess	0.6	0.96	1990	2020	2	0	CTD_human;UNIPROT
16755	5243	ABCB1	0.344	0.885	C0014544	Epilepsy	disease	C10	DiseaseorSyndrome	0.6	0.908	1995	2019	2	0	CTD_human
16805	5243	ABCB1	0.344	0.885	C0860207	Drug-InducedLiverDisease	phenotype	C06;C25	DiseaseorSyndrome	0.54	0.833	2011	2019	1	0	CTD_human
16815	5243	ABCB1	0.344	0.885	C2239176	Livercarcinoma	disease	C06;C04	NeoplasticProcess	0.6	0.96	1991	2019	1	0	CTD_human
16839	5244	ABCB4	0.529	0.615	C0268318	Cholestasisofpregnancy	disease	C06;C13	DiseaseorSyndrome	0.6	1	2000	2020	1	0	CTD_human;ORPHANET
16841	5244	ABCB4	0.529	0.615	C0566602	Primarysclerosingcholangitis	disease	C06	DiseaseorSyndrome	0.56	0.9	2004	2019	2	0	CTD_human
16844	5244	ABCB4	0.529	0.615	C1865643	Cholestasis,progressivefamilialintrahepatic3	disease	C06	DiseaseorSyndrome	0.77	1	1998	2019	12	27	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
16845	5244	ABCB4	0.529	0.615	C2239176	Livercarcinoma	disease	C06;C04	NeoplasticProcess	0.59	1	1993	2017	1	0	CTD_human
16846	5244	ABCB4	0.529	0.615	C2609268	Lowphospholipid-associatedcholelithiasis	disease	C06	DiseaseorSyndrome	0.8	0.947	2001	2020	8	25	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
16850	5244	ABCB4	0.529	0.615	C3554241	CHOLESTASIS,INTRAHEPATIC,OFPREGNANCY3	disease		DiseaseorSyndrome	0.6	1	2000	2016	4	13	GENOMICS_ENGLAND;UNIPROT
16852	5244	ABCB4	0.529	0.615	C4551898	Cholestasis,progressivefamilialintrahepatic1	disease	C06	DiseaseorSyndrome	0.7	1	1996	2020	1	4	CTD_human;GENOMICS_ENGLAND
16855	5245	PHB	0.511	0.846	C0006142	Malignantneoplasmofbreast	disease	C04;C17	NeoplasticProcess	0.6	0.944	1994	2018	0	2	CTD_human;UNIPROT
16885	5250	SLC25A3	0.566	0.692	C1835845	MitochondrialPhosphateCarrierDeficiency	disease	C18	DiseaseorSyndrome	0.7	1	2007	2016	3	1	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
16888	5251	PHEX	0.548	0.808	C0733682	HypophosphatemicRickets,X-LinkedDominant	disease	C16;C18;C13;C05;C12	DiseaseorSyndrome	1	0.976	1987	2020	14	79	CTD_human;GENOMICS_ENGLAND;UNIPROT
16891	5251	PHEX	0.548	0.808	C3536984	VitaminD-ResistantRickets,X-Linked	disease	C16;C18;C13;C05;C12	DiseaseorSyndrome	0.6	0.987	1988	2020	4	0	CTD_human;GENOMICS_ENGLAND
16892	5251	PHEX	0.548	0.808	C3540852	Rickets,X-LinkedHypophosphatemic	disease	C16;C18;C13;C05;C12	DiseaseorSyndrome	0.6	1	1988	2020	3	0	CTD_human
16894	5255	PHKA1	0.839	0.115	C1845151	GlycogenStorageDisease,TypeIXD	disease	C16;C18	DiseaseorSyndrome	0.9	1	1970	2016	4	4	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
16895	5256	PHKA2	0.678	0.462	C0017919	GlycogenStorageDisease	group	C16;C18	DiseaseorSyndrome	0.6	1	1992	2017	2	0	CTD_human;GENOMICS_ENGLAND
16897	5256	PHKA2	0.678	0.462	C3694531	GLYCOGENSTORAGEDISEASEIXa1	disease		DiseaseorSyndrome	0.7	1	1994	2017	8	26	CTD_human;GENOMICS_ENGLAND;UNIPROT
16900	5257	PHKB	0.769	0.269	C0543514	GlycogenStorageDiseaseIXB	disease	C16;C18	DiseaseorSyndrome	0.7	1	1997	2016	2	5	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
16903	5261	PHKG2	0.674	0.538	C0017919	GlycogenStorageDisease	group	C16;C18	DiseaseorSyndrome	0.57	1	1996	2018	1	0	GENOMICS_ENGLAND
16904	5261	PHKG2	0.674	0.538	C2751643	GlycogenStorageDiseaseIXC	disease	C16;C18	DiseaseorSyndrome	0.71	1	1996	2018	4	11	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
16906	5264	PHYH	0.659	0.577	C0034960	RefsumDisease	disease	C16;C18;C10	DiseaseorSyndrome	1	1	1984	2017	7	12	CTD_human;GENOMICS_ENGLAND;UNIPROT
16913	5265	SERPINA1	0.41	0.923	C0005586	BipolarDisorder	disease	F03	MentalorBehavioralDysfunction	0.51	1	2006	2015	2	0	CTD_human;PSYGENET
16925	5265	SERPINA1	0.41	0.923	C0024115	Lungdiseases	group	C08	DiseaseorSyndrome	0.6	0.983	1982	2019	1	0	CTD_human;GENOMICS_ENGLAND
16945	5265	SERPINA1	0.41	0.923	C0221757	alpha1-AntitrypsinDeficiency	disease	C23;C16;C06;C08	DiseaseorSyndrome	0.7	0.978	1978	2020	6	45	CTD_human;GENOMICS_ENGLAND
16987	5269	SERPINB6	0.547	0.769	C3150704	DEAFNESS,AUTOSOMALRECESSIVE91	disease		DiseaseorSyndrome	0.6	1	1995	1995	1	1	CTD_human;GENOMICS_ENGLAND
16992	5271	SERPINB8	0.792	0.154	C1838440	ICHTHYOSISEXFOLIATIVA	disease	C16;C17	DiseaseorSyndrome	0.51	1	2002	2016	2	0	CLINGEN;ORPHANET
17007	5274	SERPINI1	0.631	0.462	C1858680	Familialencephalopathywithneuroserpininclusionbodies	disease	C16;C10	DiseaseorSyndrome	0.95	1	1999	2018	3	4	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
17009	5277	PIGA	0.575	0.654	C0024790	Paroxysmalnocturnalhemoglobinuria	disease	C15	DiseaseorSyndrome	0.7	0.969	1993	2019	3	0	CTD_human;ORPHANET
17012	5277	PIGA	0.575	0.654	C3275508	MULTIPLECONGENITALANOMALIES-HYPOTONIA-SEIZURESSYNDROME2	disease		DiseaseorSyndrome	0.71	1	2012	2018	9	10	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
17013	5277	PIGA	0.575	0.654	C3806670	PAROXYSMALNOCTURNALHEMOGLOBINURIA1	disease		DiseaseorSyndrome	0.6	1	1993	2002	5	10	GENOMICS_ENGLAND;UNIPROT
17015	5279	PIGC	0.691	0.346	C4540521	GLYCOSYLPHOSPHATIDYLINOSITOLBIOSYNTHESISDEFECT16	disease		DiseaseorSyndrome	0.6	1	2017	2017	1	0	GENOMICS_ENGLAND;UNIPROT
17018	5283	PIGH	0.76	0.231	C4747891	GLYCOSYLPHOSPHATIDYLINOSITOLBIOSYNTHESISDEFECT17	disease		DiseaseorSyndrome	0.6	1	2018	2018	3	2	GENOMICS_ENGLAND;UNIPROT
17023	5290	PIK3CA	0.292	0.923	C0006142	Malignantneoplasmofbreast	disease	C04;C17	NeoplasticProcess	1	0.985	2001	2020	9	8	CGI;CTD_human;UNIPROT
17028	5290	PIK3CA	0.292	0.923	C0009402	ColorectalCarcinoma	disease	C06;C04	NeoplasticProcess	0.7	0.985	2002	2020	2	11	CTD_human;UNIPROT
17037	5290	PIK3CA	0.292	0.923	C0022603	Seborrheickeratosis	disease	C17	NeoplasticProcess	0.67	1	2007	2018	1	5	CTD_human;UNIPROT
17039	5290	PIK3CA	0.292	0.923	C0024121	LungNeoplasms	group	C04;C08	NeoplasticProcess	0.6	1	2003	2019	0	0	CGI;CTD_human
17040	5290	PIK3CA	0.292	0.923	C0024623	Malignantneoplasmofstomach	disease	C06;C04	NeoplasticProcess	0.7	0.992	2005	2020	1	0	CGI;CTD_human
17048	5290	PIK3CA	0.292	0.923	C0038356	StomachNeoplasms	group	C06;C04	NeoplasticProcess	0.62	1	2005	2016	1	4	CGI;CTD_human
17067	5290	PIK3CA	0.292	0.923	C0242379	Malignantneoplasmoflung	disease	C04;C08	NeoplasticProcess	0.6	0.967	2002	2019	0	0	CGI;CTD_human
17069	5290	PIK3CA	0.292	0.923	C0265552	Congenitalmacrodactylia	disease	C16;C05	CongenitalAbnormality	0.67	1	2009	2020	2	3	GENOMICS_ENGLAND;UNIPROT
17086	5290	PIK3CA	0.292	0.923	C0678222	BreastCarcinoma	disease	C04;C17	NeoplasticProcess	0.7	0.987	2001	2020	8	0	CGI;CTD_human
17090	5290	PIK3CA	0.292	0.923	C0919267	ovarianneoplasm	disease	C04;C13;C19	NeoplasticProcess	0.7	0.984	1999	2019	0	12	CGI;CTD_human
17092	5290	PIK3CA	0.292	0.923	C1140680	Malignantneoplasmofovary	disease	C04;C13;C19	NeoplasticProcess	0.7	0.986	1999	2019	1	2	CGI;CTD_human;UNIPROT
17107	5290	PIK3CA	0.292	0.923	C1865285	Megalencephalycutismarmoratatelangiectaticacongenita	disease	C16;C17;C05;C10;C14	DiseaseorSyndrome	0.77	1	2009	2020	5	16	GENOMICS_ENGLAND;ORPHANET;UNIPROT
17109	5290	PIK3CA	0.292	0.923	C2239176	Livercarcinoma	disease	C06;C04	NeoplasticProcess	0.8	0.966	2002	2020	1	11	CGI;CTD_human;UNIPROT
17110	5290	PIK3CA	0.292	0.923	C2751313	CLAPOSyndrome	disease	C16;C15;C14	DiseaseorSyndrome;CongenitalAbnormality	0.6	1	2009	2018	2	5	GENOMICS_ENGLAND;UNIPROT
17111	5290	PIK3CA	0.292	0.923	C2752042	CongenitalLipomatousOvergrowth,VascularMalformations,andEpidermalNevi	disease	C16;C04;C05;C14	DiseaseorSyndrome	0.95	1	2009	2017	4	5	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
17115	5290	PIK3CA	0.292	0.923	C3554518	COWDENSYNDROME5	disease		DiseaseorSyndrome	0.7	1	2005	2013	2	9	CTD_human;GENOMICS_ENGLAND;UNIPROT
17152	5293	PIK3CD	0.319	0.885	C0079744	DiffuseLargeB-CellLymphoma	disease	C04;C20;C15	NeoplasticProcess	0.6	1	2005	2019	1	0	CGI;CTD_human
17158	5293	PIK3CD	0.319	0.885	C3714976	ACTIVATEDPI3K-DELTASYNDROME	disease	C16;C20	DiseaseorSyndrome	0.8	1	2006	2020	3	4	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
17184	5295	PIK3R1	0.477	0.885	C0021655	InsulinResistance	phenotype	C18	PathologicFunction	0.6	1	1999	2003	1	0	CTD_human
17194	5295	PIK3R1	0.477	0.885	C0343640	AfricanBurkittslymphoma	disease	C04;C01;C20;C15	NeoplasticProcess	0.30	1	2012	2012	1	0	CTD_human
val	5295	PIK3R1	0.477	0.885	C0376358	Malignantneoplasmofprostate	disease	C04;C12	NeoplasticProcess	0.35	1	2010	2019	2	0	CTD_human
val	5295	PIK3R1	0.477	0.885	C0494261	Combinedimmunodeficiency	disease	C16;C18;C20	DiseaseorSyndrome	0.30	1	2014	2014	1	0	GENOMICS_ENGLAND
val	5295	PIK3R1	0.477	0.885	C0496920	Neoplasmofuncertainorunknownbehaviorofovary	disease	C04;C13;C19	NeoplasticProcess	0.30				0	0	CGI
val	5295	PIK3R1	0.477	0.885	C0878684	SHORTsyndrome	disease	C23;C18;C13;C12	DiseaseorSyndrome	0.80	0.955	2000	2019	7	12	CLINGEN;CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
val	5295	PIK3R1	0.477	0.885	C0919267	ovarianneoplasm	disease	C04;C13;C19	NeoplasticProcess	0.30				0	0	CGI
val	5295	PIK3R1	0.477	0.885	C0920563	InsulinSensitivity	phenotype	C18	PathologicFunction	0.30	1	2003	2003	1	0	CTD_human
val	5295	PIK3R1	0.477	0.885	C1140680	Malignantneoplasmofovary	disease	C04;C13;C19	NeoplasticProcess	0.31	1	2019	2019	0	0	CGI
val	5295	PIK3R1	0.477	0.885	C1257925	MammaryCarcinoma,Animal	disease	C04;C22	NeoplasticProcess	0.30	1	2003	2003	1	0	CTD_human
val	5295	PIK3R1	0.477	0.885	C1319315	Adenocarcinomaoflargeintestine	disease	C06;C04	NeoplasticProcess	0.30				0	0	CGI
val	5295	PIK3R1	0.477	0.885	C1621958	GlioblastomaMultiforme	disease	C04	NeoplasticProcess	0.35	0.8	2004	2012	0	0	CGI
val	5295	PIK3R1	0.477	0.885	C1832241	Agammaglobulinemia,non-Brutontype	disease	C20;C15	DiseaseorSyndrome	0.30	1	2012	2012	1	0	ORPHANET
val	5295	PIK3R1	0.477	0.885	C3554689	AGAMMAGLOBULINEMIA7,AUTOSOMALRECESSIVE	disease		DiseaseorSyndrome	0.60	1	2012	2017	2	5	CTD_human;GENOMICS_ENGLAND
val	5295	PIK3R1	0.477	0.885	C3714976	ACTIVATEDPI3K-DELTASYNDROME	disease	C16;C20	DiseaseorSyndrome	0.33	1	2014	2017	1	0	ORPHANET
val	5295	PIK3R1	0.477	0.885	C4014934	IMMUNODEFICIENCY36	disease		DiseaseorSyndrome	0.60	1	2012	2018	2	7	CTD_human;GENOMICS_ENGLAND
val	5295	PIK3R1	0.477	0.885	C4721444	BurkittLeukemia	disease	C04;C01;C20;C15	NeoplasticProcess	0.30	1	2012	2012	1	0	CTD_human
val	5296	PIK3R2	0.551	0.808	C0007103	Malignantneoplasmofendometrium	disease	C04;C13	NeoplasticProcess	0.32	1	2011	2011	0	0	CGI
val	5296	PIK3R2	0.551	0.808	C0033578	ProstaticNeoplasms	group	C04;C12	NeoplasticProcess	0.30	1	2018	2018	1	0	CTD_human
val	5296	PIK3R2	0.551	0.808	C0152427	Polydactyly	disease	C16;C05	CongenitalAbnormality	0.30	1	2015	2015	1	0	GENOMICS_ENGLAND
val	5296	PIK3R2	0.551	0.808	C0346191	Carcinomainsituofendometrium	disease	C04;C13	NeoplasticProcess	0.30				0	0	CGI
val	5296	PIK3R2	0.551	0.808	C0376358	Malignantneoplasmofprostate	disease	C04;C12	NeoplasticProcess	0.34	1	2016	2019	1	0	CTD_human
val	5296	PIK3R2	0.551	0.808	C0476089	EndometrialCarcinoma	disease	C04;C13	NeoplasticProcess	0.32	1	2011	2011	0	0	CGI
val	5296	PIK3R2	0.551	0.808	C1153706	Endometrialadenocarcinoma	disease	C04;C13	NeoplasticProcess	0.30				0	0	CGI
val	5296	PIK3R2	0.551	0.808	C1863924	MegalanecephalyPolymicrogyria-PolydactylyHydrocephalusSyndrome	disease	C16;C05;C10	DiseaseorSyndrome	0.50	1	2012	2015	2	0	CTD_human;ORPHANET
val	5296	PIK3R2	0.551	0.808	C4012727	MEGALENCEPHALY-POLYMICROGYRIA-POLYDACTYLY-HYDROCEPHALUSSYNDROME1	disease	C16;C05;C10	DiseaseorSyndrome	0.60	1	2006	2017	5	5	GENOMICS_ENGLAND;UNIPROT
val	5297	PI4KA	0.695	0.577	C0036341	Schizophrenia	disease	F03	MentalorBehavioralDysfunction	0.33	0.75	2008	2014	4	0	PSYGENET
val	5297	PI4KA	0.695	0.577	C1845668	Perisylviansyndrome	disease	C23;C16;C10;F03;F01	CongenitalAbnormality	0.30	1	2015	2015	1	0	ORPHANET
val	5297	PI4KA	0.695	0.577	C4225295	POLYMICROGYRIA,PERISYLVIAN,WITHCEREBELLARHYPOPLASIAANDARTHROGRYPOSIS	disease		DiseaseorSyndrome	0.60	1	2015	2015	1	2	GENOMICS_ENGLAND;UNIPROT
val	5300	PIN1	0.488	0.769	C0006142	Malignantneoplasmofbreast	disease	C04;C17	NeoplasticProcess	0.40	0.944	2001	2019	2	0	CTD_human
val	5300	PIN1	0.488	0.769	C0678222	BreastCarcinoma	disease	C04;C17	NeoplasticProcess	0.40	0.943	2001	2019	2	0	CTD_human
val	5300	PIN1	0.488	0.769	C1257931	MammaryNeoplasms,Human	disease	C04;C17	NeoplasticProcess	0.30	1	2009	2009	2	0	CTD_human
val	5300	PIN1	0.488	0.769	C1458155	MammaryNeoplasms	group	C04;C17	NeoplasticProcess	0.34	1	2002	2012	2	0	CTD_human
val	5300	PIN1	0.488	0.769	C4704874	MammaryCarcinoma,Human	disease	C04;C17	NeoplasticProcess	0.30	1	2009	2009	2	0	CTD_human
val	5304	PIP	0.556	0.808	C0037199	Sinusitis	disease	C01;C08;C09	DiseaseorSyndrome	0.30	1	2008	2008	1	0	CTD_human
val	5305	PIP4K2A	0.647	0.423	C0005586	BipolarDisorder	disease	F03	MentalorBehavioralDysfunction	0.33	0.667	2005	2007	3	0	PSYGENET
val	5305	PIP4K2A	0.647	0.423	C0006413	BurkittLymphoma	disease	C04;C01;C20;C15	NeoplasticProcess	0.30	1	2013	2013	1	0	ORPHANET
val	5305	PIP4K2A	0.647	0.423	C0025202	melanoma	disease	C04	NeoplasticProcess	0.30	1	2012	2012	1	0	CTD_human
val	5305	PIP4K2A	0.647	0.423	C0036341	Schizophrenia	disease	F03	MentalorBehavioralDysfunction	0.40	0.75	2005	2014	4	0	PSYGENET
val	5305	PIP4K2A	0.647	0.423	C1292769	PrecursorB-celllymphoblasticleukemia	disease	C04;C20;C15	NeoplasticProcess	0.30	1	2013	2013	1	0	ORPHANET
val	5307	PITX1	0.561	0.654	C0004352	AutisticDisorder	disease	F03	MentalorBehavioralDysfunction	0.31	1	2007	2007	1	0	CTD_human
val	5307	PITX1	0.561	0.654	C0009081	Congenitalclubfoot	disease	C16;C05	CongenitalAbnormality	0.97	0.889	2008	2019	4	2	CTD_human;GENOMICS_ENGLAND;UNIPROT
val	5307	PITX1	0.561	0.654	C0152427	Polydactyly	disease	C16;C05	CongenitalAbnormality	0.33	1	2012	2019	1	0	GENOMICS_ENGLAND
val	5307	PITX1	0.561	0.654	C1336708	TesticularGermCellTumor	disease	C04;C12;C19	NeoplasticProcess	0.41	1	2013	2013	1	1	CTD_human
val	5307	PITX1	0.561	0.654	C1851100	LAURIN-SANDROWSYNDROME	disease	C16;C05	DiseaseorSyndrome	0.31	1	2012	2012	1	0	ORPHANET
val	5307	PITX1	0.561	0.654	C1861313	Synostosis,Carpal,withDysplasticElbowJointsandBrachydactyly	disease	C16;C05	DiseaseorSyndrome	0.62	1	2012	2014	2	0	CTD_human;GENOMICS_ENGLAND;ORPHANET
val	5307	PITX1	0.561	0.654	C1861316	Radiallydeviatedwrists	phenotype		Finding	0.40				0	0	GENOMICS_ENGLAND
val	5307	PITX1	0.561	0.654	C2239176	Livercarcinoma	disease	C06;C04	NeoplasticProcess	0.32	1	2011	2017	1	0	CTD_human
val	5308	PITX2	0.489	0.808	C0004238	AtrialFibrillation	disease	C23;C14	DiseaseorSyndrome	0.50	0.956	2010	2019	1	1	CTD_human
val	5308	PITX2	0.489	0.808	C0015397	Disorderofeye	group	C11	DiseaseorSyndrome	0.30				0	0	GENOMICS_ENGLAND
val	5308	PITX2	0.489	0.808	C0018798	CongenitalHeartDefects	group	C16;C14	CongenitalAbnormality	0.30	1	1999	1999	1	0	CTD_human
val	5308	PITX2	0.489	0.808	C0038454	Cerebrovascularaccident	group	C10;C14	DiseaseorSyndrome	0.37	1	2012	2019	1	0	CTD_human
val	5308	PITX2	0.489	0.808	C0040427	ToothAbnormalities	group	C16;C07	AnatomicalAbnormality	0.30	1	1999	1999	1	0	CTD_human
val	5308	PITX2	0.489	0.808	C0086543	Cataract	disease	C11	AcquiredAbnormality	0.31	1	1998	1998	0	0	GENOMICS_ENGLAND
val	5308	PITX2	0.489	0.808	C0235480	Paroxysmalatrialfibrillation	disease	C23;C14	DiseaseorSyndrome	0.31	1	2014	2018	1	0	CTD_human
val	5308	PITX2	0.489	0.808	C0265341	Riegersyndrome	disease	C16;C11	DiseaseorSyndrome	0.50	1	1998	2018	2	1	ORPHANET
val	5308	PITX2	0.489	0.808	C0266548	Axenfeldanomaly(disorder)	disease	C16;C11	CongenitalAbnormality	0.33	1	2000	2014	2	0	ORPHANET
val	5308	PITX2	0.489	0.808	C0344559	Irido-corneo-trabeculardysgenesis(disorder)	disease	C16;C11	CongenitalAbnormality	0.61	1	1999	1999	1	0	GENOMICS_ENGLAND;ORPHANET
val	5308	PITX2	0.489	0.808	C0376634	CraniofacialAbnormalities	group	C16;C05	CongenitalAbnormality	0.30	1	1999	2003	2	0	CTD_human
val	5308	PITX2	0.489	0.808	C0524730	Odontome	disease	C16;C07	CongenitalAbnormality	0.30	1	1999	1999	1	0	CTD_human
val	5308	PITX2	0.489	0.808	C0751956	AcuteCerebrovascularAccidents	disease	C10;C14	DiseaseorSyndrome	0.30	1	2018	2018	1	0	CTD_human
val	5308	PITX2	0.489	0.808	C1384666	hearingimpairment	phenotype	C23;C10;C09	DiseaseorSyndrome	0.40				0	0	GENOMICS_ENGLAND
val	5308	PITX2	0.489	0.808	C1842031	IRIDOGONIODYSGENESIS,TYPE2	disease	C16;C11;C07	DiseaseorSyndrome	0.73	1	1996	2011	6	4	CTD_human;GENOMICS_ENGLAND;UNIPROT
val	5308	PITX2	0.489	0.808	C1843687	ATRIALFIBRILLATION,FAMILIAL,1(disorder)	disease	C23;C14	DiseaseorSyndrome	0.40	1	2014	2014	1	1	ORPHANET
val	5308	PITX2	0.489	0.808	C1867155	RINGDERMOIDOFCORNEA	disease	C04;C11	DiseaseorSyndrome	0.70	1	2001	2012	3	1	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
val	5308	PITX2	0.489	0.808	C2585653	Persistentatrialfibrillation	phenotype	C23;C14	PathologicFunction	0.30	1	2018	2018	1	0	CTD_human
val	5308	PITX2	0.489	0.808	C3468561	familialatrialfibrillation	phenotype	C23;C14	PathologicFunction	0.30	1	2018	2018	1	0	CTD_human
val	5308	PITX2	0.489	0.808	C3495488	Axenfeld-Riegersyndrome	disease	C16;C11	DiseaseorSyndrome	0.60	1	1998	2019	1	0	GENOMICS_ENGLAND;ORPHANET
val	5308	PITX2	0.489	0.808	C3714873	Axenfeld-RiegerSyndrome,Type1	disease	C16;C11	DiseaseorSyndrome	0.91	1	1996	2006	10	15	CTD_human;GENOMICS_ENGLAND;UNIPROT
val	5308	PITX2	0.489	0.808	C4310809	ANTERIORSEGMENTDYSGENESIS5	disease		DiseaseorSyndrome	0.30	1	2001	2001	1	0	GENOMICS_ENGLAND
val	5309	PITX3	0.585	0.692	C0009171	CocaineAbuse	disease	C25;F03	MentalorBehavioralDysfunction	0.31	1	2004	2004	1	0	PSYGENET
val	5309	PITX3	0.585	0.692	C0011581	Depressivedisorder	disease	F03	MentalorBehavioralDysfunction	0.30	1	2014	2014	1	0	PSYGENET
val	5309	PITX3	0.585	0.692	C0015397	Disorderofeye	group	C11	DiseaseorSyndrome	0.30	1	2010	2010	1	0	GENOMICS_ENGLAND
val	5309	PITX3	0.585	0.692	C0026010	Microphthalmos	disease	C16;C11	CongenitalAbnormality	0.44	1	2006	2012	1	0	CTD_human
val	5309	PITX3	0.585	0.692	C0027643	NeoplasmRecurrence,Local	phenotype	C23;C04	NeoplasticProcess	0.30	1	2016	2016	1	0	CTD_human
val	5309	PITX3	0.585	0.692	C0027854	NeurologicManifestations	phenotype	C23;C10	Finding	0.30	1	2006	2006	1	0	CTD_human
val	5309	PITX3	0.585	0.692	C0033578	ProstaticNeoplasms	group	C04;C12	NeoplasticProcess	0.30	1	2016	2016	1	0	CTD_human
val	5309	PITX3	0.585	0.692	C0036341	Schizophrenia	disease	F03	MentalorBehavioralDysfunction	0.32	1	2010	2017	1	0	PSYGENET
val	5309	PITX3	0.585	0.692	C0086543	Cataract	disease	C11	AcquiredAbnormality	0.50	1	1998	2019	2	0	CTD_human
val	5309	PITX3	0.585	0.692	C0178417	Anhedonia	disease	C23;C10;F01	MentalorBehavioralDysfunction	0.30	1	2014	2014	1	0	PSYGENET
val	5309	PITX3	0.585	0.692	C0235031	NeurologicSymptoms	group	C23;C10	SignorSymptom	0.30	1	2006	2006	1	0	CTD_human
val	5309	PITX3	0.585	0.692	C0376358	Malignantneoplasmofprostate	disease	C04;C12	NeoplasticProcess	0.30	1	2016	2016	1	0	CTD_human
val	5309	PITX3	0.585	0.692	C0422837	Neurologicalobservations	group	C23;C10	Finding	0.30	1	2006	2006	1	0	CTD_human
val	5309	PITX3	0.585	0.692	C0521654	NeurologicDeficits	group	C23;C10	Finding	0.30	1	2006	2006	1	0	CTD_human
val	5309	PITX3	0.585	0.692	C0524524	Pseudoaphakia	disease	C11	DiseaseorSyndrome	0.30	1	1998	2006	2	0	CTD_human
val	5309	PITX3	0.585	0.692	C0746857	FocalNeurologicDeficits	phenotype	C23;C10	Finding	0.30	1	2006	2006	1	0	CTD_human
val	5309	PITX3	0.585	0.692	C0751377	NeurologicDysfunction	phenotype	C23;C10	Finding	0.30	1	2006	2006	1	0	CTD_human
val	5309	PITX3	0.585	0.692	C0751378	NeurologicSigns	phenotype	C23;C10	SignorSymptom	0.30	1	2006	2006	1	0	CTD_human
val	5309	PITX3	0.585	0.692	C0858617	Posteriorsubcapsularcataract	disease	C11	DiseaseorSyndrome	0.31	1	2006	2019	2	0	ORPHANET
val	5309	PITX3	0.585	0.692	C1510497	LensOpacities	phenotype	C11	Finding	0.30	1	1998	2006	2	0	CTD_human
val	5309	PITX3	0.585	0.692	C1858679	CATARACT,AUTOSOMALDOMINANT	disease	C11	DiseaseorSyndrome	0.30	1	2004	2004	1	0	GENOMICS_ENGLAND
val	5309	PITX3	0.585	0.692	C1862839	Anteriorsegmentmesenchymaldysgenesis	disease	C16;C11	DiseaseorSyndrome	0.75	1	1998	2012	2	0	CTD_human;GENOMICS_ENGLAND
val	5309	PITX3	0.585	0.692	C1864567	CATARACT,POSTERIORPOLAR,4(disorder)	disease	C11	DiseaseorSyndrome	0.70	1	1998	2014	3	2	CTD_human;GENOMICS_ENGLAND;UNIPROT
val	5309	PITX3	0.585	0.692	C1970386	Cataract,PosteriorPolar,4,WithMicrophthalmiaAndNeurodevelopmentalAbnormalities	disease	C11	DiseaseorSyndrome	0.30	1	2004	2004	1	0	CTD_human
val	5309	PITX3	0.585	0.692	C4551992	ANTERIORSEGMENTDYSGENESIS1	disease	C16;C11	DiseaseorSyndrome	0.60	1	2004	2014	2	1	GENOMICS_ENGLAND
val	5310	PKD1	0.493	0.769	C0009782	ConnectiveTissueDiseases	group	C17	DiseaseorSyndrome	0.31	1	2000	2011	1	0	GENOMICS_ENGLAND
val	5310	PKD1	0.493	0.769	C0010709	Cyst	disease	C23;C04	DiseaseorSyndrome	0.40	1	1990	2019	1	0	CTD_human
val	5310	PKD1	0.493	0.769	C0022680	PolycysticKidneyDiseases	group	C16;C13;C12	DiseaseorSyndrome	0.90	0.976	1990	2019	14	23	CLINGEN;CTD_human
val	5310	PKD1	0.493	0.769	C0085413	PolycysticKidney,AutosomalDominant	disease	C16;C13;C12	DiseaseorSyndrome	0.90	0.979	1988	2020	16	1	CLINGEN;CTD_human
val	5310	PKD1	0.493	0.769	C0887850	PolycysticKidney,Type1AutosomalDominantDisease	disease	C16;C13;C12	CongenitalAbnormality	0.30	1	1994	2017	6	0	CTD_human
val	5310	PKD1	0.493	0.769	C1567435	PolycysticKidney-bodypart	disease	C16;C13;C12	AnatomicalAbnormality	0.35	1	1998	2017	3	0	CTD_human
val	5310	PKD1	0.493	0.769	C1838327	Polycystickidneys,severeinfantilewithtuberoussclerosis	disease	C16;C04;C13;C12;C10	DiseaseorSyndrome	0.30	1	2004	2011	2	0	ORPHANET
val	5310	PKD1	0.493	0.769	C2751306	Polycystickidneydisease,type2	disease	C16;C13;C12	DiseaseorSyndrome	0.37	1	1994	2018	6	0	CTD_human
val	5310	PKD1	0.493	0.769	C3149841	POLYCYSTICKIDNEYDISEASE1	disease	C16;C13;C12	DiseaseorSyndrome	1.00	0.986	1992	2018	43	133	CLINGEN;GENOMICS_ENGLAND;UNIPROT
val	5310	PKD1	0.493	0.769	C4707243	Familialthoracicaorticaneurysmandaorticdissection	disease		DiseaseorSyndrome	0.30				0	0	GENOMICS_ENGLAND
val	5311	PKD2	0.552	0.731	C0009782	ConnectiveTissueDiseases	group	C17	DiseaseorSyndrome	0.30				0	0	GENOMICS_ENGLAND
val	5311	PKD2	0.552	0.731	C0022680	PolycysticKidneyDiseases	group	C16;C13;C12	DiseaseorSyndrome	0.70	0.963	1996	2019	12	4	CLINGEN
val	5311	PKD2	0.552	0.731	C0023893	LiverCirrhosis,Experimental	disease	C23;C06	ExperimentalModelofDisease	0.30	1	2014	2014	1	0	CTD_human
val	5311	PKD2	0.552	0.731	C0035309	RetinalDiseases	group	C11	DiseaseorSyndrome	0.30	1	2014	2014	1	0	CTD_human
val	5311	PKD2	0.552	0.731	C0042373	VascularDiseases	group	C14	DiseaseorSyndrome	0.30	1	2014	2014	1	0	CTD_human
val	5311	PKD2	0.552	0.731	C0085413	PolycysticKidney,AutosomalDominant	disease	C16;C13;C12	DiseaseorSyndrome	1.00	0.984	1994	2020	20	13	CLINGEN;CTD_human;GENOMICS_ENGLAND
val	5311	PKD2	0.552	0.731	C0270715	DegenerativeDiseases,CentralNervousSystem	group	C10	DiseaseorSyndrome	0.30	1	2014	2014	1	0	CTD_human
val	5311	PKD2	0.552	0.731	C0524851	NeurodegenerativeDisorders	group	C10	DiseaseorSyndrome	0.30	1	2014	2014	1	0	CTD_human
val	5311	PKD2	0.552	0.731	C0751733	DegenerativeDiseases,SpinalCord	group	C10	DiseaseorSyndrome	0.30	1	2014	2014	1	0	CTD_human
val	5311	PKD2	0.552	0.731	C0887850	PolycysticKidney,Type1AutosomalDominantDisease	disease	C16;C13;C12	CongenitalAbnormality	0.30	1	2002	2019	6	0	CTD_human
val	5311	PKD2	0.552	0.731	C2751306	Polycystickidneydisease,type2	disease	C16;C13;C12	DiseaseorSyndrome	0.97	1	1995	2019	23	32	CTD_human;GENOMICS_ENGLAND;UNIPROT
val	5311	PKD2	0.552	0.731	C4277690	Ciliopathies	disease	C16	CongenitalAbnormality	0.30				0	0	GENOMICS_ENGLAND
val	5311	PKD2	0.552	0.731	C4707243	Familialthoracicaorticaneurysmandaorticdissection	disease		DiseaseorSyndrome	0.30				0	0	GENOMICS_ENGLAND
val	5313	PKLR	0.603	0.615	C0002152	AlloxanDiabetes	disease	C18;C19	ExperimentalModelofDisease	0.30	1	2010	2010	1	0	CTD_human
val	5313	PKLR	0.603	0.615	C0011853	DiabetesMellitus,Experimental	disease	C18;C19	ExperimentalModelofDisease	0.50	1	2006	2010	1	0	CTD_human
val	5313	PKLR	0.603	0.615	C0023893	LiverCirrhosis,Experimental	disease	C23;C06	ExperimentalModelofDisease	0.30	1	2014	2014	1	0	CTD_human
val	5313	PKLR	0.603	0.615	C0038433	StreptozotocinDiabetes	disease	C18;C19	ExperimentalModelofDisease	0.30	1	2010	2010	1	0	CTD_human
val	5313	PKLR	0.603	0.615	C0340968	Deficiencyofpyruvatekinase	disease	C16;C18;C15	DiseaseorSyndrome	1.00	1	1991	2019	20	61	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
val	5313	PKLR	0.603	0.615	C0520572	Enzymopathy	group	C18	DiseaseorSyndrome	0.30	1	1991	1996	2	0	GENOMICS_ENGLAND
val	5313	PKLR	0.603	0.615	C1863224	AdenosineTriphosphate,Elevated,OfErythrocytes	disease	C15	DiseaseorSyndrome	0.60	1	1997	1997	1	3	CTD_human;UNIPROT
val	5313	PKLR	0.603	0.615	C4551637	Erythrocytosisfamilial,1	disease	C15	DiseaseorSyndrome	0.30	1	2012	2012	1	0	GENOMICS_ENGLAND
val	5314	PKHD1	0.576	0.654	C0008340	CholedochalCyst	disease	C16;C06;C04	CongenitalAbnormality	0.30	1	2008	2008	1	0	CTD_human
val	5314	PKHD1	0.576	0.654	C0009402	ColorectalCarcinoma	disease	C06;C04	NeoplasticProcess	0.31	1	2011	2011	0	2	UNIPROT
val	5314	PKHD1	0.576	0.654	C0009439	CholedochalCyst,TypeI	disease	C16;C06;C04	CongenitalAbnormality	0.30	1	2008	2008	1	0	CTD_human
val	5314	PKHD1	0.576	0.654	C0085548	AutosomalRecessivePolycysticKidneyDisease	disease	C16;C13;C12	DiseaseorSyndrome	1.00	1	1975	2019	14	293	CTD_human;GENOMICS_ENGLAND;UNIPROT
val	5314	PKHD1	0.576	0.654	C0162510	CaroliDisease	disease	C16;C06	DiseaseorSyndrome;CongenitalAbnormality	0.34	1	2004	2017	2	0	ORPHANET
val	5314	PKHD1	0.576	0.654	C1257796	CholedochalCyst,TypeII	disease	C16;C06;C04	CongenitalAbnormality	0.30	1	2008	2008	1	0	CTD_human
val	5314	PKHD1	0.576	0.654	C1257797	CholedochalCyst,TypeIII	disease	C16;C06;C04	CongenitalAbnormality	0.30	1	2008	2008	1	0	CTD_human
val	5314	PKHD1	0.576	0.654	C1257798	CholedochalCyst,TypeIV	disease	C16;C06;C04	CongenitalAbnormality	0.30	1	2008	2008	1	0	CTD_human
val	5314	PKHD1	0.576	0.654	C1257799	CholedochalCyst,TypeV	disease	C16;C06;C04	CongenitalAbnormality	0.30	1	2008	2008	1	0	CTD_human
val	5314	PKHD1	0.576	0.654	C1833541	Carolidiseaseisolated	disease	C16;C06	DiseaseorSyndrome	0.30	1	2014	2015	2	0	ORPHANET
val	5314	PKHD1	0.576	0.654	C4277690	Ciliopathies	disease	C16	CongenitalAbnormality	0.32	1	2015	2019	0	0	GENOMICS_ENGLAND
val	5315	PKM	0.482	0.808	C0001787	Osteoporosis,Age-Related	disease	C18;C05	DiseaseorSyndrome	0.30	1	2008	2008	1	0	CTD_human
val	5315	PKM	0.482	0.808	C0007097	Carcinoma	group	C04	NeoplasticProcess	0.33	1	2005	2016	1	0	CTD_human
val	5315	PKM	0.482	0.808	C0024667	AnimalMammaryNeoplasms	phenotype	C04;C22	NeoplasticProcess	0.30	1	2005	2005	1	0	CTD_human
val	5315	PKM	0.482	0.808	C0024668	MammaryNeoplasms,Experimental	phenotype	C04	NeoplasticProcess;ExperimentalModelofDisease	0.30	1	2005	2005	1	0	CTD_human
val	5315	PKM	0.482	0.808	C0027626	NeoplasmInvasiveness	phenotype	C23;C04	PathologicFunction	0.30	1	2004	2005	2	0	CTD_human
val	5315	PKM	0.482	0.808	C0029456	Osteoporosis	disease	C18;C05	DiseaseorSyndrome	0.30	1	2008	2008	1	0	CTD_human
val	5315	PKM	0.482	0.808	C0029459	Osteoporosis,Senile	disease	C18;C05	DiseaseorSyndrome	0.30	1	2008	2008	1	0	CTD_human
val	5315	PKM	0.482	0.808	C0205696	Anaplasticcarcinoma	disease	C04	NeoplasticProcess	0.30	1	2005	2005	1	0	CTD_human
val	5315	PKM	0.482	0.808	C0205697	Carcinoma,Spindle-Cell	disease	C04	NeoplasticProcess	0.30	1	2005	2005	1	0	CTD_human
val	5315	PKM	0.482	0.808	C0205698	Undifferentiatedcarcinoma	disease	C04	NeoplasticProcess	0.30	1	2005	2005	1	0	CTD_human
val	5315	PKM	0.482	0.808	C0205699	Carcinomatosis	phenotype	C04	NeoplasticProcess	0.30	1	2005	2005	1	0	CTD_human
val	5315	PKM	0.482	0.808	C0751406	Post-TraumaticOsteoporosis	disease	C18;C05	DiseaseorSyndrome	0.30	1	2008	2008	1	0	CTD_human
val	5315	PKM	0.482	0.808	C1257925	MammaryCarcinoma,Animal	disease	C04;C22	NeoplasticProcess	0.30	1	2005	2005	1	0	CTD_human
val	5315	PKM	0.482	0.808	C2239176	Livercarcinoma	disease	C06;C04	NeoplasticProcess	0.40	1	1998	2020	1	0	CTD_human
val	5316	PKNOX1	0.674	0.538	C0009402	ColorectalCarcinoma	disease	C06;C04	NeoplasticProcess	0.30				0	1	UNIPROT
val	5317	PKP1	0.659	0.462	C1858302	Ectodermaldysplasia/skinfragilitysyndrome	disease	C16;C17	DiseaseorSyndrome	0.78	1	1997	2013	3	3	CTD_human;GENOMICS_ENGLAND;ORPHANET
val	5317	PKP1	0.659	0.462	C2239176	Livercarcinoma	disease	C06;C04	NeoplasticProcess	0.30	1	2012	2012	1	0	CTD_human
val	5318	PKP2	0.606	0.538	C0004238	AtrialFibrillation	disease	C23;C14	DiseaseorSyndrome	0.40	1	2017	2018	2	2	CTD_human
val	5318	PKP2	0.606	0.538	C0007193	Cardiomyopathy,Dilated	group	C14	DiseaseorSyndrome	0.31	1	2016	2016	1	0	GENOMICS_ENGLAND
val	5318	PKP2	0.606	0.538	C0235480	Paroxysmalatrialfibrillation	disease	C23;C14	DiseaseorSyndrome	0.30	1	2018	2018	2	0	CTD_human
val	5318	PKP2	0.606	0.538	C0264893	Nodalrhythmdisorder	phenotype	C23;C14	DiseaseorSyndrome	0.30	1	1996	2015	8	0	CLINGEN
val	5318	PKP2	0.606	0.538	C0348626	Otherspecifiedcardiacarrhythmias	phenotype	C23;C14	DiseaseorSyndrome	0.30	1	1996	2015	8	0	CLINGEN
val	5318	PKP2	0.606	0.538	C0349788	ArrhythmogenicRightVentricularDysplasia	disease	C16;C14	DiseaseorSyndrome;CongenitalAbnormality	0.50	0.974	1985	2019	3	49	GENOMICS_ENGLAND
val	5318	PKP2	0.606	0.538	C0428908	SinusNodeDysfunction(disorder)	disease	C23;C14	DiseaseorSyndrome	0.30	1	1996	2015	8	0	CLINGEN
val	5318	PKP2	0.606	0.538	C0878544	Cardiomyopathies	group	C14	DiseaseorSyndrome	0.50	1	2006	2019	0	8	GENOMICS_ENGLAND
val	5318	PKP2	0.606	0.538	C1142166	BrugadaSyndrome(disorder)	disease	C16;C14	DiseaseorSyndrome	0.65	1	1996	2016	10	0	CLINGEN;GENOMICS_ENGLAND;ORPHANET
val	5318	PKP2	0.606	0.538	C1399226	Ectopicrhythm	phenotype	C23;C14	DiseaseorSyndrome	0.30	1	1996	2015	8	0	CLINGEN
val	5318	PKP2	0.606	0.538	C1836906	ArrhythmogenicRightVentricularDysplasia,Familial,9	disease	C16;C14	DiseaseorSyndrome	0.70	1	1996	2017	16	66	CLINGEN;CTD_human;GENOMICS_ENGLAND;UNIPROT
val	5318	PKP2	0.606	0.538	C1960469	Leftventricularnoncompaction	disease	C14	DiseaseorSyndrome	0.30	1	2017	2017	1	0	ORPHANET
val	5318	PKP2	0.606	0.538	C2585653	Persistentatrialfibrillation	phenotype	C23;C14	PathologicFunction	0.30	1	2018	2018	2	0	CTD_human
val	5318	PKP2	0.606	0.538	C2748542	CARDIACCONDUCTIONDEFECT,NONSPECIFIC(disorder)	disease	C16;C14	DiseaseorSyndrome	0.30	1	1996	2015	8	0	CLINGEN
val	5318	PKP2	0.606	0.538	C3468561	familialatrialfibrillation	phenotype	C23;C14	PathologicFunction	0.30	1	2018	2018	2	0	CTD_human
val	5318	PKP2	0.606	0.538	C4551804	BrugadaSyndrome1	disease	C16;C14	DiseaseorSyndrome	0.30	1	1996	2015	8	0	CLINGEN
val	5319	PLA2G1B	0.468	0.846	C0005586	BipolarDisorder	disease	F03	MentalorBehavioralDysfunction	0.35	0.6	1995	2006	5	0	PSYGENET
val	5319	PLA2G1B	0.468	0.846	C0036341	Schizophrenia	disease	F03	MentalorBehavioralDysfunction	0.40	1	1997	2019	3	0	PSYGENET
val	5319	PLA2G1B	0.468	0.846	C0338715	Drug-induceddepressivestate	disease	C25;F03	MentalorBehavioralDysfunction	0.30	1	2010	2010	1	0	PSYGENET
val	5319	PLA2G1B	0.468	0.846	C0525045	MoodDisorders	group	F03	MentalorBehavioralDysfunction	0.32	1	1996	2003	2	0	PSYGENET
val	5320	PLA2G2A	0.488	0.808	C0004153	Atherosclerosis	disease	C14	DiseaseorSyndrome	0.40	1	1999	2018	1	0	CTD_human
val	5320	PLA2G2A	0.488	0.808	C0005586	BipolarDisorder	disease	F03	MentalorBehavioralDysfunction	0.32	0.5	2003	2011	2	0	PSYGENET
val	5320	PLA2G2A	0.488	0.808	C0011581	Depressivedisorder	disease	F03	MentalorBehavioralDysfunction	0.31	1	2012	2013	1	0	PSYGENET
val	5320	PLA2G2A	0.488	0.808	C0014175	Endometriosis	disease	C13	DiseaseorSyndrome	0.31	1	2015	2016	1	0	CTD_human
val	5320	PLA2G2A	0.488	0.808	C0035126	ReperfusionInjury	disease	C23;C14	InjuryorPoisoning	0.30	1	2003	2003	1	0	CTD_human
val	5320	PLA2G2A	0.488	0.808	C0151744	MyocardialIschemia	disease	C14	DiseaseorSyndrome	0.30	1	2005	2005	1	0	CTD_human
val	5320	PLA2G2A	0.488	0.808	C0269102	Endometrioma	disease	C13	NeoplasticProcess	0.32	1	2015	2016	1	0	CTD_human
val	5320	PLA2G2A	0.488	0.808	C0349218	Recurrentdepressivedisorder	disease	F03	MentalorBehavioralDysfunction	0.31	1	2012	2012	1	0	PSYGENET
val	5320	PLA2G2A	0.488	0.808	C1563937	Atherogenesis	phenotype	C14	PathologicFunction	0.30	1	2009	2009	1	0	CTD_human
val	5321	PLA2G4A	0.496	0.846	C0002736	AmyotrophicLateralSclerosis	disease	C18;C10	DiseaseorSyndrome	0.31	1	1999	2005	1	0	CTD_human
val	5321	PLA2G4A	0.496	0.846	C0004352	AutisticDisorder	disease	F03	MentalorBehavioralDysfunction	0.31	1	2004	2017	1	0	CTD_human
val	5321	PLA2G4A	0.496	0.846	C0005586	BipolarDisorder	disease	F03	MentalorBehavioralDysfunction	0.32	0.5	2003	2011	2	0	PSYGENET
val	5321	PLA2G4A	0.496	0.846	C0005818	BloodPlateletDisorders	group	C15	DiseaseorSyndrome	0.30	1	2008	2008	1	0	CTD_human
val	5321	PLA2G4A	0.496	0.846	C0006142	Malignantneoplasmofbreast	disease	C04;C17	NeoplasticProcess	0.55	1	2010	2019	1	1	CTD_human;UNIPROT
val	5321	PLA2G4A	0.496	0.846	C0010474	CurlingUlcer	disease	C06	DiseaseorSyndrome	0.30	1	2008	2008	1	0	CTD_human
val	5321	PLA2G4A	0.496	0.846	C0011603	Dermatitis	disease	C17	DiseaseorSyndrome	0.30	1	2008	2008	1	0	CTD_human
val	5321	PLA2G4A	0.496	0.846	C0013295	DuodenalUlcer	disease	C06	DiseaseorSyndrome	0.41	1	2008	2014	1	0	CTD_human
val	5321	PLA2G4A	0.496	0.846	C0023893	LiverCirrhosis,Experimental	disease	C23;C06	ExperimentalModelofDisease	0.50	1	2007	2014	1	0	CTD_human
val	5321	PLA2G4A	0.496	0.846	C0025521	InbornErrorsofMetabolism	group	C16;C18	DiseaseorSyndrome;CongenitalAbnormality	0.30	1	2008	2008	1	0	CTD_human
val	5321	PLA2G4A	0.496	0.846	C0035222	RespiratoryDistressSyndrome,Adult	disease	C08	DiseaseorSyndrome	0.30	1	2000	2000	1	0	CTD_human
val	5321	PLA2G4A	0.496	0.846	C0036337	SchizoaffectiveDisorder	disease	F03	MentalorBehavioralDysfunction	0.31	1	2008	2008	1	0	PSYGENET
val	5321	PLA2G4A	0.496	0.846	C0036341	Schizophrenia	disease	F03	MentalorBehavioralDysfunction	0.40	0.8	1996	2019	5	0	PSYGENET
val	5321	PLA2G4A	0.496	0.846	C0264423	Asthma,Occupational	disease	C08;C20;C24	DiseaseorSyndrome	0.30	1	2017	2017	1	0	CTD_human
val	5321	PLA2G4A	0.496	0.846	C0393554	AmyotrophicLateralSclerosisWithDementia	disease	C18;C10	DiseaseorSyndrome	0.30	1	2005	2005	1	0	CTD_human
val	5321	PLA2G4A	0.496	0.846	C0543859	AmyotrophicLateralSclerosis,GuamForm	disease	C18;C10	DiseaseorSyndrome	0.30	1	2005	2005	1	0	CTD_human
val	5321	PLA2G4A	0.496	0.846	C0678222	BreastCarcinoma	disease	C04;C17	NeoplasticProcess	0.35	1	2010	2019	1	0	CTD_human
val	5321	PLA2G4A	0.496	0.846	C1257931	MammaryNeoplasms,Human	disease	C04;C17	NeoplasticProcess	0.30	1	2011	2011	1	0	CTD_human
val	5321	PLA2G4A	0.496	0.846	C1458155	MammaryNeoplasms	group	C04;C17	NeoplasticProcess	0.30	1	2011	2011	1	0	CTD_human
val	5321	PLA2G4A	0.496	0.846	C4016672	PHOSPHOLIPASEA2,GROUPIVA,DEFICIENCYOF	disease		Finding	0.30	1	2014	2014	1	0	GENOMICS_ENGLAND
val	5321	PLA2G4A	0.496	0.846	C4302263	Cryptogenicmultifocalulcerousstenosingenteritis	disease		DiseaseorSyndrome	0.30	1	2014	2014	1	0	ORPHANET
val	5321	PLA2G4A	0.496	0.846	C4704874	MammaryCarcinoma,Human	disease	C04;C17	NeoplasticProcess	0.30	1	2011	2011	1	0	CTD_human
val	5322	PLA2G5	0.751	0.385	C0015397	Disorderofeye	group	C11	DiseaseorSyndrome	0.30				0	0	GENOMICS_ENGLAND
val	5322	PLA2G5	0.751	0.385	C1856718	FleckRetina,FamilialBenign	disease	C16;C11	DiseaseorSyndrome	0.70	1	2011	2011	1	5	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
val	5324	PLAG1	0.493	0.808	C0175693	Russell-Silversyndrome	disease	C16;C05	DiseaseorSyndrome	0.40	1	2018	2018	1	2	GENOMICS_ENGLAND
val	5324	PLAG1	0.493	0.808	C0334475	Lipoblastomatosis	disease	C04	NeoplasticProcess	0.30	1	2006	2006	1	0	CTD_human
val	5324	PLAG1	0.493	0.808	C0473935	Radiolabeledsomatostatinanalogstudy	phenotype		DiagnosticProcedure	0.30	1	2018	2018	1	0	GENOMICS_ENGLAND
val	5324	PLAG1	0.493	0.808	C0796160	MENTALRETARDATION,X-LINKED,SNYDER-ROBINSONTYPE	disease	C16;C10	DiseaseorSyndrome	0.30	1	2018	2018	1	0	GENOMICS_ENGLAND
val	5324	PLAG1	0.493	0.808	C1260965	Lipoblastoma	disease	C04	NeoplasticProcess	0.40	1	2000	2020	1	0	CTD_human
val	5324	PLAG1	0.493	0.808	C1519176	SalivaryGlandPleomorphicAdenoma	disease	C04;C07	NeoplasticProcess	0.60	0.941	1996	2019	2	0	CTD_human;ORPHANET
val	5325	PLAGL1	0.566	0.769	C0024623	Malignantneoplasmofstomach	disease	C06;C04	NeoplasticProcess	0.31	1	2006	2014	1	0	CTD_human
val	5325	PLAGL1	0.566	0.769	C0038356	StomachNeoplasms	group	C06;C04	NeoplasticProcess	0.30	1	2006	2006	1	0	CTD_human
val	5325	PLAGL1	0.566	0.769	C1708349	HereditaryDiffuseGastricCancer	disease	C06;C04	NeoplasticProcess	0.30	1	2006	2006	1	0	CTD_human
val	5325	PLAGL1	0.566	0.769	C1832386	DiabetesMellitus,TransientNeonatal,1	disease	C16;C18;C19	DiseaseorSyndrome	0.36	1	2000	2012	2	0	ORPHANET
val	5325	PLAGL1	0.566	0.769	C4749378	Paternaluniparentaldisomyofchromosome6	disease		DiseaseorSyndrome	0.30				0	0	ORPHANET
val	5327	PLAT	0.445	0.885	C0001125	Acidosis,Lactic	phenotype	C18	DiseaseorSyndrome	0.30	1	2015	2015	1	0	CTD_human
val	5327	PLAT	0.445	0.885	C0001883	AirwayObstruction	group	C08	DiseaseorSyndrome	0.30	1	2015	2015	1	0	CTD_human
val	5327	PLAT	0.445	0.885	C0002994	Angioedema	phenotype	C17;C20;C14	PathologicFunction	0.30	1	2005	2010	3	0	CTD_human
val	5327	PLAT	0.445	0.885	C0003129	Anoxemia	phenotype	C23	SignorSymptom	0.30	1	2015	2015	1	0	CTD_human
val	5327	PLAT	0.445	0.885	C0003130	Anoxia	phenotype	C23	PathologicFunction	0.30	1	2015	2015	1	0	CTD_human
val	5327	PLAT	0.445	0.885	C0003537	Aphasia	disease	C23;C10	MentalorBehavioralDysfunction	0.31	1	2003	2018	1	0	CTD_human
val	5327	PLAT	0.445	0.885	C0003546	Aphasia,Acquired	disease	C23;C10	MentalorBehavioralDysfunction	0.30	1	2003	2003	1	0	CTD_human
val	5327	PLAT	0.445	0.885	C0003838	ArterialOcclusiveDiseases	group	C14	DiseaseorSyndrome	0.30	1	2004	2004	1	0	CTD_human
val	5327	PLAT	0.445	0.885	C0004153	Atherosclerosis	disease	C14	DiseaseorSyndrome	0.36	1	1995	2010	1	0	CTD_human
val	5327	PLAT	0.445	0.885	C0004604	BackPain	phenotype	C23	SignorSymptom	0.30	1	2002	2002	1	0	CTD_human
val	5327	PLAT	0.445	0.885	C0004610	Bacteremia	disease	C23;C01	DiseaseorSyndrome	0.30	1	1992	1992	1	0	CTD_human
val	5327	PLAT	0.445	0.885	C0007177	CardiacTamponade	disease	C14	DiseaseorSyndrome	0.30	1	1998	1998	1	0	CTD_human
val	5327	PLAT	0.445	0.885	C0007781	IntracranialEmbolismandThrombosis	disease	C10;C14	DiseaseorSyndrome	0.30	1	1993	1995	2	0	CTD_human
val	5327	PLAT	0.445	0.885	C0007785	CerebralInfarction	disease	C23;C10;C14	DiseaseorSyndrome	0.39	1	1991	2019	6	0	CTD_human
val	5327	PLAT	0.445	0.885	C0007786	BrainIschemia	disease	C10;C14	DiseaseorSyndrome	0.31	1	1995	2018	24	0	CTD_human
val	5327	PLAT	0.445	0.885	C0008301	Choking	phenotype	C08	PathologicFunction	0.30	1	2015	2015	1	0	CTD_human
val	5327	PLAT	0.445	0.885	C0010072	CoronaryThrombosis	disease	C14	DiseaseorSyndrome	0.32	1	1988	2004	3	0	CTD_human
val	5327	PLAT	0.445	0.885	C0013922	Embolism	phenotype	C14	PathologicFunction	0.30	1	2005	2005	1	0	CTD_human
val	5327	PLAT	0.445	0.885	C0018801	Heartfailure	disease	C14	DiseaseorSyndrome	0.30	1	2012	2012	1	0	CTD_human
val	5327	PLAT	0.445	0.885	C0018802	Congestiveheartfailure	disease	C14	DiseaseorSyndrome	0.31	1	2009	2012	1	0	CTD_human
val	5327	PLAT	0.445	0.885	C0018946	Hematoma,Subdural	phenotype	C23;C10;C14;C26	PathologicFunction	0.30	1	1991	1991	1	0	CTD_human
val	5327	PLAT	0.445	0.885	C0018989	Hemiparesis	phenotype	C23;C10	SignorSymptom	0.30	1	2003	2003	1	0	CTD_human
val	5327	PLAT	0.445	0.885	C0019064	Hemopericardium	phenotype	C14	PathologicFunction	0.30	1	1998	1998	1	0	CTD_human
val	5327	PLAT	0.445	0.885	C0019080	Hemorrhage	phenotype	C23	PathologicFunction	0.30	1	1989	2012	8	0	CTD_human
val	5327	PLAT	0.445	0.885	C0019193	Hepatitis,Toxic	disease	C06;C25	InjuryorPoisoning	0.30	1	2012	2012	1	0	CTD_human
val	5327	PLAT	0.445	0.885	C0020538	Hypertensivedisease	group	C14	DiseaseorSyndrome	0.38	1	2001	2019	1	0	CTD_human
val	5327	PLAT	0.445	0.885	C0020649	Hypotension	phenotype	C14	Finding	0.30	1	1992	1992	1	0	CTD_human
val	5327	PLAT	0.445	0.885	C0023212	Left-SidedHeartFailure	disease	C14	DiseaseorSyndrome	0.30	1	2012	2012	1	0	CTD_human
val	5327	PLAT	0.445	0.885	C0023893	LiverCirrhosis,Experimental	disease	C23;C06	ExperimentalModelofDisease	0.50	1	2010	2014	1	0	CTD_human
val	5327	PLAT	0.445	0.885	C0024031	LowBackPain	phenotype	C23	SignorSymptom	0.30	1	1995	1995	1	0	CTD_human
val	5327	PLAT	0.445	0.885	C0025309	Meningoencephalitis	disease	C01;C10	DiseaseorSyndrome	0.30	1	1992	1992	1	0	CTD_human
val	5327	PLAT	0.445	0.885	C0027051	MyocardialInfarction	disease	C23;C14	DiseaseorSyndrome	0.40	0.978	1986	2019	33	0	CTD_human
val	5327	PLAT	0.445	0.885	C0027746	NerveDegeneration	phenotype	C23	CellorMolecularDysfunction	0.30	1	2010	2010	1	0	CTD_human
val	5327	PLAT	0.445	0.885	C0030552	Paresis	phenotype	C23;C10	DiseaseorSyndrome	0.31	1	2003	2018	1	0	CTD_human
val	5327	PLAT	0.445	0.885	C0031039	Pericardialeffusion	disease	C14	DiseaseorSyndrome	0.30	1	1998	1998	1	0	CTD_human
val	5327	PLAT	0.445	0.885	C0034065	PulmonaryEmbolism	disease	C08;C14	PathologicFunction	0.30	1	1987	2009	9	0	CTD_human
val	5327	PLAT	0.445	0.885	C0035126	ReperfusionInjury	disease	C23;C14	InjuryorPoisoning	0.50	1	1998	2004	1	0	CTD_human
val	5327	PLAT	0.445	0.885	C0035229	RespiratoryInsufficiency	phenotype	C08	PathologicFunction	0.30	1	2015	2015	1	0	CTD_human
val	5327	PLAT	0.445	0.885	C0036341	Schizophrenia	disease	F03	MentalorBehavioralDysfunction	0.32	1	2011	2018	1	0	PSYGENET
val	5327	PLAT	0.445	0.885	C0036980	Shock,Cardiogenic	phenotype	C23;C14	PathologicFunction	0.30	1	1992	1992	1	0	CTD_human
val	5327	PLAT	0.445	0.885	C0037926	Compressionofspinalcord	disease	C10;C26	DiseaseorSyndrome	0.30	1	2002	2002	1	0	CTD_human
val	5327	PLAT	0.445	0.885	C0038454	Cerebrovascularaccident	group	C10;C14	DiseaseorSyndrome	0.40	0.973	1989	2020	58	0	CTD_human
val	5327	PLAT	0.445	0.885	C0040038	Thromboembolism	phenotype	C14	PathologicFunction	0.30	1	1993	1993	1	0	CTD_human
val	5327	PLAT	0.445	0.885	C0040053	Thrombosis	phenotype	C14	PathologicFunction	0.32	1	1990	2012	4	0	CTD_human
val	5327	PLAT	0.445	0.885	C0042487	VenousThrombosis	phenotype	C14	PathologicFunction	0.30	1	2000	2009	3	0	CTD_human
val	5327	PLAT	0.445	0.885	C0079102	CerebralThrombosis	disease	C10;C14	DiseaseorSyndrome	0.30	1	1996	1996	1	0	CTD_human
val	5327	PLAT	0.445	0.885	C0085307	EmbolismandThrombosis	disease	C14	DiseaseorSyndrome	0.30	1	1998	1998	1	0	CTD_human
val	5327	PLAT	0.445	0.885	C0087086	Thrombus	phenotype	C14	PathologicFunction	0.30	1	1990	2012	4	0	CTD_human
val	5327	PLAT	0.445	0.885	C0149504	Encephalopathy,Toxic	disease	C10;C25	InjuryorPoisoning	0.30	1	2009	2009	1	0	CTD_human
val	5327	PLAT	0.445	0.885	C0149649	CholesterolEmbolism	disease	C14	DiseaseorSyndrome	0.30	1	1994	1994	1	0	CTD_human
val	5327	PLAT	0.445	0.885	C0149871	DeepVeinThrombosis	disease	C14	DiseaseorSyndrome	0.33	1	2000	2019	3	0	CTD_human
val	5327	PLAT	0.445	0.885	C0151699	IntracranialHemorrhage	group	C23;C10;C14	PathologicFunction	0.30	1	1988	2010	14	0	CTD_human
val	5327	PLAT	0.445	0.885	C0154659	ToxicEncephalitis	disease	C10;C25	InjuryorPoisoning	0.30	1	2009	2009	1	0	CTD_human
val	5327	PLAT	0.445	0.885	C0162820	Dermatitis,AllergicContact	disease	C17;C20	DiseaseorSyndrome	0.31	1	2007	2013	1	0	CTD_human
val	5327	PLAT	0.445	0.885	C0234462	Aphasia,Ageusic	phenotype	C23;C10	MentalorBehavioralDysfunction	0.30	1	2003	2003	1	0	CTD_human
val	5327	PLAT	0.445	0.885	C0234469	Aphasia,Global	disease	C23;C10	MentalorBehavioralDysfunction	0.30	1	2003	2003	1	0	CTD_human
val	5327	PLAT	0.445	0.885	C0234472	Aphasia,Functional	phenotype	C23;C10	MentalorBehavioralDysfunction	0.30	1	2003	2003	1	0	CTD_human
val	5327	PLAT	0.445	0.885	C0234474	Aphasia,Graphomotor	phenotype	C23;C10	MentalorBehavioralDysfunction	0.30	1	2003	2003	1	0	CTD_human
val	5327	PLAT	0.445	0.885	C0234476	Aphasia,Intellectual	phenotype	C23;C10	MentalorBehavioralDysfunction	0.30	1	2003	2003	1	0	CTD_human
val	5327	PLAT	0.445	0.885	C0234482	Aphasia,Semantic	phenotype	C23;C10	MentalorBehavioralDysfunction	0.30	1	2003	2003	1	0	CTD_human
val	5327	PLAT	0.445	0.885	C0234484	Aphasia,Syntactical	phenotype	C23;C10	MentalorBehavioralDysfunction	0.30	1	2003	2003	1	0	CTD_human
val	5327	PLAT	0.445	0.885	C0235032	NeurotoxicitySyndromes	group	C10;C25	InjuryorPoisoning	0.30	1	2009	2009	1	0	CTD_human
val	5327	PLAT	0.445	0.885	C0235063	RespiratoryDepression	phenotype	C08	PathologicFunction	0.30	1	2015	2015	1	0	CTD_human
val	5327	PLAT	0.445	0.885	C0235527	HeartFailure,Right-Sided	disease	C14	DiseaseorSyndrome	0.30	1	2012	2012	1	0	CTD_human
val	5327	PLAT	0.445	0.885	C0236733	Amphetamine-RelatedDisorders	group	C25;F03	MentalorBehavioralDysfunction	0.30	1	2005	2005	1	0	CTD_human
val	5327	PLAT	0.445	0.885	C0236804	AmphetamineAddiction	disease	C25;F03	MentalorBehavioralDysfunction	0.30	1	2005	2005	1	0	CTD_human
val	5327	PLAT	0.445	0.885	C0236807	AmphetamineAbuse	disease	C25;F03	MentalorBehavioralDysfunction	0.30	1	2005	2005	1	0	CTD_human
val	5327	PLAT	0.445	0.885	C0238281	MiddleCerebralArterySyndrome	phenotype	C23;C10;C14	DiseaseorSyndrome	0.30	1	2002	2010	4	0	CTD_human
val	5327	PLAT	0.445	0.885	C0242184	Hypoxia	phenotype	C23	PathologicFunction	0.30	1	2015	2015	1	0	CTD_human
val	5327	PLAT	0.445	0.885	C0242426	Chylopericardium	disease	C14	DiseaseorSyndrome	0.30	1	1998	1998	1	0	CTD_human
val	5327	PLAT	0.445	0.885	C0242698	VentricularDysfunction,Left	phenotype	C14	PathologicFunction	0.30	1	1996	1996	1	0	CTD_human
val	5327	PLAT	0.445	0.885	C0265110	CerebralVasospasm	disease	C10;C14	DiseaseorSyndrome	0.30	1	2008	2008	1	0	CTD_human
val	5327	PLAT	0.445	0.885	C0270795	Monoparesis	phenotype	C23;C10	SignorSymptom	0.30	1	2003	2003	1	0	CTD_human
val	5327	PLAT	0.445	0.885	C0338457	Aphasia,Progressive	disease	C23;C10	MentalorBehavioralDysfunction	0.30	1	2003	2003	1	0	CTD_human
val	5327	PLAT	0.445	0.885	C0393953	AnteriorCerebralCirculationInfarction	phenotype	C23;C10;C14	DiseaseorSyndrome	0.30	1	2005	2005	1	0	CTD_human
val	5327	PLAT	0.445	0.885	C0423682	LowBackPain,Mechanical	disease	C23	DiseaseorSyndrome	0.30	1	1995	1995	1	0	CTD_human
val	5327	PLAT	0.445	0.885	C0423689	LowBackPain,PosteriorCompartment	phenotype	C23	SignorSymptom	0.30	1	1995	1995	1	0	CTD_human
val	5327	PLAT	0.445	0.885	C0438921	BackPainwithoutRadiation	phenotype	C23	Finding	0.30	1	2002	2002	1	0	CTD_human
val	5327	PLAT	0.445	0.885	C0454576	Aphasia,Mixed	disease	C23;C10	MentalorBehavioralDysfunction	0.30	1	2003	2003	1	0	CTD_human
val	5327	PLAT	0.445	0.885	C0524702	PulmonaryThromboembolisms	disease	C08;C14	DiseaseorSyndrome	0.31	1	1987	2018	9	0	CTD_human
val	5327	PLAT	0.445	0.885	C0553692	Brainhemorrhage	phenotype	C23;C10;C14	PathologicFunction	0.30	1	1988	2010	14	0	CTD_human
val	5327	PLAT	0.445	0.885	C0577660	LowBackPain,Postural	phenotype	C23	SignorSymptom	0.30	1	1995	1995	1	0	CTD_human
val	5327	PLAT	0.445	0.885	C0700292	Hypoxemia	phenotype	C23	Finding	0.30	1	2015	2015	1	0	CTD_human
val	5327	PLAT	0.445	0.885	C0740363	BackPainwithRadiation	phenotype	C23	SignorSymptom	0.30	1	2002	2002	1	0	CTD_human
val	5327	PLAT	0.445	0.885	C0740376	MiddleCerebralArteryThrombosis	disease	C23;C10;C14	DiseaseorSyndrome	0.30	1	2002	2010	4	0	CTD_human
val	5327	PLAT	0.445	0.885	C0740391	MiddleCerebralArteryOcclusion	disease	C23;C10;C14	AcquiredAbnormality	0.34	1	2002	2019	4	0	CTD_human
val	5327	PLAT	0.445	0.885	C0740392	Infarction,MiddleCerebralArtery	disease	C23;C10;C14	DiseaseorSyndrome	0.50	1	2002	2010	4	0	CTD_human
val	5327	PLAT	0.445	0.885	C0742803	ConusMedullarisSyndrome	disease	C10;C26	DiseaseorSyndrome	0.30	1	2002	2002	1	0	CTD_human
val	5327	PLAT	0.445	0.885	C0750917	Aphasia,AuditoryDiscriminatory	phenotype	C23;C10	MentalorBehavioralDysfunction	0.30	1	2003	2003	1	0	CTD_human
val	5327	PLAT	0.445	0.885	C0750918	Aphasia,Commisural	phenotype	C23;C10	MentalorBehavioralDysfunction	0.30	1	2003	2003	1	0	CTD_human
val	5327	PLAT	0.445	0.885	C0750919	Aphasia,Post-Ictal	phenotype	C23;C10	MentalorBehavioralDysfunction	0.30	1	2003	2003	1	0	CTD_human
val	5327	PLAT	0.445	0.885	C0750920	Aphasia,Post-Traumatic	phenotype	C23;C10	MentalorBehavioralDysfunction	0.30	1	2003	2003	1	0	CTD_human
val	5327	PLAT	0.445	0.885	C0750921	Dejerine-LichtheimPhenomenon	phenotype	C23;C10	MentalorBehavioralDysfunction	0.30	1	2003	2003	1	0	CTD_human
val	5327	PLAT	0.445	0.885	C0750949	VertebrogenicPainSyndrome	phenotype	C23	DiseaseorSyndrome	0.30	1	2002	2002	1	0	CTD_human
val	5327	PLAT	0.445	0.885	C0751010	CerebralInfarction,LeftHemisphere	phenotype	C23;C10;C14	DiseaseorSyndrome	0.30	1	1991	2008	6	0	CTD_human
val	5327	PLAT	0.445	0.885	C0751011	CerebralInfarction,RightHemisphere	phenotype	C23;C10;C14	DiseaseorSyndrome	0.30	1	1991	2008	6	0	CTD_human
val	5327	PLAT	0.445	0.885	C0751012	AnteriorChoroidalArteryInfarction	phenotype	C23;C10;C14	DiseaseorSyndrome	0.30	1	1991	2008	6	0	CTD_human
val	5327	PLAT	0.445	0.885	C0751014	SubcorticalInfarction	disease	C23;C10;C14	DiseaseorSyndrome	0.30	1	1991	2008	6	0	CTD_human
val	5327	PLAT	0.445	0.885	C0751409	UpperExtremityParesis	phenotype	C23;C10	SignorSymptom	0.30	1	2003	2003	1	0	CTD_human
val	5327	PLAT	0.445	0.885	C0751410	LowerExtremityParesis	phenotype	C23;C10	SignorSymptom	0.30	1	2003	2003	1	0	CTD_human
val	5327	PLAT	0.445	0.885	C0751648	RecurrentLowBackPain	phenotype	C23	SignorSymptom	0.30	1	1995	1995	1	0	CTD_human
val	5327	PLAT	0.445	0.885	C0751845	MiddleCerebralArteryEmbolus	phenotype	C23;C10;C14	DiseaseorSyndrome	0.30	1	2002	2010	4	0	CTD_human
val	5327	PLAT	0.445	0.885	C0751846	LeftMiddleCerebralArteryInfarction	phenotype	C23;C10;C14	DiseaseorSyndrome	0.30	1	2002	2010	4	0	CTD_human
val	5327	PLAT	0.445	0.885	C0751847	EmbolicInfarction,MiddleCerebralArtery	phenotype	C23;C10;C14	DiseaseorSyndrome	0.30	1	2002	2010	4	0	CTD_human
val	5327	PLAT	0.445	0.885	C0751848	ThromboticInfarction,MiddleCerebralArtery	phenotype	C23;C10;C14	DiseaseorSyndrome	0.30	1	2002	2010	4	0	CTD_human
val	5327	PLAT	0.445	0.885	C0751849	RightMiddleCerebralArteryInfarction	phenotype	C23;C10;C14	DiseaseorSyndrome	0.30	1	2002	2010	4	0	CTD_human
val	5327	PLAT	0.445	0.885	C0751893	PosteriorFossaHemorrhage	phenotype	C23;C10;C14	PathologicFunction	0.30	1	1988	2010	14	0	CTD_human
val	5327	PLAT	0.445	0.885	C0751895	Vasospasm,Intracranial	disease	C10;C14	DiseaseorSyndrome	0.30	1	2008	2008	1	0	CTD_human
val	5327	PLAT	0.445	0.885	C0751952	AnteriorCirculationBrainInfarction	phenotype	C23;C10;C14	DiseaseorSyndrome	0.30	1	2005	2005	1	0	CTD_human
val	5327	PLAT	0.445	0.885	C0751953	BrainInfarction,PosteriorCirculation	phenotype	C23;C10;C14	DiseaseorSyndrome	0.30	1	2005	2005	1	0	CTD_human
val	5327	PLAT	0.445	0.885	C0751954	VenousInfarction,Brain	phenotype	C23;C10;C14	DiseaseorSyndrome	0.30	1	2005	2005	1	0	CTD_human
val	5327	PLAT	0.445	0.885	C0751955	BrainInfarction	disease	C23;C10;C14	DiseaseorSyndrome	0.31	1	2005	2020	1	0	CTD_human
val	5327	PLAT	0.445	0.885	C0751956	AcuteCerebrovascularAccidents	disease	C10;C14	DiseaseorSyndrome	0.36	1	1989	2019	58	0	CTD_human
val	5327	PLAT	0.445	0.885	C0752143	IntracranialThrombosis	disease	C10;C14	DiseaseorSyndrome	0.33	1	1996	2020	1	0	CTD_human
val	5327	PLAT	0.445	0.885	C0752144	BrainThrombosis	disease	C10;C14	DiseaseorSyndrome	0.30	1	1996	1996	1	0	CTD_human
val	5327	PLAT	0.445	0.885	C0860207	Drug-InducedLiverDisease	phenotype	C06;C25	DiseaseorSyndrome	0.30	1	2012	2012	1	0	CTD_human
val	5327	PLAT	0.445	0.885	C0877172	Hematoma,Epidural,Spinal	phenotype	C23	PathologicFunction	0.30	1	2000	2002	2	0	CTD_human
val	5327	PLAT	0.445	0.885	C0877855	CerebralEmbolismandThrombosis	disease	C10;C14	DiseaseorSyndrome	0.30	1	1993	1995	2	0	CTD_human
val	5327	PLAT	0.445	0.885	C0887799	PosteriorChoroidalArteryInfarction	phenotype	C23;C10;C14	DiseaseorSyndrome	0.30	1	1991	2008	6	0	CTD_human
val	5327	PLAT	0.445	0.885	C0917798	CerebralIschemia	disease	C10;C14	PathologicFunction	0.30	1	1995	2011	24	0	CTD_human
val	5327	PLAT	0.445	0.885	C0936247	BrainEmbolismandThrombosis	disease	C10;C14	DiseaseorSyndrome	0.30	1	1993	1995	2	0	CTD_human
val	5327	PLAT	0.445	0.885	C0936261	BrainThrombus	disease	C10;C14	DiseaseorSyndrome	0.30	1	1996	1996	1	0	CTD_human
val	5327	PLAT	0.445	0.885	C0936263	CerebralThrombus	disease	C10;C14	DiseaseorSyndrome	0.30	1	1996	1996	1	0	CTD_human
val	5327	PLAT	0.445	0.885	C0973461	Dysphasia	disease	C23;C10	DiseaseorSyndrome	0.30	1	2003	2003	1	0	CTD_human
val	5327	PLAT	0.445	0.885	C1145670	RespiratoryFailure	disease	C08	DiseaseorSyndrome	0.30	1	2015	2015	1	0	CTD_human
val	5327	PLAT	0.445	0.885	C1262760	Hepatitis,Drug-Induced	disease	C06;C25	DiseaseorSyndrome	0.30	1	2012	2012	1	0	CTD_human
val	5327	PLAT	0.445	0.885	C1563937	Atherogenesis	phenotype	C14	PathologicFunction	0.30	1	2002	2002	1	0	CTD_human
val	5327	PLAT	0.445	0.885	C1704212	Embolus	phenotype	C14	Finding	0.30	1	2005	2005	1	0	CTD_human
val	5327	PLAT	0.445	0.885	C1861172	VenousThromboembolism	phenotype	C14	DiseaseorSyndrome	0.32	1	2005	2017	1	0	CTD_human
val	5327	PLAT	0.445	0.885	C1959583	MyocardialFailure	disease	C14	DiseaseorSyndrome	0.30	1	2012	2012	1	0	CTD_human
val	5327	PLAT	0.445	0.885	C1961112	HeartDecompensation	phenotype	C14	PathologicFunction	0.30	1	2012	2012	1	0	CTD_human
val	5327	PLAT	0.445	0.885	C2676721	Thrombophilia,Familial,DueToDecreasedReleaseOfTissuePlasminogenActivator	disease	C15	DiseaseorSyndrome	0.50				0	0	CTD_human;GENOMICS_ENGLAND
val	5327	PLAT	0.445	0.885	C2937358	CerebralHemorrhage	phenotype	C23;C10;C14	PathologicFunction	0.50	1	1991	2011	20	0	CTD_human
val	5327	PLAT	0.445	0.885	C3658290	Drug-InducedAcuteLiverInjury	disease	C06;C25	DiseaseorSyndrome	0.30	1	2012	2012	1	0	CTD_human
val	5327	PLAT	0.445	0.885	C4277682	ChemicalandDrugInducedLiverInjury	disease	C06;C25	DiseaseorSyndrome	0.30	1	2012	2012	1	0	CTD_human
val	5327	PLAT	0.445	0.885	C4279912	Chemically-InducedLiverToxicity	disease	C06;C25	DiseaseorSyndrome	0.30	1	2012	2012	1	0	CTD_human
val	5328	PLAU	0.425	0.923	C0001418	Adenocarcinoma	group	C04	NeoplasticProcess	0.39	1	1991	2018	1	0	CTD_human
val	5328	PLAU	0.425	0.923	C0002395	AlzheimersDisease	disease	C10;F03	DiseaseorSyndrome	0.68	1	2002	2013	0	0	CTD_human
17220	5328	PLAU	0.425	0.923	C0027051	MyocardialInfarction	disease	C23;C14	DiseaseorSyndrome	0.51	1	1985	2011	6	0	CTD_human
17274	5336	PLCG2	0.588	0.808	C0023434	ChronicLymphocyticLeukemia	disease	C04;C20;C15	NeoplasticProcess	0.7	0.929	2007	2020	1	2	CGI;CTD_human
17290	5376	PMP22	0.471	0.885	C0393814	Hereditaryliabilitytopressurepalsies	disease	C16;C05;C10	DiseaseorSyndrome	1	0.979	1993	2019	3	6	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
17321	5376	PMP22	0.471	0.885	C3495591	Charcot-Marie-ToothDisease,Demyelinating,Type1e	disease	C23;C16;C10;C09	DiseaseorSyndrome	0.92	1	1999	2013	4	7	CTD_human;GENOMICS_ENGLAND;UNIPROT
17324	5376	PMP22	0.471	0.885	C4551910	AcuteInflammatoryDemyelinatingPolyneuropathy	disease	C20;C10	DiseaseorSyndrome	0.52	1	2002	2017	1	0	CTD_human;ORPHANET
17340	5393	EXOSC9	0.705	0.423	C4748058	PONTOCEREBELLARHYPOPLASIA,TYPE1D	disease		DiseaseorSyndrome	0.61	1	2018	2020	1	2	GENOMICS_ENGLAND;UNIPROT
17343	5395	PMS2	0.484	0.808	C0009405	HereditaryNonpolyposisColorectalNeoplasms	group	C16;C06;C04;C18	NeoplasticProcess	0.64	1	1986	2018	12	143	CLINGEN;CTD_human
17352	5395	PMS2	0.484	0.808	C0265325	Turcotsyndrome(disorder)	disease	C16;C06;C04;C10	DiseaseorSyndrome	0.8	0.978	1995	2020	21	32	CLINGEN;CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
17357	5395	PMS2	0.484	0.808	C0476089	EndometrialCarcinoma	disease	C04;C13	NeoplasticProcess	0.7	1	1999	2020	0	1	CGI;GENOMICS_ENGLAND
17366	5395	PMS2	0.484	0.808	C1140680	Malignantneoplasmofovary	disease	C04;C13;C19	NeoplasticProcess	0.63	1	2014	2019	0	1	CGI;GENOMICS_ENGLAND
17368	5395	PMS2	0.484	0.808	C1333990	HereditaryNonpolyposisColorectalCancer	disease	C16;C06;C04;C18	NeoplasticProcess	0.8	0.979	1994	2020	12	73	CLINGEN;CTD_human;ORPHANET
17369	5395	PMS2	0.484	0.808	C1838333	COLORECTALCANCER,HEREDITARYNONPOLYPOSIS,TYPE4	disease	C16;C06;C04;C18	DiseaseorSyndrome	0.7	1	1995	2017	11	49	CTD_human;GENOMICS_ENGLAND;UNIPROT
17370	5395	PMS2	0.484	0.808	C4321324	ConstitutionalMismatchRepairDeficiencySyndrome	disease	C16;C04	DiseaseorSyndrome	0.56	1	1998	2017	11	0	CLINGEN;GENOMICS_ENGLAND
17371	5395	PMS2	0.484	0.808	C4552100	LynchSyndrome	disease	C16;C06;C04;C18	DiseaseorSyndrome	0.7	0.973	1994	2020	13	0	CLINGEN;CTD_human;GENOMICS_ENGLAND
17378	5396	PRRX1	0.543	0.769	C0265242	Otocephaly	disease	C16;C05	CongenitalAbnormality	0.62	1	2011	2013	1	2	ORPHANET;UNIPROT
17389	5406	PNLIP	0.743	0.308	C3280527	PANCREATICLIPASEDEFICIENCY	disease		DiseaseorSyndrome	0.7	1	2014	2016	3	2	CTD_human;GENOMICS_ENGLAND;UNIPROT
17408	5422	POLA1	0.653	0.731	C1845050	PIGMENTARYDISORDER,RETICULATE,WITHSYSTEMICMANIFESTATIONS	disease	C23;C16;C18;C17	DiseaseorSyndrome	0.7	1	2009	2019	3	1	CTD_human;GENOMICS_ENGLAND;ORPHANET
17416	5424	POLD1	0.507	0.769	C0009402	ColorectalCarcinoma	disease	C06;C04	NeoplasticProcess	0.6	0.944	1995	2020	1	0	CTD_human;GENOMICS_ENGLAND
17426	5424	POLD1	0.507	0.769	C0476089	EndometrialCarcinoma	disease	C04;C13	NeoplasticProcess	0.69	1	2013	2016	1	0	CTD_human;GENOMICS_ENGLAND
17430	5424	POLD1	0.507	0.769	C2675481	COLORECTALCANCER,SUSCEPTIBILITYTO,10	disease		Finding	0.6	1	2006	2016	3	2	GENOMICS_ENGLAND;UNIPROT
17433	5424	POLD1	0.507	0.769	C3715192	ANDIBULARHYPOPLASIA,DEAFNESS,PROGEROIDFEATURES,ANDLIPODYSTROPHYSYNDROME	disease		DiseaseorSyndrome	0.74	1	2013	2018	2	1	CTD_human;GENOMICS_ENGLAND;ORPHANET
17437	5426	POLE	0.526	0.731	C0009402	ColorectalCarcinoma	disease	C06;C04	NeoplasticProcess	0.6	1	2013	2020	2	0	CTD_human;GENOMICS_ENGLAND
17450	5426	POLE	0.526	0.731	C3554460	COLORECTALCANCER,SUSCEPTIBILITYTO,12	disease		Finding	0.6	1	2003	2017	5	5	GENOMICS_ENGLAND;UNIPROT
17451	5426	POLE	0.526	0.731	C3554576	FACIALDYSMORPHISM,IMMUNODEFICIENCY,LIVEDO,ANDSHORTSTATURE	disease		DiseaseorSyndrome	0.71	1	2012	2012	1	4	CTD_human;GENOMICS_ENGLAND;ORPHANET
17463	5443	POMC	0.356	0.846	C0028754	Obesity	disease	C23;C18	DiseaseorSyndrome	0.9	0.959	1996	2020	2	0	CTD_human;GENOMICS_ENGLAND
17501	5444	PON1	0.409	0.885	C0002736	AmyotrophicLateralSclerosis	disease	C18;C10	DiseaseorSyndrome	0.7	0.929	2007	2019	3	0	CTD_human;ORPHANET
17629	5447	POR	0.502	0.769	C1860042	Antley-BixlerSyndromewithDisorderedSteroidogenesis	disease	C16;C18;C05	DiseaseorSyndrome	0.74	1	2004	2018	5	9	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
17632	5447	POR	0.502	0.769	C3150099	ANTLEY-BIXLERSYNDROMEWITHGENITALANOMALIESANDDISORDEREDSTEROIDOGENESIS	disease		DiseaseorSyndrome	0.7	1	2002	2006	5	9	CTD_human;GENOMICS_ENGLAND;UNIPROT
17636	5449	POU1F1	0.548	0.654	C2751608	PituitaryHormoneDeficiency,Combined,1	disease	C23;C16;C19	DiseaseorSyndrome	0.7	1	1992	2016	14	20	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
17643	5454	POU3F2	0.7	0.423	C0005586	BipolarDisorder	disease	F03	MentalorBehavioralDysfunction	0.52	1	2011	2019	2	0	CTD_human;PSYGENET
17656	5456	POU3F4	0.633	0.654	C1844678	Progressivehearinglossstapesfixation	disease	C23;C16;C10;C09	DiseaseorSyndrome	0.75	1	1995	2014	4	17	CTD_human;GENOMICS_ENGLAND;UNIPROT
17667	5459	POU4F3	0.7	0.538	C1865366	Deafness,AutosomalDominant15	disease	C23;C10;C09	DiseaseorSyndrome	0.71	1	1998	2017	8	7	CTD_human;GENOMICS_ENGLAND;UNIPROT
17693	5465	PPARA	0.432	0.885	C0015695	FattyLiver	disease	C06	DiseaseorSyndrome	0.6	1	2005	2020	1	0	CTD_human
17694	5465	PPARA	0.432	0.885	C0015696	FattyLiver,Alcoholic	disease	C06;C25	DiseaseorSyndrome	0.53	1	2006	2018	1	0	CTD_human
17700	5465	PPARA	0.432	0.885	C0020538	Hypertensivedisease	group	C14	DiseaseorSyndrome	0.57	1	2002	2018	2	0	CTD_human
17708	5465	PPARA	0.432	0.885	C0023903	Liverneoplasms	group	C06;C04	NeoplasticProcess	0.58	1	2003	2019	2	0	CTD_human
17726	5465	PPARA	0.432	0.885	C0345904	Malignantneoplasmofliver	disease	C06;C04	NeoplasticProcess	0.55	1	1999	2019	2	0	CTD_human
17774	5468	PPARG	0.358	0.885	C0271694	Familialpartiallipodystrophy	disease	C18;C17	DiseaseorSyndrome	0.6	0.938	2002	2019	1	0	CTD_human
17791	5621	PRNP	0.445	0.923	C0017495	Gerstmann-Straussler-ScheinkerDisease	disease	C16;C01;C10	DiseaseorSyndrome	1	0.993	1989	2019	14	14	CTD_human;GENOMICS_ENGLAND;UNIPROT
17793	5621	PRNP	0.445	0.923	C0022336	Creutzfeldt-Jakobdisease	disease	C01;C10;F03	DiseaseorSyndrome	1	0.98	1988	2020	13	11	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
17801	5621	PRNP	0.445	0.923	C0036457	Scrapie	disease	C01;C10;C22	DiseaseorSyndrome	0.55	1	1993	2018	4	0	CTD_human
17804	5621	PRNP	0.445	0.923	C0206042	FatalFamilialInsomnia	disease	C01;C10	DiseaseorSyndrome	1	0.989	1992	2019	5	2	CTD_human;GENOMICS_ENGLAND;UNIPROT
17806	5621	PRNP	0.445	0.923	C0376329	NewVariantCreutzfeldt-JakobDisease	disease	C01;C10;F03	DiseaseorSyndrome	0.6	0.981	1998	2019	3	0	CTD_human;ORPHANET
17814	5649	RELN	0.515	0.731	C0005586	BipolarDisorder	disease	F03	MentalorBehavioralDysfunction	0.57	1	2000	2020	8	0	CTD_human;PSYGENET
17820	5649	RELN	0.515	0.731	C0011581	Depressivedisorder	disease	F03	MentalorBehavioralDysfunction	0.53	1	2004	2018	4	0	CTD_human;PSYGENET
17827	5649	RELN	0.515	0.731	C0036341	Schizophrenia	disease	F03	MentalorBehavioralDysfunction	0.7	0.909	1998	2020	4	1	CTD_human
17836	5649	RELN	0.515	0.731	C0750900	AlzheimersDisease,FocalOnset	disease	C10;F03	MentalorBehavioralDysfunction	0.30	1	2010	2010	1	0	CTD_human
val	5649	RELN	0.515	0.731	C0750901	AlzheimerDisease,EarlyOnset	disease	C10;F03	DiseaseorSyndrome	0.30	1	2010	2010	1	0	CTD_human
val	5649	RELN	0.515	0.731	C0796089	LISSENCEPHALYSYNDROME,NORMAN-ROBERTSTYPE	disease	C16;C10	DiseaseorSyndrome	0.70	1	1993	2000	2	6	CTD_human;GENOMICS_ENGLAND;ORPHANET
val	5649	RELN	0.515	0.731	C1269683	MajorDepressiveDisorder	disease	F03	MentalorBehavioralDysfunction	0.50	1	2000	2013	3	0	CTD_human;PSYGENET
val	5649	RELN	0.515	0.731	C1510586	AutismSpectrumDisorders	disease	F03	MentalorBehavioralDysfunction	0.40	0.929	2002	2019	2	0	CTD_human
val	5649	RELN	0.515	0.731	C1571983	Involutionalparaphrenia	disease	F03	MentalorBehavioralDysfunction	0.30	1	2000	2000	1	0	CTD_human
val	5649	RELN	0.515	0.731	C1571984	Psychosis,Involutional	disease	F03	MentalorBehavioralDysfunction	0.30	1	2000	2000	1	0	CTD_human
val	5649	RELN	0.515	0.731	C1838062	AutosomalDominantLateralTemporalLobeEpilepsy	disease	C23;C10;F03	DiseaseorSyndrome	0.31	1	2015	2017	1	0	ORPHANET
val	5649	RELN	0.515	0.731	C4225327	EPILEPSY,FAMILIALTEMPORALLOBE,7	disease		DiseaseorSyndrome	0.70	1	2015	2015	1	7	CTD_human;GENOMICS_ENGLAND;UNIPROT
val	5649	RELN	0.515	0.731	C4551957	Epilepsy,FamilialTemporalLobe1	disease	C23;C10;F03	DiseaseorSyndrome	0.31	1	2017	2017	0	0	CTD_human
val	5651	TMPRSS15	0.751	0.385	C0268416	EnterokinaseDeficiency	disease	C16;C18	DiseaseorSyndrome	0.62	1	2002	2012	1	5	CTD_human;ORPHANET
val	5652	PRSS8	0.641	0.5	C0011999	Diastematomyelia	disease	C16;C10	CongenitalAbnormality	0.30	1	2014	2014	1	0	CTD_human
val	5652	PRSS8	0.641	0.5	C0013949	Embryopathies	disease	C16;C13	DiseaseorSyndrome	0.30	1	2012	2012	1	0	CTD_human
val	5652	PRSS8	0.641	0.5	C0015929	FetalDiseases	group	C16;C13	DiseaseorSyndrome	0.30	1	2012	2012	1	0	CTD_human
val	5652	PRSS8	0.641	0.5	C0027794	NeuralTubeDefects	group	C16;C10	CongenitalAbnormality	0.30	1	2014	2014	1	0	CTD_human
val	5652	PRSS8	0.641	0.5	C0027806	NeurentericCyst	disease	C16;C10	CongenitalAbnormality	0.30	1	2014	2014	1	0	CTD_human
val	5652	PRSS8	0.641	0.5	C0032045	PlacentaDisorders	group	C13	PathologicFunction	0.30	1	2014	2014	1	0	CTD_human
val	5652	PRSS8	0.641	0.5	C0033578	ProstaticNeoplasms	group	C04;C12	NeoplasticProcess	0.30	1	2006	2006	1	0	CTD_human
val	5652	PRSS8	0.641	0.5	C0037274	Dermatologicdisorders	group	C17	DiseaseorSyndrome	0.30	1	2012	2012	1	0	CTD_human
val	5652	PRSS8	0.641	0.5	C0080218	TetheredCordSyndrome	disease	C16;C10	DiseaseorSyndrome	0.30	1	2014	2014	1	0	CTD_human
val	5652	PRSS8	0.641	0.5	C0152234	Iniencephaly	disease	C16;C10	CongenitalAbnormality	0.30	1	2014	2014	1	0	CTD_human
val	5652	PRSS8	0.641	0.5	C0152426	Craniorachischisis	disease	C16;C10	CongenitalAbnormality	0.30	1	2014	2014	1	0	CTD_human
val	5652	PRSS8	0.641	0.5	C0266453	Exencephaly	disease	C16;C10	CongenitalAbnormality	0.30	1	2014	2014	1	0	CTD_human
val	5652	PRSS8	0.641	0.5	C0344479	SpinalCordMyelodysplasia	disease	C16;C10	CongenitalAbnormality	0.30	1	2014	2014	1	0	CTD_human
val	5652	PRSS8	0.641	0.5	C0376358	Malignantneoplasmofprostate	disease	C04;C12	NeoplasticProcess	0.31	1	2004	2006	1	0	CTD_human
val	5652	PRSS8	0.641	0.5	C0702169	Acrania	disease	C16;C10	CongenitalAbnormality	0.30	1	2014	2014	1	0	CTD_human
val	5654	HTRA1	0.532	0.692	C0002170	Alopecia	disease	C23;C17	DiseaseorSyndrome	0.41	1	2011	2015	1	0	GENOMICS_ENGLAND
val	5654	HTRA1	0.532	0.692	C0024121	LungNeoplasms	group	C04;C08	NeoplasticProcess	0.31	1	2006	2017	1	0	CTD_human
val	5654	HTRA1	0.532	0.692	C0026654	MoyamoyaDisease	disease	C10;C14	DiseaseorSyndrome	0.30				0	0	GENOMICS_ENGLAND
val	5654	HTRA1	0.532	0.692	C0158266	IntervertebralDiscDegeneration	disease	C05	DiseaseorSyndrome	0.33	1	2010	2017	1	0	GENOMICS_ENGLAND
val	5654	HTRA1	0.532	0.692	C0206729	Neurofibrosarcoma	disease	C04;C10	NeoplasticProcess	0.30	1	2016	2016	1	0	ORPHANET
val	5654	HTRA1	0.532	0.692	C0242379	Malignantneoplasmoflung	disease	C04;C08	NeoplasticProcess	0.30	1	2017	2017	1	0	CTD_human
val	5654	HTRA1	0.532	0.692	C0242383	Agerelatedmaculardegeneration	disease	C11	DiseaseorSyndrome	0.50	0.94	2006	2019	0	7	GENOMICS_ENGLAND
val	5654	HTRA1	0.532	0.692	C0338656	Impairedcognition	disease	F03	MentalorBehavioralDysfunction	0.41	1	2014	2015	1	1	GENOMICS_ENGLAND
val	5654	HTRA1	0.532	0.692	C0497327	Dementia	disease	C10;F03	MentalorBehavioralDysfunction	0.40	1	2014	2014	1	0	GENOMICS_ENGLAND
val	5654	HTRA1	0.532	0.692	C0751587	CADASILSyndrome	disease	C23;C16;C10;C14	DiseaseorSyndrome	0.34	1	2015	2019	0	0	CTD_human
val	5654	HTRA1	0.532	0.692	C0751690	MalignantPeripheralNerveSheathTumor	disease	C04;C10	NeoplasticProcess	0.30	1	2016	2016	1	0	ORPHANET
val	5654	HTRA1	0.532	0.692	C1449626	CADASILM	disease	C23;C16;C10;C14	DiseaseorSyndrome	0.30				0	0	CTD_human
val	5654	HTRA1	0.532	0.692	C1838577	CerebralAutosomalRecessiveArteriopathywithSubcorticalInfarctsandLeukoencephalopathy	disease	C23;C17;C05;C10;C14	DiseaseorSyndrome	0.80	0.962	2002	2019	7	10	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
val	5654	HTRA1	0.532	0.692	C1857813	MacularDegeneration,Age-Related,7	disease	C11	DiseaseorSyndrome	0.40				0	1	CTD_human
val	5654	HTRA1	0.532	0.692	C2733158	CerebralSmallVesselDiseases	group	C10;C14	DiseaseorSyndrome	0.50	1	2011	2019	1	1	GENOMICS_ENGLAND
val	5654	HTRA1	0.532	0.692	C4225211	CEREBRALARTERIOPATHY,AUTOSOMALDOMINANT,WITHSUBCORTICALINFARCTSANDLEUKOENCEPHALOPATHY,TYPE2	disease		DiseaseorSyndrome	0.60	1	2014	2015	3	12	GENOMICS_ENGLAND;UNIPROT
val	5655	KLK10	0.608	0.538	C0000786	Spontaneousabortion	phenotype	C13	PathologicFunction	0.30	1	2008	2008	1	0	CTD_human
val	5655	KLK10	0.608	0.538	C0000822	Abortion,Tubal	phenotype	C13	PathologicFunction	0.30	1	2008	2008	1	0	CTD_human
val	5655	KLK10	0.608	0.538	C0006142	Malignantneoplasmofbreast	disease	C04;C17	NeoplasticProcess	0.40	1	2000	2016	1	0	CTD_human
val	5655	KLK10	0.608	0.538	C0024623	Malignantneoplasmofstomach	disease	C06;C04	NeoplasticProcess	0.37	1	2005	2018	1	0	CTD_human
val	5655	KLK10	0.608	0.538	C0038356	StomachNeoplasms	group	C06;C04	NeoplasticProcess	0.31	1	2007	2007	1	0	CTD_human
val	5655	KLK10	0.608	0.538	C0678222	BreastCarcinoma	disease	C04;C17	NeoplasticProcess	0.40	1	2000	2016	1	0	CTD_human
val	5655	KLK10	0.608	0.538	C0919267	ovarianneoplasm	disease	C04;C13;C19	NeoplasticProcess	0.34	1	2002	2018	1	0	CTD_human
val	5655	KLK10	0.608	0.538	C1140680	Malignantneoplasmofovary	disease	C04;C13;C19	NeoplasticProcess	0.34	1	2003	2013	1	0	CTD_human
val	5655	KLK10	0.608	0.538	C1257931	MammaryNeoplasms,Human	disease	C04;C17	NeoplasticProcess	0.30	1	2006	2006	1	0	CTD_human
val	5655	KLK10	0.608	0.538	C1458155	MammaryNeoplasms	group	C04;C17	NeoplasticProcess	0.35	1	2001	2009	1	0	CTD_human
val	5655	KLK10	0.608	0.538	C1708349	HereditaryDiffuseGastricCancer	disease	C06;C04	NeoplasticProcess	0.30	1	2007	2007	1	0	CTD_human
val	5655	KLK10	0.608	0.538	C3830362	EarlyPregnancyLoss	phenotype	C13	Finding	0.30	1	2008	2008	1	0	CTD_human
val	5655	KLK10	0.608	0.538	C4552766	Miscarriage	disease	C13	DiseaseorSyndrome	0.30	1	2008	2008	1	0	CTD_human
val	5655	KLK10	0.608	0.538	C4704874	MammaryCarcinoma,Human	disease	C04;C17	NeoplasticProcess	0.30	1	2006	2006	1	0	CTD_human
val	5657	PRTN3	0.503	0.808	C0023473	MyeloidLeukemia,Chronic	disease	C04;C15	NeoplasticProcess	0.40	1	1997	2011	1	0	CTD_human
val	5657	PRTN3	0.503	0.808	C3495801	Granulomatosiswithpolyangiitis	disease	C08;C20;C14	DiseaseorSyndrome	0.60	0.988	1992	2019	2	0	CTD_human;ORPHANET
val	5660	PSAP	0.532	0.846	C0268262	MetachromaticLeukodystrophyduetoSaposinBDeficiency	disease	C16;C18;C10	DiseaseorSyndrome	0.71	1	1990	2019	8	7	CTD_human;GENOMICS_ENGLAND;UNIPROT
val	5660	PSAP	0.532	0.846	C0751273	InfantileGloboidCellLeukodystrophy	disease	C16;C18;C10	DiseaseorSyndrome	0.31	1	2005	2020	1	0	ORPHANET
val	5660	PSAP	0.532	0.846	C0751276	Metachromaticleukodystrophy,juveniletype	disease	C16;C18;C10	DiseaseorSyndrome	0.30	1	2014	2014	1	0	ORPHANET
val	5660	PSAP	0.532	0.846	C0751278	MetachromaticLeukodystrophy,Infant	disease	C16;C18;C10	DiseaseorSyndrome	0.31	1	2014	2019	1	0	ORPHANET
val	5660	PSAP	0.532	0.846	C0751279	MetachromaticLeukodystrophy,Adult-Type(disorder)	disease	C16;C18;C10	DiseaseorSyndrome	0.30	1	2014	2014	1	0	ORPHANET
val	5660	PSAP	0.532	0.846	C1864651	GAUCHERDISEASE,ATYPICAL,DUETOSAPOSINCDEFICIENCY	disease	C16;C18;C10	DiseaseorSyndrome	0.70	1	1991	2016	4	6	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
val	5660	PSAP	0.532	0.846	C2673266	KRABBEDISEASE,ATYPICAL,DUETOSAPOSINADEFICIENCY	disease	C16;C18;C10	DiseaseorSyndrome	0.62	1	2000	2020	5	1	CTD_human;GENOMICS_ENGLAND
val	5660	PSAP	0.532	0.846	C2673635	CombinedSaposinDeficiency	disease	C16;C18;C10	DiseaseorSyndrome	0.71	1	1978	2016	6	3	CTD_human;GENOMICS_ENGLAND;ORPHANET
val	5662	PSD	0.626	0.654	C0036341	Schizophrenia	disease	F03	MentalorBehavioralDysfunction	0.40	1	2005	2019	1	0	PSYGENET
val	5663	PSEN1	0.469	0.846	C0002395	AlzheimersDisease	disease	C10;F03	DiseaseorSyndrome	0.7	0.971	1990	2020	13	6	CTD_human
17852	5663	PSEN1	0.469	0.846	C0236642	PickDiseaseoftheBrain	disease	C10;F03	DiseaseorSyndrome	0.8	1	1995	2018	6	16	CTD_human;GENOMICS_ENGLAND;UNIPROT
17855	5663	PSEN1	0.469	0.846	C0338451	Frontotemporaldementia	disease	C18;C10;F03	DiseaseorSyndrome	0.8	1	1995	2018	5	18	CTD_human;GENOMICS_ENGLAND;UNIPROT
17856	5663	PSEN1	0.469	0.846	C0338462	SemanticDementia	disease	C18;C10;F03	MentalorBehavioralDysfunction	0.6	1	2000	2000	1	0	CTD_human;ORPHANET
17921	5961	PRPH2	0.551	0.5	C0311338	FundusAlbipunctatus	disease	C11	CongenitalAbnormality	0.7	1	1993	1993	1	0	CTD_human;GENOMICS_ENGLAND;ORPHANET
17923	5961	PRPH2	0.551	0.5	C1405854	Retinitispunctataalbescens(disorder)	disease	C11	DiseaseorSyndrome	0.54	1	1993	1997	1	0	CTD_human;ORPHANET
17926	5961	PRPH2	0.551	0.5	C1842475	RetinitisPigmentosa7	disease	C16;C11	DiseaseorSyndrome	0.91	1	1985	2016	11	22	CTD_human;GENOMICS_ENGLAND;UNIPROT
17927	5961	PRPH2	0.551	0.5	C1842914	Adult-OnsetVitelliformMacularDystrophy	disease	C16;C11	DiseaseorSyndrome	0.75	1	1997	2016	6	13	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
17931	5961	PRPH2	0.551	0.5	C2751290	CHOROIDALDYSTROPHY,CENTRALAREOLAR2	disease	C11	DiseaseorSyndrome	0.7	1	2006	2016	4	5	CTD_human;GENOMICS_ENGLAND;UNIPROT
17935	5961	PRPH2	0.551	0.5	C4551999	MACULARDYSTROPHY,PATTERNED,1	disease	C11	DiseaseorSyndrome	0.6	1	1993	2016	4	16	GENOMICS_ENGLAND;UNIPROT
17939	5962	RDX	0.593	0.615	C1970239	DEAFNESS,AUTOSOMALRECESSIVE,24	disease	C23;C10;C09	DiseaseorSyndrome	0.7	1	1993	2007	2	2	CTD_human;GENOMICS_ENGLAND;UNIPROT
17949	5966	REL	0.579	0.692	C0019829	HodgkinDisease	disease	C04;C20;C15	NeoplasticProcess	0.55	1	2001	2010	1	0	CGI;CTD_human
17976	5970	RELA	0.406	0.885	C0009319	Colitis	disease	C06	DiseaseorSyndrome	0.55	0.857	1996	2019	1	0	CTD_human
17988	5970	RELA	0.406	0.885	C0020538	Hypertensivedisease	group	C14	DiseaseorSyndrome	0.51	1	2006	2018	2	0	CTD_human
17989	5970	RELA	0.406	0.885	C0022661	KidneyFailure,Chronic	disease	C13;C12	DiseaseorSyndrome	0.51	1	2008	2011	1	0	CTD_human
18046	5972	REN	0.37	0.923	C0020538	Hypertensivedisease	group	C14	DiseaseorSyndrome	0.6	0.969	1975	2020	17	0	CTD_human
18068	5972	REN	0.37	0.923	C0149721	LeftVentricularHypertrophy	disease	C23;C14	DiseaseorSyndrome	0.6	0.941	1993	2018	2	0	CTD_human
18073	5972	REN	0.37	0.923	C0266313	AllansonPantzarMcLeodsyndrome	disease	C16;C13;C12	DiseaseorSyndrome	0.79	0.9	2005	2019	3	5	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
18080	5972	REN	0.37	0.923	C2751310	HyperuricemicNephropathy,FamilialJuvenile2	disease	C23;C13;C12;C15	DiseaseorSyndrome	0.71	1	2009	2009	1	1	CTD_human;GENOMICS_ENGLAND;UNIPROT
18085	5977	DPF2	0.604	0.731	C4747954	COFFIN-SIRISSYNDROME7	disease		DiseaseorSyndrome	0.61	1	2018	2020	1	5	GENOMICS_ENGLAND;UNIPROT
18088	5978	REST	0.535	0.808	C0027708	Nephroblastoma	disease	C16;C04;C13;C12	NeoplasticProcess	0.61	1	2015	2015	1	0	CTD_human;ORPHANET
18114	5978	REST	0.535	0.808	C3891301	WILMSTUMOR,SUSCEPTIBILITYTO	phenotype	C04	Finding	0.7	1	2015	2015	1	3	CTD_human;GENOMICS_ENGLAND;UNIPROT
18124	5979	RET	0.392	0.885	C0009402	ColorectalCarcinoma	disease	C06;C04	NeoplasticProcess	0.6	1	2008	2019	2	0	CTD_human;UNIPROT
18126	5979	RET	0.392	0.885	C0019569	HirschsprungDisease	disease	C16;C06	DiseaseorSyndrome	0.7	0.98	1993	2019	2	28	CTD_human
18129	5979	RET	0.392	0.885	C0025268	MultipleEndocrineNeoplasiaType2a	disease	C16;C04;C19	NeoplasticProcess	0.8	0.989	1990	2019	15	35	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
18130	5979	RET	0.392	0.885	C0025269	MultipleEndocrineNeoplasiaType2b	disease	C16;C04;C19	NeoplasticProcess	1	1	1992	2019	10	15	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
18131	5979	RET	0.392	0.885	C0027662	MultipleEndocrineNeoplasia	disease	C16;C04;C19	NeoplasticProcess	0.7	0.976	1994	2018	2	1	CTD_human;GENOMICS_ENGLAND
18132	5979	RET	0.392	0.885	C0031511	Pheochromocytoma	disease	C04	NeoplasticProcess	1	0.96	1990	2019	1	8	CGI;CTD_human;GENOMICS_ENGLAND;UNIPROT
18134	5979	RET	0.392	0.885	C0040136	ThyroidNeoplasm	disease	C04;C19	NeoplasticProcess	0.7	0.994	1992	2019	1	2	CGI;CTD_human
18140	5979	RET	0.392	0.885	C0238462	Medullarycarcinomaofthyroid	disease	C04;C19	NeoplasticProcess	0.7	0.953	1992	2020	1	18	CGI;CTD_human
18141	5979	RET	0.392	0.885	C0238463	Papillarythyroidcarcinoma	disease	C04;C19	NeoplasticProcess	0.6	0.972	1989	2020	3	0	CTD_human;ORPHANET
18179	6314	ATXN7	0.581	0.654	C0752125	SpinocerebellarAtaxiaType7	disease	C16;C10	DiseaseorSyndrome	0.8	0.985	1997	2019	3	0	CTD_human;GENOMICS_ENGLAND
18183	6315	ATXN8OS	0.65	0.423	C1837454	SPINOCEREBELLARATAXIA8	disease	C16;C10	DiseaseorSyndrome	0.6	1	2000	2019	0	0	CTD_human;ORPHANET
18233	6323	SCN1A	0.477	0.808	C0009952	FebrileConvulsions	disease	C23;C10	DiseaseorSyndrome	0.7	0.939	2002	2020	3	0	CTD_human
18261	6323	SCN1A	0.477	0.808	C0751122	InfantileSevereMyoclonicEpilepsy	disease	C10	DiseaseorSyndrome	0.9	0.974	2001	2020	17	0	CLINGEN;CTD_human;GENOMICS_ENGLAND;ORPHANET
18264	6323	SCN1A	0.477	0.808	C1510586	AutismSpectrumDisorders	disease	F03	MentalorBehavioralDysfunction	0.53	1	2011	2018	1	0	CTD_human
18266	6323	SCN1A	0.477	0.808	C1858673	GENERALIZEDEPILEPSYWITHFEBRILESEIZURESPLUS,TYPE2	disease	C23;C10	DiseaseorSyndrome	0.73	1	2000	2012	32	0	CTD_human;GENOMICS_ENGLAND;UNIPROT
18267	6323	SCN1A	0.477	0.808	C1864987	Migraine,FamilialHemiplegic,3	disease	C10	DiseaseorSyndrome	0.7	1	2000	2018	17	0	CLINGEN;CTD_human;GENOMICS_ENGLAND;UNIPROT
18271	6323	SCN1A	0.477	0.808	C3502809	GeneralizedEpilepsywithFebrileSeizuresPlus	disease	C23;C10	DiseaseorSyndrome	0.6	0.983	2000	2017	15	0	CLINGEN
18273	6323	SCN1A	0.477	0.808	C4551549	EarlyInfantileEpilepticEncephalopathy6	disease	C10	DiseaseorSyndrome	0.8	1	2000	2018	46	0	GENOMICS_ENGLAND;UNIPROT
18283	6324	SCN1B	0.575	0.538	C1142166	BrugadaSyndrome(disorder)	disease	C16;C14	DiseaseorSyndrome	0.55	1	2008	2019	7	0	CLINGEN;CTD_human
18287	6324	SCN1B	0.575	0.538	C1858672	GENERALIZEDEPILEPSYWITHFEBRILESEIZURESPLUS,TYPE1	disease	C23;C10	DiseaseorSyndrome	0.71	1	1998	2019	6	5	CTD_human;GENOMICS_ENGLAND;UNIPROT
18289	6324	SCN1B	0.575	0.538	C2748541	BrugadaSyndrome5	disease	C16;C14	DiseaseorSyndrome	0.6	1	1970	2019	4	3	CTD_human;GENOMICS_ENGLAND
18290	6324	SCN1B	0.575	0.538	C2748542	CARDIACCONDUCTIONDEFECT,NONSPECIFIC(disorder)	disease	C16;C14	DiseaseorSyndrome	0.6	1	2008	2017	7	2	CLINGEN;GENOMICS_ENGLAND
18291	6324	SCN1B	0.575	0.538	C3502809	GeneralizedEpilepsywithFebrileSeizuresPlus	disease	C23;C10	DiseaseorSyndrome	0.7	1	2000	2011	0	1	ORPHANET
18292	6324	SCN1B	0.575	0.538	C3809311	ATRIALFIBRILLATION,FAMILIAL,13	disease		DiseaseorSyndrome	0.7	1	2005	2016	3	3	CTD_human;GENOMICS_ENGLAND;UNIPROT
18293	6324	SCN1B	0.575	0.538	C4479236	EPILEPTICENCEPHALOPATHY,EARLYINFANTILE,52	disease		DiseaseorSyndrome	0.7	1	1998	2016	5	4	CTD_human;GENOMICS_ENGLAND;UNIPROT
18303	6326	SCN2A	0.518	0.731	C0220669	Familialbenignneonatalepilepsy	disease	C16;C10	DiseaseorSyndrome	0.6	1	2002	2019	3	0	GENOMICS_ENGLAND;ORPHANET
18312	6326	SCN2A	0.518	0.731	C1843140	SEIZURES,BENIGNFAMILIALINFANTILE,3	disease	C16;C10	DiseaseorSyndrome	0.66	0.97	2001	2018	17	46	GENOMICS_ENGLAND;UNIPROT
18313	6326	SCN2A	0.518	0.731	C3150987	EPILEPTICENCEPHALOPATHY,EARLYINFANTILE,11	disease		DiseaseorSyndrome	0.7	1	2004	2019	28	65	CTD_human;GENOMICS_ENGLAND;UNIPROT
18318	6327	SCN2B	0.678	0.192	C1142166	BrugadaSyndrome(disorder)	disease	C16;C14	DiseaseorSyndrome	0.51	1	2009	2016	5	0	CLINGEN;ORPHANET
18322	6327	SCN2B	0.678	0.192	C3809312	ATRIALFIBRILLATION,FAMILIAL,14	disease		DiseaseorSyndrome	0.6	1	2009	2009	1	2	CTD_human;UNIPROT
18329	6328	SCN3A	0.617	0.538	C4693694	EPILEPSY,FAMILIALFOCAL,WITHVARIABLEFOCI4	disease		DiseaseorSyndrome	0.6	1	2014	2017	2	4	GENOMICS_ENGLAND;UNIPROT
18330	6328	SCN3A	0.617	0.538	C4693699	EPILEPTICENCEPHALOPATHY,EARLYINFANTILE,62	disease		DiseaseorSyndrome	0.6	1	2017	2018	2	5	GENOMICS_ENGLAND;UNIPROT
18331	6329	SCN4A	0.554	0.731	C0027125	Myotonia	phenotype	C23;C10	Finding	0.62	1	1993	2008	2	2	CTD_human;GENOMICS_ENGLAND
18333	6329	SCN4A	0.554	0.731	C0221055	ParamyotoniaCongenita(disorder)	disease	C05;C10	DiseaseorSyndrome	0.8	0.977	1992	2019	18	19	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
18334	6329	SCN4A	0.554	0.731	C0238357	Hyperkalemicperiodicparalysis	disease	C16;C18;C05;C10	DiseaseorSyndrome	1	1	1989	2019	10	29	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
18335	6329	SCN4A	0.554	0.731	C0238358	Hypokalemicperiodicparalysis	disease	C16;C18;C05;C10	DiseaseorSyndrome	0.9	1	2001	2019	2	4	CTD_human;GENOMICS_ENGLAND
18342	6329	SCN4A	0.554	0.731	C0751882	MyasthenicSyndromes,Congenital	disease	C16;C10	DiseaseorSyndrome	0.64	1	2003	2016	1	3	CTD_human;GENOMICS_ENGLAND
18348	6329	SCN4A	0.554	0.731	C2750061	HypokalemicPeriodicParalysis,Type2	disease	C16;C18;C05;C10	DiseaseorSyndrome	0.73	1	1999	2019	14	14	CTD_human;GENOMICS_ENGLAND;UNIPROT
18350	6329	SCN4A	0.554	0.731	C2931826	Potassiumaggravatedmyotonia	disease	C16;C05;C10	DiseaseorSyndrome	0.79	1	1993	2019	15	18	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
18352	6329	SCN4A	0.554	0.731	C3280112	MYASTHENICSYNDROME,CONGENITAL,16	disease		DiseaseorSyndrome	0.6	1	2003	2016	4	10	GENOMICS_ENGLAND;UNIPROT
18357	6330	SCN4B	0.705	0.346	C1141890	CongenitallongQTsyndrome	disease	C23;C16;C14	DiseaseorSyndrome	0.51	1	2007	2007	1	0	CLINGEN;GENOMICS_ENGLAND
18359	6330	SCN4B	0.705	0.346	C2678484	LongQtSyndrome10	disease	C23;C16;C14	DiseaseorSyndrome	0.7	1	2007	2013	2	3	CTD_human;GENOMICS_ENGLAND;UNIPROT
18362	6331	SCN5A	0.513	0.654	C0007193	Cardiomyopathy,Dilated	group	C14	DiseaseorSyndrome	0.7	1	1998	2018	2	3	GENOMICS_ENGLAND
18363	6331	SCN5A	0.513	0.654	C0023976	LongQTSyndrome	disease	C23;C16;C14	DiseaseorSyndrome	0.7	0.987	1995	2020	10	4	CTD_human;GENOMICS_ENGLAND
18366	6331	SCN5A	0.513	0.654	C0038644	Suddeninfantdeathsyndrome	disease	C23	DiseaseorSyndrome	0.8	0.963	1995	2018	4	8	CTD_human;GENOMICS_ENGLAND;UNIPROT
18371	6331	SCN5A	0.513	0.654	C0340493	Paroxysmalfamilialventricularfibrillation	disease	C23;C14	DiseaseorSyndrome	0.7	1	2000	2016	0	1	CTD_human;GENOMICS_ENGLAND
18375	6331	SCN5A	0.513	0.654	C1142166	BrugadaSyndrome(disorder)	disease	C16;C14	DiseaseorSyndrome	1	0.984	1995	2020	26	102	CLINGEN;CTD_human;GENOMICS_ENGLAND
18377	6331	SCN5A	0.513	0.654	C1832680	CARDIOMYOPATHY,DILATED,1E	disease	C14	DiseaseorSyndrome	0.9	1	1995	2017	7	11	CTD_human;GENOMICS_ENGLAND;UNIPROT
18378	6331	SCN5A	0.513	0.654	C1837845	SICKSINUSSYNDROME1,AUTOSOMALRECESSIVE	disease	C23;C14	DiseaseorSyndrome	0.71	1	1995	2012	5	10	CTD_human;GENOMICS_ENGLAND;UNIPROT
18381	6331	SCN5A	0.513	0.654	C1859062	LONGQTSYNDROME3	disease	C23;C16;C14	DiseaseorSyndrome	1	1	1995	2018	30	153	CTD_human;GENOMICS_ENGLAND;UNIPROT
18382	6331	SCN5A	0.513	0.654	C1879286	Hereditarybundlebranchsystemdefect	disease	C23;C14	DiseaseorSyndrome	0.98	1	1995	2013	10	15	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
18384	6331	SCN5A	0.513	0.654	C2751898	VentricularFibrillation,ParoxysmalFamilial,1	disease	C23;C14	DiseaseorSyndrome	0.8	0.833	1995	2018	3	4	GENOMICS_ENGLAND;ORPHANET;UNIPROT
18386	6331	SCN5A	0.513	0.654	C3151464	ATRIALFIBRILLATION,FAMILIAL,10	disease		DiseaseorSyndrome	0.7	1	1995	2012	4	17	CTD_human;GENOMICS_ENGLAND;UNIPROT
18389	6331	SCN5A	0.513	0.654	C4551804	BrugadaSyndrome1	disease	C16;C14	DiseaseorSyndrome	0.91	1	1995	2018	52	234	CTD_human;GENOMICS_ENGLAND;UNIPROT
18395	6334	SCN8A	0.51	0.731	C0014544	Epilepsy	disease	C10	DiseaseorSyndrome	0.9	0.971	2007	2020	3	1	CTD_human;GENOMICS_ENGLAND
18447	6334	SCN8A	0.51	0.731	C3280415	COGNITIVEIMPAIRMENTWITHORWITHOUTCEREBELLARATAXIA	disease		DiseaseorSyndrome	0.6	1	2012	2016	2	4	CTD_human;GENOMICS_ENGLAND
18448	6334	SCN8A	0.51	0.731	C3281191	SCN8A-relatedepilepsywithencephalopathy	disease	C23;C10;F03;F01	DiseaseorSyndrome	0.72	1	2002	2017	16	52	CTD_human;GENOMICS_ENGLAND;UNIPROT
18450	6334	SCN8A	0.51	0.731	C3714756	IntellectualDisability	group	C23;C10;F03;F01	MentalorBehavioralDysfunction	0.67	1	2006	2019	1	0	CTD_human;GENOMICS_ENGLAND
18451	6334	SCN8A	0.51	0.731	C4310728	SEIZURES,BENIGNFAMILIALINFANTILE,5	disease		DiseaseorSyndrome	0.7	1	2014	2016	2	5	CTD_human;GENOMICS_ENGLAND;UNIPROT
18452	6335	SCN9A	0.543	0.615	C0002768	CongenitalPainInsensitivity	disease	C16;C10	DiseaseorSyndrome	0.6	1	2004	2018	2	0	GENOMICS_ENGLAND;ORPHANET
18456	6335	SCN9A	0.543	0.615	C0014805	PrimaryErythermalgia	disease	C14	DiseaseorSyndrome	0.8	1	2004	2017	15	0	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
18482	6335	SCN9A	0.543	0.615	C0751122	InfantileSevereMyoclonicEpilepsy	disease	C10	DiseaseorSyndrome	0.57	1	2006	2020	4	0	CTD_human;ORPHANET
18487	6335	SCN9A	0.543	0.615	C1833661	PAROXYSMALEXTREMEPAINDISORDER	disease	C23	DiseaseorSyndrome	0.8	1	2004	2018	5	0	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
18488	6335	SCN9A	0.543	0.615	C1855739	IndifferencetoPain,Congenital,AutosomalRecessive	disease	C23;C16;C10	DiseaseorSyndrome	0.8	0.95	2004	2018	4	0	CTD_human;GENOMICS_ENGLAND;UNIPROT
18489	6335	SCN9A	0.543	0.615	C2751778	GeneralizedEpilepsyWithFebrileSeizuresPlus,7	disease	C23;C10	DiseaseorSyndrome	0.7	1	1979	2014	3	0	CTD_human;GENOMICS_ENGLAND;UNIPROT
18501	6336	SCN10A	0.566	0.692	C0020429	Hyperalgesia	phenotype	C23;C10	SignorSymptom	0.62	1	2006	2017	1	0	CTD_human
18524	6336	SCN10A	0.566	0.692	C1142166	BrugadaSyndrome(disorder)	disease	C16;C14	DiseaseorSyndrome	0.8	0.929	1998	2019	9	13	CLINGEN;CTD_human;ORPHANET
18533	6336	SCN10A	0.566	0.692	C3809893	EPISODICPAINSYNDROME,FAMILIAL,2	disease		DiseaseorSyndrome	0.7	1	2005	2016	5	2	CTD_human;GENOMICS_ENGLAND;UNIPROT
18538	6337	SCNN1A	0.601	0.577	C0024115	Lungdiseases	group	C08	DiseaseorSyndrome	0.51	1	2004	2017	2	0	CTD_human;GENOMICS_ENGLAND
18547	6337	SCNN1A	0.601	0.577	C0221043	LiddleSyndrome	disease	C16;C13;C12	DiseaseorSyndrome	0.54	1	2003	2019	2	0	CTD_human;ORPHANET
18556	6337	SCNN1A	0.601	0.577	C1449843	Pseudohypoaldosteronism,TypeI,AutosomalRecessive	disease	C16;C13;C12	DiseaseorSyndrome	0.61	1	1999	2013	7	0	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
18560	6337	SCNN1A	0.601	0.577	C2751666	BRONCHIECTASISWITHORWITHOUTELEVATEDSWEATCHLORIDE2	disease	C08	DiseaseorSyndrome	0.6	1	1999	2009	2	0	CTD_human;GENOMICS_ENGLAND;UNIPROT
18566	6338	SCNN1B	0.628	0.577	C0010674	CysticFibrosis	disease	C16;C06;C08	DiseaseorSyndrome	0.6	1	2005	2019	2	0	CTD_human
18568	6338	SCNN1B	0.628	0.577	C0024115	Lungdiseases	group	C08	DiseaseorSyndrome	0.53	1	2005	2019	1	0	CTD_human;GENOMICS_ENGLAND
18570	6338	SCNN1B	0.628	0.577	C0221043	LiddleSyndrome	disease	C16;C13;C12	DiseaseorSyndrome	0.9	1	1995	2018	8	0	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
18571	6338	SCNN1B	0.628	0.577	C0268436	Pseudohypoaldosteronism,TypeI	disease	C16;C13;C12	DiseaseorSyndrome	0.52	1	1999	2019	0	0	CTD_human
18575	6338	SCNN1B	0.628	0.577	C1449843	Pseudohypoaldosteronism,TypeI,AutosomalRecessive	disease	C16;C13;C12	DiseaseorSyndrome	0.6	1	1996	2019	6	0	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
18579	6338	SCNN1B	0.628	0.577	C2749757	BRONCHIECTASISWITHORWITHOUTELEVATEDSWEATCHLORIDE1	disease	C08	DiseaseorSyndrome	0.6	1	2005	2014	5	0	CTD_human;GENOMICS_ENGLAND;UNIPROT
18588	6340	SCNN1G	0.633	0.577	C0221043	LiddleSyndrome	disease	C16;C13;C12	DiseaseorSyndrome	0.6	1	1996	2019	1	0	GENOMICS_ENGLAND;ORPHANET
18589	6340	SCNN1G	0.633	0.577	C0268436	Pseudohypoaldosteronism,TypeI	disease	C16;C13;C12	DiseaseorSyndrome	0.56	1	1996	2013	1	0	CTD_human
18593	6340	SCNN1G	0.633	0.577	C1449843	Pseudohypoaldosteronism,TypeI,AutosomalRecessive	disease	C16;C13;C12	DiseaseorSyndrome	0.7	1	1996	2015	5	1	CTD_human;GENOMICS_ENGLAND;ORPHANET
18605	6341	SCO1	0.638	0.769	C0268237	Cytochrome-cOxidaseDeficiency	disease	C16;C18	DiseaseorSyndrome;CongenitalAbnormality	0.94	1	2000	2013	6	3	CTD_human;GENOMICS_ENGLAND;UNIPROT
18606	6341	SCO1	0.638	0.769	C0751651	MitochondrialDiseases	group	C18	DiseaseorSyndrome	0.52	1	2007	2019	2	0	CTD_human;GENOMICS_ENGLAND
18623	6342	SCP2	0.644	0.5	C3150990	LEUKOENCEPHALOPATHYWITHDYSTONIAANDMOTORNEUROPATHY	disease		DiseaseorSyndrome	0.7	1	2006	2015	2	1	CTD_human;GENOMICS_ENGLAND;ORPHANET
18643	6347	CCL2	0.321	0.962	C0004096	Asthma	disease	C08;C20	DiseaseorSyndrome	0.6	0.875	2001	2019	1	0	CTD_human
18649	6347	CCL2	0.321	0.962	C0007786	BrainIschemia	disease	C10;C14	DiseaseorSyndrome	0.51	1	2005	2017	2	0	CTD_human
18650	6347	CCL2	0.321	0.962	C0010054	CoronaryArteriosclerosis	disease	C14	DiseaseorSyndrome	0.6	0.955	2001	2020	2	0	CTD_human
18652	6347	CCL2	0.321	0.962	C0011881	DiabeticNephropathy	disease	C13;C12;C19	DiseaseorSyndrome	0.6	0.969	2000	2020	1	0	CTD_human
18659	6347	CCL2	0.321	0.962	C0018801	Heartfailure	disease	C14	DiseaseorSyndrome	0.56	0.875	2003	2019	1	0	CTD_human
18660	6347	CCL2	0.321	0.962	C0018802	Congestiveheartfailure	disease	C14	DiseaseorSyndrome	0.59	0.909	1998	2019	1	0	CTD_human
18664	6347	CCL2	0.321	0.962	C0020429	Hyperalgesia	phenotype	C23;C10	SignorSymptom	0.57	1	2007	2019	1	0	CTD_human
18666	6347	CCL2	0.321	0.962	C0020459	Hyperinsulinism	disease	C18	DiseaseorSyndrome	0.56	1	2004	2018	1	0	CTD_human
18669	6347	CCL2	0.321	0.962	C0020538	Hypertensivedisease	group	C14	DiseaseorSyndrome	0.6	1	2006	2019	2	0	CTD_human
18671	6347	CCL2	0.321	0.962	C0021368	Inflammation	phenotype	C23	PathologicFunction	0.54	1	2003	2011	3	0	CTD_human
18674	6347	CCL2	0.321	0.962	C0022661	KidneyFailure,Chronic	disease	C13;C12	DiseaseorSyndrome	0.6	0.824	1995	2019	2	0	CTD_human
18688	6347	CCL2	0.321	0.962	C0028754	Obesity	disease	C23;C18	DiseaseorSyndrome	0.6	1	2005	2020	1	0	CTD_human
18690	6347	CCL2	0.321	0.962	C0032285	Pneumonia	disease	C01;C08	DiseaseorSyndrome	0.56	1	2009	2019	1	0	CTD_human
18691	6347	CCL2	0.321	0.962	C0032300	LobarPneumonia	disease	C01;C08	DiseaseorSyndrome	0.51	1	2011	2018	1	0	CTD_human
18692	6347	CCL2	0.321	0.962	C0034069	PulmonaryFibrosis	disease	C08	DiseaseorSyndrome	0.57	0.909	1994	2019	3	0	CTD_human
18700	6347	CCL2	0.321	0.962	C0038220	StatusEpilepticus	disease	C23;C10	DiseaseorSyndrome	0.51	1	2007	2019	2	0	CTD_human
18714	6347	CCL2	0.321	0.962	C0151744	MyocardialIschemia	disease	C14	DiseaseorSyndrome	0.55	0.875	1999	2019	1	0	CTD_human
18778	6347	CCL2	0.321	0.962	C3714636	Pneumonitis	disease	C01;C08	DiseaseorSyndrome	0.55	1	2009	2019	1	0	CTD_human
18836	6352	CCL5	0.403	0.885	C0004096	Asthma	disease	C08;C20	DiseaseorSyndrome	0.6	0.886	1996	2019	1	0	CTD_human
18886	6356	CCL11	0.473	0.885	C0004096	Asthma	disease	C08;C20	DiseaseorSyndrome	0.7	0.953	1995	2019	0	0	CTD_human
18894	6356	CCL11	0.473	0.885	C0032285	Pneumonia	disease	C01;C08	DiseaseorSyndrome	0.55	1	1999	2020	1	0	CTD_human
18929	6364	CCL20	0.474	0.846	C0009324	UlcerativeColitis	disease	C06	DiseaseorSyndrome	0.64	1	2004	2017	1	1	CTD_human
19029	6389	SDHA	0.517	0.731	C0023264	LeighDisease	disease	C16;C18;C10	DiseaseorSyndrome	0.73	0.917	1992	2017	11	3	CLINGEN;CTD_human;GENOMICS_ENGLAND;UNIPROT
19034	6389	SDHA	0.517	0.731	C0238198	GastrointestinalStromalTumors	group	C06;C04	NeoplasticProcess	0.7	1	2004	2019	4	0	GENOMICS_ENGLAND;ORPHANET
19045	6389	SDHA	0.517	0.731	C1855008	MitochondrialComplexIIDeficiency	disease	C16;C18	DiseaseorSyndrome	0.7	1	2000	2017	4	39	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
19047	6389	SDHA	0.517	0.731	C3150898	CARDIOMYOPATHY,DILATED,1GG	disease		DiseaseorSyndrome	0.6	1	2010	2016	2	2	GENOMICS_ENGLAND;UNIPROT
19049	6389	SDHA	0.517	0.731	C3279992	PARAGANGLIOMAS5	disease		DiseaseorSyndrome	0.7	1	2000	2017	2	39	CTD_human;GENOMICS_ENGLAND;UNIPROT
19051	6390	SDHB	0.474	0.846	C0030421	Paraganglioma	disease	C04	NeoplasticProcess	0.7	0.983	2001	2020	2	2	CGI;CTD_human
19052	6390	SDHB	0.474	0.846	C0031511	Pheochromocytoma	disease	C04	NeoplasticProcess	0.8	0.989	1982	2020	9	65	CGI;CTD_human;GENOMICS_ENGLAND;UNIPROT
19054	6390	SDHB	0.474	0.846	C0238198	GastrointestinalStromalTumors	group	C06;C04	NeoplasticProcess	0.8	0.971	1982	2019	4	57	CTD_human;GENOMICS_ENGLAND;ORPHANET
19062	6390	SDHB	0.474	0.846	C1847319	PARAGANGLIOMAANDGASTRICSTROMALSARCOMA	disease	C06;C04	DiseaseorSyndrome	0.76	0.889	2008	2016	4	6	CTD_human;GENOMICS_ENGLAND;ORPHANET
19064	6390	SDHB	0.474	0.846	C1861848	PARAGANGLIOMAS4	disease	C16;C04	NeoplasticProcess	0.71	1	1982	2017	8	67	CTD_human;GENOMICS_ENGLAND;UNIPROT
19070	6391	SDHC	0.517	0.846	C0238198	GastrointestinalStromalTumors	group	C06;C04	NeoplasticProcess	0.8	0.973	2000	2019	1	9	CTD_human;GENOMICS_ENGLAND;ORPHANET
19074	6391	SDHC	0.517	0.846	C1708353	HereditaryParaganglioma-PheochromocytomaSyndrome	disease	C16;C04	DiseaseorSyndrome	0.61	1	2000	2018	8	7	CLINGEN;GENOMICS_ENGLAND
19075	6391	SDHC	0.517	0.846	C1847319	PARAGANGLIOMAANDGASTRICSTROMALSARCOMA	disease	C06;C04	DiseaseorSyndrome	0.62	1	2008	2013	1	1	CTD_human;ORPHANET
19083	6392	SDHD	0.472	0.885	C0030421	Paraganglioma	disease	C04	NeoplasticProcess	0.8	0.994	1996	2020	6	6	CGI;CTD_human;GENOMICS_ENGLAND;UNIPROT
19084	6392	SDHD	0.472	0.885	C0031511	Pheochromocytoma	disease	C04	NeoplasticProcess	0.8	0.993	2000	2020	3	31	CGI;CTD_human;GENOMICS_ENGLAND;UNIPROT
19090	6392	SDHD	0.472	0.885	C1708353	HereditaryParaganglioma-PheochromocytomaSyndrome	disease	C16;C04	DiseaseorSyndrome	0.6	1	1997	2015	9	16	CLINGEN;GENOMICS_ENGLAND
19091	6392	SDHD	0.472	0.885	C1847319	PARAGANGLIOMAANDGASTRICSTROMALSARCOMA	disease	C06;C04	DiseaseorSyndrome	0.76	1	2000	2019	1	26	CTD_human;GENOMICS_ENGLAND;ORPHANET
19092	6392	SDHD	0.472	0.885	C1855008	MitochondrialComplexIIDeficiency	disease	C16;C18	DiseaseorSyndrome	0.72	1	2012	2015	3	3	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
19098	6399	TRAPPC2	0.722	0.308	C0038015	SpondyloepiphysealDysplasia	disease	C16;C05	DiseaseorSyndrome	0.7	1	2000	2014	0	0	CTD_human;GENOMICS_ENGLAND
19102	6399	TRAPPC2	0.722	0.308	C3541456	SpondyloepiphysealDysplasiaTarda,X-Linked	disease	C16;C05	CongenitalAbnormality	0.8	1	1999	2019	3	2	CTD_human;GENOMICS_ENGLAND;UNIPROT
19198	6418	SET	0.507	0.808	C4748195	MENTALRETARDATION,AUTOSOMALDOMINANT58	disease		DiseaseorSyndrome	0.6	1	2014	2018	3	5	GENOMICS_ENGLAND;UNIPROT
19246	6424	SFRP4	0.524	0.654	C0265294	Pylemetaphysealdysplasia	disease	C16;C05	DiseaseorSyndrome	0.73	1	2012	2019	3	0	CTD_human;GENOMICS_ENGLAND;ORPHANET
19287	6439	SFTPB	0.575	0.654	C0020192	HyalineMembraneDisease	disease	C16;C08	DiseaseorSyndrome	0.51	1	2000	2001	1	0	ORPHANET
19288	6439	SFTPB	0.575	0.654	C0024115	Lungdiseases	group	C08	DiseaseorSyndrome	0.6	1	1995	2018	1	0	CTD_human
19293	6439	SFTPB	0.575	0.654	C1968602	SurfactantMetabolismDysfunction,Pulmonary,1	disease	C08	DiseaseorSyndrome	0.7	1	1994	2015	4	5	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
19304	6440	SFTPC	0.556	0.692	C1800706	IdiopathicPulmonaryFibrosis	disease	C08	DiseaseorSyndrome	0.6	0.875	2003	2019	1	0	CTD_human;ORPHANET
19305	6440	SFTPC	0.556	0.692	C1970470	SURFACTANTMETABOLISMDYSFUNCTION,PULMONARY,2(disorder)	disease	C08	DiseaseorSyndrome	0.7	1	2001	2009	7	6	CTD_human;GENOMICS_ENGLAND;UNIPROT
19309	6441	SFTPD	0.5	0.846	C0024117	ChronicObstructiveAirwayDisease	disease	C08	DiseaseorSyndrome	0.7	0.917	2001	2019	1	3	CTD_human
19319	6442	SGCA	0.592	0.654	C2936332	Alpha-Sarcoglycanopathies	disease	C16;C05;C08;C10;C14	DiseaseorSyndrome	1	1	1994	2019	10	56	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
19327	6443	SGCB	0.656	0.346	C1858593	Limb-girdlemusculardystrophy,type2E	disease	C16;C05;C08;C10;C14	DiseaseorSyndrome	0.96	1	1995	2018	5	30	CTD_human;GENOMICS_ENGLAND;UNIPROT
19332	6444	SGCD	0.641	0.615	C0878544	Cardiomyopathies	group	C14	DiseaseorSyndrome	0.58	0.9	1997	2015	2	0	CTD_human;GENOMICS_ENGLAND
19333	6444	SGCD	0.641	0.615	C1832525	Limb-girdlemusculardystrophytype2F	disease	C16;C05;C08;C10;C14	DiseaseorSyndrome	0.94	1	1996	2017	4	12	CTD_human;GENOMICS_ENGLAND;UNIPROT
19334	6444	SGCD	0.641	0.615	C1847667	CARDIOMYOPATHY,DILATED,1L	disease	C14	DiseaseorSyndrome	0.9	1	1997	2017	4	8	CTD_human;GENOMICS_ENGLAND;UNIPROT
19338	6445	SGCG	0.621	0.615	C0410173	Severeautosomalrecessivemusculardystrophyofchildhood-NorthAfricantype(disorder)	disease	C16;C05;C08;C10;C14	DiseaseorSyndrome	1	1	1995	2018	3	23	CTD_human;GENOMICS_ENGLAND;UNIPROT
19339	6445	SGCG	0.621	0.615	C0686353	MuscularDystrophies,Limb-Girdle	group	C16;C05;C10	DiseaseorSyndrome	0.6	1	1995	2020	0	0	GENOMICS_ENGLAND
19372	6448	SGSH	0.638	0.692	C0026706	MucopolysaccharidosisIII	disease	C16;C18;C17	DiseaseorSyndrome	0.89	1	1997	2019	1	6	CTD_human;GENOMICS_ENGLAND
19374	6448	SGSH	0.638	0.692	C0086647	MucopolysaccharidosisTypeIIIA	disease	C16;C18;C17	DiseaseorSyndrome	0.8	1	1991	2019	19	63	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
19378	6452	SH3BP2	0.623	0.654	C0008029	Cherubism	disease	C16;C05;C07	DiseaseorSyndrome	1	0.971	2001	2019	4	4	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
19386	6462	SHBG	0.438	0.808	C0001973	AlcoholicIntoxication,Chronic	disease	C25;F03	MentalorBehavioralDysfunction	0.51	1	1994	2019	2	0	CTD_human;PSYGENET
19412	6469	SHH	0.461	0.846	C0079541	Holoprosencephaly	disease	C16;C05;C10	CongenitalAbnormality	0.7	1	1994	2018	6	22	CTD_human;GENOMICS_ENGLAND
19423	6469	SHH	0.461	0.846	C1840235	SOLITARYMEDIANMAXILLARYCENTRALINCISOR	disease	C16;C07	CongenitalAbnormality	0.72	1	2001	2007	4	3	CTD_human;GENOMICS_ENGLAND;UNIPROT
19424	6469	SHH	0.461	0.846	C1840529	HOLOPROSENCEPHALY3	disease	C16;C05;C10	DiseaseorSyndrome	0.9	1	1995	2013	15	35	CTD_human;GENOMICS_ENGLAND;UNIPROT
19427	6469	SHH	0.461	0.846	C1868114	POLYDACTYLY,PREAXIALII(disorder)	disease	C16;C11;C05	DiseaseorSyndrome	0.51	1	2003	2017	4	0	GENOMICS_ENGLAND;ORPHANET
19454	6473	SHOX	0.561	0.654	C0265309	Leri-Weilldyschondrosteosis	disease	C23;C16;C05	DiseaseorSyndrome	0.8	0.962	1999	2019	3	9	CTD_human;GENOMICS_ENGLAND;UNIPROT
19455	6473	SHOX	0.561	0.654	C0432230	LangerMesomelicDysplasiaSyndrome	disease	C23;C16;C05	DiseaseorSyndrome	0.8	0.958	2000	2019	3	2	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
19457	6473	SHOX	0.561	0.654	C1845118	SHORTSTATURE,IDIOPATHIC,X-LINKED	disease	C23;C16	CongenitalAbnormality	0.71	1	2017	2017	0	6	CTD_human;GENOMICS_ENGLAND;ORPHANET
19460	6476	SI	0.569	0.692	C1283620	Sucrase-isomaltasedeficiency,congenital	disease	C16;C18	DiseaseorSyndrome	0.79	1	1996	2018	6	11	CTD_human;GENOMICS_ENGLAND;UNIPROT
19476	6487	ST3GAL3	0.606	0.654	C1970200	MENTALRETARDATION,AUTOSOMALRECESSIVE12	disease	C23;C10;F03;F01	DiseaseorSyndrome	0.7	1	2007	2011	2	2	CTD_human;GENOMICS_ENGLAND;UNIPROT
19487	6491	STIL	0.584	0.731	C2675187	MICROCEPHALY,PRIMARYAUTOSOMALRECESSIVE,7(disorder)	disease	C16;C05;C10	DiseaseorSyndrome	0.71	1	2009	2015	3	6	CTD_human;GENOMICS_ENGLAND;UNIPROT
19491	6492	SIM1	0.626	0.654	C0028754	Obesity	disease	C23;C18	DiseaseorSyndrome	0.7	0.955	1998	2019	1	0	GENOMICS_ENGLAND
19505	6495	SIX1	0.496	0.692	C0265234	Branchio-Oto-RenalSyndrome	disease	C16	DiseaseorSyndrome	0.9	1	1998	2018	11	0	CLINGEN;CTD_human;GENOMICS_ENGLAND
19510	6495	SIX1	0.496	0.692	C1842124	BRANCHIOOTICSYNDROME3(disorder)	disease	C16	DiseaseorSyndrome	0.72	1	1998	2019	8	9	CTD_human;GENOMICS_ENGLAND;UNIPROT
19511	6495	SIX1	0.496	0.692	C1854594	DEAFNESS,AUTOSOMALDOMINANT23	disease	C23;C10;C09	DiseaseorSyndrome	0.6	1	1998	2009	2	4	CTD_human;GENOMICS_ENGLAND
19521	6496	SIX3	0.56	0.692	C0079541	Holoprosencephaly	disease	C16;C05;C10	CongenitalAbnormality	0.7	1	1996	2018	1	0	CTD_human;GENOMICS_ENGLAND
19522	6496	SIX3	0.56	0.692	C0266484	Schizencephaly	disease	C16;C10	CongenitalAbnormality	0.61	1	2008	2010	2	2	GENOMICS_ENGLAND;UNIPROT
19528	6496	SIX3	0.56	0.692	C1834877	HOLOPROSENCEPHALY2(disorder)	disease	C16;C05;C10	DiseaseorSyndrome	0.92	1	1999	2011	7	11	CTD_human;GENOMICS_ENGLAND;UNIPROT
19544	6497	SKI	0.503	0.808	C1321551	Shprintzen-Goldbergsyndrome	disease	C16;C17;C05;C14	DiseaseorSyndrome	0.74	1	2002	2015	4	14	CLINGEN;CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
19559	6499	SKIV2L	0.615	0.654	C1857276	TrichohepatoentericSyndrome	disease	C23;C16;C13;C17	DiseaseorSyndrome	0.67	0.889	2012	2018	3	0	CTD_human;GENOMICS_ENGLAND;ORPHANET
19560	6499	SKIV2L	0.615	0.654	C3281289	TRICHOHEPATOENTERICSYNDROME2	disease		DiseaseorSyndrome	0.6	1	2012	2017	3	0	GENOMICS_ENGLAND;UNIPROT
19574	6502	SKP2	0.492	0.808	C2239176	Livercarcinoma	disease	C06;C04	NeoplasticProcess	0.6	1	1998	2019	1	0	CTD_human
19595	6505	SLC1A1	0.561	0.654	C0152136	LowTensionGlaucoma	disease	C11	DiseaseorSyndrome	0.53	1	2007	2018	1	0	CTD_human
19622	6505	SLC1A1	0.561	0.654	C1857253	Dicarboxylicaminoaciduria	disease	C23;C16;C13;C12;C10;F03;F01	DiseaseorSyndrome	0.91	1	1992	2011	3	0	CLINGEN;CTD_human;ORPHANET;UNIPROT
19654	6506	SLC1A2	0.511	0.731	C4310717	EPILEPTICENCEPHALOPATHY,EARLYINFANTILE,41	disease		DiseaseorSyndrome	0.7	1	2012	2018	3	3	CTD_human;GENOMICS_ENGLAND;UNIPROT
19666	6507	SLC1A3	0.573	0.577	C2675211	EPISODICATAXIA,TYPE6(disorder)	disease	C23;C10	DiseaseorSyndrome	0.72	1	2005	2017	3	2	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
19672	6509	SLC1A4	0.7	0.385	C4225254	SPASTICTETRAPLEGIA,THINCORPUSCALLOSUM,ANDPROGRESSIVEMICROCEPHALY	disease		DiseaseorSyndrome	0.7	1	2015	2018	4	0	GENOMICS_ENGLAND;ORPHANET;UNIPROT
19699	6513	SLC2A1	0.388	0.808	C0036572	Seizures	phenotype	C23;C10	SignorSymptom	0.7	1	1998	2018	4	4	CTD_human;GENOMICS_ENGLAND
19751	6513	SLC2A1	0.388	0.808	C1832855	CHOREOATHETOSIS/SPASTICITY,EPISODIC	disease	C23;C05;C10	DiseaseorSyndrome	0.71	1	2008	2016	3	7	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
19752	6513	SLC2A1	0.388	0.808	C1837206	Cryohydrocytosis,Stomatin-Deficient,withMentalRetardation,Seizures,Cataracts,andMassiveHepatosplenomegaly	disease	C23;C06;C18;C11;C10;F03;F01	DiseaseorSyndrome	0.7	1	2011	2014	3	8	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
19754	6513	SLC2A1	0.388	0.808	C1842534	DYSTONIA18(disorder)	disease	C10	DiseaseorSyndrome	0.75	1	2000	2019	15	19	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
19755	6513	SLC2A1	0.388	0.808	C1847501	Glut1DeficiencySyndrome	disease	C16;C18	DiseaseorSyndrome	0.8	0.983	1989	2019	12	4	CLINGEN;CTD_human;ORPHANET
19762	6513	SLC2A1	0.388	0.808	C3553859	EPILEPSY,IDIOPATHICGENERALIZED,SUSCEPTIBILITYTO,12	disease		Finding	0.6	1	2000	2015	6	11	GENOMICS_ENGLAND;UNIPROT
19763	6513	SLC2A1	0.388	0.808	C3714756	IntellectualDisability	group	C23;C10;F03;F01	MentalorBehavioralDysfunction	0.65	1	2010	2017	2	0	CTD_human;GENOMICS_ENGLAND
19770	6513	SLC2A1	0.388	0.808	C4551966	GLUT1DEFICIENCYSYNDROME1	disease	C16;C18	DiseaseorSyndrome	0.7	1	1989	2018	25	35	CLINGEN;GENOMICS_ENGLAND;UNIPROT
19775	6514	SLC2A2	0.572	0.692	C0011860	DiabetesMellitus,Non-Insulin-Dependent	disease	C18;C19	DiseaseorSyndrome	0.7	0.839	1990	2019	1	3	CTD_human
19790	6514	SLC2A2	0.572	0.692	C3495427	Fanconi-BickelSyndrome	disease	C16;C13;C12	DiseaseorSyndrome	0.8	0.974	1997	2019	10	15	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
19817	6519	SLC3A1	0.593	0.731	C0010691	Cystinuria	disease	C16;C13;C12	DiseaseorSyndrome	1	0.987	1993	2019	20	34	CLINGEN;CTD_human;GENOMICS_ENGLAND;UNIPROT
19821	6519	SLC3A1	0.593	0.731	C1848030	Hypotonia-CystinuriaSyndrome	disease	C23;C16;C18;C13;C05;C12;C10;F03;F01	DiseaseorSyndrome	0.57	0.889	2006	2019	2	0	CTD_human;ORPHANET
19826	6521	SLC4A1	0.522	0.731	C0001126	Renaltubularacidosis	phenotype	C16;C18;C13;C12	DiseaseorSyndrome	0.69	1	1996	2013	2	0	CTD_human
19830	6521	SLC4A1	0.522	0.731	C0013902	Elliptocytosis,Hereditary	disease	C16;C15	DiseaseorSyndrome	0.62	1	1992	2005	2	0	CTD_human;GENOMICS_ENGLAND
19834	6521	SLC4A1	0.522	0.731	C0037889	Hereditaryspherocytosis	disease	C16;C15	DiseaseorSyndrome	0.6	1	1992	2019	2	0	CTD_human;ORPHANET
19841	6521	SLC4A1	0.522	0.731	C1704380	DistalRenalTubularAcidosis	disease	C16;C18;C13;C12	DiseaseorSyndrome	0.8	0.964	1997	2019	3	5	CTD_human;GENOMICS_ENGLAND;ORPHANET
19843	6521	SLC4A1	0.522	0.731	C1861453	PseudohyperkalemiaCardiff	disease	C18	DiseaseorSyndrome	0.75	1	1991	2019	4	5	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
19846	6521	SLC4A1	0.522	0.731	C1862322	Ovalocytosis,Malaysian-Melanesian-FilipinoType	disease	C16;C15	DiseaseorSyndrome	0.8	0.955	1991	2019	5	2	CTD_human;GENOMICS_ENGLAND;ORPHANET
19848	6521	SLC4A1	0.522	0.731	C1969038	RENALTUBULARACIDOSIS,DISTAL,WITHHEMOLYTICANEMIA(disorder)	disease	C16;C18;C13;C12;C15	DiseaseorSyndrome	0.7	1	1998	2004	4	6	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
19850	6521	SLC4A1	0.522	0.731	C2675212	Spherocytosis,Type4	disease	C16;C15	DiseaseorSyndrome	0.9	1	1991	2005	17	23	CTD_human;GENOMICS_ENGLAND;UNIPROT
19864	6523	SLC5A1	0.584	0.654	C0268186	Congenitalglucose-galactosemalabsorption	disease	C16;C06;C18	DiseaseorSyndrome;CongenitalAbnormality	0.8	1	1991	2019	7	5	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
19865	6524	SLC5A2	0.499	0.769	C0017980	Glycosuria,Renal	disease	C16;C18;C13;C12	DiseaseorSyndrome	0.8	1	2002	2020	4	11	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
19901	6528	SLC5A5	0.499	0.769	C1848805	ThyroidDyshormonogenesis1	disease	C16;C05;C19	DiseaseorSyndrome	0.7	1	1997	2016	8	7	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
19909	6529	SLC6A1	0.592	0.538	C0014544	Epilepsy	disease	C10	DiseaseorSyndrome	0.56	1	2002	2020	1	0	CTD_human
19911	6529	SLC6A1	0.592	0.538	C0036341	Schizophrenia	disease	F03	MentalorBehavioralDysfunction	0.54	1	2001	2015	1	0	CTD_human
19943	6529	SLC6A1	0.592	0.538	C4085238	MYOCLONIC-ATONICEPILEPSY	disease		DiseaseorSyndrome	0.74	1	2012	2019	1	16	CTD_human;GENOMICS_ENGLAND;UNIPROT
19951	6530	SLC6A2	0.49	0.846	C0011570	MentalDepression	disease	F01	MentalorBehavioralDysfunction	0.6	0.8	2008	2020	5	0	PSYGENET
19981	6530	SLC6A2	0.49	0.846	C1535893	Orthostaticintolerance	phenotype	C23;C10	Finding	0.61	1	2000	2003	2	1	CTD_human;ORPHANET;UNIPROT
19995	6531	SLC6A3	0.453	0.885	C0009171	CocaineAbuse	disease	C25;F03	MentalorBehavioralDysfunction	0.52	1	1999	2013	6	0	CTD_human;PSYGENET
20005	6531	SLC6A3	0.453	0.885	C0036341	Schizophrenia	disease	F03	MentalorBehavioralDysfunction	0.6	0.964	1993	2020	1	0	CTD_human
20008	6531	SLC6A3	0.453	0.885	C0041671	AttentionDeficitDisorder	disease	F03	MentalorBehavioralDysfunction	0.54	1	1995	2017	4	0	CTD_human
20022	6531	SLC6A3	0.453	0.885	C0600427	CocaineDependence	disease	C25;F03	MentalorBehavioralDysfunction	0.6	0.8	2001	2019	9	0	CTD_human;PSYGENET
20043	6531	SLC6A3	0.453	0.885	C2751067	Parkinsonism-Dystonia,Infantile	disease	C10	DiseaseorSyndrome	0.8	1	2009	2019	1	1	CTD_human;GENOMICS_ENGLAND;ORPHANET
20047	6531	SLC6A3	0.453	0.885	C4747621	PARKINSONISM-DYSTONIA,INFANTILE,1	disease		DiseaseorSyndrome	0.6	1	2009	2014	3	6	GENOMICS_ENGLAND;UNIPROT
20051	6532	SLC6A4	0.429	0.808	C0001973	AlcoholicIntoxication,Chronic	disease	C25;F03	MentalorBehavioralDysfunction	0.6	0.8	1998	2020	7	0	CTD_human;PSYGENET
20053	6532	SLC6A4	0.429	0.808	C0003469	AnxietyDisorders	group	F03	MentalorBehavioralDysfunction	0.6	0.945	1997	2019	1	0	CTD_human
20057	6532	SLC6A4	0.429	0.808	C0005586	BipolarDisorder	disease	F03	MentalorBehavioralDysfunction	0.6	1	1995	2019	7	0	CTD_human;PSYGENET
20058	6532	SLC6A4	0.429	0.808	C0005587	Depression,Bipolar	disease	F03	MentalorBehavioralDysfunction	0.52	1	2000	2006	4	0	CTD_human;PSYGENET
20061	6532	SLC6A4	0.429	0.808	C0011570	MentalDepression	disease	F01	MentalorBehavioralDysfunction	0.6	1	1997	2020	5	0	PSYGENET
20064	6532	SLC6A4	0.429	0.808	C0011581	Depressivedisorder	disease	F03	MentalorBehavioralDysfunction	0.7	1	1997	2020	9	0	CTD_human;PSYGENET
20069	6532	SLC6A4	0.429	0.808	C0020542	PulmonaryHypertension	phenotype	C08	PathologicFunction	0.53	1	2001	2009	1	0	CTD_human
20074	6532	SLC6A4	0.429	0.808	C0025193	Melancholia	disease	F03	MentalorBehavioralDysfunction	0.54	1	1998	2012	9	0	CTD_human;PSYGENET
20076	6532	SLC6A4	0.429	0.808	C0028768	Obsessive-CompulsiveDisorder	disease	F03	MentalorBehavioralDysfunction	0.6	0.886	1997	2019	2	0	CTD_human;GENOMICS_ENGLAND
20083	6532	SLC6A4	0.429	0.808	C0038644	Suddeninfantdeathsyndrome	disease	C23	DiseaseorSyndrome	0.8	0.933	2001	2014	2	0	CTD_human;GENOMICS_ENGLAND
20084	6532	SLC6A4	0.429	0.808	C0041696	UnipolarDepression	disease	F03	MentalorBehavioralDysfunction	0.6	0.8	1995	2020	9	0	CTD_human;PSYGENET
20086	6532	SLC6A4	0.429	0.808	C0085762	Alcoholabuse	disease	C25;F03	MentalorBehavioralDysfunction	0.51	1	2001	2006	4	0	CTD_human;PSYGENET
20106	6532	SLC6A4	0.429	0.808	C0525045	MoodDisorders	group	F03	MentalorBehavioralDysfunction	0.6	0.8	1996	2019	6	0	CTD_human;PSYGENET
20109	6532	SLC6A4	0.429	0.808	C0600427	CocaineDependence	disease	C25;F03	MentalorBehavioralDysfunction	0.55	0.75	2001	2020	5	0	CTD_human;PSYGENET
20115	6532	SLC6A4	0.429	0.808	C1269683	MajorDepressiveDisorder	disease	F03	MentalorBehavioralDysfunction	0.6	0.8	1998	2020	6	0	CTD_human;PSYGENET
20129	6535	SLC6A8	0.476	0.846	C1845862	Creatinedeficiency,X-linked	disease	C16;C18;C10	DiseaseorSyndrome	1	1	2001	2019	11	20	CTD_human;GENOMICS_ENGLAND;UNIPROT
20137	6536	SLC6A9	0.641	0.5	C4310943	GLYCINEENCEPHALOPATHYWITHNORMALSERUMGLYCINE	disease		DiseaseorSyndrome	0.7	1	2016	2016	2	4	CTD_human;GENOMICS_ENGLAND;UNIPROT
20227	6548	SLC9A1	0.55	0.731	C0035126	ReperfusionInjury	disease	C23;C14	InjuryorPoisoning	0.51	1	2007	2010	1	0	CTD_human
20244	6548	SLC9A1	0.55	0.731	C4225383	LICHTENSTEIN-KNORRSYNDROME	disease		DiseaseorSyndrome	0.72	0.667	2015	2019	2	1	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
20257	6550	SLC9A3	0.612	0.615	C0267663	Congenitalsecretorydiarrhea,sodiumtype(disorder)	disease	C23;C16;C18	CongenitalAbnormality	0.72	1	2015	2019	1	8	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
20273	6555	SLC10A2	0.621	0.538	C2750087	BileAcidMalabsorption,Primary	disease	C23;C06;C18	DiseaseorSyndrome	0.71	1	1997	1997	1	3	CTD_human;GENOMICS_ENGLAND;UNIPROT
20289	6556	SLC11A1	0.525	0.846	C0041296	Tuberculosis	disease	C01	DiseaseorSyndrome	0.6	0.971	1994	2019	1	0	CTD_human;ORPHANET
20314	6557	SLC12A1	0.631	0.538	C1866495	Barttersyndrome,antenataltype1	disease	C13;C12;C19	DiseaseorSyndrome	0.92	1	1996	2017	4	15	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
20320	6558	SLC12A2	0.552	0.808	C0020538	Hypertensivedisease	group	C14	DiseaseorSyndrome	0.55	1	2004	2019	1	0	CTD_human
20346	6559	SLC12A3	0.493	0.808	C0268450	GitelmanSyndrome	disease	C16;C13;C12	DiseaseorSyndrome	0.9	1	1996	2020	20	0	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
20358	6566	SLC16A1	0.499	0.846	C1855577	ErythrocyteLactateTransporterDefect	disease	C05;C10	DiseaseorSyndrome	0.7	1	2000	2003	2	2	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
20359	6566	SLC16A1	0.499	0.846	C1864902	Hyperinsulinemichypoglycemia,familial,7	disease	C18	DiseaseorSyndrome	0.7	1	2007	2007	1	3	CTD_human;GENOMICS_ENGLAND;ORPHANET
20360	6566	SLC16A1	0.499	0.846	C4015186	MONOCARBOXYLATETRANSPORTER1DEFICIENCY	disease		DiseaseorSyndrome	0.6	1	2014	2014	1	1	CTD_human;ORPHANET;UNIPROT
20362	6567	SLC16A2	0.592	0.577	C0795889	Allan-Herndon-Dudleysyndrome(AHDS)	disease	C23;C16;C10	DiseaseorSyndrome	1	1	2004	2020	16	29	CLINGEN;CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
20370	6569	SLC34A1	0.619	0.423	C0085682	Hypophosphatemia	phenotype	C18	DiseaseorSyndrome	0.68	1	1996	2019	1	0	CTD_human
20372	6569	SLC34A1	0.619	0.423	C0341703	AdultFanconisyndrome	disease	C16;C13;C12	DiseaseorSyndrome	0.51	1	2010	2019	1	0	CTD_human;ORPHANET
20375	6569	SLC34A1	0.619	0.423	C2676786	Nephrolithiasis-Osteoporosis,Hypophosphatemic,1	disease	C16;C18;C13;C05;C12	DiseaseorSyndrome	0.7	1	2002	2014	3	3	CTD_human;GENOMICS_ENGLAND;UNIPROT
20379	6569	SLC34A1	0.619	0.423	C4310473	Hypercalcemia,infantile,2	disease	C18	DiseaseorSyndrome	0.7	1	2010	2016	2	9	CTD_human;GENOMICS_ENGLAND;UNIPROT
20391	6571	SLC18A2	0.554	0.769	C0030567	ParkinsonDisease	disease	C10	DiseaseorSyndrome	0.6	0.966	1996	2020	1	0	CTD_human
20407	6572	SLC18A3	0.608	0.654	C0751882	MyasthenicSyndromes,Congenital	disease	C16;C10	DiseaseorSyndrome	0.55	1	2016	2019	1	0	CTD_human;GENOMICS_ENGLAND
20412	6572	SLC18A3	0.608	0.654	C4310654	MYASTHENICSYNDROME,CONGENITAL,21,PRESYNAPTIC	disease		DiseaseorSyndrome	0.6	1	2016	2019	2	0	GENOMICS_ENGLAND;UNIPROT
20453	6591	SNAI2	0.505	0.692	C0080024	Piebaldism	disease	C16;C18;C17	CongenitalAbnormality	0.73	1	1998	2014	3	0	CTD_human;GENOMICS_ENGLAND;ORPHANET
20461	6591	SNAI2	0.505	0.692	C1837203	WAARDENBURGSYNDROME,TYPEIID	disease	C16	DiseaseorSyndrome	0.7	1	1998	2002	1	0	CTD_human;GENOMICS_ENGLAND
20469	6594	SMARCA1	0.504	0.808	C0265338	Coffin-Sirissyndrome	disease	C23;C16;C05;C10;F03;C07;F01	DiseaseorSyndrome	0.57	1	2012	2019	2	0	CLINGEN;GENOMICS_ENGLAND
20473	6595	SMARCA2	0.527	0.769	C0265338	Coffin-Sirissyndrome	disease	C23;C16;C05;C10;F03;C07;F01	DiseaseorSyndrome	0.53	1	2012	2019	1	0	CTD_human;GENOMICS_ENGLAND
20475	6595	SMARCA2	0.527	0.769	C1303073	NicolaidesBaraitsersyndrome	disease	C23;C16;C17;C05;C10;F03;F01	DiseaseorSyndrome	0.8	0.929	2012	2020	4	36	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
20491	6597	SMARCA4	0.45	0.885	C0265338	Coffin-Sirissyndrome	disease	C23;C16;C05;C10;F03;C07;F01	DiseaseorSyndrome	0.57	0.875	2012	2018	1	0	CTD_human;GENOMICS_ENGLAND
20515	6648	SOD2	0.379	0.923	C0007193	Cardiomyopathy,Dilated	group	C14	DiseaseorSyndrome	0.51	1	2005	2020	2	0	CTD_human
20539	6648	SOD2	0.379	0.923	C0018801	Heartfailure	disease	C14	DiseaseorSyndrome	0.55	1	2005	2020	5	0	CTD_human
20540	6648	SOD2	0.379	0.923	C0018802	Congestiveheartfailure	disease	C14	DiseaseorSyndrome	0.57	0.917	2005	2020	5	0	CTD_human
20542	6648	SOD2	0.379	0.923	C0020538	Hypertensivedisease	group	C14	DiseaseorSyndrome	0.55	1	2002	2019	3	0	CTD_human
20565	6648	SOD2	0.379	0.923	C0027051	MyocardialInfarction	disease	C23;C14	DiseaseorSyndrome	0.52	1	1997	2019	1	0	CTD_human
20619	6648	SOD2	0.379	0.923	C0162871	AorticAneurysm,Abdominal	disease	C14	DiseaseorSyndrome	0.51	1	2007	2018	1	0	CTD_human
20704	6654	SOS1	0.485	0.808	C0028326	NoonanSyndrome	disease	C16;C17;C05;C14	DiseaseorSyndrome	1	0.969	1991	2019	13	23	CLINGEN;CTD_human;GENOMICS_ENGLAND;ORPHANET
20714	6654	SOS1	0.485	0.808	C1853120	NoonanSyndrome4	disease	C16;C17;C05;C14	DiseaseorSyndrome	0.9	1	2007	2013	11	30	CTD_human;GENOMICS_ENGLAND;UNIPROT
20719	6655	SOS2	0.608	0.692	C0028326	NoonanSyndrome	disease	C16;C17;C05;C14	DiseaseorSyndrome	0.62	1	2000	2015	4	0	CLINGEN;GENOMICS_ENGLAND;ORPHANET
20725	6655	SOS2	0.608	0.692	C4225282	NOONANSYNDROME9	disease		DiseaseorSyndrome	0.7	1	2015	2015	2	4	CTD_human;GENOMICS_ENGLAND;UNIPROT
20764	6657	SOX2	0.405	0.808	C1859773	Microphthalmia,Syndromic3	disease	C16;C06;C11;C10	DiseaseorSyndrome	0.75	1	1996	2018	7	0	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
20769	6658	SOX3	0.535	0.731	C0342376	Panhypopituitarism-X-linked	disease	C16;C10;C19	DiseaseorSyndrome	0.51	1	1981	2018	2	0	CTD_human;GENOMICS_ENGLAND
20773	6658	SOX3	0.535	0.731	C2678223	MentalRetardation,X-Linked,WithPanhypopituitarism	disease	C23;C16;C10;C19;F03;F01	DiseaseorSyndrome	0.6	1	1981	2005	3	1	CTD_human;GENOMICS_ENGLAND
20816	6662	SOX9	0.419	0.846	C0031900	PierreRobinSyndrome	disease	C16;C05;C07	CongenitalAbnormality	0.7	0.867	1996	2019	4	0	CTD_human;GENOMICS_ENGLAND;ORPHANET
20831	6662	SOX9	0.419	0.846	C1861922	CAMPOMELICDYSPLASIA	disease	C16;C05	DiseaseorSyndrome	1	0.972	1994	2019	16	0	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
20832	6662	SOX9	0.419	0.846	C1861923	AcampomelicCampomelicDysplasia	disease	C16;C05	DiseaseorSyndrome	0.69	1	2000	2018	0	0	CTD_human
20840	6663	SOX10	0.461	0.808	C0162809	KallmannSyndrome	disease	C16;C13;C12;C19	DiseaseorSyndrome	0.55	1	2013	2019	1	0	ORPHANET
20843	6663	SOX10	0.461	0.808	C1836727	PeripheralDemyelinatingNeuropathy,CentralDysmyelination,WaardenburgSyndrome,andHirschsprungDisease	disease	C16;C06;C10	DiseaseorSyndrome	0.93	1	1998	2018	9	0	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
20846	6663	SOX10	0.461	0.808	C2700265	WaardenburgSyndromeType2	disease	C16	DiseaseorSyndrome	0.57	1	2007	2017	2	0	CTD_human;ORPHANET
20847	6663	SOX10	0.461	0.808	C2700405	WAARDENBURGSYNDROME,TYPEIIE	disease	C16	DiseaseorSyndrome	0.7	1	1998	2011	5	0	CTD_human;GENOMICS_ENGLAND;UNIPROT
20848	6663	SOX10	0.461	0.808	C2750452	WaardenburgSyndrome,Type4c	disease	C16;C06	DiseaseorSyndrome	0.9	1	1990	2017	16	0	CLINGEN;CTD_human;GENOMICS_ENGLAND;UNIPROT
20849	6663	SOX10	0.461	0.808	C3266898	WaardenburgSyndrome	disease	C16	DiseaseorSyndrome	0.6	0.974	1998	2019	4	0	GENOMICS_ENGLAND;ORPHANET
20854	6664	SOX11	0.494	0.808	C0265338	Coffin-Sirissyndrome	disease	C23;C16;C05;C10;F03;C07;F01	DiseaseorSyndrome	0.66	0.833	2014	2019	1	0	CTD_human;GENOMICS_ENGLAND;ORPHANET
20855	6664	SOX11	0.494	0.808	C4014528	MENTALRETARDATION,AUTOSOMALDOMINANT27	disease		DiseaseorSyndrome	0.6	1	2014	2016	2	5	GENOMICS_ENGLAND;UNIPROT
20873	6671	SP4	0.711	0.423	C0005586	BipolarDisorder	disease	F03	MentalorBehavioralDysfunction	0.63	1	2009	2019	2	1	CTD_human;PSYGENET
20876	6671	SP4	0.711	0.423	C0036341	Schizophrenia	disease	F03	MentalorBehavioralDysfunction	0.66	1	2005	2019	1	2	CTD_human
20879	6674	SPAG1	0.663	0.577	C3809706	CILIARYDYSKINESIA,PRIMARY,28	disease		DiseaseorSyndrome	0.6	1	2013	2016	1	10	CTD_human;GENOMICS_ENGLAND
20899	6678	SPARC	0.445	0.846	C0029434	OsteogenesisImperfecta	disease	C16;C17;C05	DiseaseorSyndrome;CongenitalAbnormality	0.52	1	1991	2018	2	0	CTD_human;GENOMICS_ENGLAND
20922	6678	SPARC	0.445	0.846	C4225301	OSTEOGENESISIMPERFECTA,TYPEXVII	disease		DiseaseorSyndrome	0.7	1	2015	2015	1	2	CTD_human;GENOMICS_ENGLAND;UNIPROT
20927	6683	SPAST	0.579	0.577	C1866855	Spasticparaplegia4,autosomaldominant	disease	C16;C10	DiseaseorSyndrome	1	1	1991	2019	46	100	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
20937	6687	SPG7	0.436	0.885	C1846564	SPASTICPARAPLEGIA7,AUTOSOMALRECESSIVE	disease	C16;C10	DiseaseorSyndrome	0.93	1	1998	2018	9	35	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
20939	6687	SPG7	0.436	0.885	C3711370	SpasticParaplegiaType7	disease	C23;C16;C10	DiseaseorSyndrome	0.55	1	2004	2017	1	0	ORPHANET
20941	6688	SPI1	0.631	0.654	C0023467	Leukemia,Myelocytic,Acute	disease	C04	NeoplasticProcess	0.6	1	1999	2019	1	0	CTD_human
20946	6689	SPIB	0.628	0.538	C0008312	Primarybiliarycirrhosis	disease	C23;C06	DiseaseorSyndrome	0.62	1	2010	2015	1	2	CTD_human;ORPHANET
20954	6690	SPINK1	0.492	0.808	C0238339	Hereditarypancreatitis	disease	C06	DiseaseorSyndrome	0.8	1	2000	2018	7	12	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
20958	6690	SPINK1	0.492	0.808	C1842402	TROPICALCALCIFICPANCREATITIS	disease	C06;C18	DiseaseorSyndrome	0.8	0.938	2002	2019	3	2	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
20973	6696	SPP1	0.353	0.885	C0017638	Glioma	disease	C04	NeoplasticProcess	0.6	1	1995	2019	1	0	CTD_human
20981	6696	SPP1	0.353	0.885	C0022650	KidneyCalculi	disease	C23;C13;C12	DiseaseorSyndrome	0.6	1	1993	2019	2	0	CTD_human
21018	6696	SPP1	0.353	0.885	C0555198	MalignantGlioma	disease	C04	NeoplasticProcess	0.56	1	1998	2018	1	0	CTD_human
21048	6697	SPR	0.631	0.654	C0268468	Dystonia,Dopa-Responsive,duetoSepiapterinReductaseDeficiency	disease	C23;C16;C18;C10;F01	DiseaseorSyndrome	0.71	0.889	2001	2017	7	9	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
21063	6708	SPTA1	0.638	0.538	C0520739	Hereditarypyropoikilocytosis	disease	C16;C15	DiseaseorSyndrome	0.73	1	1989	2019	3	8	CTD_human;GENOMICS_ENGLAND;UNIPROT
21064	6708	SPTA1	0.638	0.538	C1851741	ELLIPTOCYTOSIS2(disorder)	disease	C16;C15	DiseaseorSyndrome	0.7	1	1989	1996	13	16	CTD_human;GENOMICS_ENGLAND;UNIPROT
21065	6708	SPTA1	0.638	0.538	C2678338	SPHEROCYTOSIS,TYPE3(disorder)	disease	C16;C15	DiseaseorSyndrome	0.8	1	1962	2016	2	4	CTD_human;GENOMICS_ENGLAND
21072	6709	SPTAN1	0.601	0.615	C3150731	EPILEPTICENCEPHALOPATHY,EARLYINFANTILE,5	disease		DiseaseorSyndrome	0.61	1	2010	2018	1	6	CTD_human;GENOMICS_ENGLAND
21077	6710	SPTB	0.65	0.462	C0013902	Elliptocytosis,Hereditary	disease	C16;C15	DiseaseorSyndrome	0.75	1	1990	2016	4	0	CTD_human;GENOMICS_ENGLAND;ORPHANET
21078	6710	SPTB	0.65	0.462	C0037889	Hereditaryspherocytosis	disease	C16;C15	DiseaseorSyndrome	0.68	1	1990	2020	3	3	CTD_human;ORPHANET
21082	6710	SPTB	0.65	0.462	C1866810	ELLIPTOCYTOSIS3	disease	C16;C15	DiseaseorSyndrome	0.6	1	1990	1995	4	9	GENOMICS_ENGLAND;UNIPROT
21083	6710	SPTB	0.65	0.462	C2674219	SPHEROCYTOSIS,HEREDITARY,2	disease		DiseaseorSyndrome	0.7	1	1993	2016	4	13	CTD_human;GENOMICS_ENGLAND;UNIPROT
21094	6712	SPTBN2	0.619	0.731	C0752123	SpinocerebellarAtaxiaType5	disease	C16;C10	DiseaseorSyndrome	1	0.938	2006	2019	2	5	CTD_human;GENOMICS_ENGLAND;UNIPROT
21098	6712	SPTBN2	0.619	0.731	C3809327	SPINOCEREBELLARATAXIA,AUTOSOMALRECESSIVE14	disease		DiseaseorSyndrome	0.63	1	2012	2019	2	3	GENOMICS_ENGLAND;ORPHANET
21127	6714	SRC	0.467	0.885	C4310789	THROMBOCYTOPENIA6	disease		DiseaseorSyndrome	0.7	1	2016	2016	1	1	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
21135	6715	SRD5A1	0.631	0.538	C0033578	ProstaticNeoplasms	group	C04;C12	NeoplasticProcess	0.54	1	2003	2010	2	0	CTD_human
21137	6715	SRD5A1	0.631	0.538	C0376358	Malignantneoplasmofprostate	disease	C04;C12	NeoplasticProcess	0.55	1	2006	2017	2	0	CTD_human
21149	6716	SRD5A2	0.564	0.615	C0268297	PseudovaginalPerineoscrotalHypospadias	disease	C16;C18;C13;C12;C19	DiseaseorSyndrome	0.8	1	1977	2019	18	39	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
21158	6716	SRD5A2	0.564	0.615	C3669122	5-AlphaReductaseDeficiency	disease	C16;C18;C13;C12;C19	DiseaseorSyndrome	0.6	1	1992	2019	3	0	CTD_human;ORPHANET
21165	6718	AKR1D1	0.711	0.385	C1856127	Bileacidsynthesisdefect,congenital,2	disease	C16;C06;C18	DiseaseorSyndrome	0.7	1	2003	2015	7	5	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
21180	6721	SREBF2	0.566	0.577	C0006142	Malignantneoplasmofbreast	disease	C04;C17	NeoplasticProcess	0.53	1	2003	2019	1	0	CTD_human;UNIPROT
21206	6729	SRP54	0.612	0.769	C0272170	Shwachmansyndrome	disease		DiseaseorSyndrome	0.51	1	2017	2019	1	0	CTD_human;ORPHANET
21221	6731	SRP72	0.711	0.269	C3808553	Bonemarrowfailuresyndrome1	disease		DiseaseorSyndrome	0.7	1	2012	2018	2	2	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
21233	6736	SRY	0.456	0.808	C2748895	OvotesticularDisordersofSexDevelopment	disease	C16;C13;C12;C19	CongenitalAbnormality	0.8	1	1992	2019	3	1	CTD_human;GENOMICS_ENGLAND;ORPHANET
21234	6736	SRY	0.456	0.808	C2748896	46,XyGonadalDysgenesis,Complete,Sry-Related	disease	C16;C13;C12;C19	DiseaseorSyndrome	0.7	1	1990	2017	25	27	CTD_human;GENOMICS_ENGLAND;UNIPROT
21245	6748	SSR4	0.705	0.423	C4012395	Congenitaldisorderofglycosylationtype1y	disease	C16;C18	DiseaseorSyndrome	0.7	1	2014	2015	2	5	CTD_human;GENOMICS_ENGLAND;ORPHANET
21377	6756	SSX1	0.674	0.308	C0039101	synovialsarcoma	disease	C04	NeoplasticProcess	0.7	0.918	1998	2018	2	0	CTD_human;ORPHANET
21380	6757	SSX2	0.581	0.615	C0039101	synovialsarcoma	disease	C04	NeoplasticProcess	0.7	0.973	1994	2020	1	0	CTD_human;ORPHANET
21382	6760	SS18	0.641	0.462	C0039101	synovialsarcoma	disease	C04	NeoplasticProcess	0.6	0.959	1994	2020	2	0	CTD_human;ORPHANET
21387	6768	ST14	0.514	0.769	C1835851	Ichthyosiswithhypotrichosis,autosomalrecessive	disease	C16;C17	DiseaseorSyndrome	0.75	1	2007	2018	3	4	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
21390	6770	STAR	0.513	0.808	C0032460	PolycysticOvarySyndrome	disease	C04;C13;C19	DiseaseorSyndrome	0.56	1	1999	2019	1	0	CTD_human
21391	6770	STAR	0.513	0.808	C0342474	Lipoidcongenitaladrenalhyperplasia	disease	C16;C18;C13;C12;C19	DiseaseorSyndrome	0.8	1	1995	2018	7	33	CTD_human;GENOMICS_ENGLAND;UNIPROT
21398	6772	STAT1	0.399	0.885	C0006142	Malignantneoplasmofbreast	disease	C04;C17	NeoplasticProcess	0.6	1	2000	2019	0	0	UNIPROT
21413	6772	STAT1	0.399	0.885	C3151088	IMMUNODEFICIENCY31B	disease		DiseaseorSyndrome	0.7	1	2003	2019	8	11	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
21414	6772	STAT1	0.399	0.885	C3279990	CANDIDIASIS,FAMILIAL,7	disease		DiseaseorSyndrome	0.7	1	2011	2019	8	20	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
21415	6772	STAT1	0.399	0.885	C4013950	IMMUNODEFICIENCY31A	disease		DiseaseorSyndrome	0.7	1	2001	2019	5	12	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
21417	6773	STAT2	0.569	0.615	C4225260	IMMUNODEFICIENCY44	disease		DiseaseorSyndrome	0.7	1	2012	2017	4	3	CTD_human;GENOMICS_ENGLAND;ORPHANET
21465	6774	STAT3	0.32	0.923	C0033860	Psoriasis	disease	C17	DiseaseorSyndrome	0.7	0.968	2005	2020	1	1	CTD_human
21536	6774	STAT3	0.32	0.923	C1955861	T-CellLargeGranularLymphocyteLeukemia	disease	C04;C20;C15	NeoplasticProcess	0.6	1	2012	2020	2	0	CGI;ORPHANET
21537	6774	STAT3	0.32	0.923	C1968689	Hyper-ImmunoglobulinESyndrome,AutosomalRecessive	disease	C16;C20;C15	DiseaseorSyndrome	0.55	1	2011	2019	1	0	CTD_human
21539	6774	STAT3	0.32	0.923	C2936739	Hyper-ImmunoglobulinESyndrome,AutosomalDominant	disease	C16;C20;C15	DiseaseorSyndrome	0.8	0.981	2007	2020	3	0	CTD_human;ORPHANET
21544	6774	STAT3	0.32	0.923	C3887645	JobSyndrome	disease	C16;C20;C15	DiseaseorSyndrome	0.8	1	2007	2019	3	10	CTD_human;GENOMICS_ENGLAND;ORPHANET
21545	6774	STAT3	0.32	0.923	C4014795	AUTOIMMUNEDISEASE,MULTISYSTEM,INFANTILE-ONSET,1	disease		DiseaseorSyndrome	0.7	1	2014	2017	3	12	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
21554	6774	STAT3	0.32	0.923	C4721531	HYPER-IgERECURRENTINFECTIONSYNDROME1,AUTOSOMALDOMINANT	disease	C16;C20;C15	DiseaseorSyndrome	0.63	1	2007	2018	7	14	GENOMICS_ENGLAND;UNIPROT
21557	6775	STAT4	0.471	0.769	C0004943	BehcetSyndrome	disease	C16;C11;C17;C07;C14	DiseaseorSyndrome	0.67	1	2010	2019	3	2	CTD_human;ORPHANET
21561	6775	STAT4	0.471	0.769	C0024141	LupusErythematosus,Systemic	disease	C17;C20	DiseaseorSyndrome	0.7	0.961	2002	2020	5	15	CTD_human;ORPHANET
21568	6775	STAT4	0.471	0.769	C1527336	SjogrensSyndrome	disease	C11;C17;C05;C20;C07	DiseaseorSyndrome	0.45	1	2008	2017	2	4	CTD_human
val	6775	STAT4	0.471	0.769	C2239176	Livercarcinoma	disease	C06;C04	NeoplasticProcess	0.50	1	2013	2019	1	5	CTD_human
val	6775	STAT4	0.471	0.769	C2677096	SYSTEMICLUPUSERYTHEMATOSUS,SUSCEPTIBILITYTO,11	disease		Finding	0.40				0	1	GENOMICS_ENGLAND
val	6775	STAT4	0.471	0.769	C2931171	Juvenilepauciarticularchronicarthritis	disease	C17;C05;C20	DiseaseorSyndrome	0.40	1	2013	2013	1	1	ORPHANET
val	6775	STAT4	0.471	0.769	C4551595	BiliaryCirrhosis,Primary,1	disease	C23;C06	DiseaseorSyndrome	0.30	1	2011	2011	1	0	CTD_human
val	6776	STAT5A	0.445	0.808	C0001418	Adenocarcinoma	group	C04	NeoplasticProcess	0.33	1	2004	2012	2	0	CTD_human
val	6776	STAT5A	0.445	0.808	C0006142	Malignantneoplasmofbreast	disease	C04;C17	NeoplasticProcess	0.40	0.897	1998	2018	1	0	CTD_human
val	6776	STAT5A	0.445	0.808	C0007097	Carcinoma	group	C04	NeoplasticProcess	0.31	1	2002	2013	3	0	CTD_human
val	6776	STAT5A	0.445	0.808	C0007124	NoninfiltratingIntraductalCarcinoma	disease	C04	NeoplasticProcess	0.30	1	2004	2004	1	0	CTD_human
val	6776	STAT5A	0.445	0.808	C0024121	LungNeoplasms	group	C04;C08	NeoplasticProcess	0.31	1	2008	2011	1	0	CTD_human
val	6776	STAT5A	0.445	0.808	C0024667	AnimalMammaryNeoplasms	phenotype	C04;C22	NeoplasticProcess	0.30	1	2002	2010	5	0	CTD_human
val	6776	STAT5A	0.445	0.808	C0024668	MammaryNeoplasms,Experimental	phenotype	C04	NeoplasticProcess;ExperimentalModelofDisease	0.50	1	2002	2007	3	0	CTD_human
val	6776	STAT5A	0.445	0.808	C0032927	PrecancerousConditions	group	C04	NeoplasticProcess	0.30	1	2004	2004	1	0	CTD_human
val	6776	STAT5A	0.445	0.808	C0151744	MyocardialIschemia	disease	C14	DiseaseorSyndrome	0.30	1	2005	2005	1	0	CTD_human
val	6776	STAT5A	0.445	0.808	C0205641	Adenocarcinoma,BasalCell	disease	C04	NeoplasticProcess	0.30	1	2010	2011	2	0	CTD_human
val	6776	STAT5A	0.445	0.808	C0205642	Adenocarcinoma,Oxyphilic	disease	C04	NeoplasticProcess	0.30	1	2010	2011	2	0	CTD_human
val	6776	STAT5A	0.445	0.808	C0205643	Carcinoma,Cribriform	disease	C04	NeoplasticProcess	0.30	1	2010	2011	2	0	CTD_human
val	6776	STAT5A	0.445	0.808	C0205644	Carcinoma,GranularCell	disease	C04	NeoplasticProcess	0.30	1	2010	2011	2	0	CTD_human
val	6776	STAT5A	0.445	0.808	C0205645	Adenocarcinoma,Tubular	disease	C04	NeoplasticProcess	0.30	1	2010	2011	2	0	CTD_human
val	6776	STAT5A	0.445	0.808	C0205696	Anaplasticcarcinoma	disease	C04	NeoplasticProcess	0.30	1	2002	2007	3	0	CTD_human
val	6776	STAT5A	0.445	0.808	C0205697	Carcinoma,Spindle-Cell	disease	C04	NeoplasticProcess	0.30	1	2002	2007	3	0	CTD_human
val	6776	STAT5A	0.445	0.808	C0205698	Undifferentiatedcarcinoma	disease	C04	NeoplasticProcess	0.30	1	2002	2007	3	0	CTD_human
val	6776	STAT5A	0.445	0.808	C0205699	Carcinomatosis	phenotype	C04	NeoplasticProcess	0.30	1	2002	2007	3	0	CTD_human
val	6776	STAT5A	0.445	0.808	C0206692	Carcinoma,Lobular	disease	C04;C17	NeoplasticProcess	0.30	1	2004	2004	1	0	CTD_human
val	6776	STAT5A	0.445	0.808	C0242379	Malignantneoplasmoflung	disease	C04;C08	NeoplasticProcess	0.34	1	2011	2019	1	0	CTD_human
val	6776	STAT5A	0.445	0.808	C0282313	Condition,Preneoplastic	disease	C04	NeoplasticProcess	0.30	1	2004	2004	1	0	CTD_human
val	6776	STAT5A	0.445	0.808	C0494261	Combinedimmunodeficiency	disease	C16;C18;C20	DiseaseorSyndrome	0.30	1	2006	2006	1	0	GENOMICS_ENGLAND
val	6776	STAT5A	0.445	0.808	C0678222	BreastCarcinoma	disease	C04;C17	NeoplasticProcess	0.40	0.897	1998	2018	1	0	CTD_human
val	6776	STAT5A	0.445	0.808	C1176475	DuctalCarcinoma	disease	C04	NeoplasticProcess	0.30	1	2004	2004	1	0	CTD_human
val	6776	STAT5A	0.445	0.808	C1257925	MammaryCarcinoma,Animal	disease	C04;C22	NeoplasticProcess	0.30	1	2002	2010	5	0	CTD_human
val	6776	STAT5A	0.445	0.808	C1257931	MammaryNeoplasms,Human	disease	C04;C17	NeoplasticProcess	0.30	1	2004	2004	1	0	CTD_human
val	6776	STAT5A	0.445	0.808	C1332347	AtypicalDuctalBreastHyperplasia	disease	C04	NeoplasticProcess	0.30	1	2004	2004	1	0	CTD_human
val	6776	STAT5A	0.445	0.808	C1458155	MammaryNeoplasms	group	C04;C17	NeoplasticProcess	0.38	1	2004	2011	1	0	CTD_human
val	6776	STAT5A	0.445	0.808	C4704874	MammaryCarcinoma,Human	disease	C04;C17	NeoplasticProcess	0.30	1	2004	2004	1	0	CTD_human
val	6777	STAT5B	0.442	0.808	C0007117	Basalcellcarcinoma	disease	C04	NeoplasticProcess	0.30				0	0	CGI
val	6777	STAT5B	0.442	0.808	C0023487	AcutePromyelocyticLeukemia	disease	C04	NeoplasticProcess	0.57	0.857	2000	2019	1	0	CGI;ORPHANET
val	6777	STAT5B	0.442	0.808	C0023494	Leukemia,T-Cell,Chronic	disease	C04;C20;C15	NeoplasticProcess	0.30	1	2018	2018	1	0	CTD_human
val	6777	STAT5B	0.442	0.808	C0038002	Splenomegaly	phenotype	C23	Finding	0.30	1	2018	2018	1	0	CTD_human
val	6777	STAT5B	0.442	0.808	C0079772	T-CellLymphoma	disease	C04;C20;C15	NeoplasticProcess	0.32	1	2015	2016	1	0	CTD_human
val	6777	STAT5B	0.442	0.808	C0079773	Lymphoma,T-Cell,Cutaneous	disease	C04;C20;C15	NeoplasticProcess	0.35	0.833	2002	2016	1	0	CTD_human
val	6777	STAT5B	0.442	0.808	C0376407	GranulomatousSlackSkin	disease	C04;C20;C15	NeoplasticProcess	0.30	1	2015	2015	1	0	CTD_human
val	6777	STAT5B	0.442	0.808	C0392788	NasalTypeExtranodalNK/T-CellLymphoma	disease	C04	NeoplasticProcess	0.30	1	2018	2018	1	0	CTD_human
val	6777	STAT5B	0.442	0.808	C0456889	Enteropathy-AssociatedT-CellLymphoma	disease	C04;C20;C15	NeoplasticProcess	0.30	1	2018	2018	1	0	CTD_human
val	6777	STAT5B	0.442	0.808	C0494261	Combinedimmunodeficiency	disease	C16;C18;C20	DiseaseorSyndrome	0.30	1	2016	2016	1	0	GENOMICS_ENGLAND
val	6777	STAT5B	0.442	0.808	C1522378	Leukemia,LargeGranularLymphocytic	disease	C04;C20;C15	NeoplasticProcess	0.33	1	2013	2018	2	0	CTD_human
val	6777	STAT5B	0.442	0.808	C1855548	Laronsyndrometype2	disease	C16;C05;C19	DiseaseorSyndrome	0.70	1	2003	2016	5	6	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
val	6777	STAT5B	0.442	0.808	C1955860	Leukemia,NaturalKillerCellLargeGranularLymphocytic	disease	C04;C20;C15	NeoplasticProcess	0.30	1	2015	2018	2	0	CTD_human
val	6777	STAT5B	0.442	0.808	C1955861	T-CellLargeGranularLymphocyteLeukemia	disease	C04;C20;C15	NeoplasticProcess	0.53	1	2013	2018	2	0	CGI;CTD_human
val	6777	STAT5B	0.442	0.808	C1955906	Lymphoma,ExtranodalNK-T-Cell	disease	C04	NeoplasticProcess	0.30	1	2018	2018	1	0	CTD_human
val	6777	STAT5B	0.442	0.808	C1961099	PrecursorT-CellLymphoblasticLeukemia-Lymphoma	disease	C04;C20;C15	NeoplasticProcess	0.33	1	2011	2020	1	0	CTD_human
val	6777	STAT5B	0.442	0.808	C2363142	T-CellProlymphocyticLeukemia	disease	C04;C20;C15	NeoplasticProcess	0.33	1	2014	2019	1	0	CTD_human
val	6777	STAT5B	0.442	0.808	C2931322	T-Lymphocytopenia	disease	C20;C15	Finding	0.30	1	2006	2006	1	0	CTD_human
val	6778	STAT6	0.475	0.808	C0011615	Dermatitis,Atopic	disease	C16;C17;C20	DiseaseorSyndrome	0.40	1	2002	2018	1	0	CTD_human
val	6778	STAT6	0.475	0.808	C0013604	Edema	phenotype	C23	PathologicFunction	0.30	1	2004	2004	1	0	CTD_human
val	6778	STAT6	0.475	0.808	C0018671	HeadandNeckNeoplasms	group	C04	NeoplasticProcess	0.30	1	2011	2011	1	0	CTD_human
val	6778	STAT6	0.475	0.808	C0018675	HeadNeoplasms	group	C04	NeoplasticProcess	0.30	1	2011	2011	1	0	CTD_human
val	6778	STAT6	0.475	0.808	C0018922	hemangiopericytoma	disease	C04	NeoplasticProcess	0.39	1	2013	2019	2	0	ORPHANET
val	6778	STAT6	0.475	0.808	C0027533	NeckNeoplasms	group	C04	NeoplasticProcess	0.30	1	2011	2011	1	0	CTD_human
val	6778	STAT6	0.475	0.808	C0034069	PulmonaryFibrosis	disease	C08	DiseaseorSyndrome	0.32	1	2016	2018	1	0	CTD_human
val	6778	STAT6	0.475	0.808	C0079744	DiffuseLargeB-CellLymphoma	disease	C04;C20;C15	NeoplasticProcess	0.33	1	2004	2007	0	0	CGI
val	6778	STAT6	0.475	0.808	C0086196	Eczema,Infantile	disease	C16;C17;C20	DiseaseorSyndrome	0.30	1	2004	2004	1	0	CTD_human
val	6778	STAT6	0.475	0.808	C0151603	Anasarca	phenotype	C23	PathologicFunction	0.30	1	2004	2004	1	0	CTD_human
val	6778	STAT6	0.475	0.808	C0278996	MalignantHeadandNeckNeoplasm	disease	C04	NeoplasticProcess	0.30	1	2011	2011	1	0	CTD_human
val	6778	STAT6	0.475	0.808	C0746787	CancerofNeck	disease	C04	NeoplasticProcess	0.30	1	2011	2011	1	0	CTD_human
val	6778	STAT6	0.475	0.808	C0751177	CancerofHead	disease	C04	NeoplasticProcess	0.30	1	2011	2011	1	0	CTD_human
val	6778	STAT6	0.475	0.808	C0887900	UpperAerodigestiveTractNeoplasms	group	C04	NeoplasticProcess	0.30	1	2011	2011	1	0	CTD_human
val	6778	STAT6	0.475	0.808	C1266119	Solitaryfibroustumor	disease	C04	NeoplasticProcess	0.60	0.961	2013	2020	2	0	CTD_human;ORPHANET
val	6778	STAT6	0.475	0.808	C4721507	Alveolitis,Fibrosing	disease	C08	DiseaseorSyndrome	0.30	1	2016	2016	1	0	CTD_human
val	6779	STATH	0.608	0.769	C0004352	AutisticDisorder	disease	F03	MentalorBehavioralDysfunction	0.30	1	2008	2008	1	0	CTD_human
val	6783	SULT1E1	0.508	0.808	C0019187	Hepatitis,Alcoholic	disease	C06;C25	DiseaseorSyndrome	0.30	1	2016	2016	1	0	CTD_human
val	6783	SULT1E1	0.508	0.808	C0019193	Hepatitis,Toxic	disease	C06;C25	InjuryorPoisoning	0.30	1	2014	2014	1	0	CTD_human
val	6783	SULT1E1	0.508	0.808	C0023893	LiverCirrhosis,Experimental	disease	C23;C06	ExperimentalModelofDisease	0.30	1	2006	2006	1	0	CTD_human
val	6783	SULT1E1	0.508	0.808	C0023895	Liverdiseases	group	C06	DiseaseorSyndrome	0.30	1	2015	2015	1	0	CTD_human
val	6783	SULT1E1	0.508	0.808	C0033578	ProstaticNeoplasms	group	C04;C12	NeoplasticProcess	0.31	1	2000	2007	1	0	CTD_human
val	6783	SULT1E1	0.508	0.808	C0035126	ReperfusionInjury	disease	C23;C14	InjuryorPoisoning	0.50	1	2006	2015	1	0	CTD_human
val	6783	SULT1E1	0.508	0.808	C0086565	LiverDysfunction	phenotype	C06	Finding	0.30	1	2015	2015	1	0	CTD_human
val	6783	SULT1E1	0.508	0.808	C0376358	Malignantneoplasmofprostate	disease	C04;C12	NeoplasticProcess	0.35	1	2006	2016	1	0	CTD_human
val	6783	SULT1E1	0.508	0.808	C0524610	ChronicAlcoholicHepatitis	disease	C06;C25	DiseaseorSyndrome	0.30	1	2016	2016	1	0	CTD_human
val	6783	SULT1E1	0.508	0.808	C0860207	Drug-InducedLiverDisease	phenotype	C06;C25	DiseaseorSyndrome	0.30	1	2014	2014	1	0	CTD_human
val	6783	SULT1E1	0.508	0.808	C1262760	Hepatitis,Drug-Induced	disease	C06;C25	DiseaseorSyndrome	0.30	1	2014	2014	1	0	CTD_human
val	6783	SULT1E1	0.508	0.808	C3658290	Drug-InducedAcuteLiverInjury	disease	C06;C25	DiseaseorSyndrome	0.30	1	2014	2014	1	0	CTD_human
val	6783	SULT1E1	0.508	0.808	C4277682	ChemicalandDrugInducedLiverInjury	disease	C06;C25	DiseaseorSyndrome	0.30	1	2014	2014	1	0	CTD_human
val	6783	SULT1E1	0.508	0.808	C4279912	Chemically-InducedLiverToxicity	disease	C06;C25	DiseaseorSyndrome	0.30	1	2014	2014	1	0	CTD_human
val	6785	ELOVL4	0.601	0.577	C0015397	Disorderofeye	group	C11	DiseaseorSyndrome	0.30				0	0	GENOMICS_ENGLAND
val	6785	ELOVL4	0.601	0.577	C0271093	Stargardtsdisease	phenotype		DiseaseorSyndrome	0.54	1	2005	2012	1	0	ORPHANET
21569	6785	ELOVL4	0.601	0.577	C1838644	Stargardtdisease3	disease	C11	DiseaseorSyndrome	0.9	0.929	1998	2019	0	3	CTD_human;GENOMICS_ENGLAND
21570	6785	ELOVL4	0.601	0.577	C1851481	Erythrokeratodermiawithataxia	disease	C23;C16;C17;C10	DiseaseorSyndrome	0.73	1	2014	2019	2	3	GENOMICS_ENGLAND;ORPHANET;UNIPROT
21571	6785	ELOVL4	0.601	0.577	C1855465	STARGARDTDISEASE1(disorder)	disease		DiseaseorSyndrome	0.54	1	1999	2018	1	0	ORPHANET
21572	6785	ELOVL4	0.601	0.577	C3280856	ICHTHYOSIS,SPASTICQUADRIPLEGIA,ANDMENTALRETARDATION	disease		DiseaseorSyndrome	0.6	1	2011	2011	1	5	GENOMICS_ENGLAND;ORPHANET
21580	6786	STIM1	0.501	0.808	C0410207	TubularAggregateMyopathy	disease	C05;C10	DiseaseorSyndrome	0.7	1	2013	2020	1	4	CTD_human;ORPHANET
21585	6786	STIM1	0.501	0.808	C1861451	StormorkenSyndrome	disease	C23;C16;C11;C17;C10;F03;C15	DiseaseorSyndrome	0.8	1	2013	2020	5	5	GENOMICS_ENGLAND;ORPHANET;UNIPROT
21586	6786	STIM1	0.501	0.808	C2748557	ImmunedysfunctionwithT-cellinactivationduetocalciumentrydefect2	disease	C16;C18;C20	DiseaseorSyndrome	0.72	1	2009	2017	3	9	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
21592	6786	STIM1	0.501	0.808	C4011726	MYOPATHY,TUBULARAGGREGATE,1	disease	C05;C10	DiseaseorSyndrome	0.6	1	2013	2015	4	6	GENOMICS_ENGLAND;UNIPROT
21604	6789	STK4	0.638	0.462	C3553943	T-CELLIMMUNODEFICIENCY,RECURRENTINFECTIONS,ANDAUTOIMMUNITYWITHORWITHOUTCARDIACMALFORMATIONS	disease		DiseaseorSyndrome	0.73	1	2012	2018	2	1	CTD_human;GENOMICS_ENGLAND;ORPHANET
21636	6792	CDKL5	0.522	0.692	C0162635	AngelmanSyndrome	disease	C16;C10	DiseaseorSyndrome	0.52	1	2004	2014	1	0	CTD_human;GENOMICS_ENGLAND
21660	6792	CDKL5	0.522	0.692	C1839333	EPILEPTICENCEPHALOPATHY,EARLYINFANTILE,2	disease	C10	DiseaseorSyndrome	0.7	0.972	2003	2019	23	16	CLINGEN;CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
21674	6794	STK11	0.435	0.808	C0009402	ColorectalCarcinoma	disease	C06;C04	NeoplasticProcess	0.6	1	1998	2019	0	5	GENOMICS_ENGLAND;UNIPROT
21677	6794	STK11	0.435	0.808	C0025202	melanoma	disease	C04	NeoplasticProcess	0.7	1	1999	2018	0	4	CGI;UNIPROT
21679	6794	STK11	0.435	0.808	C0030297	PancreaticNeoplasm	disease	C06;C04;C19	NeoplasticProcess	0.61	1	2004	2015	1	1	CGI;CTD_human
21680	6794	STK11	0.435	0.808	C0031269	Peutz-JeghersSyndrome	disease	C16;C06;C04;C17	DiseaseorSyndrome	1	0.992	1997	2019	19	75	CLINGEN;CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
21684	6794	STK11	0.435	0.808	C0152013	Adenocarcinomaoflung(disorder)	disease	C04	NeoplasticProcess	0.7	1	2002	2019	1	2	CGI;CTD_human
21693	6794	STK11	0.435	0.808	C0242379	Malignantneoplasmoflung	disease	C04;C08	NeoplasticProcess	0.6	1	2003	2020	1	1	CTD_human;UNIPROT
21697	6794	STK11	0.435	0.808	C0346647	Malignantneoplasmofpancreas	disease	C06;C04;C19	NeoplasticProcess	0.6	1	1999	2019	1	0	CGI;CTD_human
21704	6794	STK11	0.435	0.808	C1140680	Malignantneoplasmofovary	disease	C04;C13;C19	NeoplasticProcess	0.55	1	1999	2015	0	1	CGI;UNIPROT
21712	6795	AURKC	0.736	0.308	C0403812	MaleInfertilitywithLarge-Headed,Multiflagellar,PolyploidSpermatozoa	disease	C12	DiseaseorSyndrome	0.6	1	2007	2011	2	3	CTD_human;ORPHANET
21720	6809	STX3	0.769	0.423	C0341306	Microvillusinclusiondisease	disease	C16;C06;C18;C05;C10	DiseaseorSyndrome	0.53	1	2014	2020	2	0	GENOMICS_ENGLAND;ORPHANET
21737	6812	STXBP1	0.532	0.692	C0751122	InfantileSevereMyoclonicEpilepsy	disease	C10	DiseaseorSyndrome	0.53	1	2008	2018	2	0	CTD_human;ORPHANET
21740	6812	STXBP1	0.532	0.692	C2677326	EpilepticEncephalopathy,EarlyInfantile,4	disease	C10	DiseaseorSyndrome	0.71	1	2008	2018	13	37	CTD_human;GENOMICS_ENGLAND;UNIPROT
21743	6813	STXBP2	0.686	0.5	C2751293	HEMOPHAGOCYTICLYMPHOHISTIOCYTOSIS,FAMILIAL,5	disease	C15	DiseaseorSyndrome	0.71	1	2009	2017	4	9	CTD_human;GENOMICS_ENGLAND;UNIPROT
21775	6820	SULT2B1	0.641	0.538	C4539754	ICHTHYOSIS,CONGENITAL,AUTOSOMALRECESSIVE14	disease		CongenitalAbnormality	0.6	1	2017	2017	1	6	GENOMICS_ENGLAND;UNIPROT
21778	6821	SUOX	0.638	0.615	C0268624	Sulfiteoxidasedeficiency	disease	C16;C18	DiseaseorSyndrome	0.72	1	1996	2019	8	0	CLINGEN;CTD_human;GENOMICS_ENGLAND;ORPHANET
21781	6821	SUOX	0.638	0.615	C2931746	Sulfocysteinuria	disease	C16;C18	DiseaseorSyndrome	0.75	1	1997	2020	5	15	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
21800	6833	ABCC8	0.474	0.846	C0011860	DiabetesMellitus,Non-Insulin-Dependent	disease	C18;C19	DiseaseorSyndrome	0.7	0.9	1995	2018	2	8	CTD_human;GENOMICS_ENGLAND
21801	6833	ABCC8	0.474	0.846	C0158981	Neonataldiabetesmellitus	disease	C16;C18;C19	DiseaseorSyndrome	0.7	1	2000	2019	0	10	GENOMICS_ENGLAND
21803	6833	ABCC8	0.474	0.846	C0271714	Hypoglycemia,leucine-induced	disease	C18	DiseaseorSyndrome	0.7	1	2004	2004	1	6	CTD_human;GENOMICS_ENGLAND;UNIPROT
21806	6833	ABCC8	0.474	0.846	C1832386	DiabetesMellitus,TransientNeonatal,1	disease	C16;C18;C19	DiseaseorSyndrome	0.55	1	2000	2015	3	0	ORPHANET
21807	6833	ABCC8	0.474	0.846	C1833104	DIABETESMELLITUS,PERMANENTNEONATAL	disease	C18;C19	DiseaseorSyndrome	0.8	1	2006	2018	7	26	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
21808	6833	ABCC8	0.474	0.846	C1835887	DIABETESMELLITUS,TRANSIENTNEONATAL,2(disorder)	disease	C16;C18;C19	DiseaseorSyndrome	0.9	1	2000	2006	1	10	CTD_human;GENOMICS_ENGLAND;UNIPROT
21810	6833	ABCC8	0.474	0.846	C2931832	Hyperinsulinemichypoglycemia,familial,1	disease	C16;C06;C18	DiseaseorSyndrome	0.7	1	1995	2018	21	146	CTD_human;GENOMICS_ENGLAND;UNIPROT
21819	6834	SURF1	0.578	0.654	C0023264	LeighDisease	disease	C16;C18;C10	DiseaseorSyndrome	1	0.987	1998	2018	17	23	CLINGEN;CTD_human;GENOMICS_ENGLAND;UNIPROT
21835	6834	SURF1	0.578	0.654	C4225246	SURF1-relatedCharcot-Marie-Toothdiseasetype4	disease		DiseaseorSyndrome	0.7	1	2013	2013	1	5	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
21846	6843	VAMP1	0.628	0.538	C1970107	ATAXIA,SPASTIC,1,AUTOSOMALDOMINANT	disease	C23;C16;C10	DiseaseorSyndrome	0.7	1	2012	2017	2	0	CTD_human;GENOMICS_ENGLAND;ORPHANET
21880	6853	SYN1	0.597	0.462	C1845343	Epilepsy,X-Linked,withVariableLearningDisabilitiesandBehaviorDisorders	disease	C23;C16;C10;F03	DiseaseorSyndrome	0.7	1	2004	2011	2	7	CTD_human;GENOMICS_ENGLAND;ORPHANET
21932	6855	SYP	0.481	0.808	C3275408	MENTALRETARDATION,X-LINKED96	disease		DiseaseorSyndrome	0.7	1	2009	2009	1	2	CTD_human;GENOMICS_ENGLAND;UNIPROT
21935	6857	SYT1	0.412	0.846	C4748715	BAKER-GORDONSYNDROME	disease		DiseaseorSyndrome	0.6	1	2015	2018	3	5	ORPHANET;UNIPROT
21937	6862	TBXT	0.674	0.462	C0008487	Chordoma	disease	C04	NeoplasticProcess	0.62	1	2008	2019	2	0	CTD_human;GENOMICS_ENGLAND;ORPHANET
21950	6862	TBXT	0.674	0.462	C3810343	SACRALAGENESISWITHVERTEBRALANOMALIES	disease		DiseaseorSyndrome	0.7	1	2014	2014	1	1	GENOMICS_ENGLAND;ORPHANET;UNIPROT
21974	6863	TAC1	0.424	0.923	C0021368	Inflammation	phenotype	C23	PathologicFunction	0.51	1	1996	2018	4	0	CTD_human
21978	6863	TAC1	0.424	0.923	C0030193	Pain	phenotype	C23	SignorSymptom	0.6	0.96	1993	2020	3	0	CTD_human
22032	6866	TAC3	0.604	0.731	C0271623	Hypogonadotropichypogonadism	disease	C19	DiseaseorSyndrome	0.64	1	2009	2017	1	0	CTD_human;GENOMICS_ENGLAND
22036	6866	TAC3	0.604	0.731	C3553843	HYPOGONADOTROPICHYPOGONADISM10WITHORWITHOUTANOSMIA	disease		DiseaseorSyndrome	0.7	1	2009	2013	3	3	CTD_human;GENOMICS_ENGLAND;UNIPROT
22044	6868	ADAM17	0.453	0.808	C3280501	INFLAMMATORYSKINANDBOWELDISEASE,NEONATAL,1	disease		DiseaseorSyndrome	0.6	1	2010	2012	2	1	CTD_human;GENOMICS_ENGLAND
22048	6869	TACR1	0.502	0.885	C0001973	AlcoholicIntoxication,Chronic	disease	C25;F03	MentalorBehavioralDysfunction	0.55	1	2008	2014	5	0	CTD_human;PSYGENET
22049	6869	TACR1	0.502	0.885	C0005586	BipolarDisorder	disease	F03	MentalorBehavioralDysfunction	0.52	1	2009	2014	3	0	CTD_human;PSYGENET
22076	6870	TACR3	0.553	0.769	C0001973	AlcoholicIntoxication,Chronic	disease	C25;F03	MentalorBehavioralDysfunction	0.51	1	2008	2008	1	0	CTD_human;PSYGENET
22083	6870	TACR3	0.553	0.769	C0271623	Hypogonadotropichypogonadism	disease	C19	DiseaseorSyndrome	0.83	1	2007	2016	1	0	CTD_human;GENOMICS_ENGLAND
22088	6870	TACR3	0.553	0.769	C3553844	HYPOGONADOTROPICHYPOGONADISM11WITHORWITHOUTANOSMIA	disease		DiseaseorSyndrome	0.9	1	2007	2014	3	7	CTD_human;GENOMICS_ENGLAND;UNIPROT
22092	6872	TAF1	0.581	0.808	C1839130	Dystonia3,Torsion,X-Linked	disease	C16;C10	DiseaseorSyndrome	0.8	0.962	1992	2019	3	1	CTD_human;GENOMICS_ENGLAND;ORPHANET
22094	6872	TAF1	0.581	0.808	C4225418	MENTALRETARDATION,X-LINKED,SYNDROMIC33	disease		DiseaseorSyndrome	0.7	1	2015	2015	2	7	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
22099	6873	TAF2	0.743	0.308	C3810080	MENTALRETARDATION,AUTOSOMALRECESSIVE40	disease		DiseaseorSyndrome	0.7	1	2011	2015	3	3	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
22100	6875	TAF4B	0.792	0.192	C4014449	SPERMATOGENICFAILURE13	disease		DiseaseorSyndrome	0.6	1	2014	2014	1	1	CTD_human;GENOMICS_ENGLAND
22109	6878	TAF6	0.769	0.308	C4310702	ALAZAMI-YUANSYNDROME	disease		DiseaseorSyndrome	0.7	1	2015	2015	2	2	CTD_human;GENOMICS_ENGLAND;UNIPROT
22113	6884	TAF13	0.716	0.385	C4479476	MENTALRETARDATION,AUTOSOMALRECESSIVE60	disease		MentalorBehavioralDysfunction	0.7	1	2017	2017	1	2	CTD_human;GENOMICS_ENGLAND;UNIPROT
22116	6885	MAP3K7	0.477	0.808	C0265293	Frontometaphysealdysplasia	disease	C16;C05	CongenitalAbnormality	0.61	1	2016	2016	1	0	CTD_human;GENOMICS_ENGLAND;ORPHANET
22118	6885	MAP3K7	0.477	0.808	C2931461	ForneyRobinsonPascoesyndrome	phenotype	C23;C16;C05;C10;C09;C14	DiseaseorSyndrome	0.71	1	2016	2018	2	4	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
22120	6885	MAP3K7	0.477	0.808	C4310697	FRONTOMETAPHYSEALDYSPLASIA2	disease		DiseaseorSyndrome	0.61	1	2015	2019	3	4	GENOMICS_ENGLAND;UNIPROT
22123	6886	TAL1	0.505	0.731	C1961099	PrecursorT-CellLymphoblasticLeukemia-Lymphoma	disease	C04;C20;C15	NeoplasticProcess	0.6	0.982	1990	2019	2	0	CTD_human;ORPHANET
22133	6888	TALDO1	0.608	0.654	C1291329	TransaldolaseDeficiency	disease	C16;C18	DiseaseorSyndrome	0.74	1	2001	2015	5	4	CTD_human;GENOMICS_ENGLAND;ORPHANET
22142	6890	TAP1	0.5	0.808	C1858266	BareLymphocyteSyndrome,TypeI	disease	C16;C18;C20	DiseaseorSyndrome	0.6	1	1999	1999	1	0	CTD_human;GENOMICS_ENGLAND;ORPHANET
22145	6891	TAP2	0.517	0.808	C1858266	BareLymphocyteSyndrome,TypeI	disease	C16;C18;C20	DiseaseorSyndrome	0.71	1	1994	2014	2	3	CTD_human;GENOMICS_ENGLAND;ORPHANET
22148	6892	TAPBP	0.576	0.769	C1858266	BareLymphocyteSyndrome,TypeI	disease	C16;C18;C20	DiseaseorSyndrome	0.61	1	2002	2002	1	0	CTD_human;GENOMICS_ENGLAND;ORPHANET
22158	6898	TAT	0.492	0.846	C0268487	TyrosineTransaminaseDeficiencyDisease	disease	C16;C18;C10	DiseaseorSyndrome	0.8	1	1969	2019	7	0	CLINGEN;CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
22164	6899	TBX1	0.433	0.808	C0012236	DiGeorgeSyndrome	disease	C16;C05;C19;C15;C14	DiseaseorSyndrome	1	0.988	1995	2019	6	2	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
22169	6899	TBX1	0.433	0.808	C0039685	TetralogyofFallot	disease	C16;C14	CongenitalAbnormality	0.79	0.8	1995	2019	2	1	CTD_human;GENOMICS_ENGLAND;ORPHANET
22171	6899	TBX1	0.433	0.808	C0220704	Shprintzensyndrome	disease	C16;C05;C19;C15;C14	DiseaseorSyndrome	1	0.96	1996	2019	6	2	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
22176	6899	TBX1	0.433	0.808	C0795907	CONOTRUNCALANOMALYFACESYNDROME	disease	C16;C05;C19;C15;C14	DiseaseorSyndrome	0.51	1	2003	2006	4	0	CTD_human;ORPHANET
22178	6899	TBX1	0.433	0.808	C1857586	CONOTRUNCALHEARTMALFORMATIONS(disorder)	disease	C16;C14	DiseaseorSyndrome	0.61	1	1995	1995	0	1	CTD_human;GENOMICS_ENGLAND;UNIPROT
22183	6900	CNTN2	0.581	0.692	C3809374	EPILEPSY,FAMILIALADULTMYOCLONIC,5	disease		DiseaseorSyndrome	0.6	NA	NA	NA	0	1	CTD_human;GENOMICS_ENGLAND
22185	6901	TAZ	0.477	0.808	C0574083	3-Methylglutaconicaciduriatype2	disease	C16;C18;C14	DiseaseorSyndrome	0.8	0.979	1991	2020	10	22	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
22200	6904	TBCD	0.599	0.615	C0036572	Seizures	phenotype	C23;C10	SignorSymptom	0.61	1	2016	2019	2	0	CTD_human;GENOMICS_ENGLAND
22240	6904	TBCD	0.599	0.615	C4310671	ENCEPHALOPATHY,PROGRESSIVE,EARLY-ONSET,WITHBRAINATROPHYANDTHINCORPUSCALLOSUM	disease		DiseaseorSyndrome	0.7	1	2016	2017	4	16	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
22251	6905	TBCE	0.575	0.692	C1855648	KENNY-CAFFEYSYNDROME,TYPE1	disease	C16;C05	DiseaseorSyndrome	0.72	1	2002	2016	3	2	CTD_human;GENOMICS_ENGLAND;ORPHANET
22252	6905	TBCE	0.575	0.692	C1855840	HYPOPARATHYROIDISM-RETARDATION-DYSMORPHISMSYNDROME	disease	C23;C16;C05;C10;C19;F03;F01	DiseaseorSyndrome	0.75	1	2002	2018	3	3	CTD_human;GENOMICS_ENGLAND;ORPHANET
22253	6905	TBCE	0.575	0.692	C4310667	ENCEPHALOPATHY,PROGRESSIVE,WITHAMYOTROPHYANDOPTICATROPHY	disease		DiseaseorSyndrome	0.7	1	2016	2016	1	3	CTD_human;ORPHANET;UNIPROT
22260	6908	TBP	0.552	0.846	C1846707	SPINOCEREBELLARATAXIA17	disease	C16;C10	DiseaseorSyndrome	0.9	1	2003	2019	0	0	CTD_human;GENOMICS_ENGLAND;ORPHANET
22285	6934	TCF7L2	0.485	0.846	C0009402	ColorectalCarcinoma	disease	C06;C04	NeoplasticProcess	0.7	0.925	1999	2019	2	2	CTD_human;UNIPROT
22288	6934	TCF7L2	0.485	0.846	C0011860	DiabetesMellitus,Non-Insulin-Dependent	disease	C18;C19	DiseaseorSyndrome	0.7	0.965	2006	2020	3	14	CTD_human
22312	6935	ZEB1	0.442	0.808	C0016781	FuchsEndothelialDystrophy	disease	C16;C11	DiseaseorSyndrome	0.6	0.818	2008	2019	1	0	GENOMICS_ENGLAND;ORPHANET
22329	6935	ZEB1	0.442	0.808	C2750448	CORNEALDYSTROPHY,FUCHSENDOTHELIAL,6	disease	C16;C11	DiseaseorSyndrome	0.7	1	2005	2014	4	7	CTD_human;GENOMICS_ENGLAND;UNIPROT
22335	6938	TCF12	0.565	0.654	C0221356	Brachycephaly	disease	C16;C05	CongenitalAbnormality	0.6	1	2013	2013	1	0	CTD_human;ORPHANET
22344	6938	TCF12	0.565	0.654	C3715051	CRANIOSYNOSTOSIS3	disease		DiseaseorSyndrome	0.6	1	2013	2015	3	14	GENOMICS_ENGLAND;UNIPROT
22386	6948	TCN2	0.578	0.615	C0342701	TranscobalaminIIdeficiency	disease		DiseaseorSyndrome	0.72	1	1984	2014	5	5	CTD_human;GENOMICS_ENGLAND;ORPHANET
22394	6949	TCOF1	0.55	0.808	C0242387	MandibulofacialDysostosis	disease	C16;C11;C05	DiseaseorSyndrome	1	0.966	1996	2019	5	28	CTD_human;GENOMICS_ENGLAND;UNIPROT
22426	6999	TDO2	0.599	0.654	C2931837	Familialhypertryptophanemia	disease	C16;C18	DiseaseorSyndrome	0.51	1	2017	2017	1	1	ORPHANET;UNIPROT
22452	7003	TEAD1	0.555	0.731	C1862382	SVEINSSONCHORIORETINALATROPHY	disease	C16;C11	DiseaseorSyndrome	0.73	1	2004	2019	3	1	CTD_human;ORPHANET;UNIPROT
22455	7007	TECTA	0.7	0.385	C1832187	Deafness,AutosomalDominant12	disease	C23;C10;C09	DiseaseorSyndrome	0.9	1	1999	2014	2	20	CTD_human;GENOMICS_ENGLAND;UNIPROT
22456	7007	TECTA	0.7	0.385	C1863655	Deafness,AutosomalRecessive21	disease	C23;C10;C09	DiseaseorSyndrome	0.6	1	1999	1999	1	6	CTD_human;GENOMICS_ENGLAND
22477	7010	TEK	0.462	0.692	C1838437	VENOUSMALFORMATIONS,MULTIPLECUTANEOUSANDMUCOSAL	disease	C16;C14	CongenitalAbnormality	0.73	1	1996	2017	5	3	CTD_human;GENOMICS_ENGLAND;UNIPROT
22479	7010	TEK	0.462	0.692	C4310639	GLAUCOMA3,PRIMARYCONGENITAL,E	disease		DiseaseorSyndrome	0.6	1	2016	2016	1	4	CTD_human;UNIPROT
22487	7012	TERC	0.471	0.846	C0265965	DyskeratosisCongenita	disease	C16;C17;C15	DiseaseorSyndrome	0.7	1	2001	2019	5	27	CTD_human;GENOMICS_ENGLAND
22491	7012	TERC	0.471	0.846	C1800706	IdiopathicPulmonaryFibrosis	disease	C08	DiseaseorSyndrome	0.58	1	2007	2019	4	0	CTD_human;ORPHANET
22495	7012	TERC	0.471	0.846	C3553622	PULMONARYFIBROSISAND/ORBONEMARROWFAILURE,TELOMERE-RELATED,2	disease		DiseaseorSyndrome	0.6	1	2002	2018	3	9	CTD_human;GENOMICS_ENGLAND
22501	7015	TERT	0.374	0.846	C0002874	AplasticAnemia	disease	C15	DiseaseorSyndrome	0.79	1	2005	2013	6	0	CTD_human;GENOMICS_ENGLAND;UNIPROT
22513	7015	TERT	0.374	0.846	C0023467	Leukemia,Myelocytic,Acute	disease	C04	NeoplasticProcess	0.7	1	2003	2018	3	0	CTD_human;GENOMICS_ENGLAND
22515	7015	TERT	0.374	0.846	C0023903	Liverneoplasms	group	C06;C04	NeoplasticProcess	0.55	1	2006	2016	1	0	CTD_human
22519	7015	TERT	0.374	0.846	C0025202	melanoma	disease	C04	NeoplasticProcess	0.7	1	2001	2019	2	0	CTD_human;GENOMICS_ENGLAND
22538	7015	TERT	0.374	0.846	C0265965	DyskeratosisCongenita	disease	C16;C17;C15	DiseaseorSyndrome	0.6	1	2005	2019	5	0	CTD_human;GENOMICS_ENGLAND
22540	7015	TERT	0.374	0.846	C0345904	Malignantneoplasmofliver	disease	C06;C04	NeoplasticProcess	0.56	1	2007	2018	1	0	CTD_human
22556	7015	TERT	0.374	0.846	C1800706	IdiopathicPulmonaryFibrosis	disease	C08	DiseaseorSyndrome	0.6	1	2007	2019	5	0	CTD_human;ORPHANET
22557	7015	TERT	0.374	0.846	C1846142	HOYERAAL-HREIDARSSONSYNDROME	disease	C23;C16;C13;C17;C05;C10;F03;C15;F01	DiseaseorSyndrome	0.62	1	2007	2013	2	0	CTD_human;GENOMICS_ENGLAND;ORPHANET
22560	7015	TERT	0.374	0.846	C1956346	CoronaryArteryDisease	disease	C14	DiseaseorSyndrome	0.52	1	2005	2019	3	0	CTD_human;GENOMICS_ENGLAND
22561	7015	TERT	0.374	0.846	C2239176	Livercarcinoma	disease	C06;C04	NeoplasticProcess	0.6	0.977	1998	2019	4	0	CTD_human
22563	7015	TERT	0.374	0.846	C3151443	DYSKERATOSISCONGENITA,AUTOSOMALDOMINANT2	disease		DiseaseorSyndrome	0.6	1	2005	2016	11	0	CTD_human;GENOMICS_ENGLAND;UNIPROT
22565	7015	TERT	0.374	0.846	C3553617	PULMONARYFIBROSISAND/ORBONEMARROWFAILURE,TELOMERE-RELATED,1	disease		DiseaseorSyndrome	0.6	1	2005	2016	8	0	CTD_human;GENOMICS_ENGLAND;UNIPROT
22601	7036	TFR2	0.585	0.615	C1858664	HEMOCHROMATOSIS,TYPE3	disease	C16;C18	DiseaseorSyndrome	1	1	2001	2019	6	15	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
22604	7037	TFRC	0.437	0.885	C0002875	Cooleysanemia	disease	C16;C15	DiseaseorSyndrome	0.30	1	2006	2006	1	0	CTD_human
val	7037	TFRC	0.437	0.885	C0003756	ArenaviridaeInfections	group	C01	DiseaseorSyndrome	0.30	1	2007	2007	1	0	CTD_human
val	7037	TFRC	0.437	0.885	C0005283	betaThalassemia	disease	C16;C15	DiseaseorSyndrome	0.35	1	1990	2018	1	0	CTD_human
val	7037	TFRC	0.437	0.885	C0005684	Malignantneoplasmofurinarybladder	disease	C04;C13;C12	NeoplasticProcess	0.31	1	2006	2019	1	0	CTD_human
val	7037	TFRC	0.437	0.885	C0005695	BladderNeoplasm	disease	C04;C13;C12	NeoplasticProcess	0.31	1	2006	2019	1	0	CTD_human
val	7037	TFRC	0.437	0.885	C0006142	Malignantneoplasmofbreast	disease	C04;C17	NeoplasticProcess	0.40	1	1999	2019	2	0	CTD_human
val	7037	TFRC	0.437	0.885	C0007621	NeoplasticCellTransformation	phenotype	C23;C04	NeoplasticProcess	0.30	1	2011	2011	1	0	CTD_human
val	7037	TFRC	0.437	0.885	C0009402	ColorectalCarcinoma	disease	C06;C04	NeoplasticProcess	0.34	1	2000	2019	1	0	CTD_human
val	7037	TFRC	0.437	0.885	C0009404	ColorectalNeoplasms	group	C06;C04	NeoplasticProcess	0.30	1	2006	2006	1	0	CTD_human
val	7037	TFRC	0.437	0.885	C0012715	IronMetabolismDisorders	group	C18	DiseaseorSyndrome	0.30	1	2006	2007	2	0	CTD_human
val	7037	TFRC	0.437	0.885	C0017638	Glioma	disease	C04	NeoplasticProcess	0.35	1	1993	2018	1	0	CTD_human
val	7037	TFRC	0.437	0.885	C0019025	HemoglobinFDisease	disease	C16;C15	DiseaseorSyndrome	0.30	1	2006	2006	1	0	CTD_human
val	7037	TFRC	0.437	0.885	C0021368	Inflammation	phenotype	C23	PathologicFunction	0.30	1	2006	2006	1	0	CTD_human
val	7037	TFRC	0.437	0.885	C0023434	ChronicLymphocyticLeukemia	disease	C04;C20;C15	NeoplasticProcess	0.33	1	2006	2008	1	0	CTD_human
val	7037	TFRC	0.437	0.885	C0024121	LungNeoplasms	group	C04;C08	NeoplasticProcess	0.31	1	2005	2006	1	0	CTD_human
val	7037	TFRC	0.437	0.885	C0024302	Reticulosarcoma	disease	C04;C20;C15	NeoplasticProcess	0.30	1	2006	2006	1	0	CTD_human
val	7037	TFRC	0.437	0.885	C0024304	Lymphoma,Mixed-Cell	disease	C04;C20;C15	NeoplasticProcess	0.30	1	2006	2006	1	0	CTD_human
val	7037	TFRC	0.437	0.885	C0024305	Lymphoma,Non-Hodgkin	disease	C04;C20;C15	NeoplasticProcess	0.31	1	1994	2006	1	0	CTD_human
val	7037	TFRC	0.437	0.885	C0024306	Lymphoma,Undifferentiated	disease	C04;C20;C15	NeoplasticProcess	0.30	1	2006	2006	1	0	CTD_human
val	7037	TFRC	0.437	0.885	C0027055	MyocardialReperfusionInjury	phenotype	C23;C14	PathologicFunction	0.30	1	2008	2008	1	0	CTD_human
val	7037	TFRC	0.437	0.885	C0028754	Obesity	disease	C23;C18	DiseaseorSyndrome	0.31	1	2006	2019	2	0	CTD_human
val	7037	TFRC	0.437	0.885	C0032460	PolycysticOvarySyndrome	disease	C04;C13;C19	DiseaseorSyndrome	0.31	1	2011	2012	1	0	CTD_human
val	7037	TFRC	0.437	0.885	C0079487	HelicobacterInfections	group	C01	DiseaseorSyndrome	0.30	1	2006	2006	2	0	CTD_human
val	7037	TFRC	0.437	0.885	C0079740	HighGradeLymphoma(neoplasm)	disease	C04;C20;C15	NeoplasticProcess	0.30	1	2006	2006	1	0	CTD_human
val	7037	TFRC	0.437	0.885	C0079741	Lymphoma,Intermediate-Grade	disease	C04;C20;C15	NeoplasticProcess	0.30	1	2006	2006	1	0	CTD_human
val	7037	TFRC	0.437	0.885	C0079747	LowGradeLymphoma(neoplasm)	disease	C04;C20;C15	NeoplasticProcess	0.30	1	2006	2006	1	0	CTD_human
val	7037	TFRC	0.437	0.885	C0079757	DiffuseMixed-CellLymphoma	disease	C04;C20;C15	NeoplasticProcess	0.30	1	2006	2006	1	0	CTD_human
val	7037	TFRC	0.437	0.885	C0079770	Lymphoma,SmallNoncleaved-Cell	disease	C04;C20;C15	NeoplasticProcess	0.30	1	2006	2006	1	0	CTD_human
val	7037	TFRC	0.437	0.885	C0085110	SevereCombinedImmunodeficiency	disease	C16;C18;C20	DiseaseorSyndrome	0.30	1	2016	2016	1	0	CTD_human
val	7037	TFRC	0.437	0.885	C0085578	ThalassemiaMinor	disease	C16;C15	DiseaseorSyndrome	0.30	1	2006	2006	1	0	CTD_human
val	7037	TFRC	0.437	0.885	C0151744	MyocardialIschemia	disease	C14	DiseaseorSyndrome	0.30	1	2005	2005	1	0	CTD_human
val	7037	TFRC	0.437	0.885	C0162316	Irondeficiencyanemia	disease	C18;C15	DiseaseorSyndrome	0.40	0.923	1990	2019	3	0	CTD_human
val	7037	TFRC	0.437	0.885	C0205671	Infections,Arenavirus	group	C01	DiseaseorSyndrome	0.30	1	2007	2007	1	0	CTD_human
val	7037	TFRC	0.437	0.885	C0242379	Malignantneoplasmoflung	disease	C04;C08	NeoplasticProcess	0.34	1	2005	2019	1	0	CTD_human
val	7037	TFRC	0.437	0.885	C0242583	BareLymphocyteSyndrome	disease	C16;C18;C20	DiseaseorSyndrome	0.30	1	2016	2016	1	0	CTD_human
val	7037	TFRC	0.437	0.885	C0259783	mixedgliomas	disease	C04	NeoplasticProcess	0.30	1	2006	2006	1	0	CTD_human
val	7037	TFRC	0.437	0.885	C0271979	ThalassemiaIntermedia	disease	C16;C15	DiseaseorSyndrome	0.33	1	1997	2007	1	0	CTD_human
val	7037	TFRC	0.437	0.885	C0494261	Combinedimmunodeficiency	disease	C16;C18;C20	DiseaseorSyndrome	0.40	1	2016	2016	1	1	GENOMICS_ENGLAND
val	7037	TFRC	0.437	0.885	C0555198	MalignantGlioma	disease	C04	NeoplasticProcess	0.30	1	2006	2006	1	0	CTD_human
val	7037	TFRC	0.437	0.885	C0678222	BreastCarcinoma	disease	C04;C17	NeoplasticProcess	0.40	1	1999	2019	2	0	CTD_human
val	7037	TFRC	0.437	0.885	C1136382	SclerocysticOvaries	disease	C04;C13;C19	DiseaseorSyndrome	0.30	1	2011	2011	1	0	CTD_human
val	7037	TFRC	0.437	0.885	C1257931	MammaryNeoplasms,Human	disease	C04;C17	NeoplasticProcess	0.30	1	2006	2010	2	0	CTD_human
val	7037	TFRC	0.437	0.885	C1458155	MammaryNeoplasms	group	C04;C17	NeoplasticProcess	0.31	1	2006	2015	2	0	CTD_human
val	7037	TFRC	0.437	0.885	C2700553	OmennSyndrome	disease	C16;C18;C20	DiseaseorSyndrome	0.30	1	2016	2016	1	0	CTD_human
val	7037	TFRC	0.437	0.885	C3714542	Lymphoma,Diffuse	disease	C04;C20;C15	NeoplasticProcess	0.30	1	2006	2006	1	0	CTD_human
val	7037	TFRC	0.437	0.885	C3830362	EarlyPregnancyLoss	phenotype	C13	Finding	0.30	1	2008	2008	1	0	CTD_human
val	7037	TFRC	0.437	0.885	C4225219	IMMUNODEFICIENCY46	disease		DiseaseorSyndrome	0.70	1	2016	2016	1	2	CTD_human;ORPHANET;UNIPROT
val	7037	TFRC	0.437	0.885	C4552766	Miscarriage	disease	C13	DiseaseorSyndrome	0.30	1	2008	2008	1	0	CTD_human
val	7037	TFRC	0.437	0.885	C4704874	MammaryCarcinoma,Human	disease	C04;C17	NeoplasticProcess	0.30	1	2006	2010	2	0	CTD_human
val	7037	TFRC	0.437	0.885	C4721532	Lymphoma,Non-Hodgkin,Familial	disease	C04;C20;C15	NeoplasticProcess	0.31	1	1994	2006	1	0	CTD_human
val	7038	TG	0.48	0.808	C0003469	AnxietyDisorders	group	F03	MentalorBehavioralDysfunction	0.30	1	2018	2018	1	0	CTD_human
val	7038	TG	0.48	0.808	C0004364	AutoimmuneDiseases	group	C20	DiseaseorSyndrome	0.50	1	1994	2019	1	1	CTD_human
val	7038	TG	0.48	0.808	C0010308	CongenitalHypothyroidism	disease	C16;C05;C19	DiseaseorSyndrome	0.60	1	1986	2019	1	0	GENOMICS_ENGLAND
val	7038	TG	0.48	0.808	C0011573	Endogenousdepression	disease	F03	MentalorBehavioralDysfunction	0.30	1	2018	2018	1	0	CTD_human
val	7038	TG	0.48	0.808	C0011581	Depressivedisorder	disease	F03	MentalorBehavioralDysfunction	0.30	1	2018	2018	1	0	CTD_human
val	7038	TG	0.48	0.808	C0013336	Dwarfism	disease	C16;C05;C19	CongenitalAbnormality	0.41	1	2004	2014	1	0	CTD_human
val	7038	TG	0.48	0.808	C0018021	Goiter	phenotype	C19	DiseaseorSyndrome	0.50	0.944	1987	2019	2	0	CTD_human
val	7038	TG	0.48	0.808	C0025193	Melancholia	disease	F03	MentalorBehavioralDysfunction	0.30	1	2018	2018	1	0	CTD_human
val	7038	TG	0.48	0.808	C0041696	UnipolarDepression	disease	F03	MentalorBehavioralDysfunction	0.30	1	2018	2018	1	0	CTD_human
val	7038	TG	0.48	0.808	C0086133	DepressiveSyndrome	disease	F03	MentalorBehavioralDysfunction	0.30	1	2018	2018	1	0	CTD_human
val	7038	TG	0.48	0.808	C0282126	Depression,Neurotic	disease	F03	MentalorBehavioralDysfunction	0.30	1	2018	2018	1	0	CTD_human
val	7038	TG	0.48	0.808	C0342194	ThyroidDyshormonogenesis3	disease	C19	DiseaseorSyndrome	0.70	1	1999	2017	8	16	CTD_human;GENOMICS_ENGLAND;UNIPROT
val	7038	TG	0.48	0.808	C0376280	AnxietyStates,Neurotic	disease	F03	MentalorBehavioralDysfunction	0.30	1	2018	2018	1	0	CTD_human
val	7038	TG	0.48	0.808	C0677607	HashimotoDisease	disease	C19	DiseaseorSyndrome	0.60	0.962	1979	2019	1	0	CTD_human
val	7038	TG	0.48	0.808	C0920350	Autoimmunethyroiditis	disease	C20;C19	DiseaseorSyndrome	0.40	0.895	1994	2019	1	0	CTD_human
val	7038	TG	0.48	0.808	C1279420	Anxietyneurosis(finding)	disease	F03	MentalorBehavioralDysfunction	0.30	1	2018	2018	1	0	CTD_human
val	7038	TG	0.48	0.808	C1848805	ThyroidDyshormonogenesis1	disease	C16;C05;C19	DiseaseorSyndrome	0.30	1	2010	2011	2	0	ORPHANET
val	7039	TGFA	0.432	0.885	C0007131	Non-SmallCellLungCarcinoma	disease	C04;C08	NeoplasticProcess	0.40	0.917	1993	2017	1	0	CTD_human
val	7039	TGFA	0.432	0.885	C0018671	HeadandNeckNeoplasms	group	C04	NeoplasticProcess	0.30	1	2004	2004	1	0	CTD_human
val	7039	TGFA	0.432	0.885	C0018675	HeadNeoplasms	group	C04	NeoplasticProcess	0.30	1	2004	2004	1	0	CTD_human
val	7039	TGFA	0.432	0.885	C0019207	Hepatoma,Morris	disease	C06;C04	NeoplasticProcess;ExperimentalModelofDisease	0.30	1	1997	1997	1	0	CTD_human
val	7039	TGFA	0.432	0.885	C0019208	Hepatoma,Novikoff	disease	C06;C04	NeoplasticProcess;ExperimentalModelofDisease	0.30	1	1997	1997	1	0	CTD_human
val	7039	TGFA	0.432	0.885	C0020542	PulmonaryHypertension	phenotype	C08	PathologicFunction	0.31	1	2003	2008	1	0	CTD_human
val	7039	TGFA	0.432	0.885	C0020608	Hypodontia	disease	C16;C07	CongenitalAbnormality	0.40				0	0	ORPHANET
val	7039	TGFA	0.432	0.885	C0021368	Inflammation	phenotype	C23	PathologicFunction	0.30	1	2002	2002	1	0	CTD_human
val	7039	TGFA	0.432	0.885	C0023903	Liverneoplasms	group	C06;C04	NeoplasticProcess	0.53	1	1995	2001	1	0	CTD_human
val	7039	TGFA	0.432	0.885	C0023904	LiverNeoplasms,Experimental	phenotype	C06;C04	NeoplasticProcess;ExperimentalModelofDisease	0.50	1	1997	2006	1	0	CTD_human
val	7039	TGFA	0.432	0.885	C0024623	Malignantneoplasmofstomach	disease	C06;C04	NeoplasticProcess	0.35	1	1991	2014	1	0	CTD_human
val	7039	TGFA	0.432	0.885	C0024667	AnimalMammaryNeoplasms	phenotype	C04;C22	NeoplasticProcess	0.30	1	1995	1995	1	0	CTD_human
val	7039	TGFA	0.432	0.885	C0024668	MammaryNeoplasms,Experimental	phenotype	C04	NeoplasticProcess;ExperimentalModelofDisease	0.30	1	1995	1995	1	0	CTD_human
val	7039	TGFA	0.432	0.885	C0027533	NeckNeoplasms	group	C04	NeoplasticProcess	0.30	1	2004	2004	1	0	CTD_human
val	7039	TGFA	0.432	0.885	C0027746	NerveDegeneration	phenotype	C23	CellorMolecularDysfunction	0.30	1	1997	1997	1	0	CTD_human
val	7039	TGFA	0.432	0.885	C0030246	PustulosisofPalmsandSoles	disease	C17	DiseaseorSyndrome	0.30	1	1994	1994	1	0	CTD_human
val	7039	TGFA	0.432	0.885	C0030354	Papilloma	disease	C04	NeoplasticProcess	0.32	1	1991	1999	1	0	CTD_human
val	7039	TGFA	0.432	0.885	C0033578	ProstaticNeoplasms	group	C04;C12	NeoplasticProcess	0.32	1	2006	2011	1	0	CTD_human
val	7039	TGFA	0.432	0.885	C0033860	Psoriasis	disease	C17	DiseaseorSyndrome	0.37	1	1990	1997	1	0	CTD_human
val	7039	TGFA	0.432	0.885	C0034063	PulmonaryEdema	phenotype	C08	PathologicFunction	0.30	1	2002	2002	1	0	CTD_human
val	7039	TGFA	0.432	0.885	C0034069	PulmonaryFibrosis	disease	C08	DiseaseorSyndrome	0.38	1	1996	2019	1	0	CTD_human
val	7039	TGFA	0.432	0.885	C0038356	StomachNeoplasms	group	C06;C04	NeoplasticProcess	0.30	1	2005	2005	1	0	CTD_human
val	7039	TGFA	0.432	0.885	C0086404	ExperimentalHepatoma	disease	C06;C04	NeoplasticProcess;ExperimentalModelofDisease	0.30	1	1997	1997	1	0	CTD_human
val	7039	TGFA	0.432	0.885	C0162770	RightVentricularHypertrophy	disease	C23;C14	DiseaseorSyndrome	0.30	1	2008	2008	1	0	CTD_human
val	7039	TGFA	0.432	0.885	C0205874	Papilloma,SquamousCell	disease	C04	NeoplasticProcess	0.30	1	1995	1995	1	0	CTD_human
val	7039	TGFA	0.432	0.885	C0205875	Papillomatosis	disease	C04	NeoplasticProcess	0.30	1	1995	1995	1	0	CTD_human
val	7039	TGFA	0.432	0.885	C0206624	Hepatoblastoma	disease	C04	NeoplasticProcess	0.51	1	1992	2002	1	0	CTD_human
val	7039	TGFA	0.432	0.885	C0273115	LungInjury	disease	C08;C26	InjuryorPoisoning	0.30	1	2002	2002	1	0	CTD_human
val	7039	TGFA	0.432	0.885	C0278996	MalignantHeadandNeckNeoplasm	disease	C04	NeoplasticProcess	0.33	1	1992	2009	1	0	CTD_human
val	7039	TGFA	0.432	0.885	C0333355	Inflammatorydiseaseofmucousmembrane	group	C06;C07	PathologicFunction	0.30	1	2008	2008	1	0	CTD_human
val	7039	TGFA	0.432	0.885	C0345904	Malignantneoplasmofliver	disease	C06;C04	NeoplasticProcess	0.55	1	1996	2014	1	0	CTD_human
val	7039	TGFA	0.432	0.885	C0376358	Malignantneoplasmofprostate	disease	C04;C12	NeoplasticProcess	0.38	1	1996	2014	1	0	CTD_human
val	7039	TGFA	0.432	0.885	C0746787	CancerofNeck	disease	C04	NeoplasticProcess	0.30	1	2004	2004	1	0	CTD_human
val	7039	TGFA	0.432	0.885	C0751177	CancerofHead	disease	C04	NeoplasticProcess	0.30	1	2004	2004	1	0	CTD_human
val	7039	TGFA	0.432	0.885	C0887900	UpperAerodigestiveTractNeoplasms	group	C04	NeoplasticProcess	0.30	1	2004	2004	1	0	CTD_human
val	7039	TGFA	0.432	0.885	C1257925	MammaryCarcinoma,Animal	disease	C04;C22	NeoplasticProcess	0.30	1	1995	1995	1	0	CTD_human
val	7039	TGFA	0.432	0.885	C1708349	HereditaryDiffuseGastricCancer	disease	C06;C04	NeoplasticProcess	0.30	1	2005	2005	1	0	CTD_human
val	7039	TGFA	0.432	0.885	C2239176	Livercarcinoma	disease	C06;C04	NeoplasticProcess	0.60	1	1992	2016	2	0	CTD_human
val	7039	TGFA	0.432	0.885	C2350344	ChronicLungInjury	disease	C08;C26	DiseaseorSyndrome	0.30	1	2002	2002	1	0	CTD_human
val	7039	TGFA	0.432	0.885	C3711374	NonsyndromicDeafness	disease	C23;C10;C09	DiseaseorSyndrome	0.30	1	2016	2016	1	0	CTD_human
val	7039	TGFA	0.432	0.885	C4082304	Oligodontia	disease		CongenitalAbnormality	0.40				0	0	ORPHANET
val	7039	TGFA	0.432	0.885	C4721507	Alveolitis,Fibrosing	disease	C08	DiseaseorSyndrome	0.30	1	2008	2008	1	0	CTD_human
val	7040	TGFB1	0.287	0.962	C0000786	Spontaneousabortion	phenotype	C13	PathologicFunction	0.30	1	2008	2008	1	0	CTD_human
val	7040	TGFB1	0.287	0.962	C0000822	Abortion,Tubal	phenotype	C13	PathologicFunction	0.30	1	2008	2008	1	0	CTD_human
val	7040	TGFB1	0.287	0.962	C0001418	Adenocarcinoma	group	C04	NeoplasticProcess	0.40	1	1993	2017	1	0	CTD_human
val	7040	TGFB1	0.287	0.962	C0001787	Osteoporosis,Age-Related	disease	C18;C05	DiseaseorSyndrome	0.30	1	2003	2003	1	0	CTD_human
val	7040	TGFB1	0.287	0.962	C0002152	AlloxanDiabetes	disease	C18;C19	ExperimentalModelofDisease	0.30	1	2006	2013	2	0	CTD_human
val	7040	TGFB1	0.287	0.962	C0003504	AorticValveInsufficiency	disease	C14	DiseaseorSyndrome	0.30	1	2011	2011	1	0	CTD_human
val	7040	TGFB1	0.287	0.962	C0004096	Asthma	disease	C08;C20	DiseaseorSyndrome	0.70	0.979	1996	2020	2	0	CTD_human
val	7040	TGFB1	0.287	0.962	C0005138	Berylliosis	disease	C08;C24	InjuryorPoisoning	0.31	1	2005	2007	2	0	CTD_human
val	7040	TGFB1	0.287	0.962	C0005398	Cholestasis,Extrahepatic	disease	C06	DiseaseorSyndrome	0.30	1	2017	2018	2	0	CTD_human
val	7040	TGFB1	0.287	0.962	C0005586	BipolarDisorder	disease	F03	MentalorBehavioralDysfunction	0.31	1	2001	2001	1	0	PSYGENET
val	7040	TGFB1	0.287	0.962	C0006111	BrainDiseases	group	C10	DiseaseorSyndrome	0.31	1	1993	2018	1	0	CTD_human
val	7040	TGFB1	0.287	0.962	C0006663	Calcinosis	phenotype	C18	PathologicFunction	0.30	1	2014	2014	1	0	CTD_human
val	7040	TGFB1	0.287	0.962	C0007097	Carcinoma	group	C04	NeoplasticProcess	0.40	1	1990	2019	1	0	CTD_human
val	7040	TGFB1	0.287	0.962	C0007114	Malignantneoplasmofskin	disease	C04;C17	NeoplasticProcess	0.31	1	1994	2005	1	0	CTD_human
val	7040	TGFB1	0.287	0.962	C0007137	Squamouscellcarcinoma	disease	C04	NeoplasticProcess	0.40	1	1994	2018	1	0	CTD_human
val	7040	TGFB1	0.287	0.962	C0007140	Carcinosarcoma	disease	C04	NeoplasticProcess	0.30	1	2004	2004	1	0	CTD_human
val	7040	TGFB1	0.287	0.962	C0007621	NeoplasticCellTransformation	phenotype	C23;C04	NeoplasticProcess	0.30	1	2010	2010	1	0	CTD_human
val	7040	TGFB1	0.287	0.962	C0008312	Primarybiliarycirrhosis	disease	C23;C06	DiseaseorSyndrome	0.32	0.667	2007	2018	1	0	CTD_human
val	7040	TGFB1	0.287	0.962	C0008925	CleftPalate	disease	C16;C05;C07	CongenitalAbnormality	0.31	1	2014	2016	1	0	CTD_human
val	7040	TGFB1	0.287	0.962	C0009402	ColorectalCarcinoma	disease	C06;C04	NeoplasticProcess	0.50	0.971	1995	2020	1	1	CTD_human
val	7040	TGFB1	0.287	0.962	C0009404	ColorectalNeoplasms	group	C06;C04	NeoplasticProcess	0.40	1	1999	2014	1	0	CTD_human
val	7040	TGFB1	0.287	0.962	C0010474	CurlingUlcer	disease	C06	DiseaseorSyndrome	0.30	1	2003	2003	1	0	CTD_human
val	7040	TGFB1	0.287	0.962	C0010674	CysticFibrosis	disease	C16;C06;C08	DiseaseorSyndrome	0.70	0.952	2000	2019	1	0	CTD_human;GENOMICS_ENGLAND;ORPHANET
val	7040	TGFB1	0.287	0.962	C0011581	Depressivedisorder	disease	F03	MentalorBehavioralDysfunction	0.34	1	2012	2018	1	0	PSYGENET
val	7040	TGFB1	0.287	0.962	C0011853	DiabetesMellitus,Experimental	disease	C18;C19	ExperimentalModelofDisease	0.50	1	2005	2013	2	0	CTD_human
val	7040	TGFB1	0.287	0.962	C0011860	DiabetesMellitus,Non-Insulin-Dependent	disease	C18;C19	DiseaseorSyndrome	0.70	1	2002	2020	1	1	CTD_human
val	7040	TGFB1	0.287	0.962	C0011881	DiabeticNephropathy	disease	C13;C12;C19	DiseaseorSyndrome	0.60	0.99	1996	2019	2	0	CTD_human
val	7040	TGFB1	0.287	0.962	C0011882	DiabeticNeuropathies	group	C10;C19	DiseaseorSyndrome	0.50	1	2005	2008	1	0	CTD_human
val	7040	TGFB1	0.287	0.962	C0011989	Camurati-EngelmannSyndrome	disease	C16;C05	DiseaseorSyndrome	0.80	1	2000	2019	5	9	CTD_human;GENOMICS_ENGLAND;UNIPROT
val	7040	TGFB1	0.287	0.962	C0013238	DryEyeSyndromes	disease	C11	DiseaseorSyndrome	0.30	1	2011	2011	1	0	CTD_human
val	7040	TGFB1	0.287	0.962	C0013264	MuscularDystrophy,Duchenne	disease	C16;C05;C10	DiseaseorSyndrome	0.40	0.917	1995	2019	1	0	CTD_human
val	7040	TGFB1	0.287	0.962	C0013295	DuodenalUlcer	disease	C06	DiseaseorSyndrome	0.32	1	2003	2007	1	0	CTD_human
val	7040	TGFB1	0.287	0.962	C0014544	Epilepsy	disease	C10	DiseaseorSyndrome	0.33	1	2017	2018	1	0	CTD_human
val	7040	TGFB1	0.287	0.962	C0016059	Fibrosis	phenotype	C23	PathologicFunction	0.60	1	1999	2019	8	0	CTD_human
val	7040	TGFB1	0.287	0.962	C0017661	IGAGlomerulonephritis	disease	C13;C12;C20	DiseaseorSyndrome	0.40	0.833	1993	2019	1	0	CTD_human
val	7040	TGFB1	0.287	0.962	C0017667	Nodularglomerulosclerosis	disease	C13;C12;C19	DiseaseorSyndrome	0.30	1	2009	2010	2	0	CTD_human
val	7040	TGFB1	0.287	0.962	C0017668	Focalglomerulosclerosis	disease	C13;C12	DiseaseorSyndrome	0.36	1	1997	2011	3	0	CTD_human
val	7040	TGFB1	0.287	0.962	C0019189	Hepatitis,Chronic	disease	C06	DiseaseorSyndrome	0.34	1	1991	2012	1	0	CTD_human
val	7040	TGFB1	0.287	0.962	C0019207	Hepatoma,Morris	disease	C06;C04	NeoplasticProcess;ExperimentalModelofDisease	0.30	1	2017	2017	1	0	CTD_human
val	7040	TGFB1	0.287	0.962	C0019208	Hepatoma,Novikoff	disease	C06;C04	NeoplasticProcess;ExperimentalModelofDisease	0.30	1	2017	2017	1	0	CTD_human
val	7040	TGFB1	0.287	0.962	C0019209	Hepatomegaly	phenotype	C23;C06	Finding	0.40	1	2018	2018	1	0	CTD_human
val	7040	TGFB1	0.287	0.962	C0019284	DiaphragmaticHernia	phenotype	C23	DiseaseorSyndrome	0.50	1	2000	2009	1	0	CTD_human
val	7040	TGFB1	0.287	0.962	C0020507	Hyperplasia	phenotype	C23	PathologicFunction	0.32	1	2003	2010	1	0	CTD_human
val	7040	TGFB1	0.287	0.962	C0020517	Hypersensitivity	group	C20	PathologicFunction	0.30	1	2008	2011	2	0	CTD_human
val	7040	TGFB1	0.287	0.962	C0020538	Hypertensivedisease	group	C14	DiseaseorSyndrome	0.60	1	1996	2020	2	0	CTD_human
val	7040	TGFB1	0.287	0.962	C0021290	Neonataldisorder	group	C16	DiseaseorSyndrome	0.30	1	2018	2018	1	0	CTD_human
val	7040	TGFB1	0.287	0.962	C0021368	Inflammation	phenotype	C23	PathologicFunction	0.38	1	2002	2010	2	0	CTD_human
val	7040	TGFB1	0.287	0.962	C0021390	InflammatoryBowelDiseases	group	C06	DiseaseorSyndrome	0.40	1	2001	2020	1	0	CTD_human
val	7040	TGFB1	0.287	0.962	C0022658	KidneyDiseases	group	C13;C12	DiseaseorSyndrome	0.40	0.974	2001	2019	3	0	CTD_human
val	7040	TGFB1	0.287	0.962	C0022660	KidneyFailure,Acute	disease	C13;C12	DiseaseorSyndrome	0.33	1	1999	2019	1	0	CTD_human
val	7040	TGFB1	0.287	0.962	C0022661	KidneyFailure,Chronic	disease	C13;C12	DiseaseorSyndrome	0.60	1	1998	2018	1	0	CTD_human
val	7040	TGFB1	0.287	0.962	C0023890	LiverCirrhosis	disease	C23;C06	DiseaseorSyndrome	0.40	0.97	1991	2019	1	0	CTD_human
val	7040	TGFB1	0.287	0.962	C0023891	LiverCirrhosis,Alcoholic	disease	C23;C06;C25	DiseaseorSyndrome	0.30	1	2013	2013	1	0	CTD_human
val	7040	TGFB1	0.287	0.962	C0023892	Biliarycirrhosis	disease	C23;C06	DiseaseorSyndrome	0.40	1	2018	2018	1	0	CTD_human
val	7040	TGFB1	0.287	0.962	C0023893	LiverCirrhosis,Experimental	disease	C23;C06	ExperimentalModelofDisease	0.50	1	2003	2018	5	0	CTD_human
val	7040	TGFB1	0.287	0.962	C0023904	LiverNeoplasms,Experimental	phenotype	C06;C04	NeoplasticProcess;ExperimentalModelofDisease	0.30	1	2017	2017	1	0	CTD_human
val	7040	TGFB1	0.287	0.962	C0024115	Lungdiseases	group	C08	DiseaseorSyndrome	0.60	1	2001	2019	1	0	CTD_human
val	7040	TGFB1	0.287	0.962	C0024117	ChronicObstructiveAirwayDisease	disease	C08	DiseaseorSyndrome	0.60	0.911	1994	2020	1	0	CTD_human
val	7040	TGFB1	0.287	0.962	C0024121	LungNeoplasms	group	C04;C08	NeoplasticProcess	0.38	1	2000	2019	3	0	CTD_human
val	7040	TGFB1	0.287	0.962	C0026848	Myopathy	group	C05;C10	DiseaseorSyndrome	0.31	1	2010	2019	1	0	CTD_human
val	7040	TGFB1	0.287	0.962	C0027051	MyocardialInfarction	disease	C23;C14	DiseaseorSyndrome	0.60	1	1996	2019	1	0	CTD_human
val	7040	TGFB1	0.287	0.962	C0027626	NeoplasmInvasiveness	phenotype	C23;C04	PathologicFunction	0.30	1	2013	2016	5	0	CTD_human
val	7040	TGFB1	0.287	0.962	C0027627	NeoplasmMetastasis	phenotype	C23;C04	NeoplasticProcess	0.40	0.982	1994	2020	4	0	CTD_human
val	7040	TGFB1	0.287	0.962	C0027719	Nephrosclerosis	disease	C13;C12	DiseaseorSyndrome	0.30	1	2019	2019	1	0	CTD_human
val	7040	TGFB1	0.287	0.962	C0027726	NephroticSyndrome	group	C13;C12	DiseaseorSyndrome	0.35	1	1992	2019	3	0	CTD_human
val	7040	TGFB1	0.287	0.962	C0028797	OccupationalDiseases	group	C24	DiseaseorSyndrome	0.30	1	2014	2014	1	0	CTD_human
val	7040	TGFB1	0.287	0.962	C0029172	OralSubmucousFibrosis	disease	C07	DiseaseorSyndrome	0.36	1	2002	2018	1	0	CTD_human
val	7040	TGFB1	0.287	0.962	C0029408	Degenerativepolyarthritis	disease	C05	DiseaseorSyndrome	0.50	1	2000	2020	1	1	CTD_human
val	7040	TGFB1	0.287	0.962	C0029456	Osteoporosis	disease	C18;C05	DiseaseorSyndrome	0.60	0.962	1997	2019	1	0	CTD_human
val	7040	TGFB1	0.287	0.962	C0029458	Osteoporosis,Postmenopausal	disease	C18;C05	DiseaseorSyndrome	0.39	1	2000	2019	1	0	CTD_human
val	7040	TGFB1	0.287	0.962	C0029459	Osteoporosis,Senile	disease	C18;C05	DiseaseorSyndrome	0.30	1	2003	2003	1	0	CTD_human
val	7040	TGFB1	0.287	0.962	C0030297	PancreaticNeoplasm	disease	C06;C04;C19	NeoplasticProcess	0.37	1	2002	2019	1	0	CTD_human
val	7040	TGFB1	0.287	0.962	C0030354	Papilloma	disease	C04	NeoplasticProcess	0.32	1	2000	2010	1	0	CTD_human
val	7040	TGFB1	0.287	0.962	C0030848	PeyronieDisease	disease	C17;C12	DiseaseorSyndrome	0.40	1	2003	2019	1	0	CTD_human
val	7040	TGFB1	0.287	0.962	C0032226	PleuralDiseases	group	C08	DiseaseorSyndrome	0.30	1	2014	2014	1	0	CTD_human
val	7040	TGFB1	0.287	0.962	C0032285	Pneumonia	disease	C01;C08	DiseaseorSyndrome	0.38	0.889	2002	2018	1	0	CTD_human
val	7040	TGFB1	0.287	0.962	C0032300	LobarPneumonia	disease	C01;C08	DiseaseorSyndrome	0.30	1	2011	2011	1	0	CTD_human
val	7040	TGFB1	0.287	0.962	C0033578	ProstaticNeoplasms	group	C04;C12	NeoplasticProcess	0.40	1	1998	2015	2	0	CTD_human
val	7040	TGFB1	0.287	0.962	C0033687	Proteinuria	phenotype	C23;C13;C12	Finding	0.50	1	2003	2013	1	0	CTD_human
val	7040	TGFB1	0.287	0.962	C0033975	PsychoticDisorders	group	F03	MentalorBehavioralDysfunction	0.31	1	2007	2007	1	0	PSYGENET
val	7040	TGFB1	0.287	0.962	C0034067	PulmonaryEmphysema	disease	C08	DiseaseorSyndrome	0.36	1	2003	2017	1	0	CTD_human
val	7040	TGFB1	0.287	0.962	C0034069	PulmonaryFibrosis	disease	C08	DiseaseorSyndrome	0.70	0.983	1991	2020	7	0	CTD_human
val	7040	TGFB1	0.287	0.962	C0034189	Pyemia	phenotype	C23;C01	PathologicFunction	0.30	1	2005	2005	1	0	CTD_human
val	7040	TGFB1	0.287	0.962	C0036202	Sarcoidosis	disease	C15	DiseaseorSyndrome	0.35	1	2001	2019	1	0	CTD_human
val	7040	TGFB1	0.287	0.962	C0036341	Schizophrenia	disease	F03	MentalorBehavioralDysfunction	0.34	1	2013	2019	1	0	PSYGENET
val	7040	TGFB1	0.287	0.962	C0036690	Septicemia	disease	C23;C01	DiseaseorSyndrome	0.33	1	2005	2018	1	0	CTD_human
val	7040	TGFB1	0.287	0.962	C0037286	SkinNeoplasms	group	C04;C17	NeoplasticProcess	0.31	1	1994	2008	1	0	CTD_human
val	7040	TGFB1	0.287	0.962	C0038433	StreptozotocinDiabetes	disease	C18;C19	ExperimentalModelofDisease	0.30	1	2006	2013	2	0	CTD_human
val	7040	TGFB1	0.287	0.962	C0038454	Cerebrovascularaccident	group	C10;C14	DiseaseorSyndrome	0.35	1	2002	2018	1	0	CTD_human
val	7040	TGFB1	0.287	0.962	C0040028	Thrombocythemia,Essential	disease	C15	DiseaseorSyndrome	0.32	1	2004	2005	1	0	CTD_human
val	7040	TGFB1	0.287	0.962	C0041948	Uremia	disease	C13;C12	DiseaseorSyndrome	0.30	1	2009	2009	1	0	CTD_human
val	7040	TGFB1	0.287	0.962	C0041956	Ureteralobstruction	phenotype	C13;C12	DiseaseorSyndrome	0.40	1	1999	2020	1	0	CTD_human
val	7040	TGFB1	0.287	0.962	C0042109	Urticaria	disease	C17;C20	DiseaseorSyndrome	0.30	1	2008	2008	1	0	CTD_human
val	7040	TGFB1	0.287	0.962	C0085584	Encephalopathies	group	C10	DiseaseorSyndrome	0.41	1	2018	2018	1	0	CTD_human
val	7040	TGFB1	0.287	0.962	C0086132	DepressiveSymptoms	phenotype	F01	SignorSymptom	0.32	1	2012	2017	1	0	PSYGENET
val	7040	TGFB1	0.287	0.962	C0086237	Epilepsy,Cryptogenic	disease	C10	DiseaseorSyndrome	0.30	1	2018	2018	1	0	CTD_human
val	7040	TGFB1	0.287	0.962	C0086404	ExperimentalHepatoma	disease	C06;C04	NeoplasticProcess;ExperimentalModelofDisease	0.30	1	2017	2017	1	0	CTD_human
val	7040	TGFB1	0.287	0.962	C0086432	Hyalinosis,SegmentalGlomerular	disease	C13;C12	DiseaseorSyndrome	0.30	1	2005	2010	3	0	CTD_human
val	7040	TGFB1	0.287	0.962	C0086743	OsteoarthrosisDeformans	disease	C05	DiseaseorSyndrome	0.30	1	2019	2019	1	0	CTD_human
val	7040	TGFB1	0.287	0.962	C0149519	ChronicPersistentHepatitis	disease	C06	DiseaseorSyndrome	0.30	1	2012	2012	1	0	CTD_human
val	7040	TGFB1	0.287	0.962	C0158266	IntervertebralDiscDegeneration	disease	C05	DiseaseorSyndrome	0.36	1	2005	2020	1	0	CTD_human
val	7040	TGFB1	0.287	0.962	C0205641	Adenocarcinoma,BasalCell	disease	C04	NeoplasticProcess	0.30	1	2007	2007	1	0	CTD_human
val	7040	TGFB1	0.287	0.962	C0205642	Adenocarcinoma,Oxyphilic	disease	C04	NeoplasticProcess	0.30	1	2007	2007	1	0	CTD_human
val	7040	TGFB1	0.287	0.962	C0205643	Carcinoma,Cribriform	disease	C04	NeoplasticProcess	0.30	1	2007	2007	1	0	CTD_human
val	7040	TGFB1	0.287	0.962	C0205644	Carcinoma,GranularCell	disease	C04	NeoplasticProcess	0.30	1	2007	2007	1	0	CTD_human
val	7040	TGFB1	0.287	0.962	C0205645	Adenocarcinoma,Tubular	disease	C04	NeoplasticProcess	0.30	1	2007	2007	1	0	CTD_human
val	7040	TGFB1	0.287	0.962	C0205696	Anaplasticcarcinoma	disease	C04	NeoplasticProcess	0.30	1	2002	2002	1	0	CTD_human
val	7040	TGFB1	0.287	0.962	C0205697	Carcinoma,Spindle-Cell	disease	C04	NeoplasticProcess	0.31	0.5	2002	2005	1	0	CTD_human
val	7040	TGFB1	0.287	0.962	C0205698	Undifferentiatedcarcinoma	disease	C04	NeoplasticProcess	0.30	1	2002	2002	1	0	CTD_human
val	7040	TGFB1	0.287	0.962	C0205699	Carcinomatosis	phenotype	C04	NeoplasticProcess	0.31	1	2002	2012	1	0	CTD_human
val	7040	TGFB1	0.287	0.962	C0205874	Papilloma,SquamousCell	disease	C04	NeoplasticProcess	0.30	1	2010	2010	1	0	CTD_human
val	7040	TGFB1	0.287	0.962	C0205875	Papillomatosis	disease	C04	NeoplasticProcess	0.30	1	2010	2010	1	0	CTD_human
val	7040	TGFB1	0.287	0.962	C0221227	CentriacinarEmphysema	disease	C08	DiseaseorSyndrome	0.31	1	2003	2013	1	0	CTD_human
val	7040	TGFB1	0.287	0.962	C0236018	Aura	phenotype	C10	Finding	0.30	1	2018	2018	1	0	CTD_human
val	7040	TGFB1	0.287	0.962	C0238065	SecondaryBiliaryCholangitis	disease	C23;C06	DiseaseorSyndrome	0.30	1	2018	2018	1	0	CTD_human
val	7040	TGFB1	0.287	0.962	C0239946	Fibrosis,Liver	disease	C23;C06	DiseaseorSyndrome	0.40	0.992	1992	2020	1	0	CTD_human
val	7040	TGFB1	0.287	0.962	C0241910	AutoimmuneChronicHepatitis	disease	C06;C20	DiseaseorSyndrome	0.31	1	2010	2011	1	0	CTD_human
val	7040	TGFB1	0.287	0.962	C0242379	Malignantneoplasmoflung	disease	C04;C08	NeoplasticProcess	0.40	0.973	2000	2019	3	0	CTD_human
val	7040	TGFB1	0.287	0.962	C0242488	AcuteLungInjury	disease	C08	InjuryorPoisoning	0.30	1	2005	2005	1	0	CTD_human
val	7040	TGFB1	0.287	0.962	C0243026	Sepsis	disease	C23;C01	DiseaseorSyndrome	0.33	1	2005	2018	1	0	CTD_human
val	7040	TGFB1	0.287	0.962	C0263628	Tumoralcalcinosis	disease	C18	DiseaseorSyndrome	0.30	1	2014	2014	1	0	CTD_human
val	7040	TGFB1	0.287	0.962	C0264393	PanacinarEmphysema	disease	C08	DiseaseorSyndrome	0.30	1	2003	2003	1	0	CTD_human
val	7040	TGFB1	0.287	0.962	C0264423	Asthma,Occupational	disease	C08;C20;C24	DiseaseorSyndrome	0.30	1	2016	2016	1	0	CTD_human
val	7040	TGFB1	0.287	0.962	C0265287	AcromicricDysplasia	disease	C16;C05	CongenitalAbnormality	0.30	1	2008	2008	1	0	CTD_human
val	7040	TGFB1	0.287	0.962	C0271673	SymmetricDiabeticProximalMotorNeuropathy	disease	C10;C19	DiseaseorSyndrome	0.30	1	2005	2005	1	0	CTD_human
val	7040	TGFB1	0.287	0.962	C0271674	AsymmetricDiabeticProximalMotorNeuropathy	disease	C10;C19	DiseaseorSyndrome	0.30	1	2005	2005	1	0	CTD_human
val	7040	TGFB1	0.287	0.962	C0271678	DiabeticMononeuropathy	disease	C10;C19	DiseaseorSyndrome	0.30	1	2005	2005	1	0	CTD_human
val	7040	TGFB1	0.287	0.962	C0271680	DiabeticPolyneuropathies	group	C10;C19	DiseaseorSyndrome	0.30	1	2005	2005	1	0	CTD_human
val	7040	TGFB1	0.287	0.962	C0271685	DiabeticAmyotrophy	disease	C10;C19	DiseaseorSyndrome	0.30	1	2005	2005	1	0	CTD_human
val	7040	TGFB1	0.287	0.962	C0271686	DiabeticAutonomicNeuropathy	disease	C10;C19	DiseaseorSyndrome	0.30	1	2005	2005	1	0	CTD_human
val	7040	TGFB1	0.287	0.962	C0346647	Malignantneoplasmofpancreas	disease	C06;C04;C19	NeoplasticProcess	0.40	1	1998	2020	1	0	CTD_human
val	7040	TGFB1	0.287	0.962	C0349204	Nonorganicpsychosis	disease	F03	MentalorBehavioralDysfunction	0.31	1	2007	2007	1	0	PSYGENET
val	7040	TGFB1	0.287	0.962	C0376358	Malignantneoplasmofprostate	disease	C04;C12	NeoplasticProcess	0.40	0.929	1994	2020	2	0	CTD_human
val	7040	TGFB1	0.287	0.962	C0392164	PulmonaryCysticFibrosis	disease	C16;C06;C08	DiseaseorSyndrome	0.31	1	2006	2006	0	0	CTD_human
val	7040	TGFB1	0.287	0.962	C0393835	DiabeticAsymmetricPolyneuropathy	disease	C10;C19	DiseaseorSyndrome	0.30	1	2005	2005	1	0	CTD_human
val	7040	TGFB1	0.287	0.962	C0400966	Non-alcoholicFattyLiverDisease	disease	C06	DiseaseorSyndrome	0.34	1	2003	2019	1	0	CTD_human
val	7040	TGFB1	0.287	0.962	C0455503	H/O:depression	phenotype		Finding	0.30	1	2012	2012	1	0	PSYGENET
val	7040	TGFB1	0.287	0.962	C0520463	Chronicactivehepatitis	disease	C06	DiseaseorSyndrome	0.30	1	2012	2012	1	0	CTD_human
val	7040	TGFB1	0.287	0.962	C0521174	Microcalcification	phenotype	C18	PathologicFunction	0.30	1	2014	2014	1	0	CTD_human
val	7040	TGFB1	0.287	0.962	C0521607	PeritonealFibrosis	disease	C23;C06	DiseaseorSyndrome	0.60	1	1998	2020	1	0	CTD_human
val	7040	TGFB1	0.287	0.962	C0524611	CryptogenicChronicHepatitis	disease	C06	DiseaseorSyndrome	0.30	1	2012	2012	1	0	CTD_human
val	7040	TGFB1	0.287	0.962	C0525045	MoodDisorders	group	F03	MentalorBehavioralDysfunction	0.31	1	2001	2001	1	0	PSYGENET
val	7040	TGFB1	0.287	0.962	C0553980	EndomyocardialFibrosis	phenotype	C14	PathologicFunction	0.30	1	2015	2015	1	0	CTD_human
val	7040	TGFB1	0.287	0.962	C0600519	VentricularRemodeling	phenotype	C23	OrganorTissueFunction	0.30	1	2006	2006	1	0	CTD_human
val	7040	TGFB1	0.287	0.962	C0600520	LeftVentricleRemodeling	phenotype	C23	OrganorTissueFunction	0.30	1	2006	2006	1	0	CTD_human
val	7040	TGFB1	0.287	0.962	C0751074	DiabeticNeuralgia	disease	C10;C19	DiseaseorSyndrome	0.30	1	2005	2005	1	0	CTD_human
val	7040	TGFB1	0.287	0.962	C0751111	AwakeningEpilepsy	disease	C10	DiseaseorSyndrome	0.30	1	2018	2018	1	0	CTD_human
val	7040	TGFB1	0.287	0.962	C0751406	Post-TraumaticOsteoporosis	disease	C18;C05	DiseaseorSyndrome	0.30	1	2003	2003	1	0	CTD_human
val	7040	TGFB1	0.287	0.962	C0751956	AcuteCerebrovascularAccidents	disease	C10;C14	DiseaseorSyndrome	0.30	1	2002	2002	1	0	CTD_human
val	7040	TGFB1	0.287	0.962	C0878576	PosteriorLeukoencephalopathySyndrome	disease	C10	DiseaseorSyndrome	0.30	1	2018	2018	1	0	CTD_human
val	7040	TGFB1	0.287	0.962	C0887898	ExperimentalLungInflammation	disease	C01;C08	ExperimentalModelofDisease	0.30	1	2011	2011	1	0	CTD_human
val	7040	TGFB1	0.287	0.962	C0917713	BeckerMuscularDystrophy	disease	C16;C05;C10	DiseaseorSyndrome	0.31	1	2010	2011	1	0	CTD_human
val	7040	TGFB1	0.287	0.962	C1306571	HepaticInsufficiency	phenotype	C06	PathologicFunction	0.30	1	2018	2018	1	0	CTD_human
val	7040	TGFB1	0.287	0.962	C1527303	ChronicAirflowObstruction	disease	C08	DiseaseorSyndrome	0.30	1	2006	2006	1	0	CTD_human
val	7040	TGFB1	0.287	0.962	C1527304	AllergicReaction	phenotype	C20	PathologicFunction	0.30	1	2008	2011	2	0	CTD_human
val	7040	TGFB1	0.287	0.962	C1527396	FibrocysticDiseaseofPancreas	disease	C16;C06;C08	DiseaseorSyndrome	0.30				0	0	CTD_human
val	7040	TGFB1	0.287	0.962	C1565662	AcuteKidneyInsufficiency	disease	C13;C12	DiseaseorSyndrome	0.30	1	1999	1999	1	0	CTD_human
val	7040	TGFB1	0.287	0.962	C1623038	Cirrhosis	disease	C23	DiseaseorSyndrome	0.40	1	1991	2019	8	0	CTD_human
val	7040	TGFB1	0.287	0.962	C1719672	SevereSepsis	disease	C23;C01	DiseaseorSyndrome	0.31	1	2005	2010	1	0	CTD_human
val	7040	TGFB1	0.287	0.962	C1837218	Cleftpalate,isolated	disease	C16;C05;C07	CongenitalAbnormality	0.31	1	2014	2016	1	0	CTD_human
val	7040	TGFB1	0.287	0.962	C1876165	Copper-OverloadCirrhosis	disease	C16;C06;C18;C10	DiseaseorSyndrome	0.30	1	2012	2012	1	0	CTD_human
val	7040	TGFB1	0.287	0.962	C2239176	Livercarcinoma	disease	C06;C04	NeoplasticProcess	0.40	0.986	1990	2020	1	0	CTD_human
val	7040	TGFB1	0.287	0.962	C2350873	BerylliumDisease	disease	C08;C24	DiseaseorSyndrome	0.30	1	2005	2007	2	0	CTD_human
val	7040	TGFB1	0.287	0.962	C2350878	FocalEmphysema	disease	C08	DiseaseorSyndrome	0.30	1	2003	2003	1	0	CTD_human
val	7040	TGFB1	0.287	0.962	C2609414	Acutekidneyinjury	disease	C13;C12	InjuryorPoisoning	0.30	1	1999	1999	1	0	CTD_human
val	7040	TGFB1	0.287	0.962	C2717759	DegenerativeIntervertebralDiscs	disease	C05	AnatomicalAbnormality	0.31	1	2011	2013	1	0	CTD_human
val	7040	TGFB1	0.287	0.962	C2717859	PeritonealSclerosis	phenotype	C23;C06	Finding	0.30	1	2006	2006	1	0	CTD_human
val	7040	TGFB1	0.287	0.962	C2717860	EncapsulatingPeritonealSclerosis	disease	C23;C06	DiseaseorSyndrome	0.30	1	2006	2006	1	0	CTD_human
val	7040	TGFB1	0.287	0.962	C3160858	Posteriorreversibleencephalopathysyndrome	disease	C10	DiseaseorSyndrome	0.30	1	2018	2018	1	0	CTD_human
val	7040	TGFB1	0.287	0.962	C3241937	NonalcoholicSteatohepatitis	disease	C06	DiseaseorSyndrome	0.34	1	2006	2019	1	0	CTD_human
val	7040	TGFB1	0.287	0.962	C3489628	Thrombocytosis,AutosomalDominant	disease	C15	DiseaseorSyndrome	0.30	1	2005	2005	1	0	CTD_human
val	7040	TGFB1	0.287	0.962	C3489726	Geleophysicdysplasia	disease	C16;C05	CongenitalAbnormality	0.30	1	2008	2008	1	0	CTD_human
val	7040	TGFB1	0.287	0.962	C3542021	DuchenneandBeckerMuscularDystrophy	disease	C16;C05;C10	DiseaseorSyndrome	0.30	1	2011	2011	1	0	CTD_human
val	7040	TGFB1	0.287	0.962	C3714636	Pneumonitis	disease	C01;C08	DiseaseorSyndrome	0.40	0.929	2001	2019	1	0	CTD_human
val	7040	TGFB1	0.287	0.962	C3830362	EarlyPregnancyLoss	phenotype	C13	Finding	0.30	1	2008	2008	1	0	CTD_human
val	7040	TGFB1	0.287	0.962	C4551595	BiliaryCirrhosis,Primary,1	disease	C23;C06	DiseaseorSyndrome	0.30	1	2018	2018	1	0	CTD_human
val	7040	TGFB1	0.287	0.962	C4552766	Miscarriage	disease	C13	DiseaseorSyndrome	0.30	1	2008	2008	1	0	CTD_human
val	7040	TGFB1	0.287	0.962	C4721507	Alveolitis,Fibrosing	disease	C08	DiseaseorSyndrome	0.30	1	2004	2016	7	0	CTD_human
val	7040	TGFB1	0.287	0.962	C4748708	INFLAMMATORYBOWELDISEASE,IMMUNODEFICIENCY,ANDENCEPHALOPATHY	disease		DiseaseorSyndrome	0.40	1	2018	2018	1	3	UNIPROT
val	7042	TGFB2	0.433	0.885	C0003504	AorticValveInsufficiency	disease	C14	DiseaseorSyndrome	0.40	1	2011	2011	1	0	CTD_human
val	7042	TGFB2	0.433	0.885	C0004364	AutoimmuneDiseases	group	C20	DiseaseorSyndrome	0.31	1	2014	2017	1	0	CTD_human
val	7042	TGFB2	0.433	0.885	C0005941	BoneDiseases,Developmental	group	C05	DiseaseorSyndrome	0.30	1	1997	1997	1	0	CTD_human
val	7042	TGFB2	0.433	0.885	C0008311	Cholangitis	disease	C06	DiseaseorSyndrome	0.30	1	2014	2014	1	0	CTD_human
val	7042	TGFB2	0.433	0.885	C0008925	CleftPalate	disease	C16;C05;C07	CongenitalAbnormality	0.30	1	2014	2014	1	0	CTD_human
val	7042	TGFB2	0.433	0.885	C0010520	Cyanosis	phenotype	C23	SignorSymptom	0.30	1	1997	1997	1	0	CTD_human
val	7042	TGFB2	0.433	0.885	C0014175	Endometriosis	disease	C13	DiseaseorSyndrome	0.33	0.75	2011	2018	1	0	CTD_human
val	7042	TGFB2	0.433	0.885	C0015393	EyeAbnormalities	group	C16;C11	CongenitalAbnormality	0.30	1	1997	1997	1	0	CTD_human
val	7042	TGFB2	0.433	0.885	C0017601	Glaucoma	disease	C11	DiseaseorSyndrome	0.40	1	2007	2019	1	0	CTD_human
val	7042	TGFB2	0.433	0.885	C0018798	CongenitalHeartDefects	group	C16;C14	CongenitalAbnormality	0.31	1	1997	2013	1	0	CTD_human
val	7042	TGFB2	0.433	0.885	C0034067	PulmonaryEmphysema	disease	C08	DiseaseorSyndrome	0.30	1	2013	2013	1	0	GENOMICS_ENGLAND
val	7042	TGFB2	0.433	0.885	C0035238	Congenitalabnormalityofrespiratorysystem	group	C16;C08	CongenitalAbnormality	0.30	1	1997	1997	1	0	CTD_human
val	7042	TGFB2	0.433	0.885	C0041956	Ureteralobstruction	phenotype	C13;C12	DiseaseorSyndrome	0.31	1	2007	2016	1	0	CTD_human
val	7042	TGFB2	0.433	0.885	C0042063	UrogenitalAbnormalities	group	C16;C13;C12	CongenitalAbnormality	0.30	1	1997	1997	1	0	CTD_human
val	7042	TGFB2	0.433	0.885	C0151491	Congenitalmusculoskeletalanomalies	group	C16;C05	CongenitalAbnormality	0.30	1	1997	1997	1	0	CTD_human
val	7042	TGFB2	0.433	0.885	C0162872	AorticAneurysm,Thoracic	disease	C14	DiseaseorSyndrome	0.31	1	2012	2014	2	0	CTD_human
val	7042	TGFB2	0.433	0.885	C0206762	LimbDeformities,Congenital	group	C16;C05	CongenitalAbnormality	0.30	1	1997	1997	1	0	CTD_human
val	7042	TGFB2	0.433	0.885	C0269102	Endometrioma	disease	C13	NeoplasticProcess	0.30	1	2011	2011	1	0	CTD_human
val	7042	TGFB2	0.433	0.885	C0340630	AorticAneurysm,Thoracoabdominal	disease	C14	DiseaseorSyndrome	0.30	1	2012	2012	2	0	CTD_human
val	7042	TGFB2	0.433	0.885	C0345967	Malignantmesothelioma	disease	C04;C08	NeoplasticProcess	0.30	1	2015	2015	1	0	CTD_human
val	7042	TGFB2	0.433	0.885	C0376634	CraniofacialAbnormalities	group	C16;C05	CongenitalAbnormality	0.30	1	1997	1997	1	0	CTD_human
val	7042	TGFB2	0.433	0.885	C1836635	Loeys-DietzAorticAneurysmSyndrome	disease	C16;C05;C14	DiseaseorSyndrome	0.50	1	2012	2012	1	0	CTD_human
val	7042	TGFB2	0.433	0.885	C1837218	Cleftpalate,isolated	disease	C16;C05;C07	CongenitalAbnormality	0.31	1	1999	2014	1	0	CTD_human
val	7042	TGFB2	0.433	0.885	C2697932	Loeys-DietzSyndrome	disease	C16;C05;C14	DiseaseorSyndrome	0.89	1	2012	2018	2	3	CTD_human;GENOMICS_ENGLAND
val	7042	TGFB2	0.433	0.885	C3553762	LOEYS-DIETZSYNDROME4	disease		DiseaseorSyndrome	0.60	1	2012	2018	4	11	GENOMICS_ENGLAND;UNIPROT
val	7042	TGFB2	0.433	0.885	C4551955	Loeys-DietzSyndrome,Type1a	disease	C16;C05;C14	DiseaseorSyndrome	0.30	1	2012	2012	1	0	CTD_human
val	7042	TGFB2	0.433	0.885	C4707243	Familialthoracicaorticaneurysmandaorticdissection	disease		DiseaseorSyndrome	0.60	1	2012	2014	3	0	CLINGEN;GENOMICS_ENGLAND;ORPHANET
val	7043	TGFB3	0.498	0.808	C0008925	CleftPalate	disease	C16;C05;C07	CongenitalAbnormality	0.39	1	1995	2020	2	0	CTD_human
val	7043	TGFB3	0.498	0.808	C0023893	LiverCirrhosis,Experimental	disease	C23;C06	ExperimentalModelofDisease	0.30	1	2014	2014	1	0	CTD_human
val	7043	TGFB3	0.498	0.808	C0034067	PulmonaryEmphysema	disease	C08	DiseaseorSyndrome	0.30	1	2015	2015	1	0	GENOMICS_ENGLAND
val	7043	TGFB3	0.498	0.808	C0035238	Congenitalabnormalityofrespiratorysystem	group	C16;C08	CongenitalAbnormality	0.30	1	1995	1995	1	0	CTD_human
val	7043	TGFB3	0.498	0.808	C1836635	Loeys-DietzAorticAneurysmSyndrome	disease	C16;C05;C14	DiseaseorSyndrome	0.30				0	0	CTD_human
val	7043	TGFB3	0.498	0.808	C1837218	Cleftpalate,isolated	disease	C16;C05;C07	CongenitalAbnormality	0.39	1	1995	2020	2	0	CTD_human
val	7043	TGFB3	0.498	0.808	C1862511	ARRHYTHMOGENICRIGHTVENTRICULARDYSPLASIA,FAMILIAL,1(disorder)	disease	C16;C14	DiseaseorSyndrome	0.60	1	2015	2015	1	0	CTD_human;GENOMICS_ENGLAND
val	7043	TGFB3	0.498	0.808	C2697932	Loeys-DietzSyndrome	disease	C16;C05;C14	DiseaseorSyndrome	0.53	1	2015	2018	1	0	CTD_human;GENOMICS_ENGLAND
val	7043	TGFB3	0.498	0.808	C3711374	NonsyndromicDeafness	disease	C23;C10;C09	DiseaseorSyndrome	0.30	1	2016	2016	1	0	CTD_human
val	7043	TGFB3	0.498	0.808	C3810012	RIENHOFFSYNDROME	disease		DiseaseorSyndrome	0.61	1	2013	2015	3	0	GENOMICS_ENGLAND;UNIPROT
val	7043	TGFB3	0.498	0.808	C4016411	ARRHYTHMOGENICRIGHTVENTRICULARDYSPLASIA1	phenotype		Finding	0.30				0	0	GENOMICS_ENGLAND
val	7043	TGFB3	0.498	0.808	C4551955	Loeys-DietzSyndrome,Type1a	disease	C16;C05;C14	DiseaseorSyndrome	0.30				0	0	CTD_human
val	7043	TGFB3	0.498	0.808	C4707243	Familialthoracicaorticaneurysmandaorticdissection	disease		DiseaseorSyndrome	0.70	1	2006	2015	3	0	CLINGEN;GENOMICS_ENGLAND;ORPHANET
val	7044	LEFTY2	0.736	0.231	C0000772	Multiplecongenitalanomalies	group	C16	CongenitalAbnormality	0.30	1	1999	1999	1	0	CTD_human
val	7044	LEFTY2	0.736	0.231	C0175707	AspleniaSyndrome	disease	C16;C15;C14	DiseaseorSyndrome	0.30	1	1999	1999	1	0	CTD_human
val	7044	LEFTY2	0.736	0.231	C0265357	PolyspleniaSyndrome	disease	C16;C15;C14	CongenitalAbnormality	0.30	1	1999	1999	1	0	CTD_human
val	7044	LEFTY2	0.736	0.231	C0266642	Situsambiguus	disease	C16;C15;C14	CongenitalAbnormality	0.50	1	1999	1999	1	0	CTD_human;ORPHANET
val	7044	LEFTY2	0.736	0.231	C1167664	Situsambiguous	disease		CongenitalAbnormality	0.30				0	0	ORPHANET
val	7044	LEFTY2	0.736	0.231	C3178805	HeterotaxySyndrome	disease	C16;C15;C14	DiseaseorSyndrome	0.50	1	1999	1999	1	0	CTD_human;GENOMICS_ENGLAND
val	7044	LEFTY2	0.736	0.231	C3178806	RightAtrialIsomerism	disease	C16;C15;C14	CongenitalAbnormality	0.30	1	1999	1999	1	0	CTD_human
val	7044	LEFTY2	0.736	0.231	C3178807	LeftAtrialIsomerism	disease	C16;C15;C14	CongenitalAbnormality	0.30	1	1999	1999	1	0	CTD_human
val	7044	LEFTY2	0.736	0.231	C4277690	Ciliopathies	disease	C16	CongenitalAbnormality	0.30				0	0	GENOMICS_ENGLAND
val	7045	TGFBI	0.484	0.769	C0000786	Spontaneousabortion	phenotype	C13	PathologicFunction	0.30	1	2008	2008	1	0	CTD_human
val	7045	TGFBI	0.484	0.769	C0000822	Abortion,Tubal	phenotype	C13	PathologicFunction	0.30	1	2008	2008	1	0	CTD_human
val	7045	TGFBI	0.484	0.769	C0011881	DiabeticNephropathy	disease	C13;C12;C19	DiseaseorSyndrome	0.53	1	2003	2012	1	0	CTD_human
val	7045	TGFBI	0.484	0.769	C0017667	Nodularglomerulosclerosis	disease	C13;C12;C19	DiseaseorSyndrome	0.30	1	2009	2009	1	0	CTD_human
val	7045	TGFBI	0.484	0.769	C0034189	Pyemia	phenotype	C23;C01	PathologicFunction	0.30	1	2017	2017	1	0	CTD_human
val	7045	TGFBI	0.484	0.769	C0036690	Septicemia	disease	C23;C01	DiseaseorSyndrome	0.33	1	2017	2020	1	0	CTD_human
val	7045	TGFBI	0.484	0.769	C0243026	Sepsis	disease	C23;C01	DiseaseorSyndrome	0.33	1	2017	2020	1	0	CTD_human
val	7045	TGFBI	0.484	0.769	C0339278	Reis-Bucklerscornealdystrophy	disease	C16;C11	DiseaseorSyndrome	0.8	0.95	1998	2019	6	2	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
22605	7045	TGFBI	0.484	0.769	C0521723	Cornealdystrophy,epithelialbasementmembrane	disease	C11;C10;C14	DiseaseorSyndrome	0.71	1	1998	2016	3	2	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
22606	7045	TGFBI	0.484	0.769	C1275685	Avellinocornealdystrophy	disease	C16;C11	DiseaseorSyndrome	0.8	1	1998	2019	3	1	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
22607	7045	TGFBI	0.484	0.769	C1562894	Thiel-Behnkecornealdystrophy	disease	C16;C11	DiseaseorSyndrome	0.75	1	1998	2015	3	1	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
22608	7045	TGFBI	0.484	0.769	C1641846	GroenouwcornealdystrophytypeI(disorder)	disease	C16;C11	DiseaseorSyndrome	0.73	1	1998	2011	4	2	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
22609	7045	TGFBI	0.484	0.769	C1690006	LatticecornealdystrophyTypeI	disease	C16;C11	DiseaseorSyndrome	0.8	0.96	1998	2019	12	6	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
22611	7045	TGFBI	0.484	0.769	C1837974	CornealDystrophy,LatticeTypeIIIA	disease	C16;C11	DiseaseorSyndrome	0.73	0.857	1998	2011	4	2	CTD_human;GENOMICS_ENGLAND;UNIPROT
22628	7046	TGFBR1	0.451	0.885	C0546476	Multipleself-healingsquamousepithelioma	disease	C04;C17	NeoplasticProcess	0.56	1	1997	2018	1	0	CTD_human;ORPHANET
22631	7046	TGFBR1	0.451	0.885	C1836635	Loeys-DietzAorticAneurysmSyndrome	disease	C16;C05;C14	DiseaseorSyndrome	0.73	1	2005	2012	4	0	CTD_human;ORPHANET
22632	7046	TGFBR1	0.451	0.885	C2697932	Loeys-DietzSyndrome	disease	C16;C05;C14	DiseaseorSyndrome	1	1	1993	2019	10	8	CLINGEN;CTD_human;GENOMICS_ENGLAND;ORPHANET
22639	7046	TGFBR1	0.451	0.885	C4551955	Loeys-DietzSyndrome,Type1a	disease	C16;C05;C14	DiseaseorSyndrome	0.7	1	2005	2016	12	9	CTD_human;GENOMICS_ENGLAND;UNIPROT
22641	7046	TGFBR1	0.451	0.885	C4707243	Familialthoracicaorticaneurysmandaorticdissection	disease		DiseaseorSyndrome	0.6	1	2005	2019	8	12	CLINGEN;GENOMICS_ENGLAND
22666	7048	TGFBR2	0.413	0.846	C0033578	ProstaticNeoplasms	group	C04;C12	NeoplasticProcess	0.54	1	2004	2018	1	0	CTD_human
22669	7048	TGFBR2	0.413	0.846	C0152018	Esophagealcarcinoma	disease	C06;C04	NeoplasticProcess	0.61	1	2000	2000	1	1	CGI;UNIPROT
22687	7048	TGFBR2	0.413	0.846	C0376358	Malignantneoplasmofprostate	disease	C04;C12	NeoplasticProcess	0.6	1	2006	2018	1	0	CTD_human
22691	7048	TGFBR2	0.413	0.846	C0546837	Malignantneoplasmofesophagus	disease	C06;C04	NeoplasticProcess	0.6	1	2000	2000	1	1	CGI;CTD_human
22698	7048	TGFBR2	0.413	0.846	C1333990	HereditaryNonpolyposisColorectalCancer	disease	C16;C06;C04;C18	NeoplasticProcess	0.6	1	1995	2018	1	0	CTD_human;ORPHANET
22702	7048	TGFBR2	0.413	0.846	C1836635	Loeys-DietzAorticAneurysmSyndrome	disease	C16;C05;C14	DiseaseorSyndrome	0.73	1	2004	2012	7	0	CTD_human;ORPHANET
22703	7048	TGFBR2	0.413	0.846	C1860896	COLORECTALCANCER,HEREDITARYNONPOLYPOSIS,TYPE6	disease	C16;C06;C04;C18	NeoplasticProcess	0.6	1	1998	1998	1	4	CTD_human;UNIPROT
22704	7048	TGFBR2	0.413	0.846	C2674574	Aorticaneurysm,familialthoracic3	disease	C16;C05;C14	DiseaseorSyndrome	0.7	1	2003	2017	15	26	CTD_human;GENOMICS_ENGLAND;UNIPROT
22705	7048	TGFBR2	0.413	0.846	C2697932	Loeys-DietzSyndrome	disease	C16;C05;C14	DiseaseorSyndrome	1	1	2003	2019	10	17	CTD_human;GENOMICS_ENGLAND;ORPHANET
22711	7048	TGFBR2	0.413	0.846	C4707243	Familialthoracicaorticaneurysmandaorticdissection	disease		DiseaseorSyndrome	0.6	1	2003	2019	14	20	CLINGEN;GENOMICS_ENGLAND
22717	7050	TGIF1	0.588	0.769	C0079541	Holoprosencephaly	disease	C16;C05;C10	CongenitalAbnormality	0.7	1	1995	2018	1	0	CTD_human;GENOMICS_ENGLAND
22720	7050	TGIF1	0.588	0.769	C0751617	SemilobarHoloprosencephaly	disease	C16;C05;C10	CongenitalAbnormality	0.6	1	2006	2006	1	0	CTD_human;ORPHANET
22721	7050	TGIF1	0.588	0.769	C1840528	HOLOPROSENCEPHALY4(disorder)	disease	C16;C05;C10	DiseaseorSyndrome	0.7	1	2000	2013	3	7	CTD_human;GENOMICS_ENGLAND;UNIPROT
22724	7051	TGM1	0.565	0.769	C0020758	Congenitalichthyosis	disease	C16;C17	DiseaseorSyndrome	0.6	0.958	1997	2020	0	0	CTD_human
22727	7051	TGM1	0.565	0.769	C0079154	CongenitalNonbullousIchthyosiformErythroderma	disease	C16;C17	DiseaseorSyndrome	1	1	1994	2019	2	3	CTD_human;GENOMICS_ENGLAND;ORPHANET
22734	7051	TGM1	0.565	0.769	C1855789	Self-HealingCollodionBaby	disease	C16;C17	DiseaseorSyndrome;CongenitalAbnormality	0.51	1	1998	2017	2	0	ORPHANET
22735	7051	TGM1	0.565	0.769	C3536797	IchthyosisCongenitaII	disease	C16;C17	DiseaseorSyndrome;CongenitalAbnormality	0.51	1	1998	2010	0	0	CTD_human
22738	7051	TGM1	0.565	0.769	C4511230	Bathingsuitichthyosis	disease		DiseaseorSyndrome	0.55	1	1998	2017	1	0	ORPHANET
22739	7051	TGM1	0.565	0.769	C4551630	IchthyosisCongenitaI	disease	C16;C17	DiseaseorSyndrome	0.9	1	1995	2017	7	79	CTD_human;GENOMICS_ENGLAND;UNIPROT
22772	7053	TGM3	0.653	0.385	C0432347	Uncombablehairsyndrome	disease	C17	DiseaseorSyndrome	0.52	1	2016	2018	1	0	CTD_human;ORPHANET
22784	7054	TH	0.462	0.885	C0020538	Hypertensivedisease	group	C14	DiseaseorSyndrome	0.58	0.9	1998	2017	1	0	CTD_human
22790	7054	TH	0.462	0.885	C0030567	ParkinsonDisease	disease	C10	DiseaseorSyndrome	0.6	0.979	1989	2020	1	0	CTD_human
22796	7054	TH	0.462	0.885	C0242422	ParkinsonianDisorders	group	C10	DiseaseorSyndrome	0.7	1	1992	2019	2	0	CTD_human
22821	7054	TH	0.462	0.885	C2673535	DYSTONIA,DOPA-RESPONSIVE,WITHORWITHOUTHYPERPHENYLALANINEMIA,AUTOSOMALRECESSIVE(disorder)	disease	C10	DiseaseorSyndrome	0.72	1	1964	2018	35	52	CLINGEN;CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
22854	7056	THBD	0.457	0.769	C0035222	RespiratoryDistressSyndrome,Adult	disease	C08	DiseaseorSyndrome	0.55	1	2003	2017	1	0	CTD_human
22860	7056	THBD	0.457	0.769	C0398623	Thrombophilia	disease	C15	DiseaseorSyndrome	0.7	0.909	1991	2019	1	0	CTD_human
22871	7056	THBD	0.457	0.769	C2752036	HEMOLYTICUREMICSYNDROME,ATYPICAL,SUSCEPTIBILITYTO,6	disease		Finding	0.6	1	2009	2013	3	7	GENOMICS_ENGLAND;UNIPROT
22872	7056	THBD	0.457	0.769	C2931788	AtypicalHemolyticUremicSyndrome	disease	C13;C12;C15	DiseaseorSyndrome	0.57	1	2009	2018	1	0	CTD_human;GENOMICS_ENGLAND
22874	7056	THBD	0.457	0.769	C3280976	ThrombophiliaduetoThrombomodulinDefect	disease	C15	DiseaseorSyndrome	0.7	1	1995	2015	6	3	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
22921	7067	THRA	0.566	0.769	C3280817	HYPOTHYROIDISM,CONGENITAL,NONGOITROUS,6	disease		DiseaseorSyndrome	0.7	1	2012	2016	6	7	CTD_human;GENOMICS_ENGLAND;UNIPROT
22926	7068	THRB	0.554	0.769	C0206682	Follicularthyroidcarcinoma	disease	C04	NeoplasticProcess	0.53	1	2004	2017	1	0	CTD_human
22929	7068	THRB	0.554	0.769	C1840364	THYROIDHORMONERESISTANCE,SELECTIVEPITUITARY	disease	C19	DiseaseorSyndrome	0.7	1	1993	2014	3	5	CTD_human;GENOMICS_ENGLAND;UNIPROT
22931	7068	THRB	0.554	0.769	C2937288	THYROIDHORMONERESISTANCE,GENERALIZED,AUTOSOMALDOMINANT	disease	C19	DiseaseorSyndrome	0.72	1	1989	2014	20	40	CTD_human;GENOMICS_ENGLAND;UNIPROT
22932	7068	THRB	0.554	0.769	C2940786	ThyroidHormoneResistanceSyndrome	disease	C19	DiseaseorSyndrome	0.9	0.973	1990	2019	3	1	CTD_human;GENOMICS_ENGLAND
22934	7068	THRB	0.554	0.769	C3489796	ThyroidHormoneResistance,Generalized,AutosomalRecessive	disease	C19	DiseaseorSyndrome	0.62	1	1992	2014	1	3	CTD_human;GENOMICS_ENGLAND
22936	7068	THRB	0.554	0.769	C4722330	GeneralizedThyroidHormoneResistance	disease	C19	DiseaseorSyndrome	0.7	0.99	1988	2019	3	7	CTD_human;GENOMICS_ENGLAND
22948	7071	KLF10	0.631	0.615	C0007194	HypertrophicCardiomyopathy	disease	C14	DiseaseorSyndrome	0.51	1	1995	2017	6	0	CLINGEN;GENOMICS_ENGLAND
22949	7072	TIA1	0.595	0.577	C0221054	WelanderDistalMyopathy	disease	C16;C05;C10	DiseaseorSyndrome	0.74	1	1999	2019	3	0	GENOMICS_ENGLAND;ORPHANET;UNIPROT
22968	7076	TIMP1	0.38	0.885	C0018799	HeartDiseases	group	C14	DiseaseorSyndrome	0.51	1	2008	2018	1	0	CTD_human
22971	7076	TIMP1	0.38	0.885	C0020538	Hypertensivedisease	group	C14	DiseaseorSyndrome	0.54	1	2004	2019	1	0	CTD_human
22977	7076	TIMP1	0.38	0.885	C0034069	PulmonaryFibrosis	disease	C08	DiseaseorSyndrome	0.56	1	2011	2019	1	0	CTD_human
23021	7078	TIMP3	0.445	0.923	C1850938	FUNDUSDYSTROPHY,PSEUDOINFLAMMATORY,OFSORSBY	disease	C11	DiseaseorSyndrome	1	1	1994	2019	5	0	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
23035	7080	NKX2-1	0.457	0.808	C0238463	Papillarythyroidcarcinoma	disease	C04;C19	NeoplasticProcess	0.7	0.947	2001	2019	1	0	CTD_human;ORPHANET
23036	7080	NKX2-1	0.457	0.808	C0393584	BenignHereditaryChorea	disease	C23;C10	DiseaseorSyndrome	0.8	0.96	2002	2018	9	6	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
23042	7080	NKX2-1	0.457	0.808	C1970269	Choreoathetosis,Hypothyroidism,AndNeonatalRespiratoryDistress	disease	C23;C16;C05;C08;C10;C19	DiseaseorSyndrome	0.77	1	2002	2018	8	8	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
23058	7084	TK2	0.585	0.615	C3149750	MITOCHONDRIALDNADEPLETIONSYNDROME2(MYOPATHICTYPE)	disease		DiseaseorSyndrome	0.7	1	2001	2016	8	28	CTD_human;GENOMICS_ENGLAND;UNIPROT
23060	7084	TK2	0.585	0.615	C4310734	PROGRESSIVEEXTERNALOPHTHALMOPLEGIAWITHMITOCHONDRIALDNADELETIONS,AUTOSOMALRECESSIVE3	disease		DiseaseorSyndrome	0.7	1	2012	2012	1	3	CTD_human;GENOMICS_ENGLAND;UNIPROT
23076	7086	TKT	0.595	0.769	C4310751	SHORTSTATURE,DEVELOPMENTALDELAY,ANDCONGENITALHEARTDEFECTS	disease		DiseaseorSyndrome	0.71	1	2016	2019	2	2	GENOMICS_ENGLAND;ORPHANET;UNIPROT
23077	7087	ICAM5	0.716	0.346	C0006142	Malignantneoplasmofbreast	disease	C04;C17	NeoplasticProcess	0.53	1	2005	2013	1	0	CTD_human;UNIPROT
23106	7092	TLL1	0.716	0.5	C2751315	AtrialSeptalDefect6	disease	C16;C14	DiseaseorSyndrome;CongenitalAbnormality	0.71	1	2009	2019	1	3	CTD_human;GENOMICS_ENGLAND;UNIPROT
23128	7097	TLR2	0.361	0.923	C0021368	Inflammation	phenotype	C23	PathologicFunction	0.56	1	2005	2012	1	0	CTD_human
23129	7097	TLR2	0.361	0.923	C0022568	Keratitis	disease	C11	DiseaseorSyndrome	0.55	1	2006	2019	1	0	CTD_human
23155	7098	TLR3	0.427	0.885	C0276226	Herpesencephalitis	disease	C01;C10	DiseaseorSyndrome	0.7	0.947	2007	2019	1	0	CTD_human;ORPHANET
23156	7098	TLR3	0.427	0.885	C2751803	HERPESSIMPLEXENCEPHALITIS,SUSCEPTIBILITYTO,2	disease		Finding	0.6	1	2007	2017	2	4	GENOMICS_ENGLAND;UNIPROT
23168	7099	TLR4	0.321	0.962	C0011882	DiabeticNeuropathies	group	C10;C19	DiseaseorSyndrome	0.51	1	2004	2012	1	0	CTD_human
23186	7099	TLR4	0.321	0.962	C0035078	KidneyFailure	disease	C13;C12	DiseaseorSyndrome	0.51	1	2005	2017	1	0	CTD_human
23204	7099	TLR4	0.321	0.962	C0520459	NecrotizingEnterocolitis	disease	C06	DiseaseorSyndrome	0.6	0.929	2006	2018	1	0	CTD_human
23239	7124	TNF	0.231	0.962	C0003873	RheumatoidArthritis	disease	C17;C05;C20	DiseaseorSyndrome	0.7	0.975	1989	2020	4	1	CTD_human
23252	7124	TNF	0.231	0.962	C0006625	Cachexia	phenotype	C23	SignorSymptom	0.6	1	1990	2020	1	0	CTD_human
23259	7124	TNF	0.231	0.962	C0009324	UlcerativeColitis	disease	C06	DiseaseorSyndrome	0.6	0.971	1996	2020	3	0	CTD_human
23273	7124	TNF	0.231	0.962	C0011860	DiabetesMellitus,Non-Insulin-Dependent	disease	C18;C19	DiseaseorSyndrome	0.6	0.95	1995	2020	1	0	CTD_human
23282	7124	TNF	0.231	0.962	C0018790	CardiacArrest	disease	C14	DiseaseorSyndrome	0.6	1	1998	2019	1	0	CTD_human
23284	7124	TNF	0.231	0.962	C0018801	Heartfailure	disease	C14	DiseaseorSyndrome	0.6	0.965	1996	2019	5	0	CTD_human
23285	7124	TNF	0.231	0.962	C0018802	Congestiveheartfailure	disease	C14	DiseaseorSyndrome	0.6	0.972	1996	2020	5	0	CTD_human
23296	7124	TNF	0.231	0.962	C0020429	Hyperalgesia	phenotype	C23;C10	SignorSymptom	0.6	1	1995	2020	11	0	CTD_human
23301	7124	TNF	0.231	0.962	C0020538	Hypertensivedisease	group	C14	DiseaseorSyndrome	0.6	1	1998	2020	4	0	CTD_human
23306	7124	TNF	0.231	0.962	C0021368	Inflammation	phenotype	C23	PathologicFunction	0.6	1	2001	2016	15	0	CTD_human
23307	7124	TNF	0.231	0.962	C0021390	InflammatoryBowelDiseases	group	C06	DiseaseorSyndrome	0.6	0.964	1992	2020	2	0	CTD_human
23321	7124	TNF	0.231	0.962	C0024115	Lungdiseases	group	C08	DiseaseorSyndrome	0.6	1	1999	2019	1	0	CTD_human
23330	7124	TNF	0.231	0.962	C0027051	MyocardialInfarction	disease	C23;C14	DiseaseorSyndrome	0.6	0.961	2000	2019	2	0	CTD_human
23353	7124	TNF	0.231	0.962	C0033141	Cardiomyopathies,Primary	group	C14	DiseaseorSyndrome	0.51	1	2000	2014	1	0	CTD_human
23373	7124	TNF	0.231	0.962	C0038220	StatusEpilepticus	disease	C23;C10	DiseaseorSyndrome	0.59	1	2008	2019	1	0	CTD_human
23377	7124	TNF	0.231	0.962	C0038454	Cerebrovascularaccident	group	C10;C14	DiseaseorSyndrome	0.6	0.956	1999	2020	1	0	CTD_human
23441	7124	TNF	0.231	0.962	C0600327	ToxicShockSyndrome	disease	C23;C01	DiseaseorSyndrome	0.54	1	1990	2018	1	0	CTD_human
23452	7128	TNFAIP3	0.481	0.808	C4225218	AUTOINFLAMMATORYSYNDROME,FAMILIAL,BEHCET-LIKE	disease		DiseaseorSyndrome	0.71	1	2016	2019	3	6	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
23479	7132	TNFRSF1A	0.409	0.923	C0006625	Cachexia	phenotype	C23	SignorSymptom	0.52	1	2001	2009	1	0	CTD_human
23486	7132	TNFRSF1A	0.409	0.923	C0011860	DiabetesMellitus,Non-Insulin-Dependent	disease	C18;C19	DiseaseorSyndrome	0.59	1	2002	2019	1	0	CTD_human
23508	7132	TNFRSF1A	0.409	0.923	C1275126	TNFreceptor-associatedperiodicfeversyndrome(TRAPS)	disease	C23;C16;C17	DiseaseorSyndrome	1	1	1998	2019	7	16	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
23524	7133	TNFRSF1B	0.425	0.885	C0026948	MycosisFungoides	group	C04;C20;C15	NeoplasticProcess	0.51	1	2015	2016	1	0	CTD_human;ORPHANET
23530	7133	TNFRSF1B	0.425	0.885	C0036920	SezarySyndrome	disease	C04;C20;C15	NeoplasticProcess	0.51	1	2015	2019	1	0	CTD_human;ORPHANET
23542	7134	TNNC1	0.647	0.462	C2678475	Cardiomyopathy,Dilated,1z	disease	C14	DiseaseorSyndrome	0.7	1	2004	2019	4	1	CTD_human;GENOMICS_ENGLAND;UNIPROT
23543	7134	TNNC1	0.647	0.462	C2750472	Cardiomyopathy,FamilialHypertrophic,13	disease	C16;C14	DiseaseorSyndrome	0.9	1	2001	2019	7	6	CTD_human;GENOMICS_ENGLAND;UNIPROT
23546	7136	TNNI2	0.631	0.423	C0220662	ARTHROGRYPOSIS,DISTAL,TYPE1	disease	C16;C05	DiseaseorSyndrome;CongenitalAbnormality	0.54	1	1997	2016	1	0	ORPHANET
23547	7136	TNNI2	0.631	0.423	C1834523	ARTHROGRYPOSIS,DISTAL,TYPE2B	disease	C16;C05	DiseaseorSyndrome	0.96	1	2003	2018	4	4	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
23550	7137	TNNI3	0.52	0.769	C0007194	HypertrophicCardiomyopathy	disease	C14	DiseaseorSyndrome	0.7	0.991	1988	2019	14	19	CLINGEN;GENOMICS_ENGLAND
23551	7137	TNNI3	0.52	0.769	C0007196	Restrictivecardiomyopathy	disease	C14	DiseaseorSyndrome	0.7	1	2003	2017	1	5	CTD_human
23560	7137	TNNI3	0.52	0.769	C0878544	Cardiomyopathies	group	C14	DiseaseorSyndrome	0.69	1	2006	2018	1	5	CTD_human;GENOMICS_ENGLAND
23564	7137	TNNI3	0.52	0.769	C1860752	CARDIOMYOPATHY,FAMILIALHYPERTROPHIC,7	disease		DiseaseorSyndrome	0.9	1	1997	2019	8	15	CTD_human;GENOMICS_ENGLAND;UNIPROT
23565	7137	TNNI3	0.52	0.769	C1861861	CARDIOMYOPATHY,FAMILIALRESTRICTIVE,1(disorder)	disease	C14	DiseaseorSyndrome	0.8	1	2003	2019	4	10	CTD_human;GENOMICS_ENGLAND;UNIPROT
23566	7137	TNNI3	0.52	0.769	C2678474	CARDIOMYOPATHY,DILATED,2A(disorder)	disease	C14	DiseaseorSyndrome	0.7	1	2003	2019	5	3	CTD_human;GENOMICS_ENGLAND;UNIPROT
23567	7137	TNNI3	0.52	0.769	C2750091	Cardiomyopathy,Dilated,1FF	disease	C14	DiseaseorSyndrome	0.7	1	2003	2019	5	6	CTD_human;GENOMICS_ENGLAND;UNIPROT
23569	7138	TNNT1	0.633	0.577	C1854380	NEMALINEMYOPATHY5	disease	C05;C10	DiseaseorSyndrome	0.95	1	2000	2019	3	4	CTD_human;GENOMICS_ENGLAND;ORPHANET
23570	7139	TNNT2	0.601	0.423	C0007193	Cardiomyopathy,Dilated	group	C14	DiseaseorSyndrome	0.63	1	2000	2019	2	13	CTD_human
23571	7139	TNNT2	0.601	0.423	C0007194	HypertrophicCardiomyopathy	disease	C14	DiseaseorSyndrome	0.8	0.982	1991	2018	12	19	CLINGEN;CTD_human;GENOMICS_ENGLAND
23597	7139	TNNT2	0.601	0.423	C0878544	Cardiomyopathies	group	C14	DiseaseorSyndrome	0.7	1	2004	2019	2	3	CTD_human;GENOMICS_ENGLAND
23604	7139	TNNT2	0.601	0.423	C1832243	CARDIOMYOPATHY,DILATED,1D(disorder)	disease	C14	DiseaseorSyndrome	0.9	1	1991	2019	8	24	CTD_human;GENOMICS_ENGLAND;UNIPROT
23605	7139	TNNT2	0.601	0.423	C1861864	Cardiomyopathy,FamilialHypertrophic,2	disease	C16;C14	DiseaseorSyndrome	0.9	1	1991	2019	16	30	CTD_human;GENOMICS_ENGLAND;UNIPROT
23609	7139	TNNT2	0.601	0.423	C2676271	CARDIOMYOPATHY,FAMILIALRESTRICTIVE,3(disorder)	disease	C14	DiseaseorSyndrome	0.6	1	1991	2019	3	21	CTD_human;GENOMICS_ENGLAND
23612	7140	TNNT3	0.653	0.308	C0220662	ARTHROGRYPOSIS,DISTAL,TYPE1	disease	C16;C05	DiseaseorSyndrome;CongenitalAbnormality	0.52	1	2009	2013	2	0	GENOMICS_ENGLAND;ORPHANET
23613	7140	TNNT3	0.653	0.308	C1834523	ARTHROGRYPOSIS,DISTAL,TYPE2B	disease	C16;C05	DiseaseorSyndrome	0.52	1	2003	2013	4	0	GENOMICS_ENGLAND;ORPHANET
23625	7148	TNXB	0.572	0.731	C1848029	Ehlers-Danlossyndromecausedbytenascin-Xdeficiency	disease	C16;C17;C15;C14	DiseaseorSyndrome	0.61	1	1997	2017	4	3	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
23626	7148	TNXB	0.572	0.731	C4014831	VESICOURETERALREFLUX8	disease		DiseaseorSyndrome	0.6	1	2013	2013	1	3	GENOMICS_ENGLAND;UNIPROT
23665	7156	TOP3A	0.656	0.615	C4748176	MICROCEPHALY,GROWTHRESTRICTION,ANDINCREASEDSISTERCHROMATIDEXCHANGE2	disease		DiseaseorSyndrome	0.6	1	2018	2018	1	3	GENOMICS_ENGLAND;UNIPROT
23667	7157	TP53	0.236	0.962	C0001418	Adenocarcinoma	group	C04	NeoplasticProcess	0.7	0.975	1986	2020	3	1	CTD_human
23676	7157	TP53	0.236	0.962	C0005684	Malignantneoplasmofurinarybladder	disease	C04;C13;C12	NeoplasticProcess	0.6	0.97	1991	2020	5	0	CTD_human
23677	7157	TP53	0.236	0.962	C0005695	BladderNeoplasm	disease	C04;C13;C12	NeoplasticProcess	0.6	0.984	1991	2020	5	0	CTD_human
23678	7157	TP53	0.236	0.962	C0006118	BrainNeoplasms	group	C04;C10	NeoplasticProcess	0.7	0.947	1991	2019	0	72	UNIPROT
23679	7157	TP53	0.236	0.962	C0006142	Malignantneoplasmofbreast	disease	C04;C17	NeoplasticProcess	1	0.973	1982	2020	6	9	CGI;CTD_human;GENOMICS_ENGLAND;UNIPROT
23685	7157	TP53	0.236	0.962	C0007114	Malignantneoplasmofskin	disease	C04;C17	NeoplasticProcess	0.6	0.97	1991	2019	1	0	CTD_human
23688	7157	TP53	0.236	0.962	C0007137	Squamouscellcarcinoma	disease	C04	NeoplasticProcess	0.6	0.95	1990	2019	2	0	CTD_human
23697	7157	TP53	0.236	0.962	C0009402	ColorectalCarcinoma	disease	C06;C04	NeoplasticProcess	0.7	0.947	1989	2020	8	7	CTD_human;GENOMICS_ENGLAND
23698	7157	TP53	0.236	0.962	C0009404	ColorectalNeoplasms	group	C06;C04	NeoplasticProcess	0.7	0.989	1991	2018	8	67	CTD_human
23704	7157	TP53	0.236	0.962	C0014859	EsophagealNeoplasms	group	C06;C04	NeoplasticProcess	0.6	0.969	1990	2020	2	0	CTD_human
23706	7157	TP53	0.236	0.962	C0017638	Glioma	disease	C04	NeoplasticProcess	0.9	0.946	1991	2020	3	2	CGI;CTD_human
23708	7157	TP53	0.236	0.962	C0018923	Hemangiosarcoma	disease	C04	NeoplasticProcess	0.6	0.947	1994	2019	1	0	CTD_human
23719	7157	TP53	0.236	0.962	C0023434	ChronicLymphocyticLeukemia	disease	C04;C20;C15	NeoplasticProcess	0.8	0.977	1991	2020	6	22	CGI;CTD_human;ORPHANET
23722	7157	TP53	0.236	0.962	C0023467	Leukemia,Myelocytic,Acute	disease	C04	NeoplasticProcess	0.7	0.961	1986	2020	0	27	CGI
23724	7157	TP53	0.236	0.962	C0023903	Liverneoplasms	group	C06;C04	NeoplasticProcess	0.7	0.945	1991	2019	2	0	CTD_human
23727	7157	TP53	0.236	0.962	C0024121	LungNeoplasms	group	C04;C08	NeoplasticProcess	0.8	0.974	1990	2019	5	0	CGI;CTD_human
23730	7157	TP53	0.236	0.962	C0025202	melanoma	disease	C04	NeoplasticProcess	0.7	0.943	1991	2020	4	0	CGI;CTD_human
23731	7157	TP53	0.236	0.962	C0026640	MouthNeoplasms	group	C04;C07	NeoplasticProcess	0.55	0.875	1995	2013	1	0	CTD_human
23734	7157	TP53	0.236	0.962	C0027627	NeoplasmMetastasis	phenotype	C23;C04	NeoplasticProcess	0.6	0.936	1991	2020	1	0	CTD_human
23736	7157	TP53	0.236	0.962	C0029463	Osteosarcoma	disease	C04	NeoplasticProcess	1	0.953	1987	2020	4	9	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
23739	7157	TP53	0.236	0.962	C0030297	PancreaticNeoplasm	disease	C06;C04;C19	NeoplasticProcess	0.9	1	1993	2019	0	0	CGI;CTD_human
23748	7157	TP53	0.236	0.962	C0037286	SkinNeoplasms	group	C04;C17	NeoplasticProcess	0.7	0.977	1993	2017	1	0	CTD_human
23758	7157	TP53	0.236	0.962	C0079772	T-CellLymphoma	disease	C04;C20;C15	NeoplasticProcess	0.6	0.964	1994	2018	1	0	CTD_human
23761	7157	TP53	0.236	0.962	C0085390	Li-FraumeniSyndrome	disease	C16;C04;C18	DiseaseorSyndrome	1	0.977	1988	2020	22	180	CLINGEN;CTD_human;GENOMICS_ENGLAND;UNIPROT
23764	7157	TP53	0.236	0.962	C0149925	Smallcellcarcinomaoflung	disease	C04;C08	NeoplasticProcess	0.7	0.96	1990	2019	3	32	CTD_human;ORPHANET
23767	7157	TP53	0.236	0.962	C0153381	Malignantneoplasmofmouth	group	C04;C07	NeoplasticProcess	0.6	0.886	1992	2019	1	0	CTD_human
23770	7157	TP53	0.236	0.962	C0205641	Adenocarcinoma,BasalCell	disease	C04	NeoplasticProcess	0.51	1	1994	2012	3	0	CTD_human
23774	7157	TP53	0.236	0.962	C0205645	Adenocarcinoma,Tubular	disease	C04	NeoplasticProcess	0.54	1	1994	2015	3	0	CTD_human
23785	7157	TP53	0.236	0.962	C0205770	ChoroidPlexusPapilloma	disease	C04;C10	NeoplasticProcess	0.74	0.75	2002	2016	1	7	CTD_human;GENOMICS_ENGLAND;ORPHANET
23786	7157	TP53	0.236	0.962	C0205944	Sarcoma,Epithelioid	disease	C04	NeoplasticProcess	0.52	1	2009	2013	1	0	CTD_human
23787	7157	TP53	0.236	0.962	C0205945	Sarcoma,SpindleCell	disease	C04	NeoplasticProcess	0.51	1	2009	2018	1	0	CTD_human
23788	7157	TP53	0.236	0.962	C0205969	ThymicCarcinoma	disease	C04;C15	NeoplasticProcess	0.56	1	1995	2019	1	0	CGI;CTD_human
23790	7157	TP53	0.236	0.962	C0206686	Adrenocorticalcarcinoma	disease	C04;C19	NeoplasticProcess	0.8	0.96	1992	2017	5	18	CGI;CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
23791	7157	TP53	0.236	0.962	C0206698	Cholangiocarcinoma	disease	C04	NeoplasticProcess	0.6	0.885	1993	2019	1	0	CTD_human
23794	7157	TP53	0.236	0.962	C0235974	Pancreaticcarcinoma	disease	C06;C04;C19	NeoplasticProcess	0.7	0.965	1991	2019	0	7	CGI;GENOMICS_ENGLAND
23795	7157	TP53	0.236	0.962	C0242379	Malignantneoplasmoflung	disease	C04;C08	NeoplasticProcess	0.8	0.944	1989	2020	5	0	CGI;CTD_human
23796	7157	TP53	0.236	0.962	C0259783	mixedgliomas	disease	C04	NeoplasticProcess	0.51	1	2006	2014	3	0	CTD_human
23804	7157	TP53	0.236	0.962	C0279626	Squamouscellcarcinomaofesophagus	disease	C06;C04	NeoplasticProcess	0.6	0.98	1991	2020	1	0	CTD_human
23811	7157	TP53	0.236	0.962	C0345904	Malignantneoplasmofliver	disease	C06;C04	NeoplasticProcess	0.6	0.957	1993	2020	2	0	CTD_human
23812	7157	TP53	0.236	0.962	C0345905	IntrahepaticCholangiocarcinoma	disease	C04	NeoplasticProcess	0.6	1	1995	2019	1	0	CTD_human
23815	7157	TP53	0.236	0.962	C0346647	Malignantneoplasmofpancreas	disease	C06;C04;C19	NeoplasticProcess	0.8	0.978	1991	2019	0	0	CGI;CTD_human
23827	7157	TP53	0.236	0.962	C0546837	Malignantneoplasmofesophagus	disease	C06;C04	NeoplasticProcess	0.7	0.963	1990	2020	2	1	CTD_human
23828	7157	TP53	0.236	0.962	C0549473	Thyroidcarcinoma	disease	C04;C19	NeoplasticProcess	0.6	0.955	1991	2019	1	0	CGI;CTD_human
23829	7157	TP53	0.236	0.962	C0555198	MalignantGlioma	disease	C04	NeoplasticProcess	0.6	1	1992	2019	3	0	CTD_human
23833	7157	TP53	0.236	0.962	C0678222	BreastCarcinoma	disease	C04;C17	NeoplasticProcess	0.9	0.971	1982	2020	6	0	CGI;CTD_human
23852	7157	TP53	0.236	0.962	C0919267	ovarianneoplasm	disease	C04;C13;C19	NeoplasticProcess	0.7	0.963	1991	2020	1	170	CGI;CTD_human
23853	7157	TP53	0.236	0.962	C1140680	Malignantneoplasmofovary	disease	C04;C13;C19	NeoplasticProcess	0.7	0.958	1991	2020	1	0	CGI;CTD_human
23857	7157	TP53	0.236	0.962	C1261473	Sarcoma	group	C04	NeoplasticProcess	1	0.955	1987	2020	2	1	CGI;CTD_human;GENOMICS_ENGLAND
23865	7157	TP53	0.236	0.962	C1458155	MammaryNeoplasms	group	C04;C17	NeoplasticProcess	0.7	0.984	1982	2020	6	84	CTD_human
23871	7157	TP53	0.236	0.962	C1859972	ADRENOCORTICALCARCINOMA,HEREDITARY	disease	C04;C19	NeoplasticProcess	0.62	1	1994	2001	0	6	CTD_human;GENOMICS_ENGLAND
23875	7157	TP53	0.236	0.962	C2239176	Livercarcinoma	disease	C06;C04	NeoplasticProcess	1	0.959	1990	2020	6	67	CGI;CTD_human;GENOMICS_ENGLAND
23887	7157	TP53	0.236	0.962	C2931822	Nasopharyngealcarcinoma	disease	C04;C07;C09	NeoplasticProcess	0.7	0.924	1992	2019	1	6	CTD_human;GENOMICS_ENGLAND
23891	7157	TP53	0.236	0.962	C3714644	ThymusNeoplasms	group	C04;C15	NeoplasticProcess	0.51	1	1998	2000	0	0	CGI
23892	7157	TP53	0.236	0.962	C3805278	ExtrahepaticCholangiocarcinoma	disease	C04	NeoplasticProcess	0.56	1	2000	2019	1	0	CTD_human
23895	7157	TP53	0.236	0.962	C4704874	MammaryCarcinoma,Human	disease	C04;C17	NeoplasticProcess	0.51	1	1999	2018	6	0	CTD_human
23941	7166	TPH1	0.553	0.731	C0011570	MentalDepression	disease	F01	MentalorBehavioralDysfunction	0.6	1	2004	2019	5	0	PSYGENET
24012	7274	TTPA	0.612	0.577	C1848533	AtaxiawithvitaminEdeficiency	disease	C23;C18;C10	DiseaseorSyndrome	1	1	1985	2015	10	29	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
24017	7275	TUB	0.659	0.385	C4015424	RETINALDYSTROPHYANDOBESITY	disease		DiseaseorSyndrome	0.61	1	1996	2014	1	1	CTD_human;GENOMICS_ENGLAND
24019	7276	TTR	0.423	0.885	C0007286	CarpalTunnelSyndrome	disease	C10;C26	DiseaseorSyndrome	0.8	0.95	1991	2019	2	4	CTD_human;GENOMICS_ENGLAND;UNIPROT
24030	7276	TTR	0.423	0.885	C0206245	AmyloidNeuropathies,Familial	group	C16;C18;C10	DiseaseorSyndrome	0.7	1	1983	2019	6	0	CTD_human;GENOMICS_ENGLAND;ORPHANET
24039	7276	TTR	0.423	0.885	C0740340	Amyloidosis,Familial	disease	C16;C18	DiseaseorSyndrome	0.6	1	1981	2019	3	0	CTD_human;GENOMICS_ENGLAND
24047	7276	TTR	0.423	0.885	C2750824	DystransthyretinemicEuthyroidalHyperthyroxinemia	disease	C19	DiseaseorSyndrome	0.7	1	1990	2018	2	4	CTD_human;GENOMICS_ENGLAND;UNIPROT
24048	7276	TTR	0.423	0.885	C2751492	AMYLOIDOSIS,HEREDITARY,TRANSTHYRETIN-RELATED	disease	C16;C18;C10	DiseaseorSyndrome	1	0.992	1983	2020	74	51	CTD_human;GENOMICS_ENGLAND;UNIPROT
24054	7277	TUBA4A	0.751	0.269	C4015512	AMYOTROPHICLATERALSCLEROSIS22WITHORWITHOUTFRONTOTEMPORALDEMENTIA	disease		DiseaseorSyndrome	0.7	1	2014	2015	2	6	CTD_human;GENOMICS_ENGLAND;UNIPROT
24065	7280	TUBB2A	0.678	0.538	C3810407	CORTICALDYSPLASIA,COMPLEX,WITHOTHERBRAINMALFORMATIONS5	disease		DiseaseorSyndrome	0.7	1	2014	2014	2	5	CTD_human;GENOMICS_ENGLAND;UNIPROT
24072	7283	TUBG1	0.729	0.231	C3809420	CORTICALDYSPLASIA,COMPLEX,WITHOTHERBRAINMALFORMATIONS4	disease		DiseaseorSyndrome	0.7	1	2013	2018	3	2	CTD_human;GENOMICS_ENGLAND;UNIPROT
24076	7284	TUFM	0.678	0.615	C1857682	CombinedOxidativePhosphorylationDeficiency4	disease	C16;C18	DiseaseorSyndrome	0.71	1	2007	2019	4	4	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
24080	7287	TULP1	0.623	0.462	C0339527	LeberCongenitalAmaurosis	disease	C11	DiseaseorSyndrome	0.66	1	1999	2016	2	1	GENOMICS_ENGLAND;ORPHANET
24081	7287	TULP1	0.623	0.462	C1838603	RetinitisPigmentosa14	disease	C16;C11	DiseaseorSyndrome	0.91	1	1997	2010	5	11	CTD_human;GENOMICS_ENGLAND;UNIPROT
24082	7287	TULP1	0.623	0.462	C3151206	LEBERCONGENITALAMAUROSIS15	disease		DiseaseorSyndrome	0.7	1	2004	2007	2	4	CTD_human;GENOMICS_ENGLAND;UNIPROT
24100	7291	TWIST1	0.397	0.846	C0175699	Saethre-ChotzenSyndrome	disease	C16;C05	DiseaseorSyndrome	1	0.986	1995	2019	7	19	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
24103	7291	TWIST1	0.397	0.846	C0221356	Brachycephaly	disease	C16;C05	CongenitalAbnormality	0.6	1	2002	2007	2	0	CTD_human;ORPHANET
24105	7291	TWIST1	0.397	0.846	C0265534	Scaphycephaly	disease	C16;C05	CongenitalAbnormality	0.62	1	2002	2010	2	0	CTD_human;ORPHANET
24113	7291	TWIST1	0.397	0.846	C1867146	RobinowSoraufsyndrome	disease	C16;C05	DiseaseorSyndrome	0.6	1	1997	1998	2	1	CTD_human;GENOMICS_ENGLAND
24116	7291	TWIST1	0.397	0.846	C4551902	Craniosynostosis,Type1	disease	C16;C05	DiseaseorSyndrome	0.7	1	1997	2015	3	12	CTD_human;GENOMICS_ENGLAND;UNIPROT
24117	7292	TNFSF4	0.54	0.808	C0024141	LupusErythematosus,Systemic	disease	C17;C20	DiseaseorSyndrome	0.6	0.967	2008	2019	8	0	CTD_human;ORPHANET
24124	7293	TNFRSF4	0.547	0.692	C3810053	IMMUNODEFICIENCY16	disease		DiseaseorSyndrome	0.61	0	2013	2013	1	1	CTD_human;ORPHANET;UNIPROT
24163	7297	TYK2	0.505	0.769	C0010346	CrohnDisease	disease	C06	DiseaseorSyndrome	0.62	0.8	2010	2016	1	2	CTD_human;GENOMICS_ENGLAND
24182	7297	TYK2	0.505	0.769	C1969086	TyrosineKinase2Deficiency	disease	C16;C20;C15	DiseaseorSyndrome	0.72	1	2006	2016	3	7	CTD_human;GENOMICS_ENGLAND;ORPHANET
24196	7298	TYMS	0.425	0.846	C0009404	ColorectalNeoplasms	group	C06;C04	NeoplasticProcess	0.6	1	1998	2015	11	0	CTD_human
24259	7299	TYR	0.473	0.808	C0078918	Albinism,Oculocutaneous	disease	C16;C18;C11;C17	CongenitalAbnormality	0.9	0.982	1981	2019	3	10	CTD_human;GENOMICS_ENGLAND
24263	7299	TYR	0.473	0.808	C0268494	Oculocutaneousalbinismtype1	disease	C16;C18;C11;C17	DiseaseorSyndrome	0.7	1	1991	2018	1	1	CTD_human;GENOMICS_ENGLAND
24267	7299	TYR	0.473	0.808	C1847024	ALBINISM,OCULOCUTANEOUS,TYPEIB(disorder)	disease	C16;C18;C11;C17	DiseaseorSyndrome	0.72	1	1990	2017	6	24	CTD_human;GENOMICS_ENGLAND;UNIPROT
24268	7299	TYR	0.473	0.808	C1863198	ALBINISM,OCULAR,WITHSENSORINEURALDEAFNESS(disorder)	disease		DiseaseorSyndrome	0.6	1	1997	2017	2	12	GENOMICS_ENGLAND;ORPHANET
24270	7299	TYR	0.473	0.808	C4551504	Oculocutaneousalbinismtype1A	disease	C16;C18;C11;C17	DiseaseorSyndrome	0.8	1	1989	2017	23	100	CTD_human;GENOMICS_ENGLAND;UNIPROT
24278	7305	TYROBP	0.573	0.769	C1857316	POLYCYSTICLIPOMEMBRANOUSOSTEODYSPLASIAWITHSCLEROSINGLEUKOENCEPHALOPATHY	disease	C16;C18;C01;C17;C05;C10	DiseaseorSyndrome	0.7	1	1990	2019	0	5	CTD_human
24291	7306	TYRP1	0.507	0.846	C0342683	ALBINISM,OCULOCUTANEOUS,TYPEIII	disease	C16;C18;C11;C17	DiseaseorSyndrome	0.74	1	1997	2013	4	9	GENOMICS_ENGLAND;ORPHANET;UNIPROT
24293	7306	TYRP1	0.507	0.846	C2931599	Oculocutaneousalbinismtype3	disease	C16;C18;C11;C17	DiseaseorSyndrome	0.64	1	2004	2011	0	0	CTD_human;GENOMICS_ENGLAND;ORPHANET
24304	7307	U2AF1	0.604	0.577	C3463824	MYELODYSPLASTICSYNDROME	group	C15	NeoplasticProcess	0.8	0.963	2011	2020	2	2	CGI;CTD_human;UNIPROT
24313	7317	UBA1	0.666	0.615	C1844934	Arthrogryposismultiplexcongenita,distal,X-linked	disease	C16;C05	DiseaseorSyndrome	0.72	1	2008	2015	2	3	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
24315	7319	UBE2A	0.623	0.692	C3275464	MENTALRETARDATION,X-LINKED,SYNDROMIC,NASCIMENTOTYPE	disease		DiseaseorSyndrome	0.7	1	2006	2018	7	4	CLINGEN;CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
24351	7337	UBE3A	0.561	0.692	C0162635	AngelmanSyndrome	disease	C16;C10	DiseaseorSyndrome	1	0.967	1997	2020	12	0	CLINGEN;CTD_human;GENOMICS_ENGLAND;UNIPROT
24368	7343	UBTF	0.705	0.462	C4540086	NEURODEGENERATION,CHILDHOOD-ONSET,WITHBRAINATROPHY	disease		DiseaseorSyndrome	0.7	1	2017	2017	1	1	GENOMICS_ENGLAND;ORPHANET;UNIPROT
24376	7345	UCHL1	0.482	0.885	C3150899	PARKINSONDISEASE5,AUTOSOMALDOMINANT	disease		DiseaseorSyndrome	0.7	1	1998	2003	4	1	CTD_human;GENOMICS_ENGLAND;UNIPROT
24377	7345	UCHL1	0.482	0.885	C3809665	SPASTICPARAPLEGIA79,AUTOSOMALRECESSIVE	disease		DiseaseorSyndrome	0.71	1	1998	2018	3	4	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
24407	7351	UCP2	0.493	0.808	C0011860	DiabetesMellitus,Non-Insulin-Dependent	disease	C18;C19	DiseaseorSyndrome	0.6	0.857	1998	2019	2	0	CTD_human
24408	7351	UCP2	0.493	0.808	C0015695	FattyLiver	disease	C06	DiseaseorSyndrome	0.54	1	2000	2019	1	0	CTD_human
24411	7351	UCP2	0.493	0.808	C0020538	Hypertensivedisease	group	C14	DiseaseorSyndrome	0.59	1	2004	2019	1	0	CTD_human
24430	7352	UCP3	0.619	0.577	C0028754	Obesity	disease	C23;C18	DiseaseorSyndrome	0.7	0.907	1998	2018	1	1	CTD_human;UNIPROT
24446	7355	SLC35A2	0.525	0.808	C3806688	Solutecarrierfamily35memberA2congenitaldisorderofglycosylation	disease	C16;C18;C05;C10	DiseaseorSyndrome	0.73	1	2013	2019	3	12	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
24479	7369	UMOD	0.52	0.846	C0022658	KidneyDiseases	group	C13;C12	DiseaseorSyndrome	0.7	1	1993	2019	2	0	CTD_human
24485	7369	UMOD	0.52	0.846	C1835934	GlomerulocysticKidneyDiseasewithHyperuricemiaandIsosthenuria	disease	C23;C13;C12	DiseaseorSyndrome	0.7	1	2003	2006	3	2	CTD_human;GENOMICS_ENGLAND;UNIPROT
24486	7369	UMOD	0.52	0.846	C1859040	MedullaryCysticKidneyDiseaseType2	disease	C16;C13;C12	DiseaseorSyndrome	0.79	1	2002	2019	8	5	CTD_human;GENOMICS_ENGLAND;UNIPROT
24489	7369	UMOD	0.52	0.846	C4551496	HyperuricemicNephropathy,FamilialJuvenile1	disease	C23;C16;C18;C13;C05;C12	DiseaseorSyndrome	1	1	2001	2018	14	18	CTD_human;GENOMICS_ENGLAND;UNIPROT
24501	7422	VEGFA	0.266	0.923	C0007102	Malignanttumorofcolon	disease	C06;C04	NeoplasticProcess	0.6	0.964	1995	2019	1	0	CTD_human
24530	7422	VEGFA	0.266	0.923	C0020541	PortalHypertension	disease	C06	DiseaseorSyndrome	0.54	1	2008	2016	1	0	CTD_human
24557	7422	VEGFA	0.266	0.923	C0033860	Psoriasis	disease	C17	DiseaseorSyndrome	0.6	0.951	1994	2020	1	0	CTD_human
24560	7422	VEGFA	0.266	0.923	C0035328	RetinalVeinOcclusion	disease	C11;C14	DiseaseorSyndrome	0.6	1	2006	2019	1	0	CTD_human
24625	7504	XK	0.575	0.654	C0398568	Bloodgroupdeletionsyndrome	disease	C16;C10	DiseaseorSyndrome	0.72	1	1998	2019	3	3	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
24637	7507	XPA	0.52	0.846	C0043346	XerodermaPigmentosum	disease	C16;C04;C18;C17	CongenitalAbnormality	0.7	1	1991	2020	1	4	CTD_human
24639	7507	XPA	0.52	0.846	C0268135	Xerodermapigmentosum,groupA	disease	C16;C04;C18;C17	DiseaseorSyndrome	1	0.968	1978	2019	17	46	CLINGEN;GENOMICS_ENGLAND;UNIPROT
24652	7508	XPC	0.504	0.808	C0007137	Squamouscellcarcinoma	disease	C04	NeoplasticProcess	0.56	0.714	2005	2017	1	0	CGI;CTD_human
24659	7508	XPC	0.504	0.808	C0043346	XerodermaPigmentosum	disease	C16;C04;C18;C17	CongenitalAbnormality	0.7	0.974	1994	2019	1	5	CTD_human
24668	7508	XPC	0.504	0.808	C2752147	XERODERMAPIGMENTOSUM,COMPLEMENTATIONGROUPC	disease	C16;C04;C18;C17	DiseaseorSyndrome;CongenitalAbnormality	1	0.987	1989	2019	15	59	CLINGEN;CTD_human;GENOMICS_ENGLAND;UNIPROT
24708	7516	XRCC2	0.512	0.731	C0015625	FanconiAnemia	disease	C16;C18;C15	DiseaseorSyndrome	0.54	1	2012	2019	3	0	GENOMICS_ENGLAND;ORPHANET
24712	7516	XRCC2	0.512	0.731	C0346153	BreastCancer,Familial	disease	C04;C17	NeoplasticProcess	0.53	1	1999	2019	4	0	CLINGEN;ORPHANET
24743	7517	XRCC3	0.505	0.769	C3151417	MELANOMA,CUTANEOUSMALIGNANT,SUSCEPTIBILITYTO,6	phenotype		Finding	0.6	1	2000	2000	1	0	CTD_human;UNIPROT
24760	7518	XRCC4	0.528	0.769	C4225288	SHORTSTATURE,MICROCEPHALY,ANDENDOCRINEDYSFUNCTION	disease		DiseaseorSyndrome	0.6	1	2014	2018	5	9	GENOMICS_ENGLAND;UNIPROT
24780	7528	YY1	0.481	0.808	C3714756	IntellectualDisability	group	C23;C10;F03;F01	MentalorBehavioralDysfunction	0.6	1	2010	2010	1	0	CTD_human;GENOMICS_ENGLAND
24782	7528	YY1	0.481	0.808	C4479652	GABRIELE-DEVRIESSYNDROME	disease		DiseaseorSyndrome	0.7	1	2010	2017	2	6	GENOMICS_ENGLAND;ORPHANET;UNIPROT
24788	7531	YWHAE	0.53	0.692	C0265219	MillerDiekersyndrome	disease	C16;C10	DiseaseorSyndrome	0.6	1	2000	2017	1	0	ORPHANET
24794	7532	YWHAG	0.621	0.5	C4540034	EPILEPTICENCEPHALOPATHY,EARLYINFANTILE,56	disease		DiseaseorSyndrome	0.6	1	2014	2017	3	4	GENOMICS_ENGLAND;UNIPROT
24816	7535	ZAP70	0.497	0.769	C0085110	SevereCombinedImmunodeficiency	disease	C16;C18;C20	DiseaseorSyndrome	0.6	0.846	1994	2017	2	0	CTD_human;GENOMICS_ENGLAND
24821	7535	ZAP70	0.497	0.769	C2931299	ZAP70deficiency	disease	C16;C18;C20	DiseaseorSyndrome	0.73	1	1994	2019	5	8	CTD_human;GENOMICS_ENGLAND;UNIPROT
24823	7535	ZAP70	0.497	0.769	C4310768	AUTOIMMUNEDISEASE,MULTISYSTEM,INFANTILE-ONSET,2	disease		DiseaseorSyndrome	0.7	1	2016	2016	2	2	CTD_human;GENOMICS_ENGLAND;UNIPROT
24841	7545	ZIC1	0.545	0.731	C0030044	Acrocephaly	disease	C16;C05	CongenitalAbnormality	0.6	1	2015	2015	1	0	CTD_human;ORPHANET
24842	7545	ZIC1	0.545	0.731	C0221356	Brachycephaly	disease	C16;C05	CongenitalAbnormality	0.6	1	2015	2015	1	0	CTD_human;ORPHANET
24855	7546	ZIC2	0.556	0.769	C0036341	Schizophrenia	disease	F03	MentalorBehavioralDysfunction	0.52	1	2011	2018	1	0	PSYGENET
24867	7546	ZIC2	0.556	0.769	C1864827	HOLOPROSENCEPHALY5	disease	C16;C05;C10	DiseaseorSyndrome	0.9	1	1998	2016	8	14	CTD_human;GENOMICS_ENGLAND;UNIPROT
24871	7547	ZIC3	0.587	0.423	C0266642	Situsambiguus	disease	C16;C15;C14	CongenitalAbnormality	0.6	1	1997	2018	1	0	GENOMICS_ENGLAND;ORPHANET
24877	7547	ZIC3	0.587	0.423	C1844020	HETEROTAXY,VISCERAL,1,X-LINKED	disease	C16;C15;C14	DiseaseorSyndrome	0.91	1	1952	2014	7	15	CTD_human;GENOMICS_ENGLAND;UNIPROT
24880	7547	ZIC3	0.587	0.423	C3178805	HeterotaxySyndrome	disease	C16;C15;C14	DiseaseorSyndrome	0.52	0.889	1952	2018	0	0	GENOMICS_ENGLAND
24886	7552	ZNF711	0.691	0.423	C1136249	MentalRetardation,X-Linked	disease	C16;C10	DiseaseorSyndrome	0.52	1	1999	2010	1	0	CTD_human;GENOMICS_ENGLAND
24887	7552	ZNF711	0.691	0.423	C2749020	MentalRetardation,X-Linked,Znf711-Related	disease	C23;C16;C10;F03;F01	DiseaseorSyndrome	0.6	1	2009	2017	2	8	GENOMICS_ENGLAND;UNIPROT
24893	7555	CNBP	0.556	0.692	C2931689	Dystrophiamyotonica2	disease	C16;C05;C10	DiseaseorSyndrome	0.6	0.978	2002	2018	1	0	CTD_human;GENOMICS_ENGLAND
24897	7592	ZNF41	0.711	0.385	C1136249	MentalRetardation,X-Linked	disease	C16;C10	DiseaseorSyndrome	0.52	1	2003	2013	2	0	CTD_human;GENOMICS_ENGLAND
24913	7700	ZNF141	0.792	0.154	C3808889	POLYDACTYLY,POSTAXIAL,TYPEA6	disease		DiseaseorSyndrome	0.6	1	2013	2013	1	1	GENOMICS_ENGLAND;UNIPROT
24926	7704	ZBTB16	0.545	0.808	C0023487	AcutePromyelocyticLeukemia	disease	C04	NeoplasticProcess	0.6	0.975	1993	2019	3	0	CTD_human;ORPHANET
24933	7704	ZBTB16	0.545	0.808	C2676231	SkeletalDefects,GenitalHypoplasia,AndMentalRetardation	disease	C23;C16;C05;C12;C10;C19;F03;F01	DiseaseorSyndrome	0.7	1	2008	2008	1	1	CTD_human;GENOMICS_ENGLAND;UNIPROT
24934	7707	ZNF148	0.615	0.654	C4310644	GLOBALDEVELOPMENTALDELAY,ABSENTORHYPOPLASTICCORPUSCALLOSUM,ANDDYSMORPHICFACIES	disease		DiseaseorSyndrome	0.6	1	2016	2016	1	1	CTD_human;GENOMICS_ENGLAND
24941	7737	RNF113A	0.597	0.769	C4225420	TRICHOTHIODYSTROPHY5,NONPHOTOSENSITIVE	disease		DiseaseorSyndrome	0.6	1	2013	2017	2	1	CTD_human;GENOMICS_ENGLAND
24981	7780	SLC30A2	0.821	0.192	C1842486	ZincDeficiency,Neonatal,duetoLowBreastMilkZinc	disease	C23	DiseaseorSyndrome	0.65	0.833	2006	2019	2	2	CTD_human;UNIPROT
24988	7784	ZP3	0.805	0.115	C4540205	OOCYTEMATURATIONDEFECT3	disease		DiseaseorSyndrome	0.6	1	2017	2017	2	1	ORPHANET;UNIPROT
25009	7809	BSND	0.603	0.692	C1865270	BARTTERSYNDROME,TYPE4A	disease	C23;C13;C12;C10;C19;C09	DiseaseorSyndrome	0.91	1	1998	2017	11	6	CLINGEN;CTD_human;GENOMICS_ENGLAND;UNIPROT
25021	7827	NPHS2	0.576	0.538	C0027726	NephroticSyndrome	group	C13;C12	DiseaseorSyndrome	0.7	1	1995	2019	1	0	CTD_human
25029	7827	NPHS2	0.576	0.538	C1868672	NEPHROTICSYNDROME,STEROID-RESISTANT,AUTOSOMALRECESSIVE	disease	C13;C12	DiseaseorSyndrome	0.61	1	2000	2018	3	34	CTD_human;ORPHANET
25030	7827	NPHS2	0.576	0.538	C3496337	IdiopathicNephroticSyndrome	disease	C13;C12	DiseaseorSyndrome	0.68	1	1995	2018	15	42	GENOMICS_ENGLAND;UNIPROT
25039	7837	PXDN	0.647	0.5	C3151617	ANTERIORSEGMENTDYSGENESIS7	disease		DiseaseorSyndrome	0.7	1	2011	2015	2	4	GENOMICS_ENGLAND;ORPHANET;UNIPROT
25043	7840	ALMS1	0.559	0.808	C0268425	AlstromSyndrome	disease	C16;C11;C10	DiseaseorSyndrome	1	1	1998	2020	11	179	CLINGEN;CTD_human;GENOMICS_ENGLAND
25048	7841	MOGS	0.626	0.731	C1853736	CongenitalDisorderOfGlycosylation,TypeIIB	disease	C16;C18	DiseaseorSyndrome	0.73	1	1973	2019	5	5	CTD_human;GENOMICS_ENGLAND;UNIPROT
25059	7846	TUBA1A	0.597	0.769	C1969029	Lissencephaly3	disease	C23;C16;C05;C10;F03;F01	DiseaseorSyndrome	0.7	1	2007	2018	6	40	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
25066	7849	PAX8	0.477	0.731	C0010308	CongenitalHypothyroidism	disease	C16;C05;C19	DiseaseorSyndrome	0.7	1	1998	2019	1	0	GENOMICS_ENGLAND
25067	7849	PAX8	0.477	0.731	C0151516	ThyroidHypoplasia	disease	C16;C19	DiseaseorSyndrome	0.7	0.917	1998	2014	4	0	GENOMICS_ENGLAND;ORPHANET
25071	7849	PAX8	0.477	0.731	C1869118	HYPOTHYROIDISM,CONGENITAL,DUETOTHYROIDDYSGENESIS	disease	C16;C05;C19	CongenitalAbnormality	0.71	1	1998	2019	3	0	CTD_human;GENOMICS_ENGLAND;UNIPROT
25106	7852	CXCR4	0.362	0.923	C0472817	WHIMsyndrome	disease	C16;C01;C17;C20	DiseaseorSyndrome	1	1	2000	2019	3	5	CTD_human;GENOMICS_ENGLAND;ORPHANET
25127	7862	BRPF1	0.686	0.385	C4310617	INTELLECTUALDEVELOPMENTALDISORDERWITHDYSMORPHICFACIESANDPTOSIS	disease		DiseaseorSyndrome	0.71	1	2017	2019	2	14	CTD_human;GENOMICS_ENGLAND;UNIPROT
25131	7867	MAPKAPK3	0.743	0.308	C4310713	MACULARDYSTROPHY,PATTERNED,3	disease		DiseaseorSyndrome	0.51	1	2016	2016	1	1	ORPHANET;UNIPROT
25135	7871	SLMAP	0.686	0.462	C1142166	BrugadaSyndrome(disorder)	disease	C16;C14	DiseaseorSyndrome	0.51	1	1997	2012	4	0	CLINGEN;ORPHANET
25142	7879	RAB7A	0.597	0.692	C1833219	CHARCOT-MARIE-TOOTHDISEASE,AXONAL,TYPE2B(disorder)	disease	C16;C10	DiseaseorSyndrome	0.8	1	2003	2019	6	4	CTD_human;GENOMICS_ENGLAND;UNIPROT
25170	7915	ALDH5A1	0.619	0.462	C0268631	succinicsemialdehydedehydrogenasedeficiency	disease	C16;C18;F03	DiseaseorSyndrome	0.8	1	2000	2019	9	16	CTD_human;GENOMICS_ENGLAND;UNIPROT
25225	8291	DYSF	0.582	0.692	C1847532	MYOPATHY,DISTAL,WITHANTERIORTIBIALONSET	disease	C16;C05;C10	DiseaseorSyndrome	0.71	1	2009	2019	3	10	CTD_human;GENOMICS_ENGLAND;ORPHANET
25227	8291	DYSF	0.582	0.692	C1850889	MUSCULARDYSTROPHY,LIMB-GIRDLE,TYPE2B	disease	C16;C05;C10	DiseaseorSyndrome	1	0.992	1989	2019	17	150	CTD_human;GENOMICS_ENGLAND;UNIPROT
25230	8291	DYSF	0.582	0.692	C4551973	MiyoshiMuscularDystrophy1	disease	C23;C16;C05;C10	DiseaseorSyndrome	0.7	0.974	1996	2019	19	24	CTD_human;GENOMICS_ENGLAND;UNIPROT
25234	8292	COLQ	0.628	0.654	C1864233	ENDPLATEACETYLCHOLINESTERASEDEFICIENCY(disorder)	disease	C16;C10	DiseaseorSyndrome	0.74	1	1998	2018	7	23	CTD_human;GENOMICS_ENGLAND;UNIPROT
25257	8302	KLRC4	0.666	0.654	C0004943	BehcetSyndrome	disease	C16;C11;C17;C07;C14	DiseaseorSyndrome	0.63	1	2013	2017	2	0	CTD_human;ORPHANET
25260	8309	ACOX2	0.769	0.423	C4310624	BILEACIDSYNTHESISDEFECT,CONGENITAL,6	disease		DiseaseorSyndrome	0.6	1	2016	2017	2	2	CTD_human;UNIPROT
25276	8312	AXIN1	0.559	0.577	C2239176	Livercarcinoma	disease	C06;C04	NeoplasticProcess	0.8	0.944	2000	2019	2	4	CGI;CTD_human;UNIPROT
25294	8313	AXIN2	0.507	0.692	C1837750	Oligodontia-ColorectalCancerSyndrome	disease	C16;C06;C04;C07	NeoplasticProcess	0.71	1	2004	2017	7	14	CLINGEN;CTD_human;ORPHANET
25300	8314	BAP1	0.454	0.731	C0006142	Malignantneoplasmofbreast	disease	C04;C17	NeoplasticProcess	0.6	1	1998	2019	2	0	CGI;CTD_human
25308	8314	BAP1	0.454	0.731	C0022665	KidneyNeoplasm	disease	C04;C13;C12	NeoplasticProcess	0.62	1	2016	2019	1	1	CGI;CTD_human
25314	8314	BAP1	0.454	0.731	C0025202	melanoma	disease	C04	NeoplasticProcess	0.7	0.95	2010	2019	0	1	CGI;GENOMICS_ENGLAND
25315	8314	BAP1	0.454	0.731	C0025286	Meningioma	disease	C04;C10	NeoplasticProcess	0.69	0.9	2011	2019	1	0	CTD_human;GENOMICS_ENGLAND
25316	8314	BAP1	0.454	0.731	C0025500	Mesothelioma	disease	C04	NeoplasticProcess	0.6	0.985	2011	2020	4	0	CGI;CTD_human
25326	8314	BAP1	0.454	0.731	C0151779	CutaneousMelanoma	disease	C04;C17	NeoplasticProcess	0.8	0.955	2012	2019	2	0	CGI;CTD_human;GENOMICS_ENGLAND
25340	8314	BAP1	0.454	0.731	C0220633	Uvealmelanoma	disease	C04;C11	NeoplasticProcess	0.8	0.973	2010	2020	5	2	CGI;CTD_human;GENOMICS_ENGLAND;ORPHANET
25341	8314	BAP1	0.454	0.731	C0242379	Malignantneoplasmoflung	disease	C04;C08	NeoplasticProcess	0.55	1	2015	2019	1	0	CTD_human;UNIPROT
25345	8314	BAP1	0.454	0.731	C0279702	Conventional(ClearCell)RenalCellCarcinoma	disease	C04;C13;C12	NeoplasticProcess	0.6	0.982	2011	2019	4	0	CGI;CTD_human
25366	8314	BAP1	0.454	0.731	C0678222	BreastCarcinoma	disease	C04;C17	NeoplasticProcess	0.6	1	1998	2019	2	0	CGI;CTD_human
25367	8314	BAP1	0.454	0.731	C0740457	Malignantneoplasmofkidney	disease	C04;C13;C12	NeoplasticProcess	0.56	0.857	2013	2019	1	0	CGI;CTD_human
25399	8314	BAP1	0.454	0.731	C3280492	TUMORPREDISPOSITIONSYNDROME	disease		DiseaseorSyndrome	0.79	1	2008	2019	7	56	CLINGEN;CTD_human;GENOMICS_ENGLAND;ORPHANET
25407	8318	CDC45	0.588	0.692	C1868684	EAR,PATELLA,SHORTSTATURESYNDROME	disease	C23;C16;C05;C07;C09	DiseaseorSyndrome	0.52	1	2016	2020	1	0	CTD_human;ORPHANET
25410	8318	CDC45	0.588	0.692	C4310738	MEIER-GORLINSYNDROME7	disease		DiseaseorSyndrome	0.6	1	2015	2016	2	12	GENOMICS_ENGLAND;UNIPROT
25435	8322	FZD4	0.49	0.923	C1851402	Exudativevitreoretinopathy1	disease	C16;C11	DiseaseorSyndrome	0.74	1	2002	2017	14	4	CTD_human;GENOMICS_ENGLAND;UNIPROT
25437	8323	FZD6	0.623	0.615	C3279974	NAILDISORDER,NONSYNDROMICCONGENITAL,10	disease		DiseaseorSyndrome	0.7	1	2011	2011	1	2	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
25442	8328	GFI1B	0.623	0.5	C1861194	Thrombasthenia-Thrombocytopenia,Hereditary	disease	C16;C15	DiseaseorSyndrome	0.71	1	2002	2019	12	4	CLINGEN;CTD_human;GENOMICS_ENGLAND
25505	8398	PLA2G6	0.476	0.846	C0270724	InfantileNeuroaxonalDystrophy	disease	C10	DiseaseorSyndrome	1	1	2004	2020	7	23	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
25507	8398	PLA2G6	0.476	0.846	C1857747	NEURODEGENERATIONWITHBRAINIRONACCUMULATION2(disorder)	disease	C18;C10	DiseaseorSyndrome	0.74	1	2006	2019	5	15	CTD_human;GENOMICS_ENGLAND;UNIPROT
25508	8398	PLA2G6	0.476	0.846	C2751842	PARKINSONDISEASE14,AUTOSOMALRECESSIVE	disease	C10	DiseaseorSyndrome	0.76	0.917	2006	2019	4	7	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
25521	8405	SPOP	0.597	0.5	C0376358	Malignantneoplasmofprostate	disease	C04;C12	NeoplasticProcess	0.7	0.957	2012	2020	3	1	CTD_human;GENOMICS_ENGLAND
25522	8405	SPOP	0.597	0.5	C0476089	EndometrialCarcinoma	disease	C04;C13	NeoplasticProcess	0.57	1	2012	2019	1	0	CGI;CTD_human
25565	8419	BFSP2	0.686	0.385	C3808115	CATARACT12,MULTIPLETYPES	disease		DiseaseorSyndrome	0.6	1	2000	2004	3	0	GENOMICS_ENGLAND;UNIPROT
25567	8425	LTBP4	0.604	0.654	C0010495	CutisLaxa	disease	C16;C17	DiseaseorSyndrome	0.6	1	2013	2013	1	0	GENOMICS_ENGLAND
25574	8425	LTBP4	0.604	0.654	C2750804	CutisLaxaWithSeverePulmonary,Gastrointestinal,AndUrinaryAbnormalities	disease	C16;C06;C13;C17;C05;C12;C08	DiseaseorSyndrome	0.7	1	2009	2015	3	10	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
25580	8431	NR0B2	0.474	0.808	C0028754	Obesity	disease	C23;C18	DiseaseorSyndrome	0.69	1	2001	2020	0	0	CTD_human;GENOMICS_ENGLAND
25605	8438	RAD54L	0.633	0.423	C0006142	Malignantneoplasmofbreast	disease	C04;C17	NeoplasticProcess	0.62	0.5	2017	2017	0	0	CTD_human;GENOMICS_ENGLAND;UNIPROT
25608	8438	RAD54L	0.633	0.423	C0024305	Lymphoma,Non-Hodgkin	disease	C04;C20;C15	NeoplasticProcess	0.6	NA	NA	NA	0	0	CGI;CTD_human;UNIPROT
25615	8438	RAD54L	0.633	0.423	C0338106	Adenocarcinomaofcolon	disease	C06;C04	NeoplasticProcess	0.6	NA	NA	NA	0	1	CGI;UNIPROT
25624	8438	RAD54L	0.633	0.423	C4721532	Lymphoma,Non-Hodgkin,Familial	disease	C04;C20;C15	NeoplasticProcess	0.6	NA	NA	NA	0	0	CTD_human;GENOMICS_ENGLAND
25630	8443	GNPAT	0.663	0.462	C1857242	Rhizomelicchondrodysplasiapunctata,type2	disease	C16;C18;C05	DiseaseorSyndrome	0.92	1	1992	2017	5	3	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
25636	8450	CUL4B	0.556	0.769	C1845861	MENTALRETARDATION,X-LINKED,WITHSHORTSTATURE,HYPOGONADISM,ANDABNORMALGAIT	disease	C16;C10	DiseaseorSyndrome	0.72	1	1991	2020	9	10	CLINGEN;CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
25650	8452	CUL3	0.592	0.654	C3469606	PSEUDOHYPOALDOSTERONISM,TYPEIIE	disease	C16;C13;C12	DiseaseorSyndrome	0.71	1	2012	2015	1	8	CTD_human;GENOMICS_ENGLAND;UNIPROT
25659	8456	FOXN1	0.615	0.654	C1866426	T-cellimmunodeficiency,congenitalalopeciaandnaildystrophy	disease	C23;C16;C18;C17;C20	DiseaseorSyndrome	0.91	1	1966	2014	3	3	CTD_human;GENOMICS_ENGLAND;ORPHANET
25662	8462	KLF11	0.626	0.654	C0342276	Maturityonsetdiabetesmellitusinyoung	disease	C18;C19	DiseaseorSyndrome	0.62	1	2011	2019	1	0	GENOMICS_ENGLAND;ORPHANET
25663	8462	KLF11	0.626	0.654	C1864839	MATURITY-ONSETDIABETESOFTHEYOUNG,TYPE7(disorder)	disease	C18;C19	DiseaseorSyndrome	0.7	1	2005	2005	1	2	CTD_human;GENOMICS_ENGLAND;UNIPROT
25675	8600	TNFSF11	0.453	0.846	C0029456	Osteoporosis	disease	C18;C05	DiseaseorSyndrome	0.6	0.987	1999	2020	1	0	CTD_human
25680	8600	TNFSF11	0.453	0.846	C1850126	Osteopetrosis,mildautosomalrecessiveform	disease	C05	DiseaseorSyndrome	0.8	1	2000	2016	1	0	CTD_human;GENOMICS_ENGLAND;UNIPROT
25687	8604	SLC25A12	0.711	0.462	C2751855	Hypomyelination,GlobalCerebral	disease	C23;C16;C18;C10;F01	DiseaseorSyndrome	0.94	1	2005	2019	5	3	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
25718	8621	CDK13	0.606	0.692	C4479246	CONGENITALHEARTDEFECTS,DYSMORPHICFACIALFEATURES,ANDINTELLECTUALDEVELOPMENTALDISORDER	disease		DiseaseorSyndrome	0.71	1	2015	2019	3	8	CTD_human;GENOMICS_ENGLAND;UNIPROT
25739	8622	PDE8B	0.638	0.5	C1836694	StriatalDegeneration,AutosomalDominant	disease	C23	DiseaseorSyndrome	0.54	1	2010	2019	1	0	CTD_human;ORPHANET
25740	8622	PDE8B	0.638	0.5	C3280094	PIGMENTEDNODULARADRENOCORTICALDISEASE,PRIMARY,3	disease		DiseaseorSyndrome	0.7	1	2008	2008	2	1	CTD_human;GENOMICS_ENGLAND;UNIPROT
25746	8625	RFXANK	0.644	0.577	C2931418	Barelymphocytesyndrome2	disease	C16;C18;C20	DiseaseorSyndrome	0.73	0.833	1998	2012	4	3	CTD_human;ORPHANET;UNIPROT
25749	8626	TP63	0.362	0.769	C0005689	BladderExstrophy	disease	C16;C13;C12	DiseaseorSyndrome	0.61	1	1999	2012	1	0	ORPHANET
25755	8626	TP63	0.362	0.769	C0008924	Cleftupperlip	disease	C16;C07	CongenitalAbnormality	0.72	1	2006	2017	3	1	CTD_human;GENOMICS_ENGLAND;ORPHANET
25783	8626	TP63	0.362	0.769	C0406704	Rudigersyndrome1	disease	C16;C17;C05;C07	DiseaseorSyndrome	0.8	0.944	1999	2019	3	0	CTD_human;ORPHANET
25784	8626	TP63	0.362	0.769	C0406709	Hay-Wellssyndrome	disease	C16;C11;C17;C05;C07	DiseaseorSyndrome	0.8	0.95	2001	2019	4	7	CTD_human;GENOMICS_ENGLAND;UNIPROT
25789	8626	TP63	0.362	0.769	C1140680	Malignantneoplasmofovary	disease	C04;C13;C19	NeoplasticProcess	0.53	0.75	2001	2012	1	0	CTD_human;UNIPROT
25793	8626	TP63	0.362	0.769	C1785148	RAPP-HODGKINSYNDROME	disease	C16;C17;C05;C07	DiseaseorSyndrome	1	1	2001	2019	7	3	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
25797	8626	TP63	0.362	0.769	C1854442	SPLIT-HAND/FOOTMALFORMATION4	disease	C16;C05	DiseaseorSyndrome	0.75	1	2000	2019	2	4	CTD_human;GENOMICS_ENGLAND;UNIPROT
25798	8626	TP63	0.362	0.769	C1858562	ECTRODACTYLY,ECTODERMALDYSPLASIA,ANDCLEFTLIP/PALATESYNDROME3	disease	C16;C17;C05;C07	DiseaseorSyndrome	0.71	1	1999	2019	4	14	CTD_human;GENOMICS_ENGLAND;UNIPROT
25800	8626	TP63	0.362	0.769	C1863204	ADULTSYNDROME	disease	C23;C16;C11;C17;C05;C07	DiseaseorSyndrome	0.8	1	2001	2019	3	7	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
25801	8626	TP63	0.362	0.769	C1863753	LIMB-MAMMARYSYNDROME	disease	C16;C05	DiseaseorSyndrome	0.66	1	2001	2019	1	0	CTD_human;GENOMICS_ENGLAND;ORPHANET
25809	8629	JRK	0.612	0.5	C0270853	JuvenileMyoclonicEpilepsy	disease	C10	DiseaseorSyndrome	0.51	1	2001	2001	1	0	CTD_human;ORPHANET
25846	8912	CACNA1H	0.628	0.423	C2749872	EPILEPSY,CHILDHOODABSENCE,SUSCEPTIBILITYTO,6	phenotype		Finding	0.6	1	2003	2018	5	13	GENOMICS_ENGLAND;UNIPROT
25849	8912	CACNA1H	0.628	0.423	C4310756	HYPERALDOSTERONISM,FAMILIAL,TYPEIV	disease		DiseaseorSyndrome	0.7	1	2015	2016	2	3	CTD_human;GENOMICS_ENGLAND;UNIPROT
25865	8913	CACNA1G	0.59	0.577	C4225205	SPINOCEREBELLARATAXIA42	disease		DiseaseorSyndrome	0.73	1	2015	2020	4	1	GENOMICS_ENGLAND;ORPHANET;UNIPROT
25866	8913	CACNA1G	0.59	0.577	C4748120	SPINOCEREBELLARATAXIA42,EARLY-ONSET,SEVERE,WITHNEURODEVELOPMENTALDEFICITS	disease		DiseaseorSyndrome	0.6	1	2018	2018	1	3	GENOMICS_ENGLAND;UNIPROT
25883	8915	BCL10	0.491	0.769	C0242647	Mucosa-AssociatedLymphoidTissueLymphoma	disease	C04;C20;C15	NeoplasticProcess	0.8	0.968	1999	2018	2	3	CGI;CTD_human;ORPHANET
25889	8915	BCL10	0.491	0.769	C4015195	IMMUNODEFICIENCY37	disease		DiseaseorSyndrome	0.6	1	2014	2014	1	1	CTD_human;GENOMICS_ENGLAND
25901	8924	HERC2	0.568	0.692	C3809753	MENTALRETARDATION,AUTOSOMALRECESSIVE38	disease		DiseaseorSyndrome	0.7	1	2012	2013	2	2	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
25906	8925	HERC1	0.674	0.5	C4310766	MACROCEPHALY,DYSMORPHICFACIES,ANDPSYCHOMOTORRETARDATION	disease		DiseaseorSyndrome	0.7	1	2015	2016	3	4	CTD_human;GENOMICS_ENGLAND;UNIPROT
25917	8929	PHOX2B	0.565	0.731	C0027819	Neuroblastoma	disease	C04	NeoplasticProcess	0.8	0.897	2004	2020	3	0	CGI;CTD_human;ORPHANET
25923	8929	PHOX2B	0.565	0.731	C1275808	Congenitalcentralhypoventilation	disease	C23;C08;C10	DiseaseorSyndrome	1	0.958	2002	2020	6	3	CTD_human;GENOMICS_ENGLAND;UNIPROT
25924	8929	PHOX2B	0.565	0.731	C1859049	CCHSWITHHIRSCHSPRUNGDISEASE	disease	C23;C08;C10	DiseaseorSyndrome;CongenitalAbnormality	0.64	1	2003	2014	2	1	CTD_human;ORPHANET
25926	8929	PHOX2B	0.565	0.731	C2751683	Hirschsprungdiseaseganglioneuroblastoma	disease	C16;C06;C04	DiseaseorSyndrome	0.6	1	2017	2017	1	1	GENOMICS_ENGLAND;ORPHANET
25940	8942	KYNU	0.617	0.692	C0268474	Hydroxykynureninuria	phenotype	C16;C18	DiseaseorSyndrome	0.71	1	2007	2017	2	1	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
25946	8942	KYNU	0.617	0.692	C4540014	VERTEBRAL,CARDIAC,RENAL,ANDLIMBDEFECTSSYNDROME2	disease		DiseaseorSyndrome	0.6	1	2017	2017	1	3	GENOMICS_ENGLAND;ORPHANET
25952	8943	AP3D1	0.678	0.385	C0079504	Hermanski-PudlakSyndrome	disease	C16;C18;C11;C17;C15	DiseaseorSyndrome	0.53	1	2009	2019	1	0	CTD_human;GENOMICS_ENGLAND
25963	8974	P4HA2	0.653	0.577	C4310655	MYOPIA25,AUTOSOMALDOMINANT	disease		DiseaseorSyndrome	0.6	1	2015	2015	1	4	CTD_human;UNIPROT
25976	8985	PLOD3	0.659	0.385	C2676285	BoneFragilitywithContractures,ArterialRupture,andDeafness	disease	C23;C17;C05	DiseaseorSyndrome	0.7	1	2008	2019	3	4	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
25981	8988	HSPB3	0.448	0.769	C3150619	NEURONOPATHY,DISTALHEREDITARYMOTOR,TYPEIIC	disease		DiseaseorSyndrome	0.6	1	2010	2010	1	1	CTD_human;GENOMICS_ENGLAND;UNIPROT
25985	8989	TRPA1	0.546	0.846	C0020429	Hyperalgesia	phenotype	C23;C10	SignorSymptom	0.57	1	2008	2019	3	0	CTD_human
26005	8989	TRPA1	0.546	0.846	C3808667	EPISODICPAINSYNDROME,FAMILIAL,1	disease		DiseaseorSyndrome	0.6	1	2010	2018	3	0	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
26039	8996	NOL3	0.575	0.808	C3539916	MYOCLONUS,FAMILIALCORTICAL	disease		DiseaseorSyndrome	0.61	1	2012	2014	2	2	CTD_human;ORPHANET;UNIPROT
26091	9031	BAZ1B	0.53	0.731	C0175702	WilliamsSyndrome	disease	C16;C10;C14	DiseaseorSyndrome	0.6	1	1998	2017	1	0	CTD_human
26123	9049	AIP	0.517	0.769	C0033375	Prolactinoma	disease	C04;C10;C19	NeoplasticProcess	0.7	1	2009	2018	2	0	GENOMICS_ENGLAND;ORPHANET
26130	9049	AIP	0.517	0.769	C0221406	Pituitary-dependentCushingsdisease	disease	C10;C19	DiseaseorSyndrome	0.32	1	2010	2012	0	0	GENOMICS_ENGLAND
val	9049	AIP	0.517	0.769	C0338078	Non-FunctioningPituitaryGlandNeoplasm	disease	C04;C10;C19	NeoplasticProcess	0.31	1	2013	2018	1	0	ORPHANET
val	9049	AIP	0.517	0.769	C0346302	GrowthHormone-SecretingPituitaryAdenoma	disease	C04;C10;C19	NeoplasticProcess	0.39	1	2007	2018	0	0	CTD_human
val	9049	AIP	0.517	0.769	C1306214	ACTH-SecretingPituitaryAdenoma	disease	C04;C10;C19	NeoplasticProcess	0.32	1	2007	2014	0	0	CTD_human
val	9049	AIP	0.517	0.769	C1704374	CarcinomaofEndocrineGland	disease	C04;C19	NeoplasticProcess	0.30				0	0	GENOMICS_ENGLAND
val	9049	AIP	0.517	0.769	C3489630	Somatotrophinoma,Familial	disease	C04;C10;C19	NeoplasticProcess	0.34	1	2007	2010	0	0	CTD_human
val	9049	AIP	0.517	0.769	C4538355	PITUITARYADENOMA1,MULTIPLETYPES	disease		NeoplasticProcess	0.60	1	2006	2018	6	8	GENOMICS_ENGLAND;UNIPROT
val	9050	PSTPIP2	0.76	0.385	C0263859	Synovitis,Acne,Pustulosis,Hyperostosis,andOsteitisSyndrome	disease	C05	DiseaseorSyndrome	0.31	1	2010	2016	1	0	CTD_human
val	9051	PSTPIP1	0.65	0.577	C0001144	AcneVulgaris	disease	C17	DiseaseorSyndrome	0.30	1	2016	2016	1	0	CTD_human
val	9051	PSTPIP1	0.65	0.577	C0023893	LiverCirrhosis,Experimental	disease	C23;C06	ExperimentalModelofDisease	0.30	1	2014	2014	1	0	CTD_human
val	9051	PSTPIP1	0.65	0.577	C0079541	Holoprosencephaly	disease	C16;C05;C10	CongenitalAbnormality	0.30				0	0	GENOMICS_ENGLAND
val	9051	PSTPIP1	0.65	0.577	C0085652	PyodermaGangrenosum	disease	C17	DiseaseorSyndrome	0.44	0.8	2005	2016	1	0	CTD_human
val	9051	PSTPIP1	0.65	0.577	C0162836	HidradenitisSuppurativa	disease	C01;C17	DiseaseorSyndrome	0.30	1	2016	2016	1	0	CTD_human
val	9051	PSTPIP1	0.65	0.577	C0702166	Acne	disease	C17	DiseaseorSyndrome	0.40	1	2016	2016	1	0	CTD_human
val	9051	PSTPIP1	0.65	0.577	C1858361	PyogenicArthritis,PyodermaGangrenosumandAcne	disease	C01;C17;C05	DiseaseorSyndrome	0.80	1	2002	2019	6	2	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
val	9051	PSTPIP1	0.65	0.577	C1860229	HyperzincemiaandHypercalprotectinemia	disease	C16;C18	DiseaseorSyndrome	0.30	1	2015	2015	1	0	ORPHANET
val	9051	PSTPIP1	0.65	0.577	C3860213	Autoinflammatorydisorder	disease		DiseaseorSyndrome	0.34	1	2002	2015	1	0	GENOMICS_ENGLAND
val	9052	GPRC5A	0.579	0.692	C0003873	RheumatoidArthritis	disease	C17;C05;C20	DiseaseorSyndrome	0.31	1	2007	2007	1	0	CTD_human
val	9054	NFS1	0.861	0.308	C4750855	SevereneonatallacticacidosisduetoNFS1-ISD11complexdeficiency	disease	C23;C18;C11;C05;C10;C14	DiseaseorSyndrome	0.30	1	2014	2014	1	0	ORPHANET
val	9055	PRC1	0.599	0.692	C0006142	Malignantneoplasmofbreast	disease	C04;C17	NeoplasticProcess	0.36	1	2007	2018	1	0	CTD_human
val	9055	PRC1	0.599	0.692	C0017661	IGAGlomerulonephritis	disease	C13;C12;C20	DiseaseorSyndrome	0.30	1	2014	2014	1	0	CTD_human
val	9055	PRC1	0.599	0.692	C0678222	BreastCarcinoma	disease	C04;C17	NeoplasticProcess	0.47	1	2007	2018	1	0	CTD_human
val	9055	PRC1	0.599	0.692	C0919267	ovarianneoplasm	disease	C04;C13;C19	NeoplasticProcess	0.30	1	2019	2019	1	0	CTD_human
val	9055	PRC1	0.599	0.692	C1140680	Malignantneoplasmofovary	disease	C04;C13;C19	NeoplasticProcess	0.30	1	2019	2019	1	0	CTD_human
val	9055	PRC1	0.599	0.692	C1257931	MammaryNeoplasms,Human	disease	C04;C17	NeoplasticProcess	0.30	1	2014	2014	1	0	CTD_human
val	9055	PRC1	0.599	0.692	C1458155	MammaryNeoplasms	group	C04;C17	NeoplasticProcess	0.31	1	2007	2014	1	0	CTD_human
val	9055	PRC1	0.599	0.692	C2239176	Livercarcinoma	disease	C06;C04	NeoplasticProcess	0.35	1	2016	2019	1	0	CTD_human
val	9055	PRC1	0.599	0.692	C4704874	MammaryCarcinoma,Human	disease	C04;C17	NeoplasticProcess	0.30	1	2014	2014	1	0	CTD_human
val	9056	SLC7A7	0.603	0.654	C0002514	AminoAcidMetabolism,InbornErrors	group	C16;C18	DiseaseorSyndrome	0.30	1	2001	2001	1	0	CTD_human
val	9056	SLC7A7	0.603	0.654	C0006142	Malignantneoplasmofbreast	disease	C04;C17	NeoplasticProcess	0.30				0	0	UNIPROT
val	9056	SLC7A7	0.603	0.654	C0268647	LysinuricProteinIntolerance	disease	C16;C18	DiseaseorSyndrome	0.80	1	1980	2020	10	47	CTD_human;GENOMICS_ENGLAND;UNIPROT
val	9056	SLC7A7	0.603	0.654	C0750905	AminoAcidMetabolism,InheritedDisorders	disease	C16;C18	DiseaseorSyndrome	0.30	1	2001	2001	1	0	CTD_human
val	9060	PAPSS2	0.682	0.462	C0878659	Disproportionateshortstature	phenotype	C16;C05;C19	Finding	0.30				0	0	GENOMICS_ENGLAND
val	9060	PAPSS2	0.682	0.462	C2748515	SpondyloepimetaphysealDysplasia,PakistaniType	disease	C23;C16;C05	CongenitalAbnormality	0.92	1	1969	2015	6	11	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
val	9064	MAP3K6	0.861	0.192	C0006142	Malignantneoplasmofbreast	disease	C04;C17	NeoplasticProcess	0.30				0	0	UNIPROT
val	9064	MAP3K6	0.861	0.192	C0346163	Endometrioidcarcinomaovary	disease	C04;C13;C19	NeoplasticProcess	0.30				0	0	UNIPROT
val	9064	MAP3K6	0.861	0.192	C1708349	HereditaryDiffuseGastricCancer	disease	C06;C04	NeoplasticProcess	0.31	1	2014	2014	1	0	ORPHANET
val	9071	CLDN10	0.626	0.577	C4522164	HELIXSYNDROME	disease		DiseaseorSyndrome	0.61	1	2009	2018	3	3	GENOMICS_ENGLAND;UNIPROT
val	9075	CLDN2	0.575	0.692	C0030305	Pancreatitis	disease	C06	DiseaseorSyndrome	0.42	1	2012	2020	1	0	CTD_human
val	9076	CLDN1	0.481	0.808	C0006142	Malignantneoplasmofbreast	disease	C04;C17	NeoplasticProcess	0.40	0.9	1999	2019	2	0	CTD_human
val	9076	CLDN1	0.481	0.808	C0007621	NeoplasticCellTransformation	phenotype	C23;C04	NeoplasticProcess	0.30	1	2013	2013	1	0	CTD_human
val	9076	CLDN1	0.481	0.808	C0011616	ContactDermatitis	disease	C17	DiseaseorSyndrome	0.31	1	2013	2013	1	0	CTD_human
val	9076	CLDN1	0.481	0.808	C0014175	Endometriosis	disease	C13	DiseaseorSyndrome	0.30	1	2011	2011	1	0	CTD_human
val	9076	CLDN1	0.481	0.808	C0086873	Pseudopelade	disease	C23;C17	DiseaseorSyndrome	0.30				0	0	GENOMICS_ENGLAND
val	9076	CLDN1	0.481	0.808	C0162351	Contacthypersensitivity	phenotype	C17	PathologicFunction	0.30	1	2013	2013	1	0	CTD_human
val	9076	CLDN1	0.481	0.808	C0269102	Endometrioma	disease	C13	NeoplasticProcess	0.30	1	2011	2011	1	0	CTD_human
val	9076	CLDN1	0.481	0.808	C0678222	BreastCarcinoma	disease	C04;C17	NeoplasticProcess	0.40	0.9	1999	2019	2	0	CTD_human
val	9076	CLDN1	0.481	0.808	C1257931	MammaryNeoplasms,Human	disease	C04;C17	NeoplasticProcess	0.30	1	2009	2013	2	0	CTD_human
val	9076	CLDN1	0.481	0.808	C1458155	MammaryNeoplasms	group	C04;C17	NeoplasticProcess	0.37	1	2000	2016	2	0	CTD_human
val	9076	CLDN1	0.481	0.808	C1843355	ICHTHYOSIS,LEUKOCYTEVACUOLES,ALOPECIA,ANDSCLEROSINGCHOLANGITIS	disease	C23;C16;C06;C17;C15	DiseaseorSyndrome	0.75	1	2004	2018	2	2	CTD_human;GENOMICS_ENGLAND;ORPHANET
val	9076	CLDN1	0.481	0.808	C2936846	Scarringalopecia	disease	C23;C17;C19	DiseaseorSyndrome	0.30				0	0	GENOMICS_ENGLAND
val	9076	CLDN1	0.481	0.808	C4704874	MammaryCarcinoma,Human	disease	C04;C17	NeoplasticProcess	0.30	1	2009	2013	2	0	CTD_human
val	9077	DIRAS3	0.631	0.385	C0206682	Follicularthyroidcarcinoma	disease	C04	NeoplasticProcess	0.30	1	2005	2005	1	0	GENOMICS_ENGLAND
val	9077	DIRAS3	0.631	0.385	C2239176	Livercarcinoma	disease	C06;C04	NeoplasticProcess	0.32	1	2009	2017	1	0	CTD_human
val	9080	CLDN9	0.861	0.231	C0033578	ProstaticNeoplasms	group	C04;C12	NeoplasticProcess	0.30	1	2007	2007	1	0	CTD_human
val	9080	CLDN9	0.861	0.231	C0376358	Malignantneoplasmofprostate	disease	C04;C12	NeoplasticProcess	0.30	1	2007	2007	1	0	CTD_human
val	9081	PRY	0.861	0.115	C1839071	SpermatogenicFailure,Nonobstructive,Y-Linked	disease	C16;C12	DiseaseorSyndrome	0.30				0	0	CTD_human
val	9082	XKRY	0.931	0.077	C1839071	SpermatogenicFailure,Nonobstructive,Y-Linked	disease	C16;C12	DiseaseorSyndrome	0.30				0	0	CTD_human
val	9083	BPY2	0.76	0.231	C1839071	SpermatogenicFailure,Nonobstructive,Y-Linked	disease	C16;C12	DiseaseorSyndrome	0.30				0	0	CTD_human
val	9084	VCY	0.89	0.231	C1839071	SpermatogenicFailure,Nonobstructive,Y-Linked	disease	C16;C12	DiseaseorSyndrome	0.30				0	0	CTD_human
val	9085	CDY1	0.805	0.231	C1839071	SpermatogenicFailure,Nonobstructive,Y-Linked	disease	C16;C12	DiseaseorSyndrome	0.30				0	0	CTD_human
val	9088	PKMYT1	0.7	0.385	C0025202	melanoma	disease	C04	NeoplasticProcess	0.30	1	2012	2012	1	0	CTD_human
val	9088	PKMYT1	0.7	0.385	C2239176	Livercarcinoma	disease	C06;C04	NeoplasticProcess	0.32	1	2017	2019	1	0	CTD_human
val	9091	PIGQ	0.61	0.577	C0014544	Epilepsy	disease	C10	DiseaseorSyndrome	0.30	1	2019	2019	1	0	GENOMICS_ENGLAND
val	9091	PIGQ	0.61	0.577	C0029124	OpticAtrophy	disease	C11;C10	DiseaseorSyndrome	0.40	1	2019	2019	1	1	GENOMICS_ENGLAND
val	9091	PIGQ	0.61	0.577	C0393706	Earlyinfantileepilepticencephalopathywithsuppressionbursts	disease	C10	DiseaseorSyndrome	0.31	1	2014	2014	1	0	ORPHANET
val	9091	PIGQ	0.61	0.577	C0424605	Developmentaldelay(disorder)	phenotype	F03	MentalorBehavioralDysfunction	0.40	1	2019	2019	1	1	GENOMICS_ENGLAND
val	9091	PIGQ	0.61	0.577	C0557874	Globaldevelopmentaldelay	disease		MentalorBehavioralDysfunction	0.40	1	2019	2019	1	0	GENOMICS_ENGLAND
val	9091	PIGQ	0.61	0.577	C2674422	Seizures,intractable	phenotype		Finding	0.40	1	2019	2019	1	1	GENOMICS_ENGLAND
val	9091	PIGQ	0.61	0.577	C4552072	X-linkedinfantilespasms	disease	C10	DiseaseorSyndrome	0.30	1	2019	2019	1	0	GENOMICS_ENGLAND
val	9094	UNC119	0.691	0.462	C0015397	Disorderofeye	group	C11	DiseaseorSyndrome	0.30				0	0	GENOMICS_ENGLAND
val	9094	UNC119	0.691	0.462	C0035334	RetinitisPigmentosa	disease	C16;C11	DiseaseorSyndrome	0.31	1	2000	2019	1	0	CTD_human
val	9094	UNC119	0.691	0.462	C0206744	T-Lymphocytopenia,IdiopathicCD4-Positive	disease	C20;C15	DiseaseorSyndrome	0.30				0	0	CTD_human
val	9094	UNC119	0.691	0.462	C0494261	Combinedimmunodeficiency	disease	C16;C18;C20	DiseaseorSyndrome	0.30	1	2012	2012	1	0	GENOMICS_ENGLAND
val	9094	UNC119	0.691	0.462	C3489532	Cone-RodDystrophy2	disease	C16;C11	DiseaseorSyndrome	0.31	1	2000	2016	2	0	ORPHANET
val	9094	UNC119	0.691	0.462	C3809768	IMMUNODEFICIENCY13	disease		DiseaseorSyndrome	0.62	1	2012	2012	1	1	GENOMICS_ENGLAND;ORPHANET;UNIPROT
val	9094	UNC119	0.691	0.462	C4085590	Cone-RodDystrophies	disease	C16;C11	DiseaseorSyndrome	0.31	1	2007	2007	0	0	GENOMICS_ENGLAND
val	9095	TBX19	0.695	0.462	C0001956	AlcoholUseDisorder	disease	C25;F03	MentalorBehavioralDysfunction	0.30	1	2008	2008	1	0	CTD_human
val	9095	TBX19	0.695	0.462	C0001973	AlcoholicIntoxication,Chronic	disease	C25;F03	MentalorBehavioralDysfunction	0.30	1	2008	2008	1	0	CTD_human
val	9095	TBX19	0.695	0.462	C0011570	MentalDepression	disease	F01	MentalorBehavioralDysfunction	0.30	1	2007	2007	1	0	PSYGENET
val	9095	TBX19	0.695	0.462	C0011581	Depressivedisorder	disease	F03	MentalorBehavioralDysfunction	0.30	1	2007	2007	1	0	PSYGENET
val	9095	TBX19	0.695	0.462	C0085762	Alcoholabuse	disease	C25;F03	MentalorBehavioralDysfunction	0.30	1	2008	2008	1	0	CTD_human
val	9095	TBX19	0.695	0.462	C0271583	ACTHDeficiency,Isolated	disease	C16;C18;C19	DiseaseorSyndrome	0.76	1	2001	2019	6	9	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
val	9095	TBX19	0.695	0.462	C0342388	Adrenocorticotropichormone(ACTH)deficiency(disorder)	disease	C19	DiseaseorSyndrome	0.62	1	2003	2018	2	0	ORPHANET
val	9096	TBX18	0.695	0.231	C0521619	Obstructionofpelviuretericjunction	phenotype	C16;C13;C12	PathologicFunction	0.70	1	2015	2015	1	2	CTD_human;GENOMICS_ENGLAND;UNIPROT
val	9096	TBX18	0.695	0.231	C1840451	MULTICYSTICRENALDYSPLASIA,BILATERAL	disease	C16;C13;C12	DiseaseorSyndrome	0.40				0	3	CTD_human
val	9096	TBX18	0.695	0.231	C4048262	HydronephrosisDueToPujo	disease	C16;C13;C12	DiseaseorSyndrome	0.30				0	0	CTD_human
val	9098	USP6	0.633	0.692	C0410005	Nodularfasciitis	disease	C04;C05;C10	DiseaseorSyndrome	0.40	1	2011	2019	1	0	ORPHANET
val	9099	USP2	0.682	0.462	C2239176	Livercarcinoma	disease	C06;C04	NeoplasticProcess	0.30	1	2011	2011	1	0	CTD_human
val	9101	USP8	0.587	0.654	C0010481	CushingSyndrome	disease	C19	DiseaseorSyndrome	0.30	1	2015	2015	1	0	ORPHANET
val	9101	USP8	0.587	0.654	C0221406	Pituitary-dependentCushingsdisease	disease	C10;C19	DiseaseorSyndrome	0.8	1	2015	2020	2	4	CTD_human;ORPHANET;UNIPROT
26134	9103	FCGR2C	0.61	0.654	C0398650	Immunethrombocytopenicpurpura	disease	C23;C20;C15	DiseaseorSyndrome	0.54	0.75	2008	2019	1	0	CTD_human;ORPHANET
26200	9126	SMC3	0.535	0.846	C1853099	CorneliadeLangeSyndrome3	disease	C16;C10	DiseaseorSyndrome	0.6	1	2014	2019	3	20	CTD_human;GENOMICS_ENGLAND
26212	9128	PRPF4	0.67	0.462	C4014681	RETINITISPIGMENTOSA70	disease		DiseaseorSyndrome	0.7	1	2014	2014	2	3	CTD_human;GENOMICS_ENGLAND;UNIPROT
26216	9129	PRPF3	0.695	0.385	C1832378	RetinitisPigmentosa18	disease	C16;C11	DiseaseorSyndrome	0.93	1	2002	2011	3	3	CTD_human;GENOMICS_ENGLAND;UNIPROT
26231	9131	AIFM1	0.527	0.769	C0795910	COWCHOCKSYNDROME	disease	C23;C16;C10;C09	DiseaseorSyndrome	0.75	1	1985	2019	5	1	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
26234	9131	AIFM1	0.527	0.769	C1845095	DEAFNESS,X-LINKED5(disorder)	disease	C23;C16;C10;C09	DiseaseorSyndrome	0.7	1	2010	2017	6	17	CLINGEN;CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
26236	9131	AIFM1	0.527	0.769	C3151753	COMBINEDOXIDATIVEPHOSPHORYLATIONDEFICIENCY6	disease		DiseaseorSyndrome	0.7	1	1985	2016	8	3	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
26244	9132	KCNQ4	0.674	0.462	C2677637	Deafness,AutosomalDominant2A	disease	C23;C10;C09	DiseaseorSyndrome	0.7	1	1997	2015	6	25	CTD_human;GENOMICS_ENGLAND;UNIPROT
26277	9149	DYRK1B	0.647	0.462	C4014361	ABDOMINALOBESITY-METABOLICSYNDROME3	disease		DiseaseorSyndrome	0.7	1	2014	2014	1	2	CTD_human;GENOMICS_ENGLAND;UNIPROT
26278	9150	CTDP1	0.641	0.577	C1858726	CongenitalCataracts,FacialDysmorphism,AndNeuropathy	disease	C16;C11;C05;C10	DiseaseorSyndrome;CongenitalAbnormality	0.6	1	2003	2003	1	1	CTD_human;GENOMICS_ENGLAND
26285	9152	SLC6A5	0.67	0.5	C3553288	HYPEREKPLEXIA3	disease		DiseaseorSyndrome	0.8	1	2003	2019	3	11	GENOMICS_ENGLAND;UNIPROT
26305	9158	FIBP	0.674	0.538	C4310715	THAUVIN-ROBINET-FAIVRESYNDROME	disease		DiseaseorSyndrome	0.7	1	2016	2016	2	2	CTD_human;GENOMICS_ENGLAND;ORPHANET
26339	9179	AP4M1	0.638	0.5	C2752008	SpasticParaplegia-50,AutosomalRecessive	disease	C16;C10	DiseaseorSyndrome	0.61	1	2009	2019	2	6	CTD_human;GENOMICS_ENGLAND
26344	9180	OSMR	0.599	0.577	C0268398	Familiallichenamyloidosis	disease	C16;C18;C17	DiseaseorSyndrome	0.51	1	2010	2010	1	0	CTD_human;ORPHANET
26346	9180	OSMR	0.599	0.577	C4551501	AMYLOIDOSIS,PRIMARYLOCALIZEDCUTANEOUS,1	disease	C16;C18;C17	DiseaseorSyndrome	0.7	1	2008	2010	3	5	GENOMICS_ENGLAND;ORPHANET;UNIPROT
26357	9187	SLC24A1	0.716	0.154	C0339535	Nightblindness,congenitalstationary	disease	C16;C11	CongenitalAbnormality	0.72	1	2010	2016	1	0	CTD_human;GENOMICS_ENGLAND;ORPHANET
26361	9187	SLC24A1	0.716	0.154	C3151193	NIGHTBLINDNESS,CONGENITALSTATIONARY,TYPE1D	disease		DiseaseorSyndrome	0.6	1	2010	2015	1	5	GENOMICS_ENGLAND
26377	9197	SLC33A1	0.529	0.769	C2675528	SpasticParaplegia42,AutosomalDominant	disease	C16;C10	DiseaseorSyndrome	0.71	1	2008	2018	3	1	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
26378	9197	SLC33A1	0.529	0.769	C3280965	CONGENITALCATARACTS,HEARINGLOSS,ANDNEURODEGENERATION	disease		DiseaseorSyndrome	0.7	1	2012	2018	3	2	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
26403	9210	BMP15	0.659	0.385	C1845294	OvarianDysgenesis2	disease	C16;C13;C12;C19	DiseaseorSyndrome	0.7	1	2004	2015	8	11	CTD_human;GENOMICS_ENGLAND;UNIPROT
26407	9211	LGI1	0.568	0.731	C1838062	AutosomalDominantLateralTemporalLobeEpilepsy	disease	C23;C10;F03	DiseaseorSyndrome	0.8	0.927	2002	2020	1	0	GENOMICS_ENGLAND;ORPHANET
26408	9211	LGI1	0.568	0.731	C4551957	Epilepsy,FamilialTemporalLobe1	disease	C23;C10;F03	DiseaseorSyndrome	1	1	2002	2020	11	17	CTD_human;GENOMICS_ENGLAND;UNIPROT
26431	9241	NOG	0.518	0.731	C0175700	Multiplesynostosissyndrome	disease	C05	DiseaseorSyndrome	0.6	1	1999	2015	2	0	GENOMICS_ENGLAND;ORPHANET
26432	9241	NOG	0.518	0.731	C0342282	Multiplesynostosessyndrome1	disease	C16;C05	DiseaseorSyndrome	0.73	1	1999	2014	4	4	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
26433	9241	NOG	0.518	0.731	C1861305	TARSAL-CARPALCOALITIONSYNDROME	disease	C16;C05	DiseaseorSyndrome	0.77	1	2002	2015	3	3	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
26434	9241	NOG	0.518	0.731	C1861385	SYMPHALANGISM,PROXIMAL	disease	C05	DiseaseorSyndrome	0.8	1	1995	2019	2	0	CTD_human;GENOMICS_ENGLAND;ORPHANET
26435	9241	NOG	0.518	0.731	C1866656	STAPESANKYLOSISWITHBROADTHUMBANDTOES(disorder)	disease	C16;C05	DiseaseorSyndrome	0.75	1	2002	2015	2	2	CTD_human;GENOMICS_ENGLAND;ORPHANET
26436	9241	NOG	0.518	0.731	C1969652	BRACHYDACTYLY,TYPEB2(disorder)	disease	C16;C05	DiseaseorSyndrome	0.73	1	2007	2017	1	2	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
26437	9241	NOG	0.518	0.731	C3714899	SYMPHALANGISM,PROXIMAL,1A	disease	C05	DiseaseorSyndrome	0.7	1	1999	2019	5	10	GENOMICS_ENGLAND;UNIPROT
26441	9244	CRLF1	0.597	0.654	C1832409	Crisponisyndrome	disease	C23;C16;C17;C05;C10	DiseaseorSyndrome	0.7	1	2003	2019	3	9	CTD_human;ORPHANET
26442	9244	CRLF1	0.597	0.654	C1848947	COLD-INDUCEDSWEATINGSYNDROME1	disease	C23;C16;C17;C05;C10	DiseaseorSyndrome	0.72	1	2003	2014	7	16	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
26447	9247	GCM2	0.647	0.538	C1832648	Hypoparathyroidismfamilialisolated	disease	C19	DiseaseorSyndrome	0.72	0.857	2005	2017	6	6	CTD_human;GENOMICS_ENGLAND;UNIPROT
26448	9247	GCM2	0.647	0.538	C4479229	HYPERPARATHYROIDISM4	disease		DiseaseorSyndrome	0.6	1	2016	2017	2	4	CTD_human;GENOMICS_ENGLAND;UNIPROT
26461	9254	CACNA2D2	0.626	0.615	C0004134	Ataxia	phenotype	C23;C10	SignorSymptom	0.51	1	2004	2019	2	0	CTD_human;GENOMICS_ENGLAND
26464	9254	CACNA2D2	0.626	0.615	C0014553	AbsenceEpilepsy	disease	C10	DiseaseorSyndrome	0.51	1	2002	2010	2	0	CTD_human;GENOMICS_ENGLAND
26490	9255	AIMP1	0.566	0.769	C1850053	Pelizaeus-Merzbacher-likedisease,autosomalrecessive,2	disease	C20;C10	DiseaseorSyndrome	0.7	1	2010	2019	3	4	CTD_human;GENOMICS_ENGLAND;ORPHANET
26525	9289	ADGRG1	0.59	0.654	C1847352	POLYMICROGYRIA,BILATERALFRONTOPARIETAL	disease	C16;C10	DiseaseorSyndrome	0.8	0.958	2004	2019	6	24	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
26539	9294	S1PR2	0.585	0.731	C1835854	DEAFNESS,AUTOSOMALRECESSIVE68	disease	C23;C10;C09	DiseaseorSyndrome	0.9	1	2006	2018	8	0	CLINGEN;CTD_human;GENOMICS_ENGLAND;UNIPROT
26557	9313	MMP20	0.663	0.538	C2675858	AmelogenesisImperfecta,HypomaturationType,Iia2	disease	C16;C07	DiseaseorSyndrome	0.8	1	2002	2017	1	4	CTD_human;GENOMICS_ENGLAND
26587	9319	TRIP13	0.559	0.654	C0027708	Nephroblastoma	disease	C16;C04;C13;C12	NeoplasticProcess	0.62	1	2017	2020	1	0	CTD_human;ORPHANET
26603	9320	TRIP12	0.678	0.462	C4540324	MENTALRETARDATION,AUTOSOMALDOMINANT49	disease		MentalorBehavioralDysfunction	0.6	1	2017	2017	2	11	GENOMICS_ENGLAND;UNIPROT
26605	9321	TRIP11	0.595	0.654	C0265273	Achondrogenesistype1A	disease	C16;C05	CongenitalAbnormality	0.91	1	2010	2018	1	10	CTD_human;GENOMICS_ENGLAND;ORPHANET
26607	9321	TRIP11	0.595	0.654	C2745953	Spondylometaphysealdysplasiawithdentinogenesisimperfecta	disease	C16;C05;C07	DiseaseorSyndrome	0.61	1	2019	2019	1	7	ORPHANET;UNIPROT
26608	9325	TRIP4	0.641	0.654	C4225177	SPINALMUSCULARATROPHYWITHCONGENITALBONEFRACTURES1	disease		DiseaseorSyndrome;CongenitalAbnormality	0.6	1	2016	2016	2	3	CTD_human;GENOMICS_ENGLAND
26611	9326	ZNHIT3	0.666	0.462	C1850055	PEHOsyndrome	disease	C11;C10	DiseaseorSyndrome	0.73	1	2017	2020	1	1	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
26638	9333	TGM5	0.656	0.615	C1853354	Peelingskinsyndrome,acraltype	disease	C17	DiseaseorSyndrome	0.75	1	1998	2018	4	7	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
26647	9342	SNAP29	0.633	0.654	C1836033	Cerebraldysgenesis,neuropathy,ichthyosis,andpalmoplantarkeratodermasyndrome	disease	C16;C17;C10	DiseaseorSyndrome	0.95	1	2005	2019	3	1	CTD_human;GENOMICS_ENGLAND;ORPHANET
26649	9343	EFTUD2	0.647	0.462	C1864652	Growthandmentalretardation,mandibulofacialdysostosis,microcephaly,andcleftpalate	disease	C23;C16;C11;C05;C10;F03;F01	DiseaseorSyndrome	0.8	0.938	1997	2019	5	18	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
26666	9361	LONP1	0.517	0.808	C1838180	CODASsyndrome	disease	C23;C16;C11;C05;C07	DiseaseorSyndrome	0.78	0.8	1991	2019	5	9	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
26669	9364	RAB28	0.792	0.077	C3809299	CONE-RODDYSTROPHY18	disease		DiseaseorSyndrome	0.9	1	2013	2018	4	5	CLINGEN;CTD_human;GENOMICS_ENGLAND
26675	9365	KL	0.448	0.769	C0011860	DiabetesMellitus,Non-Insulin-Dependent	disease	C18;C19	DiseaseorSyndrome	0.57	1	2006	2019	1	0	CTD_human
26702	9365	KL	0.448	0.769	C1876187	TUMORALCALCINOSIS,HYPERPHOSPHATEMIC,FAMILIAL	disease	C16;C18;C05	DiseaseorSyndrome	0.54	1	2007	2019	2	0	ORPHANET
26706	9365	KL	0.448	0.769	C4692564	TUMORALCALCINOSIS,HYPERPHOSPHATEMIC,FAMILIAL,1	disease		DiseaseorSyndrome	0.6	1	2007	2015	2	1	ORPHANET
26707	9365	KL	0.448	0.769	C4693864	TUMORALCALCINOSIS,HYPERPHOSPHATEMIC,FAMILIAL,3	disease		DiseaseorSyndrome	0.6	1	2007	2007	1	1	GENOMICS_ENGLAND;UNIPROT
26710	9368	SLC9A3R1	0.547	0.577	C2676782	Nephrolithiasis-Osteoporosis,Hypophosphatemic,2	disease	C16;C18;C13;C05;C12	DiseaseorSyndrome	0.7	1	2008	2012	3	4	CTD_human;GENOMICS_ENGLAND;UNIPROT
26732	9370	ADIPOQ	0.376	0.885	C0011860	DiabetesMellitus,Non-Insulin-Dependent	disease	C18;C19	DiseaseorSyndrome	0.6	0.95	1999	2020	3	0	CTD_human
26744	9370	ADIPOQ	0.376	0.885	C0022661	KidneyFailure,Chronic	disease	C13;C12	DiseaseorSyndrome	0.6	0.944	2004	2019	1	0	CTD_human
26748	9370	ADIPOQ	0.376	0.885	C0028754	Obesity	disease	C23;C18	DiseaseorSyndrome	0.6	0.933	1998	2020	2	0	CTD_human
26753	9370	ADIPOQ	0.376	0.885	C0085207	GestationalDiabetes	phenotype	C18;C13;C19	DiseaseorSyndrome	0.6	0.947	2004	2020	1	0	CTD_human
26792	9373	PLAA	0.597	0.692	C4479631	NEURODEVELOPMENTALDISORDERWITHPROGRESSIVEMICROCEPHALY,SPASTICITY,ANDBRAINANOMALIES	disease		DiseaseorSyndrome	0.7	1	2017	2017	2	3	GENOMICS_ENGLAND;ORPHANET;UNIPROT
26807	9378	NRXN1	0.581	0.692	C0004352	AutisticDisorder	disease	F03	MentalorBehavioralDysfunction	0.7	0.962	2007	2019	4	0	CTD_human;GENOMICS_ENGLAND
26815	9378	NRXN1	0.581	0.692	C0036341	Schizophrenia	disease	F03	MentalorBehavioralDysfunction	0.7	0.932	2008	2019	3	1	CTD_human
26821	9378	NRXN1	0.581	0.692	C1510586	AutismSpectrumDisorders	disease	F03	MentalorBehavioralDysfunction	0.6	1	2008	2019	1	0	CTD_human
26823	9378	NRXN1	0.581	0.692	C3280479	PITT-HOPKINS-LIKESYNDROME2	disease		DiseaseorSyndrome	0.6	1	2009	2014	1	3	CTD_human;GENOMICS_ENGLAND
26828	9379	NRXN2	0.769	0.308	C1510586	AutismSpectrumDisorders	disease	F03	MentalorBehavioralDysfunction	0.74	1	2011	2018	2	0	CTD_human;GENOMICS_ENGLAND
26830	9380	GRHPR	0.722	0.308	C0020500	Hyperoxaluria	disease	C13;C12	DiseaseorSyndrome	0.61	1	2004	2012	0	0	GENOMICS_ENGLAND
26831	9380	GRHPR	0.722	0.308	C0020501	PrimaryHyperoxaluria	disease	C16;C18;C13;C12	DiseaseorSyndrome	0.64	1	2007	2019	0	3	GENOMICS_ENGLAND
26833	9380	GRHPR	0.722	0.308	C0268165	Primaryhyperoxaluriatype2	disease	C16;C18;C13;C12	DiseaseorSyndrome	0.8	1	1999	2019	1	54	CTD_human;GENOMICS_ENGLAND;ORPHANET
26843	9381	OTOF	0.691	0.385	C1832828	Deafness,AutosomalRecessive9	disease	C23;C10;C09	DiseaseorSyndrome	0.96	1	1998	2019	12	87	CLINGEN;CTD_human;GENOMICS_ENGLAND;UNIPROT
26848	9382	COG1	0.628	0.692	C2931011	Congenitaldisorderofglycosylation,type2G	disease	C16;C18	DiseaseorSyndrome	0.6	1	2009	2016	2	1	CTD_human;GENOMICS_ENGLAND
26850	9394	HS6ST1	0.617	0.731	C3553977	HYPOGONADOTROPICHYPOGONADISM15WITHORWITHOUTANOSMIA	disease		DiseaseorSyndrome	0.6	1	2011	2014	3	5	CTD_human;GENOMICS_ENGLAND;UNIPROT
26854	9401	RECQL4	0.496	0.808	C0032339	Rothmund-Thomsonsyndrome	disease	C16;C18;C17	DiseaseorSyndrome	1	0.986	1999	2019	13	12	CLINGEN;CTD_human;GENOMICS_ENGLAND
26855	9401	RECQL4	0.496	0.808	C0265308	Baller-Geroldsyndrome	disease	C16;C05	DiseaseorSyndrome	0.77	1	1999	2018	4	54	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
26857	9401	RECQL4	0.496	0.808	C1849453	Rapadilinosyndrome	disease	C16;C18;C17;C05;C19;C14	DiseaseorSyndrome	0.75	1	1999	2012	3	14	CTD_human;GENOMICS_ENGLAND;ORPHANET
26859	9409	PEX16	0.597	0.615	C0043459	ZellwegerSyndrome	disease	C16;C06;C18;C13;C12;C10	DiseaseorSyndrome	0.54	1	1998	2016	3	0	CTD_human;GENOMICS_ENGLAND
26863	9409	PEX16	0.597	0.615	C1832200	Peroxisomebiogenesisdisorders	group	C16;C18	DiseaseorSyndrome	0.53	1	1998	2019	3	0	CTD_human;GENOMICS_ENGLAND
26864	9409	PEX16	0.597	0.615	C3553959	PEROXISOMEBIOGENESISDISORDER8A(ZELLWEGER)	disease	C16;C18	DiseaseorSyndrome	0.6	1	2002	2016	4	1	CTD_human;GENOMICS_ENGLAND
26865	9409	PEX16	0.597	0.615	C3553960	PEROXISOMEBIOGENESISDISORDER8B	disease	C16;C18	DiseaseorSyndrome	0.7	1	2010	2016	2	2	CTD_human;GENOMICS_ENGLAND;UNIPROT
26875	9414	TJP2	0.663	0.5	C1384666	hearingimpairment	phenotype	C23;C10;C09	DiseaseorSyndrome	0.51	1	2011	2014	2	0	CTD_human;GENOMICS_ENGLAND
26876	9414	TJP2	0.663	0.5	C1843139	Hypercholanemia,Familial	disease	C16;C18	DiseaseorSyndrome	0.71	1	2003	2014	2	2	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
26877	9414	TJP2	0.663	0.5	C2931067	Cholestasis,progressivefamilialintrahepatic4	disease	C16;C06;C18	DiseaseorSyndrome	0.7	1	2014	2014	2	13	CTD_human;GENOMICS_ENGLAND;ORPHANET
26879	9415	FADS2	0.575	0.692	C0005586	BipolarDisorder	disease	F03	MentalorBehavioralDysfunction	0.61	1	2011	2019	2	1	CTD_human;PSYGENET
26893	9419	CRIPT	0.716	0.308	C4014339	SHORTSTATUREWITHMICROCEPHALYANDDISTINCTIVEFACIES	disease		DiseaseorSyndrome	0.6	1	2014	2016	2	3	GENOMICS_ENGLAND;UNIPROT
26912	9420	CYP7B1	0.563	0.692	C1849115	SPASTICPARAPLEGIA5A,AUTOSOMALRECESSIVE(disorder)	disease	C16;C10	DiseaseorSyndrome	0.7	1	2008	2020	8	15	GENOMICS_ENGLAND;ORPHANET;UNIPROT
26914	9420	CYP7B1	0.563	0.692	C2931356	Spasticparaplegiatype5A,recessive	disease	C16;C10	DiseaseorSyndrome	0.51	1	2010	2018	1	0	CTD_human;ORPHANET
26915	9420	CYP7B1	0.563	0.692	C3151147	BileAcidSynthesisDefect,Congenital,3	disease	C16;C06;C18	DiseaseorSyndrome	0.7	1	1998	2020	2	1	CTD_human;GENOMICS_ENGLAND;ORPHANET
26933	9427	ECEL1	0.638	0.308	C3554415	Distalarthrogryposistype5D	disease		DiseaseorSyndrome	0.95	1	2013	2018	5	20	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
26959	9429	ABCG2	0.419	0.885	C1841837	URICACIDCONCENTRATION,SERUM,QUANTITATIVETRAITLOCUS1	disease		Finding	0.6	1	2016	2016	1	2	CTD_human;GENOMICS_ENGLAND
26964	9439	MED23	0.612	0.654	C3280265	MENTALRETARDATION,AUTOSOMALRECESSIVE18	disease		DiseaseorSyndrome	0.7	1	2011	2015	2	5	CTD_human;GENOMICS_ENGLAND;UNIPROT
26968	9440	MED17	0.769	0.269	C3150921	MICROCEPHALY,POSTNATALPROGRESSIVE,WITHSEIZURESANDBRAINATROPHY	disease		DiseaseorSyndrome	0.7	1	2010	2010	1	3	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
26984	9445	ITM2B	0.617	0.654	C1861735	Dementia,familialDanish	disease	C23;C11;C10;F03;C09	DiseaseorSyndrome	0.8	0.944	2000	2019	1	1	CTD_human;GENOMICS_ENGLAND;ORPHANET
26985	9445	ITM2B	0.617	0.654	C1867773	CEREBRALAMYLOIDANGIOPATHY,ITM2B-RELATED,1	disease		DiseaseorSyndrome	0.8	1	1999	2015	2	1	CTD_human;GENOMICS_ENGLAND;ORPHANET
26986	9445	ITM2B	0.617	0.654	C4015146	RETINALDYSTROPHYWITHINNERRETINALDYSFUNCTIONANDGANGLIONCELLABNORMALITIES	disease		DiseaseorSyndrome	0.7	1	2014	2014	1	1	CTD_human;ORPHANET;UNIPROT
27021	9451	EIF2AK3	0.501	0.808	C0432217	Wolcott-Rallisonsyndrome	disease	C16;C18;C05;C20;C19	DiseaseorSyndrome	1	0.964	1995	2019	4	8	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
27036	9455	HOMER2	0.691	0.5	C4225240	DEAFNESS,AUTOSOMALDOMINANT68	disease		DiseaseorSyndrome	0.7	1	2015	2015	1	1	CTD_human;GENOMICS_ENGLAND;UNIPROT
27133	9469	CHST3	0.517	0.846	C0038015	SpondyloepiphysealDysplasia	disease	C16;C05	DiseaseorSyndrome	0.62	1	2016	2018	1	0	CTD_human;GENOMICS_ENGLAND
27136	9469	CHST3	0.517	0.846	C1837657	Spondyloepiphysealdysplasia,Omanitype	disease	C16;C05	DiseaseorSyndrome	0.75	1	2004	2017	4	16	CTD_human;GENOMICS_ENGLAND;UNIPROT
27180	9479	MAPK8IP1	0.716	0.462	C0011860	DiabetesMellitus,Non-Insulin-Dependent	disease	C18;C19	DiseaseorSyndrome	0.62	1	2000	2018	1	1	CTD_human;UNIPROT
27184	9487	PIGL	0.581	0.731	C1848392	Zunichneuroectodermalsyndrome	disease	C23;C16;C11;C17;C10;F03;C09;F01;C14	DiseaseorSyndrome	0.73	1	2012	2019	3	4	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
27216	9496	TBX4	0.576	0.731	C1840061	SMALLPATELLASYNDROME	disease	C05	DiseaseorSyndrome	0.75	1	2004	2019	2	4	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
27229	9499	MYOT	0.695	0.385	C0686353	MuscularDystrophies,Limb-Girdle	group	C16;C05;C10	DiseaseorSyndrome	0.6	1	1995	2019	1	0	CTD_human;GENOMICS_ENGLAND
27231	9499	MYOT	0.695	0.385	C1866785	Spheroidbodymyopathy	disease	C05;C10	DiseaseorSyndrome	0.72	1	2004	2006	2	1	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
27234	9499	MYOT	0.695	0.385	C3714934	MYOPATHY,MYOFIBRILLAR,3	disease	C05;C10	DiseaseorSyndrome	0.75	1	1988	2016	5	4	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
27240	9508	ADAMTS3	0.581	0.808	C4748408	HENNEKAMLYMPHANGIECTASIA-LYMPHEDEMASYNDROME3	disease		DiseaseorSyndrome	0.61	1	2017	2018	2	3	GENOMICS_ENGLAND;UNIPROT
27242	9509	ADAMTS2	0.579	0.808	C2700425	EHLERS-DANLOSSYNDROME,DERMATOSPARAXISTYPE	disease	C16;C17;C15;C14	DiseaseorSyndrome	0.76	0.923	1992	2019	2	6	CTD_human;GENOMICS_ENGLAND;ORPHANET
27249	9512	PMPCB	0.769	0.192	C4693741	MULTIPLEMITOCHONDRIALDYSFUNCTIONSSYNDROME6	disease		DiseaseorSyndrome	0.6	1	2018	2018	1	5	GENOMICS_ENGLAND;UNIPROT
27251	9516	LITAF	0.65	0.462	C0270913	Charcot-Marie-Toothdisease,Type1C	disease	C16;C10	DiseaseorSyndrome	0.79	1	2003	2017	8	8	CTD_human;GENOMICS_ENGLAND;UNIPROT
27255	9517	SPTLC2	0.736	0.346	C0020071	HereditarySensoryAutonomicNeuropathy,Type1	disease	C16;C10	DiseaseorSyndrome	0.58	1	2010	2019	3	0	GENOMICS_ENGLAND;ORPHANET
27256	9517	SPTLC2	0.736	0.346	C3150896	NEUROPATHY,HEREDITARYSENSORYANDAUTONOMIC,TYPEIC	disease		DiseaseorSyndrome	0.7	1	2010	2017	5	5	CTD_human;GENOMICS_ENGLAND;UNIPROT
27278	9524	TECR	0.674	0.423	C3151462	MENTALRETARDATION,AUTOSOMALRECESSIVE14	disease		DiseaseorSyndrome	0.6	1	2011	2013	2	1	CTD_human;UNIPROT
27282	9526	MPDU1	0.682	0.5	C1836669	CONGENITALDISORDEROFGLYCOSYLATION,TYPEIf	disease	C16;C18	DiseaseorSyndrome	0.73	1	2001	2016	3	6	CTD_human;GENOMICS_ENGLAND;UNIPROT
27289	9531	BAG3	0.498	0.846	C2678065	MyofibrillarMyopathy	disease	C05;C10	DiseaseorSyndrome	0.8	1	2006	2018	9	1	CLINGEN;CTD_human;GENOMICS_ENGLAND
27290	9531	BAG3	0.498	0.846	C2751831	Myopathy,Myofibrillar,Bag3-Related	disease	C05;C10	DiseaseorSyndrome	0.7	1	1990	2018	8	11	GENOMICS_ENGLAND;ORPHANET;UNIPROT
27291	9531	BAG3	0.498	0.846	C3151293	CARDIOMYOPATHY,DILATED,1HH	disease		DiseaseorSyndrome	0.9	1	1990	2018	6	21	CTD_human;GENOMICS_ENGLAND;UNIPROT
27295	9533	POLR1C	0.595	0.615	C1855433	Mandibulofacialdysostosis,TreacherCollinstype,autosomalrecessive	disease	C16;C11;C05	DiseaseorSyndrome	0.72	1	1998	2018	3	6	CTD_human;GENOMICS_ENGLAND;UNIPROT
27297	9533	POLR1C	0.595	0.615	C4225305	LEUKODYSTROPHY,HYPOMYELINATING,11	disease		DiseaseorSyndrome	0.7	1	1978	2015	2	19	CTD_human;GENOMICS_ENGLAND;UNIPROT
27301	9536	PTGES	0.54	0.769	C0021368	Inflammation	phenotype	C23	PathologicFunction	0.51	1	2003	2015	1	0	CTD_human
27341	9557	CHD1L	0.631	0.577	C1968949	Cakut	disease	C16;C13;C12	DiseaseorSyndrome	0.51	1	2012	2014	2	0	CLINGEN;GENOMICS_ENGLAND
27351	9562	MINPP1	0.705	0.462	C4225426	THYROIDCANCER,NONMEDULLARY,2	disease		NeoplasticProcess	0.6	1	2001	2001	1	2	GENOMICS_ENGLAND;UNIPROT
27355	9563	H6PD	0.619	0.654	C1291245	Cortisonereductasedeficiency	disease	C23;C16;C18;C13;C17;C12;C19	DiseaseorSyndrome	0.55	1	2005	2011	1	0	CTD_human;ORPHANET
27375	9568	GABBR2	0.65	0.538	C4693546	NEURODEVELOPMENTALDISORDERWITHPOORLANGUAGEANDLOSSOFHANDSKILLS	disease		DiseaseorSyndrome	0.6	1	2016	2018	4	2	GENOMICS_ENGLAND;UNIPROT
27376	9568	GABBR2	0.65	0.538	C4693550	EPILEPTICENCEPHALOPATHY,EARLYINFANTILE,59	disease		DiseaseorSyndrome	0.6	1	2017	2018	3	3	GENOMICS_ENGLAND;UNIPROT
27377	9569	GTF2IRD1	0.522	0.769	C0175702	WilliamsSyndrome	disease	C16;C10;C14	DiseaseorSyndrome	0.6	0.963	1999	2019	1	0	CTD_human
27389	9570	GOSR2	0.653	0.423	C3279627	EPILEPSY,PROGRESSIVEMYOCLONIC,6	disease		DiseaseorSyndrome	0.7	1	2011	2014	3	3	GENOMICS_ENGLAND;ORPHANET;UNIPROT
27396	9573	GDF3	0.595	0.5	C0022738	Klippel-FeilSyndrome	disease	C16;C05	DiseaseorSyndrome	0.63	1	2010	2015	1	0	GENOMICS_ENGLAND;ORPHANET
27406	9573	GDF3	0.595	0.5	C3150967	KLIPPEL-FEILSYNDROME3,AUTOSOMALDOMINANT	disease		DiseaseorSyndrome	0.6	1	2010	2010	1	1	CTD_human;GENOMICS_ENGLAND;UNIPROT
27407	9573	GDF3	0.595	0.5	C3150968	MICROPHTHALMIA,ISOLATED,WITHCOLOBOMA6	disease		DiseaseorSyndrome	0.7	1	2010	2010	1	2	CTD_human;GENOMICS_ENGLAND;UNIPROT
27408	9573	GDF3	0.595	0.5	C3150969	MICROPHTHALMIA,ISOLATED7	disease		DiseaseorSyndrome	0.7	1	2010	2010	1	2	CTD_human;GENOMICS_ENGLAND;UNIPROT
27412	9575	CLOCK	0.463	0.885	C0005586	BipolarDisorder	disease	F03	MentalorBehavioralDysfunction	0.6	1	2000	2019	5	0	PSYGENET
27434	9581	PREPL	0.644	0.538	C1848030	Hypotonia-CystinuriaSyndrome	disease	C23;C16;C18;C13;C05;C12;C10;F03;F01	DiseaseorSyndrome	0.68	0.917	2006	2019	4	0	CTD_human;GENOMICS_ENGLAND;ORPHANET
27488	9607	CARTPT	0.576	0.692	C0009171	CocaineAbuse	disease	C25;F03	MentalorBehavioralDysfunction	0.51	1	1999	2010	3	0	CTD_human;PSYGENET
27509	9611	NCOR1	0.597	0.731	C0006142	Malignantneoplasmofbreast	disease	C04;C17	NeoplasticProcess	0.55	1	2006	2016	1	0	CGI;CTD_human
27520	9611	NCOR1	0.597	0.731	C0678222	BreastCarcinoma	disease	C04;C17	NeoplasticProcess	0.55	1	2006	2016	1	0	CGI;CTD_human
27566	9630	GNA14	0.674	0.5	C0346073	Tuftedangiomaofskin	disease	C04;C17	NeoplasticProcess	0.51	1	2016	2019	1	0	GENOMICS_ENGLAND;ORPHANET
27569	9631	NUP155	0.78	0.231	C4014269	ATRIALFIBRILLATION,FAMILIAL,15	disease		DiseaseorSyndrome	0.6	1	2008	2008	1	1	CTD_human;UNIPROT
27588	9636	ISG15	0.531	0.808	C4015293	IMMUNODEFICIENCY38WITHBASALGANGLIACALCIFICATION	disease		DiseaseorSyndrome	0.7	1	2012	2015	3	3	CTD_human;GENOMICS_ENGLAND;ORPHANET
27596	9639	ARHGEF10	0.729	0.577	C1842357	SlowedNerveConductionVelocity,AutosomalDominant	disease	C16;C10	DiseaseorSyndrome	0.7	1	2003	2003	1	1	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
27601	9640	ZNF592	0.7	0.462	C1847114	SPINOCEREBELLARATAXIA,AUTOSOMALRECESSIVE5	disease	C16;C10	DiseaseorSyndrome	0.61	1	2010	2015	2	0	CTD_human;GENOMICS_ENGLAND;ORPHANET
27622	9652	TTC37	0.626	0.654	C1857276	TrichohepatoentericSyndrome	disease	C23;C16;C13;C17	DiseaseorSyndrome	0.7	0.917	2010	2018	3	0	CTD_human;GENOMICS_ENGLAND;ORPHANET
27623	9652	TTC37	0.626	0.654	C4551982	TRICHOHEPATOENTERICSYNDROME1	disease	C23;C16;C13;C17	DiseaseorSyndrome	0.6	1	2010	2017	3	10	GENOMICS_ENGLAND;UNIPROT
27625	9657	IQCB1	0.641	0.654	C0339527	LeberCongenitalAmaurosis	disease	C11	DiseaseorSyndrome	0.68	1	2005	2019	2	4	GENOMICS_ENGLAND;ORPHANET
27626	9657	IQCB1	0.641	0.654	C0403553	Renaldysplasiaandretinalaplasia(disorder)	disease	C16;C13;C11;C12;C10	DiseaseorSyndrome	0.69	1	2005	2018	1	1	GENOMICS_ENGLAND;ORPHANET
27627	9657	IQCB1	0.641	0.654	C1836517	Senior-LokenSyndrome5	disease	C16;C13;C11;C12;C10	DiseaseorSyndrome	0.6	1	2005	2013	0	11	CTD_human;GENOMICS_ENGLAND
27631	9662	CEP135	0.695	0.615	C3553414	MICROCEPHALY8,PRIMARY,AUTOSOMALRECESSIVE	disease		DiseaseorSyndrome	0.6	1	2012	2012	1	4	CTD_human;GENOMICS_ENGLAND
27637	9663	LPIN2	0.628	0.615	C1864997	Majeedsyndrome	disease	C16;C01;C05;C20;C15	DiseaseorSyndrome	0.77	1	2005	2019	5	6	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
27650	9681	DEPDC5	0.631	0.538	C1858477	Epilepsy,Partial,withVariableFoci	disease	C10	DiseaseorSyndrome	0.77	1	2013	2019	8	23	CLINGEN;CTD_human;GENOMICS_ENGLAND;ORPHANET
27653	9681	DEPDC5	0.631	0.538	C4551983	EPILEPSY,FAMILIALFOCAL,WITHVARIABLEFOCI1	disease	C10	DiseaseorSyndrome	0.6	1	1999	2016	8	67	GENOMICS_ENGLAND;UNIPROT
27660	9688	NUP93	0.729	0.385	C4225166	NEPHROTICSYNDROME,TYPE12	disease		DiseaseorSyndrome	0.7	1	2016	2016	1	6	CTD_human;GENOMICS_ENGLAND;UNIPROT
27698	9698	PUM1	0.653	0.654	C4693672	SPINOCEREBELLARATAXIA47	disease		DiseaseorSyndrome	0.6	1	2018	2018	1	3	GENOMICS_ENGLAND;UNIPROT
27707	9702	CEP57	0.615	0.615	C1850343	Mosaicvariegatedaneuploidysyndrome1	disease	C16	DiseaseorSyndrome	0.64	1	2011	2019	3	2	CTD_human;ORPHANET
27710	9702	CEP57	0.615	0.615	C3279843	MOSAICVARIEGATEDANEUPLOIDYSYNDROME2	disease		DiseaseorSyndrome	0.6	1	2002	2019	11	3	CLINGEN;GENOMICS_ENGLAND
27726	9711	RUBCN	0.716	0.423	C3810326	SPINOCEREBELLARATAXIA,AUTOSOMALRECESSIVE15	disease		DiseaseorSyndrome	0.6	1	2010	2013	2	1	GENOMICS_ENGLAND;ORPHANET
27743	9719	ADAMTSL2	0.666	0.346	C3278147	GELEOPHYSICDYSPLASIA1	disease		DiseaseorSyndrome	0.6	1	2008	2011	2	12	GENOMICS_ENGLAND;UNIPROT
27749	9723	SEMA3E	0.515	0.769	C0265354	CHARGESyndrome	disease	C16;C11	DiseaseorSyndrome	0.73	1	2002	2020	3	1	CTD_human;GENOMICS_ENGLAND;ORPHANET
27759	9731	CEP104	0.67	0.423	C0431399	Familialaplasiaofthevermis	disease	C16;C13;C11;C12	DiseaseorSyndrome	0.53	1	2015	2019	1	0	GENOMICS_ENGLAND;ORPHANET
27780	9739	SETD1A	0.619	0.615	C0036341	Schizophrenia	disease	F03	MentalorBehavioralDysfunction	0.65	1	2014	2019	2	5	GENOMICS_ENGLAND;PSYGENET
27787	9742	IFT140	0.572	0.692	C0265275	Jeunethoracicdystrophy	disease	C16;C17;C05	DiseaseorSyndrome	0.82	1	2012	2013	3	5	GENOMICS_ENGLAND;ORPHANET
27790	9742	IFT140	0.572	0.692	C1849437	Mainzer-SaldinoDisease	disease	C23;C16;C11;C10	DiseaseorSyndrome	0.93	1	2012	2017	5	20	GENOMICS_ENGLAND;ORPHANET;UNIPROT
27816	9750	RIPOR2	0.792	0.269	C4225298	DEAFNESS,AUTOSOMALRECESSIVE104	disease		DiseaseorSyndrome	0.6	1	2016	2016	1	1	CTD_human;GENOMICS_ENGLAND
27819	9754	STARD8	0.743	0.346	C0006142	Malignantneoplasmofbreast	disease	C04;C17	NeoplasticProcess	0.51	1	2007	2008	1	1	CTD_human;UNIPROT
27846	9757	KMT2B	0.529	0.808	C4310633	DYSTONIA28,CHILDHOOD-ONSET	disease		DiseaseorSyndrome	0.61	1	2016	2019	3	17	GENOMICS_ENGLAND;UNIPROT
27865	10300	KATNB1	0.674	0.346	C4015525	LISSENCEPHALY6WITHMICROCEPHALY	disease		CongenitalAbnormality	0.7	1	2014	2016	3	6	CTD_human;GENOMICS_ENGLAND;UNIPROT
27874	10309	CCNO	0.621	0.538	C4014534	CILIARYDYSKINESIA,PRIMARY,29	disease		DiseaseorSyndrome	0.7	1	2014	2019	3	8	CTD_human;GENOMICS_ENGLAND;UNIPROT
27880	10312	TCIRG1	0.565	0.692	C1850127	Osteopetrosis,AutosomalRecessive1	disease	C05	DiseaseorSyndrome	0.9	1	1985	2015	3	44	CTD_human;GENOMICS_ENGLAND;UNIPROT
27886	10318	TNIP1	0.564	0.769	C0024141	LupusErythematosus,Systemic	disease	C17;C20	DiseaseorSyndrome	0.7	0.926	2009	2019	7	5	CTD_human;ORPHANET
27906	10452	TOMM40	0.59	0.538	C0276496	FamilialAlzheimerDisease(FAD)	disease	C10;F03	DiseaseorSyndrome	0.51	1	2013	2018	5	0	CTD_human;ORPHANET
27920	10681	GNB5	0.736	0.308	C4310678	LANGUAGEDELAYANDATTENTIONDEFICIT-HYPERACTIVITYDISORDER/COGNITIVEIMPAIRMENTWITHORWITHOUTCARDIACARRHYTHMIA	disease		DiseaseorSyndrome	0.7	1	2016	2018	3	1	CTD_human;GENOMICS_ENGLAND;UNIPROT
27921	10681	GNB5	0.736	0.308	C4310682	INTELLECTUALDEVELOPMENTALDISORDERWITHCARDIACARRHYTHMIA	disease		DiseaseorSyndrome	0.71	1	2016	2018	3	6	CTD_human;GENOMICS_ENGLAND;ORPHANET
27922	10682	EBP	0.494	0.846	C0008445	ChondrodysplasiaPunctata	disease	C05	CongenitalAbnormality	0.6	1	1990	2017	1	0	CTD_human
27924	10682	EBP	0.494	0.846	C0282102	Chondrodysplasiapunctata,X-linkeddominanttype	disease	C05	DiseaseorSyndrome	1	1	1983	2019	10	38	CTD_human;GENOMICS_ENGLAND;UNIPROT
27926	10682	EBP	0.494	0.846	C4085243	MENDSYNDROME	disease		DiseaseorSyndrome	0.73	1	2003	2019	5	4	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
27937	10683	DLL3	0.552	0.654	C0265343	Jarcho-Levinsyndrome	disease	C23;C16	DiseaseorSyndrome	0.87	1	2000	2019	2	8	GENOMICS_ENGLAND;UNIPROT
27952	10683	DLL3	0.552	0.654	C1837549	SPONDYLOCOSTALDYSOSTOSIS,AUTOSOMALRECESSIVE2	disease	C05	DiseaseorSyndrome	0.52	1	2002	2004	0	0	CTD_human
27956	10686	CLDN16	0.647	0.538	C0268448	Primaryhypomagnesemia(disorder)	disease	C23;C16;C18;C13;C12	DiseaseorSyndrome	0.9	1	1999	2016	6	21	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
27957	10686	CLDN16	0.647	0.538	C3151482	HYPERCALCIURIA,CHILDHOOD,SELF-LIMITING	disease		DiseaseorSyndrome	0.6	1	2000	2010	3	1	ORPHANET
27962	10845	CLPX	0.931	0.154	C4693947	PROTOPORPHYRIA,ERYTHROPOIETIC,2	disease		DiseaseorSyndrome	0.6	1	2015	2017	2	1	GENOMICS_ENGLAND;UNIPROT
27967	10846	PDE10A	0.619	0.615	C4310791	STRIATALDEGENERATION,AUTOSOMALDOMINANT2	disease		DiseaseorSyndrome	0.7	1	2016	2016	2	3	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
27968	10846	PDE10A	0.619	0.615	C4310792	DYSKINESIA,LIMBANDOROFACIAL,INFANTILE-ONSET	disease		DiseaseorSyndrome	0.7	1	2016	2016	2	3	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
27970	10847	SRCAP	0.61	0.731	C0729582	Floating-harborsyndrome	disease	C23;C16;C05;C14	DiseaseorSyndrome	0.8	1	2012	2020	2	6	CTD_human;GENOMICS_ENGLAND;ORPHANET
28003	10861	SLC26A1	0.686	0.577	C1833683	NEPHROLITHIASIS,CALCIUMOXALATE	disease	C13;C12	DiseaseorSyndrome	0.7	1	2010	2016	2	0	CTD_human;GENOMICS_ENGLAND;UNIPROT
28061	23607	CD2AP	0.558	0.731	C0750900	AlzheimersDisease,FocalOnset	disease	C10;F03	MentalorBehavioralDysfunction	0.30	1	2011	2018	3	0	CTD_human
val	23607	CD2AP	0.558	0.731	C0750901	AlzheimerDisease,EarlyOnset	disease	C10;F03	DiseaseorSyndrome	0.30	1	2011	2018	3	0	CTD_human
val	23607	CD2AP	0.558	0.731	C1842982	FOCALSEGMENTALGLOMERULOSCLEROSIS3,SUSCEPTIBILITYTO	phenotype		Finding	0.40	1	2007	2019	2	1	GENOMICS_ENGLAND
val	23607	CD2AP	0.558	0.731	C1868672	NEPHROTICSYNDROME,STEROID-RESISTANT,AUTOSOMALRECESSIVE	disease	C13;C12	DiseaseorSyndrome	0.30	1	2007	2007	1	0	ORPHANET
val	23619	ZIM2	0.89	0.077	C0010606	AdenoidCysticCarcinoma	disease	C04	NeoplasticProcess	0.30	1	2006	2006	1	0	CTD_human
val	23619	ZIM2	0.89	0.077	C0036095	SalivaryGlandNeoplasms	group	C04;C07	NeoplasticProcess	0.30	1	2006	2006	1	0	CTD_human
val	23619	ZIM2	0.89	0.077	C0220636	Malignantneoplasmofsalivarygland	disease	C04;C07	NeoplasticProcess	0.30	1	2006	2006	1	0	CTD_human
val	23621	BACE1	0.559	0.769	C0002395	AlzheimersDisease	disease	C10;F03	DiseaseorSyndrome	0.6	0.985	1999	2020	1	0	CTD_human
28063	23621	BACE1	0.559	0.769	C0036341	Schizophrenia	disease	F03	MentalorBehavioralDysfunction	0.58	0.5	2005	2019	2	0	PSYGENET
28092	27125	AFF4	0.644	0.769	C4085597	CHOPSSYNDROME	disease	C23;C10;F03;F01	DiseaseorSyndrome	0.71	1	2015	2015	1	3	CTD_human;ORPHANET;UNIPROT
28098	27130	INVS	0.619	0.538	C1865872	NEPHRONOPHTHISIS2	disease	C13;C12	DiseaseorSyndrome	0.96	1	1993	2020	1	5	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
28107	27136	MORC1	0.805	0.192	C0041696	UnipolarDepression	disease	F03	MentalorBehavioralDysfunction	0.51	1	2014	2018	1	0	PSYGENET
28137	27151	CPAMD8	0.722	0.231	C4310622	ANTERIORSEGMENTDYSGENESIS8	disease		DiseaseorSyndrome	0.7	1	2016	2019	2	3	GENOMICS_ENGLAND;ORPHANET;UNIPROT
28139	27152	INTU	0.555	0.769	C4693616	SHORT-RIBTHORACICDYSPLASIA20WITHPOLYDACTYLY	disease		DiseaseorSyndrome	0.6	1	2016	2018	2	3	GENOMICS_ENGLAND;UNIPROT
28163	29072	SETD2	0.424	0.846	C0279702	Conventional(ClearCell)RenalCellCarcinoma	disease	C04;C13;C12	NeoplasticProcess	0.7	0.957	2003	2019	6	0	CGI;CTD_human;UNIPROT
28179	29072	SETD2	0.424	0.846	C4085873	LUSCAN-LUMISHSYNDROME	disease		DiseaseorSyndrome	0.71	1	2012	2018	4	6	CTD_human;GENOMICS_ENGLAND;UNIPROT
28183	29078	NDUFAF4	0.686	0.385	C4748778	MITOCHONDRIALCOMPLEXIDEFICIENCY,NUCLEARTYPE15	disease		DiseaseorSyndrome	0.6	1	2008	2017	2	2	GENOMICS_ENGLAND;UNIPROT
28195	29089	UBE2T	0.55	0.731	C0015625	FanconiAnemia	disease	C16;C18;C15	DiseaseorSyndrome	0.59	1	2006	2019	2	0	GENOMICS_ENGLAND;ORPHANET
28203	29089	UBE2T	0.55	0.731	C4084840	FANCONIANEMIA,COMPLEMENTATIONGROUPT	disease		DiseaseorSyndrome	0.71	1	2015	2019	3	2	CTD_human;GENOMICS_ENGLAND;UNIPROT
28207	29098	RANGRF	0.751	0.231	C1142166	BrugadaSyndrome(disorder)	disease	C16;C14	DiseaseorSyndrome	0.55	0.889	2008	2019	6	0	CLINGEN;ORPHANET
28248	29110	TBK1	0.513	0.846	C0002736	AmyotrophicLateralSclerosis	disease	C18;C10	DiseaseorSyndrome	0.7	1	2015	2019	3	1	GENOMICS_ENGLAND;ORPHANET
28254	29110	TBK1	0.513	0.846	C4225325	FRONTOTEMPORALDEMENTIAAND/ORAMYOTROPHICLATERALSCLEROSIS4	disease		DiseaseorSyndrome	0.7	1	2015	2015	2	14	CTD_human;GENOMICS_ENGLAND;UNIPROT
28255	29110	TBK1	0.513	0.846	C4693542	ENCEPHALOPATHY,ACUTE,INFECTION-INDUCED(HERPES-SPECIFIC),SUSCEPTIBILITYTO,8	phenotype		Finding	0.6	1	2012	2015	2	3	GENOMICS_ENGLAND;UNIPROT
28272	29119	CTNNA3	0.612	0.692	C3810138	ARRHYTHMOGENICRIGHTVENTRICULARDYSPLASIA,FAMILIAL,13	disease		DiseaseorSyndrome	0.7	1	2013	2013	1	2	CTD_human;GENOMICS_ENGLAND;UNIPROT
28278	29123	ANKRD11	0.556	0.808	C0220687	KBGsyndrome	disease	C23;C16;C05;C10;F03;C07;F01	DiseaseorSyndrome	0.8	1	2008	2019	13	45	CLINGEN;CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
28315	29760	BLNK	0.603	0.731	C0001768	Agammaglobulinemia	disease	C20;C15	DiseaseorSyndrome	0.61	1	2015	2015	1	0	CTD_human;GENOMICS_ENGLAND
28326	29801	ZDHHC8	0.769	0.346	C0036341	Schizophrenia	disease	F03	MentalorBehavioralDysfunction	0.6	0.2	2004	2017	5	0	PSYGENET
28327	29851	ICOS	0.502	0.731	C0009447	CommonVariableImmunodeficiency	disease	C20	DiseaseorSyndrome	0.8	1	2001	2017	0	0	CTD_human;ORPHANET
28338	29887	SNX10	0.633	0.577	C3554478	OSTEOPETROSIS,AUTOSOMALRECESSIVE8	disease		DiseaseorSyndrome	0.7	1	2012	2013	3	4	CTD_human;GENOMICS_ENGLAND;UNIPROT
28355	29899	GPSM2	0.682	0.538	C1858695	Chudley-Mcculloughsyndrome	disease	C23;C16;C04;C10;C09	DiseaseorSyndrome	0.76	1	1996	2018	8	0	CLINGEN;CTD_human;GENOMICS_ENGLAND;ORPHANET
28360	29914	UBIAD1	0.7	0.462	C0271287	Schnydercrystallinecornealdystrophy	disease	C16;C11	DiseaseorSyndrome	1	0.957	2007	2019	10	11	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
28365	29920	PYCR2	0.682	0.462	C4225332	LEUKODYSTROPHY,HYPOMYELINATING,10	disease		DiseaseorSyndrome	0.7	1	2015	2017	3	8	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
28387	29925	GMPPB	0.578	0.538	C3714932	MUSCULARDYSTROPHY-DYSTROGLYCANOPATHY(LIMB-GIRDLE),TYPEC,14	disease		DiseaseorSyndrome	0.7	1	2013	2017	5	21	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
28388	29925	GMPPB	0.578	0.538	C3809216	MUSCULARDYSTROPHY-DYSTROGLYCANOPATHY(CONGENITALWITHBRAINANDEYEANOMALIES),TYPEA,14	disease		DiseaseorSyndrome	0.6	1	2013	2017	2	13	GENOMICS_ENGLAND;UNIPROT
28389	29925	GMPPB	0.578	0.538	C3809221	MUSCULARDYSTROPHY-DYSTROGLYCANOPATHY(CONGENITALWITHMENTALRETARDATION),TYPEB,14	disease		DiseaseorSyndrome	0.7	1	2013	2017	2	13	CTD_human;GENOMICS_ENGLAND;UNIPROT
28392	29926	GMPPA	0.711	0.385	C3809738	ALACRIMA,ACHALASIA,ANDMENTALRETARDATIONSYNDROME	disease		DiseaseorSyndrome	0.7	1	2013	2013	1	0	CTD_human;GENOMICS_ENGLAND;UNIPROT
28397	29927	SEC61A1	0.722	0.5	C4310741	HYPERURICEMICNEPHROPATHY,FAMILIALJUVENILE,4	disease		DiseaseorSyndrome	0.7	1	2016	2019	2	2	CTD_human;GENOMICS_ENGLAND;UNIPROT
28398	29929	ALG6	0.805	0.231	C2930997	Congenitaldisorderofglycosylationtype1C	disease	C16;C18	DiseaseorSyndrome	0.77	1	1999	2016	8	27	CTD_human;GENOMICS_ENGLAND;UNIPROT
28400	29940	DSE	0.7	0.462	C3809845	EHLERS-DANLOSSYNDROME,MUSCULOCONTRACTURALTYPE,2	disease		DiseaseorSyndrome	0.7	1	2013	2015	2	2	CTD_human;GENOMICS_ENGLAND;UNIPROT
28421	29954	POMT2	0.544	0.615	C0265221	Walker-Warburgcongenitalmusculardystrophy	disease	C16;C11;C10	DiseaseorSyndrome	0.6	1	2005	2018	1	0	CTD_human;ORPHANET
28424	29954	POMT2	0.544	0.615	C0457133	Muscleeyebraindisease	disease	C16;C11;C10	DiseaseorSyndrome	0.53	1	2007	2018	2	0	CTD_human;ORPHANET
28428	29954	POMT2	0.544	0.615	C3150411	MUSCULARDYSTROPHY-DYSTROGLYCANOPATHY(CONGENITALWITHBRAINANDEYEANOMALIES),TYPEA,2	disease	C16;C05;C10	DiseaseorSyndrome	0.6	1	2005	2017	10	18	GENOMICS_ENGLAND;UNIPROT
28429	29954	POMT2	0.544	0.615	C3150416	MUSCULARDYSTROPHY-DYSTROGLYCANOPATHY(CONGENITALWITHMENTALRETARDATION),TYPEB,2	disease	C16;C05;C10	DiseaseorSyndrome	0.7	1	2005	2017	6	15	CTD_human;GENOMICS_ENGLAND;UNIPROT
28430	29954	POMT2	0.544	0.615	C3150418	MUSCULARDYSTROPHY-DYSTROGLYCANOPATHY(LIMB-GIRDLE),TYPEC,2	disease		DiseaseorSyndrome	0.71	1	2005	2018	6	14	CTD_human;GENOMICS_ENGLAND;UNIPROT
28434	29957	SLC25A24	0.575	0.731	C2676780	ProgeroidSyndrome,Congenital,PettyType	phenotype	C23;C16;C18	DiseaseorSyndrome	0.62	1	2017	2019	2	2	GENOMICS_ENGLAND;UNIPROT
28436	29958	DMGDH	0.89	0.154	C1853892	DimethylglycineDehydrogenaseDeficiency	disease	C16;C18	DiseaseorSyndrome	0.7	1	1997	2016	5	1	CLINGEN;CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
28442	29968	PSAT1	0.478	0.846	C0265218	Neu-Laxovasyndrome	disease	C23;C16;C13;C17;C05;C10	DiseaseorSyndrome	0.61	1	2014	2019	1	0	CTD_human;GENOMICS_ENGLAND;ORPHANET
28443	29968	PSAT1	0.478	0.846	C1970253	PhosphoserineAminotransferaseDeficiency	disease	C23;C16;C05;C10;F01	DiseaseorSyndrome	0.71	1	2007	2020	1	2	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
28444	29968	PSAT1	0.478	0.846	C4015019	NEU-LAXOVASYNDROME2	disease		DiseaseorSyndrome	0.61	1	2007	2017	3	4	GENOMICS_ENGLAND;UNIPROT
28447	29978	UBQLN2	0.656	0.462	C3275459	AMYOTROPHICLATERALSCLEROSIS15,WITHORWITHOUTFRONTOTEMPORALDEMENTIA	disease		DiseaseorSyndrome	0.7	1	2011	2015	6	9	CTD_human;GENOMICS_ENGLAND;UNIPROT
28456	29980	DONSON	0.636	0.538	C4539873	MICROCEPHALY,SHORTSTATURE,ANDLIMBABNORMALITIES	disease		DiseaseorSyndrome	0.62	1	2017	2019	2	10	GENOMICS_ENGLAND;UNIPROT
28466	30008	EFEMP2	0.559	0.692	C0003486	AorticAneurysm	disease	C14	DiseaseorSyndrome	0.62	1	2006	2018	2	0	GENOMICS_ENGLAND
28467	30008	EFEMP2	0.559	0.692	C0010495	CutisLaxa	disease	C16;C17	DiseaseorSyndrome	0.65	1	2010	2016	1	0	GENOMICS_ENGLAND
28473	30008	EFEMP2	0.559	0.692	C3280798	CUTISLAXA,AUTOSOMALRECESSIVE,TYPEIB	disease		DiseaseorSyndrome	0.7	1	1991	2016	4	11	CTD_human;GENOMICS_ENGLAND;UNIPROT
28475	30009	TBX21	0.541	0.808	C0004096	Asthma	disease	C08;C20	DiseaseorSyndrome	0.7	0.944	2002	2019	1	1	CTD_human
28499	30061	SLC40A1	0.57	0.731	C1853733	HEMOCHROMATOSIS,TYPE4	disease	C16;C18	DiseaseorSyndrome	1	1	1999	2019	15	20	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
28505	30062	RAX	0.729	0.346	C1970237	Microphthalmia,Isolated3	disease	C16;C11	DiseaseorSyndrome	0.7	1	2004	2014	3	3	CTD_human;GENOMICS_ENGLAND;UNIPROT
28515	50619	DEF6	0.751	0.346	C0024141	LupusErythematosus,Systemic	disease	C17;C20	DiseaseorSyndrome	0.52	1	2006	2018	1	0	CTD_human
28518	50628	GEMIN4	0.565	0.808	C4693567	NEURODEVELOPMENTALDISORDERWITHMICROCEPHALY,CATARACTS,ANDRENALABNORMALITIES	disease		DiseaseorSyndrome	0.6	1	2015	2019	3	1	GENOMICS_ENGLAND;UNIPROT
28530	50640	PNPLA8	0.792	0.308	C1855033	Mitochondrialmyopathywithlacticacidosis	disease	C23;C18;C05;C10;C09	DiseaseorSyndrome	0.6	1	2014	2018	2	1	CTD_human;GENOMICS_ENGLAND
28532	50651	SLC45A1	0.674	0.269	C4479636	INTELLECTUALDEVELOPMENTALDISORDERWITHNEUROPSYCHIATRICFEATURES	disease		DiseaseorSyndrome	0.6	1	2017	2017	2	3	GENOMICS_ENGLAND;UNIPROT
28534	50674	NEUROG3	0.647	0.5	C1835888	Diarrhea4,Malabsorptive,Congenital	disease	C23;C06;C18	DiseaseorSyndrome	0.7	1	2006	2006	1	3	CTD_human;ORPHANET;UNIPROT
28536	50717	DCAF8	0.821	0.115	C4013360	GIANTAXONALNEUROPATHY2,AUTOSOMALDOMINANT	disease		DiseaseorSyndrome	0.7	1	2014	2014	1	1	GENOMICS_ENGLAND;ORPHANET;UNIPROT
28559	50814	NSDHL	0.621	0.538	C0265267	CongenitalHemidysplasiawithIchthyosiformErythrodermaandLimbDefects	disease	C16;C17;C05	DiseaseorSyndrome	0.78	0.909	2000	2019	4	13	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
28561	50814	NSDHL	0.621	0.538	C3151781	CKsyndrome	disease	C23;C16;C18;C10;F03;F01	DiseaseorSyndrome	0.72	1	2000	2016	6	7	CLINGEN;CTD_human;GENOMICS_ENGLAND;ORPHANET
28567	50846	DHH	0.65	0.423	C1856273	46,XYGonadalDysgenesis,CompleteorPartial,DHH-Related	disease	C16;C13;C12;C19	CongenitalAbnormality	0.7	1	2004	2018	2	5	CTD_human;GENOMICS_ENGLAND;UNIPROT
28568	50846	DHH	0.65	0.423	C2751325	46,XyGonadalDysgenesis,Partial,WithMinifascicularNeuropathy	disease	C16;C13;C12;C10;C19	DiseaseorSyndrome	0.7	1	2000	2012	2	2	CTD_human;GENOMICS_ENGLAND;ORPHANET
28580	50937	CDON	0.601	0.731	C3280215	HOLOPROSENCEPHALY11	disease		DiseaseorSyndrome	0.9	1	2003	2011	1	6	CTD_human;GENOMICS_ENGLAND;UNIPROT
28587	50939	IMPG2	0.659	0.308	C3150819	RETINITISPIGMENTOSA56	disease		DiseaseorSyndrome	0.6	NA	NA	NA	0	5	CTD_human;GENOMICS_ENGLAND
28588	50939	IMPG2	0.659	0.308	C4015343	MACULARDYSTROPHY,VITELLIFORM,5	disease		DiseaseorSyndrome	0.6	1	2010	2017	3	4	GENOMICS_ENGLAND;UNIPROT
28591	50940	PDE11A	0.612	0.654	C1864851	PigmentedNodularAdrenocorticalDisease,Primary,2	disease	C19	DiseaseorSyndrome	0.6	1	2006	2006	1	4	CTD_human;GENOMICS_ENGLAND
28603	50943	FOXP3	0.368	0.846	C0342288	Insulin-dependentdiabetesmellitussecretorydiarrheasyndrome	disease	C23;C16;C18;C20;C19	DiseaseorSyndrome	1	0.971	1991	2019	13	15	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
28610	50944	SHANK1	0.678	0.385	C0004352	AutisticDisorder	disease	F03	MentalorBehavioralDysfunction	0.53	1	2008	2018	1	0	CTD_human;GENOMICS_ENGLAND
28631	50945	TBX22	0.603	0.577	C1844830	CLEFTPALATE,X-LINKED	disease	C16;C05;C07	DiseaseorSyndrome	0.9	0.929	2001	2018	4	4	CTD_human;GENOMICS_ENGLAND;UNIPROT
28632	50945	TBX22	0.603	0.577	C1844862	AbruzzoEricksonsyndrome	disease	C23;C16;C05;C10;C07;C09	DiseaseorSyndrome	0.71	1	2013	2013	1	1	CTD_human;GENOMICS_ENGLAND;ORPHANET
28636	50945	TBX22	0.603	0.577	C4707825	X-linkedcleftpalateandankyloglossia	disease	C16;C05;C07	CongenitalAbnormality	0.54	1	2001	2011	3	0	ORPHANET
28644	50964	SOST	0.474	0.808	C0265301	Sclerosteosis	disease	C16;C05	DiseaseorSyndrome	0.6	1	1999	2019	0	0	CTD_human
28646	50964	SOST	0.474	0.808	C0432272	VanBuchemdisease	disease	C16;C05	DiseaseorSyndrome	0.9	1	1986	2019	1	0	CTD_human;GENOMICS_ENGLAND;ORPHANET
28647	50964	SOST	0.474	0.808	C2675746	CRANIODIAPHYSEALDYSPLASIA,AUTOSOMALDOMINANT(disorder)	disease	C16;C05	DiseaseorSyndrome	0.73	1	2011	2017	1	1	CTD_human;GENOMICS_ENGLAND;UNIPROT
28650	50964	SOST	0.474	0.808	C4551483	SCLEROSTEOSIS1	disease	C16;C05	DiseaseorSyndrome	0.8	1	2001	2013	3	3	GENOMICS_ENGLAND;UNIPROT
28651	51002	TPRKB	0.691	0.385	C0795949	GallowayMowatsyndrome	disease	C23;C16;C13;C05;C12;C10	DiseaseorSyndrome	0.52	1	2017	2019	1	0	CTD_human;ORPHANET
28652	51002	TPRKB	0.691	0.385	C4540274	GALLOWAY-MOWATSYNDROME5	disease		DiseaseorSyndrome	0.6	1	2017	2018	2	2	GENOMICS_ENGLAND;UNIPROT
28658	51004	COQ6	0.76	0.385	C3553349	COENZYMEQ10DEFICIENCY,PRIMARY,6	disease		DiseaseorSyndrome	0.7	1	2011	2017	3	0	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
28667	51008	ASCC1	0.495	0.846	C4225176	SPINALMUSCULARATROPHYWITHCONGENITALBONEFRACTURES2	disease		DiseaseorSyndrome	0.6	1	2018	2018	1	1	CTD_human;GENOMICS_ENGLAND
28669	51010	EXOSC3	0.61	0.692	C1843504	PontocerebellarHypoplasiaType1	disease	C16;C10	DiseaseorSyndrome;CongenitalAbnormality	0.68	1	2012	2018	1	0	CTD_human;GENOMICS_ENGLAND;ORPHANET
28670	51010	EXOSC3	0.61	0.692	C3553449	PONTOCEREBELLARHYPOPLASIA,TYPE1B	disease		DiseaseorSyndrome	0.75	1	2012	2020	4	10	CTD_human;GENOMICS_ENGLAND;UNIPROT
28678	51021	MRPS16	0.821	0.231	C1864843	CombinedOxidativePhosphorylationDeficiency2	disease	C23;C16;C18;C05;C10	DiseaseorSyndrome	0.7	1	2004	2015	4	0	CTD_human;GENOMICS_ENGLAND;ORPHANET
28683	51025	PAM16	0.729	0.462	C2750075	Chondrodysplasia,Megarbane-Dagher-MelkiType	disease	C23;C16;C05;C19;F03	DiseaseorSyndrome	0.7	1	2014	2016	2	0	GENOMICS_ENGLAND;ORPHANET;UNIPROT
28700	51053	GMNN	0.554	0.808	C1868684	EAR,PATELLA,SHORTSTATURESYNDROME	disease	C23;C16;C05;C07;C09	DiseaseorSyndrome	0.61	1	2015	2015	1	3	CTD_human;ORPHANET
28702	51053	GMNN	0.554	0.808	C4225188	MEIER-GORLINSYNDROME6	disease		DiseaseorSyndrome	0.6	1	2015	2019	2	3	GENOMICS_ENGLAND;UNIPROT
28711	51057	WDPCP	0.576	0.769	C1857587	OrstavikLindemannSolbergsyndrome	disease	C16;C04;C05;C07;C14	DiseaseorSyndrome	0.7	1	2010	2016	3	2	CTD_human;GENOMICS_ENGLAND;UNIPROT
28714	51057	WDPCP	0.576	0.769	C3150127	BARDET-BIEDLSYNDROME15	disease		DiseaseorSyndrome	0.6	1	2010	2016	2	1	CTD_human;GENOMICS_ENGLAND
28721	51062	ATL1	0.593	0.654	C2931355	Spasticparaplegia3,autosomaldominant	disease	C16;C10	DiseaseorSyndrome	0.75	1	2001	2018	17	18	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
28722	51062	ATL1	0.593	0.654	C3150972	NEUROPATHY,HEREDITARYSENSORY,TYPEID	disease		DiseaseorSyndrome	0.7	1	2001	2015	3	3	CTD_human;GENOMICS_ENGLAND;UNIPROT
28725	51067	YARS2	0.663	0.462	C1838103	MITOCHONDRIALMYOPATHYANDSIDEROBLASTICANEMIA	disease	C16;C18;C05;C10;C14	DiseaseorSyndrome	0.56	1	2010	2017	4	0	CTD_human;ORPHANET
28726	51067	YARS2	0.663	0.462	C3150802	MYOPATHY,LACTICACIDOSIS,ANDSIDEROBLASTICANEMIA2	disease		DiseaseorSyndrome	0.62	1	2010	2018	5	7	GENOMICS_ENGLAND;UNIPROT
28734	51079	NDUFA13	0.556	0.692	C0749424	ThyroidHurthleCellCarcinoma	disease	C04;C19	NeoplasticProcess	0.6	1	2005	2015	2	1	CTD_human;GENOMICS_ENGLAND
28741	51081	MRPS7	0.722	0.5	C4693450	COMBINEDOXIDATIVEPHOSPHORYLATIONDEFICIENCY34	disease		DiseaseorSyndrome	0.7	1	2015	2015	1	1	GENOMICS_ENGLAND;ORPHANET;UNIPROT
28755	51082	POLR1D	0.603	0.692	C3150983	TREACHERCOLLINSSYNDROME2	disease		DiseaseorSyndrome	0.7	1	1996	2011	2	3	CTD_human;GENOMICS_ENGLAND;UNIPROT
28767	51083	GAL	0.493	0.846	C0020538	Hypertensivedisease	group	C14	DiseaseorSyndrome	0.51	1	2000	2017	1	0	CTD_human
28794	51083	GAL	0.493	0.846	C4225318	EPILEPSY,FAMILIALTEMPORALLOBE,8	disease		DiseaseorSyndrome	0.6	1	2015	2015	1	1	CTD_human;GENOMICS_ENGLAND;UNIPROT
28805	51086	TNNI3K	0.691	0.346	C4015285	CARDIACCONDUCTIONDISEASEWITHORWITHOUTDILATEDCARDIOMYOPATHY	disease		DiseaseorSyndrome	0.7	1	2014	2018	2	0	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
28814	51091	SEPSECS	0.656	0.423	C3151140	PONTOCEREBELLARHYPOPLASIA,TYPE2D	disease		DiseaseorSyndrome	0.75	1	2003	2018	5	6	CTD_human;GENOMICS_ENGLAND;UNIPROT
28818	51094	ADIPOR1	0.529	0.808	C0022661	KidneyFailure,Chronic	disease	C13;C12	DiseaseorSyndrome	0.53	1	2007	2014	1	0	CTD_human
28823	51095	TRNT1	0.7	0.192	C4015172	SIDEROBLASTICANEMIAWITHB-CELLIMMUNODEFICIENCY,PERIODICFEVERS,ANDDEVELOPMENTALDELAY	disease		DiseaseorSyndrome	0.73	1	2014	2016	1	3	GENOMICS_ENGLAND;ORPHANET;UNIPROT
28824	51095	TRNT1	0.7	0.192	C4310776	RETINITISPIGMENTOSAANDERYTHROCYTICMICROCYTOSIS	disease		DiseaseorSyndrome	0.6	NA	NA	NA	0	1	CTD_human;GENOMICS_ENGLAND
28833	51099	ABHD5	0.641	0.538	C0268238	Triglyceridestoragediseasewithichthyosis	disease	C16;C18;C17;C05;C10	DiseaseorSyndrome	1	1	1982	2019	5	5	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
28835	51102	MECR	0.736	0.385	C4310634	DYSTONIA,CHILDHOOD-ONSET,WITHOPTICATROPHYANDBASALGANGLIAABNORMALITIES	disease		DiseaseorSyndrome	0.7	1	2016	2016	1	6	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
28838	51103	NDUFAF1	0.7	0.308	C4748769	MITOCHONDRIALCOMPLEXIDEFICIENCY,NUCLEARTYPE11	disease		DiseaseorSyndrome	0.6	1	2007	2011	2	4	GENOMICS_ENGLAND;UNIPROT
28840	51109	RDH11	0.769	0.346	C4015242	RETINALDYSTROPHY,JUVENILECATARACTS,ANDSHORTSTATURESYNDROME	disease		DiseaseorSyndrome	0.6	1	2014	2014	1	2	CTD_human;ORPHANET
28842	51111	KMT5B	0.736	0.423	C4540474	MENTALRETARDATION,AUTOSOMALDOMINANT51	disease		MentalorBehavioralDysfunction	0.6	1	2014	2018	3	8	GENOMICS_ENGLAND;UNIPROT
28846	51112	TRAPPC12	0.751	0.385	C4540059	ENCEPHALOPATHY,PROGRESSIVE,EARLY-ONSET,WITHBRAINATROPHYANDSPASTICITY	disease		DiseaseorSyndrome	0.7	1	2017	2017	1	3	GENOMICS_ENGLAND;ORPHANET;UNIPROT
28849	51114	ZDHHC9	0.67	0.577	C3275406	MENTALRETARDATION,X-LINKED,SYNDROMIC,RAYMONDTYPE	disease		DiseaseorSyndrome	0.9	1	2007	2018	4	6	CTD_human;GENOMICS_ENGLAND;UNIPROT
28851	51116	MRPS2	0.839	0.154	C4693722	COMBINEDOXIDATIVEPHOSPHORYLATIONDEFICIENCY36	disease		DiseaseorSyndrome	0.6	1	2018	2018	1	3	GENOMICS_ENGLAND;UNIPROT
28852	51117	COQ4	0.78	0.269	C4225392	COENZYMEQ10DEFICIENCY,PRIMARY,7	disease		DiseaseorSyndrome	0.7	1	2015	2016	4	14	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
28855	51119	SBDS	0.601	0.692	C0023467	Leukemia,Myelocytic,Acute	disease	C04	NeoplasticProcess	0.62	1	2005	2017	1	0	CGI;GENOMICS_ENGLAND
28858	51119	SBDS	0.601	0.692	C0272170	Shwachmansyndrome	disease		DiseaseorSyndrome	1	0.972	2003	2019	9	7	CLINGEN;CTD_human;GENOMICS_ENGLAND
28860	51119	SBDS	0.601	0.692	C3463824	MYELODYSPLASTICSYNDROME	group	C15	NeoplasticProcess	0.62	1	2009	2017	1	0	CGI;GENOMICS_ENGLAND
28861	51119	SBDS	0.601	0.692	C4692625	SHWACHMAN-DIAMONDSYNDROME1	disease		DiseaseorSyndrome	0.6	1	2003	2015	4	9	GENOMICS_ENGLAND;UNIPROT
28863	51124	IER3IP1	0.711	0.423	C3280240	MICROCEPHALY,EPILEPSY,ANDDIABETESSYNDROME	disease		DiseaseorSyndrome	0.71	1	2011	2014	3	3	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
28867	51128	SAR1B	0.686	0.462	C0795956	Chylomicronretentiondisease	disease	C16;C06;C18	DiseaseorSyndrome	0.8	1	2003	2019	6	6	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
28892	51132	RLIM	0.686	0.5	C4283894	MENTALRETARDATION,X-LINKED61	disease		DiseaseorSyndrome	0.7	1	2009	2016	3	8	CTD_human;GENOMICS_ENGLAND;UNIPROT
28895	51134	CEP83	0.839	0.077	C3890591	NEPHRONOPHTHISIS18	disease		DiseaseorSyndrome	0.7	1	2014	2014	1	8	CTD_human;GENOMICS_ENGLAND;UNIPROT
28907	51135	IRAK4	0.578	0.769	C1843256	IRAK4Deficiency	disease	C16;C20	DiseaseorSyndrome	0.61	1	2003	2014	6	0	CTD_human;ORPHANET;UNIPROT
28910	51142	CHCHD2	0.638	0.538	C4225238	PARKINSONDISEASE22,AUTOSOMALDOMINANT	disease		DiseaseorSyndrome	0.7	1	2015	2015	2	3	CTD_human;GENOMICS_ENGLAND;UNIPROT
28925	51151	SLC45A2	0.626	0.538	C0078918	Albinism,Oculocutaneous	disease	C16;C18;C11;C17	CongenitalAbnormality	0.6	0.923	2001	2019	1	0	GENOMICS_ENGLAND
28930	51151	SLC45A2	0.626	0.538	C1847836	OculocutaneousAlbinism,TypeIV	disease	C16;C18;C11;C17	DiseaseorSyndrome	0.78	1	2001	2017	7	25	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
28936	51156	SERPINA10	0.805	0.192	C0398623	Thrombophilia	disease	C15	DiseaseorSyndrome	0.51	1	2000	2004	2	0	CTD_human;GENOMICS_ENGLAND
28940	51164	DCTN4	0.472	0.846	C0010674	CysticFibrosis	disease	C16;C06;C08	DiseaseorSyndrome	0.54	1	2012	2019	1	0	CTD_human;ORPHANET
28949	51168	MYO15A	0.722	0.346	C1838263	Deafness,AutosomalRecessive3	disease	C23;C10;C09	DiseaseorSyndrome	0.92	1	1998	2019	3	69	CTD_human;GENOMICS_ENGLAND;UNIPROT
28979	51181	DCXR	0.751	0.308	C0268162	Pentosuria	disease	C16;C18	DiseaseorSyndrome	0.7	1	2011	2017	4	2	CTD_human;GENOMICS_ENGLAND;ORPHANET
28984	51185	CRBN	0.551	0.654	C0026764	MultipleMyeloma	disease	C04;C20;C15;C14	NeoplasticProcess	0.6	0.943	2013	2020	1	0	CGI;CTD_human
28987	51185	CRBN	0.551	0.654	C1843942	MentalRetardation,AutosomalRecessive2	disease	C23;C10;F03;F01	DiseaseorSyndrome	0.91	0.857	2004	2019	3	2	CTD_human;GENOMICS_ENGLAND;UNIPROT
29008	51196	PLCE1	0.572	0.654	C1853124	NEPHROTICSYNDROME,TYPE3	disease	C13;C12	DiseaseorSyndrome	0.71	1	2006	2010	2	9	CTD_human;GENOMICS_ENGLAND;UNIPROT
29011	51199	NIN	0.659	0.731	C3553870	SECKELSYNDROME7	disease		DiseaseorSyndrome	0.7	1	2012	2014	2	2	GENOMICS_ENGLAND;ORPHANET;UNIPROT
29021	51204	TACO1	0.647	0.577	C0023264	LeighDisease	disease	C16;C18;C10	DiseaseorSyndrome	0.61	1	2009	2016	3	0	CLINGEN;CTD_human;GENOMICS_ENGLAND
29022	51204	TACO1	0.647	0.577	C0268237	Cytochrome-cOxidaseDeficiency	disease	C16;C18	DiseaseorSyndrome;CongenitalAbnormality	0.6	1	2009	2016	3	1	CTD_human;GENOMICS_ENGLAND
29032	51206	GP6	0.597	0.615	C3280120	GlycoproteinVIdeficiency	disease		DiseaseorSyndrome	0.6	1	2000	2013	6	2	CLINGEN;CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
29035	51218	GLRX5	0.659	0.538	C4225155	ANEMIA,SIDEROBLASTIC,3,PYRIDOXINE-REFRACTORY	disease		DiseaseorSyndrome	0.6	1	2007	2016	4	3	GENOMICS_ENGLAND;UNIPROT
29036	51218	GLRX5	0.659	0.538	C4225178	Childhood-onsetspasticitywithhyperglycinemia	disease	C23;C16;C18;C05;C10	DiseaseorSyndrome	0.6	1	2014	2014	2	2	GENOMICS_ENGLAND;ORPHANET
29051	51227	PIGP	0.633	0.462	C4539843	EPILEPTICENCEPHALOPATHY,EARLYINFANTILE,55	disease		DiseaseorSyndrome	0.6	1	2017	2019	2	2	GENOMICS_ENGLAND;UNIPROT
29052	51232	CRIM1	0.76	0.308	C1865286	MACROPHTHALMIA,COLOBOMATOUS,WITHMICROCORNEA	disease	C16;C11	DiseaseorSyndrome	0.51	1	2015	2016	2	0	GENOMICS_ENGLAND;ORPHANET
29053	51244	CCDC174	0.769	0.269	C4225196	HYPOTONIA,INFANTILE,WITHPSYCHOMOTORRETARDATION	disease		DiseaseorSyndrome	0.6	1	2015	2015	1	1	CTD_human;ORPHANET
29058	51251	NT5C3A	0.593	0.692	C1849507	Uridine5-PrimeMonophosphateHydrolaseDeficiency,HemolyticAnemiadueto	disease	C16;C15	DiseaseorSyndrome	0.7	1	2001	2016	10	10	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
29059	51256	TBC1D7	0.729	0.385	C0221355	Macrocephaly	disease	C16;C05;C10	CongenitalAbnormality	0.62	1	2013	2014	2	0	GENOMICS_ENGLAND;ORPHANET
29066	51259	TMEM216	0.544	0.615	C1842577	JOUBERTSYNDROME2	disease	C16;C13;C11;C12;C10	DiseaseorSyndrome	0.72	1	2010	2017	4	14	CTD_human;GENOMICS_ENGLAND;UNIPROT
29068	51259	TMEM216	0.544	0.615	C1864148	MECKELSYNDROME,TYPE2	disease	C23;C16;C13;C12;C08;C10;C09	DiseaseorSyndrome	0.71	1	2010	2014	1	12	CTD_human;GENOMICS_ENGLAND;UNIPROT
29096	51293	CD320	0.729	0.462	C3150900	METHYLMALONICACIDURIA,TRANSIENT,DUETOTRANSCOBALAMINRECEPTORDEFECT	disease		DiseaseorSyndrome	0.9	1	2010	2013	1	1	CTD_human;GENOMICS_ENGLAND;ORPHANET
29102	51294	PCDH12	0.722	0.346	C4538630	MICROCEPHALY,SEIZURES,SPASTICITY,ANDBRAINCALCIFICATIONS	disease		DiseaseorSyndrome	0.6	1	2008	2017	3	4	GENOMICS_ENGLAND;UNIPROT
29119	51305	KCNK9	0.615	0.577	C2676770	Birk-BarelMentalRetardationDysmorphismSyndrome	disease	C23;C16;C05;C10;F03;F01	DiseaseorSyndrome	0.73	1	2008	2020	1	1	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
29124	51308	REEP2	0.792	0.269	C3810160	SPASTICPARAPLEGIA72,AUTOSOMALRECESSIVE	disease		DiseaseorSyndrome	0.7	1	2014	2014	2	3	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
29138	51317	PHF21A	0.682	0.5	C1832588	Chromosome11p11.2DeletionSyndrome	disease	C23;C16;C04;C05	DiseaseorSyndrome	0.55	1	2012	2019	2	0	GENOMICS_ENGLAND;ORPHANET
29156	51322	WAC	0.686	0.615	C4225239	DESANTO-SHINAWISYNDROME	disease		DiseaseorSyndrome	0.6	1	2015	2016	1	12	CTD_human;ORPHANET
29160	51324	SPG21	0.695	0.5	C1855346	MASTSYNDROME	disease	C16;C10;F03	DiseaseorSyndrome	0.74	1	2003	2017	2	3	CTD_human;GENOMICS_ENGLAND;ORPHANET
29172	51339	DACT1	0.547	0.692	C0009402	ColorectalCarcinoma	disease	C06;C04	NeoplasticProcess	0.51	1	2008	2019	1	0	CTD_human;UNIPROT
29176	51339	DACT1	0.547	0.692	C0265246	Townessyndrome	disease	C23;C16;C06;C10;C09	DiseaseorSyndrome	0.51	1	2017	2017	1	0	CTD_human;ORPHANET
29194	51360	MBTPS2	0.513	0.769	C1839988	Ichthyosisfollicularisatrichiaphotophobiasyndrome	disease	C23;C16;C11;C17;C10	DiseaseorSyndrome	0.74	1	1997	2015	5	6	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
29199	51360	MBTPS2	0.513	0.769	C3806745	PALMOPLANTARKERATODERMA,MUTILATING,WITHPERIORIFICIALKERATOTICPLAQUES,X-LINKED	disease		DiseaseorSyndrome	0.7	1	2013	2014	2	1	CTD_human;GENOMICS_ENGLAND;UNIPROT
29200	51360	MBTPS2	0.513	0.769	C3887525	KeratosisFollicularisSpinulosaDecalvans,X-Linked	disease	C16;C17	DiseaseorSyndrome;CongenitalAbnormality	0.74	1	2010	2016	2	1	CTD_human;GENOMICS_ENGLAND;UNIPROT
29207	51364	ZMYND10	0.553	0.731	C3809543	CILIARYDYSKINESIA,PRIMARY,22	disease		DiseaseorSyndrome	0.9	1	2013	2018	4	8	CTD_human;GENOMICS_ENGLAND;UNIPROT
29220	51371	POMP	0.674	0.346	C1866029	KeratosisLineariswithIchthyosisCongenitaandSclerosingKeratoderma	disease	C16;C17	DiseaseorSyndrome	0.62	1	2010	2017	2	0	CTD_human;GENOMICS_ENGLAND;ORPHANET
29250	51422	PRKAG2	0.582	0.654	C0043202	Wolff-Parkinson-WhiteSyndrome	disease	C16;C14	DiseaseorSyndrome	0.8	1	1977	2016	6	3	CTD_human;GENOMICS_ENGLAND;UNIPROT
29252	51422	PRKAG2	0.582	0.654	C1833236	CARDIOMYOPATHY,FAMILIALHYPERTROPHIC,6(disorder)	disease	C16;C14	DiseaseorSyndrome	0.7	1	1977	2018	5	9	CTD_human;GENOMICS_ENGLAND;UNIPROT
29253	51422	PRKAG2	0.582	0.654	C1849813	GlycogenStorageDiseaseofHeart,LethalCongenital	disease	C16;C18;C14	DiseaseorSyndrome	0.7	1	1977	2016	5	4	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
29267	51428	DDX41	0.636	0.538	C4225174	MYELOPROLIFERATIVE/LYMPHOPROLIFERATIVENEOPLASMS,FAMILIAL(MULTIPLETYPES),SUSCEPTIBILITYTO	disease		Finding	0.7	1	2015	2016	3	10	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
29285	51466	EVL	0.729	0.308	C0009402	ColorectalCarcinoma	disease	C06;C04	NeoplasticProcess	0.52	1	2008	2015	2	1	CTD_human;UNIPROT
29292	51473	DCDC2	0.546	0.769	C1857750	DEAFNESS,AUTOSOMALRECESSIVE66	disease	C23;C10;C09	DiseaseorSyndrome	0.7	1	2015	2016	2	2	CTD_human;GENOMICS_ENGLAND;UNIPROT
29294	51473	DCDC2	0.546	0.769	C4015542	NEPHRONOPHTHISIS19	disease		DiseaseorSyndrome	0.61	1	2012	2020	3	3	CTD_human;GENOMICS_ENGLAND
29295	51473	DCDC2	0.546	0.769	C4479344	SCLEROSINGCHOLANGITIS,NEONATAL	disease		DiseaseorSyndrome	0.74	1	2015	2018	3	4	CTD_human;GENOMICS_ENGLAND;UNIPROT
29297	51475	CABP2	0.861	0.115	C3888355	DEAFNESS,AUTOSOMALRECESSIVE93	disease		DiseaseorSyndrome	0.8	1	2012	2017	1	1	CTD_human;GENOMICS_ENGLAND
29316	51501	HIKESHI	0.751	0.385	C4225170	LEUKODYSTROPHY,HYPOMYELINATING,13	disease		DiseaseorSyndrome	0.7	1	2016	2017	2	1	CTD_human;ORPHANET;UNIPROT
29318	51506	UFC1	0.716	0.462	C4748081	NEURODEVELOPMENTALDISORDERWITHSPASTICITYANDPOORGROWTH	disease		DiseaseorSyndrome	0.6	1	2017	2019	3	2	GENOMICS_ENGLAND;UNIPROT
29327	51520	LARS1	0.678	0.577	C3809522	INFANTILELIVERFAILURESYNDROME1	disease		DiseaseorSyndrome	0.7	1	2012	2012	1	1	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
29331	51524	TMEM138	0.656	0.385	C3280906	JOUBERTSYNDROME16	disease		DiseaseorSyndrome	0.6	1	2012	2015	1	4	GENOMICS_ENGLAND;UNIPROT
29370	51567	TDP2	0.628	0.462	C4310780	SPINOCEREBELLARATAXIA,AUTOSOMALRECESSIVE23	disease		DiseaseorSyndrome	0.61	1	2014	2019	2	2	GENOMICS_ENGLAND;ORPHANET
29372	51569	UFM1	0.722	0.385	C4693535	LEUKODYSTROPHY,HYPOMYELINATING,14	disease		DiseaseorSyndrome	0.6	1	2017	2019	3	1	GENOMICS_ENGLAND;UNIPROT
29382	51574	LARP7	0.674	0.615	C3554439	MicrocephalicprimordialdwarfismAlazamitype	disease	C23;C16;C05;C10;C19;F03;F01	DiseaseorSyndrome	0.75	1	2012	2020	3	1	CTD_human;GENOMICS_ENGLAND;ORPHANET
29403	51594	NBAS	0.566	0.692	C3541319	SHORTSTATURE,OPTICNERVEATROPHY,ANDPELGER-HUETANOMALY	disease		DiseaseorSyndrome	0.76	1	2010	2019	2	4	GENOMICS_ENGLAND;ORPHANET;UNIPROT
29404	51594	NBAS	0.566	0.692	C3809651	INFANTILELIVERFAILURESYNDROME2	disease		DiseaseorSyndrome	0.73	1	2015	2019	1	12	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
29413	51601	LIPT1	0.674	0.462	C4225379	LIPOYLTRANSFERASE1DEFICIENCY	disease		DiseaseorSyndrome	0.7	1	2013	2018	4	0	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
29419	51604	PIGT	0.633	0.615	C3809356	MULTIPLECONGENITALANOMALIES-HYPOTONIA-SEIZURESSYNDROME3	disease		DiseaseorSyndrome	0.71	1	2013	2017	4	11	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
29438	51626	DYNC2LI1	0.601	0.5	C4310724	SHORT-RIBTHORACICDYSPLASIA15WITHPOLYDACTYLY	disease		DiseaseorSyndrome	0.6	1	2015	2015	2	11	GENOMICS_ENGLAND;UNIPROT
29439	51633	OTUD6B	0.659	0.538	C4479520	INTELLECTUALDEVELOPMENTALDISORDERWITHDYSMORPHICFACIES,SEIZURES,ANDDISTALLIMBANOMALIES	disease		DiseaseorSyndrome	0.7	1	2017	2017	1	5	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
29463	51651	PTRH2	0.641	0.577	C4015728	NEUROLOGIC,ENDOCRINE,ANDPANCREATICDISEASE,MULTISYSTEM,INFANTILE-ONSET	disease		DiseaseorSyndrome	0.71	1	2014	2016	3	2	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
29478	51660	MPC1	0.653	0.577	C3553607	MITOCHONDRIALPYRUVATECARRIERDEFICIENCY	disease		DiseaseorSyndrome	0.7	1	2012	2016	2	3	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
29480	51684	SUFU	0.493	0.769	C0004779	BasalCellNevusSyndrome	disease	C16;C04;C05;C07	NeoplasticProcess	1	0.938	2006	2018	5	12	CTD_human;GENOMICS_ENGLAND;ORPHANET
29481	51684	SUFU	0.493	0.769	C0025149	Medulloblastoma	disease	C04	NeoplasticProcess	0.8	0.95	1996	2019	10	14	CGI;CLINGEN;CTD_human;GENOMICS_ENGLAND
29487	51684	SUFU	0.493	0.769	C0751291	DesmoplasticMedulloblastoma	disease	C04	NeoplasticProcess	0.74	1	2002	2014	5	1	CTD_human;GENOMICS_ENGLAND;ORPHANET
29497	51684	SUFU	0.493	0.769	C4540342	JOUBERTSYNDROME32	disease		DiseaseorSyndrome	0.6	1	2017	2019	2	2	GENOMICS_ENGLAND;UNIPROT
29502	51702	PADI3	0.78	0.192	C0432347	Uncombablehairsyndrome	disease	C17	DiseaseorSyndrome	0.51	1	2016	2016	1	0	CTD_human;ORPHANET
29510	51715	RAB23	0.541	0.654	C1275078	Acrocephalopolysyndactylytype2	disease	C16;C05	DiseaseorSyndrome	0.75	0.833	2007	2018	3	2	CTD_human;GENOMICS_ENGLAND;ORPHANET
29512	51715	RAB23	0.541	0.654	C4551510	CARPENTERSYNDROME1	disease	C16;C05	DiseaseorSyndrome	0.6	1	2007	2013	3	2	GENOMICS_ENGLAND;UNIPROT
29518	51726	DNAJB11	0.751	0.346	C4748044	POLYCYSTICKIDNEYDISEASE6WITHORWITHOUTPOLYCYSTICLIVERDISEASE	disease		DiseaseorSyndrome	0.6	1	2018	2018	2	5	GENOMICS_ENGLAND;UNIPROT
29532	51733	UPB1	0.722	0.346	C1291512	Beta-UreidopropionaseDeficiency	disease	C16;C18;C10	DiseaseorSyndrome	0.72	1	2004	2016	6	11	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
29617	51741	WWOX	0.453	0.808	C3280452	SPINOCEREBELLARATAXIA,AUTOSOMALRECESSIVE12	disease		DiseaseorSyndrome	0.73	1	2014	2019	2	9	GENOMICS_ENGLAND;ORPHANET;UNIPROT
29620	51741	WWOX	0.453	0.808	C4015519	EPILEPTICENCEPHALOPATHY,EARLYINFANTILE,28	disease		DiseaseorSyndrome	0.7	1	2014	2015	2	7	CTD_human;GENOMICS_ENGLAND;UNIPROT
29632	51750	RTEL1	0.459	0.808	C0265965	DyskeratosisCongenita	disease	C16;C17;C15	DiseaseorSyndrome	0.69	1	2013	2018	2	0	GENOMICS_ENGLAND;ORPHANET
29634	51750	RTEL1	0.459	0.808	C1800706	IdiopathicPulmonaryFibrosis	disease	C08	DiseaseorSyndrome	0.63	1	2015	2018	1	0	CTD_human;ORPHANET
29635	51750	RTEL1	0.459	0.808	C1846142	HOYERAAL-HREIDARSSONSYNDROME	disease	C23;C16;C13;C17;C05;C10;F03;C15;F01	DiseaseorSyndrome	0.59	1	2013	2018	2	0	GENOMICS_ENGLAND;ORPHANET
29636	51750	RTEL1	0.459	0.808	C3554656	DYSKERATOSISCONGENITA,AUTOSOMALRECESSIVE5	disease		DiseaseorSyndrome	0.7	1	2009	2018	8	0	CTD_human;GENOMICS_ENGLAND;UNIPROT
29638	51750	RTEL1	0.459	0.808	C4225346	PULMONARYFIBROSISAND/ORBONEMARROWFAILURE,TELOMERE-RELATED,3	disease		DiseaseorSyndrome	0.7	1	2009	2018	4	0	CTD_human;GENOMICS_ENGLAND;UNIPROT
29642	51752	ERAP1	0.556	0.692	C0004943	BehcetSyndrome	disease	C16;C11;C17;C07;C14	DiseaseorSyndrome	0.7	1	2013	2020	2	1	CTD_human;ORPHANET
29657	51761	ATP8A2	0.659	0.577	C3808977	CEREBELLARATAXIA,MENTALRETARDATION,ANDDYSEQUILIBRIUMSYNDROME4	disease		DiseaseorSyndrome	0.8	1	1969	2018	2	3	GENOMICS_ENGLAND;UNIPROT
29662	51763	INPP5K	0.587	0.654	C4479410	MUSCULARDYSTROPHY,CONGENITAL,WITHCATARACTSANDINTELLECTUALDISABILITY	disease		DiseaseorSyndrome	0.7	1	2017	2017	2	8	CTD_human;GENOMICS_ENGLAND;UNIPROT
29664	51776	MAP3K20	0.564	0.769	C0546264	CongenitalFiberTypeDisproportion	disease	C05;C10	CongenitalAbnormality	0.51	1	2017	2017	1	0	GENOMICS_ENGLAND;ORPHANET
29665	51776	MAP3K20	0.564	0.769	C4225167	SPLIT-FOOTMALFORMATIONWITHMESOAXIALPOLYDACTYLY	disease		DiseaseorSyndrome	0.7	1	2016	2016	1	0	CTD_human;ORPHANET;UNIPROT
29669	51778	MYOZ2	0.716	0.308	C3151204	CARDIOMYOPATHY,FAMILIALHYPERTROPHIC,16	disease		DiseaseorSyndrome	0.6	1	2007	2007	1	2	CTD_human;UNIPROT
29684	51807	TUBA8	0.691	0.385	C2750798	PolymicrogyriaWithOpticNerveHypoplasia	disease	C16;C10	DiseaseorSyndrome	0.71	1	2009	2017	2	0	CTD_human;GENOMICS_ENGLAND;ORPHANET
29688	51816	ADA2	0.545	0.846	C0282492	SneddonSyndrome	disease	C17;C10;C14	DiseaseorSyndrome	0.71	1	1986	2018	3	2	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
29690	51816	ADA2	0.545	0.846	C1260899	Anemia,Diamond-Blackfan	disease	C16;C15	DiseaseorSyndrome	0.61	0.667	2014	2020	2	2	GENOMICS_ENGLAND;ORPHANET
29694	51816	ADA2	0.545	0.846	C3887654	POLYARTERITISNODOSA,CHILDHOOD-ONSET	disease	C17;C14	DiseaseorSyndrome	0.76	1	2014	2019	3	12	GENOMICS_ENGLAND;ORPHANET;UNIPROT
29719	53335	BCL11A	0.541	0.769	C4310833	INTELLECTUALDEVELOPMENTALDISORDERWITHPERSISTENCEOFFETALHEMOGLOBIN	disease		DiseaseorSyndrome	0.6	1	2016	2018	2	9	CTD_human;UNIPROT
29724	53345	TM6SF2	0.638	0.462	C0400966	Non-alcoholicFattyLiverDisease	disease	C06	DiseaseorSyndrome	0.6	0.955	2014	2020	2	0	CTD_human;GENOMICS_ENGLAND
29740	53405	CLIC5	0.792	0.308	C4015050	DEAFNESS,AUTOSOMALRECESSIVE103	disease		DiseaseorSyndrome	0.6	1	2015	2015	1	1	CTD_human;GENOMICS_ENGLAND
29742	53616	ADAM22	0.678	0.615	C4693688	EPILEPTICENCEPHALOPATHY,EARLYINFANTILE,61	disease		DiseaseorSyndrome	0.6	1	2016	2019	2	2	GENOMICS_ENGLAND;UNIPROT
29743	53630	BCO1	0.705	0.462	C2676023	HypercarotenemiaAndVitaminADeficiency,AutosomalDominant	disease	C18	DiseaseorSyndrome	0.6	1	2007	2007	1	1	CTD_human;ORPHANET;UNIPROT
29769	53834	FGFRL1	0.588	0.615	C1956097	Wolf-HirschhornSyndrome	disease	C16	DiseaseorSyndrome	0.51	1	2009	2017	0	0	CTD_human
29775	53904	MYO3A	0.78	0.269	C1846784	Deafness,AutosomalRecessive30	disease	C23;C10;C09	DiseaseorSyndrome	0.81	1	2011	2018	1	7	CTD_human;GENOMICS_ENGLAND
29784	54106	TLR9	0.411	0.885	C0267380	Crohnsdiseaseoftheileum	disease	C06	DiseaseorSyndrome	0.30	1	2004	2007	2	0	CTD_human
val	54106	TLR9	0.411	0.885	C0678202	Regionalenteritis	disease	C06	DiseaseorSyndrome	0.30	1	2004	2007	2	0	CTD_human
val	54106	TLR9	0.411	0.885	C0949272	IIeocolitis	disease	C06	DiseaseorSyndrome	0.30	1	2004	2007	2	0	CTD_human
val	54112	GPR88	0.805	0.115	C4310787	CHOREA,CHILDHOOD-ONSET,WITHPSYCHOMOTORRETARDATION	disease		DiseaseorSyndrome	0.40				0	1	CTD_human
val	54187	NANS	0.545	0.692	C0005941	BoneDiseases,Developmental	group	C05	DiseaseorSyndrome	0.30	1	2016	2016	1	0	CTD_human
val	54187	NANS	0.545	0.692	C0008073	DevelopmentalDisabilities	group	F03	MentalorBehavioralDysfunction	0.30	1	2016	2016	1	0	CTD_human
val	54187	NANS	0.545	0.692	C0085996	ChildDevelopmentDeviations	disease	F03	MentalorBehavioralDysfunction	0.30	1	2016	2016	1	0	CTD_human
val	54187	NANS	0.545	0.692	C0085997	ChildDevelopmentDisorders,Specific	disease	F03	MentalorBehavioralDysfunction	0.30	1	2016	2016	1	0	CTD_human
val	54187	NANS	0.545	0.692	C1864872	Spondyloepimetaphysealdysplasia,Genevievetype	disease	C23;C16;C17;C05;C10;F03;F01	DiseaseorSyndrome	0.70	1	2016	2016	1	1	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
val	54205	CYCS	0.599	0.769	C0007786	BrainIschemia	disease	C10;C14	DiseaseorSyndrome	0.30	1	2002	2002	1	0	CTD_human
val	54205	CYCS	0.599	0.769	C0007787	TransientIschemicAttack	disease	C10;C14	DiseaseorSyndrome	0.30	1	2001	2001	1	0	CTD_human
val	54205	CYCS	0.599	0.769	C0015695	FattyLiver	disease	C06	DiseaseorSyndrome	0.30	1	2000	2000	1	0	CTD_human
val	54205	CYCS	0.599	0.769	C0022116	Ischemia	phenotype	C23	PathologicFunction	0.30	1	2004	2004	1	0	CTD_human
val	54205	CYCS	0.599	0.769	C0028754	Obesity	disease	C23;C18	DiseaseorSyndrome	0.30	1	2005	2005	1	0	CTD_human
val	54205	CYCS	0.599	0.769	C0040034	Thrombocytopenia	phenotype	C15	DiseaseorSyndrome	0.65	1	2008	2019	1	1	CTD_human;GENOMICS_ENGLAND
val	54205	CYCS	0.599	0.769	C0263454	Chloracne	disease	C17	DiseaseorSyndrome	0.30	1	2007	2007	1	0	CTD_human
val	54205	CYCS	0.599	0.769	C0268583	Methylmalonicacidemia	phenotype	C16;C18	DiseaseorSyndrome	0.30	1	2006	2006	1	0	CTD_human
val	54205	CYCS	0.599	0.769	C0472381	PosteriorCirculationTransientIschemicAttack	disease	C10;C14	DiseaseorSyndrome	0.30	1	2001	2001	1	0	CTD_human
val	54205	CYCS	0.599	0.769	C0751019	CarotidCirculationTransientIschemicAttack	disease	C10;C14	DiseaseorSyndrome	0.30	1	2001	2001	1	0	CTD_human
val	54205	CYCS	0.599	0.769	C0751020	TransientIschemicAttack,VertebrobasilarCirculation	disease	C10;C14	DiseaseorSyndrome	0.30	1	2001	2001	1	0	CTD_human
val	54205	CYCS	0.599	0.769	C0751021	CrescendoTransientIschemicAttacks	disease	C10;C14	DiseaseorSyndrome	0.30	1	2001	2001	1	0	CTD_human
val	54205	CYCS	0.599	0.769	C0751022	BrainStemIschemia,Transient	disease	C10;C14	DiseaseorSyndrome	0.30	1	2001	2001	1	0	CTD_human
val	54205	CYCS	0.599	0.769	C0917798	CerebralIschemia	disease	C10;C14	PathologicFunction	0.30	1	2002	2002	1	0	CTD_human
val	54205	CYCS	0.599	0.769	C0917805	TransientCerebralIschemia	disease	C10;C14	DiseaseorSyndrome	0.30	1	2001	2001	1	0	CTD_human
val	54205	CYCS	0.599	0.769	C1527335	TransientIschemicAttack,AnteriorCirculation	disease	C10;C14	DiseaseorSyndrome	0.30	1	2001	2001	1	0	CTD_human
val	54205	CYCS	0.599	0.769	C1855119	Methylmalonicaciduria	disease	C16;C18	DiseaseorSyndrome	0.30	1	2006	2006	1	0	CTD_human
val	54205	CYCS	0.599	0.769	C2677608	Thrombocytopenia4	disease	C15	DiseaseorSyndrome	0.71	1	2008	2018	3	3	CTD_human;GENOMICS_ENGLAND;UNIPROT
val	54205	CYCS	0.599	0.769	C2711227	Steatohepatitis	disease	C06	DiseaseorSyndrome	0.30	1	2000	2000	1	0	CTD_human
val	54206	ERRFI1	0.612	0.538	C0007621	NeoplasticCellTransformation	phenotype	C23;C04	NeoplasticProcess	0.30	1	2017	2017	1	0	CTD_human
val	54206	ERRFI1	0.612	0.538	C0014175	Endometriosis	disease	C13	DiseaseorSyndrome	0.30	1	2011	2011	1	0	CTD_human
val	54206	ERRFI1	0.612	0.538	C0032460	PolycysticOvarySyndrome	disease	C04;C13;C19	DiseaseorSyndrome	0.31	1	2011	2011	1	0	CTD_human
val	54206	ERRFI1	0.612	0.538	C0269102	Endometrioma	disease	C13	NeoplasticProcess	0.30	1	2011	2011	1	0	CTD_human
val	54206	ERRFI1	0.612	0.538	C1136382	SclerocysticOvaries	disease	C04;C13;C19	DiseaseorSyndrome	0.30	1	2011	2011	1	0	CTD_human
val	54209	TREM2	0.519	0.769	C0002395	AlzheimersDisease	disease	C10;F03	DiseaseorSyndrome	0.7	0.977	2007	2020	3	2	CTD_human;GENOMICS_ENGLAND
29788	54209	TREM2	0.519	0.769	C0276496	FamilialAlzheimerDisease(FAD)	disease	C10;F03	DiseaseorSyndrome	0.51	1	2013	2017	3	0	CTD_human;ORPHANET
29793	54209	TREM2	0.519	0.769	C0497327	Dementia	disease	C10;F03	MentalorBehavioralDysfunction	0.7	1	2005	2020	2	0	CTD_human;GENOMICS_ENGLAND
29798	54714	CNGB3	0.633	0.192	C1849792	Achromatopsia3	disease	C23;C11;C10	DiseaseorSyndrome	0.93	1	2000	2018	6	106	CTD_human;GENOMICS_ENGLAND;UNIPROT
29799	54714	CNGB3	0.633	0.192	C1855465	STARGARDTDISEASE1(disorder)	disease		DiseaseorSyndrome	0.7	1	2005	2005	1	2	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
29800	54714	CNGB3	0.633	0.192	C4282180	Juvenilemaculardegeneration	disease		DiseaseorSyndrome	0.51	0	2005	2005	0	0	CTD_human;GENOMICS_ENGLAND
29829	54716	SLC6A20	0.805	0.269	C0268654	Iminoglycinuria	disease	C16;C18;C13;C12	DiseaseorSyndrome	0.6	1	2008	2011	2	0	CTD_human;GENOMICS_ENGLAND;ORPHANET
29830	54716	SLC6A20	0.805	0.269	C0543541	HYPERGLYCINURIA(disorder)	disease	C16;C18;C13;C12	DiseaseorSyndrome	0.6	1	2008	2008	1	0	CTD_human;GENOMICS_ENGLAND
29856	54756	IL17RD	0.617	0.654	C3808975	HYPOGONADOTROPICHYPOGONADISM18WITHORWITHOUTANOSMIA	disease		DiseaseorSyndrome	0.6	1	2013	2013	1	5	CTD_human;GENOMICS_ENGLAND;UNIPROT
29858	54757	FAM20A	0.7	0.346	C2931783	Amelogenesisimperfectanephrocalcinosis	disease	C16;C18;C13;C12;C07	DiseaseorSyndrome	0.78	1	2011	2019	12	3	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
29863	54765	TRIM44	0.612	0.423	C0003076	Aniridia	disease	C16;C11	CongenitalAbnormality	0.61	1	2015	2015	1	0	CTD_human;ORPHANET
29866	54768	HYDIN	0.641	0.538	C0020255	Hydrocephalus	disease	C10	DiseaseorSyndrome	0.63	1	1973	2013	2	0	CTD_human
29873	54768	HYDIN	0.641	0.538	C1837615	CiliaryDyskinesia,Primary,5	disease	C16;C08;C09	DiseaseorSyndrome	0.6	1	2012	2019	2	3	CTD_human;GENOMICS_ENGLAND
29907	54790	TET2	0.458	0.808	C3463824	MYELODYSPLASTICSYNDROME	group	C15	NeoplasticProcess	0.8	0.973	2009	2020	2	0	CGI;CTD_human;GENOMICS_ENGLAND
29911	54795	TRPM4	0.633	0.577	C1142166	BrugadaSyndrome(disorder)	disease	C16;C14	DiseaseorSyndrome	0.53	1	2012	2018	7	0	CLINGEN;ORPHANET
29913	54795	TRPM4	0.633	0.577	C1970298	ProgressiveFamilialHeartBlock,TypeIb	disease	C23;C14	DiseaseorSyndrome	0.7	1	2005	2018	6	11	CTD_human;GENOMICS_ENGLAND;UNIPROT
29915	54796	BNC2	0.612	0.615	C0238506	Congenitalposteriorurethralvalves	disease	C16;C13;C12	CongenitalAbnormality	0.6	1	2019	2019	1	0	GENOMICS_ENGLAND;ORPHANET
29920	54800	KLHL24	0.821	0.115	C4310631	EPIDERMOLYSISBULLOSASIMPLEX,GENERALIZED,WITHSCARRINGANDHAIRLOSS	disease		DiseaseorSyndrome	0.7	1	2016	2018	4	3	CLINGEN;CTD_human;ORPHANET
29929	54802	TRIT1	0.621	0.692	C4693466	COMBINEDOXIDATIVEPHOSPHORYLATIONDEFICIENCY35	disease		DiseaseorSyndrome	0.6	1	2014	2017	2	5	GENOMICS_ENGLAND;UNIPROT
29957	54805	CNNM2	0.641	0.346	C3151295	HYPOMAGNESEMIA6,RENAL	disease		DiseaseorSyndrome	0.7	1	2011	2016	2	2	CTD_human;GENOMICS_ENGLAND;UNIPROT
29960	54805	CNNM2	0.641	0.346	C4225333	HYPOMAGNESEMIA,SEIZURES,ANDMENTALRETARDATION	disease		DiseaseorSyndrome	0.7	1	2014	2016	2	3	CTD_human;GENOMICS_ENGLAND;UNIPROT
29976	54806	AHI1	0.513	0.846	C0431399	Familialaplasiaofthevermis	disease	C16;C13;C11;C12	DiseaseorSyndrome	0.7	0.969	2004	2019	1	9	GENOMICS_ENGLAND;ORPHANET
29978	54806	AHI1	0.513	0.846	C1837713	JOUBERTSYNDROME3	disease	C23;C11;C10	DiseaseorSyndrome	0.9	1	1992	2017	7	45	CTD_human;GENOMICS_ENGLAND;UNIPROT
29985	54808	DYM	0.563	0.769	C0265286	Dyggve-Melchior-Clausensyndrome	disease	C23;C16;C05;C10;C19;F03;F01	DiseaseorSyndrome	0.78	1	2003	2017	5	8	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
29988	54808	DYM	0.563	0.769	C1846431	SMITH-MCCORTDYSPLASIA	disease	C16;C05	DiseaseorSyndrome	0.82	1	2003	2017	2	0	CTD_human;GENOMICS_ENGLAND;ORPHANET
29990	54808	DYM	0.563	0.769	C3888088	SMITH-MCCORTDYSPLASIA1	disease	C16;C05	DiseaseorSyndrome	0.65	1	2003	2018	4	3	GENOMICS_ENGLAND;UNIPROT
29997	54809	SAMD9	0.606	0.808	C1864861	TumoralCalcinosis,Normophosphatemic,Familial	disease	C16;C18;C05	DiseaseorSyndrome	0.7	1	2006	2017	2	3	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
30001	54809	SAMD9	0.606	0.808	C4284088	MIRAGESYNDROME	phenotype	C23	DiseaseorSyndrome	0.79	1	2006	2020	3	3	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
30009	54820	NDE1	0.608	0.462	C1857977	MICROHYDRANENCEPHALY	disease	C16;C05;C10	DiseaseorSyndrome	0.62	1	2011	2019	2	0	CTD_human;GENOMICS_ENGLAND;ORPHANET
30044	54832	VPS13C	0.653	0.346	C4225186	PARKINSONDISEASE23,AUTOSOMALRECESSIVEEARLY-ONSET	disease		DiseaseorSyndrome	0.7	1	2016	2018	2	5	CTD_human;GENOMICS_ENGLAND;UNIPROT
30048	54840	APTX	0.59	0.5	C1859598	ATAXIA,EARLY-ONSET,WITHOCULOMOTORAPRAXIAANDHYPOALBUMINEMIA	disease	C23;C10;C15;F01	DiseaseorSyndrome	0.8	1	2000	2017	11	15	CTD_human;GENOMICS_ENGLAND;UNIPROT
30049	54845	ESRP1	0.628	0.5	C4693935	DEAFNESS,AUTOSOMALRECESSIVE109	disease		DiseaseorSyndrome	0.6	1	2017	2017	1	1	GENOMICS_ENGLAND;UNIPROT
30059	54862	CC2D1A	0.628	0.462	C1838023	MENTALRETARDATION,AUTOSOMALRECESSIVE3	disease	C23;C10;F03;F01	DiseaseorSyndrome	0.6	1	2006	2006	1	1	CTD_human;GENOMICS_ENGLAND
30063	54872	PIGG	0.792	0.231	C4310794	MENTALRETARDATION,AUTOSOMALRECESSIVE53	disease		DiseaseorSyndrome	0.7	1	2017	2019	2	4	CTD_human;GENOMICS_ENGLAND;UNIPROT
30082	54880	BCOR	0.471	0.808	C0796016	Microphthalmia,syndromic1	disease	C16;C11	CongenitalAbnormality	0.65	1	2004	2018	1	1	CTD_human;ORPHANET
30083	54880	BCOR	0.471	0.808	C1846265	Microphthalmia,syndromic2	disease	C16;C11;C14	DiseaseorSyndrome	0.8	1	2004	2020	4	11	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
30121	54888	NSUN2	0.559	0.846	C1970199	MENTALRETARDATION,AUTOSOMALRECESSIVE5	disease	C23;C10;F03;F01	DiseaseorSyndrome	0.7	1	2011	2012	3	3	CTD_human;GENOMICS_ENGLAND;UNIPROT
30162	54899	PXK	0.821	0.231	C0024141	LupusErythematosus,Systemic	disease	C17;C20	DiseaseorSyndrome	0.67	0.875	2008	2015	2	2	CTD_human;ORPHANET
30166	54901	CDKAL1	0.617	0.615	C0011860	DiabetesMellitus,Non-Insulin-Dependent	disease	C18;C19	DiseaseorSyndrome	0.7	0.984	2007	2019	3	88	CTD_human
30202	54902	TTC19	0.663	0.385	C1852372	MITOCHONDRIALCOMPLEXIIIDEFICIENCY(disorder)	disease	C18	DiseaseorSyndrome	0.53	1	2011	2018	0	0	CTD_human;GENOMICS_ENGLAND
30213	54903	MKS1	0.505	0.769	C0431399	Familialaplasiaofthevermis	disease	C16;C13;C11;C12	DiseaseorSyndrome	0.66	1	2006	2017	2	20	GENOMICS_ENGLAND;ORPHANET
30214	54903	MKS1	0.505	0.769	C0752166	Bardet-BiedlSyndrome	disease	C16;C11;C10	DiseaseorSyndrome	0.74	1	2004	2012	2	2	CTD_human;GENOMICS_ENGLAND;ORPHANET
30216	54903	MKS1	0.505	0.769	C2673873	BARDET-BIEDLSYNDROME13	disease	C16;C11;C10	DiseaseorSyndrome	0.7	1	1969	2016	4	19	CTD_human;GENOMICS_ENGLAND;UNIPROT
30218	54903	MKS1	0.505	0.769	C3714506	Meckelsyndrometype1	disease	C23;C16;C13;C11;C12;C08;C10;C09	DiseaseorSyndrome	0.8	0.929	1969	2019	7	23	CTD_human;GENOMICS_ENGLAND;UNIPROT
30224	54919	DNAAF5	0.67	0.5	C3543825	CILIARYDYSKINESIA,PRIMARY,18	disease		DiseaseorSyndrome	0.7	1	2012	2018	3	1	CTD_human;GENOMICS_ENGLAND;UNIPROT
30238	54928	IMPAD1	0.7	0.385	C3279757	CHONDRODYSPLASIAWITHJOINTDISLOCATIONS,GPAPPTYPE	disease		DiseaseorSyndrome	0.71	1	2011	2012	2	4	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
30240	54931	TRMT10C	0.839	0.154	C4310773	COMBINEDOXIDATIVEPHOSPHORYLATIONDEFICIENCY30	disease		DiseaseorSyndrome	0.7	1	2016	2016	1	2	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
30245	54936	ADPRS	0.743	0.308	C4748527	NEURODEGENERATION,CHILDHOOD-ONSET,STRESS-INDUCED,WITHVARIABLEATAXIAANDSEIZURES	disease		DiseaseorSyndrome	0.6	1	2018	2018	2	8	GENOMICS_ENGLAND;UNIPROT
30247	54938	SARS2	0.57	0.692	C3151209	Hyperuricemia,pulmonaryhypertension,renalfailure,alkalosissyndrome	disease	C23;C18;C13;C11;C05;C12;C08;C10;C14	DiseaseorSyndrome	0.72	1	2011	2016	3	2	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
30255	54941	RNF125	0.647	0.654	C4015710	TENORIOSYNDROME	disease		DiseaseorSyndrome	0.7	1	2014	2014	1	3	CTD_human;GENOMICS_ENGLAND;UNIPROT
30266	54949	SDHAF2	0.604	0.692	C1708353	HereditaryParaganglioma-PheochromocytomaSyndrome	disease	C16;C04	DiseaseorSyndrome	0.6	1	1981	2017	6	5	CLINGEN;GENOMICS_ENGLAND
30267	54949	SDHAF2	0.604	0.692	C1866552	PARAGANGLIOMAS2(disorder)	disease	C16;C04	DiseaseorSyndrome	0.71	1	2009	2012	1	1	CTD_human;GENOMICS_ENGLAND;UNIPROT
30277	54968	TMEM70	0.636	0.654	C3279699	Encephalocardiomyopathy,Mitochondrial,Neonatal,DueToAtpSynthaseDeficiency	disease	C18;C05;C10	DiseaseorSyndrome	0.7	1	2008	2016	5	4	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
30284	54977	SLC25A38	0.716	0.462	C4225425	ANEMIA,SIDEROBLASTIC,2,PYRIDOXINE-REFRACTORY	disease		DiseaseorSyndrome	0.6	1	2009	2015	2	8	GENOMICS_ENGLAND;UNIPROT
30290	54982	CLN6	0.67	0.231	C0022340	Late-InfantileNeuronalCeroidLipfuscinosis	disease	C16;C18;C10	DiseaseorSyndrome	0.59	1	1998	2019	1	0	CTD_human
30291	54982	CLN6	0.67	0.231	C0022797	AdultNeuronalCeroidLipofuscinosis	disease	C16;C18;C10	DiseaseorSyndrome	0.83	1	1998	2019	5	6	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
30293	54982	CLN6	0.67	0.231	C0027877	NeuronalCeroid-Lipofuscinoses	disease	C16;C18;C10	DiseaseorSyndrome	0.7	0.952	1998	2019	1	6	CTD_human
30300	54982	CLN6	0.67	0.231	C0751383	JuvenileNeuronalCeroidLipofuscinosis	disease	C16;C18;C10	DiseaseorSyndrome	0.58	1	1998	2019	1	0	CTD_human
30310	54982	CLN6	0.67	0.231	C1866282	CEROIDLIPOFUSCINOSIS,NEURONAL,6	disease	C16;C18;C10	DiseaseorSyndrome	0.92	1	1998	2019	9	41	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
30324	55005	RMND1	0.674	0.462	C3554067	COMBINEDOXIDATIVEPHOSPHORYLATIONDEFICIENCY11	disease		DiseaseorSyndrome	0.7	1	2012	2016	6	6	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
30342	55149	MTPAP	0.581	0.769	C3150925	SPASTICATAXIA4,AUTOSOMALRECESSIVE	disease		DiseaseorSyndrome	0.7	1	2010	2017	3	1	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
30348	55151	TMEM38B	0.78	0.231	C3554428	OSTEOGENESISIMPERFECTA,TYPEXIV	disease		DiseaseorSyndrome	0.51	1	2012	2017	1	0	CTD_human;GENOMICS_ENGLAND
30352	55154	MSTO1	0.582	0.692	C4540096	MYOPATHY,MITOCHONDRIAL,ANDATAXIA	disease		DiseaseorSyndrome	0.7	1	2017	2018	3	6	GENOMICS_ENGLAND;ORPHANET;UNIPROT
30353	55157	DARS2	0.638	0.577	C1970180	LeukoencephalopathywithBrainstemandSpinalCordInvolvementandLactateElevation	disease	C18;C10	DiseaseorSyndrome	0.78	1	2007	2019	6	19	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
30367	55163	PNPO	0.659	0.5	C1864723	Pyridoxamine5-Prime-PhosphateOxidaseDeficiency	disease	C23;C18;C10;C14	DiseaseorSyndrome	0.71	1	2005	2019	4	10	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
30371	55165	CEP55	0.534	0.731	C1856053	HydranencephalywithRenalAplasia-Dysplasia	disease	C16;C13;C12;C10	DiseaseorSyndrome	0.62	1	2017	2019	2	3	GENOMICS_ENGLAND;ORPHANET
30379	55172	DNAAF2	0.678	0.538	C2675867	CILIARYDYSKINESIA,PRIMARY,10	disease	C16;C08;C09	DiseaseorSyndrome	0.7	1	2008	2019	1	0	CTD_human;GENOMICS_ENGLAND
30385	55180	LINS1	0.691	0.231	C3280538	MENTALRETARDATION,AUTOSOMALRECESSIVE27	disease		DiseaseorSyndrome	0.7	1	2011	2018	4	4	CTD_human;GENOMICS_ENGLAND;UNIPROT
30389	55187	VPS13D	0.769	0.346	C1846492	SPINOCEREBELLARATAXIA,AUTOSOMALRECESSIVE4	disease	C16;C10	DiseaseorSyndrome	0.7	1	2018	2018	2	11	CTD_human;GENOMICS_ENGLAND;UNIPROT
30400	55193	PBRM1	0.566	0.615	C0279702	Conventional(ClearCell)RenalCellCarcinoma	disease	C04;C13;C12	NeoplasticProcess	0.7	1	2011	2020	2	0	CGI;CTD_human
30431	55209	SETD5	0.56	0.731	C3810406	MENTALRETARDATION,AUTOSOMALDOMINANT23	disease		DiseaseorSyndrome	0.7	1	2014	2018	5	16	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
30440	55210	ATAD3A	0.628	0.692	C4310677	HAREL-YOONSYNDROME	disease		DiseaseorSyndrome	0.7	1	2015	2018	4	3	CTD_human;GENOMICS_ENGLAND;ORPHANET
30447	55212	BBS7	0.682	0.462	C1859565	BARDET-BIEDLSYNDROME7	disease	C16;C11;C10	DiseaseorSyndrome	0.7	1	2003	2015	4	11	CTD_human;GENOMICS_ENGLAND;UNIPROT
30455	55213	RCBTB1	0.572	0.692	C4310680	RETINALDYSTROPHYWITHORWITHOUTEXTRAOCULARANOMALIES	disease		DiseaseorSyndrome	0.7	1	2016	2016	1	6	CTD_human;GENOMICS_ENGLAND;UNIPROT
30458	55214	P3H2	0.743	0.308	C3280346	MYOPIA,HIGH,WITHCATARACTANDVITREORETINALDEGENERATION	disease		DiseaseorSyndrome	0.7	1	2011	2011	1	3	CTD_human;GENOMICS_ENGLAND;UNIPROT
30465	55215	FANCI	0.543	0.731	C1836861	FANCONIANEMIA,COMPLEMENTATIONGROUPI	disease	C16;C18;C15	DiseaseorSyndrome	0.71	1	2001	2018	5	6	CTD_human;GENOMICS_ENGLAND;UNIPROT
30471	55217	TMLHE	0.821	0.231	C3550875	AUTISM,SUSCEPTIBILITYTO,X-LINKED6	disease		DiseaseorSyndrome	0.6	1	2011	2015	2	0	GENOMICS_ENGLAND;UNIPROT
30481	55240	STEAP3	0.666	0.385	C3808920	ANEMIA,HYPOCHROMICMICROCYTIC,WITHIRONOVERLOAD2	disease		DiseaseorSyndrome	0.6	1	2011	2011	1	1	GENOMICS_ENGLAND;ORPHANET
30486	55249	YY1AP1	0.711	0.462	C1865267	ArterialOcclusiveDisease,Progressive,withHypertension,HeartDefects,BoneFragility,andBrachysyndactyly	disease	C16;C05;C14	DiseaseorSyndrome	0.74	1	2017	2019	1	7	CTD_human;GENOMICS_ENGLAND;ORPHANET
30491	55250	ELP2	0.716	0.538	C4310641	MENTALRETARDATION,AUTOSOMALRECESSIVE58	disease		DiseaseorSyndrome	0.7	1	2015	2015	1	4	CTD_human;GENOMICS_ENGLAND;UNIPROT
30509	55275	VPS53	0.659	0.654	C4014488	PONTOCEREBELLARHYPOPLASIA,TYPE2E	disease	C16;C10	DiseaseorSyndrome	0.7	1	1989	2018	3	4	CTD_human;GENOMICS_ENGLAND;UNIPROT
30520	55280	CWF19L1	0.691	0.346	C4015301	SPINOCEREBELLARATAXIA,AUTOSOMALRECESSIVE17	disease		DiseaseorSyndrome	0.6	1	2014	2018	3	4	GENOMICS_ENGLAND;ORPHANET
30524	55294	FBXW7	0.465	0.808	C0006142	Malignantneoplasmofbreast	disease	C04;C17	NeoplasticProcess	0.6	1	2001	2019	1	1	CTD_human;UNIPROT
30535	55294	FBXW7	0.465	0.808	C0476089	EndometrialCarcinoma	disease	C04;C13	NeoplasticProcess	0.57	1	2002	2019	1	0	CGI;CTD_human
30544	55294	FBXW7	0.465	0.808	C1961099	PrecursorT-CellLymphoblasticLeukemia-Lymphoma	disease	C04;C20;C15	NeoplasticProcess	0.6	0.935	2007	2019	2	0	CGI;CTD_human
30576	55315	SLC29A3	0.578	0.769	C1864445	Histiocytosiswithjointcontracturesandsensorineuraldeafness	disease	C23;C05;C10;C09;C15	DiseaseorSyndrome	0.8	1	1998	2019	12	18	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
30581	55325	UFSP2	0.736	0.192	C1840572	HIPDYSPLASIA,BEUKESTYPE	disease	C16;C05	DiseaseorSyndrome	0.71	1	2015	2018	1	2	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
30586	55331	ACER3	0.743	0.423	C4540358	LEUKODYSTROPHY,PROGRESSIVE,EARLYCHILDHOOD-ONSET	disease		DiseaseorSyndrome	0.6	1	2016	2018	2	2	ORPHANET;UNIPROT
30590	55343	SLC35C1	0.705	0.577	C0398739	Congenitaldisorderofglycosylation,type2C	disease	C16;C18	DiseaseorSyndrome	0.9	1	2001	2016	5	6	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
30637	55503	TRPV6	0.603	0.615	C1300287	Transientneonatalhyperparathyroidism	phenotype	C23;C19	DiseaseorSyndrome	0.61	1	2018	2019	2	6	GENOMICS_ENGLAND;UNIPROT
30644	55505	NOP10	0.631	0.654	C1857144	DYSKERATOSISCONGENITA,AUTOSOMALRECESSIVE1	disease		DiseaseorSyndrome	0.6	1	2007	2007	1	1	GENOMICS_ENGLAND;UNIPROT
30652	55521	TRIM36	0.78	0.231	C0002902	Anencephaly	disease	C16;C10	CongenitalAbnormality	0.61	1	2017	2017	1	0	CTD_human;UNIPROT
30656	55526	DHTKD1	0.711	0.385	C1859817	2-AMINOADIPIC2-OXOADIPICACIDURIA	disease		Finding	0.7	1	2012	2016	2	6	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
30657	55526	DHTKD1	0.711	0.385	C3554366	CHARCOT-MARIE-TOOTHDISEASE,AXONAL,TYPE2Q	disease		DiseaseorSyndrome	0.9	1	2012	2018	1	3	CTD_human;GENOMICS_ENGLAND;ORPHANET
30680	55532	SLC30A10	0.578	0.654	C2750442	HypermanganesemiawithDystoniaPolycythemiaandCirrhosis	disease	C18	DiseaseorSyndrome	0.74	1	2012	2018	7	14	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
30698	55572	FOXRED1	0.633	0.462	C0751651	MitochondrialDiseases	group	C18	DiseaseorSyndrome	0.51	1	2010	2016	2	0	CTD_human;GENOMICS_ENGLAND
30703	55572	FOXRED1	0.633	0.462	C1838979	MITOCHONDRIALCOMPLEXIDEFICIENCY	disease	C18	DiseaseorSyndrome	0.6	1	1998	2016	4	3	GENOMICS_ENGLAND;ORPHANET
30709	55572	FOXRED1	0.633	0.462	C4748791	MITOCHONDRIALCOMPLEXIDEFICIENCY,NUCLEARTYPE19	disease		DiseaseorSyndrome	0.6	1	2010	2015	3	3	GENOMICS_ENGLAND;UNIPROT
30731	55603	TENT5A	0.695	0.577	C4693736	OSTEOGENESISIMPERFECTA,TYPEXVIII	disease		DiseaseorSyndrome	0.6	1	2018	2018	1	3	GENOMICS_ENGLAND;UNIPROT
30734	55605	KIF21A	0.653	0.423	C1851102	FibrosisOfExtraocularMuscles,Congenital,1	disease	C23;C16;C11;C10	DiseaseorSyndrome	0.97	0.923	2001	2016	5	7	CTD_human;GENOMICS_ENGLAND;UNIPROT
30735	55605	KIF21A	0.653	0.423	C2751105	FIBROSISOFEXTRAOCULARMUSCLES,CONGENITAL,3B(disorder)	disease	C23;C16;C11;C10	DiseaseorSyndrome	0.6	1	2014	2014	0	3	CTD_human
30736	55612	FERMT1	0.599	0.577	C0406557	PoikilodermaofKindler	disease	C23;C16;C17;C07	DiseaseorSyndrome	1	0.957	2003	2019	6	24	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
30745	55621	TRMT1	0.821	0.269	C3714756	IntellectualDisability	group	C23;C10;F03;F01	MentalorBehavioralDysfunction	0.52	1	2011	2017	2	0	CTD_human;GENOMICS_ENGLAND
30748	55624	POMGNT1	0.537	0.538	C0265221	Walker-Warburgcongenitalmusculardystrophy	disease	C16;C11;C10	DiseaseorSyndrome	0.72	1	2003	2009	1	0	CTD_human;ORPHANET
30750	55624	POMGNT1	0.537	0.538	C0457133	Muscleeyebraindisease	disease	C16;C11;C10	DiseaseorSyndrome	0.7	1	2001	2017	1	74	CTD_human;ORPHANET
30754	55624	POMGNT1	0.537	0.538	C3150412	MUSCULARDYSTROPHY-DYSTROGLYCANOPATHY(CONGENITALWITHMENTALRETARDATION),TYPEB,3	disease		DiseaseorSyndrome	0.9	1	2001	2017	5	13	CTD_human;GENOMICS_ENGLAND;UNIPROT
30755	55624	POMGNT1	0.537	0.538	C3150417	MUSCULARDYSTROPHY-DYSTROGLYCANOPATHY(LIMB-GIRDLE),TYPEC,3	disease		DiseaseorSyndrome	0.7	1	2001	2017	5	12	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
30756	55624	POMGNT1	0.537	0.538	C3151519	MUSCULARDYSTROPHY-DYSTROGLYCANOPATHY(CONGENITALWITHBRAINANDEYEANOMALIES),TYPEA,3	disease	C16;C05;C10	DiseaseorSyndrome	0.6	1	2001	2016	13	18	GENOMICS_ENGLAND;UNIPROT
30758	55624	POMGNT1	0.537	0.538	C4310704	RETINITISPIGMENTOSA76	disease		DiseaseorSyndrome	0.7	1	2001	2017	4	13	CTD_human;GENOMICS_ENGLAND;UNIPROT
30764	55630	SLC39A4	0.628	0.692	C0221036	Acrodermatitisenteropathica	disease	C16;C17	DiseaseorSyndrome	1	0.957	2002	2019	10	9	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
30770	55636	CHD7	0.441	0.846	C0162809	KallmannSyndrome	disease	C16;C13;C12;C19	DiseaseorSyndrome	0.6	1	2006	2018	1	0	CTD_human;ORPHANET
30771	55636	CHD7	0.441	0.846	C0265354	CHARGESyndrome	disease	C16;C11	DiseaseorSyndrome	1	0.981	2004	2020	24	204	CLINGEN;CTD_human;GENOMICS_ENGLAND;UNIPROT
30780	55636	CHD7	0.441	0.846	C2936502	FamilialCHARGESyndrome	disease	C16;C11	DiseaseorSyndrome	0.51	1	2005	2015	2	0	CTD_human
30781	55636	CHD7	0.441	0.846	C3552553	HYPOGONADOTROPICHYPOGONADISM5WITHORWITHOUTANOSMIA	disease		DiseaseorSyndrome	0.6	1	2004	2016	5	25	GENOMICS_ENGLAND;UNIPROT
30782	55640	FLVCR2	0.736	0.346	C1856972	EncephaloclasticProliferativeVasculopathy	disease	C16;C10	DiseaseorSyndrome	0.72	1	2010	2016	3	3	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
30784	55644	OSGEP	0.626	0.615	C0795949	GallowayMowatsyndrome	disease	C23;C16;C13;C05;C12;C10	DiseaseorSyndrome	0.53	1	2017	2019	1	0	CTD_human;ORPHANET
30786	55644	OSGEP	0.626	0.615	C4540266	GALLOWAY-MOWATSYNDROME3	disease		DiseaseorSyndrome	0.6	1	2017	2017	2	12	GENOMICS_ENGLAND;UNIPROT
30787	55650	PIGV	0.636	0.615	C1855923	HyperphosphatasiawithMentalRetardation	disease	C23;C16;C18;C10;F03;F01	DiseaseorSyndrome	0.74	1	2010	2017	1	1	CTD_human;GENOMICS_ENGLAND;ORPHANET
30788	55650	PIGV	0.636	0.615	C4551502	HYPERPHOSPHATASIAWITHMENTALRETARDATIONSYNDROME1	disease	C23;C16;C18;C10;F03;F01	DiseaseorSyndrome	0.6	1	2010	2016	3	6	GENOMICS_ENGLAND;UNIPROT
30791	55651	NHP2	0.623	0.654	C3151441	DYSKERATOSISCONGENITA,AUTOSOMALRECESSIVE2	disease		DiseaseorSyndrome	0.7	1	2001	2014	4	0	CLINGEN;CTD_human;GENOMICS_ENGLAND;UNIPROT
30794	55654	TMEM127	0.638	0.615	C0031511	Pheochromocytoma	disease	C04	NeoplasticProcess	0.8	1	2010	2020	2	19	CTD_human;GENOMICS_ENGLAND;UNIPROT
30806	55670	PEX26	0.584	0.615	C0043459	ZellwegerSyndrome	disease	C16;C06;C18;C13;C12;C10	DiseaseorSyndrome	0.51	1	2003	2015	2	0	CTD_human;GENOMICS_ENGLAND
30809	55670	PEX26	0.584	0.615	C0282527	InfantileRefsumDisease(disorder)	disease	C16;C18;C10	DiseaseorSyndrome	0.61	1	2003	2006	1	0	CTD_human;GENOMICS_ENGLAND;ORPHANET
30812	55670	PEX26	0.584	0.615	C1832200	Peroxisomebiogenesisdisorders	group	C16;C18	DiseaseorSyndrome	0.64	1	2003	2016	2	3	CTD_human;GENOMICS_ENGLAND
30816	55670	PEX26	0.584	0.615	C3553951	PEROXISOMEBIOGENESISDISORDER7B	disease	C16;C18	DiseaseorSyndrome	0.7	1	2003	2017	6	5	CTD_human;GENOMICS_ENGLAND;UNIPROT
30818	55670	PEX26	0.584	0.615	C3888385	PEROXISOMEBIOGENESISDISORDER7A(ZELLWEGER)	disease	C16;C18	DiseaseorSyndrome	0.7	1	2003	2017	7	7	CTD_human;GENOMICS_ENGLAND;UNIPROT
30825	55679	LIMS2	0.751	0.308	C4225192	MUSCULARDYSTROPHY,AUTOSOMALRECESSIVE,WITHCARDIOMYOPATHYANDTRIANGULARTONGUE	disease		DiseaseorSyndrome	0.7	1	2015	2015	1	3	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
30834	55687	TRMU	0.716	0.385	C3278664	LIVERFAILURE,INFANTILE,TRANSIENT	disease		DiseaseorSyndrome	0.7	1	2009	2016	3	7	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
30849	55690	PACS1	0.603	0.615	C3554343	MENTALRETARDATION,AUTOSOMALDOMINANT17	disease	C23	DiseaseorSyndrome	0.73	1	2012	2019	1	1	GENOMICS_ENGLAND;ORPHANET;UNIPROT
30861	55691	FRMD4A	0.65	0.538	C4225193	CORPUSCALLOSUM,AGENESISOF,WITHFACIALANOMALIESANDCEREBELLARATAXIA	disease		DiseaseorSyndrome	0.7	1	2015	2019	2	1	CTD_human;GENOMICS_ENGLAND;ORPHANET
30864	55697	VAC14	0.588	0.731	C4310743	STRIATONIGRALDEGENERATION,CHILDHOOD-ONSET	disease		DiseaseorSyndrome	0.7	1	2008	2016	2	3	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
30874	55699	IARS2	0.59	0.654	C4014942	CATARACTS,GROWTHHORMONEDEFICIENCY,SENSORYNEUROPATHY,SENSORINEURALHEARINGLOSS,ANDSKELETALDYSPLASIA	disease		DiseaseorSyndrome	0.73	1	2014	2018	5	1	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
30880	55703	POLR3B	0.628	0.654	C2676243	Leukodystrophy,Hypomyelinating,withHypodontiaandHypogonadotropicHypogonadism	disease	C23;C16;C10;C19;C07	DiseaseorSyndrome	0.73	1	2011	2018	2	2	CTD_human;GENOMICS_ENGLAND;ORPHANET
30881	55703	POLR3B	0.628	0.654	C3280644	LEUKODYSTROPHY,HYPOMYELINATING,8,WITHORWITHOUTOLIGODONTIAAND/ORHYPOGONADOTROPICHYPOGONADISM	disease		DiseaseorSyndrome	0.6	1	2011	2015	5	14	GENOMICS_ENGLAND;UNIPROT
30885	55704	CCDC88A	0.61	0.615	C1850056	Progressiveencephalopathywithedema,hypsarrhythmia,andopticatrophy-likesyndrome	disease	C11;C10	DiseaseorSyndrome	0.54	0.75	2003	2020	2	0	GENOMICS_ENGLAND;ORPHANET
30892	55714	TENM3	0.599	0.692	C3554592	MICROPHTHALMIA,ISOLATED,WITHCOLOBOMA9	disease		DiseaseorSyndrome	0.6	1	2012	2012	1	2	CTD_human;GENOMICS_ENGLAND
30900	55717	WDR11	0.524	0.808	C0162809	KallmannSyndrome	disease	C16;C13;C12;C19	DiseaseorSyndrome	0.74	1	2010	2018	2	0	GENOMICS_ENGLAND;ORPHANET
30905	55717	WDR11	0.524	0.808	C3540450	HYPOGONADOTROPICHYPOGONADISM14WITHORWITHOUTANOSMIA	disease		DiseaseorSyndrome	0.7	1	2010	2018	3	6	CTD_human;GENOMICS_ENGLAND;UNIPROT
30934	55737	VPS35	0.656	0.5	C3280133	PARKINSONDISEASE17	disease		DiseaseorSyndrome	0.9	1	2011	2015	8	1	CTD_human;GENOMICS_ENGLAND;UNIPROT
30957	55743	CHFR	0.633	0.5	C0007131	Non-SmallCellLungCarcinoma	disease	C04;C08	NeoplasticProcess	0.55	0.8	2008	2015	1	1	CTD_human;UNIPROT
30972	55746	NUP133	0.678	0.577	C4748549	NEPHROTICSYNDROME,TYPE18	disease		DiseaseorSyndrome	0.6	1	2018	2018	2	3	GENOMICS_ENGLAND;UNIPROT
30981	55750	AGK	0.65	0.654	C1859317	Cataractandcardiomyopathy	disease	C11;C14	DiseaseorSyndrome	0.78	1	1986	2017	4	14	CTD_human;GENOMICS_ENGLAND;ORPHANET
30982	55750	AGK	0.65	0.654	C3553494	CATARACT38	disease		DiseaseorSyndrome	0.6	1	2016	2016	1	1	CTD_human;GENOMICS_ENGLAND
30988	55755	CDK5RAP2	0.682	0.577	C1858108	Microcephaly,PrimaryAutosomalRecessive,3	disease	C16;C05;C10	DiseaseorSyndrome	0.6	1	2005	2017	0	15	CTD_human;GENOMICS_ENGLAND
30989	55755	CDK5RAP2	0.682	0.577	C3711387	AutosomalRecessivePrimaryMicrocephaly	disease	C16;C05;C10	DiseaseorSyndrome	0.69	0.889	2007	2017	0	2	GENOMICS_ENGLAND;ORPHANET
31012	55764	IFT122	0.56	0.846	C0432235	CRANIOECTODERMALDYSPLASIA1	disease	C16;C17;C05	DiseaseorSyndrome	0.73	1	2009	2018	8	10	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
31026	55768	NGLY1	0.601	0.654	C3808991	NGLY1deficiency	disease	C16;C18	DiseaseorSyndrome	0.77	1	2012	2020	7	19	CLINGEN;CTD_human;GENOMICS_ENGLAND;ORPHANET
31028	55773	TBC1D23	0.729	0.308	C4540164	PONTOCEREBELLARHYPOPLASIA,TYPE11	disease		CongenitalAbnormality	0.6	1	2017	2018	3	4	GENOMICS_ENGLAND;UNIPROT
31030	55775	TDP1	0.612	0.538	C1846574	SPINOCEREBELLARATAXIA,AUTOSOMALRECESSIVE,WITHAXONALNEUROPATHY	disease	C16;C10	DiseaseorSyndrome	0.9	0.923	2002	2020	5	0	CTD_human;GENOMICS_ENGLAND;UNIPROT
31034	55777	MBD5	0.581	0.808	C1969562	MentalRetardation,AutosomalDominant1	disease	C23;C10;F03;F01	DiseaseorSyndrome	0.61	1	2007	2017	2	0	CTD_human;GENOMICS_ENGLAND;UNIPROT
31038	55779	CFAP44	0.792	0.077	C4539824	SPERMATOGENICFAILURE20	disease		DiseaseorSyndrome	0.6	1	2017	2017	1	6	GENOMICS_ENGLAND
31040	55780	ERMARD	0.647	0.538	C1868720	PeriventricularNodularHeterotopia	disease	C16;C10	DiseaseorSyndrome	0.72	1	2013	2017	1	0	CTD_human;GENOMICS_ENGLAND;ORPHANET
31041	55780	ERMARD	0.647	0.538	C3809872	PERIVENTRICULARNODULARHETEROTOPIA6	disease		DiseaseorSyndrome	0.6	1	2013	2013	1	1	GENOMICS_ENGLAND;UNIPROT
31055	55788	LMBRD1	0.716	0.385	C1848578	METHYLMALONICACIDURIAANDHOMOCYSTINURIA,cblFTYPE(disorder)	disease	C16;C18	DiseaseorSyndrome	0.63	1	2009	2016	2	3	CTD_human;GENOMICS_ENGLAND
31063	55800	SCN3B	0.686	0.269	C1142166	BrugadaSyndrome(disorder)	disease	C16;C14	DiseaseorSyndrome	0.53	0.917	2001	2016	11	0	CLINGEN
31067	55800	SCN3B	0.686	0.269	C2751088	BrugadaSyndrome7	disease	C16;C14	DiseaseorSyndrome	0.9	1	2009	2016	4	4	CTD_human;GENOMICS_ENGLAND;UNIPROT
31074	55806	HR	0.722	0.192	C0263505	Alopeciauniversalis	disease	C23;C17	DiseaseorSyndrome	0.71	1	1998	1998	1	0	CTD_human;GENOMICS_ENGLAND;ORPHANET
31075	55806	HR	0.722	0.192	C1859592	ATRICHIAWITHPAPULARLESIONS	disease	C23;C17	DiseaseorSyndrome	0.9	1	1998	2008	2	2	CTD_human;GENOMICS_ENGLAND;ORPHANET
31076	55806	HR	0.722	0.192	C1859877	Alopeciauniversaliscongenita	disease	C23;C17	CongenitalAbnormality	0.9	1	1998	2014	4	4	CTD_human;GENOMICS_ENGLAND;UNIPROT
31077	55806	HR	0.722	0.192	C2750815	MarieUnnaHereditaryHypotrichosis1	disease	C17	DiseaseorSyndrome	0.61	1	1999	2012	1	4	GENOMICS_ENGLAND
31078	55806	HR	0.722	0.192	C2931059	MarieUnnacongenitalhypotrichosis	disease	C17	DiseaseorSyndrome	0.51	1	2009	2009	1	0	CTD_human;ORPHANET
31091	55812	SPATA7	0.656	0.385	C0035334	RetinitisPigmentosa	disease	C16;C11	DiseaseorSyndrome	0.65	1	2009	2018	1	0	CTD_human;GENOMICS_ENGLAND;ORPHANET
31092	55812	SPATA7	0.656	0.385	C0339527	LeberCongenitalAmaurosis	disease	C11	DiseaseorSyndrome	0.67	1	2005	2018	2	0	CTD_human;GENOMICS_ENGLAND;ORPHANET
31094	55812	SPATA7	0.656	0.385	C1858677	LEBERCONGENITALAMAUROSIS3(disorder)	disease	C16;C11	DiseaseorSyndrome	0.7	1	2015	2015	0	0	CTD_human;GENOMICS_ENGLAND
31103	55823	VPS11	0.633	0.654	C4225247	LEUKODYSTROPHY,HYPOMYELINATING,12	disease		DiseaseorSyndrome	0.7	1	2015	2016	2	1	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
31124	55835	CENPJ	0.546	0.846	C0265202	Seckelsyndrome	disease	C23;C16;C05;C10;C19	DiseaseorSyndrome	0.71	1	2010	2010	1	0	GENOMICS_ENGLAND;ORPHANET
31126	55835	CENPJ	0.546	0.846	C1842109	Microcephaly,PrimaryAutosomalRecessive,6	disease	C16;C05;C10	DiseaseorSyndrome	0.71	1	2005	2011	4	11	CTD_human;GENOMICS_ENGLAND;UNIPROT
31128	55835	CENPJ	0.546	0.846	C3888212	SECKELSYNDROME4	disease		DiseaseorSyndrome	0.6	1	2006	2010	2	13	CTD_human;GENOMICS_ENGLAND
31140	55851	PSENEN	0.695	0.423	C3714534	dowling-degosdisease	disease	C16;C17	DiseaseorSyndrome	0.52	1	2010	2018	2	0	GENOMICS_ENGLAND;ORPHANET
31142	55857	KIZ	0.722	0.308	C4014312	RETINITISPIGMENTOSA69	disease		DiseaseorSyndrome	0.6	1	2014	2014	1	3	CTD_human;GENOMICS_ENGLAND
31145	55858	TMEM165	0.711	0.385	C3553571	Carbohydratedeficientglycoproteinsyndrometype2k	disease	C16;C18;C05	DiseaseorSyndrome	0.7	1	2012	2016	4	4	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
31155	55863	TMEM126B	0.716	0.385	C4748830	MITOCHONDRIALCOMPLEXIDEFICIENCY,NUCLEARTYPE29	disease		DiseaseorSyndrome	0.6	1	2016	2016	2	4	GENOMICS_ENGLAND;UNIPROT
31156	55869	HDAC8	0.511	0.885	C0270972	CorneliaDeLangeSyndrome	disease	C16;C10	DiseaseorSyndrome	0.6	0.963	2009	2019	5	0	CLINGEN;ORPHANET
31158	55869	HDAC8	0.511	0.885	C3550903	CORNELIADELANGESYNDROME5	disease		DiseaseorSyndrome	0.6	1	2012	2019	2	26	GENOMICS_ENGLAND;UNIPROT
31165	55870	ASH1L	0.623	0.577	C4540478	MENTALRETARDATION,AUTOSOMALDOMINANT52	disease		MentalorBehavioralDysfunction	0.6	1	2012	2017	4	13	GENOMICS_ENGLAND;UNIPROT
31192	55906	ZC4H2	0.561	0.731	C0796200	Wieacker-Wolffsyndrome	disease	C23;C16;C11;C05;C10;F01	DiseaseorSyndrome	0.71	1	2013	2017	2	11	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
31214	55967	NDUFA12	0.659	0.462	C0023264	LeighDisease	disease	C16;C18;C10	DiseaseorSyndrome	0.51	1	2011	2016	3	0	CLINGEN;GENOMICS_ENGLAND
31226	55975	KLHL7	0.581	0.731	C1832409	Crisponisyndrome	disease	C23;C16;C17;C05;C10	DiseaseorSyndrome	0.53	0.667	2016	2019	1	0	CTD_human;ORPHANET
31227	55975	KLHL7	0.581	0.731	C1848947	COLD-INDUCEDSWEATINGSYNDROME1	disease	C23;C16;C17;C05;C10	DiseaseorSyndrome	0.6	1	2016	2016	1	4	CTD_human;ORPHANET
31229	55975	KLHL7	0.581	0.731	C2751986	RETINITISPIGMENTOSA42	disease	C16;C11	DiseaseorSyndrome	0.7	1	2009	2011	4	3	CTD_human;GENOMICS_ENGLAND;UNIPROT
31230	55975	KLHL7	0.581	0.731	C4310742	CRISPONI/COLD-INDUCEDSWEATINGSYNDROME3	disease		DiseaseorSyndrome	0.6	1	2016	2016	1	6	GENOMICS_ENGLAND;UNIPROT
31231	55997	CFC1	0.588	0.577	C0013069	DoubleOutletRightVentricle	disease	C16;C14	CongenitalAbnormality	0.62	1	1999	2008	1	0	CTD_human
31232	55997	CFC1	0.588	0.577	C0040761	TranspositionofGreatVessels	disease	C16;C14	CongenitalAbnormality	0.61	1	1999	2002	1	0	CTD_human
31235	55997	CFC1	0.588	0.577	C1415817	HETEROTAXY,VISCERAL,2,AUTOSOMAL	disease		DiseaseorSyndrome	0.9	1	2000	2015	3	3	CTD_human;GENOMICS_ENGLAND;UNIPROT
31246	56006	SMG9	0.729	0.346	C4310793	HEARTANDBRAINMALFORMATIONSYNDROME	disease		DiseaseorSyndrome	0.6	1	2016	2019	2	2	CTD_human;GENOMICS_ENGLAND
31250	56052	ALG1	0.61	0.808	C2931005	Congenitaldisorderofglycosylationtype1K	disease	C16;C18	DiseaseorSyndrome	0.74	1	2004	2017	6	26	CTD_human;GENOMICS_ENGLAND;UNIPROT
31265	56160	NSMCE3	0.751	0.346	C4310653	LUNGDISEASE,IMMUNODEFICIENCY,ANDCHROMOSOMEBREAKAGESYNDROME	disease		DiseaseorSyndrome	0.7	1	2016	2016	1	0	CTD_human;GENOMICS_ENGLAND;UNIPROT
31274	56172	ANKH	0.606	0.692	C0856830	Calciumpyrophosphatearthropathy	disease	C05	DiseaseorSyndrome	0.75	1	1999	2012	5	4	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
31276	56172	ANKH	0.606	0.692	C1852502	CRANIOMETAPHYSEALDYSPLASIA,AUTOSOMALDOMINANT	disease	C05;C07	DiseaseorSyndrome	0.99	1	1999	2018	3	6	CTD_human;GENOMICS_ENGLAND;UNIPROT
31278	56203	LMOD3	0.7	0.423	C4015360	NEMALINEMYOPATHY10	disease		DiseaseorSyndrome	0.9	1	2014	2018	6	8	CLINGEN;CTD_human;GENOMICS_ENGLAND;UNIPROT
31280	56244	BTNL2	0.546	0.808	C0036202	Sarcoidosis	disease	C15	DiseaseorSyndrome	0.7	1	2005	2019	1	0	CTD_human;ORPHANET
31284	56246	MRAP	0.674	0.5	C4049714	FamilialGlucocorticoidDeficiencyType2	disease	C19	DiseaseorSyndrome	0.61	1	2005	2010	0	2	CTD_human;GENOMICS_ENGLAND
31286	56262	LRRC8A	0.644	0.692	C0001768	Agammaglobulinemia	disease	C20;C15	DiseaseorSyndrome	0.62	0.5	2003	2017	0	0	CTD_human;GENOMICS_ENGLAND
31328	56479	KCNQ5	0.686	0.5	C4539851	MENTALRETARDATION,AUTOSOMALDOMINANT46	disease		MentalorBehavioralDysfunction	0.6	1	2017	2019	2	4	GENOMICS_ENGLAND;UNIPROT
31336	56521	DNAJC12	0.705	0.423	C4479270	HYPERPHENYLALANINEMIA,MILD,NON-BH4-DEFICIENT	disease		DiseaseorSyndrome	0.7	1	2017	2017	1	2	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
31345	56603	CYP26B1	0.666	0.5	C3280729	RADIOHUMERALFUSIONSWITHOTHERSKELETALANDCRANIOFACIALANOMALIES	disease		DiseaseorSyndrome	0.7	1	2011	2016	2	2	GENOMICS_ENGLAND;ORPHANET;UNIPROT
31347	56606	SLC2A9	0.619	0.731	C0473219	Renalhypouricemia	disease	C23;C16;C18;C13;C12	DiseaseorSyndrome	0.6	1	2008	2019	4	0	CTD_human;ORPHANET
31349	56606	SLC2A9	0.619	0.731	C2677549	Hypouricemia,Renal,2	disease	C16;C18;C13;C12	DiseaseorSyndrome	0.72	1	2008	2019	4	6	CTD_human;GENOMICS_ENGLAND;UNIPROT
31361	56616	DIABLO	0.555	0.692	C3279948	DEAFNESS,AUTOSOMALDOMINANT64	disease		DiseaseorSyndrome	0.7	1	2011	2016	3	1	CTD_human;GENOMICS_ENGLAND;UNIPROT
31370	56623	INPP5E	0.561	0.615	C0431399	Familialaplasiaofthevermis	disease	C16;C13;C11;C12	DiseaseorSyndrome	0.78	1	2003	2017	4	3	CTD_human;GENOMICS_ENGLAND;ORPHANET
31373	56623	INPP5E	0.561	0.615	C1857802	MORMsyndrome	disease	C23;C16;C18;C11;C12;C10;F03;F01	DiseaseorSyndrome	0.72	1	2009	2019	4	1	CTD_human;GENOMICS_ENGLAND;ORPHANET
31376	56623	INPP5E	0.561	0.615	C4551568	Joubertsyndrome1	disease	C16;C13;C11;C12	DiseaseorSyndrome	0.7	1	2009	2019	7	21	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
31385	56652	TWNK	0.516	0.692	C1836439	ProgressiveExternalOphthalmoplegiawithMitochondrialDNADeletions,AutosomalDominant,3	disease	C23;C18;C11;C05;C10	DiseaseorSyndrome	0.7	1	2001	2019	15	18	CTD_human;GENOMICS_ENGLAND;UNIPROT
31386	56652	TWNK	0.516	0.692	C1843851	Sensoryataxicneuropathy,dysarthria,andophthalmoparesis	disease	C23;C16;C11;C10	DiseaseorSyndrome	0.51	1	2005	2014	1	0	CTD_human;ORPHANET
31387	56652	TWNK	0.516	0.692	C1849096	Infantileonsetspinocerebellarataxia	disease	C16;C10	DiseaseorSyndrome	0.77	1	1997	2019	8	10	CTD_human;GENOMICS_ENGLAND;UNIPROT
31388	56652	TWNK	0.516	0.692	C4015307	PERRAULTSYNDROME5	disease		DiseaseorSyndrome	0.6	1	2010	2014	2	6	GENOMICS_ENGLAND;UNIPROT
31393	56683	CFAP298	0.678	0.5	C3809684	CILIARYDYSKINESIA,PRIMARY,26	disease		DiseaseorSyndrome	0.7	1	2013	2013	1	4	CTD_human;GENOMICS_ENGLAND;UNIPROT
31395	56683	CFAP298	0.678	0.5	C4551720	PrimaryCiliaryDyskinesia	disease	C16;C08;C09	DiseaseorSyndrome	0.51	1	2013	2013	1	0	GENOMICS_ENGLAND;ORPHANET
31464	56916	SMARCAD1	0.656	0.423	C0406707	Basansyndrome	disease	C23;C16;C17	DiseaseorSyndrome	0.73	1	2014	2018	3	2	CTD_human;GENOMICS_ENGLAND;ORPHANET
31465	56916	SMARCAD1	0.656	0.423	C0406767	Keratodermawithscleroatrophyoftheextremities	disease	C04;C17	CongenitalAbnormality	0.6	1	2018	2018	1	3	CTD_human;ORPHANET
31466	56916	SMARCAD1	0.656	0.423	C1852150	Fingerprints,Absenceof	phenotype	C16;C17	Finding	0.6	1	2011	2011	1	3	CTD_human;ORPHANET
31469	56922	MCCC1	0.7	0.308	C0268600	3-methylcrotonylCoAcarboxylase1deficiency	disease	C16;C18;C10	DiseaseorSyndrome	0.73	1	2001	2016	12	50	CLINGEN;CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
31498	56945	MRPS22	0.638	0.5	C2673642	CombinedOxidativePhosphorylationDeficiency5	disease	C16;C18	DiseaseorSyndrome	0.7	1	2007	2017	3	2	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
31515	56947	MFF	0.705	0.462	C4310726	ENCEPHALOPATHYDUETODEFECTIVEMITOCHONDRIALANDPEROXISOMALFISSION2	disease		DiseaseorSyndrome	0.7	1	2012	2016	3	5	CTD_human;GENOMICS_ENGLAND;ORPHANET
31527	56975	FAM20C	0.578	0.731	C1850106	RAINESYNDROME	disease	C16;C11;C05;C10;C07	DiseaseorSyndrome	0.8	1	2000	2019	9	13	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
31535	56978	PRDM8	0.678	0.462	C4225258	EPILEPSY,PROGRESSIVEMYOCLONIC,10	disease		DiseaseorSyndrome	0.7	1	2012	2012	1	1	GENOMICS_ENGLAND;ORPHANET;UNIPROT
31539	56983	POGLUT1	0.691	0.385	C3714534	dowling-degosdisease	disease	C16;C17	DiseaseorSyndrome	0.62	1	2014	2017	1	0	CTD_human;GENOMICS_ENGLAND;ORPHANET
31540	56983	POGLUT1	0.691	0.385	C3810313	DOWLING-DEGOSDISEASE4	disease		DiseaseorSyndrome	0.6	1	2014	2017	2	6	GENOMICS_ENGLAND;UNIPROT
31541	56983	POGLUT1	0.691	0.385	C4310660	MUSCULARDYSTROPHY,LIMB-GIRDLE,AUTOSOMALRECESSIVE21	disease	C16;C05;C10	DiseaseorSyndrome	0.6	1	2016	2017	2	1	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
31549	56997	COQ8A	0.674	0.385	C2677589	SPINOCEREBELLARATAXIA,AUTOSOMALRECESSIVE9	disease	C16;C10	DiseaseorSyndrome	0.9	1	2008	2019	13	32	CTD_human;GENOMICS_ENGLAND;UNIPROT
31550	56997	COQ8A	0.674	0.385	C3551954	COENZYMEQ10DEFICIENCY,PRIMARY,1	disease		DiseaseorSyndrome	0.6	1	2008	2008	1	1	CTD_human;GENOMICS_ENGLAND
31571	57010	CABP4	0.711	0.154	C0339535	Nightblindness,congenitalstationary	disease	C16;C11	CongenitalAbnormality	0.62	1	2006	2010	1	0	GENOMICS_ENGLAND;ORPHANET
31573	57010	CABP4	0.711	0.154	C4041558	Cone-rodsynapticdisorder,congenitalnonprogressive	disease	C16;C11	DiseaseorSyndrome	0.7	1	2006	2006	1	4	CTD_human;GENOMICS_ENGLAND;UNIPROT
31592	57017	COQ9	0.7	0.423	C3553374	COENZYMEQ10DEFICIENCY,PRIMARY,5	disease		DiseaseorSyndrome	0.7	1	2001	2017	5	2	CTD_human;GENOMICS_ENGLAND;ORPHANET
31640	57038	RARS2	0.663	0.462	C1969084	PontocerebellarHypoplasiaType6	disease	C16;C10	DiseaseorSyndrome;CongenitalAbnormality	0.79	0.933	2010	2020	4	13	CTD_human;GENOMICS_ENGLAND;ORPHANET
31666	57057	TBX20	0.663	0.346	C1969657	AtrialSeptalDefect4	disease	C16;C14	DiseaseorSyndrome;CongenitalAbnormality	0.7	1	2007	2010	2	3	CTD_human;GENOMICS_ENGLAND;UNIPROT
31667	57061	HYMAI	0.67	0.538	C1832386	DiabetesMellitus,TransientNeonatal,1	disease	C16;C18;C19	DiseaseorSyndrome	0.52	1	2000	2011	2	0	CTD_human;ORPHANET
31670	57082	KNL1	0.644	0.615	C1858516	MICROCEPHALY4,PRIMARY,AUTOSOMALRECESSIVE	disease	C16;C05;C10	DiseaseorSyndrome	0.7	1	2012	2016	2	7	CTD_human;GENOMICS_ENGLAND;UNIPROT
31694	57094	CPA6	0.716	0.346	C3280730	EPILEPSY,FAMILIALTEMPORALLOBE,5	disease		DiseaseorSyndrome	0.7	1	2012	2012	2	3	CTD_human;GENOMICS_ENGLAND;UNIPROT
31695	57094	CPA6	0.716	0.346	C3280734	FEBRILESEIZURES,FAMILIAL,11	disease		DiseaseorSyndrome	0.7	1	2012	2012	2	1	CTD_human;GENOMICS_ENGLAND;UNIPROT
31699	57096	RPGRIP1	0.553	0.654	C0035334	RetinitisPigmentosa	disease	C16;C11	DiseaseorSyndrome	0.68	1	2004	2017	1	1	CTD_human;GENOMICS_ENGLAND
31711	57096	RPGRIP1	0.553	0.654	C0339527	LeberCongenitalAmaurosis	disease	C11	DiseaseorSyndrome	0.8	1	2001	2019	3	10	CTD_human;GENOMICS_ENGLAND;ORPHANET
31723	57096	RPGRIP1	0.553	0.654	C1854260	LEBERCONGENITALAMAUROSIS6(disorder)	disease	C11	DiseaseorSyndrome;CongenitalAbnormality	0.9	1	2001	2018	6	18	CTD_human;GENOMICS_ENGLAND;UNIPROT
31724	57096	RPGRIP1	0.553	0.654	C2750720	Cone-RodDystrophy13	disease	C16;C11	DiseaseorSyndrome	0.7	1	2000	2015	2	9	CTD_human;GENOMICS_ENGLAND;UNIPROT
31735	57104	PNPLA2	0.511	0.846	C1853136	NeutralLipidStorageDiseasewithMyopathy	disease	C16;C18;C05;C10	DiseaseorSyndrome	0.8	1	2007	2019	3	12	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
31738	57105	CYSLTR2	0.633	0.538	C0220633	Uvealmelanoma	disease	C04;C11	NeoplasticProcess	0.53	1	2016	2019	1	0	CTD_human;ORPHANET
31744	57107	PDSS2	0.626	0.577	C3553358	COENZYMEQ10DEFICIENCY,PRIMARY,3	disease		DiseaseorSyndrome	0.7	1	2006	2016	3	3	CTD_human;GENOMICS_ENGLAND;UNIPROT
31757	57122	NUP107	0.595	0.5	C4225228	NEPHROTICSYNDROME,TYPE11	disease		DiseaseorSyndrome	0.7	1	2015	2018	2	5	CTD_human;GENOMICS_ENGLAND;UNIPROT
31762	57128	LYRM4	0.736	0.385	C3810055	COMBINEDOXIDATIVEPHOSPHORYLATIONDEFICIENCY19	disease		DiseaseorSyndrome	0.7	1	2013	2013	1	1	CTD_human;GENOMICS_ENGLAND;UNIPROT
31778	57152	SLURP1	0.56	0.654	C0025221	MeledaDisease	disease	C16;C17	DiseaseorSyndrome;CongenitalAbnormality	1	0.973	2001	2019	12	11	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
31780	57152	SLURP1	0.56	0.654	C4551675	Keratoderma,Palmoplantar	disease	C16;C17	DiseaseorSyndrome	0.58	1	2003	2019	3	0	CTD_human;GENOMICS_ENGLAND
31789	57158	JPH2	0.736	0.154	C3151264	CARDIOMYOPATHY,FAMILIALHYPERTROPHIC,17	disease		DiseaseorSyndrome	0.7	1	2004	2019	11	4	CLINGEN;CTD_human;GENOMICS_ENGLAND;UNIPROT
31797	57165	GJC2	0.593	0.692	C1837355	Leukodystrophy,Hypomyelinating,2	disease	C16;C18;C10	DiseaseorSyndrome	0.93	1	2004	2019	8	10	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
31798	57165	GJC2	0.593	0.692	C2750784	SPASTICPARAPLEGIA44,AUTOSOMALRECESSIVE(disorder)	disease	C16;C10	DiseaseorSyndrome	0.71	1	2008	2019	3	1	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
31799	57165	GJC2	0.593	0.692	C4747646	LYMPHATICMALFORMATION3	disease		DiseaseorSyndrome	0.7	1	2008	2015	4	2	CTD_human;GENOMICS_ENGLAND;UNIPROT
31814	57465	TBC1D24	0.53	0.808	C0795934	DigitorenocerebralSyndrome	disease	C23;C16;C05;C10;F03;C09;F01	DiseaseorSyndrome	0.7	0.941	2010	2019	3	11	GENOMICS_ENGLAND;UNIPROT
31815	57465	TBC1D24	0.53	0.808	C0917800	Epilepsy,Myoclonic,Infantile	disease	C10	DiseaseorSyndrome	0.76	1	2010	2017	3	6	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
31822	57817	HAMP	0.433	0.846	C0022661	KidneyFailure,Chronic	disease	C13;C12	DiseaseorSyndrome	0.57	0.875	2006	2020	1	0	CTD_human
31826	57817	HAMP	0.433	0.846	C0282193	IronOverload	disease	C18	DiseaseorSyndrome	0.6	0.973	2002	2020	2	0	CTD_human
31832	57817	HAMP	0.433	0.846	C1865616	HEMOCHROMATOSIS,TYPE2B	disease	C16;C18	DiseaseorSyndrome	0.7	1	2003	2016	6	5	CTD_human;GENOMICS_ENGLAND;UNIPROT
31833	57817	HAMP	0.433	0.846	C2239176	Livercarcinoma	disease	C06;C04	NeoplasticProcess	0.6	0.95	2005	2019	1	0	CTD_human
31844	57822	GRHL3	0.572	0.692	C0175697	VanderWoudesyndrome	disease	C23;C16;C04;C05;C07	DiseaseorSyndrome	0.79	0.889	2014	2017	1	0	GENOMICS_ENGLAND;ORPHANET
31852	57822	GRHL3	0.572	0.692	C1847604	VanderWoudesyndrome2	disease	C16;C05;C07	DiseaseorSyndrome	0.7	1	2014	2014	1	7	CTD_human;GENOMICS_ENGLAND;UNIPROT
31864	58484	NLRC4	0.556	0.769	C0343068	Familialcoldurticaria	disease	C16;C17	DiseaseorSyndrome	0.72	1	2014	2019	1	0	CTD_human;ORPHANET
31865	58484	NLRC4	0.556	0.769	C0409818	ChronicInfantileNeurological,Cutaneous,andArticularSyndrome	disease	C16;C17	DiseaseorSyndrome	0.51	1	2017	2017	1	0	CTD_human;ORPHANET
31870	58484	NLRC4	0.556	0.769	C4015067	AUTOINFLAMMATIONWITHINFANTILEENTEROCOLITIS	disease		DiseaseorSyndrome	0.7	1	2014	2017	4	3	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
31871	58484	NLRC4	0.556	0.769	C4015276	FAMILIALCOLDAUTOINFLAMMATORYSYNDROME4	disease		DiseaseorSyndrome	0.8	1	2014	2017	2	1	GENOMICS_ENGLAND;UNIPROT
31877	58495	OVOL2	0.633	0.462	C1852555	CORNEALENDOTHELIALDYSTROPHY1,AUTOSOMALDOMINANT	disease	C16;C11	DiseaseorSyndrome	0.67	0.875	2003	2020	1	4	CTD_human;GENOMICS_ENGLAND
31878	58497	PRUNE1	0.678	0.308	C4479566	NEURODEVELOPMENTALDISORDERWITHMICROCEPHALY,HYPOTONIA,ANDVARIABLEBRAINANOMALIES	disease		DiseaseorSyndrome	0.71	1	2015	2019	4	7	GENOMICS_ENGLAND;ORPHANET;UNIPROT
31939	59067	IL21	0.441	0.769	C4014258	IMMUNODEFICIENCY,COMMONVARIABLE,11	disease		DiseaseorSyndrome	0.7	1	2009	2014	2	1	GENOMICS_ENGLAND;ORPHANET;UNIPROT
31950	59272	ACE2	0.477	0.769	C0020538	Hypertensivedisease	group	C14	DiseaseorSyndrome	0.6	0.982	2003	2019	4	0	CTD_human
31961	59335	PRDM12	0.839	0.231	C4225308	NEUROPATHY,HEREDITARYSENSORYANDAUTONOMIC,TYPEVIII	disease		DiseaseorSyndrome	0.7	1	2015	2017	4	5	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
31996	59341	TRPV4	0.457	0.808	C0265280	Spondylometaphysealdysplasia,Kozlowskitype	disease	C16;C05	CongenitalAbnormality	0.76	0.857	2009	2017	3	11	CTD_human;GENOMICS_ENGLAND;UNIPROT
31997	59341	TRPV4	0.457	0.808	C0265281	Metatropicdwarfism	disease	C16;C05;C19	CongenitalAbnormality	0.8	1	2009	2020	6	19	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
32006	59341	TRPV4	0.457	0.808	C0432227	BrachyolmiaType3	disease	C16;C05	CongenitalAbnormality	0.76	1	2008	2014	2	3	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
32018	59341	TRPV4	0.457	0.808	C0751335	ScapuloperonealFormofSpinalMuscularAtrophy	disease	C10	DiseaseorSyndrome	0.74	1	2003	2017	4	4	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
32022	59341	TRPV4	0.457	0.808	C1838492	SPINALMUSCULARATROPHY,DISTAL,CONGENITALNONPROGRESSIVE(disorder)	disease	C10	DiseaseorSyndrome	0.7	1	2010	2012	3	6	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
32023	59341	TRPV4	0.457	0.808	C1847406	DigitalArthropathy-Brachydactyly,Familial	disease	C16;C05	DiseaseorSyndrome	0.71	1	2011	2019	1	4	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
32024	59341	TRPV4	0.457	0.808	C1853710	HEREDITARYMOTORANDSENSORYNEUROPATHY,TYPEIIC(disorder)	disease	C16;C10	DiseaseorSyndrome	0.74	1	2005	2020	8	13	CTD_human;GENOMICS_ENGLAND;UNIPROT
32025	59341	TRPV4	0.457	0.808	C1868616	Parastremmaticdwarfism	disease	C23;C16;C05;C10;C19;F03;F01	CongenitalAbnormality	0.73	1	2010	2012	1	2	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
32028	59341	TRPV4	0.457	0.808	C3150755	SODIUMSERUMLEVELQUANTITATIVETRAITLOCUS1	phenotype		Finding	0.6	NA	NA	NA	0	1	CTD_human;GENOMICS_ENGLAND
32029	59341	TRPV4	0.457	0.808	C3159322	SPONDYLOEPIPHYSEALDYSPLASIA,MAROTEAUXTYPE	disease	C16;C05	DiseaseorSyndrome	0.71	1	2010	2010	1	5	CTD_human;GENOMICS_ENGLAND;ORPHANET
32046	59344	ALOXE3	0.644	0.538	C0079154	CongenitalNonbullousIchthyosiformErythroderma	disease	C16;C17	DiseaseorSyndrome	0.65	1	2003	2016	5	0	CTD_human;ORPHANET
32053	59344	ALOXE3	0.644	0.538	C3539888	ICHTHYOSIS,CONGENITAL,AUTOSOMALRECESSIVE3	disease		DiseaseorSyndrome	0.6	1	2002	2016	5	9	GENOMICS_ENGLAND;UNIPROT
32062	59345	GNB4	0.751	0.346	C3554654	CHARCOT-MARIE-TOOTHDISEASE,DOMINANTINTERMEDIATEF	disease		DiseaseorSyndrome	0.7	1	2013	2017	2	4	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
32067	59352	LGR6	0.502	0.923	C0009402	ColorectalCarcinoma	disease	C06;C04	NeoplasticProcess	0.52	1	2008	2018	2	0	CTD_human;UNIPROT
32076	60386	SLC25A19	0.653	0.577	C1846648	MICROCEPHALY,AMISHTYPE(disorder)	disease	C16;C05;C10	DiseaseorSyndrome	0.72	0.8	2002	2019	4	1	CTD_human;GENOMICS_ENGLAND;UNIPROT
32077	60386	SLC25A19	0.653	0.577	C3150973	Progressivepolyneuropathywithbilateralstriatalnecrosis	disease	C18;C10	DiseaseorSyndrome	0.71	1	2006	2019	3	6	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
32102	60481	ELOVL5	0.638	0.462	C4518337	Spinocerebellarataxiatype38	disease	C16;C10	DiseaseorSyndrome	0.74	1	2014	2019	1	2	GENOMICS_ENGLAND;ORPHANET;UNIPROT
32108	60482	SLC5A7	0.597	0.654	C0751882	MyasthenicSyndromes,Congenital	disease	C16;C10	DiseaseorSyndrome	0.53	1	2016	2019	1	0	CTD_human;GENOMICS_ENGLAND
32113	60482	SLC5A7	0.597	0.654	C1834703	Neuropathy,DistalHereditaryMotor,TypeVIIA	disease	C23;C16;C08;C10;C09	DiseaseorSyndrome	0.61	1	2012	2018	2	1	CTD_human;GENOMICS_ENGLAND
32114	60482	SLC5A7	0.597	0.654	C4310694	MYASTHENICSYNDROME,CONGENITAL,20,PRESYNAPTIC	disease		DiseaseorSyndrome	0.6	1	2016	2016	2	7	GENOMICS_ENGLAND;UNIPROT
32135	60495	HPSE2	0.588	0.692	C0403555	Ochoasyndrome	disease	C23;C13;C12	CongenitalAbnormality	0.89	1	2009	2019	2	7	CTD_human;GENOMICS_ENGLAND
32137	60506	NYX	0.678	0.192	C0339535	Nightblindness,congenitalstationary	disease	C16;C11	CongenitalAbnormality	0.7	0.923	2000	2015	0	1	CTD_human;GENOMICS_ENGLAND
32141	60506	NYX	0.678	0.192	C3495587	NightBlindness,CongenitalStationary,Type1A	disease	C16;C11	DiseaseorSyndrome	0.92	1	1998	2019	2	18	CTD_human;GENOMICS_ENGLAND;UNIPROT
32146	60509	AGBL5	0.711	0.269	C4310759	RETINITISPIGMENTOSA75	disease		DiseaseorSyndrome	0.7	1	2015	2016	4	3	CTD_human;GENOMICS_ENGLAND;UNIPROT
32152	60528	ELAC2	0.67	0.346	C2931456	Prostatecancer,familial	disease	C04;C12	NeoplasticProcess	0.6	1	2001	2016	2	0	GENOMICS_ENGLAND;ORPHANET
32154	60528	ELAC2	0.67	0.346	C3809526	COMBINEDOXIDATIVEPHOSPHORYLATIONDEFICIENCY17	disease		DiseaseorSyndrome	0.7	1	2012	2016	3	9	CLINGEN;CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
32167	60529	ALX4	0.56	0.692	C1865044	PARIETALFORAMINA2	disease	C23;C16;C10	DiseaseorSyndrome	0.7	1	2000	2018	3	9	CTD_human;GENOMICS_ENGLAND;UNIPROT
32168	60529	ALX4	0.56	0.692	C1868598	PARIETALFORAMINA	disease	C23;C16;C10	CongenitalAbnormality	0.89	1	2000	2019	2	2	GENOMICS_ENGLAND;ORPHANET
32171	60529	ALX4	0.56	0.692	C3150703	FRONTONASALDYSPLASIA2	disease		DiseaseorSyndrome	0.6	1	2013	2018	2	4	GENOMICS_ENGLAND;ORPHANET
32175	60558	GUF1	0.805	0.154	C4310737	EPILEPTICENCEPHALOPATHY,EARLYINFANTILE,40	disease		DiseaseorSyndrome	0.6	1	2016	2016	1	0	CTD_human;GENOMICS_ENGLAND;UNIPROT
32187	60675	PROK2	0.555	0.769	C0162809	KallmannSyndrome	disease	C16;C13;C12;C19	DiseaseorSyndrome	0.6	1	2007	2019	1	0	CTD_human;ORPHANET
32199	60675	PROK2	0.555	0.769	C3552343	HYPOGONADOTROPICHYPOGONADISM4WITHORWITHOUTANOSMIA	disease		DiseaseorSyndrome	0.6	1	2006	2019	5	7	GENOMICS_ENGLAND;UNIPROT
32206	60681	FKBP10	0.606	0.538	C1850168	Brucksyndrome1	disease	C16;C17;C05	DiseaseorSyndrome	0.7	1	2010	2013	5	8	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
32208	60681	FKBP10	0.606	0.538	C3151218	OSTEOGENESISIMPERFECTA,TYPEXI	disease		DiseaseorSyndrome	0.63	1	2012	2018	0	3	CTD_human;GENOMICS_ENGLAND
32210	60684	TRAPPC11	0.65	0.5	C4517996	Autosomalrecessivelimbgirdlemusculardystrophytype2S	disease		DiseaseorSyndrome	0.6	1	2013	2018	4	1	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
32228	63826	SRR	0.617	0.692	C0036341	Schizophrenia	disease	F03	MentalorBehavioralDysfunction	0.7	0.75	2005	2019	4	1	PSYGENET
32238	63894	VIPAS39	0.705	0.5	C1859722	Arthrogryposis,renaldysfunction,andcholestasis1	disease	C16;C06;C13;C05;C12	DiseaseorSyndrome	0.9	1	2010	2018	2	0	CTD_human;GENOMICS_ENGLAND;ORPHANET
32241	63895	PIEZO2	0.529	0.769	C0220666	ARTHROGRYPOSISMULTIPLEXCONGENITA,DISTAL,TYPEIIA	disease	C16;C05;C07	DiseaseorSyndrome	0.74	1	2014	2019	2	3	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
32242	63895	PIEZO2	0.529	0.769	C0796033	MARDEN-WALKERSYNDROME	disease	C16;C11;C17;C05	DiseaseorSyndrome	0.74	1	2014	2019	1	1	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
32244	63895	PIEZO2	0.529	0.769	C1862472	Oculomelicamyoplasia	disease	C23;C16;C11;C05;C10	DiseaseorSyndrome	0.75	1	2013	2019	2	11	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
32245	63895	PIEZO2	0.529	0.769	C4310692	ARTHROGRYPOSIS,DISTAL,WITHIMPAIREDPROPRIOCEPTIONANDTOUCH	disease		DiseaseorSyndrome	0.6	1	2016	2017	2	11	CTD_human;UNIPROT
32246	63901	FAM111A	0.663	0.462	C0265291	Kenny-Caffeysyndrome	disease	C16;C05	DiseaseorSyndrome	0.51	1	2013	2019	1	0	GENOMICS_ENGLAND;ORPHANET
32247	63901	FAM111A	0.663	0.462	C1865639	Gracilebonedysplasia	disease	C16;C05	DiseaseorSyndrome	0.72	1	2013	2019	1	5	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
32248	63901	FAM111A	0.663	0.462	C4316787	Kenny-Caffeysyndrome,type2	disease	C16;C18;C05;C19	DiseaseorSyndrome	0.71	1	2013	2014	3	2	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
32250	63910	SLC17A9	0.78	0.346	C0265970	Porokeratosis,DisseminatedSuperficialActinic	disease	C16;C17	DiseaseorSyndrome	0.51	1	2014	2015	2	0	GENOMICS_ENGLAND;ORPHANET
32251	63910	SLC17A9	0.78	0.346	C4015128	POROKERATOSIS8,DISSEMINATEDSUPERFICIALACTINICTYPE	disease		DiseaseorSyndrome	0.7	1	2014	2015	2	2	CTD_human;GENOMICS_ENGLAND;UNIPROT
32253	63916	ELMO2	0.729	0.538	C1847197	VascularMalformation,PrimaryIntraosseous	disease	C16;C14	DiseaseorSyndrome	0.63	1	2016	2019	1	3	CTD_human;ORPHANET
32259	63924	CIDEC	0.666	0.462	C3808940	LIPODYSTROPHY,FAMILIALPARTIAL,TYPE5	disease		DiseaseorSyndrome	0.6	1	2009	2009	1	1	GENOMICS_ENGLAND;ORPHANET
32262	63925	ZNF335	0.711	0.462	C3554499	MICROCEPHALY10,PRIMARY,AUTOSOMALRECESSIVE	disease		DiseaseorSyndrome	0.7	1	2012	2017	1	6	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
32266	63929	XPNPEP3	0.769	0.269	C3150419	NEPHRONOPHTHISIS-LIKENEPHROPATHY1	disease		DiseaseorSyndrome	0.7	1	2010	2010	1	1	CTD_human;GENOMICS_ENGLAND;UNIPROT
32289	63976	PRDM16	0.522	0.808	C3809288	LEFTVENTRICULARNONCOMPACTION8	disease		DiseaseorSyndrome	0.7	1	2013	2013	1	5	CTD_human;GENOMICS_ENGLAND;UNIPROT
32304	63982	ANO3	0.716	0.385	C3554374	DYSTONIA24	disease		DiseaseorSyndrome	0.71	1	2012	2016	3	4	GENOMICS_ENGLAND;ORPHANET;UNIPROT
32325	64167	ERAP2	0.615	0.577	C0267380	Crohnsdiseaseoftheileum	disease	C06	DiseaseorSyndrome	0.30	1	2010	2010	1	0	CTD_human
val	64167	ERAP2	0.615	0.577	C0678202	Regionalenteritis	disease	C06	DiseaseorSyndrome	0.30	1	2010	2010	1	0	CTD_human
val	64167	ERAP2	0.615	0.577	C0949272	IIeocolitis	disease	C06	DiseaseorSyndrome	0.30	1	2010	2010	1	0	CTD_human
val	64170	CARD9	0.566	0.654	C0009324	UlcerativeColitis	disease	C06	DiseaseorSyndrome	0.43	1	2008	2017	1	5	CTD_human
val	64170	CARD9	0.566	0.654	C0017661	IGAGlomerulonephritis	disease	C13;C12;C20	DiseaseorSyndrome	0.41	1	2014	2017	1	1	CTD_human
val	64170	CARD9	0.566	0.654	C0021390	InflammatoryBowelDiseases	group	C06	DiseaseorSyndrome	0.50	0.938	2009	2020	1	2	CTD_human
val	64170	CARD9	0.566	0.654	C0038013	Ankylosingspondylitis	disease	C05	DiseaseorSyndrome	0.44	1	2010	2016	1	3	CTD_human
val	64170	CARD9	0.566	0.654	C1395264	Deepseateddermatophytosis	disease	C01;C17	DiseaseorSyndrome	0.40	1	2013	2013	1	0	GENOMICS_ENGLAND
val	64170	CARD9	0.566	0.654	C1859353	Candidiasis,Familial,2	disease	C01;C17	DiseaseorSyndrome	0.70	1	2009	2013	3	7	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
val	64175	P3H1	0.736	0.231	C0023931	LobsteinDisease	disease	C16;C17;C05	DiseaseorSyndrome	0.30	1	2008	2008	1	0	CTD_human
val	64175	P3H1	0.736	0.231	C0029434	OsteogenesisImperfecta	disease	C16;C17;C05	DiseaseorSyndrome;CongenitalAbnormality	0.60	1	2007	2019	1	0	CTD_human
val	64175	P3H1	0.736	0.231	C0268358	Osteogenesisimperfecta,dominantperinatallethal	disease	C16;C17;C05	DiseaseorSyndrome;CongenitalAbnormality	0.31	1	2009	2011	1	0	ORPHANET
val	64175	P3H1	0.736	0.231	C0268362	OsteogenesisimperfectatypeIII(disorder)	disease	C16;C17;C05	DiseaseorSyndrome	0.30	1	2011	2011	1	0	ORPHANET
val	64175	P3H1	0.736	0.231	C1970458	Osteogenesisimperfecta,typeVIII	disease	C16;C17;C05	DiseaseorSyndrome	0.83	1	2007	2018	1	12	CTD_human;GENOMICS_ENGLAND
val	64207	IRF2BPL	0.631	0.462	C0004238	AtrialFibrillation	disease	C23;C14	DiseaseorSyndrome	0.30	1	2018	2018	1	0	CTD_human
val	64207	IRF2BPL	0.631	0.462	C0235480	Paroxysmalatrialfibrillation	disease	C23;C14	DiseaseorSyndrome	0.30	1	2018	2018	1	0	CTD_human
val	64207	IRF2BPL	0.631	0.462	C2585653	Persistentatrialfibrillation	phenotype	C23;C14	PathologicFunction	0.30	1	2018	2018	1	0	CTD_human
val	64207	IRF2BPL	0.631	0.462	C3468561	familialatrialfibrillation	phenotype	C23;C14	PathologicFunction	0.30	1	2018	2018	1	0	CTD_human
val	64207	IRF2BPL	0.631	0.462	C4748127	NEURODEVELOPMENTALDISORDERWITHREGRESSION,ABNORMALMOVEMENTS,LOSSOFSPEECH,ANDSEIZURES	disease		DiseaseorSyndrome	0.60	1	2014	2019	3	7	GENOMICS_ENGLAND;UNIPROT
val	64211	LHX5	1	0.038	C0005586	BipolarDisorder	disease	F03	MentalorBehavioralDysfunction	0.31	1	2003	2003	1	0	PSYGENET
val	64215	DNAJC1	0.821	0.154	C0025202	melanoma	disease	C04	NeoplasticProcess	0.30	1	2012	2012	1	0	CTD_human
val	64216	TFB2M	0.861	0.231	C3714756	IntellectualDisability	group	C23;C10;F03;F01	MentalorBehavioralDysfunction	0.30				0	0	GENOMICS_ENGLAND
val	64218	SEMA4A	0.569	0.692	C0009405	HereditaryNonpolyposisColorectalNeoplasms	group	C16;C06;C04;C18	NeoplasticProcess	0.30	1	2014	2016	2	0	CLINGEN
val	64218	SEMA4A	0.569	0.692	C0015397	Disorderofeye	group	C11	DiseaseorSyndrome	0.31	1	2006	2006	1	0	GENOMICS_ENGLAND
val	64218	SEMA4A	0.569	0.692	C0035334	RetinitisPigmentosa	disease	C16;C11	DiseaseorSyndrome	0.31	1	2006	2006	1	0	GENOMICS_ENGLAND
val	64218	SEMA4A	0.569	0.692	C1112155	Hereditarynon-polyposiscolorectalcancersyndrome	disease		CongenitalAbnormality	0.30	1	2014	2016	2	0	CLINGEN
val	64218	SEMA4A	0.569	0.692	C1333990	HereditaryNonpolyposisColorectalCancer	disease	C16;C06;C04;C18	NeoplasticProcess	0.30	1	2014	2016	2	0	CLINGEN
val	64218	SEMA4A	0.569	0.692	C1333991	HereditaryNon-PolyposisColonCancerType2	disease	C16;C04	NeoplasticProcess	0.30	1	2014	2016	2	0	CLINGEN
val	64218	SEMA4A	0.569	0.692	C1846529	CONE-RODDYSTROPHY10	disease	C16;C11	DiseaseorSyndrome	0.70	1	2006	2006	1	2	CTD_human;GENOMICS_ENGLAND;UNIPROT
val	64218	SEMA4A	0.569	0.692	C1853214	RETINITISPIGMENTOSA35	disease	C16;C11	DiseaseorSyndrome	0.70	1	2006	2012	2	2	CTD_human;GENOMICS_ENGLAND;UNIPROT
val	64218	SEMA4A	0.569	0.692	C2936783	Colorectalcancer,hereditarynonpolyposis,type1	disease	C16;C06;C04;C18	NeoplasticProcess	0.30	1	2014	2016	2	0	CLINGEN
val	64218	SEMA4A	0.569	0.692	C3489532	Cone-RodDystrophy2	disease	C16;C11	DiseaseorSyndrome	0.31	1	2006	2006	1	0	ORPHANET
val	64218	SEMA4A	0.569	0.692	C3896578	FamilialColorectalCancerTypeX	disease	C16;C06;C04;C18	NeoplasticProcess	0.31	1	2014	2014	1	0	ORPHANET
val	64219	PJA1	0.821	0.269	C0220767	Craniofrontonasaldysplasia	disease	C16;C05	DiseaseorSyndrome	0.30	1	2001	2001	1	0	GENOMICS_ENGLAND
val	64219	PJA1	0.821	0.269	C3714756	IntellectualDisability	group	C23;C10;F03;F01	MentalorBehavioralDysfunction	0.30	1	2001	2001	1	0	GENOMICS_ENGLAND
val	64220	STRA6	0.597	0.731	C0003119	Anophthalmos	disease	C16;C11	CongenitalAbnormality	0.48	1	2007	2013	1	0	CTD_human
val	64220	STRA6	0.597	0.731	C0015397	Disorderofeye	group	C11	DiseaseorSyndrome	0.31	1	2013	2013	0	0	GENOMICS_ENGLAND
val	64220	STRA6	0.597	0.731	C0018798	CongenitalHeartDefects	group	C16;C14	CongenitalAbnormality	0.31	1	2007	2007	1	0	CTD_human
val	64220	STRA6	0.597	0.731	C0019284	DiaphragmaticHernia	phenotype	C23	DiseaseorSyndrome	0.31	1	2007	2007	1	0	CTD_human
val	64220	STRA6	0.597	0.731	C0020796	ProfoundMentalRetardation	disease	C23;C10;F03;F01	MentalorBehavioralDysfunction	0.30	1	2007	2007	1	0	CTD_human
val	64220	STRA6	0.597	0.731	C0024115	Lungdiseases	group	C08	DiseaseorSyndrome	0.30	1	2007	2007	1	0	CTD_human
val	64220	STRA6	0.597	0.731	C0025363	MentalRetardation,Psychosocial	phenotype	C23;C10;F03;F01	MentalorBehavioralDysfunction	0.30	1	2007	2007	1	0	CTD_human
val	64220	STRA6	0.597	0.731	C0026010	Microphthalmos	disease	C16;C11	CongenitalAbnormality	0.44	1	2007	2013	1	0	CTD_human
val	64220	STRA6	0.597	0.731	C0243050	CardiovascularAbnormalities	group	C16;C14	CongenitalAbnormality	0.30	1	2008	2008	1	0	CTD_human
val	64220	STRA6	0.597	0.731	C0376634	CraniofacialAbnormalities	group	C16;C05	CongenitalAbnormality	0.30	1	2008	2008	1	0	CTD_human
val	64220	STRA6	0.597	0.731	C0917816	Mentaldeficiency	disease	C23;C10;F03;F01	MentalorBehavioralDysfunction	0.30	1	2007	2007	1	0	CTD_human
val	64220	STRA6	0.597	0.731	C1832661	ANOPHTHALMIAANDPULMONARYHYPOPLASIA	disease	C16;C11;C08	DiseaseorSyndrome	0.80	1	2007	2017	5	18	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
val	64220	STRA6	0.597	0.731	C2677362	Alveolarcapillarydysplasia	disease	C16;C08	CongenitalAbnormality	0.30	1	2007	2007	1	0	CTD_human
val	64220	STRA6	0.597	0.731	C2931501	Microphthalmiaassociatedwithcolobomatouscyst	phenotype	C23;C16;C04;C11	DiseaseorSyndrome	0.30	1	2011	2011	1	0	ORPHANET
val	64220	STRA6	0.597	0.731	C3714756	IntellectualDisability	group	C23;C10;F03;F01	MentalorBehavioralDysfunction	0.42	1	2007	2009	1	0	CTD_human
val	64221	ROBO3	0.52	0.808	C0004352	AutisticDisorder	disease	F03	MentalorBehavioralDysfunction	0.31	1	2008	2008	1	0	CTD_human
val	64221	ROBO3	0.52	0.808	C1846496	GazePalsy,FamilialHorizontal,withProgressiveScoliosis	disease	C05	DiseaseorSyndrome	0.40	1	2006	2015	0	0	ORPHANET
val	64221	ROBO3	0.52	0.808	C4551964	GAZEPALSY,FAMILIALHORIZONTAL,WITHPROGRESSIVESCOLIOSIS,1	disease	C23;C18;C11;C05;C10	DiseaseorSyndrome	0.80	1	2004	2015	2	11	CTD_human;GENOMICS_ENGLAND;UNIPROT
val	64224	HERPUD2	0.839	0.115	C0087031	Juvenile-OnsetStillDisease	disease	C17;C05;C20	DiseaseorSyndrome	0.30	1	2009	2009	1	0	CTD_human
val	64224	HERPUD2	0.839	0.115	C3495559	Juvenilearthritis	disease	C17;C05;C20	DiseaseorSyndrome	0.30	1	2009	2009	1	0	CTD_human
val	64224	HERPUD2	0.839	0.115	C3714758	Juvenilepsoriaticarthritis	disease	C17;C05;C20	DiseaseorSyndrome	0.30	1	2009	2009	1	0	CTD_human
val	64224	HERPUD2	0.839	0.115	C4552091	Polyarthritis,Juvenile,RheumatoidFactorNegative	disease	C17;C05;C20	DiseaseorSyndrome	0.30	1	2009	2009	1	0	CTD_human
val	64224	HERPUD2	0.839	0.115	C4704862	Polyarthritis,Juvenile,RheumatoidFactorPositive	disease	C17;C05;C20	DiseaseorSyndrome	0.30	1	2009	2009	1	0	CTD_human
val	64231	MS4A6A	0.821	0.231	C0017661	IGAGlomerulonephritis	disease	C13;C12;C20	DiseaseorSyndrome	0.30	1	2014	2014	1	0	CTD_human
val	64231	MS4A6A	0.821	0.231	C1135196	HeartFailure,Diastolic	disease	C14	DiseaseorSyndrome	0.30	1	2018	2018	1	0	CTD_human
val	64232	MS4A5	0.931	0.115	C0009402	ColorectalCarcinoma	disease	C06;C04	NeoplasticProcess	0.30				0	0	UNIPROT
val	64240	ABCG5	0.592	0.577	C0004153	Atherosclerosis	disease	C14	DiseaseorSyndrome	0.35	1	2000	2014	1	0	CTD_human
val	64240	ABCG5	0.592	0.577	C0005818	BloodPlateletDisorders	group	C15	DiseaseorSyndrome	0.30	1	2016	2016	1	0	GENOMICS_ENGLAND
val	64240	ABCG5	0.592	0.577	C0010054	CoronaryArteriosclerosis	disease	C14	DiseaseorSyndrome	0.41	1	2000	2014	2	0	CTD_human
val	64240	ABCG5	0.592	0.577	C0010068	Coronaryheartdisease	disease	C14	DiseaseorSyndrome	0.42	1	2009	2018	1	0	CTD_human
val	64240	ABCG5	0.592	0.577	C0020443	Hypercholesterolemia	disease	C18	DiseaseorSyndrome	0.46	1	2004	2019	0	0	GENOMICS_ENGLAND
val	64240	ABCG5	0.592	0.577	C0020445	Hypercholesterolemia,Familial	disease	C16;C18	DiseaseorSyndrome	0.33	1	2010	2018	1	0	GENOMICS_ENGLAND
val	64240	ABCG5	0.592	0.577	C0023772	LipidMetabolism,InbornErrors	group	C16;C18	DiseaseorSyndrome	0.30	1	2001	2001	1	0	CTD_human
val	64240	ABCG5	0.592	0.577	C0023893	LiverCirrhosis,Experimental	disease	C23;C06	ExperimentalModelofDisease	0.30	1	2014	2014	1	0	CTD_human
val	64240	ABCG5	0.592	0.577	C0033578	ProstaticNeoplasms	group	C04;C12	NeoplasticProcess	0.30	1	2012	2012	1	0	CTD_human
val	64240	ABCG5	0.592	0.577	C0043325	Xanthomatosis	disease	C18	DiseaseorSyndrome	0.30	1	2001	2001	1	0	CTD_human
val	64240	ABCG5	0.592	0.577	C0242339	Dyslipidemias	group	C18	DiseaseorSyndrome	0.30	1	2009	2009	1	0	CTD_human
val	64240	ABCG5	0.592	0.577	C0302314	Xanthoma	disease	C18	DiseaseorSyndrome	0.33	1	2001	2019	1	0	CTD_human
val	64240	ABCG5	0.592	0.577	C0342881	Familialhypercholesterolemia-homozygous	disease	C16;C18	DiseaseorSyndrome	0.30	1	2010	2010	1	0	ORPHANET
val	64240	ABCG5	0.592	0.577	C0342907	Sitosterolemia	disease	C16;C06;C18	CongenitalAbnormality	0.80	0.976	2000	2020	7	6	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
val	64240	ABCG5	0.592	0.577	C0376358	Malignantneoplasmofprostate	disease	C04;C12	NeoplasticProcess	0.31	1	2012	2015	1	0	CTD_human
val	64240	ABCG5	0.592	0.577	C0598784	Dyslipoproteinemias	phenotype	C18	PathologicFunction	0.30	1	2009	2009	1	0	CTD_human
val	64240	ABCG5	0.592	0.577	C1563937	Atherogenesis	phenotype	C14	PathologicFunction	0.30	1	2001	2001	1	0	CTD_human
val	64240	ABCG5	0.592	0.577	C1956346	CoronaryArteryDisease	disease	C14	DiseaseorSyndrome	0.32	1	2000	2014	2	0	CTD_human
val	64240	ABCG5	0.592	0.577	C2749759	Macrothrombocytopenia-Stomatocytosis,Mediterranean	disease	C16;C06;C18	DiseaseorSyndrome	0.30	1	2000	2001	2	0	CTD_human
val	64241	ABCG8	0.573	0.538	C0005818	BloodPlateletDisorders	group	C15	DiseaseorSyndrome	0.30	1	2017	2017	1	0	GENOMICS_ENGLAND
val	64241	ABCG8	0.573	0.538	C0009438	CommonBileDuctCalculi	phenotype	C23;C06	BodySubstance	0.30	1	2007	2007	1	0	CTD_human
val	64241	ABCG8	0.573	0.538	C0010054	CoronaryArteriosclerosis	disease	C14	DiseaseorSyndrome	0.42	1	2000	2010	1	0	CTD_human
val	64241	ABCG8	0.573	0.538	C0020443	Hypercholesterolemia	disease	C18	DiseaseorSyndrome	0.47	1	2004	2018	1	0	GENOMICS_ENGLAND
val	64241	ABCG8	0.573	0.538	C0020445	Hypercholesterolemia,Familial	disease	C16;C18	DiseaseorSyndrome	0.32	1	2009	2019	1	0	GENOMICS_ENGLAND
val	64241	ABCG8	0.573	0.538	C0023893	LiverCirrhosis,Experimental	disease	C23;C06	ExperimentalModelofDisease	0.30	1	2014	2014	1	0	CTD_human
val	64241	ABCG8	0.573	0.538	C0242216	Biliarycalculi	phenotype	C23;C06	BodySubstance	0.42	1	2007	2019	1	2	CTD_human
val	64241	ABCG8	0.573	0.538	C0268318	Cholestasisofpregnancy	disease	C06;C13	DiseaseorSyndrome	0.30	1	2015	2015	1	0	GENOMICS_ENGLAND
val	64241	ABCG8	0.573	0.538	C0342881	Familialhypercholesterolemia-homozygous	disease	C16;C18	DiseaseorSyndrome	0.30	1	2010	2010	1	0	ORPHANET
val	64241	ABCG8	0.573	0.538	C0342907	Sitosterolemia	disease	C16;C06;C18	CongenitalAbnormality	1.00	1	2000	2019	5	12	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
val	64241	ABCG8	0.573	0.538	C1956346	CoronaryArteryDisease	disease	C14	DiseaseorSyndrome	0.45	1	2000	2018	1	2	CTD_human
val	64241	ABCG8	0.573	0.538	C1969115	GALLBLADDERDISEASE4	disease	C06	DiseaseorSyndrome	0.40				0	1	CTD_human
val	64241	ABCG8	0.573	0.538	C2749759	Macrothrombocytopenia-Stomatocytosis,Mediterranean	disease	C16;C06;C18	DiseaseorSyndrome	0.30	1	2000	2000	1	0	CTD_human
val	64283	ARHGEF28	0.615	0.423	C0002736	AmyotrophicLateralSclerosis	disease	C18;C10	DiseaseorSyndrome	0.37	1	2013	2020	1	0	GENOMICS_ENGLAND
val	64288	ZSCAN31	0.76	0.346	C0033975	PsychoticDisorders	group	F03	MentalorBehavioralDysfunction	0.31	1	2014	2014	1	0	PSYGENET
val	64288	ZSCAN31	0.76	0.346	C0036341	Schizophrenia	disease	F03	MentalorBehavioralDysfunction	0.41	1	2014	2015	1	1	PSYGENET
val	64288	ZSCAN31	0.76	0.346	C0349204	Nonorganicpsychosis	disease	F03	MentalorBehavioralDysfunction	0.31	1	2014	2014	1	0	PSYGENET
val	64321	SOX17	0.555	0.615	C0009402	ColorectalCarcinoma	disease	C06;C04	NeoplasticProcess	0.32	1	2008	2011	1	0	CTD_human
val	64321	SOX17	0.555	0.615	C0009404	ColorectalNeoplasms	group	C06;C04	NeoplasticProcess	0.31	1	2008	2008	1	0	CTD_human
val	64321	SOX17	0.555	0.615	C0042580	Vesico-UreteralReflux	disease	C13;C12	DiseaseorSyndrome	0.41	1	2010	2010	0	0	CTD_human
val	64321	SOX17	0.555	0.615	C0232910	Teratogenesis	phenotype	C23	PathologicFunction	0.30	1	2014	2014	1	0	CTD_human
val	64321	SOX17	0.555	0.615	C0340543	Familialprimarypulmonaryhypertension	disease	C08	DiseaseorSyndrome	0.30	1	2018	2018	1	0	GENOMICS_ENGLAND
val	64321	SOX17	0.555	0.615	C1150929	2-oxo-hept-3-ene-1,7-dioatehydrataseactivity	phenotype		MolecularFunction	0.30	1	2018	2018	1	0	GENOMICS_ENGLAND
val	64321	SOX17	0.555	0.615	C3150927	VESICOURETERALREFLUX3	disease		DiseaseorSyndrome	0.60	1	2010	2010	1	2	GENOMICS_ENGLAND;UNIPROT
val	64321	SOX17	0.555	0.615	C4551858	VesicoureteralReflux1	disease	C13;C12	DiseaseorSyndrome	0.30				0	0	CTD_human
val	64321	SOX17	0.555	0.615	C4706552	Familialvesicoureteralreflux	disease		CongenitalAbnormality	0.30	1	2010	2010	1	0	ORPHANET
val	64324	NSD1	0.505	0.769	C0004352	AutisticDisorder	disease	F03	MentalorBehavioralDysfunction	0.41	1	2007	2007	1	1	CTD_human
val	64324	NSD1	0.505	0.769	C0004903	Beckwith-WiedemannSyndrome	disease	C16	DiseaseorSyndrome	0.43	1	2003	2017	2	52	GENOMICS_ENGLAND
val	64324	NSD1	0.505	0.769	C0010606	AdenoidCysticCarcinoma	disease	C04	NeoplasticProcess	0.30	1	2013	2013	1	0	CTD_human
val	64324	NSD1	0.505	0.769	C0020796	ProfoundMentalRetardation	disease	C23;C10;F03;F01	MentalorBehavioralDysfunction	0.30	1	2003	2003	1	0	CTD_human
val	64324	NSD1	0.505	0.769	C0023467	Leukemia,Myelocytic,Acute	disease	C04	NeoplasticProcess	0.70	1	2002	2019	1	4	CTD_human;GENOMICS_ENGLAND
val	64324	NSD1	0.505	0.769	C0025363	MentalRetardation,Psychosocial	phenotype	C23;C10;F03;F01	MentalorBehavioralDysfunction	0.30	1	2003	2003	1	0	CTD_human
val	64324	NSD1	0.505	0.769	C0026998	AcuteMyeloidLeukemia,M1	disease	C04	NeoplasticProcess	0.30				0	0	CTD_human
val	64324	NSD1	0.505	0.769	C0175695	Sotossyndrome	disease	C16	DiseaseorSyndrome	0.7	0.987	2002	2019	20	0	CLINGEN;CTD_human;GENOMICS_ENGLAND
32326	64324	NSD1	0.505	0.769	C0265210	Weaversyndrome	disease	C16;C05;C19	DiseaseorSyndrome	0.65	1	2003	2015	2	0	CTD_human;GENOMICS_ENGLAND;ORPHANET
32332	64324	NSD1	0.505	0.769	C4551477	SOTOSSYNDROME1	disease	C16	DiseaseorSyndrome	0.61	1	2002	2019	8	201	GENOMICS_ENGLAND;UNIPROT
32335	64327	LMBR1	0.619	0.308	C0265559	Acheiropodia	disease	C16;C05	CongenitalAbnormality	0.82	1	2001	2016	1	0	CTD_human;GENOMICS_ENGLAND;ORPHANET
32337	64327	LMBR1	0.619	0.308	C1851100	LAURIN-SANDROWSYNDROME	disease	C16;C05	DiseaseorSyndrome	0.7	1	2001	2014	2	0	CTD_human;GENOMICS_ENGLAND;ORPHANET
32341	64327	LMBR1	0.619	0.308	C1861355	Syndactyly,TypeIV	disease	C16;C05	DiseaseorSyndrome	0.61	1	2000	2014	2	0	CTD_human;GENOMICS_ENGLAND;ORPHANET
32342	64327	LMBR1	0.619	0.308	C1868114	POLYDACTYLY,PREAXIALII(disorder)	disease	C16;C11;C05	DiseaseorSyndrome	0.73	1	2000	2017	4	10	CTD_human;GENOMICS_ENGLAND;ORPHANET
32355	64374	SIL1	0.584	0.731	C0024814	Marinesco-Sjogrensyndrome	disease	C16;C10	DiseaseorSyndrome	0.8	1	2001	2019	5	1	CTD_human;GENOMICS_ENGLAND;ORPHANET
32371	64377	CHST8	0.769	0.346	C4015729	PEELINGSKINSYNDROME3	disease		DiseaseorSyndrome	0.6	1	2012	2012	1	1	GENOMICS_ENGLAND;ORPHANET;UNIPROT
32373	64388	GREM2	0.722	0.5	C4310638	TOOTHAGENESIS,SELECTIVE,9	disease		CongenitalAbnormality	0.6	1	2015	2015	1	3	CTD_human;UNIPROT
32391	64412	GZF1	0.76	0.231	C4540020	JOINTLAXITY,SHORTSTATURE,ANDMYOPIA	disease		DiseaseorSyndrome	0.6	1	2017	2017	1	2	GENOMICS_ENGLAND;ORPHANET
32392	64419	MTMR14	0.674	0.615	C0175709	Centronuclearmyopathy	disease	C05;C10	DiseaseorSyndrome	0.53	1	2008	2019	1	0	CTD_human;GENOMICS_ENGLAND
32397	64419	MTMR14	0.674	0.615	C1834558	Myopathy,Centronuclear,AutosomalDominant	disease	C05;C10	DiseaseorSyndrome	0.6	1	2006	2006	1	0	CTD_human;GENOMICS_ENGLAND;ORPHANET
32400	64419	MTMR14	0.674	0.615	C4551952	Myopathy,Centronuclear,1	disease	C05;C10	DiseaseorSyndrome	0.6	1	2006	2009	2	2	CTD_human;GENOMICS_ENGLAND;UNIPROT
32404	64421	DCLRE1C	0.544	0.808	C1865370	Severecombinedimmunodeficiencywithsensitivitytoionizingradiation	disease	C16;C18;C20	DiseaseorSyndrome	0.91	1	2001	2015	6	9	CTD_human;GENOMICS_ENGLAND;UNIPROT
32406	64421	DCLRE1C	0.544	0.808	C2700553	OmennSyndrome	disease	C16;C18;C20	DiseaseorSyndrome	0.75	1	1997	2015	1	4	GENOMICS_ENGLAND;ORPHANET;UNIPROT
32408	64423	INF2	0.644	0.423	C0017668	Focalglomerulosclerosis	disease	C13;C12	DiseaseorSyndrome	0.7	1	2010	2019	2	1	CTD_human;GENOMICS_ENGLAND
32415	64423	INF2	0.644	0.423	C2750475	FocalSegmentalGlomerulosclerosis5	disease	C13;C12	DiseaseorSyndrome	0.7	1	2010	2017	7	12	CTD_human;GENOMICS_ENGLAND;UNIPROT
32416	64423	INF2	0.644	0.423	C3280845	CHARCOT-MARIE-TOOTHDISEASE,DOMINANTINTERMEDIATEE	disease		DiseaseorSyndrome	0.7	1	2011	2017	6	7	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
32422	64446	DNAI2	0.666	0.5	C2676235	CILIARYDYSKINESIA,PRIMARY,9	disease	C16;C08;C09;C14	DiseaseorSyndrome	0.6	1	2008	2015	1	2	CTD_human;GENOMICS_ENGLAND
32431	64478	CSMD1	0.61	0.5	C0036341	Schizophrenia	disease	F03	MentalorBehavioralDysfunction	0.7	1	2011	2020	5	8	PSYGENET
32459	64699	TMPRSS3	0.65	0.538	C1832827	DEAFNESS,CHILDHOOD-ONSETNEUROSENSORY,AUTOSOMALRECESSIVE8	disease	C23;C10;C09	DiseaseorSyndrome	0.7	1	2001	2017	7	13	CTD_human;GENOMICS_ENGLAND;UNIPROT
32496	64788	LMF1	0.769	0.231	C1855498	Lipasedeficiencycombined	disease	C16;C18	DiseaseorSyndrome	0.72	1	2007	2018	3	2	CTD_human;GENOMICS_ENGLAND;ORPHANET
32498	64801	ARV1	0.691	0.423	C4310762	EPILEPTICENCEPHALOPATHY,EARLYINFANTILE,38	disease		DiseaseorSyndrome	0.7	1	2015	2016	3	2	CTD_human;GENOMICS_ENGLAND;UNIPROT
32503	64802	NMNAT1	0.656	0.269	C0339527	LeberCongenitalAmaurosis	disease	C11	DiseaseorSyndrome	0.8	1	2003	2018	5	5	CTD_human;GENOMICS_ENGLAND;ORPHANET
32505	64802	NMNAT1	0.656	0.269	C1837873	LEBERCONGENITALAMAUROSIS9(disorder)	disease	C11	DiseaseorSyndrome	0.94	1	2003	2018	6	22	CTD_human;GENOMICS_ENGLAND;UNIPROT
32515	64805	P2RY12	0.533	0.731	C1853278	BleedingDisorderDueToP2RY12Defect	disease	C16;C15	DiseaseorSyndrome	0.8	1	2001	2015	3	0	CTD_human;ORPHANET;UNIPROT
32518	64837	KLC2	0.736	0.346	C1836010	SpasticParaplegia,OpticAtrophy,andNeuropathy	disease	C23;C16;C11;C10	DiseaseorSyndrome	0.71	1	2015	2015	1	1	CTD_human;GENOMICS_ENGLAND;ORPHANET
32520	64840	PORCN	0.545	0.692	C0016395	FocalDermalHypoplasia	disease	C16;C17;C05	DiseaseorSyndrome	1	0.968	1962	2019	9	8	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
32530	64857	PLEKHG2	0.705	0.423	C4225213	LEUKODYSTROPHYANDACQUIREDMICROCEPHALYWITHORWITHOUTDYSTONIA	disease		DiseaseorSyndrome	0.7	1	2016	2016	1	1	CTD_human;GENOMICS_ENGLAND;UNIPROT
32551	64919	BCL11B	0.568	0.731	C4310656	IMMUNODEFICIENCY49	disease		DiseaseorSyndrome	0.7	1	2016	2018	2	2	CTD_human;GENOMICS_ENGLAND;UNIPROT
32571	65018	PINK1	0.516	0.769	C0030567	ParkinsonDisease	disease	C10	DiseaseorSyndrome	0.6	0.987	2002	2020	5	0	CTD_human
32574	65018	PINK1	0.516	0.769	C0242422	ParkinsonianDisorders	group	C10	DiseaseorSyndrome	0.7	1	2001	2019	6	1	CTD_human
32584	65018	PINK1	0.516	0.769	C1853833	ParkinsonDisease6,AutosomalRecessiveEarly-Onset	disease	C10	DiseaseorSyndrome	0.93	1	2004	2017	27	24	CTD_human;GENOMICS_ENGLAND;UNIPROT
32589	65055	REEP1	0.653	0.423	C1833308	NEURONOPATHY,DISTALHEREDITARYMOTOR,TYPEV	disease	C10	DiseaseorSyndrome	0.51	1	2012	2012	1	0	CTD_human;ORPHANET
32590	65055	REEP1	0.653	0.423	C1853247	SPASTICPARAPLEGIA31,AUTOSOMALDOMINANT	disease	C16;C10	DiseaseorSyndrome	0.92	1	2006	2018	7	13	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
32595	65057	ACD	0.603	0.731	C1846142	HOYERAAL-HREIDARSSONSYNDROME	disease	C23;C16;C13;C17;C05;C10;F03;C15;F01	DiseaseorSyndrome	0.51	1	2014	2014	1	0	GENOMICS_ENGLAND;ORPHANET
32597	65057	ACD	0.603	0.731	C4225284	DYSKERATOSISCONGENITA,AUTOSOMALDOMINANT6	disease		DiseaseorSyndrome	0.7	1	2014	2014	2	2	CTD_human;GENOMICS_ENGLAND;UNIPROT
32605	65062	TMEM237	0.612	0.538	C0431399	Familialaplasiaofthevermis	disease	C16;C13;C11;C12	DiseaseorSyndrome	0.51	1	2011	2012	2	0	GENOMICS_ENGLAND;ORPHANET
32611	65078	RTN4R	0.595	0.692	C0036341	Schizophrenia	disease	F03	MentalorBehavioralDysfunction	0.67	0.857	2004	2017	3	7	CTD_human;UNIPROT
32612	65080	MRPL44	0.805	0.308	C3809339	COMBINEDOXIDATIVEPHOSPHORYLATIONDEFICIENCY16	disease		DiseaseorSyndrome	0.7	1	2013	2013	1	1	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
32613	65082	VPS33A	0.695	0.538	C4310627	MUCOPOLYSACCHARIDOSIS-PLUSSYNDROME	disease		DiseaseorSyndrome	0.7	1	2017	2017	2	1	CTD_human;ORPHANET;UNIPROT
32623	65109	UPF3B	0.619	0.615	C1136249	MentalRetardation,X-Linked	disease	C16;C10	DiseaseorSyndrome	0.52	1	2007	2010	1	0	CTD_human;GENOMICS_ENGLAND
32624	65109	UPF3B	0.619	0.615	C1970822	MentalRetardation,X-Linked,Syndromic14	disease	C16;C10	DiseaseorSyndrome	0.7	1	2007	2012	1	5	CTD_human;GENOMICS_ENGLAND;UNIPROT
32638	65125	WNK1	0.416	0.846	C1840391	Pseudohypoaldosteronism,TypeIIc	disease	C16;C13;C12	DiseaseorSyndrome	0.6	1	2001	2005	2	2	CTD_human;GENOMICS_ENGLAND
32640	65125	WNK1	0.416	0.846	C2752089	Neuropathy,HereditarySensoryAndAutonomic,TypeIIA	disease	C16;C10	DiseaseorSyndrome	0.6	1	2001	2006	4	6	CTD_human;GENOMICS_ENGLAND
32658	65217	PCDH15	0.601	0.577	C1384666	hearingimpairment	phenotype	C23;C10;C09	DiseaseorSyndrome	0.63	1	2003	2019	2	4	CTD_human;GENOMICS_ENGLAND
32663	65217	PCDH15	0.601	0.577	C1832845	USHERSYNDROME,TYPEID	disease	C23;C16;C11;C10;C09	DiseaseorSyndrome	0.6	1	2003	2016	3	4	GENOMICS_ENGLAND;UNIPROT
32664	65217	PCDH15	0.601	0.577	C1836027	Deafness,AutosomalRecessive23	disease	C23;C10;C09	DiseaseorSyndrome	0.92	1	2003	2017	4	12	CTD_human;GENOMICS_ENGLAND;UNIPROT
32668	65217	PCDH15	0.601	0.577	C1865885	UsherSyndrome,TypeIF	disease	C23;C16;C11;C10;C09	DiseaseorSyndrome	0.87	1	2001	2017	3	90	GENOMICS_ENGLAND;UNIPROT
32679	65250	CPLANE1	0.575	0.692	C0431399	Familialaplasiaofthevermis	disease	C16;C13;C11;C12	DiseaseorSyndrome	0.69	1	2012	2019	4	1	GENOMICS_ENGLAND;ORPHANET
32681	65250	CPLANE1	0.575	0.692	C2745997	OROFACIODIGITALSYNDROMEVI	disease	C16;C05	DiseaseorSyndrome	0.75	1	2012	2019	3	29	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
32682	65250	CPLANE1	0.575	0.692	C3553264	JOUBERTSYNDROME17	disease		DiseaseorSyndrome	0.8	1	2012	2018	5	65	GENOMICS_ENGLAND;UNIPROT
32694	65266	WNK4	0.644	0.538	C1840390	Pseudohypoaldosteronism,TypeIIb	disease	C16;C13;C12	DiseaseorSyndrome	0.7	1	2001	2013	4	6	CTD_human;GENOMICS_ENGLAND;UNIPROT
32704	65993	MRPS34	0.722	0.346	C4540029	COMBINEDOXIDATIVEPHOSPHORYLATIONDEFICIENCY32	disease		DiseaseorSyndrome	0.6	1	2017	2017	1	2	GENOMICS_ENGLAND;UNIPROT
32711	78987	CRELD1	0.67	0.269	C1853508	ATRIOVENTRICULARSEPTALDEFECT,SUSCEPTIBILITYTO,2	disease		Finding	0.6	1	2003	2005	2	5	GENOMICS_ENGLAND;UNIPROT
32712	78987	CRELD1	0.67	0.269	C1853509	AtrioventricularSeptalDefect,Partial,withHeterotaxySyndrome	disease	C16;C15;C14	DiseaseorSyndrome	0.6	NA	NA	NA	0	1	CTD_human;GENOMICS_ENGLAND
32721	78989	COLEC11	0.641	0.654	C0796279	Carnevalesyndrome	disease	C16;C11;C05;C12;C10;C19	DiseaseorSyndrome	0.7	1	1989	2017	4	2	CTD_human;GENOMICS_ENGLAND;UNIPROT
32737	79001	VKORC1	0.603	0.731	C0750384	CoumarinResistance	phenotype	C16;C18	DiseaseorSyndrome	0.8	0.933	2004	2018	2	8	CTD_human;GENOMICS_ENGLAND;UNIPROT
32739	79001	VKORC1	0.603	0.731	C1843832	VITAMINK-DEPENDENTCLOTTINGFACTORS,COMBINEDDEFICIENCYOF,2	disease	C16;C15	DiseaseorSyndrome	0.7	1	2004	2011	3	1	CTD_human;GENOMICS_ENGLAND;UNIPROT
32778	79042	TSEN34	0.722	0.346	C2676465	PontocerebellarHypoplasiaType2C	disease	C10	DiseaseorSyndrome	0.7	1	2008	2011	2	1	CTD_human;GENOMICS_ENGLAND;UNIPROT
32788	79048	SECISBP2	0.792	0.269	C1864761	ThyroidHormoneMetabolism,Abnormal	disease	C19	DiseaseorSyndrome	0.73	1	2005	2018	3	3	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
32792	79053	ALG8	0.659	0.577	C2931002	Congenitaldisorderofglycosylationtype1H	disease	C16;C18	DiseaseorSyndrome	0.74	1	2004	2020	4	8	CTD_human;GENOMICS_ENGLAND;UNIPROT
32803	79058	ASPSCR1	0.653	0.538	C0206657	AlveolarSoftPartSarcoma	disease	C04	NeoplasticProcess	0.7	1	2001	2020	1	0	CTD_human;ORPHANET
32820	79068	FTO	0.486	0.885	C2752001	GrowthRetardation,DevelopmentalDelay,CoarseFacies,AndEarlyDeath	disease	C23;C16;C05;C19;F03	CongenitalAbnormality	0.7	1	2009	2016	4	4	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
32836	79083	MLPH	0.743	0.423	C1836573	GRISCELLISYNDROME,TYPE3	disease	C23;C16;C18;C17	DiseaseorSyndrome	0.7	1	2003	2003	1	1	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
32839	79087	ALG12	0.705	0.5	C2931001	Congenitaldisorderofglycosylationtype1G	disease	C16;C18	DiseaseorSyndrome	0.71	1	2002	2016	6	10	CTD_human;GENOMICS_ENGLAND;UNIPROT
32843	79092	CARD14	0.546	0.846	C0032027	PityriasisRubraPilaris	disease	C17	DiseaseorSyndrome	0.8	1	2012	2019	6	2	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
32844	79092	CARD14	0.546	0.846	C0033860	Psoriasis	disease	C17	DiseaseorSyndrome	0.7	0.947	2003	2019	3	1	CTD_human;GENOMICS_ENGLAND
32846	79092	CARD14	0.546	0.846	C1864497	PSORIASIS2	disease		DiseaseorSyndrome	0.81	1	2012	2018	7	13	GENOMICS_ENGLAND;UNIPROT
32856	79133	NDUFAF5	0.674	0.462	C1838979	MITOCHONDRIALCOMPLEXIDEFICIENCY	disease	C18	DiseaseorSyndrome	0.6	1	2008	2019	4	1	GENOMICS_ENGLAND;ORPHANET
32857	79133	NDUFAF5	0.674	0.462	C4748785	MITOCHONDRIALCOMPLEXIDEFICIENCY,NUCLEARTYPE16	disease		DiseaseorSyndrome	0.6	1	2008	2012	4	3	GENOMICS_ENGLAND;UNIPROT
32867	79143	MBOAT7	0.612	0.5	C4310673	MENTALRETARDATION,AUTOSOMALRECESSIVE57	disease		DiseaseorSyndrome	0.6	1	2012	2012	1	5	CTD_human;GENOMICS_ENGLAND
32869	79147	FKRP	0.513	0.731	C0265221	Walker-Warburgcongenitalmusculardystrophy	disease	C16;C11;C10	DiseaseorSyndrome	0.8	1	2001	2018	1	18	CTD_human;GENOMICS_ENGLAND;ORPHANET
32871	79147	FKRP	0.513	0.731	C0457133	Muscleeyebraindisease	disease	C16;C11;C10	DiseaseorSyndrome	0.53	1	2004	2017	2	0	CTD_human;ORPHANET
32874	79147	FKRP	0.513	0.731	C1846672	MUSCULARDYSTROPHY,LIMB-GIRDLE,TYPE2I	disease	C16;C05;C10	DiseaseorSyndrome	0.95	1	2000	2018	9	51	CTD_human;GENOMICS_ENGLAND;UNIPROT
32875	79147	FKRP	0.513	0.731	C1847759	MUSCULARDYSTROPHY,CONGENITAL,1C	disease	C16;C05;C10	DiseaseorSyndrome	0.96	1	2000	2016	9	12	CTD_human;GENOMICS_ENGLAND;UNIPROT
32877	79147	FKRP	0.513	0.731	C3150413	MUSCULARDYSTROPHY-DYSTROGLYCANOPATHY(CONGENITALWITHBRAINANDEYEANOMALIES),TYPEA,5	disease		DiseaseorSyndrome	0.6	1	2000	2016	6	7	GENOMICS_ENGLAND;UNIPROT
32882	79152	FA2H	0.573	0.654	C0037773	SpasticParaplegia,Hereditary	disease	C16;C10	DiseaseorSyndrome	0.57	1	2010	2019	1	0	GENOMICS_ENGLAND
32884	79152	FA2H	0.573	0.654	C3496228	Leukodystrophy,Dysmyelinating,AndSpasticParaparesisWithOrWithoutDystonia	disease	C16;C10	DiseaseorSyndrome	0.95	1	2008	2020	6	12	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
32885	79152	FA2H	0.573	0.654	C3668943	FattyAcidHydroxylase-AssociatedNeurodegeneration	disease	C16;C10	DiseaseorSyndrome	0.53	1	2008	2020	2	0	GENOMICS_ENGLAND;ORPHANET
32889	79158	GNPTAB	0.592	0.731	C0020725	TypeIIMucolipidosis	disease	C16;C18;C05;C10	DiseaseorSyndrome	0.9	1	2004	2020	4	0	GENOMICS_ENGLAND;ORPHANET
32890	79158	GNPTAB	0.592	0.731	C0033788	Pseudo-HurlerPolydystrophy	disease	C16;C18;C05;C10	DiseaseorSyndrome	0.73	1	2004	2019	18	101	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
32892	79158	GNPTAB	0.592	0.731	C2673377	MUCOLIPIDOSISIIALPHA/BETA(disorder)	disease	C16;C18;C05;C10	DiseaseorSyndrome	0.93	1	2004	2019	19	136	CTD_human;GENOMICS_ENGLAND;UNIPROT
32908	79188	TMEM43	0.653	0.462	C1858379	ARRHYTHMOGENICRIGHTVENTRICULARDYSPLASIA,FAMILIAL,5(disorder)	disease	C16;C14	DiseaseorSyndrome	0.7	1	2008	2017	3	2	CTD_human;GENOMICS_ENGLAND;UNIPROT
32909	79188	TMEM43	0.653	0.462	C3553060	EMERY-DREIFUSSMUSCULARDYSTROPHY7,AUTOSOMALDOMINANT	disease		DiseaseorSyndrome	0.6	1	2011	2017	3	2	GENOMICS_ENGLAND;UNIPROT
32912	79228	THOC6	0.705	0.577	C3150939	THOC6-relateddevelopmentaldelay-microcephaly-facialdysmorphismsyndrome	disease	C23;C16;C05;C10;F03;F01	DiseaseorSyndrome	0.73	1	2013	2020	2	10	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
32940	79443	FYCO1	0.769	0.269	C1864908	Cataract,autosomalrecessivecongenital2	disease	C11	DiseaseorSyndrome	0.7	1	2001	2011	2	6	CTD_human;GENOMICS_ENGLAND;UNIPROT
32970	79577	CDC73	0.543	0.615	C0262587	ParathyroidAdenoma	disease	C04;C19	NeoplasticProcess	0.7	0.882	2002	2019	0	0	CGI;CTD_human
32972	79577	CDC73	0.543	0.615	C0687150	ParathyroidGlandAdenocarcinoma	disease	C04;C19	NeoplasticProcess	0.8	0.947	2002	2019	2	18	CTD_human;GENOMICS_ENGLAND;ORPHANET
32974	79577	CDC73	0.543	0.615	C1704981	Hyperparathyroidism-JawTumorSyndrome	disease	C04;C05;C19;C07	NeoplasticProcess	0.8	1	1990	2020	9	5	CLINGEN;CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
32975	79577	CDC73	0.543	0.615	C1840402	HYPERPARATHYROIDISM1	disease	C19	DiseaseorSyndrome	0.7	1	2002	2019	6	5	CTD_human;GENOMICS_ENGLAND;UNIPROT
32978	79577	CDC73	0.543	0.615	C4551961	FamilialIsolatedHyperparathyroidism	disease	C19	DiseaseorSyndrome	0.6	0.967	1993	2020	1	0	CTD_human;ORPHANET
32979	79581	SLC52A2	0.483	0.808	C0796274	Brown-Vialetto-VanLaereSyndrome1	disease	C23;C10;C09	DiseaseorSyndrome	0.57	1	2012	2019	0	0	CTD_human;ORPHANET
32981	79581	SLC52A2	0.483	0.808	C3553538	BROWN-VIALETTO-VANLAERESYNDROME2	disease		DiseaseorSyndrome	0.7	1	2010	2017	9	20	CLINGEN;GENOMICS_ENGLAND;UNIPROT
32989	79583	TMEM231	0.554	0.692	C3554235	JOUBERTSYNDROME20	disease		DiseaseorSyndrome	0.6	1	2012	2016	4	4	GENOMICS_ENGLAND;UNIPROT
32991	79583	TMEM231	0.554	0.692	C3809352	MECKELSYNDROME,TYPE11	disease		DiseaseorSyndrome	0.6	1	2012	2016	2	6	GENOMICS_ENGLAND;UNIPROT
32993	79587	CARS2	0.7	0.423	C4225251	COMBINEDOXIDATIVEPHOSPHORYLATIONDEFICIENCY27	disease		DiseaseorSyndrome	0.7	1	2014	2018	3	3	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
33001	79600	TCTN1	0.597	0.615	C0431399	Familialaplasiaofthevermis	disease	C16;C13;C11;C12	DiseaseorSyndrome	0.61	1	2011	2017	4	0	CTD_human;GENOMICS_ENGLAND;ORPHANET
33020	79621	RNASEH2B	0.595	0.615	C0393591	AICARDI-GOUTIERESSYNDROME	disease	C16;C20;C10	DiseaseorSyndrome	0.68	1	2006	2019	1	1	CTD_human;GENOMICS_ENGLAND
33022	79621	RNASEH2B	0.595	0.615	C3489724	Aicardi-GoutieresSyndrome2	disease	C16;C20;C10	DiseaseorSyndrome	0.7	1	2006	2018	8	19	CTD_human;GENOMICS_ENGLAND;UNIPROT
33028	79628	SH3TC2	0.666	0.385	C1866636	CHARCOT-MARIE-TOOTHDISEASE,TYPE4C	disease	C16;C10	DiseaseorSyndrome	1	1	2003	2019	2	27	CTD_human;GENOMICS_ENGLAND;UNIPROT
33029	79628	SH3TC2	0.666	0.385	C3150596	MONONEUROPATHYOFTHEMEDIANNERVE,MILD	disease		DiseaseorSyndrome	0.7	1	2009	2010	2	2	CTD_human;GENOMICS_ENGLAND;UNIPROT
33031	79631	EFL1	0.638	0.577	C4693704	SHWACHMAN-DIAMONDSYNDROME2	disease		DiseaseorSyndrome	0.6	1	2017	2018	2	2	GENOMICS_ENGLAND;UNIPROT
33053	79633	FAT4	0.539	0.808	C0340834	Hennekamlymphangiectasia-lymphedemasyndrome	disease	C16;C05;C15	DiseaseorSyndrome	0.51	1	2014	2017	1	0	CTD_human;ORPHANET
33056	79633	FAT4	0.539	0.808	C1832390	VanMaldergemWetzburgerVerloessyndrome	disease	C23;C16;C05;C10;F03;F01	DiseaseorSyndrome	0.54	1	2013	2018	1	0	CTD_human;ORPHANET
33059	79633	FAT4	0.539	0.808	C3809875	VANMALDERGEMSYNDROME2	disease		DiseaseorSyndrome	0.6	1	2013	2014	2	7	GENOMICS_ENGLAND;UNIPROT
33061	79633	FAT4	0.539	0.808	C4014939	HENNEKAMLYMPHANGIECTASIA-LYMPHEDEMASYNDROME2	disease		DiseaseorSyndrome	0.6	1	2013	2018	3	5	GENOMICS_ENGLAND;UNIPROT
33062	79641	ROGDI	0.663	0.462	C0406740	KohlschutterTonzsyndrome	disease	C16;C10;F03;C07	DiseaseorSyndrome	0.74	1	1995	2017	3	11	CTD_human;GENOMICS_ENGLAND;ORPHANET
33072	79644	SRD5A3	0.604	0.692	C2675185	KahriziSyndrome	disease	C23;C16;C11;C05;C10;F03;F01	DiseaseorSyndrome	0.61	1	2011	2016	2	1	CTD_human;GENOMICS_ENGLAND
33074	79644	SRD5A3	0.604	0.692	C4317224	Congenitaldisorderofglycosylationtype1q	disease	C16;C18	DiseaseorSyndrome	0.7	1	2008	2016	5	4	CTD_human;GENOMICS_ENGLAND;ORPHANET
33077	79648	MCPH1	0.54	0.846	C1855081	MICROCEPHALY,PRIMARYAUTOSOMALRECESSIVE,1	disease	C16;C05;C10	DiseaseorSyndrome	0.76	1	2002	2014	4	13	CTD_human;GENOMICS_ENGLAND;UNIPROT
33080	79650	USB1	0.636	0.577	C0265965	DyskeratosisCongenita	disease	C16;C17;C15	DiseaseorSyndrome	0.55	1	2010	2016	3	0	GENOMICS_ENGLAND;ORPHANET
33081	79650	USB1	0.636	0.577	C1858723	PoikilodermawithNeutropenia	disease	C16;C17;C15	DiseaseorSyndrome	0.8	1	2010	2018	3	24	CTD_human;GENOMICS_ENGLAND;ORPHANET
33084	79651	RHBDF2	0.595	0.538	C1835664	TYLOSISWITHESOPHAGEALCANCER	disease	C16;C06;C04;C17	NeoplasticProcess	0.74	1	2012	2019	2	2	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
33091	79659	DYNC2H1	0.555	0.731	C0024507	MajewskiSyndrome	disease	C16;C05	DiseaseorSyndrome	0.6	1	2011	2012	3	2	CTD_human;ORPHANET
33092	79659	DYNC2H1	0.555	0.731	C0036069	Saldino-NoonanSyndrome	disease	C16;C05	DiseaseorSyndrome	0.91	1	2009	2018	7	101	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
33095	79659	DYNC2H1	0.555	0.731	C0265275	Jeunethoracicdystrophy	disease	C16;C17;C05	DiseaseorSyndrome	0.67	1	2009	2018	2	68	GENOMICS_ENGLAND;ORPHANET
33096	79659	DYNC2H1	0.555	0.731	C0432197	Shortrib-polydactylysyndrome,Verma-Naumofftype	disease	C16;C05	DiseaseorSyndrome	0.75	1	2009	2018	2	0	CTD_human;ORPHANET
33142	79695	GALNT12	0.78	0.269	C1837315	COLORECTALCANCER,SUSCEPTIBILITYTO,1	disease		Finding	0.7	1	2004	2016	5	6	CLINGEN;GENOMICS_ENGLAND;UNIPROT
33147	79717	PPCS	0.792	0.308	C4748647	CARDIOMYOPATHY,DILATED,2C	disease		DiseaseorSyndrome	0.6	1	2018	2018	1	1	GENOMICS_ENGLAND;UNIPROT
33163	79718	TBL1XR1	0.534	0.808	C1865644	PlantarLipomatosis,UnusualFacies,andDevelopmentalDelay	disease	C23;C18;C17;F03	DiseaseorSyndrome	0.75	1	1998	2018	5	4	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
33164	79718	TBL1XR1	0.534	0.808	C4310784	MENTALRETARDATION,AUTOSOMALDOMINANT41	disease		DiseaseorSyndrome	0.7	1	1998	2016	5	6	CTD_human;GENOMICS_ENGLAND;UNIPROT
33167	79719	AAGAB	0.695	0.538	C1835662	Keratosispalmoplantarispapulosa	disease	C16;C17	DiseaseorSyndrome	0.72	1	2012	2017	3	6	CTD_human;GENOMICS_ENGLAND;ORPHANET
33168	79719	AAGAB	0.695	0.538	C4551675	Keratoderma,Palmoplantar	disease	C16;C17	DiseaseorSyndrome	0.62	1	2012	2013	1	1	CTD_human;GENOMICS_ENGLAND
33179	79728	PALB2	0.485	0.769	C0006142	Malignantneoplasmofbreast	disease	C04;C17	NeoplasticProcess	0.8	0.97	2006	2020	6	221	CGI;CTD_human;GENOMICS_ENGLAND;UNIPROT
33191	79728	PALB2	0.485	0.769	C0346153	BreastCancer,Familial	disease	C04;C17	NeoplasticProcess	0.7	0.944	2006	2019	10	0	CLINGEN;GENOMICS_ENGLAND;ORPHANET
33196	79728	PALB2	0.485	0.769	C0678222	BreastCarcinoma	disease	C04;C17	NeoplasticProcess	0.7	0.961	2007	2020	1	4	CGI;CTD_human
33203	79728	PALB2	0.485	0.769	C1835817	FANCONIANEMIA,COMPLEMENTATIONGROUPN	disease	C16;C18;C15	DiseaseorSyndrome	0.71	1	2007	2018	5	13	CLINGEN;CTD_human;GENOMICS_ENGLAND
33223	79731	NARS2	0.65	0.577	C4015643	COMBINEDOXIDATIVEPHOSPHORYLATIONDEFICIENCY24	disease		DiseaseorSyndrome	0.7	1	2015	2015	3	11	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
33228	79734	KCTD17	0.743	0.308	C1834570	Myoclonicdystonia	disease	C10	DiseaseorSyndrome	0.51	1	2015	2015	1	0	CTD_human;ORPHANET
33229	79734	KCTD17	0.743	0.308	C4225341	DYSTONIA26,MYOCLONIC	disease		DiseaseorSyndrome	0.6	1	2015	2015	1	1	GENOMICS_ENGLAND;UNIPROT
33233	79738	BBS10	0.644	0.538	C0752166	Bardet-BiedlSyndrome	disease	C16;C11;C10	DiseaseorSyndrome	0.7	0.974	1966	2020	2	25	ORPHANET
33234	79738	BBS10	0.644	0.538	C1859568	BARDET-BIEDLSYNDROME10	disease	C16;C11;C10	DiseaseorSyndrome	0.9	1	2006	2017	7	94	CTD_human;GENOMICS_ENGLAND;UNIPROT
33254	79751	SLC25A22	0.595	0.577	C0270855	Earlymyoclonicencephalopathy	disease	C10	DiseaseorSyndrome	0.7	1	2005	2016	3	7	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
33256	79753	SNIP1	0.682	0.462	C3281055	PSYCHOMOTORRETARDATION,EPILEPSY,ANDCRANIOFACIALDYSMORPHISM	disease		DiseaseorSyndrome	0.6	1	2012	2012	1	1	GENOMICS_ENGLAND;UNIPROT
33257	79755	ZNF750	0.743	0.385	C1853258	Seborrhea-LikeDermatitiswithPsoriasiformElements	disease	C17	DiseaseorSyndrome	0.6	1	2006	2011	2	0	CTD_human;GENOMICS_ENGLAND;ORPHANET
33278	79783	SUGCT	0.686	0.385	C0342873	GlutaricAciduriaIII	disease	C16;C18	DiseaseorSyndrome	0.7	1	2008	2016	3	2	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
33287	79784	MYH14	0.663	0.577	C1833503	Deafness,AutosomalDominant4	disease	C23;C10;C09	DiseaseorSyndrome	0.71	1	2004	2019	4	6	CTD_human;GENOMICS_ENGLAND;UNIPROT
33288	79784	MYH14	0.663	0.577	C3280556	PERIPHERALNEUROPATHY,MYOPATHY,HOARSENESS,ANDHEARINGLOSS	disease		DiseaseorSyndrome	0.71	1	2011	2018	3	1	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
33294	79796	ALG9	0.644	0.654	C1849762	PolycysticKidneyDisease,PotterTypeI,withMicrobrachycephaly,Hypertelorism,andBrachymelia	disease	C16;C13;C05;C12	DiseaseorSyndrome	0.6	1	2004	2016	2	1	CTD_human;GENOMICS_ENGLAND
33295	79796	ALG9	0.644	0.654	C2931006	Congenitaldisorderofglycosylationtype1L	disease	C16;C18	DiseaseorSyndrome	0.73	1	2004	2020	5	2	CTD_human;GENOMICS_ENGLAND;UNIPROT
33300	79797	ZNF408	0.678	0.269	C4225315	RETINITISPIGMENTOSA72	disease		DiseaseorSyndrome	0.6	1	2015	2015	1	2	CTD_human;UNIPROT
33301	79797	ZNF408	0.678	0.269	C4225316	EXUDATIVEVITREORETINOPATHY6	disease		DiseaseorSyndrome	0.6	1	2013	2013	1	2	CTD_human;UNIPROT
33302	79798	ARMC5	0.67	0.5	C1857451	Acth-IndependentMacronodularAdrenalHyperplasia	disease	C19	DiseaseorSyndrome	0.52	1	2013	2018	1	0	CTD_human;ORPHANET
33303	79798	ARMC5	0.67	0.5	C4014803	ACTH-INDEPENDENTMACRONODULARADRENALHYPERPLASIA2	disease		DiseaseorSyndrome	0.68	1	2013	2018	10	13	GENOMICS_ENGLAND;UNIPROT
33306	79803	HPS6	0.769	0.308	C0079504	Hermanski-PudlakSyndrome	disease	C16;C18;C11;C17;C15	DiseaseorSyndrome	0.61	1	2017	2019	0	3	CTD_human;GENOMICS_ENGLAND
33307	79803	HPS6	0.769	0.308	C3888007	HERMANSKY-PUDLAKSYNDROME6	disease	C16;C18;C11;C17;C15	DiseaseorSyndrome	0.6	1	2003	2009	1	12	GENOMICS_ENGLAND
33323	79809	TTC21B	0.619	0.654	C0265275	Jeunethoracicdystrophy	disease	C16;C17;C05	DiseaseorSyndrome	0.7	1	2011	2014	3	3	CTD_human;GENOMICS_ENGLAND;ORPHANET
33328	79809	TTC21B	0.619	0.654	C3151185	SHORT-RIBTHORACICDYSPLASIA4WITHORWITHOUTPOLYDACTYLY	disease		DiseaseorSyndrome	0.6	1	2011	2014	2	2	GENOMICS_ENGLAND;UNIPROT
33329	79809	TTC21B	0.619	0.654	C3151186	NEPHRONOPHTHISIS12	disease		DiseaseorSyndrome	0.7	1	2011	2017	3	7	CTD_human;GENOMICS_ENGLAND;UNIPROT
33340	79813	EHMT1	0.46	0.808	C0795833	KLEEFSTRASYNDROME1	disease	C23;C16;C05;C10;F03;F01;C14	DiseaseorSyndrome	1	1	2006	2019	11	24	CLINGEN;CTD_human;GENOMICS_ENGLAND;UNIPROT
33343	79816	TLE6	0.931	0.038	C4225197	PREIMPLANTATIONEMBRYONICLETHALITY1	disease		DiseaseorSyndrome	0.6	1	2015	2015	1	2	CTD_human;UNIPROT
33361	79823	CAMKMT	0.51	0.808	C1848030	Hypotonia-CystinuriaSyndrome	disease	C23;C16;C18;C13;C05;C12;C10;F03;F01	DiseaseorSyndrome	0.52	1	2008	2018	1	0	CTD_human
33364	79827	CLMP	0.705	0.462	C0021847	IntestinalPseudo-Obstruction	disease	C06	DiseaseorSyndrome	0.74	1	2012	2016	1	5	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
33374	79840	NHEJ1	0.705	0.385	C1969799	SevereCombinedImmunodeficiencywithMicrocephaly,GrowthRetardation,andSensitivitytoIonizingRadiation	disease	C23;C16;C18;C05;C20;C10	DiseaseorSyndrome	0.71	1	2006	2012	3	6	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
33378	79848	CSPP1	0.544	0.769	C0431399	Familialaplasiaofthevermis	disease	C16;C13;C11;C12	DiseaseorSyndrome	0.55	1	2014	2019	3	0	GENOMICS_ENGLAND;ORPHANET
33393	79867	TCTN2	0.578	0.654	C0431399	Familialaplasiaofthevermis	disease	C16;C13;C11;C12	DiseaseorSyndrome	0.6	1	2011	2015	2	10	GENOMICS_ENGLAND;ORPHANET
33406	79868	ALG13	0.631	0.577	C3550904	EPILEPTICENCEPHALOPATHY,EARLYINFANTILE,36	disease	C10	DiseaseorSyndrome	0.7	1	2012	2016	6	2	CTD_human;GENOMICS_ENGLAND;UNIPROT
33437	79876	UBA5	0.582	0.731	C4310699	SPINOCEREBELLARATAXIA,AUTOSOMALRECESSIVE24	disease		DiseaseorSyndrome	0.6	1	2016	2016	1	0	GENOMICS_ENGLAND;UNIPROT
33438	79876	UBA5	0.582	0.731	C4310700	EPILEPTICENCEPHALOPATHY,EARLYINFANTILE,44	disease		DiseaseorSyndrome	0.7	1	2016	2016	2	0	CTD_human;GENOMICS_ENGLAND;UNIPROT
33444	79882	ZC3H14	0.691	0.308	C4310703	MENTALRETARDATION,AUTOSOMALRECESSIVE56	disease		DiseaseorSyndrome	0.6	1	2011	2011	1	1	CTD_human;GENOMICS_ENGLAND
33450	79902	NUP85	0.792	0.154	C4748545	NEPHROTICSYNDROME,TYPE17	disease		DiseaseorSyndrome	0.6	1	2018	2018	1	3	GENOMICS_ENGLAND;UNIPROT
33455	79912	PYROXD1	0.769	0.269	C4310645	MYOPATHY,MYOFIBRILLAR,8	disease		DiseaseorSyndrome	0.7	1	2016	2019	4	5	CLINGEN;GENOMICS_ENGLAND;UNIPROT
33481	79934	COQ8B	0.722	0.423	C3809965	NEPHROTICSYNDROME,TYPE9	disease		DiseaseorSyndrome	0.7	1	2013	2016	2	11	CTD_human;GENOMICS_ENGLAND;UNIPROT
33492	79944	L2HGDH	0.653	0.462	C1855995	L-2-HYDROXYGLUTARICACIDURIA	disease	C16;C18;C10	DiseaseorSyndrome	1	1	2004	2018	8	15	GENOMICS_ENGLAND;ORPHANET;UNIPROT
33493	79944	L2HGDH	0.653	0.462	C2746066	CombinedD-2-andL-2-hydroxyglutaricaciduria	disease	C16;C18;C10	DiseaseorSyndrome	0.7	1	2004	2018	3	0	CTD_human;GENOMICS_ENGLAND
33498	79947	DHDDS	0.468	0.885	C3151227	RETINITISPIGMENTOSA59	disease		DiseaseorSyndrome	0.7	1	2011	2017	3	3	CTD_human;GENOMICS_ENGLAND;UNIPROT
33499	79947	DHDDS	0.468	0.885	C4693376	DEVELOPMENTALDELAYANDSEIZURESWITHORWITHOUTMOVEMENTABNORMALITIES	disease		DiseaseorSyndrome	0.6	1	2016	2017	2	3	GENOMICS_ENGLAND;UNIPROT
33508	79955	PDZD7	0.659	0.385	C1848634	USHERSYNDROME,TYPEIIA	disease	C23;C16;C11;C10;C09	DiseaseorSyndrome	0.6	NA	NA	NA	0	2	CTD_human;GENOMICS_ENGLAND
33521	79977	GRHL2	0.59	0.731	C1837640	Deafness,AutosomalDominant28	disease	C23;C10;C09	DiseaseorSyndrome	0.61	1	2011	2014	1	2	CTD_human;GENOMICS_ENGLAND
33523	79977	GRHL2	0.59	0.731	C4014987	Nailandtoothabnormalities,marginalpalmoplantarkeratoderma,oralhyperpigmentationsyndrome	disease	C16;C05;C19	DiseaseorSyndrome	0.7	1	2014	2014	1	2	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
33526	79983	POF1B	0.751	0.308	C1845105	PrematureOvarianFailure2b	disease	C13;C19	DiseaseorSyndrome	0.7	1	2004	2016	3	1	CTD_human;GENOMICS_ENGLAND;UNIPROT
33532	79991	STN1	0.604	0.769	C2677299	CEREBRORETINALMICROANGIOPATHYWITHCALCIFICATIONSANDCYSTS(disorder)	disease	C23;C16;C04;C18;C11;C05;C10	DiseaseorSyndrome	0.51	1	2015	2016	1	0	CTD_human;ORPHANET
33533	79991	STN1	0.604	0.769	C4479220	CEREBRORETINALMICROANGIOPATHYWITHCALCIFICATIONSANDCYSTS2	disease		DiseaseorSyndrome	0.6	1	2016	2016	1	2	GENOMICS_ENGLAND;UNIPROT
33540	80000	GREB1L	0.686	0.423	C4540497	RENALHYPODYSPLASIA/APLASIA3	disease		CongenitalAbnormality	0.6	1	2017	2017	3	20	GENOMICS_ENGLAND;UNIPROT
33545	80025	PANK2	0.559	0.808	C0018523	Hallervorden-SpatzSyndrome	disease	C16;C10	DiseaseorSyndrome	0.8	0.989	2001	2019	9	41	CTD_human;GENOMICS_ENGLAND;UNIPROT
33551	80025	PANK2	0.559	0.808	C1846582	Hypoprebetalipoproteinemia,Acanthocytosis,RetinitisPigmentosa,AndPallidalDegeneration	disease	C16;C10	DiseaseorSyndrome	0.62	1	2002	2006	1	5	CTD_human;GENOMICS_ENGLAND
33590	80055	PGAP1	0.65	0.423	C4014343	MENTALRETARDATION,AUTOSOMALRECESSIVE42	disease		DiseaseorSyndrome	0.6	1	2007	2015	1	13	CTD_human;GENOMICS_ENGLAND
33593	80067	DCAF17	0.653	0.577	C0342286	WoodhouseSakatisyndrome	disease	C23;C18;C17;C10;C19;F03;F01;C14	DiseaseorSyndrome	0.8	1	2008	2020	4	9	CTD_human;GENOMICS_ENGLAND;ORPHANET
33608	80114	BICC1	0.636	0.577	C3275898	RENALDYSPLASIA,CYSTIC,SUSCEPTIBILITYTO	disease		Finding	0.6	1	2012	2012	1	2	GENOMICS_ENGLAND;UNIPROT
33618	80144	FRAS1	0.56	0.577	C0265233	Cryptophthalmossyndrome	disease	C16;C13;C11;C05;C12	DiseaseorSyndrome	1	0.867	2006	2017	2	2	CTD_human;GENOMICS_ENGLAND;ORPHANET
33629	80155	NAA15	0.7	0.423	C3714756	IntellectualDisability	group	C23;C10;F03;F01	MentalorBehavioralDysfunction	0.63	1	2015	2018	1	0	CTD_human;GENOMICS_ENGLAND
33630	80155	NAA15	0.7	0.423	C4540470	MENTALRETARDATION,AUTOSOMALDOMINANT50	disease		MentalorBehavioralDysfunction	0.6	1	2017	2017	1	12	GENOMICS_ENGLAND;UNIPROT
33644	80169	CTC1	0.601	0.538	C0265965	DyskeratosisCongenita	disease	C16;C17;C15	DiseaseorSyndrome	0.64	1	2012	2019	5	10	GENOMICS_ENGLAND;ORPHANET
33647	80169	CTC1	0.601	0.538	C2677299	CEREBRORETINALMICROANGIOPATHYWITHCALCIFICATIONSANDCYSTS(disorder)	disease	C23;C16;C04;C18;C11;C05;C10	DiseaseorSyndrome	0.76	1	2012	2018	2	3	CTD_human;GENOMICS_ENGLAND;ORPHANET
33649	80169	CTC1	0.601	0.538	C4552029	CEREBRORETINALMICROANGIOPATHYWITHCALCIFICATIONSANDCYSTS1	disease	C23;C16;C04;C18;C11;C05;C10	DiseaseorSyndrome	0.6	1	2012	2018	4	18	GENOMICS_ENGLAND;UNIPROT
33655	80184	CEP290	0.517	0.769	C0339527	LeberCongenitalAmaurosis	disease	C11	DiseaseorSyndrome	0.7	1	2006	2019	2	8	GENOMICS_ENGLAND;ORPHANET
33656	80184	CEP290	0.517	0.769	C0403553	Renaldysplasiaandretinalaplasia(disorder)	disease	C16;C13;C11;C12;C10	DiseaseorSyndrome	0.54	1	2007	2013	3	0	GENOMICS_ENGLAND;ORPHANET
33659	80184	CEP290	0.517	0.769	C1857779	SENIOR-LOKENSYNDROME6	disease	C16;C13;C11;C12;C10	DiseaseorSyndrome	0.7	1	2006	2018	7	13	CTD_human;GENOMICS_ENGLAND;UNIPROT
33660	80184	CEP290	0.517	0.769	C1857780	JOUBERTSYNDROME5	disease	C23;C13;C11;C12;C10	DiseaseorSyndrome	0.91	1	2006	2019	11	45	CTD_human;GENOMICS_ENGLAND;UNIPROT
33661	80184	CEP290	0.517	0.769	C1857821	LEBERCONGENITALAMAUROSIS10(disorder)	disease	C11	DiseaseorSyndrome	0.8	1	2006	2018	7	17	CTD_human;GENOMICS_ENGLAND
33662	80184	CEP290	0.517	0.769	C1970161	MECKELSYNDROME,TYPE4	disease	C23;C16;C13;C05;C12;C10	DiseaseorSyndrome	0.61	1	2006	2018	6	26	CTD_human;GENOMICS_ENGLAND
33663	80184	CEP290	0.517	0.769	C2673874	BARDET-BIEDLSYNDROME14(disorder)	disease	C16;C11;C10	DiseaseorSyndrome	0.6	1	2006	2018	3	13	CTD_human;GENOMICS_ENGLAND
33671	80185	TTI2	0.736	0.346	C3809853	MENTALRETARDATION,AUTOSOMALRECESSIVE39	disease		DiseaseorSyndrome	0.7	1	2013	2013	1	1	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
33676	80199	FUZ	0.597	0.731	C0027794	NeuralTubeDefects	group	C16;C10	CongenitalAbnormality	0.59	0.889	1997	2017	0	0	CTD_human;GENOMICS_ENGLAND
33684	80199	FUZ	0.597	0.731	C0344490	Sacralagenesis	disease	C23;C16;C10	CongenitalAbnormality	0.6	1	2011	2011	1	0	GENOMICS_ENGLAND;ORPHANET
33693	80204	FBXO11	0.604	0.692	C4748135	INTELLECTUALDEVELOPMENTALDISORDERWITHDYSMORPHICFACIESANDBEHAVIORALABNORMALITIES	disease		DiseaseorSyndrome	0.6	1	2006	2018	5	3	GENOMICS_ENGLAND;UNIPROT
33707	80207	OPA3	0.653	0.385	C0574084	3-Methylglutaconicaciduriatype3	disease	C23;C16;C18;C11;C10	DiseaseorSyndrome	0.9	1	2001	2016	2	11	CTD_human;GENOMICS_ENGLAND
33708	80207	OPA3	0.653	0.385	C1833809	OPTICATROPHYANDCATARACT,AUTOSOMALDOMINANT	disease	C16;C11;C10	DiseaseorSyndrome	0.71	1	2001	2016	3	4	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
33710	80208	SPG11	0.576	0.538	C1858479	Spasticparaplegia11,autosomalrecessive	disease	C16;C10	DiseaseorSyndrome	0.96	1	2004	2019	8	134	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
33711	80208	SPG11	0.576	0.538	C1865864	AMYOTROPHICLATERALSCLEROSIS5	disease	C18;C10	DiseaseorSyndrome	0.6	1	2009	2010	2	8	CTD_human;GENOMICS_ENGLAND
33714	80208	SPG11	0.576	0.538	C4225253	CHARCOT-MARIE-TOOTHDISEASE,AXONAL,TYPE2X	disease		DiseaseorSyndrome	0.7	1	2007	2016	3	8	CTD_human;GENOMICS_ENGLAND;ORPHANET
33715	80210	ARMC9	0.612	0.731	C0431399	Familialaplasiaofthevermis	disease	C16;C13;C11;C12	DiseaseorSyndrome	0.52	1	2017	2018	1	0	GENOMICS_ENGLAND;ORPHANET
33717	80210	ARMC9	0.612	0.731	C4539937	JOUBERTSYNDROME30	disease		DiseaseorSyndrome	0.6	1	2017	2017	1	9	GENOMICS_ENGLAND;UNIPROT
33729	80217	CFAP43	0.931	0.038	C4539818	SPERMATOGENICFAILURE19	disease		DiseaseorSyndrome	0.8	1	2017	2018	2	10	GENOMICS_ENGLAND;UNIPROT
33730	80222	TARS2	0.729	0.423	C4014668	COMBINEDOXIDATIVEPHOSPHORYLATIONDEFICIENCY21	disease		DiseaseorSyndrome	0.7	1	2014	2016	2	2	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
33731	80224	NUBPL	0.67	0.423	C0751651	MitochondrialDiseases	group	C18	DiseaseorSyndrome	0.51	1	2010	2016	2	0	CTD_human;GENOMICS_ENGLAND
33735	80224	NUBPL	0.67	0.423	C1838979	MITOCHONDRIALCOMPLEXIDEFICIENCY	disease	C18	DiseaseorSyndrome	0.61	1	2010	2016	4	2	GENOMICS_ENGLAND;ORPHANET
33736	80224	NUBPL	0.67	0.423	C4748792	MITOCHONDRIALCOMPLEXIDEFICIENCY,NUCLEARTYPE21	disease		DiseaseorSyndrome	0.6	1	2010	2013	2	5	GENOMICS_ENGLAND;UNIPROT
33739	80232	WDR26	0.606	0.769	C4539927	SKRABAN-DEARDORFFSYNDROME	disease		DiseaseorSyndrome	0.7	1	2017	2017	2	8	GENOMICS_ENGLAND;ORPHANET;UNIPROT
33741	80254	CEP63	0.666	0.5	C0025958	Microcephaly	disease	C16;C05;C10	CongenitalAbnormality	0.6	1	2011	2015	2	0	CTD_human;GENOMICS_ENGLAND
33751	80270	HSD3B7	0.7	0.385	C1843116	Bileacidsynthesisdefect,congenital,1	disease	C16;C06;C18	DiseaseorSyndrome	0.7	1	2000	2016	3	5	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
33768	80308	FLAD1	0.638	0.692	C4310822	LIPIDSTORAGEMYOPATHYDUETOFLAVINADENINEDINUCLEOTIDESYNTHETASEDEFICIENCY	disease		DiseaseorSyndrome	0.7	1	2006	2016	4	6	CLINGEN;GENOMICS_ENGLAND;UNIPROT
33790	80324	PUS1	0.695	0.462	C1838103	MITOCHONDRIALMYOPATHYANDSIDEROBLASTICANEMIA	disease	C16;C18;C05;C10;C14	DiseaseorSyndrome	0.64	1	2007	2014	1	0	CTD_human;GENOMICS_ENGLAND;ORPHANET
33792	80324	PUS1	0.695	0.462	C4551958	MYOPATHY,LACTICACIDOSIS,ANDSIDEROBLASTICANEMIA1	disease	C16;C18;C05;C10;C14	DiseaseorSyndrome	0.61	1	2004	2019	7	5	GENOMICS_ENGLAND;UNIPROT
33797	80326	WNT10A	0.547	0.731	C0796093	Odontoonychodermaldysplasia	disease	C16;C17;C07	DiseaseorSyndrome	0.73	1	2007	2019	5	15	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
33799	80326	WNT10A	0.547	0.731	C1835492	TOOTHAGENESIS,SELECTIVE,4(disorder)	disease	C16;C07	DiseaseorSyndrome	0.61	1	2009	2018	8	24	CTD_human;UNIPROT
33801	80326	WNT10A	0.547	0.731	C1857069	SCHOPF-SCHULZ-PASSARGESYNDROME(disorder)	disease	C16;C04;C11;C17;C07	DiseaseorSyndrome	0.77	1	2009	2018	2	4	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
33806	80331	DNAJC5	0.653	0.5	C1834207	CeroidLipofuscinosis,Neuronal,ParryType	disease	C16;C18;C10	DiseaseorSyndrome	0.7	1	2011	2013	5	2	GENOMICS_ENGLAND;ORPHANET;UNIPROT
33825	80347	COASY	0.551	0.654	C3810230	NEURODEGENERATIONWITHBRAINIRONACCUMULATION6	disease		DiseaseorSyndrome	0.7	1	2014	2018	4	3	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
33839	80704	SLC19A3	0.61	0.692	C1843807	Basalgangliadisease,biotin-responsive	disease	C10	DiseaseorSyndrome	1	1	2005	2019	4	19	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
33874	80746	TSEN2	0.705	0.423	C2676466	PontocerebellarHypoplasiaType2B	disease	C10	DiseaseorSyndrome	0.7	1	2008	2011	2	3	CTD_human;GENOMICS_ENGLAND;UNIPROT
33904	80781	COL18A1	0.449	0.808	C1849409	Knoblochsyndrome	disease	C23;C16;C11;C10	DiseaseorSyndrome	0.7	1	2000	2018	2	0	CTD_human;GENOMICS_ENGLAND;ORPHANET
33906	80781	COL18A1	0.449	0.808	C4551775	KnoblochSyndrome,TypeI	disease	C23;C16;C11;C10	DiseaseorSyndrome	0.6	1	2000	2017	3	3	CTD_human;GENOMICS_ENGLAND
33915	80816	ASXL3	0.59	0.577	C3809650	BAINBRIDGE-ROPERSSYNDROME	disease		DiseaseorSyndrome	0.76	1	2013	2019	2	17	CTD_human;GENOMICS_ENGLAND;ORPHANET
33919	80821	DDHD1	0.716	0.423	C1836295	SPASTICPARAPLEGIA28,AUTOSOMALRECESSIVE(disorder)	disease	C23;C10	DiseaseorSyndrome	0.62	1	2012	2018	2	0	CTD_human;GENOMICS_ENGLAND;ORPHANET
33934	81027	TUBB1	0.78	0.385	C2751259	Macrothrombocytopenia,AutosomalDominant,Tubb1-Related	disease	C15	DiseaseorSyndrome	0.7	1	2009	2014	2	1	CTD_human;GENOMICS_ENGLAND;UNIPROT
33946	81031	SLC2A10	0.55	0.615	C1859726	ARTERIALTORTUOSITYSYNDROME	disease	C16;C17;C05;C14	DiseaseorSyndrome	0.8	0.913	2003	2020	4	20	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
33948	81031	SLC2A10	0.55	0.615	C4707243	Familialthoracicaorticaneurysmandaorticdissection	disease		DiseaseorSyndrome	0.6	1	2003	2010	2	1	CLINGEN;GENOMICS_ENGLAND
33952	81034	SLC25A32	0.821	0.115	C4225187	EXERCISEINTOLERANCE,RIBOFLAVIN-RESPONSIVE	disease		DiseaseorSyndrome	0.6	1	2016	2017	2	2	GENOMICS_ENGLAND;UNIPROT
33986	81494	CFHR5	0.659	0.385	C3553720	CFHR5DEFICIENCY	disease		DiseaseorSyndrome	0.7	1	2010	2017	7	3	CTD_human;GENOMICS_ENGLAND;ORPHANET
33998	81545	FBXO38	0.792	0.115	C3888271	NEURONOPATHY,DISTALHEREDITARYMOTOR,TYPEIID	disease	C10	DiseaseorSyndrome	0.7	1	2013	2013	1	1	CTD_human;GENOMICS_ENGLAND;UNIPROT
34004	81562	LMAN2L	0.641	0.385	C0005586	BipolarDisorder	disease	F03	MentalorBehavioralDysfunction	0.61	1	2013	2019	2	2	CTD_human;PSYGENET
34017	81562	LMAN2L	0.641	0.385	C4225168	MENTALRETARDATION,AUTOSOMALRECESSIVE52	disease		DiseaseorSyndrome	0.6	1	2016	2016	1	1	CTD_human;UNIPROT
34036	81570	CLPB	0.631	0.654	C4225393	3-methylglutaconicaciduriatype7	disease	C16;C18	DiseaseorSyndrome	0.7	1	2015	2017	3	20	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
34054	81607	NECTIN4	0.599	0.538	C3150807	ECTODERMALDYSPLASIA-SYNDACTYLYSYNDROME1	disease		DiseaseorSyndrome	0.73	1	2010	2018	2	6	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
34071	134864	TAAR1	0.682	0.423	C0036341	Schizophrenia	disease	F03	MentalorBehavioralDysfunction	0.57	1	2007	2020	1	0	PSYGENET
34085	135656	MUCL3	0.691	0.731	C0878555	Diffusepanbronchiolitis	disease	C01;C08	DiseaseorSyndrome	0.51	1	2002	2012	1	0	CTD_human;ORPHANET
34088	135935	NOBOX	0.805	0.154	C1969060	PrematureOvarianFailure5	disease	C13;C19	DiseaseorSyndrome	0.7	1	2007	2016	4	10	CTD_human;GENOMICS_ENGLAND;UNIPROT
34100	136371	ASB10	0.805	0.077	C1863926	GLAUCOMA1,OPENANGLE,F(disorder)	disease	C11	DiseaseorSyndrome	0.7	1	2012	2012	1	18	CTD_human;GENOMICS_ENGLAND;UNIPROT
34105	136647	MPLKIP	0.604	0.654	C1955934	TrichothiodystrophySyndromes	disease	C16;C17	DiseaseorSyndrome	0.55	1	2005	2016	0	0	CTD_human;ORPHANET
34115	137392	FAM92A	0.729	0.308	C0220697	POLYDACTYLY,POSTAXIAL	disease	C16;C05	DiseaseorSyndrome	0.51	1	2019	2019	1	0	CTD_human
34118	137392	FAM92A	0.729	0.308	C3887487	PostaxialpolydactylytypeA	disease	C16;C05	DiseaseorSyndrome	0.51	1	2019	2019	1	0	CTD_human;ORPHANET
34122	137492	VPS37A	0.656	0.577	C3539494	SPASTICPARAPLEGIA53,AUTOSOMALRECESSIVE	disease		DiseaseorSyndrome	0.7	1	2012	2012	1	1	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
34129	137814	NKX2-6	0.695	0.385	C0041207	TruncusArteriosus,Persistent	disease	C16;C14	CongenitalAbnormality	0.6	1	2005	2014	2	1	GENOMICS_ENGLAND;ORPHANET
34131	137814	NKX2-6	0.695	0.385	C1857586	CONOTRUNCALHEARTMALFORMATIONS(disorder)	disease	C16;C14	DiseaseorSyndrome	0.7	1	2005	2015	4	2	CTD_human;GENOMICS_ENGLAND;UNIPROT
34144	138050	HGSNAT	0.628	0.577	C0026706	MucopolysaccharidosisIII	disease	C16;C18;C17	DiseaseorSyndrome	0.8	1	2006	2016	2	5	CTD_human;GENOMICS_ENGLAND
34148	138050	HGSNAT	0.628	0.577	C0086649	MPSIIIC	disease	C16;C18;C17	DiseaseorSyndrome	0.8	1	2006	2019	11	36	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
34150	138050	HGSNAT	0.628	0.577	C4225287	RETINITISPIGMENTOSA73	disease		DiseaseorSyndrome	0.7	1	2006	2016	3	13	CTD_human;GENOMICS_ENGLAND;UNIPROT
34166	139212	PIH1D3	0.674	0.538	C4478372	CILIARYDYSKINESIA,PRIMARY,36,X-LINKED	disease		DiseaseorSyndrome	0.6	1	2017	2017	1	2	CTD_human;GENOMICS_ENGLAND
34171	139285	AMER1	0.57	0.654	C0432268	Osteopathiastriatacranialsclerosis	disease	C05	DiseaseorSyndrome	0.99	1	2009	2019	2	8	CTD_human;GENOMICS_ENGLAND;ORPHANET
34203	140628	GATA5	0.578	0.615	C4693563	CONGENITALHEARTDEFECTS,MULTIPLETYPES,5	disease		DiseaseorSyndrome	0.6	1	2012	2015	10	6	GENOMICS_ENGLAND;UNIPROT
34216	140732	SUN5	0.805	0.154	C4310674	SPERMATOGENICFAILURE16	disease		DiseaseorSyndrome	0.75	1	2016	2018	4	7	CTD_human;ORPHANET;UNIPROT
34246	140803	TRPM6	0.656	0.538	C1865974	Hypomagnesemia1,Intestinal	disease	C18	DiseaseorSyndrome	0.8	1	2002	2019	5	8	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
34256	142680	SLC34A3	0.695	0.308	C1853271	HYPOPHOSPHATEMICRICKETSWITHHYPERCALCIURIA,HEREDITARY	disease	C23;C16;C18;C13;C05;C12	DiseaseorSyndrome	0.8	1	2006	2019	4	19	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
34329	144165	PRICKLE1	0.647	0.615	C2676254	Prickle1-RelatedProgressiveMyoclonusEpilepsywithAtaxia	disease	C10	DiseaseorSyndrome	0.7	1	2008	2011	2	3	CTD_human;GENOMICS_ENGLAND;UNIPROT
34342	144568	A2ML1	0.59	0.692	C0028326	NoonanSyndrome	disease	C16;C17;C05;C14	DiseaseorSyndrome	0.6	1	2015	2016	3	0	CLINGEN;GENOMICS_ENGLAND;ORPHANET
34359	145173	B3GLCT	0.554	0.731	C0796012	Krause-Kivlinsyndrome	disease	C23;C16;C05;C07	DiseaseorSyndrome	0.7	0.933	2006	2019	6	5	CTD_human;GENOMICS_ENGLAND
34362	145226	RDH12	0.65	0.308	C0035334	RetinitisPigmentosa	disease	C16;C11	DiseaseorSyndrome	0.66	1	2007	2019	2	5	CTD_human;GENOMICS_ENGLAND
34365	145226	RDH12	0.65	0.308	C2675186	LEBERCONGENITALAMAUROSIS13	disease	C11	DiseaseorSyndrome	0.71	1	2004	2019	8	16	CTD_human;GENOMICS_ENGLAND;UNIPROT
34369	145258	GSC	0.631	0.615	C1865361	SHORTSTATURE,AUDITORYCANALATRESIA,MANDIBULARHYPOPLASIA,SKELETALABNORMALITIES	disease	C05	DiseaseorSyndrome	0.63	1	1997	2013	2	3	GENOMICS_ENGLAND;ORPHANET
34384	145873	MESP2	0.653	0.462	C1837549	SPONDYLOCOSTALDYSOSTOSIS,AUTOSOMALRECESSIVE2	disease	C05	DiseaseorSyndrome	0.6	1	2004	2008	2	16	CTD_human;GENOMICS_ENGLAND
34395	146057	TTBK2	0.682	0.423	C1858351	SPINOCEREBELLARATAXIA11	disease	C16;C10	DiseaseorSyndrome	0.66	1	2007	2019	0	2	CTD_human;GENOMICS_ENGLAND
34397	146059	CDAN1	0.61	0.731	C0271933	Congenitaldyserythropoieticanemia,typeI	disease	C16;C15	DiseaseorSyndrome	0.78	1	2002	2018	2	12	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
34401	146167	SLC38A8	0.743	0.269	C3807873	FOVEALHYPOPLASIA2	disease		DiseaseorSyndrome	0.7	1	2013	2014	2	5	GENOMICS_ENGLAND;ORPHANET;UNIPROT
34405	146183	OTOA	0.76	0.423	C1846896	Deafness,AutosomalRecessive22	disease	C23;C10;C09	DiseaseorSyndrome	0.8	1	2012	2019	1	7	CTD_human;GENOMICS_ENGLAND
34408	146206	CARMIL2	0.695	0.462	C4748304	IMMUNODEFICIENCY58	disease		DiseaseorSyndrome	0.6	1	2016	2018	5	8	ORPHANET;UNIPROT
34414	146227	BEAN1	0.705	0.385	C1861736	SPINOCEREBELLARATAXIA31(disorder)	disease	C16;C10	DiseaseorSyndrome	0.63	1	2007	2019	3	0	CTD_human;GENOMICS_ENGLAND;ORPHANET
34428	146862	UNC45B	0.805	0.192	C4225389	CATARACT43	disease		DiseaseorSyndrome	0.6	1	2014	2014	1	1	CTD_human;UNIPROT
34430	147007	TMEM199	0.792	0.231	C4225190	CONGENITALDISORDEROFGLYCOSYLATION,TYPEIIp	disease		DiseaseorSyndrome;CongenitalAbnormality	0.7	1	2016	2016	1	4	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
34431	147138	TMC8	0.705	0.231	C0014522	EpidermodysplasiaVerruciformis	disease	C01;C17	NeoplasticProcess	0.6	1	2002	2018	1	0	GENOMICS_ENGLAND;ORPHANET
34437	147183	KRT25	0.736	0.269	C4225214	WOOLLYHAIR,AUTOSOMALRECESSIVE3	disease		DiseaseorSyndrome	0.6	1	2015	2018	3	2	GENOMICS_ENGLAND;UNIPROT
34438	147372	CCBE1	0.585	0.769	C0020305	HydropsFetalis	disease	C23;C16;C13;C20;C15	DiseaseorSyndrome	0.6	1	2003	2010	2	0	CTD_human;GENOMICS_ENGLAND
34442	147372	CCBE1	0.585	0.769	C0340834	Hennekamlymphangiectasia-lymphedemasyndrome	disease	C16;C05;C15	DiseaseorSyndrome	0.61	1	2009	2017	2	0	CTD_human;GENOMICS_ENGLAND;ORPHANET
34448	147372	CCBE1	0.585	0.769	C4012050	HENNEKAMLYMPHANGIECTASIA-LYMPHEDEMASYNDROME1	disease	C16;C05;C15	DiseaseorSyndrome	0.7	1	2003	2014	4	6	CTD_human;GENOMICS_ENGLAND;UNIPROT
34451	147409	DSG4	0.686	0.423	C1842839	HYPOTRICHOSIS6	disease	C17	DiseaseorSyndrome	0.8	1	1996	2004	1	0	CTD_human;GENOMICS_ENGLAND
34455	147495	APCDD1	0.644	0.538	C1854310	Hypotrichosissimplex	disease	C17	DiseaseorSyndrome	0.53	1	2010	2018	1	0	CTD_human;ORPHANET
34456	147495	APCDD1	0.644	0.538	C4551976	HYPOTRICHOSIS1	disease		DiseaseorSyndrome	0.6	1	2010	2012	2	1	GENOMICS_ENGLAND;UNIPROT
34473	147912	SIX5	0.666	0.5	C0265234	Branchio-Oto-RenalSyndrome	disease	C16	DiseaseorSyndrome	0.53	1	2000	2014	6	0	CLINGEN;CTD_human
34475	147912	SIX5	0.666	0.5	C1970479	BranchiootorenalSyndrome2	disease	C16	DiseaseorSyndrome	0.7	1	1999	2007	2	4	CTD_human;GENOMICS_ENGLAND;UNIPROT
34486	148022	TICAM1	0.593	0.846	C0276226	Herpesencephalitis	disease	C01;C10	DiseaseorSyndrome	0.63	0.333	2011	2015	1	0	CTD_human;ORPHANET
34487	148022	TICAM1	0.593	0.846	C3553869	ENCEPHALOPATHY,ACUTE,INFECTION-INDUCED(HERPES-SPECIFIC),SUSCEPTIBILITYTO,6	disease		Finding	0.6	1	2011	2015	2	3	GENOMICS_ENGLAND;UNIPROT
34501	148738	HJV	0.621	0.654	C0268060	Juvenilehemochromatosis	disease	C16;C18	DiseaseorSyndrome	0.7	1	2000	2020	0	1	CTD_human
34503	148738	HJV	0.621	0.654	C1865614	HEMOCHROMATOSIS,TYPE2A	disease	C16;C18	DiseaseorSyndrome	0.9	1	2004	2016	5	13	CTD_human;GENOMICS_ENGLAND;UNIPROT
34508	148789	B3GALNT2	0.578	0.577	C0457133	Muscleeyebraindisease	disease	C16;C11;C10	DiseaseorSyndrome	0.51	1	2013	2018	1	0	CTD_human;ORPHANET
34511	148789	B3GALNT2	0.578	0.577	C3554638	MUSCULARDYSTROPHY-DYSTROGLYCANOPATHY(CONGENITALWITHBRAINANDEYEANOMALIES),TYPEA,11	disease		DiseaseorSyndrome	0.6	1	2013	2017	1	13	GENOMICS_ENGLAND;UNIPROT
34520	149233	IL23R	0.466	0.769	C0009324	UlcerativeColitis	disease	C06	DiseaseorSyndrome	0.7	0.982	2006	2020	3	6	CTD_human;GENOMICS_ENGLAND
34521	149233	IL23R	0.466	0.769	C0010346	CrohnDisease	disease	C06	DiseaseorSyndrome	0.7	0.95	2006	2020	2	9	CTD_human;GENOMICS_ENGLAND
34532	149461	CLDN19	0.659	0.423	C1855466	Hypomagnesemia5,Renal,withOcularInvolvement	disease	C16;C18;C13;C11;C12	DiseaseorSyndrome	0.6	1	2006	2006	1	0	CTD_human;GENOMICS_ENGLAND;ORPHANET
34534	149461	CLDN19	0.659	0.423	C4721891	HYPOMAGNESEMIA5,RENAL,WITHORWITHOUTOCULARINVOLVEMENT	disease		DiseaseorSyndrome	0.6	1	1979	2017	3	4	GENOMICS_ENGLAND;UNIPROT
34563	150094	SIK1	0.544	0.731	C4225360	EPILEPTICENCEPHALOPATHY,EARLYINFANTILE,30	disease		DiseaseorSyndrome	0.7	1	2015	2015	1	5	CTD_human;GENOMICS_ENGLAND;UNIPROT
34574	150468	CKAP2L	0.666	0.577	C0795940	Filippisyndrome	disease	C23;C16;C05;C10;F03;F01	DiseaseorSyndrome	0.72	1	2002	2016	2	6	CTD_human;GENOMICS_ENGLAND;ORPHANET
34620	151648	SGO1	0.674	0.346	C4015474	Chronicatrialandintestinaldysrhythmia	disease	C23;C14	DiseaseorSyndrome	0.72	1	2014	2014	1	1	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
34638	152137	CCDC50	0.751	0.423	C1843895	Deafness,AutosomalDominant44	disease	C23;C10;C09	DiseaseorSyndrome	0.51	1	2007	2016	1	0	CTD_human;GENOMICS_ENGLAND
34665	152816	ODAPH	0.839	0.077	C3553830	AMELOGENESISIMPERFECTA,HYPOMATURATIONTYPE,IIA4	disease		DiseaseorSyndrome	0.6	1	2012	2012	1	5	CTD_human;GENOMICS_ENGLAND
34670	152926	PPM1K	0.656	0.5	C0024776	MapleSyrupUrineDisease	disease	C16;C18;C10	DiseaseorSyndrome	0.52	1	2009	2013	0	0	CTD_human
34692	153201	SLC36A2	0.861	0.154	C0268654	Iminoglycinuria	disease	C16;C18;C13;C12	DiseaseorSyndrome	0.61	1	2008	2008	1	1	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
34693	153201	SLC36A2	0.861	0.154	C0543541	HYPERGLYCINURIA(disorder)	disease	C16;C18;C13;C12	DiseaseorSyndrome	0.7	1	2008	2008	1	1	CTD_human;GENOMICS_ENGLAND;UNIPROT
34698	153241	CEP120	0.564	0.731	C0265275	Jeunethoracicdystrophy	disease	C16;C17;C05	DiseaseorSyndrome	0.52	1	2015	2018	2	0	GENOMICS_ENGLAND;ORPHANET
34700	153241	CEP120	0.564	0.731	C4225378	SHORT-RIBTHORACICDYSPLASIA13WITHORWITHOUTPOLYDACTYLY	disease		DiseaseorSyndrome	0.6	1	2015	2018	3	2	GENOMICS_ENGLAND;UNIPROT
34702	153241	CEP120	0.564	0.731	C4540355	JOUBERTSYNDROME31	disease		DiseaseorSyndrome	0.6	1	2016	2016	1	5	GENOMICS_ENGLAND;UNIPROT
34705	153562	MARVELD2	0.705	0.462	C1857811	DEAFNESS,AUTOSOMALRECESSIVE49	disease	C23;C10;C09	DiseaseorSyndrome	0.81	1	2006	2015	1	3	CTD_human;GENOMICS_ENGLAND
34714	154288	KHDC3L	0.76	0.115	C0678213	Completehydatidiformmole	disease	C04;C13	NeoplasticProcess	0.52	1	2011	2014	2	0	CTD_human;ORPHANET
34735	154881	KCTD7	0.65	0.423	C2673257	EPILEPSY,PROGRESSIVEMYOCLONIC3	disease	C10	DiseaseorSyndrome	0.71	1	1990	2018	5	11	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
34742	157570	ESCO2	0.581	0.615	C0392475	Roberts-SCphocomeliasyndrome	disease	C16;C05	DiseaseorSyndrome	0.8	1	1979	2019	7	28	CTD_human;GENOMICS_ENGLAND;UNIPROT
34746	157657	C8orf37	0.628	0.538	C0035334	RetinitisPigmentosa	disease	C16;C11	DiseaseorSyndrome	0.95	1	2012	2016	1	0	CTD_human;GENOMICS_ENGLAND;ORPHANET
34748	157657	C8orf37	0.628	0.538	C3281045	CONE-RODDYSTROPHY16	disease		DiseaseorSyndrome	0.9	1	2012	2018	2	0	CTD_human;GENOMICS_ENGLAND;UNIPROT
34750	157657	C8orf37	0.628	0.538	C4319932	BARDET-BIEDLSYNDROME21	disease		DiseaseorSyndrome	0.71	1	2016	2016	2	0	CTD_human;GENOMICS_ENGLAND;UNIPROT
34753	157680	VPS13B	0.579	0.769	C0265223	Cohensyndrome	disease	C23;C16;C18;C11;C05;C10;F03;F01	CongenitalAbnormality	0.8	1	1994	2020	10	284	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
34776	158326	FREM1	0.633	0.423	C0221363	Bifidnose	disease	C08;C09	CongenitalAbnormality	0.62	1	2011	2013	1	0	CTD_human;GENOMICS_ENGLAND
34779	158326	FREM1	0.633	0.423	C0265535	Trigonocephaly	disease	C16;C05	CongenitalAbnormality	0.7	1	2011	2011	1	0	CTD_human;GENOMICS_ENGLAND;ORPHANET
34785	158326	FREM1	0.633	0.423	C1855425	MarlesGreenbergPersaudsyndrome	disease	C16;C11;C05	DiseaseorSyndrome	0.75	0.875	2001	2017	4	3	CTD_human;GENOMICS_ENGLAND;UNIPROT
34787	158326	FREM1	0.633	0.423	C2750433	BifidNoseWithOrWithoutAnorectalAndRenalAnomalies	disease	C06;C13;C12	DiseaseorSyndrome	0.72	0.8	2001	2014	5	2	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
34790	158326	FREM1	0.633	0.423	C3280974	TRIGONOCEPHALY2	disease		CongenitalAbnormality	0.6	1	2001	2011	2	2	GENOMICS_ENGLAND;UNIPROT
34825	160418	TMTC3	0.636	0.538	C4310646	LISSENCEPHALY8	disease		DiseaseorSyndrome	0.6	1	2016	2016	1	5	GENOMICS_ENGLAND;UNIPROT
34858	161497	STRC	0.7	0.192	C1863561	Deafness,AutosomalRecessive16	disease	C23;C10;C09	DiseaseorSyndrome	0.83	1	2001	2018	1	3	CTD_human;GENOMICS_ENGLAND
34859	161497	STRC	0.7	0.192	C1970187	Deafness,Sensorineural,AndMaleInfertility	disease	C23;C12;C10;C09	DiseaseorSyndrome	0.6	1	2007	2007	1	0	CTD_human;ORPHANET
34870	161582	DNAAF4	0.623	0.731	C3809641	CILIARYDYSKINESIA,PRIMARY,25	disease		DiseaseorSyndrome	0.8	1	2013	2013	1	0	CTD_human;GENOMICS_ENGLAND
34879	161742	SPRED1	0.644	0.577	C1969623	NEUROFIBROMATOSIS,TYPE1-LIKESYNDROME	disease	C23;C17	DiseaseorSyndrome	0.8	0.963	2005	2019	10	32	CLINGEN;CTD_human;GENOMICS_ENGLAND;UNIPROT
34881	162417	NAGS	0.716	0.423	C0268543	Hyperammonemia,typeIII	disease	C16;C18;C10	DiseaseorSyndrome	0.76	1	1971	2018	10	18	CLINGEN;CTD_human;GENOMICS_ENGLAND;UNIPROT
34884	162514	TRPV3	0.61	0.577	C2609071	Olmstedsyndrome	disease		DiseaseorSyndrome	0.8	1	2012	2019	3	3	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
34885	162514	TRPV3	0.61	0.577	C4225339	PALMOPLANTARKERATODERMA,NONEPIDERMOLYTIC,FOCAL2	disease		DiseaseorSyndrome	0.7	1	2015	2015	1	1	CTD_human;GENOMICS_ENGLAND;UNIPROT
34889	163175	LGI4	0.678	0.308	C4479539	ARTHROGRYPOSISMULTIPLEXCONGENITA,NEUROGENIC,WITHMYELINDEFECT	disease		DiseaseorSyndrome	0.7	1	2006	2017	2	8	CTD_human;GENOMICS_ENGLAND;UNIPROT
34890	163183	SYNE4	0.861	0.115	C3147083	DEAFNESS,AUTOSOMALRECESSIVE76	disease		DiseaseorSyndrome	0.6	1	2018	2018	1	1	CTD_human;GENOMICS_ENGLAND
34904	163786	SASS6	0.691	0.423	C4225338	MICROCEPHALY14,PRIMARY,AUTOSOMALRECESSIVE	disease		DiseaseorSyndrome	0.7	1	2014	2014	1	1	CTD_human;GENOMICS_ENGLAND;UNIPROT
34907	164045	HFM1	0.659	0.615	C3810376	PREMATUREOVARIANFAILURE9	disease		DiseaseorSyndrome	0.7	1	2014	2016	2	4	CTD_human;GENOMICS_ENGLAND;UNIPROT
34916	164656	TMPRSS6	0.584	0.654	C0085576	Iron-RefractoryIronDeficiencyAnemia	disease	C18;C15	DiseaseorSyndrome	0.8	1	2008	2019	13	27	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
34922	165918	RNF168	0.653	0.731	C2677792	RiddleSyndrome	disease	C23;C16;C05;C20;C10;F03	DiseaseorSyndrome	0.97	1	2007	2017	4	1	CTD_human;GENOMICS_ENGLAND;ORPHANET
34928	166378	SPATA5	0.67	0.654	C4225276	EPILEPSY,HEARINGLOSS,ANDMENTALRETARDATIONSYNDROME	disease		DiseaseorSyndrome	0.71	1	2015	2017	3	19	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
34932	166379	BBS12	0.674	0.462	C1859570	BARDET-BIEDLSYNDROME12	disease	C16;C11;C10	DiseaseorSyndrome	0.7	1	2007	2014	4	38	CTD_human;GENOMICS_ENGLAND;UNIPROT
34937	166752	FREM3	0.805	0.269	C1269683	MajorDepressiveDisorder	disease	F03	MentalorBehavioralDysfunction	0.51	1	2012	2015	2	0	CTD_human;PSYGENET
34940	166785	MMAA	0.743	0.346	C1855109	MethylmalonicaciduriacblAtype	disease	C16;C18	DiseaseorSyndrome	0.7	1	2002	2017	8	56	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
34944	167465	ZNF366	0.729	0.423	C0006142	Malignantneoplasmofbreast	disease	C04;C17	NeoplasticProcess	0.55	1	2010	2019	1	0	CTD_human
34952	167465	ZNF366	0.729	0.423	C0678222	BreastCarcinoma	disease	C04;C17	NeoplasticProcess	0.55	1	2010	2019	1	0	CTD_human
34955	167465	ZNF366	0.729	0.423	C1458155	MammaryNeoplasms	group	C04;C17	NeoplasticProcess	0.51	1	2010	2015	1	0	CTD_human
34964	167691	LCA5	0.674	0.269	C0339527	LeberCongenitalAmaurosis	disease	C11	DiseaseorSyndrome	0.68	1	2003	2018	2	5	GENOMICS_ENGLAND;ORPHANET
34970	167691	LCA5	0.674	0.269	C1858301	LEBERCONGENITALAMAUROSIS5	disease	C11	DiseaseorSyndrome	0.91	1	2007	2017	4	3	CTD_human;GENOMICS_ENGLAND;UNIPROT
34980	168507	PKD1L1	0.729	0.231	C4310668	HETEROTAXY,VISCERAL,8,AUTOSOMAL	disease		DiseaseorSyndrome	0.7	1	2016	2016	1	2	CTD_human;GENOMICS_ENGLAND;UNIPROT
34986	168667	BMPER	0.641	0.577	C1842691	Diaphanospondylodysostosis	disease	C16;C05	DiseaseorSyndrome	0.73	1	2010	2019	2	4	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
34994	169522	KCNV2	0.736	0.115	C1835897	RetinalConeDystrophy3B	disease	C16;C11	DiseaseorSyndrome	0.74	1	2006	2013	3	11	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
35009	169792	GLIS3	0.59	0.654	C1857775	DiabetesMellitus,Neonatal,withCongenitalHypothyroidism	disease	C16;C18;C05;C19	DiseaseorSyndrome	0.9	1	2003	2009	2	4	CTD_human;GENOMICS_ENGLAND;ORPHANET
35016	170302	ARX	0.516	0.654	C0393706	Earlyinfantileepilepticencephalopathywithsuppressionbursts	disease	C10	DiseaseorSyndrome	0.78	0.944	2007	2018	10	0	CLINGEN;ORPHANET
35017	170302	ARX	0.516	0.654	C0796124	ProudSyndrome	disease	C23;C16;C13;C12;C10;F03;F01	DiseaseorSyndrome	0.7	1	2002	2004	2	1	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
35018	170302	ARX	0.516	0.654	C0796244	MENTALRETARDATION,X-LINKED,WITHORWITHOUTSEIZURES,ARX-RELATED(disorder)	disease	C16;C10	DiseaseorSyndrome	0.7	1	2002	2015	2	7	CTD_human;GENOMICS_ENGLAND;UNIPROT
35019	170302	ARX	0.516	0.654	C0796250	PARTINGTONX-LINKEDMENTALRETARDATIONSYNDROME	disease	C23;C16;C10	DiseaseorSyndrome	0.74	1	1996	2015	2	1	CTD_human;GENOMICS_ENGLAND;ORPHANET
35020	170302	ARX	0.516	0.654	C1846171	Lissencephaly,X-Linked,2	disease	C16;C13;C12;C10	DiseaseorSyndrome	0.74	1	2002	2016	3	25	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
35021	170302	ARX	0.516	0.654	C1846172	HydranencephalyandAbnormalGenitalia	disease	C16;C13;C12;C10	DiseaseorSyndrome	0.6	1	2004	2004	1	2	CTD_human;GENOMICS_ENGLAND
35023	170302	ARX	0.516	0.654	C3463992	EPILEPTICENCEPHALOPATHY,EARLYINFANTILE,1	disease	C10	DiseaseorSyndrome	0.7	1	2002	2018	12	14	CLINGEN;CTD_human;GENOMICS_ENGLAND;UNIPROT
35024	170302	ARX	0.516	0.654	C4552072	X-linkedinfantilespasms	disease	C10	DiseaseorSyndrome	0.7	0.96	2002	2018	9	0	CLINGEN;CTD_human;ORPHANET
35038	170691	ADAMTS17	0.678	0.385	C2750787	Weill-Marchesani-LikeSyndrome	disease	C16;C11;C05;C19	DiseaseorSyndrome	0.75	0.857	2009	2019	2	5	CTD_human;GENOMICS_ENGLAND;ORPHANET
35040	170692	ADAMTS18	0.636	0.654	C3809567	MICROCORNEA,MYOPICCHORIORETINALATROPHY,ANDTELECANTHUS	disease		DiseaseorSyndrome	0.71	1	2013	2013	1	4	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
35052	171023	ASXL1	0.482	0.808	C0349639	JuvenileMyelomonocyticLeukemia	disease	C04;C15	NeoplasticProcess	0.6	1	2010	2018	2	0	CTD_human;GENOMICS_ENGLAND
35053	171023	ASXL1	0.482	0.808	C0796232	Bohringsyndrome	disease	C23;C16;C05;C10;F03;F01	DiseaseorSyndrome	0.8	0.933	2011	2019	3	14	CTD_human;GENOMICS_ENGLAND;ORPHANET
35057	171023	ASXL1	0.482	0.808	C3463824	MYELODYSPLASTICSYNDROME	group	C15	NeoplasticProcess	0.8	0.96	2009	2019	2	0	CGI;CTD_human;GENOMICS_ENGLAND
35095	196527	ANO6	0.736	0.423	C0796149	ScottSyndrome	disease	C15	DiseaseorSyndrome	0.66	0.889	2010	2019	3	0	CTD_human;GENOMICS_ENGLAND;ORPHANET
35099	196528	ARID2	0.543	0.808	C2239176	Livercarcinoma	disease	C06;C04	NeoplasticProcess	0.6	0.923	2011	2018	2	0	CGI;CTD_human
35103	197131	UBR1	0.612	0.731	C0175692	Johanson-Blizzardsyndrome	disease	C23;C16;C06;C17;C10;C19;F03;C09;F01	DiseaseorSyndrome	1	1	2002	2018	7	9	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
35117	197322	ACSF3	0.743	0.308	C3280314	CombinedMalonicandMethylmalonicAciduria	disease	C16;C18	DiseaseorSyndrome	0.73	1	2011	2019	3	10	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
35119	199221	DZIP1L	0.769	0.308	C0085548	AutosomalRecessivePolycysticKidneyDisease	disease	C16;C13;C12	DiseaseorSyndrome	0.81	0	2017	2017	1	0	CTD_human;GENOMICS_ENGLAND;ORPHANET
35120	199221	DZIP1L	0.769	0.308	C4539903	POLYCYSTICKIDNEYDISEASE5	disease		DiseaseorSyndrome	0.6	1	2017	2017	1	4	GENOMICS_ENGLAND;UNIPROT
35123	199713	NLRP7	0.7	0.269	C0678213	Completehydatidiformmole	disease	C04;C13	NeoplasticProcess	0.56	0.875	2009	2014	2	0	CTD_human;ORPHANET
35125	199857	ALG14	0.722	0.308	C0751882	MyasthenicSyndromes,Congenital	disease	C16;C10	DiseaseorSyndrome	0.51	1	2013	2013	1	0	CTD_human;GENOMICS_ENGLAND
35130	199857	ALG14	0.722	0.308	C4015596	MYASTHENICSYNDROME,CONGENITAL,15	disease		DiseaseorSyndrome	0.6	1	2013	2017	3	1	GENOMICS_ENGLAND;UNIPROT
35139	200205	IBA57	0.666	0.423	C3809165	MULTIPLEMITOCHONDRIALDYSFUNCTIONSSYNDROME3	disease		DiseaseorSyndrome	0.71	1	2013	2018	4	12	GENOMICS_ENGLAND;ORPHANET;UNIPROT
35140	200205	IBA57	0.666	0.423	C4225322	SPASTICPARAPLEGIA74,AUTOSOMALRECESSIVE	disease		DiseaseorSyndrome	0.7	1	2015	2018	2	1	CTD_human;GENOMICS_ENGLAND;ORPHANET
35178	200576	PIKFYVE	0.722	0.577	C1562113	Fleckcornealdystrophy	disease	C16;C11	DiseaseorSyndrome	0.75	1	2005	2015	4	5	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
35185	200879	LIPH	0.691	0.346	C1836672	TotalHypotrichosis,Maritype	disease	C23;C17	DiseaseorSyndrome	0.7	1	2006	2016	3	3	GENOMICS_ENGLAND;UNIPROT
35189	200894	ARL13B	0.631	0.538	C2676771	JOUBERTSYNDROME8(disorder)	disease	C16;C11;C10	DiseaseorSyndrome	0.7	1	2006	2017	4	7	CTD_human;GENOMICS_ENGLAND;UNIPROT
35209	201163	FLCN	0.537	0.885	C0007134	RenalCellCarcinoma	disease	C04;C13;C12	NeoplasticProcess	0.9	0.92	2002	2020	2	0	CTD_human;GENOMICS_ENGLAND
35220	201163	FLCN	0.537	0.885	C0149781	Spontaneouspneumothorax	disease	C08	DiseaseorSyndrome	0.7	0.882	2002	2019	2	0	CTD_human;GENOMICS_ENGLAND
35223	201163	FLCN	0.537	0.885	C0279702	Conventional(ClearCell)RenalCellCarcinoma	disease	C04;C13;C12	NeoplasticProcess	0.9	0.938	2002	2020	2	2	CTD_human;UNIPROT
35225	201163	FLCN	0.537	0.885	C0346010	Multiplefibrofolliculomas	disease	C16;C04	DiseaseorSyndrome	1	0.968	2002	2020	11	53	CLINGEN;CTD_human;GENOMICS_ENGLAND;UNIPROT
35226	201163	FLCN	0.537	0.885	C0346255	Oncocytoma,renal	disease	C04;C13;C12	NeoplasticProcess	0.51	1	2002	2004	1	0	CTD_human;GENOMICS_ENGLAND
35227	201163	FLCN	0.537	0.885	C0740457	Malignantneoplasmofkidney	disease	C04;C13;C12	NeoplasticProcess	0.6	1	2002	2018	0	0	CGI;GENOMICS_ENGLAND
35234	201163	FLCN	0.537	0.885	C1378703	Renalcarcinoma	disease	C04;C13;C12	NeoplasticProcess	0.6	1	2002	2018	1	0	CGI;GENOMICS_ENGLAND
35235	201163	FLCN	0.537	0.885	C1868193	PNEUMOTHORAX,PRIMARYSPONTANEOUS	disease		DiseaseorSyndrome	0.8	0.895	2002	2019	6	6	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
35245	201294	UNC13D	0.659	0.5	C1837174	HEMOPHAGOCYTICLYMPHOHISTIOCYTOSIS,FAMILIAL,3	disease	C15	DiseaseorSyndrome	0.86	1	2003	2019	1	20	CTD_human;GENOMICS_ENGLAND
35251	201595	STT3B	0.76	0.385	C2931007	Congenitaldisorderofglycosylationtype1X	disease	C16;C18;C15	DiseaseorSyndrome	0.7	1	2013	2013	1	1	CTD_human;GENOMICS_ENGLAND;ORPHANET
35255	201973	PRIMPOL	0.839	0.269	C3809464	MYOPIA22,AUTOSOMALDOMINANT	disease		DiseaseorSyndrome	0.6	1	2013	2014	2	1	CTD_human;UNIPROT
35257	202018	TAPT1	0.674	0.538	C4225162	OSTEOCHONDRODYSPLASIA,COMPLEXLETHAL,SYMOENS-BARNES-GISTELINCKTYPE	disease		DiseaseorSyndrome	0.7	1	2015	2015	1	2	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
35265	203068	TUBB	0.603	0.692	C4014283	CORTICALDYSPLASIA,COMPLEX,WITHOTHERBRAINMALFORMATIONS6	disease		DiseaseorSyndrome	0.7	1	2012	2018	3	4	CTD_human;GENOMICS_ENGLAND;UNIPROT
35266	203068	TUBB	0.603	0.692	C4551592	SKINCREASES,CONGENITALSYMMETRICCIRCUMFERENTIAL,1	disease	C16;C04;C17	DiseaseorSyndrome	0.6	1	2015	2015	1	2	GENOMICS_ENGLAND;UNIPROT
35267	203228	C9orf72	0.496	0.769	C0002736	AmyotrophicLateralSclerosis	disease	C18;C10	DiseaseorSyndrome	0.8	0.985	2009	2020	4	14	CTD_human;GENOMICS_ENGLAND;ORPHANET
35281	203228	C9orf72	0.496	0.769	C3888102	FrontotemporalDementiaWithMotorNeuronDisease	disease	C18;C10;F03	DiseaseorSyndrome	0.8	1	2012	2020	4	1	CTD_human;GENOMICS_ENGLAND;ORPHANET
35297	203286	ANKS6	0.682	0.346	C3809320	NEPHRONOPHTHISIS16	disease		DiseaseorSyndrome	0.7	1	1990	2013	2	7	CTD_human;GENOMICS_ENGLAND;UNIPROT
35357	653361	NCF1	0.521	0.808	C1856251	GranulomatousDisease,Chronic,AutosomalRecessive,CytochromeB-Positive,TypeI	disease	C16;C20;C15	DiseaseorSyndrome	0.7	1	2000	2013	3	8	CTD_human;GENOMICS_ENGLAND;UNIPROT
35359	653509	SFTPA1	0.546	0.808	C1800706	IdiopathicPulmonaryFibrosis	disease	C08	DiseaseorSyndrome	0.57	1	2003	2019	2	0	GENOMICS_ENGLAND;ORPHANET
35529	724066	ATXN8	0.743	0.269	C1837454	SPINOCEREBELLARATAXIA8	disease	C16;C10	DiseaseorSyndrome	0.67	1	1999	2019	1	0	CTD_human;GENOMICS_ENGLAND;ORPHANET
35532	727676	SNORD118	0.686	0.462	C3281200	LEUKOENCEPHALOPATHY,BRAINCALCIFICATIONS,ANDCYSTS	disease	C16;C04;C18;C10	DiseaseorSyndrome	0.71	1	2016	2019	2	0	CTD_human;GENOMICS_ENGLAND;ORPHANET
35534	727857	BHLHA9	0.644	0.269	C1836206	Syndactyly,MesoaxialSynostotic,withPhalangealReduction	disease	C16;C05	DiseaseorSyndrome	0.71	1	2012	2014	2	3	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
35535	727857	BHLHA9	0.644	0.269	C1843758	Camptosynpolydactyly,Complex	disease	C16;C05	DiseaseorSyndrome	0.6	1	2016	2016	1	1	CTD_human;UNIPROT
35541	727897	MUC5B	0.532	0.808	C1800706	IdiopathicPulmonaryFibrosis	disease	C08	DiseaseorSyndrome	0.7	0.952	2011	2019	3	0	CTD_human;GENOMICS_ENGLAND;ORPHANET
35556	728294	D2HGDH	0.691	0.5	C2746066	CombinedD-2-andL-2-hydroxyglutaricaciduria	disease	C16;C18;C10	DiseaseorSyndrome	0.66	1	2005	2019	1	0	CTD_human;GENOMICS_ENGLAND
35557	728294	D2HGDH	0.691	0.5	C3152055	D-2-HYDROXYGLUTARICACIDURIA1	disease		DiseaseorSyndrome	0.74	1	2005	2019	5	10	GENOMICS_ENGLAND;ORPHANET;UNIPROT
35592	729238	SFTPA2	0.563	0.731	C1800706	IdiopathicPulmonaryFibrosis	disease	C08	DiseaseorSyndrome	0.74	1	2009	2017	2	2	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
35606	729920	CRPPA	0.566	0.654	C0265221	Walker-Warburgcongenitalmusculardystrophy	disease	C16;C11;C10	DiseaseorSyndrome	0.65	1	2012	2019	3	0	CTD_human;GENOMICS_ENGLAND;ORPHANET
35619	729920	CRPPA	0.566	0.654	C3553330	MUSCULARDYSTROPHY-DYSTROGLYCANOPATHY(CONGENITALWITHBRAINANDEYEANOMALIES),TYPEA,7	disease		DiseaseorSyndrome	0.6	1	1989	2015	7	19	GENOMICS_ENGLAND;UNIPROT
35620	729920	CRPPA	0.566	0.654	C4015095	MUSCULARDYSTROPHY-DYSTROGLYCANOPATHY(LIMB-GIRDLE),TYPEC,7	disease		DiseaseorSyndrome	0.7	1	1989	2017	5	8	CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT
35626	768206	PRCD	0.7	0.269	C1864621	RETINITISPIGMENTOSA36	disease	C16;C11	DiseaseorSyndrome	0.7	1	2006	2016	3	0	CTD_human;GENOMICS_ENGLAND;UNIPROT
35657	790955	UQCC3	0.839	0.038	C4015253	MITOCHONDRIALCOMPLEXIIIDEFICIENCY,NUCLEARTYPE9	disease		DiseaseorSyndrome	0.6	1	2014	2017	2	0	GENOMICS_ENGLAND;UNIPROT
35781	100128927	ZBTB42	0.931	0.115	C4015686	LETHALCONGENITALCONTRACTURESYNDROME6	disease		DiseaseorSyndrome	0.61	1	2014	2014	1	1	CTD_human;UNIPROT
35784	100131801	PET100	0.65	0.577	C0023264	LeighDisease	disease	C16;C18;C10	DiseaseorSyndrome	0.52	1	1996	2015	4	0	CLINGEN;GENOMICS_ENGLAND
35786	100131801	PET100	0.65	0.577	C0268237	Cytochrome-cOxidaseDeficiency	disease	C16;C18	DiseaseorSyndrome;CongenitalAbnormality	0.62	1	2013	2015	3	2	CTD_human;GENOMICS_ENGLAND
35799	100134444	KCNJ18	0.722	0.346	C2750473	THYROTOXICPERIODICPARALYSIS,SUSCEPTIBILITYTO,2	disease		Finding	0.7	1	2010	2016	4	6	CTD_human;GENOMICS_ENGLAND;UNIPROT
35807	100151683	RNU4ATAC	0.556	0.808	C1846059	Roifmansyndrome	disease	C16;C11;C05;C20;C10;C14	DiseaseorSyndrome	0.74	1	2015	2018	1	0	CTD_human;GENOMICS_ENGLAND;ORPHANET
35808	100151683	RNU4ATAC	0.556	0.808	C1859452	MICROCEPHALICOSTEODYSPLASTICPRIMORDIALDWARFISM,TYPEI	disease	C23;C16;C13;C05;C10;C19	CongenitalAbnormality	0.7	1	2011	2019	3	0	CTD_human;GENOMICS_ENGLAND
35817	100288687	DUX4	0.604	0.5	C0238288	MuscularDystrophy,Facioscapulohumeral	disease	C16;C05;C10	DiseaseorSyndrome	0.6	0.989	2006	2019	1	0	CTD_human;ORPHANET
36015	100506658	OCLN	0.507	0.846	C3489725	Pseudo-TORCHsyndrome	disease	C16;C20;C10	DiseaseorSyndrome	0.62	1	2010	2016	2	3	GENOMICS_ENGLAND;ORPHANET
36016	100506658	OCLN	0.507	0.846	C4552078	PSEUDO-TORCHSYNDROME1	disease	C16;C20;C10	DiseaseorSyndrome	0.7	1	2010	2013	2	5	CTD_human;GENOMICS_ENGLAND;UNIPROT
36130	100996717	NOTCH2NLC	0.78	0.192	C1863843	Neuronalintranuclearinclusiondisease	disease	C10	DiseaseorSyndrome	0.53	1	2019	2019	3	0	CTD_human;ORPHANET
NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
